PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Black, RE; Alderman, H; Bhutta, ZA; Gillespie, S; Haddad, L; Horton, S; Lartey, A; Mannar, V; Ruel, M; Victora, CG; Walker, SP; Webb, P				Black, Robert E.; Alderman, Harold; Bhutta, Zulfiqar A.; Gillespie, Stuart; Haddad, Lawrence; Horton, Susan; Lartey, Anna; Mannar, Venkatesh; Ruel, Marie; Victora, Cesar G.; Walker, Susan P.; Webb, Patrick		Maternal Child Nutr Study Grp	Maternal and child nutrition: building momentum for impact	LANCET			English	Editorial Material							UNDERNUTRITION; HEALTH		[Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Bhutta, Zulfiqar A.] Aga Khan Univ, Karachi, Pakistan; [Horton, Susan] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Lartey, Anna] Univ Ghana, Legon, Ghana; [Victora, Cesar G.] Univ Fed Pelotas, Pelotas, RS, Brazil; [Walker, Susan P.] Univ W Indies, Mona, Jamaica; [Webb, Patrick] Tufts Univ, Medford, MA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Aga Khan University; University of Waterloo; University of Ghana; Universidade Federal de Pelotas; University West Indies Mona Jamaica; Tufts University	Black, RE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.	rblack@jhsph.edu	Webb, Patrick/P-3420-2017; Victora, Cesar G/D-4476-2013; Victora, Cesar Gomes/Y-2455-2019	Webb, Patrick/0000-0002-9857-3354; Victora, Cesar G/0000-0002-2465-2180; Victora, Cesar Gomes/0000-0002-2465-2180; Horton, Susan/0000-0002-9243-4767; Black, Robert/0000-0001-9926-7984; Ruel, Marie/0000-0002-9506-348X				[Anonymous], 2010, FOOD NUTR BULL, V31, P178; [Anonymous], 2010, SCALING NUTR FRAMEWO; Bhutta ZA, 2013, LANCET; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black R., 2013, LANCET; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Dube L, 2012, P NATL ACAD SCI USA, V109, P12294, DOI 10.1073/pnas.0912951109; Gillespie S, 2013, LANCET; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Horton S, 2013, MUCH HAVE G IN PRESS; Morris SS, 2008, LANCET, V371, P608, DOI 10.1016/S0140-6736(07)61695-X; Ruel M, 2013, LANCET; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO, 2012, PROP GLOB TARG MAT I	15	113	114	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2013	382	9890					372	375		10.1016/S0140-6736(13)60988-5	http://dx.doi.org/10.1016/S0140-6736(13)60988-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194MX	23746778				2022-12-01	WOS:000322638500007
J	Wong, SD; Srnec, M; Matthews, ML; Liu, LV; Kwak, Y; Park, K; Bell, CB; Alp, EE; Zhao, JY; Yoda, Y; Kitao, S; Seto, M; Krebs, C; Bollinger, JM; Solomon, EI				Wong, Shaun D.; Srnec, Martin; Matthews, Megan L.; Liu, Lei V.; Kwak, Yeonju; Park, Kiyoung; Bell, Caleb B., III; Alp, E. Ercan; Zhao, Jiyong; Yoda, Yoshitaka; Kitao, Shinji; Seto, Makoto; Krebs, Carsten; Bollinger, J. Martin, Jr.; Solomon, Edward I.			Elucidation of the Fe(IV)=O intermediate in the catalytic cycle of the halogenase SyrB2	NATURE			English	Article							RESONANCE VIBRATIONAL SPECTROSCOPY; AUXILIARY BASIS-SETS; GAUSSIAN-BASIS SETS; CORRELATION-ENERGY; MOLECULAR CALCULATIONS; ALIPHATIC HALOGENASE; ELECTRONIC-STRUCTURE; SCATTERING BEAMLINE; ROW ATOMS; IRON	Mononuclear non-haem iron (NHFe) enzymes catalyse a broad range of oxidative reactions, including halogenation, hydroxylation, ring closure, desaturation and aromatic ring cleavage reactions. They are involved in a number of biological processes, including phenylalanine metabolism, the production of neuro-transmitters, the hypoxic response and the biosynthesis of secondary metabolites(1-3). The reactive intermediate in the catalytic cycles of these enzymes is a high-spin S = 2 Fe(IV)=O species, which has been trapped for a number of NHFe enzymes(4-8), including the halogenase SyrB2 (syringomycin biosynthesis enzyme 2). Computational studies aimed at understanding the reactivity of this Fe(IV)=O intermediate(9-13) are limited in applicability owing to the paucity of experimental knowledge about its geometric and electronic structure. Synchrotron-based nuclear resonance vibrational spectroscopy (NRVS) is a sensitive and effective method that defines the dependence of the vibrational modes involving Fe on the nature of the Fe(IV)=O active site(14-16). Here we present NRVS structural characterization of the reactive Fe(IV)=O intermediate of a NHFe enzyme, namely the halogenase SyrB2 from the bacterium Pseudomonas syringae pv. syringae. This intermediate reacts via an initial hydrogen-atom abstraction step, performing subsequent halogenation of the native substrate or hydroxylation of non-native substrates(17). Acorrelation of the experimental NRVS data to electronic structure calculations indicates that the substrate directs the orientation of the Fe(IV)=O intermediate, presenting specific frontier molecular orbitals that can activate either selective halogenation or hydroxylation.	[Wong, Shaun D.; Srnec, Martin; Liu, Lei V.; Kwak, Yeonju; Park, Kiyoung; Bell, Caleb B., III; Solomon, Edward I.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Matthews, Megan L.; Krebs, Carsten; Bollinger, J. Martin, Jr.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Alp, E. Ercan; Zhao, Jiyong] Argonne Natl Lab, APS XFD, Argonne, IL 60439 USA; [Yoda, Yoshitaka] JASRI, SPring 8, Hyogo 6795198, Japan; [Kitao, Shinji; Seto, Makoto] Kyoto Univ, Inst Res Reactor, Osaka 5900494, Japan; [Krebs, Carsten; Bollinger, J. Martin, Jr.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Solomon, Edward I.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA	Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Energy (DOE); Argonne National Laboratory; Kyoto University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Krebs, C (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	ckrebs@psu.edu; jmb21@psu.edu; edward.solomon@stanford.edu	Bollinger, Joseph/C-1425-2016; Park, Kiyoung/J-3204-2014; Srnec, Martin/F-5625-2014; Matthews, Megan/W-2217-2017; Krebs, Carsten/D-4773-2009	Matthews, Megan/0000-0003-1178-4616; Krebs, Carsten/0000-0002-3302-7053; Solomon, Edward/0000-0003-0291-3199; Yoda, Yoshitaka/0000-0003-3062-8651	National Institutes of Health [GM-40392, GM-69657]; National Science Foundation [MCB-0919027, MCB-642058, CHE-724084]; Department of Energy, Office of Science [DE-AC-02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069657, R01GM040392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Energy, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided by the National Institutes of Health (GM-40392 to E. I. S. and GM-69657 to J.M.B. and C. K.) and the National Science Foundation (MCB-0919027 to E. I. S., and MCB-642058 and CHE-724084 to J.M.B. and C. K.). Work at the Advanced Photon Source was supported by the Department of Energy, Office of Science, under contract DE-AC-02-06CH11357. Synchrotron experiments at SPring-8 were performed with the approval of the Japan Synchrotron Radiation Research Institute (JASRI; proposal no. 2010B1569). M. S. thanks the Rulisek group at the IOCB, Prague, for use of their computational resources.	AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; ALP EE, 1994, HYPERFINE INTERACT, V90, P323, DOI 10.1007/BF02069136; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bell CB, 2008, ANGEW CHEM INT EDIT, V47, P9071, DOI 10.1002/anie.200803740; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Borowski T, 2010, J AM CHEM SOC, V132, P12887, DOI 10.1021/ja101877a; Cammi R, 1999, J PHYS CHEM A, V103, P9100, DOI 10.1021/jp991564w; Cammi R, 2000, J PHYS CHEM A, V104, P5631, DOI 10.1021/jp000156l; Chumakov AI, 1999, HYPERFINE INTERACT, V123, P781, DOI 10.1023/A:1017052730094; Comba P, 2010, CHEM-EUR J, V16, P7293, DOI 10.1002/chem.201000092; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; de Visser SP, 2009, J PHYS CHEM B, V113, P12, DOI 10.1021/jp8097632; Diebold AR, 2011, J AM CHEM SOC, V133, P18148, DOI 10.1021/ja202549q; Eichkorn K, 1997, THEOR CHEM ACC, V97, P119, DOI 10.1007/s002140050244; EICHKORN K, 1995, CHEM PHYS LETT, V240, P283, DOI 10.1016/0009-2614(95)00621-A; Eser BE, 2007, J AM CHEM SOC, V129, P11334, DOI 10.1021/ja074446s; Frisch M. J., 2010, GAUSSIAN 09 REVISION; Fujimori DG, 2007, J AM CHEM SOC, V129, P13408, DOI 10.1021/ja076454e; Grimme S, 2004, J COMPUT CHEM, V25, P1463, DOI 10.1002/jcc.20078; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; HAY PJ, 1977, J CHEM PHYS, V66, P4377, DOI 10.1063/1.433731; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Krebs C, 2007, ACCOUNTS CHEM RES, V40, P484, DOI 10.1021/ar700066p; Krebs C, 2013, COORDIN CHEM REV, V257, P234, DOI 10.1016/j.ccr.2012.06.020; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; Kulik HJ, 2009, J AM CHEM SOC, V131, P14426, DOI 10.1021/ja905206k; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Leu BM, 2004, J AM CHEM SOC, V126, P4211, DOI 10.1021/ja038526h; Matthews ML, 2009, P NATL ACAD SCI USA, V106, P17723, DOI 10.1073/pnas.0909649106; Matthews ML, 2009, BIOCHEMISTRY-US, V48, P4331, DOI 10.1021/bi900109z; MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980; Mennucci B, 1997, J PHYS CHEM B, V101, P10506, DOI 10.1021/jp971959k; Mennucci B, 1997, J CHEM PHYS, V106, P5151, DOI 10.1063/1.473558; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Neidig ML, 2006, P NATL ACAD SCI USA, V103, P12966, DOI 10.1073/pnas.0605067103; Panay AJ, 2011, BIOCHEMISTRY-US, V50, P1928, DOI 10.1021/bi1019868; Pandian S, 2009, DALTON T, P6201, DOI 10.1039/b906866j; Park K, 2013, P NATL ACAD SCI USA, V110, P6275, DOI 10.1073/pnas.1304238110; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Sage JT, 2001, J PHYS-CONDENS MAT, V13, P7707, DOI 10.1088/0953-8984/13/34/315; Schafer A, 2000, PHYS CHEM CHEM PHYS, V2, P2187, DOI 10.1039/b000184h; SETO M, 1995, PHYS REV LETT, V74, P3828, DOI 10.1103/PhysRevLett.74.3828; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Srnec M, 2012, P NATL ACAD SCI USA, V109, P14326, DOI 10.1073/pnas.1212693109; Srnec M, 2012, INORG CHEM, V51, P2806, DOI 10.1021/ic2018067; Tenderholt A., 2009, GENNRVS; Usharani D, 2011, J AM CHEM SOC, V133, P176, DOI 10.1021/ja107339h; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; WACHTERS AJ, 1970, J CHEM PHYS, V52, P1033, DOI 10.1063/1.1673095; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Wong SD, 2011, ANGEW CHEM INT EDIT, V50, P3215, DOI 10.1002/anie.201007692; Yoda Y, 2001, NUCL INSTRUM METH A, V467, P715, DOI 10.1016/S0168-9002(01)00474-0	55	144	146	7	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2013	499	7458					320	+		10.1038/nature12304	http://dx.doi.org/10.1038/nature12304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23868262	Green Accepted			2022-12-01	WOS:000321910700032
J	Vikse, BE				Vikse, Bjorn Egil			Pre-eclampsia and the risk of kidney disease	LANCET			English	Editorial Material							HYPERTENSIVE DISORDERS; PREGNANCY; BIOPSY		[Vikse, Bjorn Egil] Univ Bergen, Dept Clin Med, Bergen, Norway; [Vikse, Bjorn Egil] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Vikse, Bjorn Egil] Haugesund Hosp, Dept Med, N-5504 Haugesund, Norway	University of Bergen; University of Bergen; Haukeland University Hospital	Vikse, BE (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	bjorn.vikse@med.uib.no						Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; FISHER KA, 1981, MEDICINE, V60, P267, DOI 10.1097/00005792-198107000-00002; Garovic VD, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.02.007; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; McDonald SD, 2010, AM J KIDNEY DIS, V55, P1026, DOI 10.1053/j.ajkd.2009.12.036; Nanjundan P, 2011, J OBSTET GYNAECOL, V31, P384, DOI 10.3109/01443615.2011.566389; Prakash J, 2010, RENAL FAILURE, V32, P309, DOI 10.3109/08860221003606265; Rasmussen S, 2007, HYPERTENSION, V49, P806, DOI 10.1161/01.HYP.0000259924.74947.aa; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P777, DOI 10.1016/0002-9378(90)91009-2; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Vikse BE, 2008, NEW ENGL J MED, V359, P800, DOI 10.1056/NEJMoa0706790; Vikse BE, 2006, J AM SOC NEPHROL, V17, P837, DOI 10.1681/ASN.2005050492; Vikse BE, 2010, NEPHROL DIAL TRANSPL, V25, P3289, DOI 10.1093/ndt/gfq169; Wang IK, 2013, CAN MED ASSOC J, V185, P207, DOI 10.1503/cmaj.120230	15	35	37	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 13	2013	382	9887					104	106		10.1016/S0140-6736(13)60741-2	http://dx.doi.org/10.1016/S0140-6736(13)60741-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187JY	23727168				2022-12-01	WOS:000322115300005
J	Mehine, M; Kaasinen, E; Makinen, N; Katainen, R; Kampjarvi, K; Pitkanen, E; Heinonen, HR; Butzow, R; Kilpivaara, O; Kuosmanen, A; Ristolainen, H; Gentile, M; Sjoberg, J; Vahteristo, P; Aaltonen, LA				Mehine, Miika; Kaasinen, Eevi; Makinen, Netta; Katainen, Riku; Kampjarvi, Kati; Pitkanen, Esa; Heinonen, Hanna-Riikka; Butzow, Ralf; Kilpivaara, Outi; Kuosmanen, Anna; Ristolainen, Heikki; Gentile, Massimiliano; Sjoberg, Jari; Vahteristo, Pia; Aaltonen, Lauri A.			Characterization of Uterine Leiomyomas by Whole-Genome Sequencing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE; CANCER; REARRANGEMENTS; EXPRESSION; CHROMOTHRIPSIS; T(12/14); COMPLEX; TUMORS; CUX1; PATHOGENESIS	BACKGROUND Uterine leiomyomas are benign but affect the health of millions of women. A better understanding of the molecular mechanisms involved may provide clues to the prevention and treatment of these lesions. METHODS We performed whole-genome sequencing and gene-expression profiling of 38 uterine leiomyomas and the corresponding myometrium from 30 women. RESULTS Identical variants observed in some separate tumor nodules suggested that these nodules have a common origin. Complex chromosomal rearrangements resembling chromothripsis were a common feature of leiomyomas. These rearrangements are best explained by a single event of multiple chromosomal breaks and random reassembly. The rearrangements created tissue-specific changes consistent with a role in the initiation of leiomyoma, such as translocations of the HMGA2 and RAD51B loci and aberrations at the COL4A5-COL4A6 locus, and occurred in the presence of normal TP53 alleles. In some cases, separate events had occurred more than once in single tumor-cell lineages. CONCLUSIONS Chromosome shattering and reassembly resembling chromothripsis (a single genomic event that results in focal losses and rearrangements in multiple genomic regions) is a major cause of chromosomal abnormalities in uterine leiomyomas; we propose that tumorigenesis occurs when tissue-specific tumor-promoting changes are formed through these events. Chromothripsis has previously been associated with aggressive cancer; its common occurrence in leiomyomas suggests that it also has a role in the genesis and progression of benign tumors. We observed that multiple separate tumors could be seeded from a single lineage of uterine leiomyoma cells.	[Mehine, Miika; Kaasinen, Eevi; Makinen, Netta; Katainen, Riku; Kampjarvi, Kati; Pitkanen, Esa; Heinonen, Hanna-Riikka; Kilpivaara, Outi; Kuosmanen, Anna; Ristolainen, Heikki; Vahteristo, Pia; Aaltonen, Lauri A.] Univ Helsinki, Dept Med Genet, Genome Scale Biol Res Program, Helsinki 00014, Finland; [Butzow, Ralf] Univ Helsinki, Dept Pathol, Haartman Inst, Helsinki 00014, Finland; [Butzow, Ralf] Univ Helsinki, HUSLAB, FIN-00014 Helsinki, Finland; [Sjoberg, Jari] Univ Helsinki, Dept Obstet & Gynecol, Helsinki 00014, Finland; Univ Helsinki, Cent Hosp, Helsinki 00014, Finland; [Gentile, Massimiliano] CSC IT Ctr Sci, Espoo, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Aaltonen, LA (corresponding author), Univ Helsinki, Dept Med Genet, Biomedicum Helsinki, POB 63,Haartmaninkatu 3, Helsinki 00014, Finland.	lauri.aaltonen@helsinki.fi	Heinonen, Hanna-Riikka/C-6059-2015; Aaltonen, Lauri/A-5375-2010; Gentile, Massimo/R-3270-2016; Katainen, Riku/GYR-0921-2022; Pitkanen, Esa/H-2435-2018	Heinonen, Hanna-Riikka/0000-0002-4069-2334; Aaltonen, Lauri/0000-0001-6839-4286; Gentile, Massimo/0000-0002-5256-0726; Makinen, Netta/0000-0003-0104-7794; Katainen, Riku/0000-0003-4575-4239; Pitkanen, Esa/0000-0002-9818-6370; Kuosmanen, Anna/0000-0002-7002-0803; Kaasinen, Eevi/0000-0002-1333-8049	Academy of Finland Center of Excellence program; Academy of Finland [250345, 260370, 137680]; Sigrid Juselius Foundation; Cancer Society of Finland; Jane and Aatos Erkko Foundation	Academy of Finland Center of Excellence program(Academy of Finland); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Jane and Aatos Erkko Foundation	Funded by the Academy of Finland Center of Excellence program and others.; Supported by grants from the Academy of Finland (250345, 260370, and 137680), the Sigrid Juselius Foundation, the Cancer Society of Finland, and the Jane and Aatos Erkko Foundation.	Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; CRAMER SF, 1990, AM J CLIN PATHOL, V94, P435, DOI 10.1093/ajcp/94.4.435; Cuevas EP, 2007, J HEPATOL, V46, P1089, DOI 10.1016/j.jhep.2007.01.031; Flake GP, 2003, ENVIRON HEALTH PERSP, V111, P1037, DOI 10.1289/ehp.5787; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Garcia-Torres R, 2000, NEPHROLOGIE, V21, P9; Hodge JC, 2012, HUM MOL GENET, V21, P2312, DOI 10.1093/hmg/dds051; Ingraham SE, 1999, CANCER GENET CYTOGEN, V115, P56, DOI 10.1016/S0165-4608(99)00070-9; Jacoby VL, 2009, OBSTET GYNECOL, V114, P1041, DOI 10.1097/AOG.0b013e3181b9d222; Jerez A, 2012, BLOOD, V119, P6109, DOI 10.1182/blood-2011-12-397620; Kazmierczak B, 1998, GENE CHROMOSOME CANC, V23, P279, DOI 10.1002/(SICI)1098-2264(199812)23:4<279::AID-GCC1>3.0.CO;2-1; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Lehtonen HJ, 2011, FAM CANCER, V10, P397, DOI 10.1007/s10689-011-9428-z; Lehtonen R, 2004, AM J PATHOL, V164, P17, DOI 10.1016/S0002-9440(10)63091-X; LEIBSOHN S, 1990, AM J OBSTET GYNECOL, V162, P968, DOI 10.1016/0002-9378(90)91298-Q; Ligon AH, 2002, CANCER GENET CYTOGEN, V137, P133, DOI 10.1016/S0165-4608(02)00547-2; Ligon AH, 2000, GENE CHROMOSOME CANC, V28, P235, DOI 10.1002/1098-2264(200007)28:3<235::AID-GCC1>3.3.CO;2-Z; Litovkin K. V., 2008, Experimental Oncology, V30, P106; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; McNerney ME, 2013, BLOOD, V121, P975, DOI 10.1182/blood-2012-04-426965; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Nibert M, 1990, GENE CHROMOSOME CANC, V2, P3; NILBERT M, 1990, HUM GENET, V85, P605; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; PANDIS N, 1991, INT J GYNECOL CANCER, V1, P163, DOI 10.1046/j.1525-1438.1991.01040163.x; Quintana DG, 1998, J BIOL CHEM, V273, P27137, DOI 10.1074/jbc.273.42.27137; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Sandberg AA, 2005, CANCER GENET CYTOGEN, V158, P1, DOI 10.1016/j.cancergencyto.2004.08.025; Schoenmakers EFPM, 1999, CANCER RES, V59, P19; Schoenmakers EFPM, 2013, GENE CHROMOSOME CANC, V52, P11, DOI 10.1002/gcc.22001; Sornberger KS, 1999, CANCER GENET CYTOGEN, V114, P9, DOI 10.1016/S0165-4608(99)00054-0; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Vadnais C, 2012, NUCLEIC ACIDS RES, V40, P4483, DOI 10.1093/nar/gks041; Vanharanta S, 2006, HUM MOL GENET, V15, P97, DOI 10.1093/hmg/ddi431; Wu CX, 2012, GENE CHROMOSOME CANC, V51, P1144, DOI 10.1002/gcc.21999; Yang ZM, 2009, BIOCHEM BIOPH RES CO, V386, P146, DOI 10.1016/j.bbrc.2009.05.139; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324	43	208	216	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2013	369	1					43	53		10.1056/NEJMoa1302736	http://dx.doi.org/10.1056/NEJMoa1302736			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175WE	23738515				2022-12-01	WOS:000321263500009
J	McShane, R				McShane, Rupert			Should patients with dementia who wander be electronically tagged? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRACKING; PEOPLE; FEASIBILITY; CAREGIVERS; GPS		Oxford Hlth NHS Fdn Trust, Oxford, England		McShane, R (corresponding author), Oxford Hlth NHS Fdn Trust, Oxford, England.	Rupert.McShane@oxfordhealth.nhs.uk						Ginns D, NEIGHBOURHOOD RETURN; Koester RJ, 1998, RESP 98 NASAR P; Landau R, 2009, BRIT J SOC WORK, V39, P670, DOI 10.1093/bjsw/bcp037; Landau R, 2012, INT PSYCHOGERIATR, V24, P358, DOI 10.1017/S1041610211001888; McShane R, 1998, INT J GERIATR PSYCH, V13, P556, DOI 10.1002/(SICI)1099-1166(199808)13:8<556::AID-GPS834>3.0.CO;2-6; McShane R, 1998, Int Psychogeriatr, V10, P253, DOI 10.1017/S1041610298005365; Pot AM, 2012, AGING MENT HEALTH, V16, P127, DOI 10.1080/13607863.2011.596810; Robinson L, 2007, HEALTH RISK SOC, V9, P389, DOI 10.1080/13698570701612774; Rowe MA, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-28; Scarmeas N, 2007, ARCH NEUROL-CHICAGO, V64, P1755, DOI 10.1001/archneur.64.12.1755; White EB, 2010, BRIT J OCCUP THER, V73, P152, DOI 10.4276/030802210X12706313443901	11	8	8	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 20	2013	346								f3603	10.1136/bmj.f3603	http://dx.doi.org/10.1136/bmj.f3603			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171QP	23788491				2022-12-01	WOS:000320944400002
J	Tharakaraman, K; Jayaraman, A; Raman, R; Viswanathan, K; Stebbins, NW; Johnson, D; Shriver, Z; Sasisekharan, V; Sasisekharan, R				Tharakaraman, Kannan; Jayaraman, Akila; Raman, Rahul; Viswanathan, Karthik; Stebbins, Nathan W.; Johnson, David; Shriver, Zachary; Sasisekharan, V.; Sasisekharan, Ram			Glycan Receptor Binding of the Influenza A Virus H7N9 Hemagglutinin	CELL			English	Article							RESPIRATORY-TRACT; TRANSMISSION; HA; PATHOGENESIS; ADAPTATION; SITES	The advent of H7N9 in early 2013 is of concern for a number of reasons, including its capability to infect humans, the lack of clarity in the etiology of infection, and because the human population does not have pre-existing immunity to the H7 subtype. Earlier sequence analyses of H7N9 hemagglutinin (HA) point to amino acid changes that predicted human receptor binding and impinge on the antigenic characteristics of the HA. Here, we report that the H7N9 HA shows limited binding to human receptors; however, should a single amino acid mutation occur, this would result in structural changes within the receptor binding site that allow for extensive binding to human receptors present in the upper respiratory tract. Furthermore, a subset of the H7N9 HA sequences demarcating coevolving amino acids appears to be in the antigenic regions of H7, which, in turn, could impact effectiveness of the current WHO-recommended prepandemic H7 vaccines.	[Tharakaraman, Kannan; Jayaraman, Akila; Raman, Rahul; Viswanathan, Karthik; Stebbins, Nathan W.; Johnson, David; Shriver, Zachary; Sasisekharan, V.; Sasisekharan, Ram] MIT, Singapore MIT Alliance Res & Technol, Dept Biol Engn,Koch Inst Integrat Canc Res, Infect Dis Interdisciplinary Res Grp, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART)	Sasisekharan, R (corresponding author), MIT, Singapore MIT Alliance Res & Technol, Dept Biol Engn,Koch Inst Integrat Canc Res, Infect Dis Interdisciplinary Res Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@mit.edu			National Institutes of Health [R37 GM057073-13]; National-Research-Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073, R01GM057073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National-Research-Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by National Institutes of Health (R37 GM057073-13) and the National-Research-Foundation-supported interdisciplinary research group in Infectious Diseases of SMART (Singapore-MIT Alliance for Research and Technology).	Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jayaraman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027517; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Kwon TY, 2011, VET MICROBIOL, V153, P393, DOI 10.1016/j.vetmic.2011.06.011; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Li WF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-183; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Liu D., 2013, LANCET; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mansfield KG, 2007, AM J PATHOL, V171, P1089, DOI 10.2353/ajpath.2007.070695; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Soundararajan V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00200; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Srinivasan K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0049597, 10.1371/journal.pone.0059550]; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Tharakaraman K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01822; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Viswanathan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013768	28	119	126	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1486	1493		10.1016/j.cell.2013.05.034	http://dx.doi.org/10.1016/j.cell.2013.05.034			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23746830	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000320722000017
J	Brandt, AM				Brandt, Allan M.			How AIDS Invented Global Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brandt, Allan M.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA; [Brandt, Allan M.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA	Harvard University; Harvard University; Harvard Medical School	Brandt, AM (corresponding author), Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA.							Brandt AM, 2000, AM J PUBLIC HEALTH, V90, P707, DOI 10.2105/AJPH.90.5.707; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Killen J, 2012, LANCET, V380, P314, DOI 10.1016/S0140-6736(12)60635-7; MANN JM, 1988, J ROY STAT SOC A STA, V151, P131, DOI 10.2307/2982189; Rosenberg CE, 1986, MILBANK Q         S1, V64, P55	5	56	57	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2013	368	23					2149	2152		10.1056/NEJMp1305297	http://dx.doi.org/10.1056/NEJMp1305297			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DN	23738542				2022-12-01	WOS:000319948900001
J	Peterson, DC; Martin-Gill, C; Guyette, FX; Tobias, AZ; McCarthy, CE; Harrington, ST; Delbridge, TR; Yealy, DM				Peterson, Drew C.; Martin-Gill, Christian; Guyette, Francis X.; Tobias, Adam Z.; McCarthy, Catherine E.; Harrington, Scott T.; Delbridge, Theodore R.; Yealy, Donald M.			Outcomes of Medical Emergencies on Commercial Airline Flights	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AIRCRAFT; AIR; DIVERSIONS; EXPERIENCE	BACKGROUND Worldwide, 2.75 billion passengers fly on commercial airlines annually. When in-flight medical emergencies occur, access to care is limited. We describe in-flight medical emergencies and the outcomes of these events. METHODS We reviewed records of in-flight medical emergency calls from five domestic and international airlines to a physician-directed medical communications center from January 1, 2008, through October 31, 2010. We characterized the most common medical problems and the type of on-board assistance rendered. We determined the incidence of and factors associated with unscheduled aircraft diversion, transport to a hospital, and hospital admission, and we determined the incidence of death. RESULTS There were 11,920 in-flight medical emergencies resulting in calls to the center (1 medical emergency per 604 flights). The most common problems were syncope or presyncope (37.4% of cases), respiratory symptoms (12.1%), and nausea or vomiting (9.5%). Physician passengers provided medical assistance in 48.1% of in-flight medical emergencies, and aircraft diversion occurred in 7.3%. Of 10,914 patients for whom postflight follow-up data were available, 25.8% were transported to a hospital by emergency-medical-service personnel, 8.6% were admitted, and 0.3% died. The most common triggers for admission were possible stroke (odds ratio, 3.36; 95% confidence interval [CI], 1.88 to 6.03), respiratory symptoms (odds ratio, 2.13; 95% CI, 1.48 to 3.06), and cardiac symptoms (odds ratio, 1.95; 95% CI, 1.37 to 2.77). CONCLUSIONS Most in-flight medical emergencies were related to syncope, respiratory symptoms, or gastrointestinal symptoms, and a physician was frequently the responding medical volunteer. Few in-flight medical emergencies resulted in diversion of aircraft or death; one fourth of passengers who had an in-flight medical emergency underwent additional evaluation in a hospital.	[Peterson, Drew C.; Martin-Gill, Christian; Guyette, Francis X.; Tobias, Adam Z.; McCarthy, Catherine E.; Harrington, Scott T.; Yealy, Donald M.] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA USA; [Delbridge, Theodore R.] E Carolina Univ, Brody Sch Med, Dept Emergency Med, Greenville, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; East Carolina University	Martin-Gill, C (corresponding author), Iroquois Bldg,Suite 400A,3600 Forbes Ave, Pittsburgh, PA 15261 USA.	martingillc2@upmc.edu	, Francis/AAE-1586-2022	Guyette, Francis/0000-0002-9151-4896	National Institutes of Health [UL1 RR024153, UL1 TR000005]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by grants from the National Institutes of Health (UL1 RR024153 and UL1 TR000005).; Funded by the National Institutes of Health.	[Anonymous], 2012, PASS NUMB REACH 2 75; [Anonymous], 2006, POL AC 121 33B EM ME; [Anonymous], 2009, OBSTET GYNECOL, V114, P954; Baltsezak S, 2008, J TRAVEL MED, V15, P391, DOI 10.1111/j.1708-8305.2008.00233.x; Brown AM, 2010, PREHOSP EMERG CARE, V14, P235, DOI 10.3109/10903120903572319; CUMMINS RO, 1989, JAMA-J AM MED ASSOC, V261, P1295, DOI 10.1001/jama.261.9.1295; DeJohn CA, 2000, EVALUATION IN FLIGHT; Delaune EF, 2003, AVIAT SPACE ENVIR MD, V74, P62; HORDINSKY JR, 1989, AVIAT SPACE ENVIR MD, V60, P1211; Hung KKC, 2010, ARCH INTERN MED, V170, P1401, DOI 10.1001/archinternmed.2010.267; Moore BR, 2005, PEDIATR EMERG CARE, V21, P725, DOI 10.1097/01.pec.0000186424.84764.94; ORourke MF, 1997, CIRCULATION, V96, P2849, DOI 10.1161/01.CIR.96.9.2849; RODENBERG H, 1987, ANN EMERG MED, V16, P1373, DOI 10.1016/S0196-0644(87)80422-5; Sand M, 2009, CRIT CARE, V13, DOI 10.1186/cc7690; Shepherd B, 2006, J ROY SOC MED, V99, P628, DOI 10.1258/jrsm.99.12.628; Szmajer M, 2001, RESUSCITATION, V50, P147, DOI 10.1016/S0300-9572(01)00347-1; TranStats: Research and Innovative Technology Administration Bureau of Transportation Statistics, LOAD FACT PASS MIL P	17	144	145	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					2075	2083		10.1056/NEJMoa1212052	http://dx.doi.org/10.1056/NEJMoa1212052			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AT	23718164	Green Accepted, Bronze			2022-12-01	WOS:000319574200005
J	de Bakker, MAG; Fowler, DA; den Oude, K; Dondorp, EM; Navas, MCG; Horbanczuk, JO; Sire, JY; Szczerbinska, D; Richardson, MK				de Bakker, Merijn A. G.; Fowler, Donald A.; den Oude, Kelly; Dondorp, Esther M.; Navas, M. Carmen Garrido; Horbanczuk, Jaroslaw O.; Sire, Jean-Yves; Szczerbinska, Danuta; Richardson, Michael K.			Digit loss in archosaur evolution and the interplay between selection and constraints	NATURE			English	Article							SONIC HEDGEHOG; DROMAIUS-NOVAEHOLLANDIAE; DEVELOPMENTAL BASIS; LIMB BUD; BIRDS; REDUCTION; PATTERN; LOCOMOTION; GENES; SIZE	Evolution involves interplay between natural selection and developmental constraints(1-3). This is seen, for example, when digits are lost from the limbs during evolution(1,3,4). Extant archosaurs (crocodiles and birds) show several instances of digit loss(3,5,6) under different selective regimes, and show limbs with one, two, three, four or the ancestral number of five digits. The 'lost' digits sometimes persist for millions of years as developmental vestiges(7-10). Here we examine digit loss in the Nile crocodile and five birds, using markers of three successive stages of digit development. In two independent lineages under different selection, wing digit I and all its markers disappear. In contrast, hindlimb digit V persists in all species sampled, both as cartilage, and as Sox9-expressing precartilage domains, 250 million years after the adult digit disappeared. There is therefore a mismatch between evolution of the embryonic and adult phenotypes. All limbs, regardless of digit number, showed similar expression of sonic hedgehog (Shh). Even in the one-fingered emu wing, expression of posterior genes Hoxd11 and Hoxd12 was conserved, whereas expression of anterior genes Gli3 and Alx4 was not. We suggest that the persistence of digit V in the embryo may reflect constraints, particularly the conserved posterior gene networks associated with the zone of polarizing activity (ZPA(11)). The more rapid and complete disappearance of digit I may reflect its ZPA-independent specification, and hence, weaker developmental constraints. Interacting with these constraints are selection pressures for limb functions such as flying and perching. This model may help to explain the diverse patterns of digit loss in tetrapods. Our study may also help to understand how selection on adults leads to changes in development.	[de Bakker, Merijn A. G.; Fowler, Donald A.; den Oude, Kelly; Dondorp, Esther M.; Navas, M. Carmen Garrido; Richardson, Michael K.] Leiden Univ, Inst Biol, Dept Integrat Zool, Sylvius Lab, NL-2333 BE Leiden, Netherlands; [Horbanczuk, Jaroslaw O.] Polish Acad Sci, Inst Genet & Anim Breeding, PL-05552 Jastrzebiec, Poland; [Sire, Jean-Yves] Univ Paris 06, UMR 7138, F-75005 Paris, France; [Szczerbinska, Danuta] Western Pomeranian Univ Technol, Dept Poultry & Ornamental Bird Breeding, PL-71466 Szczecin, Poland	Leiden University; Leiden University - Excl LUMC; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; West Pomeranian University of Technology	Richardson, MK (corresponding author), Leiden Univ, Inst Biol, Dept Integrat Zool, Sylvius Lab, Sylviusweg 72, NL-2333 BE Leiden, Netherlands.	m.k.richardson@biology.leidenuniv.nl	Szczerbińska, Danuta/J-5734-2016; Horbanczuk, Jaroslaw/ABD-8389-2021; Garrido Navas, M. Carmen/N-1004-2017; Navas, M. Carmen Garrido/A-9173-2019	Garrido Navas, M. Carmen/0000-0002-3965-0663; Navas, M. Carmen Garrido/0000-0002-3965-0663; Horbanczuk, Jaroslaw Olav/0000-0002-7561-0941; de Bakker, Merijn/0000-0002-2061-7986				Abourachid A, 2000, IBIS, V142, P538, DOI 10.1111/j.1474-919X.2000.tb04455.x; ALBERCH P, 1983, J EMBRYOL EXP MORPH, V76, P177; ALBERCH P, 1985, EVOLUTION, V39, P8, DOI 10.1111/j.1558-5646.1985.tb04076.x; Crumly CR, 2004, J EXP ZOOL PART B, V302B, P134, DOI 10.1002/jez.b.20010; Feduccia A, 2002, NATURWISSENSCHAFTEN, V89, P391, DOI 10.1007/s00114-002-0350-y; Gillis JA, 2009, P NATL ACAD SCI USA, V106, P5720, DOI 10.1073/pnas.0810959106; Haddrath O, 2012, P ROY SOC B-BIOL SCI, V279, P4617, DOI 10.1098/rspb.2012.1630; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harfe BD, 2011, DEV DYNAM, V240, P915, DOI 10.1002/dvdy.22597; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Kundrat M, 2009, J EXP ZOOL PART B, V312B, P30, DOI 10.1002/jez.b.21240; Larsson HCE, 2002, J EXP ZOOL, V294, P146, DOI 10.1002/jez.10153; Lorda-Diez CI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024546; Maxwell EE, 2007, J MORPHOL, V268, P423, DOI 10.1002/jmor.10527; Middleton KM, 2001, J MORPHOL, V250, P51, DOI 10.1002/jmor.1058; Muller G. B., 1990, J MORPHOL, V203, P151; Nagai H, 2011, DEV DYNAM, V240, P162, DOI 10.1002/dvdy.22520; Pagan SM, 1996, DEV BIOL, V180, P35, DOI 10.1006/dbio.1996.0282; Richardson M, 2012, CLONE BONE SYNERGY M, P328; Richardson MK, 2003, J EXP ZOOL PART B, V296B, P8, DOI 10.1002/jez.b.00013; Richardson MK, 1999, BIOESSAYS, V21, P604, DOI 10.1002/(SICI)1521-1878(199907)21:7<604::AID-BIES9>3.0.CO;2-U; Schaller NU, 2011, J EXP BIOL, V214, P1123, DOI 10.1242/jeb.043596; Scherz PJ, 2007, DEV BIOL, V308, P343, DOI 10.1016/j.ydbio.2007.05.030; Sears KE, 2011, EVOL DEV, V13, P533, DOI 10.1111/j.1525-142X.2011.00509.x; Shapiro MD, 2003, J EXP ZOOL PART B, V297B, P48, DOI 10.1002/jez.b.00019; Shapiro Michael D., 2007, P225; Sheth R, 2012, SCIENCE, V338, P1476, DOI 10.1126/science.1226804; VANDENBERG C, 1995, J EXP BIOL, V198, P1655; Welten MCM, 2005, EVOL DEV, V7, P18, DOI 10.1111/j.1525-142X.2005.05003.x; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	30	59	59	3	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2013	500	7463					445	+		10.1038/nature12336	http://dx.doi.org/10.1038/nature12336			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23831646				2022-12-01	WOS:000323316100032
J	Cisse, II; Izeddin, I; Causse, SZ; Boudarene, L; Senecal, A; Muresan, L; Dugast-Darzacq, C; Hajj, B; Dahan, M; Darzacq, X				Cisse, Ibrahim I.; Izeddin, Ignacio; Causse, Sebastien Z.; Boudarene, Lydia; Senecal, Adrien; Muresan, Leila; Dugast-Darzacq, Claire; Hajj, Bassam; Dahan, Maxime; Darzacq, Xavier			Real-Time Dynamics of RNA Polymerase II Clustering in Live Human Cells	SCIENCE			English	Article							IN-VIVO; LIVING CELLS; GENE-EXPRESSION; P-TEFB; TRANSCRIPTION; ORGANIZATION; PROTEIN; REPLICATION; ELONGATION; MECHANISMS	Transcription is reported to be spatially compartmentalized in nuclear transcription factories with clusters of RNA polymerase II (Pol II). However, little is known about when these foci assemble or their relative stability. We developed a quantitative single-cell approach to characterize protein spatiotemporal organization, with single-molecule sensitivity in live eukaryotic cells. We observed that Pol II clusters form transiently, with an average lifetime of 5.1 (+/- 0.4) seconds, which refutes the notion that they are statically assembled substructures. Stimuli affecting transcription yielded orders-of-magnitude changes in the dynamics of Pol II clusters, which implies that clustering is regulated and plays a role in the cell's ability to effect rapid response to external signals. Our results suggest that transient crowding of enzymes may aid in rate-limiting steps of gene regulation.	[Cisse, Ibrahim I.; Izeddin, Ignacio; Causse, Sebastien Z.; Boudarene, Lydia; Senecal, Adrien; Dugast-Darzacq, Claire; Darzacq, Xavier] Ecole Normale Super, Inst Biol, IBENS, CNRS,UMR8197, F-75005 Paris, France; [Cisse, Ibrahim I.; Izeddin, Ignacio; Boudarene, Lydia; Dahan, Maxime] Ecole Normale Super, Inst Biol, Dept Phys, Lab Kastler Brossel,CNRS,UMR8552, F-75230 Paris 05, France; [Cisse, Ibrahim I.; Hajj, Bassam; Dahan, Maxime; Darzacq, Xavier] Transcript Imaging Consortium, Ashburn, VA 20147 USA; [Muresan, Leila] Ecole Normale Super, Inst Biol, IBENS, DYOGEN,CNRS,UMR8197, F-75005 Paris, France; [Dugast-Darzacq, Claire] Univ Paris Diderot, Paris Cite Sorbonne, F-75013 Paris, France; [Senecal, Adrien; Dahan, Maxime] Univ Paris 06, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Dahan, M (corresponding author), Ecole Normale Super, Inst Biol, Dept Phys, Lab Kastler Brossel,CNRS,UMR8552, 46 Rue Ulm, F-75230 Paris 05, France.	maxime.dahan@curie.fr; darzacq@ens.fr	Dahan, Maxime/F-1740-2010; Muresan, Leila/AGK-4203-2022; Causse, Sebastien Zwe/AAZ-7365-2021; Izeddin, Ignacio/H-2628-2013	Muresan, Leila/0000-0002-7602-0249; Izeddin, Ignacio/0000-0002-8476-3915; Dugast-Darzacq, Claire/0000-0001-8602-3534; BOUDARENE, LYDIA/0000-0002-6204-4936; HAJJ, Bassam/0000-0002-5097-6832; Causse, Sebastien/0000-0003-3246-3491; Darzacq, Xavier/0000-0003-2537-8395; Dahan, Maxime/0000-0002-4943-2491	European Molecular Biology Organization; Foundation Pierre Gilles de Gennes (FPGG); Netherlands Organization for Scientific Research; FPGG; La Ligue nationale contre le cancer; Centre de Genetique Moleculaire [UPR 3404]; Agence Nationale de la Recherche Pol2Kinetics; DYNAFT; Nikon France	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Foundation Pierre Gilles de Gennes (FPGG); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); FPGG; La Ligue nationale contre le cancer(Ligue nationale contre le cancer); Centre de Genetique Moleculaire; Agence Nationale de la Recherche Pol2Kinetics(French National Research Agency (ANR)); DYNAFT; Nikon France	We acknowledge J. T. Lis, I. Golding, R. Phillips, O. Bensaude, and E. Bertrand for valuable discussions. We thank members of the Darzacq, Dahan, and Howard Hughes Medical Institute-Janelia Farm Transcription Imaging Consortium groups for suggestions. I. I. C. was supported by fellowships from the European Molecular Biology Organization and the Foundation Pierre Gilles de Gennes (FPGG). I. I. acknowledges the Netherlands Organization for Scientific Research and FPGG for financial support. A. S. was supported by La Ligue nationale contre le cancer. L. M. acknowledges support from Centre de Genetique Moleculaire UPR 3404. This work was supported by grants Agence Nationale de la Recherche Pol2Kinetics to X. D. and DYNAFT to X. D. and M. D.; X. D. and M. D. acknowledge the support of Nikon France.	Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; HERRERA RE, 1989, NATURE, V340, P68, DOI 10.1038/340068a0; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; MACKMAN N, 1990, P NATL ACAD SCI USA, V87, P2254, DOI 10.1073/pnas.87.6.2254; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/NMETH.1704, 10.1038/nmeth.1704]; Sugaya K, 2000, J CELL SCI, V113, P2679; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025	22	274	279	0	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					664	667		10.1126/science.1239053	http://dx.doi.org/10.1126/science.1239053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23828889				2022-12-01	WOS:000322884800041
J	Artaud, F; Dugravot, A; Sabia, S; Singh-Manoux, A; Tzourio, C; Elbaz, A				Artaud, Fanny; Dugravot, Aline; Sabia, Severine; Singh-Manoux, Archana; Tzourio, Christophe; Elbaz, Alexis			Unhealthy behaviours and disability in older adults: Three-City Dijon cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTHY LIFE-STYLE; INCIDENT MOBILITY LIMITATION; MEDITERRANEAN DIET; PHYSICAL-ACTIVITY; DISABLEMENT PROCESS; FUNCTIONAL DECLINE; COMBINED IMPACT; WOMENS HEALTH; RISK-FACTORS; MORTALITY	Objectives To examine the individual and combined associations of unhealthy behaviours (low/intermediate physical activity, consuming fruit and vegetables less than once a day, current smoking/short term ex-smoking, never/former/heavy alcohol drinking), assessed at start of follow-up, with hazard of disability among older French adults and to assess the role of potential mediators, assessed repeatedly, of these associations. Design Population based cohort study. Setting Dijon centre of Three-City study. Participants 3982 (2410 (60.5%) women) French community dwellers aged 65 or over included during 1999-2001; participants were disability-free at baseline when health behaviours were assessed. Main outcome measure Hierarchical indicator of disability (no, light, moderate, severe) combining data from three disability scales (mobility, instrumental activities of daily living, basic activities of daily living) assessed five times between 2001 and 2012. Results During the 12 year follow-up, 1236 participants (861 (69.7%) women) developed moderate or severe disability. Interval censored survival analyses (adjusted for age, sex, marital status, and education) showed low/intermediate physical activity (hazard ratio 1.72, 95% confidence interval 1.48 to 2.00), consuming fruit and vegetables less than once a day (1.24, 1.10 to 1.41), and current smoking/short term ex-smoking (1.26, 1.05 to 1.50) to be independently associated with an increased hazard of disability, whereas no robust association with alcohol consumption was found. The hazard of disability increased progressively with the number of unhealthy behaviours independently associated with disability (P<0.001); participants with three unhealthy behaviours had a 2.53 (1.86 to 3.43)-fold increased hazard of disability compared with those with none. Reverse causation bias was verified by excluding participants who developed disability in the first four years of follow-up; these analyses on 890 disability events yielded results similar to those in the main analysis. 30.5% of the association between the unhealthy behaviours score and disability was explained by body mass index, cognitive function, depressive symptoms, trauma, chronic conditions, and cardiovascular disease and its risk factors; the main contributors were chronic conditions and, to a lesser extent, depressive symptoms, trauma, and body mass index. Conclusions An unhealthy lifestyle is associated with greater hazard of incident disability, and the hazard increases progressively with the number of unhealthy behaviours. Chronic conditions, depressive symptoms, trauma, and body mass index partially explained this association.	[Artaud, Fanny; Dugravot, Aline; Singh-Manoux, Archana; Elbaz, Alexis] INSERM, Ctr Res Epidemiol & Populat Hlth CESP, U1018, F-94807 Villejuif, France; [Artaud, Fanny; Dugravot, Aline; Singh-Manoux, Archana; Elbaz, Alexis] Univ Versailles St Quentin, UMRS 1018, F-78035 Versailles, France; [Sabia, Severine; Singh-Manoux, Archana; Elbaz, Alexis] UCL, Dept Epidemiol & Publ Hlth, London, England; [Singh-Manoux, Archana] Hop Ste Perine, AP HP, Ctr Gerontol, Paris, France; [Tzourio, Christophe] INSERM, U708, Bordeaux, France; [Tzourio, Christophe] Univ Bordeaux 2, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Sainte-Perine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Elbaz, A (corresponding author), INSERM, Ctr Res Epidemiol & Populat Hlth CESP, U1018, F-94807 Villejuif, France.	alexis.elbaz@inserm.fr	Tzourio, christophe/L-6344-2019; Sabia, Séverine/G-2966-2017; Tzourio, christophe/B-4015-2009; Singh-Manoux, Archana/F-6804-2013; Elbaz, Alexis/F-8952-2017	Tzourio, christophe/0000-0002-6517-2984; Sabia, Séverine/0000-0003-3109-9720; Tzourio, christophe/0000-0002-6517-2984; Singh-Manoux, Archana/0000-0002-1244-5037; Elbaz, Alexis/0000-0001-9724-5490; ARTAUD, Fanny/0000-0003-1899-8502; Dugravot, Aline/0000-0002-4546-0970	Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; Conseils Regionaux of Bourgogne; Fondation de France; Ministry of Research-INSERM Program; "Cohortes et collections de donnees biologiques"; Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Conseil General de la Cote d'or; Fondation Plan Alzheimer; Institut national de prevention et d'education pour la sante (INPES) [063/11-DAS]; Ministere de l'Enseignement Superieur et de la Recherche, Paris, France; EHESP (Ecole des Hautes Etudes en Sante Publique), Rennes, France	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); Conseils Regionaux of Bourgogne(Region Bourgogne-Franche-Comte); Fondation de France(Fondation de France); Ministry of Research-INSERM Program; "Cohortes et collections de donnees biologiques"; Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Conseil General de la Cote d'or(Region Bourgogne-Franche-Comte); Fondation Plan Alzheimer; Institut national de prevention et d'education pour la sante (INPES); Ministere de l'Enseignement Superieur et de la Recherche, Paris, France; EHESP (Ecole des Hautes Etudes en Sante Publique), Rennes, France	The 3C study is conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Victor Segalen-Bordeaux II University, and the Sanofi-Synthelabo Company. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Conseils Regionaux of Bourgogne, Fondation de France, Ministry of Research-INSERM Program, "Cohortes et collections de donnees biologiques," Mutuelle Generale de l'Education Nationale, Institut de la Longevite, Conseil General de la Cote d'or, and Fondation Plan Alzheimer. This research was also funded by Institut national de prevention et d'education pour la sante (INPES, No 063/11-DAS). FA is the recipient of a doctoral grant from the Ministere de l'Enseignement Superieur et de la Recherche, Paris, France, and the EHESP (Ecole des Hautes Etudes en Sante Publique), Rennes, France. The sponsors had no role in study design, data collection, data analysis, data interpretation, the writing of the report, or the decision to submit the paper for publication.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Andrews G, 1999, MANAGEMENT MENTAL DI; Barberger-Gateau P, 2000, DISABIL REHABIL, V22, P308, DOI 10.1080/096382800296665; Barberger-Gateau P, 2002, DEMENT GERIATR COGN, V13, P60, DOI 10.1159/000048635; Blachier M, 2012, ANN NEUROL, V71, P661, DOI 10.1002/ana.22656; Buck B, 2012, CLUSTERING UNHEALTHY; Chakravarty EF, 2012, AM J MED, V125, P190, DOI 10.1016/j.amjmed.2011.08.006; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Chiuve SE, 2011, JAMA-J AM MED ASSOC, V306, P62, DOI 10.1001/jama.2011.907; CRIQUI MH, 1979, AM J EPIDEMIOL, V109, P394, DOI 10.1093/oxfordjournals.aje.a112695; Donald IP, 2010, AGE AGEING, V39, P337, DOI 10.1093/ageing/afq015; Duee M, 2006, DONNEES SOC SOCIETEF, V7, P613; Feart C, 2011, EUR J EPIDEMIOL, V26, P747, DOI 10.1007/s10654-011-9611-4; Ford ES, 2009, ARCH INTERN MED, V169, P1355, DOI 10.1001/archinternmed.2009.237; Fried LP, 2001, J CLIN EPIDEMIOL, V54, P889, DOI 10.1016/S0895-4356(01)00357-2; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; GLYNN RJ, 1985, AM J PUBLIC HEALTH, V75, P1413, DOI 10.2105/AJPH.75.12.1413; Hamer M, 2011, J AM GERIATR SOC, V59, P370, DOI 10.1111/j.1532-5415.2011.03258.x; Harrington J, 2010, EUR J PUBLIC HEALTH, V20, P91, DOI 10.1093/eurpub/ckp102; Hewitt M, 2003, J GERONTOL A-BIOL, V58, P82; Houston DK, 2005, AM J CLIN NUTR, V81, P515; Joly P, 2002, BIOSTATISTICS, V3, P433, DOI 10.1093/biostatistics/3.3.433; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Koster A, 2008, J AM GERIATR SOC, V56, P636, DOI 10.1111/j.1532-5415.2007.01632.x; Koster A, 2007, OBESITY, V15, P3122, DOI 10.1038/oby.2007.372; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; LACROIX AZ, 1993, AM J EPIDEMIOL, V137, P858, DOI 10.1093/oxfordjournals.aje.a116747; Landi F, 2007, AGING CLIN EXP RES, V19, P410; Larrieu S, 2004, INT J OBESITY, V28, P1555, DOI 10.1038/sj.ijo.0802755; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Liao WC, 2011, J AM GERIATR SOC, V59, P200, DOI 10.1111/j.1532-5415.2010.03272.x; Ling SM, 2006, ARTHRIT RHEUM-ARTHR, V55, P256, DOI 10.1002/art.21858; Loef M, 2012, PREV MED, V55, P163, DOI 10.1016/j.ypmed.2012.06.017; Maraldi C, 2009, J AM GERIATR SOC, V57, P1767, DOI 10.1111/j.1532-5415.2009.02479.x; Morimoto LM, 2003, AM J EPIDEMIOL, V158, P259, DOI 10.1093/aje/kwg147; Peres K, 2005, AGING CLIN EXP RES, V17, P229; Peres K, 2005, DISABIL REHABIL, V27, P263, DOI 10.1080/09638280400006515; Poortinga W, 2007, PREV MED, V44, P124, DOI 10.1016/j.ypmed.2006.10.006; Pronk NP, 2004, AM J PREV MED, V27, P25, DOI 10.1016/j.amepre.2004.04.022; ROSOW I, 1966, J GERONTOL, V21, P556, DOI 10.1093/geronj/21.4.556; Rosso AL, 2013, J AM GERIATR SOC, V61, P371, DOI 10.1111/jgs.12147; Sabia S, 2012, CAN MED ASSOC J, V184, P1985, DOI 10.1503/cmaj.121080; Sabia S, 2009, AM J EPIDEMIOL, V170, P428, DOI 10.1093/aje/kwp161; Tsubota-Utsugi M, 2011, J AM GERIATR SOC, V59, P1993, DOI 10.1111/j.1532-5415.2011.03633.x; van Dam RM, 2008, BMJ-BRIT MED J, V337, pa1440, DOI [10.1136/bmj.a1440, DOI 10.1136/BMJ.A1440]; van den Brandt PA, 2011, AM J CLIN NUTR, V94, P913, DOI 10.3945/ajcn.110.008250; Vercambre MN, 2009, BRIT J NUTR, V102, P419, DOI 10.1017/S0007114508201959; Vita AJ, 1998, NEW ENGL J MED, V338, P1035, DOI 10.1056/NEJM199804093381506; Wang L, 2002, J AM GERIATR SOC, V50, P1525, DOI 10.1046/j.1532-5415.2002.50408.x; Wong E, 2012, ANN EPIDEMIOL, V22, P710, DOI 10.1016/j.annepidem.2012.07.009; Young Y, 2010, J AM MED DIR ASSOC, V11, P645, DOI 10.1016/j.jamda.2009.12.084	55	82	86	0	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2013	347								f4240	10.1136/bmj.f4240	http://dx.doi.org/10.1136/bmj.f4240			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	192YR	23881930	Green Published, hybrid			2022-12-01	WOS:000322524400002
J	Tian, X; Azpurua, J; Hine, C; Vaidya, A; Myakishev-Rempel, M; Ablaeva, J; Mao, ZY; Nevo, E; Gorbunova, V; Seluanov, A				Tian, Xiao; Azpurua, Jorge; Hine, Christopher; Vaidya, Amita; Myakishev-Rempel, Max; Ablaeva, Julia; Mao, Zhiyong; Nevo, Eviatar; Gorbunova, Vera; Seluanov, Andrei			High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat	NATURE			English	Article							CONTACT INHIBITION; CD44; TRANSFORMATION; INSIGHTS; GROWTH; CELLS	The naked mole rat (Heterocephalus glaber) displays exceptional longevity, with a maximum lifespan exceeding 30 years(1-3). This is the longest reported lifespan for a rodent species and is especially striking considering the small body mass of the naked mole rat. In comparison, a similarly sized house mouse has a maximum lifespan of 4 years(4,5). In addition to their longevity, naked mole rats show an unusual resistance to cancer. Multi-year observations of large naked mole-rat colonies did not detect a single incidence of cancer(2,6). Here we identify a mechanism responsible for the naked mole rat's cancer resistance. We found that naked mole-rat fibroblasts secrete extremely high-molecular-mass hyaluronan (HA), which is over five times larger than human or mouse HA. This high-molecular-mass HA accumulates abundantly in naked mole-rat tissues owing to the decreased activity of HA-degrading enzymes and a unique sequence of hyaluronan synthase 2 (HAS2). Furthermore, the naked mole-rat cells are more sensitive to HA signalling, as they have a higher affinity to HA compared with mouse or human cells. Perturbation of the signalling pathways sufficient for malignant transformation of mouse fibroblasts fails to transform naked mole-rat cells. However, once high molecular-mass HA is removed by either knocking down HAS2 or overexpressing the HA-degrading enzyme, HYAL2, naked mole-rat cells become susceptible to malignant transformation and readily form tumours in mice. We speculate that naked mole rats have evolved a higher concentration of HA in the skin to provide skin elasticity needed for life in underground tunnels. This trait may have then been co-opted to provide cancer resistance and longevity to this species.	[Tian, Xiao; Azpurua, Jorge; Hine, Christopher; Vaidya, Amita; Myakishev-Rempel, Max; Ablaeva, Julia; Mao, Zhiyong; Gorbunova, Vera; Seluanov, Andrei] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Mao, Zhiyong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-31905 Haifa, Israel	University of Rochester; Tongji University; University of Haifa	Gorbunova, V (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	vera.gorbunova@rochester.edu; andrei.seluanov@rochester.edu	Tian, Xiao/E-3998-2017; Myakishev-Rempel, Max/E-9696-2014	Tian, Xiao/0000-0001-5300-3596; Hine, Christopher/0000-0003-1926-7939; Gorbunova, Vera/0000-0001-8979-0333; Seluanov, Andrei/0000-0003-3400-538X; Myakishev-Rempel, Max/0000-0002-7893-2049; Mao, Zhiyong/0000-0002-5298-1918	US National Institutes of Health; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [R01AG031227, R01AG027237] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the grants from the US National Institutes of Health and Ellison Medical Foundation to V. G. We thank M. Van Meter for critically reading the manuscript.	ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; Buffenstein Rochelle, 2002, Sci Aging Knowledge Environ, V2002, ppe7, DOI 10.1126/sageke.2002.21.pe7; de Magalhaes JP, 2005, NUCLEIC ACIDS RES, V33, pD537, DOI 10.1093/nar/gki017; Delaney M. A., 2013, VET PATHOL; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; HOLMES MWA, 1988, BIOCHEM J, V250, P435, DOI 10.1042/bj2500435; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kothapalli D, 2007, J CELL BIOL, V176, P535, DOI 10.1083/jcb.200611058; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945	21	457	482	6	349	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					346	U122		10.1038/nature12234	http://dx.doi.org/10.1038/nature12234			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23783513	Green Accepted			2022-12-01	WOS:000321910700038
J	Strom, BL; Anderson, CAM; Ix, JH				Strom, Brian L.; Anderson, Cheryl A. M.; Ix, Joachim H.			Sodium Reduction in Populations Insights From the Institute of Medicine Committee	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Strom, Brian L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Anderson, Cheryl A. M.; Ix, Joachim H.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Ix, Joachim H.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA USA	University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Strom, BL (corresponding author), Univ Penn, Perelman Sch Med, 237 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	bstrom@mail.med.upenn.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL092595] Funding Source: NIH RePORTER; NHLBI NIH HHS [K01 HL092595] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aliti GB, 2013, JAMA INTERN MED, V173, P1058, DOI 10.1001/jamainternmed.2013.552; Appel LJ, 2011, CIRCULATION, V123, P1138, DOI 10.1161/CIR.0b013e31820d0793; Cogswell ME, 2012, AM J CLIN NUTR, V96, P647, DOI 10.3945/ajcn.112.034413; Institute of Medicine, 2010, STRATEGIES TO REDUCE; Institute of Medicine, 2013, SODIUM INTAKE IN POP; US Department of Agriculture US Department of Health and Human Services, 2010, DIETARY GUIDELINES F; [USDA USDHHS], 2010, REPORT OF THE DIETAR; World Health Organization, 2012, GUIDELINE SODIUM INT	9	53	53	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					31	32		10.1001/jama.2013.7687	http://dx.doi.org/10.1001/jama.2013.7687			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175SK	23743860				2022-12-01	WOS:000321253000014
J	Hull, SC; Colloca, L; Avins, A; Gordon, NP; Somkin, CP; Kaptchuk, TJ; Miller, FG				Hull, Sara Chandros; Colloca, Luana; Avins, Andrew; Gordon, Nancy P.; Somkin, Carol P.; Kaptchuk, Ted J.; Miller, Franklin G.			Patients' attitudes about the use of placebo treatments: telephone survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUESTIONNAIRE SURVEY; CLINICAL-PRACTICE; INTERVENTIONS; PHYSICIANS; ETHICS	Objective To examine the attitudes of US patients about the use of placebo treatments in medical care. Design One time telephone surveys. Setting Northern California. Participants 853 members of Kaiser Permanente Northern California, aged 18-75, who had been seen by a primary care provider for a chronic health problem at least once in the prior six months. Results The response rate was 53.4% (853/1598) of all members who were eligible to participate, and 73.2% (853/1165) of all who could be reached by telephone. Most respondents (50-84%) judged it acceptable for doctors to recommend placebo treatments under conditions that varied according to doctors' level of certainty about the benefits and safety of the treatment, the purpose of the treatment, and the transparency with which the treatment was described to patients. Only 21.9% of respondents judged that it was never acceptable for doctors to recommend placebo treatments. Respondents valued honesty by physicians regarding the use of placebos and believed that non-transparent use could undermine the relationship between patients and physicians. Conclusions Most patients in this survey seemed favorable to the idea of placebo treatments and valued honesty and transparency in this context, suggesting that physicians should consider engaging with patients to discuss their values and attitudes about the appropriateness of using treatments aimed at promoting placebo responses in the context of clinical decision making.	[Hull, Sara Chandros] NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA; [Hull, Sara Chandros; Colloca, Luana; Miller, Franklin G.] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA; [Colloca, Luana; Miller, Franklin G.] NIMH, NIH, Bethesda, MD 20892 USA; [Colloca, Luana] NIH, Natl Ctr Complementary & Alternat Med, Bethesda, MD 20892 USA; [Avins, Andrew; Gordon, Nancy P.; Somkin, Carol P.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Kaptchuk, Ted J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Program Placebo Studies, Boston, MA 02215 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine; Kaiser Permanente; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Hull, SC (corresponding author), NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA.	shull@mail.nih.gov	Colloca, Luana/S-1389-2018	Colloca, Luana/0000-0002-6503-4709	National Center for Complementary and Alternative Medicine; Clinical Center; National Human Genome Research Institute, National Institutes of Health; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [ZIAAT000019] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIDHG200347, P20HG007243] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Clinical Center; National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by the National Center for Complementary and Alternative Medicine, the Clinical Center, and the intramural research program of the National Human Genome Research Institute, National Institutes of Health. The opinions expressed are those of the authors and do not necessarily reflect the policies or views of the National Institutes of Health or the Department of Health and Human Services. The study funders played no role in the study design; collection, analysis, and interpretation of data; writing of the report; or the decision to submit the article for publication. Researchers were independent of influence from study funders.	American Medical Association, 2007, AM MED ASS COD MED E; Berthelot JM, 2001, JOINT BONE SPINE, V68, P65, DOI 10.1016/S1297-319X(00)00225-6; Bishop FL, 2012, SOC SCI MED, V8, P1138; Boozang Kathleen M, 2002, Fla Law Rev, V54, P687; BRODY H, 1982, ANN INTERN MED, V97, P112, DOI 10.7326/0003-4819-97-1-112; Brody H, 2012, J GEN INTERN MED, V27, P739, DOI 10.1007/s11606-011-1977-1; Chen GF, 2009, NEW ZEAL MED J, V122, P35; Colloca L, 2011, PHILOS T R SOC B, V366, P1922, DOI 10.1098/rstb.2010.0399; Fassler M, 2011, BRIT J GEN PRACT, V61, P101, DOI 10.3399/bjgp11X556209; Fassler M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-15; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Gordon NP, 2015, SIMILARITY ADULT KAI; Hrobjartsson A, 2003, EVAL HEALTH PROF, V26, P153, DOI 10.1177/0163278703026002002; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Kermen R, 2010, FAM MED, V42, P636; Kolber AJ., 2007, YALE LAW POLICY REV, V26; Louhiala P, 2012, J MED ETHICS, V38, P403, DOI 10.1136/medethics-2011-100420; LYNOE N, 1993, SOC SCI MED, V36, P767, DOI 10.1016/0277-9536(93)90037-5; Miller FG, 2009, AM J BIOETHICS, V9, P39, DOI 10.1080/15265160903316263; Nitzan U, 2004, BMJ-BRIT MED J, V329, P944, DOI 10.1136/bmj.38236.646678.55; ONEILL O, 1984, J MED ETHICS, V10, P173, DOI 10.1136/jme.10.4.173; Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938	22	63	63	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2013	347								f3757	10.1136/bmj.f3757	http://dx.doi.org/10.1136/bmj.f3757			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180CL	23819963	Green Published, hybrid			2022-12-01	WOS:000321570400002
J	Menon, S; Manning, BD				Menon, Suchithra; Manning, Brendan D.			CELL SIGNALLING Nutrient sensing lost in cancer	NATURE			English	Editorial Material							DEPRIVATION; COMPLEX; MTORC1		[Menon, Suchithra; Manning, Brendan D.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Menon, S (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	bmanning@hsph.harvard.edu	Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956				Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Li F, 2004, CANCER RES, V64, P6438, DOI 10.1158/0008-5472.CAN-03-3869; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Neklesa TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000515; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008	9	8	9	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					444	445		10.1038/498444a	http://dx.doi.org/10.1038/498444a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803840				2022-12-01	WOS:000320929400041
J	Moyer, MW				Moyer, Melinda Wenner			CELL BANKS Life blood	NATURE			English	Editorial Material							UMBILICAL-CORD BLOOD; TRANSPLANTATION											Ballen KK, 2008, BIOL BLOOD MARROW TR, V14, P356, DOI 10.1016/j.bbmt.2007.11.005; Brunstein C. G., BLOOD, V116, P4693; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Kaimal AJ, 2009, OBSTET GYNECOL, V114, P848, DOI 10.1097/AOG.0b013e3181b8fc0d; Perales MA, 2012, BLOOD, V120, P4882, DOI 10.1182/blood-2012-06-437236; Smith AR, 2009, BRIT J HAEMATOL, V147, P246, DOI 10.1111/j.1365-2141.2009.07828.x	6	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					S16	S16		10.1038/498S16a	http://dx.doi.org/10.1038/498S16a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803945	Bronze			2022-12-01	WOS:000320929400009
J	Joynt, KE; Gawande, AA; Orav, EJ; Jha, AK				Joynt, Karen E.; Gawande, Atul A.; Orav, E. John; Jha, Ashish K.			Contribution of Preventable Acute Care Spending to Total Spending for High-Cost Medicare Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY-DEPARTMENT VISITS; SENSITIVE CONDITIONS; HEALTH-CARE; HOSPITALIZATIONS; BENEFICIARIES; PROGRAMS	Importance A small proportion of patients account for the majority of US health care spending, and understanding patterns of spending among this cohort is critical to reducing health care costs. The degree to which preventable acute care services account for spending among these patients is largely unknown. Objective To quantify preventable acute care services among high-cost Medicare patients. Design, Setting, and Participants We summed standardized costs for each inpatient and outpatient service contained in standard 5% Medicare files from 2009 and 2010 across the year for each patient in our sample, and defined those in the top decile of spending in 2010 as high-cost patients and those in the top decile in both 2009 and 2010 as persistently high-cost patients. We used standard algorithms to identify potentially preventable emergency department (ED) visits and acute care inpatient hospitalizations. A total of 1 114 469 Medicare fee-for-service beneficiaries aged 65 years or older were included. Main Outcomes and Measures Proportion of acute care hospital and ED costs deemed preventable among high-cost patients. Results The 10% of Medicare patients in the high-cost group were older, more often male, more often black, and had more comorbid illnesses than non-high-cost patients. In 2010, 32.9% (95% CI, 32.9%-32.9%) of total ED costs were incurred by high-cost patients. Based on validated algorithms, 41.0% (95% CI, 40.9%-41.0%) of these costs among high-cost patients were potentially preventable compared with 42.6% (95% CI, 42.6%-42.6%) among non-high-cost patients. High-cost patients accounted for 79.0% (95% CI, 79.0%-79.0%) of inpatient costs, 9.6% (95% CI, 9.6%-9.6%) of which were due to preventable hospitalizations; 16.8% (95% CI, 16.8%-16.8%) of costs within the non-high-cost group were due to preventable hospitalizations. Comparable proportions of ED spending (43.3%; 95% CI, 43.3%-43.3%) and inpatient spending (13.5%; 95% CI, 13.5%-13.5%) were preventable among persistently high-cost patients. Regions with high primary care physician supply had higher preventable spending for high-cost patients. Conclusions and Relevance Among a sample of patients in the top decile of Medicare spending in 2010, only a small percentage of costs appeared to be related to preventable ED visits and hospitalizations. The ability to lower costs for these patients through better outpatient care may be limited.	[Joynt, Karen E.; Gawande, Atul A.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Orav, E. John] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Orav, E. John; Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Gawande, Atul A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Gawande, Atul A.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Joynt, Karen E.; Jha, Ashish K.] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Joynt, KE (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org		Gawande, Atul/0000-0002-1824-9176	Rx Foundation; West Wireless Foundation	Rx Foundation; West Wireless Foundation	This study was funded by the Rx Foundation and the West Wireless Foundation.	Agency for Healthcare Research and Quality, 2011, PREV QUAL IND OV; Baicker K, 2004, HEALTH AFFAIR, V23, pW4184, DOI 10.1377/hlthaff.W4.184; Ballard DW, 2010, MED CARE, V48, P58, DOI 10.1097/MLR.0b013e3181bd49ad; Basu J, 2002, MED CARE, V40, P1260, DOI 10.1097/00005650-200212000-00013; Bhattacharya J, 2010, RES FINDINGS EC AGIN, P387; Billings J, 1996, HEALTH AFFAIR, V15, P239, DOI 10.1377/hlthaff.15.3.239; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Braunstein JB, 2003, J AM COLL CARDIOL, V42, P1226, DOI 10.1016/S0735-1097(03)00947-1; Brown RS, 2012, HEALTH AFFAIR, V31, P1156, DOI 10.1377/hlthaff.2012.0393; Cebul RD, 2008, J ECON PERSPECT, V22, P93, DOI 10.1257/jep.22.4.93; Congressional Budget Office, 2012, LESS MED DEM PROJ DI; Congressional Budget Office,, 2005, HIGH COST MED BEN; Dartmouth Institute for Health Policy and Clinical Practice, 2012, DARTM ATL HLTH CAR; Garber AM, 1998, NBER FR HLTH POL RES, V1, P153; Miller DC, 2011, HEALTH AFFAIR, V30, P2107, DOI 10.1377/hlthaff.2011.0783; Niefeld MR, 2003, DIABETES CARE, V26, P1344, DOI 10.2337/diacare.26.5.1344; NYU Wagner, 2000, NYU ED ALG BACKGR; Oster A, 2003, MED CARE, V41, P198, DOI 10.1097/00005650-200302000-00002; Riley GF, 2007, HEALTH AFFAIR, V26, P808, DOI 10.1377/hlthaff.26.3.808; Smulowitz PB, 2011, ANN EMERG MED, V58, P225, DOI 10.1016/j.annemergmed.2011.02.020; Wharam JF, 2007, JAMA-J AM MED ASSOC, V297, P1093, DOI 10.1001/jama.297.10.1093	21	150	150	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2572	2578		10.1001/jama.2013.7103	http://dx.doi.org/10.1001/jama.2013.7103			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	170KD	23797716	Bronze, Green Published			2022-12-01	WOS:000320848100027
J	Chang, HC; Guarente, L				Chang, Hung-Chun; Guarente, Leonard			SIRT1 Mediates Central Circadian Control in the SCN by a Mechanism that Decays with Aging	CELL			English	Article							REV-ERB-ALPHA; WHEEL-RUNNING ACTIVITY; CALORIE RESTRICTION; DEACETYLASE SIRT1; GENE-EXPRESSION; CLOCK; MICE; METABOLISM; MELATONIN; BRAIN	SIRT1 is a NAD(+)-dependent protein deacetylase that governs many physiological pathways, including circadian rhythm in peripheral tissues. Here, we show that SIRT1 in the brain governs central circadian control by activating the transcription of the two major circadian regulators, BMAL1 and CLOCK. This activation comprises an amplifying circadian loop involving SIRT1, PGC-1 alpha, and Nampt. In aged wildtype mice, SIRT1 levels in the suprachiasmatic nucleus are decreased, as are those of BMAL1 and PER2, giving rise to a longer intrinsic period, a more disrupted activity pattern, and an inability to adapt to changes in the light entrainment schedule. Young mice lacking brain SIRT1 phenocopy these aging-dependent circadian changes, whereas mice that overexpress SIRT1 in the brain are protected from the effects of aging. Our findings indicate that SIRT1 activates the central pacemaker to maintain robust circadian control in young animals, and a decay in this activity may play an important role in aging.	[Chang, Hung-Chun; Guarente, Leonard] MIT, Dept Biol, Glenn Lab Sci Aging, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, Glenn Lab Sci Aging, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu		zhang, hong jun/0000-0003-0030-8323	National Institutes of Health; Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING [R01AG011119, R01AG015339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Puigserver and C.-C. Lee for Pgc-1 alpha constructs and PER2 antibody, respectively. We also thank E. Bell, E. Williams, and Y.-C. Tang for reagents and comments on experiments and members in the Guarente laboratory for discussions. This work was supported by grants from the National Institutes of Health and the Glenn Foundation for Medical Research to L.G. H.-C.C. is an Ellison Medical Foundation Fellow of the Life Science Research Foundation. L.G. consults for Sirtris (a GlaxoSmithKline company).	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P3333, DOI 10.1073/pnas.1214266110; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Chang HM, 2009, J PINEAL RES, V47, P211, DOI 10.1111/j.1600-079X.2009.00704.x; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Grace MS, 1999, VISUAL NEUROSCI, V16, P909, DOI 10.1017/S0952523899165106; Guarente L, 2012, NAT REV MOL CELL BIO, V13, P207, DOI 10.1038/nrm3308; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; Libert S, 2012, AGING CELL, V11, P794, DOI 10.1111/j.1474-9726.2012.00846.x; Libert S, 2011, CELL, V147, P1459, DOI 10.1016/j.cell.2011.10.054; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Miki T, 2012, EMBO J, V31, P1427, DOI 10.1038/emboj.2012.1; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; PIERPAOLI W, 1994, P NATL ACAD SCI USA, V91, P787, DOI 10.1073/pnas.91.2.787; Pifferi F, 2011, J BIOL RHYTHM, V26, P271, DOI 10.1177/0748730411401788; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Ramadori G, 2011, CELL METAB, V14, P301, DOI 10.1016/j.cmet.2011.06.014; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; SACK RL, 1986, J PINEAL RES, V3, P379, DOI 10.1111/j.1600-079X.1986.tb00760.x; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Sato F, 2004, EUR J BIOCHEM, V271, P4409, DOI 10.1111/j.1432-1033.2004.04379.x; Satoh A, 2010, J NEUROSCI, V30, P10220, DOI 10.1523/JNEUROSCI.1385-10.2010; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Siepka SM, 2005, METHOD ENZYMOL, V393, P230, DOI 10.1016/S0076-6879(05)93008-5; Sujino M, 2003, CURR BIOL, V13, P664, DOI 10.1016/S0960-9822(03)00222-7; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Wyse CA, 2010, BRAIN RES, V1337, P21, DOI 10.1016/j.brainres.2010.03.113	54	378	398	3	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1448	1460		10.1016/j.cell.2013.05.027	http://dx.doi.org/10.1016/j.cell.2013.05.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791176	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000320722000014
J	Giordano, F; Saheki, Y; Idevall-Hagren, O; Colombo, SF; Pirruccello, M; Milosevic, I; Gracheva, EO; Bagriantsev, SN; Borgese, N; De Camilli, P				Giordano, Francesca; Saheki, Yasunori; Idevall-Hagren, Olof; Colombo, Sara Francesca; Pirruccello, Michelle; Milosevic, Ira; Gracheva, Elena O.; Bagriantsev, Sviatoslav N.; Borgese, Nica; De Camilli, Pietro			PI(4,5) P-2-Dependent and Ca2+-Regulated ER-PM Interactions Mediated by the Extended Synaptotagmins	CELL			English	Article							ENDOPLASMIC-RETICULUM; PHOSPHOLIPID-BINDING; MEMBRANE-PROTEINS; CONTACT SITES; CA2+ SENSOR; STORE; DOMAINS; COMPLEX; STIM1; FORM	Most available information on endoplasmic reticulum (ER)-plasma membrane (PM) contacts in cells of higher eukaryotes concerns proteins implicated in the regulation of Ca2+ entry. However, growing evidence suggests that such contacts play more general roles in cell physiology, pointing to the existence of additionally ubiquitously expressed ER-PM tethers. Here, we show that the three extended synaptotagmins (E-Syts) are ER proteins that participate in such tethering function via C2 domain-dependent interactions with the PM that require PI(4,5) P-2 in the case of E-Syt2 and E-Syt3 and also elevation of cytosolic Ca2+ in the case of E-Syt1. As they form heteromeric complexes, the E-Syts confer cytosolic Ca2+ regulation to ER-PM contact formation. E-Syts-dependent contacts, however, are not required for store-operated Ca2+ entry. Thus, the ER-PM tethering function of the E-Syts (tricalbins in yeast) mediates the formation of ER-PM contacts sites, which are functionally distinct from those mediated by STIM1 and Orai1.	[Giordano, Francesca; Saheki, Yasunori; Idevall-Hagren, Olof; Pirruccello, Michelle; Milosevic, Ira; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Gracheva, Elena O.; Bagriantsev, Sviatoslav N.] Yale Univ, Sch Med, Dept Physiol, New Haven, CT 06510 USA; [Giordano, Francesca; Saheki, Yasunori; Idevall-Hagren, Olof; Pirruccello, Michelle; Milosevic, Ira; Gracheva, Elena O.; De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA; [Giordano, Francesca; Saheki, Yasunori; Idevall-Hagren, Olof; Pirruccello, Michelle; Milosevic, Ira; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Colombo, Sara Francesca; Borgese, Nica] Univ Milan, CNR, Inst Neurosci, I-20129 Milan, Italy; [Colombo, Sara Francesca; Borgese, Nica] Univ Milan, BIOMETRA Dept, I-20129 Milan, Italy; [Borgese, Nica] Magna Graecia Univ Catanzaro, Dept Hlth Sci, I-88100 Catanzaro, Italy	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; Magna Graecia University of Catanzaro	De Camilli, P (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu	Saheki, Yasunori/D-5430-2016; Cruz e Silva, Odete/AAH-5595-2020; Giordano, Francesca/E-4039-2017; Borgese, Nica/GWZ-8895-2022	Saheki, Yasunori/0000-0002-1229-6668; Giordano, Francesca/0000-0002-5942-1753; Borgese, Nica/0000-0002-7537-3974; Bagriantsev, Sviatoslav/0000-0002-6661-3403; Milosevic, Ira/0000-0001-6440-3763; Gracheva, Elena O/0000-0002-0846-3427; COLOMBO, SARA FRANCESCA/0000-0001-9714-3961; GIORDANO, Francesca/0000-0002-7621-1969; Pirruccello-Straub, Michelle/0000-0002-7996-857X	NIH [NS36251, DK082700, DK45735, DA018343]; Simons Foundation; Italian Association for Cancer Research [IG9040]; Uehara Memorial Foundation; Japan Society for Promotion and Science; Swedish Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK082700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036251, R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for Promotion and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Scott Emr (Cornell University) for his critical input in this work with discussion of unpublished data. We also thank Frank Wilson for outstanding technical support; Abel Alcazar-Roman for discussion and help; Heather Czapla, Yumei Wu, Morven Graham, Xinran Liu, and Stacy Wilson for help with microscopy experiments; Nicholas Ingolia (Carnegie Institution for Science) for consultation; and Thomas Sudhof (Stanford University), Richard S. Lewis (Stanford University), Volker Haucke (Leibniz Institute, Berlin), Erik Snapp (Albert Einstein College of Medicine), Isabelle Derre, and Herve Agaisse (Yale University) for the generous gift of reagents, including unpublished reagents. We also acknowledge the Yale Center for Cellular and Molecular Imaging and Yale Center for Genomics and Proteomics. This work was supported in part by grants from the NIH (NS36251, DK082700, DK45735, and DA018343) and the Simons Foundation to P.D.C., the Italian Association for Cancer Research (AIRC grant IG9040) to N.B., fellowships from the Uehara Memorial Foundation and the Japan Society for Promotion and Science to Y.S., and the Swedish Research Council to O.I.-H.	Anderie I, 2007, EXP CELL RES, V313, P3189, DOI 10.1016/j.yexcr.2007.05.025; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Creutz CE, 2004, CELL MOL LIFE SCI, V61, P1208, DOI 10.1007/s00018-004-4029-8; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Elbaz Y, 2011, TRENDS BIOCHEM SCI, V36, P616, DOI 10.1016/j.tibs.2011.08.004; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; FRANZINIARMSTRONG C, 1994, ANNU REV PHYSIOL, V56, P509, DOI 10.1146/annurev.ph.56.030194.002453; Giordano F, 2009, HUM MOL GENET, V18, P4530, DOI 10.1093/hmg/ddp415; Groer GJ, 2008, FEBS LETT, V582, P3941, DOI 10.1016/j.febslet.2008.10.038; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Jean S, 2010, DEV CELL, V19, P426, DOI 10.1016/j.devcel.2010.08.007; Kida Y, 2005, EMBO J, V24, P3202, DOI 10.1038/sj.emboj.7600788; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Lee I, 2006, FASEB J, V20, P202, DOI 10.1096/fj.05-4581hyp; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Michel AH, 2012, BIOCHEM SOC T, V40, P445, DOI 10.1042/BST20110758; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PORTER KR, 1957, J BIOPHYS BIOCHEM CY, V3, P269, DOI 10.1083/jcb.3.2.269; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROSENBLUTH J, 1962, J CELL BIOL, V13, P405, DOI 10.1083/jcb.13.3.405; Schikorski T, 2007, J NEUROSCI METH, V165, P210, DOI 10.1016/j.jneumeth.2007.06.004; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Shen WW, 2011, BIOL CELL, V103, P365, DOI 10.1042/BC20100152; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Toulmay A, 2012, J CELL SCI, V125, P49, DOI 10.1242/jcs.085118; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	54	348	361	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1494	1509		10.1016/j.cell.2013.05.026	http://dx.doi.org/10.1016/j.cell.2013.05.026			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791178	Green Accepted, Bronze			2022-12-01	WOS:000320722000018
J	Wang, Y				Wang, Yu			The H7N9 Influenza Virus in China - Changes since SARS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Wang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.							Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; World Health Organization, CUM NUMB CONF HUM CA	4	22	23	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2348	2349		10.1056/NEJMp1305311	http://dx.doi.org/10.1056/NEJMp1305311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	167AE	23782176				2022-12-01	WOS:000320601700002
J	Floyd, SR; Pacold, ME; Huang, QY; Clarke, SM; Lam, FC; Cannell, IG; Bryson, BD; Rameseder, J; Lee, MJ; Blake, EJ; Fydrych, A; Ho, R; Greenberger, BA; Chen, GC; Maffa, A; Del Rosario, AM; Root, DE; Carpenter, AE; Hahn, WC; Sabatini, DM; Chen, CC; White, FM; Bradner, JE; Yaffe, MB				Floyd, Scott R.; Pacold, Michael E.; Huang, Qiuying; Clarke, Scott M.; Lam, Fred C.; Cannell, Ian G.; Bryson, Bryan D.; Rameseder, Jonathan; Lee, Michael J.; Blake, Emily J.; Fydrych, Anna; Ho, Richard; Greenberger, Benjamin A.; Chen, Grace C.; Maffa, Amanda; Del Rosario, Amanda M.; Root, David E.; Carpenter, Anne E.; Hahn, William C.; Sabatini, David M.; Chen, Clark C.; White, Forest M.; Bradner, James E.; Yaffe, Michael B.			The bromodomain protein Brd4 insulates chromatin from DNA damage signalling	NATURE			English	Article							P-TEFB; GAMMA-H2AX; ACTIVATION; TRANSCRIPTION; REPAIR; BREAKS	DNA damage activates a signalling network that blocks cell-cycle progression, recruits DNA repair factors and/or triggers senescence or programmed cell death(1). Alterations in chromatin structure are implicated in the initiation and propagation of the DNA damage response(2). Here we further investigate the role of chromatin structure in the DNA damage response by monitoring ionizing-radiation-induced signalling and response events with a high-content multiplex RNA-mediated interference screen of chromatin-modifying and -interacting genes. We discover that an isoform of Brd4, a bromodomain and extra-terminal (BET) family member, functions as an endogenous inhibitor of DNA damage response signalling by recruiting the condensin II chromatin remodelling complex to acetylated histones through bromodomain interactions. Loss of this isoform results in relaxed chromatin structure, rapid cell-cycle checkpoint recovery and enhanced survival after irradiation, whereas functional gain of this isoform compacted chromatin, attenuated DNA damage response signalling and enhanced radiation-induced lethality. These data implicate Brd4, previously known for its role in transcriptional control, as an insulator of chromatin that can modulate the signalling response to DNA damage.	[Floyd, Scott R.; Pacold, Michael E.; Huang, Qiuying; Clarke, Scott M.; Lam, Fred C.; Cannell, Ian G.; Bryson, Bryan D.; Rameseder, Jonathan; Lee, Michael J.; Blake, Emily J.; Fydrych, Anna; Ho, Richard; Greenberger, Benjamin A.; Chen, Grace C.; Maffa, Amanda; Del Rosario, Amanda M.; White, Forest M.; Yaffe, Michael B.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Floyd, Scott R.] Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02215 USA; [Pacold, Michael E.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Pacold, Michael E.; Sabatini, David M.] Whitehead Inst, Cambridge, MA 02139 USA; [Root, David E.; Carpenter, Anne E.; Hahn, William C.; Sabatini, David M.; Bradner, James E.; Yaffe, Michael B.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Hahn, William C.; Chen, Clark C.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Chen, Clark C.; Yaffe, Michael B.] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [White, Forest M.; Yaffe, Michael B.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Yaffe, Michael B.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Yaffe, MB (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	myaffe@mit.edu	Cannell, Ian/AAL-7852-2020; Carpenter, Anne/C-4982-2008; Chen, Clark C/C-8714-2013	Cannell, Ian/0000-0001-5832-9210; Carpenter, Anne/0000-0003-1555-8261; Chen, Clark C/0000-0001-6258-9277; Lee, Michael/0000-0003-3378-6196; White, Forest/0000-0002-1545-1651; Greenberger, Benjamin/0000-0002-2262-5867; floyd, scott/0000-0002-8067-2426; /0000-0002-1446-7256	Koch Institute; Center for Environmental Health Sciences National Institutes of Health [P30-CA14051, ES-002109]; SPARC; Holman Pathway Research Resident Seed Grant; American Society for Radiation Oncology Junior Faculty Career Research Training Award; Burroughs Wellcome Career Award for Medical Scientists;  [R01-ES15339];  [1-U54-CA112967-04];  [R21-NS063917]; NATIONAL CANCER INSTITUTE [U54CA112967, K08CA158149, R21CA109661, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015339, P30ES002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063917] Funding Source: NIH RePORTER	Koch Institute; Center for Environmental Health Sciences National Institutes of Health; SPARC; Holman Pathway Research Resident Seed Grant; American Society for Radiation Oncology Junior Faculty Career Research Training Award; Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Le, T. R. Jones and M. Vokes for assistance with screening and image analysis. We thank C. Whittaker, S. Hoersch and M. Moran for computing and data analysis assistance; C. Reinhardt, C. Ellson and A. Gardino for manuscript editing; and P. Filippakopoulos and S. Knapp for discussions. This work was partially supported by the Koch Institute and Center for Environmental Health Sciences National Institutes of Health Core Grants P30-CA14051 and ES-002109; and by grants R01-ES15339, 1-U54-CA112967-04 and R21-NS063917; a SPARC grant to M.B.Y.; and a Holman Pathway Research Resident Seed Grant, American Society for Radiation Oncology Junior Faculty Career Research Training Award, Klarman Scholar, Koch Institute Clinical Investigator Award, and Burroughs Wellcome Career Award for Medical Scientists to S.R.F.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Carey M., 2007, CSH PROTOC, V2007; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Lee HS, 2010, EMBO J, V29, P1434, DOI 10.1038/emboj.2010.27; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Smyth G.K., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Wu N, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-5; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	22	211	238	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					246	+		10.1038/nature12147	http://dx.doi.org/10.1038/nature12147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23728299	Green Submitted, Green Accepted			2022-12-01	WOS:000320283400052
J	Aktan, AO				Aktan, Ahmet Ozdemir			PERSONAL VIEW Tear gas is a chemical weapon, and Turkey should not use it to torture civilians	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Aktan, Ahmet Ozdemir] Turkish Med Assoc, Istanbul, Turkey; [Aktan, Ahmet Ozdemir] Marmara Univ Hosp, Dept Surg, Istanbul, Turkey	The Health Foundation Of Turkey; Marmara University	Aktan, AO (corresponding author), Turkish Med Assoc, Istanbul, Turkey.	aoaktan@turk.net						Hurley R, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3674; Morgan R, 2002, COMBATING TORTURE EU; United Nations Office for Disarmament Affairs, 1925 GEN PROT PROT P	3	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2013	346								f3801	10.1136/bmj.f3801	http://dx.doi.org/10.1136/bmj.f3801			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166VQ	23757759				2022-12-01	WOS:000320587600002
J	Chou, R; Wasson, N				Chou, Roger; Wasson, Ngoc			Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							PLATELET RATIO INDEX; CHRONIC VIRAL-HEPATITIS; SERUM HYALURONIC-ACID; STEPWISE COMBINATION ALGORITHMS; ALANINE AMINOTRANSFERASE RATIO; PREDICTS ADVANCED FIBROSIS; STANDARD LABORATORY TESTS; SIMPLE NONINVASIVE INDEX; LIVER FIBROSIS; BIOCHEMICAL MARKERS	Background: Many blood tests have been proposed as alternatives to liver biopsy for identifying fibrosis or cirrhosis. Purpose: To evaluate the diagnostic accuracy of blood tests to identify fibrosis or cirrhosis in patients with hepatitis C virus (HCV) infection. Data Sources: MEDLINE (1947 to January 2013), the Cochrane Library, and reference lists. Study Selection: Studies that compared the diagnostic accuracy of blood tests with that of liver biopsy. Data Extraction: Investigators abstracted and checked study details and quality by using predefined criteria. Data Synthesis: 172 studies evaluated diagnostic accuracy. For identifying clinically significant fibrosis, the platelet count, age-platelet index, aspartate aminotransferase-platelet ratio index (APRI), FibroIndex, FibroTest, and Forns index had median positive likelihood ratios of 5 to 10 at commonly used cutoffs and areas under the receiver-operating characteristic curve (AUROCs) of 0.70 or greater (range, 0.71 to 0.86). For identifying cirrhosis, the plate-let count, age-platelet index, APRI, and Hepascore had median positive likelihood ratios of 5 to 10 and AUROCs of 0.80 or greater (range, 0.80 to 0.91). The Goteborg University Cirrhosis Index and the Lok index had slightly lower positive likelihood ratios (4.8 and 4.4, respectively). In direct comparisons, the APRI was associated with a slightly lower AUROC than the FibroTest for identifying fibrosis and a substantially higher AUROC than the aspartate aminotransferase-alanine aminotransferase ratio for identifying fibrosis or cirrhosis. Limitation: Only English-language articles were included, and most studies had methodological limitations, including failure to describe blinded interpretation of liver biopsy specimens and inadequate description of enrollment methods. Conclusion: Many blood tests are moderately useful for identifying clinically significant fibrosis or cirrhosis in HCV-infected patients.	[Chou, Roger; Wasson, Ngoc] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Mail Code BICC, 3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610	AHRQ, Rockville, Maryland [290-2007-10057-I]; Agency for Healthcare Research and Quality	AHRQ, Rockville, Maryland; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.; By AHRQ (contract 290-2007-10057-I, task order 8), Rockville, Maryland.	Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; Adler M, 2008, HEPATOLOGY, V47, P762, DOI 10.1002/hep.22085; *AG HLTH RES QUAL, 2012, AHRQ PUBL, V10; Ahmad W, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-44; Alsatie M, 2007, J CLIN GASTROENTEROL, V41, P416, DOI 10.1097/01.mcg.0000225593.93577.64; ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; Anderson FH, 2000, HEPATOL RES, V18, P63, DOI 10.1016/S1386-6346(99)00085-6; Andriulli A, 2004, J VIRAL HEPATITIS, V11, P536, DOI 10.1111/j.1365-2893.2004.00519.x; [Anonymous], 1997, HEPATOLOGY, V26, pS2; Arabul M, 2012, TURK J GASTROENTEROL, V23, P538, DOI 10.4318/tjg.2012.0358; Arain SA, 2011, SAUDI MED J, V32, P1241; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Attallah AM, 2007, J IMMUNOASS IMMUNOCH, V28, P331, DOI 10.1080/15321810701603476; Attallah AM, 2007, J IMMUNOASS IMMUNOCH, V28, P155, DOI 10.1080/15321810701212088; Attallah AM, 2013, ANN HEPATOL, V12, P44, DOI 10.1016/S1665-2681(19)31384-5; Attallah Abdelfattah M, 2011, Egypt J Immunol, V18, P33; Attallah AM, 2012, CLIN CHIM ACTA, V413, P1725, DOI 10.1016/j.cca.2012.06.031; Attallah AM, 2011, HEPATOL RES, V41, P1075, DOI 10.1111/j.1872-034X.2011.00862.x; Attallah AM, 2006, CLIN CHIM ACTA, V369, P66, DOI 10.1016/j.cca.2006.01.004; Attallah AM, 2006, HEPATOL RES, V34, P163, DOI 10.1016/j.hepres.2005.12.004; Bain VG, 2004, J VIRAL HEPATITIS, V11, P375, DOI 10.1111/j.1365-2893.2004.00520.x; Becker L, 2009, CLIN GASTROENTEROL H, V7, P696, DOI 10.1016/j.cgh.2009.01.010; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bejarano G, 2009, REV ESP ENFERM DIG, V101, P325, DOI 10.4321/s1130-01082009000500004; Ben Jazia E, 2009, INFECT DIS CLIN PRAC, V17, P385; Berg T, 2004, HEPATOLOGY, V39, P1456, DOI 10.1002/hep.20226; Boeker KHW, 2002, CLIN CHIM ACTA, V316, P71, DOI 10.1016/S0009-8981(01)00730-6; Bonacini M, 1997, AM J GASTROENTEROL, V92, P1302; Borroni G, 2006, ALIMENT PHARM THER, V24, P797, DOI 10.1111/j.1365-2036.2006.03034.x; Bota S, 2011, HEPAT MON, V11, P548; Bourliere M, 2008, ALIMENT PHARM THER, V28, P458, DOI 10.1111/j.1365-2036.2008.03742.x; Bourliere M, 2006, J VIRAL HEPATITIS, V13, P659, DOI 10.1111/j.1365-2893.2006.00736.x; Boursier J, 2012, HEPATOLOGY, V55, P58, DOI 10.1002/hep.24654; Boursier J, 2011, AM J GASTROENTEROL, V106, P1255, DOI 10.1038/ajg.2011.100; Boursier J, 2009, EUR J GASTROEN HEPAT, V21, P28, DOI 10.1097/MEG.0b013e32830cebd7; Burton MJ, 2011, SOUTH MED J, V104, P309, DOI 10.1097/SMJ.0b013e318213cf52; Busch MP, 2001, TRANSFUS CLIN BIOL, V8, P200, DOI 10.1016/S1246-7820(01)00125-2; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; Cales P, 2008, LIVER INT, V28, P1352, DOI 10.1111/j.1478-3231.2008.01789.x; Cales P, 2010, CLIN BIOCHEM, V43, P1315, DOI 10.1016/j.clinbiochem.2010.08.010; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2009, J HEPATOL, V50, P59, DOI 10.1016/j.jhep.2008.08.018; Castera L, 2010, J HEPATOL, V52, P191, DOI 10.1016/j.jhep.2009.11.008; Castera L, 2009, J VIRAL HEPATITIS, V16, P300, DOI 10.1111/j.1365-2893.2009.01087.x; Cheong JY, 2011, DIGEST DIS SCI, V56, P555, DOI 10.1007/s10620-010-1305-3; Cheung KJ, 2011, EUR J GASTROEN HEPAT, V23, P701, DOI 10.1097/MEG.0b013e3283471b74; Cheung RC, 2008, J CLIN GASTROENTEROL, V42, P827, DOI 10.1097/MCG.0b013e318046ea9a; CHOU R, 2012, COMP EFFECTIVENESS R; Christensen C, 2006, J VIRAL HEPATITIS, V13, P652, DOI 10.1111/j.1365-2893.2006.00743.x; Chrysanthos NV, 2006, EUR J GASTROEN HEPAT, V18, P389, DOI 10.1097/00042737-200604000-00012; Cobbold JFL, 2010, J VIRAL HEPATITIS, V17, P537, DOI 10.1111/j.1365-2893.2009.01209.x; Colletta C, 2005, HEPATOLOGY, V42, P838, DOI 10.1002/hep.20814; Colli A, 2005, WORLD J GASTROENTERO, V11, P7318, DOI 10.3748/wjg.v11.i46.7318; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Crisan D, 2012, HEPAT MON, V12, P177, DOI 10.5812/hepatmon.853; Cross TJS, 2010, J VIRAL HEPATITIS, V17, P546, DOI 10.1111/j.1365-2893.2009.01210.x; Cross TJS, 2009, EUR J GASTROEN HEPAT, V21, P730, DOI 10.1097/MEG.0b013e32830dfcb3; da Silva RG, 2008, BRAZ J INFECT DIS, V12, P15, DOI 10.1590/S1413-86702008000100005; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Deghady A, 2012, GENET TEST MOL BIOMA, V16, P531, DOI 10.1089/gtmb.2011.0098; Dinesen L, 2008, DIGEST LIVER DIS, V40, P743, DOI 10.1016/j.dld.2008.01.013; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Ehsan N, 2008, ARAB J GASTROENTEROL, V9, P7; El-Gindy Iman, 2003, Egypt J Immunol, V10, P27; El-Mezayen HA, 2013, EUR J GASTROEN HEPAT, V25, P69, DOI 10.1097/MEG.0b013e3283594924; El-Sayed Rokaya, 2011, Trop Gastroenterol, V32, P267; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; el-Shorbagy Eman, 2004, J Egypt Soc Parasitol, V34, P459; Fabris C, 2008, CLIN CHEM LAB MED, V46, P253, DOI 10.1515/CCLM.2008.051; Amorim TGF, 2012, ANN HEPATOL, V11, P855; Ferraioli G, 2012, AM J ROENTGENOL, V199, P19, DOI 10.2214/AJR.11.7517; Fontana RJ, 2008, HEPATOLOGY, V47, P789, DOI 10.1002/hep.22099; Fontanges T, 2008, GASTROEN CLIN BIOL, V32, P858, DOI 10.1016/j.gcb.2008.05.019; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Fouad SA, 2012, WORLD J GASTROENTERO, V18, P2988, DOI 10.3748/wjg.v18.i23.2988; Friedrich-Rust M, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-103; Gabrielli GB, 1997, CLIN CHIM ACTA, V265, P21, DOI 10.1016/S0009-8981(97)00103-4; Gara N, 2013, CLIN GASTROENTEROL H, V11, P303, DOI 10.1016/j.cgh.2012.10.044; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Giannini E, 2003, ARCH INTERN MED, V163, P218, DOI 10.1001/archinte.163.2.218; Giannini E, 2003, HEPATOLOGY, V38, P1312, DOI 10.1053/jhep.2003.50500; Giannini EG, 2006, J CLIN GASTROENTEROL, V40, P521, DOI 10.1097/00004836-200607000-00011; Gordon A, 2005, J GASTROEN HEPATOL, V20, P825, DOI 10.1111/j.1440-1746.2005.03828.x; Grigorescu M, 2007, J GASTROINTEST LIVER, V16, P31; Guechot J, 1996, CLIN CHEM, V42, P558; GUECHOT J, 1994, J HEPATOL, V20, P388, DOI 10.1016/S0168-8278(94)80013-8; Guechot J, 2012, CLIN CHEM LAB MED, V50, P693, DOI 10.1515/cclm-2011-0858; Guechot J, 2010, CLIN CHIM ACTA, V411, P86, DOI 10.1016/j.cca.2009.10.011; Guzelbulut F, 2011, TURK J GASTROENTEROL, V22, P279, DOI 10.4318/tjg.2011.0213; Halfon P, 2006, AM J GASTROENTEROL, V101, P547, DOI 10.1111/j.1572-0241.2006.00411.x; Halfon P, 2007, HEPATOLOGY, V46, P280, DOI 10.1002/hep.21717; Halfon P, 2007, J HEPATOL, V46, P395, DOI 10.1016/j.jhep.2006.09.020; Halfon Philippe, 2005, Comp Hepatol, V4, P6, DOI 10.1186/1476-5926-4-6; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hsieh YY, 2012, WORLD J GASTROENTERO, V18, P746, DOI 10.3748/wjg.v18.i8.746; Hsieh Yung-Yu, 2009, Chang Gung Med J, V32, P614; Iacobellis A, 2005, ALIMENT PHARM THER, V22, P769, DOI 10.1111/j.1365-2036.2005.02633.x; Iacobellis A, 2005, AM J GASTROENTEROL, V100, P868, DOI 10.1111/j.1572-0241.2005.40881.x; Ichino N, 2010, WORLD J GASTROENTERO, V16, P4809, DOI 10.3748/wjg.v16.i38.4809; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Imperiale TF, 2000, AM J GASTROENTEROL, V95, P2328, DOI 10.1111/j.1572-0241.2000.02322.x; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Islam S, 2005, SCAND J GASTROENTERO, V40, P867, DOI 10.1080/00365520510015674; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Jeffers Lennox J, 2007, Gastroenterol Hepatol (N Y), V3, P367; Kalantari H, 2011, HEPAT RES TREAT, V2011, DOI DOI 10.1155/2011/972759]; Kaul V, 2002, AM J GASTROENTEROL, V97, P2623, DOI 10.1111/j.1572-0241.2002.06040.x; Khairy M, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.6718; Khan Dilshad Ahmad, 2008, J Ayub Med Coll Abbottabad, V20, P122; Khokhar N, 2003, J Pak Med Assoc, V53, P101; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Koda M, 2007, HEPATOLOGY, V45, P297, DOI 10.1002/hep.21520; Lackner C, 2006, HEPATOLOGY, V43, P378, DOI 10.1002/hep.21037; Lackner C, 2005, HEPATOLOGY, V41, P1376, DOI 10.1002/hep.20717; Lambert J, 2008, CLIN CHEM, V54, P1372, DOI 10.1373/clinchem.2007.097923; Le Calvez S, 2004, HEPATOLOGY, V39, P862, DOI 10.1002/hep.20099; Leroy V, 2004, AM J GASTROENTEROL, V99, P271, DOI 10.1111/j.1572-0241.2004.04055.x; Leroy V, 2008, CLIN BIOCHEM, V41, P1368, DOI 10.1016/j.clinbiochem.2008.06.020; Leroy V, 2007, J HEPATOL, V46, P775, DOI 10.1016/j.jhep.2006.12.013; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Liu CH, 2006, LIVER INT, V26, P1087, DOI 10.1111/j.1478-3231.2006.01355.x; Lo Iacono O, 1998, ALIMENT PHARM THERAP, V12, P1091; Loaeza-del-Castillo A, 2008, ANN HEPATOL, V7, P350, DOI 10.1016/S1665-2681(19)31836-8; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; Lu SN, 2006, CANCER-AM CANCER SOC, V107, P2212, DOI 10.1002/cncr.22242; Luo JC, 2002, HEPATO-GASTROENTEROL, V49, P478; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Martinez SM, 2011, ALIMENT PHARM THER, V33, P138, DOI 10.1111/j.1365-2036.2010.04500.x; McHutchison JG, 2000, J GASTROEN HEPATOL, V15, P945, DOI 10.1046/j.1440-1746.2000.02233.x; Metwally MA, 2007, DIGEST DIS SCI, V52, P582, DOI 10.1007/s10620-006-9366-z; Morali G, 2007, ISR MED ASSOC J, V9, P588; Morra R, 2007, ALIMENT PHARM THER, V26, P847, DOI 10.1111/j.1365-2036.2007.03427.x; Morrison A, 2012, INT J TECHNOL ASSESS, V28, P138, DOI 10.1017/S0266462312000086; Mossong Joel, 2011, Bull Soc Sci Med Grand Duche Luxemb, P19; Murawaki Y, 2001, J GASTROEN HEPATOL, V16, P777, DOI 10.1046/j.1440-1746.2001.02515.x; Murawaki Y, 2001, J GASTROENTEROL, V36, P399, DOI 10.1007/s005350170084; Myers RP, 2003, DIGEST DIS SCI, V48, P146, DOI 10.1023/A:1021702902681; Myers RP, 2002, AM J GASTROENTEROL, V97, P2419, DOI 10.1111/j.1572-0241.2002.05997.x; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; Obrador BD, 2006, EUR J GASTROEN HEPAT, V18, P57, DOI 10.1097/00042737-200601000-00010; Obuchowski NA, 2005, ACAD RADIOL, V12, P1198, DOI 10.1016/j.acra.2005.05.013; Ohta T, 2006, ACTA MED OKAYAMA, V60, P77; Omran Mohamed M, 2011, Arab J Gastroenterol, V12, P74, DOI 10.1016/j.ajg.2011.04.006; Paggi S, 2008, J HEPATOL, V49, P564, DOI 10.1016/j.jhep.2008.07.007; Parise ER, 2006, LIVER INT, V26, P1095, DOI 10.1111/j.1478-3231.2006.01356.x; Park G, 2005, AM J GASTROENTEROL, V100, P1623, DOI 10.1111/j.1572-0241.2005.50006_6.x; Park GJH, 2000, J GASTROEN HEPATOL, V15, P386, DOI 10.1046/j.1440-1746.2000.02172.x; Park JJ, 2011, HEPATO-GASTROENTEROL, V58, P1321, DOI 10.5754/hge11041; Park Joong-Won, 2005, Korean J Gastroenterol, V45, P217; Park SH, 2011, CLIN BIOCHEM, V44, P1396, DOI 10.1016/j.clinbiochem.2011.08.1151; Parkes J, 2011, J VIRAL HEPATITIS, V18, P23, DOI 10.1111/j.1365-2893.2009.01263.x; Patel K, 2009, J VIRAL HEPATITIS, V16, P178, DOI 10.1111/j.1365-2893.2008.01062.x; Patel K, 2004, J HEPATOL, V41, P935, DOI 10.1016/j.jhep.2004.08.008; Pham B, 2005, J CLIN EPIDEMIOL, V58, P769, DOI 10.1016/j.jclinepi.2004.08.021; Plevris JN, 2000, EUR J GASTROEN HEPAT, V12, P1121, DOI 10.1097/00042737-200012100-00009; Pohl A, 2001, AM J GASTROENTEROL, V96, P3142, DOI 10.1111/j.1572-0241.2001.05268.x; Poynard T, 2003, HEPATOLOGY, V38, P481, DOI 10.1053/jhep.2003.50319; Poynard T, 2002, J VIRAL HEPATITIS, V9, P128, DOI 10.1046/j.1365-2893.2002.00341.x; Poynard T, 1997, J VIRAL HEPATITIS, V4, P199, DOI 10.1046/j.1365-2893.1997.00141.x; Poynard T, 2007, CLIN CHEM, V53, P1615, DOI 10.1373/clinchem.2007.085795; Poynard T, 2010, ANTIVIR THER, V15, P617, DOI 10.3851/IMP1570; Pradat P, 2002, HEPATOLOGY, V36, P973, DOI 10.1053/jhep.2002.35530; Reedy DW, 1998, DIGEST DIS SCI, V43, P2156, DOI 10.1023/A:1018888021118; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Renou C, 2001, AM J GASTROENTEROL, V96, P1657, DOI 10.1111/j.1572-0241.2001.03830.x; Romagnuolo J, 2001, AM J GASTROENTEROL, V96, P3165, DOI 10.1111/j.1572-0241.2001.05275.x; Romera M, 2006, REV ESP ENFERM DIG, V98, P161, DOI 10.4321/s1130-01082006000300002; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Rossi E, 2003, CLIN CHEM, V49, P450, DOI 10.1373/49.3.450; Saadeh S, 2001, HEPATOLOGY, V33, P196, DOI 10.1053/jhep.2001.20534; Said Yosra, 2010, Tunis Med, V88, P573; Saitou Y, 2005, WORLD J GASTROENTERO, V11, P476, DOI 10.3748/wjg.v11.i4.476; Schiano TD, 2005, CLIN GASTROENTEROL H, V3, P930, DOI 10.1016/S1542-3565(05)00541-0; Schneider ARJ, 2006, CLIN EXP PHARMACOL P, V33, P300, DOI 10.1111/j.1440-1681.2006.04365.x; Sebastian G, 2008, J VIRAL HEPATITIS, V15, P212, DOI 10.1111/j.1365-2893.2007.00932.x; Sebastiani G, 2006, J HEPATOL, V44, P686, DOI 10.1016/j.jhep.2006.01.007; Sebastiani G, 2012, ALIMENT PHARM THER, V35, P92, DOI 10.1111/j.1365-2036.2011.04897.x; Sebastiani G, 2011, ALIMENT PHARM THER, V34, P1202, DOI 10.1111/j.1365-2036.2011.04861.x; Sebastiani G, 2009, HEPATOLOGY, V49, P1821, DOI 10.1002/hep.22859; Seeff LB, 2010, CLIN GASTROENTEROL H, V8, P877, DOI 10.1016/j.cgh.2010.03.025; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Shaheen AAM, 2007, HEPATOLOGY, V46, P912, DOI 10.1002/hep.21835; Sheth SG, 1998, AM J GASTROENTEROL, V93, P44, DOI 10.1111/j.1572-0241.1998.044_c.x; Shlomai A, 2013, J VIRAL HEPATITIS, V20, P95, DOI 10.1111/j.1365-2893.2012.01628.x; Silva ISS, 2004, J GASTROEN HEPATOL, V19, P314, DOI 10.1111/j.1440-1746.2003.03256.x; Sirli R, 2010, HEPAT MON, V10, P88; Snyder N, 2007, CLIN CHIM ACTA, V381, P119, DOI 10.1016/j.cca.2007.02.046; Snyder N, 2006, J CLIN GASTROENTEROL, V40, P535, DOI 10.1097/00004836-200607000-00013; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Stibbe KJM, 2011, SCAND J GASTROENTERO, V46, P962, DOI 10.3109/00365521.2011.574725; Sud A, 2004, HEPATOLOGY, V39, P1239, DOI 10.1002/hep.20207; Testa R, 2006, J INTERN MED, V260, P142, DOI 10.1111/j.1365-2796.2006.01673.x; Thabut D, 2003, HEPATOLOGY, V37, P1220, DOI 10.1053/jhep.2003.50109; Trocme C, 2006, J VIRAL HEPATITIS, V13, P643, DOI 10.1111/j.1365-2893.2006.00730.x; Usluer G, 2012, EUR J CLIN MICROBIOL, V31, P1873, DOI 10.1007/s10096-011-1513-6; Uyar C, 2010, INDIAN J PATHOL MICR, V53, P470, DOI 10.4103/0377-4929.68281; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Viana MSVB, 2009, ANN HEPATOL, V8, P26, DOI 10.1016/S1665-2681(19)31807-1; Verbaan H, 1997, SCAND J GASTROENTERO, V32, P494, DOI 10.3109/00365529709025088; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Walsh KM, 2000, J HEPATOL, V32, P325, DOI 10.1016/S0168-8278(00)80079-3; Walsh KM, 1999, DIGEST DIS SCI, V44, P624, DOI 10.1023/A:1026630129025; Walsh KM, 1999, EUR J GASTROEN HEPAT, V11, P827, DOI 10.1097/00042737-199908000-00003; West J, 2010, GASTROENTEROLOGY, V139, P1230, DOI 10.1053/j.gastro.2010.06.015; Westin J, 2008, SCAND J GASTROENTERO, V43, P73, DOI 10.1080/00365520701514461; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WILLIAMS ALB, 1988, GASTROENTEROLOGY, V95, P734, DOI 10.1016/S0016-5085(88)80022-2; Wilson LE, 2006, HEPATOLOGY, V43, P788, DOI 10.1002/hep.21091; Wong VS, 1998, J VIRAL HEPATITIS, V5, P187, DOI 10.1046/j.1365-2893.1998.00100.x; Yano M, 1996, HEPATOLOGY, V23, P1334, DOI 10.1002/hep.510230607; Yilmaz Y, 2011, HEPAT MON, V11, P103; Zaman A, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.06.044; Zarski JP, 2012, J HEPATOL, V56, P55, DOI 10.1016/j.jhep.2011.05.024; Zeng MD, 2005, HEPATOLOGY, V42, P1437, DOI 10.1002/hep.20960; ZWEIG MH, 1993, CLIN CHEM, V39, P561	215	240	245	2	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 4	2013	158	11					807	+		10.7326/0003-4819-158-11-201306040-00005	http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00005			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164AA	23732714				2022-12-01	WOS:000320379800004
J	Ashby, M				Ashby, Michael			Caring for dying patients is not about prolonging life at all costs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE		[Ashby, Michael] Univ Tasmania, Royal Hobart Hosp, Southern Tasmania Area Hlth Serv, Hobart, Tas 7001, Australia; [Ashby, Michael] Univ Tasmania, Fac Hlth Sci, Hobart, Tas 7001, Australia	Royal Hobart Hospital; University of Tasmania; University of Tasmania	Ashby, M (corresponding author), Univ Tasmania, Royal Hobart Hosp, Southern Tasmania Area Hlth Serv, Hobart, Tas 7001, Australia.	michael.ashby@dhhs.tas.gov.au						[Anonymous], 1996, HASTINGS CTR REPOR S, V26, pS1; Ashby MA, 2013, MED J AUSTRALIA, V198, P188, DOI 10.5694/mja12.10498; Ashby MA, 2011, J BIOETHIC INQ, V8, P151, DOI 10.1007/s11673-011-9291-5; Breen E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1837; Economist Intelligence Unit, 2010, QUAL DEATH RANK END; Ellershaw J, 2003, BRIT MED J, V326, P30, DOI 10.1136/bmj.326.7379.30; Hanson MJ, 1999, GOALS MED FORGOTTEN; Hastings Center, J LYNN CALLS REF END; Kellehear A., 1999, HLTH PROMOTING PALLI	9	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2013	346								f3027	10.1136/bmj.f3027	http://dx.doi.org/10.1136/bmj.f3027			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158CZ	23714191				2022-12-01	WOS:000319947500004
J	Leprivier, G; Remke, M; Rotblat, B; Dubuc, A; Mateo, ARF; Kool, M; Agnihotri, S; El-Naggar, A; Yu, B; Somasekharan, SP; Faubert, B; Bridon, G; Tognon, CE; Mathers, J; Thomas, R; Li, A; Barokas, A; Kwok, B; Bowden, M; Smith, S; Wu, XC; Korshunov, A; Hielscher, T; Northcott, PA; Galpin, JD; Ahern, CA; Wang, Y; McCabe, MG; Collins, VP; Jones, RG; Pollak, M; Delattre, O; Gleave, ME; Jan, E; Pfister, SM; Proud, CG; Derry, WB; Taylor, MD; Sorensen, PH				Leprivier, Gabriel; Remke, Marc; Rotblat, Barak; Dubuc, Adrian; Mateo, Abigail-Rachele F.; Kool, Marcel; Agnihotri, Sameer; El-Naggar, Amal; Yu, Bin; Somasekharan, Syam Prakash; Faubert, Brandon; Bridon, Gaelle; Tognon, Cristina E.; Mathers, Joan; Thomas, Ryan; Li, Amy; Barokas, Adi; Kwok, Brian; Bowden, Mary; Smith, Stephanie; Wu, Xiaochong; Korshunov, Andrey; Hielscher, Thomas; Northcott, Paul A.; Galpin, Jason D.; Ahern, Christopher A.; Wang, Ye; McCabe, Martin G.; Collins, V. Peter; Jones, Russell G.; Pollak, Michael; Delattre, Olivier; Gleave, Martin E.; Jan, Eric; Pfister, Stefan M.; Proud, Christopher G.; Derry, W. Brent; Taylor, Michael D.; Sorensen, Poul H.			The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation	CELL			English	Article							ETV6-NTRK3 GENE FUSION; TUMOR-CELL SURVIVAL; MESSENGER-RNA; PATHWAY; GROWTH; INHIBITION; PHOSPHORYLATION; PROLIFERATION; HOMEOSTASIS; METABOLISM	Metabolic adaptation is essential for cell survival during nutrient deprivation. We report that eukaryotic elongation factor 2 kinase (eEF2K), which is activated by AMP-kinase (AMPK), confers cell survival under acute nutrient depletion by blocking translation elongation. Tumor cells exploit this pathway to adapt to nutrient deprivation by reactivating the AMPK-eEF2K axis. Adaptation of transformed cells to nutrient withdrawal is severely compromised in cells lacking eEF2K. Moreover, eEF2K knockdown restored sensitivity to acute nutrient deprivation in highly resistant human tumor cell lines. In vivo, overexpression of eEF2K rendered murine tumors remarkably resistant to caloric restriction. Expression of eEF2K strongly correlated with overall survival in human medulloblastoma and glioblastoma multiforme. Finally, C. elegans strains deficient in efk-1, the eEF2K ortholog, were severely compromised in their response to nutrient depletion. Our data highlight a conserved role for eEF2K in protecting cells from nutrient deprivation and in conferring tumor cell adaptation to metabolic stress.	[Leprivier, Gabriel; Rotblat, Barak; El-Naggar, Amal; Somasekharan, Syam Prakash; Tognon, Cristina E.; Mathers, Joan; Thomas, Ryan; Li, Amy; Barokas, Adi; Kwok, Brian; Sorensen, Poul H.] Univ British Columbia, British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L4, Canada; [Leprivier, Gabriel; Rotblat, Barak; El-Naggar, Amal; Somasekharan, Syam Prakash; Tognon, Cristina E.; Mathers, Joan; Thomas, Ryan; Li, Amy; Barokas, Adi; Kwok, Brian; Sorensen, Poul H.] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1L4, Canada; [Remke, Marc; Dubuc, Adrian; Agnihotri, Sameer; Wu, Xiaochong; Northcott, Paul A.; Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON M5G 1L7, Canada; [Remke, Marc; Dubuc, Adrian; Agnihotri, Sameer; Wu, Xiaochong; Northcott, Paul A.; Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1L7, Canada; [Remke, Marc; Dubuc, Adrian; Mateo, Abigail-Rachele F.; Wu, Xiaochong; Derry, W. Brent; Taylor, Michael D.] Univ Toronto, HSC, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Remke, Marc; Kool, Marcel; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Hielscher, Thomas] German Canc Res Ctr, Div Biostat, D-69120 Heidelberg, Germany; [Mateo, Abigail-Rachele F.; Yu, Bin; Taylor, Michael D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 2M9, Canada; [Faubert, Brandon; Jones, Russell G.] McGill Univ, Dept Physiol, Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Bridon, Gaelle] McGill Univ, Goodman Canc Res Ctr, Metabol Core Facil, Montreal, PQ H3A 1A3, Canada; [Bowden, Mary; Smith, Stephanie; Gleave, Martin E.] Univ British Columbia, Dept Urol Sci, Vancouver, BC V6H 3Z6, Canada; [Bowden, Mary; Smith, Stephanie; Gleave, Martin E.] Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada; [Korshunov, Andrey] Heidelberg Univ, DKFZ, Dept Neuropathol, D-69120 Heidelberg, Germany; [Galpin, Jason D.; Ahern, Christopher A.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Wang, Ye; Pollak, Michael] Lady Davis Res Inst, Montreal, PQ H3T 1E2, Canada; [Wang, Ye; Pollak, Michael] McGill Univ, Montreal, PQ H3T 1E2, Canada; [McCabe, Martin G.] Univ Manchester, Sch Canc & Enabling Sci, Manchester M20 4BX, Lancs, England; [McCabe, Martin G.; Collins, V. Peter] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Delattre, Olivier] Inst Curie, INSERM, U830, Lab Genet & Biol Canc, F-75248 Paris, France; [Jan, Eric] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Proud, Christopher G.] Univ Southampton, Ctr Biol Sci, Southampton SO17 1BJ, Hants, England	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; McGill University; McGill University; University of British Columbia; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Iowa; McGill University; McGill University; University of Manchester; University of Cambridge; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; University of British Columbia; Ruprecht Karls University Heidelberg; University of Southampton	Sorensen, PH (corresponding author), Univ British Columbia, British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L4, Canada.	psor@mail.ubc.ca	Jan, Eric/O-1923-2019; Jones, Russell Graham/ABD-5261-2021; Jones, Russell/AAC-2861-2022; McCabe, Martin/P-5896-2015; Kool, Marcel/H-2541-2013; EL-Naggar, Amal/AAE-5565-2022; Pfister, Stefan M/F-6860-2013; Northcott, Paul A/N-4022-2018; Rotblat, Barak/H-5970-2019; Derry, Brent/CAF-4503-2022	Jones, Russell Graham/0000-0003-2250-4675; McCabe, Martin/0000-0002-5138-0707; Pfister, Stefan M/0000-0002-5447-5322; Northcott, Paul A/0000-0002-1220-5252; Rotblat, Barak/0000-0003-2985-7115; delattre, olivier/0000-0002-8730-2276; EL-Naggar, Amal/0000-0002-3202-6171; Gleave, Martin/0000-0003-4235-0167; Faubert, Brandon/0000-0002-2886-886X; Somasekharan, Syam/0000-0002-9006-8206; Korshunov, Andrey/0000-0002-5257-3623; Remke, Marc/0000-0002-9404-9993; AGNIHOTRI, SAMEER/0000-0001-6584-3795; Proud, Christopher/0000-0003-0704-6442; Taylor, Michael/0000-0001-7009-3466; Ahern, Christopher/0000-0002-7975-2744; Galpin, Jason/0000-0003-1923-5312; Derry, Brent/0000-0002-1977-8475; Pollak, Michael/0000-0003-3047-0604	Canadian Cancer Society Research Institute; British Columbia Cancer Foundation; National Institutes of Health [CA159859]; Terry Fox Research Institute; Pediatric Brain Tumor Foundation; The Brain Tumour Charity [10/106] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA159859] Funding Source: NIH RePORTER	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); British Columbia Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry Fox Research Institute; Pediatric Brain Tumor Foundation; The Brain Tumour Charity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Tang, M. Robertson, and C. Chow for technical assistance and B. Fonseca (McGill University), S. Aparicio, S. Mullaly, T. Ng (UBC), J.A. Pospisilik, and R. Teperino (Max Planck Institute, Freiburg) for helpful discussions. This work was supported by the Canadian Cancer Society Research Institute and the British Columbia Cancer Foundation (to P.H.S.) through generous donations from Team Finn and other riders in the Ride to Conquer Cancer and by the National Institutes of Health (CA159859), the Terry Fox Research Institute, and the Pediatric Brain Tumor Foundation (to M.D.T.).	Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; BRENNER S, 1974, GENETICS, V77, P71; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Caro-Maldonado A., 2011, OPEN CELL SIGNAL J, V3, P42, DOI [10.2174/1876390101103010042, DOI 10.2174/1876390101103010042]; Chiaradonna F, 2006, ONCOGENE, V25, P5391, DOI 10.1038/sj.onc.1209528; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; FAN H, 1970, J MOL BIOL, V50, P655, DOI 10.1016/0022-2836(70)90091-4; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; MATHEWS MB, 2007, COLD SPRING HARB MON, V48, P1; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; Ng TL, 2012, CELL DEATH DIFFER, V19, P501, DOI 10.1038/cdd.2011.119; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Sakagami H, 2002, NEUROSCI LETT, V330, P41, DOI 10.1016/S0304-3940(02)00715-2; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; Somasekharan Syam Prakash, 2012, J Proteomics, V77, pe1, DOI 10.1016/j.jprot.2012.08.019; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	42	277	290	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					1064	1079		10.1016/j.cell.2013.04.055	http://dx.doi.org/10.1016/j.cell.2013.04.055			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706743	Bronze, Green Accepted			2022-12-01	WOS:000319456800014
J	Watanabe, T; Kiso, M; Fukuyama, S; Nakajima, N; Imai, M; Yamada, S; Murakami, S; Yamayoshi, S; Iwatsuki-Horimoto, K; Sakoda, Y; Takashita, E; McBride, R; Noda, T; Hatta, M; Imai, H; Zhao, DM; Kishida, N; Shirakura, M; de Vries, RP; Shichinohe, S; Okamatsu, M; Tamura, T; Tomita, Y; Fujimoto, N; Goto, K; Katsura, H; Kawakami, E; Ishikawa, I; Watanabe, S; Ito, M; Sakai-Tagawa, Y; Sugita, Y; Uraki, R; Yamaji, R; Eisfeld, AJ; Zhong, GX; Fan, SF; Ping, JH; Maher, EA; Hanson, A; Uchida, Y; Saito, T; Ozawa, M; Neumann, G; Kida, H; Odagiri, T; Paulson, JC; Hasegawa, H; Tashiro, M; Kawaoka, Y				Watanabe, Tokiko; Kiso, Maki; Fukuyama, Satoshi; Nakajima, Noriko; Imai, Masaki; Yamada, Shinya; Murakami, Shin; Yamayoshi, Seiya; Iwatsuki-Horimoto, Kiyoko; Sakoda, Yoshihiro; Takashita, Emi; McBride, Ryan; Noda, Takeshi; Hatta, Masato; Imai, Hirotaka; Zhao, Dongming; Kishida, Noriko; Shirakura, Masayuki; de Vries, Robert P.; Shichinohe, Shintaro; Okamatsu, Masatoshi; Tamura, Tomokazu; Tomita, Yuriko; Fujimoto, Naomi; Goto, Kazue; Katsura, Hiroaki; Kawakami, Eiryo; Ishikawa, Izumi; Watanabe, Shinji; Ito, Mutsumi; Sakai-Tagawa, Yuko; Sugita, Yukihiko; Uraki, Ryuta; Yamaji, Reina; Eisfeld, Amie J.; Zhong, Gongxun; Fan, Shufang; Ping, Jihui; Maher, Eileen A.; Hanson, Anthony; Uchida, Yuko; Saito, Takehiko; Ozawa, Makoto; Neumann, Gabriele; Kida, Hiroshi; Odagiri, Takato; Paulson, James C.; Hasegawa, Hideki; Tashiro, Masato; Kawaoka, Yoshihiro			Characterization of H7N9 influenza A viruses isolated from humans	NATURE			English	Article							MOLECULAR-BASIS; AVIAN H5N1; IN-VITRO; TRANSMISSION; REPLICATION; INFECTION; BINDING; FERRETS; SITE; PATHOGENESIS	Avian influenza A viruses rarely infect humans; however, when human infection and subsequent human-to-human transmission occurs, worldwide outbreaks (pandemics) can result. The recent sporadic infections of humans in China with a previously unrecognized avian influenza A virus of the H7N9 subtype (A(H7N9)) have caused concern owing to the appreciable case fatality rate associated with these infections (more than 25%), potential instances of human-to-human transmission(1), and the lack of pre-existing immunity among humans to viruses of this subtype. Here we characterize two early human A(H7N9) isolates, A/Anhui/1/2013 (H7N9) and A/Shanghai/1/2013 (H7N9); hereafter referred to as Anhui/1 and Shanghai/1, respectively. In mice, Anhui/1 and Shanghai/1 were more pathogenic than a control avian H7N9 virus (A/duck/Gunma/466/2011 (H7N9); Dk/GM466) and a representative pandemic 2009 H1N1 virus (A/California/4/2009 (H1N1pdm09); CA04). Anhui/1, Shanghai/1 and Dk/GM466 replicated well in the nasal turbinates of ferrets. In nonhuman primates, Anhui/1 and Dk/GM466 replicated efficiently in the upper and lower respiratory tracts, whereas the replicative ability of conventional human influenza viruses is typically restricted to the upper respiratory tract of infected primates. By contrast, Anhui/1 did not replicate well in miniature pigs after intranasal inoculation. Critically, Anhui/1 transmitted through respiratory droplets in one of three pairs of ferrets. Glycan arrays showed that Anhui/1, Shanghai/1 and A/Hangzhou/1/2013 (H7N9) (a third human A(H7N9) virus tested in this assay) bind to human virus-type receptors, a property that may be critical for virus transmissibility in ferrets. Anhui/1 was found to be less sensitive in mice to neuraminidase inhibitors than a pandemic H1N1 2009 virus, although both viruses were equally susceptible to an experimental antiviral polymerase inhibitor. The robust replicative ability in mice, ferrets and nonhuman primates and the limited transmissibility in ferrets of Anhui/1 suggest that A(H7N9) viruses have pandemic potential.	[Watanabe, Tokiko; Fukuyama, Satoshi; Zhao, Dongming; Tomita, Yuriko; Fujimoto, Naomi; Goto, Kazue; Kawakami, Eiryo; Ishikawa, Izumi; Watanabe, Shinji; Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan; [Kiso, Maki; Yamada, Shinya; Yamayoshi, Seiya; Iwatsuki-Horimoto, Kiyoko; Noda, Takeshi; Katsura, Hiroaki; Ito, Mutsumi; Sakai-Tagawa, Yuko; Sugita, Yukihiko; Uraki, Ryuta; Yamaji, Reina; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; [Nakajima, Noriko; Hasegawa, Hideki] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; [Imai, Masaki; Takashita, Emi; Kishida, Noriko; Shirakura, Masayuki; Odagiri, Takato; Tashiro, Masato] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo 2080011, Japan; [Murakami, Shin; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens,Minato Ku, Tokyo 1088639, Japan; [Sakoda, Yoshihiro; Shichinohe, Shintaro; Okamatsu, Masatoshi; Tamura, Tomokazu; Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Microbiol Lab, Sapporo, Hokkaido 0600818, Japan; [McBride, Ryan; de Vries, Robert P.; Paulson, James C.] Scripps Res Inst, La Jolla, CA 92037 USA; [Hatta, Masato; Imai, Hirotaka; Eisfeld, Amie J.; Zhong, Gongxun; Fan, Shufang; Ping, Jihui; Maher, Eileen A.; Hanson, Anthony; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53711 USA; [Watanabe, Shinji] Miyazaki Univ, Dept Vet Sci, Lab Vet Microbiol, Miyazaki 8892192, Japan; [Uchida, Yuko; Saito, Takehiko] Natl Inst Anim Hlth, Influenza & Pr Dis Res Ctr, Tsukuba, Ibaraki 3050856, Japan; [Ozawa, Makoto] Kagoshima Univ, Joint Fac Vet Med, Lab Anim Hyg, Kagoshima 8900065, Japan; [Ozawa, Makoto] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, Kagoshima 8900065, Japan; [Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido 0010020, Japan; [Kawaoka, Yoshihiro] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Bioresponses Regulat, Kyoto 6068507, Japan	Japan Science & Technology Agency (JST); University of Tokyo; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); University of Tokyo; Hokkaido University; Scripps Research Institute; University of Wisconsin System; University of Wisconsin Madison; University of Miyazaki; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Kagoshima University; Kagoshima University; Hokkaido University; Kyoto University	Kawaoka, Y (corresponding author), Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan.	kawaokay@svm.vetmed.wisc.edu	Hasegawa, Hideki/C-7978-2014; Yamayoshi, Seiya/C-1982-2013; McBride, Ryan/E-6812-2011; Ozawa, Makoto/AFM-4137-2022; Tamura, Tomokazu/AAP-6081-2021; Saito, Takehiko/AFM-3038-2022; Yukihiko, Sugita/K-9319-2013; Paulson, James/AAG-3565-2019; Yamayoshi, Seiya/Y-7430-2019; de Vries, Robert/K-7212-2013; Shichinohe, Shintaro/C-7937-2017	Ozawa, Makoto/0000-0002-7731-5321; Tamura, Tomokazu/0000-0003-1395-6610; Yamayoshi, Seiya/0000-0001-7768-5157; Shichinohe, Shintaro/0000-0002-8783-2103; Eisfeld, Amie/0000-0003-2231-3107; de Vries, Robert/0000-0002-1586-4464; Zhong, Gongxun/0000-0002-0748-9641; Sugita, Yukihiko/0000-0001-6861-4840	Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labour and Welfare, Japan; ERATO (Japan Science and Technology Agency); NIAID Public Health Service [AI099274, AI058113]; NIAID [HHSN266200700010C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113, T32AI078985] Funding Source: NIH RePORTER	Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); ERATO (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); NIAID Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Shufor A/Anhui/1/2013 (H7N9) and A/Shanghai/1/2013 (H7N9) viruses. We thank the IMSUT serum bank for providing human sera. We thank R. Webster for providing monoclonal antibody to A/seal/Massachusetts/1/80 (H7N7). Polyclonal anti-influenza virus H7 HA, A/Netherlands/219/2003 (H7N7) (anti-serum, goat) NR-9226, was obtained through the National Institutes of Health (NIH) Biodefense and Emerging Infections Research Resources Repository, National Institute of Allergy and Infectious Diseases (NIAID), NIH. We thank S. Watson for editing the manuscript, T. Suzuki, K. Takahashi, S. Fujisaki and H. Xu for discussions, and Y. Sato, H. Sugawara, A. Sato, M. Ejima and T. Miura for technical assistance. We thank Toyama Chemical Co. for providing favipiravir, Daiichi Sankyo Co. for providing laninamivir, F. Hoffmann-La Roche for providing oseltamivir carboxylate, GlaxoSmithKline for providing zanamivir and Shionogi & Co. for providing peramivir. This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, Japan; by grants-in-aid from the Ministry of Health, Labour and Welfare, Japan; by ERATO (Japan Science and Technology Agency); by NIAID Public Health Service research grants AI099274 and AI058113 to J.C.P., and by an NIAID-funded Center for Research on Influenza Pathogenesis (CRIP, HHSN266200700010C) to Y.K.	Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jackson S, 2009, J VIROL, V83, P8131, DOI 10.1128/JVI.00534-09; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; Jernigan D, 2013, MMWR-MORBID MORTAL W, V62, P366; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; LIU Q, 2013, MICROBES INFECT; Liu XH, 2013, EMERG MICROBES INFEC, V2, DOI [10.1038/emi2013.30, 10.1038/emi.2013.30]; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Makarova NV, 2003, VIROLOGY, V310, P8, DOI 10.1016/S0042-6822(03)00094-1; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; Min JY, 2010, VIROLOGY, V408, P128, DOI 10.1016/j.virol.2010.09.009; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Srinivasan K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0049597, 10.1371/journal.pone.0059550]; SUBBARAO EK, 1993, J VIROL, V67, P7223, DOI 10.1128/JVI.67.12.7223-7228.1993; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; Wetherall NT, 2003, J CLIN MICROBIOL, V41, P742, DOI 10.1128/JCM.41.2.742-750.2003; World Health Organization, 2013, CHINA WHO JOINT MISS; World Health Organization, 2013, REPORT 8 DATA IN WHO; Xu R, 2013, NAT STRUCT MOL BIOL, V20, P363, DOI 10.1038/nsmb.2500; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; ZHU H, 2013, SCIENCE	36	312	334	6	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					551	+		10.1038/nature12392	http://dx.doi.org/10.1038/nature12392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	23842494	Green Accepted			2022-12-01	WOS:000324826300059
J	Flot, JF; Hespeels, B; Li, X; Noel, B; Arkhipova, I; Danchin, EGJ; Hejnol, A; Henrissat, B; Koszul, R; Aury, JM; Barbe, V; Barthelemy, RM; Bast, J; Bazykin, GA; Chabrol, O; Couloux, A; Da Rocha, M; Da Silva, C; Gladyshev, E; Gouret, P; Hallatschek, O; Hecox-Lea, B; Labadie, K; Lejeune, B; Piskurek, O; Poulain, J; Rodriguez, F; Ryan, JF; Vakhrusheva, OA; Wajnberg, E; Wirth, B; Yushenova, I; Kellis, M; Kondrashov, AS; Welch, DBM; Pontarotti, P; Weissenbach, J; Wincker, P; Jaillon, O; Van Doninck, K				Flot, Jean-Francois; Hespeels, Boris; Li, Xiang; Noel, Benjamin; Arkhipova, Irina; Danchin, Etienne G. J.; Hejnol, Andreas; Henrissat, Bernard; Koszul, Romain; Aury, Jean-Marc; Barbe, Valerie; Barthelemy, Roxane-Marie; Bast, Jens; Bazykin, Georgii A.; Chabrol, Olivier; Couloux, Arnaud; Da Rocha, Martine; Da Silva, Corinne; Gladyshev, Eugene; Gouret, Philippe; Hallatschek, Oskar; Hecox-Lea, Bette; Labadie, Karine; Lejeune, Benjamin; Piskurek, Oliver; Poulain, Julie; Rodriguez, Fernando; Ryan, Joseph F.; Vakhrusheva, Olga A.; Wajnberg, Eric; Wirth, Benedicte; Yushenova, Irina; Kellis, Manolis; Kondrashov, Alexey S.; Welch, David B. Mark; Pontarotti, Pierre; Weissenbach, Jean; Wincker, Patrick; Jaillon, Olivier; Van Doninck, Karine			Genomic evidence for ameiotic evolution in the bdelloid rotifer Adineta vaga	NATURE			English	Article							GENE CONVERSION	Loss of sexual reproduction is considered an evolutionary dead end for metazoans, but bdelloid rotifers challenge this view as they appear to have persisted asexually for millions of years(1). Neither male sex organs nor meiosis have ever been observed in these microscopic animals: oocytes are formed through mitotic divisions, with no reduction of chromosome number and no indication of chromosome pairing(2). However, current evidence does not exclude that they may engage in sex on rare, cryptic occasions. Here we report the genome of a bdelloid rotifer, Adineta vaga (Davis, 1873)(3), and show that its structure is incompatible with conventional meiosis. At gene scale, the genome of A. vaga is tetraploid and comprises both anciently duplicated segments and less divergent allelic regions. However, in contrast to sexual species, the allelic regions are rearranged and sometimes even found on the same chromosome. Such structure does not allow meiotic pairing; instead, we find abundant evidence of gene conversion, which may limit the accumulation of deleterious mutations in the absence of meiosis. Gene families involved in resistance to oxidation, carbohydrate metabolism and defence against transposons are significantly expanded, which may explain why transposable elements cover only 3% of the assembled sequence. Furthermore, 8% of the genes are likely to be of non-metazoan origin and were probably acquired horizontally. This apparent convergence between bdelloids and prokaryotes sheds new light on the evolutionary significance of sex.	[Flot, Jean-Francois; Hespeels, Boris; Li, Xiang; Lejeune, Benjamin; Van Doninck, Karine] Univ Namur, Dept Biol, URBE, Lab Evolutionary Genet & Ecol, B-5000 Namur, Belgium; [Flot, Jean-Francois; Hespeels, Boris; Li, Xiang; Lejeune, Benjamin; Van Doninck, Karine] Namur Res Inst Life Sci NARILIS, B-5000 Namur, Belgium; [Flot, Jean-Francois; Noel, Benjamin; Aury, Jean-Marc; Barbe, Valerie; Couloux, Arnaud; Da Silva, Corinne; Labadie, Karine; Poulain, Julie; Weissenbach, Jean; Wincker, Patrick; Jaillon, Olivier] Ctr Natl Sequencage, GENOSCOPE, CEA Inst Genom, F-91057 Evry, France; [Flot, Jean-Francois; Weissenbach, Jean; Wincker, Patrick; Jaillon, Olivier] Univ Evry, UMR8030, F-91057 Evry, France; [Flot, Jean-Francois; Weissenbach, Jean; Wincker, Patrick; Jaillon, Olivier] CNRS, UMR 8030, F-91057 Evry, France; [Flot, Jean-Francois; Hallatschek, Oskar] Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany; [Arkhipova, Irina; Gladyshev, Eugene; Hecox-Lea, Bette; Rodriguez, Fernando; Yushenova, Irina; Welch, David B. Mark] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Danchin, Etienne G. J.; Da Rocha, Martine; Wajnberg, Eric] INRA, UMR ISA 1355, Inst Sophia Agrobiotech, F-06903 Sophia Antipolis, France; [Danchin, Etienne G. J.; Da Rocha, Martine; Wajnberg, Eric] CNRS, UMR ISA 7254, Inst Sophia Agrobiotech, F-06903 Sophia Antipolis, France; [Danchin, Etienne G. J.; Da Rocha, Martine; Wajnberg, Eric] Univ Nice Sophia Antipolis, UMR ISA, Inst Sophia Agrobiotech, F-06903 Sophia Antipolis, France; [Hejnol, Andreas; Ryan, Joseph F.] Univ Bergen, Sars Int Ctr Marine Mol Biol, N-5008 Bergen, Norway; [Henrissat, Bernard] Aix Marseille Univ, CNRS, UMR Architecture & Fonct Macromol Biol 7257, F-13288 Marseille, France; [Koszul, Romain] Inst Pasteur, CNRS, UMR 3525, Grp Spatial Regulat Genomes,Dept Genomes & Genet, F-75724 Paris, France; [Barthelemy, Roxane-Marie; Chabrol, Olivier; Gouret, Philippe; Wirth, Benedicte; Pontarotti, Pierre] Aix Marseille Univ, LATP UMR CNRS 7353, F-13331 Marseille 3, France; [Bast, Jens] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Bazykin, Georgii A.; Vakhrusheva, Olga A.; Kondrashov, Alexey S.] Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, Moscow 119991, Russia; [Bazykin, Georgii A.; Vakhrusheva, Olga A.] Russian Acad Sci, Kharkevich Inst, Inst Informat Transmiss Problems, Moscow 127994, Russia; [Hallatschek, Oskar] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Hecox-Lea, Bette] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Piskurek, Oliver] Univ Gottingen, Courant Res Ctr Geobiol, D-37077 Gottingen, Germany; [Kellis, Manolis; Jaillon, Olivier] Broad Inst MIT & Harvard, MIT Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Kondrashov, Alexey S.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Kondrashov, Alexey S.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Namur; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Max Planck Society; Marine Biological Laboratory - Woods Hole; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; University of Bergen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; University of Gottingen; Lomonosov Moscow State University; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; University of California System; University of California Berkeley; Northeastern University; University of Gottingen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jaillon, O (corresponding author), Ctr Natl Sequencage, GENOSCOPE, CEA Inst Genom, 2 Rue Gaston Cremieux,CP5706, F-91057 Evry, France.	jean-francois.flot@ds.mpg.de; ojaillon@genoscope.cns.fr; karine.vandoninck@fundp.ac.be	Labadie, Karine/AAG-7355-2022; Hejnol, Andreas/C-5577-2012; Danchin, Etienne G.J./A-6648-2008; Bazykin, Georgii/E-4601-2012; Rodriguez, Fernando/E-9392-2013; Jaillon, Olivier/GRY-6287-2022; , pontarotti/ABB-1753-2021; Danchin, Etienne GJ/X-6969-2019; Wajnberg, Eric/A-4862-2009; Kellis, Manolis/ABE-7385-2020; Aury, Jean-Marc/N-1621-2019; Vakhrusheva, Olga/AAP-3270-2021; Yushenova, Irina/J-8175-2019; Hallatschek, Oskar/E-5541-2015; Labadie, Karine/AFL-7408-2022; Henrissat, Bernard/J-2475-2012; Van Doninck, Karine/B-3218-2016	Labadie, Karine/0000-0001-7467-8509; Hejnol, Andreas/0000-0003-2196-8507; Danchin, Etienne G.J./0000-0003-4146-5608; Bazykin, Georgii/0000-0003-2334-2751; Rodriguez, Fernando/0000-0003-4044-8734; Danchin, Etienne GJ/0000-0003-4146-5608; Wajnberg, Eric/0000-0002-6700-7114; Kellis, Manolis/0000-0001-7113-9630; Aury, Jean-Marc/0000-0003-1718-3010; Yushenova, Irina/0000-0001-6291-6215; Labadie, Karine/0000-0001-7467-8509; Henrissat, Bernard/0000-0002-3434-8588; Mark Welch, David/0000-0001-9774-4580; Couloux, Arnaud/0000-0003-2356-0062; Noel, Benjamin/0000-0002-5830-3253; DA ROCHA, MARTINE/0000-0003-0959-2295; Flot, Jean-Francois/0000-0003-4091-7916; Vakhrusheva, Olga/0000-0002-9617-2303; Jaillon, Olivier/0000-0002-7237-9596; Gladyshev, Eugene/0000-0002-4074-4966; Arkhipova, Irina/0000-0002-4805-1339; Lejeune, Benjamin/0000-0001-6881-8931; Bast, Jens/0000-0003-0017-3860; Poulain, Julie/0000-0002-8744-3116; Ryan, Joseph/0000-0001-5478-0522; Van Doninck, Karine/0000-0002-4790-8951; DA SILVA, Corinne/0000-0002-7618-7831; Pierre, Pontarotti/0000-0001-7202-3648; Koszul, Romain/0000-0002-3086-1173	Genoscope-CES; US National Science Foundation [MCB-0821956, MCB-1121334, MCB-0923676]; German Research Foundation [HA 5163/2-1]; Ministry of Education and Science of the Russian Federation [11.G34.31.0008]; NSF CAREER [0644282]; FRFC from the Belgian Fonds National de la Recherche Scientifique (FNRS) [2.4.655.09.F]; University of Namur; Direct For Biological Sciences [1039946, 1121334, 0821956] Funding Source: National Science Foundation; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation	Genoscope-CES; US National Science Foundation(National Science Foundation (NSF)); German Research Foundation(German Research Foundation (DFG)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); FRFC from the Belgian Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); University of Namur; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors would like to thank M. Meselson for his support during the initiation phase of this project and for inspiring us with his seminal works on bdelloid genetics. The authors are also grateful to M. Radman for useful discussions, M. Knapen and N. Debortoli for participating in laboratory work, M. Lliros for helping with Fig. 1, S. Henrissat for participating in CAZyme analyses, and S. Oztas, B. Vacherie, P. Lenoble and S. Mangenot for performing PCR validations of the assembly. This work was supported by Genoscope-CES (where most of the sequencing was performed), by US National Science Foundation grants MCB-0821956 and MCB-1121334 to I.A., by German Research Foundation grant HA 5163/2-1 to O.H., by grant 11.G34.31.0008 from the Ministry of Education and Science of the Russian Federation to A.S.K., by grant NSF CAREER number 0644282 to M.K., by US National Science Foundation grant MCB-0923676 to D.B.M.W., by FRFC grant 2.4.655.09.F from the Belgian Fonds National de la Recherche Scientifique (FNRS) and a start-up grant from the University of Namur to K.V.D.; J.F.F. and K.V.D. thank also J.-P. Descy (University of Namur) for funding support.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Arkhipova I, 2005, BIOESSAYS, V27, P76, DOI 10.1002/bies.20159; Birky CW, 1996, GENETICS, V144, P427; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Chevreux B, 1999, COMP SCI BIOL P GER, V99, P45, DOI DOI 10.1.1.23/7465; Danchin EGJ, 2011, EVOLUTIONARY BIOLOGY: CONCEPTS, BIODIVERSITY, MACROEVOLUTION AND GENOME EVOLUTION, P223, DOI 10.1007/978-3-642-20763-1_13; Davis H, 1873, MON MICR J, V9, P201, DOI DOI 10.1111/J.1365-2818.1873.TB02268.X; Forche A, 2008, PLOS BIOL, V6, P1084, DOI 10.1371/journal.pbio.0060110; Geisler-Lee J, 2006, PLANT PHYSIOL, V140, P946, DOI 10.1104/pp.105.072652; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Gladyshev EA, 2007, GENE, V390, P136, DOI 10.1016/j.gene.2006.09.025; HICKEY DA, 1982, GENETICS, V101, P519; Hsu WS, 1956, CELLULE, V57, P283; Hur JH, 2009, MOL BIOL EVOL, V26, P375, DOI 10.1093/molbev/msn260; Krisko A, 2012, P NATL ACAD SCI USA, V109, P2354, DOI 10.1073/pnas.1119762109; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Ricci C, 1998, HYDROBIOLOGIA, V387, P321, DOI 10.1023/A:1017086425934; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Segers Hendrik, 2007, Zootaxa, V1564, P1; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; SMITH JM, 1986, NATURE, V324, P300; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Teshima KM, 2004, GENETICS, V166, P1553, DOI 10.1534/genetics.166.3.1553; Vijg J, 2002, MECH AGEING DEV, V123, P907, DOI 10.1016/S0047-6374(02)00028-3; Wang YP, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Welch DBM, 2001, P NATL ACAD SCI USA, V98, P6720, DOI 10.1073/pnas.111144598	30	247	255	1	170	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					453	457		10.1038/nature12326	http://dx.doi.org/10.1038/nature12326			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23873043	Green Published, hybrid			2022-12-01	WOS:000323316100034
J	Periyannan, S; Moore, J; Ayliffe, M; Bansal, U; Wang, XJ; Huang, L; Deal, K; Luo, MC; Kong, XY; Bariana, H; Mago, R; McIntosh, R; Dodds, P; Dvorak, J; Lagudah, E				Periyannan, Sambasivam; Moore, John; Ayliffe, Michael; Bansal, Urmil; Wang, Xiaojing; Huang, Li; Deal, Karin; Luo, Mingcheng; Kong, Xiuying; Bariana, Harbans; Mago, Rohit; McIntosh, Robert; Dodds, Peter; Dvorak, Jan; Lagudah, Evans			The Gene Sr33, an Ortholog of Barley Mla Genes, Encodes Resistance to Wheat Stem Rust Race Ug99	SCIENCE			English	Article							POWDERY MILDEW; AEGILOPS-TAUSCHII; HEXAPLOID WHEAT; LEAF RUST; GENOME; LOCUS; LINES	Wheat stem rust, caused by the fungus Puccinia graminis f. sp. tritici, afflicts bread wheat (Triticum aestivum). New virulent races collectively referred to as "Ug99" have emerged, which threaten global wheat production. The wheat gene Sr33, introgressed from the wild relative Aegilops tauschii into bread wheat, confers resistance to diverse stem rust races, including the Ug99 race group. We cloned Sr33, which encodes a coiled-coil, nucleotide-binding, leucine-rich repeat protein. Sr33 is orthologous to the barley (Hordeum vulgare) Mla mildew resistance genes that confer resistance to Blumeria graminis f. sp. hordei. The wheat Sr33 gene functions independently of RAR1, SGT1, and HSP90 chaperones. Haplotype analysis from diverse collections of Ae. tauschii placed the origin of Sr33 resistance near the southern coast of the Caspian Sea.	[Periyannan, Sambasivam; Moore, John; Ayliffe, Michael; Mago, Rohit; Dodds, Peter; Lagudah, Evans] Commonwealth Sci & Ind Res Org CSIRO Plant Ind, Canberra, ACT 2601, Australia; [Bansal, Urmil; Bariana, Harbans; McIntosh, Robert] Univ Sydney, Plant Breeding Inst Cobbitty, Narellan, NSW 2567, Australia; [Deal, Karin; Luo, Mingcheng; Dvorak, Jan] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Wang, Xiaojing; Huang, Li] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Kong, Xiuying] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Wang, Xiaojing] Northwest Agr & Forestry Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Wang, Xiaojing] Northwest Agr & Forestry Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney; University of California System; University of California Davis; Montana State University System; Montana State University Bozeman; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Northwest A&F University - China; Northwest A&F University - China	Lagudah, E (corresponding author), Commonwealth Sci & Ind Res Org CSIRO Plant Ind, Gen POB 1600, Canberra, ACT 2601, Australia.	evans.lagudah@csiro.au	Mago, Rohit/AAB-7878-2022; Lagudah, Evans/A-2007-2010; Periyannan, Sambasivam/C-1722-2014; Mago, Rohit/D-3927-2009; Ayliffe, Michael A/A-2089-2010; Bansal, Urmil/AAI-4039-2020; Dodds, Peter/D-1181-2009	Lagudah, Evans/0000-0002-6234-1789; Periyannan, Sambasivam/0000-0002-5421-2872; Mago, Rohit/0000-0001-5286-073X; Bansal, Urmil/0000-0003-1119-4464; Luo, Ming-Cheng/0000-0002-9744-5887; Dodds, Peter/0000-0003-0620-5923	Borlaug Global Rust Initiative (BGRI) Durable Rust Resistance in Wheat (DRRW) Project; Bill & Melinda Gates Foundation; UK Department for International Development; Office of the Chief Executive (OCE) Post Doctoral Fellowship of CSIRO, Australia; Grains Research and Development Corporation, Australia; Endeavor International Postgraduate Research Scholarship of Department of Education, Science and Training (DEST) and Sydney University, Australia; Australian Centre for International Agricultural Research project [CIM2007/084]; Basic Research to Enable Agricultural Development Program of the National Science Foundation (NSF) of the United States [IOS-0965429]; NSF Plant Genome Research Program [DBI-0701916]	Borlaug Global Rust Initiative (BGRI) Durable Rust Resistance in Wheat (DRRW) Project; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK Department for International Development; Office of the Chief Executive (OCE) Post Doctoral Fellowship of CSIRO, Australia; Grains Research and Development Corporation, Australia(Grains R&D Corp); Endeavor International Postgraduate Research Scholarship of Department of Education, Science and Training (DEST) and Sydney University, Australia; Australian Centre for International Agricultural Research project; Basic Research to Enable Agricultural Development Program of the National Science Foundation (NSF) of the United States(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported in part by funds provided through a grant from the Borlaug Global Rust Initiative (BGRI) Durable Rust Resistance in Wheat (DRRW) Project (administered by Cornell University with a grant from the Bill & Melinda Gates Foundation and the UK Department for International Development); Office of the Chief Executive (OCE) Post Doctoral Fellowship of CSIRO, Australia; Grains Research and Development Corporation, Australia; Endeavor International Postgraduate Research Scholarship of Department of Education, Science and Training (DEST) and Sydney University, Australia; Australian Centre for International Agricultural Research project (CIM2007/084). X. W. acknowledges support from the Basic Research to Enable Agricultural Development Program of the National Science Foundation (NSF) of the United States (IOS-0965429) and partial support from NSF Plant Genome Research Program grant DBI-0701916 (J.D. is principal investigator). We are grateful to M. Rouse (USDA-ARS Cereal Disease Laboratory) for the tests with Ug99 and derived races. We thank N. Upadhyaya, A. Ashton, S. Chandramohan, L. Viccars, T. Richardson, K. Newell, H. Miah, and X. Xia for technical assistance. Sequences of Resistance Gene Analog (RGA) genes from Ae. tauschii and hexaploid wheats were deposited in GenBank under accession numbers KF031279 to KF031303.	Ayliffe M, 2013, MOL PLANT MICROBE IN, V26, P658, DOI 10.1094/MPMI-12-12-0291-R; Jin Y, 2006, PLANT DIS, V90, P476, DOI 10.1094/PD-90-0476; JONES SS, 1991, GENOME, V34, P505, DOI 10.1139/g91-077; Jordan T, 2011, PLANT J, V65, P610, DOI 10.1111/j.1365-313X.2010.04445.x; KERBER ER, 1987, CROP SCI, V27, P204, DOI 10.2135/cropsci1987.0011183X002700020013x; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; Mago R, 2002, THEOR APPL GENET, V104, P1317, DOI 10.1007/s00122-002-0879-3; Moullet O, 1999, THEOR APPL GENET, V99, P305, DOI 10.1007/s001220051237; Olson EL, 2013, THEOR APPL GENET, V126, P1179, DOI 10.1007/s00122-013-2045-5; Pardey PG, 2013, SCIENCE, V340, P147, DOI 10.1126/science.122970; Rouse MN, 2011, CROP SCI, V51, P2074, DOI 10.2135/cropsci2010.12.0719; Saintenac C, 2013, SCIENCE, V341, P783, DOI 10.1126/science.1239022; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Seeholzer S, 2010, MOL PLANT MICROBE IN, V23, P497, DOI 10.1094/MPMI-23-4-0497; Shirasu K, 2009, ANNU REV PLANT BIOL, V60, P139, DOI 10.1146/annurev.arplant.59.032607.092906; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; Wei FS, 2002, PLANT CELL, V14, P1903, DOI 10.1105/tpc.002238	18	245	263	5	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2013	341	6147					786	788		10.1126/science.1239028	http://dx.doi.org/10.1126/science.1239028			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23811228				2022-12-01	WOS:000323122200048
J	Nakajima, Y; Meyer, EJ; Kroesen, A; McKinney, SA; Gibson, MC				Nakajima, Yu-ichiro; Meyer, Emily J.; Kroesen, Amanda; McKinney, Sean A.; Gibson, Matthew C.			Epithelial junctions maintain tissue architecture by directing planar spindle orientation	NATURE			English	Article							ASYMMETRIC CELL-DIVISION; TRANSGENIC RNAI; DROSOPHILA; POLARITY; CENTROSOME; PROTEINS; CANCER; MISORIENTATION; MORPHOGENESIS; ZEBRAFISH	During epithelial cell proliferation, planar alignment of the mitotic spindle coordinates the local process of symmetric cell cleavage with the global maintenance of polarized tissue architecture(1,2). Although the disruption of planar spindle alignment is proposed to cause epithelial to mesenchymal transition and cancer(3-6), the in vivo mechanisms regulating mitotic spindle orientation remain elusive. Here we demonstrate that the actomyosin cortex and the junction-localized neoplastic tumour suppressors Scribbled and Discs large 1 have essential roles in planar spindle alignment and thus the control of epithelial integrity in the Drosophila imaginal disc. We show that defective alignment of the mitotic spindle correlates with cell delamination and apoptotic death, and that blocking the death of misaligned cells is sufficient to drive the formation of basally localized tumour-like masses. These findings indicate a key role for junction-mediated spindle alignment in the maintenance of epithelial integrity, and also reveal a previously unknown cell-death-mediated tumour-suppressor function inherent in the polarized architecture of epithelia.	[Nakajima, Yu-ichiro; Meyer, Emily J.; Kroesen, Amanda; McKinney, Sean A.; Gibson, Matthew C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Gibson, Matthew C.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Gibson, MC (corresponding author), Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA.	MG2@stowers.org	Nakajima, Yu-ichiro/AAA-5016-2021	McKinney, Sean/0000-0002-9740-6247; Gibson, Matthew/0000-0001-5588-8842; Nakajima, Yuichiro/0000-0002-1823-5989	Stowers Institute for Medical Research; Burroughs Wellcome Fund for Biomedical Research	Stowers Institute for Medical Research; Burroughs Wellcome Fund for Biomedical Research(Burroughs Wellcome Fund)	We thank D. Bilder, M. Miura, Y. Yamashita, the Bloomington Stock Center, Vienna Drosophila RNAi Center, TRiP, and FlyTrap project for fly stocks and C. Doe, F. Matsuzaki and the Developmental Studies Hybridoma Bank for antibodies. We thank R. Fehon for suggestions. We thank T. Akiyama, A. Fritz, A. Ikmi and M. Szuperak for comments on the manuscript and L. Liang for technical advice. We also thank M. Gogol for graphical assistance, F. Guo for TEM support and L. Gutchewsky for administrative support. This work was supported by the Stowers Institute for Medical Research and the Burroughs Wellcome Fund for Biomedical Research.	Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bloor JW, 2001, DEV BIOL, V239, P215, DOI 10.1006/dbio.2001.0452; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fleming ES, 2007, J HISTOCHEM CYTOCHEM, V55, P1173, DOI 10.1369/jhc.7A7234.2007; Fleming ES, 2009, MOL CARCINOGEN, V48, P592, DOI 10.1002/mc.20506; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Gibson WT, 2011, CELL, V144, P427, DOI 10.1016/j.cell.2010.12.035; Gillies TE, 2011, CURR BIOL, V21, pR599, DOI 10.1016/j.cub.2011.06.055; Guilgur LG, 2012, DEVELOPMENT, V139, P503, DOI 10.1242/dev.071027; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; Megraw TL, 2002, J CELL SCI, V115, P4707, DOI 10.1242/jcs.00134; Meyer EJ, 2011, CURR BIOL, V21, P485, DOI 10.1016/j.cub.2011.02.002; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Noatynska A, 2012, J CELL BIOL, V199, P1025, DOI 10.1083/jcb.201209015; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pease JC, 2011, J CELL SCI, V124, P1007, DOI 10.1242/jcs.081406; Quintin S, 2008, TRENDS GENET, V24, P221, DOI 10.1016/j.tig.2008.02.005; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Sandquist JC, 2011, DEV CELL, V21, P410, DOI 10.1016/j.devcel.2011.07.018; Segalen M, 2010, DEV CELL, V19, P740, DOI 10.1016/j.devcel.2010.10.004; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Spear PC, 2012, DEV BIOL, V370, P33, DOI 10.1016/j.ydbio.2012.06.031; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Varmark H, 2007, CURR BIOL, V17, P1735, DOI 10.1016/j.cub.2007.09.031; Vasiliev JM, 2004, P NATL ACAD SCI USA, V101, P12526, DOI 10.1073/pnas.0404723101	41	136	137	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2013	500	7462					359	+		10.1038/nature12335	http://dx.doi.org/10.1038/nature12335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23873041				2022-12-01	WOS:000323112400038
J	Taylor, A; Dangour, AD; Reddy, KS				Taylor, Anna; Dangour, Alan D.; Reddy, K. Srinath			Only collective action will end undernutrition	LANCET			English	Editorial Material									[Taylor, Anna; Dangour, Alan D.] UK Dept Int Dev, London SW1A 2EG, England; [Dangour, Alan D.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Dangour, Alan D.] London Sch Hyg & Trop Med, Leverhulme Ctr Integrat Res Agr & Hlth, London WC1, England; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India	Taylor, A (corresponding author), UK Dept Int Dev, London SW1A 2EG, England.	a-taylor@dfid.gov.uk		Dangour, Alan/0000-0001-6908-1273; Reddy, K Srinath/0000-0003-3416-3548				Black R., 2013, LANCET; Eastwood R, 2011, POP STUD-J DEMOG, V65, P9, DOI 10.1080/00324728.2010.547946; Horton SSR, 2013, MALNUTRITION GLOBAL; Monteiro CA, 2010, B WORLD HEALTH ORGAN, V88, P305, DOI 10.2471/BLT.09.069195	4	8	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 10	2013	382	9891					490	491		10.1016/S0140-6736(13)61084-3	http://dx.doi.org/10.1016/S0140-6736(13)61084-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201SD	23746777				2022-12-01	WOS:000323162400009
J	Reaves, ML; Young, BD; Hosios, AM; Xu, YF; Rabinowitz, JD				Reaves, Marshall Louis; Young, Brian D.; Hosios, Aaron M.; Xu, Yi-Fan; Rabinowitz, Joshua D.			Pyrimidine homeostasis is accomplished by directed overflow metabolism	NATURE			English	Article							COLI ASPARTATE TRANSCARBAMOYLASE; ESCHERICHIA-COLI; UMP KINASE; INHIBITION; BIOSYNTHESIS; QUANTITATION; SYNTHETASE; MECHANISM; EVOLUTION; NITROGEN	Cellular metabolism converts available nutrients into usable energy and biomass precursors. The process is regulated to facilitate efficient nutrient use and metabolic homeostasis. Feedback inhibition of the first committed step of a pathway by its final product is a classical means of controlling biosynthesis(1-4). In a canonical example, the first committed enzyme in the pyrimidine pathway in Escherichia coli is allosterically inhibited by cytidine triphosphate(1,4,5). The physiological consequences of disrupting this regulation, however, have not been previously explored. Here we identify an alternative regulatory strategy that enables precise control of pyrimidine pathway end-product levels, even in the presence of dysregulated biosynthetic flux. The mechanism involves cooperative feedback regulation of the near-terminal pathway enzyme uridine monophosphate kinase(6). Such feedback leads to build-up of the pathway intermediate uridine monophosphate, which is in turn degraded by a conserved phosphatase, here termed UmpH, with previously unknown physiological function(7,8). Such directed overflow metabolism allows homeostasis of uridine triphosphate and cytidine triphosphate levels at the expense of uracil excretion and slower growth during energy limitation. Disruption of the directed overflow regulatory mechanism impairs growth in pyrimidine-rich environments. Thus, pyrimidine homeostasis involves dual regulatory strategies, with classical feedback inhibition enhancing metabolic efficiency and directed overflow metabolism ensuring end-product homeostasis.	[Reaves, Marshall Louis; Young, Brian D.; Hosios, Aaron M.; Xu, Yi-Fan; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Reaves, Marshall Louis; Young, Brian D.; Hosios, Aaron M.; Rabinowitz, Joshua D.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Xu, Yi-Fan; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Rabinowitz, JD (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	joshr@genomics.princeton.edu	Rabinowitz, Joshua/GPP-4019-2022; xu, yifan/GWZ-7154-2022	Rabinowitz, Joshua/0000-0002-1247-4727; 	National Science foundation (NSF) [MCB-0643859]; NSF CDI [CBET-0941143]; DOE-AFOSR [DE-SC0002077/FA9550-09-1-0580]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097382] Funding Source: NIH RePORTER	National Science foundation (NSF)(National Science Foundation (NSF)); NSF CDI(National Science Foundation (NSF)); DOE-AFOSR; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M.L.R. was supported by an National Science foundation (NSF) Graduate Research Fellowship. J.D.R. was supported by NSF CDI Award CBET-0941143 and CAREER Award MCB-0643859, and DOE-AFOSR Award DE-SC0002077/FA9550-09-1-0580, and an American Heart Association Scientist Development Grant.	ANDERSON PM, 1966, BIOCHEMISTRY-US, V5, P3164, DOI 10.1021/bi00874a013; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Bucurenci N, 1998, J BACTERIOL, V180, P473, DOI 10.1128/JB.180.3.473-477.1998; Clasquin M. F., 2012, CURR PROTOC BIOINFOR, V14, P1411; CRABTREE B, 1987, BIOCHEM J, V247, P113, DOI 10.1042/bj2470113; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delannay S, 1999, J MOL BIOL, V286, P1217, DOI 10.1006/jmbi.1999.2561; Fell D., 1997, UNDERSTANDING CONTRO; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; GERHART JC, 1962, J BIOL CHEM, V237, P891; Goodarzi H, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.33; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; HOFMEYR JHS, 1991, EUR J BIOCHEM, V200, P223, DOI 10.1111/j.1432-1033.1991.tb21071.x; KACSER H, 1995, BIOCHEM SOC T, V23, P341, DOI 10.1042/bst0230341; Kantrowitz ER, 2012, ARCH BIOCHEM BIOPHYS, V519, P81, DOI 10.1016/j.abb.2011.10.024; KELL DB, 1986, FEMS MICROBIOL LETT, V39, P305, DOI 10.1111/j.1574-6968.1986.tb01863.x; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Loh KD, 2006, P NATL ACAD SCI USA, V103, P5114, DOI 10.1073/pnas.0600521103; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Lu WY, 2006, J AM SOC MASS SPECTR, V17, P37, DOI 10.1016/j.jasms.2005.09.001; Meyer P, 2008, J BIOL CHEM, V283, P36011, DOI 10.1074/jbc.M802614200; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Peterson AW, 2012, BIOCHEMISTRY-US, V51, P4776, DOI 10.1021/bi3006219; Proudfoot M, 2004, J BIOL CHEM, V279, P54687, DOI 10.1074/jbc.M411023200; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; SAVAGEAU MA, 1975, J MOL EVOL, V5, P199, DOI 10.1007/BF01741242; Silhavy T.J., 1984, EXPT GENE FUSIONS; SMALL JR, 1993, EUR J BIOCHEM, V213, P613, DOI 10.1111/j.1432-1033.1993.tb17801.x; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; Tremblay LW, 2006, BIOCHEMISTRY-US, V45, P1183, DOI 10.1021/bi051842j; UMBARGER HE, 1956, SCIENCE, V123, P848, DOI 10.1126/science.123.3202.848; WILD JR, 1989, P NATL ACAD SCI USA, V86, P46, DOI 10.1073/pnas.86.1.46; YATES RA, 1956, J BIOL CHEM, V221, P757	43	65	66	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					237	+		10.1038/nature12445	http://dx.doi.org/10.1038/nature12445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23903661	Green Accepted, Green Submitted			2022-12-01	WOS:000322825500041
J	Sarkies, P; Miska, EA				Sarkies, Peter; Miska, Eric A.			Is There Social RNA?	SCIENCE			English	Editorial Material							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; EPIGENETIC MEMORY; C. ELEGANS; GERMLINE; MICRORNA; NEMATODE; POTENT; PIRNAS		[Sarkies, Peter] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Sarkies, P (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England.	e.miska@gurdon.cam.ac.uk		Sarkies, Peter/0000-0003-0279-6199; Miska, Eric/0000-0002-4450-576X	Cancer Research UK [11832] Funding Source: Medline; Wellcome Trust [092096] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Brosnan CA, 2011, CURR OPIN PLANT BIOL, V14, P580, DOI 10.1016/j.pbi.2011.07.011; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Dieterich C, 2009, TRENDS GENET, V25, P203, DOI 10.1016/j.tig.2009.03.006; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ibrahim HMM, 2011, EXP PARASITOL, V127, P90, DOI 10.1016/j.exppara.2010.06.037; Jose AM, 2011, NAT STRUCT MOL BIOL, V18, P1183, DOI 10.1038/nsmb.2134; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Liu HJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2071; Maule AG, 2011, TRENDS PARASITOL, V27, P505, DOI 10.1016/j.pt.2011.07.004; McEwan DL, 2012, MOL CELL, V47, P746, DOI 10.1016/j.molcel.2012.07.014; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Selkirk ME, 2012, PARASITOLOGY, V139, P605, DOI 10.1017/S0031182011002332; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Winston WM, 2007, P NATL ACAD SCI USA, V104, P10565, DOI 10.1073/pnas.0611282104; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Yao B, 2012, EMBO REP, V13, P1102, DOI 10.1038/embor.2012.160; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-381; Zhuang JJ, 2012, PARASITOLOGY, V139, P560, DOI 10.1017/S0031182011001788	25	39	42	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					467	468		10.1126/science.1243175	http://dx.doi.org/10.1126/science.1243175			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	193UJ	23908213				2022-12-01	WOS:000322586700027
J	Liu, SY; Selck, C; Friedrich, B; Lutz, R; Vila-Farre, M; Dahl, A; Brandl, H; Lakshmanaperumal, N; Henry, I; Rink, JC				Liu, S. -Y.; Selck, C.; Friedrich, B.; Lutz, R.; Vila-Farre, M.; Dahl, A.; Brandl, H.; Lakshmanaperumal, N.; Henry, I.; Rink, J. C.			Reactivating head regrowth in a regeneration-deficient planarian species	NATURE			English	Article							DENDROCOELUM-LACTEUM; POLARITY; NEOBLASTS; ALIGNMENT; REGION; CELLS	Species capable of regenerating lost body parts occur throughout the animal kingdom, yet close relatives are often regeneration incompetent(1,2). Why in the face of 'survival of the fittest' some animals regenerate but others do not remains a fascinating question(3). Planarian flatworms are well known and studied for their ability to regenerate from minute tissue pieces, yet species with limited regeneration abilities have been described even amongst planarians(4). Here we report the characterization of the regeneration defect in the planarian Dendrocoelum lacteum and its successful rescue. Tissue fragments cut from the posterior half of the body of this species are unable to regenerate a head and ultimately die(5). We find that this defect originates during the early stages of head specification, which require inhibition of canonical Wnt signalling in other planarian species(6-8). Notably, RNA interference (RNAi)-mediated knockdown of Dlac-beta-catenin-1, the Wnt signal transducer, restored the regeneration of fully functional heads on tail pieces, rescuing D. lacteum's regeneration defect. Our results demonstrate the utility of comparative studies towards the reactivation of regenerative abilities in regeneration-deficient animals. Furthermore, the availability of D. lacteum as a regeneration-impaired planarian model species provides a first step towards elucidating the evolutionary mechanisms that ultimately determine why some animals regenerate and others do not.	[Liu, S. -Y.; Vila-Farre, M.; Brandl, H.; Lakshmanaperumal, N.; Henry, I.; Rink, J. C.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Selck, C.; Friedrich, B.; Lutz, R.; Rink, J. C.] Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden CRTD, D-01307 Dresden, Germany; [Dahl, A.] Tech Univ Dresden, Biotechnol Ctr Biotec, DFG Ctr Regenerat Therapies Dresden CRTD, Deep Sequencing Grp SFB655, D-01307 Dresden, Germany	Max Planck Society; Technische Universitat Dresden; Technische Universitat Dresden	Rink, JC (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	rink@mpi-cbg.de	Dahl, Andreas/E-3783-2017; Henry, Ian/J-7328-2019	Dahl, Andreas/0000-0002-2668-8371; Henry, Ian/0000-0002-7134-3110; Vila Farre, Miquel/0000-0002-2553-2842; Brandl, Holger/0000-0003-1911-8570; Selck, Claudia/0000-0002-1831-752X				Agata K, 1999, SEMIN CELL DEV BIOL, V10, P377, DOI 10.1006/scdb.1999.0324; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Beane WS, 2011, CHEM BIOL, V18, P77, DOI 10.1016/j.chembiol.2010.11.012; Bely AE, 2010, TRENDS ECOL EVOL, V25, P161, DOI 10.1016/j.tree.2009.08.005; Blassberg RA, 2013, DEVELOPMENT, V140, P730, DOI 10.1242/dev.082982; Brondsted H. V., 1969, PLANARIAN REGENERATI; Buchholz F, 2006, NAT METHODS, V3, P696, DOI 10.1038/NMETH912; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Chen CCG, 2013, DEVELOPMENT, V140, P719, DOI 10.1242/dev.083741; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Felix DA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000915; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Gurley KA, 2010, DEV BIOL, V347, P24, DOI 10.1016/j.ydbio.2010.08.007; Iglesias M, 2008, DEVELOPMENT, V135, P1215, DOI 10.1242/dev.020289; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Morgan TH, 1904, BIOL BULL-US, V6, P159, DOI 10.2307/1535722; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2011, SCIENCE, V332, P852, DOI 10.1126/science.1202143; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Reddien PW, 2007, DEVELOPMENT, V134, P4043, DOI 10.1242/dev.007138; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rink JC, 2013, DEV GENES EVOL, V223, P67, DOI 10.1007/s00427-012-0426-4; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; SAUZINMONNOT MJ, 1973, J ULTRA MOL STRUCT R, V45, P206, DOI 10.1016/S0022-5320(73)80048-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schockaert ER, 2008, HYDROBIOLOGIA, V595, P41, DOI 10.1007/s10750-007-9002-8; STEPH.F, 1961, J EMBRYOL EXP MORPH, V9, P642; STEPHANDUBOIS F, 1975, ARCH ANAT MICROSC MO, V64, P75; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Tanaka EM, 2003, CELL, V113, P559, DOI 10.1016/S0092-8674(03)00395-7; Wenemoser D, 2012, GENE DEV, V26, P988, DOI 10.1101/gad.187377.112	39	115	119	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2013	500	7460					81	U103		10.1038/nature12414	http://dx.doi.org/10.1038/nature12414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23883932	Green Submitted			2022-12-01	WOS:000322514800032
J	Fuchs, Y; Brown, S; Gorenc, T; Rodriguez, J; Fuchs, E; Steller, H				Fuchs, Yaron; Brown, Samara; Gorenc, Travis; Rodriguez, Joe; Fuchs, Elaine; Steller, Hermann			Sept4/ARTS Regulates Stem Cell Apoptosis and Skin Regeneration	SCIENCE			English	Article							HAIR FOLLICLE; TISSUE REGENERATION; TARGETED THERAPIES; CANCER; NICHE; XIAP; ARTS; HOMEOSTASIS; PROGENY; PROTEIN	Adult stem cells are essential for tissue homeostasis and wound repair. Their proliferative capacity must be tightly regulated to prevent the emergence of unwanted and potentially dangerous cells, such as cancer cells. We found that mice deficient for the proapoptotic Sept4/ARTS gene have elevated numbers of hair follicle stem cells (HFSCs) that are protected against apoptosis. Sept4/ARTS(-/-) mice display marked improvement in wound healing and regeneration of hair follicles. These phenotypes depend on HFSCs, as indicated by lineage tracing. Inactivation of XIAP, a direct target of ARTS, abrogated these phenotypes and impaired wound healing. Our results indicate that apoptosis plays an important role in regulating stem cell-dependent regeneration and suggest that this pathway may be a target for regenerative medicine.	[Fuchs, Yaron; Brown, Samara; Gorenc, Travis; Rodriguez, Joe; Steller, Hermann] Rockefeller Univ, Howard Hughes Med Inst, Strang Lab Apoptosis & Canc Biol, New York, NY 10065 USA; [Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu; steller@rockefeller.edu	Fuchs, Elaine/G-1565-2016		NIH [RO1GM60124, R01-AR050452]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to colleagues whose contributions we could not adequately cite because of space constraints. We thank B. Keyes, Y. C. Hsu, N. Stokes, and I. Shachrai for discussion, advice, and technical assistance; S. Mazel, X. Li, S. Semova, and S. Tadesse for FACS sorting; the Comparative Biology Center (AAALAC-accredited) for health care to our mice; and members of the Steller lab. H. S. and E. F. are Investigators of the Howard Hughes Medical Institute. Supported by NIH grants RO1GM60124 (H. S.) and R01-AR050452 (E. F.). The Sept4/ARTS and XIAP mouse mutant strains used in this study are available from the Rockefeller University to academic groups through a materials transfer agreement and to for-profit groups through a license.	Bergmann A, 2003, CURR OPIN CELL BIOL, V15, P717, DOI 10.1016/j.ceb.2003.10.002; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Edison N, 2012, CELL DEATH DIFFER, V19, P356, DOI 10.1038/cdd.2011.112; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Garcia-Fernandez M, 2010, GENE DEV, V24, P2282, DOI 10.1101/gad.1970110; Garrison JB, 2011, MOL CELL, V41, P107, DOI 10.1016/j.molcel.2010.12.002; Gottfried Y, 2004, EMBO J, V23, P1627, DOI 10.1038/sj.emboj.7600155; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jahoda CAB, 2011, CELL, V146, P678, DOI 10.1016/j.cell.2011.08.020; Kornbluth S, 2005, J CELL SCI, V118, P1779, DOI 10.1242/jcs.02377; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Larisch S, 2000, NAT CELL BIOL, V2, P915, DOI 10.1038/35046566; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Schile AJ, 2008, GENE DEV, V22, P2256, DOI 10.1101/gad.1663108; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Woo WM, 2011, CELL, V146, P334, DOI 10.1016/j.cell.2011.07.001	31	60	60	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					286	289		10.1126/science.1233029	http://dx.doi.org/10.1126/science.1233029			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23788729	Green Accepted			2022-12-01	WOS:000321959300046
J	Magnon, C; Hall, SJ; Lin, J; Xue, XN; Gerber, L; Freedland, SJ; Frenette, PS				Magnon, Claire; Hall, Simon J.; Lin, Juan; Xue, Xiaonan; Gerber, Leah; Freedland, Stephen J.; Frenette, Paul S.			Autonomic Nerve Development Contributes to Prostate Cancer Progression	SCIENCE			English	Article							BEAM RADIATION-THERAPY; PERINEURAL INVASION; RADICAL PROSTATECTOMY; BETA-BLOCKERS; CHOLINERGIC INNERVATION; MUSCARINIC RECEPTORS; BREAST-CANCER; TUMOR-GROWTH; SURVIVAL; CELLS	Nerves are a common feature of the microenvironment, but their role in tumor growth and progression remains unclear. We found that the formation of autonomic nerve fibers in the prostate gland regulates prostate cancer development and dissemination in mouse models. The early phases of tumor development were prevented by chemical or surgical sympathectomy and by genetic deletion of stromal beta(2)- and beta(3)-adrenergic receptors. Tumors were also infiltrated by parasympathetic cholinergic fibers that promoted cancer dissemination. Cholinergic-induced tumor invasion and metastasis were inhibited by pharmacological blockade or genetic disruption of the stromal type 1 muscarinic receptor, leading to improved survival of the mice. A retrospective blinded analysis of prostate adenocarcinoma specimens from 43 patients revealed that the densities of sympathetic and parasympathetic nerve fibers in tumor and surrounding normal tissue, respectively, were associated with poor clinical outcomes. These findings may lead to novel therapeutic approaches for prostate cancer.	[Magnon, Claire; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA; [Magnon, Claire; Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Magnon, Claire; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Hall, Simon J.] Mt Sinai Sch Med, Dept Urol, New York, NY 10029 USA; [Lin, Juan; Xue, Xiaonan] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Gerber, Leah; Freedland, Stephen J.] Durham VA Med Ctr, Dept Surg, Durham, NC 27705 USA; [Gerber, Leah; Freedland, Stephen J.] Duke Univ, Dept Surg, Div Urol, Durham, NC 27705 USA; [Freedland, Stephen J.] Duke Univ, Dept Pathol, Durham, NC 27705 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University	Magnon, C (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA.	clairemagnon@free.fr; paul.frenette@einstein.yu.edu	Frenette, Paul S/J-8272-2012; MAGNON, Claire/A-4343-2016; Magnon, Claire/N-7073-2019	Frenette, Paul S/0000-0003-0862-9922; Magnon, Claire/0000-0003-2946-5269	U.S. Department of Defense Idea Development award [W81XWH-07-1-0165]; NIH [DK056638, HL069438, HL097819]; Fondation pour la Recherche Medicale, France; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438, R01HL097819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER	U.S. Department of Defense Idea Development award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale, France(Fondation pour la Recherche Medicale); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Mall, J. Harding, and R. Basu for tissue sectioning and H&E staining; Y. Zhou for assistance with bioluminescence scanning; E. Fine, L. Jelicks, and W. Koba for help with microPET scanning at the Gruss Magnetic Resonance Research Center at Einstein; W. Guo for comments on the manuscript; and H. Ostrer for advice on human samples. Supported by U.S. Department of Defense Idea Development award W81XWH-07-1-0165 and NIH grants DK056638, HL069438, and HL097819. C. M. was the recipient of a fellowship from the Fondation pour la Recherche Medicale, France. Albert Einstein College of Medicine and the authors (C. M., P. S. F.) have filed a patent application (WO 2012071573 A2) relating to the use of adrenergic and muscarinic receptor antagonists for cancer therapy.	Anderson PR, 1998, INT J RADIAT ONCOL, V41, P1087, DOI 10.1016/S0360-3016(98)00167-9; Anisuzzaman ASM, 2008, J PHARMACOL SCI, V106, P271, DOI 10.1254/jphs.FP0071435; Ayala GE, 2006, CANCER RES, V66, P5159, DOI 10.1158/0008-5472.CAN-05-1847; Ayala GE, 2001, PROSTATE, V49, P213, DOI 10.1002/pros.1137; Barron TI, 2011, J CLIN ONCOL, V29, P2635, DOI 10.1200/JCO.2010.33.5422; CARDEN MJ, 1987, J NEUROSCI, V7, P3489; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Farnsworth WE, 1999, PROSTATE, V38, P60; Grytli HH, 2014, EUR UROL, V65, P635, DOI 10.1016/j.eururo.2013.01.007; Grytli HH, 2013, PROSTATE, V73, P250, DOI 10.1002/pros.22564; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P745, DOI 10.1023/B:CLIN.0000006817.25962.87; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Lemeshow S, 2011, CANCER EPIDEM BIOMAR, V20, P2273, DOI 10.1158/1055-9965.EPI-11-0249; Liebig C, 2009, CANCER-AM CANCER SOC, V115, P3379, DOI 10.1002/cncr.24396; Magnon C, 2005, CANCER RES, V65, P4353, DOI 10.1158/0008-5472.CAN-04-3536; MALICK JB, 1975, J PHARM SCI, V64, P1066, DOI 10.1002/jps.2600640650; Maru N, 2001, HUM PATHOL, V32, P828, DOI 10.1053/hupa.2001.26456; MCVARY KT, 1994, BIOL REPROD, V51, P99, DOI 10.1095/biolreprod51.1.99; Melhem-Bertrandt A, 2011, J CLIN ONCOL, V29, P2645, DOI 10.1200/JCO.2010.33.4441; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Palm D, 2006, INT J CANCER, V118, P2744, DOI 10.1002/ijc.21723; Schuller HM, 2012, CARCINOGENESIS, V33, P191, DOI 10.1093/carcin/bgr251; SIMON RH, 1980, SCIENCE, V209, P1132, DOI 10.1126/science.6250220; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Ventura S, 2002, PHARMACOL THERAPEUT, V94, P93, DOI 10.1016/S0163-7258(02)00174-2; VILLERS A, 1989, J UROLOGY, V142, P763, DOI 10.1016/S0022-5347(17)38881-X; VISINTAINER MA, 1982, SCIENCE, V216, P437, DOI 10.1126/science.7200261; Wecker L, 2010, BRODYS HUMAN PHARM; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; WITKIN JM, 1988, LIFE SCI, V42, P2467, DOI 10.1016/0024-3205(88)90345-1; Witte LPW, 2008, EUR UROL, V54, P326, DOI 10.1016/j.eururo.2007.12.007	36	626	661	14	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	2013	341	6142					143	+	1236361	10.1126/science.1236361	http://dx.doi.org/10.1126/science.1236361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23846904				2022-12-01	WOS:000321965300033
J	Posor, Y; Eichhorn-Gruenig, M; Puchkov, D; Schoneberg, J; Ullrich, A; Lampe, A; Muller, R; Zarbakhsh, S; Gulluni, F; Hirsch, E; Krauss, M; Schultz, C; Schmoranzer, J; Noe, F; Haucke, V				Posor, York; Eichhorn-Gruenig, Marielle; Puchkov, Dmytro; Schoeneberg, Johannes; Ullrich, Alexander; Lampe, Andre; Mueller, Rainer; Zarbakhsh, Sirus; Gulluni, Federico; Hirsch, Emilio; Krauss, Michael; Schultz, Carsten; Schmoranzer, Jan; Noe, Frank; Haucke, Volker			Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate	NATURE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PHOSPHOINOSITIDE 3-KINASE; COATED VESICLES; HOMOLOGY-DOMAIN; PROTEINS; KINASE; CELLS; PHOSPHOINOSITIDE-3-KINASE-C2-ALPHA; 4,5-BISPHOSPHATE; IDENTIFICATION	Phosphoinositides serve crucial roles in cell physiology, ranging from cell signalling to membrane traffic(1,2). Among the seven eukaryotic phosphoinositides the best studied species is phosphatidylinositol-4,5-bisphosphate (PI(4,5)P-2), which is concentrated at the plasma membrane where, among other functions, it is required for the nucleation of endocytic clathrin-coated pits(3-6). No phosphatidylinositol other than PI(4,5)P-2 has been implicated in clathrin-mediated endocytosis, whereas the subsequent endosomal stages of the endocytic pathway are dominated by phosphatidylinositol-3-phosphates(PI(3)P)(7). How phosphatidylinositol conversion from PI(4,5)P-2-positive endocytic intermediates to PI(3)P-containing endosomes is achieved is unclear. Here we show that formation of phosphatidylinositol-3,4-bisphosphate (PI(3,4)P-2) by class II phosphatidylinositol-3-kinase C2 alpha (PI(3) K C2 alpha) spatiotemporally controls clathrin-mediated endocytosis. Depletion of PI(3,4)P-2 or PI(3)K C2 alpha impairs the maturation of late-stage clathrin-coated pits before fission. Timed formation of PI(3,4)P-2 by PI(3)K C2 alpha is required for selective enrichment of the BAR domain protein SNX9 at late-stage endocytic intermediates. These findings provide a mechanistic framework for the role of PI(3,4)P-2 in endocytosis and unravel a novel discrete function of PI(3,4)P-2 in a central cell physiological process.	[Posor, York; Eichhorn-Gruenig, Marielle; Puchkov, Dmytro; Lampe, Andre; Krauss, Michael; Schmoranzer, Jan; Haucke, Volker] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Posor, York; Eichhorn-Gruenig, Marielle; Puchkov, Dmytro; Lampe, Andre; Krauss, Michael; Schmoranzer, Jan; Haucke, Volker] Free Univ Berlin, D-13125 Berlin, Germany; [Schoeneberg, Johannes; Ullrich, Alexander; Noe, Frank] Free Univ Berlin, DFG Res Ctr MATHEON, D-14195 Berlin, Germany; [Mueller, Rainer; Zarbakhsh, Sirus; Schultz, Carsten] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Gulluni, Federico; Hirsch, Emilio] Univ Turin, Ctr Mol Biotechnol, Dept Genet, I-10126 Turin, Italy; [Gulluni, Federico; Hirsch, Emilio] Univ Turin, Ctr Mol Biotechnol, Dept Biol, I-10126 Turin, Italy; [Gulluni, Federico; Hirsch, Emilio] Univ Turin, Ctr Mol Biotechnol, Dept Biochem, I-10126 Turin, Italy; [Haucke, Volker] Charite, NeuroCure Cluster Excellence, D-10117 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Free University of Berlin; German Research Foundation (DFG); European Molecular Biology Laboratory (EMBL); University of Turin; University of Turin; University of Turin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Haucke, V (corresponding author), Leibniz Inst Mol Pharmakol FMP, Robert Roessle Str 10, D-13125 Berlin, Germany.	haucke@fmp-berlin.de	GULLUNI, Federico/AAZ-8223-2021; Noe, Frank/Y-2766-2019; Hirsch, Emilio/F-4848-2013	GULLUNI, Federico/0000-0001-7706-1635; Hirsch, Emilio/0000-0002-9073-6024; Schoneberg, Johannes/0000-0001-7083-1828; Ullrich, Alexander/0000-0002-4894-6124; Schmoranzer, Jan/0000-0002-4482-7080; Puchkov, Dmytro/0000-0001-8341-4847; Schultz, Carsten/0000-0002-5824-2171; Lampe, Andre/0000-0003-0750-4757; Mueller, Rainer/0000-0003-3464-494X; Krauss, Michael/0000-0003-1010-9723; Haucke, Volker/0000-0003-3119-6993	Deutsche Forschungsgemeinschaft [SFB 740/C8, SFB 740/D7, SFB 958/A04, SFB 958/A07, SFB 958/Z02]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank E. Ungewickell, P. Di Fiore, P. De Camilli, H. McMahon, E. Wancker, T. Sudhof and S. Carlsson for antibodies, L. Cantley, T. Takenawa, M. Wymann, T. Ross, O. Daumke and W. Yang for plasmids, and O. Daumke, B. Eickolt and F. Wieland for critical comments. Supported by grants from the Deutsche Forschungsgemeinschaft (SFB 740/C8; SFB 740/D7; SFB 958/A04; SFB 958/A07; SFB 958/Z02).	Antonescu CN, 2011, MOL BIOL CELL, V22, P2588, DOI 10.1091/mbc.E11-04-0362; Bae YH, 2010, P NATL ACAD SCI USA, V107, P21547, DOI 10.1073/pnas.1002309107; Borner GHH, 2012, J CELL BIOL, V197, P141, DOI 10.1083/jcb.201111049; CAMPBELL C, 1984, BIOCHEMISTRY-US, V23, P4420, DOI 10.1021/bi00314a028; Chang-Ileto B, 2011, DEV CELL, V20, P206, DOI 10.1016/j.devcel.2010.12.008; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Fili N, 2006, P NATL ACAD SCI USA, V103, P15473, DOI 10.1073/pnas.0607040103; Gaidarov I, 2005, J BIOL CHEM, V280, P40766, DOI 10.1074/jbc.M507731200; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Gruenberg J, 2003, CURR OPIN CELL BIOL, V15, P382, DOI 10.1016/S0955-0674(03)00078-4; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Laketa V, 2009, CHEM BIOL, V16, P1190, DOI 10.1016/j.chembiol.2009.10.005; Leibiger B, 2010, FASEB J, V24, P1824, DOI 10.1096/fj.09-148072; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Malecz N, 2000, CURR BIOL, V10, P1383, DOI 10.1016/S0960-9822(00)00778-8; Maritzen T, 2012, P NATL ACAD SCI USA, V109, P10382, DOI 10.1073/pnas.1206468109; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Park J, 2010, J CELL SCI, V123, P1742, DOI 10.1242/jcs.064170; Pirola L, 2001, J BIOL CHEM, V276, P21544, DOI 10.1074/jbc.M011330200; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Stahelin RV, 2006, J BIOL CHEM, V281, P39396, DOI 10.1074/jbc.M607079200; Subramanian D, 2010, NAT CHEM BIOL, V6, P324, DOI 10.1038/nchembio.348; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wieffer M, 2012, METHOD CELL BIOL, V108, P209, DOI 10.1016/B978-0-12-386487-1.00011-0; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yarar D, 2008, TRAFFIC, V9, P133, DOI 10.1111/j.1600-0854.2007.00675.x; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	36	272	279	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2013	499	7457					233	+		10.1038/nature12360	http://dx.doi.org/10.1038/nature12360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23823722				2022-12-01	WOS:000321557600067
J	Berggren, G; Adamska, A; Lambertz, C; Simmons, TR; Esselborn, J; Atta, M; Gambarelli, S; Mouesca, JM; Reijerse, E; Lubitz, W; Happe, T; Artero, V; Fontecave, M				Berggren, G.; Adamska, A.; Lambertz, C.; Simmons, T. R.; Esselborn, J.; Atta, M.; Gambarelli, S.; Mouesca, J. -M.; Reijerse, E.; Lubitz, W.; Happe, T.; Artero, V.; Fontecave, M.			Biomimetic assembly and activation of [FeFe]-hydrogenases	NATURE			English	Article							FE-ONLY HYDROGENASE; ACTIVE-SITE; H-CLUSTER; DESULFOVIBRIO-DESULFURICANS; CHLAMYDOMONAS-REINHARDTII; S-ADENOSYLMETHIONINE; LINKAGE ISOMERISM; BIOFUEL CELL; IRON; COORDINATION	Hydrogenases are the most active molecular catalysts for hydrogen production and uptake(1,2), and could therefore facilitate the development of new types of fuel cell(3-5). In [FeFe]-hydrogenases, catalysis takes place at a unique di-iron centre (the [2Fe] subsite), which contains a bridging dithiolate ligand, three CO ligands and two CN- ligands(6,7). Through a complex multienzymatic biosynthetic process, this [2Fe] subsite is first assembled on a maturation enzyme, HydF, and then delivered to the apo-hydrogenase for activation(8). Synthetic chemistry has been used to prepare remarkably similar mimics of that subsite(1), but it has failed to reproduce the natural enzymatic activities thus far. Here we show that three synthetic mimics (containing different bridging dithiolate ligands) can be loaded onto bacterial Thermotoga maritima HydF and then transferred to apo-HydA1, one of the hydrogenases of Chlamy-domonas reinhardtii algae. Full activation of HydA1 was achieved only when using the HydF hybrid protein containing the mimic with an azadithiolate bridge, confirming the presence of this ligand in the active site of native [FeFe]-hydrogenases(9,10). This is an example of controlled metalloenzyme activation using the combination of a specific protein scaffold and active-site synthetic analogues. This simple methodology provides both new mechanistic and structural insight into hydrogenase maturation and a unique tool for producing recombinant wild-type and variant [FeFe]-hydrogenases, with no requirement for the complete maturation machinery.	[Berggren, G.; Simmons, T. R.; Atta, M.; Artero, V.; Fontecave, M.] Univ Grenoble 1, CNRS, CEA, Lab Chim & Biol Met, F-38054 Grenoble 9, France; [Berggren, G.; Fontecave, M.] Coll France, F-75231 Paris 5, France; [Adamska, A.; Reijerse, E.; Lubitz, W.] Max Planck Inst Chem Energiekonvers, D-45470 Mulheim, Germany; [Lambertz, C.; Esselborn, J.; Happe, T.] Ruhr Univ Bochum, AG Photobiotechnol, Lehrstuhl Biochem Pflanzen, D-44801 Bochum, Germany; [Gambarelli, S.; Mouesca, J. -M.] Univ Grenoble 1, CEA INAC, Lab Chim Inorgan & Biol, UMR E 3, F-38054 Grenoble 9, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; PSL Research University Paris; College de France; Max Planck Society; Ruhr University Bochum; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Fontecave, M (corresponding author), Univ Grenoble 1, CNRS, CEA, Lab Chim & Biol Met, 17 Rue Martyrs, F-38054 Grenoble 9, France.	marc.fontecave@cea.fr	Artero, Vincent/C-6853-2008; Simmons, Trevor/B-8182-2016; Berggren, Gustav/H-8659-2013	Artero, Vincent/0000-0002-6148-8471; Simmons, Trevor/0000-0002-6057-7704; Berggren, Gustav/0000-0002-6717-6612; Happe, Thomas/0000-0003-1206-5234; Esselborn, Julian/0000-0002-3499-8417	Bengt Lundqvist Minnesfond, FORMAS [213-2010-563]; Swedish Royal Academy of Sciences; French National Research Agency (ANR) [07-BLAN-0298-01]; Labex programme (ARCANE) [11-LABX-003]; European Research Council under the European Union's Seventh Framework Programme [306398]; Deutsche Forschungsgemeinschaft [HA 255/2-1]; BMBF [Bio-H2]; Volkswagen foundation [LigH2t]; Max Planck Society	Bengt Lundqvist Minnesfond, FORMAS; Swedish Royal Academy of Sciences; French National Research Agency (ANR)(French National Research Agency (ANR)); Labex programme (ARCANE); European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Volkswagen foundation(Volkswagen); Max Planck Society(Max Planck Society)	G. B. acknowledges support from the Bengt Lundqvist Minnesfond, FORMAS (contract number 213-2010-563) and the Swedish Royal Academy of Sciences. This work was supported by the French National Research Agency (ANR) through grant 07-BLAN-0298-01 and the Labex programme (ARCANE, 11-LABX-003). V. A. acknowledges support from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013/ERC Grant Agreement no. 306398). T. H. was supported by the Deutsche Forschungsgemeinschaft (HA 255/2-1), the BMBF (Bio-H2) and the Volkswagen foundation (LigH2t). A. A., E. R. and W. L. thank the Max Planck Society for financial support, and A. Silakov for providing the FTIR processing software.	Adamska A, 2012, ANGEW CHEM INT EDIT, V51, P11458, DOI 10.1002/anie.201204800; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Chen DW, 2003, J AM CHEM SOC, V125, P11788, DOI 10.1021/ja036120z; Ciaccafava A, 2012, ELECTROCHEM COMMUN, V23, P25, DOI 10.1016/j.elecom.2012.06.035; Coronado E, 2005, J AM CHEM SOC, V127, P4580, DOI 10.1021/ja043166z; Cracknell JA, 2008, CHEM REV, V108, P2439, DOI 10.1021/cr0680639; Czech I, 2010, FEBS LETT, V584, P638, DOI 10.1016/j.febslet.2009.12.016; Darensbourg MY, 2003, P NATL ACAD SCI USA, V100, P3683, DOI 10.1073/pnas.0536955100; Fiedler AT, 2005, INORG CHEM, V44, P1794, DOI 10.1021/ic048739n; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Gambarelli S, 2005, CHEMBIOCHEM, V6, P1960, DOI 10.1002/cbic.200500182; Geiss A, 2000, INORG CHEM, V39, P4029, DOI 10.1021/ic0001412; Hambourger M, 2008, J AM CHEM SOC, V130, P2015, DOI 10.1021/ja077691k; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; Hemschemeier A, 2009, PHOTOSYNTH RES, V102, P523, DOI 10.1007/s11120-009-9415-5; Hubrich M, 1996, J CHEM PHYS, V104, P2172, DOI 10.1063/1.470973; Kamp C, 2008, BBA-BIOENERGETICS, V1777, P410, DOI 10.1016/j.bbabio.2008.02.002; Krishnan S, 2012, CHEM SCI, V3, P1015, DOI 10.1039/c2sc01103d; Kuchenreuther JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015491; Le Cloirec A, 1999, CHEM COMMUN, P2285; Li HX, 2002, J AM CHEM SOC, V124, P726, DOI 10.1021/ja016964n; Lyon EJ, 1999, ANGEW CHEM INT EDIT, V38, P3178, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3178::AID-ANIE3178>3.0.CO;2-4; Mertens R, 2004, CURR OPIN BIOTECH, V15, P343, DOI 10.1016/j.copbio.2004.06.010; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2001, J AM CHEM SOC, V123, P1596, DOI 10.1021/ja0020963; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Schmidt M, 1999, J AM CHEM SOC, V121, P9736, DOI 10.1021/ja9924187; Shatruk M, 2007, J AM CHEM SOC, V129, P6104, DOI 10.1021/ja066273x; Silakov A, 2009, PHYS CHEM CHEM PHYS, V11, P6592, DOI 10.1039/b905841a; Song LC, 2004, ORGANOMETALLICS, V23, P3082, DOI 10.1021/om049752i; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; Sybirna K, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-73; Tard C, 2009, CHEM REV, V109, P2245, DOI 10.1021/cr800542q	36	484	486	11	574	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2013	499	7456					66	+		10.1038/nature12239	http://dx.doi.org/10.1038/nature12239			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23803769	Green Accepted			2022-12-01	WOS:000321285600034
J	Brandes, M; Klauschen, F; Kuchen, S; Germain, RN				Brandes, Marlene; Klauschen, Frederick; Kuchen, Stefan; Germain, Ronald N.			A Systems Analysis Identifies a Feedforward Inflammatory Circuit Leading to Lethal Influenza Infection	CELL			English	Article							KAPPA-B-ALPHA; IMMUNE-RESPONSE; DENDRITIC CELLS; PROTECTS MICE; HOST IMMUNE; VIRUS; NEUTROPHILS; RECEPTOR; MACROPHAGES; EXPRESSION	For acutely lethal influenza infections, the relative pathogenic contributions of direct viral damage to lung epithelium versus dysregulated immunity remain unresolved. Here, we take a top-down systems approach to this question. Multigene transcriptional signatures from infected lungs suggested that elevated activation of inflammatory signaling networks distinguished lethal from sublethal infections. Flow cytometry and gene expression analysis involving isolated cell subpopulations from infected lungs showed that neutrophil influx largely accounted for the predictive transcriptional signature. Automated imaging analysis, together with these gene expression and flow data, identified a chemokine-driven feedforward circuit involving proinflammatory neutrophils potently driven by poorly contained lethal viruses. Consistent with these data, attenuation, but not ablation, of the neutrophil-driven response increased survival without changing viral spread. These findings establish the primacy of damaging innate inflammation in at least some forms of influenza-induced lethality and provide a roadmap for the systematic dissection of infection-associated pathology.	[Brandes, Marlene; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Kuchen, Stefan] NIAMSD, Immunogenet Mol Lab, NIH, Bethesda, MD 20892 USA; [Klauschen, Frederick] Univ Med Berlin, Inst Pathol, D-10117 Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Brandes, M (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	marlene.brandes@insel.ch; rgermain@nih.gov	Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019; Klauschen, Frederick/C-5637-2015	Kuchen, Stefan/0000-0003-4899-8132	Intramural Research Program of NIAID, NIH; Swiss Science Foundation [PA00A-1114666]; Human Frontier Science Program Young Investigator Award [RGY0077/2011]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001034, ZIAAI000974] Funding Source: NIH RePORTER	Intramural Research Program of NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Human Frontier Science Program Young Investigator Award(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J.R. Bennink and S.E. Hensley for virus seeds and initial advice; T.A. Torrey, C.L. Thomas, and the animal facility team for support and animal health observations; K.L. Holmes and C.L. Eigsti for FACS Aria operation; T.G. Myers, G. Owens, and A. Godinez for microarray hybridization and QC analysis; R. Kastenmayer, M.S. Orandle, O.M. Schwartz, and L. Koo for slide scanner access and advice; Y. Belkaid for bones from germ-free mice; and B. Dutta, J.R. Bennink, W. Resch, and I. Fraser for critical reading of the manuscript and valuable comments. This work was supported by the Intramural Research Program of NIAID, NIH, a fellowship from the Swiss Science Foundation PA00A-1114666 (M.B.), and a Human Frontier Science Program Young Investigator Award RGY0077/2011 (F.K.).	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Boon ACM, 2011, MBIO, V2, DOI 10.1128/mBio.00171-11; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brincks EL, 2008, J IMMUNOL, V181, P4918, DOI 10.4049/jimmunol.181.7.4918; Chakrabarti AK, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-219; Chang ST, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-202; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; de Bruin AM, 2012, BLOOD, V119, P1543, DOI 10.1182/blood-2011-07-367706; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Garigliany MM, 2010, EMERG INFECT DIS, V16, P595, DOI 10.3201/eid1604.091061; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Goldbach-Mansky R, 2009, J ALLERGY CLIN IMMUN, V124, P1141, DOI 10.1016/j.jaci.2009.11.016; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Jacobs JP, 2010, ARTHRITIS RHEUM-US, V62, P1921, DOI 10.1002/art.27470; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Otte A, 2011, AM J PATHOL, V179, P230, DOI 10.1016/j.ajpath.2011.03.041; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Qi L, 2011, VIROLOGY, V412, P426, DOI 10.1016/j.virol.2011.01.029; Qiu LQ, 2012, J IMMUNOL, V188, P5150, DOI 10.4049/jimmunol.1103700; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shinya K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-97; Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tate MD, 2012, IMMUNOL CELL BIOL, V90, P197, DOI 10.1038/icb.2011.26; Tate MD, 2011, J IMMUNOL, V187, P1884, DOI 10.4049/jimmunol.1100295; Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Wang JP, 2008, BLOOD, V112, P2028, DOI 10.1182/blood-2008-01-132860; Watanabe T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001218; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603	54	254	258	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					197	212		10.1016/j.cell.2013.06.013	http://dx.doi.org/10.1016/j.cell.2013.06.013			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827683	Green Accepted, Bronze			2022-12-01	WOS:000321327900020
J	Mevissen, TET; Hospenthal, MK; Geurink, PP; Elliott, PR; Akutsu, M; Arnaudo, N; Ekkebus, R; Kulathu, Y; Wauer, T; El Oualid, F; Freund, SMV; Ovaa, H; Komander, D				Mevissen, Tycho E. T.; Hospenthal, Manuela K.; Geurink, Paul P.; Elliott, Paul R.; Akutsu, Masato; Arnaudo, Nadia; Ekkebus, Reggy; Kulathu, Yogesh; Wauer, Tobias; El Oualid, Farid; Freund, Stefan M. V.; Ovaa, Huib; Komander, David			OTU Deubiquitinases Reveal Mechanisms of Linkage Specificity and Enable Ubiquitin Chain Restriction Analysis	CELL			English	Article							KAPPA-B ACTIVATION; CROSS-REACTIVITY; LINKED UBIQUITIN; STRUCTURAL BASIS; POLYUBIQUITIN; ENZYME; RECOGNITION; PROTEIN; UBIQUITYLATION; INFLAMMATION	Sixteen ovarian tumor (OTU) family deubiquitinases (DUBs) exist in humans, and most members regulate cell-signaling cascades. Several OTU DUBs were reported to be ubiquitin (Ub) chain linkage specific, but comprehensive analyses are missing, and the underlying mechanisms of linkage specificity are unclear. Using Ub chains of all eight linkage types, we reveal that most human OTU enzymes are linkage specific, preferring one, two, or a defined subset of linkage types, including unstudied atypical Ub chains. Biochemical analysis and five crystal structures of OTU DUBs with or without Ub substrates reveal four mechanisms of linkage specificity. Additional Ub-binding domains, the ubiquitinated sequence in the substrate, and defined S1' and S2 Ub-binding sites on the OTU domain enable OTU DUBs to distinguish linkage types. We introduce Ub chain restriction analysis, in which OTU DUBs are used as restriction enzymes to reveal linkage type and the relative abundance of Ub chains on substrates.	[Mevissen, Tycho E. T.; Hospenthal, Manuela K.; Elliott, Paul R.; Akutsu, Masato; Arnaudo, Nadia; Kulathu, Yogesh; Wauer, Tobias; Freund, Stefan M. V.; Komander, David] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Mevissen, Tycho E. T.] Free Univ Berlin, Fachbereich Biol, D-14195 Berlin, Germany; [Geurink, Paul P.; Ekkebus, Reggy; El Oualid, Farid; Ovaa, Huib] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	MRC Laboratory Molecular Biology; Free University of Berlin; Netherlands Cancer Institute	Komander, D (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	dk@mrc-lmb.cam.ac.uk	Mevissen, Tycho E.T./AAX-4366-2020; Hospenthal, Manuela/AAU-3210-2020; akutsu, masato/L-4095-2016; ovaa, huib/M-2334-2016	Mevissen, Tycho E.T./0000-0002-2324-5292; Hospenthal, Manuela/0000-0003-1175-6826; akutsu, masato/0000-0002-9839-3345; Elliott, Paul/0000-0002-7641-2103; ovaa, huib/0000-0002-0068-054X; Kulathu, Yogesh/0000-0002-3274-1642; Geurink, Paul/0000-0003-1849-1111	MRC [U105192732]; European Research Council [309756]; European Molecular Biology Organization Young Investigator program; Lister Institute for Preventive Medicine; Netherlands Organization for Scientific Research [700.58.011]; Marie Curie Initial Training Network UPStream; Medical Research Council [MC_U105192732] Funding Source: researchfish; MRC [MC_U105192732] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization Young Investigator program(European Molecular Biology Organization (EMBO)); Lister Institute for Preventive Medicine; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Marie Curie Initial Training Network UPStream; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank E. Bennett (University of California, San Diego) for sharing unpublished mass spectrometry data, K. Bianchi and P. Meier (the Institute of Cancer Research, London) for the RIP1 purification protocol, T. Mund (Medical Research Council [MRC] Laboratory of Molecular Biology) for providing GST-tagged NEDD4 and E6AP, and members of the D.K. lab for reagents and helpful discussions. This work was supported by the MRC (U105192732 to D.K.), the European Research Council (309756 to D.K.), the European Molecular Biology Organization Young Investigator program (to D.K.), the Lister Institute for Preventive Medicine (to D.K.), the Netherlands Organization for Scientific Research (700.58.011 to H.O.), and the Marie Curie Initial Training Network UPStream (to T.E.T.M.). Crystallographic data were collected at the European Synchrotron Radiation Facility at beam lines ID23-1 and ID29 and at the Diamond Light Source beam lines I-03 and I-04. H.O. and F.E. are cofounders of UbiQ Bio BV.	Akutsu M, 2011, P NATL ACAD SCI USA, V108, P2228, DOI 10.1073/pnas.1015287108; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Drag M, 2008, BIOCHEM J, V415, P367, DOI 10.1042/BJ20080779; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Ekkebus R, 2013, J AM CHEM SOC, V135, P2867, DOI 10.1021/ja309802n; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Geurink PP, 2012, CHEMBIOCHEM, V13, P293, DOI 10.1002/cbic.201100706; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hospenthal MK, 2013, NAT STRUCT MOL BIOL, V20, P555, DOI 10.1038/nsmb.2547; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Huang OW, 2012, NAT STRUCT MOL BIOL, V19, P171, DOI 10.1038/nsmb.2206; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Iwai K, 2011, CELL CYCLE, V10, P3095, DOI 10.4161/cc.10.18.17437; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Licchesi JDF, 2012, NAT STRUCT MOL BIOL, V19, P62, DOI 10.1038/nsmb.2169; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nakasone MA, 2013, STRUCTURE, V21, P727, DOI 10.1016/j.str.2013.02.019; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Schaefer JB, 2011, J BIOL CHEM, V286, P45186, DOI 10.1074/jbc.M111.310094; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tsai YC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001038; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Williamson A, 2013, MOL CELL, V49, P591, DOI 10.1016/j.molcel.2013.01.028; Williamson A, 2011, MOL CELL, V42, P744, DOI 10.1016/j.molcel.2011.04.022; Ye Y, 2012, NATURE, V492, P266, DOI 10.1038/nature11722; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17	45	357	382	0	79	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					169	184		10.1016/j.cell.2013.05.046	http://dx.doi.org/10.1016/j.cell.2013.05.046			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827681	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000321327900018
J	Dennis, KM; Liao, QH; Wu, P; Gao, ZC; Cao, B; Feng, LZ; Xu, XL; Jiang, H; Li, M; Bao, J; Zheng, JD; Zhang, Q; Chang, ZR; Li, Y; Yu, JX; Liu, FF; Ni, MY; Wu, JT; Cowling, BJ; Yang, WZ; Leung, GM; Yu, HJ				Dennis, K. M.; Liao, Qiaohong; Wu, Peng; Gao, Zhancheng; Cao, Bin; Feng, Luzhao; Xu, Xiaoling; Jiang, Hui; Li, Ming; Bao, Jing; Zheng, Jiandong; Zhang, Qian; Chang, Zhaorui; Li, Yu; Yu, Jianxing; Liu, Fengfeng; Ni, Michael Y.; Wu, Joseph T.; Cowling, Benjamin J.; Yang, Weizhong; Leung, Gabriel M.; Yu, Hongjie			Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case series	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DISEASE; POULTRY; VIRUS; MARCH	Objective To characterise the complete case series of influenza A/H7N9 infections as of 27 May 2013, detected by China's national sentinel surveillance system for influenza-like illness. Design Case series. Setting Outpatient clinics and emergency departments of 554 sentinel hospitals across 31 provinces in mainland China. Cases Infected individuals were identified through cross-referencing people who had laboratory confirmed A/H7N9 infection with people detected by the sentinel surveillance system for influenza-like illness, where patients meeting the World Health Organization's definition of influenza-like illness undergo weekly surveillance, and 10-15 nasopharyngeal swabs are collected each week from a subset of patients with influenza-like illness in each hospital for virological testing. We extracted relevant epidemiological data from public health investigations by the Centers for Disease Control and Prevention at the local, provincial, and national level; and clinical and laboratory data from chart review. Main outcome measure Epidemiological, clinical, and laboratory profiles of the case series. Results Of 130 people with laboratory confirmed A/H7N9 infection as of 27 May 2013, five (4%) were detected through the sentinel surveillance system for influenza-like illness. Mean age was 13 years (range 2-26), and none had any underlying medical conditions. Exposure history, geographical location, and timing of symptom onset of these five patients were otherwise similar to the general cohort of laboratory confirmed cases so far. Only two of the five patients needed hospitalisation, and all five had mild or moderate disease with an uneventful course of recovery. Conclusion Our findings support the existence of a "clinical iceberg" phenomenon in influenza A/H7N9 infections, and reinforce the need for vigilance to the diverse presentation that can be associated with A/H7N9 infection. At the public health level, indirect evidence suggests a substantial proportion of mild disease in A/H7N9 infections.	[Dennis, K. M.; Wu, Peng; Ni, Michael Y.; Wu, Joseph T.; Cowling, Benjamin J.; Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China; [Liao, Qiaohong; Feng, Luzhao; Jiang, Hui; Li, Ming; Zheng, Jiandong; Zhang, Qian; Chang, Zhaorui; Li, Yu; Yu, Jianxing; Liu, Fengfeng; Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing 102206, Peoples R China; [Gao, Zhancheng; Bao, Jing] Peking Univ, Peoples Hosp, Dept Resp & Crit Care Med, Beijing 100871, Peoples R China; [Cao, Bin] Capital Med Univ, Beijing Inst Resp Med, Beijing Chao Yang Hosp, Dept Infect Dis & Clin Microbiol, Beijing, Peoples R China; [Xu, Xiaoling] Anhui Prov Hosp, Dept Resp Med, Hefei, Peoples R China; [Yang, Weizhong] Chinese Ctr Dis Control & Prevent, Off Director, Beijing, Peoples R China	University of Hong Kong; Chinese Center for Disease Control & Prevention; Peking University; Capital Medical University; Chinese Center for Disease Control & Prevention	Leung, GM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China.	gmleung@hku.hk; yuhj@chinacdc.cn	Cowling, Benjamin John/C-4263-2009; Wu, Joseph/ABD-5880-2021; Yu, Hongjie/GZK-5351-2022; Ip, Dennis Kai Ming/C-4283-2009	Cowling, Benjamin John/0000-0002-6297-7154; Leung, Gabriel/0000-0002-2503-6283; Ni, Michael/0000-0002-1217-5858; Wu, Peng/0000-0003-1157-9401; YU, Jianxing/0000-0002-9696-2460; Ip, Dennis Kai Ming/0000-0003-3592-8709	US National Institutes of Health (Comprehensive International Program for Research on AIDS) [U19 AI51915]; China-US collaborative program on emerging and re-emerging infectious diseases; Chinese Ministry of Science and Technology [2012 ZX10004-201]; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; Research Fund for the Control of Infectious Disease, Food, and Health Bureau (government of the Hong Kong Special Administrative Region); Hong Kong University [AoE/M-12/06]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	US National Institutes of Health (Comprehensive International Program for Research on AIDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China-US collaborative program on emerging and re-emerging infectious diseases; Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; Research Fund for the Control of Infectious Disease, Food, and Health Bureau (government of the Hong Kong Special Administrative Region); Hong Kong University(University of Hong Kong); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study received funding from the US National Institutes of Health (Comprehensive International Program for Research on AIDS grant U19 AI51915); the China-US collaborative program on emerging and re-emerging infectious diseases. The study was also funded by grants from the Chinese Ministry of Science and Technology (2012 ZX10004-201); the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant U54 GM088558); the Research Fund for the Control of Infectious Disease, Food, and Health Bureau (government of the Hong Kong Special Administrative Region), and the area of excellence scheme of the Hong Kong University grants committee (grant AoE/M-12/06). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish.	[Anonymous], CHIN WHO JOINT MISS; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, EUROSURVEILLANCE, V18, P2; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guan Y, 2013, J INFECT DEV COUNTR, V7, P302, DOI 10.3855/jidc.3675; Han J, 2013, EUROSURVEILLANCE, V18, P6; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Lu SH, 2013, EMERG INFECT DIS, V19, P1142, DOI [10.3201/eid1907.130612, 10.3201/eid.1907.130612]; Meijer A, 2006, J VIROL METHODS, V132, P113, DOI 10.1016/j.jviromet.2005.10.001; Shu YL, 2010, EMERG INFECT DIS, V16, P725, DOI 10.3201/eid1604.091578; Wu JT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001103; Xu CL, 2013, EMERG INFECT DIS, V19, P1289, DOI 10.3201/eid1908.130662; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang Wenyi, 2013, Clin Infect Dis, V57, P619, DOI 10.1093/cid/cit277	17	65	69	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2013	346								f3693	10.1136/bmj.f3693	http://dx.doi.org/10.1136/bmj.f3693			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QH	23798720	Green Published, hybrid			2022-12-01	WOS:000321245800001
J	Park, J; Al-Ramahi, I; Tan, QM; Mollema, N; Diaz-Garcia, JR; Gallego-Flores, T; Lu, HC; Lagalwar, S; Duvick, L; Kang, H; Lee, Y; Jafar-Nejad, P; Sayegh, LS; Richman, R; Liu, XY; Gao, Y; Shaw, CA; Arthur, JSC; Orr, HT; Westbrook, TF; Botas, J; Zoghbi, HY				Park, Jeehye; Al-Ramahi, Ismael; Tan, Qiumin; Mollema, Nissa; Diaz-Garcia, Javier R.; Gallego-Flores, Tatiana; Lu, Hsiang-Chih; Lagalwar, Sarita; Duvick, Lisa; Kang, Hyojin; Lee, Yoontae; Jafar-Nejad, Paymaan; Sayegh, Layal S.; Richman, Ronald; Liu, Xiuyun; Gao, Yan; Shaw, Chad A.; Arthur, J. Simon C.; Orr, Harry T.; Westbrook, Thomas F.; Botas, Juan; Zoghbi, Huda Y.			RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1	NATURE			English	Article							POLYGLUTAMINE-INDUCED NEURODEGENERATION; SPINOCEREBELLAR ATAXIA; PARKINSONS-DISEASE; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; TRANSGENIC MICE; KINASE INHIBITORS; LOCUS DUPLICATION; CAG REPEAT; MODEL	Many neurodegenerative disorders, such as Alzheimer's, Parkinson's and polyglutamine diseases, share a common pathogenic mechanism: the abnormal accumulation of disease-causing proteins, due to either the mutant protein's resistance to degradation or overexpression of the wild-type protein. We have developed a strategy to identify therapeutic entry points for such neurodegenerative disorders by screening for genetic networks that influence the levels of disease-driving proteins. We applied this approach, which integrates parallel cell-based and Drosophila genetic screens, to spinocerebellar ataxia type 1 (SCA1), a disease caused by expansion of a polyglutamine tract in ataxin 1 (ATXN1). Our approach revealed that downregulation of several components of the RAS-MAPK-MSK1 pathway decreases ATXN1 levels and suppresses neurodegeneration in Drosophila and mice. Importantly, pharmacological inhibitors of components of this pathway also decrease ATXN1 levels, suggesting that these components represent new therapeutic targets in mitigating SCA1. Collectively, these data reveal new therapeutic entry points for SCA1 and provide a proof-of-principle for tackling other classes of intractable neurodegenerative diseases.	[Park, Jeehye; Al-Ramahi, Ismael; Tan, Qiumin; Diaz-Garcia, Javier R.; Gallego-Flores, Tatiana; Kang, Hyojin; Lee, Yoontae; Jafar-Nejad, Paymaan; Sayegh, Layal S.; Richman, Ronald; Liu, Xiuyun; Gao, Yan; Shaw, Chad A.; Westbrook, Thomas F.; Botas, Juan; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Park, Jeehye; Al-Ramahi, Ismael; Tan, Qiumin; Diaz-Garcia, Javier R.; Gallego-Flores, Tatiana; Lu, Hsiang-Chih; Kang, Hyojin; Lee, Yoontae; Jafar-Nejad, Paymaan; Sayegh, Layal S.; Richman, Ronald; Liu, Xiuyun; Gao, Yan; Botas, Juan; Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Park, Jeehye; Tan, Qiumin; Lee, Yoontae; Richman, Ronald; Liu, Xiuyun; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Mollema, Nissa; Lagalwar, Sarita; Duvick, Lisa; Orr, Harry T.] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA; [Mollema, Nissa; Lagalwar, Sarita; Duvick, Lisa; Orr, Harry T.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Lu, Hsiang-Chih; Westbrook, Thomas F.; Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Arthur, J. Simon C.] Univ Dundee, Sch Life Sci, MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Westbrook, Thomas F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; University of Dundee; Baylor College of Medicine	Orr, HT (corresponding author), Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA.	orrxx002@umn.edu; thomasw@bcm.edu; jbotas@bcm.edu; hzoghbi@bcm.edu	Woo, Jean/K-2625-2014; Al-Ramahi, Ismael/B-4000-2017	Woo, Jean/0000-0001-7593-3081; Al-Ramahi, Ismael/0000-0002-1275-1114; Tan, Qiumin/0000-0003-2266-3238; Orr, Harry/0000-0001-6118-741X; Gallego, Tatiana/0000-0003-0773-0578; Arthur, Simon/0000-0002-8135-1958; Shaw, Chad/0000-0001-7267-5398; Zoghbi, Huda/0000-0002-0700-3349	Howard Hughes Medical Institute Collaborative Innovation Awards grant; NIH Brain Disorders and Development training grant [NIH-NS42179]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699, R01NS042179, T32NS043124, R56NS042179] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12016/10, MC_U127081014] Funding Source: researchfish; MRC [MC_UU_12016/10, MC_U127081014] Funding Source: UKRI	Howard Hughes Medical Institute Collaborative Innovation Awards grant; NIH Brain Disorders and Development training grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the members of the Zoghbi, Botas, Orr and Westbrook laboratories for suggestions and discussions, and V. Brandt for editorial input. We also appreciate the help from CCSC and C-BASS cores at The Baylor College of Medicine (BCM) for FACS analysis and the confocal microscopy and mouse behavioural cores of the BCM Intellectual and Developmental Disabilities Research Center (HD024064). Thanks to J. Barrish at Texas Children's Hospital for help with scanning electron microscopy. This work was supported by a Howard Hughes Medical Institute Collaborative Innovation Awards grant and grant NIH-NS42179 (J. B.) I.A.-R. was supported by an NIH Brain Disorders and Development training grant.	Al-Ramahi I, 2007, PLOS GENET, V3, P2551, DOI 10.1371/journal.pgen.0030234; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Bowman AB, 2007, NAT GENET, V39, P373, DOI 10.1038/ng1977; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Dar AC, 2012, NATURE, V486, P80, DOI 10.1038/nature11127; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; EVANS DA, 1990, MILBANK Q, V68, P267, DOI 10.2307/3350099; Falsig J, 2008, NAT PROTOC, V3, P555, DOI 10.1038/nprot.2008.13; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hindle JV, 2010, AGE AGEING, V39, P156, DOI 10.1093/ageing/afp223; Jafar-Nejad P, 2011, P NATL ACAD SCI USA, V108, P2142, DOI 10.1073/pnas.1018748108; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jorgensen ND, 2009, J NEUROCHEM, V110, P675, DOI 10.1111/j.1471-4159.2009.06164.x; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lorenzetti D, 2000, HUM MOL GENET, V9, P779, DOI 10.1093/hmg/9.5.779; MARSDEN CD, 1977, LANCET, V1, P345; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Scarpini E, 2003, LANCET NEUROL, V2, P539, DOI 10.1016/S1474-4422(03)00502-7; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Shaharabany M, 2008, FEBS J, V275, P1631, DOI 10.1111/j.1742-4658.2008.06318.x; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Teixeira-Castro A, 2011, HUM MOL GENET, V20, P2996, DOI 10.1093/hmg/ddr203; van Ham TJ, 2009, EMBO MOL MED, V1, P360, DOI 10.1002/emmm.200900051; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	49	97	100	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					325	+		10.1038/nature12204	http://dx.doi.org/10.1038/nature12204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23719381	Green Accepted			2022-12-01	WOS:000320592900032
J	Bradley, A; Sheridan, P				Bradley, Alastair; Sheridan, Paul			10-MINUTE CONSULTATION Atrial fibrillation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STROKE; RISK		[Bradley, Alastair] No Gen Hosp, Acad Unit Primary Med Care, Sheffield S5 7AU, S Yorkshire, England; [Sheridan, Paul] Sheffield Teaching Hosp NHS Fdn Trust, No Gen Hosp, Sheffield, S Yorkshire, England	Northern General Hospital; Northern General Hospital; University of Sheffield	Bradley, A (corresponding author), No Gen Hosp, Acad Unit Primary Med Care, Sheffield S5 7AU, S Yorkshire, England.	a.bradley@sheffield.ac.uk			Department of Health [IAT/I-PF/010/003] Funding Source: Medline; National Institute for Health Research [IAT/I-PF/010/003] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Lip GYH, 2007, LANCET, V370, P604, DOI 10.1016/S0140-6736(07)61300-2; Lip GYH, 2010, AM J MED, V123, P484, DOI 10.1016/j.amjmed.2009.12.013; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134	5	2	2	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2013	346								f3719	10.1136/bmj.f3719	http://dx.doi.org/10.1136/bmj.f3719			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171OV	23775800				2022-12-01	WOS:000320939700002
J	Lenzer, J				Lenzer, Jeanne			Why we can't trust clinical guidelines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPINAL-CORD-INJURY; TISSUE-PLASMINOGEN ACTIVATOR; EMERGENCY PHYSICIANS; OF-INTEREST; STROKE; METHYLPREDNISOLONE; THROMBOLYSIS; FAILURE; CLAIMS					jeanne.lenzer@gmail.com						Abramson JE, 2004, E PETITION NATL I HT; American College of Emergency Physicians, 2013, Ann Emerg Med, V61, P225, DOI 10.1016/j.annemergmed.2012.11.005; [Anonymous], 2013, POLL SUPP NEW GUID T; Armstrong D., 2006, WALL STREET J; Bracken MB., 2009, COCHRANE DB SYST REV, V1; Brown DL, 2005, ANN EMERG MED, V46, P56, DOI 10.1016/j.annemergmed.2004.12.025; Canadian Association of Emergency Physicians, 2003, CJEM, V5, P7; Coleman WP, 2000, J SPINAL DISORD, V13, P185, DOI 10.1097/00002517-200006000-00001; Cundiff D., 2010, STORY WHISTLEBLOWER; Fatovich DM, 2012, EMERG MED AUSTRALAS, V24, P477, DOI 10.1111/j.1742-6723.2012.01605.x; Fatovich DM, 2012, EMERG MED J, V29, P82, DOI 10.1136/emermed-2011-200476; Gale EAM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5728; Garber AM, 2005, HEALTH AFFAIR, V24, P174, DOI 10.1377/hlthaff.24.1.174; Guyatt G, 2010, ANN INTERN MED, V152, P738, DOI 10.7326/0003-4819-152-11-201006010-00254; Hoffman JR, 2012, EMERG MED AUSTRALAS, V24, P473, DOI 10.1111/j.1742-6723.2012.01604.x; Hoffman JR, 2009, ANN EMERG MED, V54, P329, DOI 10.1016/j.annemergmed.2009.03.019; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; Institute of Medicine, 2011, CLIN PRACT GUID WE C; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Klauer K., 2012, EMERG PHYS MONTH NOV; Kolata G., 2007, NY TIMES; Kung J, 2012, ARCH INTERN MED, V172, P1628, DOI 10.1001/2013.jamainternmed.56; Lenzer J, 2002, BRIT MED J, V324, P723, DOI 10.1136/bmj.324.7339.723; Lenzer J., 2006, NEW REPUBLIC; Lenzer Jeanne, 2012, WASHINGTON MONTHLY; LYONS MK, 1990, NEW ENGL J MED, V323, P1207; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Molloy S, 2002, INJURY, V33, P575, DOI 10.1016/S0020-1383(02)00142-0; Nesathurai S, 1998, J TRAUMA, V45, P1088, DOI 10.1097/00005373-199812000-00021; Newman D., 2013, SCI MED RES TRA 0417; Newman D., 2012, THROMBOLYTICS ACUTE; Newman DH, 2012, LANCET, V380, P1053, DOI 10.1016/S0140-6736(12)61593-1; Radecki RP, 2012, NAT REV NEUROL, V8, P176, DOI 10.1038/nrneurol.2011.89-c1; Ransohoff DF, 2013, JAMA-J AM MED ASSOC, V309, P139, DOI 10.1001/jama.2012.156703; Scott PA, 2010, STROKE, V41, P2026, DOI 10.1161/STROKEAHA.110.581942; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Sloane EP., CLIN USE TPA ACUTE I; Timmermans S, 2005, HEALTH AFFAIR, V24, P18, DOI 10.1377/hlthaff.24.1.18; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2	39	109	114	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2013	346								f3830	10.1136/bmj.f3830	http://dx.doi.org/10.1136/bmj.f3830			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166XQ	23771225				2022-12-01	WOS:000320593900009
J	Zhang, YLV; Ni, JF; Montell, C				Zhang, Yali V.; Ni, Jinfei; Montell, Craig			The Molecular Basis for Attractive Salt-Taste Coding in Drosophila	SCIENCE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; BITTER TASTE; MELANOGASTER; EXPRESSION; GENES; ARCHITECTURE; NEURONS; CHANNEL; MICE	Below a certain level, table salt (NaCl) is beneficial for animals, whereas excessive salt is harmful. However, it remains unclear how low- and high-salt taste perceptions are differentially encoded. We identified a salt-taste coding mechanism in Drosophila melanogaster. Flies use distinct types of gustatory receptor neurons (GRNs) to respond to different concentrations of salt. We demonstrated that a member of the newly discovered ionotropic glutamate receptor (IR) family, IR76b, functioned in the detection of low salt and was a Na+ channel. The loss of IR76b selectively impaired the attractive pathway, leaving salt-aversive GRNs unaffected. Consequently, low salt became aversive. Our work demonstrated that the opposing behavioral responses to low and high salt were determined largely by an elegant bimodal switch system operating in GRNs.	[Montell, Craig] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93110 USA; [Montell, Craig] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93110 USA; [Zhang, Yali V.; Ni, Jinfei; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Zhang, Yali V.; Ni, Jinfei; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Johns Hopkins University; Johns Hopkins University	Montell, C (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93110 USA.	craig.montell@lifesci.ucsb.edu	Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Zhang, Yali/0000-0003-4083-4352	National Institute on Deafness and Other Communication Disorders [DC007864]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007864] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by a grant to C.M. from the National Institute on Deafness and Other Communication Disorders (DC007864).	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; BALAKRISHNAN R, 1991, J EXP BIOL, V157, P161; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; DESIMONE JA, 1981, SCIENCE, V214, P1039, DOI 10.1126/science.7302576; FUJISHIRO N, 1984, J INSECT PHYSIOL, V30, P317, DOI 10.1016/0022-1910(84)90133-1; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Nakamura M, 2002, J NEUROSCI, V22, P3463; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	26	194	202	7	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1334	1338		10.1126/science.1234133	http://dx.doi.org/10.1126/science.1234133			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766326	Green Accepted			2022-12-01	WOS:000320320200046
J	Christensen, K; Thinggaard, M; Oksuzyan, A; Steenstrup, T; Andersen-Ranberg, K; Jeune, B; McGue, M; Vaupel, JW				Christensen, Kaare; Thinggaard, Mikael; Oksuzyan, Anna; Steenstrup, Troels; Andersen-Ranberg, Karen; Jeune, Bernard; McGue, Matt; Vaupel, James W.			Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart	LANCET			English	Article							AGE TRAJECTORIES; UNITED-STATES; HEALTH; TRENDS; POPULATION; IMPAIRMENT; PREVALENCE; MORTALITY; AMERICANS; NONAGENARIANS	Background A rapidly increasing proportion of people in high-income countries are surviving into their tenth decade. Concern is widespread that the basis for this development is the survival of frail and disabled elderly people into very old age. To investigate this issue, we compared the cognitive and physical functioning of two cohorts of Danish nonagenarians, born 10 years apart. Methods People in the first cohort were born in 1905 and assessed at age 93 years (n=2262); those in the second cohort were born in 1915 and assessed at age 95 years (n=1584). All cohort members were eligible irrespective of type of residence. Both cohorts were assessed by surveys that used the same design and assessment instrument, and had almost identical response rates (63%). Cognitive functioning was assessed by mini-mental state examination and a composite of five cognitive tests that are sensitive to age-related changes. Physical functioning was assessed by an activities of daily living score and by physical performance tests (grip strength, chair stand, and gait speed). Findings The chance of surviving from birth to age 93 years was 28% higher in the 1915 cohort than in the 1905 cohort (6.50% vs 5.06%), and the chance of reaching 95 years was 32% higher in 1915 cohort (3.93% vs 2.98%). The 1915 cohort scored significantly better on the mini-mental state examination than did the 1905 cohort (22.8 [SD 5.6] vs 21.4 [6.0]; p<0.0001), with a substantially higher proportion of participants obtaining maximum scores (28-30 points; 277 [23%] vs 235 [13%]; p<0.0001). Similarly, the cognitive composite score was significantly better in the 1915 than in the 1905 cohort (0.49 [SD 3.6] vs 0.01 [SD 3.6]; p=0.0003). The cohorts did not differ consistently in the physical performance tests, but the 1915 cohort had significantly better activities of daily living scores than did the 1905 cohort (2.0 [SD 0.8] vs 1.8 [0.7]; p<0.0001). Interpretation Despite being 2 years older at assessment, the 1915 cohort scored significantly better than the 1905 cohort on both the cognitive tests and the activities of daily living score, which suggests that more people are living to older ages with better overall functioning.	[Christensen, Kaare; Thinggaard, Mikael; Oksuzyan, Anna; Andersen-Ranberg, Karen; Jeune, Bernard; Vaupel, James W.] Univ Southern Denmark, Inst Publ Hlth, Danish Aging Res Ctr, DK-5000 Odense C, Denmark; [Steenstrup, Troels] Univ Southern Denmark, Dept Biostat, DK-5000 Odense C, Denmark; [Christensen, Kaare; Vaupel, James W.] Univ Southern Denmark, Max Planck Odense Ctr, DK-5000 Odense C, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Andersen-Ranberg, Karen] Odense Univ Hosp, Dept Geriatr, DK-5000 Odense, Denmark; [McGue, Matt] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Vaupel, James W.] Max Planck Inst Demog Res, Rostock, Germany	University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Minnesota System; University of Minnesota Twin Cities; Max Planck Society	Christensen, K (corresponding author), Univ Southern Denmark, Inst Publ Hlth, Danish Aging Res Ctr, JB Winslows Vej 9B, DK-5000 Odense C, Denmark.	kchristensen@health.sdu.dk	Andersen, Mette Adalheidur/D-5608-2017; Jeune, Bernard/P-6866-2015; Andersen-Ranberg, Karen/P-7053-2015; Christensen, Kaare/C-2360-2009	Andersen-Ranberg, Karen/0000-0003-1970-7076; Christensen, Kaare/0000-0002-5429-5292; Thinggaard, Mikael/0000-0002-7029-453X; Vaupel, James/0000-0003-0783-3905; Oksuzyan, Anna/0000-0003-4138-5886	Danish National Research Foundation; US National Institutes of Health-National Institute on Aging; Danish Agency for Science, Technology and Innovation; VELUX Foundation; NATIONAL INSTITUTE ON AGING [P01AG031719, P01AG008761, P30AG034424] Funding Source: NIH RePORTER	Danish National Research Foundation(Danmarks Grundforskningsfond); US National Institutes of Health-National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Danish Agency for Science, Technology and Innovation; VELUX Foundation(Velux Fonden); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding Danish National Research Foundation; US National Institutes of Health-National Institute on Aging; Danish Agency for Science, Technology and Innovation; VELUX Foundation.	Baltes PB, 2003, GERONTOLOGY, V49, P123, DOI 10.1159/000067946; Bramell-Risberg E, 2012, CLIN INTERV AGING, V7, P195, DOI 10.2147/CIA.S31777; Christensen K, 1999, J AGING HEALTH, V11, P49, DOI 10.1177/089826439901100103; Christensen K, 2003, BEHAV GENET, V33, P125, DOI 10.1023/A:1022501817781; Christensen K, 2002, AM J EPIDEMIOL, V155, P132, DOI 10.1093/aje/155.2.132; Christensen K., 2010, INT DIFFERENCES MORT, P385; Christensen K, 2008, P NATL ACAD SCI USA, V105, P13274, DOI 10.1073/pnas.0804931105; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P75, DOI 10.1093/geronb/gbq088; Engberg H, 2008, DEMENT GERIATR COGN, V26, P153, DOI 10.1159/000149819; Engberg H, 2008, J GERONTOL A-BIOL, V63, P1186, DOI 10.1093/gerona/63.11.1186; Flynn JR, 1999, AM PSYCHOL, V54, P5, DOI 10.1037/0003-066X.54.1.5; Frederiksen H, 2006, ANN EPIDEMIOL, V16, P554, DOI 10.1016/j.annepidem.2005.10.006; Freedman VA, 2001, J GERONTOL B-PSYCHOL, V56, pS100, DOI 10.1093/geronb/56.2.S100; Gerstorf D, 2011, DEV PSYCHOL, V47, P1026, DOI 10.1037/a0023426; King DE, 2013, JAMA INTERN MED, V173, P385, DOI 10.1001/jamainternmed.2013.2006; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Manton KG, 2008, J GERONTOL B-PSYCHOL, V63, pS269, DOI 10.1093/geronb/63.5.S269; Nybo H, 2001, J AM GERIATR SOC, V49, P601, DOI 10.1046/j.1532-5415.2001.49121.x; Nybo H, 2003, J AM GERIATR SOC, V51, P1365, DOI 10.1046/j.1532-5415.2003.51453.x; Parker MG, 2005, J GERONTOL A-BIOL, V60, P1351, DOI 10.1093/gerona/60.10.1351; Rodgers WL, 2003, J GERONTOL B-PSYCHOL, V58, pS338, DOI 10.1093/geronb/58.6.S338; Sarkeala T, 2011, EUR J AGEING, V8, P87, DOI 10.1007/s10433-011-0188-2; Schaie K Warner, 2005, Res Hum Dev, V2, P43, DOI 10.1207/s15427617rhd0201&2_3; Seeman TE, 2010, AM J PUBLIC HEALTH, V100, P100, DOI 10.2105/AJPH.2008.157388; Sheffield KM, 2011, AM J EPIDEMIOL, V174, P274, DOI 10.1093/aje/kwr074; WAIDMANN T, 1995, MILBANK Q, V73, P253, DOI 10.2307/3350259; WEISSMAN MM, 1992, JAMA-J AM MED ASSOC, V268, P3098, DOI 10.1001/jama.1992.03490210080039	29	228	232	4	53	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1507	1513		10.1016/S0140-6736(13)60777-1	http://dx.doi.org/10.1016/S0140-6736(13)60777-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247MR	23849796	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000326622500028
J	Simanshu, DK; Kamlekar, RK; Wijesinghe, DS; Zou, XQ; Zhai, XH; Mishra, SK; Molotkovsky, JG; Malinina, L; Hinchcliffe, EH; Chalfant, CE; Brown, RE; Patel, DJ				Simanshu, Dhirendra K.; Kamlekar, Ravi Kanth; Wijesinghe, Dayanjan S.; Zou, Xianqiong; Zhai, Xiuhong; Mishra, Shrawan K.; Molotkovsky, Julian G.; Malinina, Lucy; Hinchcliffe, Edward H.; Chalfant, Charles E.; Brown, Rhoderick E.; Patel, Dinshaw J.			Non-vesicular trafficking by a ceramide-1-phosphate transfer protein regulates eicosanoids	NATURE			English	Article							GLYCOLIPID TRANSFER PROTEIN; CERAMIDE KINASE; STRUCTURAL BASIS; EVOLUTION; COMPLEX; LOCALIZATION; ORGANIZATION; 1-PHOSPHATE; RECOGNITION; TRANSPORT	Phosphorylated sphingolipids ceramide-1-phosphate (C1P) and sphingosine-1-phosphate (S1P) have emerged as key regulators of cell growth, survival, migration and inflammation(1-5). C1P produced by ceramide kinase is an activator of group IVA cytosolic phospholipase A(2)alpha (cPLA(2)alpha), the rate-limiting releaser of arachidonic acid used for pro-inflammatory eicosanoid production(3,6-9), which contributes to disease pathogenesis in asthma or airway hyper-responsiveness, cancer, atherosclerosis and thrombosis. To modulate eicosanoid action and avoid the damaging effects of chronic inflammation, cells require efficient targeting, trafficking and presentation of C1P to specific cellular sites. Vesicular trafficking is likely(10) but non-vesicular mechanisms for C1P sensing, transfer and presentation remain unexplored(11,12). Moreover, the molecular basis for selective recognition and binding among signalling lipids with phosphate headgroups, namely C1P, phosphatidic acid or their lyso-derivatives, remains unclear. Here, a ubiquitously expressed lipid transfer protein, human GLTPD1, named here CPTP, is shown to specifically transfer C1P between membranes. Crystal structures establish C1P binding through a novel surface-localized, phosphate headgroup recognition centre connected to an interior hydrophobic pocket that adaptively expands to ensheath differing-length lipid chains using a cleft-like gating mechanism. The two-layer, alpha-helically-dominated 'sandwich' topology identifies CPTP as the prototype for a new glycolipid transfer protein fold(13) subfamily. CPTP resides in the cell cytosol but associates with the trans-Golgi network, nucleus and plasma membrane. RNA interference-induced CPTP depletion elevates C1P steady-state levels and alters Golgi cisternae stack morphology. The resulting C1P decrease in plasma membranes and increase in the Golgi complex stimulates cPLA(2)alpha release of arachidonic acid, triggering pro-inflammatory eicosanoid generation.	[Simanshu, Dhirendra K.; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Kamlekar, Ravi Kanth; Zou, Xianqiong; Zhai, Xiuhong; Mishra, Shrawan K.; Hinchcliffe, Edward H.; Brown, Rhoderick E.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Wijesinghe, Dayanjan S.; Chalfant, Charles E.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Molotkovsky, Julian G.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Malinina, Lucy] CIC BioGUNE, Struct Biol Unit, Derio Bilbao 48160, Spain; [Chalfant, Charles E.] Hunter Holmes McGuire Vet Adm Med Ctr, Richmond, VA 23249 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA	Memorial Sloan Kettering Cancer Center; University of Minnesota System; Virginia Commonwealth University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; CIC bioGUNE; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University	Brown, RE (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	ehinchcliffe@hi.umn.edu; cechalfant@vcu.edu; reb@umn.edu; pateld@mskcc.org	Mishra, Shrawan K/J-7972-2013; Mishra, Shrawan/N-1592-2019; Kamlekar, Ravikanth/B-9447-2009; Malinina, Lucy/B-8161-2013	Mishra, Shrawan/0000-0001-5513-9876; Kamlekar, Ravikanth/0000-0003-1627-122X; Brown, Rhoderick/0000-0002-7337-3604; Malinina, Lucy/0000-0001-7973-1831; Simanshu, Dhirendra/0000-0002-9717-4618	NIH/NCI [CA121493]; NIH/NIGMS [GM45928, GM072754]; VA Merit Award; VA Research Career Scientist Award; VA Career Devel. Award; Spanish Ministerio de Ciencia e Innovacion [BFU2010-17711]; Russian Foundation for Basic Research [12-04-00168]; Hormel Foundation; Abby Rockefeller Mauze Trust; Maloris Foundation;  [NIH/CA154314];  [NRS-T32/NIGMS 008695]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA121493, R01CA154314] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072754, R01GM045928] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010641] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001792] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); VA Merit Award(US Department of Veterans Affairs); VA Research Career Scientist Award; VA Career Devel. Award; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Hormel Foundation; Abby Rockefeller Mauze Trust; Maloris Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This research was supported by NIH/NCI CA121493 (D.J.P. & R.E.B.), NIH/NIGMS GM45928 (R.E.B.), NIH/NIGMS GM072754 (E.H.H.), NIH/CA154314 (C.E.C.), VA Merit Award (C.E.C.), VA Research Career Scientist Award (C.E.C.), VA Career Devel. Award (D.S.W.), NRS-T32/NIGMS 008695 (D.S.W.), Spanish Ministerio de Ciencia e Innovacion BFU2010-17711 (L.M.), Russian Foundation for Basic Research #12-04-00168 (J.G.M.), Hormel Foundation. (R.E.B.), Abby Rockefeller Mauze Trust (D.J.P.) and Maloris Foundation (D.J.P.). We thank H. Pike for expressing and purifying protein used for transfer activity analyses, K. Karanjeet for preparing cells for confocal and epifluorescence microscopy, and the staff of X-29 beamline at the National Synchrotron Light Source and ID-24-C/E beamlines at the Advanced Photon Source for help.	Bechler ME, 2012, TRENDS CELL BIOL, V22, P116, DOI 10.1016/j.tcb.2011.10.003; Berna A, 2009, CELL MOL LIFE SCI, V66, P2205, DOI 10.1007/s00018-009-0006-6; Blaho VA, 2009, J BIOL CHEM, V284, P21599, DOI 10.1074/jbc.M109.003822; Boath A, 2008, J BIOL CHEM, V283, P8517, DOI 10.1074/jbc.M707107200; Bornancin F, 2011, CELL SIGNAL, V23, P999, DOI 10.1016/j.cellsig.2010.11.012; Bourquin F, 2010, STRUCTURE, V18, P1054, DOI 10.1016/j.str.2010.05.011; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Durcan TM, 2008, J CELL BIOL, V181, P595, DOI 10.1083/jcb.200711160; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Galperin MY, 2012, J BIOL CHEM, V287, P21, DOI 10.1074/jbc.R111.241976; Gangoiti P, 2010, PROG LIPID RES, V49, P316, DOI 10.1016/j.plipres.2010.02.004; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Hirsch AKH, 2007, ANGEW CHEM INT EDIT, V46, P338, DOI 10.1002/anie.200603420; Hornick JE, 2011, CURR BIOL, V21, P598, DOI 10.1016/j.cub.2011.02.049; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Lamour NF, 2008, CURR DRUG TARGETS, V9, P674, DOI 10.2174/138945008785132349; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Lamour NF, 2009, J BIOL CHEM, V284, P26897, DOI 10.1074/jbc.M109.001677; Leslie CC, 2010, BIOCHIMIE, V92, P620, DOI 10.1016/j.biochi.2010.03.001; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Liberles DA, 2012, PROTEIN SCI, V21, P769, DOI 10.1002/pro.2071; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Malakhova ML, 2005, J BIOL CHEM, V280, P26312, DOI 10.1074/jbc.M500481200; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; MANDERS EMM, 1992, J CELL SCI, V103, P857; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Prinz WA, 2010, CELL, V143, P870, DOI 10.1016/j.cell.2010.11.031; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Samygina VR, 2011, STRUCTURE, V19, P1644, DOI 10.1016/j.str.2011.09.011; Wijesinghe DS, 2010, J LIPID RES, V51, P641, DOI 10.1194/jlr.D000430; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Zou XQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-72	34	130	136	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2013	500	7463					463	+		10.1038/nature12332	http://dx.doi.org/10.1038/nature12332			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23863933	Green Published, Green Accepted			2022-12-01	WOS:000323316100036
J	Simon, MS; Weiss, D; Gulick, RM				Simon, Matthew S.; Weiss, Don; Gulick, Roy M.			Invasive Meningococcal Disease in Men Who Have Sex With Men	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							NEISSERIA-MENINGITIDIS		Weill Cornell Med Coll, New York, NY 10065 USA; New York City Dept Hlth & Mental Hyg, New York, NY USA	Cornell University; New York City Department of Health & Mental Hygiene	Simon, MS (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, 402 East 67th St, New York, NY 10065 USA.	mss9008@med.cornell.edu			Clinical and Translational Science Center at Weill Cornell Medical College [UL1 TR000457]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER	Clinical and Translational Science Center at Weill Cornell Medical College; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Grant Support: In part by grant UL1 TR000457 from the Clinical and Translational Science Center at Weill Cornell Medical College.	Brooks R, 2006, CLIN INFECT DIS, V43, P49, DOI 10.1086/504804; Cohen C, 2010, AIDS, V24, P1351, DOI 10.1097/QAD.0b013e32833a2520; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; JANDA WM, 1980, JAMA-J AM MED ASSOC, V244, P2060, DOI 10.1001/jama.244.18.2060; Lujan-Zilbermann J, 2012, J PEDIATR-US, V161, P676, DOI 10.1016/j.jpeds.2012.04.005; Neal KR, 2000, BRIT MED J, V320, P846, DOI 10.1136/bmj.320.7238.846; Schmink S, 2007, J CLIN MICROBIOL, V45, P3768, DOI 10.1128/JCM.01190-07; STEPHENS DS, 1995, ANN INTERN MED, V123, P937, DOI 10.7326/0003-4819-123-12-199512150-00007; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0; Zucker JR, 2013, 2012 ALERT 5 UPDATE	10	29	29	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4					300	+		10.7326/0003-4819-159-4-201308200-00674	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-00674			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	23778867	Green Accepted			2022-12-01	WOS:000323421700022
J	O'Regan, DP; Harden, SP; Cook, SA				O'Regan, Declan P.; Harden, Stephen P.; Cook, Stuart A.			RATIONAL IMAGING Investigating stable chest pain of suspected cardiac origin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONARY-ARTERY-DISEASE; COMPUTED-TOMOGRAPHY ANGIOGRAPHY; CARDIOVASCULAR MAGNETIC-RESONANCE; DIAGNOSTIC PERFORMANCE; HEART-DISEASE; CALCIFICATION; ECHOCARDIOGRAPHY; COMPLICATIONS; SEVERITY; ACCURACY		[O'Regan, Declan P.; Cook, Stuart A.] MRC Clin Sci Ctr, Robert Steiner MRI Unit, London W12 0NN, England; [Harden, Stephen P.] Univ Hosp Southampton NHS Fdn Trust, Dept Cardiothorac Radiol, Southampton, Hants, England; [Cook, Stuart A.] Natl Heart Ctr Singapore, Dept Cardiol, Singapore, Singapore	University of Southampton; University Hospital Southampton NHS Foundation Trust; National Heart Centre Singapore	O'Regan, DP (corresponding author), MRC Clin Sci Ctr, Robert Steiner MRI Unit, London W12 0NN, England.	declan.oregan@imperial.ac.uk		Cook, Stuart/0000-0001-6628-194X; O'Regan, Declan/0000-0002-0691-0270				Achenbach S, 2010, EUR HEART J, V31, P340, DOI 10.1093/eurheartj/ehp470; [Anonymous], 2010, CG95; Arbab-Zadeh A, 2012, J AM COLL CARDIOL, V59, P379, DOI 10.1016/j.jacc.2011.06.079; d'Othee BJ, 2008, EUR J RADIOL, V65, P449, DOI 10.1016/j.ejrad.2007.05.003; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Geleijnse ML, 2010, CIRCULATION, V121, P1756, DOI 10.1161/CIRCULATIONAHA.109.859264; GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87; Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4; Hamon M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-29; Jaarsma C, 2012, J AM COLL CARDIOL, V59, P1719, DOI 10.1016/j.jacc.2011.12.040; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Mulvagh SL, 2000, J AM SOC ECHOCARDIOG, V13, P331, DOI 10.1067/mje.2000.105462; Nandalur KR, 2007, J AM COLL CARDIOL, V50, P1343, DOI 10.1016/j.jacc.2007.06.030; National Institute for Health and Care Excellence, 2011, CG126; National Institute for Health and Clinical Excellence, 2010, CHEST PAIN OF RECENT; National Institute for Health and Clinical Excellence, 2012, CT750; Nilsson S, 2003, BRIT J GEN PRACT, V53, P378; Office for National Statistics, 2011, DEATHS REGISTERED IN; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Sarwar A, 2009, JACC-CARDIOVASC IMAG, V2, P675, DOI 10.1016/j.jcmg.2008.12.031; Sicari R, 2009, EUR HEART J, V30, P278, DOI 10.1093/eurheartj/ehn492; Villines TC, 2011, J AM COLL CARDIOL, V58, P2533, DOI 10.1016/j.jacc.2011.10.851; West R, 2006, HEART, V92, P810, DOI 10.1136/hrt.2005.073890; Westwood M, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17090	25	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2013	347								f3940	10.1136/bmj.f3940	http://dx.doi.org/10.1136/bmj.f3940			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192XV	23878151	Green Submitted			2022-12-01	WOS:000322522200001
J	Reis, JP; Loria, CM; Lewis, CE; Powell-Wiley, TM; Wei, GS; Carr, JJ; Terry, JG; Liu, K				Reis, Jared P.; Loria, Catherine M.; Lewis, Cora E.; Powell-Wiley, Tiffany M.; Wei, Gina S.; Carr, J. Jeffrey; Terry, James G.; Liu, Kiang			Association Between Duration of Overall and Abdominal Obesity Beginning in Young Adulthood and Coronary Artery Calcification in Middle Age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEPENDENT DIABETES-MELLITUS; BODY-MASS INDEX; RISK DEVELOPMENT; ADIPOSE-TISSUE; WEIGHT CHANGE; ATHEROSCLEROSIS; TRENDS; OVERWEIGHT; CALCIUM; HYPERTENSION	IMPORTANCE Younger individuals are experiencing a greater cumulative exposure to excess adiposity over their lifetime. However, few studies have determined the consequences of long-term obesity. OBJECTIVE To examine whether the duration of overall and abdominal obesity was associated with the presence and 10-year progression of coronary artery calcification (CAC), a subclinical predictor of coronary heart disease. DESIGN, SETTING, AND PARTICIPANTS Prospective study of 3275 white and black adults aged 18 to 30 years at baseline in 1985-1986 who did not initially have overall obesity (body mass index [BMI] >= 30) or abdominal obesity (men: waist circumference [WC] >102 cm; women: >88 cm) in the multicenter, community-based Coronary Artery Risk Development in Young Adults (CARDIA) study. Participants completed computed tomography scanning for the presence of CAC during the 15-, 20-, or 25-year follow-up examinations. Duration of overall and abdominal obesity was calculated using repeat measurements of BMI and WC, respectively, performed 2, 5, 7, 10, 15, 20, and 25 years after baseline. MAIN OUTCOMES AND MEASURES Presence of CAC was measured by computed tomography at the year 15 (2000-2001), year 20 (2005-2006), or year 25 (2010-2011) follow-up examinations. Ten-year progression of CAC (2000-2001 to 2010-2011) was defined as incident CAC in 2010-2011 or an increase in CAC score of 20 Agatston units or greater. RESULTS During follow-up, 40.4% and 41.0% developed overall and abdominal obesity, respectively. Rates of CAC per 1000 person-years were higher for those who experienced more than 20 years vs 0 years of overall obesity (16.0 vs 11.0, respectively) and abdominal obesity (16.7 vs 11.0). Approximately 25.2% and 27.7% of those with more than 20 years of overall and abdominal obesity, respectively, experienced progression of CAC vs 20.2% and 19.5% of those with 0 years. After adjustment for BMI or WC and potential confounders, the hazard ratios for CAC for each additional year of overall or abdominal obesity were 1.02 (95% CI, 1.01-1.03) and 1.03 (95% CI, 1.02-1.05), respectively. The adjusted odds ratios for CAC progression were 1.04 (95% CI, 1.01-1.06) and 1.04 (95% CI, 1.01-1.07), respectively. Associations were attenuated but largely persisted following additional adjustment for potential intermediate metabolic factors during follow-up. CONCLUSIONS AND RELEVANCE Longer duration of overall and abdominal obesity was associated with subclinical coronary heart disease and its progression through midlife independent of the degree of adiposity. Preventing or at least delaying the onset of obesity in young adulthood may lower the risk of developing atherosclerosis through middle age.	[Reis, Jared P.; Loria, Catherine M.; Wei, Gina S.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Lewis, Cora E.] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL USA; [Powell-Wiley, Tiffany M.] NHLBI, Cardiovasc & Pulm Branch, Bethesda, MD 20892 USA; [Powell-Wiley, Tiffany M.] NCI, Appl Res Program, Div Canc Control & Populat Studies, Bethesda, MD 20892 USA; [Carr, J. Jeffrey; Terry, James G.] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA; [Liu, Kiang] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Wake Forest University; Northwestern University; Feinberg School of Medicine	Reis, JP (corresponding author), NHLBI, Div Cardiovasc Sci, 6701 Rockledge Dr,Ste 10197, Bethesda, MD 20892 USA.	reisjp@mail.nih.gov	Carr, John Jeffrey/A-1938-2012; Carr, John/AAN-7531-2021	Carr, John Jeffrey/0000-0002-4398-8237; Carr, John/0000-0002-4398-8237; Terry, James/0000-0001-6659-3441	National Heart, Lung, and Blood Institute [N01-HC95095, N01-HC48047, N01-HC48050, N01-HC48049, N01-HC48048, R01-HL098445]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048047, N01HC048048, N01HC048050, N01HC095095, N01HC048049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098445, R01HL048049, ZIAHL006148, R01HL048048, R29HL048048, R01HL048050] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Coronary Risk Development in Young Adults Study (CARDIA) was conducted and supported by grants from the National Heart, Lung, and Blood Institute (N01-HC95095 and N01-HC48047 awarded to the University of Alabama at Birmingham; grant N01-HC48050 awarded to the Kaiser Foundation Research Institute; grant N01-HC48049 awarded to Northwestern University; N01-HC48048 awarded to the University of Minnesota; and grant R01-HL098445 awarded to Wake Forest School of Medicine). Dr Powell-Wiley is supported by the intramural research program of the National Heart, Lung, and Blood Institute.	Abdullah A, 2011, INT J EPIDEMIOL, V40, P985, DOI 10.1093/ije/dyr018; Abdullah A, 2011, PUBLIC HEALTH NUTR, V14, P119, DOI 10.1017/S1368980010001813; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Arad Y, 1996, CIRCULATION, V93, P1951, DOI 10.1161/01.CIR.93.11.1951; Avogaro A, 2005, CLIN CHIM ACTA, V360, P9, DOI 10.1016/j.cccn.2005.04.020; Carlsson S, 1998, AM J EPIDEMIOL, V148, P539, DOI 10.1093/oxfordjournals.aje.a009679; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Cassidy AE, 2005, CIRCULATION, V111, P1877, DOI 10.1161/01.CIR.0000161820.40494.5D; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Ford ES, 2011, INT J OBESITY, V35, P736, DOI 10.1038/ijo.2010.186; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hekimsoy Z, 2003, DIABETES OBES METAB, V5, P432, DOI 10.1046/j.1463-1326.2003.00298.x; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; Janowitz WR, 2001, J THORAC IMAG, V16, P2, DOI 10.1097/00005382-200101000-00002; Janssen I, 2004, ANN EPIDEMIOL, V14, P585, DOI 10.1016/j.annepidem.2004.01.007; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143; Lee CD, 2007, AM J CLIN NUTR, V86, P48, DOI 10.1093/ajcn/86.1.48; Little RJ., 2019, STAT ANAL MISSING DA, VVolume 793; McClelland RL, 2006, CIRCULATION, V113, P30, DOI 10.1161/CIRCULATIONAHA.105.580696; MCDONALD A, 1991, J AM DIET ASSOC, V91, P1104; Mertens I, 2002, Obes Rev, V3, P85, DOI 10.1046/j.1467-789X.2002.00056.x; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pontiroli AE, 1998, ACTA DIABETOL, V35, P130, DOI 10.1007/s005920050117; Raghunathan T, 2001, SURV METHODOL, V27, P85, DOI DOI 10.1002/SIM.1186; Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929; Reis JP, 2010, ARTERIOSCL THROM VAS, V30, P2059, DOI 10.1161/ATVBAHA.110.208280; Sakurai Y, 1999, AM J EPIDEMIOL, V149, P256; Sheehan TJ, 2003, INT J OBESITY, V27, P498, DOI 10.1038/sj.ijo.0802263; Silver AE, 2007, CIRCULATION, V115, P627, DOI 10.1161/CIRCULATIONAHA.106.657486; Solerte SB, 1997, INT J OBESITY, V21, P417, DOI 10.1038/sj.ijo.0800421; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Walls HL, 2011, OBESITY, V19, P216, DOI 10.1038/oby.2010.149; Wannamethee SG, 1999, DIABETES CARE, V22, P1266, DOI 10.2337/diacare.22.8.1266	36	121	131	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					280	288		10.1001/jama.2013.7833	http://dx.doi.org/10.1001/jama.2013.7833			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23860986	Green Accepted, Bronze			2022-12-01	WOS:000321835700015
J	Deweerdt, S				Deweerdt, Sarah			GENETICS Written in blood	NATURE			English	Editorial Material							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; MUTATIONS											Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Ramsay AJ, 2013, NAT GENET, V45, P526, DOI 10.1038/ng.2584; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Vassiliou GS, 2011, NAT GENET, V43, P470, DOI 10.1038/ng.796; Xu H, 2013, JNCI-J NATL CANCER I, V105, P733, DOI 10.1093/jnci/djt042	7	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					S4	S6		10.1038/498S4a	http://dx.doi.org/10.1038/498S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803948				2022-12-01	WOS:000320929400003
J	Memtsoudis, SG; Besculides, MC; Mazumdar, M				Memtsoudis, Stavros G.; Besculides, Melanie C.; Mazumdar, Madhu			A Rude Awakening - The Perioperative Sleep Apnea Epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Memtsoudis, Stavros G.] Cornell Univ, Hosp Special Surg, Dept Anesthesiol, Princeton, NJ USA; [Mazumdar, Madhu] Cornell Univ, Div Biostatist & Epidemiol, Princeton, NJ USA	Cornell University; Cornell University	Memtsoudis, SG (corresponding author), Cornell Univ, Hosp Special Surg, Dept Anesthesiol, Princeton, NJ USA.							Amer Soc Anesthesiologists, 2006, ANESTHESIOLOGY, V104, P1081; Chung F, 2012, BRIT J ANAESTH, V108, P768, DOI 10.1093/bja/aes022; Kaw R, 2012, CHEST, V141, P436, DOI 10.1378/chest.11-0283; Memtsoudis S, 2011, ANESTH ANALG, V112, P113, DOI 10.1213/ANE.0b013e3182009abf; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	5	73	80	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2352	2353		10.1056/NEJMp1302941	http://dx.doi.org/10.1056/NEJMp1302941			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23782177				2022-12-01	WOS:000320601700004
J	Morens, DM; Taubenberger, JK; Fauci, AS				Morens, David M.; Taubenberger, Jeffery K.; Fauci, Anthony S.			Pandemic Influenza Viruses - Hoping for the Road Not Taken	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Morens, David M.; Fauci, Anthony S.] Natl Inst Allergy & Infect Dis, Natl Inst Hlth, Off Director, Bethesda, MD USA; [Taubenberger, Jeffery K.] Natl Inst Allergy & Infect Dis, Natl Inst Hlth, Viral Pathogenesis & Evolut Sect, Lab Infect Dis, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Morens, DM (corresponding author), Natl Inst Allergy & Infect Dis, Natl Inst Hlth, Off Director, Bethesda, MD USA.		Taubenberger, Jeffery/AAQ-1407-2021		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000986] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA AI000986-06] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		[Anonymous], 2012, NATURE, V486, P335; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Morens DM, 2013, CLIN INFECT DIS, V56, P1213, DOI 10.1093/cid/cit051; Morens DM, 2011, REV MED VIROL, V21, P262, DOI 10.1002/rmv.689; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819	5	50	53	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2345	2348		10.1056/NEJMp1307009	http://dx.doi.org/10.1056/NEJMp1307009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	167AE	23738514	Green Accepted			2022-12-01	WOS:000320601700001
J	Famiglietti, JS; Rodell, M				Famiglietti, James S.; Rodell, Matthew			Water in the Balance	SCIENCE			English	Editorial Material							GROUNDWATER DEPLETION; GRACE; CYCLE		[Famiglietti, James S.] Univ Calif Irvine, UC Ctr Hydrol Modeling, Irvine, CA 92697 USA; [Famiglietti, James S.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Famiglietti, James S.] Univ Calif Irvine, Dept Civil & Environm Engn, Irvine, CA 92697 USA; [Rodell, Matthew] NASA, Hydrol Sci Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Famiglietti, JS (corresponding author), Univ Calif Irvine, UC Ctr Hydrol Modeling, Irvine, CA 92697 USA.	jfamigli@uci.edu	Famiglietti, James S/G-7383-2017; Rodell, Matthew/E-4946-2012	Famiglietti, James S/0000-0002-6053-5379; Rodell, Matthew/0000-0003-0106-7437				Blunden J, 2013, B AM METEOROL SOC, V94, pS1, DOI 10.1175/2013BAMSStateoftheClimate.1; Durack PJ, 2012, SCIENCE, V336, P455, DOI 10.1126/science.1212222; Famiglietti J. S., 2012, FALL M 3 7 DEC; Houborg R, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011291; Ramillien G, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004331; Reager JT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040826; Scanlon BR, 2012, P NATL ACAD SCI USA, V109, P9320, DOI 10.1073/pnas.1200311109; Soden BJ, 2006, J CLIMATE, V19, P3354, DOI 10.1175/JCLI3799.1; Swenson SC, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004628; Swenson S, 2009, J HYDROL, V370, P163, DOI 10.1016/j.jhydrol.2009.03.008; Tapley BD, 2004, SCIENCE, V305, P503, DOI 10.1126/science.1099192; Tiwari VM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039401; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Voss KA, 2013, WATER RESOUR RES, V49, P904, DOI 10.1002/wrcr.20078; Zaitchik BF, 2008, J HYDROMETEOROL, V9, P535, DOI 10.1175/2007JHM951.1	15	246	257	7	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1300	1301		10.1126/science.1236460	http://dx.doi.org/10.1126/science.1236460			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766323				2022-12-01	WOS:000320320200034
J	Dancer, SJ				Dancer, Stephanie J.			Put your ties back on: scruffy doctors damage our reputation and indicate a decline in hygiene	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTION-CONTROL; WASH		Hairmyres Hosp, E Kilbride G75 8RG, Lanark, Scotland	University Hospital Hairmyres	Dancer, SJ (corresponding author), Hairmyres Hosp, E Kilbride G75 8RG, Lanark, Scotland.	stephanie.dancer@lanarkshire.scot.nhs.uk		Dancer, Stephanie/0000-0002-8777-2614				[Anonymous], 2007, LANCET, V370, P1102; [Anonymous], 2008, BMA NEWS        0927; Burden M, 2011, J HOSP MED, V6, P177, DOI 10.1002/jhm.864; Cubitt J, 2010, B ROYAL COLL SURG EN, V92, P242; Dancer SJ, 2012, J HOSP INFECT, V80, P189, DOI 10.1016/j.jhin.2011.12.003; Dancer SJ, 2010, J HOSP INFECT, V74, P10, DOI 10.1016/j.jhin.2009.10.012; Dancer SJ, 2008, BMJ; Horlock A, 2012, DAILY MAIL; Magee TR, 2008, B ROYAL COLL SURG EN, V90, P126; Mann CM, 2006, J HOSP INFECT, V64, P366, DOI 10.1016/j.jhin.2006.06.030; Mooney H., 2008, NURSING TIMES; Price EH, 2008, J HOSP INFECT, V69, P89, DOI 10.1016/j.jhin.2008.01.009; Rehman SU, 2005, AM J MED, V118, P1279, DOI 10.1016/j.amjmed.2005.04.026; Steinlechner C, 2002, ANN R COLL SURG EN S, V84, P307; Wellcome Collection, 2011, DIRT FILTH REAL EV L; Whitby M, 2006, INFECT CONT HOSP EP, V27, P484, DOI 10.1086/503335	16	12	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2013	346								f3211	10.1136/bmj.f3211	http://dx.doi.org/10.1136/bmj.f3211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166WQ	23766481				2022-12-01	WOS:000320590800016
J	Silverman, E				Silverman, Ed			Pfizer versus Kaiser: insurers want their day in court	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Pharmalot, Millburn, NJ USA		Silverman, E (corresponding author), Pharmalot, Millburn, NJ USA.	pharmalot@gmail.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2013	346								f3738	10.1136/bmj.f3738	http://dx.doi.org/10.1136/bmj.f3738			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166WH	23760967				2022-12-01	WOS:000320589800008
J	Efron, B				Efron, Bradley			Bayes' Theorem in the 21st Century	SCIENCE			English	Editorial Material									Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University	Efron, B (corresponding author), Stanford Univ, Dept Stat, Stanford, CA 94305 USA.	brad@stat.stanford.edu			Direct For Mathematical & Physical Scien [1208787] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB002784] Funding Source: NIH RePORTER; NIBIB NIH HHS [R37 EB002784] Funding Source: Medline	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger J, 2006, BAYESIAN ANAL, V1, P385, DOI 10.1214/06-BA115; Efron B, 2010, I MATH STAT MONOGRAP; Efron B, 2013, B AM MATH SOC, V50, P129, DOI 10.1090/S0273-0979-2012-01374-5; Robbins H., 1956, P 3 BERK S MATH STAT, P157; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Wang S, 2013, SCIENCE, V339, P758, DOI 10.1126/science.1232290	7	106	112	2	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1177	1178		10.1126/science.1236536	http://dx.doi.org/10.1126/science.1236536			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744934				2022-12-01	WOS:000319972800030
J	Kempermann, G				Kempermann, Gerd			What the Bomb Said About the Brain	SCIENCE			English	Editorial Material							ADULT NEUROGENESIS; NEURONS		[Kempermann, Gerd] Tech Univ Dresden, DZNE, D-01307 Dresden, Germany; [Kempermann, Gerd] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden; Technische Universitat Dresden	Kempermann, G (corresponding author), Tech Univ Dresden, DZNE, Fetscherstr 105, D-01307 Dresden, Germany.	gerd.kempermann@dzne.de	Kempermann, Gerd/F-5416-2010	Kempermann, Gerd/0000-0002-5304-4061				Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Appleby PA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001063; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Freund J, 2013, SCIENCE, V340, P756, DOI 10.1126/science.1235294; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002	11	7	7	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1180	1181		10.1126/science.1240681	http://dx.doi.org/10.1126/science.1240681			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744936				2022-12-01	WOS:000319972800032
J	Colak, D; Ji, SJ; Porse, BT; Jaffrey, SR				Colak, Dilek; Ji, Sheng-Jian; Porse, Bo T.; Jaffrey, Samie R.			Regulation of Axon Guidance by Compartmentalized Nonsense-Mediated mRNA Decay	CELL			English	Article							LOCAL PROTEIN-SYNTHESIS; COMMISSURAL AXONS; MAMMALIAN-CELLS; MIDLINE SWITCH; SPINAL-CORD; GROWTH CONE; IN-VIVO; TRANSLATION; EXPRESSION; SURVEILLANCE	Growth cones enable axons to navigate toward their targets by responding to extracellular signaling molecules. Growth-cone responses are mediated in part by the local translation of axonal messenger RNAs (mRNAs). However, the mechanisms that regulate local translation are poorly understood. Here we show that Robo3.2, a receptor for the Slit family of guidance cues, is synthesized locally within axons of commissural neurons. Robo3.2 translation is induced by floor-plate-derived signals as axons cross the spinal cord midline. Robo3.2 is also a predicted target of the nonsense-mediated mRNA decay (NMD) pathway. We find that NMD regulates Robo3.2 synthesis by inducing the degradation of Robo3.2 transcripts in axons that encounter the floor plate. Commissural neurons deficient in NMD proteins exhibit aberrant axonal trajectories after crossing the midline, consistent with misregulation of Robo3.2 expression. These data show that local translation is regulated by mRNA stability and that NMD acts locally to influence axonal pathfinding.	[Colak, Dilek; Ji, Sheng-Jian; Jaffrey, Samie R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Porse, Bo T.] Univ Copenhagen, Fac Hlth Sci, Finsen Lab, Rigshosp, DK-2200 Copenhagen, Denmark; [Porse, Bo T.] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Porse, Bo T.] Univ Copenhagen, Fac Hlth Sci, Danish Stem Cell Ctr DanStem, DK-2200 Copenhagen, Denmark	Cornell University; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Jaffrey, SR (corresponding author), Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA.	srj2003@med.cornell.edu	Ji, Sheng-Jian/H-6288-2013	Jaffrey, Samie/0000-0003-3615-6958; Porse, Bo/0000-0001-6043-0844	NIH [NS56306]; European Molecular Biology Organization (EMBO); Lundbeck Foundation [R5-2006-99] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056306] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Lykke-Andersen for generously providing the hUpf1 K498A construct and anti-Upf1 and anti-Upf2 antibodies, S. Blanchard and L. Wang for equipment and helpful suggestions regarding the polysome experiments, S. Kadison for advice on DiI labeling, and M. Tessier-Lavigne and Genentech for sharing Robo3.1- and Robo3.2-specific antibodies. We also thank members of the Jaffrey lab for helpful comments and suggestions. This work was supported by NIH grant NS56306 to S.R.J. and a European Molecular Biology Organization (EMBO) postdoctoral fellowship to D.C.	Black DL, 2008, NEURON, V58, P297, DOI 10.1016/j.neuron.2008.04.019; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Cohen MS, 2011, P NATL ACAD SCI USA, V108, P11246, DOI 10.1073/pnas.1012401108; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Evans TA, 2010, CURR BIOL, V20, P567, DOI 10.1016/j.cub.2010.02.021; Feng Y, 2010, PROTEIN CELL, V1, P237, DOI 10.1007/s13238-010-0021-2; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Hengst U, 2009, NAT CELL BIOL, V11, P1024, DOI 10.1038/ncb1916; HODGKIN J, 1989, GENETICS, V123, P301; Imondi R, 2001, DEVELOPMENT, V128, P4859; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Jaworski A, 2010, J NEUROSCI, V30, P9445, DOI 10.1523/JNEUROSCI.6290-09.2010; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kadison SR, 2004, J COMP NEUROL, V472, P411, DOI 10.1002/cne.20086; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; MAQUAT LE, 1981, CELL, V27, P543, DOI 10.1016/0092-8674(81)90396-2; Matsumoto Y, 2007, J NEUROSCI, V27, P4342, DOI 10.1523/JNEUROSCI.0700-07.2007; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Moore Simon W, 2008, Curr Protoc Neurosci, VChapter 3, DOI [10.1002/0471142301.ns0320s43, 10.1002/0471142301.ns0320s45]; Nawabi H, 2010, GENE DEV, V24, P396, DOI 10.1101/gad.542510; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; PERRY VH, 1991, EUR J NEUROSCI, V3, P102, DOI 10.1111/j.1460-9568.1991.tb00815.x; Reeber SL, 2008, J NEUROSCI, V28, P8698, DOI 10.1523/JNEUROSCI.1479-08.2008; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Spitzweck B, 2010, CELL, V140, P409, DOI 10.1016/j.cell.2010.01.002; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; TENNYSON VM, 1970, J CELL BIOL, V44, P62, DOI 10.1083/jcb.44.1.62; Vitriol EA, 2012, NEURON, V73, P1068, DOI 10.1016/j.neuron.2012.03.005; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Weischenfeldt J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r35; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272; Zheng S, 2012, NAT NEUROSCI, V15, P381, DOI 10.1038/nn.3026; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	46	133	135	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1252	1265		10.1016/j.cell.2013.04.056	http://dx.doi.org/10.1016/j.cell.2013.04.056			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746841	Bronze, Green Accepted			2022-12-01	WOS:000319979200011
J	Shi, T; Bunker, RD; Mattarocci, S; Ribeyre, C; Faty, M; Gut, H; Scrima, A; Rass, U; Rubin, SM; Shore, D; Thoma, NH				Shi, Tianlai; Bunker, Richard D.; Mattarocci, Stefano; Ribeyre, Cyril; Faty, Mahamadou; Gut, Heinz; Scrima, Andrea; Rass, Ulrich; Rubin, Seth M.; Shore, David; Thomae, Nicolas H.			Rif1 and Rif2 Shape Telomere Function and Architecture through Multivalent Rap1 Interactions	CELL			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERES; LENGTH REGULATION; YEAST; DNA; PROTEIN; BINDING; ANTICHECKPOINT; ASSOCIATION; PATHWAYS; COMPLEX	Yeast telomeres comprise irregular TG1-3 DNA repeats bound by the general transcription factor Rap1. Rif1 and Rif2, along with Rap1, form the telosome, a protective cap that inhibits telomerase, counteracts SIR-mediated transcriptional silencing, and prevents inadvertent recognition of telomeres as DNA double-strand breaks. We provide a molecular, biochemical, and functional dissection of the protein backbone at the core of the yeast telosome. The X-ray structures of Rif1 and Rif2 bound to the Rap1 C-terminal domain and that of the Rif1 C terminus are presented. Both Rif1 and Rif2 have separable and independent Rap1-binding epitopes, allowing Rap1 binding over large distances (42-110 angstrom). We identify tetramerization (Rif1) and polymerization (Rif2) modules that, in conjunction with the long-range binding, give rise to a higher-order architecture that interlinks Rap1 units. This molecular Velcro relies on Rif1 and Rif2 to recruit and stabilize Rap1 on telomeric arrays and is required for telomere homeostasis in vivo.	[Shi, Tianlai; Bunker, Richard D.; Faty, Mahamadou; Gut, Heinz; Scrima, Andrea; Rass, Ulrich; Thomae, Nicolas H.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Mattarocci, Stefano; Ribeyre, Cyril; Shore, David] NCCR Frontiers Genet Program, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Mattarocci, Stefano; Ribeyre, Cyril; Shore, David] Inst Genet & Genom Geneva iGE3, CH-1211 Geneva, Switzerland; [Rubin, Seth M.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	Friedrich Miescher Institute for Biomedical Research; University of Geneva; University of California System; University of California Santa Cruz	Thoma, NH (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	nicolas.thoma@fmi.ch	Shore, David/F-6240-2015	Shore, David/0000-0002-9859-143X; Ribeyre, Cyril/0000-0002-5146-0977; Rubin, Seth/0000-0002-1670-4147; Bunker, Richard/0000-0001-8866-5290; Thoma, Nicolas/0000-0003-2685-906X; Rass, Ulrich/0000-0001-9275-9062	Swiss National Fund; Canton of Geneva; Novartis Research Foundation; European Research Council [ERC-2010-StG 260481-MoBa-CS]; AICR; Oncosuisse; Swiss National Science Foundation	Swiss National Fund(Swiss National Science Foundation (SNSF)); Canton of Geneva; Novartis Research Foundation; European Research Council(European Research Council (ERC)European Commission); AICR; Oncosuisse; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank S. Gasser, J. Lingner, P. Baumann, M. Wellinger, P. Cejka, and D. Schubeler for discussion and J. Keusch and D. Hess from the Friedrich Miescher Institute for help and analysis. Crystallographic experiments described were performed with the X10SA beamline at Swiss Light Source, Paul Scherrer Institut, Villigen, Switzerland. D.S. received support from the Swiss National Fund and the Canton of Geneva. Work in the lab of N.H.T. is supported by the Novartis Research Foundation, the European Research Council (ERC-2010-StG 260481-MoBa-CS), AICR, and Oncosuisse. N.H.T. and A.S. received support from the Swiss National Science Foundation. R.D.B. and S.M. contributed equally to this work.	Anbalagan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002024; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Bonetti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014142; Borsi V, 2010, J MED CHEM, V53, P4285, DOI 10.1021/jm901723z; Chen Y, 2011, NAT STRUCT MOL BIOL, V18, P213, DOI 10.1038/nsmb.1974; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Feeser EA, 2008, J MOL BIOL, V380, P520, DOI 10.1016/j.jmb.2008.04.078; Gallardo F, 2011, MOL CELL, V44, P819, DOI 10.1016/j.molcel.2011.09.020; GILSON E, 1993, J MOL BIOL, V231, P293, DOI 10.1006/jmbi.1993.1283; GILSON E, 1994, NUCLEIC ACIDS RES, V22, P5310, DOI 10.1093/nar/22.24.5310; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; Levy DL, 2004, MOL CELL BIOL, V24, P10857, DOI 10.1128/MCB.24.24.10857-10867.2004; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lisby M, 2004, CURR OPIN CELL BIOL, V16, P328, DOI 10.1016/j.ceb.2004.03.011; LONGTINE MS, 1989, CURR GENET, V16, P225, DOI 10.1007/BF00422108; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marcand S, 2008, GENE DEV, V22, P1153, DOI 10.1101/gad.455108; Matot B, 2012, NUCLEIC ACIDS RES, V40, P3197, DOI 10.1093/nar/gkr1166; Michelson RJ, 2005, GENE DEV, V19, P2546, DOI 10.1101/gad.1293805; MILLER WG, 1968, BIOCHEMISTRY-US, V7, P3925, DOI 10.1021/bi00851a021; Ribeyre C, 2012, NAT STRUCT MOL BIOL, V19, P307, DOI 10.1038/nsmb.2225; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; Vodenicharov MD, 2006, MOL CELL, V24, P127, DOI 10.1016/j.molcel.2006.07.035; Vodenicharov MD, 2010, EMBO J, V29, P3007, DOI 10.1038/emboj.2010.155; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; Williams TL, 2010, J BIOL CHEM, V285, P35814, DOI 10.1074/jbc.M110.170167; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197	32	75	77	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1340	1353		10.1016/j.cell.2013.05.007	http://dx.doi.org/10.1016/j.cell.2013.05.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746845	Bronze, Green Published			2022-12-01	WOS:000319979200017
J	Hawkes, N				Hawkes, Nigel			The government's drug pricing policy is falling apart messily	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Collins M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1363; Hawkes N, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2933; Kmietowicz K., 2010, BRIT MED J, V340, pc2832; O'Dowd A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2965	4	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ BRIT MED J	BMJ-British Medical Journal	JUN 5	2013	346								f3634	10.1136/bmj.f3634	http://dx.doi.org/10.1136/bmj.f3634			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YF	23741032				2022-12-01	WOS:000320229500005
J	McNamara, JM; Fawcett, TW; Houston, AI				McNamara, John M.; Fawcett, Tim W.; Houston, Alasdair I.			An Adaptive Response to Uncertainty Generates Positive and Negative Contrast Effects	SCIENCE			English	Article							DECISIONS; BEHAVIOR; REWARD; RISK	Successive contrast effects, in which behavior is dependent on whether conditions are currently better or worse than they were before, are a striking illustration of the fact that animals evaluate the world in relative terms. Existing explanations for these effects are based on descriptive models of psychological and physiological processes, but little attention has been paid to the factors promoting their evolution. Using a simple and general optimality model, we show that contrast effects can result from an adaptive response to uncertainty in a changing, unpredictable world. A wide range of patterns of environmental change will select for sensitivity to past conditions, generating positive and negative contrast effects. Our analysis reveals the importance of incorporating uncertainty and environmental stochasticity into models of adaptive behavior.	[McNamara, John M.] Univ Bristol, Sch Math, Bristol BS8 1TW, Avon, England; [Fawcett, Tim W.; Houston, Alasdair I.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Bristol; University of Bristol	Fawcett, TW (corresponding author), Univ Bristol, Sch Biol Sci, Woodland Rd, Bristol BS8 1UG, Avon, England.	tim.fawcett@cantab.net	Fawcett, Tim/A-5439-2010	Fawcett, Tim/0000-0001-6337-901X	European Research Council [250209]	European Research Council(European Research Council (ERC)European Commission)	We thank A. Higginson, A. Radford, D. Mallpress, and P. Trimmer for discussion and the European Research Council for funding (Advanced Grant 250209 to A.I.H.). J.M.M. and A.I.H. conceived the project, J.M.M. built the model, and T.W.F. analyzed the model and wrote the paper with input from the other authors.	Amsel A., 1992, FRUSTRATION THEORY; Bentosela M, 2009, J COMP PSYCHOL, V123, P125, DOI 10.1037/a0013340; CAPALDI EJ, 1967, J EXP PSYCHOL, V75, P226, DOI 10.1037/h0024986; COUVILLON PA, 1984, J COMP PSYCHOL, V98, P100, DOI 10.1037/0735-7036.98.1.100; Crespi LP, 1942, AM J PSYCHOL, V55, P467, DOI 10.2307/1417120; Flaherty C.F., 1996, INCENTIVE RELATIVITY; Freidin E, 2009, ANIM BEHAV, V77, P857, DOI 10.1016/j.anbehav.2008.12.010; Gray J.A., 1987, PSYCHOL FEAR STRESS, V2nd, P422; Higginson AD, 2012, AM NAT, V180, P589, DOI 10.1086/667885; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; Houston AI., 1999, MODELS ADAPTIVE BEHA; HUBER J, 1982, J CONSUM RES, V9, P90, DOI 10.1086/208899; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KOBRE KR, 1972, J EXP CHILD PSYCHOL, V14, P81, DOI 10.1016/0022-0965(72)90033-1; MCHOSE JH, 1975, ANIM LEARN BEHAV, V3, P239, DOI 10.3758/BF03213438; MCNAMARA J, 1980, J THEOR BIOL, V85, P673, DOI 10.1016/0022-5193(80)90265-9; McNamara J. M., 2011, ECOL LETT, V14, P58; MCNAMARA JM, 1986, AM NAT, V127, P358, DOI 10.1086/284489; McNamara JM, 2009, TRENDS ECOL EVOL, V24, P670, DOI 10.1016/j.tree.2009.05.011; Morgan KV, 2012, BEHAV PROCESS, V89, P115, DOI 10.1016/j.beproc.2011.08.017; Mustaca AE, 2000, LEARN MOTIV, V31, P272, DOI 10.1006/lmot.2000.1055; Nilsson JA, 2002, P ROY SOC B-BIOL SCI, V269, P1735, DOI 10.1098/rspb.2002.2071; PAPINI MR, 1988, ANIM LEARN BEHAV, V16, P53, DOI 10.3758/BF03209043; TVERSKY A, 1993, MANAGE SCI, V39, P1179, DOI 10.1287/mnsc.39.10.1179; Tversky A., 1991, SUBJECTIVE WELL BEIN, P101; ZEAMAN D, 1949, J EXP PSYCHOL, V39, P466, DOI 10.1037/h0060477	27	44	44	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1084	1086		10.1126/science.1230599	http://dx.doi.org/10.1126/science.1230599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154HJ	23723234				2022-12-01	WOS:000319664500041
J	Willcox, ML; Mant, J; O'Dempsey, T				Willcox, Merlin L.; Mant, Jill; O'Dempsey, Tim			Imported malaria	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SEVERE FALCIPARUM-MALARIA; RAPID DIAGNOSTIC-TESTS; RETURNING TRAVELERS; RANDOMIZED-TRIAL; CHILDREN; ARTESUNATE; QUININE		[Willcox, Merlin L.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2EP, England; [Mant, Jill] Luton Hosp, Dept Paediat, Luton, Beds, England; [O'Dempsey, Tim] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of Oxford; Liverpool School of Tropical Medicine; University of Liverpool	Willcox, ML (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2EP, England.	merlin.willcox@phc.ox.ac.uk	Willcox, Merlin/I-6255-2019	Willcox, Merlin/0000-0002-5227-3444; O'Dempsey, Tim/0000-0002-9596-9687				Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; [Anonymous], 2007, MAIL ONLINE     0110; Batwala V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-349; Bottieau E, 2007, EUR J CLIN MICROBIOL, V26, P181, DOI 10.1007/s10096-007-0264-x; British Medical Association, 2013, BRIT NATL FORMULARY, V65, p[422, 428]; Centers for Disease Control and Prevention, 2012, DOM REF HLTH GUID MA; Checkley AM, 2012, BRIT MED J, V344; D'Acremont V, 2002, AM J TROP MED HYG, V66, P481, DOI 10.4269/ajtmh.2002.66.481; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Dubos F, 2010, DIAGN MICR INFEC DIS, V66, P169, DOI 10.1016/j.diagmicrobio.2009.08.018; Faiz MA, 2005, LANCET, V366, P717; Green ST, 2009, J INFECTION, V58, P172, DOI 10.1016/j.jinf.2008.12.001; Health Protection Agency, 2012, IMP MAL CAS DEATHS U; Kiang KM, 2013, ARCH DIS CHILDHOOD-E, V98, P7, DOI 10.1136/archdischild-2011-301530; Ladhani S, 2003, PEDIATR INFECT DIS J, V22, P814, DOI 10.1097/01.inf.0000086401.13592.79; Ladhani S, 2007, LANCET INFECT DIS, V7, P349, DOI 10.1016/S1473-3099(07)70110-X; Lalloo DG, 2007, J INFECTION, V54, P111, DOI 10.1016/j.jinf.2006.12.003; Newman RD, 2004, ANN INTERN MED, V141, P547, DOI 10.7326/0003-4819-141-7-200410050-00012; Rossi IA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-377; SVENSON JE, 1995, ARCH INTERN MED, V155, P861, DOI 10.1001/archinte.155.8.861; WHO, 2011, WORLD MALARIA REPORT 2011, P1; World Health Organization (WHO), 2010, GUID TREATM MAL	22	3	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2013	346								f3214	10.1136/bmj.f3214	http://dx.doi.org/10.1136/bmj.f3214			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DM	23723453	Green Accepted			2022-12-01	WOS:000319948800005
J	Lang, GI; Rice, DP; Hickman, MJ; Sodergren, E; Weinstock, GM; Botstein, D; Desai, MM				Lang, Gregory I.; Rice, Daniel P.; Hickman, Mark J.; Sodergren, Erica; Weinstock, George M.; Botstein, David; Desai, Michael M.			Pervasive genetic hitchhiking and clonal interference in forty evolving yeast populations	NATURE			English	Article							INTEGRATIVE GENOMICS VIEWER; LONG-TERM EXPERIMENT; ASEXUAL POPULATIONS; BENEFICIAL MUTATIONS; SACCHAROMYCES-CEREVISIAE; ADAPTIVE MUTATIONS; ESCHERICHIA-COLI; VIRAL ADAPTATION; EVOLUTION; ALIGNMENT	The dynamics of adaptation determine which mutations fix in a population, and hence how reproducible evolution will be. This is central to understanding the spectra of mutations recovered in the evolution of antibiotic resistance(1), the response of pathogens to immune selection(2,3), and the dynamics of cancer progression(4,5). In laboratory evolution experiments, demonstrably beneficial mutations are found repeatedly(6-8), but are often accompanied by other mutations with no obvious benefit. Here we use whole-genome whole-population sequencing to examine the dynamics of genome sequence evolution at high temporal resolution in 40 replicate Saccharomyces cerevisiae populations growing in rich medium for 1,000 generations. We find pervasive genetic hitchhiking: multiple mutations arise and move synchronously through the population as mutational 'cohorts'. Multiple clonal cohorts are often present simultaneously, competing with each other in the same population. Our results show that patterns of sequence evolution are driven by a balance between these chance effects of hitchhiking and interference, which increase stochastic variation in evolutionary outcomes, and the deterministic action of selection on individual mutations, which favours parallel evolutionary solutions in replicate populations.	[Lang, Gregory I.; Botstein, David] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Lang, Gregory I.; Botstein, David] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Rice, Daniel P.; Desai, Michael M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Rice, Daniel P.; Desai, Michael M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Rice, Daniel P.; Desai, Michael M.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Hickman, Mark J.] Rowan Univ, Dept Biol Sci, Glassboro, NJ 08028 USA; [Hickman, Mark J.] Rowan Univ, Dept Chem & Biochem, Glassboro, NJ 08028 USA; [Sodergren, Erica; Weinstock, George M.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA	Princeton University; Princeton University; Harvard University; Harvard University; Harvard University; Rowan University; Rowan University; Washington University (WUSTL)	Lang, GI (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	glang@lehigh.edu; mmdesai@fas.harvard.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Desai, Michael/0000-0002-9581-1150; Hickman, Mark/0000-0003-3643-8023	NSF; NIGMS Centers of Excellence [GM071508]; NIH [GM046406]; James S. McDonnell Foundation; Alfred P. Sloan Foundation; Harvard Milton Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046406, R01GM046406, P50GM071508] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIGMS Centers of Excellence; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Harvard Milton Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the production team led by L. Fulton and R. Fulton at the Genome Institute at Washington University for sample management and data production, and E. Lobos for coordinating the project. We thank L. Parsons and J. Wiggins for assistance with data management, P. Gibney for assistance with sample preparation, and T. DeCoste for assistance with flow cytometry. We thank K. Kosheleva for discussions, and A. Murray, C. Marx, M. McDonald, G. Sherlock and D. Kvitek for comments on the manuscript. D. P. R. acknowledges support from an NSF Graduate Research Fellowship. D. B. acknowledges support from NIGMS Centers of Excellence grant GM071508 and NIH grant GM046406. M. M. D. acknowledges support from the James S. McDonnell Foundation, the Alfred P. Sloan Foundation, and the Harvard Milton Fund.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ATWOOD KC, 1951, P NATL ACAD SCI USA, V37, P146, DOI 10.1073/pnas.37.3.146; Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Betancourt AJ, 2009, GENETICS, V181, P1535, DOI 10.1534/genetics.107.085837; Bollback JP, 2007, MOL BIOL EVOL, V24, P1397, DOI 10.1093/molbev/msm056; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; Dettman JR, 2012, MOL ECOL, V21, P2058, DOI 10.1111/j.1365-294X.2012.05484.x; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Good BH, 2012, P NATL ACAD SCI USA, V109, P4950, DOI 10.1073/pnas.1119910109; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Hartl :D. L, 2000, PRIMER POPULATION GE; Joseph SB, 2004, GENETICS, V168, P1817, DOI 10.1534/genetics.104.033761; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; Lang GI, 2011, GENETICS, V188, P647, DOI 10.1534/genetics.111.128942; Levin Bruce R., 1994, Trends in Microbiology, V2, P76, DOI 10.1016/0966-842X(94)90538-X; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Miller CR, 2011, GENETICS, V187, P185, DOI 10.1534/genetics.110.121400; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; PAQUIN C, 1983, NATURE, V302, P495, DOI 10.1038/302495a0; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rouzine IM, 2003, P NATL ACAD SCI USA, V100, P587, DOI 10.1073/pnas.242719299; Saxer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014184; Schiffels S, 2011, GENETICS, V189, P1361, DOI 10.1534/genetics.111.132027; Sprouffske K, 2012, CURR BIOL, V22, pR762, DOI 10.1016/j.cub.2012.06.065; Strelkowa N, 2012, GENETICS, V192, P671, DOI 10.1534/genetics.112.143396; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103	36	345	349	0	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					571	+		10.1038/nature12344	http://dx.doi.org/10.1038/nature12344			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23873039	Green Accepted, Green Submitted			2022-12-01	WOS:000323625900033
J	Kucsko, G; Maurer, PC; Yao, NY; Kubo, M; Noh, HJ; Lo, PK; Park, H; Lukin, MD				Kucsko, G.; Maurer, P. C.; Yao, N. Y.; Kubo, M.; Noh, H. J.; Lo, P. K.; Park, H.; Lukin, M. D.			Nanometre-scale thermometry in a living cell	NATURE			English	Article							TEMPERATURE; CANCER; THERMOGENESIS; FLUORESCENCE; TISSUE; SPACE; SPINS; TIME	Sensitive probing of temperature variations on nanometre scales is an outstanding challenge in many areas of modern science and technology(1). In particular, a thermometer capable of subdegree temperature resolution over a large range of temperatures as well as integration within a living system could provide a powerful new tool in many areas of biological, physical and chemical research. Possibilities range from the temperature-induced control of gene expression(2-5) and tumour metabolism(6) to the cell-selective treatment of disease(7,8) and the study of heat dissipation in integrated circuits(1). By combining local light-induced heat sources with sensitive nanoscale thermometry, it may also be possible to engineer biological processes at the subcellular level(2-5). Here we demonstrate a new approach to nanoscale thermometry that uses coherent manipulation of the electronic spin associated with nitrogen-vacancy colour centres in diamond. Our technique makes it possible to detect temperature variations as small as 1.8 mK (a sensitivity of 9 mK Hz(-1/2)) in an ultrapure bulk diamond sample. Using nitrogen-vacancy centres in diamond nanocrystals (nanodiamonds), we directly measure the local thermal environment on length scales as short as 200 nanometres. Finally, by introducing both nanodiamonds and gold nanoparticles into a single human embryonic fibroblast, we demonstrate temperature-gradient control and mapping at the subcellular level, enabling unique potential applications in life sciences.	[Kucsko, G.; Maurer, P. C.; Yao, N. Y.; Park, H.; Lukin, M. D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Kubo, M.; Park, H.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Noh, H. J.; Park, H.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Noh, H. J.; Park, H.] Harvard Univ, Cambridge, MA 02142 USA; [Lo, P. K.] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; City University of Hong Kong	Park, H (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	hongkun_park@harvard.edu; lukin@physics.harvard.edu	lo, pik Kwan peggy/D-3196-2012; Park, Hongkun/R-9842-2019; Yao, Norman/A-3929-2009	Park, Hongkun/0000-0001-9576-8829; Kucsko, Georg/0000-0002-4189-3154; Yao, Norman/0000-0003-0194-7266; Lo, Pik Kwan/0000-0001-5255-1718	NSF; Center for Ultracold Atoms; Defense Advanced Research Projects Agency (QUASAR programme); Army Research Office (MURI programme); Packard Foundation; NIH [5DP1OD003893-03]; NHGRI [1P50HG006193-01]; Swiss National Science Foundation [PBSKP2_143918]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA035083] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003893] Funding Source: NIH RePORTER; Division Of Physics [1125846] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Center for Ultracold Atoms; Defense Advanced Research Projects Agency (QUASAR programme)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Army Research Office (MURI programme); Packard Foundation(The David & Lucile Packard Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank R. Walsworth, V. Denic, C. Latta, L. Jiang, A. Gorshkov, P. Cappellaro, A. Sushkov and I. Lovchinsky for discussions and help with experiments. This work was supported by the NSF, the Center for Ultracold Atoms, the Defense Advanced Research Projects Agency (QUASAR programme), the Army Research Office (MURI programme), the Packard Foundation, NIH Pioneer Awards (5DP1OD003893-03), the NHGRI (1P50HG006193-01) and the Swiss National Science Foundation (PBSKP2_143918) (P.C.M.).	Acosta VM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070801; Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Chen XD, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3652910; Dolde F, 2011, NAT PHYS, V7, P459, DOI [10.1038/nphys1969, 10.1038/NPHYS1969]; Donner JS, 2012, NANO LETT, V12, P2107, DOI 10.1021/nl300389y; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hodges JS, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.032118; Jin CY, 2011, NANO LETT, V11, P4818, DOI 10.1021/nl2026585; Kamei Y, 2009, NAT METHODS, V6, P79, DOI [10.1038/NMETH.1278, 10.1038/nmeth.1278]; Kim SH, 2006, J MICROMECH MICROENG, V16, P526, DOI 10.1088/0960-1317/16/3/007; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Lauschke VM, 2013, NATURE, V493, P101, DOI 10.1038/nature11804; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Majumdar A, 1999, ANNU REV MATER SCI, V29, P505, DOI 10.1146/annurev.matsci.29.1.505; Maurer PC, 2010, NAT PHYS, V6, P912, DOI [10.1038/nphys1774, 10.1038/NPHYS1774]; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004; Okabe K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1714; Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180; Shalek AK, 2010, P NATL ACAD SCI USA, V107, P1870, DOI 10.1073/pnas.0909350107; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; Toyli DM, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031001; Tsoli M, 2012, CANCER RES, V72, P4372, DOI 10.1158/0008-5472.CAN-11-3536; Vetrone F, 2010, ACS NANO, V4, P3254, DOI 10.1021/nn100244a; Vreugdenburg TD, 2013, BREAST CANCER RES TR, V137, P665, DOI 10.1007/s10549-012-2393-x; Wee TL, 2007, J PHYS CHEM A, V111, P9379, DOI 10.1021/jp073938o; Xu GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049021; Yang JM, 2011, ACS NANO, V5, P5067, DOI 10.1021/nn201142f; Yue Y., 2012, NANO REV	30	1130	1162	35	778	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2013	500	7460					54	U71		10.1038/nature12373	http://dx.doi.org/10.1038/nature12373			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23903748	Green Accepted, Green Published, Green Submitted			2022-12-01	WOS:000322514800026
J	Vallurupalli, M				Vallurupalli, Mounica			Mourning on Morning Rounds	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEATH-ROUNDS; RESIDENTS		Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Vallurupalli, M (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Hough CL, 2005, J CRIT CARE, V20, P20, DOI 10.1016/j.jcrc.2004.09.006; Jackson VA, 2005, ACAD MED, V80, P648, DOI 10.1097/00001888-200507000-00007; Khot S, 2011, ARCH NEUROL-CHICAGO, V68, P1395, DOI 10.1001/archneurol.2011.618	3	5	5	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					404	405		10.1056/NEJMp1300969	http://dx.doi.org/10.1056/NEJMp1300969			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193GQ	23902480				2022-12-01	WOS:000322547400005
J	Gulev, SK; Latif, M; Keenlyside, N; Park, W; Koltermann, KP				Gulev, Sergey K.; Latif, Mojib; Keenlyside, Noel; Park, Wonsun; Koltermann, Klaus Peter			North Atlantic Ocean control on surface heat flux on multidecadal timescales	NATURE			English	Article							THERMOHALINE CIRCULATION; INTERDECADAL VARIATIONS; DECADAL VARIABILITY; CLIMATE; IMPACT; OSCILLATION; ANOMALIES; TRENDS	Nearly 50 years ago Bjerknes(1) suggested that the character of large-scale air-sea interaction over the mid-latitude North Atlantic Ocean differs with timescales: the atmosphere was thought to drive directly most short-term-interannual-sea surface temperature (SST) variability, and the ocean to contribute significantly to long-term-multidecadal-SST and potentially atmospheric variability. Although the conjecture for short timescales is well accepted, understanding Atlantic multidecadal variability (AMV) of SST2,3 remains a challenge as a result of limited ocean observations. AMV is nonetheless of major socio-economic importance because it is linked to important climate phenomena such as Atlantic hurricane activity and Sahel rainfall, and it hinders the detection of anthropogenic signals in the North Atlantic sector(4-6). Direct evidence of the oceanic influence of AMV can only be provided by surface heat fluxes, the language of ocean-atmosphere communication. Here we provide observational evidence that in the mid-latitude North Atlantic and on timescales longer than 10 years, surface turbulent heat fluxes are indeed driven by the ocean and may force the atmosphere, whereas on shorter timescales the converse is true, thereby confirming the Bjerknes conjecture. This result, although strongest in boreal winter, is found in all seasons. Our findings suggest that the predictability of mid-latitude North Atlantic air-sea interaction could extend beyond the ocean to the climate of surrounding continents.	[Gulev, Sergey K.] PP Shirshov Inst Oceanol, Moscow 117997, Russia; [Gulev, Sergey K.; Latif, Mojib; Park, Wonsun] GEOMAR Helmholtz Zentrum Ozeanforsch Kiel, D-24105 Kiel, Germany; [Gulev, Sergey K.; Koltermann, Klaus Peter] Moscow MV Lomonosov State Univ, Fac Geog, Moscow 119991, Russia; [Latif, Mojib] Univ Kiel, Cluster Excellence Future Ocean, D-24118 Kiel, Germany; [Keenlyside, Noel] Univ Bergen, Inst Geophys, N-5007 Bergen, Norway; [Keenlyside, Noel] Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway	Russian Academy of Sciences; Shirshov Institute of Oceanology; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Lomonosov Moscow State University; University of Kiel; University of Bergen; Bjerknes Centre for Climate Research; University of Bergen	Gulev, SK (corresponding author), PP Shirshov Inst Oceanol, 36 Nakhimovsky Prospect, Moscow 117997, Russia.	gul@sail.msk.ru	Keenlyside, Noel S/E-8303-2013; Park, Wonsun/J-8097-2012; Koltermann, Klaus Peter/D-4817-2014; Latif, Mojib/C-2428-2016; Gulev, Sergey/A-4994-2014	Keenlyside, Noel S/0000-0002-8708-6868; Park, Wonsun/0000-0002-6345-8428; Latif, Mojib/0000-0003-1079-5604; Koltermann, Klaus Peter/0000-0002-6038-7599	Deutsche Forschungsgemeinschaft [KE 1471/2-1]; Russian Ministry of Education and Science through the Special Grant for establishing excellence at Russian Universities [11.G34.31.0007]; Russian Ministry of Education and Science; RACE project of the German Federal Ministry of Education and Research;  [2011-16-420-1-001];  [11.519.11.6034]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Russian Ministry of Education and Science through the Special Grant for establishing excellence at Russian Universities; Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); RACE project of the German Federal Ministry of Education and Research; ; 	This study was supported by the Deutsche Forschungsgemeinschaft under grant KE 1471/2-1 and by the Russian Ministry of Education and Science through the Special Grant for establishing excellence at Russian Universities, no. 11.G34.31.0007. We also benefited from contracts 2011-16-420-1-001 and 11.519.11.6034 with the Russian Ministry of Education and Science and the RACE project of the German Federal Ministry of Education and Research.	Bjerknes J., 1964, ADV GEOPHYS, V10, P1, DOI [10.1016/S0065-2687(08)60005-9, DOI 10.1016/S0065-2687(08)60005-9]; Booth BBB, 2012, NATURE, V484, P228, DOI 10.1038/nature10946; CAYAN DR, 1992, J PHYS OCEANOGR, V22, P859, DOI 10.1175/1520-0485(1992)022<0859:LASHFA>2.0.CO;2; Compo GP, 2011, Q J ROY METEOR SOC, V137, P1, DOI 10.1002/qj.776; DELWORTH T, 1993, J CLIMATE, V6, P1993, DOI 10.1175/1520-0442(1993)006<1993:IVOTTC>2.0.CO;2; DUCHON CE, 1979, J APPL METEOROL, V18, P1016, DOI 10.1175/1520-0450(1979)018<1016:LFIOAT>2.0.CO;2; Ebisuzaki W, 1997, J CLIMATE, V10, P2147, DOI 10.1175/1520-0442(1997)010<2147:AMTETS>2.0.CO;2; Eden C, 2001, J CLIMATE, V14, P2266, DOI 10.1175/1520-0442(2001)014<2266:MOITDV>2.0.CO;2; Fairall C. W., 2003, J CLIMATOL, V16, P591; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Gulev S, 2007, J CLIMATE, V20, P279, DOI 10.1175/JCLI4010.1; Gulev SK, 2012, J CLIMATE, V25, P184, DOI 10.1175/2011JCLI4211.1; Hayashi Y., 1981, J METEOROL SOC JPN, V59, P621; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Josey SA, 1999, J CLIMATE, V12, P2856, DOI 10.1175/1520-0442(1999)012<2856:NIITOH>2.0.CO;2; Kent EC, 2007, J ATMOS OCEAN TECH, V24, P214, DOI 10.1175/JTECH1949.1; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Kushnir Y, 2002, J CLIMATE, V15, P2233, DOI 10.1175/1520-0442(2002)015<2233:AGRTES>2.0.CO;2; KUSHNIR Y, 1994, J CLIMATE, V7, P141, DOI 10.1175/1520-0442(1994)007<0141:IVINAS>2.0.CO;2; Latif M, 2004, J CLIMATE, V17, P1605, DOI 10.1175/1520-0442(2004)017<1605:RMAPMC>2.0.CO;2; LIVEZEY RE, 1983, MON WEATHER REV, V111, P46, DOI 10.1175/1520-0493(1983)111<0046:SFSAID>2.0.CO;2; Ottera OH, 2010, NAT GEOSCI, V3, P688, DOI 10.1038/NGEO955; Pohlmann H, 2006, J CLIMATE, V19, P6062, DOI 10.1175/JCLI3941.1; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Rodwell MJ, 1999, NATURE, V398, P320, DOI 10.1038/18648; Semenov VA, 2010, J CLIMATE, V23, P5668, DOI 10.1175/2010JCLI3347.1; Shaffrey L, 2006, J CLIMATE, V19, P1167, DOI 10.1175/JCLI3652.1; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Ting MF, 2009, J CLIMATE, V22, P1469, DOI 10.1175/2008JCLI2561.1; Woodruff SD, 2011, INT J CLIMATOL, V31, P951, DOI 10.1002/joc.2103; Yu B, 2011, CLIM DYNAM, V36, P589, DOI 10.1007/s00382-009-0669-6; Yu LS, 2007, B AM METEOROL SOC, V88, P527, DOI 10.1175/BAMS-88-4-527; Zhang R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026267	33	212	227	1	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					464	+		10.1038/nature12268	http://dx.doi.org/10.1038/nature12268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23887431				2022-12-01	WOS:000322157900037
J	Gilbert, LA; Larson, MH; Morsut, L; Liu, ZR; Brar, GA; Torres, SE; Stern-Ginossar, N; Brandman, O; Whitehead, EH; Doudna, JA; Lim, WA; Weissman, JS; Qi, LS				Gilbert, Luke A.; Larson, Matthew H.; Morsut, Leonardo; Liu, Zairan; Brar, Gloria A.; Torres, Sandra E.; Stern-Ginossar, Noam; Brandman, Onn; Whitehead, Evan H.; Doudna, Jennifer A.; Lim, Wendell A.; Weissman, Jonathan S.; Qi, Lei S.			CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes	CELL			English	Article							GENE-EXPRESSION; REPRESSION; BACTERIA; ACTIVATION; CHROMATIN; REVEALS; GENOMES; SYSTEMS; CELLS	The genetic interrogation and reprogramming of cells requires methods for robust and precise targeting of genes for expression or repression. The CRISPR-associated catalytically inactive dCas9 protein offers a general platform for RNA-guided DNA targeting. Here, we show that fusion of dCas9 to effector domains with distinct regulatory functions enables stable and efficient transcriptional repression or activation in human and yeast cells, with the site of delivery determined solely by a coexpressed short guide (sg)RNA. Coupling of dCas9 to a transcriptional repressor domain can robustly silence expression of multiple endogenous genes. RNA-seq analysis indicates that CRISPR interference (CRISPRi)-mediated transcriptional repression is highly specific. Our results establish that the CRISPR system can be used as a modular and flexible DNA-binding platform for the recruitment of proteins to a target DNA sequence, revealing the potential of CRISPRi as a general tool for the precise regulation of gene expression in eukaryotic cells.	[Gilbert, Luke A.; Larson, Matthew H.; Morsut, Leonardo; Brar, Gloria A.; Torres, Sandra E.; Stern-Ginossar, Noam; Brandman, Onn; Whitehead, Evan H.; Lim, Wendell A.; Weissman, Jonathan S.; Qi, Lei S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Gilbert, Luke A.; Larson, Matthew H.; Morsut, Leonardo; Brar, Gloria A.; Torres, Sandra E.; Stern-Ginossar, Noam; Brandman, Onn; Doudna, Jennifer A.; Lim, Wendell A.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Whitehead, Evan H.; Lim, Wendell A.; Weissman, Jonathan S.; Qi, Lei S.] Univ Calif San Francisco, UCSF Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [Gilbert, Luke A.; Larson, Matthew H.; Brar, Gloria A.; Torres, Sandra E.; Stern-Ginossar, Noam; Brandman, Onn; Whitehead, Evan H.; Doudna, Jennifer A.; Lim, Wendell A.; Weissman, Jonathan S.; Qi, Lei S.] Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Gilbert, Luke A.; Larson, Matthew H.; Brar, Gloria A.; Torres, Sandra E.; Stern-Ginossar, Noam; Brandman, Onn; Doudna, Jennifer A.; Weissman, Jonathan S.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Liu, Zairan] Peking Univ, Beijing 100871, Peoples R China	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Peking University	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu	Larson, Matthew/C-8289-2014; Qi, Lei S/AAC-5088-2019; Gilbert, Luke/AAC-5300-2019	Larson, Matthew/0000-0002-6778-2604; , Noam/0000-0003-3583-5932; Qi, Lei S/0000-0002-3965-3223; Gilbert, Luke/0000-0001-5854-0825; Whitehead, Evan/0000-0002-4132-2140; Weissman, Jonathan/0000-0003-2445-670X	UCSF Center for Systems and Synthetic Biology; NIH [P50 GM102706, P50 GM081879, U01 CA168370]; Howard Hughes Medical Institute; NSF SynBERC [EEC-0540879]; NIGMS IMSD; Human Frontiers Scientific Program; Ruth L. Kirschstein National Research Service Award; NATIONAL CANCER INSTITUTE [U01CA168370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100611, P50GM081879, P50GM102706] Funding Source: NIH RePORTER	UCSF Center for Systems and Synthetic Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF SynBERC(National Science Foundation (NSF)); NIGMS IMSD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Human Frontiers Scientific Program; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Martin Jinek for discussion and distribution of the dCas9 gene. The authors also thank Jason Park, Martin Kampmann, Mike Bassik, and Xin Xiong for lentiviral vectors, technical advice, and helpful discussion. L.S.Q. acknowledges support from the UCSF Center for Systems and Synthetic Biology. This work was supported by NIH P50 GM102706 (J.S.W. and J.A.D.), NIH P50 GM081879 (L.S.Q., W.A.L., Z.L., and E.H.W.), NIH U01 CA168370 (J.S.W.), Howard Hughes Medical Institute (L.A.G., G.A.B., O.B., J.A.D., J.S.W., and W.A.L.), NSF SynBERC EEC-0540879 (W.A.L.), NIGMS IMSD (S.E.T.), the Human Frontiers Scientific Program (N.S. and L.M.), and a Ruth L. Kirschstein National Research Service Award (M.H.L.).	Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; BATY D, 1984, NUCLEIC ACIDS RES, V12, P915, DOI 10.1093/nar/12.2.915; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Conaway JW, 2012, ANNU REV BIOCHEM, V81, P61, DOI 10.1146/annurev-biochem-090711-093103; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Fu Y., 2013, NAT BIOTECHNOL; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gratz SJ, 2013, GENETICS; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Harper SE, 1996, P NATL ACAD SCI USA, V93, P8536, DOI 10.1073/pnas.93.16.8536; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kasten MM, 1996, MOL CELL BIOL, V16, P4215; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Maeder ML, 2013, NAT METHODS, V10, P243, DOI [10.1038/NMETH.2366, 10.1038/nmeth.2366]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Millau JF, 2011, BIOCHEM CELL BIOL, V89, P505, DOI [10.1139/O11-052, 10.1139/o11-052]; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/NMETH.2361, 10.1038/nmeth.2361]; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zhang L, 2000, J BIOL CHEM, V275, P33850, DOI 10.1074/jbc.M005341200; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	46	2091	2394	48	795	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 18	2013	154	2					442	451		10.1016/j.cell.2013.06.044	http://dx.doi.org/10.1016/j.cell.2013.06.044			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23849981	Green Accepted, Bronze			2022-12-01	WOS:000321950700019
J	Fidock, DA				Fidock, David A.			Eliminating Malaria	SCIENCE			English	Editorial Material							RESISTANT PLASMODIUM-FALCIPARUM; ARTEMISININ RESISTANCE; WESTERN CAMBODIA; CLEARANCE		[Fidock, David A.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Fidock, David A.] Columbia Univ, Med Ctr, Dept Med, Div Infect Dis, New York, NY 10032 USA	Columbia University; Columbia University	Fidock, DA (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.	df2260@columbia.edu		Fidock, David/0000-0001-6753-8938	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079709, R01AI050234] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI079709, R01 AI050234, R37 AI050234] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Boiteux S, 2013, GENETICS, V193, P1025, DOI 10.1534/genetics.112.145219; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Cheng Q, 2012, INT J PARASITOL-DRUG, V2, P249, DOI 10.1016/j.ijpddr.2012.01.001; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gold B, 2012, P NATL ACAD SCI USA, V109, P16004, DOI 10.1073/pnas.1214188109; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Vaughan AM, 2012, J CLIN INVEST, V122, P3618, DOI 10.1172/JCI62684; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Witkowski B, 2013, ANTIMICROB AGENTS CH, V57, P914, DOI 10.1128/AAC.01868-12	16	14	14	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1531	1533		10.1126/science.1240539	http://dx.doi.org/10.1126/science.1240539			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172ME	23812705	Green Accepted			2022-12-01	WOS:000321007000025
J	Lewin, SR				Lewin, Sharon R.			A cure for HIV: where we've been, and where we're headed	LANCET			English	Editorial Material									[Lewin, Sharon R.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic 3004, Australia; [Lewin, Sharon R.] Monash Univ, Ctr Biomed Res, Burnet Inst, Melbourne, Vic 3004, Australia	Florey Institute of Neuroscience & Mental Health; Burnet Institute; Monash University	Lewin, SR (corresponding author), Alfred Hosp, Dept Infect Dis, Melbourne, Vic 3004, Australia.	sharon.lewin@monash.edu	Lewin, Sharon/Z-3297-2019	Lewin, Sharon Ruth/0000-0002-0330-8241	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096109, R56AI095073] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI096109, R56 AI095073] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Elliott J., 2013, 20 C RETR OPP INF MA; Henrich TJ, 2013, J INFECT DIS, V207, P1694, DOI 10.1093/infdis/jit086; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Persaud D., 2013, 20 C RETR OPP INF MA; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; UN, 2012, UNAIDS GLOB REP 2012	9	11	11	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 15	2013	381	9883					2057	2058		10.1016/S0140-6736(13)61180-0	http://dx.doi.org/10.1016/S0140-6736(13)61180-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KA	23769215	Green Accepted			2022-12-01	WOS:000320924800004
J	Etter, JF				Etter, Jean-Francois			Should electronic cigarettes be as freely available as tobacco? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEPENDENCE		Univ Geneva, Fac Med, Inst Social & Prevent Med, CH-1211 Geneva 4, Switzerland	University of Geneva	Etter, JF (corresponding author), Univ Geneva, Fac Med, Inst Social & Prevent Med, CH-1211 Geneva 4, Switzerland.	Jean-Francois.Etter@unige.ch		ETTER, Jean-Francois/0000-0002-1426-3157				Etter JF, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015487; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; European Union, 2012, PROP DIR EUR PARL CO; Goniewicz M. L, 2013, TOB CONTROL; Harris JE, 2004, BMJ-BRIT MED J, V328, P72, DOI 10.1136/bmj.37936.585382.44; Hughes JR, 2004, NICOTINE TOB RES, V6, P79, DOI 10.1080/14622200310001656894; HUGHES JR, 1989, BIOMED PHARMACOTHER, V43, P11, DOI 10.1016/0753-3322(89)90185-6; Koch W., 2012, US TODAY; Sparks I., 2013, DAILY MAIL	9	50	50	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2013	346								f3845	10.1136/bmj.f3845	http://dx.doi.org/10.1136/bmj.f3845			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	166XQ	23771039				2022-12-01	WOS:000320593900011
J	Lukens, JR; Vogel, P; Johnson, GR; Kelliher, MA; Iwakura, Y; Lamkanfi, M; Kanneganti, TD				Lukens, John R.; Vogel, Peter; Johnson, Gordon R.; Kelliher, Michelle A.; Iwakura, Yoichiro; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi			RIP1-driven autoinflammation targets IL-1 alpha independently of inflammasomes and RIP3	NATURE			English	Article							STERILE INFLAMMATION; MOTH-EATEN; CELL; GENE; ACTIVATION; DISEASE; MICE; IDENTIFICATION; AUTOIMMUNITY; PHOSPHATASES	The protein-tyrosine phosphatase SHP-1 has critical roles in immune signalling, but how mutations in SHP-1 cause inflammatory disease in humans remains poorly defined(1). Mice homozygous for the Tyr208Asn amino acid substitution in the carboxy terminus of SHP-1 (referred to as Ptpn6(spin) mice) spontaneously develop a severe inflammatory syndrome that resembles neutrophilic dermatosis in humans and is characterized by persistent footpad swelling and suppurative inflammation(2,3). Here we report that receptor-interacting protein 1 (RIP1)-regulated interleukin (IL)-1 alpha production by haematopoietic cells critically mediates chronic inflammatory disease in Ptpn6(spin) mice, whereas inflammasome signalling and IL-1 beta-mediated events are dispensable. IL-1 alpha was also crucial for exacerbated inflammatory responses and unremitting tissue damage upon footpad microabrasion of Ptpn6(spin) mice. Notably, pharmacological and genetic blockade of the kinase RIP1 protected against wound-induced inflammation and tissue damage in Ptpn6(spin) mice, whereas RIP3 deletion failed to do so. Moreover, RIP1-mediated inflammatory cytokine production was attenuated by NF-kappa B and ERK inhibition. Together, our results indicate that wound-induced tissue damage and chronic inflammation in Ptpn6(spin) mice are critically dependent on RIP1-mediated IL-1 alpha production, whereas inflammasome signalling and RIP3-mediated necroptosis are dispensable. Thus, we have unravelled a novel inflammatory circuit in which RIP1-mediated IL-1 alpha secretion in response to deregulated SHP-1 activity triggers an inflammatory destructive disease that proceeds independently of inflammasomes and programmed necrosis.	[Lukens, John R.; Johnson, Gordon R.; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA; [Kelliher, Michelle A.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo 1088639, Japan; [Lamkanfi, Mohamed] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Tokyo; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Kanneganti, Thirumala-Devi/M-9435-2018; Vogel, Peter/N-2490-2018; Iwakura, Yoichiro/E-5457-2011; Kanneganti, Thirumala-Devi/Y-2503-2019	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Vogel, Peter/0000-0002-7535-0545; Iwakura, Yoichiro/0000-0002-9934-5775; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Lukens, John/0000-0002-6795-0866	European Union [256432]; ERC [281600]; Fund for Scientific Research-Flanders [G030212N, 1.2.201.10.N.00, 1.5.122.11.N.00]; National Institutes of Health [AR056296, CA163507, AI101935]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [R01CA163507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI101935, R01AI101935, R01AI075118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	European Union(European Commission); ERC(European Research Council (ERC)European Commission); Fund for Scientific Research-Flanders(FWO); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank B. A. Buetler, V. M. Dixit and D. R. Green for supply of mutant mice. We thank R. Weinlich for helpful discussions. We thank M. Johnson in the St Jude Small Animal Imaging Center for helping to evaluate embryonic development in fetal liver transplantation studies. M. L. is supported by European Union Marie-Curie grant 256432, ERC grant 281600, and grants G030212N, 1.2.201.10.N.00 and 1.5.122.11.N.00 from the Fund for Scientific Research-Flanders. This work was supported by grants from the National Institutes of Health (grants AR056296, CA163507 and AI101935) and the American Lebanese Syrian Associated Charities (ALSAC) to T.-D.K.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Cao HN, 2002, J HUM GENET, V47, P445, DOI 10.1007/s100380200062; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Christophi GP, 2008, LAB INVEST, V88, P243, DOI 10.1038/labinvest.3700720; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Croker BA, 2008, P NATL ACAD SCI USA, V105, P15028, DOI 10.1073/pnas.0806619105; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kranich J, 2011, SEMIN IMMUNOL, V23, P139, DOI 10.1016/j.smim.2011.01.011; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Lukens JR, 2011, DISCOV MED, V11, P65; Matsuki T, 2006, INT IMMUNOL, V18, P399, DOI 10.1093/intimm/dxh379; Nesterovitch AB, 2011, AM J PATHOL, V178, P1701, DOI 10.1016/j.ajpath.2010.12.053; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; SHULTZ LD, 1984, AM J PATHOL, V116, P179; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4	27	126	131	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					224	+		10.1038/nature12174	http://dx.doi.org/10.1038/nature12174			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23708968	Green Accepted			2022-12-01	WOS:000320283400047
J	Fleming, N				Fleming, Nic			Tell fans definitive calls are an impossible goal	NATURE			English	Editorial Material												nicfleming106@hotmail.com						COLLINS H, 2011, PUBLIC UNDERSTANDING	1	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					537	537		10.1038/497537a	http://dx.doi.org/10.1038/497537a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	152UF	23719426	Bronze			2022-12-01	WOS:000319556100006
J	Nabarro, D				Nabarro, David			Global child and maternal nutrition-the SUN rises	LANCET			English	Editorial Material									SUN Movement Secretariat, CH-1201 Geneva, Switzerland		Nabarro, D (corresponding author), SUN Movement Secretariat, Villa Pelouse 2nd Floor, CH-1201 Geneva, Switzerland.	david.nabarro@undp.org						Bhutta ZA, 2013, LANCET; Black R., 2013, LANCET; Gillespie S, 2013, LANCET; Ruel M, 2013, LANCET	4	15	15	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 24	2013	382	9893					666	667		10.1016/S0140-6736(13)61086-7	http://dx.doi.org/10.1016/S0140-6736(13)61086-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	206SI	23746773				2022-12-01	WOS:000323542400007
J	Collart, C; Allen, GE; Bradshaw, CR; Smith, JC; Zegerman, P				Collart, Clara; Allen, George E.; Bradshaw, Charles R.; Smith, James C.; Zegerman, Philip			Titration of Four Replication Factors Is Essential for the Xenopus laevis Midblastula Transition	SCIENCE			English	Article							MAJOR DEVELOPMENTAL TRANSITION; INITIATION; DEGRADATION; EMBRYOS; KINASE; ONSET	The rapid, reductive early divisions of many metazoan embryos are followed by the midblastula transition (MBT), during which the cell cycle elongates and zygotic transcription begins. It has been proposed that the increasing nuclear to cytoplasmic (N/C) ratio is critical for controlling the events of the MBT. We show that four DNA replication factors-Cut5, RecQ4, Treslin, and Drf1-are limiting for replication initiation at increasing N/C ratios in vitro and in vivo in Xenopus laevis. The levels of these factors regulate multiple events of the MBT, including the slowing of the cell cycle, the onset of zygotic transcription, and the developmental activation of the kinase Chk1. This work provides a mechanism for how the N/C ratio controls the MBT and shows that the regulation of replication initiation is fundamental for normal embryogenesis.	[Collart, Clara; Allen, George E.; Bradshaw, Charles R.; Zegerman, Philip] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Collart, Clara; Smith, James C.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Zegerman, Philip] Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	University of Cambridge; MRC National Institute for Medical Research; University of Cambridge	Zegerman, P (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Henry Wellcome Bldg Canc & Dev Biol, Cambridge CB2 1QN, England.	p.zegerman@gurdon.cam.ac.uk		Zegerman, Philip/0000-0002-5707-1083; Bradshaw, Charles/0000-0002-3528-458X; Smith, Jim/0000-0003-2413-9392	AICR [10-0908]; Wellcome Trust [092096]; UK Medical Research Council [U117597140]; CRUK [C6946/A14492]; MRC [MC_U117597140] Funding Source: UKRI; Medical Research Council [MC_U117597140] Funding Source: researchfish; Worldwide Cancer Research [10-0908] Funding Source: researchfish	AICR; Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research	We are grateful to T. Takahashi, J. Walter, V. Costanzo, J. Diffley, H. Takisawa, and R. Laskey for reagents. DNA combing analysis was performed with assistance from V. Gaggioli. We are grateful to J. Pines, R. Laskey, and members of the Zegerman group for critical reading of this manuscript and S. Di Talia for discussions. P.Z. is funded by AICR 10-0908. J.C.S. and C.C. were supported by the Wellcome Trust and by the UK Medical Research Council (programme no. U117597140). All authors acknowledge the core support provided by CRUK C6946/A14492 and the Wellcome Trust 092096.	BLUMENTH.AB, 1973, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/SQB.1974.038.01.024; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; Fogarty P, 1997, CURR BIOL, V7, P418, DOI 10.1016/S0960-9822(06)00189-8; Hartley RS, 1997, DEV BIOL, V188, P312, DOI 10.1006/dbio.1997.8647; Howe JA, 1996, P NATL ACAD SCI USA, V93, P2060, DOI 10.1073/pnas.93.5.2060; HYRIEN O, 1995, SCIENCE, V270, P994, DOI 10.1126/science.270.5238.994; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Lu XM, 2009, DEVELOPMENT, V136, P2101, DOI 10.1242/dev.034421; Mantiero D, 2011, EMBO J, V30, P4805, DOI 10.1038/emboj.2011.404; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; McCleland ML, 2009, J CELL BIOL, V187, P7, DOI 10.1083/jcb.200906191; MCKNIGHT SL, 1977, CELL, V12, P795, DOI 10.1016/0092-8674(77)90278-1; NEWPORT J, 1989, J CELL SCI, P149; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Shermoen AW, 2010, CURR BIOL, V20, P2067, DOI 10.1016/j.cub.2010.10.021; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Silva T, 2006, J BIOL CHEM, V281, P11569, DOI 10.1074/jbc.M510278200; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Vastag Livia, 2011, PLoS One, V6, pe16881, DOI 10.1371/journal.pone.0016881; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; WOODLAND HR, 1972, BIOCHEM J, V127, P597, DOI 10.1042/bj1270597	26	143	144	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 23	2013	341	6148					893	896		10.1126/science.1241530	http://dx.doi.org/10.1126/science.1241530			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23907533	Green Accepted			2022-12-01	WOS:000323370600044
J	Chen, C; Ke, JY; Zhou, XE; Yi, W; Brunzelle, JS; Li, J; Yong, EL; Xu, HE; Melcher, K				Chen, Chen; Ke, Jiyuan; Zhou, X. Edward; Yi, Wei; Brunzelle, Joseph S.; Li, Jun; Yong, Eu-Leong; Xu, H. Eric; Melcher, Karsten			Structural basis for molecular recognition of folic acid by folate receptors	NATURE			English	Article							DIFFRACTION	Folate receptors (FR alpha, FR beta and FR gamma) are cysteine-rich cell-surface glycoproteins that bind folate with high affinity to mediate cellular uptake of folate. Although expressed at very low levels in most tissues, folate receptors, especially FR alpha, are expressed at high levels in numerous cancers to meet the folate demand of rapidly dividing cells under low folate conditions(1-3). The folate dependency of many tumours has been therapeutically and diagnostically exploited by administration of anti-FR alpha antibodies, high-affinity antifolates(4,5), folate-based imaging agents and folate-conjugated drugs and toxins(6-8). To understand how folate binds its receptors, we determined the crystal structure of human FR alpha in complex with folic acid at 2.8 angstrom resolution. FR alpha has a globular structure stabilized by eight disulphide bonds and contains a deep open folate-binding pocket comprised of residues that are conserved in all receptor subtypes. The folate pteroate moiety is buried inside the receptor, whereas its glutamate moiety is solvent-exposed and sticks out of the pocket entrance, allowing it to be conjugated to drugs without adversely affecting FR alpha binding. The extensive interactions between the receptor and ligand readily explain the high folate-binding affinity of folate receptors and provide a template for designing more specific drugs targeting the folate receptor system.	[Chen, Chen; Ke, Jiyuan; Zhou, X. Edward; Xu, H. Eric; Melcher, Karsten] Van Andel Res Inst, Program Struct Biol & Drug Discovery, Grand Rapids, MI 49503 USA; [Chen, Chen] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Yi, Wei; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, VARI SIMM Ctr,Ctr Struct & Funct Drug Targets, Shanghai 201203, Peoples R China; [Brunzelle, Joseph S.] Northwestern Univ, Synchrotron Res Ctr, Life Sci Collaborat Access Team, Argonne, IL 60439 USA; [Li, Jun; Yong, Eu-Leong] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hosp, Dept Obstet & Gynecol, Singapore 119074, Singapore	Van Andel Institute; National University of Singapore; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Northwestern University; National University of Singapore	Yong, EL (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hosp, Dept Obstet & Gynecol, Singapore 119074, Singapore.	eu_leong_yong@nuhs.edu.sg; eric.xu@vai.org; Karsten.Melcher@vai.org	Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021	Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144; Yong, Eu-Leong/0000-0001-6511-770X	Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; Office of Science of the US Department of Energy [DE-AC02-06CH11357]; Jay and Betty Van Andel Foundation; American Asthma Foundation; Ministry of Science and Technology (China) [2012ZX09301001-005, 2012CB910403]; Amway (China); National Institutes of Health [R01 DK071662, R01 GM102545]; National Research Foundation Singapore [NMRC/CSA/026/2011]; NUS Graduate School for Integrative Sciences and Engineering Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104212, R01GM102545] Funding Source: NIH RePORTER	Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Jay and Betty Van Andel Foundation; American Asthma Foundation; Ministry of Science and Technology (China)(Ministry of Science and Technology, China); Amway (China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation Singapore(National Research Foundation, Singapore); NUS Graduate School for Integrative Sciences and Engineering Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Jones for the pHL-Fc plasmid and H. L. Monaco for providing the chicken riboflavin-binding protein coordinates. The atomic coordinates have been deposited in the Protein Data Bank with accession codes listed in Supplementary Table 1. We thank staff members of the Life Science Collaborative Access Team of the Advanced Photon Source (APS) for assistance in data collection at the beam lines of sector 21, which is in part funded by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). Use of APS was supported by the Office of Science of the US Department of Energy, under contract no. DE-AC02-06CH11357. This work was supported by the Jay and Betty Van Andel Foundation, and work by the Yong, Xu and Melcher laboratories is supported by the American Asthma Foundation, Ministry of Science and Technology (China) grants 2012ZX09301001-005 and 2012CB910403, Amway (China), by National Institutes of Health grants R01 DK071662 (H.E.X.) and R01 GM102545 (K.M.), and by the National Research Foundation Singapore under its Clinician Scientist Award NMRC/CSA/026/2011 (E.-L.Y.). C.C. is recipient of the NUS Graduate School for Integrative Sciences and Engineering Scholarship.	ANTONY AC, 1992, BLOOD, V79, P2807; Bailey LB, 1999, J NUTR, V129, P779, DOI 10.1093/jn/129.4.779; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Deng YJ, 2009, J MED CHEM, V52, P2940, DOI 10.1021/jm8011323; Elnakat H, 2004, ADV DRUG DELIVER REV, V56, P1067, DOI 10.1016/j.addr.2004.01.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KANE MA, 1988, J CLIN INVEST, V81, P1398, DOI 10.1172/JCI113469; Kelemen LE, 2006, INT J CANCER, V119, P243, DOI 10.1002/ijc.21712; Leamon CP, 2007, MOL PHARMACEUT, V4, P659, DOI 10.1021/mp070049c; Leamon CP, 2004, ADV DRUG DELIVER REV, V56, P1127, DOI 10.1016/j.addr.2004.01.008; Leamon CP, 1999, J DRUG TARGET, V7, P157, DOI 10.3109/10611869909085499; Liu Q, 2012, SCIENCE, V336, P1033, DOI 10.1126/science.1218753; MATSUE H, 1992, P NATL ACAD SCI USA, V89, P6006, DOI 10.1073/pnas.89.13.6006; McGuire JJ, 2003, CURR PHARM DESIGN, V9, P2593, DOI 10.2174/1381612033453712; Monaco HL, 1997, EMBO J, V16, P1475, DOI 10.1093/emboj/16.7.1475; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Ratnam M., 1990, FOLIC ACID METABOLIS, P91; Reddy JA, 2007, CANCER RES, V67, P4434, DOI 10.1158/0008-5472.CAN-07-0033; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Zhao RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000969; Zhao RB, 2009, J BIOL CHEM, V284, P4267, DOI 10.1074/jbc.M807665200	28	442	459	16	364	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					486	+		10.1038/nature12327	http://dx.doi.org/10.1038/nature12327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23851396	Green Accepted			2022-12-01	WOS:000323316100041
J	Koehler, KR; Mikosz, AM; Molosh, AI; Patel, D; Hashino, E				Koehler, Karl R.; Mikosz, Andrew M.; Molosh, Andrei I.; Patel, Dharmeshkumar; Hashino, Eri			Generation of inner ear sensory epithelia from pluripotent stem cells in 3D culture	NATURE			English	Article							IN-VITRO; NEURONAL DIFFERENTIATION; 3-DIMENSIONAL CULTURE; CORTICAL TISSUES; SELF-FORMATION; HAIR-CELLS; HUMAN ES; MOUSE; INDUCTION; EXPRESSION	The inner ear contains sensory epithelia that detect head movements, gravity and sound. It is unclear how to develop these sensory epithelia from pluripotent stem cells, a process that will be critical for modelling inner ear disorders or developing cell-based therapies for profound hearing loss and balance disorders(1,2). So far, attempts to derive inner ear mechanosensitive hair cells and sensory neurons have resulted in inefficient or incomplete phenotypic conversion of stem cells into inner-ear-like cells(3-7). A key insight lacking from these previous studies is the importance of the nonneural and preplacodal ectoderm, two critical precursors during inner ear development(8-11). Here we report the stepwise differentiation of inner ear sensory epithelia from mouse embryonic stem cells (ESCs) in three-dimensional culture(12,13). We show that by recapitulating in vivo development with precise temporal control of signalling pathways, ESC aggregates transform sequentially into non-neural, preplacodal and otic-placode-like epithelia. Notably, in a self-organized process that mimics normal development, vesicles containing prosensory cells emerge from the presumptive otic placodes and give rise to hair cells bearing stereocilia bundles and a kinocilium. Moreover, these stem-cell-derived hair cells exhibit functional properties of native mechanosensitive hair cells and form specialized synapses with sensory neurons that have also arisen from ESCs in the culture. Finally, we demonstrate how these vesicles are structurally and biochemically comparable to developing vestibular end organs. Our data thus establish a new in vitro model of inner ear differentiation that can be used to gain deeper insight into inner ear development and disorder.	[Koehler, Karl R.; Hashino, Eri] Indiana Univ Sch Med, Med Neurosci Grad Program, Indianapolis, IN 46202 USA; [Koehler, Karl R.; Mikosz, Andrew M.; Molosh, Andrei I.; Patel, Dharmeshkumar; Hashino, Eri] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Koehler, Karl R.; Mikosz, Andrew M.; Patel, Dharmeshkumar; Hashino, Eri] Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA; [Molosh, Andrei I.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Hashino, E (corresponding author), Indiana Univ Sch Med, Med Neurosci Grad Program, Indianapolis, IN 46202 USA.	krkoehle@iupui.edu; ehashino@iupui.edu		Koehler, Karl/0000-0002-0685-538X; Molosh, Andrei/0000-0001-6451-7912; Mikosz, Andrew/0000-0002-1235-9948	National Institutes of Health (NIH) [RC1DC010706, R21DC012617, R01GM086544]; Paul and Carole Stark Neurosciences Fellowship; Indiana Clinical and Translational Science Institute Predoctoral Fellowship [NIH TL1RR025759]; NIH [R01MH52619]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC012617, RC1DC010706] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul and Carole Stark Neurosciences Fellowship; Indiana Clinical and Translational Science Institute Predoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors would like to thank G. Oxford for contributing unpublished data and discussion; E. Beans, G. Kamocka, K. Dunn and C. Miller for technical assistance; P. Dolle, R. Romand, J. Williams, J. Meyer, X. Zhang and T. Cummins for comments and discussion; E. Tobin, R. Meadows, J. Hamilton, S. Majumdar and G. Wagner for editorial assistance. This work was supported by National Institutes of Health (NIH) grants RC1DC010706, R21DC012617 and R01GM086544. K. R. K. was supported by a Paul and Carole Stark Neurosciences Fellowship and an Indiana Clinical and Translational Science Institute Predoctoral Fellowship (NIH TL1RR025759). A.I.M. was supported by NIH R01MH52619 (awarded to A. Shekhar).	Bermingham-McDonogh O, 2011, NEURON, V71, P389, DOI 10.1016/j.neuron.2011.07.015; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Brigande JV, 2009, NAT NEUROSCI, V12, P679, DOI 10.1038/nn.2311; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Coate TM, 2012, NEURON, V73, P49, DOI 10.1016/j.neuron.2011.10.029; Desai SS, 2005, J NEUROPHYSIOL, V93, P251, DOI 10.1152/jn.00746.2003; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2012, NAT PROTOC, V7, P69, DOI 10.1038/nprot.2011.429; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Geleoc GSG, 2004, J NEUROSCI, V24, P11148, DOI 10.1523/JNEUROSCI.2662-04.2004; Grocott T, 2012, DEV BIOL, V370, P3, DOI 10.1016/j.ydbio.2012.06.028; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hu ZQ, 2007, P NATL ACAD SCI USA, V104, P16675, DOI 10.1073/pnas.0704576104; JEGALIAN BG, 1992, CELL, V71, P901, DOI 10.1016/0092-8674(92)90387-R; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Koehler KR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-82; Kondo T, 2008, P NATL ACAD SCI USA, V105, P5780, DOI 10.1073/pnas.0708704105; Kwon HJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001133; Kwon HJ, 2009, DEV DYNAM, V238, P1582, DOI 10.1002/dvdy.21955; Ladher RK, 2010, DEVELOPMENT, V137, P1777, DOI 10.1242/dev.040055; Laine H, 2010, DEV BIOL, V337, P134, DOI 10.1016/j.ydbio.2009.10.027; Li A, 2008, J NEUROPHYSIOL, V99, P718, DOI 10.1152/jn.00831.2007; Lysakowski A, 2011, J NEUROSCI, V31, P10101, DOI 10.1523/JNEUROSCI.0521-11.2011; Meyers JR, 2003, J NEUROSCI, V23, P4054; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Oesterle EC, 2008, JARO-J ASSOC RES OTO, V9, P65, DOI 10.1007/s10162-007-0106-7; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Ouji Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.56; Pieper M, 2012, DEVELOPMENT, V139, P1175, DOI 10.1242/dev.074468; Reyes JH, 2008, J NEUROSCI, V28, P12622, DOI 10.1523/JNEUROSCI.0563-08.2008; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Warchol ME, 2009, DEV NEUROBIOL, V69, P191, DOI 10.1002/dneu.20684; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	38	241	258	3	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 8	2013	500	7461					217	+		10.1038/nature12298	http://dx.doi.org/10.1038/nature12298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23842490	Green Accepted			2022-12-01	WOS:000322825500037
J	Smith, PM; Howitt, MR; Panikov, N; Michaud, M; Gallini, CA; Bohlooly-Y, M; Glickman, JN; Garrett, WS				Smith, Patrick M.; Howitt, Michael R.; Panikov, Nicolai; Michaud, Monia; Gallini, Carey Ann; Bohlooly-Y, Mohammad; Glickman, Jonathan N.; Garrett, Wendy S.			The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T-reg Cell Homeostasis	SCIENCE			English	Article							LARGE-INTESTINE; GUT MICROBIOTA; DIVERSITY; INFLAMMATION; INHIBITION; RECEPTOR; PROTECT; MICE	Regulatory T cells (T-regs) that express the transcription factor Foxp3 are critical for regulating intestinal inflammation. Candidate microbe approaches have identified bacterial species and strain-specific molecules that can affect intestinal immune responses, including species that modulate T-reg responses. Because neither all humans nor mice harbor the same bacterial strains, we posited that more prevalent factors exist that regulate the number and function of colonic T-regs. We determined that short-chain fatty acids, gut microbiota-derived bacterial fermentation products, regulate the size and function of the colonic T-reg pool and protect against colitis in a Ffar2-dependent manner in mice. Our study reveals that a class of abundant microbial metabolites underlies adaptive immune microbiota coadaptation and promotes colonic homeostasis and health.	[Smith, Patrick M.; Howitt, Michael R.; Panikov, Nicolai; Michaud, Monia; Gallini, Carey Ann; Garrett, Wendy S.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Smith, Patrick M.; Howitt, Michael R.; Panikov, Nicolai; Michaud, Monia; Gallini, Carey Ann; Garrett, Wendy S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Garrett, Wendy S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Garrett, Wendy S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Garrett, Wendy S.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Bohlooly-Y, Mohammad] AstraZeneca, RAD Transgen, Molndal, Sweden; [Glickman, Jonathan N.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Glickman, Jonathan N.] Miraca Life Sci, Newton, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; AstraZeneca; Harvard University; Harvard Medical School	Garrett, WS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	wgarrett@hsph.harvard.edu		Garrett, Wendy/0000-0002-5092-0150	National Research Service Award (NRSA) [F32DK095506]; NRSA [F32DK098826]; Burroughs Wellcome Career in Medical Sciences Award; Searle Scholars Award; Cancer Research Institute; Harvard University;  [R01CA154426];  [K08AI078942]; NATIONAL CANCER INSTITUTE [R01CA154426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI078942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK098826, P30DK034854, F32DK095506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099537] Funding Source: NIH RePORTER	National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career in Medical Sciences Award; Searle Scholars Award; Cancer Research Institute; Harvard University; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Garrett Lab for discussion, K. Sigrist for embryo rederivation, C. Gallini for genotyping, J. Ramirez for animal husbandry, and A. Rudensky (Memorial Sloan-Kettering Cancer Center) for Foxp3<SUP>YFP-Cre</SUP> mice. A material transfer agreement was required for obtaining Ffar2<SUP>+/-</SUP> embryos from AstraZeneca. The data presented in this study are tabulated in the main paper and the supplementary materials. This study was supported by National Research Service Award (NRSA) F32DK095506 to P. M. S.; NRSA F32DK098826 to M. R. H.; and grants R01CA154426 and K08AI078942, a Burroughs Wellcome Career in Medical Sciences Award, a Searle Scholars Award, and a Cancer Research Institute Investigator Award to W. S. G. A patent (U.S. 61/800,299) was filed with the U.S. Patent and Trademark Office on 15 March 2013 on short chain fatty acids and their regulation of colonic regulatory T cell populations and function by Harvard University, with W. S. G. and P. M. S. as co-inventors. P. M. S., M. R. H., and W. S. G. designed and carried out the experiments and wrote the manuscript; M. M., C. A. G., and N.P. carried out experiments; J.N.G. performed all histological assessment; and M.B.-Y provided Ffar2<SUP>+/-</SUP> embryos.	Atarashi K, 2011, SEMIN IMMUNOL, V23, P146, DOI 10.1016/j.smim.2011.01.010; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Beier UH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002873; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; HOVERSTAD T, 1986, J NUTR, V116, P1772, DOI 10.1093/jn/116.9.1772; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kim SV, 2013, SCIENCE, V340, P1456, DOI 10.1126/science.1237013; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002	25	2809	2970	47	617	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					569	573		10.1126/science.1241165	http://dx.doi.org/10.1126/science.1241165			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23828891	Green Accepted, Green Submitted			2022-12-01	WOS:000322586700059
J	Umesono, Y; Tasaki, J; Nishimura, Y; Hrouda, M; Kawaguchi, E; Yazawa, S; Nishimura, O; Hosoda, K; Inoue, T; Agata, K				Umesono, Yoshihiko; Tasaki, Junichi; Nishimura, Yui; Hrouda, Martina; Kawaguchi, Eri; Yazawa, Shigenobu; Nishimura, Osamu; Hosoda, Kazutaka; Inoue, Takeshi; Agata, Kiyokazu			The molecular logic for planarian regeneration along the anterior-posterior axis	NATURE			English	Article							DOUBLE-STRANDED-RNA; STEM-CELLS; EXPRESSION; POLARITY; BRAIN; GENE; HEAD; HOMOLOG; SYSTEM; REGION	The planarian Dugesia japonica can regenerate a complete individual from a head, trunk or tail fragment via activation of somatic pluripotent stem cells(1,2). About a century ago, Thomas Hunt Morgan attempted to explain the extraordinary regenerative ability of planarians by positing two opposing morphogenetic gradients of formative "head stuff" and "tail stuff" along the anterior-posterior axis(3,4). However, Morgan's hypothesis remains open to debate. Here we show that extracellular signal-related kinase (ERK) and Wnt/beta-catenin signalling pathways establish a solid framework for planarian regeneration. Our data suggest that ERK signalling forms a spatial gradient in the anterior region during regeneration. The fibroblast growth factor receptor-like gene nou-darake(5) (which serves as an output of ERK signalling in the differentiating head) and posteriorly biased beta-catenin activity(6-8) negatively regulate ERK signalling along the anterior-posterior axis in distinct manners, and thereby posteriorize regenerating tissues outside the head region to reconstruct a complete head-to-tail axis. On the basis of this knowledge about D. japonica, we proposed that beta-catenin signalling is responsible for the lack of head-regenerative ability of tail fragments in the planarian Phagocata kawakatsui, and our confirmation thereof supports the notion that posterior beta-catenin signalling negatively modulates the ERK signalling involved in anteriorization across planarian species. These findings suggest that ERK signalling has a pivotal role in triggering globally dynamic differentiation of stem cells in a head-to-tail sequence through a default program that promotes head tissue specification in the absence of posteriorizing signals. Thus, we have confirmed the broad outline of Morgan's hypothesis, and refined it on the basis of our proposed default property of planarian stem cells.	[Umesono, Yoshihiko] RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Umesono, Yoshihiko; Tasaki, Junichi; Nishimura, Yui; Hrouda, Martina; Kawaguchi, Eri; Yazawa, Shigenobu; Nishimura, Osamu; Hosoda, Kazutaka; Inoue, Takeshi; Agata, Kiyokazu] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan	RIKEN; Kyoto University	Umesono, Y (corresponding author), Univ Tokushima, Inst Technol & Sci, Dept Life Syst, 2-1 Minami Jyosanjima Cho, Tokushima 7708506, Japan.	umesono.yoshihiko@tokushima-u.ac.jp	Inoue, Takeshi/S-5623-2019; Yazawa, Shigenobu/E-6395-2014; Nishimura, Osamu/AAC-1236-2020	Inoue, Takeshi/0000-0003-3289-4478; Yazawa, Shigenobu/0000-0003-4539-3875; Nishimura, Osamu/0000-0003-1969-2580; Tasaki, Junichi/0000-0003-1798-5160; Agata, Kiyokazu/0000-0002-5195-2576	Naito Foundation; Sasakawa Scientific Research Grant; JSPS; Kyoto University;  [22124004];  [22124001];  [17GS0318]; Grants-in-Aid for Scientific Research [22124004] Funding Source: KAKEN	Naito Foundation(Naito Memorial Foundation); Sasakawa Scientific Research Grant; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kyoto University; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank C. Hashimoto for discussions and comments. We also thank E. Nakajima and A. Alie for critical reading of the manuscript, Y. Saito for illustrations, and all of our other laboratory members for their help and encouragement. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas to Y.U. (22124004), a Grant-in-Aid for Scientific Research on Innovative Areas to K.A. (22124001), a Grant-in-Aid for Creative Scientific Research to K.A. (17GS0318), Global COE Program A06 of Kyoto University, the Naito Foundation, a Sasakawa Scientific Research Grant, and a JSPS Research Fellowship to J.T.	Agata K, 2003, DEV DYNAM, V226, P308, DOI 10.1002/dvdy.10249; Agata K, 2008, PHILOS T R SOC B, V363, P2071, DOI 10.1098/rstb.2008.2260; Agata K, 2007, DEV GROWTH DIFFER, V49, P73, DOI 10.1111/j.1440-169x.2007.00919.x; Agata K, 2012, DEV GROWTH DIFFER, V54, P143, DOI 10.1111/j.1440-169X.2011.01323.x; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; Kobayashi C, 1999, MECH DEVELOP, V89, P25, DOI 10.1016/S0925-4773(99)00192-6; Koinuma S, 2000, GENE, V259, P171, DOI 10.1016/S0378-1119(00)00426-1; LAWRENCE PA, 1988, CELL, V54, P1, DOI 10.1016/0092-8674(88)90172-9; Morgan TH, 1904, ARCH ENTWICKLUNG ORG, V17, P683, DOI 10.1007/BF02161815; Morgan TM, 1905, J EXP ZOOL, V2, P495, DOI 10.1002/jez.1400020404; Nishimura K, 2007, DEV NEUROBIOL, V67, P1059, DOI 10.1002/dneu.20377; Nogi T, 2001, DEV GROWTH DIFFER, V43, P177; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; Rouhana L, 2013, DEV DYNAM, V242, P718, DOI 10.1002/dvdy.23950; Shibata N, 2010, DEV GROWTH DIFFER, V52, P27, DOI 10.1111/j.1440-169X.2009.01155.x; Takano T, 2007, DEV GROWTH DIFFER, V49, P383, DOI 10.1111/j.1440-169x.2007.00936.x; Tasaki J, 2011, DEVELOPMENT, V138, P2417, DOI 10.1242/dev.060764; Umesono Y, 1997, DEV GROWTH DIFFER, V39, P723; Umesono Y, 2009, DEV GROWTH DIFFER, V51, P185, DOI 10.1111/j.1440-169X.2009.01099.x; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Yazawa S, 2009, P NATL ACAD SCI USA, V106, P22329, DOI 10.1073/pnas.0907464106	25	119	121	0	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2013	500	7460					73	U93		10.1038/nature12359	http://dx.doi.org/10.1038/nature12359			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23883928				2022-12-01	WOS:000322514800030
J	Lupski, JR				Lupski, James R.			Genome Mosaicism-One Human, Multiple Genomes	SCIENCE			English	Editorial Material							L1 RETROTRANSPOSITION; HUMAN BRAIN; STEM-CELLS; ARRAY CGH; RECOMBINATION; EMBRYOS		[Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room 604B, Houston, TX 77030 USA.	jlupski@bcm.edu						Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Balliff BC, 2006, AM J MED GENET A, V140A, P2757, DOI 10.1002/ajmg.a.31539; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Cheung SW, 2007, AM J MED GENET A, V143A, P1679, DOI 10.1002/ajmg.a.31740; Conlin LK, 2010, HUM MOL GENET, V19, P1263, DOI 10.1093/hmg/ddq003; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Flores M, 2007, P NATL ACAD SCI USA, V104, P6099, DOI 10.1073/pnas.0701631104; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Liang Q, 2008, P NATL ACAD SCI USA, V105, P17453, DOI 10.1073/pnas.0805638105; Macosko EZ, 2012, NAT GENET, V44, P614, DOI 10.1038/ng.2311; Mertzanidou A, 2013, HUM REPROD, V28, P256, DOI 10.1093/humrep/des362; Mizuno K, 2013, NATURE, V493, P246, DOI 10.1038/nature11676; O'Huallachain M, 2012, P NATL ACAD SCI USA, V109, P18018, DOI 10.1073/pnas.1213736109; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Robberecht C, 2013, GENOME RES, V23, P411, DOI 10.1101/gr.145631.112; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924	17	116	120	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					358	359		10.1126/science.1239503	http://dx.doi.org/10.1126/science.1239503			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888031				2022-12-01	WOS:000322259200037
J	Ackerman, M; Alter, G				Ackerman, Margaret; Alter, Galit			Mapping the Journey to an HIV Vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BROAD		[Ackerman, Margaret] Dartmouth Coll, Sch Engn, Hanover, NH 03755 USA; [Alter, Galit] MIT, Ragon Inst, Massachusetts Gen Hosp, Cambridge, MA 02139 USA; [Alter, Galit] Harvard Univ, Cambridge, MA 02138 USA	Dartmouth College; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Ackerman, M (corresponding author), Dartmouth Coll, Sch Engn, Hanover, NH 03755 USA.							Jardine J, 2013, SCIENCE; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930	5	14	14	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					389	391		10.1056/NEJMcibr1304437	http://dx.doi.org/10.1056/NEJMcibr1304437			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188VJ	23883384				2022-12-01	WOS:000322223900016
J	Prado-Martinez, J; Sudmant, PH; Kidd, JM; Li, H; Kelley, JL; Lorente-Galdos, B; Veeramah, KR; Woerner, AE; O'Connor, TD; Santpere, G; Cagan, A; Theunert, C; Casals, F; Laayouni, H; Munch, K; Hobolth, A; Halager, AE; Malig, M; Hernandez-Rodriguez, J; Hernando-Herraez, I; Prufer, K; Pybus, M; Johnstone, L; Lachmann, M; Alkan, C; Twigg, D; Petit, N; Baker, C; Hormozdiari, F; Fernandez-Callejo, M; Dabad, M; Wilson, ML; Stevison, L; Camprubi, C; Carvalho, T; Ruiz-Herrera, A; Vives, L; Mele, M; Abello, T; Kondova, I; Bontrop, RE; Pusey, A; Lankester, F; Kiyang, JA; Bergl, RA; Lonsdorf, E; Myers, S; Ventura, M; Gagneux, P; Comas, D; Siegismund, H; Blanc, J; Agueda-Calpena, L; Gut, M; Fulton, L; Tishkoff, SA; Mullikin, JC; Wilson, RK; Gut, IG; Gonder, MK; Ryder, OA; Hahn, BH; Navarro, A; Akey, JM; Bertranpetit, J; Reich, D; Mailund, T; Schierup, MH; Hvilsom, C; Andres, AM; Wall, JD; Bustamante, CD; Hammer, MF; Eichler, EE; Marques-Bonet, T				Prado-Martinez, Javier; Sudmant, Peter H.; Kidd, Jeffrey M.; Li, Heng; Kelley, Joanna L.; Lorente-Galdos, Belen; Veeramah, Krishna R.; Woerner, August E.; O'Connor, Timothy D.; Santpere, Gabriel; Cagan, Alexander; Theunert, Christoph; Casals, Ferran; Laayouni, Hafid; Munch, Kasper; Hobolth, Asger; Halager, Anders E.; Malig, Maika; Hernandez-Rodriguez, Jessica; Hernando-Herraez, Irene; Pruefer, Kay; Pybus, Marc; Johnstone, Laurel; Lachmann, Michael; Alkan, Can; Twigg, Dorina; Petit, Natalia; Baker, Carl; Hormozdiari, Fereydoun; Fernandez-Callejo, Marcos; Dabad, Marc; Wilson, Michael L.; Stevison, Laurie; Camprubi, Cristina; Carvalho, Tiago; Ruiz-Herrera, Aurora; Vives, Laura; Mele, Marta; Abello, Teresa; Kondova, Ivanela; Bontrop, Ronald E.; Pusey, Anne; Lankester, Felix; Kiyang, John A.; Bergl, Richard A.; Lonsdorf, Elizabeth; Myers, Simon; Ventura, Mario; Gagneux, Pascal; Comas, David; Siegismund, Hans; Blanc, Julie; Agueda-Calpena, Lidia; Gut, Marta; Fulton, Lucinda; Tishkoff, Sarah A.; Mullikin, James C.; Wilson, Richard K.; Gut, Ivo G.; Gonder, Mary Katherine; Ryder, Oliver A.; Hahn, Beatrice H.; Navarro, Arcadi; Akey, Joshua M.; Bertranpetit, Jaume; Reich, David; Mailund, Thomas; Schierup, Mikkel H.; Hvilsom, Christina; Andres, Aida M.; Wall, Jeffrey D.; Bustamante, Carlos D.; Hammer, Michael F.; Eichler, Evan E.; Marques-Bonet, Tomas			Great ape genetic diversity and population history	NATURE			English	Article							HUMAN GENOME; CHIMPANZEE GENOME; SEQUENCE; EVOLUTION; SELECTION; PATTERNS; DECLINE	Most great ape genetic variation remains uncharacterized(1,2); however, its study is critical for understanding population history(3-6), recombination(7), selection(8) and susceptibility to disease(9,10). Here we sequence to high coverage a total of 79 wild-and captive-born individuals representing all six great ape species and seven subspecies and report 88.8 million single nucleotide polymorphisms. Our analysis provides support for genetically distinct populations within each species, signals of gene flow, and the split of common chimpanzees into two distinct groups: Nigeria-Cameroon/western and central/eastern populations. We find extensive inbreeding in almost all wild populations, with eastern gorillas being the most extreme. Inferred effective population sizes have varied radically over time in different lineages and this appears to have a profound effect on the genetic diversity at, or close to, genes in almost all species. We discover and assign 1,982 loss-of-function variants throughout the human and great ape lineages, determining that the rate of gene loss has not been different in the human branch compared to other internal branches in the great ape phylogeny. This comprehensive catalogue of great ape genome diversity provides a framework for understanding evolution and a resource for more effective management of wild and captive great ape populations.	[Prado-Martinez, Javier; Lorente-Galdos, Belen; Santpere, Gabriel; Casals, Ferran; Laayouni, Hafid; Hernandez-Rodriguez, Jessica; Hernando-Herraez, Irene; Pybus, Marc; Petit, Natalia; Fernandez-Callejo, Marcos; Dabad, Marc; Carvalho, Tiago; Mele, Marta; Comas, David; Navarro, Arcadi; Bertranpetit, Jaume; Marques-Bonet, Tomas] Univ Pompeu Fabra, Inst Biol Evolut, CSIC, PRBB, Barcelona 08003, Catalonia, Spain; [Sudmant, Peter H.; O'Connor, Timothy D.; Malig, Maika; Baker, Carl; Hormozdiari, Fereydoun; Vives, Laura; Akey, Joshua M.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kidd, Jeffrey M.; Twigg, Dorina] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Kidd, Jeffrey M.; Kelley, Joanna L.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Li, Heng; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Veeramah, Krishna R.; Woerner, August E.; Johnstone, Laurel; Hammer, Michael F.] Univ Arizona, Div Biotechnol, Arizona Res Labs, Tucson, AZ 85721 USA; [Cagan, Alexander; Theunert, Christoph; Pruefer, Kay; Lachmann, Michael; Andres, Aida M.] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Munch, Kasper; Hobolth, Asger; Halager, Anders E.; Mailund, Thomas; Schierup, Mikkel H.] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus C, Denmark; [Alkan, Can] Bilkent Univ, Fac Engn, TR-06800 Ankara, Turkey; [Wilson, Michael L.] Univ Minnesota, Dept Anthropol, Minneapolis, MN 55455 USA; [Stevison, Laurie; Wall, Jeffrey D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Camprubi, Cristina; Ruiz-Herrera, Aurora] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Cerdanyola Del Valles 08193, Catalonia, Spain; [Ruiz-Herrera, Aurora] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Cerdanyola Del Valles 08193, Catalonia, Spain; [Abello, Teresa] Parc Zool Barcelona, Barcelona 08003, Catalonia, Spain; [Kondova, Ivanela; Bontrop, Ronald E.] Biomed Primate Res Ctr, NL-2280 GH Rijswijk, Netherlands; [Pusey, Anne] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Lankester, Felix; Kiyang, John A.] Limbe Wildlife Ctr, Limbe, Cameroon; [Lankester, Felix] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Bergl, Richard A.] North Carolina Zool Pk, Asheboro, NC 27205 USA; [Lonsdorf, Elizabeth] Franklin & Marshall Coll, Dept Psychol, Lancaster, PA 17604 USA; [Myers, Simon] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Ventura, Mario] Univ Bari, Dept Genet & Microbiol, I-70126 Bari, Italy; [Gagneux, Pascal] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Siegismund, Hans; Hvilsom, Christina] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Blanc, Julie; Agueda-Calpena, Lidia; Gut, Marta; Gut, Ivo G.] PCB, Ctr Nacl Anal Genom CNAG, Barcelona 08028, Catalonia, Spain; [Fulton, Lucinda; Wilson, Richard K.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; [Tishkoff, Sarah A.] Univ Penn, Dept Biol & Genet, Philadelphia, PA 19104 USA; [Mullikin, James C.] NIH, Intramural Sequencing Ctr NISC, Bethesda, MD 20892 USA; [Gonder, Mary Katherine] SUNY Albany, Albany, NY 12222 USA; [Ryder, Oliver A.] San Diego Zoo, Genet Div, Inst Conservat Res, Escondido, CA 92027 USA; [Hahn, Beatrice H.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hahn, Beatrice H.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Navarro, Arcadi] UPF, Inst Nacl Bioinformat, Barcelona 08003, Catalonia, Spain; [Navarro, Arcadi; Marques-Bonet, Tomas] ICREA, Barcelona 08010, Catalonia, Spain; [Schierup, Mikkel H.] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark; [Hvilsom, Christina] Copenhagen Zoo, DK-2000 Frederiksberg, Denmark; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Stanford University; Harvard University; Harvard Medical School; University of Arizona; Max Planck Society; Aarhus University; Ihsan Dogramaci Bilkent University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; Autonomous University of Barcelona; Autonomous University of Barcelona; Duke University; Washington State University; Franklin & Marshall College; University of Oxford; Universita degli Studi di Bari Aldo Moro; University of California System; University of California San Diego; University of Copenhagen; University of Barcelona; Washington University (WUSTL); University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); State University of New York (SUNY) System; State University of New York (SUNY) Albany; Zoological Society of San Diego; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Pompeu Fabra University; ICREA; Aarhus University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Marques-Bonet, T (corresponding author), Univ Pompeu Fabra, Inst Biol Evolut, CSIC, PRBB, Doctor Aiguader 88, Barcelona 08003, Catalonia, Spain.	eee@gs.washington.edu; tomas.marques@upf.edu	Marques-Bonet, Tomas/I-4618-2014; Kelley, Joanna L/H-1693-2012; Schierup, Mikkel Heide/AAM-4997-2020; Casals, Ferran/H-4347-2015; Prado-Martinez, Javier/AAA-6341-2020; Marty, Natalia Petit/AAI-7449-2021; Comas, David/D-5382-2014; Andres, Aida/B-4088-2014; Gut, Ivo/ABF-3188-2020; Marques-Bonet, Tomas/ABF-3734-2020; Dabad, Marc/Q-9601-2019; hernando-herraez, irene/AAO-5832-2020; Santpere, Gabriel/I-9437-2014; Munch, Kasper/A-1434-2010; Ruiz-Herrera, Aurora/K-3728-2012; Laayouni, Hafid/AAA-9254-2019; Navarro, Arcadi/F-1592-2011; Wilson, Richard K./AAF-4139-2019; Bertranpetit, Jaume/F-8550-2012; Hernando-Herraez, Irene/ABH-8676-2020; Stevison, Laurie/F-2881-2010; Myers, Simon R/A-6792-2015; Wilson, Michael Lawrence/AAC-9154-2020; Schierup, Mikkel H/F-1675-2010; Bontrop, Ronald E/J-3628-2012; Siegismund, Hans R./K-4332-2014; Alkan, Can/D-2982-2009; Dabad, Marc/M-9522-2015; Ventura, Mario/E-6420-2011	Marques-Bonet, Tomas/0000-0002-5597-3075; Kelley, Joanna L/0000-0002-7731-605X; Schierup, Mikkel Heide/0000-0002-5028-1790; Casals, Ferran/0000-0002-8941-0369; Prado-Martinez, Javier/0000-0001-5402-2721; Marty, Natalia Petit/0000-0002-3810-1152; Comas, David/0000-0002-5075-0956; Andres, Aida/0000-0002-8590-9672; Marques-Bonet, Tomas/0000-0002-5597-3075; Dabad, Marc/0000-0002-6094-747X; Santpere, Gabriel/0000-0001-5909-8637; Munch, Kasper/0000-0003-2880-6252; Ruiz-Herrera, Aurora/0000-0003-3868-6151; Laayouni, Hafid/0000-0003-1297-5078; Navarro, Arcadi/0000-0003-2162-8246; Wilson, Richard K./0000-0002-1992-1358; Bertranpetit, Jaume/0000-0003-0100-0590; Hernando-Herraez, Irene/0000-0003-1193-8419; Stevison, Laurie/0000-0001-7900-5266; Myers, Simon R/0000-0002-2585-9626; Wilson, Michael Lawrence/0000-0003-3073-4518; Schierup, Mikkel H/0000-0002-5028-1790; Bontrop, Ronald E/0000-0003-0874-6467; Siegismund, Hans R./0000-0001-5757-3131; Alkan, Can/0000-0002-5443-0706; Dabad, Marc/0000-0002-6094-747X; Lankester, Felix/0000-0002-0802-0693; Mailund, Thomas/0000-0001-6206-9239; Hvilsom, Christina/0000-0001-7870-6888; Gut, Ivo/0000-0001-7219-632X; Akey, Joshua/0000-0002-4411-1330; Bustamante, Carlos D./0000-0002-4187-7920; Johnstone, Laurel/0000-0001-7335-3972; Lorente-Galdos, Belen/0000-0001-5390-2452; Sudmant, Peter/0000-0002-9573-8248; Hormozdiari, Fereydoun/0000-0003-2703-9274; Hobolth, Asger/0000-0003-4056-1286; Ventura, Mario/0000-0001-7762-8777; Cagan, Alex/0000-0002-7857-4771; O'Connor, Timothy/0000-0002-0276-1896; Carvalho, Tiago/0000-0002-8943-8732; Hernandez-Rodriguez, Jessica/0000-0002-0402-286X; Kidd, Jeffrey/0000-0002-9631-1465; Hahn, Beatrice/0000-0002-9400-9887; Pybus, Marc/0000-0002-6195-5738; mele, marta/0000-0001-8874-6453; Pusey, Anne/0000-0002-2280-8954	ERC [260372]; NIH [HG002385, R01_HG005226, GM100233]; NSF HOMINID [1032255]; MICINN(Spain) [BFU2011-28549, BFU2010-19443]; Spanish Government; FEDER [BFU2009-13409-C02-02, BFU2012-38236]; Direccio General de Recerca, Generalitat de Catalunya [2009 SGR 1101]; ERC Advanced Grant [233297]; Max Planck Society; Danish Council for Independent Research Natural Sciences; Zoo de Barcelona (Beca PRIC); EUPRIM-Net; NSF [0755823]; G. Harold and Leila Y. Mathers Foundation; HHMI;  [CGL-2010-20170];  [DP1ES022577-04 NIH]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005226, ZIAHG200330, R01HG002385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES022577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233, R01GM095882] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	ERC(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF HOMINID; MICINN(Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Government(Spanish GovernmentEuropean Commission); FEDER(European Commission); Direccio General de Recerca, Generalitat de Catalunya(Generalitat de Catalunya); ERC Advanced Grant(European Research Council (ERC)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Danish Council for Independent Research Natural Sciences(Det Frie Forskningsrad (DFF)); Zoo de Barcelona (Beca PRIC); EUPRIM-Net; NSF(National Science Foundation (NSF)); G. Harold and Leila Y. Mathers Foundation; HHMI(Howard Hughes Medical Institute); ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)	We thank the following funding agencies: ERC Starting Grant (260372) to T.M.-B.; NIH grants HG002385 to E. E. E., R01_HG005226 to K. R. V., A. E. W., M. F. H., L. S. and J.D.W., GM100233 and NSF HOMINID grant 1032255 to D. R. and He.Li.; MICINN(Spain) BFU2011-28549to T.M.-B., BFU2010-19443to Ja.Be., Spanish Government and FEDER for grants BFU2009-13409-C02-02 and BFU2012-38236 to A.N. and J.P.-M., Direccio General de Recerca, Generalitat de Catalunya (Grup de Recerca Consolidat 2009 SGR 1101) to Ja.Be., D. C., A.N. and T.M.-B.; ERC Advanced Grant (233297) and Max Planck Society to S. Paabo; Danish Council for Independent Research Natural Sciences to H. S.; Spanish Grant (CGL-2010-20170) and Zoo de Barcelona (Beca PRIC) to A. R.-H.; EUPRIM-Net to BPRC; DP1ES022577-04 NIH grant to S. A. T.; NSF Grant 0755823 to M. K. G.; P. G. is supported by the G. Harold and Leila Y. Mathers Foundation. A. N. and T. M.-B. are ICREA Research Investigators (Institut Catala d'Estudis i RecercaAvancats delaGeneralitat de Catalunya). J. P.-M. is supported by the Zoo de Barcelona and l'Ajuntament de Barcelona. P. H. S. is supported by an HHMI International Student Fellowship. E. E. E. is an investigator with the Howard Hughes Medical Institute. We are especially grateful to all those who generously provided the samples for the project: O. Thalmann and H. Siedel from Limbe Sanctuary; R. Garriga from Tacugama Sanctuary; W. Schempp (University of Freiburg), Burgers' Zoo; Zoo of Antwerp; Wilhelma Zoo; Givskud Zoo; Ngamba Island Chimpanzee Sanctuary and Centre de Primatologie; Centre International de Recherches Medicales de Franceville; North Carolina Zoological Park; Zoo Atlanta; the Lincoln Park Zoo (Chicago); the Antwerp Zoo and the Limbe Wildlife Centre (Cameroon); D. Travis from University of Minnesota and M. Kinsel from University of Illinois Urbana-Champaign and S. Paabo and L. Vigilant, Max Planck Institute for Evolutionary Anthropology. We thank T. Brown for revising the manuscript, L. Capilla and E. Eyras for technical support, and M. Dierssen for comments on genes expressed in the brain.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Beaumont MA, 2002, GENETICS, V162, P2025; Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Bjork A, 2011, MOL BIOL EVOL, V28, P615, DOI 10.1093/molbev/msq227; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Campbell G, 2008, CURR BIOL, V18, pR903, DOI 10.1016/j.cub.2008.08.015; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gonder MK, 2011, P NATL ACAD SCI USA, V108, P4766, DOI 10.1073/pnas.1015422108; Gonder MK, 1997, NATURE, V388, P337, DOI 10.1038/41005; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hammer MF, 2010, NAT GENET, V42, P830, DOI 10.1038/ng.651; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Junker J, 2012, DIVERS DISTRIB, V18, P1077, DOI 10.1111/ddi.12005; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mailund T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003125; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Nsubuga AM, 2010, CONSERV GENET, V11, P161, DOI 10.1007/s10592-009-0015-x; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Pool JE, 2007, EVOLUTION, V61, P3001, DOI 10.1111/j.1558-5646.2007.00238.x; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052	30	511	520	3	331	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2013	499	7459					471	475		10.1038/nature12228	http://dx.doi.org/10.1038/nature12228			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23823723	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-01	WOS:000322157900039
J	Zeng, H; Yang, K; Cloer, C; Neale, G; Vogel, P; Chi, HB				Zeng, Hu; Yang, Kai; Cloer, Caryn; Neale, Geoffrey; Vogel, Peter; Chi, Hongbo			mTORC1 couples immune signals and metabolic programming to establish T-reg-cell function	NATURE			English	Article							CUTTING EDGE; DIFFERENTIATION; ACTIVATION; EFFECTOR; DISEASE; CTLA-4; AKT; SUPPRESSION; HOMEOSTASIS; EXPRESSION	The mechanistic target of rapamycin (mTOR) pathway integrates diverse environmental inputs, including immune signals and metabolic cues, to direct T-cell fate decisions(1). The activation of mTOR, which is the catalytic subunit of the mTORC1 and mTORC2 complexes, delivers an obligatory signal for the proper activation and differentiation of effector CD4(+) T cells(2,3), whereas in the regulatory T-cell (T-reg) compartment, the Akt-mTOR axis is widely acknowledged as a crucial negative regulator of T-reg-cell de novo differentiation(4-8) and population expansion(9). However, whether mTOR signalling affects the homeostasis and function of T-reg cells remains largely unexplored. Here we show that mTORC1 signalling is a pivotal positive determinant of T-reg-cell function in mice. T-reg cells have elevated steady-state mTORC1 activity compared to naive T cells. Signals through the T-cell antigen receptor (TCR) and interleukin-2 (IL-2) provide major inputs for mTORC1 activation, which in turn programs the suppressive function of T-reg cells. Disruption of mTORC1 through T-reg-specific deletion of the essential component raptor leads to a profound loss of T-reg-cell suppressive activity in vivo and the development of a fatal early onset inflammatory disorder. Mechanistically, raptor/mTORC1 signalling in T-reg cells promotes cholesterol and lipid metabolism, with the mevalonate pathway particularly important for coordinating T-reg-cell proliferation and upregulation of the suppressive molecules CTLA4 and ICOS to establish T-reg-cell functional competency. By contrast, mTORC1 does not directly affect the expression of Foxp3 or anti-and pro-inflammatory cytokines in T-reg cells, suggesting a non-conventional mechanism for T-reg-cell functional regulation. Finally, we provide evidence that mTORC1 maintains T-reg-cell function partly through inhibiting the mTORC2 pathway. Our results demonstrate that mTORC1 acts as a fundamental 'rheostat' in T-reg cells to link immunological signals from TCR and IL-2 to lipogenic pathways and functional fitness, and highlight a central role of metabolic programming of T-reg-cell suppressive activity in immune homeostasis and tolerance.	[Zeng, Hu; Yang, Kai; Cloer, Caryn; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	Vogel, Peter/N-2490-2018; Zeng, Hu/AAA-2706-2020; Chi, Hongbo/M-9397-2018	Vogel, Peter/0000-0002-7535-0545; Zeng, Hu/0000-0002-9909-7732; Chi, Hongbo/0000-0002-9997-2496	US National Institutes of Health [K01 AR053573, R21 AI094089, R01 AI101407, R01 NS064599]; Lupus Research Institute; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101407, R21AI094089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR053573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064599] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Institute; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Rudensky for Foxp3<SUP>YFP-Cre</SUP> mice, D. Green for help with metabolic assays, N. Brydon for animal colony management, Y. Wang for editing of the manuscript, and the St Jude Immunology FACS core facility for cell sorting. This work was supported by the US National Institutes of Health (K01 AR053573, R21 AI094089, R01 AI101407 and R01 NS064599), the Lupus Research Institute, and the American Lebanese Syrian Associated Charities (all to H.C.).	Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Corse E, 2012, J IMMUNOL, V189, P1123, DOI 10.4049/jimmunol.1200695; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kanangat S, 1996, EUR J IMMUNOL, V26, P161, DOI 10.1002/eji.1830260125; Kelly AP, 2007, EMBO J, V26, P3441, DOI 10.1038/sj.emboj.7601761; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tai XG, 2012, BLOOD, V119, P5155, DOI 10.1182/blood-2011-11-388918; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068	32	520	544	4	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					485	+		10.1038/nature12297	http://dx.doi.org/10.1038/nature12297			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23812589	Green Accepted			2022-12-01	WOS:000322157900042
J	Marsden, G; Perry, M; Kelley, K; Davies, AH				Marsden, Grace; Perry, Mark; Kelley, Kate; Davies, Alun H.		Guideline Dev Grp	GUIDELINES Diagnosis and management of varicose veins in the legs: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POPULATION; PREVALENCE		[Marsden, Grace; Perry, Mark; Kelley, Kate] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Davies, Alun H.] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Vasc Surg Sect, London W6 8RF, England	Royal College of Physicians; Imperial College London	Marsden, G (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	grace.marsden@rcplondon.ac.uk	Hampson, Grace/M-4470-2014	Hampson, Grace/0000-0002-2019-1268; Wonderling, David/0000-0003-0315-6273				Bergan JJ, 2006, NEW ENGL J MED, V355, P488, DOI 10.1056/NEJMra055289; Carpentier PH, 2004, J VASC SURG, V40, P650, DOI 10.1016/j.jvs.2004.07.025; Evans CJ, 1999, J EPIDEMIOL COMMUN H, V53, P149, DOI 10.1136/jech.53.3.149; Lim CS, 2010, PHLEBOLOGY, V25, P184, DOI 10.1258/phleb.2009.009035; National Institute for Health and Care Excellence, 2013, CLIN GUID, V168; National Institute for Health and Clinical Excellence, 2003, INT PROC GUID, V8; National Institute for Health and Clinical Excellence, 2004, INT PROC GUID, V52; National Institute for Health and Clinical Excellence, 2008, CLIN GUID, V62; National Institute for Health and Clinical Excellence, 2006, CLIN GUID, V43; National Institute for Health and Clinical Excellence, 2013, INT PROC GUID, V440; Shepherd AC, 2011, J VASC SURG, V53, P374, DOI 10.1016/j.jvs.2010.09.022; Smith JJ, 1999, J VASC SURG, V30, P710, DOI 10.1016/S0741-5214(99)70110-2	12	103	105	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2013	347								f4279	10.1136/bmj.f4279	http://dx.doi.org/10.1136/bmj.f4279			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193BM	23884969				2022-12-01	WOS:000322531800001
J	Keenan, TF; Hollinger, DY; Bohrer, G; Dragoni, D; Munger, JW; Schmid, HP; Richardson, AD				Keenan, Trevor F.; Hollinger, David Y.; Bohrer, Gil; Dragoni, Danilo; Munger, J. William; Schmid, Hans Peter; Richardson, Andrew D.			Increase in forest water-use efficiency as atmospheric carbon dioxide concentrations rise	NATURE			English	Article							NET ECOSYSTEM EXCHANGE; STOMATAL CONDUCTANCE; CO2; RESPONSES; PHOTOSYNTHESIS; PRODUCTIVITY; LESSONS; PLANT; LAND; FLUX	Terrestrial plants remove CO2 from the atmosphere through photosynthesis, a process that is accompanied by the loss of water vapour from leaves(1). The ratio of water loss to carbon gain, or water-use efficiency, is a key characteristic of ecosystem function that is central to the global cycles of water, energy and carbon(2). Here we analyse direct, long-term measurements of whole-ecosystem carbon and water exchange(3). We find a substantial increase in water-use efficiency in temperate and boreal forests of the Northern Hemisphere over the past two decades. We systematically assess various competing hypotheses to explain this trend, and find that the observed increase is most consistent with a strong CO2 fertilization effect. The results suggest a partial closure of stomata(1)-small pores on the leaf surface that regulate gas exchange-to maintain a near-constant concentration of CO2 inside the leaf even under continually increasing atmospheric CO2 levels. The observed increase in forest water-use efficiency is larger than that predicted by existing theory and 13 terrestrial biosphere models. The increase is associated with trends of increasing ecosystem-level photosynthesis and net carbon uptake, and decreasing evapotranspiration. Our findings suggest a shift in the carbon-and water-based economics of terrestrial vegetation, which may require a reassessment of the role of stomatal control in regulating interactions between forests and climate change, and a re-evaluation of coupled vegetation-climate models.	[Keenan, Trevor F.; Richardson, Andrew D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Hollinger, David Y.] US Forest Serv, No Res Stn, Durham, NH 03824 USA; [Bohrer, Gil] Ohio State Univ, Dept Civil Environm & Geodet Engn, Columbus, OH 43210 USA; [Dragoni, Danilo] Indiana Univ, Dept Geog, Bloomington, IN 47405 USA; [Munger, J. William] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Munger, J. William] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Schmid, Hans Peter] Karlsruhe Inst Technol, Inst Meteorol & Climate Res, IMK IFU, D-82467 Garmisch Partenkirchen, Germany	Harvard University; United States Department of Agriculture (USDA); United States Forest Service; University System of Ohio; Ohio State University; Indiana University System; Indiana University Bloomington; Harvard University; Harvard University; Helmholtz Association; Karlsruhe Institute of Technology	Keenan, TF (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	tkeenan@oeb.harvard.edu; arichardson@oeb.harvard.edu	Schmid, Hans Peter/AAP-4450-2021; Bohrer, Gil/A-9731-2008; Hollinger, David Y/G-7185-2012; Munger, J William/H-4502-2013; Richardson, Andrew/F-5691-2011; Keenan, Trevor F./B-2744-2010; Keenan, Trevor/AAY-7786-2020; Schmid, Hans Peter E/I-1224-2012	Schmid, Hans Peter/0000-0001-9076-4466; Bohrer, Gil/0000-0002-9209-9540; Munger, J William/0000-0002-1042-8452; Richardson, Andrew/0000-0002-0148-6714; Keenan, Trevor F./0000-0002-3347-0258; Keenan, Trevor/0000-0002-3347-0258; Schmid, Hans Peter E/0000-0001-9076-4466	NOAA Climate Program Office, Global Carbon Cycle Program [NA11OAR4310054]; Office of Science (Biological and Environmental Research), US Department of Energy; National Science Foundation [DEB-0911461, DEB-1114804]; US Department of Energy, Biological and Environmental Research, Terrestrial Carbon Program [DE-FG02-04ER63917, DE-FG02-04ER63911, DE-SC0006708]; CFCAS; NSERC; BIOCAP; Environment Canada; NRCan; CarboEuropeIP; FAO-GTOS-TCO; iLEAPS; Max-Planck Institute for Biogeochemistry; University of Tuscia; Universite Laval and Environment Canada; US Department of Energy; USDA Forest Service's Northern Research Station; Office of Science (BER), US Department of Energy; Direct For Biological Sciences [1114804] Funding Source: National Science Foundation; Division Of Environmental Biology [0911461, 1237491] Funding Source: National Science Foundation	NOAA Climate Program Office, Global Carbon Cycle Program; Office of Science (Biological and Environmental Research), US Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Biological and Environmental Research, Terrestrial Carbon Program(United States Department of Energy (DOE)); CFCAS; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); BIOCAP; Environment Canada(CGIAR); NRCan(Natural Resources Canada); CarboEuropeIP(European Commission); FAO-GTOS-TCO; iLEAPS; Max-Planck Institute for Biogeochemistry; University of Tuscia; Universite Laval and Environment Canada; US Department of Energy(United States Department of Energy (DOE)); USDA Forest Service's Northern Research Station; Office of Science (BER), US Department of Energy(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the NOAA Climate Program Office, Global Carbon Cycle Program (award NA11OAR4310054) and the Office of Science (Biological and Environmental Research), US Department of Energy. G. B. acknowledges a grant from the National Science Foundation (grant number DEB-0911461). This work used eddy covariance data acquired by the FLUXNET community and in particular by the AmeriFlux, CarboEuropeIP and Fluxnet-Canada networks. AmeriFlux was supported by the US Department of Energy, Biological and Environmental Research, Terrestrial Carbon Program (grant numbers DE-FG02-04ER63917 and DE-FG02-04ER63911, DE-SC0006708) and Fluxnet-Canada was supported by CFCAS, NSERC, BIOCAP, Environment Canada and NRCan. We acknowledge financial support of the eddy covariance data harmonization provided by CarboEuropeIP, FAO-GTOS-TCO, iLEAPS, the Max-Planck Institute for Biogeochemistry, National Science Foundation, University of Tuscia, Universite Laval and Environment Canada and US Department of Energy and of the database development and technical support from Berkeley Water Center, Lawrence Berkeley National Laboratory, Microsoft Research eScience, Oak Ridge National Laboratory, University of California-Berkeley, University of Virginia. We thank all those involved in the NACP Site Synthesis, inparticular the modelling teams who provided model output. Research at the Bartlett Experimental Forest tower is supported by the National Science Foundation (grant DEB-1114804), and the USDA Forest Service's Northern Research Station. Research at Howland Forest is supported by the Office of Science (BER), US Department of Energy. Carbon flux and biometric measurements at Harvard Forest have been supported by the Office of Science (BER), US Department of Energy and the National Science Foundation Long-Term Ecological Research programmes. We thank S. Ollinger and S. Frey for maintaining the long-term leaf nitrogen measurements at Harvard Forest, and B. Yang for providing gap-filled meteorological data for the regional focus sites.	Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Ballantyne AP, 2012, NATURE, V488, P70, DOI 10.1038/nature11299; Battipaglia G, 2013, NEW PHYTOL, V197, P544, DOI 10.1111/nph.12044; Beer C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003233; Bernacchi CJ, 2007, PLANT PHYSIOL, V143, P134, DOI 10.1104/pp.106.089557; Berry JA, 2010, CURR OPIN PLANT BIOL, V13, P232, DOI 10.1016/j.pbi.2010.04.013; Betts RA, 2007, NATURE, V448, P1037, DOI 10.1038/nature06045; Buckley TN, 2008, J EXP BOT, V59, P1951, DOI 10.1093/jxb/erm234; Desai AR, 2008, AGR FOREST METEOROL, V148, P821, DOI 10.1016/j.agrformet.2007.11.012; Dragoni D, 2011, GLOBAL CHANGE BIOL, V17, P886, DOI 10.1111/j.1365-2486.2010.02281.x; Drake JE, 2011, ECOL LETT, V14, P349, DOI 10.1111/j.1461-0248.2011.01593.x; FIELD CB, 1995, PLANT CELL ENVIRON, V18, P1214, DOI 10.1111/j.1365-3040.1995.tb00630.x; Grelle A, 1997, J HYDROL, V197, P70, DOI 10.1016/S0022-1694(96)03267-2; Jones JA, 2012, BIOSCIENCE, V62, P390, DOI 10.1525/bio.2012.62.4.10; Katul GG, 2009, PLANT CELL ENVIRON, V32, P968, DOI 10.1111/j.1365-3040.2009.01977.x; Keys PW, 2012, BIOGEOSCIENCES, V9, P733, DOI 10.5194/bg-9-733-2012; KHAIRI MMA, 1976, PHYSIOL PLANTARUM, V36, P35, DOI 10.1111/j.1399-3054.1976.tb05024.x; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; McMahon SM, 2010, P NATL ACAD SCI USA, V107, P3611, DOI 10.1073/pnas.0912376107; Medlyn BE, 2011, GLOBAL CHANGE BIOL, V17, P2134, DOI 10.1111/j.1365-2486.2010.02375.x; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Niinemets U, 2011, TRENDS ECOL EVOL, V26, P136, DOI 10.1016/j.tree.2010.12.012; Norby RJ, 2011, ANNU REV ECOL EVOL S, V42, P181, DOI 10.1146/annurev-ecolsys-102209-144647; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Salzer MW, 2009, P NATL ACAD SCI USA, V106, P20348, DOI 10.1073/pnas.0903029106; Saurer M, 2004, GLOBAL CHANGE BIOL, V10, P2109, DOI 10.1111/j.1365-2486.2004.00869.x; Schmidt A, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002100; Schubert BA, 2012, GEOCHIM COSMOCHIM AC, V96, P29, DOI 10.1016/j.gca.2012.08.003; Seibt U, 2008, OECOLOGIA, V155, P441, DOI 10.1007/s00442-007-0932-7	33	740	774	36	958	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2013	499	7458					324	+		10.1038/nature12291	http://dx.doi.org/10.1038/nature12291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23842499				2022-12-01	WOS:000321910700033
J	Freudenthal, BD; Beard, WA; Shock, DD; Wilson, SH				Freudenthal, Bret D.; Beard, William A.; Shock, David D.; Wilson, Samuel H.			Observing a DNA Polymerase Choose Right from Wrong	CELL			English	Article							INDUCED-FIT; MECHANISM; BETA; INTERMEDIATE	DNA polymerase (pol) beta is a model polymerase involved in gap-filling DNA synthesis utilizing two metals to facilitate nucleotidyl transfer. Previous structural studies have trapped catalytic intermediates by utilizing substrate analogs (dideoxy-terminated primer or nonhydrolysable incoming nucleotide). To identify additional intermediates during catalysis, we now employ natural substrates (correct and incorrect nucleotides) and follow product formation in real time with 15 different crystal structures. We are able to observe molecular adjustments at the active site that hasten correct nucleotide insertion and deter incorrect insertion not appreciated previously. A third metal binding site is transiently formed during correct, but not incorrect, nucleotide insertion. Additionally, long incubations indicate that pyrophosphate more easily dissociates after incorrect, compared to correct, nucleotide insertion. This appears to be coupled to subdomain repositioning that is required for catalytic activation/deactivation. The structures provide insights into a fundamental chemical reaction that impacts polymerase fidelity and genome stability.	[Freudenthal, Bret D.; Beard, William A.; Shock, David D.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Intramural Research Program of the NIH; National Institute of Environmental Health Sciences [ZO1-ES050158, Z01-ES050161]; National Institutes of Health [1U19CA105010]; NATIONAL CANCER INSTITUTE [U19CA177547, U19CA105010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050158, Z01ES050161, ZIAES050158] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Lars Pedersen, Juno Krahn, and the Collaborative Crystallography group at the NIEHS for help with data collection and analysis. Use of the advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract W-31-109-Eng-38. This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (project numbers ZO1-ES050158 and Z01-ES050161) and in association with the National Institutes of Health grant 1U19CA105010.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BLASCO MA, 1991, J BIOL CHEM, V266, P7904; Chou KM, 2002, NATURE, V415, P655, DOI 10.1038/415655a; Crespan E, 2012, EMBO REP, V13, P68, DOI 10.1038/embor.2011.226; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freudenthal BD, 2012, STRUCTURE, V20, P1829, DOI 10.1016/j.str.2012.08.008; Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Krahn JM, 2004, STRUCTURE, V12, P1823, DOI 10.1016/j.str.2004.08.001; Lin P, 2006, P NATL ACAD SCI USA, V103, P13294, DOI 10.1073/pnas.0606006103; MCAULEYHECHT KE, 1994, BIOCHEMISTRY-US, V33, P10266, DOI 10.1021/bi00200a006; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812	23	156	158	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					157	168		10.1016/j.cell.2013.05.048	http://dx.doi.org/10.1016/j.cell.2013.05.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827680	Green Accepted, Bronze			2022-12-01	WOS:000321327900017
J	Hatch, EM; Fischer, AH; Deerinck, TJ; Hetzer, MW				Hatch, Emily M.; Fischer, Andrew H.; Deerinck, Thomas J.; Hetzer, Martin W.			Catastrophic Nuclear Envelope Collapse in Cancer Cell Micronuclei	CELL			English	Article							ENDOPLASMIC-RETICULUM; DNA-DAMAGE; REPLICATION; GENOME; TRANSCRIPTION; ANEUPLOIDY; RESOLUTION; INTEGRITY; CHROMATIN; MITOSIS	During mitotic exit, missegregated chromosomes can recruit their own nuclear envelope (NE) to form micronuclei (MN). MN have reduced functioning compared to primary nuclei in the same cell, although the two compartments appear to be structurally comparable. Here we show that over 60% of MN undergo an irreversible loss of compartmentalization during interphase due to NE collapse. This disruption of the MN, which is induced by defects in nuclear lamina assembly, drastically reduces nuclear functions and can trigger massive DNA damage. MN disruption is associated with chromatin compaction and invasion of endoplasmic reticulum (ER) tubules into the chromatin. We identified disrupted MN in both major subtypes of human non-small-cell lung cancer, suggesting that disrupted MN could be a useful objective biomarker for genomic instability in solid tumors. Our study shows that NE collapse is a key event underlying MN dysfunction and establishes a link between aberrant NE organization and aneuploidy.	[Hatch, Emily M.; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Fischer, Andrew H.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; [Deerinck, Thomas J.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Dept Neurosci, La Jolla, CA 92093 USA; [Deerinck, Thomas J.] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA	Salk Institute; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Diego; University of California System; University of California San Diego	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu		Hatch, Emily/0000-0002-3393-4075; Fischer, Andrew/0000-0002-5944-4621	National Institutes of Health [RO1GM098749, NIH/NIGMS GM103412]; American Cancer Society; American Cancer Society [PF-12-137-01-CSM]; National Cancer Institute [P30CA014118195]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103412, R01GM098749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Jamie Kasuboski in the Waitt Advanced Biophotonics Core at the Salk Institute for performing structured illumination microscopy. M.W.H. is supported by the National Institutes of Health grant RO1GM098749 and a scholar award from the American Cancer Society. E.M.H. is supported by a postdoctoral fellowship, PF-12-137-01-CSM, from the American Cancer Society. T.J.D. is supported by the National Institutes of Health grant NIH/NIGMS GM103412. The project described was supported by Award Number P30CA014118195 from the National Cancer Institute.	Abr?moff MD., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Anderson DJ, 2008, J CELL SCI, V121, P137, DOI 10.1242/jcs.005777; Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Coffinier C, 2010, P NATL ACAD SCI USA, V107, P5076, DOI 10.1073/pnas.0908790107; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fischer A.H., 2008, CSH PROTOC, DOI DOI 10.1101/PDB.PR0T4989; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Gant TM, 1997, ANNU REV CELL DEV BI, V13, P669, DOI 10.1146/annurev.cellbio.13.1.669; Hetzer M.W., 2010, PERSPECT BIOL, V2; Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6; Holland N, 2008, MUTAT RES-REV MUTAT, V659, P93, DOI 10.1016/j.mrrev.2008.03.007; Lemaitre JM, 1998, J CELL BIOL, V142, P1159, DOI 10.1083/jcb.142.5.1159; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Lu L, 2011, J CELL BIOL, V194, P425, DOI 10.1083/jcb.201012063; Mackay DR, 2009, MOL BIOL CELL, V20, P1652, DOI 10.1091/mbc.E08-08-0883; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Nakamura H, 2003, CLIN CANCER RES, V9, P2294; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; PaulinLevasseur M, 1996, CHROMOSOMA, V104, P367, DOI 10.1007/BF00337226; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Schumacher J, 2006, FEBS LETT, V580, P6211, DOI 10.1016/j.febslet.2006.10.023; Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982; Terradas M, 2012, MUTAT RES-FUND MOL M, V729, P35, DOI 10.1016/j.mrfmmm.2011.09.003; Terradas M, 2009, DNA REPAIR, V8, P1225, DOI 10.1016/j.dnarep.2009.07.004; Thompson SL, 2011, P NATL ACAD SCI USA, V108, P17974, DOI 10.1073/pnas.1109720108; Vargas JD, 2012, NUCLEUS-PHILA, V3, P88, DOI 10.4161/nucl.18954; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018618	41	385	394	1	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					47	60		10.1016/j.cell.2013.06.007	http://dx.doi.org/10.1016/j.cell.2013.06.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827674	Green Accepted, Bronze			2022-12-01	WOS:000321327900009
J	Zhou, J; Lancaster, L; Donohue, JP; Noller, HF				Zhou, Jie; Lancaster, Laura; Donohue, John Paul; Noller, Harry F.			Crystal Structures of EF-G-Ribosome Complexes Trapped in Intermediate States of Translocation	SCIENCE			English	Article							ELONGATION-FACTOR-G; TRANSFER-RNA BINDING; MESSENGER-RNA; HYBRID-STATE; BACTERIAL RIBOSOME; GTPASE ACTIVATION; TRANSLATION; ROTATION; TU; MOVEMENT	Translocation of messenger and transfer RNA (mRNA and tRNA) through the ribosome is a crucial step in protein synthesis, whose mechanism is not yet understood. The crystal structures of three Thermus ribosome-tRNA-mRNA-EF-G complexes trapped with beta,gamma-imidoguanosine 5'-triphosphate (GDPNP) or fusidic acid reveal conformational changes occurring during intermediate states of translocation, including large-scale rotation of the 30S subunit head and body. In all complexes, the tRNA acceptor ends occupy the 50S subunit E site, while their anticodon stem loops move with the head of the 30S subunit to positions between the P and E sites, forming chimeric intermediate states. Two universally conserved bases of 16S ribosomal RNA that intercalate between bases of the mRNA may act as "pawls" of a translocational ratchet. These findings provide new insights into the molecular mechanism of ribosomal translocation.	[Noller, Harry F.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Noller, HF (corresponding author), Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.	harry@nuvolari.ucsc.edu		, Zhou/0000-0001-6521-1384	NIH [GM-17129, GM-59140, Y1-CO-1020, Y1-GM-1104, GM-105404, P41-GM-103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059140, R01GM017129, R37GM017129, P41GM103393, R01GM105404] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Amiri for critical reading of the manuscript, S. Mohan for helpful discussions, and the synchtrotron beamline staffs at the ALS, APS, and SSRL for expert help with data collection. Supported by NIH grants GM-17129 and GM-59140. Synchrotron facilities were supported by the U.S. Department of Energy and by NIH grants Y1-CO-1020 and Y1-GM-1104 (to the APS), and GM-105404 (to the ALS), and P41-GM-103393 (to the SSRL). Coordinates and structure factors have been deposited with the following PDB accession codes: (GDPNP-I) 4KCY, 4KCZ, 4KD0, 4KD2; (GDPNP-2) 4KBT, 4KBU, 4KBV, 4KBW; (Fus-3.6) 4KD8, 4KD9, 4KDA, 4KDB; (Fus-4.2) 4KDG, 4KDH, 4KDJ, 4KDK.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; BODLEY JW, 1969, BIOCHEM BIOPH RES CO, V37, P437, DOI 10.1016/0006-291X(69)90934-6; Borovinskaya MA, 2007, ACS CHEM BIOL, V2, P545, DOI 10.1021/cb700100n; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2012, CURR OPIN STRUC BIOL, V22, P778, DOI 10.1016/j.sbi.2012.08.001; Gao HX, 2004, J STRUCT BIOL, V147, P283, DOI 10.1016/j.jsb.2004.02.008; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Guo ZJ, 2012, P NATL ACAD SCI USA, V109, P20391, DOI 10.1073/pnas.1218999109; Helgstrand M, 2007, J MOL BIOL, V365, P468, DOI 10.1016/j.jmb.2006.10.025; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Jin H, 2011, P NATL ACAD SCI USA, V108, P15798, DOI 10.1073/pnas.1112185108; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Korostelev A, 2007, J MOL BIOL, V373, P1058, DOI 10.1016/j.jmb.2007.08.054; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LASA I, 1992, MOL MICROBIOL, V6, P1555, DOI 10.1111/j.1365-2958.1992.tb00877.x; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 2011, BIOCHEM SOC T, V39, P658, DOI 10.1042/BST0390658; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Spiegel PC, 2007, RNA, V13, P1473, DOI 10.1261/rna.601507; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; WOESE C, 1970, NATURE, V226, P817, DOI 10.1038/226817a0; Zhou J, 2012, RNA, V18, P230, DOI 10.1261/rna.031187.111	45	166	168	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1543	+	1236086	10.1126/science.1236086	http://dx.doi.org/10.1126/science.1236086			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812722	Green Accepted			2022-12-01	WOS:000321007000032
J	Malhotra, A				Malhotra, Aseem			It's time to ban junk food on hospital premises	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUGAR-SWEETENED BEVERAGES; CARDIOVASCULAR-DISEASE; OBESITY; WEIGHT; HEALTH; TRIAL		Royal Free Hosp, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Malhotra, A (corresponding author), Royal Free Hosp, London, England.	aseem_malhotra@hotmail.com						Arnold SV, 2013, PRED MET SYNDR 2013; Bunim J., 2013, AFRICAN AM LATINOCHI; Capewell S, 2011, EUR HEART J, V32, P1187, DOI 10.1093/eurheartj/ehr049; Cohen DA, 2012, NEW ENGL J MED, V367, P1381, DOI 10.1056/NEJMp1209443; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Malik VS, 2011, AM J CLIN NUTR, V94, P1161, DOI 10.3945/ajcn.111.025676; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Marteau TM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d228; National Institute for Health and Clinical Excellence, 2012, OB WORK LOC COMM COS; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Quaas J., 2010, MEDITERRANEAN DIET S; Royal College of Physicians, 2013, ACT OB COMPR CAR ALL; Sahud HB, 2006, PEDIATRICS, V118, P2290, DOI 10.1542/peds.2006-1228; Singh G, 2013, EPIN PAM 2013 NEW OR; SustainWeb, 20 YEARS HOSP FOOD F; Telethon Institute for Child Health Research, 2013, SUG DRINKS TEENS LIN; Tucker ME, 2013, DIABETES COST US 245; von Bibra H, 2013, PRED MET SYNDR 2013; Wang YC, 2012, HEALTH AFFAIR, V31, P199, DOI 10.1377/hlthaff.2011.0410; Weiss R, 2013, ANN NY ACAD SCI, V1281, P123, DOI 10.1111/nyas.12030; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	24	3	4	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2013	346								f3932	10.1136/bmj.f3932	http://dx.doi.org/10.1136/bmj.f3932			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179AA	23803757				2022-12-01	WOS:000321487300004
J	OuYang, B; Xie, SQ; Berardi, MJ; Zhao, XH; Dev, J; Yu, WJ; Sun, B; Chou, JJ				OuYang, Bo; Xie, Shiqi; Berardi, Marcelo J.; Zhao, Xinhao; Dev, Jyoti; Yu, Wenjing; Sun, Bing; Chou, James J.			Unusual architecture of the p7 channel from hepatitis C virus	NATURE			English	Article							ION-CHANNEL; POLYACRYLAMIDE GELS; CHEMICAL-SHIFT; PROTEIN; NMR; SENSITIVITY; AMANTADINE; ALIGNMENT; INHIBITION; MECHANISM	The hepatitis C virus (HCV) has developed a small membrane protein, p7, which remarkably can self-assemble into a large channel complex that selectively conducts cations(1-4). We wanted to examine the structural solution that the viroporin adopts in order to achieve selective cation conduction, because p7 has no homology with any of the known prokaryotic or eukaryotic channel proteins. The activity of p7 can be inhibited by amantadine and rimantadine(2,5), which are potent blockers of the influenza M2 channel(6) and licensed drugs against influenza infections(7). The adamantane derivatives have been used in HCV clinical trials(8), but large variation in drug efficacy among the various HCV genotypes has been difficult to explain without detailed molecular structures. Here we determine the structures of this HCV viroporin as well as its drug-binding site using the latest nuclear magnetic resonance (NMR) technologies. The structure exhibits an unusual mode of hexameric assembly, where the individual p7 monomers, i, not only interact with their immediate neighbours, but also reach farther to associate with the i+2 and i+3 monomers, forming a sophisticated, funnel-like architecture. The structure also points to a mechanism of cation selection: an asparagine/histidine ring that constricts the narrow end of the funnel serves as a broad cation selectivity filter, whereas an arginine/lysine ring that defines the wide end of the funnel may selectively allow cation diffusion into the channel. Our functional investigation using whole-cell channel recording shows that these residues are critical for channel activity. NMR measurements of the channel-drug complex revealed six equivalent hydrophobic pockets between the peripheral and pore-forming helices to which amantadine or rimantadine binds, and compound binding specifically to this position may allosterically inhibit cation conduction by preventing the channel from opening. Our data provide a molecular explanation for p7-mediated cation conductance and its inhibition by adamantane derivatives.	[OuYang, Bo; Berardi, Marcelo J.; Dev, Jyoti; Chou, James J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [OuYang, Bo; Chou, James J.] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [OuYang, Bo; Chou, James J.] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Natl Ctr Prot Sci, Shanghai 200031, Peoples R China; [Xie, Shiqi; Zhao, Xinhao; Yu, Wenjing; Sun, Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Mol Virus Unit,Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China; [Sun, Bing] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China	Harvard University; Harvard Medical School; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chou, JJ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	bsun@sibs.ac.cn; chou@cmcd.hms.harvard.edu	Chou, James J/N-9840-2013; Dev, Jyoti/I-4109-2016; Chou, James/AAD-6230-2022	Chou, James J/0000-0002-4442-0344; Dev, Jyoti/0000-0002-9217-7406; Chou, James/0000-0002-4442-0344; Xie, Shiqi/0000-0002-0516-3621	National Key Project of 973 [2013CB530504]; National Science and Technology Major Project [2012ZX10002-007-003]; NIH [GM094608]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094608] Funding Source: NIH RePORTER	National Key Project of 973(National Basic Research Program of China); National Science and Technology Major Project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Sounier for helping with making specific methyl-labelled protein, S. Brueschweiler for helping with ITC measurements, G. Bellot, J. Min and W. Shih for providing DNA nanotube liquid crystal, and K. Oxenoid for discussion. This work was supported by the National Key Project of 973 (2013CB530504) and National Science and Technology Major Project (2012ZX10002-007-003) (to B. S.) and NIH grant GM094608 (to J.J.C.).	Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; Cook GA, 2011, BBA-BIOMEMBRANES, V1808, P1448, DOI 10.1016/j.bbamem.2010.08.010; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; Fischer WB, 2002, BBA-BIOMEMBRANES, V1561, P27, DOI 10.1016/S0304-4157(01)00009-0; Foster TL, 2011, HEPATOLOGY, V54, P79, DOI 10.1002/hep.24371; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Griffin S, 2008, HEPATOLOGY, V48, P1779, DOI 10.1002/hep.22555; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luik P, 2009, P NATL ACAD SCI USA, V106, P12712, DOI 10.1073/pnas.0905966106; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Mihm U, 2006, ANTIVIR THER, V11, P507; Montserret R, 2010, J BIOL CHEM, V285, P31446, DOI 10.1074/jbc.M110.122895; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pielak RM, 2011, STRUCTURE, V19, P1655, DOI 10.1016/j.str.2011.09.003; Plugge B, 2000, SCIENCE, V287, P1641, DOI 10.1126/science.287.5458.1641; Popescu CI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001278; Premkumar A, 2004, FEBS LETT, V557, P99, DOI 10.1016/S0014-5793(03)01453-4; Sakai A, 2003, P NATL ACAD SCI USA, V100, P11646, DOI 10.1073/pnas.1834545100; Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Steinmann E, 2007, HEPATOLOGY, V46, P330, DOI 10.1002/hep.21686; StGelais C, 2009, J VIROL, V83, P7970, DOI 10.1128/JVI.00521-09; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; SZYPERSKI T, 1992, J BIOMOL NMR, V2, P323, DOI 10.1007/BF01874811; Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Vieyres G, 2013, J VIROL, V87, P1664, DOI 10.1128/JVI.02782-12; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; Wozniak AL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001087; Wu JH, 2004, J AM CHEM SOC, V126, P15018, DOI 10.1021/ja045300l	42	217	217	1	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					521	+		10.1038/nature12283	http://dx.doi.org/10.1038/nature12283			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23739335	Green Accepted, Green Submitted			2022-12-01	WOS:000320929400060
J	Davies, E				Davies, Edward			ASSISTED DYING Assisted dying: what happens after Vermont?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								\				edavies@bmj.com						[Anonymous], 2012, BOSTON GLOBE; Canadian Press, 2012, NATIONAL POST   0613; Giglio C., 2013, LIFENEWS; Gram D, 2013, BURLINGTON FREE PRES; Johnson K., 2009, NY TIMES; Leffler SM, 2013, PATIENT CHOICE END L; McCarthy M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3210; Montana Legislature, 2013, DET BILL INF; State of Connecticut, 2013, ACT DEATH DIGN; Turner D, 2012, LA TIMES        1106	10	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2013	346								f4041	10.1136/bmj.f4041	http://dx.doi.org/10.1136/bmj.f4041			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QH	23798734				2022-12-01	WOS:000321245800005
J	Lin, HH; Chu, LA; Fu, TF; Dickson, BJ; Chiang, AS				Lin, Hui-Hao; Chu, Li-An; Fu, Tsai-Feng; Dickson, Barry J.; Chiang, Ann-Shyn			Parallel Neural Pathways Mediate CO2 Avoidance Responses in Drosophila	SCIENCE			English	Article							REPRESENTATION; NEURONS; MAP; BEHAVIOR; GFP	Different stimulus intensities elicit distinct perceptions, implying that input signals are either conveyed through an overlapping but distinct subpopulation of sensory neurons or channeled into divergent brain circuits according to intensity. In Drosophila, carbon dioxide (CO2) is detected by a single type of olfactory sensory neuron, but information is conveyed to higher brain centers through second-order projection neurons (PNs). Two distinct pathways, PNv-1 and PNv-2, are necessary and sufficient for avoidance responses to low and high CO2 concentrations, respectively. Whereas low concentrations activate PNv-1, high concentrations activate both PN(v)s and GABAergic PNv-3, which may inhibit PNv-1 pathway-mediated avoidance behavior. Channeling a sensory input into distinct neural pathways allows the perception of an odor to be further modulated by both stimulus intensity and context.	[Lin, Hui-Hao; Chu, Li-An; Chiang, Ann-Shyn] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan; [Fu, Tsai-Feng] Natl Chi Nan Univ, Dept Appl Chem, Puli 545, Nantou, Taiwan; [Dickson, Barry J.] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Chiang, Ann-Shyn] Natl Tsing Hua Univ, Brain Res Ctr, Hsinchu 30013, Taiwan; [Chiang, Ann-Shyn] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chiang, Ann-Shyn] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	National Tsing Hua University; National Chi Nan University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); National Tsing Hua University; Academia Sinica - Taiwan; University of California System; University of California San Diego	Chiang, AS (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan.	aschiang@life.nthu.edu.tw		Dickson, Barry/0000-0003-0715-892X; Fu, Tsai-Feng/0000-0002-0343-3018; Chiang, Ann-Shyn/0000-0001-9668-7115	National Science Council; Ministry of Education in Taiwan; Direct For Computer & Info Scie & Enginr [1212778] Funding Source: National Science Foundation	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education in Taiwan(Ministry of Education, Taiwan); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank J. Lippincott-Schwartz, D. F. Reiff, K. Scott, T. Lee, G. Struhl, A. Fiala, and the Bloomington Stock Center for fly stocks. We also thank G. S. B. Suh for helpful comments on the manuscript, Y.-T. Huang and S.-T. Wu for generating and testing Brainbow flies, and the National Center for High-performance Computing for FlyCircuit images. This work was supported by grants from the National Science Council and Ministry of Education in Taiwan.	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Lee T, 1999, DEVELOPMENT, V126, P4065; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wasserman S, 2013, CURR BIOL, V23, P301, DOI 10.1016/j.cub.2012.12.038; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	25	46	46	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1338	1341		10.1126/science.1236693	http://dx.doi.org/10.1126/science.1236693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766327				2022-12-01	WOS:000320320200047
J	Ross, BD; Rosin, L; Thomae, AW; Hiatt, MA; Vermaak, D; de la Cruz, AFA; Imhof, A; Mellone, BG; Malik, HS				Ross, Benjamin D.; Rosin, Leah; Thomae, Andreas W.; Hiatt, Mary Alice; Vermaak, Danielle; de la Cruz, Aida Flor A.; Imhof, Axel; Mellone, Barbara G.; Malik, Harmit S.			Stepwise Evolution of Essential Centromere Function in a Drosophila Neogene	SCIENCE			English	Article							GENE; HETEROCHROMATIN; CHROMODOMAIN; MUTATIONS; INSIGHTS; BINDING; MODELS; DOMAIN	Evolutionarily young genes that serve essential functions represent a paradox; they must perform a function that either was not required until after their birth or was redundant with another gene. How young genes rapidly acquire essential function is largely unknown. We traced the evolutionary steps by which the Drosophila gene Umbrea acquired an essential role in chromosome segregation in D. melanogaster since the gene's origin less than 15 million years ago. Umbrea neofunctionalization occurred via loss of an ancestral heterochromatin-localizing domain, followed by alterations that rewired its protein interaction network and led to species-specific centromere localization. Our evolutionary cell biology approach provides temporal and mechanistic detail about how young genes gain essential function. Such innovations may constantly alter the repertoire of centromeric proteins in eukaryotes.	[Ross, Benjamin D.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Ross, Benjamin D.; Hiatt, Mary Alice; Vermaak, Danielle; de la Cruz, Aida Flor A.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Rosin, Leah; Mellone, Barbara G.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Thomae, Andreas W.; Imhof, Axel] Univ Munich, Munich Ctr Integrated Prot Sci, D-08336 Munich, Germany; [Thomae, Andreas W.; Imhof, Axel] Univ Munich, Adolf Butenandt Inst, D-08336 Munich, Germany; [Hiatt, Mary Alice] Law Firm Fitzpatrick Cella Harper & Scinto, New York, NY 10104 USA; [de la Cruz, Aida Flor A.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Connecticut; University of Munich; University of Munich; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Malik, HS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	hsmalik@fhcrc.org	Malik, Harmit S/I-5591-2019; Imhof, Axel/AAU-5313-2021	Malik, Harmit S/0000-0001-6005-0016; Imhof, Axel/0000-0003-2993-8249; Mellone, Barbara/0000-0002-2785-5119; Thomae, Andreas/0000-0003-3156-9075; Ross, Benjamin/0000-0002-8817-3138	NIH [T32HG000035, R01GM074108]; EU [EpiGeneSys 257082]; NSF [1024973]; Mathers Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074108] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1024973] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); NSF(National Science Foundation (NSF)); Mathers Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Bloom, M. Daugherty, M. Emerman, D. Gottschling, M. Levine, M. Patel, N. Phadnis, K. Peichel, and W. Shou for helpful comments, and Drosophila colleagues for generous sharing of reagents. Supported by NIH Training grant T32HG000035 and an NSF predoctoral fellowship (B. D. R.), an EU network grant (EpiGeneSys 257082, A. I.), NSF award 1024973 (B. G. M.), and a grant from the Mathers Foundation and NIH grant R01GM074108 (H. S. M.). H. S. M. is an HHMI Early Career Scientist. Umbrea DNA sequences have been submitted to GenBank under accession numbers KC660086 to KC660100. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (PRIDE partner repository dataset identifier PXD000163).	Abel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005089; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Force A, 1999, GENETICS, V151, P1531; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hahn MW, 2009, J HERED, V100, P605, DOI 10.1093/jhered/esp047; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Joppich C, 2009, CHROMOSOME RES, V17, P19, DOI 10.1007/s10577-008-9002-1; Levine MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002729; LOHE AR, 1987, J MOL BIOL, V194, P161, DOI 10.1016/0022-2836(87)90365-2; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; OHTA T, 1988, GENETICS, V120, P841; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Vermaak D, 2002, MOL CELL BIOL, V22, P7553, DOI 10.1128/MCB.22.21.7553-7561.2002; Zhang DY, 2011, CHROMOSOMA, V120, P97, DOI 10.1007/s00412-010-0294-5; Zhang JM, 2004, P NATL ACAD SCI USA, V101, P16246, DOI 10.1073/pnas.0407066101	25	62	64	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2013	340	6137					1211	1214		10.1126/science.1234393	http://dx.doi.org/10.1126/science.1234393			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744945	Green Accepted			2022-12-01	WOS:000319972800044
J	Gostin, LO				Gostin, Lawrence O.			Who Owns Human Genes? Is DNA Patentable?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Jolie A, 2013, NY TIMES, pA25; Pollack A, 2013, NY TIMES, pA16	2	4	4	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					791	792		10.1001/jama.2013.177833	http://dx.doi.org/10.1001/jama.2013.177833			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23877839				2022-12-01	WOS:000323561400013
J	Jorgensen, L; McKerrall, SJ; Kuttruff, CA; Ungeheuer, F; Felding, J; Baran, PS				Jorgensen, Lars; McKerrall, Steven J.; Kuttruff, Christian A.; Ungeheuer, Felix; Felding, Jakob; Baran, Phil S.			14-Step Synthesis of (+)-Ingenol from (+)-3-Carene	SCIENCE			English	Article							DRUG DISCOVERY; INGENOL; EUPHORBIACEAE; OXIDATIONS; ECONOMY; ACCESS; PLANTS	Ingenol is a diterpenoid with unique architecture and has derivatives possessing important anticancer activity, including the recently Food and Drug Administration-approved Picato, a first-in-class drug for the treatment of the precancerous skin condition actinic keratosis. Currently, that compound is sourced inefficiently from Euphorbia peplus. Here, we detail an efficient, highly stereocontrolled synthesis of (+)-ingenol proceeding in only 14 steps from inexpensive (+)-3-carene and using a two-phase design. This synthesis will allow for the creation of fully synthetic analogs of bioactive ingenanes to address pharmacological limitations and provides a strategic blueprint for chemical production. These results validate two-phase terpene total synthesis as not only an academic curiosity but also a viable alternative to isolation or bioengineering for the efficient preparation of polyoxygenated terpenoids at the limits of chemical complexity.	[Jorgensen, Lars; McKerrall, Steven J.; Kuttruff, Christian A.; Ungeheuer, Felix; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Felding, Jakob] LEO Pharma AS, External Discovery, DK-2750 Ballerup, Denmark	Scripps Research Institute; LEO Pharma	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu	Kuttruff, Christian/ABC-4160-2020; Ungeheuer, Felix/C-4520-2017	Ungeheuer, Felix/0000-0001-6159-1228; McKerrall, Steven/0000-0002-2966-5810	LEO Pharma; Carlsberg Foundation; Danish Council for Independent Research (Technology and Production Sciences); Alexander von Humboldt Foundation	LEO Pharma(LEO Pharma); Carlsberg Foundation(Carlsberg Foundation); Danish Council for Independent Research (Technology and Production Sciences)(Det Frie Forskningsrad (DFF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	Financial support for this work was provided by LEO Pharma. The Carlsberg Foundation and the Danish Council for Independent Research (Technology and Production Sciences) provided postdoctoral fellowships for L.J., and the Alexander von Humboldt Foundation provided a postdoctoral fellowship for C.A.K. We are grateful to A. Rheingold and C. E. Moore (University of California, San Diego) for x-ray crystallographic analysis and G. Siuzdak (the Scripps Research Institute) for mass spectrometry assistance. We thank H. Bladh (LEO Pharma) for valuable discussions and LEO Pharma for generous donations of natural 20-deoxyingenol and ingenol. Metrical parameters for the structures of compounds 14, 20, and 21 are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-943074, 943076, and 943075, respectively. A provisional patent application has been filed and is available under patent application no. U.S. 61/829,861.	Alder RW, 1996, CHEM REV, V96, P2097, DOI 10.1021/cr940246k; [Anonymous], 2012, EUR MED AG EMA PUBL; Appendino G, 1999, EUR J ORG CHEM, V1999, P3413; Appendino G, 1999, J NAT PROD, V62, P76, DOI 10.1021/np980218n; Brummond KM, 2002, ORG LETT, V4, P1931, DOI 10.1021/ol025955w; Burns NZ, 2009, ANGEW CHEM INT EDIT, V48, P2854, DOI 10.1002/anie.200806086; Chen K, 2009, NATURE, V459, P824, DOI 10.1038/nature08043; Epstein OL, 2005, ANGEW CHEM INT EDIT, V44, P121, DOI 10.1002/anie.200461807; Fujiwara M, 1996, ANTIMICROB AGENTS CH, V40, P271, DOI 10.1128/AAC.40.1.271; Hale V, 2007, AM J TROP MED HYG, V77, P198, DOI 10.4269/ajtmh.2007.77.198; HASLER CM, 1992, CANCER RES, V52, P202; HECKER E, 1968, CANCER RES, V28, P2338; Hohmann J, 2000, PLANTA MED, V66, P291, DOI 10.1055/s-2000-8568; Keasling JD, 2012, NATURE, V492, P188, DOI 10.1038/492188a; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kirby J, 2010, PHYTOCHEMISTRY, V71, P1466, DOI 10.1016/j.phytochem.2010.06.001; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Konegawa T, 1997, SYNLETT, P1297; Kuwajima I, 2005, CHEM REV, V105, P4661, DOI 10.1021/cr040636z; Liang XF, 2012, SYNLETT, P2647, DOI 10.1055/s-0032-1317415; Mountford P. G., 2010, GREEN CHEM PHARM IND, P145, DOI DOI 10.1002/9783527629688.CH7; Nakamura A, 2013, SYNTHESIS-STUTTGART, V45, P1421, DOI 10.1055/s-0033-1338426; Nickel A, 2004, J AM CHEM SOC, V126, P16300, DOI 10.1021/ja044123l; Ogbourne SM, 2004, CANCER RES, V64, P2833, DOI 10.1158/0008-5472.CAN-03-2837; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Schmidt R. J., 1987, J LINN SOC BOT, V94, P221; SHIBUYA K, 1994, SYNTHETIC COMMUN, V24, P2923, DOI 10.1080/00397919408010614; Siller G, 2010, AUSTRALAS J DERMATOL, V51, P99, DOI 10.1111/j.1440-0960.2010.00626.x; Tanino K, 2003, J AM CHEM SOC, V125, P1498, DOI 10.1021/ja029226n; U.S. Food and Drug Administration, 2013, 2012 NOV NEW DRUGS S; Vasas A, 2012, EUR J ORG CHEM, V2012, P5115, DOI 10.1002/ejoc.201200733; Watanabe K, 2004, J ORG CHEM, V69, P7802, DOI 10.1021/jo048833l; Wender PA, 2008, ACCOUNTS CHEM RES, V41, P40, DOI 10.1021/ar700155p; Winkler JD, 2002, J AM CHEM SOC, V124, P9726, DOI 10.1021/ja026600a; ZECHEIST.K, 1970, TETRAHEDRON LETT, P4075; Zhu CY, 2012, J AM CHEM SOC, V134, P13577, DOI 10.1021/ja3061479	37	217	220	17	360	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 23	2013	341	6148					878	882		10.1126/science.1241606	http://dx.doi.org/10.1126/science.1241606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MY	23907534				2022-12-01	WOS:000323370600040
J	Atanur, SS; Diaz, AG; Maratou, K; Sarkis, A; Rotival, M; Game, L; Tschannen, MR; Kaisaki, PJ; Otto, GW; Ma, MCJ; Keane, TM; Hummel, O; Saar, K; Chen, W; Guryev, V; Gopalakrishnan, K; Garrett, MR; Joe, B; Citterio, L; Bianchi, G; McBride, M; Dominiczak, A; Adams, DJ; Serikawa, T; Flicek, P; Cuppen, E; Hubner, N; Petretto, E; Gauguier, D; Kwitek, A; Jacob, H; Aitman, TJ				Atanur, Santosh S.; Diaz, Ana Garcia; Maratou, Klio; Sarkis, Allison; Rotival, Maxime; Game, Laurence; Tschannen, Michael R.; Kaisaki, Pamela J.; Otto, Georg W.; Ma, Man Chun John; Keane, Thomas M.; Hummel, Oliver; Saar, Kathrin; Chen, Wei; Guryev, Victor; Gopalakrishnan, Kathirvel; Garrett, Michael R.; Joe, Bina; Citterio, Lorena; Bianchi, Giuseppe; McBride, Martin; Dominiczak, Anna; Adams, David J.; Serikawa, Tadao; Flicek, Paul; Cuppen, Edwin; Hubner, Norbert; Petretto, Enrico; Gauguier, Dominique; Kwitek, Anne; Jacob, Howard; Aitman, Timothy J.			Genome Sequencing Reveals Loci under Artificial Selection that Underlie Disease Phenotypes in the Laboratory Rat	CELL			English	Article							OXIDATIVE STRESS; CARDIAC-HYPERTROPHY; GENETIC-ANALYSIS; ANGIOTENSIN-II; HYPERTENSION; GENERATION; PRESSURE; MUTATION; MECHANISMS; PHYSIOLOGY	Large numbers of inbred laboratory rat strains have been developed for a range of complex disease phenotypes. To gain insights into the evolutionary pressures underlying selection for these phenotypes, we sequenced the genomes of 27 rat strains, including 11 models of hypertension, diabetes, and insulin resistance, along with their respective control strains. Altogether, we identified more than 13 million single-nucleotide variants, indels, and structural variants across these rat strains. Analysis of strain-specific selective sweeps and gene clusters implicated genes and pathways involved in cation transport, angiotensin production, and regulators of oxidative stress in the development of cardiovascular disease phenotypes in rats. Many of the rat loci that we identified overlap with previously mapped loci for related traits in humans, indicating the presence of shared pathways underlying these phenotypes in rats and humans. These data represent a step change in resources available for evolutionary analysis of complex traits in disease models.	[Atanur, Santosh S.; Diaz, Ana Garcia; Maratou, Klio; Aitman, Timothy J.] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Physiol Genom & Med Grp, London W12 0NN, England; [Atanur, Santosh S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0NN, England; [Rotival, Maxime; Petretto, Enrico] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Integrat Genom & Med Grp, London W12 0NN, England; [Game, Laurence] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Genom Core Lab, London W12 0NN, England; [Sarkis, Allison; Tschannen, Michael R.; Jacob, Howard] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Kaisaki, Pamela J.; Otto, Georg W.; Gauguier, Dominique] Univ Oxford, Welcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Ma, Man Chun John; Kwitek, Anne] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; [Keane, Thomas M.; Adams, David J.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Hummel, Oliver; Saar, Kathrin; Chen, Wei; Hubner, Norbert] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Guryev, Victor; Cuppen, Edwin] Hubrecht Inst KNAW, NL-3584 Utrecht, Netherlands; [Guryev, Victor; Cuppen, Edwin] Univ Med Ctr Utrecht, NL-3584 Utrecht, Netherlands; [Guryev, Victor] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, NL-9700 AD Groningen, Netherlands; [Gopalakrishnan, Kathirvel; Joe, Bina] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Ctr Hypertens & Personalized Med, Toledo, OH 43606 USA; [Garrett, Michael R.] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Citterio, Lorena; Bianchi, Giuseppe] Univ Vita Salute San Raffaele, Chair Nephrol, San Raffaele Sci Inst, OU Nephrol, I-20132 Milan, Italy; [McBride, Martin; Dominiczak, Anna] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Serikawa, Tadao] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto 6068501, Japan; [Flicek, Paul] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Hubner, Norbert] DZHK German Ctr Cardiovasc Res, D-13092 Berlin, Germany; [Gauguier, Dominique] INSERM, Cordeliers Res Ctr, UMR S872, F-75006 Paris, France	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Medical College of Wisconsin; University of Oxford; Wellcome Centre for Human Genetics; University of Iowa; Wellcome Trust Sanger Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Groningen; University System of Ohio; University of Toledo; University of Mississippi; University of Mississippi Medical Center; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Glasgow; Kyoto University; European Molecular Biology Laboratory (EMBL); German Centre for Cardiovascular Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Aitman, TJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Physiol Genom & Med Grp, London W12 0NN, England.	t.aitman@csc.mrc.ac.uk	Cuppen, Edwin/F-5696-2011; Citterio, Lorena/AAC-1589-2019; Gauguier, Dominique/G-2190-2016; Chen, Wei/C-1273-2011; Dominiczak, Anna F/P-9390-2017; Cuppen, Edwin/H-2389-2016	Cuppen, Edwin/0000-0002-0400-9542; Citterio, Lorena/0000-0001-6455-2291; Gauguier, Dominique/0000-0001-6156-9530; Dominiczak, Anna F/0000-0003-4913-3608; Cuppen, Edwin/0000-0002-0400-9542; Guryev, Victor/0000-0002-5810-6022; Otto, Georg W/0000-0002-3929-948X; Ma, John/0000-0002-2000-8144; Kwitek, Anne/0000-0003-1024-4116; Adams, David/0000-0001-9490-0306; Maratou, Klio/0000-0001-6061-2322; Keane, Thomas/0000-0001-7532-6898; Faber, Allison/0000-0003-0657-8746; Saar, Kathrin/0000-0002-4483-1557; Aitman, Timothy/0000-0002-7875-4502; Flicek, Paul/0000-0002-3897-7955; Garcia Diaz, Ana Isabel/0000-0001-6941-6272; Rotival, Maxime/0000-0003-2519-8044; Bianchi, Giuseppe/0000-0002-8365-3618	Medical Research Council; British Heart Foundation Center of Research Excellence [RE/08/002]; EU-funded Euratrans project [HEALTH-F4-2010-241504]; National BioResource Project-Rat; TOP grant from the Netherlands Research Council (NWO-CW) [700.58.303]; NIH [5R01HL069321]; Euratrans; BMPF-funded German Center for Cardiovascular Research; Wellcome Trust Senior Fellowship in Basic Biomedical Science [057733]; Wellcome Trust Core Award Grant [075491/Z/04]; Institute of Cardiometabolism and Nutrition [ICAN, ANR10- IAHU-05]; NIH/NHLBI [HL094446]; Robert M. Hearin Foundation; EMBL; EU-funded Euratrans project; Cancer Research UK [13031] Funding Source: researchfish; Medical Research Council [MC_U120061454, MC_U120097112, G0800024] Funding Source: researchfish; MRC [G0800024, MC_U120097112, MC_U120061454] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089895, R01HL094446, R01HL020176, R01HL069321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK089417] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation Center of Research Excellence; EU-funded Euratrans project; National BioResource Project-Rat; TOP grant from the Netherlands Research Council (NWO-CW); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Euratrans; BMPF-funded German Center for Cardiovascular Research; Wellcome Trust Senior Fellowship in Basic Biomedical Science(Wellcome Trust); Wellcome Trust Core Award Grant(Wellcome Trust); Institute of Cardiometabolism and Nutrition; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert M. Hearin Foundation; EMBL; EU-funded Euratrans project; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	T.J.A. acknowledges funding from the Medical Research Council, British Heart Foundation Center of Research Excellence (RE/08/002), and the EU-funded Euratrans project (HEALTH-F4-2010-241504). We thank the National BioResource Project-Rat (http://www.anim.med.kyoto-u.ac.jp/NBR/) for providing DNA from rat strain LE/Stm and Jean Sassard for provision of rats for DNA sequencing of LH, LN, and LL rats. E.C. is supported by a TOP grant (700.58.303) from the Netherlands Research Council (NWO-CW). H.J. acknowledges funding from NIH grant 5R01HL069321. N.H. acknowledges funding from Euratrans and the BMPF-funded German Center for Cardiovascular Research. D.G. acknowledges support from a Wellcome Trust Senior Fellowship in Basic Biomedical Science (057733), a Wellcome Trust Core Award Grant (075491/Z/04), and support from the Institute of Cardiometabolism and Nutrition (ICAN, ANR10- IAHU-05). M.R.G. is supported by NIH/NHLBI HL094446 and Robert M. Hearin Foundation. P.F. acknowledges funding from EMBL and from the EU-funded Euratrans project. We thank Allen Cowley for helpful discussions on the manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BIANCHI G, 1986, J HYPERTENS, V4, pS33; Bianchi G, 2005, HYPERTENSION, V45, P331, DOI 10.1161/01.HYP.0000156497.39375.37; BIANCHI G, 1990, J HYPERTENS, V8, pS213; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cusi D, 1997, LANCET, V349, P1353, DOI 10.1016/S0140-6736(97)01029-5; Dalberg U, 2007, INT IMMUNOL, V19, P447, DOI 10.1093/intimm/dxm009; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; DEKEIJZER MH, 1988, RENAL PHYSIOL BIOCH, V11, P103; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Feisenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferrandi M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001815; Gamliel-Lazarovich A, 2012, ATHEROSCLEROSIS, V222, P92, DOI 10.1016/j.atherosclerosis.2012.01.047; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hebert SC, 2004, PFLUG ARCH EUR J PHY, V447, P580, DOI 10.1007/s00424-003-1066-3; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Hornum L, 2002, DIABETES, V51, P1972, DOI 10.2337/diabetes.51.6.1972; JACKSON R, 1983, METABOLISM, V32, P83, DOI 10.1016/S0026-0495(83)80017-1; Jacob HJ, 2010, TRENDS GENET, V26, P510, DOI 10.1016/j.tig.2010.08.006; Jong D. W., 1984, HDB HYPERTENSION, V4; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; KREISBERG JI, 1978, AM J PATHOL, V92, P637; Kriz W, 1998, NEPHROL DIAL TRANSPL, V13, P2781, DOI 10.1093/ndt/13.11.2781; KURTZ TW, 1989, HYPERTENSION, V13, P188, DOI 10.1161/01.HYP.13.2.188; Kushiro T, 2005, CLIN EXP HYPERTENS, V27, P9, DOI 10.1081/CEH-200044244; Kwasnicka-Crawford DA, 2005, GENOMICS, V86, P182, DOI 10.1016/j.ygeno.2005.04.002; Lezin ES, 1999, HYPERTENSION, V34, P187, DOI 10.1161/01.HYP.34.2.187; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li M, 2004, J CLIN INVEST, V114, P112, DOI 10.1172/JCI200420805; Li YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030214; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lindsey J. R., 1979, The laboratory rat. Volume I. Biology and diseases., P1; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Mattson DL, 2007, AM J PHYSIOL-RENAL, V293, pF1905, DOI 10.1152/ajprenal.00012.2007; McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Precourt LP, 2011, ATHEROSCLEROSIS, V214, P20, DOI 10.1016/j.atherosclerosis.2010.08.076; Rapp JP, 2000, PHYSIOL REV, V80, P135, DOI 10.1152/physrev.2000.80.1.135; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Sato T, 2005, BIOINFORMATICS, V21, P3482, DOI 10.1093/bioinformatics/bti564; Simonis M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r31; Sober S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006034; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473; Swei A, 1997, HYPERTENSION, V30, P1628, DOI 10.1161/01.HYP.30.6.1628; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; TAJIMA F, 1989, GENETICS, V123, P585; Tillier ERM, 2009, GENOME RES, V19, P1861, DOI 10.1101/gr.092452.109; Uehara Y, 2013, CURR PHARM DESIGN, V19, P3054; van Rodijnen WF, 2002, HYPERTENSION, V39, P111, DOI 10.1161/hy1201.096817; Vaziri ND, 2006, NAT CLIN PRACT NEPHR, V2, P582, DOI 10.1038/ncpneph0283; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF1103, DOI 10.1152/ajprenal.00374.2007; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Wu YR, 2013, J RENIN-ANGIO-ALDO S, V14, P263, DOI 10.1177/1470320312448949; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620	65	126	126	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					691	703		10.1016/j.cell.2013.06.040	http://dx.doi.org/10.1016/j.cell.2013.06.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23890820	Green Published, Green Accepted, hybrid			2022-12-01	WOS:000322629900020
J	Suzuki, J; Denning, DP; Imanishi, E; Horvitz, HR; Nagata, S				Suzuki, Jun; Denning, Daniel P.; Imanishi, Eiichi; Horvitz, H. Robert; Nagata, Shigekazu			Xk-Related Protein 8 and CED-8 Promote Phosphatidylserine Exposure in Apoptotic Cells	SCIENCE			English	Article							PHOSPHOLIPID SCRAMBLASE; CALCIUM; IDENTIFICATION; APPEARANCE; ENGULFMENT; CLEARANCE	A classic feature of apoptotic cells is the cell-surface exposure of phosphatidylserine (PtdSer) as an "eat me" signal for engulfment. We show that the Xk-family protein Xkr8 mediates PtdSer exposure in response to apoptotic stimuli. Mouse Xkr8(-/-) cells or human cancer cells in which Xkr8 expression was repressed by hypermethylation failed to expose PtdSer during apoptosis and were inefficiently engulfed by phagocytes. Xkr8 was activated directly by caspases and required a caspase-3 cleavage site for its function. CED-8, the only Caenorhabditis elegans Xk-family homolog, also promoted apoptotic PtdSer exposure and cell-corpse engulfment. Thus, Xk-family proteins have evolutionarily conserved roles in promoting the phagocytosis of dying cells by altering the phospholipid distribution in the plasma membrane.	[Suzuki, Jun; Imanishi, Eiichi; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; [Denning, Daniel P.; Horvitz, H. Robert] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Denning, Daniel P.; Horvitz, H. Robert] MIT, Dept Biol, Cambridge, MA 02139 USA; [Nagata, Shigekazu] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Japan Society for the Promotion of Science (JSPS); JSPS; Damon Runyon Cancer Research Foundation; Charles A. King Trust; Grants-in-Aid for Scientific Research [22000013] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Damon Runyon Cancer Research Foundation; Charles A. King Trust; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank W. Hiraoka, M. Umeda, and M. Fujii for the PLB-985 cell line, the RO09-0198 peptide, and secretarial assistance, respectively. This work was supported in part by Grants-in-Aid for Specially Promoted Research from the Japan Society for the Promotion of Science (JSPS) to S.N., a Grant-in-Aid for Young Scientists (B) from JSPS to J.S., and postdoctoral fellowships from the Damon Runyon Cancer Research Foundation and the Charles A. King Trust to D. P. D. H. R. H. is the David H. Koch Professor of Biology at the Massachusetts Institute of Technology and is a Howard Hughes Medical Institute Investigator.	Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Calenda G, 2006, GENE, V370, P6, DOI 10.1016/j.gene.2005.10.037; Denning DP, 2012, NATURE, V488, P226, DOI 10.1038/nature11240; Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P504, DOI 10.1006/bbrc.1999.1820; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; Franks AL, 2012, ANTICANCER RES, V32, P1119; Hampton MB, 1996, FEBS LETT, V399, P277, DOI 10.1016/S0014-5793(96)01341-5; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Mapes J, 2012, CURR BIOL, V22, P1267, DOI 10.1016/j.cub.2012.05.052; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Schoenwaelder SM, 2009, BLOOD, V114, P663, DOI 10.1182/blood-2009-01-200345; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Venegas V, 2007, MOL BIOL CELL, V18, P3180, DOI 10.1091/mbc.E07-02-0138; Williamson P, 2001, BIOCHEMISTRY-US, V40, P8065, DOI 10.1021/bi001929z; Wu YC, 2000, GENE DEV, V14, P536; Zhang Y, 2012, CURR BIOL, V22, P1276, DOI 10.1016/j.cub.2012.06.004	24	332	341	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2013	341	6144					403	406		10.1126/science.1236758	http://dx.doi.org/10.1126/science.1236758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23845944	Green Published			2022-12-01	WOS:000322259200051
J	Groves, T				Groves, Trish			OPEN DATA What does oseltamivir do, and how will we know?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tgroves@bmj.com	Groves, Trish/A-9119-2009	Groves, Trish/0000-0001-7915-6419				Krumholz HM, 2013, BMJ-BRIT MED J, V346, pf547	1	4	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2013	347								f4687	10.1136/bmj.f4687	http://dx.doi.org/10.1136/bmj.f4687			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193BM	23884974				2022-12-01	WOS:000322531800013
J	Sebag, JA; Zhang, C; Hinkle, PM; Bradshaw, AM; Cone, RD				Sebag, Julien A.; Zhang, Chao; Hinkle, Patricia M.; Bradshaw, Amanda M.; Cone, Roger D.			Developmental Control of the Melanocortin-4 Receptor by MRAP2 Proteins in Zebrafish	SCIENCE			English	Article							ACCESSORY PROTEIN; FRAMESHIFT MUTATION; OBESITY; TRAFFICKING; MC4R; MC2	The melanocortin-4 receptor (MC4R) is essential for control of energy homeostasis in vertebrates. MC4R interacts with melanocortin receptor accessory protein 2 (MRAP2) in vitro, but its functions in vivo are unknown. We found that MRAP2a, a larval form, stimulates growth of zebrafish by specifically blocking the action of MC4R. In cell culture, this protein binds MC4R and reduces the ability of the receptor to bind its ligand, alpha-melanocyte-stimulating hormone (alpha-MSH). A paralog, MRAP2b, expressed later in development, also binds MC4R but increases ligand sensitivity. Thus, MRAP2 proteins allow for developmental control of MC4R activity, with MRAP2a blocking its function and stimulating growth during larval development, whereas MRAP2b enhances responsiveness to alpha-MSH once the zebrafish begins feeding, thus increasing the capacity for regulated feeding and growth.	[Sebag, Julien A.; Zhang, Chao; Bradshaw, Amanda M.; Cone, Roger D.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Hinkle, Patricia M.] Univ Rochester, Med Ctr, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	Vanderbilt University; University of Rochester	Cone, RD (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	roger.cone@vanderbilt.edu	sebag, julien/AAU-2142-2020	sebag, julien/0000-0002-8366-312X	NIH [DK075721, DK070332, DK19974, F23DK091055]; United States-Israel Binational Agricultural Research and Development Fund (BARD) [IS-4489-12]; Vanderbilt Diabetes Research and Training Center [DK020593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070332, F32DK091055, P60DK020593, P30DK020593, R01DK019974, R56DK075721, T32DK007563, R01DK075721] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Agricultural Research and Development Fund (BARD)(US-Israel Binational Science Foundation); Vanderbilt Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by NIH grants DK075721 and DK070332 (R. D. C.), DK19974 (P. M. H.), and F23DK091055 (J.A.S.); United States-Israel Binational Agricultural Research and Development Fund (BARD) research grant IS-4489-12 (R. D. C. and C.Z.); and Vanderbilt Diabetes Research and Training Center grant DK020593 (R. D. C.). All data and methods are publicly available in the supplementary materials.	Asai M, 2013, SCIENCE, V341, P275, DOI 10.1126/science.1233000; Chan LF, 2009, P NATL ACAD SCI USA, V106, P6146, DOI 10.1073/pnas.0809918106; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Hinkle PM, 2011, EUR J PHARMACOL, V660, P94, DOI 10.1016/j.ejphar.2010.10.113; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Agulleiro MJ, 2010, MOL CELL ENDOCRINOL, V320, P145, DOI 10.1016/j.mce.2010.01.032; Lampert KP, 2010, CURR BIOL, V20, P1729, DOI 10.1016/j.cub.2010.08.029; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Roy S, 2007, MOL ENDOCRINOL, V21, P1656, DOI 10.1210/me.2007-0041; Sebag JA, 2007, P NATL ACAD SCI USA, V104, P20244, DOI 10.1073/pnas.0708916105; Sebag JA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000593; Sebag JA, 2009, J BIOL CHEM, V284, P22641, DOI 10.1074/jbc.M109.022400; Sebag JA, 2009, J BIOL CHEM, V284, P610, DOI 10.1074/jbc.M804413200; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Zhang C, 2012, CELL METAB, V15, P256, DOI 10.1016/j.cmet.2011.12.014	16	109	114	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					278	281		10.1126/science.1232995	http://dx.doi.org/10.1126/science.1232995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869017	Green Accepted			2022-12-01	WOS:000321959300044
J	Millay, DP; O'Rourke, JR; Sutherland, LB; Bezprozvannaya, S; Shelton, JM; Bassel-Duby, R; Olson, EN				Millay, Douglas P.; O'Rourke, Jason R.; Sutherland, Lillian B.; Bezprozvannaya, Svetlana; Shelton, John M.; Bassel-Duby, Rhonda; Olson, Eric N.			Myomaker is a membrane activator of myoblast fusion and muscle formation	NATURE			English	Article							CELL-CELL FUSION; PROTEIN; MOUSE; EXPRESSION; MYOGENESIS; MICE; RAC1; GENE	Fusion of myoblasts is essential for the formation of multi-nucleated muscle fibres. However, the identity of muscle-specific proteins that directly govern this fusion process in mammals has remained elusive. Here we identify a muscle-specific membrane protein, named myomaker, that controls myoblast fusion. Myomaker is expressed on the cell surface of myoblasts during fusion and is downregulated thereafter. Overexpression of myomaker in myoblasts markedly enhances fusion, and genetic disruption of myomaker in mice causes perinatal death due to an absence of multi-nucleated muscle fibres. Remarkably, forced expression of myomaker in fibroblasts promotes fusion with myoblasts, demonstrating the direct participation of this protein in the fusion process. Pharmacological perturbation of the actin cytoskeleton abolishes the activity of myomaker, consistent with previous studies implicating actin dynamics in myoblast fusion. These findings reveal a long-sought myogenic fusion protein that controls mammalian myoblast fusion and provide new insights into the molecular underpinnings of muscle formation.	[Millay, Douglas P.; O'Rourke, Jason R.; Sutherland, Lillian B.; Bezprozvannaya, Svetlana; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Shelton, John M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu			National Institutes of Health National Research Service Award Fellowship [F32AR05948403]; National Institutes of Health [HL-077439, HL-111665, HL093039, U01-HL-100401]; Robert A. Welch Foundation [1-0025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111665, R01HL077439, R01HL093039, U01HL100401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR059484] Funding Source: NIH RePORTER	National Institutes of Health National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Cabrera for graphics, the Transgenic Technology Center at University of Texas Southwestern Medical Center for embryonic stem cell injections, J. A. Richardson for histology and the University of Texas Southwestern Live Cell Imaging Facility (K. Luby-Phelps and A. Budge) for microscopy and live cell-imaging assistance. We thank D. Rosenbaum, W. Snell, S. Schmid, J. Seemann and members of the Olson laboratory for scientific discussions. D. P. M. was financed by a National Institutes of Health National Research Service Award Fellowship (F32AR05948403). This work was supported by grants from the National Institutes of Health (HL-077439, HL-111665, HL093039 and U01-HL-100401) and the Robert A. Welch Foundation (grant 1-0025) (to E.N.O.).	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; Charrasse S, 2007, MOL BIOL CELL, V18, P1734, DOI 10.1091/mbc.E06-08-0766; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen EH, 2001, DEV CELL, V1, P705, DOI 10.1016/S1534-5807(01)00084-3; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Corcoran JA, 2004, J VIROL, V78, P4342, DOI 10.1128/JVI.78.8.4342-4351.2004; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Gruenbaum-Cohen Y, 2012, P NATL ACAD SCI USA, V109, P11211, DOI 10.1073/pnas.1116065109; Hargrave M, 2000, METH MOL B, V123, P279; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Kang JS, 2010, CURR OPIN CLIN NUTR, V13, P243, DOI 10.1097/MCO.0b013e328336ea98; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Nowak SJ, 2009, J CELL SCI, V122, P3282, DOI 10.1242/jcs.047597; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Pei JM, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-37; Powell GT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001216; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Shelton JM, 2000, J LIPID RES, V41, P532; Shilagardi K, 2013, SCIENCE, V340, P359, DOI 10.1126/science.1234781; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Vasyutina E, 2009, P NATL ACAD SCI USA, V106, P8935, DOI 10.1073/pnas.0902501106; Wilson NF, 1998, TRENDS CELL BIOL, V8, P93, DOI 10.1016/S0962-8924(98)01234-3; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0	32	292	304	1	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					301	+		10.1038/nature12343	http://dx.doi.org/10.1038/nature12343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23868259	Green Accepted			2022-12-01	WOS:000321910700028
J	Song, JM; Gao, X; Galan, JE				Song, Jeongmin; Gao, Xiang; Galan, Jorge E.			Structure and function of the Salmonella Typhi chimaeric A(2)B(5) typhoid toxin	NATURE			English	Article							CYTOLETHAL DISTENDING TOXIN; PERTUSSIS TOXIN; TYPHIMURIUM; MICROARRAY; DELIVERY; GENES; EXPRESSION; DEFICIENT; EXOTOXIN; STRATEGY	Salmonella enterica serovar Typhi (S. Typhi) differs from most other salmonellae in that it causes a life-threatening systemic infection known as typhoid fever(1). The molecular bases for its unique clinical presentation are unknown(2). Here we find that the systemic administration of typhoid toxin, a unique virulence factor of S. Typhi, reproduces many of the acute symptoms of typhoid fever in an animal model. We identify specific carbohydrate moieties on specific surface glycoproteins that serve as receptors for typhoid toxin, which explains its broad cell target specificity. We present the atomic structure of typhoid toxin, which shows an unprecedented A(2)B(5) organization with two covalently linked A subunits non-covalently associated to a pentameric B subunit. The structure provides insight into the toxin's receptor-binding specificity and delivery mechanisms and reveals how the activities of two powerful toxins have been co-opted into a single, unique toxin that can induce many of the symptoms characteristic of typhoid fever. These findings may lead to the development of potentially life-saving therapeutics against typhoid fever.	[Song, Jeongmin; Gao, Xiang; Galan, Jorge E.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	jorge.galan@yale.edu		gao, xiang/0000-0001-6397-5639; Song, Jeongmin/0000-0002-6777-3505	PHS Grant [GM098791]; Northeast Biodefense Center [U54-AI057158]; NIAID [AI079022]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R01AI114618, R56AI079022, R01AI079022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM098791] Funding Source: NIH RePORTER	PHS Grant; Northeast Biodefense Center; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Galan laboratory for careful review of this manuscript. We thank E. Folta-Stogniew for help with conducting the surface plasmon resonance and light-scattering size-exclusion chromatography assays. We also thank M. Lara-Tejero and X. Liu for mass spectrometry analysis, J. M. Kim for help with glycan array analysis software, and K.-W. Kim for help in animal inoculations. We thank W. Meng for providing help with X-ray diffraction data collection, J. Wang and C. Yan for suggestions and providing help with structure refinement, and X. Gong and M. Ke for help and suggestions with molecular docking. The glycan array analysis was carried out at the Consortium for Functional Glycomics Protein-Glycan Interaction Core, at Emory University, which is supported by PHS Grant GM098791. J. S. was supported in part by a grant from the Northeast Biodefense Center U54-AI057158 and this work was supported by NIAID Grant AI079022 to J.E.G.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Butler T, 2011, CLIN MICROBIOL INFEC, V17, P959, DOI 10.1111/j.1469-0691.2011.03552.x; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Charles R. C., 2010, CLIN VACCINE IMMUNOL; Connor BA, 2005, LANCET INFECT DIS, V5, P623, DOI 10.1016/S1473-3099(05)70239-5; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GALAN JE, 1991, INFECT IMMUN, V59, P2901; Haghjoo E, 2004, P NATL ACAD SCI USA, V101, P4614, DOI 10.1073/pnas.0400932101; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; KUMAR R, 1990, P NATL ACAD SCI USA, V87, P9948, DOI 10.1073/pnas.87.24.9948; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lara-Tejero M, 2002, TRENDS MICROBIOL, V10, P147, DOI 10.1016/S0966-842X(02)02316-8; Liang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01043; Liu XY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002562; Locht C, 2011, FEBS J, V278, P4668, DOI 10.1111/j.1742-4658.2011.08237.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MERRITT EA, 1995, CURR OPIN STRUC BIOL, V5, P165, DOI 10.1016/0959-440X(95)80071-9; Millen SH, 2010, BIOCHEMISTRY-US, V49, P5954, DOI 10.1021/bi100474z; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Saitoh M, 2005, MICROBIOL-SGM, V151, P3089, DOI 10.1099/mic.0.27933-0; Song XZ, 2011, NAT METHODS, V8, P85, DOI 10.1038/NMETH.1540; Spano S, 2008, CURR OPIN MICROBIOL, V11, P15, DOI 10.1016/j.mib.2007.12.002; Spano S, 2008, CELL HOST MICROBE, V3, P30, DOI 10.1016/j.chom.2007.11.001; Spano S, 2011, P NATL ACAD SCI USA, V108, P18418, DOI 10.1073/pnas.1111959108; STANLEY P, 1975, P NATL ACAD SCI USA, V72, P3323, DOI 10.1073/pnas.72.9.3323; STEIN PE, 1994, NAT STRUCT BIOL, V1, P591, DOI 10.1038/nsb0994-591; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Yu CY, 2007, MOL BIOL CELL, V18, P1710, DOI 10.1091/mbc.E06-07-0629; Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537	40	141	146	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2013	499	7458					350	U129		10.1038/nature12377	http://dx.doi.org/10.1038/nature12377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23842500	Green Accepted			2022-12-01	WOS:000321910700039
J	White, JK; Gerdin, AK; Karp, NA; Ryder, E; Buljan, M; Bussell, JN; Salisbury, J; Clare, S; Ingham, NJ; Podrini, C; Houghton, R; Estabel, J; Bottomley, JR; Melvin, DG; Sunter, D; Adams, NC; Tannahill, D; Logan, DW; MacArthur, DG; Flint, J; Mahajan, VB; Tsang, SH; Smyth, I; Watt, FM; Skarnes, WC; Dougan, G; Adams, DJ; Ramirez-Solis, R; Bradley, A; Steel, KP				White, Jacqueline K.; Gerdin, Anna-Karin; Karp, Natasha A.; Ryder, Ed; Buljan, Marija; Bussell, James N.; Salisbury, Jennifer; Clare, Simon; Ingham, Neil J.; Podrini, Christine; Houghton, Richard; Estabel, Jeanne; Bottomley, Joanna R.; Melvin, David G.; Sunter, David; Adams, Niels C.; Tannahill, David; Logan, Darren W.; MacArthur, Daniel G.; Flint, Jonathan; Mahajan, Vinit B.; Tsang, Stephen H.; Smyth, Ian; Watt, Fiona M.; Skarnes, William C.; Dougan, Gordon; Adams, David J.; Ramirez-Solis, Ramiro; Bradley, Allan; Steel, Karen P.		Sanger Inst Mouse Genetics Project	Genome-wide Generation and Systematic Phenotyping of Knockout Mice Reveals New Roles for Many Genes	CELL			English	Article							DUPLICATE GENES; INTELLECTUAL DISABILITY; TRANSMEMBRANE PROTEINS; DEFICIENCY CAUSES; MOUSE; RESOURCE; EXPRESSION; MUTATIONS; GENETICS; ROBUSTNESS	Mutations in whole organisms are powerful ways of interrogating gene function in a realistic context. We describe a program, the Sanger Institute Mouse Genetics Project, that provides a step toward the aim of knocking out all genes and screening each line for a broad range of traits. We found that hitherto unpublished genes were as likely to reveal phenotypes as known genes, suggesting that novel genes represent a rich resource for investigating the molecular basis of disease. We found many unexpected phenotypes detected only because we screened for them, emphasizing the value of screening all mutants for a wide range of traits. Haploinsufficiency and pleiotropy were both surprisingly common. Forty-two percent of genes were essential for viability, and these were less likely to have a paralog and more likely to contribute to a protein complex than other genes. Phenotypic data and more than 900 mutants are openly available for further analysis.	[White, Jacqueline K.; Gerdin, Anna-Karin; Karp, Natasha A.; Ryder, Ed; Buljan, Marija; Bussell, James N.; Salisbury, Jennifer; Clare, Simon; Ingham, Neil J.; Podrini, Christine; Houghton, Richard; Estabel, Jeanne; Bottomley, Joanna R.; Melvin, David G.; Sunter, David; Adams, Niels C.; Tannahill, David; Logan, Darren W.; MacArthur, Daniel G.; Skarnes, William C.; Dougan, Gordon; Adams, David J.; Ramirez-Solis, Ramiro; Bradley, Allan; Steel, Karen P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Flint, Jonathan] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Mahajan, Vinit B.] Univ Iowa, Omics Lab, Iowa City, IA 52242 USA; [Tsang, Stephen H.] Columbia Univ, Harkness Eye Inst, New York, NY 10032 USA; [Smyth, Ian] Monash Univ, Melbourne, Vic 3800, Australia; [Watt, Fiona M.; Sanger Inst Mouse Genetics Project] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Steel, Karen P.] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 1UL, England	Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; University of Iowa; Columbia University; Monash University; University of Cambridge; University of London; King's College London	Steel, KP (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	karen.steel@kcl.ac.uk	Liakath-Ali, Kif/AAB-7672-2020; Watt, Fiona/AHB-0226-2022; Yalcin, Binnaz/P-5482-2016; Ismail, Ozama/AFQ-9517-2022; Carragher, Damian/E-6673-2016; Yalcin, Binnaz/ABB-7735-2020; Ryder, Edward/AAK-1243-2021; Podrini, Christine/K-8621-2016	Watt, Fiona/0000-0001-9151-5154; Yalcin, Binnaz/0000-0002-1924-6807; Carragher, Damian/0000-0003-4341-4943; Yalcin, Binnaz/0000-0002-1924-6807; Ryder, Edward/0000-0002-1799-9899; Podrini, Christine/0000-0002-5391-3378; Adams, David/0000-0001-9490-0306; Ramirez-Solis, Ramiro/0000-0003-4182-173X; Ismail, Ozama/0000-0002-0871-3924; Agu, Chukwuma/0000-0002-8368-4457; Mahajan, Vinit/0000-0003-1886-1741; Karp, Natasha/0000-0002-8404-2907; Dumeau, Charles-Etienne/0000-0002-6916-7277; Tannahill, David/0000-0002-3811-6864; Smyth, Ian/0000-0002-1727-7829; Liakath-Ali, Kif/0000-0001-9047-7424; Flint, Jonathan/0000-0002-9427-4429; Ingham, Neil Jon/0000-0002-0916-7347; Oakley, Darren/0000-0001-8075-3368; Bradley, Allan/0000-0002-2349-8839; Logan, Darren/0000-0003-1545-5510; MacArthur, Daniel/0000-0002-5771-2290; Richardson, David/0000-0003-0247-9118	Wellcome Trust [098051, RG45277 PCAG/116]; Medical Research Council; European Commission (EUMODIC) [LSHG-CT-2006-037188]; NIH [EY08213, 5K08EY020530-02]; Research to Prevent Blindness; Australian Research Council [DP1092723]; Cancer Research UK; MRC [MC_qA137918, G0300212] Funding Source: UKRI; NATIONAL EYE INSTITUTE [R01EY008213, R01EY018213, K08EY020530] Funding Source: NIH RePORTER; Cancer Research UK [13031, 12401] Funding Source: researchfish; Medical Research Council [G0300212, MC_qA137918] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission (EUMODIC)(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Australian Research Council(Australian Research Council); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Alex Bateman, Lars Barquist, Steve O'Rahilly, Keith Burling, Seth Grant, Pentao Liu, and Lorraine Everett for advice and the EUMODIC consortium for discussions. This work was supported by the Wellcome Trust (grant Nos. 098051 to Wellcome Trust Sanger Institute and RG45277 PCAG/116 to F.M.W.), Medical Research Council (to K.P.S. and F.M.W.), European Commission (EUMODIC contract No. LSHG-CT-2006-037188), NIH (EY08213 to S.H.T. and 5K08EY020530-02 to V.B.M.), Research to Prevent Blindness (to S.H.T. and V.B.M.), Australian Research Council (DP1092723 to I.S.), and Cancer Research UK (to D.J.A.). J.K.W. and K.P.S. conceived and devised the single phenotyping pipeline and principles of analysis and presentation of the data; R.R.S., J.K.W., R.H., J.R.B., and E.R. managed mouse production and genotyping; J.N.B. and J.S. managed mouse breeding; A.K.G., C.P., J.E., D.S., N.I., and J.K.W. managed mouse phenotyping and analyzed data; the Sanger Institute Mouse Genetics Project team contributed to all aspects of the work; S.C. and G.D. led the infectious challenge screen; V.B.M. and S.H.T. led the eye histopathology screen; I.S. and F.M.W. led the skin screen; J.F. led the brain histopathology screen; D.J.A. led the micronucleus screen; J.N.B. and J.R.B. managed mouse distribution; J.K.W., A.K.G., M.B., and K.P.S. compiled Tables S1, S2, S5, and S6; N.A.K., D.M., D.S., and M.B. carried out annotation and statistical analysis; N.C.A., D.G.M., and W.C.S. led development of informatics support; D.W.L. wrote Wiki pages for the mutants; J.K.W., D.J.A., R.R.S., and K.P.S. led the project; and K.P.S., A.B., and J.K.W. wrote the paper with contributions from all authors.	Abou Jamra R, 2011, AM J HUM GENET, V88, P788, DOI 10.1016/j.ajhg.2011.04.019; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Andrews TD, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120061; Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Bearer EL, 2000, ANN HUM GENET, V64, P189, DOI 10.1046/j.1469-1809.2000.6430189.x; Brown SDM, 2012, DIS MODEL MECH, V5, P289, DOI 10.1242/dmm.009878; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Conant GC, 2004, P ROY SOC B-BIOL SCI, V271, P89, DOI 10.1098/rspb.2003.2560; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Fischer H, 2011, J INVEST DERMATOL, V131, P1208, DOI 10.1038/jid.2011.13; Fisher CL, 2010, BLOOD, V115, P38, DOI 10.1182/blood-2009-07-230698; Flint J, 2012, NAT REV GENET, V13, P807, DOI 10.1038/nrg3335; Forzati F, 2012, J CLIN INVEST, V122, P612, DOI 10.1172/JCI58620; Friesema ECH, 2006, MOL ENDOCRINOL, V20, P2761, DOI 10.1210/me.2005-0256; Fuchs H, 2012, MAMM GENOME, V23, P611, DOI 10.1007/s00335-012-9415-1; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hawkins TE, 1999, MOL CELL BIOL, V19, P8028; Jimenez-Sanchez G, 2001, NATURE, V409, P853, DOI 10.1038/35057050; Kim YK, 2007, GENE EXPR PATTERNS, V7, P143, DOI 10.1016/j.modgep.2006.06.006; Laughlin MR, 2012, MAMM GENOME, V23, P623, DOI 10.1007/s00335-012-9425-z; Liang H, 2007, TRENDS GENET, V23, P375, DOI 10.1016/j.tig.2007.04.005; Liao BY, 2007, TRENDS GENET, V23, P378, DOI 10.1016/j.tig.2007.05.006; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; Miller LD, 2001, MOL CELL BIOL, V21, P6626, DOI 10.1128/MCB.21.19.6626-6639.2001; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Moreno-De-Luca A, 2011, J MED GENET, V48, P141, DOI 10.1136/jmg.2010.082263; Nijnik A, 2012, J IMMUNOL, V189, P102, DOI 10.4049/jimmunol.1200282; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Prosser HM, 2011, NAT BIOTECHNOL, V29, P843, DOI 10.1038/nbt.1929; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Schmalzigaug R, 2009, NEUROSCI LETT, V451, P156, DOI 10.1016/j.neulet.2008.12.034; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wakana S, 2009, EXP ANIM TOKYO, V58, P443, DOI 10.1538/expanim.58.443	41	337	350	0	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					452	464		10.1016/j.cell.2013.06.022	http://dx.doi.org/10.1016/j.cell.2013.06.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870131	Green Published, hybrid, Green Submitted			2022-12-01	WOS:000321950700020
J	Zheng, Y; Zhang, CJ; Croucher, DR; Soliman, MA; St-Denis, N; Pasculescu, A; Taylor, L; Tate, SA; Hardy, WR; Colwill, K; Dai, AY; Bagshaw, R; Dennis, JW; Gingras, AC; Daly, RJ; Pawson, T				Zheng, Yong; Zhang, Cunjie; Croucher, David R.; Soliman, Mohamed A.; St-Denis, Nicole; Pasculescu, Adrian; Taylor, Lorne; Tate, Stephen A.; Hardy, W. Rod; Colwill, Karen; Dai, Anna Yue; Bagshaw, Rick; Dennis, James W.; Gingras, Anne-Claude; Daly, Roger J.; Pawson, Tony			Temporal regulation of EGF signalling networks by the scaffold protein Shc1	NATURE			English	Article							TYROSINE PHOSPHATASE-PEST; ADAPTER PROTEIN; BINDING PROTEIN; BREAST-CANCER; PHOSPHORYLATION; INVOLVEMENT; ACTIVATION; DIVERSITY; GTPASE; ROLES	Cell-surface receptors frequently use scaffold proteins to recruit cytoplasmic targets, but the rationale for this is uncertain. Activated receptor tyrosine kinases, for example, engage scaffolds such as Shc1 that contain phosphotyrosine (pTyr)-binding (PTB) domains. Using quantitative mass spectrometry, here we show that mammalian Shc1 responds to epidermal growth factor (EGF) stimulation through multiple waves of distinct phosphorylation events and protein interactions. After stimulation, Shc1 rapidly binds a group of proteins that activate pro-mitogenic or survival pathways dependent on recruitment of the Grb2 adaptor to Shc1 pTyr sites. Akt-mediated feedback phosphorylation of Shc1 Ser 29 then recruits the Ptpn12 tyrosine phosphatase. This is followed by a sub-network of proteins involved in cytoskeletal reorganization, trafficking and signal termination that binds Shc1 with delayed kinetics, largely through the SgK269 pseudokinase/adaptor protein. Ptpn12 acts as a switch to convert Shc1 from pTyr/Grb2-based signalling to SgK269-mediated pathways that regulate cell invasion and morphogenesis. The Shc1 scaffold therefore directs the temporal flow of signalling information after EGF stimulation.	[Zheng, Yong; Zhang, Cunjie; Soliman, Mohamed A.; St-Denis, Nicole; Pasculescu, Adrian; Taylor, Lorne; Colwill, Karen; Dai, Anna Yue; Bagshaw, Rick; Dennis, James W.; Gingras, Anne-Claude; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Croucher, David R.] Natl Univ Ireland Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland; [Soliman, Mohamed A.; Dennis, James W.; Gingras, Anne-Claude; Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Soliman, Mohamed A.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Tate, Stephen A.] AB SCIEX, Concord, ON L4K 4V8, Canada; [Hardy, W. Rod] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Daly, Roger J.] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Daly, Roger J.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW 2010, Australia	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University College Dublin; University of Toronto; Egyptian Knowledge Bank (EKB); Cairo University; University of Massachusetts System; University of Massachusetts Worcester; Monash University; Garvan Institute of Medical Research	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	pawson@lunenfeld.ca	Colwill, Karen/K-5101-2012; Gingras, Anne-Claude/E-9982-2010; Bagshaw, Rick/B-7739-2009; Dennis, James/E-7268-2013; Gingras, Anne-Claude/ABA-8341-2020; Pawson, Tony J/E-4578-2013	Colwill, Karen/0000-0002-8979-1659; Gingras, Anne-Claude/0000-0002-6090-4437; Bagshaw, Rick/0000-0001-5013-4291; Gingras, Anne-Claude/0000-0002-6090-4437; Croucher, David/0000-0003-4965-8674; tate, stephen/0000-0001-5508-0819; Daly, Roger/0000-0002-5739-8027	Genome Canada through the Ontario Genomics Institute; Ontario Research Fund from the Ontario Ministry of Research and Innovation; Terry Fox Foundation; Canadian Institutes of Health Research [MOP-13466-6849]; Canada Foundation for Innovation; Vanier Canada Graduate Studentship; CIHR; National Health and Medical Research Council of Australia; Cancer Council New South Wales (NSW); Cancer Institute NSW	Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Research Fund from the Ontario Ministry of Research and Innovation; Terry Fox Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Vanier Canada Graduate Studentship; CIHR(Canadian Institutes of Health Research (CIHR)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council New South Wales (NSW)(Cancer Council New South Wales); Cancer Institute NSW	We thank J. Moffat for shRNA lentiviruses and K. Shokat for PI3Kp110 isoform-specific inhibitors. We thank C. Jorgensen, R. Williams, I. Louria-Hayon, R. Tian, and E. Petsalaki for critical input, A. James, V. Nguyen, and B. Larsen for technical assistance and M. M. Stacey, C. Chen and J. Jin for comments on the manuscript. Supported by Genome Canada through the Ontario Genomics Institute, the Ontario Research Fund from the Ontario Ministry of Research and Innovation, a Terry Fox Foundation team grant, the Canadian Institutes of Health Research (MOP-13466-6849), and the Canada Foundation for Innovation. M. A. S. is supported by a Vanier Canada Graduate Studentship and R. B. is supported by a CIHR postdoctoral fellowship. Support for R. J. D. was from the National Health and Medical Research Council of Australia and Cancer Council New South Wales (NSW), and for D. R. C. from Cancer Institute NSW.	Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Bisson N, 2011, NAT BIOTECHNOL, V29, P653, DOI 10.1038/nbt.1905; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Charest A, 1996, J BIOL CHEM, V271, P8424, DOI 10.1074/jbc.271.14.8424; Chen D, 1996, J BIOL CHEM, V271, P6328, DOI 10.1074/jbc.271.11.6328; Croucher DR, 2013, CANCER RES, V73, P1969, DOI 10.1158/0008-5472.CAN-12-1472; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Debily MA, 2004, HUM MOL GENET, V13, P323, DOI 10.1093/hmg/ddh024; Faisal A, 2002, J BIOL CHEM, V277, P30144, DOI 10.1074/jbc.M203229200; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hardy WR, 2007, SCIENCE, V317, P251, DOI 10.1126/science.1140114; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kondo A, 2000, MOL BIOL CELL, V11, P1315, DOI 10.1091/mbc.11.4.1315; Kuroiwa M, 2011, J CELL SCI, V124, P1726, DOI 10.1242/jcs.080291; Lai KMV, 2000, GENE DEV, V14, P1132; Lange V, 2008, MOL CELL PROTEOMICS, V7, P1489, DOI 10.1074/mcp.M800032-MCP200; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Luzi L, 2000, CURR OPIN GENET DEV, V10, P668, DOI 10.1016/S0959-437X(00)00146-5; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muller T, 2010, ONCOGENE, V29, P2393, DOI 10.1038/onc.2010.6; Okabayashi Y, 1996, J BIOL CHEM, V271, P5265; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; R Development Core Team, 2010, LANG ENV STAT COMP; Rittling SR, 1996, EXP CELL RES, V229, P7, DOI 10.1006/excr.1996.0337; Sarkar D, 2008, USE R, P1; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schmandt R, 1999, ONCOGENE, V18, P1867, DOI 10.1038/sj.onc.1202507; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Tanaka H, 2006, J BIOL CHEM, V281, P10355, DOI 10.1074/jbc.M511314200; Tashiro K, 2009, J BIOL CHEM, V284, P20206, DOI 10.1074/jbc.M109.021139; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Unwin RD, 2009, NAT PROTOC, V4, P870, DOI 10.1038/nprot.2009.57; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; Vanderlaan RD, 2011, CIRC RES, V108, P184, DOI 10.1161/CIRCRESAHA.110.233924; Wang YC, 2010, P NATL ACAD SCI USA, V107, P10920, DOI 10.1073/pnas.0914776107	41	193	202	7	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					166	+		10.1038/nature12308	http://dx.doi.org/10.1038/nature12308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23846654	Green Accepted			2022-12-01	WOS:000321557600053
J	Chaffer, CL; Marjanovic, ND; Lee, T; Bell, G; Kleer, CG; Reinhardt, F; D'Alessio, AC; Young, RA; Weinberg, RA				Chaffer, Christine L.; Marjanovic, Nemanja D.; Lee, Tony; Bell, George; Kleer, Celina G.; Reinhardt, Ferenc; D'Alessio, Ana C.; Young, Richard A.; Weinberg, Robert A.			Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HISTONE METHYLTRANSFERASE ACTIVITY; STEM-CELLS; PROTEIN; STATE; COMPLEX; RISE	The recent discovery that normal and neoplastic epithelial cells re-enter the stem cell state raised the intriguing possibility that the aggressiveness of carcinomas derives not from their existing content of cancer stem cells (CSCs) but from their proclivity to generate new CSCs from non-CSC populations. Here, we demonstrate that non-CSCs of human basal breast cancers are plastic cell populations that readily switch from a non-CSC to CSC state. The observed cell plasticity is dependent on ZEB1, a key regulator of the epithelial-mesenchymal transition. We find that plastic non-CSCs maintain the ZEB1 promoter in a bivalent chromatin configuration, enabling them to respond readily to microenvironmental signals, such as TGF beta. In response, the ZEB1 promoter converts from a bivalent to active chromatin configuration, ZEB1 transcription increases, and non-CSCs subsequently enter the CSC state. Our findings support a dynamic model in which interconversions between low and high tumorigenic states occur frequently, thereby increasing tumorigenic and malignant potential.	[Chaffer, Christine L.; Marjanovic, Nemanja D.; Lee, Tony; Bell, George; Reinhardt, Ferenc; D'Alessio, Ana C.; Young, Richard A.; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kleer, Celina G.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Young, Richard A.; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Weinberg, Robert A.] Ludwig MIT Ctr Mol Oncol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT)	Chaffer, CL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	chaffer@wi.mit.edu; weinberg@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	Advanced Medical Research Foundation (A.M.R.F.); Breast Cancer Research Foundation; NIH [HG002668, CA146445]; NATIONAL CANCER INSTITUTE [R01CA125577, P30CA014051, U01CA154224, R01CA146445] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	Advanced Medical Research Foundation (A.M.R.F.); Breast Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was largely supported by the Advanced Medical Research Foundation (A.M.R.F.), with additional support from the Breast Cancer Research Foundation (R.A.W.), and NIH grants HG002668 (R.A.Y.) and CA146445 (R.A.Y. and T.I.L.). R.A.W. is an American Cancer Society Research Professor and a Daniel K. Ludwig Foundation Cancer Research Professor. The authors thank the core Flow Cytometry Facilities at Whitehead Institute for Biomedical Research and The Koch Institute of MIT and Elinor Ng-Eaton for technical support, as well as Paul Bernath for critical review of the manuscript. R.A.Y is a founder of Syros Pharmaceuticals.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maruyama R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001369; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998	29	597	617	4	104	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					61	74		10.1016/j.cell.2013.06.005	http://dx.doi.org/10.1016/j.cell.2013.06.005			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827675	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000321327900010
J	Li, X; Erclik, T; Bertet, C; Chen, ZQ; Voutev, R; Venkatesh, S; Morante, J; Celik, A; Desplan, C				Li, Xin; Erclik, Ted; Bertet, Claire; Chen, Zhenqing; Voutev, Roumen; Venkatesh, Srinidhi; Morante, Javier; Celik, Arzu; Desplan, Claude			Temporal patterning of Drosophila medulla neuroblasts controls neural fates	NATURE			English	Article							NEURONAL SUBTYPE SPECIFICATION; CELL-DIVISION; TRANSCRIPTION FACTORS; GENE-EXPRESSION; OPTIC LOBE; IDENTITY; LINEAGE; NOTCH; COMPETENCE; SPECIFY	In the Drosophila optic lobes, the medulla processes visual information coming from inner photoreceptors R7 and R8 and from lamina neurons. It contains approximately 40,000 neurons belonging to more than 70 different types. Here we describe how precise temporal patterning of neural progenitors generates these different neural types. Five transcription factors-Homothorax, Eyeless, Sloppy paired, Dichaete and Tailless-are sequentially expressed in a temporal cascade in each of the medulla neuroblasts as they age. Loss of Eyeless, Sloppy paired or Dichaete blocks further progression of the temporal sequence. We provide evidence that this temporal sequence in neuroblasts, together with Notch-dependent binary fate choice, controls the diversification of the neuronal progeny. Although a temporal sequence of transcription factors had been identified in Drosophila embryonic neuroblasts, our work illustrates the generality of this strategy, with different sequences of transcription factors being used in different contexts.	[Li, Xin; Erclik, Ted; Bertet, Claire; Chen, Zhenqing; Venkatesh, Srinidhi; Morante, Javier; Celik, Arzu; Desplan, Claude] NYU, Dept Biol, New York, NY 10003 USA; [Voutev, Roumen] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA	New York University; Columbia University	Desplan, C (corresponding author), NYU, Dept Biol, 100 Washington Sq East, New York, NY 10003 USA.	cd38@nyu.edu	Fuss, ARZU Celik/AAD-2870-2020; Morante, Javier/E-3292-2014; Morante, Javier/P-2976-2019; Li, Xin/D-3421-2013	Fuss, ARZU Celik/0000-0001-9889-6957; Morante, Javier/0000-0002-5594-0644; Morante, Javier/0000-0002-5594-0644; Chen, Zhenqing/0000-0002-9214-9480; Voutev, Roumen/0000-0003-0066-4731; Desplan, Claude/0000-0002-6914-1413; Li, Xin/0000-0002-3428-3569	National Institutes of Health (NIH) [R01 Ey017916]; The Robert Leet and Clara Guthrie Patterson Trust Postdoctoral Fellowship; Canadian Institutes of Health Research (CIHR); EMBO [ALTF 680-2009]; HFSPO [LT000077/2010-L]; NIH [GM058575]; Leukemia and Lymphoma Society; NATIONAL EYE INSTITUTE [R01EY017916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058575] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Robert Leet and Clara Guthrie Patterson Trust Postdoctoral Fellowship; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); EMBO(European Molecular Biology Organization (EMBO)); HFSPO(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the fly community and the modENCODE team for gifts of antibodies and fly stocks. K. White, N. Negre, D. Vasiliauskas and R. Johnston contributed to screening the modENCODE antibodies. Special thanks to C.-H. Lee for sharing unpublished information and the OrtC1-gal4 line. We thank R. Mann for suggestions and reagents; and Desplan laboratory members for discussion and support, especially R. Johnston, D. Vasiliauskas and N. Neriec for critically reading the manuscript. This work was supported by National Institutes of Health (NIH) grant R01 Ey017916 to C. D.; The Robert Leet and Clara Guthrie Patterson Trust Postdoctoral Fellowship to X. L.; The Canadian Institutes of Health Research (CIHR) to T. E.; fellowships from EMBO (ALTF 680-2009) and HFSPO (LT000077/2010-L) to C. B.; NIH grant GM058575 and a Career Development fellowship from the Leukemia and Lymphoma Society to R. V.	Akiyama-Oda Y, 1999, DEVELOPMENT, V126, P1967; Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829; Ceron J, 2001, DEV BIOL, V230, P125, DOI 10.1006/dbio.2000.0110; Cleary MD, 2006, GENE DEV, V20, P429, DOI 10.1101/gad.1382206; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; Colonques J, 2007, MECH DEVELOP, V124, P327, DOI 10.1016/j.mod.2007.01.004; Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1; Egger B, 2010, DEVELOPMENT, V137, P2981, DOI 10.1242/dev.051250; Elliott J, 2008, NEURON, V60, P26, DOI 10.1016/j.neuron.2008.08.008; Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Grosskortenhaus R, 2006, GENE DEV, V20, P2618, DOI 10.1101/gad.1445306; GROSSNIKLAUS U, 1992, GENE DEV, V6, P1030, DOI 10.1101/gad.6.6.1030; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hasegawa E, 2013, DEV BIOL, V377, P90, DOI 10.1016/j.ydbio.2013.02.012; Hasegawa E, 2011, DEVELOPMENT, V138, P983, DOI 10.1242/dev.058370; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jacob J, 2008, DEVELOPMENT, V135, P3481, DOI 10.1242/dev.016931; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Kao CF, 2012, NEURON, V73, P677, DOI 10.1016/j.neuron.2011.12.018; Kohwi M, 2013, CELL, V152, P97, DOI 10.1016/j.cell.2012.11.049; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Lee T, 1999, DEVELOPMENT, V126, P4065; Lin SW, 2010, DEVELOPMENT, V137, P43, DOI 10.1242/dev.041699; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morante J., 2011, COLD SPRING HARB PRO, V2011, P653; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Morante J, 2011, DEVELOPMENT, V138, P687, DOI 10.1242/dev.056069; Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482; Ngo KT, 2010, DEV BIOL, V346, P284, DOI 10.1016/j.ydbio.2010.07.036; Novotny T, 2002, DEVELOPMENT, V129, P1027; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910; Reddy BVVG, 2010, DEVELOPMENT, V137, P2397, DOI 10.1242/dev.050013; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sato A, 2007, DEVELOPMENT, V134, P659, DOI 10.1242/dev.02786; Skeath JB, 1998, DEVELOPMENT, V125, P1857; Soustelle L, 2007, DEV DYNAM, V236, P2101, DOI 10.1002/dvdy.21232; Tran KD, 2008, DEVELOPMENT, V135, P3491, DOI 10.1242/dev.024349; Truman JW, 2010, DEVELOPMENT, V137, P53, DOI 10.1242/dev.041749; Yasugi T, 2008, DEVELOPMENT, V135, P1471, DOI 10.1242/dev.019117; Yasugi T, 2010, DEVELOPMENT, V137, P3193, DOI 10.1242/dev.048058; Yu HH, 2009, NAT NEUROSCI, V12, P947, DOI 10.1038/nn.2345	48	166	167	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					456	+		10.1038/nature12319	http://dx.doi.org/10.1038/nature12319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23783517	Green Accepted, Green Submitted			2022-12-01	WOS:000320929400046
J	Sawyers, CL				Sawyers, Charles L.			PERSPECTIVE Combined forces	NATURE			English	Editorial Material							CHRONIC MYELOID-LEUKEMIA; MUTATIONS; IMATINIB		[Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Sawyers, CL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.		Sawyers, Charles/G-5327-2016					Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Experts in Chronic Myeloid Leukemia, 2013, BLOOD, V121, P4439; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Marin D, 2012, J CLIN ONCOL, V30, P232, DOI 10.1200/JCO.2011.38.6565; Shah NP, 2007, J CLIN INVEST, V117, P2562, DOI 10.1172/JCI30890; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X	6	11	11	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					S7	S7		10.1038/498S7a	http://dx.doi.org/10.1038/498S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803949	Bronze			2022-12-01	WOS:000320929400004
J	Nelder, C				Nelder, Chris			Positive energy	NATURE			English	Editorial Material												chris@getreallist.com						American Psychological Association Task Force on the Interface between Psychology and Global Climate Change, 2009, PSYCH GLOB CLIM CHAN; International Energy Agency, 2012, WORLD EN OUTL 2012; Kahan D, 2010, NATURE, V463, P296, DOI 10.1038/463296a; Littlefield SR, 2013, ENERG POLICY, V52, P779, DOI 10.1016/j.enpol.2012.10.040; United States Energy Information Administration, 2013, TECHN REC SHAL OIL S; US Energy Information Administration, 2010, ANN EN OUTL RETR REV; Yergin Daniel, 2011, WALL STREET J	7	3	3	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					293	295		10.1038/498293a	http://dx.doi.org/10.1038/498293a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166XI	23783612				2022-12-01	WOS:000320592900013
J	Cnattingius, S; Villamor, E; Johansson, S; Bonamy, AKE; Persson, M; Wikstrom, AK; Granath, F				Cnattingius, Sven; Villamor, Eduardo; Johansson, Stefan; Bonamy, Anna-Karin Edstedt; Persson, Martina; Wikstrom, Anna-Karin; Granath, Fredrik			Maternal Obesity and Risk of Preterm Delivery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; GESTATIONAL WEIGHT-GAIN; VISCERAL FAT; BIRTH; PREGNANCY; EPIDEMIOLOGY; ULTRASOUND; WOMEN; OVERWEIGHT; VALIDITY	Importance Preterm birth is a leading cause of infant mortality, morbidity, and long-term disability, and these risks increase with decreasing gestational age. Obesity increases the risk of preterm delivery, but the associations between overweight and obesity and subtypes of preterm delivery are not clear. Objective To study the associations between early pregnancy body mass index (BMI) and risk of preterm delivery by gestational age and by precursors of preterm delivery. Design, Setting, and Participants Population-based cohort study of women with live singleton births in Sweden from 1992 through 2010. Maternal and pregnancy characteristics were obtained from the nationwide Swedish Medical Birth Register. Main Outcomes and Measures Risks of preterm deliveries (extremely, 22-27 weeks; very, 28-31 weeks; and moderately, 32-36 weeks). These outcomes were further characterized as spontaneous (related to preterm contractions or preterm premature rupture of membranes) and medically indicated preterm delivery (cesarean delivery before onset of labor or induced onset of labor). Risk estimates were adjusted for maternal age, parity, smoking, education, height, mother's country of birth, and year of delivery. Results Among 1 599 551 deliveries with information on early pregnancy BMI, 3082 were extremely preterm, 6893 were very preterm, and 67 059 were moderately preterm. Risks of extremely, very, and moderately preterm deliveries increased with BMI and the overweight and obesity-related risks were highest for extremely preterm delivery. Among normal-weight women (BMI 18.5-<25), the rate of extremely preterm delivery was 0.17%. As compared with normal-weight women, rates (%) and adjusted odds ratios (ORs [95% CIs]) of extremely preterm delivery were as follows: BMI 25 to less than 30 (0.21%; OR, 1.26; 95% CI, 1.15-1.37), BMI 30 to less than 35 (0.27%; OR, 1.58; 95% CI, 1.39-1.79), BMI 35 to less than 40 (0.35%; OR, 2.01; 95% CI, 1.66-2.45), and BMI of 40 or greater (0.52%; OR, 2.99; 95% CI, 2.28-3.92). Risk of spontaneous extremely preterm delivery increased with BMI among obese women (BMI >= 30). Risks of medically indicated preterm deliveries increased with BMI among overweight and obese women. Conclusions and Relevance In Sweden, maternal overweight and obesity during pregnancy were associated with increased risks of preterm delivery, especially extremely preterm delivery. These associations should be assessed in other populations.	[Cnattingius, Sven; Johansson, Stefan; Bonamy, Anna-Karin Edstedt; Persson, Martina; Wikstrom, Anna-Karin; Granath, Fredrik] Karolinska Inst, Karolinska Univ Hosp, Clin Epidemiol Unit, Dept Med Solna, SE-17176 Stockholm, Sweden; [Persson, Martina] Karolinska Inst, Dept Clin Sci Intervent & Technol, SE-17176 Stockholm, Sweden; [Villamor, Eduardo] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Wikstrom, Anna-Karin] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Michigan System; University of Michigan; Uppsala University	Cnattingius, S (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Clin Epidemiol Unit, Dept Med Solna, T2, SE-17176 Stockholm, Sweden.	sven.cnattingius@ki.se	Bonamy, Anna-Karin E/B-7106-2012; Persson, Martina/B-7667-2015	Bonamy, Anna-Karin E/0000-0003-4552-9912; Persson, Martina/0000-0003-2268-3159; Johansson, Stefan/0000-0001-8832-6918	Karolinska Institutet	Karolinska Institutet(Karolinska Institutet)	The study was funded by grants from Karolinska Institutet (Distinguished Professor Award to Dr Cnattingius).	Aviram A, 2011, INT J GYNECOL OBSTET, V115, pS6, DOI 10.1016/S0020-7292(11)60004-0; Bartha JL, 2007, OBESITY, V15, P2233, DOI 10.1038/oby.2007.265; Behrman, PRETERM BIRTH CAUSES; Caughey AB, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.034; Dalenius K, 2012, PREGNANCY NUTR SURVE; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; HACK M, 1993, NEW ENGL J MED, V329, P1649, DOI 10.1056/NEJM199311253292210; Hedderson MM, 2010, OBSTET GYNECOL, V115, P597, DOI 10.1097/AOG.0b013e3181cfce4f; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; Hutcheon JA, 2012, PAEDIATR PERINAT EP, V26, P109, DOI 10.1111/j.1365-3016.2011.01254.x; Jarvie E, 2010, CLIN SCI, V119, P123, DOI 10.1042/CS20090640; Khatibi A, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.002; Lucca A, 2010, CAD SAUDE PUBLICA, V26, P110, DOI 10.1590/S0102-311X2010000100012; McDonald SD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3428; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; NAEYE RL, 1990, AM J CLIN NUTR, V52, P273, DOI 10.1093/ajcn/52.2.273; Nohr EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008444; Nohr EA, 2007, PAEDIATR PERINAT EP, V21, P5, DOI 10.1111/j.1365-3016.2007.00762.x; Raisanen S, PLOS ONE, DOI [10.1371/journal.pone.0060660/PONE-D-13-04948, DOI 10.1371/JOURNAL.PONE.0060660/PONE-D-13-04948]; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6; Salihu H, 2010, J MATERN-FETAL NEO M, V23, P1444, DOI 10.3109/14767051003678044; Sarris I, 2010, HUM REPROD, V25, P1895, DOI 10.1093/humrep/deq132; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Simmons LE, 2010, SEMIN PERINATOL, V34, P408, DOI 10.1053/j.semperi.2010.09.005; Soltani H, 2000, BRIT J NUTR, V84, P95, DOI 10.1017/S0007114500001276; The Swedish Centre for Epidemiology, SWED MED BIRTH REG S; Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561; Tucker J, 2004, BRIT MED J, V329, P675, DOI 10.1136/bmj.329.7467.675; United States Department of Health and Human Services ; Centers for Disease Control and Prevention; National Center for Health Statistics, LINK BIRTH INF DEATH; Wei SY, 2009, OBESITY, V17, P1070, DOI 10.1038/oby.2008.641; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; World Health Organisation (WHO), GLOB DAT BOD MASS IN	38	409	421	3	82	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2013	309	22					2362	2370		10.1001/jama.2013.6295	http://dx.doi.org/10.1001/jama.2013.6295			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161EV	23757084	Bronze			2022-12-01	WOS:000320176000026
J	Thomsen, M; Ingebrigtsen, TS; Marott, JL; Dahl, M; Lange, P; Vestbo, J; Nordestgaard, BG				Thomsen, Mette; Ingebrigtsen, Truls Sylvan; Marott, Jacob Louis; Dahl, Morten; Lange, Peter; Vestbo, Jorgen; Nordestgaard, Borge G.			Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISCHEMIC-HEART-DISEASE; C-REACTIVE PROTEIN; SYSTEMIC INFLAMMATION; COPD EXACERBATIONS; PLASMA-FIBRINOGEN; RISK; ASSOCIATION; POPULATION; PREDICTION; INFECTION	Importance Exacerbations of respiratory symptoms in chronic obstructive pulmonary disease (COPD) have profound and long-lasting adverse effects on patients. Objective To test the hypothesis that elevated levels of inflammatory biomarkers in individuals with stable COPD are associated with an increased risk of having exacerbations. Design, Setting, and Participants Prospective cohort study examining 61 650 participants with spirometry measurements from the Copenhagen City Heart Study (20012003) and the Copenhagen General Population Study (2003-2008). Of these, 6574 had COPD, defined as a ratio between forced expiratory volume in 1 second (FEV1) and forced vital capacity below 0.7. Main Outcomes and Measures Baseline levels of C-reactive protein (CRP) and fibrinogen and leukocyte count were measured in participants at a time when they were not experiencing symptoms of exacerbations. Exacerbations were recorded and defined as short-course treatment with oral corticosteroids alone or in combination with an antibiotic or as a hospital admission due to COPD. Levels of CRP and fibrinogen and leukocyte count were defined as high or low according to cut points of 3 mg/L, 14 mu mol/L, and 9 x 10(9)/L, respectively. Results During follow-up, 3083 exacerbations were recorded (mean, 0.5/participant). In the first year of follow-up, multivariable-adjusted odds ratios for having frequent exacerbations were 1.2 (95% CI, 0.7-2.2; 17 events/1000 person-years) for individuals with 1 high biomarker, 1.7 (95% CI, 0.9-3.2; 32 events/1000 person-years) for individuals with 2 high biomarkers, and 3.7 (95% CI, 1.9-7.4; 81 events/1000 person-years) for individuals with 3 high biomarkers compared with individuals who had no elevated biomarkers (9 events/1000 person-years; trend: P=2 x 10(-5)). Corresponding hazard ratios using maximum follow-up time were 1.4 (95% CI, 1.1-1.8), 1.6 (95% CI, 1.3-2.2), and 2.5 (95% CI, 1.8-3.4), respectively (trend: P=1 x 10(-8)). The addition of inflammatory biomarkers to a basic model including age, sex, FEV1 percent predicted, smoking, use of any inhaled medication, body mass index, history of previous exacerbations, and time since most recent prior exacerbation improved the C statistics from 0.71 to 0.73 (comparison: P=9 x 10(-5)). Relative risks were consistent in those with milder COPD, in those with no history of frequent exacerbations, and in the 2 studies separately. The highest 5-year absolute risks of having frequent exacerbations in those with 3 high biomarkers (vs no high biomarkers) were 62% (vs 24%) for those with Global Initiative for Chronic Obstructive Lung Disease (GOLD) grades C-D (n=558), 98% (vs 64%) in those with a history of frequent exacerbations (n=127), and 52% (vs 15%) for those with GOLD grades 3-4 (n=465). Conclusions and Relevance Simultaneously elevated levels of CRP and fibrinogen and leukocyte count in individuals with COPD were associated with increased risk of having exacerbations, even in those with milder COPD and in those without previous exacerbations. Further investigation is needed to determine the clinical value of these biomarkers for risk stratification.	[Thomsen, Mette; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Thomsen, Mette; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, DK-2730 Herlev, Denmark; [Ingebrigtsen, Truls Sylvan; Marott, Jacob Louis; Lange, Peter; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Frederiksberg, Denmark; [Dahl, Morten] Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark; [Lange, Peter] Copenhagen Univ Hosp, Hvidovre Hosp, Resp Sect, Hvidovre, Denmark; [Thomsen, Mette; Dahl, Morten; Lange, Peter; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Lange, Peter] Univ Copenhagen, Dept Publ Hlth, Sect Social Med, Copenhagen, Denmark; [Ingebrigtsen, Truls Sylvan; Vestbo, Jorgen] Univ Southern Denmark, Odense Univ Hosp, Dept Resp Med, Odense, Denmark; [Vestbo, Jorgen] Univ Hosp South Manchester NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Resp Res Grp, Manchester, Lancs, England	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	boerge.nordestgaard@regionh.dk	Vestbo, Jorgen/Y-2912-2019; Dahl, Morten/F-4219-2014	Vestbo, Jorgen/0000-0001-6355-6362; Dahl, Morten/0000-0002-6686-312X; Nordestgaard, Borge/0000-0002-1954-7220	Herlev Hospital from Denmark; Copenhagen University Hospital from Denmark; Danish Heart Foundation from Denmark; Copenhagen County Foundation from Denmark; University of Copenhagen from Denmark	Herlev Hospital from Denmark; Copenhagen University Hospital from Denmark; Danish Heart Foundation from Denmark; Copenhagen County Foundation from Denmark; University of Copenhagen from Denmark	This work was supported by Herlev Hospital, Copenhagen University Hospital, the Danish Heart Foundation, the Copenhagen County Foundation, and the University of Copenhagen, all from Denmark.	Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; [Anonymous], 2010, INT CLASS DIS 2010; Cazzola M, 2012, EUR RESPIR J, V40, P724, DOI 10.1183/09031936.00213711; Celli BR, 2007, EUR RESPIR J, V29, P1224, DOI 10.1183/09031936.00109906; Celli BR, 2012, AM J RESP CRIT CARE, V185, P1065, DOI 10.1164/rccm.201110-1792OC; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Dahl M, 2001, AM J RESP CRIT CARE, V164, P1008, DOI 10.1164/ajrccm.164.6.2010067; Dahl M, 2007, AM J RESP CRIT CARE, V175, P250, DOI 10.1164/rccm.200605-713OC; Dahl M, 2011, THORAX, V66, P197, DOI 10.1136/thx.2009.131193; Dentener MA, 2001, THORAX, V56, P721, DOI 10.1136/thorax.56.9.721; Dickens JA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-146; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Groenewegen KH, 2008, CHEST, V133, P350, DOI 10.1378/chest.07-1342; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hogg JC, 2001, AM J RESP CRIT CARE, V164, pS71, DOI 10.1164/ajrccm.164.supplement_2.2106063; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Juul K, 2004, ANN INTERN MED, V140, P330, DOI 10.7326/0003-4819-140-5-200403020-00008; Kessler R, 2006, CHEST, V130, P133, DOI 10.1378/chest.130.1.133; Lange P, 2012, AM J RESP CRIT CARE, V186, P975, DOI 10.1164/rccm.201207-1299OC; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Mallia P, 2011, AM J RESP CRIT CARE, V183, P734, DOI 10.1164/rccm.201006-0833OC; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Powrie DJ, 2007, EUR RESPIR J, V30, P472, DOI 10.1183/09031936.00023907; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; SENEFF MG, 1995, JAMA-J AM MED ASSOC, V274, P1852, DOI 10.1001/jama.274.23.1852; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Thomsen M, 2012, AM J RESP CRIT CARE, V186, P982, DOI 10.1164/rccm.201206-1113OC; Thomsen RW, 2011, RESP MED, V105, P1063, DOI 10.1016/j.rmed.2011.01.012; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wedzicha JA, 2000, THROMB HAEMOSTASIS, V84, P210; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830; WHO Collaborating Centre for Drug Statistics Methodology, ATC DDD IND 2013; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	39	265	278	1	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2013	309	22					2353	2361		10.1001/jama.2013.5732	http://dx.doi.org/10.1001/jama.2013.5732			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161EV	23757083	Green Published, Bronze			2022-12-01	WOS:000320176000025
J	Cohen, D				Cohen, Deborah			DIABETES DRUGS Has pancreatic damage from glucagon suppressing diabetes drugs been underplayed?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALPHA CELL HYPERPLASIA; HYPERINSULINEMIC HYPOGLYCEMIA; RECEPTOR ACTIVATION; PEPTIDE-1 ANALOG; LIRAGLUTIDE; ENDOCRINE; RATS; HYPERGLUCAGONEMIA; GLUCOSE		BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						Bergenstal RM, 2010, LANCET, V376, P431, DOI 10.1016/S0140-6736(10)60590-9; Bernstein Research, 2009, NOV LILL GLP 1S BYET; Bock T, 2003, APMIS, V111, P1117, DOI 10.1111/j.1600-0463.2003.apm1111207.x; Buse JB, 2013, LANCET, V381, P117, DOI 10.1016/S0140-6736(12)61267-7; Butler AE, 2013, DIABETES; Butler PC, 2013, DIABETES CARE; Campbell JE, 2013, CELL METAB; Cohen D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1808; Cummings BP, 2010, DIABETES, V59, P2653, DOI 10.2337/db09-1564; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gier B, 2012, DIABETES, V61, P1250, DOI 10.2337/db11-1109; Hirschler B, 2012, REUTERS; Institute for Safe Medication Practices, 2013, PERSP GLP 1 AG DIAB; Koehler JA, 2009, DIABETES, V58, P2148, DOI 10.2337/db09-0626; Matveyenko AV, 2009, DIABETES, V58, P1604, DOI 10.2337/db09-0058; Nauck MA:, 2013, DIABETES CARE; Nyborg NCB, 2012, DIABETES, V61, P1243, DOI 10.2337/db11-0936; Rabiee A, 2011, J SURG RES, V167, P199, DOI 10.1016/j.jss.2010.09.047; Raun K, 2007, DIABETES, V56, P8, DOI 10.2337/db06-0565; Service GJ, 2005, NEW ENGL J MED, V353, P249, DOI 10.1056/NEJMoa043690; Singh S, 2013, JAMA INTERN MED, V173, P534, DOI 10.1001/jamainternmed.2013.2720; Sloop KW, 2004, J CLIN INVEST, V113, P1571, DOI 10.1172/JCI200420911; Stearns Bear, TYPE 2 DIAB OUR THOU; Tatarkiewicz K, 2013, DIABETES OBES METAB, V15, P417, DOI 10.1111/dom.12040; Vrang N, 2012, AM J PHYSIOL-ENDOC M, V303, pE253, DOI 10.1152/ajpendo.00182.2012; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021255; Zhou CQ, 2009, PANCREAS, V38, P941, DOI 10.1097/MPA.0b013e3181b2bb03	29	38	39	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2013	346								f3680	10.1136/bmj.f3680	http://dx.doi.org/10.1136/bmj.f3680			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166VK	23748128				2022-12-01	WOS:000320586700013
J	Spence, D				Spence, Des			Bad medicine: statins	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONARY-HEART-DISEASE; DECLINE					destwo@yahoo.co.uk						Bandosz P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8136; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P649; Health and Social Care Information Centre, 2013, PRESCR COST AN ENGL; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Thompson RC, 2013, LANCET, V381, P1211, DOI 10.1016/S0140-6736(13)60598-X; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3	8	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2013	346								f3566	10.1136/bmj.f3566	http://dx.doi.org/10.1136/bmj.f3566			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DQ	23729321				2022-12-01	WOS:000319949200007
J	Fiorillo, CD				Fiorillo, Christopher D.			Two Dimensions of Value: Dopamine Neurons Represent Reward But Not Aversiveness	SCIENCE			English	Article							ROSTROMEDIAL TEGMENTAL NUCLEUS; LATERAL HABENULA; STIMULI; RESPONSES; SIGNALS; DIFFERENCE; PREDICTION; PUNISHMENT; ACTIVATION; AVOIDANCE	Whereas reward (appetitiveness) and aversiveness (punishment) have been distinguished as two discrete dimensions within psychology and behavior, physiological and computational models of their neural representation have treated them as opposite sides of a single continuous dimension of "value." Here, I show that although dopamine neurons of the primate ventral midbrain are activated by evidence for reward and suppressed by evidence against reward, they are insensitive to aversiveness. This indicates that reward and aversiveness are represented independently as two dimensions, even by neurons that are closely related to motor function. Because theory and experiment support the existence of opponent neural representations for value, the present results imply four types of value-sensitive neurons corresponding to reward-ON (dopamine), reward-OFF, aversive-ON, and aversive-OFF.	Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Fiorillo, CD (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, 291 Daehak Ro,Bldg 611, Taejon 305701, South Korea.	fiorillo@kaist.ac.kr	Fiorillo, Christopher Dante/C-1718-2011	Fiorillo, Christopher/0000-0002-7232-9505	Basic Science Research Program [2012R1A1A2006996]; World Class University (WCU) program of the National Research Foundation of Korea (NRF) [R32-2008-000-10218-0]; Ministry of Education, Science and Technology; Howard Hughes Medical Institute	Basic Science Research Program; World Class University (WCU) program of the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	I thank W. T. Newsome for advice and helpful discussions, J. R. Brown for excellent technical assistance, and W. A. Phillips, J. R. Wickens, and M. R. Song for constructive comments on the manuscript. Research was supported by grants from the Basic Science Research Program (2012R1A1A2006996) and World Class University (WCU) program (R32-2008-000-10218-0) of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, and a grant to W. T. Newsome from the Howard Hughes Medical Institute.	Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dayan P, 2009, ANNU REV NEUROSCI, V32, P95, DOI 10.1146/annurev.neuro.051508.135607; Fiorillo CD, 2011, NEUROSCIENCE, V197, P162, DOI 10.1016/j.neuroscience.2011.09.037; Fiorillo CD, 2013, J NEUROSCI, V33, P4710, DOI 10.1523/JNEUROSCI.3883-12.2013; Fiorillo CD, 2013, J NEUROSCI, V33, P4693, DOI 10.1523/JNEUROSCI.3886-12.2013; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Moutoussis M, 2008, NETWORK-COMP NEURAL, V19, P137, DOI 10.1080/09548980802192784; Oleson EB, 2012, J NEUROSCI, V32, P14804, DOI 10.1523/JNEUROSCI.3087-12.2012; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Ravel S, 2003, J NEUROSCI, V23, P8489; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Skinner B. F., 1969, CONTINGENCIES OF REI; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tobler PN, 2003, J NEUROSCI, V23, P10402; Wang DV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017047	26	127	127	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					546	549		10.1126/science.1238699	http://dx.doi.org/10.1126/science.1238699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908236				2022-12-01	WOS:000322586700053
J	Mahler, DL; Ingram, T; Revell, LJ; Losos, JB				Mahler, D. Luke; Ingram, Travis; Revell, Liam J.; Losos, Jonathan B.			Exceptional Convergence on the Macroevolutionary Landscape in Island Lizard Radiations	SCIENCE			English	Article							ADAPTIVE RADIATION; ECOLOGICAL OPPORTUNITY; STABILIZING SELECTION; EVOLUTION; MODELS; DIVERSIFICATION; DETERMINISM; CONTINGENCY; SPECIATION; DIVERSITY	G. G. Simpson, one of the chief architects of evolutionary biology's modern synthesis, proposed that diversification occurs on a macroevolutionary adaptive landscape, but landscape models are seldom used to study adaptive divergence in large radiations. We show that for Caribbean Anolis lizards, diversification on similar Simpsonian landscapes leads to striking convergence of entire faunas on four islands. Parallel radiations unfolding at large temporal scales shed light on the process of adaptive diversification, indicating that the adaptive landscape may give rise to predictable evolutionary patterns in nature, that adaptive peaks may be stable over macroevolutionary time, and that available geographic area influences the ability of lineages to discover new adaptive peaks.	[Mahler, D. Luke] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Ingram, Travis; Losos, Jonathan B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Revell, Liam J.] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	University of California System; University of California Davis; Harvard University; University of Massachusetts System; University of Massachusetts Boston	Mahler, DL (corresponding author), Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA.	lmahler@ucdavis.edu	Revell, Liam J/AAF-1151-2019; Ingram, Travis/HCI-1116-2022	Revell, Liam J/0000-0003-0767-4713; Ingram, Travis/0000-0003-0709-5260	National Evolutionary Synthesis Center; NSF	National Evolutionary Synthesis Center; NSF(National Science Foundation (NSF))	We thank G. Bradburd, C. Davis, L. Harmon, and F. Jenkins for discussion and advice; the National Evolutionary Synthesis Center and NSF for financial support; and three anonymous reviewers for insightful feedback. Data are archived in Dryad (http://datadryad.org, doi: 10.5061/dryad.9g182).	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; CODY ML, 1978, ANNU REV ECOL SYST, V9, P265, DOI 10.1146/annurev.es.09.110178.001405; Conte GL, 2012, P ROY SOC B-BIOL SCI, V279, P5039, DOI 10.1098/rspb.2012.2146; Estes S, 2007, AM NAT, V169, P227, DOI 10.1086/510633; Frederich B, 2013, AM NAT, V181, P94, DOI 10.1086/668599; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Givnish T.J., 1999, BIOL BIODIVERSITY, P67; Gould S.J., 1989, WONDERFUL LIFE BURGE; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Hansen TF, 2012, ADAPTIVE LANDSCAPE IN EVOLUTIONARY BIOLOGY, P205; Harmon LJ, 2010, EVOLUTION, V64, P2385, DOI 10.1111/j.1558-5646.2010.01025.x; Ingram T, 2013, METHODS ECOL EVOL, V4, P416, DOI 10.1111/2041-210X.12034; Kassen R, 2009, ANN NY ACAD SCI, V1168, P3, DOI 10.1111/j.1749-6632.2009.04574.x; Kisel Y, 2010, AM NAT, V175, P316, DOI 10.1086/650369; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Mahler DL, 2010, EVOLUTION, V64, P2731, DOI 10.1111/j.1558-5646.2010.01026.x; Muschick M, 2012, CURR BIOL, V22, P2362, DOI 10.1016/j.cub.2012.10.048; Pinto G, 2008, P ROY SOC B-BIOL SCI, V275, P2749, DOI 10.1098/rspb.2008.0686; Rabosky DL, 2010, P NATL ACAD SCI USA, V107, P22178, DOI 10.1073/pnas.1007606107; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Stayton CT, 2008, J THEOR BIOL, V252, P1, DOI 10.1016/j.jtbi.2008.01.008; Stiassny MLJ, 1999, SCI AM, V280, P64, DOI 10.1038/scientificamerican0299-64; Svensson EI, 2012, ADAPTIVE LANDSCAPE IN EVOLUTIONARY BIOLOGY, P1; Thomas GH, 2012, METHODS ECOL EVOL, V3, P145, DOI 10.1111/j.2041-210X.2011.00132.x; Uyeda JC, 2011, P NATL ACAD SCI USA, V108, P15908, DOI 10.1073/pnas.1014503108; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144; Williams E.E., 1983, P326; Young KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004740	32	287	289	2	238	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2013	341	6143					292	295		10.1126/science.1232392	http://dx.doi.org/10.1126/science.1232392			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869019				2022-12-01	WOS:000321959300048
J	Quental, TB; Marshall, CR				Quental, Tiago B.; Marshall, Charles R.			How the Red Queen Drives Terrestrial Mammals to Extinction	SCIENCE			English	Article							NORTH-AMERICAN MAMMALS; FOSSIL RECORD; COURT JESTER; DIVERSITY; DIVERSIFICATION; EVOLUTION; HISTORY	Most species disappear by the processes of background extinction, yet those processes are poorly understood. We analyzed the evolutionary dynamics of 19 Cenozoic terrestrial mammalian clades with rich fossil records that are now fully extinct or in diversity decline. We find their diversity loss was not just a consequence of "gamblers ruin" but resulted from the evolutionary loss to the Red Queen, a failure to keep pace with a deteriorating environment. Diversity loss is driven equally by both depressed origination rates and elevated extinction rates. Although we find diversity-dependent origination and extinction rates, the diversity of each clade only transiently equaled the implied equilibrium diversity. Thus, the processes that drove diversity loss in terrestrial mammal clades were fundamentally nonequilibrial and overwhelmed diversity-dependent processes.	[Quental, Tiago B.] Univ Sao Paulo, Dept Ecol, Sao Paulo, Brazil; [Marshall, Charles R.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA	Universidade de Sao Paulo; University of California System; University of California Berkeley	Quental, TB (corresponding author), Univ Sao Paulo, Dept Ecol, Sao Paulo, Brazil.	tbquental@usp.br; crmarshall@berkeley.edu	Quental, Tiago B/C-7077-2013		Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/04072-3]; USP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); USP	We thank all those who generated the mammal data as well as those who entered the data into the Paleobiology Database, especially J. Alroy, K. Behrensmeyer, A. Turner, M. Uhen, and M. Carrano. This is the Paleobiology Database publication number 178. We thank S. Finnegan, H. Morlon, and S. P. Quek for discussion. T. B. Q. thanks Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2012/04072-3) and USP for funding. All of the data are available from the Paleobiology Database (http://paleodb.org).	Alroy J, 1996, PALAEOGEOGR PALAEOCL, V127, P285, DOI 10.1016/S0031-0182(96)00100-9; Alroy John, 2009, P301; Bambach RK, 2006, ANNU REV EARTH PL SC, V34, P127, DOI 10.1146/annurev.earth.33.092203.122654; Bambach RK, 2004, PALEOBIOLOGY, V30, P522, DOI 10.1666/0094-8373(2004)030<0522:OEAMDO>2.0.CO;2; Barnosky AD, 2001, J VERTEBR PALEONTOL, V21, P172, DOI 10.1671/0272-4634(2001)021[0172:DTEOTR]2.0.CO;2; Benton MJ, 2007, PALAEONTOLOGY, V50, P23, DOI 10.1111/j.1475-4983.2006.00612.x; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Foote M, 2007, PALEOBIOLOGY, V33, P517, DOI 10.1666/06084.1; Gilinsky L., 1987, PALEOBIOLOGY, V13, P427; MAC ARTHUR ROBERT H., 1967; RAUP DM, 1973, J GEOL, V81, P525, DOI 10.1086/627905; RAUP DM, 1986, SCIENCE, V231, P1528, DOI 10.1126/science.11542058; SEPKOSKI JJ, 1981, PALEOBIOLOGY, V7, P36, DOI 10.1017/S0094837300003778; STANLEY SM, 1981, PALEOBIOLOGY, V7, P115, DOI 10.1017/S0094837300003833; Stanley SM, 2008, PALEOBIOLOGY, V34, P1, DOI 10.1666/07026.1; Stanley SM, 2007, PALEOBIOLOGY, V33, P1, DOI 10.1666/06020.1; Tolkien J. R. R., 2012, LORD RINGS; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x	19	82	83	2	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					290	292		10.1126/science.1239431	http://dx.doi.org/10.1126/science.1239431			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23788731				2022-12-01	WOS:000321959300047
J	Almada, AE; Wu, XB; Kriz, AJ; Burge, CB; Sharp, PA				Almada, Albert E.; Wu, Xuebing; Kriz, Andrea J.; Burge, Christopher B.; Sharp, Phillip A.			Promoter directionality is controlled by U1 snRNP and polyadenylation signals	NATURE			English	Article							PRE-MESSENGER-RNAS; DIVERGENT TRANSCRIPTION; UPSTREAM; CLEAVAGE; SEQUENCE; REVEALS; TERMINATION; DOWNSTREAM; EXOSOME	Transcription of the mammalian genome is pervasive, but productive transcription outside of protein-coding genes is limited by unknown mechanisms(1). In particular, although RNA polymerase II (RNAPII) initiates divergently from most active gene promoters, productive elongation occurs primarily in the sense-coding direction(2-4). Here we show in mouse embryonic stem cells that asymmetric sequence determinants flanking gene transcription start sites control promoter directionality by regulating promoter-proximal cleavage and polyadenylation. We find that upstream antisense RNAs are cleaved and polyadenylated at poly(A) sites (PASs) shortly after initiation. De novo motif analysis shows PAS signals and U1 small nuclear ribonucleoprotein (snRNP) recognition sites to be the most depleted and enriched sequences, respectively, in the sense direction relative to the upstream antisense direction. These U1 snRNP sites and PAS sites are progressively gained and lost, respectively, at the 5' end of coding genes during vertebrate evolution. Functional disruption of U1 snRNP activity results in a dramatic increase in promoter-proximal cleavage events in the sense direction with slight increases in the antisense direction. These data suggest that a U1-PAS axis characterized by low U1 snRNP recognition and a high density of PASs in the upstream antisense region reinforces promoter directionality by promoting early termination in upstream antisense regions, whereas proximal sense PAS signals are suppressed by U1 snRNP. We propose that the U1-PAS axis limits pervasive transcription throughout the genome.	[Almada, Albert E.; Wu, Xuebing; Sharp, Phillip A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Almada, Albert E.; Kriz, Andrea J.; Burge, Christopher B.; Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Wu, Xuebing; Burge, Christopher B.] MIT, Computat & Syst Biol Grad Program, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu	Wu, Xuebing/C-9152-2013; Burge, Christopher B./AAH-2177-2020	Wu, Xuebing/0000-0003-0369-5269; 	United States Public Health Service grants from the National Institutes of Health [RO1-GM34277, R01-CA133404]; National Cancer Institute [P30-CA14051]; Public Health Service research grant from the National Institute of General Medical Sciences [M-085319]; NATIONAL CANCER INSTITUTE [R01CA133404, P01CA042063, P30CA014051] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277, R01GM085319] Funding Source: NIH RePORTER	United States Public Health Service grants from the National Institutes of Health; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Public Health Service research grant from the National Institute of General Medical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the service to the MIT community of the late Sean Collier. We would like to thank N. Spies for generously sharing his optimized 3'-end sequencing protocol, C. Lin for providing computational assistance, M. Lindstrom for assistance on constructing Supplementary Figure 11, and S. Chen, A. Chiu, M. Jangi, Q. Liu, J. Wilusz and J. Zamudio for reading of the manuscript. We also thank the Core Facility in the Swanson Biotechnology Center at the David H. Koch Institute for Integrative Cancer Research at MIT for their assistance with high-throughput sequencing. This work was supported by United States Public Health Service grants RO1-GM34277 and R01-CA133404 from the National Institutes of Health (P. A. S.), partially by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute, and by a Public Health Service research grant (G<SUP>M</SUP>-085319) from the National Institute of General Medical Sciences (C. B. B.). X. W. is a Howard Hughes Medical Institute International Student Research fellow.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Andersen PK, 2012, GENE DEV, V26, P2169, DOI 10.1101/gad.189126.112; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; CONNELLY S, 1989, CELL, V57, P561, DOI 10.1016/0092-8674(89)90126-8; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; GIL A, 1987, CELL, V49, P399, DOI 10.1016/0092-8674(87)90292-3; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; MACDONALD CC, 1994, MOL CELL BIOL, V14, P6647, DOI 10.1128/MCB.14.10.6647; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Martin M., 2011, EMBNETJ, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Preker P, 2011, NUCLEIC ACIDS RES, V39, P7179, DOI 10.1093/nar/gkr370; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xie C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002942; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang L, 2013, BIOCHEM BIOPH RES CO, V430, P26, DOI 10.1016/j.bbrc.2012.11.052; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	34	274	279	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2013	499	7458					360	U141		10.1038/nature12349	http://dx.doi.org/10.1038/nature12349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23792564	Green Submitted, Green Accepted			2022-12-01	WOS:000321910700041
J	Laxman, S; Sutter, BM; Wu, X; Kumar, S; Guo, XF; Trudgian, DC; Mirzaei, H; Tu, BP				Laxman, Sunil; Sutter, Benjamin M.; Wu, Xi; Kumar, Sujai; Guo, Xiaofeng; Trudgian, David C.; Mirzaei, Hamid; Tu, Benjamin P.			Sulfur Amino Acids Regulate Translational Capacity and Metabolic Homeostasis through Modulation of tRNA Thiolation	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; ELONGATOR COMPLEX; THIO-MODIFICATION; MODIFIER URM1; CELL-GROWTH; YEAST; PATHWAY; SYSTEM; CYCLE; MECHANISM	Protein translation is an energetically demanding process that must be regulated in response to changes in nutrient availability. Herein, we report that intracellular methionine and cysteine availability directly controls the thiolation status of wobble-uridine (U-34) nucleotides present on lysine, glutamine, or glutamate tRNAs to regulate cellular translational capacity and metabolic homeostasis. tRNA thiolation is important for growth under nutritionally challenging environments and required for efficient translation of genes enriched in lysine, glutamine, and glutamate codons, which are enriched in proteins important for translation and growth-specific processes. tRNA thiolation is downregulated during sulfur starvation in order to decrease sulfur consumption and growth, and its absence leads to a compensatory increase in enzymes involved in methionine, cysteine, and lysine biosynthesis. Thus, tRNA thiolation enables cells to modulate translational capacity according to the availability of sulfur amino acids, establishing a functional significance for this conserved tRNA nucleotide modification in cell growth control.	[Laxman, Sunil; Sutter, Benjamin M.; Wu, Xi; Guo, Xiaofeng; Trudgian, David C.; Mirzaei, Hamid; Tu, Benjamin P.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kumar, Sujai] Univ Edinburgh, Ashworth Labs, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Edinburgh	Tu, BP (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	benjamin.tu@utsouthwestern.edu	Laxman, Sunil/F-9886-2018; Trudgian, David/D-4785-2012; Kumar, Sujai/D-1768-2011	Laxman, Sunil/0000-0002-0861-5080; Trudgian, David/0000-0002-7084-6787; Kumar, Sujai/0000-0001-5902-6641	UTSW Endowed Scholars Program; Welch Foundation [I-1797]; NIGMS [R01GM094314]; Burroughs Wellcome Fund; David and Lucile Packard Foundation; Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094314] Funding Source: NIH RePORTER	UTSW Endowed Scholars Program; Welch Foundation(The Welch Foundation); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Uttam Tambar for suggestions during the synthesis of APM; Randal Halfmann, Paul Dutchak, and members of the Tu Lab for extensive discussions and critical input. This work was supported by the UTSW Endowed Scholars Program, the Welch Foundation (I-1797), award R01GM094314 from NIGMS, the Burroughs Wellcome Fund, the David and Lucile Packard Foundation, and the Damon Runyon Cancer Research Foundation. B.P.T. is a consultant and shareholder of Peloton Therapeutics.	Abdullah U, 2009, EUKARYOT CELL, V8, P1362, DOI 10.1128/EC.00015-09; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Blagosklonny MV, 2009, AGING-US, V1, P357, DOI 10.18632/aging.100040; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Charneski CA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001508; Chen CC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002258; Chen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020783; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fichtner L, 2003, MOL MICROBIOL, V49, P1297, DOI 10.1046/j.1365-2958.2003.03632.x; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.E03-02-0079; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kalhor HR, 2003, MOL CELL BIOL, V23, P9283, DOI 10.1128/MCB.23.24.9283-9292.2003; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; Murray DB, 2003, EXP CELL RES, V287, P10, DOI 10.1016/S0014-4827(03)00068-5; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Nakai Y, 2008, J BIOL CHEM, V283, P27469, DOI 10.1074/jbc.M804043200; NAU F, 1976, BIOCHIMIE, V58, P629, DOI 10.1016/S0300-9084(76)80387-2; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Phelps SS, 2004, J MOL BIOL, V338, P439, DOI 10.1016/j.jmb.2004.02.070; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Schlieker CD, 2008, P NATL ACAD SCI USA, V105, P18255, DOI 10.1073/pnas.0808756105; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Sutter BM, 2013, CELL, V154, P403, DOI 10.1016/j.cell.2013.06.041; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Van der Veen AG, 2011, P NATL ACAD SCI USA, V108, P1763, DOI 10.1073/pnas.1014402108; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; Wu X, 2011, MOL BIOL CELL, V22, P4124, DOI 10.1091/mbc.E11-06-0525; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	44	141	143	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					416	429		10.1016/j.cell.2013.06.043	http://dx.doi.org/10.1016/j.cell.2013.06.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870129	Green Accepted, Bronze			2022-12-01	WOS:000321950700017
J	Lyons, DB; Allen, WE; Goh, T; Tsai, L; Barnea, G; Lomvardas, S				Lyons, David B.; Allen, William E.; Goh, Tracie; Tsai, Lulu; Barnea, Gilad; Lomvardas, Stavros			An Epigenetic Trap Stabilizes Singular Olfactory Receptor Expression	CELL			English	Article							ODORANT RECEPTORS; GENE-EXPRESSION; SENSORY NEURONS; MOUSE; LSD1; CRE; MAP; DEMETHYLATION; FEEDBACK; MICE	The molecular mechanisms regulating olfactory receptor (OR) expression in the mammalian nose are not yet understood. Here, we identify the transient expression of histone demethylase LSD1 and the OR-dependent expression of adenylyl cyclase 3 (Adcy3) as requirements for initiation and stabilization of OR expression. As a transcriptional coactivator, LSD1 is necessary for desilencing and initiating OR transcription, but as a transcriptional corepressor, it is incompatible with maintenance of OR expression, and its downregulation is imperative for stable OR choice. Adcy3, a sensor of OR expression and a transmitter of an OR-elicited feedback, mediates the downregulation of LSD1 and promotes the differentiation of olfactory sensory neurons (OSNs). This novel, three-node signaling cascade locks the epigenetic state of the chosen OR, stabilizes its singular expression, and prevents the transcriptional activation of additional OR alleles for the life of the neuron.	[Lyons, David B.; Lomvardas, Stavros] Univ Calif San Francisco, Tetrad Program, San Francisco, CA 94158 USA; [Goh, Tracie; Lomvardas, Stavros] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Allen, William E.; Tsai, Lulu; Barnea, Gilad] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Brown University	Lomvardas, S (corresponding author), Univ Calif San Francisco, Tetrad Program, San Francisco, CA 94158 USA.	stavros.lomvardas@ucsf.edu		Lomvardas, Stavros/0000-0002-7668-3026; Lyons, David/0000-0002-5721-4080; Korsak, Lulu/0000-0001-7662-3448	Roadmap for Epigenomics grant [5R01DA030320-02]; EUREKA grant [5R01MH091661-02]; Mcknight Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601, T32GM007810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030320] Funding Source: NIH RePORTER	Roadmap for Epigenomics grant; EUREKA grant; Mcknight Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Excellent technical support was provided by Zoe Evans. We would like to thank Dr. Geoff Rosenfeld for the LSD1 conditional KO mice and Dr. Nicholas Ryba for the G gamma 8 tTA transgenic mice. We would also like to thank Drs. Shah and Ngai, as well as members of the Lomvardas lab, for critical reading of the manuscript. This project was funded by the Roadmap for Epigenomics grant #5R01DA030320-02 and a EUREKA grant #5R01MH091661-02, as well as the Mcknight Foundation.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Anand R, 2007, J BIOL CHEM, V282, P35425, DOI 10.1074/jbc.R700027200; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chesler AT, 2007, P NATL ACAD SCI USA, V104, P1039, DOI 10.1073/pnas.0609215104; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Clowney EJ, 2011, GENOME RES, V21, P1249, DOI 10.1101/gr.120162.110; Dal Col JA, 2007, DEVELOPMENT, V134, P2481, DOI 10.1242/dev.006346; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Hou HF, 2010, CURR OPIN STRUC BIOL, V20, P739, DOI 10.1016/j.sbi.2010.09.006; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Iwema CL, 2003, J COMP NEUROL, V459, P209, DOI 10.1002/cne.10583; Johnston RJ, 2011, CELL, V145, P956, DOI 10.1016/j.cell.2011.05.003; Klungland A, 2007, DNA REPAIR, V6, P481, DOI 10.1016/j.dnarep.2006.10.012; Krolewski RC, 2013, J COMP NEUROL, V521, P833, DOI 10.1002/cne.23204; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; McIntyre JC, 2008, CHEM SENSES, V33, P825, DOI 10.1093/chemse/bjn061; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Michaloski JS, 2006, GENOME RES, V16, P1091, DOI 10.1101/gr.5185406; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Nickell MD, 2012, J COMP NEUROL, V520, P2608, DOI 10.1002/cne.23052; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; RYBA NJP, 1995, J BIOL CHEM, V270, P6757, DOI 10.1074/jbc.270.12.6757; Santoro SW, 2012, ELIFE, V1, DOI 10.7554/eLife.00070; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; Tian HK, 2008, MOL CELL NEUROSCI, V38, P484, DOI 10.1016/j.mcn.2008.04.006; Vasiliauskas D, 2011, NATURE, V479, P108, DOI 10.1038/nature10451; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zou DJ, 2007, J NEUROSCI, V27, P6675, DOI 10.1523/JNEUROSCI.0699-07.2007	57	103	105	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 18	2013	154	2					325	336		10.1016/j.cell.2013.06.039	http://dx.doi.org/10.1016/j.cell.2013.06.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870122	Green Accepted, Bronze			2022-12-01	WOS:000321950700010
J	Chung, WM; Buseman, CM; Joyner, SN; Hughes, SM; Fomby, TB; Luby, JP; Haley, RW				Chung, Wendy M.; Buseman, Christen M.; Joyner, Sibeso N.; Hughes, Sonya M.; Fomby, Thomas B.; Luby, James P.; Haley, Robert W.			The 2012 West Nile Encephalitis Epidemic in Dallas, Texas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADULT MOSQUITO MANAGEMENT; HUMAN-HEALTH-RISK; UNITED-STATES; VIRUS-INFECTION; SACRAMENTO COUNTY; DISEASE; CALIFORNIA; INSECTICIDE; EXPOSURE; COLORADO	IMPORTANCE After progressive declines over recent years, in 2012 West Nile virus epidemics resurged nationwide, with the greatest number of cases centered in Dallas County, Texas. OBJECTIVE To analyze the epidemiologic, meteorologic, and geospatial features of the 2012 Dallas West Nile virus epidemic to guide future prevention efforts. DESIGN, SETTING, AND PATIENTS Public health surveillance of Dallas County, an area of 2257 km(2) and population of 2.4 million. Surveillance data included numbers of residents diagnosed with West Nile virus infection between May 30, 2012, and December 3, 2012; mosquito trap results; weather data; and syndromic surveillance from area emergency departments. MAIN OUTCOMES AND MEASURES Incidence and age-adjusted incidence rates of West Nile neuroinvasive disease (WNND), daily prevalence of emergency department visits for asthma and skin rash, and Culex quinquefasciatus species-specific vector index (an estimate of the average number of West Nile virus-infected mosquitoes per trap-night). RESULTS The investigation identified 173 cases of WNND, 225 of West Nile fever, 17 West Nile virus-positive blood donors, and 19 deaths in 2012. The incidence rate for WNND was 7.30 per 100 000 residents in 2012, compared with 2.91 per 100 000 in 2006, the largest previous Dallas County outbreak. An unusually rapid and early escalation of large numbers of human cases closely followed increasing infection trends in mosquitoes. The Cx quinquefasciatus species-specific vector index predicted the onset of symptoms among WNND cases 1 to 2 weeks later (count regression beta = 2.97 [95% CI, 2.34 to 3.60]; P < .001). Although initially widely distributed, WNND cases soon clustered in neighborhoods with high housing density in the north central area of the county, reflecting higher vector indices and following geospatial patterns of West Nile virus in prior years. During the 11 years since West Nile virus was first identified in Dallas, the log-transformed annual prevalence of WNND was inversely associated with the number of days with low temperatures below 28 degrees F (-2.2 degrees C) in December through February (beta = -0.29 [95% CI, -0.36 to -0.21]; P < .001). Aerial insecticide spraying was not associated with increases in emergency department visits for respiratory symptoms (beta = -4.03 [95% CI, -13.76 to 5.70]; P = .42) or skin rash (beta = -1.00 [95% CI, -6.92 to 4.92]; P = .74). CONCLUSIONS AND RELEVANCE Large West Nile virus epidemics in Dallas County begin early after unusually warm winters, revisit similar geographical distributions, and are strongly predicted by the mosquito vector index. Consideration of weather patterns and historical geographical hot spots and acting on the vector index may help prevent West Nile virus-associated illness.	[Chung, Wendy M.; Buseman, Christen M.; Joyner, Sibeso N.; Hughes, Sonya M.] Dallas Cty Hlth & Human Serv, Program Epidemiol, Dallas, TX USA; [Luby, James P.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Infect Dis, Dallas, TX 75390 USA; [Haley, Robert W.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Epidemiol, Dallas, TX 75390 USA; [Fomby, Thomas B.] So Methodist Univ, Dept Econ, Richard B Johnson Ctr Econ Studies, Dallas, TX 75275 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Southern Methodist University	Haley, RW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Epidemiol, 5325 Harry Hines Blvd, Dallas, TX 75390 USA.	robert.haley@utsouthwestern.edu	Luby, James/AAS-7788-2021; Haley, Robert/P-9026-2014	Haley, Robert/0000-0001-8849-9579				Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; [Anonymous], 2013, LOCAL CLIMATOLOGICAL; Barber LM, 2010, EMERG INFECT DIS, V16, P480, DOI 10.3201/eid1603.090667; Biggerstaff B. J., 2009, POOLEDINFRATE VERSIO; Bolling BG, 2009, J MED ENTOMOL, V46, P1519, DOI 10.1603/033.046.0641; Brown HE, 2008, EMERG INFECT DIS, V14, P1539, DOI 10.3201/eid1410.071396; Carney RM, 2008, EMERG INFECT DIS, V14, P747, DOI 10.3201/eid1405.071347; Chuang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046882; Chuang TW, 2012, J MED ENTOMOL, V49, P851, DOI 10.1603/ME11150; Clayton J.S., 2002, ASP APPL BIOL, V66, P1; Division of Notifiable Diseases and Healthcare Information, 2012, 2012 NATIONALLY NOTI; Division of Vector-borne Diseases Centers for Disease Control and Prevention (CDC), 2013, WEST NILE VIRUS IN T; Elnaiem DEA, 2008, J MED ENTOMOL, V45, P751, DOI 10.1603/0022-2585(2008)45[751:IOASOP]2.0.CO;2; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gomez A, 2008, EMERG INFECT DIS, V14, P962, DOI 10.3201/eid1406.070352; Gujral IB, 2007, EMERG INFECT DIS, V13, P419, DOI 10.3201/eid1303.060941; Haley RW, 2012, JAMA-J AM MED ASSOC, V308, P1325, DOI 10.1001/2012.jama.11930; Hamer GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023767; Huhn GD, 2005, AM J TROP MED HYG, V72, P768, DOI 10.4269/ajtmh.2005.72.768; Jones RC, 2011, J AM MOSQUITO CONTR, V27, P315, DOI 10.2987/10-6098.1; Karpati AM, 2004, ENVIRON HEALTH PERSP, V112, P1183, DOI 10.1289/ehp.6946; Kwan JL, 2012, EMERG INFECT DIS, V18, P1298, DOI 10.3201/eid1808.111558; Landesman WJ, 2007, VECTOR-BORNE ZOONOT, V7, P337, DOI 10.1089/vbz.2006.0590; Luby J P, 1979, Epidemiol Rev, V1, P55; LUBY JP, 1972, AM J EPIDEMIOL, V96, P107, DOI 10.1093/oxfordjournals.aje.a121436; Macedo PA, 2007, J TOXICOL ENV HEAL A, V70, P1758, DOI 10.1080/15287390701459049; Macedo PA, 2010, J AM MOSQUITO CONTR, V26, P57, DOI 10.2987/09-5961.1; MacKinlay AC, 1997, J ECON LIT, V35, P13; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; Mount GA, 1996, J AM MOSQUITO CONTR, V12, P601; Nasci RS, 2005, PRESENTED AT 71ST AN; Paz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056398; Petersen LR, 2012, NEW ENGL J MED, V367, P1281, DOI 10.1056/NEJMp1210537; Peterson RKD, 2006, ENVIRON HEALTH PERSP, V114, P366, DOI 10.1289/ehp.8667; Preftakes CJ, 2011, INT J ENV RES PUB HE, V8, P2142, DOI 10.3390/ijerph8062142; Reisen WK, 2008, EMERG INFECT DIS, V14, P1747, DOI 10.3201/eid1411.080719; Rochlin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023280; Ruiz MO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-19; Turner Kathryn, 2011, Morbidity and Mortality Weekly Report, V60, P1421; U.S. Census Bureau, 2010, AMERICAN FACTFINDER; Walsh MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030620; Winters AM, 2010, AM J TROP MED HYG, V82, P945, DOI 10.4269/ajtmh.2010.09-0648; Zohrabian A, 2004, EMERG INFECT DIS, V10, P1736, DOI 10.3201/eid1010.030925	43	62	64	1	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					297	307		10.1001/jama.2013.8267	http://dx.doi.org/10.1001/jama.2013.8267			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23860988	Bronze			2022-12-01	WOS:000321835700017
J	Tourigny, DS; Fernandez, IS; Kelley, AC; Ramakrishnan, V				Tourigny, David S.; Fernandez, Israel S.; Kelley, Ann C.; Ramakrishnan, V.			Elongation Factor G Bound to the Ribosome in an Intermediate State of Translocation	SCIENCE			English	Article							TRANSFER-RNA BINDING; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; MESSENGER-RNA; HYBRID-STATE; BACTERIAL RIBOSOME; FACTOR TU; L1 STALK; EF-TU; ACTIVATION	A key step of translation by the ribosome is translocation, which involves the movement of messenger RNA (mRNA) and transfer RNA (tRNA) with respect to the ribosome. This allows a new round of protein chain elongation by placing the next mRNA codon in the A site of the 30S subunit. Translocation proceeds through an intermediate state in which the acceptor ends of the tRNAs have moved with respect to the 50S subunit but not the 30S subunit, to form hybrid states. The guanosine triphosphatase (GTPase) elongation factor G (EF-G) catalyzes the subsequent movement of mRNA and tRNA with respect to the 30S subunit. Here, we present a crystal structure at 3 angstrom resolution of the Thermus thermophilus ribosome with a tRNA in the hybrid P/E state bound to EF-G with a GTP analog. The structure provides insights into structural changes that facilitate translocation and suggests a common GTPase mechanism for EF-G and elongation factor Tu.	[Tourigny, David S.; Fernandez, Israel S.; Kelley, Ann C.; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk		Fernandez, Israel/0000-0001-7218-1603; Ramakrishnan, V/0000-0002-4699-2194	UK Medical Research Council [U105184332]; Wellcome Trust; Agouron Institute; Louis-Jeantet Foundation; MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332, 1359296] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are indebted to P. R. Elliott and the beamline staff on IO4 at Diamond Light Source and ID14-4 at the European Synchrotron Radiation Facility for help and advice with data collection, and to R. M. Voorhees and C. Spahn for critical comments. This work was supported by grants to V. R. from the UK Medical Research Council (U105184332), a program grant and Senior Investigator Award from the Wellcome Trust, the Agouron Institute, and the Louis-Jeantet Foundation. Coordinates and structure factors have been deposited in the PDB with codes 4JUW and 4JUX.	Adamczyk AJ, 2011, P NATL ACAD SCI USA, V108, P9827, DOI 10.1073/pnas.1105714108; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Agirrezabala X, 2012, P NATL ACAD SCI USA, V109, P6094, DOI 10.1073/pnas.1201288109; Borovinskaya MA, 2007, ACS CHEM BIOL, V2, P545, DOI 10.1021/cb700100n; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Chen CL, 2011, MOL CELL, V42, P367, DOI 10.1016/j.molcel.2011.03.024; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; Czworkowski J, 1997, BIOCHEMISTRY-US, V36, P10327, DOI 10.1021/bi970610k; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; DeLano W. L., 2006, PYMOL MOL GRAPHICS S; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ermolenko DN, 2007, J MOL BIOL, V370, P530, DOI 10.1016/j.jmb.2007.04.042; Ermolenko DN, 2011, NAT STRUCT MOL BIOL, V18, P457, DOI 10.1038/nsmb.2011; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Guo ZJ, 2012, P NATL ACAD SCI USA, V109, P20391, DOI 10.1073/pnas.1218999109; Hansson S, 2005, FEBS LETT, V579, P4492, DOI 10.1016/j.febslet.2005.07.016; INOUEYOKOSAWA N, 1974, J BIOL CHEM, V249, P4321; Jin H, 2011, P NATL ACAD SCI USA, V108, P15798, DOI 10.1073/pnas.1112185108; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Liljas A, 2011, SCIENCE, V333, P37, DOI 10.1126/science.1202472; LINDAHL M, 1994, EMBO J, V13, P1249, DOI 10.1002/j.1460-2075.1994.tb06376.x; Martemyanov KA, 2000, J BIOL CHEM, V275, P35820, DOI 10.1074/jbc.M002656200; McCarthy AA, 2009, J SYNCHROTRON RADIAT, V16, P803, DOI 10.1107/S0909049509035377; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Munro JB, 2010, P NATL ACAD SCI USA, V107, P709, DOI 10.1073/pnas.0908597107; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shi XY, 2012, J MOL BIOL, V419, P125, DOI 10.1016/j.jmb.2012.03.016; Spiegel PC, 2007, RNA, V13, P1473, DOI 10.1261/rna.601507; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Voorhees RM, 2011, SCIENCE, V333, P37, DOI 10.1126/science.1202532; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275; Zhou J, 2012, RNA, V18, P230, DOI 10.1261/rna.031187.111	50	166	169	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1542	+	1235490	10.1126/science.1235490	http://dx.doi.org/10.1126/science.1235490			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812720	Green Accepted			2022-12-01	WOS:000321007000031
J	Willyard, C				Willyard, Cassandra			STEM CELLS Bad seeds	NATURE			English	Editorial Material							ACUTE MYELOID-LEUKEMIA											Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Jan M., 2012, SCI TRANSL MED, V4; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Saito Y, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004387; Uy GL, 2012, BLOOD, V119, P3917, DOI 10.1182/blood-2011-10-383406	5	6	6	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					S12	S13		10.1038/498S12a	http://dx.doi.org/10.1038/498S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803943	Bronze			2022-12-01	WOS:000320929400007
J	Zhang, RL; Han, PD; Yang, HB; Ouyang, KF; Lee, D; Lin, YF; Ocorr, K; Kang, GS; Chen, J; Stainier, DYR; Yelon, D; Chi, NC				Zhang, Ruilin; Han, Peidong; Yang, Hongbo; Ouyang, Kunfu; Lee, Derek; Lin, Yi-Fan; Ocorr, Karen; Kang, Guson; Chen, Ju; Stainier, Didier Y. R.; Yelon, Deborah; Chi, Neil C.			In vivo cardiac reprogramming contributes to zebrafish heart regeneration	NATURE			English	Article							CARDIOMYOCYTE; RENEWAL; DIFFERENTIATION; TRANSIENT; ABLATION; MYOCYTES; FIELD; TUBE	Despite current treatment regimens, heart failure remains the leading cause of morbidity and mortality in the developed world due to the limited capacity of adult mammalian ventricular cardiomyocytes to divide and replace ventricular myocardium lost from ischaemia-induced infarct(1,2). Hence there is great interest to identify potential cellular sources and strategies to generate new ventricular myocardium(3). Past studies have shown that fish and amphibians and early postnatal mammalian ventricular cardiomyocytes can proliferate to help regenerate injured ventricles(4-6); however, recent studies have suggested that additional endogenous cellular sources may contribute to this overall ventricular regeneration(3). Here we have developed, in the zebrafish (Danio rerio), a combination of fluorescent reporter transgenes, genetic fate-mapping strategies and a ventricle-specific genetic ablation system to discover that differentiated atrial cardiomyocytes can transdifferentiate into ventricular cardiomyocytes to contribute to zebrafish cardiac ventricular regeneration. Using in vivo time-lapse and confocal imaging, we monitored the dynamic cellular events during atrial-to-ventricular cardiomyocyte transdifferentiation to define intermediate cardiac reprogramming stages. We observed that Notch signalling becomes activated in the atrial endocardium following ventricular ablation, and discovered that inhibiting Notch signalling blocked the atrial-to-ventricular transdifferentiation and cardiac regeneration. Overall, these studies not only provide evidence for the plasticity of cardiac lineages during myocardial injury, but more importantly reveal an abundant new potential cardiac resident cellular source for cardiac ventricular regeneration.	[Zhang, Ruilin; Han, Peidong; Yang, Hongbo; Ouyang, Kunfu; Lee, Derek; Chen, Ju; Chi, Neil C.] Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; [Lin, Yi-Fan; Yelon, Deborah] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Ocorr, Karen] Sanford Burnham Inst Med Res, Dev & Aging Program, La Jolla, CA 92037 USA; [Kang, Guson; Stainier, Didier Y. R.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Chi, Neil C.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Francisco; University of California System; University of California San Diego	Chi, NC (corresponding author), Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA.	nchi@ucsd.edu	Chen, Ju/E-5579-2011; zhang, ruilin/J-5074-2013; ouyang, kunfu/B-3073-2011	zhang, ruilin/0000-0002-0358-8415; ouyang, kunfu/0000-0003-0292-375X; Stainier, Didier/0000-0002-0382-0026; Zhang, Ruilin/0000-0002-6594-450X	American Heart Association [0940041N, 11POST7090024, 12POST12050080]; Packard Foundation; National Institutes of Health (NIH) [HL54737]; NIH/NHLBI (NIH Heart, Lung, and Blood Institute); NIH [OD007464, HL104239]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069305] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054737, R01HL104239, R01HL069594, R01HL108599] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007464] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Packard Foundation(The David & Lucile Packard Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NHLBI (NIH Heart, Lung, and Blood Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank N. Tedeschi, L. Pandolfo and A. Ayala for fish care; O. Huang, J. Kim, T. Kuo and J. Sun for experimental assistance; S. Tu and other laboratory members for comments on the manuscript; Q. Liu for anti-N-cadherin antibody; M. Lardelli, J. Lenis and W. Clements for plasmids; and N. Lawson for the Notch reporter line. This work was supported in part by grants from the American Heart Association to D.Y. (0940041N), R.Z. (11POST7090024) and H.Y. (12POST12050080); the Packard Foundation and the National Institutes of Health (NIH) (HL54737) to D.Y.R.S.; NIH/NHLBI (NIH Heart, Lung, and Blood Institute) to J. C.; and the NIH (OD007464, HL104239) to N.C.C.	Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Brend Tim, 2009, J Vis Exp, DOI 10.3791/1229; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; D'Amico L, 2007, CURR BIOL, V17, P252, DOI 10.1016/j.cub.2006.12.023; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Dong ZQ, 2011, JOVE-J VIS EXP, DOI 10.3791/2594; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; Genead R, 2010, STEM CELL RES, V4, P69, DOI 10.1016/j.scr.2009.10.001; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Hinits Y, 2012, DEV BIOL, V369, P199, DOI 10.1016/j.ydbio.2012.06.019; Huang W, 2009, DEV BIOL, V331, P237, DOI 10.1016/j.ydbio.2009.04.039; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kerstetter AE, 2004, DEV DYNAM, V230, P137, DOI 10.1002/dvdy.20021; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lin YF, 2012, DEV BIOL, V362, P242, DOI 10.1016/j.ydbio.2011.12.005; Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046; MCDONNELL TJ, 1984, CELL TISSUE RES, V235, P583; Ninov N, 2012, DEVELOPMENT, V139, P1557, DOI 10.1242/dev.076000; OBERPRILLER JO, 1987, AM J ANAT, V179, P285, DOI 10.1002/aja.1001790310; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; STAINIER DYR, 1992, DEV BIOL, V153, P91, DOI 10.1016/0012-1606(92)90094-W; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Wang YY, 2011, DEVELOPMENT, V138, P609, DOI 10.1242/dev.059097; Zhang RL, 2009, DEV DYNAM, V238, P1564, DOI 10.1002/dvdy.21929; Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094	41	169	176	3	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					497	+		10.1038/nature12322	http://dx.doi.org/10.1038/nature12322			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23783515	Green Accepted			2022-12-01	WOS:000320929400055
J	Amunts, K; Lepage, C; Borgeat, L; Mohlberg, H; Dickscheid, T; Rousseau, ME; Bludau, S; Bazin, PL; Lewis, LB; Oros-Peusquens, AM; Shah, NJ; Lippert, T; Zilles, K; Evans, AC				Amunts, Katrin; Lepage, Claude; Borgeat, Louis; Mohlberg, Hartmut; Dickscheid, Timo; Rousseau, Marc-Etienne; Bludau, Sebastian; Bazin, Pierre-Louis; Lewis, Lindsay B.; Oros-Peusquens, Ana-Maria; Shah, Nadim J.; Lippert, Thomas; Zilles, Karl; Evans, Alan C.			BigBrain: An Ultrahigh-Resolution 3D Human Brain Model	SCIENCE			English	Article							HUMAN CEREBRAL-CORTEX; IN-VIVO; CORTICAL AREAS; PATTERNS; ATLASES; MRI; CYTOARCHITECTURE; SYSTEM; MONKEY; MAP	Reference brains are indispensable tools in human brain mapping, enabling integration of multimodal data into an anatomically realistic standard space. Available reference brains, however, are restricted to the macroscopic scale and do not provide information on the functionally important microscopic dimension. We created an ultrahigh-resolution three-dimensional (3D) model of a human brain at nearly cellular resolution of 20 micrometers, based on the reconstruction of 7404 histological sections. "BigBrain" is a free, publicly available tool that provides considerable neuroanatomical insight into the human brain, thereby allowing the extraction of microscopic data for modeling and simulation. BigBrain enables testing of hypotheses on optimal path lengths between interconnected cortical regions or on spatial organization of genetic patterning, redefining the traditional neuroanatomy maps such as those of Brodmann and von Economo.	[Amunts, Katrin; Mohlberg, Hartmut; Dickscheid, Timo; Bludau, Sebastian; Oros-Peusquens, Ana-Maria; Shah, Nadim J.; Zilles, Karl] Res Ctr Julich, Inst Neurosci & Med INM 1, INM 4, D-52425 Julich, Germany; [Amunts, Katrin; Mohlberg, Hartmut; Dickscheid, Timo; Bludau, Sebastian; Oros-Peusquens, Ana-Maria; Shah, Nadim J.; Zilles, Karl] Julich Aachen Res Alliance JARA, Julich, Germany; [Amunts, Katrin; Zilles, Karl] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Sect Struct Funct Brain Mapping, D-52074 Aachen, Germany; [Amunts, Katrin; Zilles, Karl] Univ Dusseldorf, C&O Vogt Inst Brain Res, D-40001 Dusseldorf, Germany; [Lepage, Claude; Rousseau, Marc-Etienne; Lewis, Lindsay B.; Evans, Alan C.] McGill Univ, Montreal Neurol Inst MNI, Montreal, PQ, Canada; [Borgeat, Louis] Natl Res Council Canada, Ottawa, ON, Canada; [Bazin, Pierre-Louis] Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany; [Lippert, Thomas] Res Ctr Julich, Julich Supercomp Ctr JSC, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University; Heinrich Heine University Dusseldorf; McGill University; National Research Council Canada; Max Planck Society; Helmholtz Association; Research Center Julich	Amunts, K (corresponding author), Res Ctr Julich, Inst Neurosci & Med INM 1, INM 4, D-52425 Julich, Germany.	k.amunts@fz-juelich.de	Dickscheid, Timo/AAF-9819-2022; Dickscheid, Timo/AFK-2544-2022; Zilles, Karl/Y-3784-2019; Shah, N. Jon/H-5849-2013; Amunts, Katrin/I-3470-2013; Zilles, Karl/J-9704-2013; Evans, Alan C/B-2373-2013	Dickscheid, Timo/0000-0002-9051-3701; Dickscheid, Timo/0000-0002-9051-3701; Zilles, Karl/0000-0002-4705-4175; Shah, N. Jon/0000-0002-8151-6169; Amunts, Katrin/0000-0001-5828-0867; Zilles, Karl/0000-0001-9296-9959; Evans, Alan C/0000-0003-3841-6098; Bazin, Pierre-Louis/0000-0002-0141-5510; Bludau, Sebastian/0000-0001-6173-9050; Rousseau, Marc-Etienne/0000-0001-6281-1691; Mohlberg, Hartmut/0000-0002-7040-3812; Oros-Peusquens, Ana-Maria/0000-0002-8536-8044	Canada's Advanced Research and Innovation Network (CANARIE); Portfolio project "Supercomputing and Modeling for the Human Brain"; Helmholtz Association Germany; Human Brain Project, a European Union Flagship project	Canada's Advanced Research and Innovation Network (CANARIE); Portfolio project "Supercomputing and Modeling for the Human Brain"; Helmholtz Association Germany(Helmholtz Association); Human Brain Project, a European Union Flagship project	We acknowledge funding support from Canada's Advanced Research and Innovation Network (CANARIE; www.canarie.ca) for the software development of the CBRAIN portal. We also thank Compute Canada (www.computecanada.ca) for continued support through extensive access to the Compute Canada HPC grid. We thank P. Morosan and U. Pietrzyk for helpful discussion, as well as F. Kocaer and U. Blohm for technical assistance. We are particularly grateful to R. Adalat for his efforts in management and coordination on this collaboration. This work was supported by the Portfolio project "Supercomputing and Modeling for the Human Brain," funded by the Helmholtz Association Germany, and the Human Brain Project, a European Union Flagship project. The normalized BigBrain data are available at: http://bigbrain.cbrain.mcgill.ca (upon free subscription).	Alivisatos AP, 2013, SCIENCE, V339, P1284, DOI 10.1126/science.1236939; Amunts K, 2004, NEUROIMAGE, V22, P42, DOI 10.1016/j.neuroimage.2003.12.031; Armstrong E, 1991, CEREB CORTEX, V1, P426, DOI 10.1093/cercor/1.5.426; Augustinack JC, 2013, NEUROIMAGE, V64, P32, DOI 10.1016/j.neuroimage.2012.08.071; Axer Markus, 2011, Front Neuroinform, V5, P34, DOI 10.3389/fninf.2011.00034; Bludau S, 2014, NEUROIMAGE, V93, P260, DOI 10.1016/j.neuroimage.2013.05.052; Chen HB, 2013, CEREB CORTEX, V23, P1208, DOI 10.1093/cercor/bhs113; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Evans AC, 2012, NEUROIMAGE, V62, P911, DOI 10.1016/j.neuroimage.2012.01.024; Fatterpekar GM, 2002, AM J NEURORADIOL, V23, P1313; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Herculano-Houzel S, 2012, P NATL ACAD SCI USA, V109, P10661, DOI 10.1073/pnas.1201895109; Hilgetag CC, 2009, BRAIN STRUCT FUNCT, V213, P365, DOI 10.1007/s00429-009-0202-z; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Kasthuri N, 2007, NAT METHODS, V4, P307, DOI 10.1038/nmeth0407-307; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Lefevre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000749; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; LUPPINO G, 1991, J COMP NEUROL, V311, P463, DOI 10.1002/cne.903110403; MERKER B, 1983, J NEUROSCI METH, V9, P235, DOI 10.1016/0165-0270(83)90086-9; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Roland P E, 1994, Hum Brain Mapp, V1, P173, DOI 10.1002/hbm.460010303; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P458, DOI 10.1016/0166-2236(94)90131-7; Sanchez-Panchuelo RM, 2012, J MAGN RESON IMAGING, V35, P287, DOI 10.1002/jmri.22822; Schleicher A, 2009, J AUTISM DEV DISORD, V39, P1568, DOI 10.1007/s10803-009-0790-8; Shen EH, 2012, TRENDS NEUROSCI, V35, P711, DOI 10.1016/j.tins.2012.09.005; Talairach J., 1988, COPLANAR STEREOTAXIC, P5; Toga AW, 2006, NAT REV NEUROSCI, V7, P952, DOI 10.1038/nrn2012; Toro R, 2008, CEREB CORTEX, V18, P2352, DOI 10.1093/cercor/bhm261; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Walters NB, 2007, HUM BRAIN MAPP, V28, P1, DOI 10.1002/hbm.20267; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Zilles K, 2012, SCIENCE, V335, P1582, DOI 10.1126/science.1221366; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776; Zilles K, 2009, CURR OPIN NEUROL, V22, P331, DOI 10.1097/WCO.0b013e32832d95db	38	355	362	13	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1472	1475		10.1126/science.1235381	http://dx.doi.org/10.1126/science.1235381			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23788795	Green Published			2022-12-01	WOS:000320647000047
J	Saintenac, C; Zhang, WJ; Salcedo, A; Rouse, MN; Trick, HN; Akhunov, E; Dubcovsky, J				Saintenac, Cyrille; Zhang, Wenjun; Salcedo, Andres; Rouse, Matthew N.; Trick, Harold N.; Akhunov, Eduard; Dubcovsky, Jorge			Identification of Wheat Gene Sr35 That Confers Resistance to Ug99 Stem Rust Race Group	SCIENCE			English	Article							POLYPLOID WHEAT; GENOME; TRANSCRIPTS; CC	Wheat stem rust, caused by Puccinia graminis f. sp. tritici (Pgt), is a devastating disease that can cause severe yield losses. A previously uncharacterized Pgt race, designated Ug99, has overcome most of the widely used resistance genes and is threatening major wheat production areas. Here, we demonstrate that the Sr35 gene from Triticum monococcum is a coiled-coil, nucleotide-binding, leucine-rich repeat gene that confers near immunity to Ug99 and related races. This gene is absent in the A-genome diploid donor and in polyploid wheat but is effective when transferred from T. monococcum to polyploid wheat. The cloning of Sr35 opens the door to the use of biotechnological approaches to control this devastating disease and to analyses of the molecular interactions that define the wheat-rust pathosystem.	[Saintenac, Cyrille; Salcedo, Andres; Trick, Harold N.; Akhunov, Eduard] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Zhang, Wenjun; Dubcovsky, Jorge] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Rouse, Matthew N.] ARS, Cereal Dis Lab, USDA, St Paul, MN 55108 USA; [Dubcovsky, Jorge] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Kansas State University; University of California System; University of California Davis; United States Department of Agriculture (USDA); Howard Hughes Medical Institute	Akhunov, E (corresponding author), Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA.	eakhunov@ksu.edu; jdubcovsky@ucdavis.edu	Rouse, Matthew N/G-5474-2011; Dubcovsky, Jorge/A-4969-2008; Dubcovsky, Jorge/T-5214-2019	Dubcovsky, Jorge/0000-0002-7571-4345; Akhunov, Eduard/0000-0002-0416-5211; Trick, Harold/0000-0001-5255-5575	Agricultural and Food Research Initiative from the USDA National Institute of Food and Agriculture [2011-68002-30029, 2012-67013-19401]; Borlaug Global Rust Initiative; HHMI; Gordon and Betty Moore Foundation [GBMF3031]	Agricultural and Food Research Initiative from the USDA National Institute of Food and Agriculture; Borlaug Global Rust Initiative; HHMI(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This project was supported by Agricultural and Food Research Initiative grants 2011-68002-30029 (Triticeae-CAP) and 2012-67013-19401 from the USDA National Institute of Food and Agriculture, by the Borlaug Global Rust Initiative, and by support to J.D. from the HHMI and the Gordon and Betty Moore Foundation grant GBMF3031. We thank J. Nirmala, S. Sehgal, M. Padilla, S. Chao, K. Jordan, H. Lee, and D. Burdan for excellent technical support; B. Bowden and J. Dvorak for providing critical materials; K. Krasileva, A. Akhunova, and C. Li for valuable suggestions; and the University of California, Davis, and Kansas State University Genomic facilities. We also thank M. Pumphrey for his collaboration in the initial stages of the project, including design and initial development of the high-resolution mapping and TILLING populations. Sequences have been deposited in GenBank under accession numbers KC573058, KC816724, KF113354 to KF113357, and KC876115 to KC876121. Author contributions are listed in the supplementary materials.	Costanzo S, 2009, PLANT SCI, V177, P468, DOI 10.1016/j.plantsci.2009.07.012; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; DVORAK J, 1988, GENOME, V30, P680, DOI 10.1139/g88-115; Ferrier-Cana E, 2005, THEOR APPL GENET, V110, P895, DOI 10.1007/s00122-004-1908-1; Gassmann W, 2008, CURR TOP MICROBIOL, V326, P219; Halterman DA, 2006, MOL PLANT PATHOL, V7, P167, DOI [10.1111/j.1364-3703.2006.00329.x, 10.1111/J.1364-3703.2006.00329.X]; Halterman DA, 2003, PLANT PHYSIOL, V131, P558, DOI 10.1104/pp.014407; Huerta-Espino J., 1992, THESIS U MINNESOTA S; Lijavetzky D, 1999, GENOME, V42, P1176, DOI 10.1139/gen-42-6-1176; Loutre C, 2009, PLANT J, V60, P1043, DOI 10.1111/j.1365-313X.2009.04024.x; McIntosh R., 1995, WHEAT RUSTS ATLAS RU, DOI [10.1071/9780643101463, DOI 10.1071/9780643101463]; MCINTOSH RA, 1984, Z PFLANZENZUCHT, V92, P1; Periyannan S, 2013, SCIENCE, V341, P786, DOI 10.1126/science.1239028; Pretorius ZA, 2000, PLANT DIS, V84, P924, DOI 10.1094/PDIS.2000.84.8.924A; Rouse MN, 2011, PLANT DIS, V95, P941, DOI 10.1094/PDIS-04-10-0260; Rouse MN, 2011, CROP SCI, V51, P2074, DOI 10.2135/cropsci2010.12.0719; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Sela H, 2012, MOL PLANT PATHOL, V13, P276, DOI 10.1111/j.1364-3703.2011.00744.x; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Wicker T, 2003, PLANT CELL, V15, P1186, DOI 10.1105/tpc.011023; Yue JX, 2012, NEW PHYTOL, V193, P1049, DOI 10.1111/j.1469-8137.2011.04006.x; Zhang WJ, 2010, CROP SCI, V50, P2464, DOI 10.2135/cropsci2010.04.0202	23	195	205	11	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					783	786		10.1126/science.1239022	http://dx.doi.org/10.1126/science.1239022			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23811222	Green Accepted			2022-12-01	WOS:000323122200047
J	Brucker, RM; Bordenstein, SR				Brucker, Robert M.; Bordenstein, Seth R.			The Hologenomic Basis of Speciation: Gut Bacteria Cause Hybrid Lethality in the Genus Nasonia	SCIENCE			English	Article							INCOMPATIBILITIES	Although the gut microbiome influences numerous aspects of organismal fitness, its role in animal evolution and the origin of new species is largely unknown. Here we present evidence that beneficial bacterial communities in the guts of closely related species of the genus Nasonia form species-specific phylosymbiotic assemblages that cause lethality in interspecific hybrids. Bacterial constituents and abundance are irregular in hybrids relative to parental controls, and antibiotic curing of the gut bacteria significantly rescues hybrid survival. Moreover, feeding bacteria to germ-free hybrids reinstates lethality and recapitulates the expression of innate immune genes observed in conventionally reared hybrids. We conclude that in this animal complex, the gut microbiome and host genome represent a coadapted "hologenome" that breaks down during hybridization, promoting hybrid lethality and assisting speciation.	[Brucker, Robert M.; Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Bordenstein, Seth R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Brucker, RM (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA.	bruckerm@gmail.com; s.bordenstein@vanderbilt.edu			NSF [DEB 1046149]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Sequences are available at the Dryad Digital Repository, doi:10.5061/dryad.3c190. We thank S. Bordenstein and A. Williams for technical assistance during the development of the in vitro cultivation method; L. Funkhouser, D. Sutherland, and C. Wogsland for their assistance in genotyping Nasonia hybrids; R. Pauly for bioinformatic assistance; and B. Jovanovic, L. Funkhouser, K. Jernigan, and N. Renner for providing feedback on an earlier version of the manuscript. We apologize in advance to colleagues whose papers we could not cite due to space restrictions. This research was made possible by NSF award DEB 1046149 to S.R.B.	Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; BREEUWER JAJ, 1995, EVOLUTION, V49, P705, DOI 10.1111/j.1558-5646.1995.tb02307.x; Brucker RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051269; Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011; Brucker RM, 2012, EVOLUTION, V66, P349, DOI 10.1111/j.1558-5646.2011.01454.x; Koevoets T, 2012, HEREDITY, V108, P302, DOI 10.1038/hdy.2011.75; Koevoets T, 2012, J EVOLUTION BIOL, V25, P304, DOI 10.1111/j.1420-9101.2011.02424.x; Mayr E, 1963, ANIMAL SPECIES EVOLU; Niehuis O, 2008, GENETICS, V178, P413, DOI 10.1534/genetics.107.080523; Orr HA, 1996, GENETICS, V144, P1331; Werren J. H., 2009, COLD SPRING HARBOR P, V2009, DOI [10.1101/pdb.emo134, DOI 10.1101/PDB.EM0134]; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	13	253	259	11	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					667	669		10.1126/science.1240659	http://dx.doi.org/10.1126/science.1240659			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23868918				2022-12-01	WOS:000322884800042
J	Hou, PP; Li, YQ; Zhang, X; Liu, C; Guan, JY; Li, HG; Zhao, T; Ye, JQ; Yang, WF; Liu, K; Ge, J; Xu, J; Zhang, Q; Zhao, Y; Deng, HK				Hou, Pingping; Li, Yanqin; Zhang, Xu; Liu, Chun; Guan, Jingyang; Li, Honggang; Zhao, Ting; Ye, Junqing; Yang, Weifeng; Liu, Kang; Ge, Jian; Xu, Jun; Zhang, Qiang; Zhao, Yang; Deng, Hongkui			Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds	SCIENCE			English	Article							S-ADENOSYLHOMOCYSTEINE HYDROLASE; REGENERATIVE MEDICINE; STATE	Pluripotent stem cells can be induced from somatic cells, providing an unlimited cell resource, with potential for studying disease and use in regenerative medicine. However, genetic manipulation and technically challenging strategies such as nuclear transfer used in reprogramming limit their clinical applications. Here, we show that pluripotent stem cells can be generated from mouse somatic cells at a frequency up to 0.2% using a combination of seven small-molecule compounds. The chemically induced pluripotent stem cells resemble embryonic stem cells in terms of their gene expression profiles, epigenetic status, and potential for differentiation and germline transmission. By using small molecules, exogenous "master genes" are dispensable for cell fate reprogramming. This chemical reprogramming strategy has potential use in generating functional desirable cell types for clinical applications.	[Hou, Pingping; Li, Yanqin; Zhang, Xu; Liu, Chun; Guan, Jingyang; Li, Honggang; Zhao, Ting; Ye, Junqing; Liu, Kang; Ge, Jian; Xu, Jun; Zhang, Qiang; Zhao, Yang; Deng, Hongkui] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Hou, Pingping; Li, Yanqin; Zhang, Xu; Liu, Chun; Guan, Jingyang; Li, Honggang; Zhao, Ting; Ye, Junqing; Liu, Kang; Ge, Jian; Xu, Jun; Zhang, Qiang; Zhao, Yang; Deng, Hongkui] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Zhang, Xu; Liu, Chun; Ye, Junqing; Ge, Jian; Zhang, Qiang; Deng, Hongkui] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Shenzhen 518055, Peoples R China; [Yang, Weifeng] Beijing Vitalstar Biotechnol Co Ltd, Beijing 100012, Peoples R China	Peking University; Peking University; Peking University; University Town of Shenzhen	Zhao, Y (corresponding author), Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China.	yangzhao@pku.edu.cn; hongkui_deng@pku.edu.cn	Zhang, Xu/G-7395-2011; kang, liu/ABB-8964-2020; LIU, CHUN/N-6909-2014	Zhang, Xu/0000-0002-9817-4492; Ge, Jian/0000-0001-5745-6605; Guan, Jingyang/0000-0002-1638-3339; Liu, Chun/0000-0002-8242-3896	National 973 Basic Research Program of China [2012CB966401, 2010CB945204]; Key New Drug Creation and Manufacturing Program [2011ZX09102-010-03]; National Natural Science Foundation of China [90919031]; Ministry of Science and Technology [2011AA020107, 2011DFA30730, 2013DFG30680]; Beijing Science and Technology Plan [Z121100005212001]; Ministry of Education of China (111 project); Peking-Tsinghua Center for Life Sciences	National 973 Basic Research Program of China(National Basic Research Program of China); Key New Drug Creation and Manufacturing Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Beijing Science and Technology Plan; Ministry of Education of China (111 project); Peking-Tsinghua Center for Life Sciences	We thank X. Zhang, J. Wang, C. Han, Z. Hou, J. Liu, and L. Ai for technical assistance. This work was supported by grants from the National 973 Basic Research Program of China (2012CB966401 and 2010CB945204), the Key New Drug Creation and Manufacturing Program (2011ZX09102-010-03), the National Natural Science Foundation of China (90919031), the Ministry of Science and Technology (2011AA020107, 2011DFA30730 and 2013DFG30680), the Beijing Science and Technology Plan (Z121100005212001), the Ministry of Education of China (111 project), and a Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences. Microarray and RNA-seq data are deposited in the Gene Expression Omnibus (GEO) database (accession no. GSE48243). The authors have filed a patent for the small-molecule combinations used in the chemical reprogramming reported in this paper.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chiang PK, 1998, PHARMACOL THERAPEUT, V77, P115, DOI 10.1016/S0163-7258(97)00089-2; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gordon RK, 2003, EUR J BIOCHEM, V270, P3507, DOI 10.1046/j.1432-1033.2003.03726.x; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li W, 2012, P NATL ACAD SCI USA, V109, P20853, DOI 10.1073/pnas.1219181110; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Neff AW, 2011, DEV DYNAM, V240, P979, DOI 10.1002/dvdy.22554; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhu SY, 2011, ANNU REV BIOMED ENG, V13, P73, DOI 10.1146/annurev-bioeng-071910-124715	26	895	1025	39	675	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					651	654		10.1126/science.1239278	http://dx.doi.org/10.1126/science.1239278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23868920				2022-12-01	WOS:000322884800037
J	Kumar, R; DiMenna, L; Schrode, N; Liu, TC; Franck, P; Munoz-Descalzo, S; Hadjantonakis, AK; Zarrin, AA; Chaudhuri, J; Elemento, O; Evans, T				Kumar, Ritu; DiMenna, Lauren; Schrode, Nadine; Liu, Ting-Chun; Franck, Philipp; Munoz-Descalzo, Silvia; Hadjantonakis, Anna-Katerina; Zarrin, Ali A.; Chaudhuri, Jayanta; Elemento, Olivier; Evans, Todd			AID stabilizes stem-cell phenotype by removing epigenetic memory of pluripotency genes	NATURE			English	Article							INDUCED CYTIDINE DEAMINASE; DNA METHYLATION; EXPRESSION	The activation-induced cytidine deaminase (AID; also known as AICDA) enzyme is required for somatic hypermutation and class switch recombination at the immunoglobulin locus(1). In germinal-centre B cells, AID is highly expressed, and has an inherent mutator activity that helps generate antibody diversity(2). However, AID may also regulate gene expression epigenetically by directly deaminating 5-methylcytosine in concert with base-excision repair to exchange cytosine(3). This pathway promotes gene demethylation, thereby removing epigenetic memory. For example, AID promotes active demethylation of the genome in primordial germ cells(4). However, different studies have suggested either a requirement(5) or a lack of function(6) for AID in promoting pluripotency in somatic nuclei after fusion with embryonic stem cells. Here we tested directly whether AID regulates epigenetic memory by comparing the relative ability of cells lacking AID to reprogram from a differentiated murine cell type to an induced pluripotent stem cell. We show that Aid-null cells are transiently hyper-responsive to the reprogramming process. Although they initiate expression of pluripotency genes, they fail to stabilize in the pluripotent state. The genome of Aid-null cells remains hypermethylated in reprogramming cells, and hypermethylated genes associated with pluripotency fail to be stably upregulated, including many MYC target genes. Recent studies identified a late step of reprogramming associated with methylation status(7), and implicated a secondary set of pluripotency network components(8). AID regulates this late step, removing epigenetic memory to stabilize the pluripotent state.	[Kumar, Ritu; Liu, Ting-Chun; Franck, Philipp; Evans, Todd] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA; [DiMenna, Lauren; Chaudhuri, Jayanta] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, New York, NY 10065 USA; [Schrode, Nadine; Munoz-Descalzo, Silvia; Hadjantonakis, Anna-Katerina] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Zarrin, Ali A.] Genentech Inc, San Francisco, CA 94080 USA; [Elemento, Olivier] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10065 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Roche Holding; Genentech; Cornell University	Evans, T (corresponding author), Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA.	tre2003@med.cornell.edu	Munoz-Descalzo, Silvia/A-3433-2011; Munoz-Descalzo, Silvia/M-8094-2013	Munoz-Descalzo, Silvia/0000-0003-0939-7721; Munoz-Descalzo, Silvia/0000-0003-0939-7721; Schrode, Nadine/0000-0001-5315-6816; Hadjantonakis, Anna-Katerina/0000-0002-7580-5124	National Institutes of Health [HL056182, AI072194]; National Science Foundation CAREER [1054964]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052115] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056182, R37HL056182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072194, T32AI007621] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1054964] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CAREER(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank G. Mostoslavsky for the gift of reprogramming vectors. A. Melnick provided advice and consultation. We are grateful to T. Honjo for AID-knockout mice, and N. Papavasiliou for assistance in designing genotyping PCR primers. The Epigenomics Core Facility of Weill Cornell Medical College carried out the bisulphite sequencing and provided consultation. This study was supported by National Institutes of Health grant HL056182 (T.E.), AI072194 (J.C.) and National Science Foundation CAREER grant 1054964 (O.E.).	Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; Behringer R., 2003, MANIPULATING MOUSE E; Bhutani N, 2013, FASEB J, V27, P1107, DOI 10.1096/fj.12-222125; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Foshay KM, 2012, MOL CELL, V46, P159, DOI 10.1016/j.molcel.2012.02.013; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Joyner AL, 2000, GENE TARGETING PRACT; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Sun YL, 2013, AUTOIMMUNITY, V46, P157, DOI 10.3109/08916934.2012.750301; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708	28	72	75	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2013	500	7460					89	U114		10.1038/nature12299	http://dx.doi.org/10.1038/nature12299			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23803762	Green Accepted			2022-12-01	WOS:000322514800034
J	Brewer, C				Brewer, Colin			NOTHING'S SACRED How to learn scepticism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												brewerismo@gmail.com						Feynman RP, 1992, SURELY YOURE JOKING	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2013	347								f4626	10.1136/bmj.f4626	http://dx.doi.org/10.1136/bmj.f4626			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193BM	23884972				2022-12-01	WOS:000322531800011
J	Hirabayashi, T; Takeuchi, D; Tamura, K; Miyashita, Y				Hirabayashi, Toshiyuki; Takeuchi, Daigo; Tamura, Keita; Miyashita, Yasushi			Microcircuits for Hierarchical Elaboration of Object Coding Across Primate Temporal Areas	SCIENCE			English	Article							FUNCTIONAL CONNECTIVITY; VISUAL-CORTEX; MEMORY; MONKEY; INFORMATION; SIGNAL; RETRIEVAL; DYNAMICS; CORTICES; NEURONS	In primates, neuronal representations of objects are processed hierarchically in occipitotemporal cortices. A "novel" feature of objects is thought to emerge and become prevalent at a cortical area because of processing in this area. We tested the possibility that a feature representation prevalent in a given area emerges in the microcircuit of a hierarchically prior area as a small number of prototypes and then becomes prevalent in the subsequent area. We recorded multiple single units in each of hierarchically sequential areas TE and 36 of macaque temporal cortex and found the predicted convergent microcircuit for object-object association in area TE. Associative codes were then built up over time in the microcircuit of area 36. These results suggest a computational principle underlying sequentially elaborated object representations.	[Hirabayashi, Toshiyuki; Takeuchi, Daigo; Tamura, Keita; Miyashita, Yasushi] Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan; [Miyashita, Yasushi] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama 3320012, Japan; [Miyashita, Yasushi] Natl Inst Nat Sci, Dept Brain Sci, Ctr Novel Sci Initiat, Minato Ku, Tokyo 1050001, Japan	University of Tokyo; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan	Miyashita, Y (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp	Miyashita, Yasushi/B-7171-2019; Tamura, Keita/I-2931-2012	Miyashita, Yasushi/0000-0003-3496-8637; Tamura, Keita/0000-0003-2697-1510	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)/JSPS KAKENHI [19002010, 24220008]; CREST, Japan Science and Technology Agency; Takeda Science Foundation; MEXT [18700378]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank G. Rangarajan for kindly providing the script to conduct the nonparametric Granger causality analysis, H. Kasahara and T. Watanabe for experimental assistance, and M. Takeda and K. W. Koyano for helpful discussions. This work was supported in part by Ministry of Education, Culture, Sports, Science, and Technology (MEXT)/JSPS KAKENHI grant nos. 19002010 and 24220008 to Y.M.; by CREST, Japan Science and Technology Agency to Y.M.; by a grant from Takeda Science Foundation to Y.M.; and a Grant-in-Aid for Young Scientists (B) from MEXT to T. H. (18700378).	Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Atencio CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009521; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hirabayashi T, 2005, J NEUROSCI, V25, P10299, DOI 10.1523/JNEUROSCI.3036-05.2005; Hirabayashi T, 2013, NEURON, V77, P192, DOI 10.1016/j.neuron.2012.10.031; Hirabayashi T, 2010, J NEUROSCI, V30, P10407, DOI 10.1523/JNEUROSCI.0135-10.2010; Kourtzi Z, 2011, ANNU REV NEUROSCI, V34, P45, DOI 10.1146/annurev-neuro-060909-153218; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Menz MD, 2004, J NEUROPHYSIOL, V91, P1794, DOI 10.1152/jn.00574.2003; Menz MD, 2003, NAT NEUROSCI, V6, P59, DOI 10.1038/nn986; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Naya Y, 2003, J NEUROSCI, V23, P2861; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; Priebe NJ, 2012, NEURON, V75, P194, DOI 10.1016/j.neuron.2012.06.011; Reid RC, 1996, CURR OPIN NEUROBIOL, V6, P475, DOI 10.1016/S0959-4388(96)80052-3; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Saleem KS, 1996, J NEUROSCI, V16, P4757; Sherman SM, 2011, J NEUROPHYSIOL, V106, P1068, DOI 10.1152/jn.00429.2011; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Takeuchi D, 2011, SCIENCE, V331, P1443, DOI 10.1126/science.1199967; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Tsui JMG, 2010, J NEUROPHYSIOL, V103, P3123, DOI 10.1152/jn.00654.2009	28	30	31	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	2013	341	6142					191	195		10.1126/science.1236927	http://dx.doi.org/10.1126/science.1236927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23846902				2022-12-01	WOS:000321965300047
J	Takeo, M; Chou, WC; Sun, Q; Lee, W; Rabbani, P; Loomis, C; Taketo, MM; Ito, M				Takeo, Makoto; Chou, Wei Chin; Sun, Qi; Lee, Wendy; Rabbani, Piul; Loomis, Cynthia; Taketo, M. Mark; Ito, Mayumi			Wnt activation in nail epithelium couples nail growth to digit regeneration	NATURE			English	Article							HAIR FOLLICLE; MOUSE; CELLS; MICE; AMPUTATION; MUTATION; TIP	The tips of mammalian digits can regenerate after amputation(1,2), like those of amphibians. It is unknown why this capacity is limited to the area associated with the nail(2-4). Here we show that nail stem cells (NSCs) reside in the proximal nail matrix and that the mechanisms governing NSC differentiation are coupled directly with their ability to orchestrate digit regeneration. Early nail progenitors undergo Wnt-dependent differentiation into the nail. After amputation, this Wnt activation is required for nail regeneration and also for attracting nerves that promote mesenchymal blastema growth, leading to the regeneration of the digit. Amputations proximal to the Wnt-active nail progenitors result in failure to regenerate the nail or digit. Nevertheless, beta-catenin stabilization in the NSC region induced their regeneration. These results establish a link between NSC differentiation and digit regeneration, and suggest that NSCs may have the potential to contribute to the development of novel treatments for amputees.	[Takeo, Makoto; Chou, Wei Chin; Sun, Qi; Lee, Wendy; Rabbani, Piul; Loomis, Cynthia; Ito, Mayumi] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA; [Takeo, Makoto; Chou, Wei Chin; Sun, Qi; Lee, Wendy; Rabbani, Piul; Loomis, Cynthia; Ito, Mayumi] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Taketo, M. Mark] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan	New York University; New York University; Kyoto University	Ito, M (corresponding author), NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA.	Mayumi.Ito@nyumc.org		Lee, Wendy/0000-0002-8807-0550; Rabbani, Piul/0000-0001-8302-8225; Takeo, Makoto/0000-0002-5597-5994; Sun, Qi/0000-0002-0495-1407	Genome Technology Center at NYU (National Institutes of Health (NIH)) [5P30CA0016087-32, P30 CA016087-30]; NYU Kimmel Stem Cell Center; NYSTEM [C026880]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [1R01AR059768-01A1]; Ellison Medical Foundation; Department of Dermatology and Cell Biology; Helen and Martin Kimmel Center for Stem Cell Biology, at NYU; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059768] Funding Source: NIH RePORTER	Genome Technology Center at NYU (National Institutes of Health (NIH)); NYU Kimmel Stem Cell Center; NYSTEM; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Ellison Medical Foundation(Lawrence Ellison Foundation); Department of Dermatology and Cell Biology; Helen and Martin Kimmel Center for Stem Cell Biology, at NYU; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank T. Andl, T. Endo, L. Miller, P. Myung, M. Schober and T. T. Sun for invaluable suggestions and discussion. We thank T. Endo for demonstrating the method of bead implantation. We thank T. T. Sun for the AE13 antibody, K. Muneoka for the Bmp4 plasmid, and A. Mansukhani for 3T3 cells. We thank the Genome Technology Center at NYU (National Institutes of Health (NIH) grant 5P30CA0016087-32 and P30 CA016087-30), and the Center for Functional Genomics at University at Albany for carrying out microarray analyses. We thank F. Liang at the NYU Microscopy Core for transmission electron microscopy (TEM) analysis. We thank the NYU Microscopy Core for the use of a confocal microscope (NCRRS10 RR023704-01A1). M. T. is supported by the NYU Kimmel Stem Cell Center and NYSTEM training grant C026880. M. I. is supported by NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grant 1R01AR059768-01A1, the Ellison Medical Foundation and funding from the Department of Dermatology and Cell Biology, and the Helen and Martin Kimmel Center for Stem Cell Biology, at NYU.	Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Al-Qattan MM, 2011, J HAND SURG-EUR VOL, V36E, P9, DOI 10.1177/1753193410380502; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; BROCKES JP, 1987, J EXP BIOL, V132, P79; DasGupta R, 1999, DEVELOPMENT, V126, P4557; DOUGLAS BS, 1972, AUST PAEDIATR J, V8, P86; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fleckman P, 2013, ANAT REC, V296, P521, DOI 10.1002/ar.22660; Han M, 2008, DEV BIOL, V315, P125, DOI 10.1016/j.ydbio.2007.12.025; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Lin MH, 2003, DEV BIOL, V263, P343, DOI 10.1016/j.ydbio.2003.07.007; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; Mohammad KS, 2000, WOUND REPAIR REGEN, V8, P277, DOI 10.1046/j.1524-475x.2000.00277.x; Mohammad KS, 1999, CALCIFIED TISSUE INT, V65, P408, DOI 10.1007/s002239900722; Mullen LM, 1996, DEVELOPMENT, V122, P3487; Myung P. S., 2013, J INVEST DERMATOL; Nakamura M, 2008, J INVEST DERMATOL, V128, P728, DOI 10.1038/sj.jid.5701062; NEUFELD DA, 1993, PROG CLIN BIOL RES, V383, P243; NEUFELD DA, 1980, J EXP ZOOL, V212, P31, DOI 10.1002/jez.1402120105; NORTON LA, 1971, J INVEST DERMATOL, V56, P61, DOI 10.1111/1523-1747.ep12291905; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Yokoyama H, 2007, DEV BIOL, V306, P170, DOI 10.1016/j.ydbio.2007.03.014; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459; ZHAO WG, 1995, J EXP ZOOL, V271, P155, DOI 10.1002/jez.1402710212; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	38	150	156	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					228	+		10.1038/nature12214	http://dx.doi.org/10.1038/nature12214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23760480	Green Accepted			2022-12-01	WOS:000321557600066
J	Bateman, IJ; Harwood, AR; Mace, GM; Watson, RT; Abson, DJ; Andrews, B; Binner, A; Crowe, A; Day, BH; Dugdale, S; Fezzi, C; Foden, J; Hadley, D; Haines-Young, R; Hulme, M; Kontoleon, A; Lovett, AA; Munday, P; Pascual, U; Paterson, J; Perino, G; Sen, A; Siriwardena, G; van Soest, D; Termansen, M				Bateman, Ian J.; Harwood, Amii R.; Mace, Georgina M.; Watson, Robert T.; Abson, David J.; Andrews, Barnaby; Binner, Amy; Crowe, Andrew; Day, Brett H.; Dugdale, Steve; Fezzi, Carlo; Foden, Jo; Hadley, David; Haines-Young, Roy; Hulme, Mark; Kontoleon, Andreas; Lovett, Andrew A.; Munday, Paul; Pascual, Unai; Paterson, James; Perino, Grischa; Sen, Antara; Siriwardena, Gavin; van Soest, Daan; Termansen, Mette			Bringing Ecosystem Services into Economic Decision-Making: Land Use in the United Kingdom	SCIENCE			English	Article							TRADEOFFS; POLICY	Landscapes generate a wide range of valuable ecosystem services, yet land-use decisions often ignore the value of these services. Using the example of the United Kingdom, we show the significance of land-use change not only for agricultural production but also for emissions and sequestration of greenhouse gases, open-access recreational visits, urban green space, and wild-species diversity. We use spatially explicit models in conjunction with valuation methods to estimate comparable economic values for these services, taking account of climate change impacts. We show that, although decisions that focus solely on agriculture reduce overall ecosystem service values, highly significant value increases can be obtained from targeted planning by incorporating all potential services and their values and that this approach also conserves wild-species diversity.	[Bateman, Ian J.; Harwood, Amii R.; Andrews, Barnaby; Binner, Amy; Day, Brett H.; Dugdale, Steve; Fezzi, Carlo; Hadley, David; Lovett, Andrew A.; Munday, Paul; Perino, Grischa; Sen, Antara] Univ E Anglia, Sch Environm Sci, CSERGE, Norwich NR4 7TJ, Norfolk, England; [Mace, Georgina M.] UCL, Dept Genet Ecol & Environm, London WC1E 6BT, England; [Watson, Robert T.] Univ E Anglia, Dept Environm Sci, Tyndall Ctr, Norwich NR4 7TJ, Norfolk, England; [Watson, Robert T.] Monash Univ, Monash Sustainabil Inst, Melbourne, Vic 3004, Australia; [Abson, David J.] Univ Luneburg, FuturES Res Ctr, D-21335 Luneburg, Germany; [Abson, David J.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Crowe, Andrew] HM Govt, Food & Environm Res Agcy, Dept Environm Food & Rural Affairs, London SW1P 3JR, England; [Foden, Jo] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft NR33 0HT, Suffolk, England; [Hadley, David] Univ New England, UNE Business Sch, Armidale, NSW 2351, Australia; [Haines-Young, Roy] Univ Nottingham, Sch Geog, CEM, Nottingham NG7 2RD, England; [Hulme, Mark; Siriwardena, Gavin] British Trust Ornithol, Thetford IP24 2PU, Norfolk, England; [Kontoleon, Andreas; Pascual, Unai] Univ Cambridge, Dept Land Econ, Cambridge CB3 9EP, England; [Pascual, Unai] Basque Fdn Sci, Basque Ctr Climate Change, Bilbao 48011, Bizkaia, Spain; [Pascual, Unai] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Bizkaia, Spain; [Paterson, James] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland; [Perino, Grischa] Univ Hamburg, Sch Business Econ & Social Sci, D-20354 Hamburg, Germany; [van Soest, Daan] Vrije Univ Amsterdam, Dept Spatial Econ, NL-1081 HV Amsterdam, Netherlands; [van Soest, Daan] Vrije Univ Amsterdam, Inst Environm Studies IVM, NL-1081 HV Amsterdam, Netherlands; [van Soest, Daan] Tilburg Univ, Dept Econ, NL-5037 Tilburg, Netherlands; [Termansen, Mette] Aarhus Univ, Dept Environm Sci, DK-8000 Aarhus, Denmark	University of East Anglia; University of London; University College London; University of East Anglia; Monash University; Leuphana University Luneburg; University of Leeds; Food & Environment Research Agency; Centre for Environment Fisheries & Aquaculture Science; University of New England; University of Nottingham; British Trust for Ornithology; University of Cambridge; Basque Centre for Climate Change (BC3); Basque Foundation for Science; Basque Foundation for Science; University of Edinburgh; University of Hamburg; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Tilburg University; Aarhus University	Bateman, IJ (corresponding author), Univ E Anglia, Sch Environm Sci, CSERGE, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	i.bateman@uea.ac.uk	PASCUAL, UNAI/B-4766-2012; Azkarate, Ainhoa/K-9087-2013; Lovett, Andrew/Q-6723-2019; Abson, David/AAE-9027-2019; Lovett, Andrew A/C-9942-2011; van Soest, Daan P/C-5544-2013; Pascual, Unai/O-7946-2019; Foden, Jo/Q-7452-2018; Crowe, Andrew/AAF-9669-2020; Harwood, Amii R/H-8032-2013; Mace, Georgina M/I-3072-2016; Hadley, David/C-5924-2008; Hulme, Mark/AAT-2651-2020	PASCUAL, UNAI/0000-0002-5696-236X; Azkarate, Ainhoa/0000-0003-0471-3094; Lovett, Andrew/0000-0003-0554-9273; van Soest, Daan P/0000-0002-3100-1810; Pascual, Unai/0000-0002-5696-236X; Crowe, Andrew/0000-0003-3521-7501; Harwood, Amii R/0000-0002-2808-4109; Mace, Georgina M/0000-0001-8965-5211; Hadley, David/0000-0001-8634-2586; Hulme, Mark/0000-0002-7211-3464; Binner, Amy/0000-0003-3235-0585; Fezzi, Carlo/0000-0002-4860-9128; Paterson, James/0000-0003-3264-8242; Perino, Grischa/0000-0001-6519-1029; Day, Brett/0000-0001-7519-5672; Abson, David/0000-0003-3755-785X; Bateman, Ian/0000-0002-2791-6137; Termansen, Mette/0000-0003-4875-2810	UK-NEA; UK Defra; Social and Environmental Economic Research (SEER) project (ESRC) [RES-060-25-0063]; ESRC [ES/G035989/1] Funding Source: UKRI; Economic and Social Research Council [ES/G035989/1] Funding Source: researchfish	UK-NEA; UK Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Social and Environmental Economic Research (SEER) project (ESRC); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by The UK-NEA and its Follow-On program [which are together supported by the UK Defra; the devolved administrations of Scotland, Wales, and Northern Ireland; the Natural Environment Research Council (NERC) and the Economic and Social Research Council (ESRC)]; and the Social and Environmental Economic Research (SEER) project (ESRC Funder Ref: RES-060-25-0063). I.J.B. led the project with support from all authors; the analysis was designed by I.J.B., A. R. H., G. M. M., and R. W.; C. F., I.J.B., U. P., D. H., P. M., A. R. H., and A. S. undertook the farm land-use analysis; D.J.A., U. P., M. T., C. F., and I.J.B. undertook the GHG analysis; A. S., A. R. H., I.J.B., A. C., J.F., and P. M. undertook the recreation analysis; G. P., B. A., A. K., and I.J.B. undertook the urban green space analysis; M. H., G. S., S. D., and A. A. L. undertook the biodiversity analysis; R. H.-Y. and J.P. undertook the scenario-building exercise; A. R. H. undertook the synthesis and targeting analysis with I.J.B., G. M. M., A. B., B. H. D., and D. v. S.; I.J.B., A. R. H., and G. M. M. wrote the paper with contributions from all authors. We are grateful to P. Dasgupta and K.-G. Maler for research advice. We declare no conflict of interest. Data are included in the supplementary materials available on Science Online.	[Anonymous], 2013, ENCY BIODIVERSITY; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Bateman I.J., 2003, APPL ENV EC GIS APPR, DOI [10.1017/CBO9780511493461, DOI 10.1017/CBO9780511493461]; Bateman IJ, 2011, ENVIRON RESOUR ECON, V48, P177, DOI 10.1007/s10640-010-9418-x; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Casweb, 2001, UK DAT SERV CENS SUP; Defra, 2013, CAP PAYM; Department for Environment Food and Rural Affairs, 2010, JUN AGR CENS; Department for Environment Food and Rural Affairs (Defra) (United Kingdom); Department of Agriculture and Rural Development (Northern Ireland); The Department for Rural Affairs and Heritage Welsh Assembly Government; Rural and Environment Research and Analysis Directorate The Scottish Government, 2011, AGR UK 2011; Department of Energy and Climate Change, 2009, GUID EST CARB VAL 20; Ferraro PJ, 2008, ECOL ECON, V65, P810, DOI 10.1016/j.ecolecon.2007.07.029; Fezzi C, 2008, AGR ECON-BLACKWELL, V39, P197, DOI 10.1111/j.1574-0862.2008.00323.x; Fezzi C, 2011, AM J AGR ECON, V93, P1168, DOI 10.1093/ajae/aar037; Fezzi C, 2010, AGR ECON-BLACKWELL, V41, P123, DOI 10.1111/j.1574-0862.2009.00430.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Goldstein JH, 2012, P NATL ACAD SCI USA, V109, P7565, DOI 10.1073/pnas.1201040109; Jenkins GJ, 2009, UK CLIMATE PROJECTIO; Kinzig AP, 2011, SCIENCE, V334, P603, DOI 10.1126/science.1210297; Lal R, 2004, ENVIRON INT, V30, P981, DOI 10.1016/j.envint.2004.03.005; Lawton J., 2010, MAKING SPACE NATURE; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Mosier AR, 1998, CLIMATIC CHANGE, V40, P39, DOI 10.1023/A:1005338731269; Moxey A., 2012, AGR WATER QUALITY MO; Naidoo R, 2006, PLOS BIOL, V4, P2153, DOI 10.1371/journal.pbio.0040360; National Ecosystem Assessment (NEA), 2011, UK NAT EC ASS TECHN; Natural England, 2010, NECR050; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Ordnance Survey, 2010, LAND FORM PANORAMA D; Polasky S, 2011, ENVIRON RESOUR ECON, V48, P219, DOI 10.1007/s10640-010-9407-0; Risely K., 2011, 624 BTO; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith P, 2007, AGR ECOSYST ENVIRON, V118, P6, DOI 10.1016/j.agee.2006.06.006; U.K. Agriculture, 2013, EC TRENDS; Van Liedekerke M., 2005, ESDBV2 RASTER ARCH	40	653	701	65	1099	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2013	341	6141					45	50		10.1126/science.1234379	http://dx.doi.org/10.1126/science.1234379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828934				2022-12-01	WOS:000321291700042
J	Vilboux, T; Lev, A; Malicdan, MCV; Simon, AJ; Jarvinen, P; Racek, T; Puchalka, J; Sood, R; Carrington, B; Bishop, K; Mullikin, J; Huizing, M; Garty, BZ; Eyal, E; Wolach, B; Gavrieli, R; Toren, A; Soudack, M; Atawneh, OM; Babushkin, T; Schiby, G; Cullinane, A; Avivi, C; Polak-Charcon, S; Barshack, I; Amariglio, N; Rechavi, G; ten Bosch, JV; Anikster, Y; Klein, C; Gahl, WA; Somech, R				Vilboux, Thierry; Lev, Atar; Malicdan, May Christine V.; Simon, Amos J.; Jaervinen, Paeivi; Racek, Tomas; Puchalka, Jacek; Sood, Raman; Carrington, Blake; Bishop, Kevin; Mullikin, James; Huizing, Marjan; Garty, Ben Zion; Eyal, Eran; Wolach, Baruch; Gavrieli, Ronit; Toren, Amos; Soudack, Michalle; Atawneh, Osama M.; Babushkin, Tatiana; Schiby, Ginette; Cullinane, Andrew; Avivi, Camila; Polak-Charcon, Sylvie; Barshack, Iris; Amariglio, Ninette; Rechavi, Gideon; ten Bosch, Jutte van der Werff; Anikster, Yair; Klein, Christoph; Gahl, William A.; Somech, Raz			A Congenital Neutrophil Defect Syndrome Associated with Mutations in VPS45	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HERMANSKY-PUDLAK-SYNDROME; OCULOCUTANEOUS ALBINISM; GENETIC-DEFECTS; PROTEIN; ZEBRAFISH; RABENOSYN-5; TRAFFICKING; DEFICIENCY; TRANSPORT; HOMOLOG	BACKGROUND Neutrophils are the predominant phagocytes that provide protection against bacterial and fungal infections. Genetically determined neutrophil disorders confer a predisposition to severe infections and reveal novel mechanisms that control vesicular trafficking, hematopoiesis, and innate immunity. METHODS We clinically evaluated seven children from five families who had neutropenia, neutrophil dysfunction, bone marrow fibrosis, and nephromegaly. To identify the causative gene, we performed homozygosity mapping using single-nucleotide polymorphism arrays, whole-exome sequencing, immunoblotting, immunofluorescence, electron microscopy, a real-time quantitative polymerase-chain-reaction assay, immunohistochemistry, flow cytometry, fibroblast motility assays, measurements of apoptosis, and zebrafish models. Correction experiments were performed by transfecting mutant fibroblasts with the nonmutated gene. RESULTS All seven affected children had homozygous mutations (Thr224Asn or Glu238Lys, depending on the child's ethnic origin) in VPS45, which encodes a protein that regulates membrane trafficking through the endosomal system. The level of VPS45 protein was reduced, as were the VPS45 binding partners rabenosyn-5 and syntaxin-16. The level of beta 1 integrin was reduced on the surface of VPS45-deficient neutrophils and fibroblasts. VPS45-deficient fibroblasts were characterized by impaired motility and increased apoptosis. A zebrafish model of vps45 deficiency showed a marked paucity of myeloperoxidase-positive cells (i.e., neutrophils). Transfection of patient cells with nonmutated VPS45 corrected the migration defect and decreased apoptosis. CONCLUSIONS Defective endosomal intracellular protein trafficking due to biallelic mutations in VPS45 underlies a new immunodeficiency syndrome involving impaired neutrophil function.	[Vilboux, Thierry; Malicdan, May Christine V.; Huizing, Marjan; Cullinane, Andrew; Gahl, William A.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Sood, Raman; Carrington, Blake; Bishop, Kevin] NHGRI, Zebrafish Core Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Mullikin, James] NHGRI, Comparat Genom Unit, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Lev, Atar; Simon, Amos J.; Somech, Raz] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Jeffrey Modell Fdn, Pediat Immunol Serv, Tel Hashomer, Israel; [Eyal, Eran; Amariglio, Ninette; Rechavi, Gideon] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Canc Res Ctr, Tel Hashomer, Israel; [Toren, Amos] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Pediat Hemato Oncol Unit, Tel Hashomer, Israel; [Soudack, Michalle] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Imaging Unit, Tel Hashomer, Israel; [Babushkin, Tatiana; Schiby, Ginette; Avivi, Camila; Polak-Charcon, Sylvie; Barshack, Iris] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Dept Pathol, Tel Hashomer, Israel; [Anikster, Yair] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Metab Dis Unit, Tel Hashomer, Israel; [Garty, Ben Zion; Wolach, Baruch; Gavrieli, Ronit; Toren, Amos; Soudack, Michalle; Babushkin, Tatiana; Schiby, Ginette; Avivi, Camila; Polak-Charcon, Sylvie; Barshack, Iris; Rechavi, Gideon; Anikster, Yair; Somech, Raz] Tel Aviv Univ, Sackler Fac Med, IL-52621 Tel Aviv, Israel; [Garty, Ben Zion] Schneider Childrens Med Ctr Israel, Dept Pediat B, Petah Tiqwa, Israel; [Garty, Ben Zion] Felsenstein Med Res Ctr, Petah Tiqwa, Israel; [Wolach, Baruch; Gavrieli, Ronit] Meir Med Ctr, Dept Pediat, Kefar Sava, Israel; [Wolach, Baruch; Gavrieli, Ronit] Meir Med Ctr, Lab Leukocyte Funct, Kefar Sava, Israel; [Atawneh, Osama M.] Palestine Red Crescent Soc Hosp, Hebron City, Germany; [Jaervinen, Paeivi; Racek, Tomas; Puchalka, Jacek; Klein, Christoph] Univ Munich, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany; [ten Bosch, Jutte van der Werff] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Dept Pediat, Brussels, Belgium	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; University of Munich; University Hospital Brussels; Vrije Universiteit Brussel	Somech, R (corresponding author), Tel Aviv Univ, Sackler Fac Med, Chaim Sheba Med Ctr, Edmond & Lily Safra Childrens Hosp, IL-52621 Tel Aviv, Israel.	raz.somech@sheba.health.gov.il	Malicdan, May Christine/AAK-7422-2021; Huizing, Marjan/AAR-8860-2020		National Human Genome Research Institute; Intramural Research Program of the National Human Genome Research Institute; European Research Council; Gottfried-Wilhelm-Leibniz Program of the Deutsche Forschungsgemeinschaft; Care-for-Rare Foundation; German Network on Primary Immunodeficiency Diseases; Jeffrey Modell Foundation; Israeli Science Foundation; Chief Scientist Office of the Israeli Ministry of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIGHG200351, ZIBHG000196, ZIAHG000215, ZIAHG200330, ZIAHG200322] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); European Research Council(European Research Council (ERC)European Commission); Gottfried-Wilhelm-Leibniz Program of the Deutsche Forschungsgemeinschaft; Care-for-Rare Foundation; German Network on Primary Immunodeficiency Diseases; Jeffrey Modell Foundation; Israeli Science Foundation(Israel Science Foundation); Chief Scientist Office of the Israeli Ministry of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funded by the National Human Genome Research Institute and others.; Supported by the Intramural Research Program of the National Human Genome Research Institute, an advanced grant (EXPLORE) from the European Research Council, the Gottfried-Wilhelm-Leibniz Program of the Deutsche Forschungsgemeinschaft, the Care-for-Rare Foundation, and the German Network on Primary Immunodeficiency Diseases. Dr. Somech is the recipient of grants from the Jeffrey Modell Foundation, the Israeli Science Foundation, and the Chief Scientist Office of the Israeli Ministry of Health.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bishop JB, 2004, TOXICOL SCI, V81, P512, DOI 10.1093/toxsci/kfh208; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; Boztug K, 2009, NEW ENGL J MED, V360, P32, DOI 10.1056/NEJMoa0805051; Chen C, 2006, IMMUNITY, V25, P895, DOI 10.1016/j.immuni.2006.10.013; COWLES CR, 1994, J CELL SCI, V107, P3449; Cullinane AR, 2011, J INVEST DERMATOL, V131, P2017, DOI 10.1038/jid.2011.157; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Gahl WA, 1998, NEW ENGL J MED, V338, P1258, DOI 10.1056/NEJM199804303381803; Gengyo-Ando K, 2007, EMBO REP, V8, P152, DOI 10.1038/sj.embor.7400882; Gissen P, 2006, HUM GENET, V120, P396, DOI 10.1007/s00439-006-0232-z; Grenda DS, 2007, BLOOD, V110, P4179, DOI 10.1182/blood-2006-11-057299; Horn D, 2000, AM J MED GENET, V92, P285, DOI 10.1002/(SICI)1096-8628(20000605)92:4<285::AID-AJMG13>3.3.CO;2-4; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Klein C, 2013, HEMATOL ONCOL CLIN N, V27, pXI, DOI 10.1016/j.hoc.2012.11.005; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Morrison HA, 2008, MOL BIOL CELL, V19, P4167, DOI 10.1091/mbc.E08-07-0716; Nanua S, 2011, BLOOD, V117, P3539, DOI 10.1182/blood-2010-10-311704; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Perskvist N, 2002, J CELL SCI, V115, P1321; Rahajeng J, 2010, EXP CELL RES, V316, P859, DOI 10.1016/j.yexcr.2009.11.007; Rajasekariah P, 1999, INT J BIOCHEM CELL B, V31, P683, DOI 10.1016/S1357-2725(99)00017-5; Rubio JP, 1997, AM J HUM GENET, V61, P899, DOI 10.1086/514876; Schaffer AA, 2007, CURR OPIN ALLERGY CL, V7, P481, DOI 10.1097/ACI.0b013e3282f1d690; Shanks SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049628; Sood Raman, 2012, Adv Hematol, V2012, P830703, DOI 10.1155/2012/830703; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; Tall GG, 1999, MOL BIOL CELL, V10, P1873, DOI 10.1091/mbc.10.6.1873; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tomita Y, 2004, AM J MED GENET C, V131C, P75, DOI 10.1002/ajmg.c.30036; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Westerfield M., 1993, GUIDE LAB USE ZEBRAF; Wider C, 2008, PARKINSONISM RELAT D, V14, P465, DOI 10.1016/j.parkreldis.2007.11.013; ZUCKERFRANKLIN D, 1977, BLOOD, V49, P425	43	87	91	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2013	369	1					54	65		10.1056/NEJMoa1301296	http://dx.doi.org/10.1056/NEJMoa1301296			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175WE	23738510	Green Accepted			2022-12-01	WOS:000321263500010
J	Cotney, J; Leng, J; Yin, J; Reilly, SK; DeMare, LE; Emera, D; Ayoub, AE; Rakic, P; Noonan, JP				Cotney, Justin; Leng, Jing; Yin, Jun; Reilly, Steven K.; DeMare, Laura E.; Emera, Deena; Ayoub, Albert E.; Rakic, Pasko; Noonan, James P.			The Evolution of Lineage-Specific Regulatory Activities in the Human Embryonic Limb	CELL			English	Article							GENOME-WIDE ASSOCIATION; TRANSPOSABLE ELEMENTS; GENE-EXPRESSION; ENHANCER; MAP; SEQUENCES; DEFINES; HEIGHT; MOUSE; STATE	The evolution of human anatomical features likely involved changes in gene regulation during development. However, the nature and extent of human-specific developmental regulatory functions remain unknown. We obtained a genome-wide view of cis-regulatory evolution in human embryonic tissues by comparing the histone modification H3K27ac, which provides a quantitative readout of promoter and enhancer activity, during human, rhesus, and mouse limb development. Based on increased H3K27ac, we find that 13% of promoters and 11% of enhancers have gained activity on the human lineage since the human-rhesus divergence. These gains largely arose by modification of ancestral regulatory activities in the limb or potential co-option from other tissues and are likely to have heterogeneous genetic causes. Most enhancers that exhibit gain of activity in humans originated in mammals. Gains at promoters and enhancers in the human limb are associated with increased gene expression, suggesting they include molecular drivers of human morphological evolution.	[Cotney, Justin; Yin, Jun; Reilly, Steven K.; DeMare, Laura E.; Emera, Deena; Noonan, James P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Ayoub, Albert E.; Rakic, Pasko] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Ayoub, Albert E.; Rakic, Pasko; Noonan, James P.] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06520 USA; [Leng, Jing; Noonan, James P.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06511 USA	Yale University; Yale University; Yale University; Yale University	Noonan, JP (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA.	james.noonan@yale.edu	Cotney, Justin L/ABE-8500-2021; Noonan, James/ABF-1320-2021; Yin, Jun/A-7502-2010	Cotney, Justin L/0000-0001-8230-2157; Yin, Jun/0000-0003-4543-1229; Reilly, Steven/0000-0003-3140-1483	National Institutes of Health [GM094780, DA023999, NS014841]; Edward J. Mallinckrodt Jr. Foundation; Rudolph Andersen Fellowship; Howard Hughes Medical Research Scholars Fellowship; NSF Graduate Research Fellowship; MRC [MC_PC_15004, G0700089] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023999] Funding Source: NIH RePORTER; Medical Research Council [MC_PC_15004, G0700089] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward J. Mallinckrodt Jr. Foundation; Rudolph Andersen Fellowship; Howard Hughes Medical Research Scholars Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by National Institutes of Health grants GM094780 (to J.P.N.), DA023999 (to P.R.), and NS014841 (to P.R.); a career award from the Edward J. Mallinckrodt Jr. Foundation (to J.P.N.); a Rudolph Andersen Fellowship (to J.C.); a Howard Hughes Medical Research Scholars Fellowship (to L.E.D.); and an NSF Graduate Research Fellowship (to S.K.R.). The human embryonic and fetal material was provided by the Joint MRC (G0700089)/Wellcome Trust (GR082557) Human Developmental Biology Resource. We thank Marianne Horn and Steve R. Wilson for technical assistance and veterinary expertise. We also thank Shrikant Mane, John Overton, Sheila Umlauf, and Alex Lopez at the Yale Center for Genome Analysis for generating sequencing data and Nicholas Carriero and Robert Bjornson at the Yale University Biomedical Performance Computing Center for computer resource support.	Aiello L., 2002, INTRO HUMAN EVOLUTIO; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Cormier TA, 2001, MAMM GENOME, V12, P796, DOI 10.1007/s00335-001-1006-5; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dominguez MH, 2013, CEREB CORTEX, V23, P2632, DOI 10.1093/cercor/bhs252; Duboc V, 2011, DEV DYNAM, V240, P1017, DOI 10.1002/dvdy.22582; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Goke J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002304; Green P, 2013, SCIENCE, V340, DOI 10.1126/science.1233195; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lorenzo P, 1998, J BIOL CHEM, V273, P23463, DOI 10.1074/jbc.273.36.23463; Marzke MW, 2000, J ANAT, V197, P121, DOI 10.1046/j.1469-7580.2000.19710121.x; Masuya H, 1997, DEV BIOL, V182, P42, DOI 10.1006/dbio.1996.8457; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schoenwolf G., 2009, LARSENS HUMAN EMBRYO; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shibata Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002789; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Taher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028358; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wakabayashi T, 2010, BIOCHEM BIOPH RES CO, V391, P1116, DOI 10.1016/j.bbrc.2009.12.034; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhao JH, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-96	47	130	133	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					185	196		10.1016/j.cell.2013.05.056	http://dx.doi.org/10.1016/j.cell.2013.05.056			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827682	Green Accepted, Bronze			2022-12-01	WOS:000321327900019
J	Pulk, A; Cate, JHD				Pulk, Arto; Cate, Jamie H. D.			Control of Ribosomal Subunit Rotation by Elongation Factor G	SCIENCE			English	Article							MESSENGER-RNA TRANSLOCATION; EF-G; GTP HYDROLYSIS; CONFORMATIONAL-CHANGES; INTERSUBUNIT ROTATION; INTERMEDIATE STATES; PROTEIN-SYNTHESIS; KINETIC-ANALYSIS; SWITCH-I; MOVEMENT	Protein synthesis by the ribosome requires the translocation of transfer RNAs and messenger RNA by one codon after each peptide bond is formed, a reaction that requires ribosomal subunit rotation and is catalyzed by the guanosine triphosphatase (GTPase) elongation factor G (EF-G). We determined 3 angstrom resolution x-ray crystal structures of EF-G complexed with a nonhydrolyzable guanosine 5'-triphosphate (GTP) analog and bound to the Escherichia coli ribosome in different states of ribosomal subunit rotation. The structures reveal that EF-G binding to the ribosome stabilizes switch regions in the GTPase active site, resulting in a compact EF-G conformation that favors an intermediate state of ribosomal subunit rotation. These structures suggest that EF-G controls the translocation reaction by cycles of conformational rigidity and relaxation before and after GTP hydrolysis.	[Pulk, Arto; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biosci, 229 Stanley Hall, Berkeley, CA 94720 USA.	jcate@lbl.gov	Classen, Scott/AAY-8176-2020	Pulk, Arto/0000-0001-8793-3038	NIH [R01-GM65050]; NIH project MINOS [R01GM105404]; U.S. Department of Energy [DEAC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065050, R01GM105404] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH project MINOS; U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Doudna for helpful discussions and comments, J. Holton and G. Meigs for help with x-ray data collection, and P. Afonine and J. Headd for advice on crystallographic refinement. This work was supported by NIH grant R01-GM65050 to J. H. D. C., by the NIH project MINOS grant R01GM105404 for the Structural Integrated Biology for Life Sciences (SIBYLS) and 8.3.1 beam lines at the Advanced Light Source (ALS), and by the U.S. Department of Energy (DEAC02-05CH11231 for the SIBYLS and 8.3.1 beam-lines at the ALS). Coordinates for the ribosomes have been deposited in the Protein Data Bank (PDB): 4KIX, 4KIY, 4KIZ, 4KJ0, 4KJ1, 4KJ2, 4KJ3, 4KJ4, 4KJ5, 4KJ6, 4KJ7, 4KJ8, 4KJ9, 4KJA, 4KJB, and 4KJC.	Agirrezabala X, 2012, P NATL ACAD SCI USA, V109, P6094, DOI 10.1073/pnas.1201288109; Agirrezabala X, 2009, Q REV BIOPHYS, V42, P159, DOI 10.1017/S0033583509990060; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Bartish G, 2008, BIOCHIMIE, V90, P736, DOI 10.1016/j.biochi.2008.01.006; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Budkevich T, 2011, MOL CELL, V44, P214, DOI 10.1016/j.molcel.2011.07.040; Chen CL, 2011, MOL CELL, V42, P367, DOI 10.1016/j.molcel.2011.03.024; Clementi N, 2010, RNA BIOL, V7, P521, DOI 10.4161/rna.7.5.12467; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Ermolenko DN, 2007, J MOL BIOL, V370, P530, DOI 10.1016/j.jmb.2007.04.042; Ermolenko DN, 2011, NAT STRUCT MOL BIOL, V18, P457, DOI 10.1038/nsmb.2011; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Fei JY, 2011, NAT STRUCT MOL BIOL, V18, P1043, DOI 10.1038/nsmb.2098; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gabashvili IS, 1999, J MOL BIOL, V286, P1285, DOI 10.1006/jmbi.1999.2538; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; GAVRILOV.LP, 1971, FEBS LETT, V17, P324, DOI 10.1016/0014-5793(71)80177-1; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]; Kjeldgaard M, 1996, FASEB J, V10, P1347, DOI 10.1096/fasebj.10.12.8903506; Kolesnikov A, 2002, FEBS LETT, V514, P67, DOI 10.1016/S0014-5793(02)02300-1; Konevega AL, 2007, NAT STRUCT MOL BIOL, V14, P318, DOI 10.1038/nsmb1221; Liang H, 2008, BEILSTEIN J ORG CHEM, V4, DOI 10.3762/bjoc.4.31; Margus T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022789; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Mohr D, 2000, EMBO J, V19, P3458, DOI 10.1093/emboj/19.13.3458; Munro JB, 2010, NAT STRUCT MOL BIOL, V17, P1470, DOI 10.1038/nsmb.1925; Munro JB, 2010, EMBO J, V29, P770, DOI 10.1038/emboj.2009.384; Peske F, 2005, MOL CELL, V18, P403, DOI 10.1016/j.molcel.2005.04.009; Peske F, 2004, J MOL BIOL, V343, P1183, DOI 10.1016/j.jmb.2004.08.097; PESTKA S, 1969, J BIOL CHEM, V244, P1533; Petrov A, 2011, CURR OPIN STRUC BIOL, V21, P137, DOI 10.1016/j.sbi.2010.11.007; Ramrath DJF, 2012, NATURE, V485, P526, DOI 10.1038/nature11006; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; ROHRBACH MS, 1976, BIOCHEMISTRY-US, V15, P4565, DOI 10.1021/bi00666a003; Savelsbergh A, 2000, J MOL BIOL, V300, P951, DOI 10.1006/jmbi.2000.3886; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Shoji S, 2006, MOL CELL, V24, P931, DOI 10.1016/j.molcel.2006.11.025; Sohmen D, 2009, CELL, V139, DOI 10.1016/j.cell.2009.08.009; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Ticu C, 2011, J BIOL CHEM, V286, P21697, DOI 10.1074/jbc.M110.214056; Ticu C, 2009, EMBO J, V28, P2053, DOI 10.1038/emboj.2009.169; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Walker SE, 2008, P NATL ACAD SCI USA, V105, P9192, DOI 10.1073/pnas.0710146105; Wang LY, 2011, RNA, V17, P2189, DOI 10.1261/rna.029033.111; Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	56	129	130	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1544	+	1235970	10.1126/science.1235970	http://dx.doi.org/10.1126/science.1235970			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812721	Green Accepted			2022-12-01	WOS:000321007000033
J	Colbert, JA; Adler, JN				Colbert, James A.; Adler, Jonathan N.			Family Presence during Cardiopulmonary Resuscitation - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Henderson DP, 2005, PEDIATR EMERG CARE, V21, P787, DOI 10.1097/01.pec.0000188877.41095.5a; Jabre P, 2013, NEW ENGL J MED, V368, P1008, DOI 10.1056/NEJMoa1203366	3	19	20	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					E38	+		10.1056/NEJMclde1307088	http://dx.doi.org/10.1056/NEJMclde1307088			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KQ	23802541				2022-12-01	WOS:000320926900002
J	Goldberger, JJ; Buxton, AE				Goldberger, Jeffrey J.; Buxton, Alfred E.			Personalized Medicine vs Guideline-Based Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; ACUTE MYOCARDIAL-INFARCTION; RISK STRATIFICATION		[Goldberger, Jeffrey J.] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Goldberger, Jeffrey J.] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA; [Buxton, Alfred E.] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc, Boston, MA 02215 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Harvard University; Beth Israel Deaconess Medical Center	Goldberger, JJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 251 E Huron St,Feinberg 8-503, Chicago, IL 60611 USA.	j-goldberger@northwestern.edu	Goldberger, Jeffrey J/AAB-3684-2020					[Anonymous], PRIOR PERS MED; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Goldberger JJ, 2011, CIRCULATION, V123, P2423, DOI 10.1161/CIRCULATIONAHA.110.959734; Goldberger JJ, 2009, J AM COLL CARDIOL, V54, P2001, DOI 10.1016/j.jacc.2009.08.018; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P288, DOI 10.1016/j.jacc.2007.08.058; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Steinbeck G, 2009, NEW ENGL J MED, V361, P1427, DOI 10.1056/NEJMoa0901889; VanderWeele TJ, 2011, ANN INTERN MED, V154, P680, DOI 10.7326/0003-4819-154-10-201105170-00008; Wilber DJ, 2004, CIRCULATION, V109, P1082, DOI 10.1161/01.CIR.0000121328.12536.07	10	68	71	1	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2559	2560		10.1001/jama.2013.6629	http://dx.doi.org/10.1001/jama.2013.6629			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23712449				2022-12-01	WOS:000320848100024
J	Kumagai, A; Ando, R; Miyatake, H; Greimel, P; Kobayashi, T; Hirabayashi, Y; Shimogori, T; Miyawaki, A				Kumagai, Akiko; Ando, Ryoko; Miyatake, Hideyuki; Greimel, Peter; Kobayashi, Toshihide; Hirabayashi, Yoshio; Shimogori, Tomomi; Miyawaki, Atsushi			A Bilirubin-Inducible Fluorescent Protein from Eel Muscle	CELL			English	Article							HUMAN SERUM-ALBUMIN; ACID-BINDING PROTEINS; PHYTOCHROME; RED; ANTIOXIDANT; EXPRESSION; INSIGHTS	The fluorescent protein toolbox has revolutionized experimental biology. Despite this advance, no fluorescent proteins have been identified from vertebrates, nor has chromogenic ligand-inducible activation or clinical utility been demonstrated. Here, we report the cloning and characterization of UnaG, a fluorescent protein from Japanese eel. UnaG belongs to the fatty-acid-binding protein (FABP) family, and expression in eel is restricted to small-diameter muscle fibers. On heterologous expression in cell lines or mouse brain, UnaG produces oxygen-independent green fluorescence. Remarkably, UnaG fluorescence is triggered by an endogenous ligand, bilirubin, a membrane-permeable heme metabolite and clinical health biomarker. The holoUnaG structure at 1.2 angstrom revealed a biplanar coordination of bilirubin by reversible p-conjugation, and we used this high-affinity and high-specificity interaction to establish a fluorescence-based human bilirubin assay with promising clinical utility. UnaG will be the prototype for a versatile class of ligand-activated fluorescent proteins, with applications in research, medicine, and bioengineering.	[Kumagai, Akiko; Ando, Ryoko; Hirabayashi, Yoshio; Shimogori, Tomomi; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Miyatake, Hideyuki] RIKEN, Global Res Cluster Collaborat Promot Unit, Wako, Saitama 3510198, Japan; [Greimel, Peter; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Wako, Saitama 3510198, Japan; [Kumagai, Akiko; Miyawaki, Atsushi] JST, ERATO, Wako, Saitama 3510198, Japan	RIKEN; RIKEN; RIKEN; Japan Science & Technology Agency (JST)	Miyawaki, A (corresponding author), RIKEN, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsushi@brain.riken.jp	hideyuki, miyatake/S-4993-2019; Shimogori, Tomomi/L-2893-2013; Miyawaki, Atsushi/K-3569-2014; Kobayashi, Toshihide/B-6298-2015; KOBAYASHI, TOSHIHIDE/S-8313-2019	hideyuki, miyatake/0000-0001-8872-9784; Shimogori, Tomomi/0000-0002-6931-5401; Miyawaki, Atsushi/0000-0002-2329-3235; Kobayashi, Toshihide/0000-0002-4811-7270; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Hirabayashi, Yoshio/0000-0002-5774-7354; Greimel, Peter/0000-0002-4931-6183	Japan MEXT; Human Frontier Science Program	Japan MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program)	We thank Dr. S. Hayashi, Dr. O. Nureki, H. Kato, and S. Karasawa for valuable advice; Y. Ide, H. Iizuka, K. Nagai, H. Sakurai, and Unagi-no-Miyagawa (Wako) for help with acquiring eels; Dr. A. Kikuchi, Dr. N. Domae, H. Takagi, H. Shima, M. Sonoda, H. Watanabe, E. Oshima, and K. Tanaka for assistance; and Dr. D. Mou, Dr. A. Terashima, and Dr. C. Yokoyama for valuable advice and critical reading of the manuscript. This work was partly supported by grants from Japan MEXT Grant-in-Aid for Scientific Research on Priority Areas and the Human Frontier Science Program. A. K. and A. M. conceived and designed the study. A. K. performed all of the experiments and analyzed the data. R. A. performed the molecular cloning and histological experiments. H. M. supervised the crystallographic experiments. P. G. and T. K. contributed to the ligand identification. Y. H. contributed to the experiments using human serum. T. S. performed the in utero electroporation experiment. A. M. analyzed the data, designed and wrote the manuscript, and supervised the project.	Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; ARIAS IM, 1980, MOL CELL BIOCHEM, V29, P71; Athar H, 1999, INT J BIOL MACROMOL, V25, P353, DOI 10.1016/S0141-8130(99)00056-2; Auldridge ME, 2012, J BIOL CHEM, V287, P7000, DOI 10.1074/jbc.M111.295121; Balendiran GK, 2000, J BIOL CHEM, V275, P27045; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Fukui M, 2008, KIDNEY INT, V74, P1197, DOI 10.1038/ki.2008.398; GLAZER AN, 1989, J BIOL CHEM, V264, P1; Hayashi S, 2009, FISHERIES SCI, V75, P1461, DOI 10.1007/s12562-009-0176-z; Huber AH, 2012, CLIN CHEM, V58, P869, DOI 10.1373/clinchem.2011.176412; Inoue JG, 2010, BIOL LETTERS, V6, P363, DOI 10.1098/rsbl.2009.0989; Kapitulnik J, 2004, MOL PHARMACOL, V66, P773, DOI 10.1124/mol.104.002832; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Lo SF, 2011, SEMIN PERINATOL, V35, P141, DOI 10.1053/j.semperi.2011.02.008; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; Miyawaki A, 2012, CURR OPIN STRUC BIOL, V22, P679, DOI 10.1016/j.sbi.2012.09.002; Petersen CE, 2000, J BIOL CHEM, V275, P20985, DOI 10.1074/jbc.M001038200; Piatkevich KD, 2013, CHEM SOC REV, V42, P3441, DOI 10.1039/c3cs35458j; Qu H, 2007, MOL CELL BIOCHEM, V299, P45, DOI 10.1007/s11010-005-9036-z; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; ROWLERSON A, 1985, J MUSCLE RES CELL M, V6, P601, DOI 10.1007/BF00711917; Sadhu KK, 2011, CHEMBIOCHEM, V12, P1299, DOI 10.1002/cbic.201100137; Schaap FG, 2002, MOL CELL BIOCHEM, V239, P69, DOI 10.1023/A:1020519011939; Sedlak TW, 2004, PEDIATRICS, V113, P1776, DOI 10.1542/peds.113.6.1776; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Weisiger RA, 2001, J BIOL CHEM, V276, P29953, DOI 10.1074/jbc.M104628200; Wennberg RP, 2006, PEDIATRICS, V117, P474, DOI 10.1542/peds.2005-0395; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y; Zunszain PA, 2008, J MOL BIOL, V381, P394, DOI 10.1016/j.jmb.2008.06.016	37	189	197	3	83	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 20	2013	153	7					1602	1611		10.1016/j.cell.2013.05.038	http://dx.doi.org/10.1016/j.cell.2013.05.038			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23768684	Bronze			2022-12-01	WOS:000320722000026
J	Lammermann, T; Afonso, PV; Angermann, BR; Wang, JM; Kastenmuller, W; Parent, CA; Germain, RN				Laemmermann, Tim; Afonso, Philippe V.; Angermann, Bastian R.; Wang, Ji Ming; Kastenmueller, Wolfgang; Parent, Carole A.; Germain, Ronald N.			Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo	NATURE			English	Article							INNATE IMMUNE-RESPONSE; IMAGING REVEALS; HOST-DEFENSE; MICE LACKING; LYMPH-NODES; MIGRATION; RECRUITMENT; RECEPTOR; MOLECULE; LEUKOTRIENE-B4	Neutrophil recruitment from blood to extravascular sites of sterile or infectious tissue damage is a hallmark of early innate immune responses, and the molecular events leading to cell exit from the bloodstream have been well defined(1,2). Once outside the vessel, individual neutrophils often show extremely coordinated chemotaxis and cluster formation reminiscent of the swarming behaviour of insects(3-11). The molecular players that direct this response at the single-cell and population levels within the complexity of an inflamed tissue are unknown. Using two-photon intravital microscopy in mouse models of sterile injury and infection, we show a critical role for intercellular signal relay among neutrophils mediated by the lipid leukotriene B4, which acutely amplifies local cell death signals to enhance the radius of highly directed interstitial neutrophil recruitment. Integrin receptors are dispensable for long-distance migration(12), but have a previously unappreciated role in maintaining dense cellular clusters when congregating neutrophils rearrange the collagenous fibre network of the dermis to form a collagen-free zone at the wound centre. In this newly formed environment, integrins, in concert with neutrophil-derived leukotriene B4 and other chemoattractants, promote local neutrophil interaction while forming a tight wound seal. This wound seal has borders that cease to grow in kinetic concert with late recruitment of monocytes and macrophages at the edge of the displaced collagen fibres. Together, these data provide an initial molecular map of the factors that contribute to neutrophil swarming in the extravascular space of a damaged tissue. They reveal how local events are propagated over large-range distances, and how auto-signalling produces coordinated, self-organized neutrophil-swarming behaviour that isolates the wound or infectious site from surrounding viable tissue.	[Laemmermann, Tim; Angermann, Bastian R.; Kastenmueller, Wolfgang; Germain, Ronald N.] NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Afonso, Philippe V.; Parent, Carole A.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wang, Ji Ming] NCI, Lab Mol Immunoregulat, Canc & Inflammat Program, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Kastenmueller, Wolfgang] Univ Bonn, Inst Mol Med, D-53105 Bonn, Germany; [Kastenmueller, Wolfgang] Univ Bonn, Inst Expt Immunol, D-53105 Bonn, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bonn; University of Bonn	Lammermann, T (corresponding author), NIAID, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	laemmermannt@niaid.nih.gov; rgermain@niaid.nih.gov	Afonso, Philippe/D-2234-2014; Afonso, Philippe V/ABB-5692-2021; Lämmermann, Tim/AAD-7453-2022; Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020	Afonso, Philippe/0000-0002-4828-3797; Afonso, Philippe V/0000-0002-4828-3797; 	Human Frontiers Science Program Long-Term Fellowship; Deutsche Forschungsgemeinschaft (DFG); National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010725, ZIABC011216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER	Human Frontiers Science Program Long-Term Fellowship; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Birnbaumer, R. Fassler, E. Tuomanen, P. M. Murphy, S. Akira, S. Monkley, D. Critchley, R. Wedlich-Soldner and M. Sixt for providing mice for this study, J.G. Egen and J. Tang for assistance with imaging, M. Parsek for providing P. aeruginosa-GFP, J. H. Kehrl, P. M. Murphy, R. Varma and members of the Germain laboratory for discussions. This work was supported by the Intramural Research Program of National Institute of Allergy and Infectious Diseases and National Cancer Institute, National Institutes of Health. T. L. was supported by a Human Frontiers Science Program Long-Term Fellowship. W. K. is presently a member of the Deutsche Forschungsgemeinschaft (DFG)-funded excellence cluster ImmunoSensation, Bonn, Germany.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Bruns S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000873; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Cho H, 2012, MOL CELL BIOL, V32, P4561, DOI 10.1128/MCB.00651-12; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DIPERSIO JF, 1988, J IMMUNOL, V140, P4315; Faust N, 2000, BLOOD, V96, P719; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Gaiser MR, 2012, P NATL ACAD SCI USA, V109, pE889, DOI 10.1073/pnas.1117674109; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Guggenberger C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002434; Harvie EA, 2013, INFECT IMMUN, V81, P110, DOI 10.1128/IAI.00642-12; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Liese J., 2012, CELL MICROBIOL; Malawista SE, 2008, P NATL ACAD SCI USA, V105, P17949, DOI 10.1073/pnas.0802572105; McDonald B, 2011, J MOL MED, V89, P1079, DOI 10.1007/s00109-011-0784-9; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Ng LG, 2011, J INVEST DERMATOL, V131, P2058, DOI 10.1038/jid.2011.179; Oh Hana, 2008, J Vis Exp, DOI 10.3791/745; Oyoshi MK, 2012, IMMUNITY, V37, P747, DOI 10.1016/j.immuni.2012.06.018; PALMBLAD J, 1981, BLOOD, V58, P658; Pero RS, 2007, P NATL ACAD SCI USA, V104, P4371, DOI 10.1073/pnas.0700185104; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Radin JN, 2005, INFECT IMMUN, V73, P7827, DOI 10.1128/IAI.73.12.7827-7835.2005; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Sadik CD, 2012, P NATL ACAD SCI USA, V109, pE3177, DOI 10.1073/pnas.1213797109; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847	49	567	574	5	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					371	+		10.1038/nature12175	http://dx.doi.org/10.1038/nature12175			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23708969	Green Accepted, Green Published			2022-12-01	WOS:000320592900042
J	Ziegler, AG; Rewers, M; Simell, O; Simell, T; Lempainen, J; Steck, A; Winkler, C; Ilonen, J; Veijola, R; Knip, M; Bonifacio, E; Eisenbarth, GS				Ziegler, Anette G.; Rewers, Marian; Simell, Olli; Simell, Tuula; Lempainen, Johanna; Steck, Andrea; Winkler, Christiane; Ilonen, Jorma; Veijola, Riitta; Knip, Mikael; Bonifacio, Ezio; Eisenbarth, George S.			Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; INTERVENTION TRIAL; GENERAL-POPULATION; TYPE-1; INSULIN; AUTOIMMUNITY; ANTIBODIES; MELLITUS; PREDICTION; RELATIVES	Importance Type 1 diabetes usually has a preclinical phase identified by circulating islet autoantibodies, but the rate of progression to diabetes after seroconversion to islet autoantibodies is uncertain. Objective To determine the rate of progression to diabetes after islet autoantibody seroconversion. Design, Setting, and Participants Data were pooled from prospective cohort studies performed in Colorado (recruitment, 1993-2006), Finland (recruitment, 19942009), and Germany (recruitment, 1989-2006) examining children genetically at risk for type 1 diabetes for the development of insulin autoantibodies, glutamic acid decarboxylase 65 (GAD65) autoantibodies, insulinoma antigen 2 (IA2) autoantibodies, and diabetes. Participants were all children recruited and followed up in the 3 studies (Colorado, 1962; Finland, 8597; Germany, 2818). Follow-up assessment in each study was concluded by July 2012. Main Outcomes and Measures The primary analysis was the diagnosis of type 1 diabetes in children with 2 or more autoantibodies. The secondary analysis was the diagnosis of type 1 diabetes in children with 1 autoantibody or no autoantibodies. Results Progression to type 1 diabetes at 10-year follow-up after islet autoantibody seroconversion in 585 children with multiple islet autoantibodies was 69.7% (95% CI, 65.1%-74.3%), and in 474 children with a single islet autoantibody was 14.5% (95% CI, 10.3%-18.7%). Risk of diabetes in children who had no islet autoantibodies was 0.4% (95% CI, 0.2%-0.6%) by the age of 15 years. Progression to type 1 diabetes in the children with multiple islet autoantibodies was faster for children who had islet autoantibody seroconversion younger than age 3 years (hazard ratio [HR], 1.65 [95% CI, 1.30-2.09; P < .001]; 10-year risk, 74.9% [95% CI, 69.7%-80.1%]) vs children 3 years or older (60.9% [95% CI, 51.5%-70.3%]); for children with the human leukocyte antigen (HLA) genotype DR3/ DR4-DQ8 (HR, 1.35 [95% CI, 1.09-1.68; P=.007]; 10-year risk, 76.6% [95% CI, 69.2%-84%]) vs other HLA genotypes (66.2% [95% CI, 60.2%-72.2%]); and for girls (HR, 1.28 [95% CI, 1.04-1.58; P=.02]; 10-year risk, 74.8% [95% CI, 68.0%-81.6%]) vs boys (65.7% [95% CI, 59.3%-72.1%]). Conclusions and Relevance The majority of children at risk of type 1 diabetes who had multiple islet autoantibody seroconversion progressed to diabetes over the next 15 years. Future prevention studies should focus on this high-risk population.	[Ziegler, Anette G.; Winkler, Christiane] Tech Univ Munich, Diabet Res Inst, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Ziegler, Anette G.; Winkler, Christiane] Tech Univ Munich, Klinikum Rechts Isar, Forschergrp Diabet, D-85764 Neuherberg, Germany; [Rewers, Marian; Steck, Andrea; Eisenbarth, George S.] Univ Colorado, Sch Med, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Simell, Olli; Simell, Tuula; Lempainen, Johanna] Univ Turku, Dept Pediat, Turku, Finland; [Lempainen, Johanna; Ilonen, Jorma] Univ Turku, Immunogenet Lab, Turku, Finland; [Simell, Olli; Simell, Tuula; Lempainen, Johanna] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland; [Ilonen, Jorma] Univ Eastern Finland, Dept Clin Microbiol, Kuopio, Finland; [Veijola, Riitta] Univ Oulu, Dept Pediat, Inst Clin Med, SF-90100 Oulu, Finland; [Knip, Mikael] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Knip, Mikael] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Knip, Mikael] Tampere Univ Hosp, Dept Pediat, Tampere, Finland; [Bonifacio, Ezio] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany; [Bonifacio, Ezio] Tech Univ Dresden, Paul Langerhans Inst Dresden, German Ctr Diabet Res, Dresden, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Turku; University of Turku; University of Turku; University of Eastern Finland; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University Hospital; Technische Universitat Dresden; Technische Universitat Dresden	Ziegler, AG (corresponding author), Tech Univ Munich, Diabet Res Inst, Helmholtz Zentrum Munchen, Ingolstaedter Landstrase 1, D-85764 Neuherberg, Germany.	anette-g.ziegler@helmholtz-muenchen.de	Knip, Mikael/AAL-3773-2020; Ziegler, Anette-Gabriele/M-4614-2014; Bonifacio, Ezio/E-7700-2010	Ziegler, Anette-Gabriele/0000-0002-6290-5548; Bonifacio, Ezio/0000-0002-8704-4713; Knip, Mikael/0000-0003-0474-0033; Ilonen, Jorma/0000-0002-9973-2062	Juvenile Diabetes Research Foundation [1-2000-619, 4-1999-731, 4-2001-435]; National Institutes of Health [R01 DK32493]; Bundesministerium fur Bildung und Forschung [01KD89030, 1KD9601]; Deutsche Forschungsgemeinschaft [ZI-310/14-1, ZI-310/14-2, ZI-310/14-3, ZI-310/14-4]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK063821, R01DK032493] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Primary support for this work was provided by grants 1-2000-619 (BABYDIAB) and 4-1999-731 and 4-2001-435 (DIPP) from the Juvenile Diabetes Research Foundation; R01 DK32493 (DAISY) from the National Institutes of Health; 01KD89030 and 1KD9601 (BABYDIAB) from Bundesministerium fur Bildung und Forschung; and ZI-310/14-1, ZI-310/14-2, ZI-310/14-3, and ZI-310/14-4(BABYDIET) from Deutsche Forschungsgemeinschaft.	Achenbach P, 2004, DIABETES, V53, P384, DOI 10.2337/diabetes.53.2.384; Achenbach P, 2009, DIABETOLOGIA, V52, P1881, DOI 10.1007/s00125-009-1438-0; Bingley PJ, 2006, DIABETOLOGIA, V49, P881, DOI 10.1007/s00125-006-0160-4; Bonifacio E, 1998, J IMMUNOL, V161, P2648; BONIFACIO E, 1990, LANCET, V335, P147, DOI 10.1016/0140-6736(90)90013-U; Colman PG, 2000, DIABETOLOGIA, V43, P203, DOI 10.1007/s001250050030; Decochez K, 2005, DIABETOLOGIA, V48, P687, DOI 10.1007/s00125-005-1702-x; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Hummel M, 2004, ANN INTERN MED, V140, P882, DOI 10.7326/0003-4819-140-11-200406010-00009; Hummel S, 2011, DIABETES CARE, V34, P1301, DOI 10.2337/dc10-2456; Knip M, 2010, DIABETES CARE, V33, P1206, DOI 10.2337/dc09-1040; Koczwara K, 2004, DIABETES, V53, P1; Kukko M, 2005, J CLIN ENDOCR METAB, V90, P2712, DOI 10.1210/jc.2004-1371; Milton B, 2006, DIABETIC MED, V23, P821, DOI 10.1111/j.1464-5491.2006.01796.x; Nanto-Salonen K, 2008, LANCET, V372, P1746, DOI 10.1016/S0140-6736(08)61309-4; Orban T, 2009, DIABETES CARE, V32, P2269, DOI 10.2337/dc09-0934; Puavilai G, 1999, DIABETES RES CLIN PR, V44, P21, DOI 10.1016/S0168-8227(99)00008-X; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; TARN AC, 1988, LANCET, V1, P845; Vehik K, 2011, DIABETES CARE, V34, P1585, DOI 10.2337/dc11-0523; VIVES M, 1992, DIABETES, V41, P1624, DOI 10.2337/diabetes.41.12.1624; Yu LP, 2012, DIABETES CARE, V35, P1213, DOI 10.2337/dc11-2081; Yu LP, 1996, J CLIN ENDOCR METAB, V81, P4264, DOI 10.1210/jc.81.12.4264; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460	26	660	685	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2473	2479		10.1001/jama.2013.6285	http://dx.doi.org/10.1001/jama.2013.6285			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23780460	Bronze, Green Accepted			2022-12-01	WOS:000320505100028
J	Robinson, D; Garmo, H; Bill-Axelson, A; Mucci, L; Holmberg, L; Stattin, P				Robinson, David; Garmo, Hans; Bill-Axelson, Anna; Mucci, Lorelei; Holmberg, Lars; Stattin, Par			Use of 5 alpha-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HIGH-GRADE; MODELING APPROACH; PREVENTION TRIAL; FINASTERIDE; DUTASTERIDE; HYPERPLASIA; BIAS	Objective To assess the association between 5 alpha-reductase inhibitor (5-ARI) use in men with lower urinary tract symptoms and prostate cancer risk. Design Nationwide, population based case-control study for men diagnosed with prostate cancer in 2007-09 within the Prostate Cancer data Base Sweden 2.0. Setting The National Prostate Cancer Register, National Patient Register, census, and Prescribed Drug Register in Sweden, from which we obtained data on 5-ARI use before date of prostate cancer diagnosis. Participants 26 735 cases and 133 671 matched controls; five controls per case were randomly selected from matched men in the background population. 7815 men (1499 cases and 6316 controls) had been exposed to 5-ARI. 412 men had been exposed to 5-ARI before the diagnosis of a cancer with Gleason score 8-10. Main outcome measures Risk of prostate cancer calculated as odds ratios and 95% confidence intervals by conditional logistic regression analyses. Results Risk of prostate cancer overall decreased with an increasing duration of exposure; men on 5-ARI treatment for more than three years had an odds ratio of 0.72 (95% confidence interval 0.59 to 0.89; P<0.001 for trend). The same pattern was seen for cancers with Gleason scores 2-6 and score 7 (both P<0.001 for trend). By contrast, the risk of tumours with Gleason scores 8-10 did not decrease with increasing exposure time to 5-ARI (for 0-1 year of exposure, odds ratio 0.96 (95% confidence interval 0.83 to 1.11); for 1-2 years, 1.07 (0.88 to 1.31); for 2-3 years, 0.96 (0.72 to 1.27); for >3 years, 1.23 (0.90 to 1.68); P=0.46 for trend). Conclusions Men treated with 5-ARI for lower urinary tract symptoms had a decreased risk of cancer with Gleason scores 2-7, and showed no evidence of an increased risk of cancer with Gleason scores 8-10 after up to four years' treatment.	[Robinson, David; Stattin, Par] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, S-90185 Umea, Sweden; [Robinson, David] Ryhov Cty Hosp, Dept Urol, S-55185 Jonkoping, Sweden; [Garmo, Hans; Holmberg, Lars] Univ Uppsala Hosp, Reg Canc Ctr, Uppsala, Sweden; [Bill-Axelson, Anna] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Mucci, Lorelei] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Garmo, Hans; Holmberg, Lars] Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London WC2R 2LS, England; [Stattin, Par] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA	Umea University; Uppsala University; Uppsala University Hospital; Uppsala University; Harvard University; Harvard T.H. Chan School of Public Health; University of London; King's College London; Memorial Sloan Kettering Cancer Center	Robinson, D (corresponding author), Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, S-90185 Umea, Sweden.	drobinson@telia.com			Swedish Research Council [2010-5950]; Swedish Cancer Society [11 0471, 11 0718]; Lion's Cancer Research Foundation; Umea University Hospital; Umea University Hospital; Futurum; Jonkoping county council; Cancer Research Foundation, Jonkoping	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Lion's Cancer Research Foundation; Umea University Hospital; Umea University Hospital; Futurum; Jonkoping county council; Cancer Research Foundation, Jonkoping	This study was funded by the Swedish Research Council (2010-5950); the Swedish Cancer Society (11 0471, 11 0718); the Lion's Cancer Research Foundation, Umea University Hospital; Futurum, Jonkoping county council; and the Cancer Research Foundation, Jonkoping. None of these funders had any part in the collection, management, analysis, interpretation of the data and not in preparation, review, or approval of the manuscript.	Adolfsson J, 2007, SCAND J UROL NEPHROL, V41, P456, DOI 10.1080/00365590701673625; Andriole GL, 2011, J UROLOGY, V185, P126, DOI 10.1016/j.juro.2010.09.011; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Bostwick David G, 2004, Clin Prostate Cancer, V2, P228, DOI 10.3816/CGC.2004.n.004; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen YC, 2007, J NATL CANCER I, V99, P1366, DOI 10.1093/jnci/djm130; Cox DR., 1984, ANAL SURVIVAL DATA; Fleshner NE, 2012, LANCET, V379, P1103, DOI 10.1016/S0140-6736(11)61619-X; Hagel E, 2009, SCAND J UROL NEPHROL, P1; Hamilton RJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-105; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; McConnell JD, 1998, NEW ENGL J MED, V338, P557, DOI 10.1056/NEJM199802263380901; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Mohler J, 2010, J NATL COMPR CANC NE, V8, P162, DOI 10.6004/jnccn.2010.0012; Murtola TJ, 2009, BRIT J CANCER, V101, P843, DOI 10.1038/sj.bjc.6605188; Muthusamy S, 2011, P NATL ACAD SCI USA, V108, P20090, DOI 10.1073/pnas.1117772108; Nacusi LP, 2011, NAT REV UROL, V8, P378, DOI 10.1038/nrurol.2011.67; National Prostate Cancer Register, 2012, PROST CANC NAT QUAL; Orsted DD, 2011, EUR UROL, V60, P691, DOI 10.1016/j.eururo.2011.06.016; Pinsky P, 2008, CANCER PREV RES, V1, P182, DOI 10.1158/1940-6207.CAPR-07-0007; Redman MW, 2008, CANCER PREV RES, V1, P174, DOI 10.1158/1940-6207.CAPR-08-0092; Roehrborn CG, 2011, EUR UROL, V59, P244, DOI 10.1016/j.eururo.2010.10.040; Socialstyrelsen, NAT PAT REG; Thompson IM, 2006, J NATL CANCER I, V98, P1128, DOI 10.1093/jnci/djj307; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Thompson IM, 2003, EUR UROL, V44, P650, DOI 10.1016/j.eururo.2003.11.001; *US FDA, 2011, FDA DRUG SAF COMM 5; Van Hemelrijck M, 2013, INT J EPIDEMIOL, V42, P956, DOI 10.1093/ije/dys068; World Health Organization, 2009, DEF GEN CONS	30	25	26	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2013	346								f3406	10.1136/bmj.f3406	http://dx.doi.org/10.1136/bmj.f3406			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171PQ	23778271	Green Published, hybrid			2022-12-01	WOS:000320941900004
J	Hudson, MM; Ness, KK; Gurney, JG; Mulrooney, DA; Chemaitilly, W; Krull, KR; Green, DM; Armstrong, GT; Nottage, KA; Jones, KE; Sklar, CA; Srivastava, DK; Robison, LL				Hudson, Melissa M.; Ness, Kirsten K.; Gurney, James G.; Mulrooney, Daniel A.; Chemaitilly, Wassim; Krull, Kevin R.; Green, Daniel M.; Armstrong, Gregory T.; Nottage, Kerri A.; Jones, Kendra E.; Sklar, Charles A.; Srivastava, Deo Kumar; Robison, Leslie L.			Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM SURVIVORS; CARE	Importance Adult survivors of childhood cancer are known to be at risk for treatment-related adverse health outcomes. A large population of survivors has not been evaluated using a comprehensive systematic clinical assessment to determine the prevalence of chronic health conditions. Objective To determine the prevalence of adverse health outcomes and the proportion associated with treatment-related exposures in a large cohort of adult survivors of childhood cancer. Design, Setting, and Participants Presence of health outcomes was ascertained using systematic exposure-based medical assessments among 1713 adult (median age, 32 [range, 18-60] years) survivors of childhood cancer (median time from diagnosis, 25 [range, 10-47] years) enrolled in the St Jude Lifetime Cohort Study since October 1, 2007, and undergoing follow-up through October 31, 2012. Main Outcomes and Measures Age-specific cumulative prevalence of adverse outcomes by organ system. Results Using clinical criteria, the crude prevalence of adverse health outcomes was highest for pulmonary (abnormal pulmonary function, 65.2% [95% CI, 60.4%-69.8%]), auditory (hearing loss, 62.1% [95% CI, 55.8%-68.2%]), endocrine or reproductive (any endocrine condition, such as hypothalamic-pituitary axis disorders and male germ cell dysfunction, 62.0% [95% CI, 59.5%-64.6%]), cardiac (any cardiac condition, such as heart valve disorders, 56.4% [95% CI, 53.5%-59.2%]), and neurocognitive (neurocognitive impairment, 48.0% [95% CI, 44.9%-51.0%]) function, whereas abnormalities involving hepatic (liver dysfunction, 13.0% [95% CI, 10.8%-15.3%]), skeletal (osteoporosis, 9.6% [95% CI, 8.0%-11.5%]), renal (kidney dysfunction, 5.0% [95% CI, 4.0%-6.3%]), and hematopoietic (abnormal blood cell counts, 3.0% [95% CI, 2.1%-3.9%]) function were less common. Among survivors at risk for adverse outcomes following specific cancer treatment modalities, the estimated cumulative prevalence at age 50 years was 21.6% (95% CI, 19.3%-23.9%) for cardiomyopathy, 83.5% (95% CI, 80.2%-86.8%) for heart valve disorder, 81.3% (95% CI, 77.6%-85.0%) for pulmonary dysfunction, 76.8% (95% CI, 73.6%-80.0%) for pituitary dysfunction, 86.5% (95% CI, 82.3%-90.7%) for hearing loss, 31.9% (95% CI, 28.0%-35.8%) for primary ovarian failure, 31.1% (95% CI, 27.3%-34.9%) for Leydig cell failure, and 40.9% (95% CI, 32.0%-49.8%) for breast cancer. At age 45 years, the estimated cumulative prevalence of any chronic health condition was 95.5% (95% CI, 94.8%-98.6%) and 80.5% (95% CI, 73.0%-86.6%) for a serious/disabling or life-threatening chronic condition. Conclusions and Relevance Among adult survivors of childhood cancer, the prevalence of adverse health outcomes was high, and a systematic risk-based medical assessment identified a substantial number of previously undiagnosed problems that are more prevalent in an older population. These findings underscore the importance of ongoing health monitoring for adults who survive childhood cancer.	[Hudson, Melissa M.; Mulrooney, Daniel A.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Hudson, Melissa M.; Ness, Kirsten K.; Gurney, James G.; Mulrooney, Daniel A.; Chemaitilly, Wassim; Krull, Kevin R.; Green, Daniel M.; Armstrong, Gregory T.; Jones, Kendra E.; Robison, Leslie L.] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA; [Chemaitilly, Wassim] St Jude Childrens Res Hosp, Dept Pediat Med, Memphis, TN 38105 USA; [Nottage, Kerri A.] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA; [Srivastava, Deo Kumar] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; Univ Tennessee, Coll Med, Memphis, TN USA; [Sklar, Charles A.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Memorial Sloan Kettering Cancer Center	Hudson, MM (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, Div Canc Survivorship, 262 Danny Thomas Pl,Mailstop 735, Memphis, TN 38105 USA.	melissa.hudson@stjude.org	Armstrong, Gregory/N-8096-2018; Hudson, Melissa M/N-4441-2018; Krull, Kevin R/N-3882-2018; Srivastava, Deo Kumar/P-2435-2017; Robison, Leslie/N-8122-2018; Ness, Kirsten K/N-2550-2018; Chemaitilly, Wassim/AAQ-3397-2021; Chemaitilly, Wassim/N-8178-2018	Hudson, Melissa M/0000-0001-6984-2407; Krull, Kevin R/0000-0002-0476-7001; Srivastava, Deo Kumar/0000-0001-6693-8120; Ness, Kirsten K/0000-0002-2084-1507; 	National Cancer Institute (NCI) [CA 21765]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Cancer Center Support (CORE) grant CA 21765 from the National Cancer Institute (NCI) and by the American Lebanese Syrian Associated Charities (ALSAC).	Allison P.D., 2010, SURVIVAL ANAL USING; Armstrong GT, 2013, JNCI-J NATL CANCER I, V105, P899, DOI 10.1093/jnci/djt089; Asbell PA, 2005, LANCET, V365, P599; Children's Oncology Group, LONG TERM FOLL UP GU; de Haas EC, 2010, LANCET ONCOL, V11, P193, DOI 10.1016/S1470-2045(09)70287-6; Dowling E, 2010, CANCER-AM CANCER SOC, V116, P3712, DOI 10.1002/cncr.25141; Frisina RD, 2009, ANN NY ACAD SCI, V1170, P708, DOI 10.1111/j.1749-6632.2009.03931.x; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Green DM, 2013, PEDIATR BLOOD CANCER, V60, P1083, DOI 10.1002/pbc.24487; Hogan MJS, 2013, PEDIATR BLOOD CANCER, V60, P682, DOI 10.1002/pbc.24360; Hudson MM, 2012, PEDIATR BLOOD CANCER, V58, P334, DOI 10.1002/pbc.23385; Hudson MM, 2011, PEDIATR BLOOD CANCER, V56, P825, DOI 10.1002/pbc.22875; Landier W, 2012, J CLIN ONCOL, V30, P4401, DOI 10.1200/JCO.2012.43.4951; Marin-Garcia J, 2008, AGING HEART, P209; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; National Cancer Institute, CANC THER EV PROGR C; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Ojha RP, 2013, PEDIATR BLOOD CANCER, V60, P856, DOI 10.1002/pbc.24348; Parry C, 2011, CANCER EPIDEM BIOMAR, V20, P1996, DOI 10.1158/1055-9965.EPI-11-0729; Rebholz CE, 2011, J CLIN ONCOL, V29, P4181, DOI 10.1200/JCO.2011.36.5619; Riddle D, 2007, BRAIN AGING MODELS M; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; Sun CL, 2010, BLOOD, V116, P3129, DOI 10.1182/blood-2009-06-229369; Wasilewski-Masker K, 2010, PEDIATR BLOOD CANCER, V54, P976, DOI 10.1002/pbc.22431	24	729	735	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2013	309	22					2371	2381		10.1001/jama.2013.6296	http://dx.doi.org/10.1001/jama.2013.6296			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161EV	23757085	Bronze, Green Accepted			2022-12-01	WOS:000320176000027
J	Andrey, G; Montavon, T; Mascrez, B; Gonzalez, F; Noordermeer, D; Leleu, M; Trono, D; Spitz, F; Duboule, D				Andrey, Guillaume; Montavon, Thomas; Mascrez, Benedicte; Gonzalez, Federico; Noordermeer, Daan; Leleu, Marion; Trono, Didier; Spitz, Francois; Duboule, Denis			A Switch Between Topological Domains Underlies HoxD Genes Collinearity in Mouse Limbs	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; DEVELOPMENTAL REGULATORS; EXPRESSION; MURINE; DROSOPHILA; POLYCOMB; GENOME; DIGITS; ORGANIZATION; MECHANISMS	Hox genes are major determinants of the animal body plan, where they organize structures along both the trunk and appendicular axes. During mouse limb development, Hoxd genes are transcribed in two waves: early on, when the arm and forearm are specified, and later, when digits form. The transition between early and late regulations involves a functional switch between two opposite topological domains. This switch is reflected by a subset of Hoxd genes mapping centrally into the cluster, which initially interact with the telomeric domain and subsequently swing toward the centromeric domain, where they establish new contacts. This transition between independent regulatory landscapes illustrates both the modularity of the limbs and the distinct evolutionary histories of its various pieces. It also allows the formation of an intermediate area of low HOX proteins content, which develops into the wrist, the transition between our arms and our hands. This regulatory strategy accounts for collinear Hox gene regulation in land vertebrate appendages.	[Andrey, Guillaume; Montavon, Thomas; Noordermeer, Daan; Leleu, Marion; Trono, Didier; Duboule, Denis] Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Mascrez, Benedicte; Gonzalez, Federico; Duboule, Denis] Univ Geneva, Dept Genet & Evolut, Natl Res Ctr Frontiers Genet, CH-1211 Geneva 4, Switzerland; [Spitz, Francois] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany	University of Geneva; European Molecular Biology Laboratory (EMBL)	Duboule, D (corresponding author), Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland.	denis.duboule@unige.ch	Andrey, Guillaume/AAL-4397-2020; Noordermeer, Daan/F-3306-2011	Montavon, Thomas/0000-0001-8247-1399; Andrey, Guillaume/0000-0002-0911-4907; Gonzalez Grassi, Federico/0000-0002-7147-2246; duboule, denis/0000-0001-9961-2960; Noordermeer, Daan/0000-0002-9296-7002; Spitz, Francois/0000-0002-1960-829X	Ecole Polytechnique Federale de Lausanne; University of Geneva; National Center for Competence in Research Frontiers in Genetics; Boninchi Foundation; European Research Council grant SystemsHox.ch	Ecole Polytechnique Federale de Lausanne; University of Geneva; National Center for Competence in Research Frontiers in Genetics; Boninchi Foundation; European Research Council grant SystemsHox.ch	We thank I. Barde, S. Verp, and A. Quazzola, from the Ecole Polytechnique Federale de Lausanne transgenic platform, for their help; M. Docquier and P. Descombes, from the National Center in Genetics genomic platform; U. Gunthert and L. Thevenet for the CD44 and inv(attP-CD44) mice, respectively; B. Ren for permission to use and adapt data; and J.-P. Changeux for discussions. Computations were performed at the Vital-IT (www.vital-it.ch) computing center of the Swiss Institute of Bioinformatics using tools described in http://bbcf.epfl.ch. We also thank M. Friedli, N. Soshnikova, E. Joye, P. Schorderet, N. Lonfat, and other members of the Duboule laboratories for discussions and sharing reagents. This work was supported by the Ecole Polytechnique Federale de Lausanne, the University of Geneva, the National Center for Competence in Research Frontiers in Genetics, the Boninchi Foundation, and European Research Council grant SystemsHox.ch (to D. D.). The GEO accession number for the data is GSE45457. Authors' contributions: G. A., T. M., and D. D. designed the experiments; experiments were mostly performed by G. A., with some performed by T. M. F. G., B. M., and F. S. provided mutant mice. D. N. provided material and helped with 4C experiments. M. L. helped with data analysis, and D. T. collaborated on the transgenic screen. G. A. and D. D. wrote the manuscript with input from other coauthors.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bruneau S, 2001, DEV BIOL, V237, P345, DOI 10.1006/dbio.2001.0382; Changeux JP, 2011, PROTEIN SCI, V20, P1119, DOI 10.1002/pro.658; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Friedli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015741; GAUNT SJ, 1988, DEVELOPMENT, V104, P169; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Herault Y, 1997, DEVELOPMENT, V124, P3493; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Montavon T, 2008, GENE DEV, V22, P346, DOI 10.1101/gad.1631708; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Spitz F, 2005, NAT GENET, V37, P889, DOI 10.1038/ng1597; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; Tschopp P, 2011, DEV BIOL, V351, P288, DOI 10.1016/j.ydbio.2010.12.034; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Villavicencio-Lorini P, 2010, J CLIN INVEST, V120, P1994, DOI 10.1172/JCI41554; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Woltering JM, 2010, DEV CELL, V18, P526, DOI 10.1016/j.devcel.2010.04.002; YOKOUCHI Y, 1991, NATURE, V353, P443, DOI 10.1038/353443a0	41	292	300	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1195	+	1234167	10.1126/science.1234167	http://dx.doi.org/10.1126/science.1234167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744951				2022-12-01	WOS:000319972800038
J	Chang, RL; Andrews, K; Kim, D; Li, ZW; Godzik, A; Palsson, BO				Chang, Roger L.; Andrews, Kathleen; Kim, Donghyuk; Li, Zhanwen; Godzik, Adam; Palsson, Bernhard O.			Structural Systems Biology Evaluation of Metabolic Thermotolerance in Escherichia coli	SCIENCE			English	Article							RECONSTRUCTION; STABILITY; EVOLUTION; PROTEINS; ENZYMES; K-12	Genome-scale network reconstruction has enabled predictive modeling of metabolism for many systems. Traditionally, protein structural information has not been represented in such reconstructions. Expansion of a genome-scale model of Escherichia coli metabolism by including experimental and predicted protein structures enabled the analysis of protein thermostability in a network context. This analysis allowed the prediction of protein activities that limit network function at superoptimal temperatures and mechanistic interpretations of mutations found in strains adapted to heat. Predicted growth-limiting factors for thermotolerance were validated through nutrient supplementation experiments and defined metabolic sensitivities to heat stress, providing evidence that metabolic enzyme thermostability is rate-limiting at superoptimal temperatures. Inclusion of structural information expanded the content and predictive capability of genome-scale metabolic networks that enable structural systems biology of metabolism.	[Chang, Roger L.; Palsson, Bernhard O.] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Andrews, Kathleen; Kim, Donghyuk; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Li, Zhanwen; Godzik, Adam] Sanford Burnham Med Res Inst, Bioinformat & Syst Biol Program, La Jolla, CA 92037 USA; [Li, Zhanwen; Godzik, Adam] JCSG, La Jolla, CA 92037 USA; [Palsson, Bernhard O.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2970 Horsholm, Denmark	University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; Technical University of Denmark	Palsson, BO (corresponding author), Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA.	palsson@ucsd.edu	Kim, Donghyuk/AAS-9141-2020; Godzik, Adam/A-7279-2009; Godzik, Adam/AAW-1467-2020	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Palsson, Bernhard/0000-0003-2357-6785; Chang, Roger/0000-0003-1630-6584	NSF [GK-12 742551]; U.S. Department of Energy [DE-SC0004917]; NIH [R01GM101457, R01 GM057089, U54GM094586]; Novo Nordisk Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101457, R01GM057089, U54GM094586] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank H. Nagarajan, A. M. Feist, P. Charusanti, P. E. Bourne, J. A. Lerman, E. T. O'Brien, D. Zielinski, Y. Zhang, and L. Jaroszewski for insightful discussion on this work and J. Orth for providing the iJO1366 network map. This work was supported by NSF grant GK-12 742551 to R. L. C.; U.S. Department of Energy grant DE-SC0004917 to R. L. C., K. A., D. K., and B.O.P.; NIH grants R01GM101457, R01 GM057089, and U54GM094586 to Z.L. and A. G.; and the Novo Nordisk Foundation to B.O.P. Data reported in this report are available in the supplementary materials and the National Center for Biotechnology Information Gene Expression Omnibus (GEO) database (GSE42675). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The University of California San Diego has filed a provisional patent for the method to predict proteins responsible for cellular thermosensitivity.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Beltrao P, 2007, CURR OPIN STRUC BIOL, V17, P378, DOI 10.1016/j.sbi.2007.05.005; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blaby IK, 2012, APPL ENVIRON MICROB, V78, P144, DOI 10.1128/AEM.05773-11; Chang RL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000938; Cheng TMK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002738; Cooper VS, 2001, EVOLUTION, V55, P889, DOI 10.1554/0014-3820(2001)055[0889:EOTDOG]2.0.CO;2; Dill KA, 2011, P NATL ACAD SCI USA, V108, P17876, DOI 10.1073/pnas.1114477108; Duplantis BN, 2010, P NATL ACAD SCI USA, V107, P13456, DOI 10.1073/pnas.1004119107; Fischer CR, 2008, METAB ENG, V10, P295, DOI 10.1016/j.ymben.2008.06.009; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Huang ZM, 2011, NUCLEIC ACIDS RES, V39, pD663, DOI 10.1093/nar/gkq1022; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Ku TH, 2009, COMPUT BIOL CHEM, V33, P445, DOI 10.1016/j.compbiolchem.2009.10.002; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; MURPHY KP, 1993, PURE APPL CHEM, V65, P1939, DOI 10.1351/pac199365091939; OOBATAKE M, 1993, PROG BIOPHYS MOL BIO, V59, P237, DOI 10.1016/0079-6107(93)90002-2; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Van Derlinden E, 2008, J APPL MICROBIOL, V104, P438, DOI 10.1111/j.1365-2672.2007.03592.x; Van Derlinden E, 2012, INT J FOOD MICROBIOL, V158, P73, DOI 10.1016/j.ijfoodmicro.2012.05.015; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhang Y, 2009, SCIENCE, V325, P1544, DOI 10.1126/science.1174671	30	83	91	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1220	1223		10.1126/science.1234012	http://dx.doi.org/10.1126/science.1234012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744946	Green Accepted			2022-12-01	WOS:000319972800047
J	Chen, DH; Madan, D; Weaver, J; Lin, Z; Schroder, GF; Chiu, W; Rye, HS				Chen, Dong-Hua; Madan, Damian; Weaver, Jeremy; Lin, Zong; Schroeder, Gunnar F.; Chiu, Wah; Rye, Hays S.			Visualizing GroEL/ES in the Act of Encapsulating a Folding Protein	CELL			English	Article							CHAPERONIN ATPASE CYCLE; CRYO-EM STRUCTURE; CRYOELECTRON MICROSCOPY; CENTRAL CAVITY; GROES COMPLEX; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; INTERMEDIATE; POLYPEPTIDE; RESOLUTION	The GroEL/ES chaperonin system is required for the assisted folding of many proteins. How these substrate proteins are encapsulated within the GroEL-GroES cavity is poorly understood. Using symmetry-free, single-particle cryo-electron microscopy, we have characterized a chemically modified mutant of GroEL (EL43Py) that is trapped at a normally transient stage of substrate protein encapsulation. We show that the symmetric pattern of the GroEL subunits is broken as the GroEL cis-ring apical domains reorient to accommodate the simultaneous binding of GroES and an incompletely folded substrate protein (RuBisCO). The collapsed RuBisCO folding intermediate binds to the lower segment of two apical domains, as well as to the normally unstructured GroEL C-terminal tails. A comparative structural analysis suggests that the allosteric transitions leading to substrate protein release and folding involve concerted shifts of GroES and the GroEL apical domains and C-terminal tails.	[Chen, Dong-Hua; Chiu, Wah] Baylor Coll Med, Natl Ctr Macromolecular Imaging, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Madan, Damian; Lin, Zong] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Weaver, Jeremy; Rye, Hays S.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77845 USA; [Schroeder, Gunnar F.] Forschungszentrum Julich, Dept Struct Biochem, Inst Complex Syst ICS 6, D-52425 Julich, Germany; [Schroeder, Gunnar F.] Univ Dusseldorf, Dept Phys, D-40225 Dusseldorf, Germany	Baylor College of Medicine; Princeton University; Texas A&M University System; Texas A&M University College Station; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Chiu, W (corresponding author), Baylor Coll Med, Natl Ctr Macromolecular Imaging, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	wah@bcm.edu; haysrye@tamu.edu	Schröder, Gunnar F/H-5261-2013	Schröder, Gunnar F/0000-0003-1803-5431; Weaver, Jeremy/0000-0002-5556-4757; Rye, Hays/0000-0002-9420-3137	National Institutes of Health [P41GM103832, PN2EY016525, GM065421]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065421, P41GM103832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research has been supported by grants from the National Institutes of Health (P41GM103832 and PN2EY016525 to W.C.) (GM065421 to H.S.R.). We would like to thank Dr. Chavela Carr for her comments on the manuscript and Dr. Steven J. Ludtke and Dr. Michael F. Schmid for helpful discussions.	BADCOE IG, 1991, BIOCHEMISTRY-US, V30, P9195, DOI 10.1021/bi00102a010; Baker ML, 2007, STRUCTURE, V15, P7, DOI 10.1016/j.str.2006.11.008; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; Chen DH, 2008, J MOL BIOL, V381, P707, DOI 10.1016/j.jmb.2008.06.021; Chen DH, 2006, STRUCTURE, V14, P1711, DOI 10.1016/j.str.2006.09.010; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; Clare DK, 2009, NATURE, V457, P107, DOI 10.1038/nature07479; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Cliff MJ, 2006, J BIOL CHEM, V281, P21266, DOI 10.1074/jbc.M601605200; Cong Y, 2012, EMBO J, V31, P720, DOI 10.1038/emboj.2011.366; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; Falke S, 2005, J MOL BIOL, V348, P219, DOI 10.1016/j.jmb.2005.02.027; Farr GW, 2007, P NATL ACAD SCI USA, V104, P5342, DOI 10.1073/pnas.0700820104; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Frank GA, 2010, P NATL ACAD SCI USA, V107, P6270, DOI 10.1073/pnas.0910246107; Grason JP, 2008, P NATL ACAD SCI USA, V105, P17339, DOI 10.1073/pnas.0807418105; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Horovitz A, 2001, J STRUCT BIOL, V135, P104, DOI 10.1006/jsbi.2001.4377; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; Kad NM, 1998, J MOL BIOL, V278, P267, DOI 10.1006/jmbi.1998.1704; Kanno R, 2009, STRUCTURE, V17, P287, DOI 10.1016/j.str.2008.12.012; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; Madan D, 2008, J BIOL CHEM, V283, P32003, DOI 10.1074/jbc.M802898200; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; MCLENNAN NF, 1993, MOL MICROBIOL, V7, P49, DOI 10.1111/j.1365-2958.1993.tb01096.x; Penczek PA, 2006, J STRUCT BIOL, V154, P168, DOI 10.1016/j.jsb.2006.01.003; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Rye HS, 2001, METHODS, V24, P278, DOI 10.1006/meth.2001.1188; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Sparrer H, 1997, J BIOL CHEM, V272, P14080, DOI 10.1074/jbc.272.22.14080; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; VANDERVIES SM, 1992, BIOCHEMISTRY-US, V31, P3635, DOI 10.1021/bi00129a012; VIITANEN PV, 1991, BIOCHEMISTRY-US, V30, P9716, DOI 10.1021/bi00104a021; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Yifrach O, 2000, P NATL ACAD SCI USA, V97, P1521, DOI 10.1073/pnas.040449997	53	61	63	0	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1354	1365		10.1016/j.cell.2013.04.052	http://dx.doi.org/10.1016/j.cell.2013.04.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746846	Green Accepted, Bronze			2022-12-01	WOS:000319979200018
J	Zhou, CM; Zhang, TQ; Wang, X; Yu, S; Lan, H; Tang, HB; Feng, ZY; Zozomova-Lihova, J; Wang, JW				Zhou, Chuan-Miao; Zhang, Tian-Qi; Wang, Xi; Yu, Sha; Lan, Heng; Tang, Hongbo; Feng, Zheng-Yan; Zozomova-Lihova, Judita; Wang, Jia-Wei			Molecular Basis of Age-Dependent Vernalization in Cardamine flexuosa	SCIENCE			English	Article							FLOWERING-TIME; MIR156; TRANSITIONS; COMPETENCE; REPRESSOR; CONSTANS; MICRORNA; CONFERS; GENES; FLC	Plants flower in response to many varied cues, such as temperature, photoperiod, and age. The floral transition of Cardamine flexuosa, a herbaceous biennial-to-perennial plant, requires exposure to cold temperature, a treatment known as vernalization. C. flexuosa younger than 5 weeks old are not fully responsive to cold treatment. We demonstrate that the levels of two age-regulated microRNAs, miR156 and miR172, regulate the timing of sensitivity in response to vernalization. Age and vernalization pathways coordinately regulate flowering through modulating the expression of CfSOC1, a flower-promoting MADS-box gene. The related annual Arabidopsis thaliana, which has both vernalization and age pathways, does not possess an age-dependent vernalization response. Thus, the recruitment of age cue in response to environmental signals contributes to the evolution of life cycle in plants.	[Zhou, Chuan-Miao; Zhang, Tian-Qi; Yu, Sha; Lan, Heng; Tang, Hongbo; Feng, Zheng-Yan; Wang, Jia-Wei] Shanghai Inst Biol Sci SIBS, Inst Plant Physiol & Ecol SIPPE, Natl Key Lab Plant Mol Genet NKLPMG, Shanghai 200032, Peoples R China; [Zhang, Tian-Qi; Yu, Sha; Feng, Zheng-Yan] Univ Chinese Acad Sci CAS, Shanghai 200032, Peoples R China; [Wang, Xi; Wang, Jia-Wei] Max Planck Inst MPI Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Zozomova-Lihova, Judita] Slovak Acad Sci, Inst Bot, SK-84523 Bratislava, Slovakia	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Slovak Academy of Sciences	Wang, JW (corresponding author), Shanghai Inst Biol Sci SIBS, Inst Plant Physiol & Ecol SIPPE, Natl Key Lab Plant Mol Genet NKLPMG, Shanghai 200032, Peoples R China.	jwwang@sibs.ac.cn	Zozomova-Lihova, Judita/P-3151-2019; Zozomova-Lihova, Judita/B-5011-2011	Zozomova-Lihova, Judita/0000-0002-8950-6643; Zozomova-Lihova, Judita/0000-0002-8950-6643; Zhang, Tian-Qi/0000-0001-8000-4770; Wang, Jia-Wei/0000-0003-3885-6296	National Natural Science Foundation of China [31222029, 912173023]; State Key Basic Research Program of China [2013CB127000]; Shanghai Pujiang Program [12PJ1409900]; Recruitment Program of Global Experts (China); NKLPMG (SIPPE, SIBS); Open Project Program of NKLPMG (SIPPE, SIBS)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research Program of China(National Basic Research Program of China); Shanghai Pujiang Program(Shanghai Pujiang Program); Recruitment Program of Global Experts (China); NKLPMG (SIPPE, SIBS); Open Project Program of NKLPMG (SIPPE, SIBS)	We thank I. R. Somoza and D. Weigel (MPI, Tubingen) for commenting on the manuscript, S. Bergonzi and G. Coupland (MPI, Koln) for exchanging unpublished results, and Y.-L. Guo (Institute of Botany, CAS, Beijing) for suggestion on phylogenetic analyses. The early phase of the work was conducted at the MM for Developmental Biology, where it was supported by Max Planck Society funds to D. Weigel. The majority of this work was conducted at SIPPE and supported by grants from National Natural Science Foundation of China (31222029 and 912173023), State Key Basic Research Program of China (2013CB127000), Shanghai Pujiang Program (12PJ1409900), Recruitment Program of Global Experts (China), and NKLPMG (SIPPE, SIBS) to J.-W.W., and Open Project Program of NKLPMG (SIPPE, SIBS) to X.W.	Albani MC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003130; Albani MC, 2010, CURR TOP DEV BIOL, V91, P323, DOI 10.1016/S0070-2153(10)91011-9; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Amasino R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-228; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bergonzi S, 2011, J EXP BOT, V62, P4415, DOI 10.1093/jxb/err192; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; de Felippes FF, 2012, PLANT J, V70, P541, DOI 10.1111/j.1365-313X.2011.04896.x; Hepworth SR, 2002, EMBO J, V21, P4327, DOI 10.1093/emboj/cdf432; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Lihova J, 2006, AM J BOT, V93, P1206, DOI 10.3732/ajb.93.8.1206; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Poethig RS, 2010, PLANT PHYSIOL, V154, P541, DOI 10.1104/pp.110.161620; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Song J, 2012, J CELL SCI, V125, P3723, DOI 10.1242/jcs.084764; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; Wang JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002012; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang RH, 2011, PLANT CELL, V23, P1307, DOI 10.1105/tpc.111.083451; Wang RH, 2009, NATURE, V459, P423, DOI 10.1038/nature07988; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Yang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00260; Yu S, 2013, ELIFE, V2, DOI 10.7554/eLife.00269	30	102	118	5	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1097	1100		10.1126/science.1234340	http://dx.doi.org/10.1126/science.1234340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723237				2022-12-01	WOS:000319664500045
J	Casanova-Acebes, M; Pitaval, C; Weiss, LA; Nombela-Arrieta, C; Chevre, R; A-Gonzalez, N; Kunisaki, Y; Zhang, DC; van Rooijen, N; Silberstein, LE; Weber, C; Nagasawa, T; Frenette, PS; Castrillo, A; Hidalgo, A				Casanova-Acebes, Maria; Pitaval, Christophe; Weiss, Linnea A.; Nombela-Arrieta, Cesar; Chevre, Raphael; A-Gonzalez, Noelia; Kunisaki, Yuya; Zhang, Dachuan; van Rooijen, Nico; Silberstein, Leslie E.; Weber, Christian; Nagasawa, Takashi; Frenette, Paul S.; Castrillo, Antonio; Hidalgo, Andres			Rhythmic Modulation of the Hematopoietic Niche through Neutrophil Clearance	CELL			English	Article							STEM-CELL NICHE; BONE-MARROW; G-CSF; PROGENITOR CELLS; P-SELECTIN; INFLAMMATION; CXCR4; MOBILIZATION; RELEASE; MICE	Unique among leukocytes, neutrophils follow daily cycles of release from and migration back into the bone marrow, where they are eliminated. Because removal of dying cells generates homeostatic signals, we explored whether neutrophil elimination triggers circadian events in the steady state. Here, we report that the homeostatic clearance of neutrophils provides cues that modulate the physiology of the bone marrow. We identify a population of CD62L(LO) CXCR4(HI) neutrophils that have "aged'' in the circulation and are eliminated at the end of the resting period in mice. Aged neutrophils infiltrate the bone marrow and promote reductions in the size and function of the hematopoietic niche. Modulation of the niche depends on macrophages and activation of cholesterol-sensing nuclear receptors and is essential for the rhythmic egress of hematopoietic progenitors into the circulation. Our results unveil a process that synchronizes immune and hematopoietic rhythms and expand the ascribed functions of neutrophils beyond inflammation.	[Casanova-Acebes, Maria; Pitaval, Christophe; Weiss, Linnea A.; Chevre, Raphael; A-Gonzalez, Noelia; Hidalgo, Andres] Fdn Ctr Nacl Invest Cardiovasc CNIC, Dept Epidemiol Atherothrombosis & Imaging, Madrid 28029, Spain; [Nombela-Arrieta, Cesar; Silberstein, Leslie E.] Childrens Hosp, Joint Program Transfus Med, Boston, MA 02115 USA; [Kunisaki, Yuya; Zhang, Dachuan; Frenette, Paul S.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, VUMC, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands; [Weber, Christian] Univ Munich, Inst Cardiovasc Prevent, D-80539 Munich, Germany; [Nagasawa, Takashi] Kyoto Univ, Core Res Evolut Sci & Technol CREST, Kyoto 6068507, Japan; [Nagasawa, Takashi] Kyoto Univ, Dept Immunobiol & Hematol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Nagasawa, Takashi] Japan Sci & Technol Agcy JST, Kyoto 6068507, Japan; [Castrillo, Antonio] UAM Madrid, CSIC, Inst Invest Biomed Alberto Sols, Las Palmas Gran Canaria 35016, Spain; [Castrillo, Antonio] Univ Las Palmas, CSIC, Unidad Asociada Biomed IIBM, Las Palmas Gran Canaria 35016, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Harvard University; Boston Children's Hospital; Yeshiva University; Albert Einstein College of Medicine; Vrije Universiteit Amsterdam; University of Munich; Japan Science & Technology Agency (JST); Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Universidad de Las Palmas de Gran Canaria	Hidalgo, A (corresponding author), Fdn Ctr Nacl Invest Cardiovasc CNIC, Dept Epidemiol Atherothrombosis & Imaging, Madrid 28029, Spain.	ahidalgo@cnic.es	Hidalgo, Andrés/L-5643-2014; Weber, Christian/AAW-2153-2020; Van Rooijen, Nico/Z-1578-2019; Weiss, Linnea A/K-8062-2014; Acebes, Maria Casanova/AAH-1929-2019; Zhang, Dachuan/GZA-8781-2022; Gonzalez, Noelia Alonso/ABC-7381-2021; Frenette, Paul S/J-8272-2012; Weiss, Linnea A/AFV-8680-2022; Gonzalez, Noelia Alonso/H-4488-2015	Hidalgo, Andrés/0000-0001-5513-555X; Weber, Christian/0000-0003-4610-8714; Acebes, Maria Casanova/0000-0002-5790-1163; Gonzalez, Noelia Alonso/0000-0003-0533-5216; Frenette, Paul S/0000-0003-0862-9922; Gonzalez, Noelia Alonso/0000-0003-0533-5216; Nombela-Arrieta, Cesar/0000-0003-0415-259X; Zhang, Dachuan/0000-0002-1746-275X; Nagasawa, Takashi/0000-0002-1085-0960; , Linnea/0000-0002-7593-7821	Deutsche Forschungsgemeinschaft (DFG) [WE1913/11-2, SFB914-B8, R01-DK056638, R01-HL69438, SAF2008-00057, SAF2011-29244]; Ramon y Cajal Fellowship [RYC-2007-00697]; MINECO [SAF2009-11037]; Comunidad de Madrid [S2010/BMD-2314]; FP7-People-IRG Program [246655]; Human Frontiers in Science Program long-term fellowship [00194/2008]; Spanish Ministry of Economy and Competitivity; Pro-CNIC Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116340, R01HL069438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ramon y Cajal Fellowship(Spanish Government); MINECO(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); FP7-People-IRG Program; Human Frontiers in Science Program long-term fellowship; Spanish Ministry of Economy and Competitivity(Spanish Government); Pro-CNIC Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Nacher, J. Ogonek, I. Ortega, V. Zorita, M. Leboeuf, J.M. Ligos, and the Cellomics, Microscopy, and Comparative Medicine Units at CNIC for technical support; J. Garaude, D. Lucas, and A. Ramiro for critically reviewing the manuscript; and S. Gonzalez and D. Sanz for reagents. This study was supported by Deutsche Forschungsgemeinschaft (DFG WE1913/11-2 and SFB914-B8) to C.W.; R01-DK056638 and R01-HL69438 to P.S.F.; grants SAF2008-00057 and SAF2011-29244 to A.C.; Ramon y Cajal Fellowship (RYC-2007-00697) and SAF2009-11037 from MINECO, S2010/BMD-2314 from Comunidad de Madrid, and FP7-People-IRG Program (246655) to A.H.; C.N-A. is funded by a Human Frontiers in Science Program long-term fellowship 00194/2008. M.C-A. is supported by a FPI fellowship from the Spanish Ministry of Economy and Competitivity. The Centro Nacional de Investigaciones Cardiovasculares is supported by the Spanish Ministry of Economy and Competitivity and the Pro-CNIC Foundation. M.C-A performed experiments and wrote the manuscript; L.A.W., C.P., and N.A-G performed experiments and edited the manuscript. C.N-A., R.C., Y.K., and D.Z. performed experiments; N.V.R., L.E.S., C.W., T.N., P.S.F., and A.C. contributed reagents, discussed experiments and helped in editing the manuscript; A.H. conceived the study, performed experiments and wrote the manuscript. C.P., L.A.W., and C.N-A. contributed equally to this study.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Furze RC, 2008, FASEB J, V22, P3111, DOI 10.1096/fj.08-109876; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; HAUS E, 1983, AM J ANAT, V168, P467, DOI 10.1002/aja.1001680406; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Hong C, 2012, J CLIN INVEST, V122, P337, DOI 10.1172/JCI58393; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Papayannopoulou T, 2004, BLOOD, V103, P1580, DOI 10.1182/blood-2003-05-1595; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638; Suratt BT, 2001, AM J PHYSIOL-LUNG C, V281, pL913, DOI 10.1152/ajplung.2001.281.4.L913; Van Eeden SF, 1997, AM J PHYSIOL-HEART C, V272, pH401, DOI 10.1152/ajpheart.1997.272.1.H401; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; von Vietinghoff S, 2008, J IMMUNOL, V181, P5183, DOI 10.4049/jimmunol.181.8.5183; Westerterp M, 2012, CELL STEM CELL, V11, P195, DOI 10.1016/j.stem.2012.04.024; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534	50	397	401	3	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1025	1035		10.1016/j.cell.2013.04.040	http://dx.doi.org/10.1016/j.cell.2013.04.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706740	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000319456800011
J	Hashem, Y; Georges, AD; Dhote, V; Langlois, R; Liao, HY; Grassucci, RA; Hellen, CUT; Pestova, TV; Frank, J				Hashem, Yaser; Georges, Amedee des; Dhote, Vidya; Langlois, Robert; Liao, Hstau Y.; Grassucci, Robert A.; Hellen, Christopher U. T.; Pestova, Tatyana V.; Frank, Joachim			Structure of the Mammalian Ribosomal 43S Preinitiation Complex Bound to the Scanning Factor DHX29	CELL			English	Article							EUKARYOTIC TRANSLATION INITIATION; CRYO-EM STRUCTURE; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; TRANSFER-RNA; CRYOELECTRON MICROSCOPY; START CODON; ESCHERICHIA-COLI; 26S PROTEASOME; ALPHA-SUBUNIT	Eukaryotic translation initiation begins with assembly of a 43S preinitiation complex. First, methionylated initiator methionine transfer RNA (Met-tRNA(i)(Met)), eukaryotic initiation factor (eIF) 2, and guanosine triphosphate form a ternary complex (TC). The TC, eIF3, eIF1, and eIF1A cooperatively bind to the 40S subunit, yielding the 43S preinitiation complex, which is ready to attach to messenger RNA (mRNA) and start scanning to the initiation codon. Scanning on structured mRNAs additionally requires DHX29, a DExH-box protein that also binds directly to the 40S subunit. Here, we present a cryo-electron microscopy structure of the mammalian DHX29-bound 43S complex at 11.6 angstrom resolution. It reveals that eIF2 interacts with the 40S subunit via its a subunit and supports Met-tRNA(i)(Met) in an unexpected P/I orientation (eP/I). The structural core of eIF3 resides on the back of the 40S subunit, establishing two principal points of contact, whereas DHX29 binds around helix 16. The structure provides insights into eukaryote-specific aspects of translation, including the mechanism of action of DHX29.	[Dhote, Vidya; Hellen, Christopher U. T.; Pestova, Tatyana V.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Hashem, Yaser; Georges, Amedee des; Grassucci, Robert A.; Frank, Joachim] Columbia Univ, HHMI, New York, NY 10032 USA; [Hashem, Yaser; Georges, Amedee des; Langlois, Robert; Liao, Hstau Y.; Grassucci, Robert A.; Frank, Joachim] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Frank, Joachim] Columbia Univ, Dept Biol Sci, New York, NY 10032 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Frank, J (corresponding author), Columbia Univ, HHMI, New York, NY 10032 USA.	jf2192@columbia.edu	Georges, Amédée des/C-3588-2014	Georges, Amédée des/0000-0002-9704-3781	HHMI; NIH [R01 GM29169, R01 GM59660]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029169, R01GM059660] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Melissa Thomas for the assistance in preparation of figures and Assen Marintchev and Trevor Sweeney for critical reading of the manuscript. This work was supported by HHMI and NIH grant R01 GM29169 (to J.F.) and NIH grant R01 GM59660 (to T.V.P.).	Abaeva IS, 2011, EMBO J, V30, P115, DOI 10.1038/emboj.2010.302; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; CIGAN AM, 1989, P NATL ACAD SCI USA, V86, P2784, DOI 10.1073/pnas.86.8.2784; Cuchalova L, 2010, MOL CELL BIOL, V30, P4671, DOI 10.1128/MCB.00430-10; Dhote V., 2012, P NATL ACAD SCI US, V109, pE3150; Dmitriev SE, 2011, J MOL BIOL, V413, P106, DOI 10.1016/j.jmb.2011.08.026; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gao HX, 2005, P NATL ACAD SCI USA, V102, P10206, DOI 10.1073/pnas.0500926102; Grassucci RA, 2007, NAT PROTOC, V2, P3239, DOI 10.1038/nprot.2007.452; Hashem Y, 2013, NATURE, V494, P385, DOI 10.1038/nature11872; He YZ, 2010, EMBO REP, V11, P180, DOI 10.1038/embor.2010.11; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Herrmannova A, 2012, NUCLEIC ACIDS RES, V40, P2294, DOI 10.1093/nar/gkr765; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Ito T, 2004, STRUCTURE, V12, P1693, DOI 10.1016/j.str.2004.07.010; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Julian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001095; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; Lomakin IB, 2006, EMBO J, V25, P196, DOI 10.1038/sj.emboj.7600904; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Lumsden T, 2010, NUCLEIC ACIDS RES, V38, P1261, DOI 10.1093/nar/gkp1113; Luna RE, 2012, CELL REPORTS, V1, P689, DOI 10.1016/j.celrep.2012.04.007; Maag D, 2006, J MOL BIOL, V356, P724, DOI 10.1016/j.jmb.2005.11.083; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Naveau M, 2013, NUCLEIC ACIDS RES, V41, P1047, DOI 10.1093/nar/gks1180; Nika J, 2001, J BIOL CHEM, V276, P1051, DOI 10.1074/jbc.M007398200; Parsyan A, 2009, P NATL ACAD SCI USA, V106, P22217, DOI 10.1073/pnas.0909773106; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pena V, 2007, MOL CELL, V25, P615, DOI 10.1016/j.molcel.2007.01.023; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 2001, RNA, V7, P1496, DOI 10.1017/S135583820101038X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Pisarev AV, 2007, METHOD ENZYMOL, V430, P147, DOI 10.1016/S0076-6879(07)30007-4; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmitt E, 2002, EMBO J, V21, P1821, DOI 10.1093/emboj/21.7.1821; Schmitt E, 2012, NAT STRUCT MOL BIOL, V19, P450, DOI 10.1038/nsmb.2259; Shin BS, 2011, NAT STRUCT MOL BIOL, V18, P1227, DOI 10.1038/nsmb.2133; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; SRIVASTAVA S, 1992, J MOL BIOL, V226, P301, DOI 10.1016/0022-2836(92)90946-H; Stolboushkina E, 2008, J MOL BIOL, V382, P680, DOI 10.1016/j.jmb.2008.07.039; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Taylor KA, 2008, J STRUCT BIOL, V163, P214, DOI 10.1016/j.jsb.2008.06.004; Valasek LS, 2012, CURR PROTEIN PEPT SC, V13, P305; WAGENKNECHT T, 1988, J MOL BIOL, V203, P753, DOI 10.1016/0022-2836(88)90207-0; Yatime L, 2006, STRUCTURE, V14, P119, DOI 10.1016/j.str.2005.09.020; Yatime L, 2007, P NATL ACAD SCI USA, V104, P18445, DOI 10.1073/pnas.0706784104; Yu YP, 2011, EMBO J, V30, P4423, DOI 10.1038/emboj.2011.306; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	72	142	145	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1108	1119		10.1016/j.cell.2013.04.036	http://dx.doi.org/10.1016/j.cell.2013.04.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706745	Green Accepted, Bronze			2022-12-01	WOS:000319456800017
J	Arinaminpathy, N; Cordier-Lassalle, T; Vijay, A; Dye, C				Arinaminpathy, Nimalan; Cordier-Lassalle, Thierry; Vijay, Anant; Dye, Christopher			The Global Drug Facility and its role in the market for tuberculosis drugs	LANCET			English	Article							TB; PROCUREMENT; FUND; PLAN	Universal access to high-quality treatment is central to the Global Plan to Stop TB. The Global Drug Facility (GDF) was launched in 2001 to help to achieve this goal, through services including the supply of affordable, quality-assured drugs to countries in need. We assess the scale of GDF drug supplies worldwide and find that the GDF commands a substantial proportion of the market for drugs for first-line and second-line treatment regimens, having supplied, for example, first-line drugs for roughly 35% of cases reported worldwide in 2011. Significant potential remains for GDF expansion, especially in the provision of second-line drugs, which would be aided by future increases in case detection.	[Arinaminpathy, Nimalan] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Cordier-Lassalle, Thierry] WHO, Stop TB Global Drug Facil, CH-1211 Geneva, Switzerland; [Vijay, Anant] WHO, Stop TB Partnership Secretariat, CH-1211 Geneva, Switzerland; [Dye, Christopher] WHO, HIV AIDS TB Malaria & Neglected Trop Dis, CH-1211 Geneva, Switzerland	Princeton University; World Health Organization; World Health Organization; World Health Organization	Arinaminpathy, N (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	nimpathy@princeton.edu	Dye, Christopher/AIC-4659-2022	Arinaminpathy, Nimalan/0000-0001-9502-6876; Dye, Christopher/0000-0002-2957-1793	Stop TB Partnership; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish	Stop TB Partnership; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	NA was partly funded for this analysis by the Stop TB Partnership. TC-L is a staff member of the Stop TB Global Drug Facility and WHO. AV has been a member of the Stop TB Partnership. CD is a staff member of WHO. The authors alone are responsible for the views expressed in this publication, which do not necessarily represent the decisions, policy, or views of WHO.	Bate R, 2013, INT J TUBERC LUNG D, V17, P308, DOI 10.5588/ijtld.12.0355; Butler D, 2012, NATURE, V491, P508, DOI 10.1038/491508a; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 2009, NAT REV MICROBIOL, V7, P81, DOI 10.1038/nrmicro2048; Global Drug Facility, ANN REP 2010; Global Drug Facility, 2010, QUAL ASS POL PROC; Hanif SNM, 2011, INT J TUBERC LUNG D, V15, P1274, DOI 10.5588/ijtld.11.0394; Kumaresan J, 2004, INT J TUBERC LUNG D, V8, P130; Matiru R, 2007, B WORLD HEALTH ORGAN, V85, P348, DOI 10.2471/BLT.06.035402; Maxmen A, 2012, NATURE, V490, P13, DOI 10.1038/490013a; Norval PY, 1999, INT J TUBERC LUNG D, V3, pS292; Portero JL, 2003, TROP MED INT HEALTH, V8, P329, DOI 10.1046/j.1365-3156.2003.01032.x; Raviglione MC, 2011, EUR RESPIR J, V37, P978, DOI 10.1183/09031936.00003111; Raviglione MC, 2006, INT J TUBERC LUNG D, V10, P238; Sabot O, 2012, LANCET, V379, pE25, DOI 10.1016/S0140-6736(11)61756-X; Stop TB Partnership, DOTS EXP WORK GROUP; Stop TB Partnership, 2001, GLOB PLAN STOP TB PH; Stop TB Partnership, 2011, FALL SHORT ENS ACC S; Styblo K, 1991, TUBERCULOSIS CAN BE, V2, P60; TB Stop partnership, 2011, GLOB PLAN STOP TB 20; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 2003, TUBERCULOSIS, V83, P156, DOI 10.1016/S1472-9792(02)00073-2; Waning B, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-9; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; Word Health Organization, GLOB TUB REP 2012; World Health Organization, 1998, GLOB TUB PROGR REP A; World Health Organization, 2006, ENG ALL HLTH CAR PRO; World Health Organization, 2011, SURV QUAL ANT MED CI; World Hlth Org, 2002, INT J TUBERC LUNG D, V6, P378	29	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2013	382	9901					1373	1379		10.1016/S0140-6736(13)60896-X	http://dx.doi.org/10.1016/S0140-6736(13)60896-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238UG	23726162				2022-12-01	WOS:000325975700027
J	Moellering, RE; Cravatt, BF				Moellering, Raymond E.; Cravatt, Benjamin F.			Functional Lysine Modification by an Intrinsically Reactive Primary Glycolytic Metabolite	SCIENCE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PHOSPHORYLATION; ACTIVATION; COMPLEXES; PROTEIN; CELLS; SITE; KEY	The posttranslational modification of proteins and their regulation by metabolites represent conserved mechanisms in biology. At the confluence of these two processes, we report that the primary glycolytic intermediate 1,3-bisphosphoglycerate (1,3-BPG) reacts with select lysine residues in proteins to form 3-phosphoglyceryl-lysine (pgK). This reaction, which does not require enzyme catalysis, but rather exploits the electrophilicity of 1,3-BPG, was found by proteomic profiling to be enriched on diverse classes of proteins and prominently in or around the active sites of glycolytic enzymes. pgK modifications inhibit glycolytic enzymes and, in cells exposed to high glucose, accumulate on these enzymes to create a potential feedback mechanism that contributes to the buildup and redirection of glycolytic intermediates to alternate biosynthetic pathways.	[Moellering, Raymond E.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Moellering, RE (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	rmoeller@scripps.edu; cravatt@scripps.edu		Moellering, Raymond/0000-0002-2043-7838	NIH [CA087660]; Damon Runyon Cancer Research Foundation; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R37CA087660, R01CA087660] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Dix and S. Niessen for assistance with mass spectrometry, C. Wang for support and advice on the use of CIMAGE software, and G. Simon for helpful discussions. Supported by the NIH (CA087660), the Damon Runyon Cancer Research Foundation (R.E.M. is a Howard Hughes Medical Institute Postdoctoral Fellow), and the Skaggs Institute for Chemical Biology.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Boel G, 2004, J MOL BIOL, V337, P485, DOI 10.1016/j.jmb.2003.12.082; Codreanu SG, 2009, MOL CELL PROTEOMICS, V8, P670, DOI 10.1074/mcp.M800070-MCP200; DEMOSS JA, 1956, P NATL ACAD SCI USA, V42, P325, DOI 10.1073/pnas.42.6.325; Fueger BJ, 2006, J NUCL MED, V47, P999; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kanwar M, 2009, DIABETES, V58, P227, DOI 10.2337/db08-1025; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; LIAW SH, 1995, PROTEIN SCI, V4, P2358, DOI 10.1002/pro.5560041114; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; ROSA R, 1978, J CLIN INVEST, V62, P907, DOI 10.1172/JCI109218; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Sims PA, 2003, BIOCHEMISTRY-US, V42, P8298, DOI 10.1021/bi0346345; Sola-Penna M, 2010, IUBMB LIFE, V62, P791, DOI 10.1002/iub.393; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Swint-Kruse L, 2009, CURR OPIN MICROBIOL, V12, P129, DOI 10.1016/j.mib.2009.01.009; Walsh C., 2006, POSTTRANSLATIONAL MO; Wang TN, 2012, J AM CHEM SOC, V134, P8958, DOI 10.1021/ja301994d; Yego ECK, 2010, J BIOL CHEM, V285, P3181, DOI 10.1074/jbc.M109.083907; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	25	134	143	3	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					549	553		10.1126/science.1238327	http://dx.doi.org/10.1126/science.1238327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908237	Green Accepted			2022-12-01	WOS:000322586700054
J	Nakashima, R; Sakurai, K; Yamasaki, S; Hayashi, K; Nagata, C; Hoshino, K; Onodera, Y; Nishino, K; Yamaguchi, A				Nakashima, Ryosuke; Sakurai, Keisuke; Yamasaki, Seiji; Hayashi, Katsuhiko; Nagata, Chikahiro; Hoshino, Kazuki; Onodera, Yoshikuni; Nishino, Kunihiko; Yamaguchi, Akihito			Structural basis for the inhibition of bacterial multidrug exporters	NATURE			English	Article							EFFLUX PUMP INHIBITORS; GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; RESISTANCE; ACRB; TRANSPORTER; STRATEGIES; REVEAL; SYSTEM	The multidrug efflux transporter AcrB and its homologues are important in the multidrug resistance of Gram-negative pathogens(1,2). However, despite efforts to develop efflux inhibitors(3), clinically useful inhibitors are not available at present(4,5). Pyridopyrimidine derivatives are AcrB- and MexB-specific inhibitors that do not inhibit MexY(6,7); MexB and MexY are principal multidrug exporters in Pseudomonas aeruginosa(8-10). We have previously determined the crystal structure of AcrB in the absence and presence of antibiotics(11-13). Drugs were shown to be exported by a functionally rotating mechanism(12) through tandem proximal and distal multisite drug-binding pockets(13). Here we describe the first inhibitor-bound structures of AcrB and MexB, in which these proteins are bound by a pyridopyrimidine derivative. The pyridopyrimidine derivative binds tightly to a narrow pit composed of a phenylalanine cluster located in the distal pocket and sterically hinders the functional rotation. This pit is a hydrophobic trap that branches off from the substrate-translocation channel. Phe 178 is located at the edge of this trap in AcrB and MexB and contributes to the tight binding of the inhibitor molecule through a pi-pi interaction with the pyridopyrimidine ring. The voluminous side chain of Trp 177 located at the corresponding position in MexY prevents inhibitor binding. The structure of the hydrophobic trap described in this study will contribute to the development of universal inhibitors of MexB and MexY in P. aeruginosa.	[Nakashima, Ryosuke; Sakurai, Keisuke; Yamaguchi, Akihito] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Ibaraki, Osaka 5670047, Japan; [Yamasaki, Seiji; Hayashi, Katsuhiko; Yamaguchi, Akihito] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Nagata, Chikahiro; Hoshino, Kazuki; Onodera, Yoshikuni] Daiichi Sankyo Co Ltd, Edogawa Ku, Tokyo 1348630, Japan; [Nishino, Kunihiko] Osaka Univ, Inst Sci & Ind Res, Lab Microbiol & Infect Dis, Ibaraki, Osaka 5670047, Japan	Osaka University; Osaka University; Daiichi Sankyo Company Limited; Osaka University	Yamaguchi, A (corresponding author), Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Ibaraki, Osaka 5670047, Japan.	akihito@sanken.osaka-u.ac.jp	Yamasaki, Seiji/GRF-3261-2022	Hayashi, Katsuhiko/0000-0001-7359-5939	Academia Sinica; National Synchrotron Radiation Research Center (Taiwan); CREST from the Japan Science and Technology Agency; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Ministry of Education, Culture, Sports, Science and Technology of Japan	Academia Sinica(Academia Sinica - Taiwan); National Synchrotron Radiation Research Center (Taiwan); CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Nakae for providing the plasmids encoding mexB, mexY, mexAB-oprM and mexXY-oprM. We also thank N. Kato for discussion regarding the organic chemistry of the inhibitor that was investigated in this study. Our diffraction data were collected using Osaka University's BL44XU beamline at SPring-8, which was equipped with an MX225-HECCD detector (Rayonix) and was financially supported by the Academia Sinica and the National Synchrotron Radiation Research Center (Taiwan). We thank K. Harada for assistance with the liquid chromatography-tandem mass spectrometry assay. This work was supported by CREST from the Japan Science and Technology Agency, the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation and Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aeschlimann JR, 2003, PHARMACOTHERAPY, V23, P916, DOI 10.1592/phco.23.7.916.32722; Askoura M, 2011, LIBYAN J MED, V6, DOI 10.3402/ljm.v6i0.5870; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bohnert JA, 2008, J BACTERIOL, V190, P8225, DOI 10.1128/JB.00912-08; Eda S, 2003, J BIOL CHEM, V278, P2085, DOI 10.1074/jbc.C200661200; Eicher T, 2012, P NATL ACAD SCI USA, V109, P5687, DOI 10.1073/pnas.1114944109; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hocquet D, 2006, ANTIMICROB AGENTS CH, V50, P1347, DOI 10.1128/AAC.50.4.1347-1351.2006; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lomovskaya O, 2006, BIOCHEM PHARMACOL, V71, P910, DOI 10.1016/j.bcp.2005.12.008; Lomovskaya O, 2001, J MOL MICROB BIOTECH, V3, P225; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P2242, DOI 10.1128/AAC.44.9.2242-2246.2000; Matsumoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018547; Mokhonov VV, 2004, BIOCHEM BIOPH RES CO, V322, P483, DOI 10.1016/j.bbrc.2004.07.140; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nakashima R, 2011, NATURE, V480, P565, DOI 10.1038/nature10641; Nakayama K, 2003, BIOORG MED CHEM LETT, V13, P4201, DOI 10.1016/j.bmcl.2003.07.024; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pages JM, 2009, BBA-PROTEINS PROTEOM, V1794, P826, DOI 10.1016/j.bbapap.2008.12.011; Poole K, 2001, CURR OPIN MICROBIOL, V4, P500, DOI 10.1016/S1369-5274(00)00242-3; Poole Keith, 2001, Current Topics in Medicinal Chemistry, V1, P59, DOI 10.2174/1568026013395605; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Sobel ML, 2003, ANTIMICROB AGENTS CH, V47, P3202, DOI 10.1128/AAC.47.10.3202-3207.2003; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Takatsuka Y, 2010, P NATL ACAD SCI USA, V107, P6559, DOI 10.1073/pnas.1001460107; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Vargiu AV, 2011, J AM CHEM SOC, V133, P10704, DOI 10.1021/ja202666x; Yoshida KI, 2007, BIOORGAN MED CHEM, V15, P7087, DOI 10.1016/j.bmc.2007.07.039	33	183	196	2	102	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 1	2013	500	7460					102	U131		10.1038/nature12300	http://dx.doi.org/10.1038/nature12300			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23812586				2022-12-01	WOS:000322514800037
J	Ramirez, S; Liu, X; Lin, PA; Suh, J; Pignatelli, M; Redondo, RL; Ryan, TJ; Tonegawa, S				Ramirez, Steve; Liu, Xu; Lin, Pei-Ann; Suh, Junghyup; Pignatelli, Michele; Redondo, Roger L.; Ryan, Tomas J.; Tonegawa, Susumu			Creating a False Memory in the Hippocampus	SCIENCE			English	Article							LONG-TERM POTENTIATION; FEAR MEMORY; ASSOCIATIVE MEMORY; PATTERN SEPARATION; DENTATE GYRUS; AMYGDALA; RECALL; BRAIN	Memories can be unreliable. We created a false memory in mice by optogenetically manipulating memory engram-bearing cells in the hippocampus. Dentate gyrus (DG) or CA1 neurons activated by exposure to a particular context were labeled with channelrhodopsin-2. These neurons were later optically reactivated during fear conditioning in a different context. The DG experimental group showed increased freezing in the original context, in which a foot shock was never delivered. The recall of this false memory was context-specific, activated similar downstream regions engaged during natural fear memory recall, and was also capable of driving an active fear response. Our data demonstrate that it is possible to generate an internally represented and behaviorally expressed fear memory via artificial means.	[Ramirez, Steve; Liu, Xu; Lin, Pei-Ann; Suh, Junghyup; Pignatelli, Michele; Redondo, Roger L.; Ryan, Tomas J.; Tonegawa, Susumu] MIT, Dept Biol, Picower Inst Learning & Memory, RIKEN Massachusetts Inst Technol MIT Ctr Neural C, Cambridge, MA 02139 USA; [Ramirez, Steve; Liu, Xu; Lin, Pei-Ann; Suh, Junghyup; Pignatelli, Michele; Redondo, Roger L.; Ryan, Tomas J.; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Liu, Xu; Redondo, Roger L.; Ryan, Tomas J.; Tonegawa, Susumu] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Tonegawa, S (corresponding author), MIT, Dept Biol, Picower Inst Learning & Memory, RIKEN Massachusetts Inst Technol MIT Ctr Neural C, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu	Suh, Junghyup/AAO-8265-2020	Ryan, Tomas/0000-0003-0121-8514; Pignatelli, Michele/0000-0002-4918-2066; Lin, Pei-Ann/0000-0003-4727-4407	RIKEN Brain Science Institute	RIKEN Brain Science Institute	We thank S. Huang, M. Serock, A. Mockett, J. Zhou, and D. S. Roy for help with the experiments; J. Z. Young and K. L. Mulroy for comments and discussions on the manuscript; and all the members of the Tonegawa lab for their support. This work was supported by the RIKEN Brain Science Institute.	Bartlett F.C., 1995, REMEMBERING STUDY EX, DOI 10.1017/CBO9780511759185; Brandon SE, 2000, BEHAV BRAIN RES, V110, P67, DOI 10.1016/S0166-4328(99)00185-0; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; DOYERE V, 1992, HIPPOCAMPUS, V2, P39, DOI 10.1002/hipo.450020106; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Loftus E, 2003, NAT REV NEUROSCI, V4, P231, DOI 10.1038/nrn1054; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; McTighe SM, 2010, SCIENCE, V330, P1408, DOI 10.1126/science.1194780; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pavlov IP, 1927, CONDITIONED REFLEXES; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2013, NAT NEUROSCI, V16, P119, DOI 10.1038/nn.3294; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935	30	479	496	16	470	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					387	391		10.1126/science.1239073	http://dx.doi.org/10.1126/science.1239073			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888038	Green Submitted			2022-12-01	WOS:000322259200047
J	Terasaki, M; Shemesh, T; Kasthuri, N; Klemm, RW; Schalek, R; Hayworth, KJ; Hand, AR; Yankova, M; Huber, G; Lichtman, JW; Rapoport, TA; Kozlov, MM				Terasaki, Mark; Shemesh, Tom; Kasthuri, Narayanan; Klemm, Robin W.; Schalek, Richard; Hayworth, Kenneth J.; Hand, Arthur R.; Yankova, Maya; Huber, Greg; Lichtman, Jeff W.; Rapoport, Tom A.; Kozlov, Michael M.			Stacked Endoplasmic Reticulum Sheets Are Connected by Helicoidal Membrane Motifs	CELL			English	Article							GRAIN-BOUNDARY MORPHOLOGY; TRANSLOCON COMPLEXES; ELECTRON-MICROSCOPY; RIBOSOME RECEPTOR; HOMOTYPIC FUSION; ER; CELLS; MICROTUBULES; PROTEINS; BINDING	The endoplasmic reticulum (ER) often forms stacked membrane sheets, an arrangement that is likely required to accommodate a maximum of membrane-bound polysomes for secretory protein synthesis. How sheets are stacked is unknown. Here, we used improved staining and automated ultrathin sectioning electron microscopy methods to analyze stacked ER sheets in neuronal cells and secretory salivary gland cells of mice. Our results show that stacked ER sheets form a continuous membrane system in which the sheets are connected by twisted membrane surfaces with helical edges of left- or right-handedness. The three-dimensional structure of tightly stacked ER sheets resembles a parking garage, in which the different levels are connected by helicoidal ramps. A theoretical model explains the experimental observations and indicates that the structure corresponds to a minimum of elastic energy of sheet edges and surfaces. The structure allows the dense packing of ER sheets in the restricted space of a cell.	[Terasaki, Mark; Huber, Greg] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06030 USA; [Yankova, Maya] Univ Connecticut, Ctr Hlth, Cent Electron Microscopy Facil, Farmington, CT 06030 USA; [Shemesh, Tom] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA; [Kasthuri, Narayanan; Schalek, Richard; Hayworth, Kenneth J.; Lichtman, Jeff W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Klemm, Robin W.; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Klemm, Robin W.; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Hand, Arthur R.] Univ Connecticut, Sch Dent Med, Dept Craniofacial Sci, Farmington, CT 06032 USA; [Hand, Arthur R.] Univ Connecticut, Sch Dent Med, Dept Cell Biol, Farmington, CT 06032 USA; [Huber, Greg] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Kozlov, Michael M.] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	University of Connecticut; University of Connecticut; Columbia University; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Connecticut; University of Connecticut; University of California System; University of California Santa Barbara; Tel Aviv University; Sackler Faculty of Medicine	Terasaki, M (corresponding author), Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06030 USA.	terasaki@uchc.edu; tom_rapoport@hms.harvard.edu	Klemm, Robin/C-5463-2014; Klemm, Robin/ABA-2252-2020; Shemesh, Tom/J-5060-2013	Klemm, Robin/0000-0003-2313-8240; Klemm, Robin/0000-0003-2313-8240; 	Israel Science Foundation (ISF); Marie Curie network "Virus Entry"; National Science Foundation [NSF PHY11-25915]; Richard Berlin Center for Cell Analysis and Modeling; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016411] Funding Source: NIH RePORTER	Israel Science Foundation (ISF)(Israel Science Foundation); Marie Curie network "Virus Entry"; National Science Foundation(National Science Foundation (NSF)); Richard Berlin Center for Cell Analysis and Modeling; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank Shigeki Watanabe for providing his unpublished freeze substitution protocol and Yoko Shibata, Rindy Jaffe, and Adrian Salic for critical reading of the manuscript. We thank Sid Tamm for pointing out the parking garage analogy. M.M.K. is supported by the Israel Science Foundation (ISF) and the Marie Curie network "Virus Entry" and holds the Joseph Klafter Chair in Biophysics. T.A.R. is a Howard Hughes Medical Institute Investigator. G.H. acknowledges support from the National Science Foundation under grant NSF PHY11-25915 and from the Richard Berlin Center for Cell Analysis and Modeling.	Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Becker F, 1999, J CELL BIOL, V146, P273, DOI 10.1083/jcb.146.2.273; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; CATALAN E., 1842, J MATH PURE APPL, V7, P203; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.E06-01-0080; do Carmo M.P., 1986, MATH MODELS COLLECTI, P44; Fawcett D.W., 1981, CELL; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Gido SP, 1997, MACROMOLECULES, V30, P3739, DOI 10.1021/ma9603037; GIDO SP, 1993, MACROMOLECULES, V26, P4506, DOI 10.1021/ma00069a016; HAND AR, 1972, AM J ANAT, V135, P71, DOI 10.1002/aja.1001350107; Hayworth K., 2006, MICROSCOPY MICROA S2, V12, P86, DOI [DOI 10.1017/S1431927606066268, 10.1017/s1431927606066268]; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2011, CELL, V147, P1226, DOI 10.1016/j.cell.2011.11.022; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Kamien RD, 1997, J PHYS II, V7, P157, DOI 10.1051/jp2:1997119; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Nikonov AV, 2007, J CELL SCI, V120, P2248, DOI 10.1242/jcs.008979; Nikonov AV, 2002, J CELL BIOL, V158, P497, DOI 10.1083/jcb.200201116; Ogawa-Goto K, 2007, MOL BIOL CELL, V18, P3741, DOI 10.1091/mbc.E06-12-1125; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; PALADE GE, 1956, J BIOPHYS BIOCHEM CY, V2, P171, DOI 10.1083/jcb.2.2.171; PALADE GE, 1956, J BIOPHYS BIOCHEM CY, V2, P671, DOI 10.1083/jcb.2.6.671; PORTER KR, 1953, ANAT REC, V117, P685, DOI 10.1002/ar.1091170403; Puhka M, 2012, MOL BIOL CELL, V23, P2424, DOI 10.1091/mbc.E10-12-0950; SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0; Senda T, 1998, ANAT REC, V251, P339; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Tapia JC, 2012, NAT PROTOC, V7, P193, DOI 10.1038/nprot.2011.439; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047	39	142	143	1	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					285	296		10.1016/j.cell.2013.06.031	http://dx.doi.org/10.1016/j.cell.2013.06.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870120	Green Accepted, Bronze			2022-12-01	WOS:000321950700007
J	Ferner, R				Ferner, Robin			Hallucination	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England		Ferner, R (corresponding author), Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				Abouesh A, 2002, J CLIN PSYCHOPHARM, V22, P71, DOI 10.1097/00004714-200202000-00012; ALLEN JR, 1985, NEW ENGL J MED, V313, P642; ARASKIEWICZ A, 1994, MED HYPOTHESES, V42, P261, DOI 10.1016/0306-9877(94)90128-7; BATCHELOR RCL, 1951, LANCET, V261, P195; Bouso JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042421; Grob CS, 1996, J NERV MENT DIS, V184, P86, DOI 10.1097/00005053-199602000-00004; Keeley PW, 2000, BRIT MED J, V321, P1608, DOI 10.1136/bmj.321.7276.1608; Landais A, 2014, REV MED INTERNE, V35, P199, DOI 10.1016/j.revmed.2013.02.027; McKenna D.J., 1998, HEFFTER REV PSYCHEDE, V1, P65; Sacks OW, 2012, HALLUCINATIONS: RESEARCH AND PRACTICE, P133, DOI 10.1007/978-1-4614-0959-5_11	10	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2013	347								f4570	10.1136/bmj.f4570	http://dx.doi.org/10.1136/bmj.f4570			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	189DG	23873925				2022-12-01	WOS:000322246700012
J	Lapuente-Brun, E; Moreno-Loshuertos, R; Acin-Perez, R; Latorre-Pellicer, A; Colas, C; Balsa, E; Perales-Clemente, E; Quiros, PM; Calvo, E; Rodriguez-Hernandez, MA; Navas, P; Cruz, R; Carracedo, A; Lopez-Otin, C; Perez-Martos, A; Fernandez-Silva, P; Fernandez-Vizarra, E; Enriquez, JA				Lapuente-Brun, Esther; Moreno-Loshuertos, Raquel; Acin-Perez, Rebeca; Latorre-Pellicer, Ana; Colas, Carmen; Balsa, Eduardo; Perales-Clemente, Ester; Quiros, Pedro M.; Calvo, Enrique; Rodriguez-Hernandez, M. A.; Navas, Placido; Cruz, Raquel; Carracedo, Angel; Lopez-Otin, Carlos; Perez-Martos, Acisclo; Fernandez-Silva, Patricio; Fernandez-Vizarra, Erika; Antonio Enriquez, Jose			Supercomplex Assembly Determines Electron Flux in the Mitochondrial Electron Transport Chain	SCIENCE			English	Article							CYTOCHROME-C-OXIDASE; RESPIRATORY-CHAIN; COMPLEX-I; MAMMALIAN MITOCHONDRIA; MOUSE FIBROBLASTS; DNA; ASSEMBLY/STABILITY; IDENTIFICATION; RESPIRASOME; COMPONENTS	The textbook description of mitochondrial respiratory complexes (RCs) views them as free-moving entities linked by the mobile carriers coenzyme Q (CoQ) and cytochrome c (cyt c). This model (known as the fluid model) is challenged by the proposal that all RCs except complex II can associate in supercomplexes (SCs). The proposed SCs are the respirasome (complexes I, III, and IV), complexes I and III, and complexes III and IV. The role of SCs is unclear, and their existence is debated. By genetic modulation of interactions between complexes I and III and III and IV, we show that these associations define dedicated CoQ and cyt c pools and that SC assembly is dynamic and organizes electron flux to optimize the use of available substrates.	[Lapuente-Brun, Esther; Acin-Perez, Rebeca; Latorre-Pellicer, Ana; Colas, Carmen; Balsa, Eduardo; Perales-Clemente, Ester; Calvo, Enrique; Antonio Enriquez, Jose] Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain; [Lapuente-Brun, Esther; Moreno-Loshuertos, Raquel; Perez-Martos, Acisclo; Fernandez-Silva, Patricio; Antonio Enriquez, Jose] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain; [Balsa, Eduardo] Univ Autonoma Madrid, Inst Invest Sanitaria Princesa IIS IP, Hosp Univ La Princesa, Serv Inmunol, Madrid 28006, Spain; [Rodriguez-Hernandez, M. A.; Navas, Placido] Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain; [Rodriguez-Hernandez, M. A.; Navas, Placido] ISCIII, Ctr Invest Biomed Red Enfermedades Raras, Seville 41013, Spain; [Quiros, Pedro M.; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Cruz, Raquel; Carracedo, Angel] Univ Santiago de Compostela, Ctr Invest Biomed Red Enfermedades Raras, Fac Med, Grp Med Xen, Santiago De Compostela 15782, A Coruna, Spain; [Fernandez-Vizarra, Erika] Hosp Univ Miguel Servet, IIS Aragon, Inst Aragones Ciencias Salud, Unidad Invest Traslac, Zaragoza 50009, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Zaragoza; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Oviedo; Instituto Universitario de Oncologia de Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Miguel Servet University Hospital	Enriquez, JA (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain.	jaenriquez@cnic.es	Fernandez-Vizarra, Erika/AAE-5600-2020; Moreno-Loshuertos, Raquel/H-4545-2015; Silva, Patricio Fernandez/U-2256-2017; Carracedo, Angel/D-4257-2012; Acin-Perez, Rebeca/H-6160-2015; Rodríguez-Hernández, Ángeles/K-9717-2015; López-Otín, Carlos/AAB-2106-2020; Quiros, Pedro M/L-3186-2017; Enríquez, J.A./M-8468-2016; Pellicer, Ana Latorre/A-8601-2019; NAVAS, PLACIDO/R-5943-2019; Acin-Perez, Rebeca/AAU-4913-2020; Balsa Martinez, Eduardo/A-8111-2019	Silva, Patricio Fernandez/0000-0001-8971-7355; Carracedo, Angel/0000-0003-1085-8986; Acin-Perez, Rebeca/0000-0001-9553-8337; Rodríguez-Hernández, Ángeles/0000-0003-1846-0606; López-Otín, Carlos/0000-0001-6964-1904; Quiros, Pedro M/0000-0002-7793-6291; Enríquez, J.A./0000-0002-3671-2961; Pellicer, Ana Latorre/0000-0002-4703-6620; NAVAS, PLACIDO/0000-0002-4115-7966; Acin-Perez, Rebeca/0000-0001-9553-8337; Balsa Martinez, Eduardo/0000-0002-6836-7023; CRUZ, RAQUEL/0000-0002-6964-8898; Fernandez-Vizarra, Erika/0000-0002-2469-142X; Perales-Clemente, Ester/0000-0002-6333-4070; Moreno Loshuertos, Raquel/0000-0002-6600-1618				Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P5349, DOI 10.1093/nar/gkg739; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Eubel H, 2004, PLANT PHYSIOL, V134, P1450, DOI 10.1104/pp.103.038018; Gallardo ME, 2006, HUM MUTAT, V27, P575, DOI 10.1002/humu.20338; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; Lenaz G, 2007, AM J PHYSIOL-CELL PH, V292, pC1221, DOI 10.1152/ajpcell.00263.2006; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schafer E, 2007, BIOCHEMISTRY-US, V46, P12579, DOI 10.1021/bi700983h; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Staden R, 2000, Methods Mol Biol, V132, P115; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Vempati UD, 2009, J BIOL CHEM, V284, P4383, DOI 10.1074/jbc.M805972200; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016	21	514	527	5	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1567	1570		10.1126/science.1230381	http://dx.doi.org/10.1126/science.1230381			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812712				2022-12-01	WOS:000321007000040
J	Ablasser, A; Goldeck, M; Cavlar, T; Deimling, T; Witte, G; Rohl, I; Hopfner, KP; Ludwig, J; Hornung, V				Ablasser, Andrea; Goldeck, Marion; Cavlar, Taner; Deimling, Tobias; Witte, Gregor; Roehl, Ingo; Hopfner, Karl-Peter; Ludwig, Janos; Hornung, Veit			cGAS produces a 2 '-5 '-linked cyclic dinucleotide second messenger that activates STING	NATURE			English	Article							GMP-AMP SYNTHASE; C-DI-GMP; CYTOSOLIC DNA; RECOGNITION; ADAPTER; REVEALS; DISEASE; SIGNALS; BINDING; SENSOR	Detection of cytoplasmic DNA represents one of the most fundamental mechanisms of the innate immune system to sense the presence of microbial pathogens(1). Moreover, erroneous detection of endogenous DNA by the same sensing mechanisms has an important pathophysiological role in certain sterile inflammatory conditions(2,3). The endoplasmic-reticulum-resident protein STING is critically required for the initiation of type I interferon signalling upon detection of cytosolic DNA of both exogenous and endogenous origin(4-8). Next to its pivotal role in DNA sensing, STING also serves as a direct receptor for the detection of cyclic dinucleotides, which function as second messenger molecules in bacteria(9-13). DNA recognition, however, is triggered in an indirect fashion that depends on a recently characterized cytoplasmic nucleotidyl transferase, termed cGAMP synthase (cGAS), which upon interaction with DNA synthesizes a dinucleotide molecule that in turn binds to and activates STING(14,15). We here show in vivo and in vitro that the cGAS-catalysed reaction product is distinct from previously characterized cyclic dinucleotides. Using a combinatorial approach based on mass spectrometry, enzymatic digestion, NMR analysis and chemical synthesis we demonstrate that cGAS produces a cyclic GMP-AMP dinucleotide, which comprises a 2'-5' and a 3'-5' phosphodiester linkage. Gp(2'-5') Ap(3'-5')>. We found that the presence of this 2'-5' linkage was required to exert potent activation of human STING. Moreover, we show that cGAS first catalyses the synthesis of a linear 2'-5'-linked dinucleotide, which is then subject to cGAS-dependent cyclization in a second step through a 3'-5' phosphodiester linkage. This 13-membered ring structure defines a novel class of second messenger molecules, extending the family of 2'-5'-linked antiviral biomolecules.	[Ablasser, Andrea; Goldeck, Marion; Cavlar, Taner; Ludwig, Janos; Hornung, Veit] Univ Bonn, Univ Hosp, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Deimling, Tobias; Witte, Gregor; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Deimling, Tobias; Witte, Gregor; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Roehl, Ingo] Axolabs GmbH, D-95326 Kulmbach, Germany; [Hopfner, Karl-Peter] Ctr Integrated Prot Sci, D-81377 Munich, Germany	University of Bonn; University of Munich; University of Munich; University of Munich	Ablasser, A (corresponding author), Univ Bonn, Univ Hosp, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany.	andrea.ablasser@uni-bonn.de; veit.hornung@uni-bonn.de	Hopfner, Karl-Peter/B-6864-2014; Ludwig, Janos/I-3544-2013; Goldeck, Marion/AAX-5599-2020; Hornung, Veit/C-3565-2012; Witte, Gregor/B-4635-2011	Hopfner, Karl-Peter/0000-0002-4528-8357; Hornung, Veit/0000-0002-4150-194X; Witte, Gregor/0000-0003-0313-0962; Goldeck, Marion/0000-0003-1899-4763	National Institutes of Health [U19AI083025]; European Research Council [322869, ERC 243046]; Center for Integrated Protein Science Munich (CIPSM); German Research Foundation [SFB670]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Center for Integrated Protein Science Munich (CIPSM); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Pelegrin for providing us with LL171 cells. K.-P. H. is supported by the National Institutes of Health (U19AI083025), the European Research Council Advanced Grant 322869, and the Center for Integrated Protein Science Munich (CIPSM). A. A. and V. H. are members of the excellence cluster ImmunoSensation. V. H. is supported by grants from the German Research Foundation (SFB670) and the European Research Council (ERC 243046).	Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Gaffney BL, 2010, ORG LETT, V12, P3269, DOI 10.1021/ol101236b; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kristiansen H, 2011, J INTERF CYTOK RES, V31, P41, DOI 10.1089/jir.2010.0107; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Rao F, 2009, ANAL BIOCHEM, V389, P138, DOI 10.1016/j.ab.2009.03.031; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	24	844	900	14	247	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					380	+		10.1038/nature12306	http://dx.doi.org/10.1038/nature12306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23722158	Green Accepted			2022-12-01	WOS:000320592900044
J	Ferreon, ACM; Ferreon, JC; Wright, PE; Deniz, AA				Ferreon, Allan Chris M.; Ferreon, Josephine C.; Wright, Peter E.; Deniz, Ashok A.			Modulation of allostery by protein intrinsic disorder	NATURE			English	Article							ADENOVIRUS E1A; STRUCTURAL BASIS; PHASE-DIAGRAMS; P300; BIOLOGY; BINDING; DOMAIN	Allostery is an intrinsic property of many globular proteins and enzymes that is indispensable for cellular regulatory and feedback mechanisms. Recent theoretical(1) and empirical(2) observations indicate that allostery is also manifest in intrinsically disordered proteins, which account for a substantial proportion of the proteome(3,4). Many intrinsically disordered proteins are promiscuous binders that interact with multiple partners and frequently function as molecular hubs in protein interaction networks. The adenovirus early region 1A (E1A) oncoprotein is a prime example of a molecular hub intrinsically disordered protein(5). E1A can induce marked epigenetic reprogramming of the cell within hours after infection, through interactions with a diverse set of partners that include key host regulators such as the general transcriptional coactivator CREB binding protein (CBP), its paralogue p300, and the retinoblastoma protein (pRb; also called RB1)(6,7). Little is known about the allosteric effects at play in E1A-CBP-pRb interactions, or more generally in hub intrinsically disordered protein interaction networks. Here we used single-molecule fluorescence resonance energy transfer (smFRET) to study coupled binding and folding processes in the ternary E1A system. The low concentrations used in these high-sensitivity experiments proved to be essential for these studies, which are challenging owing to a combination of E1A aggregation propensity and high-affinity binding interactions. Our data revealed that E1A-CBP-pRb interactions have either positive or negative cooperativity, depending on the available E1A interaction sites. This striking cooperativity switch enables fine-tuning of the thermodynamic accessibility of the ternary versus binary E1A complexes, and may permit a context-specific tuning of associated downstream signalling outputs. Such a modulation of allosteric interactions is probably a common mechanism in molecular hub intrinsically disordered protein function.	[Ferreon, Allan Chris M.; Ferreon, Josephine C.; Wright, Peter E.; Deniz, Ashok A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Wright, Peter E.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Deniz, AA (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	wright@scripps.edu; deniz@scripps.edu		Allan Chris, Ferreon/0000-0002-8538-1732; Ferreon, Josephine/0000-0002-3175-5700; Wright, Peter/0000-0002-1368-0223	National Institutes of Health [GM066833, CA96865]; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R01CA096865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Manlapaz for technical support, A. Jansma and G. Bhabha for preparation of plasmid constructs, P. Haberz for mass spectrometry, and J. Dyson and M. Martinez-Yamout for discussions. This work was supported by grants GM066833 (A. A. D.) and CA96865 (P. E. W.) from the National Institutes of Health, and the Skaggs Institute for Chemical Biology.	Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Deniz AA, 2008, J R SOC INTERFACE, V5, P15, DOI 10.1098/rsif.2007.1021; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Ferreon ACM, 2007, BIOPHYS J, V92, P245, DOI 10.1529/biophysj.106.092262; Ferreon ACM, 2010, METHOD ENZYMOL, V472, P179, DOI 10.1016/S0076-6879(10)72010-3; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P13260, DOI 10.1073/pnas.0906770106; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Green M, 2008, ONCOGENE, V27, P4446, DOI 10.1038/onc.2008.85; Heise C, 2000, NAT MED, V6, P1134, DOI 10.1038/80474; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Kadri Z, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000123; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Liu X, 2007, GENE DEV, V21, P2711, DOI 10.1101/gad.1590607; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Motlagh HN, 2012, P NATL ACAD SCI USA, V109, P4134, DOI 10.1073/pnas.1120519109; Nguyen DX, 2004, EMBO J, V23, P1609, DOI 10.1038/sj.emboj.7600176; Pelka P, 2008, J VIROL, V82, P7252, DOI 10.1128/JVI.00104-08; Rosgen J, 2003, J MOL BIOL, V328, P255, DOI 10.1016/S0022-2836(03)00246-8; Sang NL, 1997, J CELL BIOCHEM, V66, P277, DOI 10.1002/(SICI)1097-4644(19970901)66:3<277::AID-JCB1>3.0.CO;2-M; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; WANG HGH, 1995, J VIROL, V69, P7917, DOI 10.1128/JVI.69.12.7917-7924.1995; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u	31	238	241	1	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					390	+		10.1038/nature12294	http://dx.doi.org/10.1038/nature12294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23783631	Green Accepted			2022-12-01	WOS:000320592900046
J	Kamarulzaman, A				Kamarulzaman, Adeeba			Fighting the HIV epidemic in the Islamic world	LANCET			English	Editorial Material									Univ Malaya, Fac Med, Ctr Excellence Res AIDS, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Kamarulzaman, A (corresponding author), Univ Malaya, Fac Med, Ctr Excellence Res AIDS, Kuala Lumpur 50603, Malaysia.	adeeba@um.edu.my	KAMARULZAMAN, ADEEBA/B-5216-2010					Abu-Raddad LJ, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000386729.56683.33; Busulwa R., 2006, Eastern Mediterranean Health Journal, V12, pS64; El Feki S, 2006, LANCET, V367, P975, DOI 10.1016/S0140-6736(06)68409-2; Global HIV/AIDS Response, EP UPD HLTH SECT PRO; Gray PB, 2004, SOC SCI MED, V58, P1751, DOI 10.1016/S0277-9536(03)00367-8; Kamarulzaman A, 2010, INT J DRUG POLICY, V21, P115, DOI 10.1016/j.drugpo.2009.11.003; Ministry of Health Malaysia, 2013, SEM HIV IMP ASS; Naning H, 2013, 7 IAS C HIV PATH TRE; Obermeyer CM, 2006, BMJ-BRIT MED J, V333, P851, DOI 10.1136/bmj.38994.400370.7C; Rahmati-Najarkolaei F, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-27; Reid G, 2007, INT J DRUG POLICY, V18, P136, DOI 10.1016/j.drugpo.2006.12.015; UNAIDS, 2010, REP GLOB AIDS EP 201	12	30	30	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 15	2013	381	9883					2058	2060		10.1016/S0140-6736(13)61033-8	http://dx.doi.org/10.1016/S0140-6736(13)61033-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KA	23769216				2022-12-01	WOS:000320924800005
J	Mirceta, S; Signore, AV; Burns, JM; Cossins, AR; Campbell, KL; Berenbrink, M				Mirceta, Scott; Signore, Anthony V.; Burns, Jennifer M.; Cossins, Andrew R.; Campbell, Kevin L.; Berenbrink, Michael			Evolution of Mammalian Diving Capacity Traced by Myoglobin Net Surface Charge	SCIENCE			English	Article							MARINE MAMMALS; BODY-SIZE; OXYGEN; ADAPTATIONS; ALLOMETRY; STABILITY; BEHAVIOR; LIMITS; BIRDS; SEALS	Extended breath-hold endurance enables the exploitation of the aquatic niche by numerous mammalian lineages and is accomplished by elevated body oxygen stores and adaptations that promote their economical use. However, little is known regarding the molecular and evolutionary underpinnings of the high muscle myoglobin concentration phenotype of divers. We used ancestral sequence reconstruction to trace the evolution of this oxygen-storing protein across a 130-species mammalian phylogeny and reveal an adaptive molecular signature of elevated myoglobin net surface charge in diving species that is mechanistically linked with maximal myoglobin concentration. This observation provides insights into the tempo and routes to enhanced dive capacity evolution within the ancestors of each major mammalian aquatic lineage and infers amphibious ancestries of echidnas, moles, hyraxes, and elephants, offering a fresh perspective on the evolution of this iconic respiratory pigment.				michaelb@liv.ac.uk	Berenbrink, Michael/W-7519-2019; Burns, Jennifer/AAC-8243-2019	Burns, Jennifer/0000-0001-9652-2943; Signore, Anthony/0000-0002-0664-0864; Cossins, Andrew/0000-0002-0813-5212; Campbell, Kevin/0000-0001-7005-7086	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ANDREWS CW, 1906, DESCRIPT CATAL; Antonini E., 1971, FRONT BIOL, DOI DOI 10.1126/SCIENCE.178.4058.296; Berenbrink M, 2005, SCIENCE, V307, P1752, DOI 10.1126/science.1107793; Berenbrink M, 2006, RESP PHYSIOL NEUROBI, V154, P165, DOI 10.1016/j.resp.2006.01.002; BERTA A, 1989, SCIENCE, V244, P60, DOI 10.1126/science.244.4900.60; Butler PJ, 1997, PHYSIOL REV, V77, P837, DOI 10.1152/physrev.1997.77.3.837; Campbell B, 1939, AM J ANAT, V64, P1, DOI 10.1002/aja.1000640102; Clementz MT, 2008, PALAIOS, V23, P574, DOI 10.2110/palo.2007.p07-054r; Court Nicholas, 1993, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V226, P125; Domning DP, 2001, NATURE, V413, P625, DOI 10.1038/35098072; FISCHER MS, 1992, MAMMALIA, V8; GALLIVAN GJ, 1986, J COMP PHYSIOL B, V156, P415, DOI 10.1007/BF01101104; Gros G, 2010, J EXP BIOL, V213, P2713, DOI 10.1242/jeb.043075; Halsey LG, 2006, AM NAT, V167, P276, DOI 10.1086/499439; Helbo S, 2012, AM J PHYSIOL-REG I, V302, pR693, DOI 10.1152/ajpregu.00501.2011; HOCHACHKA PW, 1984, MOL PHYSIOL, V5, P165; HOCHACHKA PW, 1988, COLD OCEAN PHYSIOL, P391; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; Kooyman GL, 1998, ANNU REV PHYSIOL, V60, P19, DOI 10.1146/annurev.physiol.60.1.19; KOOYMAN GL, 1980, J COMP PHYSIOL, V138, P335, DOI 10.1007/BF00691568; Kramer RM, 2012, BIOPHYS J, V102, P1907, DOI 10.1016/j.bpj.2012.01.060; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Lestyk KC, 2009, J COMP PHYSIOL B, V179, P985, DOI 10.1007/s00360-009-0378-9; Liu AGSC, 2008, P NATL ACAD SCI USA, V105, P5786, DOI 10.1073/pnas.0800884105; MADDISON DR, 2000, MACCLADE 4 ANAL; MADDISON WP, 2011, MESQUITE MOD SYST; McIntyre IW, 2002, J EXP BIOL, V205, P45; MCLELLAN T, 1984, BIOCHEM GENET, V22, P181, DOI 10.1007/BF00499297; Meijaard E, 2010, MAMM BIOL, V75, P471, DOI 10.1016/j.mambio.2009.05.007; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Nagao S, 2012, DALTON T, V41, P11378, DOI 10.1039/c2dt30893b; Noren SR, 2000, COMP BIOCHEM PHYS A, V126, P181, DOI 10.1016/S1095-6433(00)00182-3; OSBORN HF, 1899, P 4 INT C ZOOL CAMBR, P172; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; Phillips MJ, 2009, P NATL ACAD SCI USA, V106, P17089, DOI 10.1073/pnas.0904649106; Ponganis PJ, 2011, J EXP BIOL, V214, P3325, DOI 10.1242/jeb.031252; Reeds PJ, 2000, J NUTR, V130, p1835S; Regis WCB, 2005, ARCH BIOCHEM BIOPHYS, V436, P168, DOI 10.1016/j.abb.2005.01.016; REYNAFARJE B, 1963, J LAB CLIN MED, V61, P138; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Scholander PF, 1941, J CELL COMPAR PHYSL, V17, P169, DOI 10.1002/jcp.1030170204; Schreer JF, 1997, CAN J ZOOL, V75, P339, DOI 10.1139/z97-044; SCHWARTZ GT, 1995, J MAMMAL, V76, P1088, DOI 10.2307/1382601; Scott EE, 2000, J BIOL CHEM, V275, P27129; Seiffert ER, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-224; Steller G. W., 1751, NOVI COMMENTARII ACA, V2, P289; STEWART BS, 1995, J MAMMAL, V76, P196, DOI 10.2307/1382328; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; Totzeck M, 2012, CIRCULATION, V126, P325, DOI 10.1161/CIRCULATIONAHA.111.087155; Uhen MD, 2007, ANAT REC, V290, P514, DOI 10.1002/ar.20545; VANDENOORD AH, 1969, EUR J BIOCHEM, V10, P140; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Williams TM, 2011, MAR MAMMAL SCI, V27, P334, DOI 10.1111/j.1748-7692.2010.00408.x; Williams TM, 1999, PHILOS T R SOC B, V354, P193, DOI 10.1098/rstb.1999.0371; WITTENBERG JB, 1970, PHYSIOL REV, V50, P559, DOI 10.1152/physrev.1970.50.4.559; Zorrilla S, 2004, PROTEIN SCI, V13, P2960, DOI 10.1110/ps.04809404; [No title captured]	62	124	131	4	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138							1234192	10.1126/science.1234192	http://dx.doi.org/10.1126/science.1234192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766330	Green Submitted			2022-12-01	WOS:000320320200036
J	Yong, KJ; Gao, C; Lim, JSJ; Yan, B; Yang, H; Dimitrov, T; Kawasaki, A; Ong, CW; Wong, KF; Lee, S; Ravikumar, S; Srivastava, S; Tian, X; Poon, RT; Fan, ST; Luk, JM; Dan, YY; Salto-Tellez, M; Chai, L; Tenen, DG				Yong, Kol Jia; Gao, Chong; Lim, Joline S. J.; Yan, Benedict; Yang, Henry; Dimitrov, Todor; Kawasaki, Akira; Ong, Chee Wee; Wong, Kwong-Fai; Lee, Sanghoon; Ravikumar, Sharada; Srivastava, Supriya; Tian, Xi; Poon, Ronnie T.; Fan, Sheung Tat; Luk, John M.; Dan, Yock Young; Salto-Tellez, Manuel; Chai, Li; Tenen, Daniel G.			Oncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							YOLK-SAC TUMORS; EXPRESSION; TRICHOSTATIN; ONCOGENE; LEUKEMIA; UTILITY; CANCER; CELLS	BACKGROUND Hepatocellular carcinoma is the third leading cause of cancer-related deaths worldwide. In the heterogeneous group of hepatocellular carcinomas, those with characteristics of embryonic stem-cell and progenitor-cell gene expression are associated with the worst prognosis. The oncofetal gene SALL4, a marker of a subtype of hepatocellular carcinoma with progenitor-like features, is associated with a poor prognosis and is a potential target for treatment. METHODS We screened specimens obtained from patients with primary hepatocellular carcinoma for the expression of SALL4 and carried out a clinicopathological analysis. Loss-of-function studies were then performed to evaluate the role of SALL4 in hepatocarcinogenesis and its potential as a molecular target for therapy. To assess the therapeutic effects of a peptide that targets SALL4, we used in vitro functional and in vivo xenograft assays. RESULTS SALL4 is an oncofetal protein that is expressed in the human fetal liver and silenced in the adult liver, but it is reexpressed in a subgroup of patients who have hepatocellular carcinoma and an unfavorable prognosis. Gene-expression analysis showed the enrichment of progenitor-like gene signatures with overexpression of proliferative and metastatic genes in SALL4-positive hepatocellular carcinomas. Loss-of-function studies confirmed the critical role of SALL4 in cell survival and tumorigenicity. Blocking SALL4-corepressor interactions released suppression of PTEN (the phosphatase and tensin homologue protein) and inhibited tumor formation in xenograft models in vivo. CONCLUSIONS SALL4 is a marker for a progenitor subclass of hepatocellular carcinoma with an aggressive phenotype. The absence of SALL4 expression in the healthy adult liver enhances the potential of SALL4 as a treatment target in hepatocellular carcinoma. (Funded by the Singapore National Medical Research Council and others.)	[Yong, Kol Jia; Yang, Henry; Kawasaki, Akira; Ong, Chee Wee; Wong, Kwong-Fai; Lee, Sanghoon; Ravikumar, Sharada; Srivastava, Supriya; Luk, John M.; Salto-Tellez, Manuel; Tenen, Daniel G.] Natl Univ Hlth Syst, Canc Sci Inst Singapore, Singapore, Singapore; [Yong, Kol Jia] Natl Univ Hlth Syst, Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Lim, Joline S. J.] Natl Univ Hlth Syst, Natl Univ Canc Inst, Singapore, Singapore; [Yan, Benedict] Natl Univ Hlth Syst, Dept Pathol, Singapore, Singapore; [Luk, John M.] Natl Univ Hlth Syst, Dept Pharmacol, Singapore, Singapore; [Dan, Yock Young] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore; [Dan, Yock Young] Natl Univ Singapore, Singapore 117599, Singapore; [Gao, Chong; Lim, Joline S. J.; Dimitrov, Todor; Tian, Xi; Chai, Li] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Tenen, Daniel G.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Poon, Ronnie T.; Fan, Sheung Tat; Luk, John M.] Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Salto-Tellez, Manuel] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Hong Kong; Queens University Belfast	Tenen, DG (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Canc Sci Inst Singapore, Ctr Translat Med MD6,Unit 01, 12th Fl,14 Med Dr, Singapore 117599, Singapore.	daniel.tenen@nus.edu.sg	Srivastava, Supriya/HDJ-9671-2022; Luk, John/A-4085-2008	Luk, John/0000-0002-6323-7940; Salto-Tellez, Manuel/0000-0001-8586-282X; Chai, Li/0000-0003-1937-4750; Srivastava, Supriya/0000-0002-6727-3076; Tenen, Daniel/0000-0002-6423-3888	Singapore National Medical Research Council; Singapore Translational Research Award from the Singapore National Medical Research Council [NMRC/STaR/0001/2008]; Singapore Ministry of Education; National Research Foundation; National Institutes of Health [PO1DK080665, RO1HL092437, PO1HL095489]; NATIONAL CANCER INSTITUTE [R01CA118316, P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112719, R01HL056745, P01HL095489, R01HL092437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK080665] Funding Source: NIH RePORTER	Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Translational Research Award from the Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore); National Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the Singapore National Medical Research Council and others.; Supported by a Singapore Translational Research Award from the Singapore National Medical Research Council (NMRC/STaR/0001/2008, to Dr. Tenen) and grants from the Singapore Ministry of Education and National Research Foundation (to Dr. Tenen) and the National Institutes of Health (PO1DK080665, to Drs. Tenen and Chai; and RO1HL092437 and PO1HL095489, to Dr. Chai).	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Cao DF, 2009, CANCER-AM CANCER SOC, V115, P2640, DOI 10.1002/cncr.24308; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Cui W, 2006, MODERN PATHOL, V19, P1585, DOI 10.1038/modpathol.3800694; de Celis JF, 2009, INT J DEV BIOL, V53, P1385, DOI 10.1387/ijdb.072408jd; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao C, 2013, BLOOD, V121, P1413, DOI 10.1182/blood-2012-04-424275; Keating GM, 2009, DRUGS, V69, P223, DOI 10.2165/00003495-200969020-00006; Kobayashi D, 2011, INT J ONCOL, V38, P933, DOI 10.3892/ijo.2011.929; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Mukhopadhyay NK, 2006, ANN THORAC SURG, V81, P1034, DOI 10.1016/j.athoracsur.2005.06.059; Oikawa T, 2013, HEPATOLOGY, V57, P1469, DOI 10.1002/hep.26159; Oikawa T, 2009, GASTROENTEROLOGY, V136, P1000, DOI 10.1053/j.gastro.2008.11.018; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang FH, 2009, AM J SURG PATHOL, V33, P1529, DOI 10.1097/PAS.0b013e3181ad25d5; Woo HG, 2010, CANCER RES, V70, P3034, DOI 10.1158/0008-5472.CAN-09-2823; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	22	168	187	0	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					2266	2276		10.1056/NEJMoa1300297	http://dx.doi.org/10.1056/NEJMoa1300297			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YN	23758232	Green Accepted, Green Published			2022-12-01	WOS:000320230500002
J	Dworzynski, K; Ritchie, G; Fenu, E; MacDermott, K; Playford, ED				Dworzynski, Katharina; Ritchie, Gill; Fenu, Elisabetta; MacDermott, Keith; Playford, E. Diane		Guideline Dev Grp	Rehabilitation after stroke: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dworzynski, Katharina; Ritchie, Gill; Fenu, Elisabetta] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Playford, E. Diane] UCL Inst Neurol, London WC1N 1PJ, England	Royal College of Physicians; University of London; University College London	Dworzynski, K (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	Katharina.Dworzynski@rcplondon.ac.uk		Playford, E Diane/0000-0001-7314-787X				Department of Health, 2007, 284536 DOH; GRADE Working Group, 2011, GRAD REC ASS DEV EV; National Institute for Health and Care Excellence, 2013, STROK REH LONG TERM; Townsend N, 2012, CORONARY HEART DIS S	4	45	48	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2013	346								f3615	10.1136/bmj.f3615	http://dx.doi.org/10.1136/bmj.f3615			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166WH	23760965				2022-12-01	WOS:000320589800003
J	Chatterjee, P				Chatterjee, Patralekha			Added benefits of polio eradication	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												patralekha.chatterjee@gmail.com						Unicef, 2005, COV EV SURV; UNICEF, 2009, COV EV SURV; Vashishtha VM, 2013, INDIAN PEDIATR, V50, P111, DOI 10.1007/s13312-013-0025-0	3	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ BRIT MED J	BMJ-British Medical Journal	JUN 7	2013	346								f3378	10.1136/bmj.f3378	http://dx.doi.org/10.1136/bmj.f3378			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YM	23747750				2022-12-01	WOS:000320230400005
J	Willmann, G; Fischer, MD; Schatz, A; Schommer, K; Gekeler, F				Willmann, Gabriel; Fischer, M. Dominik; Schatz, Andreas; Schommer, Kai; Gekeler, Florian			Retinal Vessel Leakage at High Altitude	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Willmann, Gabriel; Fischer, M. Dominik; Schatz, Andreas; Gekeler, Florian] Univ Tubingen, Ctr Ophthalmol, Tubingen, Germany; [Schommer, Kai] Heidelberg Univ, Med Clin, Dept Sports Med, Heidelberg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg	Willmann, G (corresponding author), Univ Tubingen, Ctr Ophthalmol, Tubingen, Germany.	gekeler@uni-tuebingen.de						Albert DM, 2008, ALBERT JAKOBIECS PRI, V3rd; FRAYSER R, 1971, ARCH INTERN MED, V127, P708, DOI 10.1001/archinte.127.4.708; FRAYSER R, 1970, NEW ENGL J MED, V282, P1183, DOI 10.1056/NEJM197005212822106; MCFADDEN DM, 1981, JAMA-J AM MED ASSOC, V245, P581, DOI 10.1001/jama.245.6.581; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; SINGH I, 1969, NEW ENGL J MED, V280, P175, DOI 10.1056/NEJM196901232800402	6	19	20	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2013	309	21					2210	2212		10.1001/jama.2013.5550	http://dx.doi.org/10.1001/jama.2013.5550			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156YC	23736726	Bronze			2022-12-01	WOS:000319859200018
J	Walker, K; Neuburger, J; Groene, O; Cromwell, DA; van der Meulen, J				Walker, Kate; Neuburger, Jenny; Groene, Oliver; Cromwell, David A.; van der Meulen, Jan			Public reporting of surgeon outcomes: low numbers of procedures lead to false complacency	LANCET			English	Article							CARDIAC-SURGERY; SURGICAL MORTALITY; PERFORMANCE; LESSONS; CARE	The English National Health Service published outcome information for individual surgeons for ten specialties in June, 2013. We looked at whether individual surgeons do sufficient numbers of procedures to be able to reliably identify those with poor performance. For some specialties, the number of procedures that a surgeon does each year is low and, as a result, the chance of identifying a surgeon with increased mortality rates is also low. Therefore, public reporting of individual surgeons' outcomes could lead to false complacency. We recommend use of outcomes that are fairly frequent, considering the hospital as the unit of reporting when numbers are low, and avoiding interpretation of no evidence of poor performance as evidence of acceptable performance.	[Walker, Kate; Neuburger, Jenny; Groene, Oliver; Cromwell, David A.; van der Meulen, Jan] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Neuburger, J (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England.	jenny.neuburger@lshtm.ac.uk	Cromwell, David/AAD-6519-2019	van der Meulen, Jan/0000-0002-9451-2335; Groene, Oliver/0000-0002-1099-2950; Walker, Kate/0000-0001-5392-6323	Royal College of Surgeons of England	Royal College of Surgeons of England	We thank Rob Wakeman for providing information on surgeon volume for hip fracture surgery. No specific funding was received for this report. The salaries of KW, JN, and OG were funded by a grant from the Royal College of Surgeons of England.	ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Bridgewater B, 2005, BMJ-BRIT MED J, V330, P506, DOI 10.1136/bmj.330.7490.506; Bridgewater B, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1139; Dimick JB, 2004, JAMA-J AM MED ASSOC, V292, P847, DOI 10.1001/jama.292.7.847; Dimick JB, 2010, HEALTH SERV RES, V45, P1614, DOI 10.1111/j.1475-6773.2010.01158.x; Ghaferi AA, 2011, MED CARE, V49, P1076, DOI 10.1097/MLR.0b013e3182329b97; Girling AJ, 2012, BMJ QUAL SAF, V21, P1052, DOI 10.1136/bmjqs-2012-001202; Hannan EL, 2012, J AM COLL CARDIOL, V59, P2309, DOI 10.1016/j.jacc.2011.12.051; Health and Social Care Information Centre, NATIONAL BOWEL CANCE; Health and Social Care Information Centre, NATIONAL OESOPHAGO G; Health and Social Care Information Centre, HOSPITAL EPISODE; Johal A, 2013, HOSPITAL EPISODE STA; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; National Hip Fracture Database, 2012, NATIONAL REPORT 2012; National Institute for Cardiovascular Outcomes Research, 2013, ADULT CARDIAC SURGER; NHS Commissioning Board, 2012, EVERYONE COUNTS PLAN; Shahian DM, 2012, J AM COLL CARDIOL, V59, P2383, DOI 10.1016/j.jacc.2011.12.050; Shahian DM, 2011, ANN THORAC SURG, V92, pS2, DOI 10.1016/j.athoracsur.2011.06.100; Society for Cardiothoracic Surgery in Great Britain and Ireland, UK SURGEONS RESULTS; Spiegelhalter DJ, 2005, QUAL SAF HEALTH CARE, V14, P347, DOI 10.1136/qshc.2005.013755	21	81	81	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1674	1677		10.1016/S0140-6736(13)61491-9	http://dx.doi.org/10.1016/S0140-6736(13)61491-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254CN	23831144				2022-12-01	WOS:000327140700027
J	Peng, T; Tian, Y; Boogerd, CJ; Lu, MM; Kadzik, RS; Stewart, KM; Evans, SM; Morrisey, EE				Peng, Tien; Tian, Ying; Boogerd, Cornelis J.; Lu, Min Min; Kadzik, Rachel S.; Stewart, Kathleen M.; Evans, Sylvia M.; Morrisey, Edward E.			Coordination of heart and lung co-development by a multipotent cardiopulmonary progenitor	NATURE			English	Article							SONIC HEDGEHOG; CELLS; EXPRESSION; DIFFERENTIATION; PROLIFERATION; SUFFICIENT; ENDODERM; LINEAGES; FOREGUT; ISL1	Co-development of the cardiovascular and pulmonary systems is a recent evolutionary adaption to terrestrial life that couples cardiac output with the gas exchange function of the lung(1). Here we show that the murine pulmonary vasculature develops even in the absence of lung development. We have identified a population of multipotent cardiopulmonary mesoderm progenitors (CPPs) within the posterior pole of the heart that are marked by the expression of Wnt2, Gli1 and Isl1. We show that CPPs arise from cardiac progenitors before lung development. Lineage tracing and clonal analysis demonstrates that CPPs generate the mesoderm lineages within the cardiac inflow tract and lung including cardiomyocytes, pulmonary vascular and airway smooth muscle, proximal vascular endothelium, and pericyte-like cells. CPPs are regulated by hedgehog expression from the foregut endoderm, which is required for connection of the pulmonary vasculature to the heart. Together, these studies identify a novel population of multipotent cardiopulmonary progenitors that coordinates heart and lung co-development that is required for adaptation to terrestrial existence.	[Peng, Tien; Tian, Ying; Stewart, Kathleen M.; Morrisey, Edward E.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Peng, Tien] Univ Penn, Div Pulm & Crit Care, Philadelphia, PA 19104 USA; [Tian, Ying; Lu, Min Min; Stewart, Kathleen M.; Morrisey, Edward E.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Boogerd, Cornelis J.; Evans, Sylvia M.] Univ Calif San Diego, Dept Med, Skaggs Sch Pharm, San Diego, CA 92093 USA; [Kadzik, Rachel S.; Morrisey, Edward E.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of California System; University of California San Diego; University of Pennsylvania; Pennsylvania Medicine	Morrisey, EE (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu	Boogerd, Cornelis J/D-3244-2009; Evans, Sylvia/G-1980-2015; Boogerd, Cornelis/A-7470-2016	Boogerd, Cornelis J/0000-0002-7119-5381; 	National Institutes of Health [HL110942, HL100405, HL087825, HL117649]; American Heart Association Jon DeHaan Myogenesis Center;  [T32 HL07586-23];  [P30 NS047101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100405, U01HL107442, T32HL007586, R01HL087825, U01HL110942, T32HL007843, DP1HL117649, R01HL074066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Jon DeHaan Myogenesis Center(American Heart Association); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors appreciate the input of M. Kahn and J. Epstein in these studies. The authors are grateful to A. Stout for help in imaging. L. Guo provided assistance with figure illustrations. These studies were supported by funds from the National Institutes of Health (HL110942, HL100405, HL087825 to E. E. M. and HL117649 to S. M. E.) and the American Heart Association Jon DeHaan Myogenesis Center. T. P. is supported by T32 HL07586-23. C. J. B. is supported by P30 NS047101.	Bai LY, 2008, LEUKEMIA, V22, P226, DOI 10.1038/sj.leu.2404978; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Goss AM, 2011, DEV BIOL, V356, P541, DOI 10.1016/j.ydbio.2011.06.011; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harris-Johnson KS, 2009, P NATL ACAD SCI USA, V106, P16287, DOI 10.1073/pnas.0902274106; Hoffmann AD, 2009, DEVELOPMENT, V136, P1761, DOI 10.1242/dev.034157; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Lavine KJ, 2008, DEVELOPMENT, V135, P3161, DOI 10.1242/dev.019919; Lepore JJ, 2005, GENESIS, V41, P179, DOI 10.1002/gene.20112; Lin LZ, 2006, DEV BIOL, V295, P756, DOI 10.1016/j.ydbio.2006.03.053; Long FX, 2001, DEVELOPMENT, V128, P5099; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Peng T, 2013, PULM CIRC, V3, P176, DOI 10.4103/2045-8932.109954; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Shu WG, 2002, DEVELOPMENT, V129, P4831; Snippert HJ, 2011, NAT PROTOC, V6, P1221, DOI 10.1038/nprot.2011.365; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Tian Y, 2010, DEV CELL, V18, P275, DOI 10.1016/j.devcel.2010.01.008; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; White AC, 2007, DEVELOPMENT, V134, P3743, DOI 10.1242/dev.004879; Yokomizo T, 2012, NAT PROTOC, V7, P421, DOI 10.1038/nprot.2011.441	25	129	132	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					589	+		10.1038/nature12358	http://dx.doi.org/10.1038/nature12358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23873040	Green Accepted, Green Submitted			2022-12-01	WOS:000323625900037
J	Carpenter, S; Aiello, D; Atianand, MK; Ricci, EP; Gandhi, P; Hall, LL; Byron, M; Monks, B; Henry-Bezy, M; Lawrence, JB; O'Neill, LAJ; Moore, MJ; Caffrey, DR; Fitzgerald, KA				Carpenter, Susan; Aiello, Daniel; Atianand, Maninjay K.; Ricci, Emiliano P.; Gandhi, Pallavi; Hall, Lisa L.; Byron, Meg; Monks, Brian; Henry-Bezy, Meabh; Lawrence, Jeanne B.; O'Neill, Luke A. J.; Moore, Melissa J.; Caffrey, Daniel R.; Fitzgerald, Katherine A.			A Long Noncoding RNA Mediates Both Activation and Repression of Immune Response Genes	SCIENCE			English	Article							IN-VIVO; EXPRESSION; REVEALS; GENOME; CELLS; A/B; TRANSCRIPTOMES; OSTEOPONTIN; TRANSLATION; RESOLUTION	An inducible program of inflammatory gene expression is central to antimicrobial defenses. This response is controlled by a collaboration involving signal-dependent activation of transcription factors, transcriptional co-regulators, and chromatin-modifying factors. We have identified a long noncoding RNA (lncRNA) that acts as a key regulator of this inflammatory response. Pattern recognition receptors such as the Toll-like receptors induce the expression of numerous lncRNAs. One of these, lincRNA-Cox2, mediates both the activation and repression of distinct classes of immune genes. Transcriptional repression of target genes is dependent on interactions of lincRNA-Cox2 with heterogeneous nuclear ribonucleoprotein A/B and A2/B1. Collectively, these studies unveil a central role of lincRNA-Cox2 as a broad-acting regulatory component of the circuit that controls the inflammatory response.	[Carpenter, Susan; Aiello, Daniel; Atianand, Maninjay K.; Gandhi, Pallavi; Monks, Brian; Henry-Bezy, Meabh; Caffrey, Daniel R.; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Carpenter, Susan; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Ricci, Emiliano P.; Moore, Melissa J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Hall, Lisa L.; Byron, Meg; Lawrence, Jeanne B.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Trinity College Dublin; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Caffrey, DR (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	daniel.caffrey@umassmed.edu; kate.fitzgerald@umassmed.edu	Atianand, Maninjay/AAF-7823-2019; Fitzgerald, Katherine/ABE-6317-2020; Ricci, Emiliano/G-7619-2012; Monks, Brian/B-8362-2015	Atianand, Maninjay/0000-0003-4135-2515; Ricci, Emiliano/0000-0002-9789-5837; Monks, Brian/0000-0003-4008-3093; O'Neill, Luke/0000-0002-4333-2748; Fitzgerald, Kate/0000-0003-3175-609X; Lawrence, Jeanne/0000-0001-6572-3128	Ireland Health Research Board/Marie Curie Fellowship [MCPD/2010/04]; NIH [AI067497, GM053234]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067497, R37AI067497, R56AI067497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053234] Funding Source: NIH RePORTER	Ireland Health Research Board/Marie Curie Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Singh for advice on RNA-seq, A. J. Crawford for help with quantification of RNA FISH, and K. Jeffrey, L. Stuart, N. Silverman, D. Golenbock, and E. Lien for critical reading of this manuscript. The data presented in this paper are tabulated in the main paper and in the supplementary materials. All RNA-seq data are available for download from NCBI Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) under accession number GSE40978. Supported by Ireland Health Research Board/Marie Curie Fellowship MCPD/2010/04 (S. C.) and by NIH grants AI067497 (K.A.F.) and GM053234 (J.B.L.).	Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Collier SP, 2012, J IMMUNOL, V189, P2084, DOI 10.4049/jimmunol.1200774; Dreyfuss G, 1996, CELL, V85, P963, DOI 10.1016/S0092-8674(00)81298-2; Gao CJ, 2005, J IMMUNOL, V175, P523, DOI 10.4049/jimmunol.175.1.523; Gao CJ, 2004, J BIOL CHEM, V279, P11236, DOI 10.1074/jbc.M313385200; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Peng XX, 2010, MBIO, V1, DOI 10.1128/mBio.00206-10; Raju CS, 2008, MOL BIOL CELL, V19, P3008, DOI 10.1091/mbc.E07-10-1083; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Wu QF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002803	28	687	749	3	226	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 16	2013	341	6147					789	792		10.1126/science.1240925	http://dx.doi.org/10.1126/science.1240925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23907535	Green Submitted, Green Accepted			2022-12-01	WOS:000323122200049
J	Kueh, HY; Champhekhar, A; Nutt, SL; Elowitz, MB; Rothenberg, EV				Kueh, Hao Yuan; Champhekhar, Ameya; Nutt, Stephen L.; Elowitz, Michael B.; Rothenberg, Ellen V.			Positive Feedback Between PU.1 and the Cell Cycle Controls Myeloid Differentiation	SCIENCE			English	Article							TRANSCRIPTION FACTOR PU.1; HEMATOPOIETIC STEM-CELLS; GENE-EXPRESSION; LEUKEMIA; PROGENITORS; FATES; MICE; PROLIFERATION; ACTIVATION; MACROPHAGE	Regulatory gene circuits with positive-feedback loops control stem cell differentiation, but several mechanisms can contribute to positive feedback. Here, we dissect feedback mechanisms through which the transcription factor PU.1 controls lymphoid and myeloid differentiation. Quantitative live-cell imaging revealed that developing B cells decrease PU.1 levels by reducing PU.1 transcription, whereas developing macrophages increase PU.1 levels by lengthening their cell cycles, which causes stable PU.1 accumulation. Exogenous PU.1 expression in progenitors increases endogenous PU.1 levels by inducing cell cycle lengthening, implying positive feedback between a regulatory factor and the cell cycle. Mathematical modeling showed that this cell cycle-coupled feedback architecture effectively stabilizes a slow-dividing differentiated state. These results show that cell cycle duration functions as an integral part of a positive autoregulatory circuit to control cell fate.	[Kueh, Hao Yuan; Champhekhar, Ameya; Elowitz, Michael B.; Rothenberg, Ellen V.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Nutt, Stephen L.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA	California Institute of Technology; Royal Melbourne Hospital; Walter & Eliza Hall Institute; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Kueh, HY (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	kueh@caltech.edu; evroth@its.caltech.edu	Nutt, Stephen L/C-9256-2013	Nutt, Stephen L/0000-0002-0020-6637; Rothenberg, Ellen/0000-0002-3901-347X	Cancer Research Institute/Irvington Postdoctoral Fellowship; Australian Research Council Future Fellowship; Victorian State Government Operational Infrastructure Support; National Health and Medical Research Council of Australia Independent Research Institute Infrastructure Scheme; NIH [RC2 CA148278, R33 HL089123, R01 AI083514, R01 CA90233]; Albert Billings Ruddock Professorship; Al Sherman Foundation; Louis A. Garfinkle Memorial Laboratory Fund; NATIONAL CANCER INSTITUTE [RC2CA148278, R01CA090233] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL089123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083514] Funding Source: NIH RePORTER	Cancer Research Institute/Irvington Postdoctoral Fellowship; Australian Research Council Future Fellowship(Australian Research Council); Victorian State Government Operational Infrastructure Support; National Health and Medical Research Council of Australia Independent Research Institute Infrastructure Scheme(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Billings Ruddock Professorship; Al Sherman Foundation; Louis A. Garfinkle Memorial Laboratory Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Butler and S. Washburn for mouse care and J. Verceles, J. Grimm, and D. Perez of the Caltech Flow Cytometry Facility for cell sorting. We also thank members of the Rothenberg and Elowitz labs and L. Goentoro for insightful discussions. The data presented in this manuscript are tabulated in the main paper and the supplementary materials. This work was supported by a Cancer Research Institute/Irvington Postdoctoral Fellowship to H.Y.K.; an Australian Research Council Future Fellowship and the Victorian State Government Operational Infrastructure Support, National Health and Medical Research Council of Australia Independent Research Institute Infrastructure Scheme to S.L.N.; NIH grants to E. V. R. (RC2 CA148278, R33 HL089123, R01 AI083514, and R01 CA90233); the Albert Billings Ruddock Professorship; the Al Sherman Foundation; and the Louis A. Garfinkle Memorial Laboratory Fund.	Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Back J, 2005, EXP HEMATOL, V33, P395, DOI 10.1016/j.exphem.2004.12.010; Bellon T, 1997, BLOOD, V90, P1828, DOI 10.1182/blood.V90.5.1828; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Choe KS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.077727; Cook WD, 2004, BLOOD, V104, P3437, DOI 10.1182/blood-2004-06-2234; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Delgado MD, 1998, BIOCHEM BIOPH RES CO, V252, P383, DOI 10.1006/bbrc.1998.9587; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Franco CB, 2006, P NATL ACAD SCI USA, V103, P11993, DOI 10.1073/pnas.0601188103; Kihara-Negishi F, 1998, INT J CANCER, V76, P523, DOI 10.1002/(SICI)1097-0215(19980518)76:4<523::AID-IJC14>3.0.CO;2-8; Leddin M, 2011, BLOOD, V117, P2827, DOI 10.1182/blood-2010-08-302976; Metcalf D, 2006, P NATL ACAD SCI USA, V103, P1486, DOI 10.1073/pnas.0510616103; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Singh H, 1999, COLD SPRING HARB SYM, V64, P13, DOI 10.1101/sqb.1999.64.13; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Staber PB, 2013, MOL CELL, V49, P934, DOI 10.1016/j.molcel.2013.01.007; Steinman RA, 2002, ONCOGENE, V21, P3403, DOI 10.1038/sj.onc.1205325; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Trivedi AK, 2007, ONCOGENE, V26, P1789, DOI 10.1038/sj.onc.1209964; Walter MJ, 2005, P NATL ACAD SCI USA, V102, P12513, DOI 10.1073/pnas.0504247102; Zarnegar MA, 2010, MOL CELL BIOL, V30, P4922, DOI 10.1128/MCB.00354-10	33	180	181	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					670	673		10.1126/science.1240831	http://dx.doi.org/10.1126/science.1240831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23868921	Green Accepted			2022-12-01	WOS:000322884800043
J	Ward, BB				Ward, Bess B.			How Nitrogen Is Lost	SCIENCE			English	Editorial Material							OXYGEN-MINIMUM-ZONE; ANAEROBIC AMMONIUM OXIDATION; EASTERN SOUTH-PACIFIC; ARABIAN SEA; DENITRIFICATION; CYCLE; ANAMMOX; WATERS; CARBON		Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Princeton University	Ward, BB (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	bbw@princeton.edu						Babbin A. R., 2013, AM SOC LIMN OC AQ SC; Babbin AR, 2013, ENVIRON SCI TECHNOL, V47, P4189, DOI 10.1021/es304842r; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Dalsgaard T, 2012, LIMNOL OCEANOGR, V57, P1331, DOI 10.4319/lo.2012.57.5.1331; Hamersley MR, 2007, LIMNOL OCEANOGR, V52, P923, DOI 10.4319/lo.2007.52.3.0923; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/ngeo1739, 10.1038/NGEO1739]; Koeve W, 2010, BIOGEOSCIENCES, V7, P2327, DOI 10.5194/bg-7-2327-2010; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Nicholls JC, 2007, LIMNOL OCEANOGR, V52, P156, DOI 10.4319/lo.2007.52.1.0156; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; Thamdrup B, 2012, DEEP-SEA RES PT I, V65, P36, DOI 10.1016/j.dsr.2012.03.001; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Ward BB, 2008, DEEP-SEA RES PT I, V55, P1672, DOI 10.1016/j.dsr.2008.07.005	15	78	84	5	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					352	353		10.1126/science.1240314	http://dx.doi.org/10.1126/science.1240314			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888027				2022-12-01	WOS:000322259200033
J	Schwabe, T; Neuert, H; Clandinin, TR				Schwabe, Tina; Neuert, Helen; Clandinin, Thomas R.			A Network of Cadherin-Mediated Interactions Polarizes Growth Cones to Determine Targeting Specificity	CELL			English	Article							DROSOPHILA VISUAL-SYSTEM; STRUCTURED-ILLUMINATION MICROSCOPY; PLANAR CELL POLARITY; N-CADHERIN; CYTOSKELETAL DYNAMICS; FOCAL ADHESION; NERVE GROWTH; LIPRIN-ALPHA; AXON-AXON; FLAMINGO	Neuronal growth cones select synaptic partners through interactions with multiple cell surfaces in their environment. Many of these interactions are adhesive, yet it is unclear how growth cones integrate adhesive cues to direct their movements. Here, we examine the mechanisms that enable photoreceptors in the Drosophila visual system to choose synaptic partners. We demonstrate that the classical cadherin, N-cadherin, and an atypical cadherin, Flamingo, act redundantly to instruct the targeting choices made by every photoreceptor axon. These molecules gradually bias the spatial distribution of growth cone filopodia, polarizing each growth cone toward its future synaptic target before direct contact with the target occurs. We demonstrate that these molecules are localized to distinct subcellular domains and create a network of adhesive interactions distributed across many growth cones. Because this network comprises multiple redundant interactions, a complex wiring diagram can be constructed with extraordinary fidelity, suggesting a general principle.	[Schwabe, Tina; Clandinin, Thomas R.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Neuert, Helen] Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	Stanford University; University of Munster	Clandinin, TR (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	trc@stanford.edu	Schwabe, Tina/AAA-3822-2021		postdoctoral fellowship from Walter V. and Idun Berry; Heinrich Hertz-Stiftung; National Eye Institute [R01 EY015231]; NATIONAL EYE INSTITUTE [R01EY015231] Funding Source: NIH RePORTER	postdoctoral fellowship from Walter V. and Idun Berry; Heinrich Hertz-Stiftung; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank P. Garrity, L. Luo, G. Rubin, I. Salecker, G. Struhl, L. Zipursky, the Bloomington and San Diego Stock Centers, as well as the Developmental Studies Hybridoma Bank, BacPac Resources, and the Vienna Drosophila RNAi Center for fly strains, antibodies, and plasmids. We are grateful to D. Clark for help with quantification and statistics, M. Silies for help with fly husbandry, and K. Shen, A. Huberman, and members of the Clandinin lab for helpful comments on the manuscript. This work was supported by a postdoctoral fellowship from Walter V. and Idun Berry (to T.S.), a travel fellowship of the Heinrich Hertz-Stiftung (to H.N.), and funding from the National Eye Institute, R01 EY015231 (to T.R.C.).	Bard L, 2008, J NEUROSCI, V28, P5879, DOI 10.1523/JNEUROSCI.5331-07.2008; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Chen PL, 2008, NEURON, V58, P26, DOI 10.1016/j.neuron.2008.01.007; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Choe KM, 2006, P NATL ACAD SCI USA, V103, P11601, DOI 10.1073/pnas.0601185103; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; Giannone G, 2009, TRENDS CELL BIOL, V19, P475, DOI 10.1016/j.tcb.2009.07.001; GODEMENT P, 1994, J NEUROSCI, V14, P7024; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Hadjieconomou D, 2011, CURR OPIN NEUROBIOL, V21, P76, DOI 10.1016/j.conb.2010.07.012; Hakeda-Suzuki S, 2011, NAT NEUROSCI, V14, P314, DOI 10.1038/nn.2756; Hiesinger PR, 2006, CURR BIOL, V16, P1835, DOI 10.1016/j.cub.2006.07.047; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; HORRIDGE GA, 1970, PROC R SOC SER B-BIO, V175, P69, DOI 10.1098/rspb.1970.0012; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Mason CA, 1997, J NEUROSCI, V17, P1086; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Meinertzhagen Ian A., 1993, P1363; Millard SS, 2007, NATURE, V447, P720, DOI 10.1038/nature05855; Millard SS, 2010, NEURON, V67, P761, DOI 10.1016/j.neuron.2010.08.030; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Myers JP, 2011, J NEUROSCI, V31, P13585, DOI 10.1523/JNEUROSCI.2381-11.2011; Nern A, 2008, NEURON, V58, P34, DOI 10.1016/j.neuron.2008.03.022; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Prakash S, 2009, DEV BIOL, V336, P10, DOI 10.1016/j.ydbio.2009.09.016; RAPER JA, 1983, COLD SPRING HARB SYM, V48, P587, DOI 10.1101/SQB.1983.048.01.063; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Thoumine O, 2006, MOL BIOL CELL, V17, P862, DOI 10.1091/mbc.E05-04-0335; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Vitriol EA, 2012, NEURON, V73, P1068, DOI 10.1016/j.neuron.2012.03.005; Woo S, 2009, J NEUROSCI, V29, P13981, DOI 10.1523/JNEUROSCI.4028-09.2009; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	45	47	47	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 18	2013	154	2					351	364		10.1016/j.cell.2013.06.011	http://dx.doi.org/10.1016/j.cell.2013.06.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870124	Green Accepted, Bronze			2022-12-01	WOS:000321950700012
J	Wang, XM; Abraham, S; McKenzie, JAG; Jeffs, N; Swire, M; Tripathi, VB; Luhmann, UFO; Lange, CAK; Zhai, ZH; Arthur, HM; Bainbridge, JWB; Moss, SE; Greenwood, J				Wang, Xiaomeng; Abraham, Sabu; McKenzie, Jenny A. G.; Jeffs, Natasha; Swire, Matthew; Tripathi, Vineeta B.; Luhmann, Ulrich F. O.; Lange, Clemens A. K.; Zhai, Zhenhua; Arthur, Helen M.; Bainbridge, James W. B.; Moss, Stephen E.; Greenwood, John			LRG1 promotes angiogenesis by modulating endothelial TGF-beta signalling	NATURE			English	Article							OXYGEN-INDUCED RETINOPATHY; RETINAL VEIN OCCLUSION; GROWTH-FACTOR-BETA; CHOROIDAL NEOVASCULARIZATION; PATHOLOGICAL ANGIOGENESIS; VASCULAR DEVELOPMENT; BASEMENT-MEMBRANE; GENE-EXPRESSION; MOUSE; ENDOGLIN	Aberrant neovascularization contributes to diseases such as cancer, blindness and atherosclerosis, and is the consequence of inappropriate angiogenic signalling. Although many regulators of pathogenic angiogenesis have been identified, our understanding of this process is incomplete. Here we explore the transcriptome of retinal microvessels isolated from mouse models of retinal disease that exhibit vascular pathology, and uncover an upregulated gene, leucine-rich alpha-2-glycoprotein 1 (Lrg1), of previously unknown function. We show that in the presence of transforming growth factor-beta 1 (TGF-beta 1), LRG1 is mitogenic to endothelial cells and promotes angiogenesis. Mice lacking Lrg1 develop a mild retinal vascular phenotype but exhibit a significant reduction in pathological ocular angiogenesis. LRG1 binds directly to the TGF-beta accessory receptor endoglin, which, in the presence of TGF-beta 1, results in promotion of the pro-angiogenic Smad1/5/8 signalling pathway. LRG1 antibody blockade inhibits this switch and attenuates angiogenesis. These studies reveal a new regulator of angiogenesis that mediates its effect by modulating TGF-beta signalling.	[Wang, Xiaomeng; Abraham, Sabu; McKenzie, Jenny A. G.; Jeffs, Natasha; Swire, Matthew; Tripathi, Vineeta B.; Moss, Stephen E.; Greenwood, John] UCL Inst Ophthalmol, Dept Cell Biol, London EC1V 9EL, England; [Luhmann, Ulrich F. O.; Lange, Clemens A. K.; Bainbridge, James W. B.] UCL Inst Ophthalmol, Dept Genet, London EC1V 9EL, England; [Lange, Clemens A. K.; Bainbridge, James W. B.] Moorfields Eye Hosp, NIHR Biomed Res Ctr Ophthalmol, London EC1V 2PD, England; [Lange, Clemens A. K.] Univ Eye Hosp Freiburg, D-79106 Freiburg, Germany; [Zhai, Zhenhua; Arthur, Helen M.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Freiburg; Newcastle University - UK	Greenwood, J (corresponding author), UCL Inst Ophthalmol, Dept Cell Biol, London EC1V 9EL, England.	s.moss@ucl.ac.uk; j.greenwood@ucl.ac.uk	Abraham, Sabu/E-1144-2019; Zhai, Zhen/GYA-1598-2022; Wang, Xiaomeng/F-9504-2015; Arthur, Helen/C-7808-2009	Abraham, Sabu/0000-0002-0916-5827; Luhmann, Ulrich F.O./0000-0002-1993-1951; Bainbridge, James/0000-0003-1318-8201; Greenwood, John/0000-0003-4496-2984; Swire, Matthew/0000-0003-4294-4926; Arthur, Helen/0000-0001-6522-1363	Lowy Medical Research Foundation; Medical Research Council; Wellcome Trust; UCL Business (Proof of Concept Grant); Rosetrees Trust; NIHR Research Professorship; British Heart Foundation Senior Fellowship; MRC [G1000466, G0902206] Funding Source: UKRI; British Heart Foundation [RG/12/2/29416] Funding Source: researchfish; Medical Research Council [G0902206, G1000466] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-003] Funding Source: researchfish	Lowy Medical Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); UCL Business (Proof of Concept Grant); Rosetrees Trust(Rosetrees Trust); NIHR Research Professorship; British Heart Foundation Senior Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was supported by grants from the Lowy Medical Research Foundation, the Medical Research Council, The Wellcome Trust, UCL Business (Proof of Concept Grant) and the Rosetrees Trust. J.W.B.B. is supported by a NIHR Research Professorship. H. M. A. is supported by a British Heart Foundation Senior Fellowship. We would also like to thank M. Gillies for his role in initiating the original project, P. Luthert and C. Thaung for human tissue samples and advice on human pathology specimens, S. Perkins and R. Nan for assistance with the surface plasmon resonance analysis, and P. ten Dijke for discussions and advice.	ABBOTT NJ, 1992, J CELL SCI, V103, P23; Anderberg C, 2013, J EXP MED, V210, P563, DOI 10.1084/jem.20120662; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Balaggan KS, 2006, GENE THER, V13, P1153, DOI 10.1038/sj.gt.3302769; BLANKS JC, 1986, J COMP NEUROL, V254, P543, DOI 10.1002/cne.902540407; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Cunha SI, 2011, BLOOD, V117, P6999, DOI 10.1182/blood-2011-01-330142; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; Deckers M, 2001, LAB INVEST, V81, P5, DOI 10.1038/labinvest.3780207; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Gregory AD, 2010, J LEUKOCYTE BIOL, V88, P123, DOI 10.1189/jlb.0709499; Hackett SF, 2002, J CELL PHYSIOL, V192, P182, DOI 10.1002/jcp.10128; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Kumar B, 1998, OPHTHALMOLOGY, V105, P424, DOI 10.1016/S0161-6420(98)93022-6; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Li XF, 2007, NEUROSCI LETT, V413, P141, DOI 10.1016/j.neulet.2006.11.039; Lynch J, 2012, CARCINOGENESIS, V33, P976, DOI 10.1093/carcin/bgs114; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; McKenzie JAG, 2012, AM J PATHOL, V180, P399, DOI 10.1016/j.ajpath.2011.09.035; NICOSIA RF, 1990, LAB INVEST, V63, P115; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Ray BN, 2010, CARCINOGENESIS, V31, P435, DOI 10.1093/carcin/bgp327; Romero IA, 2003, NEUROSCI LETT, V344, P112, DOI 10.1016/S0304-3940(03)00348-3; Saito K, 2002, J IMMUNOL, V168, P1050, DOI 10.4049/jimmunol.168.3.1050; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Spirin KS, 1999, CURR EYE RES, V18, P490, DOI 10.1076/ceyr.18.6.490.5267; SUN DT, 1995, CANCER LETT, V89, P73, DOI 10.1016/0304-3835(95)90160-4; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Toma HS, 2010, MICROVASC RES, V80, P295, DOI 10.1016/j.mvr.2010.05.011; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; ZHAO JL, 1993, OPHTHALMOLOGY, V100, P423	46	285	308	6	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					306	+		10.1038/nature12345	http://dx.doi.org/10.1038/nature12345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23868260	Green Accepted			2022-12-01	WOS:000321910700029
J	Baxter, R; Bartlett, J; Rowhani-Rahbar, A; Fireman, B; Klein, NP				Baxter, Roger; Bartlett, Joan; Rowhani-Rahbar, Ali; Fireman, Bruce; Klein, Nicola P.			Effectiveness of pertussis vaccines for adolescents and adults: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BORDETELLA-PERTUSSIS; IMMUNIZATION; EPIDEMIOLOGY; DIPHTHERIA; IMMUNITY; TETANUS; RECORDS	Objective To assess the effectiveness of reduced acellular pertussis (Tdap) vaccines in adolescents and adults. Setting Kaiser Permanente Northern California. Design Case-control study. Participants All polymerase chain reaction (PCR) confirmed cases of pertussis in members aged 11 years and older from January 2006 to December 2011. We compared the Tdap vaccination status of PCR positive cases with two control groups: people testing negative for pertussis by PCR and closely matched people from the general Kaiser Permanente Northern California population. Main outcome measure PCR confirmed pertussis. The association of Tdap vaccination with the odds of pertussis infection was estimated by conditional logistic regression, with adjustment for calendar time, pertussis vaccine type received in early childhood, age, sex, race or ethnic group, and medical clinic. We calculated Tdap vaccine effectiveness as 1 minus the adjusted odds ratio. Results The study population included 668 PCR positive cases, 10 098 PCR negative controls, and 21 599 Kaiser Permanente Northern California matched controls. Tdap vaccination rates were 24.0% in PCR positive cases and 31.9% in PCR negative controls (P < 0.001). The adjusted estimate of effectiveness of Tdap vaccination against pertussis was 53.0% (95% confidence interval 41.9% to 62.0%) in the comparison with PCR controls, and 64.0% (55.5% to 70.9%) in the comparison with Kaiser Permanente Northern California controls. Conclusion Tdap vaccination was moderately effective at preventing PCR confirmed pertussis among adolescents and adults.	[Baxter, Roger; Bartlett, Joan; Rowhani-Rahbar, Ali; Fireman, Bruce; Klein, Nicola P.] Kaiser Permanente Vaccine Study Ctr, Oakland, CA 94612 USA	Kaiser Permanente	Baxter, R (corresponding author), Kaiser Permanente Vaccine Study Ctr, 1 Kaiser Plaza, Oakland, CA 94612 USA.	roger.baxter@kp.org		Rowhani-Rahbar, Ali/0000-0002-2705-4485	Kaiser Permanente	Kaiser Permanente	This study was funded by Kaiser Permanente. There was no support from any other organizations for this work.	Administration. FFaD, 2005, PROP NAM TET TOX RED; Administration. FFaD, 2005, TET TOX RED DIPHTH T; Anonymous, 2012, Morbidity and Mortality Weekly Report, V61, P468; [Anonymous], 2010, HUM VACCINES, V6, P684; [Anonymous], 2013, VACCINES-BASEL; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Centers for Disease Control and Prevention (CDC) HIPAA Privacy Rule and Public Health, 2003, MMWR-MORBID MORTAL W, V52, P1; Cherry JD, 2006, PEDIATR INFECT DIS J, V25, P361, DOI 10.1097/01.inf.0000210478.60841.69; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; Elliott MN, 2008, HEALTH SERV RES, V43, P1722, DOI 10.1111/j.1475-6773.2008.00854.x; Gordon NP, 2015, SIMILARITY ADULT KAI; Klein NP, 2013, PEDIATRICS, V131, pE1716, DOI 10.1542/peds.2012-3836; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; Kretsinger Katrina, 2006, Morbidity and Mortality Weekly Report, V55, P1; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Lavine J, 2010, VACCINE, V29, P11, DOI 10.1016/j.vaccine.2010.10.029; Misegades LK, 2012, JAMA-J AM MED ASSOC, V308, P2126, DOI 10.1001/jama.2012.14939; Nennig ME, 1996, JAMA-J AM MED ASSOC, V275, P1672, DOI 10.1001/jama.275.21.1672; Olin P, 2001, CLIN INFECT DIS, V33, pS288, DOI 10.1086/322564; Olin P, 1997, LANCET, V350, P1569, DOI 10.1016/S0140-6736(97)06508-2; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Rank C, 2009, PEDIATR INFECT DIS J, V28, P152, DOI 10.1097/INF.0b013e318185608e; Roehr B, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4627; Selby JVSD, 2005, KAISER PERMANENTE ME; Sheridan SL, 2012, CLIN INFECT DIS, V55, P1434, DOI 10.1093/cid/cis672; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; Wei SC, 2010, CLIN INFECT DIS, V51, P315, DOI 10.1086/653938; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287	32	61	62	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 17	2013	347								f4249	10.1136/bmj.f4249	http://dx.doi.org/10.1136/bmj.f4249			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	189DG	23873919	hybrid			2022-12-01	WOS:000322246700007
J	Ejima, H; Richardson, JJ; Liang, K; Best, JP; van Koeverden, MP; Such, GK; Cui, JW; Caruso, F				Ejima, Hirotaka; Richardson, Joseph J.; Liang, Kang; Best, James P.; van Koeverden, Martin P.; Such, Georgina K.; Cui, Jiwei; Caruso, Frank			One-Step Assembly of Coordination Complexes for Versatile Film and Particle Engineering	SCIENCE			English	Article							METAL-ORGANIC FRAMEWORK; TANNIC-ACID; MICROCAPSULES; MULTILAYERS; COATINGS; NETWORKS; GOLD	The development of facile and versatile strategies for thin-film and particle engineering is of immense scientific interest. However, few methods can conformally coat substrates of different composition, size, shape, and structure. We report the one-step coating of various interfaces using coordination complexes of natural polyphenols and Fe(III) ions. Film formation is initiated by the adsorption of the polyphenol and directed by pH-dependent, multivalent coordination bonding. Aqueous deposition is performed on a range of planar as well as inorganic, organic, and biological particle templates, demonstrating an extremely rapid technique for producing structurally diverse, thin films and capsules that can disassemble. The ease, low cost, and scalability of the assembly process, combined with pH responsiveness and negligible cytotoxicity, makes these films potential candidates for biomedical and environmental applications.	[Ejima, Hirotaka; Richardson, Joseph J.; Liang, Kang; Best, James P.; van Koeverden, Martin P.; Such, Georgina K.; Cui, Jiwei; Caruso, Frank] Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3010, Australia	University of Melbourne	Caruso, F (corresponding author), Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3010, Australia.	fcaruso@unimelb.edu.au	Such, Georgina K/B-1157-2011; Caruso, Frank/A-9587-2011; Cui, Jiwei/E-9876-2012; Liang, Kang/D-5684-2013; Liang, Kang/AAC-4533-2019; Ejima, Hirotaka/E-8730-2012	Such, Georgina K/0000-0002-2868-5799; Caruso, Frank/0000-0002-0197-497X; Cui, Jiwei/0000-0003-1018-4336; Liang, Kang/0000-0003-3985-7688; Ejima, Hirotaka/0000-0002-4965-9493; Best, James/0000-0003-4728-2052; van Koeverden, Martin/0000-0002-7339-5168	Australian Research Council [FF0776078, FL120100030, DP0877360, FT120100564, FS110200025]; Japan Society for the Promotion of Science (JSPS)	Australian Research Council(Australian Research Council); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Supported by the Australian Research Council under Federation Fellowship FF0776078 (F. C.), Australian Laureate Fellowship FL120100030 (F. C.), Discovery Project DP0877360 (F. C.), Future Fellowship FT120100564 (G. K. S.), and Super Science Fellowship FS110200025 (J.C. and F. C.) schemes. H. E. thanks the Japan Society for the Promotion of Science (JSPS) for a postdoctoral fellowship for research abroad. The data presented in this paper are given in the main text and in the supplementary materials. We thank X. Duan (Surface and Chemical Analysis Network, the University of Melbourne) for assistance with XPS analysis. The University of Melbourne has filed a provisional patent on the assembly process.	Betard A, 2012, CHEM REV, V112, P1055, DOI 10.1021/cr200167v; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Hanke M, 2012, LANGMUIR, V28, P6877, DOI 10.1021/la300457z; Hatzor A, 1998, J AM CHEM SOC, V120, P13469, DOI 10.1021/ja9828307; Holten-Andersen N, 2011, P NATL ACAD SCI USA, V108, P2651, DOI 10.1073/pnas.1015862108; Kaminker R, 2010, J AM CHEM SOC, V132, P14554, DOI 10.1021/ja105518n; Kozlovskaya V, 2010, SOFT MATTER, V6, P3596, DOI 10.1039/b927369g; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Makiura R, 2010, NAT MATER, V9, P565, DOI [10.1038/nmat2769, 10.1038/NMAT2769]; Mori T, 2012, J BIOL CHEM, V287, P6912, DOI 10.1074/jbc.M111.294025; Motiei L, 2011, LANGMUIR, V27, P1319, DOI 10.1021/la103936t; ROSS TK, 1978, CORROS SCI, V18, P351, DOI 10.1016/S0010-938X(78)80049-3; Rouchon V, 2011, ANAL CHEM, V83, P2589, DOI 10.1021/ac1029242; Ryu DY, 2005, SCIENCE, V308, P236, DOI 10.1126/science.1106604; Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020; Shutava T, 2005, MACROMOLECULES, V38, P2850, DOI 10.1021/ma047629x; Sungur S, 2008, SPECTROCHIM ACTA A, V69, P225, DOI 10.1016/j.saa.2007.03.038; TANIZAWA Y, 1990, J CHEM SOC FARADAY T, V86, P1071, DOI 10.1039/ft9908601071; Tong WJ, 2012, CHEM SOC REV, V41, P6103, DOI 10.1039/c2cs35088b; Vinogradova OI, 2006, ANNU REV MATER RES, V36, P143, DOI 10.1146/annurev.matsci.36.011205.123733; Wanunu M, 2005, J AM CHEM SOC, V127, P17877, DOI 10.1021/ja0556676; Xu H, 2012, ACS MACRO LETT, V1, P457, DOI 10.1021/mz200217d; Yan Y, 2010, COORDIN CHEM REV, V254, P1072, DOI 10.1016/j.ccr.2009.12.024; Ye Q, 2011, CHEM SOC REV, V40, P4244, DOI 10.1039/c1cs15026j	25	1269	1310	170	2312	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					154	157		10.1126/science.1237265	http://dx.doi.org/10.1126/science.1237265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23846899	Green Submitted			2022-12-01	WOS:000321965300037
J	Itkin, M; Heinig, U; Tzfadia, O; Bhide, AJ; Shinde, B; Cardenas, PD; Bocobza, SE; Unger, T; Malitsky, S; Finkers, R; Tikunov, Y; Bovy, A; Chikate, Y; Singh, P; Rogachev, I; Beekwilder, J; Giri, AP; Aharoni, A				Itkin, M.; Heinig, U.; Tzfadia, O.; Bhide, A. J.; Shinde, B.; Cardenas, P. D.; Bocobza, S. E.; Unger, T.; Malitsky, S.; Finkers, R.; Tikunov, Y.; Bovy, A.; Chikate, Y.; Singh, P.; Rogachev, I.; Beekwilder, J.; Giri, A. P.; Aharoni, A.			Biosynthesis of Antinutritional Alkaloids in Solanaceous Crops Is Mediated by Clustered Genes	SCIENCE			English	Article							GLYCOALKALOIDS; POTATO; PLANT; METABOLITES; PATHWAYS; SAPONINS; TOMATO	Steroidal glycoalkaloids (SGAs) such as alpha-solanine found in solanaceous food plants-as, for example, potato-are antinutritional factors for humans. Comparative coexpression analysis between tomato and potato coupled with chemical profiling revealed an array of 10 genes that partake in SGA biosynthesis. We discovered that six of them exist as a cluster on chromosome 7, whereas an additional two are adjacent in a duplicated genomic region on chromosome 12. Following systematic functional analysis, we suggest a revised SGA biosynthetic pathway starting from cholesterol up to the tetrasaccharide moiety linked to the tomato SGA aglycone. Silencing GLYCOALKALOID METABOLISM 4 prevented accumulation of SGAs in potato tubers and tomato fruit. This may provide a means for removal of unsafe, antinutritional substances present in these widely used food crops.	[Itkin, M.; Heinig, U.; Tzfadia, O.; Bhide, A. J.; Shinde, B.; Cardenas, P. D.; Bocobza, S. E.; Malitsky, S.; Chikate, Y.; Singh, P.; Rogachev, I.; Giri, A. P.; Aharoni, A.] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Bhide, A. J.; Shinde, B.; Chikate, Y.; Singh, P.; Giri, A. P.] CSIR, Natl Chem Lab, Div Biochem Sci, Plant Mol Biol Unit, Pune 411008, Maharashtra, India; Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, IL-76100 Rehovot, Israel; [Unger, T.] Weizmann Inst Sci, Israel Struct Prote Ctr, IL-76100 Rehovot, Israel; [Finkers, R.; Tikunov, Y.; Bovy, A.; Beekwilder, J.] Univ Wageningen & Res Ctr, NL-6700 AA Wageningen, Netherlands	Weizmann Institute of Science; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Hebrew University of Jerusalem; Weizmann Institute of Science; Wageningen University & Research	Aharoni, A (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	asaph.aharoni@weizmann.ac.il	aharoni, asaph/W-6670-2019; Beekwilder, Jules/A-6802-2011; Tikunov, Yury/M-4748-2017; Finkers, Richard/G-1706-2010; Itkin, Maxim/ABB-9183-2020; Malitsky, Sergey/ABC-2545-2020; Itkin, Maxim/AFU-5181-2022	Beekwilder, Jules/0000-0003-3238-4427; Tikunov, Yury/0000-0001-5417-5066; Finkers, Richard/0000-0002-4368-8058; Malitsky, Sergey/0000-0003-4619-7219; Itkin, Maxim/0000-0003-1348-2814; Cardenas, Pablo D./0000-0002-4141-2410; Bovy, Arnaud/0000-0003-2643-7377; Shinde, Balkrishna A/0000-0002-7806-5424; Tzfadia, Oren/0000-0002-7096-8063	European Research Council (SAMIT-FP7 program); European Union [FP7-KBBE-2009-3-245121-ATHENA]; Volkswagen Foundation, Hannover, Germany [AZ: I/82 754]; Council of Scientific and Industrial Research (India); University Grants Commission (India)	European Research Council (SAMIT-FP7 program); European Union(European Commission); Volkswagen Foundation, Hannover, Germany(Volkswagen); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (India)(University Grants Commission, India)	We thank A. Tishbee and R. Kramer for operating the UPLC-qTOF-MS instrument and the European Research Council (SAMIT-FP7 program) for supporting the work in the A. A. laboratory. A. A. is the incumbent of the Peter J. Cohn Professorial Chair. J. B. was supported by the European Union 7th Frame Anthocyanin and Polyphenol Bioactives for Health Enhancement through Nutritional Advancement (ATHENA) Project (FP7-KBBE-2009-3-245121-ATHENA). U. H. was partially supported by fellowship AZ: I/82 754, Volkswagen Foundation, Hannover, Germany. We thank the Council of Scientific and Industrial Research (India) for support to A. P. G. (Raman Research Fellowship), A. J. B., Y.C., and P. S. (Research Fellowship) and the University Grants Commission (India) for supporting B. S. We also thank D. R. Nelson for assistance with CYP450 gene classification and R. Last for critically reading the manuscript. A. A. and M. I. are inventors on publication number WO2012095843 A1, submitted by Yeda Research and Development Co. Ltd, which covers the use of the GAME4 gene for generating low-alkaloid fruit and tubers.	[Anonymous], 2012, FDA Poisonous Plant Database, Patent No. [20120159676 A1, 20120519676]; Desfosses M., 1820, J PHARM, V6, P374; Dolan LC, 2010, TOXINS, V2, P2289, DOI 10.3390/toxins2092289; Dowd PF, 2011, J CHEM ECOL, V37, P443, DOI 10.1007/s10886-011-9950-3; Eich E., 2008, SOLANACEAE AND CONVO; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Friedman M, 2006, J AGR FOOD CHEM, V54, P8655, DOI 10.1021/jf061471t; Itkin M, 2011, PLANT CELL, V23, P4507, DOI 10.1105/tpc.111.088732; Kliebenstein DJ, 2012, CURR OPIN PLANT BIOL, V15, P415, DOI 10.1016/j.pbi.2012.05.005; McCue KF, 2005, PLANT SCI, V168, P267, DOI 10.1016/j.plantsci.2004.08.006; Narayanan NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021996; Osbourn A, 2010, PLANT PHYSIOL, V154, P531, DOI 10.1104/pp.110.161315; RODDICK JG, 1989, PHYTOCHEMISTRY, V28, P2631, DOI 10.1016/S0031-9422(00)98055-5; Sanford LL, 1998, AM J POTATO RES, V75, P167, DOI 10.1007/BF02853568; Sparg SG, 2004, J ETHNOPHARMACOL, V94, P219, DOI 10.1016/j.jep.2004.05.016; Winzer T, 2012, SCIENCE, V336, P1704, DOI 10.1126/science.1220757; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yamanaka T, 2009, J AGR FOOD CHEM, V57, P3786, DOI 10.1021/jf900017n	18	321	339	17	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					175	179		10.1126/science.1240230	http://dx.doi.org/10.1126/science.1240230			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23788733				2022-12-01	WOS:000321965300043
J	Molina, DM; Jafari, R; Ignatushchenko, M; Seki, T; Larsson, EA; Dan, C; Sreekumar, L; Cao, YH; Nordlund, P				Molina, Daniel Martinez; Jafari, Rozbeh; Ignatushchenko, Marina; Seki, Takahiro; Larsson, E. Andreas; Dan, Chen; Sreekumar, Lekshmy; Cao, Yihai; Nordlund, Par			Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay	SCIENCE			English	Article							KINASE INHIBITORS; PROTEIN STABILITY; PHASE-I; CANCER; RESISTANCE; PARP; PHARMACOKINETICS; SUPPRESSION; MECHANISMS; DISCOVERY	The efficacy of therapeutics is dependent on a drug binding to its cognate target. Optimization of target engagement by drugs in cells is often challenging, because drug binding cannot be monitored inside cells. We have developed a method for evaluating drug binding to target proteins in cells and tissue samples. This cellular thermal shift assay (CETSA) is based on the biophysical principle of ligand-induced thermal stabilization of target proteins. Using this assay, we validated drug binding for a set of important clinical targets and monitored processes of drug transport and activation, off-target effects and drug resistance in cancer cell lines, as well as drug distribution in tissues. CETSA is likely to become a valuable tool for the validation and optimization of drug target engagement.	[Molina, Daniel Martinez; Jafari, Rozbeh; Ignatushchenko, Marina; Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Seki, Takahiro; Cao, Yihai] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Larsson, E. Andreas; Dan, Chen; Sreekumar, Lekshmy; Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Cao, Yihai] Linkoping Univ, Dept Med & Hlth Sci, S-58183 Linkoping, Sweden	Karolinska Institutet; Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Linkoping University	Nordlund, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Scheeles Vag 2, SE-17177 Stockholm, Sweden.	par.nordlund@ki.se		Larsson, Andreas/0000-0002-8706-3789; Chen, Dan/0000-0002-2790-5606; Seki, Takahiro/0000-0001-8910-4612; Jafari, Rozbeh/0000-0002-3396-4709	KI (Distinguished Professor Award); Swedish Research Council (Vetenskapsradet); Swedish Cancer Society (Cancerfonden); Strategic Centre grant from Nanyang Technological University (Singapore); Karolinska Institute Foundation; Torsten Soderbergs Foundation; European Research Council [250021]	KI (Distinguished Professor Award); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Strategic Centre grant from Nanyang Technological University (Singapore)(Nanyang Technological University); Karolinska Institute Foundation(Karolinska Institutet); Torsten Soderbergs Foundation; European Research Council(European Research Council (ERC)European Commission)	We thank K. Johansson [Karolinska Institute (KI), Department of Medical Biochemistry and Biophysics (MBB)] for assistance with cell culturing, H. Schuler KI/MBB for PARP-1 constructs, and T. Lundback KI/Chemical Biology Consortium Sweden for valuable discussions. This work was supported by grants from the KI (Distinguished Professor Award), the Swedish Research Council (Vetenskapsradet), and the Swedish Cancer Society (Cancerfonden) to P.N. and Y.C., as well as a Strategic Centre grant from Nanyang Technological University (Singapore) to P. N. and grants from the Karolinska Institute Foundation, the Torsten Soderbergs Foundation, and the European Research Council advanced grant ANGIOFAT (project no. 250021) to Y.H. P. N. is the inventor on a pending patent application covering aspects of the CETSA method, to be assigned to Pelago Bioscience AB. P. N. and D. M. M. are cofounders of Pelago Bioscience AB, which will develop CETSA for commercial applications.	Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Barouch-Bentov R, 2011, EXPERT OPIN INV DRUG, V20, P153, DOI 10.1517/13543784.2011.546344; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Cicenas J, 2011, J CANCER RES CLIN, V137, P1409, DOI 10.1007/s00432-011-1039-4; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dean E, 2012, BRIT J CANCER, V106, P468, DOI 10.1038/bjc.2011.555; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gillet JP, 2010, METHODS MOL BIOL, V596, P47, DOI 10.1007/978-1-60761-416-6_4; Guha M, 2011, NAT BIOTECHNOL, V29, P373, DOI 10.1038/nbt0511-373; Hagner Nicole, 2010, Cancer Manag Res, V2, P293, DOI 10.2147/CMR.S10043; Huang M, 2003, J PHARMACOL EXP THER, V304, P753, DOI 10.1124/jpet.102.044214; Hussmann GP, 2012, J PHARMACOL EXP THER, V343, P434, DOI 10.1124/jpet.112.198069; Kaitin KI, 2010, CLIN PHARMACOL THER, V87, P356, DOI 10.1038/clpt.2009.293; Kurganov BI, 2002, BIOCHEMISTRY-MOSCOW+, V67, P409, DOI 10.1023/A:1015277805345; Lee JT, 2010, PIGM CELL MELANOMA R, V23, P820, DOI 10.1111/j.1755-148X.2010.00763.x; Liu XS, 2012, CLIN CANCER RES, V18, P510, DOI 10.1158/1078-0432.CCR-11-1973; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marsh S, 2005, INVEST NEW DRUG, V23, P533, DOI 10.1007/s10637-005-4021-7; Matthews PM, 2012, BRIT J CLIN PHARMACO, V73, P175, DOI 10.1111/j.1365-2125.2011.04085.x; Moore JD, 2000, CANCER CHEMOTH PHARM, V46, P173, DOI 10.1007/s002800000149; Orloff J, 2009, NAT REV DRUG DISCOV, V8, P949, DOI 10.1038/nrd3025; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Ruiz-Garcia A, 2008, J PHARM SCI-US, V97, P654, DOI 10.1002/jps.21009; Schmidt C, 2010, NAT BIOTECHNOL, V28, P185, DOI 10.1038/nbt0310-185; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Visentin M, 2012, HEMATOL ONCOL CLIN N, V26, P629, DOI 10.1016/j.hoc.2012.02.002; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; West GM, 2008, ANAL CHEM, V80, P4175, DOI 10.1021/ac702610a; Yap TA, 2010, NAT REV CANCER, V10, P514, DOI 10.1038/nrc2870; Yin SQ, 2012, CURR MED CHEM, V19, P1021, DOI 10.2174/092986712799320709	36	974	999	43	389	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					84	87		10.1126/science.1233606	http://dx.doi.org/10.1126/science.1233606			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828940				2022-12-01	WOS:000321291700054
J	Wakefield, ED; Bodey, TW; Bearhop, S; Blackburn, J; Colhoun, K; Davies, R; Dwyer, RG; Green, JA; Gremillet, D; Jackson, AL; Jessopp, MJ; Kane, A; Langston, RHW; Lescroel, A; Murray, S; Le Nuz, M; Patrick, SC; Peron, C; Soanes, LM; Wanless, S; Votier, SC; Hamer, KC				Wakefield, Ewan D.; Bodey, Thomas W.; Bearhop, Stuart; Blackburn, Jez; Colhoun, Kendrew; Davies, Rachel; Dwyer, Ross G.; Green, Jonathan A.; Gremillet, David; Jackson, Andrew L.; Jessopp, Mark J.; Kane, Adam; Langston, Rowena H. W.; Lescroel, Amelie; Murray, Stuart; Le Nuz, Melanie; Patrick, Samantha C.; Peron, Clara; Soanes, Louise M.; Wanless, Sarah; Votier, Stephen C.; Hamer, Keith C.			Space Partitioning Without Territoriality in Gannets	SCIENCE			English	Article							INTRA-SPECIFIC COMPETITION; FORAGING AREAS; PUBLIC INFORMATION; GPS TRACKING; SEABIRDS; BEHAVIOR; FOOD; COLONIES; NEIGHBORS; EVOLUTION	Colonial breeding is widespread among animals. Some, such as eusocial insects, may use agonistic behavior to partition available foraging habitat into mutually exclusive territories; others, such as breeding seabirds, do not. We found that northern gannets, satellite-tracked from 12 neighboring colonies, nonetheless forage in largely mutually exclusive areas and that these colony-specific home ranges are determined by density-dependent competition. This segregation may be enhanced by individual-level public information transfer, leading to cultural evolution and divergence among colonies.	[Wakefield, Ewan D.; Davies, Rachel; Hamer, Keith C.] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Bodey, Thomas W.; Bearhop, Stuart; Dwyer, Ross G.] Univ Exeter, Ctr Ecol & Conservat, Penryn TR10 9EZ, Cornwall, England; [Blackburn, Jez] British Trust Ornithol, The Nunnery IP24 2PU, Thetford, England; [Colhoun, Kendrew] Royal Soc Protect Birds, Belfast BT8 4QT, Antrim, North Ireland; [Green, Jonathan A.; Soanes, Louise M.] Univ Liverpool, Sch Environm Sci, Liverpool L69 3GP, Merseyside, England; [Gremillet, David; Lescroel, Amelie; Peron, Clara] CNRS, CEFE, F-34293 Montpellier 5, France; [Gremillet, David] Univ Cape Town, FitzPatrick Inst, Dept Sci & Technol, Natl Res Fdn Ctr Excellence, ZA-7701 Rondebosch, South Africa; [Jackson, Andrew L.; Kane, Adam] Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin 2, Ireland; [Jessopp, Mark J.] Natl Univ Ireland Univ Coll Cork, Coastal & Marine Res Ctr, Cork, Ireland; [Langston, Rowena H. W.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Lescroel, Amelie] Univ Rennes 1, Museum Natl Hist Nat, UMR 7204, F-35042 Rennes, France; [Murray, Stuart] Easter Craigie Dhu, Dunkeld PH8 0EY, Perth, England; [Le Nuz, Melanie] Ligue Protect Oiseaux, Reserve Nat Sept Iles, F-22560 Pleumeur Bodou, France; [Patrick, Samantha C.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Wanless, Sarah] Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland; [Votier, Stephen C.] Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9EZ, Cornwall, England	University of Leeds; University of Exeter; British Trust for Ornithology; Royal Society for Protection of Birds; University of Liverpool; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; National Research Foundation - South Africa; University of Cape Town; Trinity College Dublin; University College Cork; Royal Society for Protection of Birds; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite de Rennes 1; University of Plymouth; UK Centre for Ecology & Hydrology (UKCEH); University of Exeter	Wakefield, ED (corresponding author), Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England.	e.d.wakefield@leeds.ac.uk; t.w.bodey@exeter.ac.uk; s.bearhop@exeter.ac.uk; stephen.votier@plymouth.ac.uk; k.c.hamer@leeds.ac.uk	Gremillet, David/W-1946-2018; Green, Jonathan A/B-8799-2011; PERON, Clara/E-9840-2015; Jackson, Andrew L/D-3441-2009; Jessopp, Mark/AAI-4786-2020; Bearhop, Stuart/G-3105-2012; Votier, Stephen C/G-2348-2014; Kane, Adam/H-6449-2013	Gremillet, David/0000-0002-7711-9398; Green, Jonathan A/0000-0001-8692-0163; PERON, Clara/0000-0002-6529-4578; Jackson, Andrew L/0000-0001-7334-0434; Jessopp, Mark/0000-0002-2692-3730; Bearhop, Stuart/0000-0002-5864-0129; Votier, Stephen C/0000-0002-0976-0167; Kane, Adam/0000-0002-2830-5338; Colhoun, Kendrew/0000-0003-4451-695X; Bodey, Thomas/0000-0002-5334-9615; Dwyer, Ross/0000-0003-1136-5489	Natural Environment Research Council [NE/H007466/1]; UK Department of Energy and Climate Change; Centre for Ecology and Hydrology; Centre National de la Recherche Scientifique; Ligue pour la Protection des Oiseaux; Alderney Commission for Renewable Energy; Beaufort Marine Research Award; European Union; NERC [NE/H007199/1, NE/H007466/1, NE/H007423/1] Funding Source: UKRI; Natural Environment Research Council [NE/H007423/1, NE/H007199/1, CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Department of Energy and Climate Change; Centre for Ecology and Hydrology; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ligue pour la Protection des Oiseaux; Alderney Commission for Renewable Energy; Beaufort Marine Research Award; European Union(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by the Natural Environment Research Council (Standard Grant NE/H007466/1 to K. C. H., S. B., and S. C. V.), the UK Department of Energy and Climate Change, the Centre for Ecology and Hydrology, the Centre National de la Recherche Scientifique, the Ligue pour la Protection des Oiseaux, the Alderney Commission for Renewable Energy, the Beaufort Marine Research Award, and the European Union INTERREG projects CHARM III and FAME. We acknowledge use of www.seaturtle.org and their analysis tools. Data reported in this paper are tabulated in the supplementary materials and archived by BirdLife International (www.seabirdtracking.org).	Adams ES, 2001, ANNU REV ECOL SYST, V32, P277, DOI 10.1146/annurev.ecolsys.32.081501.114034; Ainley DG, 2004, ECOL MONOGR, V74, P159, DOI 10.1890/02-4073; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Baude M, 2011, P ROY SOC B-BIOL SCI, V278, P2806, DOI 10.1098/rspb.2010.2659; Baylis AMM, 2008, MAR ECOL PROG SER, V361, P279, DOI 10.3354/meps07258; Buckley NJ, 1997, AM NAT, V149, P1091, DOI 10.1086/286040; Burger AE, 1997, COLON WATERBIRD, V20, P55, DOI 10.2307/1521764; CAIRNS DK, 1989, AM NAT, V134, P141, DOI 10.1086/284970; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Dechmann DKN, 2009, P ROY SOC B-BIOL SCI, V276, P2721, DOI 10.1098/rspb.2009.0473; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; FURNESS RW, 1984, NATURE, V311, P655, DOI 10.1038/311655a0; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Hamer KC, 2007, MAR ECOL PROG SER, V338, P295, DOI 10.3354/meps338295; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; Nelson B., 2001, ATLANTIC GANNET, V2; RICHNER H, 1995, ADV STUD BEHAV, V24, P1, DOI 10.1016/S0065-3454(08)60391-5; Silverman ED, 2004, MAR ECOL PROG SER, V277, P25, DOI 10.3354/meps277025; Valone TJ, 2007, BEHAV ECOL SOCIOBIOL, V62, P1, DOI 10.1007/s00265-007-0439-6; Votier SC, 2011, MAR BIOL, V158, P355, DOI 10.1007/s00227-010-1563-9; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Wakefield ED, 2011, ECOL MONOGR, V81, P141, DOI 10.1890/09-0763.1; WANLESS S, 1993, COLON WATERBIRD, V16, P176, DOI 10.2307/1521435; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Weimerskirch H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009928; Wittenberger J.F., 1985, Avian Biology, V8, P1	27	212	220	9	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					68	70		10.1126/science.1236077	http://dx.doi.org/10.1126/science.1236077			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23744776	Green Accepted			2022-12-01	WOS:000321291700049
J	O'Malley, J; Skylaki, S; Iwabuchi, KA; Chantzoura, E; Ruetz, T; Johnsson, A; Tomlinson, SR; Linnarsson, S; Kaji, K				O'Malley, James; Skylaki, Stavroula; Iwabuchi, Kumiko A.; Chantzoura, Eleni; Ruetz, Tyson; Johnsson, Anna; Tomlinson, Simon R.; Linnarsson, Sten; Kaji, Keisuke			High-resolution analysis with novel cell-surface markers identifies routes to iPS cells	NATURE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; SOMATIC-CELLS; REPROGRAMMING FACTORS; PLURIPOTENCY; BIOINFORMATICS; TRANSPOSITION; BIOCONDUCTOR; INDUCTION; PIGGYBAC; MURINE	The generation of induced pluripotent stem (iPS) cells presents a challenge to normal developmental processes. The low efficiency and heterogeneity of most methods have hindered understanding of the precise molecular mechanisms promoting, and roadblocks preventing, efficient reprogramming. Although several intermediate populations have been described(1-7), it has proved difficult to characterize the rare, asynchronous transition from these intermediate stages to iPS cells. The rapid expansion of minor reprogrammed cells in the heterogeneous population can also obscure investigation of relevant transition processes. Understanding the biological mechanisms essential for successful iPS cell generation requires both accurate capture of cells undergoing the reprogramming process and identification of the associated global gene expression changes. Here we demonstrate that in mouse embryonic fibroblasts, reprogramming follows an orderly sequence of stage transitions, marked by changes in the cell-surface markers CD44 and ICAM1, and a Nanog-enhanced green fluorescent protein (Nanog-eGFP) reporter. RNA-sequencing analysis of these populations demonstrates two waves of pluripotency gene upregulation, and unexpectedly, transient upregulation of several epidermis-related genes, demonstrating that reprogramming is not simply the reversal of the normal developmental processes. This novel high-resolution analysis enables the construction of a detailed reprogramming route map, and the improved understanding of the reprogramming process will lead to new reprogramming strategies.	[O'Malley, James; Iwabuchi, Kumiko A.; Chantzoura, Eleni; Ruetz, Tyson; Tomlinson, Simon R.; Kaji, Keisuke] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh BioQuarter, Edinburgh EH16 4UU, Midlothian, Scotland; [Skylaki, Stavroula] Helmholtz Ctr Munich, Stem Cell Dynam Res Unit, D-85764 Neuherberg, Germany; [Johnsson, Anna; Linnarsson, Sten] Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, SE-17177 Stockholm, Sweden	University of Edinburgh; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Karolinska Institutet	Kaji, K (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh BioQuarter, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	keisuke.kaji@ed.ac.uk	Linnarsson, Sten/HCH-3909-2022	Kaji, Keisuke/0000-0001-5946-8415; Ruetz, Tyson/0000-0002-3568-7717	ERC grant ROADTOIPS [261075]; ERC grant BRAINCELL [261063]; Anne Rowling Regenerative Neurology Clinic; MRC PhD Studentship; Darwin Trust of Edinburgh Scholarship; Medical Research Council [G0700711B] Funding Source: researchfish	ERC grant ROADTOIPS; ERC grant BRAINCELL; Anne Rowling Regenerative Neurology Clinic; MRC PhD Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Darwin Trust of Edinburgh Scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Nagy and K. Woltjen for providing the 6c iPS cell line, I. Chambers for providing TNG mice, S. Monard and O. Rodrigues for assistance with flow cytometry, and T. Kunath, T. Burdon, S. Lowell and N. Festuccia for discussions and comments on the manuscript. We also thank L. Robertson for technical assistance, and Biomed unit staff for mouse husbandry. This work was supported by ERC grants ROADTOIPS (no. 261075) and BRAINCELL (no. 261063), and the Anne Rowling Regenerative Neurology Clinic. J.O.'M. and T. R. are funded by an MRC PhD Studentship and a Darwin Trust of Edinburgh Scholarship, respectively.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fu HQ, 2006, NAT BIOTECHNOL, V24, P572, DOI 10.1038/nbt1202; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Halbritter F, 2012, NAT METHODS, V9, P7, DOI 10.1038/nmeth.1809; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Ligges, 2003, J STAT SOFTW, V8, P1, DOI [DOI 10.18637/JSS.V008.I11, 10.18637/jss.v008.i11]; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nemajerova A, 2012, CELL DEATH DIFFER, V19, P1268, DOI 10.1038/cdd.2012.45; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu HL, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-173	38	108	108	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					88	+		10.1038/nature12243	http://dx.doi.org/10.1038/nature12243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23728301	Green Accepted			2022-12-01	WOS:000321285600039
J	Suthanthiran, M; Schwartz, JE; Ding, RC; Abecassis, M; Dadhania, D; Samstein, B; Knechtle, SJ; Friedewald, J; Becker, YT; Sharma, VK; Williams, NM; Chang, CS; Hoang, C; Muthukumar, T; August, P; Keslar, KS; Fairchild, RL; Hricik, DE; Heeger, PS; Han, LY; Liu, J; Riggs, M; Ikle, DN; Bridges, ND; Shaked, A				Suthanthiran, Manikkam; Schwartz, Joseph E.; Ding, Ruchuang; Abecassis, Michael; Dadhania, Darshana; Samstein, Benjamin; Knechtle, Stuart J.; Friedewald, John; Becker, Yolanda T.; Sharma, Vijay K.; Williams, Nikki M.; Chang, Christina S.; Hoang, Christine; Muthukumar, Thangamani; August, Phyllis; Keslar, Karen S.; Fairchild, Robert L.; Hricik, Donald E.; Heeger, Peter S.; Han, Leiya; Liu, Jun; Riggs, Michael; Ikle, David N.; Bridges, Nancy D.; Shaked, Abraham		CTOT-04 Study Investigators	Urinary-Cell mRNA Profile and Acute Cellular Rejection in Kidney Allografts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-ALLOGRAFT; PREDICTION; MODELS; TRANSPLANTATION; CLASSIFICATION; CURVE	BACKGROUND The standard test for the diagnosis of acute rejection in kidney transplants is the renal biopsy. Noninvasive tests would be preferable. METHODS We prospectively collected 4300 urine specimens from 485 kidney-graft recipients from day 3 through month 12 after transplantation. Messenger RNA (mRNA) levels were measured in urinary cells and correlated with allograft-rejection status with the use of logistic regression. RESULTS A three-gene signature of 18S ribosomal (rRNA)-normalized measures of CD3 epsilon mRNA and interferon-inducible protein 10 (IP-10) mRNA, and 18S rRNA discriminated between biopsy specimens showing acute cellular rejection and those not showing rejection (area under the curve [AUC], 0.85; 95% confidence interval [CI], 0.78 to 0.91; P<0.001 by receiver-operating-characteristic curve analysis). The cross-validation estimate of the AUC was 0.83 by bootstrap resampling, and the Hosmer-Lemeshow test indicated good fit (P = 0.77). In an external-validation data set, the AUC was 0.74 (95% CI, 0.61 to 0.86; P<0.001) and did not differ significantly from the AUC in our primary data set (P = 0.13). The signature distinguished acute cellular rejection from acute antibody-mediated rejection and borderline rejection (AUC, 0.78; 95% CI, 0.68 to 0.89; P<0.001). It also distinguished patients who received anti-interleukin-2 receptor antibodies from those who received T-cell-depleting antibodies (P<0.001) and was diagnostic of acute cellular rejection in both groups. Urinary tract infection did not affect the signature (P = 0.69). The average trajectory of the signature in repeated urine samples remained below the diagnostic threshold for acute cellular rejection in the group of patients with no rejection, but in the group with rejection, there was a sharp rise during the weeks before the biopsy showing rejection (P<0.001). CONCLUSIONS A molecular signature of CD3 epsilon mRNA, IP-10 mRNA, and 18S rRNA levels in urinary cells appears to be diagnostic and prognostic of acute cellular rejection in kidney allografts.	[Suthanthiran, Manikkam; Ding, Ruchuang; Dadhania, Darshana; Sharma, Vijay K.; Chang, Christina S.; Hoang, Christine; Muthukumar, Thangamani; August, Phyllis] Weill Cornell Med Coll, New York, NY USA; [Samstein, Benjamin] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Heeger, Peter S.] Mt Sinai Sch Med, New York, NY USA; [Schwartz, Joseph E.] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Abecassis, Michael; Friedewald, John] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Becker, Yolanda T.] Univ Chicago, Chicago, IL 60637 USA; [Knechtle, Stuart J.] Emory Univ, Atlanta, GA 30322 USA; [Williams, Nikki M.; Bridges, Nancy D.] NIAID, Bethesda, MD 20892 USA; [Keslar, Karen S.; Fairchild, Robert L.] Cleveland Clin, Cleveland, OH USA; [Hricik, Donald E.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Han, Leiya; Liu, Jun] Pharmaceut Prod Dev, Wilmington, NC USA; [Riggs, Michael; Ikle, David N.] Rho Fed Syst, Chapel Hill, NC USA; [Shaked, Abraham] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Cornell University; Columbia University; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Northwestern University; Feinberg School of Medicine; University of Chicago; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University Hospital; University of Pennsylvania	Suthanthiran, M (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Med & Transplantat Med, Div Nephrol & Hypertens, Hamad bin Khalifa Med Res Bldg,525 E 68th St,Box, New York, NY 10065 USA.	msuthan@med.cornell.edu	Dadhania, Darshana/L-4651-2019; Ikle, David/AAK-7541-2020; Suthanthiran, Manikkam/AAL-9104-2020; Samstein, Benjamin/AAJ-5846-2020	Ikle, David/0000-0003-0091-5246; Samstein, Benjamin/0000-0002-3934-2564; Friedewald, John/0000-0002-9344-9928; Schwartz, Joseph/0000-0002-8944-3566; Knechtle, Stuart/0000-0002-1625-385X	National Institutes of Health [UO1AI63589, R37AI051652]; Qatar National Research Foundation [NPRP 08-503-3-111]; Clinical and Translational Science Center Award [UL1TR000457]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051652, U01AI063589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qatar National Research Foundation(National Research Foundation of Korea); Clinical and Translational Science Center Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health and others.; Supported in part by grants from the National Institutes of Health (UO1AI63589 and R37AI051652) and the Qatar National Research Foundation (NPRP 08-503-3-111) and by a Clinical and Translational Science Center Award (UL1TR000457, to Weill Cornell Medical College).	ALMOND PS, 1993, TRANSPLANTATION, V55, P752, DOI 10.1097/00007890-199304000-00013; Anglicheau D, 2008, TRANSPLANTATION, V86, P192, DOI 10.1097/TP.0b013e31817eef7b; Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Furness PN, 2001, KIDNEY INT, V60, P1998, DOI 10.1046/j.1523-1755.2001.00030.x; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Langone AJ, 2005, SEMIN DIALYSIS, V18, P185, DOI 10.1111/j.1525-139X.2005.18305.x; Le CT, 2006, STAT METHODS MED RES, V15, P571, DOI 10.1177/0962280206070637; LODISH HF, 1976, ANNU REV BIOCHEM, V45, P39, DOI 10.1146/annurev.bi.45.070176.000351; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Schenk AD, 2008, CLIN LAB MED, V28, P441, DOI 10.1016/j.cll.2008.07.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; STROM TB, 1975, NEW ENGL J MED, V292, P1257, DOI 10.1056/NEJM197506122922402; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; Tripepi G, 2010, NEPHROL DIAL TRANSPL, V25, P1402, DOI 10.1093/ndt/gfq046; Williams WW, 2012, NAT REV NEPHROL, V8, P110, DOI 10.1038/nrneph.2011.213	18	230	241	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	2013	369	1					20	31		10.1056/NEJMoa1215555	http://dx.doi.org/10.1056/NEJMoa1215555			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175WE	23822777	Green Accepted, Green Published			2022-12-01	WOS:000321263500007
J	Ma, J; Bai, L; Wang, MD				Ma, Jie; Bai, Lu; Wang, Michelle D.			Transcription Under Torsion	SCIENCE			English	Article							SINGLE-MOLECULE ANALYSIS; COLI RNA-POLYMERASE; UPSTREAM DNA; BACKTRACKING; ELONGATION; TEMPLATE; TOPOISOMERASE; SUPERCOILS; PROMOTER; STRESS	In cells, RNA polymerase (RNAP) must transcribe supercoiled DNA, whose torsional state is constantly changing, but how RNAP deals with DNA supercoiling remains elusive. We report direct measurements of individual Escherichia coli RNAPs as they transcribed supercoiled DNA. We found that a resisting torque slowed RNAP and increased its pause frequency and duration. RNAP was able to generate 11 +/- 4 piconewton-nanometers (mean +/- standard deviation) of torque before stalling, an amount sufficient to melt DNA of arbitrary sequence and establish RNAP as a more potent torsional motor than previously known. A stalled RNAP was able to resume transcription upon torque relaxation, and transcribing RNAP was resilient to transient torque fluctuations. These results provide a quantitative framework for understanding how dynamic modification of DNA supercoiling regulates transcription.	[Ma, Jie; Wang, Michelle D.] Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Ma, Jie; Wang, Michelle D.] Cornell Univ, Howard Hughes Med Inst, Ithaca, NY 14853 USA; [Bai, Lu] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16801 USA; [Bai, Lu] Penn State Univ, Dept Phys, University Pk, PA 16801 USA	Cornell University; Cornell University; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wang, MD (corresponding author), Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA.	mwang@physics.cornell.edu			NIH [GM059849]; NSF [MCB-0820293]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059849] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Wang lab for critical reading of the manuscript. We especially thank R. M. Fulbright for purification of the RNAP and S. Forth, Y. Yang, M. Y. Sheinin, J. T. Inman, and R. A. Forties for assistance with single-molecule assays, data acquisition, data analysis, and figure preparation. We wish to acknowledge support from an NIH grant (GM059849 to M.D.W) and an NSF grant (MCB-0820293 to M.D.W).	Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; Bai L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.068103; Bai L, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/12/P12007; Deufel C, 2007, NAT METHODS, V4, P223, DOI 10.1038/nmeth1013; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Forth S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.148301; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Gore J, 2006, NATURE, V439, P100, DOI 10.1038/nature04319; Harada Y, 2001, NATURE, V409, P113, DOI 10.1038/35051126; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Kouzine F, 2004, NAT STRUCT MOL BIOL, V11, P1092, DOI 10.1038/nsmb848; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; KOWALSKI D, 1989, EMBO J, V8, P4335, DOI 10.1002/j.1460-2075.1989.tb08620.x; La Porta A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.190801; Lavelle C, 2007, BIOCHIMIE, V89, P516, DOI 10.1016/j.biochi.2006.09.019; Levchenko V, 2005, BIOCHEMISTRY-US, V44, P5357, DOI 10.1021/bi047786o; LILLEY DMJ, 1991, MOL MICROBIOL, V5, P779, DOI 10.1111/j.1365-2958.1991.tb00749.x; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Matsumoto K, 2004, J CELL SCI, V117, P3797, DOI 10.1242/jcs.01225; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Sheinin MY, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.108102; Strick TR, 2000, NATURE, V404, P901, DOI 10.1038/35009144; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8	28	182	183	4	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1580	1583		10.1126/science.1235441	http://dx.doi.org/10.1126/science.1235441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812716	Green Accepted			2022-12-01	WOS:000321007000044
J	Lagha, M; Bothma, JP; Esposito, E; Ng, S; Stefanik, L; Tsui, C; Johnston, J; Chen, K; Gilmour, DS; Zeitlinger, J; Levine, MS				Lagha, Mounia; Bothma, Jacques P.; Esposito, Emilia; Ng, Samuel; Stefanik, Laura; Tsui, Chiahao; Johnston, Jeffrey; Chen, Kai; Gilmour, David S.; Zeitlinger, Julia; Levine, Michael S.			Paused Pol II Coordinates Tissue Morphogenesis in the Drosophila Embryo	CELL			English	Article							RNA-POLYMERASE-II; GENE-EXPRESSION; SPATIAL RANGE; GAGA FACTOR; IN-VIVO; GASTRULATION; SNAIL; DYNAMICS; ELONGATION; ACTIVATION	Paused RNA polymerase (Pol II) is a pervasive feature of Drosophila embryos and mammalian stem cells, but its role in development is uncertain. Here, we demonstrate that a spectrum of paused Pol II determines the "time to synchrony''-the time required to achieve coordinated gene expression across the cells of a tissue. To determine whether synchronous patterns of gene activation are significant in development, we manipulated the timing of snail expression, which controls the coordinated invagination of similar to 1,000 mesoderm cells during gastrulation. Replacement of the strongly paused snail promoter with moderately paused or nonpaused promoters causes stochastic activation of snail expression and increased variability of mesoderm invagination. Computational modeling of the dorsal-ventral patterning network recapitulates these variable and bistable gastrulation profiles and emphasizes the importance of timing of gene activation in development. We conclude that paused Pol II and transcriptional synchrony are essential for coordinating cell behavior during morphogenesis.	[Lagha, Mounia; Esposito, Emilia; Ng, Samuel; Tsui, Chiahao; Levine, Michael S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bothma, Jacques P.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Stefanik, Laura; Gilmour, David S.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA; [Johnston, Jeffrey; Chen, Kai; Zeitlinger, Julia] Stowers Inst Med Res, Kansas City, MO 64110 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stowers Institute for Medical Research	Levine, MS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mlevine@berkeley.edu	Lagha, Mounia/T-7351-2018	Lagha, Mounia/0000-0002-7082-1950; Levine, Michael/0000-0001-7629-0081; ESPOSITO, EMILIA/0000-0003-3664-8063; Johnston, Jeff/0000-0002-8962-6186	Human Frontier fellowship; NIH [GM46638, GM47477]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047477, R37GM046638, R01GM046638] Funding Source: NIH RePORTER	Human Frontier fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to Alistair Boettiger for sharing his ideas about Snail autoregulation. We also thank Mike Perry and Valerie Hilgers for their insightful discussions, Didier Rocancourt for help with artwork, and Lily Mirels and Eileen Wagner for comments on the manuscript. M.L. is the recipient of a Human Frontier fellowship. This work was funded by grants from the NIH, GM46638 to M.S.L. and GM47477 to D.S.G. M.L. and J.P.B. initiated efforts to create a stochastic pattern of snail activation. They also worked closely to determine activation profiles of both endogenous genes and transgenes containing minimal promoter sequences. J.P.B. conceived the use of esg as a means for identifying sna<SUP>-</SUP>/sna<SUP>-</SUP> mutant embryos. M.L. worked with L.S. and D.S.G. to document the sufficiency of minimal promoter sequences in establishing paused RNA polymerase II via permanganate protection assays. She also worked with E.E., K.C., J.J., and J.Z. to document the spectrum of Pol II binding at different promoters via whole-genome ChIP-seq assays. J.P.B. performed the imaging and developed the segmentation algorithms needed to determine t50 activation profiles. He also performed imaging to count mRNAs and analyzed the models exploring the relationship between timing and levels of gene expression. J.P.B. modeled the dynamics of Snail protein expression. M.L. and E.E. designed and created minigenes and BAC transgenes. M.L. performed the genetic crosses. C.T. injected all the plasmid transgenes, and BestGene injected all the BAC transgenes. S.N. helped M.L. and J.P.B. to collect and stain embryos. M.L., J.P.B., and M.S.L wrote the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Ashe HL, 2000, DEVELOPMENT, V127, P3305; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Boettiger AN, 2013, CELL REP, V3, P8, DOI 10.1016/j.celrep.2012.12.015; Bothma JP, 2011, CURR BIOL, V21, P1571, DOI 10.1016/j.cub.2011.08.019; Chen HT, 2012, CELL, V149, P618, DOI 10.1016/j.cell.2012.03.018; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Dunipace L, 2011, DEVELOPMENT, V138, P4075, DOI 10.1242/dev.069146; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Fay A, 2011, CURR BIOL, V21, P1624, DOI 10.1016/j.cub.2011.08.036; Gaertner B, 2012, CELL REP, V2, P1670, DOI 10.1016/j.celrep.2012.11.024; Gilchrist DA, 2012, GENE DEV, V26, P933, DOI 10.1101/gad.187781.112; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Guenther MG, 2012, CELL STEM CELL, V10, P484, DOI 10.1016/j.stem.2012.04.016; Hemavathy K, 1997, DEVELOPMENT, V124, P3683; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kanodia JS, 2011, DEVELOPMENT, V138, P4867, DOI 10.1242/dev.071571; Kanodia JS, 2009, P NATL ACAD SCI USA, V106, P21707, DOI 10.1073/pnas.0912395106; KOSMAN D, 1991, SCIENCE, V254, P118, DOI 10.1126/science.1925551; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; Leptin M, 2005, DEV CELL, V8, P305, DOI 10.1016/j.devcel.2005.02.007; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li J, 2011, CURR OPIN GENET DEV, V21, P231, DOI 10.1016/j.gde.2011.01.010; Liberman LM, 2009, P NATL ACAD SCI USA, V106, P22317, DOI 10.1073/pnas.0906227106; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Morachis JM, 2010, GENE DEV, V24, P135, DOI 10.1101/gad.1856710; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Reeves GT, 2012, DEV CELL, V22, P544, DOI 10.1016/j.devcel.2011.12.007; Rushlow CA, 2012, CURR OPIN GENET DEV, V22, P542, DOI 10.1016/j.gde.2012.08.005; Saga Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008201; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; SHOPLAND LS, 1995, GENE DEV, V9, P2756, DOI 10.1101/gad.9.22.2756; SWEETON D, 1991, DEVELOPMENT, V112, P775; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	46	120	121	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					976	987		10.1016/j.cell.2013.04.045	http://dx.doi.org/10.1016/j.cell.2013.04.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706736	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000319456800007
J	Balanoff, AM; Bever, GS; Rowe, TB; Norell, MA				Balanoff, Amy M.; Bever, Gabe S.; Rowe, Timothy B.; Norell, Mark A.			Evolutionary origins of the avian brain	NATURE			English	Article							ORGANIZATION; THEROPOD; EAR; CHINA; BIRDS	Features that were once considered exclusive to modern birds, such as feathers and a furcula, are now known to have first appeared in non-avian dinosaurs(1). However, relatively little is known of the early evolutionary history of the hyperinflated brain that distinguishes birds from other living reptiles and provides the important neurological capablities required by flight(2). Here we use high-resolution computed tomography to estimate and compare cranial volumes of extant birds, the early avialan Archaeopteryx lithographica, and a number of non-avian maniraptoran dinosaurs that are phylogenetically close to the origins of both Avialae and avian flight. Previous work established that avian cerebral expansion began early in theropod history and that the cranial cavity of Archaeopteryx was volumetrically intermediate between these early forms and modern birds(3,4). Our new data indicate that the relative size of the cranial cavity of Archaeopteryx is reflective of a more generalized maniraptoran volumetric signature and in several instances is actually smaller than that of other non-avian dinosaurs. Thus, bird-like encephalization indices evolved multiple times, supporting the conclusion that if Archaeopteryx had the neurological capabilities required of flight, so did at least some other non-avian maniraptorans. This is congruent with recent findings that avialans were not unique among maniraptorans in their ability to fly in some form(5,6).	[Balanoff, Amy M.; Bever, Gabe S.; Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Balanoff, Amy M.] Columbia Univ, Dept Earth & Environm Sci, New York, NY 10027 USA; [Bever, Gabe S.] SUNY Coll Old Westbury, New York Inst Technol, Old Westbury, NY 11568 USA; [Rowe, Timothy B.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA	American Museum of Natural History (AMNH); Columbia University; New York Institute Technology; State University of New York (SUNY) System; SUNY Old Westbury; University of Texas System; University of Texas Austin	Balanoff, AM (corresponding author), SUNY Stony Brook, Sch Med, Dept Anat Sci, Stony Brook, NY 11794 USA.	abalanoff@gmail.com			NSF DDIG [DEB 0909970]; NSF [IIS-0208675, EAR-0948842]; Columbia University International Travel Fellowship	NSF DDIG(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Columbia University International Travel Fellowship	Funding for this project was provided by a NSF DDIG (DEB 0909970) to A. M. B. and M.A.N., NSF IIS-0208675 and EAR-0948842 to T. B. R. and a Columbia University International Travel Fellowship to A. M. B. The University of Texas Computed Tomography Facility and the AMNH MIF helped with computed tomographic scanning and processing imagery. M. Colbert, P. Gignac, D. Ksepka, J. Flynn and J. Meng read and provided useful comments on the text.	Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; Bever GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023393; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; Butler A.B., 2005, COMP VERTEBRATE NEUR; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Franzosa J.W., 2004, THESIS U TEXAS; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; GILL F.B., 2006, ORNITHOLOGY; Hopson J.A., 1979, P39; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Jerison HJ., 1973, EVOLUTION BRAIN INTE, DOI 10.4324/9781315787107-3; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; Milner AC, 2009, ZOOL J LINN SOC-LOND, V155, P198, DOI 10.1111/j.1096-3642.2008.00443.x; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Northcutt RG, 2011, SCIENCE, V332, P926, DOI 10.1126/science.1206915; NORTHCUTT RG, 1995, TRENDS NEUROSCI, V18, P373; Northcutt RG, 2002, INTEGR COMP BIOL, V42, P743, DOI 10.1093/icb/42.4.743; Reiner A, 2005, ANAT REC PART A, V287A, P1080, DOI 10.1002/ar.a.20253; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; Rowe Timothy B., 2005, Journal of Mammalian Evolution, V12, P303, DOI 10.1007/s10914-005-5731-5; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; Shimizu Toru, 1993, P103; Smaers JB, 2012, P NATL ACAD SCI USA, V109, P18006, DOI 10.1073/pnas.1212181109; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Turner AH, 2012, B AM MUS NAT HIST, P5; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6	30	103	105	1	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					93	+		10.1038/nature12424	http://dx.doi.org/10.1038/nature12424			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	23903660				2022-12-01	WOS:000323888300038
J	Uda, S; Saito, TH; Kudo, T; Kokaji, T; Tsuchiya, T; Kubota, H; Komori, Y; Ozaki, Y; Kuroda, S				Uda, Shinsuke; Saito, Takeshi H.; Kudo, Takamasa; Kokaji, Toshiya; Tsuchiya, Takaho; Kubota, Hiroyuki; Komori, Yasunori; Ozaki, Yu-ichi; Kuroda, Shinya			Robustness and Compensation of Information Transmission of Signaling Pathways	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; DIFFERENTIATION; GROWTH	Robust transmission of information despite the presence of variation is a fundamental problem in cellular functions. However, the capability and characteristics of information transmission in signaling pathways remain poorly understood. We describe robustness and compensation of information transmission of signaling pathways at the cell population level. We calculated the mutual information transmitted through signaling pathways for the growth factor-mediated gene expression. Growth factors appeared to carry only information sufficient for a binary decision. Information transmission was generally more robust than average signal intensity despite pharmacological perturbations, and compensation of information transmission occurred. Information transmission to the biological output of neurite extension appeared robust. Cells may use information entropy as information so that messages can be robustly transmitted despite variation in molecular activities among individual cells.	[Uda, Shinsuke; Saito, Takeshi H.; Kudo, Takamasa; Tsuchiya, Takaho; Kubota, Hiroyuki; Komori, Yasunori; Ozaki, Yu-ichi; Kuroda, Shinya] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Kokaji, Toshiya; Kuroda, Shinya] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Bunkyo Ku, Tokyo 1130033, Japan; [Kuroda, Shinya] Japan Sci & Technol Corp, CREST, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Kuroda, S (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan.	skuroda@bi.s.u-tokyo.ac.jp			Dynamic Mechanisms of and Fundamental Technology for Biological Systems; Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics; CREST from Japan Science and Technology (JST); KAKENHI [21240025]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [25830142]; Strategic International Cooperative Program (Research Exchange Type), JST; Human Frontier Science Project (HFSP) [RGP0061/2011]	Dynamic Mechanisms of and Fundamental Technology for Biological Systems; Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics; CREST from Japan Science and Technology (JST); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic International Cooperative Program (Research Exchange Type), JST; Human Frontier Science Project (HFSP)(Human Frontier Science Program)	We thank our laboratory members for critical reading of the manuscript and for technical assistance with the experiments and Y. Kabashima (Tokyo Institute of Technology) and K. Horimoto (Computational Biology Research Center, AIST) for helpful discussion and critical reading of manuscript. This work was supported by the Dynamic Mechanisms of and Fundamental Technology for Biological Systems and the Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics, CREST, from Japan Science and Technology (JST); by a KAKENHI Scientific Research grant (A) (no. 21240025) and a Young Scientists grant (B) (no. 25830142) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); by the Strategic International Cooperative Program (Research Exchange Type), JST; and by a Human Frontier Science Project (HFSP) grant (RGP0061/2011).	Alberts B., 2008, MOL BIOL CELL, VFifth; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Cheng M, 1996, J BIOL CHEM, V271, P8951, DOI 10.1074/jbc.271.15.8951; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Coulombe P, 2003, MOL CELL BIOL, V23, P4542, DOI 10.1128/MCB.23.13.4542-4558.2003; Cover TM, 2006, ELEMENTS OF INFORMAT; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; Farah CA, 2012, ADV EXP MED BIOL, V740, P663, DOI 10.1007/978-94-007-2888-2_29; Foehr ED, 2000, J NEUROSCI, V20, P7556; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Lenaerts T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-9; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mehta P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.79; Ozaki Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009955; Pierobon M, 2011, IEEE T SIGNAL PROCES, V59, P2532, DOI 10.1109/TSP.2011.2114656; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Thomas P. J., 2003, PAPER PRESENTED AT N; Tkacik G, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011910; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; Tostevin F, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061917; Tostevin F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218101; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Waltermann C, 2011, BBA-GEN SUBJECTS, V1810, P924, DOI 10.1016/j.bbagen.2011.07.009; YOUNG SW, 1994, FEBS LETT, V338, P212, DOI 10.1016/0014-5793(94)80367-6; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	29	84	86	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					558	561		10.1126/science.1234511	http://dx.doi.org/10.1126/science.1234511			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908238				2022-12-01	WOS:000322586700056
J	Baugh, CW; Schuur, JD				Baugh, Christopher W.; Schuur, Jeremiah D.			Observation Care - High-Value Care or a Cost-Shifting Loophole?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								<p id="p002">Protocolized observation care in dedicated hospital units can result in higher-value care for some conditions, but by treating observation billing for inpatient care the same as for observation-unit care, current policy promotes cost shifting without rewarding higher value. <p id="p003">A 2012 New York Times article told the story of Miriam Nyman, an 83-year-old Rhode Island woman who was hospitalized after a fall in 2009.(1) Mrs. Nyman broke her neck and spent 4 nights in the hospital, so she was shocked to learn that the entire hospitalization was classified as an outpatient visit and billed as an observation stay. That meant that her subsequent stay in a skilled nursing facility was not covered by Medicare, and she was left with more than $35,000 in out-of-pocket expenses. Similar cases reported elsewhere in the United States highlight a critical and overlooked Medicare ...	[Baugh, Christopher W.; Schuur, Jeremiah D.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Baugh, CW (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA.		Baugh, Christopher William/AAJ-3688-2021	Baugh, Christopher William/0000-0002-2360-1891				American Hospital's Association, 2013, EXPL IMP RAC PROGR H; Baugh CW, 2012, HEALTH AFFAIR, V31, P2314, DOI 10.1377/hlthaff.2011.0926; Feng ZL, 2012, HEALTH AFFAIR, V31, P1251, DOI 10.1377/hlthaff.2012.0129; Medicare Payment Advisory Commission, 2012, EXPL IMP RAC PROGR H; Span P., 2012, NEW YORK TIMES  0622	5	52	52	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					302	305		10.1056/NEJMp1304493	http://dx.doi.org/10.1056/NEJMp1304493			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	188VJ	23883376				2022-12-01	WOS:000322223900004
J	Chinthapalli, K				Chinthapalli, Krishna			PALLIATIVE CARE The birth and death of the Liverpool care pathway	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				Doughty, 2012, DAILY MAIL; Economist Intelligence Unit, 2010, QUAL DEATH RANK END; Hawkes N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4568; Koestler-Grack RA, 2009, M CURIE SCI; Neuberger J., 2013, MORE CARE LESS PATHW	5	7	7	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 24	2013	347								f4669	10.1136/bmj.f4669	http://dx.doi.org/10.1136/bmj.f4669			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193BM	23884973				2022-12-01	WOS:000322531800012
J	Chen, JL; Carta, S; Soldado-Magraner, J; Schneider, BL; Helmchen, F				Chen, Jerry L.; Carta, Stefano; Soldado-Magraner, Joana; Schneider, Bernard L.; Helmchen, Fritjof			Behaviour-dependent recruitment of long-range projection neurons in somatosensory cortex	NATURE			English	Article							PRIMARY MOTOR CORTEX; BARREL CORTEX; TACTILE DISCRIMINATION; OBJECT LOCALIZATION; SENSORIMOTOR SYSTEM; NEURAL ACTIVITY; RAT PRIMARY; WHISKER; MICE; AWAKE	In the mammalian neocortex, segregated processing streams are thought to be important for forming sensory representations of the environment(1,2), but how local information in primary sensory cortex is transmitted to other distant cortical areas during behaviour is unclear. Here we show task-dependent activation of distinct, largely non-overlapping long-range projection neurons in the whisker region of primary somatosensory cortex (S1) in awake, behaving mice. Using two-photon calcium imaging, we monitored neuronal activity in anatomically identified S1 neurons projecting to secondary somatosensory (S2) or primary motor (M1) cortex in mice using their whiskers to perform a texture-discrimination task or a task that required them to detect the presence of an object at a certain location. Whisking-related cells were found among S2-projecting (S2P) but not M1-projecting (M1P) neurons. A higher fraction of S2P than M1P neurons showed touch-related responses during texture discrimination, whereas a higher fraction of M1P than S2P neurons showed touch-related responses during the detection task. In both tasks, S2P and M1P neurons could discriminate similarly between trials producing different behavioural decisions. However, in trials producing the same decision, S2P neurons performed better at discriminating texture, whereas M1P neurons were better at discriminating location. Sensory stimulus features alone were not sufficient to elicit these differences, suggesting that selective transmission of S1 information to S2 and M1 is driven by behaviour.	[Chen, Jerry L.; Carta, Stefano; Soldado-Magraner, Joana; Helmchen, Fritjof] Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; [Carta, Stefano; Helmchen, Fritjof] Univ Zurich, ETH Zurich, Neurosci Ctr Zurich, CH-8057 Zurich, Switzerland; [Soldado-Magraner, Joana] Univ Zurich, ETH Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland; [Schneider, Bernard L.] Ecole Polytech Fed Lausanne, Brain Mind Inst, EPFL SV BMI LEN, CH-1015 Lausanne, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Helmchen, F (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	helmchen@hifo.uzh.ch	Schneider, Bernard/H-6168-2011; Helmchen, Fritjof/A-6255-2008	Schneider, Bernard/0000-0001-5485-8748; Helmchen, Fritjof/0000-0002-8867-9569; Chen, Jerry/0000-0002-7409-7859	Swiss National Science Foundation [310030-127091]; EU [223524, 243914]; Swiss SystemsX.ch initiative; National Center of Competence in Research 'Neural Plasticity and Repair'; Forschungskredit of the University of Zurich [541541808]; US National Science Foundation [1158914]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); Swiss SystemsX.ch initiative; National Center of Competence in Research 'Neural Plasticity and Repair'(Swiss National Science Foundation (SNSF)); Forschungskredit of the University of Zurich; US National Science Foundation(National Science Foundation (NSF))	We thank S. Soldado-Magraner and L. Sumanovski for assistance with data analysis, H. Kasper, M. Wieckhorst, S. Giger and F. Voigt for technical assistance, A. Miyawaki for plasmid reagents, and D. Margolis, H. Lutcke and K. Schulz for help with initial experiments, helpful discussions and comments on the manuscript and V. Padrun and F. Pidoux for virus production. This work was supported by grants from the Swiss National Science Foundation (310030-127091 to F. H.), the EU-FP7 program(PLASTICISE project 223524 to F. H. and B. L. S.; and the BRAIN-I-NETS project 243914 to F. H.), the Swiss SystemsX.ch initiative (project 2008/2011-Neurochoice to F. H. and B. L. S.), the National Center of Competence in Research 'Neural Plasticity and Repair' (F. H.), Forschungskredit of the University of Zurich (grant 541541808 to J.L.C.) and a fellowship from the US National Science Foundation, International Research Fellowship Program (grant 1158914 to J.L.C.).	Alloway KD, 2008, CEREB CORTEX, V18, P979, DOI 10.1093/cercor/bhm138; Aronoff R, 2010, EUR J NEUROSCI, V31, P2221, DOI 10.1111/j.1460-9568.2010.07264.x; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Chakraibarti S, 2006, J COMP NEUROL, V498, P624, DOI 10.1002/cne.21052; Conte WL, 2009, NAT PROTOC, V4, P1157, DOI 10.1038/nprot.2009.93; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Green DG., 1966, SIGNAL DETECTION THE, DOI 10.1901/jeab.1969.12-475; Guic E, 2008, BIOL RES, V41, P425, DOI /S0716-97602008000400008; GUICROBLES E, 1992, BEHAV BRAIN RES, V48, P145, DOI 10.1016/S0166-4328(05)80150-0; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Krupa DJ, 2004, SCIENCE, V304, P1989, DOI 10.1126/science.1093318; Langer D, 2013, J NEUROSCI METH, V215, P38, DOI 10.1016/j.jneumeth.2013.02.006; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Margolis DJ, 2012, NAT NEUROSCI, V15, P1539, DOI 10.1038/nn.3240; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Melzer P, 2006, EXP BRAIN RES, V172, P370, DOI 10.1007/s00221-005-0334-1; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Sato TR, 2010, J NEUROSCI, V30, P4256, DOI 10.1523/JNEUROSCI.3774-09.2010; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; Wiest MC, 2010, J NEUROPHYSIOL, V104, P300, DOI 10.1152/jn.00194.2010; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601	39	184	185	4	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					336	+		10.1038/nature12236	http://dx.doi.org/10.1038/nature12236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23792559	Green Accepted, Green Published			2022-12-01	WOS:000321910700036
J	Reining, A; Nozinovic, S; Schlepckow, K; Buhr, F; Furtig, B; Schwalbe, H				Reining, Anke; Nozinovic, Senada; Schlepckow, Kai; Buhr, Florian; Fuertig, Boris; Schwalbe, Harald			Three-state mechanism couples ligand and temperature sensing in riboswitches	NATURE			English	Article							BASE-PAIR RESOLUTION; ADENINE RIBOSWITCH; ESCHERICHIA-COLI; GENE-EXPRESSION; MESSENGER-RNAS; MELTING CURVES; NMR; BINDING; SPECTROSCOPY; TRANSCRIPTION	Riboswitches are cis-acting gene-regulatory RNA elements that can function at the level of transcription, translation and RNA cleavage(1-3). The commonly accepted molecular mechanism for riboswitch function proposes a ligand-dependent conformational switch between two mutually exclusive states(4). According to this mechanism, ligand binding to an aptamer domain induces an allosteric conformational switch of an expression platform, leading to activation or repression of ligand-related gene expression(5). However, many riboswitch properties cannot be explained by a pure two-state mechanism. Here we show that the regulation mechanism of the adenine-sensing riboswitch, encoded by the add gene on chromosome II of the human Gram-negative pathogenic bacterium Vibrio vulnificus(6), is notably different from a two-state switch mechanism in that it involves three distinct stable conformations. We characterized the temperature and Mg2+ dependence of the population ratios of the three conformations and the kinetics of their interconversion at nucleotide resolution. The observed temperature dependence of a pre-equilibrium involving two structurally distinct ligand-free conformations of the add riboswitch conferred efficient regulation over a physiologically relevant temperature range. Such robust switching is a key requirement for gene regulation in bacteria that have to adapt to environments with varying temperatures. The translational adenine-sensing riboswitch represents the first example, to our knowledge, of a temperature-compensated regulatory RNA element.	[Reining, Anke; Nozinovic, Senada; Schlepckow, Kai; Buhr, Florian; Fuertig, Boris; Schwalbe, Harald] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Schwalbe, H (corresponding author), Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Ctr Biomol Magnet Resonance, Max von Laue Str 7, D-60438 Frankfurt, Germany.	fuertig@nmr.uni-frankfurt.de; schwalbe@nmr.uni-frankfurt.de	Schwalbe, Harald/AAB-3143-2020; Schwalbe, Harald J/F-9023-2010	Schwalbe, Harald/0000-0001-5693-7909; Schwalbe, Harald J/0000-0001-5693-7909; Furtig, Boris/0000-0001-6443-7656	German funding agency (DFG) in Collaborative Research Center 902	German funding agency (DFG) in Collaborative Research Center 902	We thank E. Stirnal, H. Keller and C. Richter for technical support. We thank F. Narberhaus, J. Wohnert, J. Wachtveitl, J. Soppa, E. Schleiff, A. Heckel, M. Hengesbach and C. Griesinger for stimulating discussions. This work was funded by the German funding agency (DFG) in Collaborative Research Center 902.	Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Birikh KR, 1997, EUR J BIOCHEM, V245, P1, DOI 10.1111/j.1432-1033.1997.t01-3-00001.x; Buck J, 2007, P NATL ACAD SCI USA, V104, P15699, DOI 10.1073/pnas.0703182104; Dixon N, 2010, P NATL ACAD SCI USA, V107, P2830, DOI 10.1073/pnas.0911209107; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fasman GD, 1975, HDB BIOCH MOL BIOL, VI, P65; Garst AD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003533; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Kortmann J, 2012, NAT REV MICROBIOL, V10, P255, DOI 10.1038/nrmicro2730; Lee MK, 2010, P NATL ACAD SCI USA, V107, P9192, DOI 10.1073/pnas.1001195107; Lemay JF, 2007, RNA, V13, P339, DOI 10.1261/rna.142007; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Li YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018954, 10.1371/journal.pone.0025286]; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Mok KH, 2003, J AM CHEM SOC, V125, P12484, DOI 10.1021/ja036357v; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Neupane K, 2011, NUCLEIC ACIDS RES, V39, P7677, DOI 10.1093/nar/gkr305; Noeske J, 2005, P NATL ACAD SCI USA, V102, P1372, DOI 10.1073/pnas.0406347102; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Rinnenthal J, 2010, NUCLEIC ACIDS RES, V38, P3834, DOI 10.1093/nar/gkq124; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Stoddard CD, 2013, J MOL BIOL, V425, P1596, DOI 10.1016/j.jmb.2013.02.023; Stoldt M, 1999, EMBO J, V18, P6508, DOI 10.1093/emboj/18.22.6508; Wacker A, 2012, RNA BIOL, V9, P672, DOI 10.4161/rna.20106; Wang JB, 2009, J MOL BIOL, V393, P717, DOI 10.1016/j.jmb.2009.08.001; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Wilson RC, 2011, J MOL BIOL, V405, P926, DOI 10.1016/j.jmb.2010.10.056; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2003, CHEMBIOCHEM, V4, P1024, DOI 10.1002/cbic.200300685; Xu Q, 2003, P NATL ACAD SCI USA, V100, P1286, DOI 10.1073/pnas.0337479100	36	142	145	3	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					355	U135		10.1038/nature12378	http://dx.doi.org/10.1038/nature12378			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23842498				2022-12-01	WOS:000321910700040
J	Chaigne-Delalande, B; Li, FY; O'Connor, GM; Lukacs, MJ; Jiang, P; Zheng, LX; Shatzer, A; Biancalana, M; Pittaluga, S; Matthews, HF; Jancel, TJ; Bleesing, JJ; Marsh, RA; Kuijpers, TW; Nichols, KE; Lucas, CL; Nagpal, S; Mehmet, H; Su, HC; Cohen, JI; Uzel, G; Lenardo, MJ				Chaigne-Delalande, Benjamin; Li, Feng-Yen; O'Connor, Geraldine M.; Lukacs, Marshall J.; Jiang, Ping; Zheng, Lixin; Shatzer, Amber; Biancalana, Matthew; Pittaluga, Stefania; Matthews, Helen F.; Jancel, Timothy J.; Bleesing, Jack J.; Marsh, Rebecca A.; Kuijpers, Taco W.; Nichols, Kim E.; Lucas, Carrie L.; Nagpal, Sunil; Mehmet, Huseyin; Su, Helen C.; Cohen, Jeffrey I.; Uzel, Gulbu; Lenardo, Michael J.			Mg2+ Regulates Cytotoxic Functions of NK and CD8 T Cells in Chronic EBV Infection Through NKG2D	SCIENCE			English	Article							KILLER-CELLS; MAGNESIUM; MAGT1; ACTIVATION; COSTIMULATION; SURVEILLANCE; METABOLISM; GROWTH; TRPM7	The magnesium transporter 1 (MAGT1) is a critical regulator of basal intracellular free magnesium (Mg2+) concentrations. Individuals with genetic deficiencies in MAGT1 have high levels of Epstein-Barr virus (EBV) and a predisposition to lymphoma. We show that decreased intracellular free Mg2+ causes defective expression of the natural killer activating receptor NKG2D in natural killer (NK) and CD8(+) T cells and impairs cytolytic responses against EBV. Notably, magnesium supplementation in MAGT1-deficient patients restores intracellular free Mg2+ and NKG2D while concurrently reducing EBV-infected cells in vivo, demonstrating a link between NKG2D cytolytic activity and EBV antiviral immunity in humans. Moreover, these findings reveal a specific molecular function of free basal intracellular Mg2+ in eukaryotic cells.	[Chaigne-Delalande, Benjamin; Li, Feng-Yen; Lukacs, Marshall J.; Jiang, Ping; Zheng, Lixin; Biancalana, Matthew; Matthews, Helen F.; Lucas, Carrie L.; Lenardo, Michael J.] NIAID, Mol Dev Immune Syst Sect, Lymphocyte Mol Genet Unit, Immunol Lab,NIH, Bethesda, MD 20892 USA; [Li, Feng-Yen] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [O'Connor, Geraldine M.; Cohen, Jeffrey I.] Frederick Natl Lab Canc Res, Canc & Inflammat Program, Expt Immunol Lab, Frederick, MD 21702 USA; [Shatzer, Amber] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Pittaluga, Stefania] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Jancel, Timothy J.] NIH, Ctr Clin, Dept Pharm, Bethesda, MD 20892 USA; [Bleesing, Jack J.; Marsh, Rebecca A.] Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA; [Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Nichols, Kim E.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Nagpal, Sunil; Mehmet, Huseyin] Merck Res Labs, Resp & Immunol Div, Boston, MA USA; [Su, Helen C.] NIAID, Immunol Dis Unit, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Uzel, Gulbu] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Cincinnati Children's Hospital Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Merck & Company; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lenardo, MJ (corresponding author), NIAID, Mol Dev Immune Syst Sect, Lymphocyte Mol Genet Unit, Immunol Lab,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	lenardo@nih.gov	Su, Helen C/H-9541-2015; Nichols, Kim/AAP-8592-2020; Timothy Jancel, PharmD/K-5570-2019; Nichols, Kim/E-9353-2016	Su, Helen C/0000-0002-5582-9110; Nichols, Kim/0000-0002-5581-6555; Timothy Jancel, PharmD/0000-0002-2022-0970; Nichols, Kim/0000-0002-5581-6555; O'Connor, Geraldine/0000-0002-7440-162X; Biancalana, Matthew/0000-0002-1078-1838; Lucas, Carrie/0000-0002-5754-0820	Division of Intramural Research, National Institute of Allergy and Infectious Diseases; National Cancer Institute, NIH; Medical Scientist Training Program at the University of California-San Francisco; NIH; Pharmacology Research Associate Training (PRAT) program; National Institute of General Medical Sciences, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001059, ZIAAI000718, ZIAAI000566, ZIAAI000565, ZIAAI000717, ZIAAI000913, ZIAAI001187, ZIAAI000769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL006002] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Scientist Training Program at the University of California-San Francisco; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacology Research Associate Training (PRAT) program; National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CLINICAL CENTER	This research was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases and the National Cancer Institute, NIH. We thank H. Malech, A. Snow, J. Niemela, G. Fahle, and T. Dimaggio for assistance in various aspects of the research and patient evaluation and S. Holland for clinical insights and support. We also thank R. Germain, P. Schwartzberg, R. Siegel, T. Waldmann, K. Schafer-Weaver, C. Kanellopoulou, S. Muljo, D. McVicar, J. Milner, R. Baker, and S. Holland for critically reading the manuscript. We thank E. Long and S. Rajagopalan for sharing antibodies and cell lines and helpful assistance with NK experiments; we also thank K. Dowdell, R. Orentas, and B. Lafont for sharing reagents and D. Douek, D. Price, and M. Quigley for assistance with tetramer staining. We are grateful to Merck Research Laboratories for generous support in kind of reagents and materials, and to P. R. Vagelos and R. Vessey for fostering the collaboration. F.-Y.L. was supported by the Medical Scientist Training Program at the University of California-San Francisco and the NIH M.D./Ph.D. Partnership program, and thanks K. Shannon and J. Toutolmin for support and encouragement. We also acknowledge support by the Pharmacology Research Associate Training (PRAT) program (to C. L. L.), National Institute of General Medical Sciences, NIH. The data presented in this paper are tabulated in the main paper and in the supplementary materials.	Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Deason-Towne F, 2011, FEBS LETT, V585, P2275, DOI 10.1016/j.febslet.2011.05.052; Filipovich AH, 2010, BLOOD, V116, P3398, DOI 10.1182/blood-2010-03-275909; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; GRUBBS RD, 1987, MAGNESIUM, V6, P113; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hayakawa Y, 2006, SEMIN IMMUNOL, V18, P176, DOI 10.1016/j.smim.2006.03.005; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Li FY, 2011, MAGNESIUM RES, V24, pS109, DOI 10.1684/mrh.2011.0286; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Nakajima H, 2000, EUR J IMMUNOL, V30, P3309, DOI 10.1002/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3; Obeidy P, 2009, INT J BIOCHEM CELL B, V41, P2364, DOI 10.1016/j.biocel.2009.07.005; Ogasawara K, 2005, J CLIN IMMUNOL, V25, P534, DOI 10.1007/s10875-005-8786-4; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Palendira U, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001187; Pappworth IY, 2007, J VIROL, V81, P474, DOI 10.1128/JVI.01777-06; Park YP, 2011, BLOOD, V118, P3019, DOI 10.1182/blood-2011-04-346825; Pievani A, 2011, BLOOD, V118, P3301, DOI 10.1182/blood-2011-02-336321; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; Reiners KS, 2013, MOL THER, V21, P895, DOI 10.1038/mt.2013.14; Rettinger E, 2012, CYTOTHERAPY, V14, P91, DOI 10.3109/14653249.2011.613931; Rezaei N, 2011, J ALLERGY CLIN IMMUN, V127, P1329, DOI 10.1016/j.jaci.2011.02.047; Rezaei N, 2011, BRIT J HAEMATOL, V152, P13, DOI 10.1111/j.1365-2141.2010.08442.x; RUBIN H, 1975, P NATL ACAD SCI USA, V72, P3551, DOI 10.1073/pnas.72.9.3551; Schweigel M, 2008, MAGNESIUM RES, V21, P118; Sharifi R, 2004, BLOOD, V103, P3821, DOI 10.1182/blood-2003-09-3359; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Slavuljica I, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00085; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Wang R, 2012, P NATL ACAD SCI USA, V109, pE3578, DOI 10.1073/pnas.1214088109; Wolf FI, 2010, CELL CYCLE, V9, P3399, DOI 10.4161/cc.9.17.13072; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106; Zingoni A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00408	37	198	206	4	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	2013	341	6142					186	191		10.1126/science.1240094	http://dx.doi.org/10.1126/science.1240094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23846901	Green Accepted			2022-12-01	WOS:000321965300046
J	Trinajstic, K; Sanchez, S; Dupret, V; Tafforeau, P; Long, J; Young, G; Senden, T; Boisvert, C; Power, N; Ahlberg, PE				Trinajstic, Kate; Sanchez, Sophie; Dupret, Vincent; Tafforeau, Paul; Long, John; Young, Gavin; Senden, Tim; Boisvert, Catherine; Power, Nicola; Ahlberg, Per Erik			Fossil Musculature of the Most Primitive Jawed Vertebrates	SCIENCE			English	Article							EVOLUTION; ORIGIN; GNATHOSTOMES; NECK	The transition from jawless to jawed vertebrates (gnathostomes) resulted in the reconfiguration of the muscles and skeleton of the head, including the creation of a separate shoulder girdle with distinct neck muscles. We describe here the only known examples of preserved musculature from placoderms (extinct armored fishes), the phylogenetically most basal jawed vertebrates. Placoderms possess a regionalized muscular anatomy that differs radically from the musculature of extant sharks, which is often viewed as primitive for gnathostomes. The placoderm data suggest that neck musculature evolved together with a dermal joint between skull and shoulder girdle, not as part of a broadly flexible neck as in sharks, and that transverse abdominal muscles are an innovation of gnathostomes rather than of tetrapods.	[Trinajstic, Kate] Curtin Univ, Dept Chem, Western Australian Organ & Isotope Geochem, Perth, WA 6102, Australia; [Trinajstic, Kate] Western Australian Museum, Perth, WA 6000, Australia; [Sanchez, Sophie; Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Sanchez, Sophie; Dupret, Vincent; Ahlberg, Per Erik] Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, S-75236 Uppsala, Sweden; [Long, John] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Long, John; Young, Gavin; Power, Nicola] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Senden, Tim] Australian Natl Univ, Res Sch Phys & Engn, Dept Appl Math, Canberra, ACT 0200, Australia; [Boisvert, Catherine] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia	Curtin University; Western Australian Museum; European Synchrotron Radiation Facility (ESRF); Uppsala University; Flinders University South Australia; Australian National University; Australian National University; Australian Regenerative Medicine Institute; Monash University	Ahlberg, PE (corresponding author), Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, Norbyvagen 18A, S-75236 Uppsala, Sweden.	per.ahlberg@ebc.uu.se	Sanchez, Sophie/AAE-1168-2022; Senden, Tim J/A-7319-2008; Boisvert, Catherine A/A-9782-2019; Dupret, Vincent/L-2306-2015	Senden, Tim J/0000-0001-6808-7219; Boisvert, Catherine A/0000-0002-0618-7270; Dupret, Vincent/0000-0002-6859-1041; Trinajstic, Kate/0000-0002-6519-6396; Tafforeau, Paul/0000-0002-5962-1683; Sanchez, Sophie/0000-0002-3611-6836; Ahlberg, Per/0000-0001-9054-2900; Long, John/0000-0001-8012-0114	Australian Research Council (ARC) QEII Fellowship [DP 110101127]; ARC [DP 1092870, DP 1096002]; European Research Council [233111]; Knut and Alice Wallenberg Foundation; Human Frontiers Research Program; European Synchrotron Radiation Facility in Grenoble, France [EC770]; The Australian Geographic Society	Australian Research Council (ARC) QEII Fellowship(Australian Research Council); ARC(Australian Research Council); European Research Council(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Human Frontiers Research Program; European Synchrotron Radiation Facility in Grenoble, France; The Australian Geographic Society	We acknowledge M. Siversson at the Western Australian Museum, Perth, and Z. Johanson at the Natural History Museum, London, for lending us specimens in their care. We thank I. Montero Verdu for his picture of the muscle bundles (Fig. 3D) and A. Ritchie for an Eastmanosteus image. K. T., P. E. A., and C. B. are supported by Australian Research Council (ARC) QEII Fellowship DP 110101127; J.L., K. T., T. S., and G.Y. by ARC DP 1092870; S. S., V. D., and P. E. A. by European Research Council Advanced Investigator Grant 233111; P. E. A. by a Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation; and C. B. by a Human Frontiers Research Program and an ARC Discovery Project, DP 1096002. The scan performed at the European Synchrotron Radiation Facility in Grenoble, France, was part of project EC770. K. T. acknowledges the 2010 Prime Minister's Science Prize, and J.L. acknowledges funding from The Australian Geographic Society, which supported fieldwork at the Gogo Formation. Specimens are housed in the collections of the Western Australian Museum, Australian National University, Australian Museum, and Museum Victoria, Australia, and the Natural History Museum, UK.	Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; CHRIST B, 1983, ANAT EMBRYOL, V166, P87, DOI 10.1007/BF00317946; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Edgeworth F. H., 1935, CRANAIL MUSCLES VERT; Gemballa S, 2003, P ROY SOC B-BIOL SCI, V270, P1229, DOI 10.1098/rspb.2003.2345; Heintz A., 1930, BASHFORD DEAN MEMORI, P115; JANVIER P., 1996, EARLY VERTEBRATES; Kuratani S, 2004, J ANAT, V205, P335, DOI 10.1111/j.0021-8782.2004.00345.x; Kuratani S, 2008, DEV GROWTH DIFFER, V50, pS189, DOI 10.1111/j.1440-169X.2008.00985.x; Mallatt J, 1996, ZOOL J LINN SOC-LOND, V117, P329, DOI 10.1111/j.1096-3642.1996.tb01658.x; Mathew SJ, 2011, DEVELOPMENT, V138, P371, DOI 10.1242/dev.057463; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; Miles R.S., 1968, EARTH ENV SCI T R SO, V67, P373, DOI [10.1017/S0080456800024078, DOI 10.1017/S0080456800024078]; Oisi Y, 2013, NATURE, V493, P175, DOI 10.1038/nature11794; Onimaru K, 2011, DEV BIOL, V359, P124, DOI 10.1016/j.ydbio.2011.08.003; Schilling N, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-4; Trinajstic K, 2007, BIOL LETTERS, V3, P197, DOI 10.1098/rsbl.2006.0604; WAINWRIGHT SA, 1978, SCIENCE, V202, P747, DOI 10.1126/science.202.4369.747; Zhu M, 2012, BIOL LETTERS, V8, P453, DOI 10.1098/rsbl.2011.1033	19	39	41	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					160	164		10.1126/science.1237275	http://dx.doi.org/10.1126/science.1237275			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23765280	Green Submitted			2022-12-01	WOS:000321965300039
J	Read, BA; Kegel, J; Klute, MJ; Kuo, A; Lefebvre, SC; Maumus, F; Mayer, C; Miller, J; Monier, A; Salamov, A; Young, J; Aguilar, M; Claverie, JM; Frickenhaus, S; Gonzalez, K; Herman, EK; Lin, YC; Napier, J; Ogata, H; Sarno, AF; Shmutz, J; Schroeder, D; de Vargas, C; Verret, F; von Dassow, P; Valentin, K; Van de Peer, Y; Wheeler, G; Dacks, JB; Delwiche, CF; Dyhrman, ST; Glockner, G; John, U; Richards, T; Worden, AZ; Zhang, XY; Grigoriev, IV; Allen, AE; Bidle, K; Borodovsky, M; Bowler, C; Brownlee, C; Cock, JM; Elias, M; Gladyshev, VN; Groth, M; Guda, C; Hadaegh, A; Iglesias-Rodriguez, MD; Jenkins, J; Jones, BM; Lawson, T; Leese, F; Lindquist, E; Lobanov, A; Lomsadze, A; Malik, SB; Marsh, ME; Mackinder, L; Mock, T; Mueller-Roeber, B; Pagarete, A; Parker, M; Probert, I; Quesneville, H; Raines, C; Rensing, SA; Riano-Pachon, DM; Richier, S; Rokitta, S; Shiraiwa, Y; Soanes, DM; van der Giezen, M; Wahlund, TM; Williams, B; Wilson, W; Wolfe, G; Wurch, LL				Read, Betsy A.; Kegel, Jessica; Klute, Mary J.; Kuo, Alan; Lefebvre, Stephane C.; Maumus, Florian; Mayer, Christoph; Miller, John; Monier, Adam; Salamov, Asaf; Young, Jeremy; Aguilar, Maria; Claverie, Jean-Michel; Frickenhaus, Stephan; Gonzalez, Karina; Herman, Emily K.; Lin, Yao-Cheng; Napier, Johnathan; Ogata, Hiroyuki; Sarno, Analissa F.; Shmutz, Jeremy; Schroeder, Declan; de Vargas, Colomban; Verret, Frederic; von Dassow, Peter; Valentin, Klaus; Van de Peer, Yves; Wheeler, Glen; Dacks, Joel B.; Delwiche, Charles F.; Dyhrman, Sonya T.; Gloeckner, Gernot; John, Uwe; Richards, Thomas; Worden, Alexandra Z.; Zhang, Xiaoyu; Grigoriev, Igor V.; Allen, Andrew E.; Bidle, Kay; Borodovsky, M.; Bowler, C.; Brownlee, Colin; Cock, J. Mark; Elias, Marek; Gladyshev, Vadim N.; Groth, Marco; Guda, Chittibabu; Hadaegh, Ahmad; Iglesias-Rodriguez, Maria Debora; Jenkins, J.; Jones, Bethan M.; Lawson, Tracy; Leese, Florian; Lindquist, Erika; Lobanov, Alexei; Lomsadze, Alexandre; Malik, Shehre-Banoo; Marsh, Mary E.; Mackinder, Luke; Mock, Thomas; Mueller-Roeber, Bernd; Pagarete, Antonio; Parker, Micaela; Probert, Ian; Quesneville, Hadi; Raines, Christine; Rensing, Stefan A.; Riano-Pachon, Diego Mauricio; Richier, Sophie; Rokitta, Sebastian; Shiraiwa, Yoshihiro; Soanes, Darren M.; van der Giezen, Mark; Wahlund, Thomas M.; Williams, Bryony; Wilson, Willie; Wolfe, Gordon; Wurch, Louie L.		Emiliania Huxleyi Annotation	Pan genome of the phytoplankton Emiliania underpins its global distribution	NATURE			English	Article							HUXLEYI PRYMNESIOPHYCEAE; HIGH LIGHT; INDICATORS; GROWTH	Coccolithophores have influenced the global climate for over 200 million years(1). These marine phytoplankton can account for 20 per cent of total carbon fixation in some systems(2). They form blooms that can occupy hundreds of thousands of square kilometres and are distinguished by their elegantly sculpted calcium carbonate exoskeletons (coccoliths), rendering them visible from space(3). Although coccolithophores export carbon in the form of organic matter and calcite to the sea floor, they also release CO2 in the calcification process. Hence, they have a complex influence on the carbon cycle, driving either CO2 production or uptake, sequestration and export to the deep ocean(4). Here we report the first haptophyte reference genome, from the coccolithophore Emiliania huxleyi strain CCMP1516, and sequences from 13 additional isolates. Our analyses reveal a pan genome (core genes plus genes distributed variably between strains) probably supported by an atypical complement of repetitive sequence in the genome. Comparisons across strains demonstrate that E. huxleyi, which has long been considered a single species, harbours extensive genome variability reflected in different metabolic repertoires. Genome variability within this species complex seems to underpin its capacity both to thrive in habitats ranging from the equator to the subarctic and to form large-scale episodic blooms under a wide variety of environmental conditions.	[Read, Betsy A.; Sarno, Analissa F.; Wahlund, Thomas M.] Calif State Univ San Marcos, Dept Biol Sci, San Marcos, CA 92096 USA; [Kegel, Jessica; Frickenhaus, Stephan; Valentin, Klaus; John, Uwe; Rokitta, Sebastian] Helmholtz Ctr Polar & Marine Res AWI, Alfred Wegener Inst, D-27570 Bremerhaven, Germany; [Klute, Mary J.; Aguilar, Maria; Herman, Emily K.; Dacks, Joel B.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; [Kuo, Alan; Salamov, Asaf; Shmutz, Jeremy; Grigoriev, Igor V.; Lindquist, Erika] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Lefebvre, Stephane C.; Allen, Andrew E.] J Craig Venter Inst, San Diego, CA 92121 USA; [Maumus, Florian; Quesneville, Hadi] INRA, Unite Rech Genom Info, F-78026 Versailles, France; [Mayer, Christoph] Forsch Museum, D-53113 Bonn, Germany; [Mayer, Christoph; Leese, Florian] Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, D-44801 Bochum, Germany; [Miller, John; Delwiche, Charles F.] Univ Maryland, College Pk, MD 20742 USA; [Miller, John; Delwiche, Charles F.] Univ Maryland, Maryland Agr Expt Stn, College Pk, MD 20742 USA; [Monier, Adam; Worden, Alexandra Z.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Young, Jeremy] UCL, Dept Earth Sci, London WC1E 6BT, England; [Claverie, Jean-Michel; Ogata, Hiroyuki] Aix Marseille Univ, Mediterranean Inst Microbiol, CNRS, Struct & Genom Informat Lab, FR-3479 Marseille, France; [Frickenhaus, Stephan] Hsch Bremerhaven, D-27568 Bremerhaven, Germany; [Gonzalez, Karina] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Lin, Yao-Cheng; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Napier, Johnathan] Rothamsted Res, Dept Biol Chem, Harpenden AL5 2JQ, Herts, England; [Shmutz, Jeremy; Jenkins, J.] HudsonAlpha Genome Sequencing Ctr, Huntsville, AL 35806 USA; [Schroeder, Declan; Wheeler, Glen; Brownlee, Colin; Mackinder, Luke] Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England; [de Vargas, Colomban; Probert, Ian] CNRS, UMR 7144, F-29682 Roscoff, France; [de Vargas, Colomban; Probert, Ian] Univ Paris 06, EPEP Team, Stn Biol Roscoff, F-29682 Roscoff, France; [Verret, Frederic] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [von Dassow, Peter] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; [Wheeler, Glen] Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England; [Dyhrman, Sonya T.; Wurch, Louie L.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Dyhrman, Sonya T.] Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA; [Dyhrman, Sonya T.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Gloeckner, Gernot] Univ Cologne, Fac Med, Inst Biochem 1, D-50931 Cologne, Germany; [Gloeckner, Gernot] Leibniz Inst Freshwater Ecol & Inland Fisheries, D-12587 Berlin, Germany; [Richards, Thomas] Nat Hist Museum, Dept Zool, London SW7 5BD, England; [Zhang, Xiaoyu; Hadaegh, Ahmad] Calif State Univ San Marcos, Dept Comp Sci & Informat Syst, San Marcos, CA 92096 USA; [Bidle, Kay] Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Grp, New Brunswick, NJ 08901 USA; [Borodovsky, M.; Lomsadze, Alexandre] Georgia Tech, Joint Georgia Tech & Emory Dept Biomed Engn, Sch Computat Sci & Engn, Atlanta, GA 30322 USA; [Borodovsky, M.] Moscow Inst Phys & Technol, Dept Bioinformat, Moscow 117303, Russia; [Bowler, C.] Inst Natl Sante & Rech Med U1024, Environm & Evolutionary Genom Sect, Inst Biol lEcole Normale Super, Ctr Natl Rech Sci,UMR8197, F-75230 Paris, France; [Cock, J. Mark] CNRS, UMR 7139, Lab Int Associe Dispersal & Adaptat Marin Species, Stn Biol Roscoff, F-29682 Roscoff, France; [Cock, J. Mark] UPMC Univ Paris 06, Marine Plants & Biomol Lab, UMR 7139, Stn Biol Roscoff, F-29682 Roscoff, France; [Elias, Marek] Univ Ostrava, Fac Sci, Dept Biol & Ecol, Life Sci Res Ctr, Ostrava 71000, Czech Republic; [Gladyshev, Vadim N.; Lobanov, Alexei] Brigham & Womens Hosp, Harvard Med Sch, Dept Med, Div Genet, Boston, MA 02115 USA; [Groth, Marco] Leibniz Inst Age Res, Fritz Lipmann Inst, D-07745 Jena, Germany; [Guda, Chittibabu] Univ Nebraska Med Ctr, Dept Genet, Cell Biol & Anat, Omaha, NE 68198 USA; [Iglesias-Rodriguez, Maria Debora] Univ California Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Iglesias-Rodriguez, Maria Debora; Jones, Bethan M.; Richier, Sophie] Univ Southampton, Ocean & Earth Sci Natl Oceanog Ctr Southampton, Southampton SO17 1BJ, Hants, England; [Jones, Bethan M.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Lawson, Tracy; Raines, Christine] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Malik, Shehre-Banoo] Dalhousie Univ, Canadian Inst Adv Res, Integrated Microbial Biodivers Program, Halifax, NS B3H 4R2, Canada; [Marsh, Mary E.] Univ Texas Houston Med Sch, Houston, TX 77030 USA; [Mock, Thomas] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Mueller-Roeber, Bernd] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Pagarete, Antonio] Univ Bergen, Dept Biol, N-5006 Bergen, Norway; [Parker, Micaela] Univ Washington, Ctr Environm Genom, PNW Ctr Human Hlth & Ocean Studies, Seattle, WA 98195 USA; [Rensing, Stefan A.] Univ Freiburg, Fac Biol, BIOSS Ctr Biol Signalling Studies, D-79098 Freiburg, Germany; [Rensing, Stefan A.] Univ Marburg, Fac Biol, D-35043 Marburg, Germany; [Riano-Pachon, Diego Mauricio] Univ Los Andes, Dept Ciencias Biol, Bogota 111711, DC, Colombia; [Richier, Sophie] CNRS, INSU, UMR 7093, Lab Oceanog Villefranche, F-06230 Villefranche Sur Mer, France; [Richier, Sophie] Univ Paris 06, Observ Oceanol Villefranche, F-06230 Villefranche Sur Mer, France; [Shiraiwa, Yoshihiro] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Soanes, Darren M.; van der Giezen, Mark; Williams, Bryony] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QD, Devon, England; [Wilson, Willie] Bigelow Lab Ocean Sci, Provasoli Guillard Natl Ctr, E Boothbay, ME 04544 USA; [Wolfe, Gordon] California State Univ, Dept Biol Sci, Chico, CA 95929 USA; [Wurch, Louie L.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA	California State University System; California State University San Marcos; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Alberta; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; J. Craig Venter Institute; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ruhr University Bochum; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Monterey Bay Aquarium Research Institute; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Harvard University; Harvard Medical School; Flanders Institute for Biotechnology (VIB); Ghent University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; HudsonAlpha Institute for Biotechnology; Marine Biological Association United Kingdom; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Essex; Pontificia Universidad Catolica de Chile; Plymouth Marine Laboratory; Woods Hole Oceanographic Institution; Columbia University; Columbia University; University of Cologne; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Natural History Museum London; California State University System; California State University San Marcos; Rutgers State University New Brunswick; University System of Georgia; Georgia Institute of Technology; Moscow Institute of Physics & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Ostrava; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Nebraska System; University of Nebraska Medical Center; University of California System; University of California Santa Barbara; University of Southampton; Oregon State University; University of Essex; Canadian Institute for Advanced Research (CIFAR); Dalhousie University; University of Texas System; University of Texas Health Science Center Houston; University of East Anglia; University of Potsdam; University of Bergen; University of Washington; University of Washington Seattle; University of Freiburg; Philipps University Marburg; Universidad de los Andes (Colombia); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Tsukuba; University of Exeter; Bigelow Laboratory for Ocean Sciences; California State University System; California State University Chico; California State University East Bay; United States Department of Energy (DOE); Oak Ridge National Laboratory	Read, BA (corresponding author), Calif State Univ San Marcos, Dept Biol Sci, San Marcos, CA 92096 USA.	bread@csusm.edu	Mueller-Roeber, Bernd/Z-4052-2019; Allen, Andrew E/C-4896-2012; Worden, Alexandra Z./AAD-6567-2019; Mayer, Christoph/AAD-6696-2019; Leese, Florian/D-4277-2012; Elias, Marek/D-6851-2014; Riaño-Pachón, Diego Mauricio/B-4891-2014; Shiraiwa, Yoshihiro/AAD-2501-2022; LIN, Yao-Cheng/B-4394-2008; Claverie, Jean Michel/Z-2183-2019; Valentin, Klaus/G-5862-2014; van der Giezen, Mark/J-9550-2019; von Dassow, Peter/A-5399-2012; Probert, Ian/M-9807-2019; Zhang, xiaoyu/GXA-3206-2022; Raines, Christine/AAF-7036-2019; Delwiche, Charles F/C-6549-2008; Van de Peer, Yves/AAE-7666-2019; Kegel, Jessica U./L-1726-2014; Schroeder, Declan C./O-9131-2019; Claverie, Jean-Michel/AAG-4889-2019; Maumus, Florian/O-5426-2016; Glöckner, Gernot/A-7800-2010; Van de Peer, Yves/D-4388-2009; Pagarete, António/B-9358-2009; Dacks, Joel/AAE-3308-2021; john, uwe/S-3009-2016; Mock, Thomas/A-3127-2008; Riaño-Pachón, Diego M/A-1755-2010; Quesneville, Hadi/AAG-1048-2020; Rokitta, Sebastian/ABC-6832-2020; Bowler, Chris/AAC-6256-2019; Schmutz, Jeremy/N-3173-2013	Allen, Andrew E/0000-0001-5911-6081; Mayer, Christoph/0000-0001-5104-6621; Leese, Florian/0000-0002-5465-913X; Elias, Marek/0000-0003-0066-6542; Riaño-Pachón, Diego Mauricio/0000-0001-9803-3465; LIN, Yao-Cheng/0000-0002-9390-795X; Valentin, Klaus/0000-0001-7401-9423; van der Giezen, Mark/0000-0002-1033-1335; Delwiche, Charles F/0000-0001-7854-8584; Van de Peer, Yves/0000-0003-4327-3730; Kegel, Jessica U./0000-0002-4740-9554; Schroeder, Declan C./0000-0001-5991-2838; Claverie, Jean-Michel/0000-0003-1424-0315; Maumus, Florian/0000-0001-7325-0527; Glöckner, Gernot/0000-0002-9061-1061; Van de Peer, Yves/0000-0003-4327-3730; Pagarete, António/0000-0003-1347-0282; Dacks, Joel/0000-0003-4520-5694; john, uwe/0000-0002-1297-4086; Mock, Thomas/0000-0001-9604-0362; Riaño-Pachón, Diego M/0000-0001-9803-3465; Quesneville, Hadi/0000-0003-3001-4908; Rokitta, Sebastian/0000-0002-7540-9033; Schmutz, Jeremy/0000-0001-8062-9172; Worden, Alexandra/0000-0002-9888-9324; Frickenhaus, Stephan/0000-0002-0356-9791; Williams, Bryony/0000-0003-1123-2176; Groth, Marco/0000-0002-9199-8990; Verret, Frederic/0000-0002-8175-7325; Bowler, Chris/0000-0003-3835-6187; Gladyshev, Vadim/0000-0002-0372-7016; Cock, J. Mark/0000-0002-2650-0383; Malik, Shehre-Banoo/0000-0003-0833-0648; Parker, Micaela/0000-0003-1007-4612; Monier, Adam/0000-0002-6018-5153; Young, Jeremy/0000-0001-9320-9804; von Dassow, Peter/0000-0002-1858-1953; Napier, Johnathan/0000-0003-3580-3607; Grigoriev, Igor/0000-0002-3136-8903; Probert, Ian/0000-0002-1643-1759; Lawson, Tracy/0000-0002-4073-7221; Richards, Thomas/0000-0002-9692-0973	Office of Science of the US Department of Energy (DOE) [7DE-AC02-05CH11231]; BBSRC [BBS/E/C/00005207] Funding Source: UKRI; NERC [NBAF010005, pml010004, NE/E018319/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005207] Funding Source: researchfish; Natural Environment Research Council [pml010004, NE/E018319/1, NBAF010005] Funding Source: researchfish; Alberta Innovates [201001324] Funding Source: researchfish; Division Of Ocean Sciences [1061883] Funding Source: National Science Foundation; Emerging Frontiers & Multidisciplinary Activities [0938157] Funding Source: National Science Foundation	Office of Science of the US Department of Energy (DOE)(United States Department of Energy (DOE)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Alberta Innovates; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Emerging Frontiers & Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Joint Genome Institute (JGI) contributions were supported by the Office of Science of the US Department of Energy (DOE) under contract no. 7DE-AC02-05CH11231. We thank A. Gough for assistance with figures, C. Gentemann for Fig. 3 ocean colour analysis and P. Keeling for discussions.	Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; CONTE MH, 1992, ORG GEOCHEM, V19, P287, DOI 10.1016/0146-6380(92)90044-X; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; Danbara A, 1999, PLANT CELL PHYSIOL, V40, P762, DOI 10.1093/oxfordjournals.pcp.a029603; Erdner DL, 1999, LIMNOL OCEANOGR, V44, P1609, DOI 10.4319/lo.1999.44.7.1609; Havaux M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-130; HOLLIGAN PM, 1983, NATURE, V304, P339, DOI 10.1038/304339a0; Karl D, 2002, DYNAMICS DOP BIOGEOC, P249; Kislyuk AO, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-32; Lessard EJ, 2005, LIMNOL OCEANOGR, V50, P1020, DOI 10.4319/lo.2005.50.3.1020; Nanninga HJ, 1996, MAR ECOL PROG SER, V136, P195, DOI 10.3354/meps136195; Oura T, 2010, MICROBIOL-SGM, V156, P1234, DOI 10.1099/mic.0.033985-0; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Poulton AJ, 2007, DEEP-SEA RES PT II, V54, P538, DOI 10.1016/j.dsr2.2006.12.003; Reid EL, 2011, MAR DRUGS, V9, P586, DOI 10.3390/md9040586; Rost B, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P99; Sayanova O, 2011, PHYTOCHEMISTRY, V72, P594, DOI 10.1016/j.phytochem.2011.01.022; Schulz KG, 2004, NATURE, V430, P673, DOI 10.1038/nature02631; SUNDA WG, 1992, LIMNOL OCEANOGR, V37, P25, DOI 10.4319/lo.1992.37.1.0025; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Turner D. R., 2001, BIOGEOCHEMISTRY IRON, V7, P1; Vaananen H. K., 1991, CARBONIC ANHYDRASES, P351; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Wu QY, 1999, MAR BIOTECHNOL, V1, P346, DOI 10.1007/PL00011785; Xu Y, 2006, J PHYCOL, V42, P835, DOI 10.1111/j.1529-8817.2006.00243.x; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003	28	330	349	6	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					209	213		10.1038/nature12221	http://dx.doi.org/10.1038/nature12221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23760476	Green Accepted, hybrid, Green Published			2022-12-01	WOS:000321557600062
J	Harvey, HB; Cohen, IG				Harvey, H. Benjamin; Cohen, I. Glenn			The Looming Threat of Liability for Accountable Care Organizations and What to Do About It	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Harvey, H. Benjamin] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Cohen, I. Glenn] Harvard Univ, Sch Law, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Cohen, IG (corresponding author), Harvard Univ, Sch Law, 1525 Massachusetts Ave,Griswold Hall,Room 503, Cambridge, MA 02138 USA.	igcohen@law.harvard.edu						[Anonymous], 2012, NEW RISK MAN FRONT A; Blue Cross Blue Shield of Massachusetts, 2012, MASS PAYM REF MOD RE; Emanuel EJ, 2012, JAMA-J AM MED ASSOC, V307, P2263, DOI 10.1001/jama.2012.4313; Hellinger FJ, 2005, AM J PUBLIC HEALTH, V95, P217, DOI 10.2105/AJPH.2004.037895; Orszag P, 2010, NY TIMES; Smith Christopher, 2011, Ann Health Law, V20, P165; Weisman R, 2012, BOSTON GLOBE	7	7	7	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					141	142		10.1001/jama.2013.7339	http://dx.doi.org/10.1001/jama.2013.7339			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23775236				2022-12-01	WOS:000321511500008
J	Creighton, CJ; Morgan, M; Gunaratne, PH; Wheeler, DA; Gibbs, RA; Robertson, AG; Chu, A; Beroukhim, R; Cibulskis, K; Signoretti, S; Vandin, F; Wu, HT; Raphael, BJ; Verhaak, RGW; Tamboli, P; Torres-Garcia, W; Akbani, R; Weinstein, JN; Reuter, V; Hsieh, JJ; Brannon, AR; Hakimi, AA; Jacobsen, A; Ciriello, G; Reva, B; Ricketts, CJ; Linehan, WM; Stuart, JM; Rathmell, WK; Shen, H; Laird, PW; Muzny, D; Davis, C; Morgan, M; Xi, L; Chang, K; Kakkar, N; Trevino, LR; Benton, S; Reid, JG; Morton, D; Doddapaneni, H; Han, Y; Lewis, L; Dinh, H; Kovar, C; Zhu, YM; Santibanez, J; Wang, M; Hale, W; Kalra, D; Creighton, CJ; Wheeler, DA; Gibbs, RA; Getz, G; Cibulskis, K; Lawrence, MS; Sougnez, C; Carter, SL; Sivachenko, A; Lichtenstein, L; Stewart, C; Voet, D; Fisher, S; Gabriel, SB; Lander, E; Beroukhim, R; Schumacher, SE; Tabak, B; Saksena, G; Onofrio, RC; Carter, SL; Cherniack, AD; Gentry, J; Ardlie, K; Sougnez, C; Getz, G; Gabriel, SB; Meyerson, M; Robertson, AG; Chu, AD; Chun, HJE; Mungall, AJ; Sipahimalani, P; Stoll, D; Ally, A; Balasundaram, M; Butterfield, YSN; Carlsen, R; Carter, C; Chuah, E; Coope, RJN; Dhalla, N; Gorski, S; Guin, R; Hirst, C; Hirst, M; Holt, RA; Lebovitz, C; Lee, D; Li, HYI; Mayo, M; Moore, RA; Pleasance, E; Plettner, P; Schein, JE; Shafiei, A; Slobodan, JR; Tam, A; Thiessen, N; Varhol, RJ; Wye, N; Zhao, YJ; Birol, I; Jones, SJM; Marra, MA; Auman, JT; Tan, DH; Jones, CD; Hoadley, KA; Mieczkowski, PA; Mose, LE; Jefferys, SR; Topal, M; Liquori, C; Turman, YJ; Shi, Y; Waring, S; Buda, E; Walsh, J; Wu, JY; Bodenheimer, T; Hoyle, AP; Simons, JV; Soloway, M; Balu, S; Parker, JS; Hayes, DN; Perou, CM; Kucherlapati, R; Park, P; Shen, H; Triche, T; Weisenberger, DJ; Lai, PH; Bootwalla, MS; Maglinte, DT; Mahurkar, S; Berman, BP; Van den Berg, DJ; Cope, L; Baylin, SB; Laird, PW; Creighton, CJ; Wheeler, DA; Getz, G; Noble, MS; DiCara, D; Zhang, HL; Cho, J; Heiman, DI; Gehlenborg, N; Voet, D; Mallard, W; Lin, P; Frazer, S; Stojanov, P; Liu, YC; Zhou, LH; Kim, J; Lawrence, MS; Chin, L; Vandin, F; Wu, HT; Raphael, BJ; Benz, C; Yau, C; Reynolds, SM; Shmulevich, I; Verhaak, RGW; Torres-Garcia, W; Vegesna, R; Kim, H; Zhang, W; Cogdell, D; Jonasch, E; Ding, ZY; Lu, YL; Akbani, R; Zhang, NX; Unruh, AK; Casasent, TD; Wakefield, C; Tsavachidou, D; Chin, L; Mills, GB; Weinstein, JN; Jacobsen, A; Brannon, AR; Ciriello, G; Schultz, N; Hakimi, AA; Reva, B; Antipin, Y; Gao, JJ; Cerami, E; Gross, B; Aksoy, BA; Sinha, R; Weinhold, N; Sumer, SO; Taylor, BS; Shen, RL; Ostrovnaya, I; Hsieh, JJ; Berger, MF; Ladanyi, M; Sander, C; Fei, SS; Stout, A; Spellman, PT; Rubin, DL; Liu, TT; Stuart, JM; Ng, S; Paull, EO; Carlin, D; Goldstein, T; Waltman, P; Ellrott, K; Zhu, J; Haussler, D; Gunaratne, PH; Xiao, WM; Shelton, C; Gardner, J; Penny, R; Sherman, M; Mallery, D; Morris, S; Paulauskis, J; Burnett, K; Shelton, T; Signoretti, S; Kaelin, WG; Choueiri, T; Atkins, MB; Penny, R; Burnett, K; Mallery, D; Curley, E; Tickoo, S; Reuter, V; Rathmell, WK; Thorne, L; Boice, L; Huang, M; Fisher, JC; Linehan, WM; Vocke, CD; Peterson, J; Worrell, R; Merino, MJ; Schmidt, LS; Tamboli, P; Czerniak, BA; Aldape, KD; Wood, CG; Boyd, J; Weaver, J; Iacocca, MV; Petrelli, N; Witkin, G; Brown, J; Czerwinski, C; Huelsenbeck-Dill, L; Rabeno, B; Myers, J; Morrison, C; Bergsten, J; Eckman, J; Harr, J; Smith, C; Tucker, K; Zach, LA; Bshara, W; Gaudioso, C; Morrison, C; Dhir, R; Maranchie, J; Nelson, J; Parwani, A; Potapova, O; Fedosenko, K; Cheville, JC; Thompson, RH; Signoretti, S; Kaelin, WG; Atkins, MB; Tickoo, S; Reuter, V; Linehan, WM; Vocke, CD; Peterson, J; Merino, MJ; Schmidt, LS; Tamboli, P; Mosquera, JM; Rubin, MA; Blute, ML; Rathmell, WK; Pihl, T; Jensen, M; Sfeir, R; Kahn, A; Chu, A; Kothiyal, P; Snyder, E; Pontius, J; Ayala, B; Backus, M; Walton, J; Baboud, J; Berton, D; Nicholls, M; Srinivasan, D; Raman, R; Girshik, S; Kigonya, P; Alonso, S; Sanbhadti, R; Barletta, S; Pot, D; Sheth, M; Demchok, JA; Davidsen, T; Wang, ZN; Yang, LM; Tarnuzzer, RW; Zhang, JS; Eley, G; Ferguson, ML; Shaw, KRM; Guyer, MS; Ozenberger, BA; Sofia, HJ				Creighton, Chad J.; Morgan, Margaret; Gunaratne, Preethi H.; Wheeler, David A.; Gibbs, Richard A.; Robertson, A. Gordon; Chu, Andy; Beroukhim, Rameen; Cibulskis, Kristian; Signoretti, Sabina; Vandin, Fabio; Wu, Hsin-Ta; Raphael, Benjamin J.; Verhaak, Roel G. W.; Tamboli, Pheroze; Torres-Garcia, Wandaliz; Akbani, Rehan; Weinstein, John N.; Reuter, Victor; Hsieh, James J.; Brannon, A. Rose; Hakimi, A. Ari; Jacobsen, Anders; Ciriello, Giovanni; Reva, Boris; Ricketts, Christopher J.; Linehan, W. Marston; Stuart, Joshua M.; Rathmell, W. Kimryn; Shen, Hui; Laird, Peter W.; Muzny, Donna; Davis, Caleb; Morgan, Margaret; Xi, Liu; Chang, Kyle; Kakkar, Nipun; Trevino, Lisa R.; Benton, Susan; Reid, Jeffrey G.; Morton, Donna; Doddapaneni, Harsha; Han, Yi; Lewis, Lora; Dinh, Huyen; Kovar, Christie; Zhu, Yiming; Santibanez, Jireh; Wang, Min; Hale, Walker; Kalra, Divya; Creighton, Chad J.; Wheeler, David A.; Gibbs, Richard A.; Getz, Gad; Cibulskis, Kristian; Lawrence, Michael S.; Sougnez, Carrie; Carter, Scott L.; Sivachenko, Andrey; Lichtenstein, Lee; Stewart, Chip; Voet, Doug; Fisher, Sheila; Gabriel, Stacey B.; Lander, Eric; Beroukhim, Rameen; Schumacher, Steve E.; Tabak, Barbara; Saksena, Gordon; Onofrio, Robert C.; Carter, Scott L.; Cherniack, Andrew D.; Gentry, Jeff; Ardlie, Kristin; Sougnez, Carrie; Getz, Gad; Gabriel, Stacey B.; Meyerson, Matthew; Robertson, A. Gordon; Chu, Andy; Chun, Hye-Jung E.; Mungall, Andrew J.; Sipahimalani, Payal; Stoll, Dominik; Ally, Adrian; Balasundaram, Miruna; Butterfield, Yaron S. N.; Carlsen, Rebecca; Carter, Candace; Chuah, Eric; Coope, Robin J. N.; Dhalla, Noreen; Gorski, Sharon; Guin, Ranabir; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Lebovitz, Chandra; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Pleasance, Erin; Plettner, Patrick; Schein, Jacqueline E.; Shafiei, Arash; Slobodan, Jared R.; Tam, Angela; Thiessen, Nina; Varhol, Richard J.; Wye, Natasja; Zhao, Yongjun; Birol, Inanc; Jones, Steven J. M.; Marra, Marco A.; Auman, J. Todd; Tan, Donghui; Jones, Corbin D.; Hoadley, Katherine A.; Mieczkowski, Piotr A.; Mose, Lisle E.; Jefferys, Stuart R.; Topal, MichaelD.; Liquori, Christina; Turman, Yidi J.; Shi, Yan; Waring, Scot; Buda, Elizabeth; Walsh, Jesse; Wu, Junyuan; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, MathewG.; Balu, Saianand; Parker, Joel S.; Hayes, D. Neil; Perou, Charles M.; Kucherlapati, Raju; Park, Peter; Shen, Hui; Triche, Timothy, Jr.; Weisenberger, Daniel J.; Lai, Phillip H.; Bootwalla, Moiz S.; Maglinte, Dennis T.; Mahurkar, Swapna; Berman, Benjamin P.; Van den Berg, David J.; Cope, Leslie; Baylin, Stephen B.; Laird, Peter W.; Creighton, Chad J.; Wheeler, David A.; Getz, Gad; Noble, Michael S.; DiCara, Daniel; Zhang, Hailei; Cho, Juok; Heiman, David I.; Gehlenborg, Nils; Voet, Doug; Mallard, William; Lin, Pei; Frazer, Scott; Stojanov, Petar; Liu, Yingchun; Zhou, Lihua; Kim, Jaegil; Lawrence, Michael S.; Chin, Lynda; Vandin, Fabio; Wu, Hsin-Ta; Raphael, Benjamin J.; Benz, Christopher; Yau, Christina; Reynolds, Sheila M.; Shmulevich, Ilya; Verhaak, Roel G. W.; Torres-Garcia, Wandaliz; Vegesna, Rahul; Kim, Hoon; Zhang, Wei; Cogdell, David; Jonasch, Eric; Ding, Zhiyong; Lu, Yiling; Akbani, Rehan; Zhang, Nianxiang; Unruh, Anna K.; Casasent, Tod D.; Wakefield, Chris; Tsavachidou, Dimitra; Chin, Lynda; Mills, Gordon B.; Weinstein, John N.; Jacobsen, Anders; Brannon, A. Rose; Ciriello, Giovanni; Schultz, Nikolaus; Hakimi, A. Ari; Reva, Boris; Antipin, Yevgeniy; Gao, Jianjiong; Cerami, Ethan; Gross, Benjamin; Aksoy, B. Arman; Sinha, Rileen; Weinhold, Nils; Sumer, S. Onur; Taylor, Barry S.; Shen, Ronglai; Ostrovnaya, Irina; Hsieh, James J.; Berger, Michael F.; Ladanyi, Marc; Sander, Chris; Fei, Suzanne S.; Stout, Andrew; Spellman, Paul T.; Rubin, Daniel L.; Liu, Tiffany T.; Stuart, Joshua M.; Sam Ng; Paull, Evan O.; Carlin, Daniel; Goldstein, Theodore; Waltman, Peter; Ellrott, Kyle; Zhu, Jing; Haussler, David; Gunaratne, Preethi H.; Xiao, Weimin; Shelton, Candace; Gardner, Johanna; Penny, Robert; Sherman, Mark; Mallery, David; Morris, Scott; Paulauskis, Joseph; Burnett, Ken; Shelton, Troy; Signoretti, Sabina; Kaelin, William G.; Choueiri, Toni; Atkins, Michael B.; Penny, Robert; Burnett, Ken; Mallery, David; Curley, Erin; Tickoo, Satish; Reuter, Victor; Rathmell, W. Kimryn; Thorne, Leigh; Boice, Lori; Huang, Mei; Fisher, Jennifer C.; Linehan, W. Marston; Vocke, Cathy D.; Peterson, James; Worrell, Robert; Merino, Maria J.; Schmidt, Laura S.; Tamboli, Pheroze; Czerniak, Bogdan A.; Aldape, Kenneth D.; Wood, Christopher G.; Boyd, Jeff; Weaver, JoEllen; Iacocca, Mary V.; Petrelli, Nicholas; Witkin, Gary; Brown, Jennifer; Czerwinski, Christine; Huelsenbeck-Dill, Lori; Rabeno, Brenda; Myers, Jerome; Morrison, Carl; Bergsten, Julie; Eckman, John; Harr, Jodi; Smith, Christine; Tucker, Kelinda; Zach, Leigh Anne; Bshara, Wiam; Gaudioso, Carmelo; Morrison, Carl; Dhir, Rajiv; Maranchie, Jodi; Nelson, Joel; Parwani, Anil; Potapova, Olga; Fedosenko, Konstantin; Cheville, John C.; Thompson, R. Houston; Signoretti, Sabina; Kaelin, William G.; Atkins, Michael B.; Tickoo, Satish; Reuter, Victor; Linehan, W. Marston; Vocke, Cathy D.; Peterson, James; Merino, Maria J.; Schmidt, Laura S.; Tamboli, Pheroze; Mosquera, Juan M.; Rubin, Mark A.; Blute, Michael L.; Rathmell, W. Kimryn; Pihl, Todd; Jensen, Mark; Sfeir, Robert; Kahn, Ari; Chu, Anna; Kothiyal, Prachi; Snyder, Eric; Pontius, Joan; Ayala, Brenda; Backus, Mark; Walton, Jessica; Baboud, Julien; Berton, Dominique; Nicholls, Matthew; Srinivasan, Deepak; Raman, Rohini; Girshik, Stanley; Kigonya, Peter; Alonso, Shelley; Sanbhadti, Rashmi; Barletta, Sean; Pot, David; Sheth, Margi; Demchok, John A.; Davidsen, Tanja; Wang, Zhining; Yang, Liming; Tarnuzzer, Roy W.; Zhang, Jiashan; Eley, Greg; Ferguson, Martin L.; Shaw, Kenna R. Mills; Guyer, Mark S.; Ozenberger, Bradley A.; Sofia, Heidi J.		Canc Genome Atlas Res Network; Anal Working Grp	Comprehensivemolecular characterization of clear cell renal cell carcinoma	NATURE			English	Article							KIDNEY CANCER; TUMOR-SUPPRESSOR; GENETIC-BASIS; METHYLATION; PROTEIN; ARM	Genetic changes underlying clear cell renal cell carcinoma(ccRCC) include alterations in genes controlling cellular oxygen sensing (for example, VHL) and the maintenance of chromatin states (for example, PBRM1). We surveyed more than 400 tumours using different genomic platforms and identified 19 significantly mutated genes. The PI(3) K/AKT pathway was recurrently mutated, suggesting this pathway as a potential therapeutic target. Widespread DNA hypomethylation was associated with mutation of the H3K36 methyltransferase SETD2, and integrative analysis suggested that mutations involving the SWI/SNF chromatin remodelling complex (PBRM1, ARID1A, SMARCA4) could have far-reaching effects on other pathways. Aggressive cancers demonstrated evidence of a metabolic shift, involving downregulation of genes involved in the TCA cycle, decreased AMPK and PTEN protein levels, upregulation of the pentose phosphate pathway and the glutamine transporter genes, increased acetyl-CoA carboxylase protein, and altered promoter methylation of miR-21 (also known as MIR21) and GRB10. Remodelling cellular metabolism thus constitutes a recurrent pattern in ccRCC that correlates with tumour stage and severity and offers new views on the opportunities for disease treatment.	[Creighton, Chad J.; Morgan, Margaret; Gunaratne, Preethi H.; Wheeler, David A.; Gibbs, Richard A.; Muzny, Donna; Davis, Caleb; Xi, Liu; Chang, Kyle; Kakkar, Nipun; Trevino, Lisa R.; Benton, Susan; Reid, Jeffrey G.; Morton, Donna; Doddapaneni, Harsha; Han, Yi; Lewis, Lora; Dinh, Huyen; Kovar, Christie; Zhu, Yiming; Santibanez, Jireh; Wang, Min; Hale, Walker; Kalra, Divya] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Xiao, Weimin] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Robertson, A. Gordon; Chu, Andy; Chun, Hye-Jung E.; Mungall, Andrew J.; Sipahimalani, Payal; Stoll, Dominik; Ally, Adrian; Balasundaram, Miruna; Butterfield, Yaron S. N.; Carlsen, Rebecca; Carter, Candace; Chuah, Eric; Coope, Robin J. N.; Dhalla, Noreen; Gorski, Sharon; Guin, Ranabir; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Lebovitz, Chandra; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Pleasance, Erin; Plettner, Patrick; Schein, Jacqueline E.; Shafiei, Arash; Slobodan, Jared R.; Tam, Angela; Thiessen, Nina; Varhol, Richard J.; Wye, Natasja; Zhao, Yongjun; Birol, Inanc; Jones, Steven J. M.; Marra, Marco A.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z, Canada; [Beroukhim, Rameen; Beroukhim, Rameen; Carter, Scott L.] Harvard Univ, Dept Med, Sch Med, Boston, MA 02215 USA; [Beroukhim, Rameen; Cibulskis, Kristian; Getz, Gad; Lawrence, Michael S.; Sougnez, Carrie; Carter, Scott L.; Sivachenko, Andrey; Lichtenstein, Lee; Stewart, Chip; Voet, Doug; Fisher, Sheila; Gabriel, Stacey B.; Lander, Eric; Beroukhim, Rameen; Schumacher, Steve E.; Tabak, Barbara; Saksena, Gordon; Onofrio, Robert C.; Cherniack, Andrew D.; Gentry, Jeff; Ardlie, Kristin; Meyerson, Matthew; Noble, Michael S.; DiCara, Daniel; Zhang, Hailei; Cho, Juok; Heiman, David I.; Gehlenborg, Nils; Mallard, William; Lin, Pei; Frazer, Scott; Stojanov, Petar; Liu, Yingchun; Zhou, Lihua; Kim, Jaegil; Chin, Lynda] Eli & Edythe L Broad Inst Massachusetts Inst Tech, Cambridge, MA 02142 USA; [Beroukhim, Rameen; Carter, Scott L.; Sivachenko, Andrey; Lichtenstein, Lee; Stewart, Chip; Fisher, Sheila; Lander, Eric; Beroukhim, Rameen; Schumacher, Steve E.; Tabak, Barbara; Saksena, Gordon; Onofrio, Robert C.; Cherniack, Andrew D.; Gentry, Jeff; Ardlie, Kristin; Meyerson, Matthew; Noble, Michael S.; DiCara, Daniel; Zhang, Hailei; Cho, Juok; Heiman, David I.; Gehlenborg, Nils; Mallard, William; Lin, Pei; Frazer, Scott; Stojanov, Petar; Liu, Yingchun; Zhou, Lihua; Kim, Jaegil] Harvard Univ, Cambridge, MA 02142 USA; [Signoretti, Sabina; Meyerson, Matthew] Harvard Univ, Dept Pathol, Sch Med, Boston, MA 02215 USA; [Vandin, Fabio; Wu, Hsin-Ta; Raphael, Benjamin J.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Verhaak, Roel G. W.; Torres-Garcia, Wandaliz; Akbani, Rehan; Weinstein, John N.; Vegesna, Rahul; Kim, Hoon; Jonasch, Eric; Ding, Zhiyong; Zhang, Nianxiang; Unruh, Anna K.; Casasent, Tod D.; Wakefield, Chris] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Tamboli, Pheroze; Zhang, Wei; Cogdell, David; Czerniak, Bogdan A.; Aldape, Kenneth D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Reuter, Victor; Brannon, A. Rose; Berger, Michael F.; Tickoo, Satish] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Hsieh, James J.; Hakimi, A. Ari; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Jacobsen, Anders; Ciriello, Giovanni; Reva, Boris; Schultz, Nikolaus; Antipin, Yevgeniy; Gao, Jianjiong; Cerami, Ethan; Gross, Benjamin; Aksoy, B. Arman; Sinha, Rileen; Weinhold, Nils; Sumer, S. Onur; Taylor, Barry S.; Shen, Ronglai; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Ricketts, Christopher J.; Linehan, W. Marston; Vocke, Cathy D.; Peterson, James; Worrell, Robert; Merino, Maria J.; Schmidt, Laura S.] NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Stuart, Joshua M.; Sam Ng; Paull, Evan O.; Carlin, Daniel; Goldstein, Theodore; Waltman, Peter; Ellrott, Kyle; Zhu, Jing; Haussler, David] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Sam Ng; Paull, Evan O.; Carlin, Daniel; Goldstein, Theodore; Waltman, Peter; Ellrott, Kyle; Zhu, Jing; Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Rathmell, W. Kimryn; Hoadley, Katherine A.; Liquori, Christina; Turman, Yidi J.; Shi, Yan; Waring, Scot; Buda, Elizabeth; Walsh, Jesse; Wu, Junyuan; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, MathewG.; Balu, Saianand; Parker, Joel S.; Hayes, D. Neil; Perou, Charles M.; Thorne, Leigh; Boice, Lori; Huang, Mei; Fisher, Jennifer C.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Shen, Hui; Laird, Peter W.; Triche, Timothy, Jr.; Weisenberger, Daniel J.; Lai, Phillip H.; Bootwalla, Moiz S.; Maglinte, Dennis T.; Mahurkar, Swapna; Berman, Benjamin P.; Van den Berg, David J.] Univ So Calif, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Auman, J. Todd] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Tan, Donghui] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Jones, Corbin D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Hoadley, Katherine A.; Mose, Lisle E.; Topal, MichaelD.; Perou, Charles M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Hoadley, Katherine A.; Mieczkowski, Piotr A.; Jefferys, Stuart R.; Topal, MichaelD.; Perou, Charles M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Hayes, D. Neil] Univ N Carolina, Dept Internal Med, Div Med Oncol, Chapel Hill, NC 27599 USA; [Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Kucherlapati, Raju; Park, Peter] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Park, Peter; Gehlenborg, Nils] Harvard Univ, Ctr Biomed Informat, Sch Med, Boston, MA 02115 USA; [Park, Peter] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Cope, Leslie; Baylin, Stephen B.] Johns Hopkins Univ, Canc Biol Div, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Reynolds, Sheila M.; Shmulevich, Ilya] Inst Syst Biol, Seattle, WA 98109 USA; [Lu, Yiling; Tsavachidou, Dimitra; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77054 USA; [Ostrovnaya, Irina] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Fei, Suzanne S.; Stout, Andrew; Spellman, Paul T.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portand, OR 97239 USA; [Rubin, Daniel L.; Liu, Tiffany T.] Stanford Univ, Dept Radiol, Med Ctr, Stanford, CA 94305 USA; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Shelton, Candace; Gardner, Johanna; Penny, Robert; Sherman, Mark; Mallery, David; Morris, Scott; Paulauskis, Joseph; Burnett, Ken; Shelton, Troy; Curley, Erin] Int Genom Consortium, Phoenix, AZ 85004 USA; [Atkins, Michael B.] Georgetown Univ, Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; SAIC Frederick Inc, Basic Sci Program, Frederick Natl Lab, Frederick, MD 21702 USA; [Wood, Christopher G.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Boyd, Jeff; Weaver, JoEllen] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Iacocca, Mary V.; Petrelli, Nicholas; Witkin, Gary; Brown, Jennifer; Czerwinski, Christine; Huelsenbeck-Dill, Lori; Rabeno, Brenda] Christiana Care, Helen F Graham Canc Ctr, Newark, DC 19713 USA; [Myers, Jerome; Morrison, Carl; Bergsten, Julie; Eckman, John; Harr, Jodi; Smith, Christine; Tucker, Kelinda; Zach, Leigh Anne] Penrose St Francis Hlth Serv, Colorado Springs, CO 80907 USA; [Bshara, Wiam; Gaudioso, Carmelo; Morrison, Carl] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Dhir, Rajiv; Maranchie, Jodi; Nelson, Joel; Parwani, Anil] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Potapova, Olga] Cureline Inc, San Francisco, CA 94080 USA; [Fedosenko, Konstantin] St Petersburg City Clin Oncol Dispensary, St Petersburg 198255, Russia; [Mosquera, Juan M.; Rubin, Mark A.] Weill Cornell Coll Med, Dept Pathol & Lab Med, New York, NY 10065 USA; [Blute, Michael L.] Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; [Pihl, Todd; Jensen, Mark; Sfeir, Robert; Kahn, Ari; Chu, Anna; Kothiyal, Prachi; Snyder, Eric; Pontius, Joan; Ayala, Brenda; Backus, Mark; Walton, Jessica; Baboud, Julien; Berton, Dominique; Nicholls, Matthew; Srinivasan, Deepak; Raman, Rohini; Girshik, Stanley; Kigonya, Peter; Alonso, Shelley; Sanbhadti, Rashmi; Barletta, Sean; Pot, David] SRA Int, Fairfax, VA 22033 USA; [Sheth, Margi; Demchok, John A.; Davidsen, Tanja; Wang, Zhining; Yang, Liming; Tarnuzzer, Roy W.; Zhang, Jiashan; Shaw, Kenna R. Mills] NCI, Canc Genome Atlas Program Off, Ctr Canc Genom, Bethesda, MD 20892 USA; [Eley, Greg] TCGA Consultant Scimentis LLC, Atlanta, GA 30666 USA; [Ferguson, Martin L.] MLF Consulting, Arlington, MA 02474 USA; [Guyer, Mark S.; Ozenberger, Bradley A.; Sofia, Heidi J.] NHGRI, NIH, Bethesda, MD 20892 USA; [Beroukhim, Rameen; Meyerson, Matthew; Stojanov, Petar; Kaelin, William G.; Choueiri, Toni] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Benz, Christopher; Yau, Christina] Buck Inst Res Aging, Novato, CA 94945 USA; [Beroukhim, Rameen; Schumacher, Steve E.; Tabak, Barbara] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Cheville, John C.; Thompson, R. Houston] Mayo Clin, Rochester, MN 55905 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston; British Columbia Cancer Agency; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Brown University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Johns Hopkins University; Johns Hopkins Medicine; Institute for Systems Biology (ISB); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Stanford University; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; International Genomics Consortium; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Texas System; UTMD Anderson Cancer Center; Fox Chase Cancer Center; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; Roswell Park Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cornell University; Weill Cornell Medical College Qatar; Harvard University; Massachusetts General Hospital; SRA International; International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Dana-Farber Cancer Institute; Buck Institute for Research on Aging; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Mayo Clinic; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Gibbs, RA (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	agibbs@bcm.edu; linehanm@mail.nih.gov	Reva, Boris A./B-6436-2014; Gao, JianJiong/B-5673-2016; Gorski, Sharon M/E-9375-2012; Schultz, Nikolaus/ABE-6347-2020; Schumacher, Steven/E-9821-2013; Ladanyi, Marc/AAG-8585-2019; Kim, Hoon/AAL-9283-2020; Cibulskis, Kristian/AAC-7380-2019; parwani, anil/AAH-5464-2020; Jones, Steven J/C-3621-2009; , Pathology Services Core/CEZ-2246-2022; Lawrence, Michael/AAC-8202-2020; Hirst, Martin/B-7684-2016; Cherniack, Andrew/AAC-5310-2019; Perou, Charles M/H-9934-2014; Choueiri, Toni/K-5238-2019; Holt, Robert A/C-3303-2009; Schein, Jacquie E/G-3674-2015; Kalra, D/H-6661-2019; Birol, Inanc/G-5440-2011; Kalra, Divya/N-5453-2014; Parker, Joel/AAG-1108-2019; Akbani, Rehan/AAG-1490-2019; Van Den Berg, David J/G-8598-2017; Stojanov, Petar/GQI-4462-2022; Reva, Boris/AAB-8932-2022; Verhaak, Roel/ABE-7058-2020; Kucherlapati, Raju/ABC-8807-2021; Maranchie, Jodi/AAG-1035-2020; Marra, Marco A/B-5987-2008; Ricketts, Christopher/AAV-9580-2020; Mungall, Andrew J./U-7067-2018; Weisenberger, Daniel/AAA-8314-2020; Laird, Peter W/G-8683-2012; Shen, Hui/AAO-4387-2020; Wheeler, David A/M-9740-2018; Skanderup, Anders Jacobsen/K-1081-2013; Torres-Garcia, Wandaliz/L-6347-2017; Berman, Benjamin P/D-5942-2014; BERMAN, BENJAMIN/AAT-3720-2021; Cherniack, Andrew D./AAY-8132-2020	Reva, Boris A./0000-0002-8805-389X; Gao, JianJiong/0000-0002-5739-1781; Gorski, Sharon M/0000-0002-3821-8289; Schumacher, Steven/0000-0002-6819-5647; Kim, Hoon/0000-0003-4244-6126; Jones, Steven J/0000-0003-3394-2208; Perou, Charles M/0000-0001-9827-2247; Choueiri, Toni/0000-0002-9201-3217; Holt, Robert A/0000-0002-7259-1247; Kalra, D/0000-0001-5254-4067; Birol, Inanc/0000-0003-0950-7839; Van Den Berg, David J/0000-0002-5404-5218; Stojanov, Petar/0000-0001-7815-776X; Marra, Marco A/0000-0001-7146-7175; Mungall, Andrew J./0000-0002-0905-2742; Weisenberger, Daniel/0000-0001-8303-2603; Laird, Peter W/0000-0001-9117-3641; Wheeler, David A/0000-0002-9056-6299; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Berman, Benjamin P/0000-0002-2099-9005; BERMAN, BENJAMIN/0000-0002-2099-9005; Cherniack, Andrew D./0000-0003-0470-0111; Hoadley, Katherine/0000-0002-1216-477X; Cibulskis, Kristian/0000-0003-1343-1582; Stuart, Joshua/0000-0002-2171-565X; parwani, anil/0000-0002-7616-1666; Rubin, Mark/0000-0002-8321-9950; Meyerson, Matthew/0000-0002-9133-8108; Tarnuzzer, Roy/0000-0002-3725-4173; Triche, Tim/0000-0001-5665-946X; Maranchie, Jodi/0000-0002-8534-9468; Davis, Caleb/0000-0002-5125-0494; Gehlenborg, Nils/0000-0003-0327-8297; Schultz, Nikolaus/0000-0002-0131-4904; Ciriello, Giovanni/0000-0003-2021-8683; Stoll, Dominik/0000-0003-0701-4301; Auman, James/0000-0002-9328-8829; Heiman, David/0000-0001-7895-4259; Mieczkowski, Piotr/0000-0003-2418-0096; Weinstein, John/0000-0001-9401-6908; Shen, Hui/0000-0001-9767-4084; doddapaneni, harshavardhan/0000-0002-2433-633X; Mahurkar-Joshi, Swapna/0000-0001-9591-4590; Lebovitz, Chandra/0000-0002-8679-0431; Fei, Suzanne/0000-0002-9688-2890; Kothiyal, Prachi/0000-0002-5457-3029; Stout, Andrew/0000-0001-9470-1032; Pot, David/0000-0002-1480-9826; Jensen, Mark/0000-0001-5215-101X; Casasent, Anna/0000-0002-7857-179X; Chang, Kyle/0000-0001-5295-9676; Sinha, Rileen/0000-0001-5497-5055; Benton, Susan/0000-0002-7694-2091	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NCI NIH HHS [U24 CA143840, U24 CA143845, U24 CA143843, U24 CA143835, U24 CA143848, U24 CA143866, U24 CA143883, K24 CA172355, T32 CA082088, T32 CA071341, P30 CA016672, U24 CA143858, P30 CA008748, U24 CA144025, U24 CA143799, U24 CA143882, U24 CA143867, R01 CA068490] Funding Source: Medline; NHGRI NIH HHS [U54 HG003079, U54 HG003273, R01 HG005690, U54 HG003067] Funding Source: Medline; Div Of Biological Infrastructure [0845783] Funding Source: National Science Foundation	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brannon A Rose, 2010, Genes Cancer, V1, P152; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Clark J, 1997, ONCOGENE, V15, P2233, DOI 10.1038/sj.onc.1201394; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Hakimi A.A., 2013, CLIN CANC RES; He X, 2011, ONCOGENE, V30, P535, DOI 10.1038/onc.2010.427; Herbers J, 1997, GENE CHROMOSOME CANC, V19, P29, DOI 10.1002/(SICI)1098-2264(199705)19:1<29::AID-GCC5>3.3.CO;2-J; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Linehan WM, 2003, J UROLOGY, V170, P2163, DOI 10.1097/01.ju.0000096060.92397.ed; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Modena P, 2003, ONCOGENE, V22, P4586, DOI 10.1038/sj.onc.1206472; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Ravaud A, 2008, J CLIN ONCOL, V26, P2285, DOI 10.1200/JCO.2007.14.5029; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Tong WH, 2011, CANCER CELL, V20, P315, DOI 10.1016/j.ccr.2011.07.018; Vandin F, 2011, J COMPUT BIOL, V18, P507, DOI 10.1089/cmb.2010.0265; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0	33	1897	1913	9	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					43	+		10.1038/nature12222	http://dx.doi.org/10.1038/nature12222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23792563	Green Accepted, hybrid, Green Submitted, Green Published			2022-12-01	WOS:000321285600029
J	Hu, YW; Lu, SH; Song, ZG; Wang, W; Hao, P; Li, JH; Zhang, XN; Yen, HL; Shi, BS; Li, T; Guan, WC; Xu, L; Liu, Y; Wang, S; Zhang, XL; Tian, D; Zhu, ZQ; He, J; Huang, K; Chen, HJ; Zheng, LL; Li, X; Ping, J; Kang, B; Xi, XH; Zha, LJ; Li, YX; Zhang, ZY; Peiris, M; Yuan, ZH				Hu, Yunwen; Lu, Shuihua; Song, Zhigang; Wang, Wei; Hao, Pei; Li, Jianhua; Zhang, Xiaonan; Yen, Hui-Ling; Shi, Bisheng; Li, Tao; Guan, Wencai; Xu, Lei; Liu, Yi; Wang, Sen; Zhang, Xiaoling; Tian, Di; Zhu, Zhaoqin; He, Jing; Huang, Kai; Chen, Huijie; Zheng, Lulu; Li, Xuan; Ping, Jie; Kang, Bin; Xi, Xiuhong; Zha, Lijun; Li, Yixue; Zhang, Zhiyong; Peiris, Malik; Yuan, Zhenghong			Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance	LANCET			English	Article							MUTATIONS	Background On March 30, a novel influenza A subtype H7N9 virus (A/H7N9) was detected in patients with severe respiratory disease in eastern China. Virological factors associated with a poor clinical outcome for this virus remain unclear. We quantified the viral load and analysed antiviral resistance mutations in specimens from patients with A/H7N9. Methods We studied 14 patients with A/H7N9 disease admitted to the Shanghai Public Health Clinical Centre (SPHCC), China, between April 4, and April 20, 2013, who were given antiviral treatment (oseltamivir or peramivir) for less than 2 days before admission. We investigated the viral load in throat, stool, serum, and urine specimens obtained sequentially from these patients. We also sequenced viral RNA from these specimens to study the mutations associated with resistance to neuraminidase inhibitors and their association with disease outcome. Findings All patients developed pneumonia, seven of them required mechanical ventilation, and three of them further deteriorated to become dependent on extracorporeal membrane oxygenation (ECMO), two of whom died. Antiviral treatment was associated with a reduction of viral load in throat swab specimens in 11 surviving patients. Three patients with persistently high viral load in the throat in spite of antiviral therapy became ECMO dependent. An Arg292Lys mutation in the virus neuraminidase (NA) gene known to confer resistance to both zanamivir and oseltamivir was identified in two of these patients, both also received corticosteroid treatment. In one of them, wild-type sequence Arg292 was noted 2 days after start of antiviral treatment, and the resistant mutant Lys292 dominated 9 days after start of treatment. Interpretation Reduction of viral load following antiviral treatment correlated with improved outcome. Emergence of NA Arg292Lys mutation in two patients who also received corticosteroid treatment led to treatment failure and a poor clinical outcome. The emergence of antiviral resistance in A/H7N9 viruses, especially in patients receiving corticosteroid therapy, is concerning, needs to be closely monitored, and considered in pandemic preparedness planning.	[Hu, Yunwen; Song, Zhigang; Wang, Wei; Zhang, Xiaonan; Shi, Bisheng; Guan, Wencai; Xu, Lei; Liu, Yi; Zhang, Xiaoling; Tian, Di; Zhu, Zhaoqin; He, Jing; Kang, Bin; Zhang, Zhiyong] Fudan Univ, Shanghai Med Coll, Dept Pathogen Diag & Biosafety, Shanghai Publ Hlth Clin Ctr,Key Lab Med Mol Virol, Shanghai 200030, Peoples R China; [Wang, Sen; Li, Yixue; Yuan, Zhenghong] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol, Shanghai 200030, Peoples R China; [Lu, Shuihua; Li, Tao; Xi, Xiuhong; Zha, Lijun] Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai 200030, Peoples R China; [Hao, Pei; Ping, Jie] Chinese Acad Sci, Inst Pasteur Shanghai, Pathogen Diagnost Ctr, Shanghai, Peoples R China; [Huang, Kai; Chen, Huijie; Zheng, Lulu; Li, Xuan; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Yen, Hui-Ling; Peiris, Malik] Univ Hong Kong, Sch Publ Hlth, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; University of Hong Kong	Yuan, ZH (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol, 138 Yi Xue Yuan Rd, Shanghai 200030, Peoples R China.	malik@hkucc.hku.hk; zhyuan@shaphc.org	zheng, lu/GXH-7035-2022; Yen, Hui-Ling/GNH-5083-2022; Yen, Hui-Ling/C-4501-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Yen, Hui-Ling/0000-0003-2493-3609; Zhang, Xiaonan/0000-0002-1286-7280; Hao, Pei/0000-0002-1498-7059; Li, Jianhua/0000-0001-7329-5688; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995	National Megaprojects of China for Infectious Diseases [2012ZX10004211]; National Natural Science Foundation of China [81341004]; Ministry of Science and Technology [KJYJ-2013-01-01]; Shanghai Municipal Health and Family Planning Commission; National Key Basic Research Program of China [2012CB519000]; Area of Excellence Scheme of the University Grants Committee [AoE/M-12/06]; Hong Kong SAR Government; National Institutes of Health (NIAID) [HHSN266200700005C]	National Megaprojects of China for Infectious Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Shanghai Municipal Health and Family Planning Commission; National Key Basic Research Program of China(National Basic Research Program of China); Area of Excellence Scheme of the University Grants Committee; Hong Kong SAR Government; National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Yumei Wen (Shanghai Medical College of Fudan University) and Guoping Zhao (Shanghai Institutes for Biological Sciences, CAS) for their valuable suggestions and useful discussion. We thank B J Cowling for help with statistical analysis for supplementary figure S2 (appendix). This research was supported by the National Megaprojects of China for Infectious Diseases (2012ZX10004211), National Natural Science Foundation of China (81341004), Ministry of Science and Technology (KJYJ-2013-01-01), Shanghai Municipal Health and Family Planning Commission, and the National Key Basic Research Program of China (2012CB519000). H-LY and MP are supported by Funding from the Area of Excellence Scheme of the University Grants Committee (AoE/M-12/06), Hong Kong SAR Government and National Institutes of Health (NIAID contract HHSN266200700005C).	Chan MCW, 2011, EMERG INFECT DIS, V17, P2038, DOI 10.3201/eid1711.110205; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gubareva LV, 2004, VIRUS RES, V103, P199, DOI 10.1016/j.virusres.2004.02.034; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022534; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Whitley RJ, 2013, CLIN INFECT DIS, V56, P1197, DOI 10.1093/cid/cis1220; Zurcher T, 2006, J ANTIMICROB CHEMOTH, V58, P723, DOI 10.1093/jac/dkl321	15	252	289	2	96	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 29	2013	381	9885					2273	2279		10.1016/S0140-6736(13)61125-3	http://dx.doi.org/10.1016/S0140-6736(13)61125-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173SU	23726392				2022-12-01	WOS:000321100300031
J	Carolin, SA; Cobb, KM; Adkins, JF; Clark, B; Conroy, JL; Lejau, S; Malang, J; Tuen, AA				Carolin, Stacy A.; Cobb, Kim M.; Adkins, Jess F.; Clark, Brian; Conroy, Jessica L.; Lejau, Syria; Malang, Jenny; Tuen, Andrew A.			Varied Response of Western Pacific Hydrology to Climate Forcings over the Last Glacial Period	SCIENCE			English	Article							EAST-ASIAN MONSOON; PAST 130,000 YEARS; SOUTH CHINA SEA; U-TH AGES; MILLENNIAL-SCALE; INTERGLACIAL PERIOD; TEMPERATURE-CHANGE; LATE PLEISTOCENE; NORTHERN BORNEO; WARM POOL	Atmospheric deep convection in the west Pacific plays a key role in the global heat and moisture budgets, yet its response to orbital and abrupt climate change events is poorly resolved. Here, we present four absolutely dated, overlapping stalagmite oxygen isotopic records from northern Borneo that span most of the last glacial cycle. The records suggest that northern Borneo's hydroclimate shifted in phase with precessional forcing but was only weakly affected by glacial-interglacial changes in global climate boundary conditions. Regional convection likely decreased during Heinrich events, but other Northern Hemisphere abrupt climate change events are notably absent. The new records suggest that the deep tropical Pacific hydroclimate variability may have played an important role in shaping the global response to the largest abrupt climate change events.	[Carolin, Stacy A.; Cobb, Kim M.; Conroy, Jessica L.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Adkins, Jess F.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Clark, Brian; Lejau, Syria; Malang, Jenny] Gunung Mulu Natl Pk, Sarawak, Malaysia; [Tuen, Andrew A.] Univ Malaysia Sarawak, Inst Biodivers & Environm Conservat, Sarawak, Malaysia	University System of Georgia; Georgia Institute of Technology; California Institute of Technology; University of Malaysia Sarawak	Carolin, SA (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.	stacy.carolin@gatech.edu	Adkins, Jess/GYI-8778-2022	Cobb, Kim/0000-0002-2125-9164; Carolin, Stacy Anne/0000-0001-7181-2370	NSF PECASE [0645291]; NSF AGS [0903099]; NSF	NSF PECASE(National Science Foundation (NSF)); NSF AGS; NSF(National Science Foundation (NSF))	We thank N. Meckler, J. Partin, and S. Clark (Gunung Mulu National Park) for field assistance; J. Partin for assistance in sample analysis; G. Paris, M. Raven, S. Hines, and A. Subhas for assistance in U-Th dating; and J. Lynch-Stieglitz for providing comments on early versions of the manuscript. S. A. C, K. M. C., and J. F. A. were involved in the writing and design of this study; A. A. T. and B. C. facilitated the fieldwork for this study; S. A. C, K. M. C., S. L., and J. M. collected samples; and S. A. C. analyzed the samples. The research was funded by NSF PECASE Award no. 0645291 to K. M. C., NSF AGS award no. 0903099 to J. F. A., and a NSF Graduate Research Fellowship to S. A. C. Permits for this work were granted by the Malaysian Economic Planning Unit, the Sarawak State Planning Unit, and the Sarawak Forestry Department. All data reported in this paper are archived at the National Climatic Data Center (ftp://ftp.ncdc.noaa.gov/pub/data/paleo/speleothem/pacific/borneo2013.txt).	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0; BARD E, 1990, NATURE, V346, P456, DOI 10.1038/346456a0; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Bush ABG, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003027; Cane M, 1999, GEOPH MONOG SERIES, V112, P373; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Cobb KM, 2007, EARTH PLANET SC LETT, V263, P207, DOI 10.1016/j.epsl.2007.08.024; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; Dannenmann S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000390; DANSGAARD W, 1964, TELLUS, V16, P436; De Deckker P, 2003, GLOBAL PLANET CHANGE, V35, P25, DOI 10.1016/S0921-8181(02)00089-9; DiNezio PN, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002083; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Kanner LC, 2012, SCIENCE, V335, P570, DOI 10.1126/science.1213397; MADDEN RA, 1972, J ATMOS SCI, V29, P1109, DOI 10.1175/1520-0469(1972)029<1109:DOGSCC>2.0.CO;2; Meckler AN, 2012, SCIENCE, V336, P1301, DOI 10.1126/science.1218340; Moerman JW, 2013, EARTH PLANET SC LETT, V369, P108, DOI 10.1016/j.epsl.2013.03.014; Oppo DW, 2005, GEOLOGY, V33, P785, DOI 10.1130/G21867.1; Partin JW, 2007, NATURE, V449, P452, DOI 10.1038/nature06164; Rashid H, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000913; ROZANSKI K, 1992, SCIENCE, V258, P981, DOI 10.1126/science.258.5084.981; Scholz D, 2011, QUAT GEOCHRONOL, V6, P369, DOI 10.1016/j.quageo.2011.02.002; Storey M, 2012, P NATL ACAD SCI USA, V109, P18684, DOI 10.1073/pnas.1208178109; Tierney JE, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018060; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Wolff EW, 2010, QUATERNARY SCI REV, V29, P2828, DOI 10.1016/j.quascirev.2009.10.013; Zhang R, 2005, J CLIMATE, V18, P1853, DOI 10.1175/JCLI3460.1; Zhao MX, 2006, PALAEOGEOGR PALAEOCL, V236, P39, DOI 10.1016/j.palaeo.2005.11.033	33	106	112	4	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1564	1566		10.1126/science.1233797	http://dx.doi.org/10.1126/science.1233797			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23744779				2022-12-01	WOS:000321007000039
J	Dupont, S; Portner, H				Dupont, Sam; Poertner, Hans			Get ready for ocean acidification	NATURE			English	Editorial Material									[Dupont, Sam] Univ Gothenburg, Kristineberg, Sweden; [Poertner, Hans] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany	University of Gothenburg; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Dupont, S (corresponding author), Univ Gothenburg, Kristineberg, Sweden.	sam.dupont@bioenv.gu.se	Pörtner, Hans-O./K-9429-2016; Dupont, Sam T/F-5527-2013	Pörtner, Hans-O./0000-0001-6535-6575; 				Dupont S., 2012, MAR BIOL; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010	3	83	85	2	148	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					429	429		10.1038/498429a	http://dx.doi.org/10.1038/498429a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803827	Bronze			2022-12-01	WOS:000320929400026
J	Roach, NT; Venkadesan, M; Rainbow, MJ; Lieberman, DE				Roach, Neil T.; Venkadesan, Madhusudhan; Rainbow, Michael J.; Lieberman, Daniel E.			Elastic energy storage in the shoulder and the evolution of high-speed throwing in Homo	NATURE			English	Article							HUMERAL TORSION; BASEBALL; BIOMECHANICS; RETROVERSION	Some primates, including chimpanzees, throw objects occasionally(1,2), but only humans regularly throw projectiles with high speed and accuracy. Darwin noted that the unique throwing abilities of humans, which were made possible when bipedalism emancipated the arms, enabled foragers to hunt effectively using projectiles(3). However, there has been little consideration of the evolution of throwing in the years since Darwin made his observations, in part because of a lack of evidence of when, how and why hominins evolved the ability to generate high-speed throws(4-8). Here we use experimental studies of humans throwing projectiles to show that our throwing capabilities largely result from several derived anatomical features that enable elastic energy storage and release at the shoulder. These features first appear together approximately 2 million years ago in the species Homo erectus. Taking into consideration archaeological evidence suggesting that hunting activity intensified around this time(9), we conclude that selection for throwing as a means to hunt probably had an important role in the evolution of the genus Homo.	[Roach, Neil T.; Lieberman, Daniel E.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Roach, Neil T.] George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Washington, DC 20052 USA; [Venkadesan, Madhusudhan] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Rainbow, Michael J.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Spaulding Natl Running Ctr, Cambridge, MA 02138 USA	Harvard University; George Washington University; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Harvard University	Roach, NT (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.	ntroach@email.gwu.edu	Venkadesan, Madhusudhan/B-4697-2008	Venkadesan, Madhusudhan/0000-0001-5754-7478	National Science Foundation [BCS-0961943]; American School for Prehistoric Research; Wellcome Trust/DBT India Alliance [500158/Z/09/Z]	National Science Foundation(National Science Foundation (NSF)); American School for Prehistoric Research; Wellcome Trust/DBT India Alliance(Wellcome TrustWellcome Trust DBT India Alliance)	We would like to thank the Wyss Institute, L. Stirling, A. Biewener, R. Wrangham, S. Larson, B. Roach, L. Meszoly, A. Lobell and many undergraduate research assistants for their feedback, help and support. Funding was provided by the National Science Foundation (BCS-0961943 to N.T.R. and D. E. L.), the American School for Prehistoric Research (to N.T.R. and D. E. L.) and the Wellcome Trust/DBT India Alliance (500158/Z/09/Z to M.V.).	Astley HC, 2012, BIOL LETTERS, V8, P386, DOI 10.1098/rsbl.2011.0982; BENNETT MB, 1986, J ZOOL, V209, P537, DOI 10.1111/j.1469-7998.1986.tb03609.x; Bingham PM, 2000, EVOL ANTHROPOL, V9, P248, DOI 10.1002/1520-6505(2000)9:6<248::AID-EVAN1003>3.0.CO;2-X; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Calvin W. H., 1983, THROWING MADONNA ESS; Churchill SE, 2009, VERTEBR PALEOBIOL PA, P201, DOI 10.1007/978-1-4020-9699-0_15; Cowgill LW, 2007, AM J PHYS ANTHROPOL, V134, P472, DOI 10.1002/ajpa.20689; Darwin C., 1871, P423; Dempster W.T., 1955, SPACE REQUIREMENTS S; Digiovine N M, 1992, J Shoulder Elbow Surg, V1, P15, DOI 10.1016/S1058-2746(09)80011-6; DILLMAN CJ, 1993, J ORTHOP SPORT PHYS, V18, P402, DOI 10.2519/jospt.1993.18.2.402; Fifer F.C., 1987, HUMAN EVOLUTION, V2, P135; FLEISIG GS, 1995, AM J SPORT MED, V23, P233, DOI 10.1177/036354659502300218; Goodall J., 1986, CHIMPANZEES GOMBE PA; GOWAN ID, 1987, AM J SPORT MED, V15, P586, DOI 10.1177/036354658701500611; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; Hirashima M, 2002, J SPORT SCI, V20, P301, DOI 10.1080/026404102753576071; Hirashima M, 2007, J NEUROPHYSIOL, V97, P680, DOI 10.1152/jn.00348.2006; Larson SG, 2007, EVOL ANTHROPOL, V16, P172, DOI 10.1002/evan.20149; Osbahr DC, 2002, AM J SPORT MED, V30, P347, DOI 10.1177/03635465020300030801; PAPPAS AM, 1985, AM J SPORT MED, V13, P216, DOI 10.1177/036354658501300402; Patek SN, 2007, J EXP BIOL, V210, P3677, DOI 10.1242/jeb.006486; Pieper HG, 1998, AM J SPORT MED, V26, P247, DOI 10.1177/03635465980260021501; Reagan KM, 2002, AM J SPORT MED, V30, P354, DOI 10.1177/03635465020300030901; Richmond BG, 2001, YEARB PHYS ANTHROPOL, V44, P70, DOI 10.1002/ajpa.10019; Roach NT, 2012, J ANAT, V220, P293, DOI 10.1111/j.1469-7580.2011.01464.x; Shea JJ, 2006, J ARCHAEOL SCI, V33, P823, DOI 10.1016/j.jas.2005.10.015; SNYDER S J, 1990, Arthroscopy, V6, P274, DOI 10.1016/0749-8063(90)90056-J; Stanford C. B., 2001, HUMAN EVOLUTION SERI; Walker A., 1993, NARIOKOTOME HOMO ERE; WERNER SL, 1993, J ORTHOP SPORT PHYS, V17, P274, DOI 10.2519/jospt.1993.17.6.274; Westergaard GC, 2000, NEUROPSYCHOLOGIA, V38, P1511, DOI 10.1016/S0028-3932(00)00056-7; Winter D.A., 1990, BIOMECHANICS MOTOR C, P107	33	161	162	4	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					483	+		10.1038/nature12267	http://dx.doi.org/10.1038/nature12267			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803849	Green Accepted, Green Submitted			2022-12-01	WOS:000320929400052
J	Heckmann, D; Schulze, S; Denton, A; Gowik, U; Westhoff, P; Weber, APM; Lercher, MJ				Heckmann, David; Schulze, Stefanie; Denton, Alisandra; Gowik, Udo; Westhoff, Peter; Weber, Andreas P. M.; Lercher, Martin J.			Predicting C-4 Photosynthesis Evolution: Modular, Individually Adaptive Steps on a Mount Fuji Fitness Landscape	CELL			English	Article							GLYCINE DECARBOXYLASE; BENEFICIAL MUTATIONS; CO2 ASSIMILATION; SIGN EPISTASIS; USE EFFICIENCY; ADAPTATION; MODEL; LEAVES; CARBON; PHOTORESPIRATION	An ultimate goal of evolutionary biology is the prediction and experimental verification of adaptive trajectories on macroevolutionary timescales. This aim has rarely been achieved for complex biological systems, as models usually lack clear correlates of organismal fitness. Here, we simulate the fitness landscape connecting two carbon fixation systems: C-3 photosynthesis, used by most plant species, and the C-4 system, which is more efficient at ambient CO2 levels and elevated temperatures and which repeatedly evolved from C-3. Despite extensive sign epistasis, C-4 photosynthesis is evolutionarily accessible through individually adaptive steps from any intermediate state. Simulations show that biochemical subtraits evolve in modules; the order and constitution of modules confirm and extend previous hypotheses based on species comparisons. Plant-species-designated C-3-C-4 intermediates lie on predicted evolutionary trajectories, indicating that they indeed represent transitory states. Contrary to expectations, we find no slowdown of adaptation and no diminishing fitness gains along evolutionary trajectories.	[Heckmann, David; Lercher, Martin J.] Univ Dusseldorf, Inst Comp Sci, D-40225 Dusseldorf, Germany; [Schulze, Stefanie; Gowik, Udo; Westhoff, Peter] Univ Dusseldorf, Inst Plant Mol & Dev Biol, D-40225 Dusseldorf, Germany; [Denton, Alisandra; Weber, Andreas P. M.] Univ Dusseldorf, Inst Plant Biochem, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Lercher, MJ (corresponding author), Univ Dusseldorf, Inst Comp Sci, D-40225 Dusseldorf, Germany.	lercher@cs.uni-duesseldorf.de	Weber, Andreas Paul Michael/O-3043-2019; Weber, Andreas PM/A-6250-2011; Lercher, Martin/K-7939-2013	Weber, Andreas Paul Michael/0000-0003-0970-4672; Weber, Andreas PM/0000-0003-0970-4672; Lercher, Martin/0000-0003-3940-1621; Gowik, Udo/0000-0002-8986-7318; Schulze, Stefanie/0000-0002-7659-8825	Deutsche Forschungsgemeinschaft [IRTG 1525, FOR 1186, EXC 1028, CRC 680]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Veronica Maurino, Itai Yanai, Eugene Koonin, Joachim Krug, and Andrea Brautigam for helpful discussions. Computational support and infrastructure was provided by the "Center for Information and Media Technology" (ZIM) at the Heinrich Heine University Dusseldorf. This work was supported by the Deutsche Forschungsgemeinschaft (IRTG 1525 to D.H. and A.D.; FOR 1186 to S.S.; EXC 1028 to M.J.L., A.P.M.W., and P.W.; and CRC 680 to M.J.L.).	[Anonymous], 2010, R LANG ENV STAT COMP; Ashton A.R., 1990, J EXP BOT, P39; BEALE CV, 1995, PLANT CELL ENVIRON, V18, P641, DOI 10.1111/j.1365-3040.1995.tb00565.x; Berry J., 1978, Photosynthesis 77. Proceedings of the fourth international congress on photosynthesis. [Hall, D. O.; Coombs, J.; Goodwin, T. J. (Editors)]., P119; Brodribb TJ, 2010, FUNCT PLANT BIOL, V37, P488, DOI 10.1071/FP10010; BROWN RH, 1978, CROP SCI, V18, P93, DOI 10.2135/cropsci1978.0011183X001800010025x; BROWN RH, 1991, PLANT PHYSIOL, V97, P985, DOI 10.1104/pp.97.3.985; Caemmerer S. V., 2000, TECHNIQUES PLANT SCI; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Christin PA, 2013, P NATL ACAD SCI USA, V110, P1381, DOI 10.1073/pnas.1216777110; Christin PA, 2011, EVOLUTION, V65, P643, DOI 10.1111/j.1558-5646.2010.01168.x; Dal'Molin CGD, 2010, PLANT PHYSIOL, V154, P1871, DOI 10.1104/pp.110.166488; Drincovich MF, 2011, ADV PHOTOSYNTH RESP, V32, P277; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Edwards G., 1987, BIOCH PLANTS, P275, DOI DOI 10.1016/B978-0-12-675410-0.50011-7; EHLERINGER J, 1983, PLANT PHYSIOL, V73, P555, DOI 10.1104/pp.73.3.555; EHLERINGER JR, 1991, TRENDS ECOL EVOL, V6, P95, DOI 10.1016/0169-5347(91)90183-X; Engel N, 2007, PLANT PHYSIOL, V144, P1328, DOI 10.1104/pp.107.099317; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Furbank RT, 2011, J EXP BOT, V62, P3103, DOI 10.1093/jxb/err080; Ghannoum O, 2001, AUST J PLANT PHYSIOL, V28, P213, DOI 10.1071/PP00078; Ghannoum O, 2011, ADV PHOTOSYNTH RESP, V32, P129; GILLESPIE JH, 1983, THEOR POPUL BIOL, V23, P202, DOI 10.1016/0040-5809(83)90014-X; Gowik U, 2011, PLANT PHYSIOL, V155, P56, DOI 10.1104/pp.110.165308; Hatch MD, 1975, AUST J PLANT PHYSIOL, V2, P111, DOI DOI 10.1071/PP9750111; Hibberd JM, 2008, CURR OPIN PLANT BIOL, V11, P228, DOI 10.1016/j.pbi.2007.11.002; Hindre T, 2012, NAT REV MICROBIOL, V10, P352, DOI 10.1038/nrmicro2750; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; HYLTON CM, 1988, PLANTA, V175, P452, DOI 10.1007/BF00393064; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kiirats O, 2002, PLANT PHYSIOL, V130, P964, DOI 10.1104/pp.008201; KIMURA M, 1957, ANN MATH STAT, V28, P882, DOI 10.1214/aoms/1177706791; KU MSB, 1983, PLANT PHYSIOL, V71, P944, DOI 10.1104/pp.71.4.944; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lobkovsky AE, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002302; Lozovsky ER, 2009, P NATL ACAD SCI USA, V106, P12025, DOI 10.1073/pnas.0905922106; Maurino VG, 2010, CURR OPIN PLANT BIOL, V13, P249, DOI 10.1016/j.pbi.2010.01.006; McKown AD, 2005, AM J BOT, V92, P1911, DOI 10.3732/ajb.92.11.1911; Muhaidat R, 2011, PLANT CELL ENVIRON, V34, P1723, DOI 10.1111/j.1365-3040.2011.02367.x; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Pal C, 2006, NATURE, V440, P667, DOI 10.1038/nature04568; Papp B, 2011, NAT REV GENET, V12, P591, DOI 10.1038/nrg3033; PEISKER M, 1986, PLANT CELL ENVIRON, V9, P627, DOI 10.1111/j.1365-3040.1986.tb01620.x; Pick TR, 2011, PLANT CELL, V23, P4208, DOI 10.1105/tpc.111.090324; Poelwijk FJ, 2011, J THEOR BIOL, V272, P141, DOI 10.1016/j.jtbi.2010.12.015; Sage R.F., 2007, CHARTING NEW PATHWAY, P195; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sage RF, 2012, ANNU REV PLANT BIOL, V63, P19, DOI 10.1146/annurev-arplant-042811-105511; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; Savir Y, 2010, P NATL ACAD SCI USA, V107, P3475, DOI 10.1073/pnas.0911663107; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; VONCAEMMERER S, 1989, PLANTA, V178, P463, DOI 10.1007/BF00963816; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165; Yin X, 2009, NJAS-WAGEN J LIFE SC, V57, P27, DOI 10.1016/j.njas.2009.07.001; Yizhak K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.11	59	125	124	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1579	1588		10.1016/j.cell.2013.04.058	http://dx.doi.org/10.1016/j.cell.2013.04.058			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791184	Bronze			2022-12-01	WOS:000320722000024
J	Barbui, C; Bighelli, I				Barbui, Corrado; Bighelli, Irene			Regulatory science in Europe: the case of schizophrenia trials	LANCET			English	Editorial Material							QUALITY		[Barbui, Corrado; Bighelli, Irene] Univ Verona, Dept Publ Hlth & Community Med, WHO Collaborating Ctr Res & Training Mental Hlth, Sect Psychiat, I-37134 Verona, Italy	University of Verona	Barbui, C (corresponding author), Univ Verona, Dept Publ Hlth & Community Med, WHO Collaborating Ctr Res & Training Mental Hlth, Sect Psychiat, I-37134 Verona, Italy.	corrado.barbui@univr.it	Bighelli, Irene/I-1118-2019	Bighelli, Irene/0000-0002-5661-5149				[Anonymous], 2012, GUID CLIN INV MED PR; Barbui C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2291; Bighelli I, 2012, EPIDEMIOL PSYCH SCI, V21, P245, DOI 10.1017/S2045796012000170; Chalmers I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f105; Garattini S, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1025; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Miyar J, 2013, SCHIZOPHRENIA BULL, V39, P226, DOI 10.1093/schbul/sbr140; Mulla SM, 2012, JAMA-J AM MED ASSOC, V308, P2605, DOI 10.1001/2012.jama.11235; O'Connor AB, 2010, JAMA-J AM MED ASSOC, V303, P979, DOI 10.1001/jama.2010.257; Psaty BM, 2012, JAMA-J AM MED ASSOC, V307, P2491, DOI 10.1001/jama.2012.5545; van Os J, 2009, LANCET, V374, P635, DOI 10.1016/S0140-6736(15)01121-6	11	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2013	382	9900					1234	1235		10.1016/S0140-6736(13)60255-X	http://dx.doi.org/10.1016/S0140-6736(13)60255-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235XP	23791471				2022-12-01	WOS:000325756400010
J	Kreimer, AR; Campbell, CMP; Lin, HY; Fulp, W; Papenfuss, MR; Abrahamsen, M; Hildesheim, A; Villa, LL; Salmeron, JJ; Lazcano-Ponce, E; Giuliano, AR				Kreimer, Aimee R.; Campbell, Christine M. Pierce; Lin, Hui-Yi; Fulp, William; Papenfuss, Mary R.; Abrahamsen, Martha; Hildesheim, Allan; Villa, Luisa L.; Salmeron, Jorge J.; Lazcano-Ponce, Eduardo; Giuliano, Anna R.			Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study	LANCET			English	Article							SQUAMOUS-CELL CARCINOMA; UNITED-STATES; HPV INFECTION; RISK-FACTOR; OROPHARYNGEAL CANCER; TOBACCO-SMOKE; YOUNG MEN; PREVALENCE; PERSISTENCE; HEAD	Background Oral human papillomavirus (HPV) infection causes a subset of oropharyngeal cancers. These cancers disproportionately affect men, are increasing in incidence, and have no proven prevention methods. We aimed to establish the natural history of oral HPV infection in men. Methods To estimate incidence and clearance of HPV infections, men residing in Brazil, Mexico, and the USA who were HIV negative and reported no history of anogenital cancer were recruited into the HPV Infection in Men (HIM) cohort study. A subset of the cohort who provided two or more oral rinse-and-gargle samples with valid HPV results and who completed a minimum of 2 weeks of follow-up were included in this analysis. Oral rinse-and-gargle samples and questionnaire data were obtained every 6 months for up to 4 years. Samples were analysed for the presence of oncogenic and non-oncogenic HPV infections by the linear array method. Findings 1626 men aged 18-73 years and with a median follow-up of 12.7 months (IQR 12.1-14.7) were included in the analysis. During the first 12 months of follow-up, 4.4% (95% CI 3.5-5.6; n=115 incident infections) of men acquired an incident oral HPV infection, 1.7% (1.2-2.5; n=53 incident infections) an oral oncogenic HPV infection, and 0.6% (0.3-1.1; n=18 incident infections) an oral HPV 16 infection. Acquisition of oral oncogenic HPV was significantly associated with smoking and not being married or cohabiting, but was similar across countries, age groups, and reported sexual behaviours. Median duration of infection was 6.9 months (95 % CI 6.2-9.3; n=45 cleared infections) for any HPV, 6.3 months (6.0-9.9; n=18 cleared infections) for oncogenic HPV, and 7.3 months (6.0-not estimable; n=5 cleared infections) for HPV 16. Eight of the 18 incident oral HPV 16 infections persisted for two or more study visits. Interpretation Newly acquired oral oncogenic HPV infections in healthy men were rare and most were cleared within 1 year. Additional studies into the natural history of HPV are needed to inform development of infection-related prevention efforts.	[Kreimer, Aimee R.; Hildesheim, Allan] NCI, NIH, Bethesda, MD 20892 USA; [Campbell, Christine M. Pierce; Lin, Hui-Yi; Fulp, William; Papenfuss, Mary R.; Abrahamsen, Martha; Giuliano, Anna R.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Villa, Luisa L.] Univ Sao Paulo, Sch Med, Dept Radiol & Basic Oncol, Sao Paulo, Brazil; [Villa, Luisa L.] Univ Sao Paulo, Sch Med, HPV Inst, Sao Paulo, Brazil; [Salmeron, Jorge J.] Inst Mexicano Seguro Social, Cuernavaca, Morelos, Mexico; [Lazcano-Ponce, Eduardo] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Mexicano del Seguro Social; Instituto Nacional de Salud Publica	Kreimer, AR (corresponding author), NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr,RM 6-E104, Bethesda, MD 20892 USA.	kreimera@mail.nih.gov	Kreimer, Aimee ARK/H-1687-2015; Papilomavirus, Inct/I-2406-2013; USP, Oncologia/F-9053-2014; VILLA, LUISA/AAH-4761-2019; Hildesheim, Allan/B-9760-2015; Fulp, William/AAD-2369-2022	VILLA, LUISA/0000-0003-4074-2335; Hildesheim, Allan/0000-0003-0257-2363; Fulp, William/0000-0001-6888-0794; Pierce, Christine/0000-0002-0233-4894; Lin, Hui-Yi/0000-0002-3307-5549; Salmeron, Jorge/0000-0002-5113-299X	US National Cancer Institute; Merck Sharp Dohme; NATIONAL CANCER INSTITUTE [ZIACP010209, ZIACP010217, P30CA076292, R25CA147832, R01CA098803] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Merck Sharp Dohme(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	US National Cancer Institute, Merck Sharp & Dohme.	Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Cancer IAfRo, 2007, IARC MON EV CARC RIS, P90; Castle PE, 2008, J VIROL, V82, P6084, DOI 10.1128/JVI.00103-08; Rodriguez AC, 2010, JNCI-J NATL CANCER I, V102, P315, DOI 10.1093/jnci/djq001; Chaturvedi AK, 2010, 26 INT PAP C MONTR C, P575; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Edelstein ZR, 2012, SEX TRANSM DIS, V39, P860, DOI 10.1097/OLQ.0b013e318269d098; Fakhry C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011918; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; HO GYF, 1995, JNCI-J NATL CANCER I, V87, P1365, DOI 10.1093/jnci/87.18.1365; Hong AM, 2010, VACCINE, V28, P3269, DOI 10.1016/j.vaccine.2010.02.098; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Kreimer AR, 2011, CANCER EPIDEM BIOMAR, V20, P172, DOI 10.1158/1055-9965.EPI-10-0682; Kreimer AR, 2010, SEX TRANSM DIS, V37, P386, DOI 10.1097/OLQ.0b013e3181c94a3b; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Nyitray AG, 2011, J INFECT DIS, V204, P1711, DOI 10.1093/infdis/jir637; Pickard RKL, 2012, SEX TRANSM DIS, V39, P559, DOI 10.1097/OLQ.0b013e31824f1c65; Sanders AE, 2012, ORAL DIS, V18, P430, DOI 10.1111/j.1601-0825.2011.01892.x; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; YING Z, 1994, J MULTIVARIATE ANAL, V50, P17, DOI 10.1006/jmva.1994.1031	31	182	183	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 7	2013	382	9895					877	887		10.1016/S0140-6736(13)60809-0	http://dx.doi.org/10.1016/S0140-6736(13)60809-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215WE	23827089	Green Accepted			2022-12-01	WOS:000324240700029
J	Liu, B; Baskin, RJ; Kowalczykowski, SC				Liu, Bian; Baskin, Ronald J.; Kowalczykowski, Stephen C.			DNA unwinding heterogeneity by RecBCD results from static molecules able to equilibrate	NATURE			English	Article							RECOMBINATION HOTSPOT CHI; SINGLE-MOLECULE; ENZYME; RECOGNITION; TRANSLOCATION; HELICASE; PROTEIN; ENERGY; DYNAMICS; MOTOR	Single-molecule studies can overcome the complications of asynchrony and ensemble-averaging in bulk-phase measurements, provide mechanistic insights into molecular activities, and reveal interesting variations between individual molecules(1-3). The application of these techniques to the RecBCD helicase of Escherichia coli has resolved some long-standing discrepancies, and has provided otherwise unattainable mechanistic insights into its enzymatic behaviour(4-6). Enigmatically, the DNA unwinding rates of individual enzyme molecules are seen to vary considerably(6-8), but the origin of this heterogeneity remains unknown. Here we investigate the physical basis for this behaviour. Although any individual RecBCD molecule unwound DNA at a constant rate for an average of approximately 30,000 steps, we discover that transiently halting a single enzyme-DNA complex by depleting Mg2+-ATP could change the subsequent rates of DNA unwinding by that enzyme after reintroduction to ligand. The proportion of molecules that changed rate increased exponentially with the duration of the interruption, with a half-life of approximately 1 second, suggesting that a conformational change occurred during the time that the molecule was arrested. The velocity after pausing an individual molecule was any velocity found in the starting distribution of the ensemble. We suggest that substrate binding stabilizes the enzyme in one of many equilibrium conformational sub-states that determine the rate-limiting translocation behaviour of each RecBCD molecule. Each stabilized sub-state can persist for the duration (approximately 1 minute) of processive unwinding of a DNA molecule, comprising tens of thousands of catalytic steps, each of which is much faster than the time needed for the conformational change required to alter kinetic behaviour. This ligand-dependent stabilization of rate-defining conformational sub-states results in seemingly static molecule-to-molecule variation in RecBCD helicase activity, but in fact reflects one microstate from the equilibrium ensemble that a single molecule manifests during an individual processive translocation event.	[Liu, Bian; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [Liu, Bian; Baskin, Ronald J.; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Liu, Bian; Kowalczykowski, Stephen C.] Univ Calif Davis, Biophys Grad Grp, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu	Liu, Bian/C-4865-2011	Liu, Bian/0000-0001-8806-820X	National Institutes of Health [GM-62653, GM-64745]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062653, R01GM064745, R01GM041347, R37GM062653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the laboratory for their comments on this work. S.C.K. was supported by the National Institutes of Health (GM-62653 and GM-64745).	Amitani I, 2010, METHOD ENZYMOL, V472, P261, DOI 10.1016/S0076-6879(10)72007-3; Bianco PR, 1997, P NATL ACAD SCI USA, V94, P6706, DOI 10.1073/pnas.94.13.6706; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Craig DB, 1996, J AM CHEM SOC, V118, P5245, DOI 10.1021/ja9540839; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dillingham MS, 2005, J BIOL CHEM, V280, P37069, DOI 10.1074/jbc.M505520200; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Frauenfelder H, 2001, P NATL ACAD SCI USA, V98, P2370, DOI 10.1073/pnas.041614298; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; Handa N, 2005, MOL CELL, V17, P745, DOI 10.1016/j.molcel.2005.02.011; Handa N, 2012, P NATL ACAD SCI USA, V109, P8901, DOI 10.1073/pnas.1206076109; IKAI A, 1971, NATURE, V230, P100, DOI 10.1038/230100a0; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; LAM ST, 1974, GENETICS, V77, P425; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Nguyen HD, 2002, BIOTECHNOL BIOENG, V80, P823, DOI 10.1002/bit.10448; ONUCHIC JN, 1995, P NATL ACAD SCI USA, V92, P3626, DOI 10.1073/pnas.92.8.3626; Perkins TT, 2004, BIOPHYS J, V86, P1640, DOI 10.1016/S0006-3495(04)74232-0; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2863, DOI 10.1021/bi00433a018; SELA M, 1957, SCIENCE, V125, P691, DOI 10.1126/science.125.3250.691; Shi J, 2004, J AM CHEM SOC, V126, P6914, DOI 10.1021/ja038902y; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Spies M, 2005, J BIOL CHEM, V280, P37078, DOI 10.1074/jbc.M505521200; Spies M, 2007, CELL, V131, P694, DOI 10.1016/j.cell.2007.09.023; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Xie XS, 1999, J BIOL CHEM, V274, P15967, DOI 10.1074/jbc.274.23.15967; XUE QF, 1995, NATURE, V373, P681, DOI 10.1038/373681a0	35	59	64	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 22	2013	500	7463					482	+		10.1038/nature12333	http://dx.doi.org/10.1038/nature12333			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23851395	Green Accepted, Green Submitted			2022-12-01	WOS:000323316100040
J	Black, JC; Manning, AL; Van Rechem, C; Kim, J; Ladd, B; Cho, J; Pineda, CM; Murphy, N; Daniels, DL; Montagna, C; Lewis, PW; Glass, K; Allis, CD; Dyson, NJ; Getz, G; Whetstine, JR				Black, Joshua C.; Manning, Amity L.; Van Rechem, Capucine; Kim, Jaegil; Ladd, Brendon; Cho, Juok; Pineda, Cristiana M.; Murphy, Nancy; Daniels, Danette L.; Montagna, Cristina; Lewis, Peter W.; Glass, Kimberly; Allis, C. David; Dyson, Nicholas J.; Getz, Gad; Whetstine, Johnathan R.			KDM4A Lysine Demethylase Induces Site-Specific Copy Gain and Rereplication of Regions Amplified in Tumors	CELL			English	Article							REPLICATION ORIGINS; NUMBER ALTERATION; DRUG-RESISTANCE; CANCER; MECHANISMS; AMPLIFICATION; INHIBITION; FEATURES; PR-SET7; DOMAIN	Acquired chromosomal instability and copy number alterations are hallmarks of cancer. Enzymes capable of promoting site-specific copy number changes have yet to be identified. Here, we demonstrate that H3K9/36me3 lysine demethylase KDM4A/JMJD2A overexpression leads to localized copy gain of 1q12, 1q21, and Xq13.1 without global chromosome instability. KDM4A-amplified tumors have increased copy gains for these same regions. 1q12h copy gain occurs within a single cell cycle, requires S phase, and is not stable but is regenerated each cell division. Sites with increased copy number are rereplicated and have increased KDM4A, MCM, and DNA polymerase occupancy. Suv39h1/KMT1A or HP1 gamma overexpression suppresses the copy gain, whereas H3K9/K36 methylation interference promotes gain. Our results demonstrate that overexpression of a chromatin modifier results in site-specific copy gains. This begins to establish how copy number changes could originate during tumorigenesis and demonstrates that transient overexpression of specific chromatin modulators could promote these events.	[Black, Joshua C.; Manning, Amity L.; Van Rechem, Capucine; Ladd, Brendon; Pineda, Cristiana M.; Dyson, Nicholas J.; Getz, Gad; Whetstine, Johnathan R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA; [Black, Joshua C.; Manning, Amity L.; Van Rechem, Capucine; Ladd, Brendon; Pineda, Cristiana M.; Dyson, Nicholas J.; Whetstine, Johnathan R.] Harvard Univ, Dept Med, Sch Med, Charlestown, MA 02129 USA; [Getz, Gad] Harvard Univ, Dept Pathol, Sch Med, Charlestown, MA 02129 USA; [Kim, Jaegil; Cho, Juok; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Murphy, Nancy; Daniels, Danette L.] Promega Corp, Madison, WI 53711 USA; [Montagna, Cristina] Yeshiva Univ Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Lewis, Peter W.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Glass, Kimberly] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Glass, Kimberly] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Promega Corporation; Yeshiva University; Albert Einstein College of Medicine; Rockefeller University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Getz, G (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, 13th St, Charlestown, MA 02129 USA.	gadgetz@broadinstitute.org; jwhetstine@hms.harvard.edu	Manning, Amity/AAC-8205-2019; Black, Joshua/Q-2484-2015	Manning, Amity/0000-0003-1332-9086; Glass, Kimberly/0000-0003-4394-5779; Van Rechem, Capucine/0000-0002-5408-6124; Lewis, Peter/0000-0002-9816-7823; Black, Joshua/0000-0002-2491-8815	Ellison Medical Foundation [CA059267, R01GM097360]; NIH [U24CA143845]; Jane Coffin Childs Memorial Fund for Medical Research; MGH ECOR Tosteson Postdoctoral Fellowship; CCSG [P30CA013330];  [R01CA155202]; NATIONAL CANCER INSTITUTE [C06CA059267, U24CA143845, P30CA013330, R01CA155202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097360] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research; MGH ECOR Tosteson Postdoctoral Fellowship; CCSG; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Ravi Mylvaganam and the MGH Flow Cytometry core for assistance with the cell sorting. We thank Mo Motamedi for helpful comments on the manuscript. This work was supported by funding to J.R.W. from the Ellison Medical Foundation, CA059267 and R01GM097360. G.G. and J.K. are supported by NIH U24CA143845. J.C.B. was a Fellow of The Jane Coffin Childs Memorial Fund for Medical Research. This investigation has been aided by a grant from The Jane Coffin Childs Memorial Fund for Medical Research. N.J.D. is supported by R01CA155202. A.L.M. is supported by MGH ECOR Tosteson Postdoctoral Fellowship. C.M. is supported by CCSG P30CA013330.	Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Beck DB, 2012, GENE DEV, V26, P2580, DOI 10.1101/gad.195636.112; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Berry WL, 2012, INT J ONCOL, V41, P1701, DOI 10.3892/ijo.2012.1618; Black JC, 2010, MOL CELL, V40, P736, DOI 10.1016/j.molcel.2010.11.008; Brunet A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-144; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; Ding QY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001112; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hook SS, 2007, CURR OPIN CELL BIOL, V19, P663, DOI 10.1016/j.ceb.2007.10.007; Inoue J, 2004, AM J PATHOL, V165, P71, DOI 10.1016/S0002-9440(10)63276-2; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Kiang L, 2010, J CELL SCI, V123, P3047, DOI 10.1242/jcs.067470; Kim TD, 2012, J CELL BIOCHEM, V113, P1368, DOI 10.1002/jcb.24009; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Kudoh K, 1999, CLIN CANCER RES, V5, P2526; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mallette FA, 2012, CELL REP, V2, P1233, DOI 10.1016/j.celrep.2012.09.033; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Manning AL, 2010, GENE DEV, V24, P1364, DOI 10.1101/gad.1917310; Maslov AY, 2009, BBA-GEN SUBJECTS, V1790, P963, DOI 10.1016/j.bbagen.2009.03.020; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Papamichos-Chronakis M, 2013, NAT REV GENET, V14, P62, DOI 10.1038/nrg3345; SCHIMKE RT, 1984, CANCER RES, V44, P1735; Snaith HA, 1999, GENETICS, V152, P839; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Takano M, 2001, Hum Cell, V14, P267; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Van Rechem C, 2011, J BIOL CHEM, V286, P30462, DOI 10.1074/jbc.M111.273508; Vassilev LT, 2006, CELL CYCLE, V5, P2555, DOI 10.4161/cc.5.22.3463; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wong N, 2001, AM J PATHOL, V159, P465, DOI 10.1016/S0002-9440(10)61718-X; Yakut T, 2006, LUNG CANCER, V54, P293, DOI 10.1016/j.lungcan.2006.08.011	39	156	162	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					541	555		10.1016/j.cell.2013.06.051	http://dx.doi.org/10.1016/j.cell.2013.06.051			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23871696	Green Accepted, Bronze			2022-12-01	WOS:000322629900009
J	Voskoboynik, A; Newman, AM; Corey, DM; Sahoo, D; Pushkarev, D; Neff, NF; Passarelli, B; Koh, W; Ishizuka, KJ; Palmeri, KJ; Dimov, IK; Keasar, C; Fan, HC; Mantalas, GL; Sinha, R; Penland, L; Quake, SR; Weissman, IL				Voskoboynik, Ayelet; Newman, Aaron M.; Corey, Daniel M.; Sahoo, Debashis; Pushkarev, Dmitry; Neff, Norma F.; Passarelli, Benedetto; Koh, Winston; Ishizuka, Katherine J.; Palmeri, Karla J.; Dimov, Ivan K.; Keasar, Chen; Fan, H. Christina; Mantalas, Gary L.; Sinha, Rahul; Penland, Lolita; Quake, Stephen R.; Weissman, Irving L.			Identification of a Colonial Chordate Histocompatibility Gene	SCIENCE			English	Article							IMMUNE-SYSTEM; PROTOCHORDATE; ALLORECOGNITION; CELLS; MODEL; GERM	Histocompatibility is the basis by which multicellular organisms of the same species distinguish self from nonself. Relatively little is known about the mechanisms underlying histocompatibility reactions in lower organisms. Botryllus schlosseri is a colonial urochordate, a sister group of vertebrates, that exhibits a genetically determined natural transplantation reaction, whereby self-recognition between colonies leads to formation of parabionts with a common vasculature, whereas rejection occurs between incompatible colonies. Using genetically defined lines, whole-transcriptome sequencing, and genomics, we identified a single gene that encodes self-nonself and determines "graft" outcomes in this organism. This gene is significantly up-regulated in colonies poised to undergo fusion and/or rejection, is highly expressed in the vasculature, and is functionally linked to histocompatibility outcomes. These findings establish a platform for advancing the science of allorecognition.	[Voskoboynik, Ayelet; Newman, Aaron M.; Corey, Daniel M.; Sahoo, Debashis; Ishizuka, Katherine J.; Palmeri, Karla J.; Dimov, Ivan K.; Sinha, Rahul; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Voskoboynik, Ayelet; Ishizuka, Katherine J.; Palmeri, Karla J.; Weissman, Irving L.] Stanford Univ, Hopkins Marine Stn, Dept Dev Biol, Pacific Grove, CA 93950 USA; [Pushkarev, Dmitry; Neff, Norma F.; Passarelli, Benedetto; Koh, Winston; Fan, H. Christina; Mantalas, Gary L.; Penland, Lolita; Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Pushkarev, Dmitry; Neff, Norma F.; Passarelli, Benedetto; Koh, Winston; Fan, H. Christina; Mantalas, Gary L.; Penland, Lolita; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Pushkarev, Dmitry; Neff, Norma F.; Passarelli, Benedetto; Koh, Winston; Fan, H. Christina; Mantalas, Gary L.; Penland, Lolita; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Keasar, Chen] Ben Gurion Univ Negev, Dept Comp Sci, IL-84105 Beer Sheva, Israel; [Weissman, Irving L.] Stanford Univ, Sch Med, Ludwig Ctr Canc Stem Cell Res & Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Ben Gurion University; Stanford University	Voskoboynik, A (corresponding author), Illumina Inc, Hayward, CA 94545 USA.	ayeletv@stanford.edu; amnewman@stanford.edu; quake@stanford.edu; irv@stanford.edu	Newman, Aaron M/ABE-1620-2021; Keasar, Chen/J-8413-2012; Koh, Lian Chye Winston/GYD-5873-2022	Newman, Aaron M/0000-0002-1857-8172; Koh, Lian Chye Winston/0000-0003-4611-6490; Keasar, Chen/0000-0003-0994-1520	NIH [1R56AI089968, R01GM100315, 1R01AG037968, K99CA151673-01A1]; Virginia and D. K. Ludwig Fund for Cancer Research; Department of Defense [W81XWH-10-1-0500]; Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; NATIONAL CANCER INSTITUTE [R00CA151673, K99CA151673, T32CA009302] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL087746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI089968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037968] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia and D. K. Ludwig Fund for Cancer Research; Department of Defense(United States Department of Defense); Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank B. Rinkevich for pointing out the difficulty with the original cFuHC assignments and T. Snyder, J. Okamoto, L. Me, L. Ooi, A. Dominguez, C. Lowe, K. Uhlinger, L. Crowder, S. Karten, C. Patton, L. Jerabek, and T. Storm for invaluable technical advice and help. A. De Tomaso provided the fosmid sequence used to characterize cFuHC (12) (table S5). D. P., A. V., and S. R. Q. have filed U.S. and international patent applications (61/532,882 and 13/608,778, respectively) entitled "Methods for obtaining a sequence." This invention allows for the sequencing of long continuous (kilobase scale) nucleic acid fragments using conventional short read-sequencing technologies, useful for consensus sequencing and haplotype determination. This study was supported by NIH grants 1R56AI089968, R01GM100315, and 1R01AG037968 awarded to I. L. W., A. V., and S. R. Q., respectively, and the Virginia and D. K. Ludwig Fund for Cancer Research awarded to I. L. W. D. S. was supported by NIH grant K99CA151673-01A1 and Department of Defense Grant W81XWH-10-1-0500, and A.M.N., D. M. C., D. S., and I. K. D. were supported by a grant from the Siebel Stem Cell Institute and the Thomas and Stacey Siebel Foundation. The data in this paper are tabulated in the main manuscript and in the supplementary materials. BHF, sFuHC, and mFuHC sequences are available in GenBank under accession numbers KF017887-KF017889, and the RNA-Seq data are available on the Sequence Read Archive (SRA) database: BioProject SRP022042.	Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Colonna M, 2010, NAT IMMUNOL, V11, P1079, DOI [10.1038/ni1210-1079, 10.1038/ni0211-107]; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; De Tomaso AW, 1998, GENETICS, V149, P277; De Tomaso AW, 2003, IMMUNOGENETICS, V55, P480, DOI 10.1007/s00251-003-0612-7; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dishaw LJ, 2009, CURR BIOL, V19, pR286, DOI 10.1016/j.cub.2009.02.035; Girardi G, 2011, MOL IMMUNOL, V48, P1621, DOI 10.1016/j.molimm.2011.04.011; Hirano M, 2011, ADV IMMUNOL, V109, P125, DOI 10.1016/B978-0-12-387664-5.00004-2; Laird DJ, 2005, CELL, V123, P1351, DOI 10.1016/j.cell.2005.10.026; LaRosa DF, 2007, J IMMUNOL, V178, P7503, DOI 10.4049/jimmunol.178.12.7503; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Nakashima A, 2012, AM J REPROD IMMUNOL, V67, P304, DOI 10.1111/j.1600-0897.2012.01115.x; Oka H., 1957, Proceedings of the Japan Academy, V33, P657; OKA HIDEMITI, 1960, BULL MAR BIOL STA ASAMUSHI TOHOKU UNIV, V10, P153; Oren M, 2007, DEV COMP IMMUNOL, V31, P889, DOI 10.1016/j.dci.2006.12.009; Rinkevich B, 2012, DEV COMP IMMUNOL, V36, P718, DOI 10.1016/j.dci.2011.10.015; SABBADIN A, 1962, REND ACCAD NAZ LINCE, V32, P1031; Sachs DH, 2011, SEMIN IMMUNOL, V23, P165, DOI 10.1016/j.smim.2011.07.001; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Stoner DS, 1996, P NATL ACAD SCI USA, V93, P15254, DOI 10.1073/pnas.93.26.15254; Voskoboynik A, 2008, CELL STEM CELL, V3, P456, DOI 10.1016/j.stem.2008.07.023; Voskoboynik A, 2013, ELIFE, V2, DOI 10.7554/eLife.00569	24	56	56	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2013	341	6144					384	387		10.1126/science.1238036	http://dx.doi.org/10.1126/science.1238036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888037	Green Accepted			2022-12-01	WOS:000322259200046
J	Taylor, RC; Ryan, MJ				Taylor, R. C.; Ryan, M. J.			Interactions of Multisensory Components Perceptually Rescue Tungara Frog Mating Signals	SCIENCE			English	Article							BEHAVIOR; COMMUNICATION; INFERENCE; SELECTION; CHOICE	Sexual signals are often complex and perceived by multiple senses. How animals integrate signal components across sensory modalities can influence signal evolution. Here we show that two relatively unattractive signals that are perceived acoustically and visually can be combined in a pattern to form a signal that is attractive to female tungara frogs. Such unanticipated perceptual effects suggest that the evolution of complex signals can occur by alteration of the relationships among already-existing traits.	[Taylor, R. C.] Salisbury Univ, Dept Biol, Salisbury, MD 21801 USA; [Ryan, M. J.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Ryan, M. J.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	University System of Maryland; Salisbury University; University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian Tropical Research Institute	Ryan, MJ (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	mryan@utexas.edu			NSF [IBN 0517328, IBN 0078150, IOS 1120031]; Clark Hubbs Regents Professorship	NSF(National Science Foundation (NSF)); Clark Hubbs Regents Professorship	We are grateful to the NSF (grants IBN 0517328, IBN 0078150, and IOS 1120031) and the Clark Hubbs Regents Professorship (M.J.R.) for funding and the Smithsonian Tropical Research Institute for logistical support. We thank E. Balaban for helpful discussion and H. Farris, S. Partan, S. Pika, G. Rosenthal, and three anonymous reviewers for their comments on the manuscript. We thank B. Klein and Moey, Incorporated for design and fabrication of the robotic frogs. We are especially grateful to the interns who assisted in data collection. All research reported here complied with IACUC protocols from Salisbury University, the University of Texas, and the Smithsonian Tropical Research Institute. We obtained all required permits from the Government of Panama. Data will be archived in the Dryad Data Repository at dx.doi.org/10.5061/dryad.pk85.	Agresti A, 2001, STAT MED, V20, P2709, DOI 10.1002/sim.738; Agresti A, 2007, INTRO CATEGORICAL DA, V2nd; Bahrick LE, 2004, CURR DIR PSYCHOL SCI, V13, P99, DOI 10.1111/j.0963-7214.2004.00283.x; Bee MA, 2008, J COMP PSYCHOL, V122, P235, DOI 10.1037/0735-7036.122.3.235; Bregman A.S., 1994, AUDITORY SCENE ANAL; Driver J, 1996, NATURE, V381, P66, DOI 10.1038/381066a0; Farris HE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1417; Gridi-Papp M, 2006, NATURE, V441, P38, DOI 10.1038/441038a; GUILFORD T, 1991, ANIM BEHAV, V42, P1, DOI 10.1016/S0003-3472(05)80600-1; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Marler P, 1997, J NEUROBIOL, V33, P501; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Pauly GB, 2006, PHYSIOL BIOCHEM ZOOL, V79, P708, DOI 10.1086/504613; PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347; Rowe C, 1996, NATURE, V383, P520, DOI 10.1038/383520a0; Ryan M. J., ANN REV ECO IN PRESS; Ryan MJ, 2011, INTEGR COMP BIOL, V51, P756, DOI 10.1093/icb/icr065; Seeba F, 2010, ANIM BEHAV, V79, P1317, DOI 10.1016/j.anbehav.2010.03.004; Taylor RC, 2008, ANIM BEHAV, V76, P1089, DOI 10.1016/j.anbehav.2008.01.031; Taylor RC, 2007, ANIM BEHAV, V74, P1753, DOI 10.1016/j.anbehav.2007.03.010; Taylor RC, 2011, J EXP BIOL, V214, P815, DOI 10.1242/jeb.043638; Wilczynski W, 1999, ANIM BEHAV, V58, P841, DOI 10.1006/anbe.1999.1208	24	75	75	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					273	274		10.1126/science.1237113	http://dx.doi.org/10.1126/science.1237113			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23744778				2022-12-01	WOS:000321959300042
J	Cook, NR; Lee, IM; Zhang, SMM; Moorthy, MV; Buring, JE				Cook, Nancy R.; Lee, I-Min; Zhang, Shumin M.; Moorthy, M. Vinayaga; Buring, Julie E.			Alternate-Day, Low-Dose Aspirin and Cancer Risk: Long-Term Observational Follow-up of a Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							COLORECTAL-CANCER; PRIMARY PREVENTION; CHEMOPREVENTION; MORTALITY; MODELS; DRUGS	Background: Recent evidence suggests that daily aspirin use decreases cancer risk, particularly for colorectal cancer, but evidence for alternate-day use is scant. Objective: To examine the association between long-term, alternate-day, low-dose aspirin and cancer in healthy women. Design: Observational follow-up of a randomized trial. Setting: Female health professionals. Participants: 39 876 women aged 45 years or older in the Women's Health Study (ClinicalTrials.gov: NCT00000479), 33 682 of whom continued observational follow-up. Intervention: 100 mg of alternate-day aspirin or placebo through March 2004, with a median 10-year follow-up. Posttrial follow-up continued through March 2012. Measurements: Cancer incidence. Results: A total of 5071 cancer cases (including 2070 breast, 451 colorectal, and 431 lung cancer cases) and 1391 cancer deaths were confirmed. Over the entire follow-up, aspirin had no association with total (hazard ratio [HR], 0.97 [95% CI, 0.92 to 1.03]; P = 0.31), breast (HR, 0.98 [CI, 0.90 to 1.07]; P = 0.65), or lung (HR, 1.04 [CI, 0.86 to 1.26]; P = 0.67) cancer. Colorectal cancer was reduced in the aspirin group (HR, 0.80 [CI, 0.67 to 0.97]; P = 0.021), primarily for proximal colon cancer (HR, 0.73 [CI, 0.55 to 0.95]; P = 0.022). The difference emerged after 10 years, with a posttrial reduction of 42% (HR, 0.58 [CI, 0.42 to 0.80]; P < 0.001). There was no extended effect on cancer deaths or colorectal polyps. More gastrointestinal bleeding (HR, 1.14 [CI, 1.06 to 1.22]; P < 0.001) and peptic ulcers (HR, 1.17 [CI, 1.09 to 1.27]; P < 0.001) occurred in the aspirin group. Limitations: Not all women received extended follow-up, and posttrial ascertainment bias cannot be ruled out. Gastrointestinal bleeding, peptic ulcers, and polyps were self-reported during extended follow-up. Conclusion: Long-term use of alternate-day, low-dose aspirin may reduce risk for colorectal cancer in healthy women.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Cook, NR (corresponding author), Brigham & Womens Hosp, 900 Commonwealth Ave East, Boston, MA 02215 USA.	ncook@rics.bwh.harvard.edu	Lee, I-Min/ABD-5409-2021		National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099355, R01HL080467, R01HL043851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Primary Funding Source: National Institutes of Health.	Austin PC, 2012, STAT MED; Bosetti C, 2012, ANN ONCOL, V23, P1403, DOI 10.1093/annonc/mds113; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P27; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Calonge N, 2009, ANN INTERN MED, V150, P396; Chan AT, 2012, LANCET, V379, P1569, DOI 10.1016/S0140-6736(11)61654-1; Chan AT, 2012, CANCER PREV RES, V5, P164, DOI 10.1158/1940-6207.CAPR-11-0391; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; COX DR, 1972, J R STAT SOC B, V34, P187; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Dorresteijn JAN, 2011, EUR HEART J, V32, P2962, DOI 10.1093/eurheartj/ehr423; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Langley RE, 2011, BRIT J CANCER, V105, P1107, DOI 10.1038/bjc.2011.289; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Patrono C, 2001, CHEST, V119, p39S, DOI 10.1378/chest.119.1_suppl.39S; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Seshasai SRK, 2012, ARCH INTERN MED, V172, P209, DOI 10.1001/archinternmed.2011.628; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003; THERNEAU TM, 2000, STAT BIOL HEALTH, pR7; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; Thun MJ, 2000, EPIDEMIOLOGY, V11, P371, DOI 10.1097/00001648-200007000-00001	28	225	229	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2					77	W32		10.7326/0003-4819-159-2-201307160-00002	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-00002			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23856681	Green Accepted			2022-12-01	WOS:000322112000013
J	Faith, JJ; Guruge, JL; Charbonneau, M; Subramanian, S; Seedorf, H; Goodman, AL; Clemente, JC; Knight, R; Heath, AC; Leibel, RL; Rosenbaum, M; Gordon, JI				Faith, Jeremiah J.; Guruge, Janaki L.; Charbonneau, Mark; Subramanian, Sathish; Seedorf, Henning; Goodman, Andrew L.; Clemente, Jose C.; Knight, Rob; Heath, Andrew C.; Leibel, Rudolph L.; Rosenbaum, Michael; Gordon, Jeffrey I.			The Long-Term Stability of the Human Gut Microbiota	SCIENCE			English	Article							ENERGY-EXPENDITURE; RIBOSOMAL-RNA; TWINS; WEIGHT; DIVERSITY; BACTERIA; GENOME; OBESE; FLORA	A low-error 16S ribosomal RNA amplicon sequencing method, in combination with whole-genome sequencing of >500 cultured isolates, was used to characterize bacterial strain composition in the fecal microbiota of 37 U.S. adults sampled for up to 5 years. Microbiota stability followed a power-law function, which when extrapolated suggests that most strains in an individual are residents for decades. Shared strains were recovered from family members but not from unrelated individuals. Sampling of individuals who consumed a monotonous liquid diet for up to 32 weeks indicated that changes in strain composition were better predicted by changes in weight than by differences in sampling interval. This combination of stability and responsiveness to physiologic change confirms the potential of the gut microbiota as a diagnostic tool and therapeutic target.	[Faith, Jeremiah J.; Guruge, Janaki L.; Charbonneau, Mark; Subramanian, Sathish; Seedorf, Henning; Goodman, Andrew L.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Clemente, Jose C.; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Biofrontiers Inst, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Leibel, Rudolph L.; Rosenbaum, Michael] Columbia Univ Coll Phys & Surg, Div Mol Genet, Dept Pediat, New York, NY 10032 USA; [Leibel, Rudolph L.; Rosenbaum, Michael] Columbia Univ Coll Phys & Surg, Div Mol Genet, Dept Med, New York, NY 10032 USA	Washington University (WUSTL); Washington University (WUSTL); University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Columbia University; Columbia University	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu	Seedorf, Henning/AAW-6023-2020; Knight, Rob/D-1299-2010	Seedorf, Henning/0000-0002-5763-0236; Knight, Rob/0000-0002-0975-9019	NIH [DK30292, DK078669, DK70977, DK64774, UL1TR000040]; Crohn's and Colitis Foundation of America; Groupe Danone; Howard Hughes Medical Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030292, R01DK070977, P01DK078669, R01DK064773, P30DK026687, R37DK030292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017688] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Groupe Danone(Danone Nutricia); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank D. Hopper and S. Marion for their contributions to the recruitment of twins from the MOAFTS cohort and for obtaining fecal samples for the present study; J. Hoisington-Lopez, M. Meier, and S. Deng for technical assistance; and members of the Gordon lab for their many helpful suggestions during the course of this study. Supported by NIH grants DK30292, DK078669, DK70977, DK64774, and UL1TR000040; the Crohn's and Colitis Foundation of America; Groupe Danone (through partial support of the postdoctoral stipend of J. J. F.); and the Howard Hughes Medical Institute. Draft genome assemblies are available from the European Bioinformatics Institute (EBI) under accession numbers PRJEB3419 to PRJEB3951. Raw and processed LEA-Seq data, as well as experimental protocols for LEA-Seq and phased 16S rRNA amplicon sequencing, can be found at http://gordonlab.wustl.edu/microbiota_stability/. The authors do not declare any conflicts of interest. Author contributions: J. J. F. and J. I. G. designed the experiments; A. C. H., R. L. L., and M. R. oversaw human studies; J. J. F., J. L. G., M. C., S. S., H. S., and A. L. G. generated the data; J. J. F., R. K., J. C. C., S. S., and J. I. G. analyzed data; J. J. F. and J. I. G. wrote the paper.	Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Halfvarson J, 2011, INFLAMM BOWEL DIS, V17, P6, DOI 10.1002/ibd.21295; Hansen EE, 2011, P NATL ACAD SCI USA, V108, P4599, DOI 10.1073/pnas.1000071108; Henz Stefan R, 2005, Bioinformatics, V21, P2329, DOI 10.1093/bioinformatics/bth324; Hiatt JB, 2010, NAT METHODS, V7, P119, DOI [10.1038/NMETH.1416, 10.1038/nmeth.1416]; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Kissileff HR, 2012, AM J CLIN NUTR, V95, P309, DOI 10.3945/ajcn.111.012385; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/NMETH.1778, 10.1038/nmeth.1778]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; MITSUOKA T, 1992, NUTR REV, V50, P438, DOI 10.1111/j.1753-4887.1992.tb02499.x; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2013, ENVIRON MICROBIOL, V15, P1146, DOI 10.1111/1462-2920.12023; Rosenbaum M, 1997, J CLIN ENDOCR METAB, V82, P3647, DOI 10.1210/jc.82.11.3647; Rosenbaum M, 1996, AM J PHYSIOL-REG I, V270, pR496, DOI 10.1152/ajpregu.1996.270.3.R496; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Slutske WS, 2004, J ABNORM PSYCHOL, V113, P530, DOI 10.1037/0021-843X.113.4.530; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Waldron M, 2013, J STUD ALCOHOL DRUGS, V74, P337, DOI 10.15288/jsad.2013.74.337; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	28	1133	1199	17	381	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2013	341	6141					44	+	1237439	10.1126/science.1237439	http://dx.doi.org/10.1126/science.1237439			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23828941	Green Accepted			2022-12-01	WOS:000321291700041
J	Ghafur, A				Ghafur, Abdul			India must overhaul medical training to act on antimicrobial resistance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Apollo Hosp, Madras, Tamil Nadu, India		Ghafur, A (corresponding author), Apollo Hosp, Madras, Tamil Nadu, India.	drghafur@hotmail.com						Ghafur A, 2013, INDIAN J CANCER, V50, P71, DOI 10.4103/0019-509X.104065; Hopkins S., 2013, BRIT MED J, V346, pf591	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2013	347								f4230	10.1136/bmj.f4230	http://dx.doi.org/10.1136/bmj.f4230			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180CZ	23823999				2022-12-01	WOS:000321571800004
J	Shima, T; Hu, SW; Luo, G; Kang, XH; Luo, Y; Hou, ZM				Shima, Takanori; Hu, Shaowei; Luo, Gen; Kang, Xiaohui; Luo, Yi; Hou, Zhaomin			Dinitrogen Cleavage and Hydrogenation by a Trinuclear Titanium Polyhydride Complex	SCIENCE			English	Article							BIOLOGICAL NITROGEN-FIXATION; SIDE-ON; CATALYTIC-REDUCTION; END-ON; AMMONIA; CHEMISTRY; MOLYBDENUM; NITRIDE; N-2; COORDINATION	Both the Haber-Bosch and biological ammonia syntheses are thought to rely on the cooperation of multiple metals in breaking the strong N=N triple bond and forming an N-H bond. This has spurred investigations of the reactivity of molecular multimetallic hydrides with dinitrogen. We report here the reaction of a trinuclear titanium polyhydride complex with dinitrogen, which induces dinitrogen cleavage and partial hydrogenation at ambient temperature and pressure. By H-1 and N-15 nuclear magnetic resonance, x-ray crystallographic, and computational studies of some key reaction steps and products, we have determined that the dinitrogen (N-2) reduction proceeds sequentially through scission of a N-2 molecule bonded to three Ti atoms in a mu-eta(1):eta(2):eta(2)-end-on-side-on fashion to give a mu(2)-N/mu(3\)-N dinitrido species, followed by intramolecular hydrogen migration from Ti to the mu(2)-N nitrido unit.	[Shima, Takanori; Hu, Shaowei; Hou, Zhaomin] RIKEN Ctr Sustainable Resource Sci, Adv Catalysis Res Grp, Wako, Saitama 3510198, Japan; [Shima, Takanori; Hu, Shaowei; Kang, Xiaohui; Hou, Zhaomin] RIKEN, Organometall Chem Lab, Wako, Saitama 3510198, Japan; [Luo, Gen; Kang, Xiaohui; Luo, Yi; Hou, Zhaomin] Dalian Univ Technol, State Key Lab Fine Chem, Dalian 116024, Peoples R China; [Luo, Gen; Kang, Xiaohui; Luo, Yi; Hou, Zhaomin] Dalian Univ Technol, Sch Pharmaceut Sci & Technol, Dalian 116024, Peoples R China	RIKEN; RIKEN; Dalian University of Technology; Dalian University of Technology	Hou, ZM (corresponding author), RIKEN Ctr Sustainable Resource Sci, Adv Catalysis Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	houz@riken.jp	Hu, Shaowei/C-7982-2017; Shima, Takanori/C-8166-2017; Luo, Yi/B-3277-2013; Hou, Zhaomin/I-5981-2014; Luo/C-8149-2017	Shima, Takanori/0000-0003-1813-0439; Luo, Yi/0000-0001-6390-8639; Hou, Zhaomin/0000-0003-2841-5120; Luo/0000-0002-5297-6756; Hu, Shaowei/0000-0002-7209-438X	Japan Society for the Promotion of Science [21750068, 21225004]; RIKEN; National Natural Science Foundation of China [21028001, 21174023]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a Grant-in-Aid for Young Scientists (B) (no. 21750068) and a Grant-in-Aid for Scientific Research (S) (no. 21225004) from the Japan Society for the Promotion of Science, an Incentive Research Grant from RIKEN, and grants from the National Natural Science Foundation of China (nos. 21028001 and 21174023). We gratefully appreciate access to the RIKEN Integrated Cluster of Clusters and the Network and Information Center of Dalian University of Technology for computational resources. Metrical parameters for the structures of compounds 2 to 6 are available free of charge from the Cambridge Crystallographic Data Centre under reference nos. CCDC-937384 to 937388. Correspondence on DFT calculations should be sent to Y.L. (luoyi@dlut.edu.cn). Z.H., T. S., and S. H. conceived and designed the experiments. S. H. carried out most of the experiments. T. S. carried out the x-ray analyses and part of the experiments. G. L., X. K., and Y.L. performed the DFT calculations. Z.H., T. S., and S. H. analyzed the data and co-wrote the manuscript. Z.H. directed the project.	Akagi F, 2007, ANGEW CHEM INT EDIT, V46, P8778, DOI 10.1002/anie.200703336; Arashiba K, 2011, NAT CHEM, V3, P120, DOI 10.1038/NCHEM.906; Avenier P, 2007, SCIENCE, V317, P1056, DOI 10.1126/science.1143078; Ballmann J, 2010, CHEM COMMUN, V46, P1013, DOI 10.1039/b922853e; BAZHENOVA TA, 1995, COORDIN CHEM REV, V144, P69, DOI 10.1016/0010-8545(95)01139-G; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Caselli A, 2000, J AM CHEM SOC, V122, P3652, DOI 10.1021/ja9943288; CHATT J, 1978, CHEM REV, V78, P589, DOI 10.1021/cr60316a001; Eady RR, 1996, CHEM REV, V96, P3013, DOI 10.1021/cr950057h; Ertl G, 2008, ANGEW CHEM INT EDIT, V47, P3524, DOI 10.1002/anie.200800480; Evans WJ, 2004, J AM CHEM SOC, V126, P14574, DOI 10.1021/ja046047s; Fryzuk MD, 1998, J AM CHEM SOC, V120, P11024, DOI 10.1021/ja982377z; Fryzuk MD, 1997, SCIENCE, V275, P1445, DOI 10.1126/science.275.5305.1445; HIDAI M, 1995, CHEM REV, V95, P1115, DOI 10.1021/cr00036a008; Honkala K, 2005, SCIENCE, V307, P555, DOI 10.1126/science.1106435; Hou ZM, 2007, EUR J INORG CHEM, P2535, DOI 10.1002/ejic.200700085; Howard JB, 2006, P NATL ACAD SCI USA, V103, P17088, DOI 10.1073/pnas.0603978103; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; Hu SW, 2013, ORGANOMETALLICS, V32, P2145, DOI 10.1021/om400012a; Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445; LAPLAZA CE, 1995, SCIENCE, V268, P861, DOI 10.1126/science.268.5212.861; MacKay BA, 2004, CHEM REV, V104, P385, DOI 10.1021/cr020610c; Matsuo T, 2003, ORGANOMETALLICS, V22, P5379, DOI 10.1021/om034147l; Mori M, 2004, J ORGANOMET CHEM, V689, P4210, DOI 10.1016/j.jorganchem.2004.05.053; Nikiforov GB, 2009, ANGEW CHEM INT EDIT, V48, P7415, DOI 10.1002/anie.200903648; Nishiura M, 2011, CHEM-EUR J, V17, P5033, DOI 10.1002/chem.201002998; Nishiura M, 2010, NAT CHEM, V2, P257, DOI 10.1038/nchem.595; Pool JA, 2004, NATURE, V427, P527, DOI 10.1038/nature02274; Rodriguez MM, 2011, SCIENCE, V334, P780, DOI 10.1126/science.1211906; ROESKY HW, 1989, ANGEW CHEM INT EDIT, V28, P754, DOI 10.1002/anie.198907541; Schlogl R, 2003, ANGEW CHEM INT EDIT, V42, P2004, DOI 10.1002/anie.200301553; Schrock RR, 2008, ANGEW CHEM INT EDIT, V47, P5512, DOI 10.1002/anie.200705246; Semproni SP, 2012, ORGANOMETALLICS, V31, P3672, DOI 10.1021/om300156z; Semproni SP, 2011, J AM CHEM SOC, V133, P10406, DOI 10.1021/ja2042595; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; Yandulov DV, 2003, SCIENCE, V301, P76, DOI 10.1126/science.1085326	36	250	255	14	483	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1549	1552		10.1126/science.1238663	http://dx.doi.org/10.1126/science.1238663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812710				2022-12-01	WOS:000321007000035
J	King, B; Trimarchi, T; Reavie, L; Xu, LY; Mullenders, J; Ntziachristos, P; Aranda-Orgilles, B; Perez-Garcia, A; Shi, JW; Vakoc, C; Sandy, P; Shen, SS; Ferrando, A; Aifantis, I				King, Bryan; Trimarchi, Thomas; Reavie, Linsey; Xu, Luyao; Mullenders, Jasper; Ntziachristos, Panagiotis; Aranda-Orgilles, Beatriz; Perez-Garcia, Arianne; Shi, Junwei; Vakoc, Christopher; Sandy, Peter; Shen, Steven S.; Ferrando, Adolfo; Aifantis, Iannis			The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability	CELL			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GAMMA-SECRETASE INHIBITORS; EMBRYONIC STEM-CELLS; C-MYC; TUMOR-SUPPRESSOR; GENE-EXPRESSION; TRANSCRIPTIONAL NETWORK; MOLECULAR PATHOGENESIS; BET BROMODOMAINS; T-ALL	Sequencing efforts led to the identification of somatic mutations that could affect the self-renewal and differentiation of cancer-initiating cells. One such recurrent mutation targets the binding pocket of the ubiquitin ligase Fbxw7. Missense FBXW7 mutations are prevalent in various tumors, including T cell acute lymphoblastic leukemia (T-ALL). To study the effects of such lesions, we generated animals carrying regulatable Fbxw7 mutant alleles. Here, we show that these mutations specifically bolster cancer-initiating cell activity in collaboration with Notch1 oncogenes but spare normal hematopoietic stem cell function. We were also able to show that FBXW7 mutations specifically affect the ubiquitylation and half-life of c-Myc protein, a key T-ALL oncogene. Using animals carrying c-Myc fusion alleles, we connected Fbxw7 function to c-Myc abundance and correlated c-Myc expression to leukemia-initiating activity. Finally, we demonstrated that small-molecule-mediated suppression of MYC activity leads to T-ALL remission, suggesting an effective therapeutic strategy.	[King, Bryan; Trimarchi, Thomas; Reavie, Linsey; Mullenders, Jasper; Ntziachristos, Panagiotis; Aranda-Orgilles, Beatriz; Shen, Steven S.; Aifantis, Iannis] NYU Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [King, Bryan; Trimarchi, Thomas; Reavie, Linsey; Mullenders, Jasper; Ntziachristos, Panagiotis; Aranda-Orgilles, Beatriz; Shen, Steven S.; Aifantis, Iannis] NYU Sch Med, NYU Canc Inst, New York, NY 10016 USA; [Aifantis, Iannis] NYU Sch Med, Dept Pathol, New York, NY 10016 USA; [Shen, Steven S.] NYU Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Reavie, Linsey] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Xu, Luyao; Perez-Garcia, Arianne; Ferrando, Adolfo] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Shi, Junwei; Vakoc, Christopher] Cold Spring Harbor, Cold Spring Harbor Lab, New York, NY 11224 USA; [Sandy, Peter] Constellat Pharmaceut, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University; IRCCS European Institute of Oncology (IEO); Columbia University; Cold Spring Harbor Laboratory	Aifantis, I (corresponding author), NYU Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	iannis.aifantis@nyumc.org	xu, Luyao/F-2381-2015; Mullenders, Jasper/J-2398-2015; Ntziachristos, Panagiotis/CAG-2071-2022	Mullenders, Jasper/0000-0003-3737-6901; Shen, Steven/0000-0001-7725-1260; Vakoc, Christopher/0000-0002-1158-7180	NIH/NCI [P30 CA016087-30]; NYU Cancer Institute Center [5P30CA16087-31]; NIH [1RO1CA133379, 1RO1CA105129, 1RO1CA149655, 5RO1CA173636, 1RO1GM088847]; William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society [6340-11, 6373-13]; Chemotherapy Foundation; V Foundation for Cancer Research; St. Baldrick's Foundation; NYU CMB Training Program; Ruth L. Kirschstein F31 Award; Marie Curie Actions Fellowship; NWO Rubicon; Dutch Cancer Society; Jose Carreras Leukemia Foundation [FIJC-12/EDTHOMAS]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA133379, R01CA149655, R01CA174793, R01CA173636, R01CA105129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088847] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NYU Cancer Institute Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Chemotherapy Foundation; V Foundation for Cancer Research; St. Baldrick's Foundation; NYU CMB Training Program; Ruth L. Kirschstein F31 Award; Marie Curie Actions Fellowship; NWO Rubicon(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); Jose Carreras Leukemia Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Constellation Pharmaceuticals for providing CPI203; W. Pear, P. Premsrirut, J. Aster, J. Silva, M. Kelliher, and A. Klinakis for sharing materials; the NYU Genome Technology Center (supported in part by an NIH/NCI P30 CA016087-30 grant); L. Deriano and J. Chaumeil for mFISH analysis; the NYU Flow Cytometry facility for cell sorting; and the NYU Histology Core and Transgenic Mouse Core (NYU Cancer Institute Center grant 5P30CA16087-31). I.A. was supported by the NIH (1RO1CA133379, 1RO1CA105129, 1RO1CA149655, 5RO1CA173636, and 1RO1GM088847). I.A. was also supported by the William Lawrence and Blanche Hughes Foundation, the Leukemia & Lymphoma Society (TRP#6340-11 and LLS#6373-13), the Chemotherapy Foundation, the V Foundation for Cancer Research, and the St. Baldrick's Foundation. B.K. was supported by the NYU CMB Training Program. L.R. is supported by a Ruth L. Kirschstein F31 Award and a Marie Curie Actions Fellowship. J.M. is supported by NWO Rubicon and the Dutch Cancer Society. B.A.-O. is supported by the Jose Carreras Leukemia Foundation (FIJC-12/EDTHOMAS). I.A. is a Howard Hughes Medical Institute Early Career Scientist. I.A. and B.K. designed experiments and wrote the manuscript. B.K. performed most of the experiments. L.R. generated Eef1a1-targeted ESCs. L.X., A.P.-G., and A.F. assisted with in vivo and primary human T-ALL drug studies. P.S. assisted with inhibitor production and provided advice for use. C.V., J.S., and J. M. performed BRD4 knockdown experiments. B.A.-O. performed ubiquitylation assays. P.N., T.T., and S.S.S. performed and analyzed RNA-seq and ChIP-seq experiments. P.S. is an employee of Constellation Pharmaceuticals.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Armstrong F, 2009, BLOOD, V113, P1730, DOI 10.1182/blood-2008-02-138172; Aster JC, 1997, J BIOL CHEM, V272, P11336; Buchstaller J, 2012, CANCER CELL, V21, P240, DOI 10.1016/j.ccr.2011.12.027; Buonamici S, 2009, NATURE, V459, P1000, DOI 10.1038/nature08020; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; Davis H, 2011, J PATHOL, V224, P180, DOI 10.1002/path.2874; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Downing JR, 2012, NAT GENET, V44, P619, DOI 10.1038/ng.2287; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Ferrando AA, 2003, SEMIN HEMATOL, V40, P274, DOI 10.1016/S0037-1963(03)00195-1; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Francis R, 2007, GENE DEV, V21, P1064, DOI 10.1101/gad.1522807; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Grim JE, 2012, MOL CELL BIOL, V32, P2160, DOI 10.1128/MCB.00305-12; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Klinakis A, 2009, P NATL ACAD SCI USA, V106, P2359, DOI 10.1073/pnas.0810221106; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee MS, 2004, INT IMMUNOL, V16, P1109, DOI 10.1093/intimm/dxh112; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Reavie L, 2013, CANCER CELL, V23, P362, DOI 10.1016/j.ccr.2013.01.025; Reavie L, 2010, NAT IMMUNOL, V11, P207, DOI 10.1038/ni.1839; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Wang ZW, 2012, FEBS LETT, V586, P1409, DOI 10.1016/j.febslet.2012.03.017; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	53	221	228	1	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 20	2013	153	7					1552	1566		10.1016/j.cell.2013.05.041	http://dx.doi.org/10.1016/j.cell.2013.05.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791182	Green Accepted, Bronze			2022-12-01	WOS:000320722000022
J	Shah, P; Ding, Y; Niemczyk, M; Kudla, G; Plotkin, JB				Shah, Premal; Ding, Yang; Niemczyk, Malwina; Kudla, Grzegorz; Plotkin, Joshua B.			Rate-Limiting Steps in Yeast Protein Translation	CELL			English	Article							GENOME-WIDE ANALYSIS; GENE-EXPRESSION; CODON USAGE; TRANSFER-RNA; SECONDARY STRUCTURE; BINDING-SITES; IN-VIVO; EFFICIENCY; BIAS; TRANSCRIPTION	Deep sequencing now provides detailed snapshots of ribosome occupancy on mRNAs. We leverage these data to parameterize a computational model of translation, keeping track of every ribosome, tRNA, and mRNA molecule in a yeast cell. We determine the parameter regimes in which fast initiation or high codon bias in a transgene increases protein yield and infer the initiation rates of endogenous Saccharomyces cerevisiae genes, which vary by several orders of magnitude and correlate with 5' mRNA folding energies. Our model recapitulates the previously reported 5'-to-3' ramp of decreasing ribosome densities, although our analysis shows that this ramp is caused by rapid initiation of short genes rather than slow codons at the start of transcripts. We conclude that protein production in healthy yeast cells is typically limited by the availability of free ribosomes, whereas protein production under periods of stress can sometimes be rescued by reducing initiation or elongation rates.	[Shah, Premal; Ding, Yang; Plotkin, Joshua B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Niemczyk, Malwina; Kudla, Grzegorz] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH3 9LP, Midlothian, Scotland	University of Pennsylvania; University of Edinburgh	Plotkin, JB (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	jplotkin@sas.upenn.edu	Taylor, Graham/A-4027-2012	Prater, Malwina/0000-0002-8202-5345; Shah, Premal/0000-0002-8424-4218; Kudla, Grzegorz/0000-0002-7924-2744	Burroughs Wellcome Fund; David and Lucile Packard Foundation; James S. McDonnell Foundation; Alfred P. Sloan Foundation; Foundational Questions in Evolutionary Biology Fund [RFP-12-16]; U.S. Department of the Interior [D12AP00025]; Wellcome Trust [077248]; Darwin Trust of Edinburgh	Burroughs Wellcome Fund(Burroughs Wellcome Fund); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); James S. McDonnell Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Foundational Questions in Evolutionary Biology Fund; U.S. Department of the Interior; Wellcome Trust(Wellcome TrustEuropean Commission); Darwin Trust of Edinburgh	We thank M.A. Gilchrist, S.S. Yadavalli, and S. Jagannathan. J.B.P. acknowledges support from the Burroughs Wellcome Fund, the David and Lucile Packard Foundation, the James S. McDonnell Foundation, the Alfred P. Sloan Foundation, the Foundational Questions in Evolutionary Biology Fund (RFP-12-16), and grant D12AP00025 from the U.S. Department of the Interior. M.N. and G.K. were supported by The Wellcome Trust grant 077248 to David Tollervey and also thank the Tollervey lab. M.N. was supported by the Darwin Trust of Edinburgh.	ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Brackley CA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002203; BULMER M, 1991, GENETICS, V129, P897; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chu D, 2012, NUCLEIC ACIDS RES, V40, P10098, DOI 10.1093/nar/gks825; Chu D, 2011, NUCLEIC ACIDS RES, V39, P6705, DOI 10.1093/nar/gkr300; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Ding Y, 2012, GENOME BIOL EVOL, V4, P1046, DOI 10.1093/gbe/evs082; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Gilchrist MA, 2006, J THEOR BIOL, V239, P417, DOI 10.1016/j.jtbi.2005.08.007; Gilchrist MA, 2007, MOL BIOL EVOL, V24, P2362, DOI 10.1093/molbev/msm169; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; HALL MN, 1982, NATURE, V295, P616, DOI 10.1038/295616a0; Hinnebusch AG, 2012, COLD SPRING HARB PER, V4; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hurowitz EH, 2004, GENOME BIOL, V5; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Lin ZG, 2012, MOL BIOL EVOL, V29, P81, DOI 10.1093/molbev/msr143; Mitarai N, 2008, J MOL BIOL, V382, P236, DOI 10.1016/j.jmb.2008.06.068; MOEHLE CM, 1991, MOL CELL BIOL, V11, P2723, DOI 10.1128/MCB.11.5.2723; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Politz JCR, 2003, MOL BIOL CELL, V14, P4805, DOI 10.1091/mbc.E03-06-0395; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Reuveni S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002127; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Shah P, 2011, P NATL ACAD SCI USA, V108, P10231, DOI 10.1073/pnas.1016719108; Shah P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001128; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Siwiak M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000865; Tanguay RL, 1996, MOL CELL BIOL, V16, P146; Tuller T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r110; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; von der Haar T, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-87; WALDRON C, 1975, J BACTERIOL, V122, P855, DOI 10.1128/JB.122.3.855-865.1975; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Werner A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq808; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	58	286	290	1	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1589	1601		10.1016/j.cell.2013.05.049	http://dx.doi.org/10.1016/j.cell.2013.05.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791185	hybrid, Green Published			2022-12-01	WOS:000320722000025
J	Sun, S; Del Rosario, BC; Szanto, A; Ogawa, Y; Jeon, Y; Lee, JT				Sun, Sha; Del Rosario, Brian C.; Szanto, Attila; Ogawa, Yuya; Jeon, Yesu; Lee, Jeannie T.			Jpx RNA Activates Xist by Evicting CTCF	CELL			English	Article							X-CHROMOSOME INACTIVATION; EMBRYONIC STEM-CELLS; DOSAGE COMPENSATION; SEX DETERMINATION; MOUSE; TSIX; GENE; TRANSCRIPTION; SWITCH; BINDING	In mammals, dosage compensation between XX and XY individuals occurs through X chromosome inactivation (XCI). The noncoding Xist RNA is expressed and initiates XCI only when more than one X chromosome is present. Current models invoke a dependency on the X-to-autosome ratio (X:A), but molecular factors remain poorly defined. Here, we demonstrate that molecular titration between an X-encoded RNA and an autosomally encoded protein dictates Xist induction. In pre-XCI cells, CTCF protein represses Xist transcription. At the onset of XCI, Jpx RNA is upregulated, binds CTCF, and extricates CTCF from one Xist allele. We demonstrate that CTCF is an RNA-binding protein and is titrated away from the Xist promoter by Jpx RNA. Thus, Jpx activates Xist by evicting CTCF. The functional antagonism via molecular titration reveals a role for long noncoding RNA in epigenetic regulation.	[Sun, Sha; Del Rosario, Brian C.; Szanto, Attila; Ogawa, Yuya; Jeon, Yesu; Lee, Jeannie T.] Howard Hughes Med Inst, Boston, MA 02114 USA; [Sun, Sha; Del Rosario, Brian C.; Szanto, Attila; Ogawa, Yuya; Jeon, Yesu; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Sun, Sha; Del Rosario, Brian C.; Szanto, Attila; Ogawa, Yuya; Jeon, Yesu; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu	Szanto, Attila/B-2198-2012		National Institutes of Health [RO1-GM58839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839, R37GM058839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to R. Jaenisch for the gift of F1-2.1 ES cells and G. Daley for Ainv15. We thank S. Pinter for sharing unpublished data, J. Ahn for sharing ChIP primers, B. Payer and D. Lessing for critically reading the manuscript, and all lab members for engaging discussions. This work is supported by a grant from the National Institutes of Health (RO1-GM58839 to J.T.L.). J.T.L. is an Investigator of the Howard Hughes Medical Institute.	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Barakat TS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002001; BARBASH DA, 1995, GENETICS, V141, P1451; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BROWN SW, 1973, P NATL ACAD SCI USA, V70, P195, DOI 10.1073/pnas.70.1.195; Chow JC, 2003, GENOMICS, V82, P309, DOI 10.1016/S0888-7543(03)00170-8; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Cifuentes-Rojas C, 2011, P NATL ACAD SCI USA, V108, P73, DOI 10.1073/pnas.1013021107; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Essien K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r131; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Gartler SM, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-41; Gontan C, 2012, NATURE, V485, P386, DOI 10.1038/nature11070; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Johnston CM, 2002, GENOMICS, V80, P236, DOI 10.1006/geno.2002.6819; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; LYON MF, 1971, NATURE-NEW BIOL, V232, P229, DOI 10.1038/newbio232229a0; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; Navarro P, 2006, GENE DEV, V20, P2787, DOI 10.1101/gad.389006; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; OHNO S, 1969, ANNU REV GENET, V3, P495, DOI 10.1146/annurev.ge.03.120169.002431; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Ptashne M, 2011, NAT CHEM BIOL, V7, P484, DOI 10.1038/nchembio.611; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; Sado T, 2001, DEVELOPMENT, V128, P1275; Salz HK, 2010, FLY, V4, P60, DOI 10.4161/fly.4.1.11277; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Shin J, 2010, NATURE, V467, P977, DOI 10.1038/nature09457; Spencer RJ, 2011, GENETICS, V189, P441, DOI 10.1534/genetics.111.132662; Starmer J, 2009, DEVELOPMENT, V136, P1, DOI 10.1242/dev.025908; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Yang Y, 2003, NAT BIOTECHNOL, V21, P447, DOI 10.1038/nbt803; Yao HJ, 2010, GENE DEV, V24, P2543, DOI 10.1101/gad.1967810; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	53	221	227	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 20	2013	153	7					1537	1551		10.1016/j.cell.2013.05.028	http://dx.doi.org/10.1016/j.cell.2013.05.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791181	Green Accepted, Bronze			2022-12-01	WOS:000320722000021
J	Van de Perre, P; Tylleskar, T; Delfraissy, JF; Nagot, N				Van de Perre, Philippe; Tylleskar, Thorkild; Delfraissy, Jean-Francois; Nagot, Nicolas			How evidence based are public health policies for prevention of mother to child transmission of HIV?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTED MOTHERS; CONTROLLED-TRIAL; DOSE NEVIRAPINE; PROPHYLAXIS; DIARRHEA; ZIDOVUDINE; MORTALITY; INFANTS; BORN		[Van de Perre, Philippe; Nagot, Nicolas] INSERM, Infect HIV & Agents Mucocutaneous Tropism Pathoge, F-34394 Montpellier, France; [Van de Perre, Philippe; Nagot, Nicolas] Univ Montpellier I, F-34090 Montpellier, France; [Van de Perre, Philippe; Nagot, Nicolas] CHU Montpellier, Dept Bacteriol Virol, F-34295 Montpellier, France; [Van de Perre, Philippe; Nagot, Nicolas] CHU Montpellier, Dept Med Informat, F-34295 Montpellier, France; [Tylleskar, Thorkild] Univ Bergen, Ctr Int Hlth, N-5020 Bergen, Norway; [Delfraissy, Jean-Francois] Agence Natl Rech Sida & Hepatites Virales, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Bergen	Van de Perre, P (corresponding author), INSERM, Infect HIV & Agents Mucocutaneous Tropism Pathoge, F-34394 Montpellier, France.	p-van_de_perre@chu-montpellier.fr	Nagot, Nicolas/I-9467-2014; Tylleskär, Thorkild/S-5529-2017; Van de Perre, Philippe/B-9692-2008	Tylleskär, Thorkild/0000-0003-4801-4324; Van de Perre, Philippe/0000-0002-3912-0427; Nagot, Nicolas/0000-0002-3493-2821				Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P1; [Anonymous], 2006, HIV INFANT FEEDING N; Arvelo W, 2010, INT J INFECT DIS, V14, pE1002, DOI 10.1016/j.ijid.2010.06.014; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chi BH, 2012, JAIDS-J ACQ IMM DEF, V60, pS78, DOI 10.1097/QAI.0b013e31825f3284; Ciaranello AL, 2013, CLIN INFECT DIS, V56, P430, DOI 10.1093/cid/cis858; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; Coutsoudis A, 2013, LANCET, V381, P269, DOI 10.1016/S0140-6736(12)61807-8; Fawzy A, 2011, J INFECT DIS, V203, P1222, DOI 10.1093/infdis/jir019; Fogel J, 2011, CLIN INFECT DIS, V52, P1069, DOI 10.1093/cid/cir008; Kuhn L, 2010, CLIN INFECT DIS, V50, P437, DOI 10.1086/649886; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Lidstrom J., 2010, 17 C RETR OPP INF SA; Luo C., 2012, 19 INT AIDS C WASH D; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Mofenson LM, 2000, LANCET, V355, P2237, DOI 10.1016/S0140-6736(00)02415-6; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Nagot N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-246; National Institutes of Health IMPAACT Trial Network, 2010, P1077 NIH IMPAACT TR, P1077; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1; TZIPORI S, 1980, AUST VET J, V56, P274, DOI 10.1111/j.1751-0813.1980.tb05723.x; UNFPA/UNICEF/WHO/UNAIDS Interagency Task Team on Mother-to-Child Transmission of HIV, 2001, NEW DAT PREV MOTH TO; Unicef, 2012, OPT B B KEY CONS COU; WHO, 2010, GUID HIV INF FEED 21; *WHO, 2004, ANT DRUGS PREV MOTH; World Health Organization, 2012, US ANT DRUGS TREAT P; World Health Organization, 1994, REC M PREV MOTH TO I; World Health Organization (WHO), 2010, ANT DRUGS TREAT PREG; Zeh C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000430	31	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 20	2013	346								f3763	10.1136/bmj.f3763	http://dx.doi.org/10.1136/bmj.f3763			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171QP	23788455				2022-12-01	WOS:000320944400005
J	Spence, PJ; Jarra, W; Levy, P; Reid, AJ; Chappell, L; Brugat, T; Sanders, M; Berriman, M; Langhorne, J				Spence, Philip J.; Jarra, William; Levy, Prisca; Reid, Adam J.; Chappell, Lia; Brugat, Thibaut; Sanders, Mandy; Berriman, Matthew; Langhorne, Jean			Vector transmission regulates immune control of Plasmodium virulence	NATURE			English	Article							MOSQUITO-TRANSMISSION; RODENT MALARIA; EXPRESSION ANALYSIS; ANTIGENIC VARIANTS; CHABAUDI-CHABAUDI; MULTIGENE FAMILY; FALCIPARUM; INFECTIONS; DIVERSITY; PARASITES	Defining mechanisms by which Plasmodium virulence is regulated is central to understanding the pathogenesis of human malaria. Serial blood passage of Plasmodium through rodents(1-3), primates(4) or humans(5) increases parasite virulence, suggesting that vector transmission regulates Plasmodium virulence within the mammalian host. In agreement, disease severity can be modified by vector transmission(6-8), which is assumed to 'reset' Plasmodium to its original character(3). However, direct evidence that vector transmission regulates Plasmodium virulence is lacking. Here we use mosquito transmission of serially blood passaged (SBP) Plasmodium chabaudi chabaudi(9) to interrogate regulation of parasite virulence. Analysis of SBP P.c. chabaudi before and after mosquito transmission demonstrates that vector transmission intrinsically modifies the asexual blood-stage parasite, which in turn modifies the elicited mammalian immune response, which in turn attenuates parasite growth and associated pathology. Attenuated parasite virulence associates with modified expression of the pir multi-gene family. Vector transmission of Plasmodium therefore regulates gene expression of probable variant antigens in the erythrocytic cycle, modifies the elicited mammalian immune response, and thus regulates parasite virulence. These results place the mosquito at the centre of our efforts to dissect mechanisms of protective immunity to malaria for the development of an effective vaccine.	[Spence, Philip J.; Jarra, William; Levy, Prisca; Brugat, Thibaut; Langhorne, Jean] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England; [Reid, Adam J.; Chappell, Lia; Sanders, Mandy; Berriman, Matthew] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	MRC National Institute for Medical Research; Wellcome Trust Sanger Institute	Langhorne, J (corresponding author), Natl Inst Med Res, MRC, Div Parasitol, Mill Hill, London NW7 1AA, England.	jlangho@nimr.mrc.ac.uk	Berriman, Matthew/A-7618-2011	Berriman, Matthew/0000-0002-9581-0377; Chappell, Lia/0000-0002-2317-3524; Langhorne, Jean/0000-0002-2257-9733; Spence, Phil/0000-0002-5506-2773; Reid, Adam/0000-0002-5926-7768	Medical Research Council [U117584248]; Wellcome Trust [089553, 098051]; Leverhulme Trust; MRC [MC_U117584248] Funding Source: UKRI; Medical Research Council [MC_U117584248] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Leverhulme Trust(Leverhulme Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (U117584248) and the Wellcome Trust (089553 and 098051). P.J.S. is the recipient of a Leverhulme Trust Early Career Fellowship. The authors thank R. Sinden, K. Baker and M. Tunnicliff for provision of Anopheles stephensi, and Biological Services at NIMR. M. Blackman, G. Kassiotis and G. Stockinger are thanked for critical reading of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; ALGER NE, 1971, J PROTOZOOL, V18, P598, DOI 10.1111/j.1550-7408.1971.tb03382.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BRANNAN LR, 1993, PARASITE IMMUNOL, V15, P135, DOI 10.1111/j.1365-3024.1993.tb00593.x; CHIN W, 1968, AM J TROP MED HYG, V17, P355, DOI 10.4269/ajtmh.1968.17.355; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Cunningham D, 2010, MOL BIOCHEM PARASIT, V170, P65, DOI 10.1016/j.molbiopara.2009.12.010; DEARSLY AL, 1990, PARASITOLOGY, V100, P359, DOI 10.1017/S0031182000078628; del Portillo HA, 2012, CELL MICROBIOL, V14, P343, DOI 10.1111/j.1462-5822.2011.01741.x; GLYNN JR, 1995, T ROY SOC TROP MED H, V89, P281, DOI 10.1016/0035-9203(95)90540-5; HARTLEY EG, 1969, T ROY SOC TROP MED H, V63, P411, DOI 10.1016/0035-9203(69)90023-6; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; KNOWLES G, 1980, PARASITOLOGY, V81, P211, DOI 10.1017/S0031182000055165; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/NMETH.1311, 10.1038/nmeth.1311]; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lawton J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-125; Mackinnon MJ, 2005, INT J PARASITOL, V35, P145, DOI 10.1016/j.ijpara.2004.11.011; Mackinnon MJ, 1999, P ROY SOC B-BIOL SCI, V266, P741, DOI 10.1098/rspb.1999.0699; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; MCLEAN SA, 1987, PARASITOLOGY, V94, P443, DOI 10.1017/S0031182000055797; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Spence PJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-407; Spence PJ, 2012, CURR OPIN IMMUNOL, V24, P444, DOI 10.1016/j.coi.2012.05.003; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; Stephens R, 2012, TRENDS PARASITOL, V28, P73, DOI 10.1016/j.pt.2011.10.006; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; YOELI M, 1975, ANN TROP MED PARASIT, V69, P173, DOI 10.1080/00034983.1975.11686998	31	103	103	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					228	+		10.1038/nature12231	http://dx.doi.org/10.1038/nature12231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23719378	Green Accepted			2022-12-01	WOS:000320283400048
J	Inomata, H; Shibata, T; Haraguchi, T; Sasai, Y				Inomata, Hidehiko; Shibata, Tatsuo; Haraguchi, Tomoko; Sasai, Yoshiki			Scaling of Dorsal-Ventral Patterning by Embryo Size-Dependent Degradation of Spemann's Organizer Signals	CELL			English	Article							BMP MORPHOGEN GRADIENTS; XENOPUS EMBRYOS; CHORDIN; INHIBITION; INVARIANCE; DEPLETION; MESODERM; CLEAVAGE; BINDING; PROTEIN	Spemann's organizer plays a key role in dorsal-ventral (DV) patterning in the amphibian embryo by secreting diffusible proteins such as Chordin, an antagonist to ventralizing bone morphogenetic proteins (BMPs). The DV patterning is so robust that an amphibian embryo with its ventral half surgically removed can develop into a smaller but proportionally patterned larva. Here, we show that this robust patterning depends on facilitated Chordin degradation and requires the expression of the Chordin-proteinase inhibitor Sizzled on the opposite side. Sizzled, which is stable and diffuses widely along the DV axis, stabilizes Chordin and expands its distribution in the ventral direction. This expanded Chordin distribution, in turn, limits BMP-dependent Sizzled production, forming an axis-wide feedback loop for shaping Chordin's activity. Using bisection assays, we demonstrate that Chordin degradation is dynamically controlled by embryo-size-coupled Sizzled accumulation. We propose a scaling model that enables the DV pattern to adjust proportionally to embryonic axis size.	[Inomata, Hidehiko; Haraguchi, Tomoko; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; [Shibata, Tatsuo] RIKEN, Ctr Dev Biol, Phys Biol Lab, Kobe, Hyogo 6500047, Japan; [Inomata, Hidehiko] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO Progr, Kawaguchi, Saitama 3320012, Japan	RIKEN; RIKEN; Japan Science & Technology Agency (JST)	Inomata, H (corresponding author), RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	hideino@cdb.riken.jp; yoshikisasai@cdb.riken.jp	Inomata, Hidehiko/N-7390-2015; Shibata, Tatsuo/A-8119-2012	Shibata, Tatsuo/0000-0002-9294-9998	MEXT (Ministry of Education, Culture, Sports, Science, and Technology) Program; PRESTO Program of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25111736] Funding Source: KAKEN	MEXT (Ministry of Education, Culture, Sports, Science, and Technology) Program; PRESTO Program of the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Yoshihiro Morishita, Masatoshi Ohgushi, and Mototsugu Eiraku for invaluable comments and discussion on this study. This study was supported by grants-in-aid from the MEXT (Ministry of Education, Culture, Sports, Science, and Technology) Program (Y.S., H.I., and T.S.) and the PRESTO Program of the Japan Science and Technology Agency.	Aramaki T, 2010, DEV CELL, V19, P547, DOI 10.1016/j.devcel.2010.09.001; Ashe HL, 1999, NATURE, V398, P427, DOI 10.1038/18892; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Ben-Zvi D, 2011, CURR OPIN GENET DEV, V21, P704, DOI 10.1016/j.gde.2011.07.011; Ben-Zvi D, 2010, P NATL ACAD SCI USA, V107, P6924, DOI 10.1073/pnas.0912734107; Chen HM, 2008, METHOD CELL BIOL, V89, P3, DOI 10.1016/S0091-679X(08)00601-8; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; COOKE J, 1975, J EMBRYOL EXP MORPH, V33, P147; COOKE J, 1973, J EMBRYOL EXP MORPH, V30, P49; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Francois P, 2009, NATURE, V461, pE1, DOI 10.1038/nature08305; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hecht I, 2009, P NATL ACAD SCI USA, V106, P1710, DOI 10.1073/pnas.0807655106; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kimelman D, 2005, CELL, V123, P982, DOI 10.1016/j.cell.2005.11.028; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Marom K, 1999, MECH DEVELOP, V87, P33, DOI 10.1016/S0925-4773(99)00137-9; McHale P, 2006, PHYS BIOL, V3, P107, DOI 10.1088/1478-3975/3/2/003; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; O'Connor MB, 2006, DEVELOPMENT, V133, P183; OTHMER HG, 1980, P NATL ACAD SCI-BIOL, V77, P4180, DOI 10.1073/pnas.77.7.4180; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Peluso CE, 2011, DEV CELL, V21, P375, DOI 10.1016/j.devcel.2011.06.025; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Spemann H, 1918, W ROUX ARCH ENTWMECH, V43, P448, DOI [10.1007/BF02267308, DOI 10.1007/BF02267308]; SPEMANN H, 1924, WILHELM ROUX ARCH EN, V100, P599; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Umulis DM, 2009, J R SOC INTERFACE, V6, P1179, DOI [10.1098/rsif.2009.0015, 10.1098/rsif.2008.0015]	38	80	83	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1296	1311		10.1016/j.cell.2013.05.004	http://dx.doi.org/10.1016/j.cell.2013.05.004			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746842	Bronze			2022-12-01	WOS:000319979200014
J	Wang, F; Ekiert, DC; Ahmad, I; Yu, WL; Zhang, Y; Bazirgan, O; Torkamani, A; Raudsepp, T; Mwangi, W; Criscitiello, MF; Wilson, IA; Schultz, PG; Smider, VV				Wang, Feng; Ekiert, Damian C.; Ahmad, Insha; Yu, Wenli; Zhang, Yong; Bazirgan, Omar; Torkamani, Ali; Raudsepp, Terje; Mwangi, Waithaka; Criscitiello, Michael F.; Wilson, Ian A.; Schultz, Peter G.; Smider, Vaughn V.			Reshaping Antibody Diversity	CELL			English	Article							EXCEPTIONALLY LONG CDR3H; V-H FAMILY; CRYSTAL-STRUCTURE; BOVINE; AFFINITY; REGION; PROTEINS; ANTIGEN; CATTLE; DOMAIN	Some species mount a robust antibody response despite having limited genome-encoded combinatorial diversity potential. Cows are unusual in having exceptionally long CDR H3 loops and few V regions, but the mechanism for creating diversity is not understood. Deep sequencing reveals that ultralong CDR H3s contain a remarkable complexity of cysteines, suggesting that disulfide-bonded minidomains may arise during repertoire development. Indeed, crystal structures of two cow antibodies reveal that these CDR H3s form a very unusual architecture composed of a beta strand "stalk'' that supports a structurally diverse, disulfide-bonded "knob'' domain. Diversity arises from somatic hypermutation of an ultralong DH with a severe codon bias toward mutation to cysteine. These unusual antibodies can be elicited to recognize defined antigens through the knob domain. Thus, the bovine immune system produces an antibody repertoire composed of ultralong CDR H3s that fold into a diversity of minidomains generated through combinations of somatically generated disulfides.	[Wang, Feng; Zhang, Yong; Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Ekiert, Damian C.; Yu, Wenli; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Ahmad, Insha; Smider, Vaughn V.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Torkamani, Ali] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Bazirgan, Omar; Smider, Vaughn V.] Fabrus Inc, La Jolla, CA 92037 USA; [Raudsepp, Terje] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Mwangi, Waithaka; Criscitiello, Michael F.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Wilson, IA (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	wilson@scripps.edu; vvsmider@scripps.edu		Ekiert, Damian/0000-0002-2570-0404; Smider, Vaughn/0000-0003-3488-6383	American Cancer Society [ACS RSG-09-1601]; National Institutes of Health [R01GM062159, R01 AI084817]; Skaggs Institute for Chemical Biology; Scripps Translational Sciences Institute Clinical Translational Science Award [UL1 RR025774-03]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062159] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; Scripps Translational Sciences Institute Clinical Translational Science Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Richard Lerner, Michael McHeyzer-Williams, Jeffery Kelly, and Michael Weiss for helpful discussions and Cory Bentley, Evan Holmes, James Graziano, Miguel de los Rios, and Jocelyn Bray for technical support. This work was supported by American Cancer Society Grant ACS RSG-09-1601 (to V.V.S.), National Institutes of Health Grants R01GM062159 (to P.G.S.) and R01 AI084817 (to I.A.W.), the Skaggs Institute for Chemical Biology (to P.G.S. and I.A.W.), and the Scripps Translational Sciences Institute Clinical Translational Science Award UL1 RR025774-03 (to A.T.). This is manuscript number 21869 of The Scripps Research Institute. V.V.S. and O.B. have equity interests in Fabrus, Inc. Please contact I.A.W. for structural information and V.V.S. for other inquiries.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agapov EV, 2004, J VIROL, V78, P2414, DOI 10.1128/JVI.78.5.2414-2425.2004; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Almagro JC, 2012, J MOL RECOGNIT, V25, P125, DOI 10.1002/jmr.1168; Berens SJ, 1997, INT IMMUNOL, V9, P189, DOI 10.1093/intimm/9.1.189; CAI L, 1995, GENOMICS, V29, P413, DOI 10.1006/geno.1995.9986; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Decanniere K, 1999, STRUCTURE, V7, P361, DOI 10.1016/S0969-2126(99)80049-5; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gracy J, 2011, CURR PHARM DESIGN, V17, P4337, DOI 10.2174/138161211798999339; Han BW, 2008, SCIENCE, V321, P1834, DOI 10.1126/science.1162484; Hosseini A, 2004, INT IMMUNOL, V16, P843, DOI 10.1093/intimm/dxh085; Kato L, 2012, J IMMUNOL, V188, P3559, DOI 10.4049/jimmunol.1102397; KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206; Kolmar H, 2009, CURR OPIN PHARMACOL, V9, P608, DOI 10.1016/j.coph.2009.05.004; Koti M, 2008, DEV BIOLOGICALS, V132, P307, DOI 10.1159/000317176; Koti M, 2010, MOL IMMUNOL, V47, P2119, DOI 10.1016/j.molimm.2010.02.014; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Lopez O, 1998, IMMUNOL REV, V162, P55, DOI 10.1111/j.1600-065X.1998.tb01429.x; Mao HY, 2010, NAT BIOTECHNOL, V28, P1195, DOI 10.1038/nbt.1694; Mariat D, 2001, CYTOGENET CELL GENET, V92, P144, DOI 10.1159/000056886; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moore SJ, 2012, METHOD ENZYMOL, V503, P223, DOI 10.1016/B978-0-12-396962-0.00009-4; Njongmeta LM, 2012, VACCINE, V30, P1624, DOI 10.1016/j.vaccine.2011.12.110; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Parng CL, 1996, J IMMUNOL, V157, P5478; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Raudsepp Terje, 2008, V422, P31, DOI 10.1007/978-1-59745-581-7_3; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Saini SS, 2003, INT IMMUNOL, V15, P845, DOI 10.1093/intimm/dxg083; Saini SS, 1999, EUR J IMMUNOL, V29, P2420, DOI 10.1002/(SICI)1521-4141(199908)29:08&lt;2420::AID-IMMU2420&gt;3.0.CO;2-A; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Silverman J, 2005, NAT BIOTECHNOL, V23, P1556, DOI 10.1038/nbt1166; Sinclair MC, 1997, J IMMUNOL, V159, P3883; Smider V, 1997, Semin Immunol, V9, P189, DOI 10.1006/smim.1997.0070; Smith JJ, 2011, P NATL ACAD SCI USA, V108, P10478, DOI 10.1073/pnas.1103501108; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Thomson CA, 2008, EMBO J, V27, P2592, DOI 10.1038/emboj.2008.179; Wang F, 2013, P NATL ACAD SCI USA, V110, P4261, DOI 10.1073/pnas.1301810110; Zhao YF, 2006, DEV COMP IMMUNOL, V30, P175, DOI 10.1016/j.dci.2005.06.012	47	137	151	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1379	1393		10.1016/j.cell.2013.04.049	http://dx.doi.org/10.1016/j.cell.2013.04.049			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746848	Green Accepted, Bronze			2022-12-01	WOS:000319979200020
J	Srivastava, R				Srivastava, Ranjana			The art of medicine Free-floating anxiety	LANCET			English	Editorial Material									Dandenong Hosp, Dept Med Oncol, Dandenong, Vic 3175, Australia		Srivastava, R (corresponding author), Dandenong Hosp, Dept Med Oncol, Dandenong, Vic 3175, Australia.	ranjana.srivastava@southernhealth.org.au						Srivastava R., 2012, DYING CHAT COMMUNICA	1	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 25	2013	381	9880					1808	1809		10.1016/S0140-6736(13)61110-1	http://dx.doi.org/10.1016/S0140-6736(13)61110-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151EO	23717835				2022-12-01	WOS:000319443700014
J	Xue, ZG; Huang, K; Cai, CC; Cai, LB; Jiang, CY; Feng, Y; Liu, ZS; Zeng, Q; Cheng, LM; Sun, YE; Liu, JY; Horvath, S; Fan, GP				Xue, Zhigang; Huang, Kevin; Cai, Chaochao; Cai, Lingbo; Jiang, Chun-yan; Feng, Yun; Liu, Zhenshan; Zeng, Qiao; Cheng, Liming; Sun, Yi E.; Liu, Jia-yin; Horvath, Steve; Fan, Guoping			Genetic programs in human and mouse early embryos revealed by single-cell RNA sequencing	NATURE			English	Article							ZYGOTIC TRANSITION; PREIMPLANTATION; TRANSCRIPTOME; SEQ; LANDSCAPE; NETWORKS	Mammalian pre-implantation development is a complex process involving dramatic changes in the transcriptional architecture(1-4). We report here a comprehensive analysis of transcriptome dynamics from oocyte to morula in both human and mouse embryos, using single-cell RNA sequencing. Based on single-nucleotide variants in human blastomere messenger RNAs and paternal-specific single-nucleotide polymorphisms, we identify novel stage-specific monoallelic expression patterns for a significant portion of polymorphic gene transcripts (25 to 53%). By weighted gene co-expression network analysis(5,6), we find that each developmental stage can be delineated concisely by a small number of functional modules of co-expressed genes. This result indicates a sequential order of transcriptional changes in pathways of cell cycle, gene regulation, translation and metabolism, acting in a step-wise fashion from cleavage to morula. Cross-species comparisons with mouse pre-implantation embryos reveal that the majority of human stage-specific modules (7 out of 9) are notably preserved, but developmental specificity and timing differ between human and mouse. Furthermore, we identify conserved key members (or hub genes) of the human and mouse networks. These genes represent novel candidates that are likely to be key in driving mammalian pre-implantation development. Together, the results provide a valuable resource to dissect gene regulatory mechanisms underlying progressive development of early mammalian embryos.	[Xue, Zhigang; Feng, Yun; Liu, Zhenshan; Zeng, Qiao; Cheng, Liming; Sun, Yi E.] Tongji Univ, Sch Med, Dept Regenerat Med, Translat Ctr Stem Cell Res,Tongji Hosp, Shanghai 200065, Peoples R China; [Huang, Kevin; Cai, Chaochao; Horvath, Steve; Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Cai, Lingbo; Jiang, Chun-yan; Liu, Jia-yin] Nanjing Med Univ, Affiliated Hosp 1, Ctr Clin Reprod Med, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China	Tongji University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Nanjing Medical University	Fan, GP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	xuezhigang75@gmail.com; jyliu_nj@126.com; gfan@mednet.ucla.edu	cheng, liming/GMX-4116-2022; Albertini, David/AAD-3856-2021; Xiao, Hu/GMX-0258-2022	Albertini, David/0000-0001-6536-2828; cai, lingbo/0000-0001-5094-0082; Fan, Guoping/0000-0001-5235-6410	Ministry of Science and Technology in China [2012CB966300, 2011CB966204, 2011CB965102]; International Science and Technology Cooperation Program of China [2011DFB30010]; National Natural Science Foundation of China [81271258]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004612] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD006576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	Ministry of Science and Technology in China(Ministry of Science and Technology, China); International Science and Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank many of our colleagues for invaluable discussions and comments on our study, in particular, P. Pajukanta at UCLA for very helpful suggestions on SNP analyses and D. Geschwind for critically reading the manuscript. This work was supported by 973 Grant Programs 2012CB966300, 2011CB966204 and 2011CB965102 from the Ministry of Science and Technology in China; the International Science and Technology Cooperation Program of China (no. 2011DFB30010); and the National Natural Science Foundation of China (81271258).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Dobson AT, 2004, HUM MOL GENET, V13, P1461, DOI 10.1093/hmg/ddh157; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hu JJ, 2010, J BIOL CHEM, V285, P33113, DOI 10.1074/jbc.M110.117044; Hu ZJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-17; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Tang FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021208; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; Walser CB, 2011, CURR OPIN GENET DEV, V21, P431, DOI 10.1016/j.gde.2011.03.003; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Xie D, 2010, GENOME RES, V20, P804, DOI 10.1101/gr.100594.109; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007844	37	609	636	10	281	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2013	500	7464					593	+		10.1038/nature12364	http://dx.doi.org/10.1038/nature12364			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23892778	Green Accepted, Green Published			2022-12-01	WOS:000323625900038
J	Cook-Deegan, R				Cook-Deegan, Robert			Are Human Genes Patentable?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Cook-Deegan, Robert] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Cook-Deegan, Robert] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Duke University; Duke University	Cook-Deegan, R (corresponding author), Duke Univ, Box 90141,304 Res Dr,North Bldg,Room 242, Durham, NC 27708 USA.	bob.cd@duke.edu		Cook-Deegan, Robert/0000-0002-8251-4237	National Human Genome Research Institute [P50 HG003391]; Ewing Marion Kauffman Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Ewing Marion Kauffman Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Grant Support: In part by the National Human Genome Research Institute (grant P50 HG003391) and the Ewing Marion Kauffman Foundation.	Caulfield T, 2007, GENET MED, V9, P850, DOI 10.1097/GIM.0b013e31815bf965	1	3	3	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4					298	+		10.7326/0003-4819-159-4-201308200-00668	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-00668			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	23752709	Green Accepted			2022-12-01	WOS:000323421700021
J	Singh, R; Low, ETL; Ooi, LCL; Ong-Abdullah, M; Ting, NC; Nagappan, J; Nookiah, R; Amiruddin, MD; Rosli, R; Manaf, MAA; Chan, KL; Halim, MA; Azizi, N; Lakey, N; Smith, SW; Budiman, MA; Hogan, M; Bacher, B; Van Brunt, A; Wang, CY; Ordway, JM; Sambanthamurthi, R; Martienssen, RA				Singh, Rajinder; Low, Eng-Ti Leslie; Ooi, Leslie Cheng-Li; Ong-Abdullah, Meilina; Ting, Ngoot-Chin; Nagappan, Jayanthi; Nookiah, Rajanaidu; Amiruddin, Mohd Din; Rosli, Rozana; Manaf, Mohamad Arif Abdul; Chan, Kuang-Lim; Halim, Mohd Amin; Azizi, Norazah; Lakey, Nathan; Smith, Steven W.; Budiman, Muhammad A.; Hogan, Michael; Bacher, Blaire; Van Brunt, Andrew; Wang, Chunyan; Ordway, Jared M.; Sambanthamurthi, Ravigadevi; Martienssen, Robert A.			The oil palm SHELL gene controls oil yield and encodes a homologue of SEEDSTICK	NATURE			English	Article							MADS-BOX GENES; ELAEIS-GUINEENSIS; AGAMOUS SUBFAMILY; LINKAGE MAP; DIVERSIFICATION; CONSERVATION; ARABIDOPSIS; CARPEL; FRUIT; LOCUS	A key event in the domestication and breeding of the oil palm Elaeis guineensis was loss of the thick coconut-like shell surrounding the kernel. Modern E. guineensis has three fruit forms, dura (thick-shelled), pisifera (shell-less) and tenera (thin-shelled), a hybrid between dura and pisifera(1-4). The pisifera palm is usually female-sterile. The tenera palm yields far more oil than dura, and is the basis for commercial palm oil production in all of southeast Asia(5). Here we describe the mapping and identification of the SHELL gene responsible for the different fruit forms. Using homozygosity mapping by sequencing, we found two independent mutations in the DNA-binding domain of a homologue of the MADS-box gene SEEDSTICK (STK, also known as AGAMOUS-LIKE 11), which controls ovule identity and seed development in Arabidopsis. The SHELL gene is responsible for the tenera phenotype in both cultivated and wild palms from sub-Saharan Africa, and our findings provide a genetic explanation for the single gene hybrid vigour (or heterosis) attributed to SHELL, via heterodimerization. This gene mutation explains the single most important economic trait in oil palm, and has implications for the competing interests of global edible oil production, biofuels and rainforest conservation(6).	[Singh, Rajinder; Low, Eng-Ti Leslie; Ooi, Leslie Cheng-Li; Ong-Abdullah, Meilina; Ting, Ngoot-Chin; Nagappan, Jayanthi; Nookiah, Rajanaidu; Amiruddin, Mohd Din; Rosli, Rozana; Manaf, Mohamad Arif Abdul; Chan, Kuang-Lim; Halim, Mohd Amin; Azizi, Norazah; Sambanthamurthi, Ravigadevi] Persiaran Inst, Malaysian Palm Oil Board, Kajang 43000, Selangor, Malaysia; [Lakey, Nathan; Smith, Steven W.; Budiman, Muhammad A.; Hogan, Michael; Bacher, Blaire; Van Brunt, Andrew; Wang, Chunyan; Ordway, Jared M.] Orion Genom, St Louis, MO 63108 USA; [Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Cold Spring Harbor, NY 11724 USA	Malaysian Palm Oil Board; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Sambanthamurthi, R (corresponding author), Persiaran Inst, Malaysian Palm Oil Board, Kajang 43000, Selangor, Malaysia.	raviga@mpob.gov.my; martiens@cshl.edu	Low, Eng Ti Leslie/AHD-7011-2022; Singh, Rajinder/P-9179-2015	Low, Eng Ti Leslie/0000-0003-3414-8401; Singh, Rajinder/0000-0001-9933-4884; Ong-Abdullah, Meilina/0000-0003-4825-5021; Ooi, Leslie/0000-0002-6996-2801; Chan, Kuang-Lim/0000-0002-8419-0432; Sambanthamurthi, Ravi/0000-0003-3023-9306; Azizi, Norazah/0000-0001-5023-9763	Malaysian Palm Oil Board; National Science Foundation [0421604]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER	Malaysian Palm Oil Board; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Jansen for assistance with JoinMap, and Beijing Genome Institute, The Genome Institute at Washington University, Tufts University Core Facility and the Arizona Genome Institute for mapping and genome sequencing. We thank Kulim, Sime Darby, FELDA Agricultural Services, United Plantations and Applied Agricultural Resources for providing materials and phenotype information of individual palms. Phylogeny, Inc. performed in situ hybridization services. Creative Biolabs performed yeast two-hybrid co-transformations and interaction assays. We thank J. Birchler and Z. Lippman for discussions on hybrid vigour. We appreciate the constant support of Y. M. Choo, and the Ministry of Plantation Industries and Commodities, Malaysia. The project was endorsed by the Cabinet Committee on the Competitiveness of the Palm Oil Industry (CCPO) and funded by the Malaysian Palm Oil Board. R. A. M. is supported by a grant from National Science Foundation 0421604 'Genomics of Comparative Seed Plant Evolution'.	Beirnaert A., 1941, PUBL I NAT ETUDE AGR, V27, P1; Bhasker Salini, 2001, Indian Journal of Experimental Biology, V39, P160; Billotte N, 2005, THEOR APPL GENET, V110, P754, DOI 10.1007/s00122-004-1901-8; Corley R. H. V., 2003, OIL PALM, V4th, P1; Cui RF, 2010, PLANT J, V61, P767, DOI 10.1111/j.1365-313X.2009.04101.x; Danielsen F, 2009, CONSERV BIOL, V23, P348, DOI 10.1111/j.1523-1739.2008.01096.x; DEVUYST A, 1953, NATURE, V172, P685, DOI 10.1038/172685a0; Dinneny JR, 2005, BIOESSAYS, V27, P42, DOI 10.1002/bies.20165; Dreni L, 2007, PLANT J, V52, P690, DOI 10.1111/j.1365-313X.2007.03272.x; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; GODDING R., 1930, BULL AGRIC CONGO BELGE, V21, P1263; Gschwend M, 1996, AM J HUM GENET, V59, P377; HARTLEY C, 1988, OIL PALM, P47; Huang H, 1996, PLANT CELL, V8, P81, DOI 10.1105/tpc.8.1.81; Immink RGH, 2010, SEMIN CELL DEV BIOL, V21, P87, DOI 10.1016/j.semcdb.2009.10.004; Janssens P, 1927, B AGR CONGO BELGE, V18, P29; Kramer EM, 2004, GENETICS, V166, P1011, DOI 10.1534/genetics.166.2.1011; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Mayes S, 1997, GENOME, V40, P116, DOI 10.1139/g97-016; Moretzsohn MC, 2000, THEOR APPL GENET, V100, P63, DOI 10.1007/s001220050009; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Rajanaidu N., 1989, Elaeis, V1, P1; Rajanaidu N., 2000, ADV OIL PALM RES, P171; Singh R, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-114; Tani E, 2007, TREE PHYSIOL, V27, P649, DOI 10.1093/treephys/27.5.649; Tani E, 2009, PLANT PHYSIOL BIOCH, V47, P690, DOI 10.1016/j.plaphy.2009.03.013; Veitia RA, 2011, FASEB J, V25, P476, DOI 10.1096/fj.10-170639; Vrebalov J, 2009, PLANT CELL, V21, P3041, DOI 10.1105/tpc.109.066936; Zahn LM, 2006, EVOL DEV, V8, P30, DOI 10.1111/j.1525-142X.2006.05073.x	30	123	138	5	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					340	+		10.1038/nature12356	http://dx.doi.org/10.1038/nature12356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23883930	Green Accepted			2022-12-01	WOS:000323112400034
J	Chao, DY; Dilkes, B; Luo, HB; Douglas, A; Yakubova, E; Lahner, B; Salt, DE				Chao, Dai-Yin; Dilkes, Brian; Luo, Hongbing; Douglas, Alex; Yakubova, Elena; Lahner, Brett; Salt, David E.			Polyploids Exhibit Higher Potassium Uptake and Salinity Tolerance in Arabidopsis	SCIENCE			English	Article							THALIANA	Genome duplication (or polyploidization) has occurred throughout plant evolutionary history and is thought to have driven the adaptive radiation of plants. We found that the cytotype of the root, and not the genotype, determined the majority of heritable natural variation in leaf potassium (K) concentration in Arabidopsis thaliana. Autopolyploidy also provided resistance to salinity and may represent an adaptive outcome of the enhanced K accumulation of plants with higher ploidy.	[Chao, Dai-Yin; Douglas, Alex; Salt, David E.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 3UU, Scotland; [Dilkes, Brian; Luo, Hongbing; Yakubova, Elena; Lahner, Brett] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	University of Aberdeen; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Salt, DE (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Cruickshank Bldg,St Machar Dr, Aberdeen AB24 3UU, Scotland.	david.salt@abdn.ac.uk	Chao, Dai-Yin/GYV-5944-2022; Dilkes, Brian/C-9293-2012	Dilkes, Brian/0000-0003-2799-954X; ?, ??/0000-0003-2832-4800; Douglas, Alex/0000-0001-6606-1058	NIH [R01GM078536]; European Commission [PCIG9-GA-2011-291798]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078536] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Chan for diploid Wa-1 and the haploid inducer, C. P. Huang for help with microscopy, and T. Graham and E. Svedin for flow cytometry results. We acknowledge support from the NIH (grant R01GM078536) and the European Commission (grant PCIG9-GA-2011-291798). ICP-MS data for Fig. 1, A to F, and fig. S1 are stored at www.ionomicshub.org. All other data are available as supplementary materials on Science Online. D.-Y.C., B. D., and D. E. S. conceived and designed the experiments; D.-Y.C., H. L., B. L., and E.Y. performed the experiments; D.-Y.C., B. D., B. L., A. D., and D. E. S. analyzed the data; and D.-Y.C., B. D., and D. E. S. wrote the manuscript.	Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Henry IM, 2005, GENETICS, V170, P1979, DOI 10.1534/genetics.104.037788; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Schiff CL, 2001, PLANT PATHOL, V50, P690, DOI 10.1046/j.1365-3059.2001.00611.x	7	209	228	9	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					658	659		10.1126/science.1240561	http://dx.doi.org/10.1126/science.1240561			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23887874	Green Accepted			2022-12-01	WOS:000322884800039
J	Moum, JN; Perlin, A; Nash, JD; McPhaden, MJ				Moum, James N.; Perlin, Alexander; Nash, Jonathan D.; McPhaden, Michael J.			Seasonal sea surface cooling in the equatorial Pacific cold tongue controlled by ocean mixing	NATURE			English	Article							TROPICAL PACIFIC; ANNUAL CYCLE; SHEAR-FLOW; TEMPERATURE; TURBULENCE; INSTABILITY; BALANCE; MODELS; BUDGET	Sea surface temperature (SST) is a critical control on the atmosphere(1), and numerical models of atmosphere-ocean circulation emphasize its accurate prediction. Yet many models demonstrate large, systematic biases in simulated SST in the equatorial 'cold tongues' (expansive regions of net heat uptake from the atmosphere) of the Atlantic(2) and Pacific(3) oceans, particularly with regard to a central but little-understood feature of tropical oceans: a strong seasonal cycle. The biases may be related to the inability of models to constrain turbulent mixing realistically(4), given that turbulent mixing, combined with seasonal variations in atmospheric heating, determines SST. In temperate oceans, the seasonal SST cycle is clearly related to varying solar heating(5); in the tropics, however, SSTs vary seasonally in the absence of similar variations in solar inputs(6). Turbulent mixing has long been a likely explanation, but firm, long-term observational evidence has been absent. Here we show the existence of a distinctive seasonal cycle of subsurface cooling via mixing in the equatorial Pacific cold tongue, using multi-year measurements of turbulence in the ocean. In boreal spring, SST rises by 2 kelvin when heating of the upper ocean by the atmosphere exceeds cooling by mixing from below. In boreal summer, SST decreases because cooling from below exceeds heating from above. When the effects of lateral advection are considered, the magnitude of summer cooling via mixing (4 kelvin per month) is equivalent to that required to counter the heating terms. These results provide quantitative assessment of how mixing varies on timescales longer than a few weeks, clearly showing its controlling influence on seasonal cooling of SST in a critical oceanic regime.	[Moum, James N.; Perlin, Alexander; Nash, Jonathan D.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [McPhaden, Michael J.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA	Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA	Moum, JN (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	moum@coas.oregonstate.edu	Moum, James N/A-1880-2012; Nash, Jonathan/K-8101-2019; McPhaden, Michael J/D-9799-2016; Moum, James N/N-1187-2019	McPhaden, Michael J/0000-0002-8423-5805; Nash, Jonathan/0000-0003-4005-9368	National Science Foundation [0424133, 0728375, 1256620]; Directorate For Geosciences [1256620] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by the National Science Foundation (grants 0424133, 0728375 and 1256620). We thank M. Neeley-Brown and R. Kreth, who were primarily responsible for construction, testing and maintenance of chi-pods, and P. Freitag and NOAA's PMEL mooring group, who helped us to get started with these measurements. We also thank NOAA's NDBC group, who have continued to deploy our chi-pods on TAO moorings. E. Shroyer, S. de Szoeke, K. Benoit-Bird and D. Chelton provided comments on the paper. This is PMEL contribution no. 3970. We dedicate this paper to the memory of our colleague and co-author A. Perlin, who passed away during final revisions, and to the memory of lab engineer R. Kreth.	GREGG MC, 1985, NATURE, V318, P140, DOI 10.1038/318140a0; Hummels R, 2013, PROG OCEANOGR, V111, P52, DOI 10.1016/j.pocean.2012.11.001; Inoue R, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007767; Jouanno J, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006912; Kumar BP, 2012, CLIM DYNAM, V38, P1521, DOI 10.1007/s00382-011-1115-0; LIEN RC, 1995, J GEOPHYS RES-OCEANS, V100, P6881, DOI 10.1029/94JC03312; Mcphaden MJ, 2008, J CLIMATE, V21, P3240, DOI 10.1175/2007JCLI2115.1; McPhaden MJ, 1998, J GEOPHYS RES-OCEANS, V103, P14169, DOI 10.1029/97JC02906; MITCHELL TP, 1992, J CLIMATE, V5, P1140, DOI 10.1175/1520-0442(1992)005<1140:TACIEC>2.0.CO;2; Moum JN, 2011, J PHYS OCEANOGR, V41, P397, DOI 10.1175/2010JPO4450.1; Moum JN, 2009, NAT GEOSCI, V2, P761, DOI 10.1038/NGEO657; Moum JN, 2009, J ATMOS OCEAN TECH, V26, P317, DOI 10.1175/2008JTECHO617.1; MOUM JN, 1985, SCIENCE, V230, P315, DOI 10.1126/science.230.4723.315; Ohlmann JC, 1996, J CLIMATE, V9, P2265, DOI 10.1175/1520-0442(1996)009<2265:OMLRHA>2.0.CO;2; Osborn T. R., 1972, Geophysical Fluid Dynamics, V3, P321, DOI 10.1080/03091927208236085; Perlin A, 2012, J ATMOS OCEAN TECH, V29, P1347, DOI 10.1175/JTECH-D-12-00019.1; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Richter I, 2008, CLIM DYNAM, V31, P587, DOI 10.1007/s00382-008-0364-z; Smyth W. D., J PHYS OCEANOG UNPUB; Sun CJ, 1998, J GEOPHYS RES-OCEANS, V103, P10323, DOI 10.1029/98JC00191; Swenson MS, 1999, J PHYS OCEANOGR, V29, P69, DOI 10.1175/1520-0485(1999)029<0069:TPOMLH>2.0.CO;2; Trenberth KE, 2001, CLIM DYNAM, V17, P259, DOI 10.1007/PL00007927; Wang B, 2001, J CLIMATE, V14, P2250, DOI 10.1175/1520-0442(2001)014<0001:PDTRRO>2.0.CO;2; Wang WM, 1999, J PHYS OCEANOGR, V29, P1812, DOI 10.1175/1520-0485(1999)029<1812:TSLHBI>2.0.CO;2; Wittenberg AT, 2006, J CLIMATE, V19, P698, DOI 10.1175/JCLI3631.1; Xie SP, 2004, B AM METEOROL SOC, V85, P195, DOI 10.1175/BAMS-85-2-195; XIE SP, 1994, J CLIMATE, V7, P2008, DOI 10.1175/1520-0442(1994)007<2008:OTGOTE>2.0.CO;2; Zaron ED, 2009, J PHYS OCEANOGR, V39, P2652, DOI 10.1175/2009JPO4133.1	28	85	87	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2013	500	7460					64	67		10.1038/nature12363	http://dx.doi.org/10.1038/nature12363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23883934				2022-12-01	WOS:000322514800028
J	Zhou, JF; Wang, DY; Gao, RB; Zhao, BH; Song, JD; Qi, X; Zhang, YJ; Shi, YL; Yang, L; Zhu, WF; Bai, T; Qin, K; Lan, Y; Zou, SM; Guo, JF; Dong, J; Dong, LB; Zhang, Y; Wei, HJ; Li, XD; Lu, J; Liu, LQ; Zhao, X; Li, XY; Huang, WJ; Wen, LY; Bo, H; Xin, L; Chen, YK; Xu, CL; Pei, YQ; Yang, Y; Zhang, XD; Wang, SW; Feng, ZJ; Han, J; Yang, WZ; Gao, GF; Wu, GZ; Li, DX; Wang, Y; Shu, YL				Zhou, Jianfang; Wang, Dayan; Gao, Rongbao; Zhao, Baihui; Song, Jingdong; Qi, Xian; Zhang, Yanjun; Shi, Yonglin; Yang, Lei; Zhu, Wenfei; Bai, Tian; Qin, Kun; Lan, Yu; Zou, Shumei; Guo, Junfeng; Dong, Jie; Dong, Libo; Zhang, Ye; Wei, Hejiang; Li, Xiaodan; Lu, Jian; Liu, Liqi; Zhao, Xiang; Li, Xiyan; Huang, Weijuan; Wen, Leying; Bo, Hong; Xin, Li; Chen, Yongkun; Xu, Cuilin; Pei, Yuquan; Yang, Yue; Zhang, Xiaodong; Wang, Shiwen; Feng, Zijian; Han, Jun; Yang, Weizhong; Gao, George F.; Wu, Guizhen; Li, Dexin; Wang, Yu; Shu, Yuelong			Biological features of novel avian influenza A (H7N9) virus	NATURE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INCREASED EXPRESSION; INFECTION; BINDING; CELLS; HEMAGGLUTININ; TRANSMISSION; SPECIFICITY; ADAPTATION; FERRETS	Human infection associated with a novel reassortant avian influenza H7N9 virus has recently been identified in China(1). A total of 132 confirmed cases and 39 deaths have been reported(2). Most patients presented with severe pneumonia and acute respiratory distress syndrome(3,4). Although the first epidemic has subsided, the presence of a natural reservoir and the disease severity highlight the need to evaluate its risk on human public health and to understand the possible pathogenesis mechanism. Here we show that the emerging H7N9 avian influenza virus poses a potentially high risk to humans. We discover that the H7N9 virus can bind to both avian-type (alpha 2,3-linked sialic acid) and human-type (alpha 2,6-linked sialic acid) receptors. It can invade epithelial cells in the human lower respiratory tract and type II pneumonocytes in alveoli, and replicated efficiently in ex vivo lung and trachea explant culture and several mammalian cell lines. In acute serum samples of H7N9-infected patients, increased levels of the chemokines and cytokines IP-10, MIG, MIP-1 beta, MCP-1, IL-6, IL-8 and IFN-alpha were detected. We note that the human population is naive to the H7N9 virus, and current seasonal vaccination could not provide protection.	[Zhou, Jianfang; Wang, Dayan; Gao, Rongbao; Song, Jingdong; Yang, Lei; Zhu, Wenfei; Bai, Tian; Qin, Kun; Lan, Yu; Zou, Shumei; Guo, Junfeng; Dong, Jie; Dong, Libo; Zhang, Ye; Wei, Hejiang; Li, Xiaodan; Lu, Jian; Liu, Liqi; Zhao, Xiang; Li, Xiyan; Huang, Weijuan; Wen, Leying; Bo, Hong; Xin, Li; Chen, Yongkun; Xu, Cuilin; Wang, Shiwen; Wu, Guizhen; Li, Dexin; Shu, Yuelong] Natl Hlth & Family Planning Commiss, Key Lab Med Virol, China CDC, Nat Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China; [Zhao, Baihui] Shanghai Municipal Dis Control & Prevent, Shanghai 200336, Peoples R China; [Qi, Xian] Jiangsu Prov Dis Control & Prevent, Nanjing 210009, Jiangsu, Peoples R China; [Zhang, Yanjun] Zhejiang Prov Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China; [Shi, Yonglin] Anhui Prov Dis Control & Prevent, Hefei 230601, Peoples R China; [Pei, Yuquan; Yang, Yue; Zhang, Xiaodong] Peking Univ, Canc Hosp, Key Lab Carcinogenesis & Translat Res, Beijing 100142, Peoples R China; [Feng, Zijian; Han, Jun; Yang, Weizhong; Gao, George F.; Wang, Yu] Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China	Chinese Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Peking University; Chinese Center for Disease Control & Prevention	Shu, YL (corresponding author), Natl Hlth & Family Planning Commiss, Key Lab Med Virol, China CDC, Nat Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.	yshu@cnic.org.cn	Yang, Lei/GSD-3834-2022; Gao, George Fu/ABD-5229-2021		National Basic Research Program (973) of China [2011CB504704]; National Ministry of Science and Technology [KJYJ-2013-01-01]; National Mega-projects for Infectious Diseases [2013ZX10004611]	National Basic Research Program (973) of China(National Basic Research Program of China); National Ministry of Science and Technology; National Mega-projects for Infectious Diseases	This study was supported by the National Basic Research Program (973) of China (2011CB504704, to Y.S.), Emergency Research Project on human infection with avian influenza H7N9 virus from the National Ministry of Science and Technology (no. KJYJ-2013-01-01 to Y.S.), and National Mega-projects for Infectious Diseases (2013ZX10004611 to J.Z.). We would like to acknowledge the Consortium for Functional Glycomics for providing the glycans for the receptor-binding test. We thank the US Centre for Disease Control and Prevention (CDC) for providing the strains A/Washington/1/2007(H3N2, WT), A/Texas/12/2007(H3N2, E119V), A/California/7/2009 (2009pdmH1N1, WT) and A/North Carolina/39/2009 (2009pdmH1N1, H275Y), and for the antiviral drug susceptibility test. We thank C. Li for critical comments of the manuscript and proofreading. We thank L. Huang, X. Xing, X. Zeng, Y. Zhu, L. Liu, S. Yang, Z. Li and T. Liu for technical support. We thank the provincial CDCs including Fujian, Sichuan, Guangdong, Hunan, Hubei and Jiangxi for providing sera specimens of patients with H5N1. The contents of this article are solely the responsibility of the authors and do not necessarily represent the views of the China CDC or other organizations.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Bateman AC, 2010, J BIOL CHEM, V285, P34016, DOI 10.1074/jbc.M110.115998; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Freeman CM, 2007, AM J PATHOL, V171, P767, DOI 10.2353/ajpath.2007.061177; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Goldsmith CS, 2003, VIRUS RES, V92, P89, DOI 10.1016/S0168-1702(02)00323-4; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hu Y., 2013, LANCET; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Nidom CA, 2010, EMERG INFECT DIS, V16, P1515, DOI 10.3201/eid1610.100508; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saetta M, 2002, AM J RESP CRIT CARE, V165, P1404, DOI 10.1164/rccm.2107139; Shalekoff S, 2004, CLIN DIAGN LAB IMMUN, V11, P229, DOI 10.1128/CDLI.11.1.229-234.2004; Srinivasan K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0049597, 10.1371/journal.pone.0059550]; Tarazona R, 2000, MECH AGEING DEV, V121, P77; Walther T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003223; WHO, AV INFL A H7N9 VIR; *WHO COLL CTR REF, 1982, CONC PROC LAB BAS IN; WHO Global Influenza Surveillance Network, MAN LAB DIAGN VIR SU; Wu H, 2013, N ENGL J MED; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001081	30	285	330	6	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2013	499	7459					500	+		10.1038/nature12379	http://dx.doi.org/10.1038/nature12379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23823727	Bronze			2022-12-01	WOS:000322157900045
J	Wallinga, D; Burch, DGS				Wallinga, David; Burch, David G. S.			Does adding routine antibiotics to animal feed pose a serious risk to human health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wallinga, David] Keep Antibiot Working Campaign End Antibiot Overu, St Paul, MN 55105 USA; [Burch, David G. S.] Octagon Serv, Old Windsor SL4 2NR, Berks, England		Wallinga, D (corresponding author), Keep Antibiot Working Campaign End Antibiot Overu, 305 Brimhall St, St Paul, MN 55105 USA.	dwallinga@gmail.com; d.burch@octagon-services.co.uk						Aarestrup F, 2012, NATURE, V486, P465, DOI 10.1038/486465a; Allen HK, 2011, MBIO, V2, DOI 10.1128/mBio.00260-11; Andreoletti O, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2106; Animal Health and Veterinary Laboratories Agency (AHVLA), 2012, OV SALM LIV POULTR S; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Commensal indicator organisms, 2011, MARAN 2009 MONITORIN, P49; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Herigon JC, 2010, PEDIATRICS, V125, pE1294, DOI 10.1542/peds.2009-2867; Institute for Agriculture and Trade Policy, 2012, NO TIM LOS 147 STUD; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; McDonald L. Clifford, 2012, Morbidity and Mortality Weekly Report, V61, P157; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Statums Serum Institut National Veterinary Institute National Food Institute, 2012, DANM 2011 US ANT AG, P111; US Food and Drug Administration, 2013, ANT AN DRUG DISTR RE; Veterinary Medicines Directorate, 2012, SECT SAL ROUT ADM SA, P20; WHO, 2011, CRIT IMP ANT HUM MED	17	19	19	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2013	347								f4214	10.1136/bmj.f4214	http://dx.doi.org/10.1136/bmj.f4214			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184MC	23843500				2022-12-01	WOS:000321893000006
J	Ezraty, B; Vergnes, A; Banzhaf, M; Duverger, Y; Huguenot, A; Brochado, AR; Su, SY; Espinosa, L; Loiseau, L; Py, B; Typas, A; Barras, F				Ezraty, Benjamin; Vergnes, Alexandra; Banzhaf, Manuel; Duverger, Yohann; Huguenot, Allison; Brochado, Ana Rita; Su, Shu-Yi; Espinosa, Leon; Loiseau, Laurent; Py, Beatrice; Typas, Athanasios; Barras, Frederic			Fe-S Cluster Biosynthesis Controls Uptake of Aminoglycosides in a ROS-Less Death Pathway	SCIENCE			English	Article							ESCHERICHIA-COLI; BACTERICIDAL ANTIBIOTICS; PROTEINS; BINDING; IRON; GENTAMICIN; EXPRESSION; MECHANISM; ISCR	All bactericidal antibiotics were recently proposed to kill by inducing reactive oxygen species (ROS) production, causing destabilization of iron-sulfur (Fe-S) clusters and generating Fenton chemistry. We find that the ROS response is dispensable upon treatment with bactericidal antibiotics. Furthermore, we demonstrate that Fe-S clusters are required for killing only by aminoglycosides. In contrast to cells, using the major Fe-S cluster biosynthesis machinery, ISC, cells using the alternative machinery, SUF, cannot efficiently mature respiratory complexes I and II, resulting in impendence of the proton motive force (PMF), which is required for bactericidal aminoglycoside uptake. Similarly, during iron limitation, cells become intrinsically resistant to aminoglycosides by switching from ISC to SUF and down-regulating both respiratory complexes. We conclude that Fe-S proteins promote aminoglycoside killing by enabling their uptake.	[Ezraty, Benjamin; Vergnes, Alexandra; Duverger, Yohann; Huguenot, Allison; Espinosa, Leon; Loiseau, Laurent; Py, Beatrice; Barras, Frederic] Aix Marseille Univ, CNRS, Chim Bacterienne Lab, Inst Microbiol Mediterranee,UMR 7283, F-13009 Marseille, France; [Banzhaf, Manuel; Brochado, Ana Rita; Su, Shu-Yi; Typas, Athanasios] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; European Molecular Biology Laboratory (EMBL)	Barras, F (corresponding author), Aix Marseille Univ, CNRS, Chim Bacterienne Lab, Inst Microbiol Mediterranee,UMR 7283, 31 Chemin Joseph Aiguier, F-13009 Marseille, France.	barras@imm.cnrs.fr	Espinosa, Leon/V-8410-2017; Vergnes, Alexandra/AAM-2842-2020	Banzhaf, Manuel/0000-0002-4682-1037; Barras, Frederic/0000-0003-3458-2574; Typas, Athanasios/0000-0002-0797-9018; Ezraty, Benjamin/0000-0003-3818-6907; Brochado, Ana Rita/0000-0003-1703-383X	Agence Nationale Recherche [ANR Blanc SPV 05511]; Institut Universitaire de France; Fondation pour la Recherche Medicale; European Molecular Biology Laboratory	Agence Nationale Recherche(French National Research Agency (ANR)); Institut Universitaire de France; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Molecular Biology Laboratory	We are grateful to C. Gross (University of California, San Francisco, USA) for critically reading the manuscript and providing feedback. We thank T. Friedrich (Freiburg University, Germany), T. Yagi and J. Torres Bacete (La Jolla, CA, USA), E. Bouveret (Laboratoire d'Ingenierie des Systemes Macromoleculaires, Marseille, France), J. Armitage (Oxford, UK), and P. Moreau and T. Mignot (Laboratoire de Chimie Bacterienne, Marseille, France) for providing materials and strains. This work was supported by grants from Agence Nationale Recherche (ANR Blanc SPV 05511), the Institut Universitaire de France, the Fondation pour la Recherche Medicale, and European Molecular Biology Laboratory. Data are deposited in the Dryad Repository: http://dx.doi.org/10.5061/dryad.3062c.	BRYAN LE, 1983, ANTIMICROB AGENTS CH, V23, P835, DOI 10.1128/AAC.23.6.835; Chen Z, 2007, NUCLEIC ACIDS RES, V35, P6762, DOI 10.1093/nar/gkm631; DAVIS BD, 1986, P NATL ACAD SCI USA, V83, P6164, DOI 10.1073/pnas.83.16.6164; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Giel JL, 2013, MOL MICROBIOL, V87, P478, DOI 10.1111/mmi.12052; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; MATES SM, 1982, P NATL ACAD SCI-BIOL, V79, P6693, DOI 10.1073/pnas.79.21.6693; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Simon J, 2008, BBA-BIOENERGETICS, V1777, P1480, DOI 10.1016/j.bbabio.2008.09.008; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Vento S, 2006, LANCET INFECT DIS, V6, P226, DOI 10.1016/S1473-3099(06)70437-6; Vinella D, 2013, MOL MICROBIOL, V87, P493, DOI 10.1111/mmi.12135; Walter JM, 2007, P NATL ACAD SCI USA, V104, P2408, DOI 10.1073/pnas.0611035104; Yao ZZ, 2012, MOL CELL, V48, P705, DOI 10.1016/j.molcel.2012.09.016	26	143	150	6	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1583	1587		10.1126/science.1238328	http://dx.doi.org/10.1126/science.1238328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812717				2022-12-01	WOS:000321007000045
J	Courchet, J; Lewis, TL; Lee, S; Courchet, V; Liou, DY; Aizawa, S; Polleux, F				Courchet, Julien; Lewis, Tommy L., Jr.; Lee, Sohyon; Courchet, Virginie; Liou, Deng-Yuan; Aizawa, Shinichi; Polleux, Franck			Terminal Axon Branching Is Regulated by the LKB1-NUAK1 Kinase Pathway via Presynaptic Mitochondrial Capture	CELL			English	Article							ACTIVATED PROTEIN-KINASE; NEURONAL POLARIZATION; PYRAMIDAL NEURONS; NEURAL ACTIVITY; SAD KINASES; GROWTH CONE; LKB1; MECHANISMS; NEOCORTEX; GUIDANCE	The molecular mechanisms underlying the axon arborization of mammalian neurons are poorly understood but are critical for the establishment of functional neural circuits. We identified a pathway defined by two kinases, LKB1 and NUAK1, required for cortical axon branching in vivo. Conditional deletion of LKB1 after axon specification or knockdown of NUAK1 drastically reduced axon branching in vivo, whereas their overexpression was sufficient to increase axon branching. The LKB1-NUAK1 pathway controls mitochondria immobilization in axons. Using manipulation of Syntaphilin, a protein necessary and sufficient to arrest mitochondrial transport specifically in the axon, we demonstrate that the LKB1-NUAK1 kinase pathway regulates axon branching by promoting mitochondria immobilization. Finally, we show that LKB1 and NUAK1 are necessary and sufficient to immobilize mitochondria specifically at nascent presynaptic sites. Our results unravel a link between presynaptic mitochondrial capture and axon branching.	[Courchet, Julien; Lewis, Tommy L., Jr.; Lee, Sohyon; Courchet, Virginie; Liou, Deng-Yuan; Polleux, Franck] Scripps Res Inst, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Courchet, Julien; Lewis, Tommy L., Jr.; Lee, Sohyon; Courchet, Virginie; Liou, Deng-Yuan; Polleux, Franck] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Aizawa, Shinichi] Riken Inst Phys & Chem Res, Chuo Ku, Kobe, Hyogo 6500047, Japan	Scripps Research Institute; Scripps Research Institute; RIKEN	Polleux, F (corresponding author), Scripps Res Inst, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	polleux@scripps.edu	Courchet, Virginie/G-9431-2017; COURCHET, JULIEN/E-9645-2016; Polleux, Franck/H-9948-2014	Courchet, Virginie/0000-0002-7186-3669; COURCHET, JULIEN/0000-0002-1199-9329; Lewis, Tommy/0000-0001-7033-7010; Polleux, Franck/0000-0003-4313-0481; Liou, Deng-Yuan/0000-0001-8466-2033; Lee, Sohyon/0000-0003-4790-4990	NIH [R01AG031524, 5F32NS080464]; ADI-Novartis funds; Fondation pour la Recherche Medicale; Philippe Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS080464, R01NS089456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031524] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADI-Novartis funds; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Philippe Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank members of the Polleux lab and Sandra Encalada for useful discussions. We thank Kathy Spencer for excellent help with microscopy and Trevor Sauerbrey for technical help. We would also like to thank Brendan Lilley, Ulrich Muller, Anton Maximov, and Sandra Encalada for critical reading of the manuscript. We thank Joshua Sanes, Zu-Hang Shen, Ulrich Muller, Etienne Herzog, and Don Arnold for sharing reagents. This work was funded by NIH R01AG031524 (F.P.), ADI-Novartis funds (F.P.), Fondation pour la Recherche Medicale (J.C.), Philippe Foundation (J.C.), and NIH 5F32NS080464 (T.L.). J.C, T.L., and F. P. conceived the experiments and interpreted the results, and J.C., T.L., S.L., V.C., and D.-Y.L. performed the experiments. S.A. provided the NUAK1 knockout mice. J.C., T.L., and F.P. prepared the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Amato S, 2011, SCIENCE, V332, P247, DOI 10.1126/science.1201678; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Brickley K, 2011, J BIOL CHEM, V286, P18079, DOI 10.1074/jbc.M111.236018; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Donahoo ALS, 2009, SEMIN PEDIATR NEUROL, V16, P127, DOI 10.1016/j.spen.2009.07.003; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Gallo G, 2011, DEV NEUROBIOL, V71, P201, DOI 10.1002/dneu.20852; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hand R, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-30; Harris KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005587; Herzog E, 2011, J NEUROSCI, V31, P15544, DOI 10.1523/JNEUROSCI.2073-11.2011; Hirano M, 2006, DEV DYNAM, V235, P2229, DOI 10.1002/dvdy.20823; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Jaleel M, 2005, FEBS LETT, V579, P1417, DOI 10.1016/j.febslet.2005.01.042; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Mian I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031583; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007; Mizuno H, 2010, EUR J NEUROSCI, V31, P410, DOI 10.1111/j.1460-9568.2009.07070.x; Nishimura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041413; Polleux F, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001925; Ruthazer ES, 2006, J NEUROSCI, V26, P3594, DOI 10.1523/JNEUROSCI.0069-06.2006; Sabo SL, 2006, J NEUROSCI, V26, P10813, DOI 10.1523/JNEUROSCI.2052-06.2006; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Uesaka N, 2006, NEUROSCIENTIST, V12, P102, DOI 10.1177/1073858405281673; Vos Melissa, 2010, Front Synaptic Neurosci, V2, P139, DOI 10.3389/fnsyn.2010.00139; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Watts JL, 2000, DEVELOPMENT, V127, P1467; Williams T, 2011, P NATL ACAD SCI USA, V108, P5849, DOI 10.1073/pnas.1013660108; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zagorska A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000616; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	53	210	213	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1510	1525		10.1016/j.cell.2013.05.021	http://dx.doi.org/10.1016/j.cell.2013.05.021			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791179	Green Published, Bronze, Green Accepted			2022-12-01	WOS:000320722000019
J	Wallace, DJ; Greenberg, DS; Sawinski, J; Rulla, S; Notaro, G; Kerr, JND				Wallace, Damian J.; Greenberg, David S.; Sawinski, Juergen; Rulla, Stefanie; Notaro, Giuseppe; Kerr, Jason N. D.			Rats maintain an overhead binocular field at the expense of constant fusion	NATURE			English	Article							HEAD MOVEMENTS; EYE; EXPERIENCE; REFLEX; SEE	Fusing left and right eye images into a single view is dependent on precise ocular alignment, which relies on coordinated eye movements. During movements of the head this alignment is maintained by numerous reflexes. Although rodents share with other mammals the key components of eye movement control, the coordination of eye movements in freely moving rodents is unknown. Here we show that movements of the two eyes in freely moving rats differ fundamentally from the precisely controlled eye movements used by other mammals to maintain continuous binocular fusion. The observed eye movements serve to keep the visual fields of the two eyes continuously overlapping above the animal during free movement, but not continuously aligned. Overhead visual stimuli presented to rats freely exploring an open arena evoke an immediate shelter-seeking behaviour, but are ineffective when presented beside the arena. We suggest that continuously overlapping visual fields overhead would be of evolutionary benefit for predator detection by minimizing blind spots.	[Wallace, Damian J.; Greenberg, David S.; Sawinski, Juergen; Rulla, Stefanie; Notaro, Giuseppe; Kerr, Jason N. D.] Max Planck Inst Biol Cybernet, Network Imaging Grp, D-72076 Tubingen, Germany; [Notaro, Giuseppe; Kerr, Jason N. D.] Bernstein Ctr Computat Neurosci Tubingen, D-72076 Tubingen, Germany	Max Planck Society	Kerr, JND (corresponding author), Max Planck Inst Biol Cybernet, Network Imaging Grp, Spemannstr 41, D-72076 Tubingen, Germany.	jason@tuebingen.mpg.de		Greenberg, David/0000-0002-8515-0459; Notaro, Giuseppe/0000-0002-5355-6577; Kerr, Jason/0000-0001-9459-883X	German Federal Ministry of Education and Research (BMBF) [FKZ: 01GQ1002]; Max Planck Society	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank W. Denk, R. Hahnloser, K. Kirchfeld, K. Martin, A. Schwartz and F. Wolf for comments on earlier versions of this manuscript and M. Rictis for help with electronics fabrication. We also thank A. Benali, A. Brauer, U. Czubayko, M.-L. Silva, V. Pawlak, V. Ramachandra and T. Senkova from the Network Imaging Group for data processing, A. Schaefer and M. Kollo for loan of the spherical treadmill, and F. Wolf for advice on the modelling and discussions throughout the project. We thank N. Logothetis for support and C. Sakmann for insights. G.N.'s salary was financed by the German Federal Ministry of Education and Research (BMBF; FKZ: 01GQ1002). The Max Planck Society financed research. We apologize to all authors whom we have not been able to cite because of space restrictions.	Anjum F, 2006, P NATL ACAD SCI USA, V103, P16544, DOI 10.1073/pnas.0605573103; Artal P, 1998, VISUAL NEUROSCI, V15, P597, DOI 10.1017/S0952523898154020; Berardi N, 1999, J NEUROBIOL, V41, P119, DOI 10.1002/(SICI)1097-4695(199910)41:1<119::AID-NEU15>3.0.CO;2-N; CHELAZZI L, 1989, EUR J NEUROSCI, V1, P639, DOI 10.1111/j.1460-9568.1989.tb00369.x; Dawkins MS, 2002, ANIM BEHAV, V63, P991, DOI [10.1006/anbe.2002.999, 10.1006/anbe.2002.1999]; Dell'Osso LF, 1998, J NEURO-OPHTHALMOL, V18, P112; DONCASTER CP, 1990, J MAMMAL, V71, P188, DOI 10.2307/1382166; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; DUWAER AL, 1981, PERCEPT PSYCHOPHYS, V29, P295, DOI 10.3758/BF03207338; EULER T, 1995, J COMP NEUROL, V361, P461, DOI 10.1002/cne.903610310; Fernandez-Juricic E, 2011, BRAIN BEHAV EVOLUT, V77, P147, DOI 10.1159/000326053; FULLER JH, 1985, VISION RES, V25, P1121, DOI 10.1016/0042-6989(85)90101-4; HESS BJM, 1990, EUR J NEUROSCI, V2, P909, DOI 10.1111/j.1460-9568.1990.tb00003.x; HUGHES A, 1979, VISION RES, V19, P569, DOI 10.1016/0042-6989(79)90143-3; HUGHES A, 1977, VISION RES, V17, P927, DOI 10.1016/0042-6989(77)90068-2; Hughes A., 1977, HDB SENSORY PHYSL, V5, P613, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; LEGG CR, 1990, BEHAV BRAIN RES, V41, P11, DOI 10.1016/0166-4328(90)90049-K; LYLE T K, 1955, Br J Ophthalmol, V39, P474, DOI 10.1136/bjo.39.8.474; MORRIS P, 1979, J ZOOL, V189, P540, DOI 10.1111/j.1469-7998.1979.tb03983.x; Munz M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00191; Prusky GT, 2008, J NEUROSCI, V28, P9817, DOI 10.1523/JNEUROSCI.1940-08.2008; Quinn KJ, 1998, J NEUROSCI METH, V80, P201, DOI 10.1016/S0165-0270(98)00005-3; Russell JT, 1932, PEDAGOG SEMIN J GEN, V40, P136; Wallace DG, 2002, BEHAV BRAIN RES, V131, P185, DOI 10.1016/S0166-4328(01)00384-9; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021; Zee DS., 1999, NEUROLOGY EYE MOVEME; Zoccolan D, 2009, P NATL ACAD SCI USA, V106, P8748, DOI 10.1073/pnas.0811583106	27	162	164	0	54	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					65	69		10.1038/nature12153	http://dx.doi.org/10.1038/nature12153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23708965				2022-12-01	WOS:000319947800033
J	Ralph, LJ; McCoy, SI; Hallett, T; Padian, N				Ralph, Lauren J.; McCoy, Sandra I.; Hallett, Timothy; Padian, Nancy			Next steps for research on hormonal contraception and HIV	LANCET			English	Editorial Material							FEASIBILITY; ACQUISITION; RISK		[Ralph, Lauren J.; McCoy, Sandra I.; Padian, Nancy] Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94704 USA; [Hallett, Timothy] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	University of California System; University of California Berkeley; Imperial College London	Ralph, LJ (corresponding author), Univ Calif Berkeley, Div Epidemiol, Berkeley, CA 94704 USA.	lauren.ralph@berkeley.edu		Hallett, Timothy/0000-0002-9681-0424	NIMH NIH HHS [K01 MH094246] Funding Source: Medline; Medical Research Council [MR/K010174/1B] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH094246] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Blanchard K, 2011, CONTRACEPTION, V83, P556, DOI 10.1016/j.contraception.2010.10.018; Butler AR, 2013, AIDS, V27, P105, DOI 10.1097/QAD.0b013e32835a5a52; Feldblum PJ, 2005, CONTRACEPTION, V72, P187, DOI 10.1016/j.contraception.2005.03.006; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Hernan MA, 2012, CLIN TRIALS, V9, P48, DOI 10.1177/1740774511420743; Hubacher D, 2008, CONTRACEPTION, V78, P73, DOI 10.1016/j.contraception.2008.03.002; Hubacher D, 2008, CONTRACEPTION, V77, P366, DOI 10.1016/j.contraception.2008.01.006; Jain AK, 2012, CONTRACEPTION, V86, P645, DOI 10.1016/j.contraception.2012.03.008; Morrison CS, 2012, LANCET INFECT DIS, V12, P2, DOI 10.1016/S1473-3099(11)70254-7; Polis CB, 2012, XIX INTERNATIONAL AI; Pollack AE, 2007, REPORT PREPARED FOR; Singh S, 2009, ADDING IT UP THE COS; Smith J, 2013, 20TH CONFERENCE ON R, P114; Stringer EM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.031; Toh S., 2008, INT J BIOSTAT, V4, P22, DOI DOI 10.2202/1557-4679.1117; United Nations, 1994, UNITED NATIONS INTER; World Health Organization, 2012, HORMONAL CONTRACEPTI	17	19	19	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1467	1469		10.1016/S0140-6736(13)61420-8	http://dx.doi.org/10.1016/S0140-6736(13)61420-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247MR	23810224				2022-12-01	WOS:000326622500008
J	Kayagaki, N; Wong, MT; Stowe, IB; Ramani, SR; Gonzalez, LC; Akashi-Takamura, S; Miyake, K; Zhang, J; Lee, WP; Muszynski, A; Forsberg, LS; Carlson, RW; Dixit, VM				Kayagaki, Nobuhiko; Wong, Michael T.; Stowe, Irma B.; Ramani, Sree Ranjani; Gonzalez, Lino C.; Akashi-Takamura, Sachiko; Miyake, Kensuke; Zhang, Juan; Lee, Wyne P.; Muszynski, Artur; Forsberg, Lennart S.; Carlson, Russell W.; Dixit, Vishva M.			Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4	SCIENCE			English	Article							BACTERIAL LIPOPOLYSACCHARIDE; PATTERN-RECOGNITION; IMMUNE RECOGNITION; INTERLEUKIN-1-BETA; CASPASE-11; FLAGELLIN; PROTEASE; TOLL; RECEPTORS; IPAF	Gram-negative bacteria including Escherichia coli, Citrobacter rodentium, Salmonella typhimurium, and Shigella flexneri are sensed in an ill-defined manner by an intracellular inflammasome complex that activates caspase-11. We show that macrophages loaded with synthetic lipid A, E. coli lipopolysaccharide (LPS), or S. typhimurium LPS activate caspase-11 independently of the LPS receptor Toll-like receptor 4 (TLR4). Consistent with lipid A triggering the noncanonical inflammasome, LPS containing a divergent lipid A structure antagonized caspase-11 activation in response to E. coli LPS or Gram-negative bacteria. Moreover, LPS-mutant E. coli failed to activate caspase-11. Tlr4(-/-) mice primed with TLR3 agonist polyinosinic:polycytidylic acid [poly(I:C)] to induce pro-caspase-11 expression were as susceptible as wild-type mice were to sepsis induced by E. coli LPS. These data unveil a TLR4-independent mechanism for innate immune recognition of LPS.	[Kayagaki, Nobuhiko; Wong, Michael T.; Stowe, Irma B.; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Ramani, Sree Ranjani; Gonzalez, Lino C.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Akashi-Takamura, Sachiko; Miyake, Kensuke] Univ Tokyo, Dept Microbiol & Immunol, Ctr Expt Med & Syst Biol, Div Innate Immun,Lab Innate Immun,Inst Med Sci, Tokyo 1088639, Japan; [Zhang, Juan; Lee, Wyne P.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Muszynski, Artur; Forsberg, Lennart S.; Carlson, Russell W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Roche Holding; Genentech; Roche Holding; Genentech; University of Tokyo; Roche Holding; Genentech; University System of Georgia; University of Georgia	Kayagaki, N (corresponding author), Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA.	kayagaki@gene.com; dixit@gene.com	dixit, vishva m/A-4496-2012; Gonzalez, Lino/E-4102-2012	dixit, vishva m/0000-0001-6983-0326; Gonzalez, Lino/0000-0003-3817-6450; Muszynski, Artur/0000-0003-3497-9977	U.S. Department of Energy [DE-FG02-09ER20097]; Japan Society for the Promotion of Science [KAKENHI 23590564]; Ministry of Education, Culture, Sports, Science and Technology [KAKENHI 21117002]	U.S. Department of Energy(United States Department of Energy (DOE)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank S. Louie, J. Dong, J. Starks, K. O'Rourke, E. Suto, B. L. Lee, and P. Martinez for technical support; M. van Lookeren Campagne, G.-J. Boons, M. Roose-Girma, E. Naik, and K. Newton for discussions and manuscript editing; S. Akira, O. Takeuchi, and W. W. Leitner for mice; and T. M. Stephen for CMR300. Structural work on LPS was supported, in part, by U.S. Department of Energy grant DE-FG02-09ER20097 to the Complex Carbohydrate Research Center. Generation of Md1<SUP>-/-</SUP>Md2<SUP>-/-</SUP> and Rp105<SUP>-/-</SUP> mice was supported by grants from the Japan Society for the Promotion of Science (KAKENHI 23590564) and Ministry of Education, Culture, Sports, Science and Technology (KAKENHI 21117002).	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Carlson RW, 2010, SUBCELL BIOCHEM, V53, P339, DOI 10.1007/978-90-481-9078-2_16; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Chung HS, 2010, BIOCHEMISTRY-US, V49, P4126, DOI 10.1021/bi100343e; FAUCHEU C, 1995, EMBO J, V14, P1914, DOI 10.1002/j.1460-2075.1995.tb07183.x; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kenyon JJ, 2011, GLYCOBIOLOGY, V21, P1131, DOI 10.1093/glycob/cwr006; Kitchens RL, 1998, J IMMUNOL, V160, P1920; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2007, MICROBES INFECT, V9, P664, DOI 10.1016/j.micinf.2007.01.017; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Moran AP, 1997, J BACTERIOL, V179, P6453, DOI 10.1128/jb.179.20.6453-6463.1997; Ogawa T, 2003, FEMS IMMUNOL MED MIC, V36, P1, DOI 10.1016/S0928-8244(03)00093-2; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thieblemont N, 1998, IMMUNITY, V8, P771, DOI 10.1016/S1074-7613(00)80582-8; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5	35	931	977	18	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1246	1249		10.1126/science.1240248	http://dx.doi.org/10.1126/science.1240248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	23887873				2022-12-01	WOS:000324248800045
J	Hirose, T; Horvitz, HR				Hirose, Takashi; Horvitz, H. Robert			An Sp1 transcription factor coordinates caspase-dependent and -independent apoptotic pathways	NATURE			English	Article							PROGRAMMED CELL-DEATH; C-ELEGANS; PROTEIN; GENETICS; ENCODES; EGL-1	During animal development, the proper regulation of apoptosis requires the precise spatial and temporal execution of cell-death programs, which can include both caspase-dependent and caspase-independent pathways(1,2). Although the mechanisms of caspase-dependent and -independent cell killing have been examined extensively, how these pathways are coordinated within a single cell that is fated to die is unknown. Here we show that the Caenorhabditis elegans Sp1 transcription factor SPTF-3 specifies the programmed cell deaths of at least two cells-the sisters of the pharyngeal M4 motor neuron and the AQR sensory neuron-by transcriptionally activating both caspase-dependent and -independent apoptotic pathways. SPTF-3 directly drives the transcription of the geneegl-1, which encodes a BH3-only protein that promotes apoptosis through the activation of the CED-3 caspase(3). In addition, SPTF-3 directly drives the transcription of the AMP-activated protein kinase-related gene pig-1, which encodes a protein kinase and functions in apoptosis of the M4 sister and AQR sister independently of the pathway that activates-CED-3 (refs 4, 5). Thus, a single transcription factor controls two distinct cell-killing programs that act in parallel to drive apoptosis. Our findings reveal a bivalent regulatory node for caspase-dependent and -independent pathways in the regulation of cell-type-specific apoptosis. We propose that such nodes might act as features of a general mechanism for regulating cell-type-specific apoptosis and could be therapeutic targets for diseases involving the dysregulation of apoptosis through multiple cell-killing mechanisms.	[Hirose, Takashi; Horvitz, H. Robert] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Horvitz, HR (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	horvitz@mit.edu			NIH Office of Research Infrastructure Programs [P40 OD010440]; National BioResource project for strains; Howard Hughes Medical Institute; Ministry of Education, Science, Technology, Sports and Culture of Japan; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs; National BioResource project for strains; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ministry of Education, Science, Technology, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Fire, J. Gaudet, C. Barbara and Y. Iino for reporter constructs used to observe cell-type-specific apoptosis; G. Garriga for pig-1 strains; the Caenorhabditis Genetic Center, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440) and the National BioResource project for strains; D. Denning, K. Boulias, A. Corrionero and H. Johnsen for comments about the manuscript; and members of the Horvitz laboratory for technical support and discussions. This work was supported by the Howard Hughes Medical Institute. T. H. was supported in part by the Ministry of Education, Science, Technology, Sports and Culture of Japan. H. R. H. is the David H. Koch Professor of Biology at the Massachusetts Institute of Technology and an Investigator of the Howard Hughes Medical Institute.	Andersen EC, 2008, GENETICS, V179, P2001, DOI 10.1534/genetics.108.092197; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BRENNER S, 1974, GENETICS, V77, P71; CLARK SG, 1994, GENETICS, V137, P987; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Cordes S, 2006, DEVELOPMENT, V133, P2747, DOI 10.1242/dev.02447; Denning DP, 2012, NATURE, V488, P226, DOI 10.1038/nature11240; Ercan S, 2007, NAT GENET, V39, P403, DOI 10.1038/ng1983; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; Hirose T, 2010, P NATL ACAD SCI USA, V107, P15479, DOI 10.1073/pnas.1010023107; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; MADURO M, 1995, GENETICS, V141, P977; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Rosenbaum DM, 2010, J NEUROSCI RES, V88, P1569, DOI 10.1002/jnr.22314; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Ulm EA, 2011, MECH DEVELOP, V128, P428, DOI 10.1016/j.mod.2011.08.003; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yochem J, 1998, GENETICS, V149, P1323; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410	28	46	59	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					354	+		10.1038/nature12329	http://dx.doi.org/10.1038/nature12329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23851392	Green Submitted, Green Published, Green Accepted			2022-12-01	WOS:000323112400037
J	Venkatraman, A; He, XC; Thorvaldsen, JL; Sugimura, R; Perry, JM; Tao, F; Zhao, M; Christenson, MK; Sanchez, R; Yu, JY; Peng, L; Haug, JS; Paulson, A; Li, H; Zhong, XB; Clemens, TL; Bartolomei, MS; Li, LH				Venkatraman, Aparna; He, Xi C.; Thorvaldsen, Joanne L.; Sugimura, Ryohichi; Perry, John M.; Tao, Fang; Zhao, Meng; Christenson, Matthew K.; Sanchez, Rebeca; Yu, Jaclyn Y.; Peng, Lai; Haug, Jeffrey S.; Paulson, Ariel; Li, Hua; Zhong, Xiao-bo; Clemens, Thomas L.; Bartolomei, Marisa S.; Li, Linheng			Maternal imprinting at the H19-Igf2 locus maintains adult haematopoietic stem cell quiescence	NATURE			English	Article							PROBE LEVEL DATA; SELF-RENEWAL; RNA-SEQ; GROWTH; NICHE; EXPRESSION; GENES; DIFFERENTIATION; IDENTIFICATION; NORMALIZATION	The epigenetic regulation of imprinted genes by monoallelic DNA methylation of either maternal or paternal alleles is critical for embryonic growth and development(1). Imprinted genes were recently shown to be expressed in mammalian adult stem cells to support self-renewal of neural and lung stem cells(2-4); however, a role for imprinting per se in adult stem cells remains elusive. Here we show upregulation of growth-restricting imprinted genes, including in the H19-Igf2 locus(5), in long-term haematopoietic stem cells and their downregulation upon haematopoietic stem cell activation and proliferation. A differentially methylated region upstream of H19 (H19-DMR), serving as the imprinting control region, determines the reciprocal expression of H19 from the maternal allele and Igf2 from the paternal allele(1). In addition, H19 serves as a source of miR-675, which restricts Igf1r expression(6). We demonstrate that conditional deletion of the maternal but not the paternal H19-DMR reduces adult haematopoietic stem cell quiescence, a state required for long-term maintenance of haematopoietic stem cells, and compromises haematopoietic stem cell function. Maternal-specific H19-DMR deletion results in activation of the Igf2-Igfr1 pathway, as shown by the translocation of phosphorylated FoxO3 (an inactive form) from nucleus to cytoplasm and the release of FoxO3-mediated cell cycle arrest, thus leading to increased activation, proliferation and eventual exhaustion of haematopoietic stem cells. Mechanistically, maternal-specific H19-DMR deletion leads to Igf2 upregulation and increased translation of Igf1r, which is normally suppressed by H19-derived miR-675. Similarly, genetic inactivation of Igf1r partly rescues the H19-DMR deletion phenotype. Our work establishes a new role for this unique form of epigenetic control at the H19-Igf2 locus in maintaining adult stem cells.	[Venkatraman, Aparna; He, Xi C.; Sugimura, Ryohichi; Perry, John M.; Tao, Fang; Zhao, Meng; Christenson, Matthew K.; Sanchez, Rebeca; Yu, Jaclyn Y.; Haug, Jeffrey S.; Paulson, Ariel; Li, Hua; Li, Linheng] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Venkatraman, Aparna] Christian Med Coll & Hosp, Ctr Stem Cell Res, Vellore 632002, Tamil Nadu, India; [Thorvaldsen, Joanne L.; Bartolomei, Marisa S.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Sanchez, Rebeca] Inst Recerca Vall Dhebron, Cell Therapy & Genet Lab, Barcelona 08035, Spain; [Peng, Lai; Zhong, Xiao-bo] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Clemens, Thomas L.] Johns Hopkins Med, Ctr Musculoskeletal Res, Baltimore, MD 21287 USA; [Li, Linheng] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; Christian Medical College & Hospital (CMCH) Vellore; University of Pennsylvania; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Kansas; University of Kansas Medical Center; Johns Hopkins University; Johns Hopkins Medicine; University of Kansas; University of Kansas Medical Center	Li, LH (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	lil@stowers.org	Sugimura, Rio/AAR-7280-2020; Sanchez, Rebeca/GXH-6596-2022; Sanchez, Rebeca/L-7138-2014	Sugimura, Rio/0000-0001-5701-3628; Sanchez, Rebeca/0000-0002-2073-2810; Sanchez, Rebeca/0000-0002-2073-2810; Bartolomei, Marisa/0000-0001-9410-5222; Li, Linheng/0000-0001-9963-430X	Stowers Institute for Medical Research; Department of Biotechnology, Ministry of Science and Technology, Government of India; National Institutes of Health [GM51279]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051279, R01GM087376, R37GM051279] Funding Source: NIH RePORTER	Stowers Institute for Medical Research; Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Hembree, T. Johnson, H. Marshall, B. Lewis, D. Dukes, C. Semerad, J. Park and A. Box for technical support, and members of the Li laboratory for scientific discussion. We thank J. Lu and Y. Huang for communications about miR-675 and Let-7. We thank K. Tannen for editing. This work was supported by the Stowers Institute for Medical Research and by the Department of Biotechnology, Ministry of Science and Technology, Government of India, as an overseas associateship to A. Venkatraman. M. Bartolomei is supported by the National Institutes of Health (GM51279).	Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Berg JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026410; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; Dijke P., 2006, SMAD SIGNAL TRANSDUC; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Hudson QJ, 2010, HEREDITY, V105, P45, DOI 10.1038/hdy.2010.23; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kang HM, 2011, CELL PROLIFERAT, V44, P254, DOI 10.1111/j.1365-2184.2011.00755.x; Karlsson G, 2007, J EXP MED, V204, P467, DOI 10.1084/jem.20060465; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; Klinakis A, 2009, P NATL ACAD SCI USA, V106, P2359, DOI 10.1073/pnas.0810221106; Kubota Y, 2009, BLOOD, V114, P4383, DOI 10.1182/blood-2009-07-230292; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LERNER C, 1990, EXP HEMATOL, V18, P114; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Smith FM, 2006, CYTOGENET GENOME RES, V113, P279, DOI 10.1159/000090843; Smyth G.K., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Thorvaldsen JL, 2006, MOL CELL BIOL, V26, P1245, DOI 10.1128/MCB.26.4.1245-1258.2006; Toledano H, 2012, NATURE, V485, P605, DOI 10.1038/nature11061; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Yu W, 2007, ONCOGENE, V26, P1178, DOI 10.1038/sj.onc.1209899; Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	42	183	190	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					345	+		10.1038/nature12303	http://dx.doi.org/10.1038/nature12303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23863936	Green Accepted			2022-12-01	WOS:000323112400035
J	Lu, GW; Hu, YW; Wang, QH; Qi, JX; Gao, F; Li, Y; Zhang, YF; Zhang, W; Yuan, Y; Bao, JK; Zhang, BC; Shi, Y; Yan, JH; Gao, GF				Lu, Guangwen; Hu, Yawei; Wang, Qihui; Qi, Jianxun; Gao, Feng; Li, Yan; Zhang, Yanfang; Zhang, Wei; Yuan, Yuan; Bao, Jinku; Zhang, Buchang; Shi, Yi; Yan, Jinghua; Gao, George F.			Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26	NATURE			English	Article							CRYSTAL-STRUCTURE; SPIKE PROTEIN; FUNCTIONAL RECEPTOR; AMINOPEPTIDASE-N; MIDDLE-EAST; REVEALS; MEMBRANE; COMPLEX; ORIGIN; VIRUS	The newly emergent Middle East respiratory syndrome coronavirus (MERS-CoV) can cause severe pulmonary disease in humans(1,2), representing the second example of a highly pathogenic coronavirus, the first being SARS-CoV3. CD26 (also known as dipeptidyl peptidase 4, DPP4) was recently identified as the cellular receptor for MERS-CoV4. The engagement of the MERS-CoV spike protein with CD26 mediates viral attachment to host cells and virus-cell fusion, thereby initiating infection. Here we delineate the molecular basis of this specific interaction by presenting the first crystal structures of both the free receptor binding domain (RBD) of the MERS-CoV spike protein and its complex with CD26. Furthermore, binding between the RBD and CD26 is measured using real-time surface plasmon resonance with a dissociation constant of 16.7 nM. The viral RBD is composed of a core subdomain homologous to that of the SARS-CoV spike protein, and a unique strand-dominated external receptor binding motif that recognizes blades IV and V of the CD26 beta-propeller. The atomic details at the interface between the two binding entities reveal a surprising protein-protein contact mediated mainly by hydrophilic residues. Sequence alignment indicates, among beta-coronaviruses, a possible structural conservation for the region homologous to the MERS-CoV RBD core, but a high variation in the external receptor binding motif region for virus-specific pathogenesis such as receptor recognition.	[Lu, Guangwen; Wang, Qihui; Qi, Jianxun; Li, Yan; Zhang, Yanfang; Zhang, Wei; Yuan, Yuan; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Hu, Yawei; Zhang, Buchang] Anhui Univ, Sch Life Sci, Hefei 230039, Peoples R China; [Gao, Feng] Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100101, Peoples R China; [Gao, Feng; Bao, Jinku] Sichuan Univ, Sch Life Sci, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Yanfang; Gao, George F.] Tianjin Inst Ind Biotechnol, Lab Prot Engn & Vaccines, Tianjin 300308, Peoples R China; [Yuan, Yuan; Gao, George F.] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Shi, Yi; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing 100101, Peoples R China; [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Anhui University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Sichuan University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Chinese Center for Disease Control & Prevention	Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	gaof@im.ac.cn	Qihui, Wang/GLR-4206-2022; Gao, George Fu/ABD-5229-2021; Qi, Jianxun/ABF-1646-2021; Lu, Guangwen/HCH-9193-2022	Qihui, Wang/0000-0003-3768-0401; 	Ministry of Science and Technology of China (MOST) [2011CB504703]; National Natural Science Foundation of China (NSFC) [81290342]; NSFC Innovative Research Group [81021003]	Ministry of Science and Technology of China (MOST)(Ministry of Science and Technology, China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC Innovative Research Group	This work was supported by the Ministry of Science and Technology of China (MOST) 973 Project (Grant no. 2011CB504703) and the National Natural Science Foundation of China (NSFC, Grant no. 81290342). Assistance by the staff at the Shanghai Synchrotron Radiation Facility (SSRF) of China and the High Energy Accelerator Research Organization (KEK) of Japan is acknowledged. We thank Z. Fan and T. Zhao for their technical assistance. G. F. G. is a leading principal investigator of the NSFC Innovative Research Group (Grant no. 81021003). We thank M. Yang from Tsinghua University for his help with data collection.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; Gao GF, 2007, COMBATING THE THREAT OF PANDEMIC INFLUENZA: DRUG DISCOVERY APPROACHES, P226, DOI 10.1002/9780470179727.ch10; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Lai M.M.C., 2007, FIELDS VIROLOGY, P1305; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li F, 2012, J VIROL, V86, P2856, DOI 10.1128/JVI.06882-11; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lu GW, 2012, PROTEIN CELL, V3, P803, DOI 10.1007/s13238-012-2811-1; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng GQ, 2011, P NATL ACAD SCI USA, V108, P10696, DOI 10.1073/pnas.1104306108; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reguera J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002859; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; Weihofen WA, 2004, J BIOL CHEM, V279, P43330, DOI 10.1074/jbc.M405001200; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; WHO, CUM NUMB REP PROB CA; World Health Organization, 2013, NOV COR INF UPD; Wu KL, 2009, P NATL ACAD SCI USA, V106, P19970, DOI 10.1073/pnas.0908837106; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang W, 2010, PROTEIN CELL, V1, P459, DOI 10.1007/s13238-010-0059-1; Zhu JQ, 2004, BIOCHEM BIOPH RES CO, V319, P283, DOI 10.1016/j.bbrc.2004.04.141	38	469	518	5	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					227	+		10.1038/nature12328	http://dx.doi.org/10.1038/nature12328			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23831647	Green Published, Bronze			2022-12-01	WOS:000322825500039
J	Feder, J				Feder, Judith			Bundle with Care Rethinking Medicare Incentives for Post-Acute Care Services	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Feder, Judith] Georgetown Univ, Urban Inst, Ctr Hlth Policy, Washington, DC USA; [Feder, Judith] Georgetown Univ, Georgetown Publ Policy Inst, Washington, DC USA	Georgetown University; Urban Institute; Georgetown University	Feder, J (corresponding author), Georgetown Univ, Urban Inst, Ctr Hlth Policy, Washington, DC USA.							Christman E, 2009, MED PAYM ASS COMM NO; Korea Health Promotion Institute, 2020, 04202000301; Newhouse JP, 2012, HEALTH AFFAIR, V31, P2618, DOI 10.1377/hlthaff.2012.0345; Newhouse JP, 1997, HLTH AFF MILLWOOD, V16, P16	4	13	13	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					400	401		10.1056/NEJMp1302730	http://dx.doi.org/10.1056/NEJMp1302730			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193GQ	23841702				2022-12-01	WOS:000322547400003
J	Xiong, XL; Martin, SR; Haire, LF; Wharton, SA; Daniels, RS; Bennett, MS; McCauley, JW; Collins, PJ; Walker, PA; Skehel, JJ; Gamblin, SJ				Xiong, Xiaoli; Martin, Stephen R.; Haire, Lesley F.; Wharton, Stephen A.; Daniels, Rodney S.; Bennett, Michael S.; McCauley, John W.; Collins, Patrick J.; Walker, Philip A.; Skehel, John J.; Gamblin, Steven J.			Receptor binding by an H7N9 influenza virus from humans	NATURE			English	Article							HUMAN INFECTION; A VIRUSES; HEMAGGLUTININ; TRANSMISSION; FUSION; H9N2; PATHOGENICITY; CELL	Of the 132 people known to have been infected with H7N9 influenza viruses in China, 37 died, and many were severely ill(1). Infection seems to have involved contact with infected poultry(2,3). We have examined the receptor-binding properties of this H7N9 virus and compared them with those of an avian H7N3 virus. We find that the human H7 virus has significantly higher affinity for alpha-2, 6-linked sialic acid analogues ('human receptor') than avian H7 while retaining the strong binding to alpha-2,3-linked sialic acid analogues ('avian receptor') characteristic of avian viruses. The human H7 virus does not, therefore, have the preference for human versus avian receptors characteristic of pandemic viruses. X-ray crystallography of the receptor-binding protein, haemagglutinin (HA), in complex with receptor analogues indicates that both human and avian receptors adopt different conformations when bound to human H7 HA than they do when bound to avian H7 HA. Human receptor bound to human H7 HA exits the binding site in a different direction to that seen in complexes formed by HAs from pandemic viruses(4,5) and from an aerosol-transmissible H5 mutant(6). The human-receptor-binding properties of human H7 probably arise from the introduction of two bulky hydrophobic residues by the substitutions Gln226Leu and Gly186Val. The former is shared with the 1957 H2 and 1968 H3 pandemic viruses and with the aerosol-transmissible H5 mutant. We conclude that the human H7 virus has acquired some of the receptor-binding characteristics that are typical of pandemic viruses, but its retained preference for avian receptor may restrict its further evolution towards a virus that could transmit efficiently between humans, perhaps by binding to avian-receptor-rich mucins in the human respiratory tract(7) rather than to cellular receptors.	[Xiong, Xiaoli; Martin, Stephen R.; Haire, Lesley F.; Collins, Patrick J.; Walker, Philip A.; Skehel, John J.; Gamblin, Steven J.] Ridgeway, Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England; [Wharton, Stephen A.; Daniels, Rodney S.; Bennett, Michael S.; McCauley, John W.] Ridgeway, Natl Inst Med Res, MRC, WHO Collaborating Ctr Reference & Res Influenza, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Gamblin, SJ (corresponding author), Ridgeway, Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	skeheljj@nimr.mrc.ac.uk; sgambli@nimr.mrc.ac.uk		Gamblin, Steve/0000-0001-5331-639X; Xiong, Xiaoli/0000-0002-4632-9122	Medical Research Council [U117584222, U117570592, U117585868, U117512723]; Medical Research Council [MC_U117585868, MC_U117584222] Funding Source: researchfish; MRC [MC_U117585868, MC_U117584222] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge Y. Shu for sharing information and samples on recent H7N9 virus infections. We are grateful to staff at the Diamond Light Source Synchrotron for assistance and beamline access under proposal 7707 and the staff of the NIMR Large Scale laboratory. This work was funded by the Medical Research Council through programmes U117584222, U117570592, U117585868 and U117512723.	Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gambaryan AS, 2012, J VIROL, V86, P4370, DOI 10.1128/JVI.06959-11; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Garten W, 1999, TRENDS MICROBIOL, V7, P99, DOI 10.1016/S0966-842X(99)01460-2; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; RUIGROK RWH, 1986, VIROLOGY, V155, P484, DOI 10.1016/0042-6822(86)90210-2; Russell RJ, 2006, GLYCOCONJUGATE J, V23, P85, DOI 10.1007/s10719-006-5440-1; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1971, VIROLOGY, V44, P396, DOI 10.1016/0042-6822(71)90270-4; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; World Health Organization, 2013, 8 WHO, V15, P45; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Zhang W, 2013, SCIENCE, V340, P1463, DOI 10.1126/science.1236787	29	236	253	0	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					496	+		10.1038/nature12372	http://dx.doi.org/10.1038/nature12372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23787694				2022-12-01	WOS:000322157900044
J	Chen, TW; Wardill, TJ; Sun, Y; Pulver, SR; Renninger, SL; Baohan, A; Schreiter, ER; Kerr, RA; Orger, MB; Jayaraman, V; Looger, LL; Svoboda, K; Kim, DS				Chen, Tsai-Wen; Wardill, Trevor J.; Sun, Yi; Pulver, Stefan R.; Renninger, Sabine L.; Baohan, Amy; Schreiter, Eric R.; Kerr, Rex A.; Orger, Michael B.; Jayaraman, Vivek; Looger, Loren L.; Svoboda, Karel; Kim, Douglas S.			Ultrasensitive fluorescent proteins for imaging neuronal activity	NATURE			English	Article							PRIMARY VISUAL-CORTEX; ENCODED CA2+ INDICATORS; IN-VIVO; NEURAL ACTIVITY; ORIENTATION SELECTIVITY; CORTICAL-NEURONS; CALCIUM TRANSIENTS; TARGET RECOGNITION; DENDRITIC SPINES; STRUCTURAL BASIS	Fluorescent calcium sensors are widely used to image neural activity. Using structure-based mutagenesis and neuron-based screening, we developed a family of ultrasensitive protein calcium sensors (GCaMP6) that outperformed other sensors in cultured neurons and in zebrafish, flies and mice in vivo. In layer 2/3 pyramidal neurons of the mouse visual cortex, GCaMP6 reliably detected single action potentials in neuronal somata and orientation-tuned synaptic calcium transients in individual dendritic spines. The orientation tuning of structurally persistent spines was largely stable over timescales of weeks. Orientation tuning averaged across spine populations predicted the tuning of their parent cell. Although the somata of GABAergic neurons showed little orientation tuning, their dendrites included highly tuned dendritic segments (5-40-mm long). GCaMP6 sensors thus provide new windows into the organization and dynamics of neural circuits over multiple spatial and temporal scales.	[Chen, Tsai-Wen; Wardill, Trevor J.; Sun, Yi; Pulver, Stefan R.; Baohan, Amy; Schreiter, Eric R.; Kerr, Rex A.; Jayaraman, Vivek; Looger, Loren L.; Svoboda, Karel; Kim, Douglas S.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Renninger, Sabine L.; Orger, Michael B.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal; [Baohan, Amy] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; Fundacao Champalimaud; University of California System; University of California Los Angeles	Orger, MB (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Ave Brasilia, P-1400038 Lisbon, Portugal.	michael.orger@neuro.fchampalimaud.org; jayaramanv@janelia.hhmi.org; loogerl@janelia.hhmi.org; svobodak@janelia.hhmi.org; kimd@janelia.hhmi.org	Sun, Yi/I-1450-2012	Chen, Tsai-Wen/0000-0001-6782-3819; Wardill, Trevor/0000-0002-2049-113X; Orger, Michael/0000-0002-9763-8902; Sun, Yi/0000-0002-1746-0404; Schreiter, Eric/0000-0002-2864-7469; Pulver, Stefan/0000-0001-5170-7522; Kim, Douglas/0000-0001-9029-314X; Renninger, Sabine/0000-0003-3228-3204	Swiss National Science Foundation; Marie Curie Career Integration Grant [PCIG09-GA-2011-294049]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie Career Integration Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Akerboom and L. Tian for constructs and advice; J. Hasseman, M. Ramirez, G. Tsegaye for molecular cloning; B. Shields for neuronal culture; A. Hu for histology; B. Fosque, R. Behnam, K. Ritola for virus production; J. Macklin and R. Patel for spectroscopy; B. Coop and L. Ramasamy for multiwell electrode manufacturing; K. Smith for mouse viral transduction; K. Hibbard for fly husbandry; and J. Yu, C. Niell, M. Stryker, J. Trachtenberg and A. Kerlin for advice on visual cortex experiments. S. L. R. is supported by a Fellowship from the Swiss National Science Foundation. M.B.O. is supported by a Marie Curie Career Integration Grant PCIG09-GA-2011-294049.	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BAKER PF, 1971, J PHYSIOL-LONDON, V218, P709, DOI 10.1113/jphysiol.1971.sp009641; Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P49, DOI 10.1113/jphysiol.2003.042580; Guerrero G, 2005, NAT NEUROSCI, V8, P1188, DOI 10.1038/nn1526; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; Hansel D, 2012, J NEUROSCI, V32, P4049, DOI 10.1523/JNEUROSCI.6284-11.2012; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Katona G, 2011, P NATL ACAD SCI USA, V108, P2148, DOI 10.1073/pnas.1009270108; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kobat D, 2009, OPT EXPRESS, V17, P13354, DOI 10.1364/OE.17.013354; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Suter BA, 2010, FRONT NEURAL CIRCUIT, V4, P100, DOI DOI 10.3389/FNCIR.2010.00100; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	64	3350	3401	47	723	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					295	+		10.1038/nature12354	http://dx.doi.org/10.1038/nature12354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23868258	Green Accepted			2022-12-01	WOS:000321910700027
J	Selkoe, DJ				Selkoe, Dennis J.			SnapShot: Pathobiology of Alzheimer's Disease	CELL			English	Editorial Material									Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Selkoe, DJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.				NIA NIH HHS [R01 AG006173] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG006173] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Castellano J.M., 2011, COLD SPRING HARB PER, V3; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Selkoe DJ, 2012, BIOL ALZHEIMER DIS; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346	7	40	41	0	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					468	+	468.e1	10.1016/j.cell.2013.07.003	http://dx.doi.org/10.1016/j.cell.2013.07.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870132	Bronze			2022-12-01	WOS:000321950700022
J	Teno, JM; Gozalo, P; Mitchell, SL; Tyler, D; Mor, V				Teno, Joan M.; Gozalo, Pedro; Mitchell, Susan L.; Tyler, Denise; Mor, Vincent			Survival After Multiple Hospitalizations for Infections and Dehydration in Nursing Home Residents With Advanced Cognitive Impairment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MINIMUM DATA SET		[Teno, Joan M.; Gozalo, Pedro; Tyler, Denise; Mor, Vincent] Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA; [Mitchell, Susan L.] Hebrew SeniorLife, Inst Aging Res, Boston, MA USA	Brown University; Harvard University; Hebrew SeniorLife	Teno, JM (corresponding author), Brown Univ, Ctr Gerontol & Hlth Care Res, 121 S Main St,Room 612, Providence, RI 02912 USA.	joan_teno@brown.edu		Tyler, Denise/0000-0001-8555-9011	NIA NIH HHS [P01 AG027296, K24 AG033640, P01AG027296] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K24AG033640, P01AG027296] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Loeb M, 2006, JAMA-J AM MED ASSOC, V295, P2503, DOI 10.1001/jama.295.21.2503; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Mor V, 2004, MED CARE, V42, P50, DOI 10.1097/01.mlr.0000120104.01232.5e; Mor V, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-78; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174	5	21	21	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					319	320		10.1001/jama.2013.8392	http://dx.doi.org/10.1001/jama.2013.8392			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23860991	Green Accepted, Bronze			2022-12-01	WOS:000321835700020
J	Guttman, M; Russell, P; Ingolia, NT; Weissman, JS; Lander, ES				Guttman, Mitchell; Russell, Pamela; Ingolia, Nicholas T.; Weissman, Jonathan S.; Lander, Eric S.			Ribosome Profiling Provides Evidence that Large Noncoding RNAs Do Not Encode Proteins	CELL			English	Article							TRANSLATION INITIATION; NUCLEOTIDE RESOLUTION; HUMAN-CELLS; GENOME; GENE; REVEALS; MECHANISM; LINCRNAS; EXPRESSION; PRINCIPLES	Large noncoding RNAs are emerging as an important component in cellular regulation. Considerable evidence indicates that these transcripts act directly as functional RNAs rather than through an encoded protein product. However, a recent study of ribosome occupancy reported that many large intergenic ncRNAs (lincRNAs) are bound by ribosomes, raising the possibility that they are translated into proteins. Here, we show that classical noncoding RNAs and 50 UTRs show the same ribosome occupancy as lincRNAs, demonstrating that ribosome occupancy alone is not sufficient to classify transcripts as coding or noncoding. Instead, we define a metric based on the known property of translation whereby translating ribosomes are released upon encountering a bona fide stop codon. We show that this metric accurately discriminates between protein-coding transcripts and all classes of known noncoding transcripts, including lincRNAs. Taken together, these results argue that the large majority of lincRNAs do not function through encoded proteins.	[Guttman, Mitchell; Russell, Pamela; Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Guttman, Mitchell; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Ingolia, Nicholas T.] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Carnegie Institution for Science; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Harvard Medical School	Guttman, M (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	mguttman@caltech.edu; lander@broadinstitute.org		Weissman, Jonathan/0000-0003-2445-670X; Russell, Pamela/0000-0003-2997-6392	NIH Director's Early Independence Award [DP5OD012190]; NHGRI [U54HG003067]; Broad Institute of MIT and Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012190] Funding Source: NIH RePORTER	NIH Director's Early Independence Award; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Broad Institute of MIT and Harvard; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Manuel Garber and John Rinn for helpful discussions and thoughtful comments on the manuscript, Moran Cabili and Jesse Engreitz for critical reading and suggestions on the manuscript, Alex Shishkin for generating the non-polyA-selected RNA-seq libraries, Shari Grossman for help with population-level dN/dS calculations, and Leslie Gaffney for assistance with figures. This work was funded by an NIH Director's Early Independence Award (DP5OD012190 to M.G.), NHGRI (U54HG003067 to E.S.L.), and funds from the Broad Institute of MIT and Harvard.	Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Fritsch C, 2012, GENOME RES, V22, P2208, DOI 10.1101/gr.139568.112; GEBALLE AP, 1994, TRENDS BIOCHEM SCI, V19, P159, DOI 10.1016/0968-0004(94)90277-1; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kin T, 2007, NUCLEIC ACIDS RES, V35, pD145, DOI 10.1093/nar/gkl837; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Starck SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003460; STARK BC, 1978, P NATL ACAD SCI USA, V75, P3717, DOI 10.1073/pnas.75.8.3717; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018	33	509	523	3	80	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					240	251		10.1016/j.cell.2013.06.009	http://dx.doi.org/10.1016/j.cell.2013.06.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23810193	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000321327900023
J	Abreu, AP; Dauber, A; Macedo, DB; Noel, SD; Brito, VN; Gill, JC; Cukier, P; Thompson, IR; Navarro, VM; Gagliardi, PC; Rodrigues, T; Kochi, C; Longui, CA; Beckers, D; de Zegher, F; Montenegro, LR; Mendonca, BB; Carroll, RS; Hirschhorn, JN; Latronico, AC; Kaiser, UB				Abreu, Ana Paula; Dauber, Andrew; Macedo, Delanie B.; Noel, Sekoni D.; Brito, Vinicius N.; Gill, John C.; Cukier, Priscilla; Thompson, Iain R.; Navarro, Victor M.; Gagliardi, Priscila C.; Rodrigues, Tania; Kochi, Cristiane; Longui, Carlos Alberto; Beckers, Dominique; de Zegher, Francis; Montenegro, Luciana R.; Mendonca, Berenice B.; Carroll, Rona S.; Hirschhorn, Joel N.; Latronico, Ana Claudia; Kaiser, Ursula B.			Central Precocious Puberty Caused by Mutations in the Imprinted Gene MKRN3	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRADER-WILLI-SYNDROME; IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; NEUROBIOLOGICAL MECHANISMS; ARCUATE NUCLEUS; CHINESE GIRLS; NEUROKININ B; ASSOCIATION; EXPRESSION; GROWTH; MOUSE	BACKGROUND The onset of puberty is first detected as an increase in pulsatile secretion of gonadotropin-releasing hormone (GnRH). Early activation of the hypothalamic-pituitary-gonadal axis results in central precocious puberty. The timing of pubertal development is driven in part by genetic factors, but only a few, rare molecular defects associated with central precocious puberty have been identified. METHODS We performed whole-exome sequencing in 40 members of 15 families with central precocious puberty. Candidate variants were confirmed with Sanger sequencing. We also performed quantitative real-time polymerase-chain-reaction assays to determine levels of messenger RNA (mRNA) in the hypothalami of mice at different ages. RESULTS We identified four novel heterozygous mutations in MKRN3, the gene encoding makorin RING-finger protein 3, in 5 of the 15 families; both sexes were affected. The mutations included three frameshift mutations, predicted to encode truncated proteins, and one missense mutation, predicted to disrupt protein function. MKRN3 is a paternally expressed, imprinted gene located in the Prader-Willi syndrome critical region (chromosome 15q11-q13). All affected persons inherited the mutations from their fathers, a finding that indicates perfect segregation with the mode of inheritance expected for an imprinted gene. Levels of Mkrn3 mRNA were high in the arcuate nucleus of prepubertal mice, decreased immediately before puberty, and remained low after puberty. CONCLUSIONS Deficiency of MKRN3 causes central precocious puberty in humans.	[Abreu, Ana Paula; Noel, Sekoni D.; Gill, John C.; Thompson, Iain R.; Navarro, Victor M.; Carroll, Rona S.; Kaiser, Ursula B.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Abreu, Ana Paula; Noel, Sekoni D.; Gill, John C.; Thompson, Iain R.; Navarro, Victor M.; Carroll, Rona S.; Kaiser, Ursula B.] Harvard Univ, Sch Med, Boston, MA USA; [Dauber, Andrew; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Hirschhorn, Joel N.] Boston Childrens Hosp, Div Genet, Boston, MA USA; [Dauber, Andrew; Hirschhorn, Joel N.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Abreu, Ana Paula; Macedo, Delanie B.; Brito, Vinicius N.; Cukier, Priscilla; Montenegro, Luciana R.; Mendonca, Berenice B.; Latronico, Ana Claudia] Univ Sao Paulo, Fac Med, Hosp Clin,Lab Hormonios & Genet Mol,LIM42, Disciplina Endocrinol,Unidade Endocrinol Desenvol, BR-05403900 Sao Paulo, Brazil; [Kochi, Cristiane; Longui, Carlos Alberto] Fac Ciencias Med Santa Casa Sao Paulo, Dept Pediat, Sao Paulo, Brazil; [Rodrigues, Tania] Univ Fed Minas Gerais, Hosp Clin, Div Pediat Endocrinol, Belo Horizonte, MG, Brazil; [Gagliardi, Priscila C.] Nemours Childrens Clin, Div Endocrinol Diabet & Metab, Jacksonville, FL USA; [Beckers, Dominique; de Zegher, Francis] Univ Hosp Gasthuisberg, Dept Pediat, B-3000 Louvain, Belgium	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Universidade de Sao Paulo; Faculdade de Ciencias Medicas Santa Casa de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Minas Gerais; KU Leuven; University Hospital Leuven	Latronico, AC (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Disciplina Endocrinol & Metabol, Av Dr Eneas de Carvalho Aguiar,255-7 Andar,Sala 7, BR-05403900 Sao Paulo, Brazil.	anacl@usp.br	Latronico, Ana Claudia/AAC-5112-2019; Longui, Carlos A/B-8112-2013; Brito, Vinicius Nahime/AAA-2013-2020; BRITO, VINICIUS N/B-3776-2013; Mendonca, Berenice B/J-6917-2015; Latronico, Ana Claudia/E-1198-2012; Mendonca, Berenice/AAS-3742-2021	Latronico, Ana Claudia/0000-0001-6782-693X; BRITO, VINICIUS N/0000-0003-4140-6296; Mendonca, Berenice B/0000-0003-1762-1084; Latronico, Ana Claudia/0000-0001-6782-693X; Mendonca, Berenice/0000-0003-1762-1084; /0000-0002-5505-0852	National Institutes of Health [1K23HD073351]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [3806-11-1]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [1F05HD072773-01, U54HD28138, R21HD066495]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [302825/2011-8, 305743/2011-2]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2005/04726-0]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD071970, P30HD018655, K23HD073351, U54HD028138, K99HD071970, F05HD072773] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD066495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institutes of Health and others.; Supported by grants from the National Institutes of Health (1K23HD073351, to Dr. Dauber), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (3806-11-1, to Dr. Abreu), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (1F05HD072773-01, to Dr. Abreu; U54HD28138, as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research; and R21HD066495, to Dr. Kaiser), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (302825/2011-8, to Dr. Latronico; and 305743/2011-2, to Dr. Mendoca), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2005/04726-0, to Dr. Latronico).	[Anonymous], 2013, EX VAR SERV; Bianco SDC, 2009, NAT REV ENDOCRINOL, V5, P569, DOI 10.1038/nrendo.2009.177; Bohne A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-721; Buettner VI, 2005, MAMM GENOME, V16, P219, DOI 10.1007/s00335-004-2452-7; Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0; Dauber A, 2013, J PEDIATR-US, V162, P202, DOI 10.1016/j.jpeds.2012.07.055; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; de Vries L, 2004, J CLIN ENDOCR METAB, V89, P1794, DOI 10.1210/jc.2003-030361; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; FISCHBEIN S, 1977, ANN HUM BIOL, V4, P417, DOI 10.1080/03014467700002401; Friedman DS, 2008, OPHTHALMOLOGY, V115, P1786, DOI 10.1016/j.ophtha.2008.04.006; Gajdos ZKZ, 2009, CURR OPIN ENDOCRINOL, V16, P16, DOI 10.1097/MED.0b013e328320253c; Gill JC, 2012, ENDOCRINOLOGY, V153, P4883, DOI 10.1210/en.2012-1529; Gill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011911; Golub MS, 2008, PEDIATRICS, V121, pS218, DOI 10.1542/peds.2007-1813G; Gray TA, 2000, GENOMICS, V66, P76, DOI 10.1006/geno.2000.6199; Greulich W.W., 1971, RADIOGRAPHIC ATLAS S; Jong MTC, 1999, HUM MOL GENET, V8, P783, DOI 10.1093/hmg/8.5.783; Kanber D, 2009, EUR J HUM GENET, V17, P582, DOI 10.1038/ejhg.2008.232; Luan X, 2007, NEUROENDOCRINOLOGY, V86, P77, DOI 10.1159/000107511; Freitas KCM, 2007, FERTIL STERIL, V87, P627, DOI 10.1016/j.fertnstert.2006.07.1519; NAKAYAMA Y, 1990, J CLIN ENDOCR METAB, V70, P1233, DOI 10.1210/jcem-70-5-1233; Navarro VM, 2011, AM J PHYSIOL-ENDOC M, V300, pE202, DOI 10.1152/ajpendo.00517.2010; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; NEELY EK, 1995, J PEDIATR-US, V127, P40, DOI 10.1016/S0022-3476(95)70254-7; Palmert MR, 2003, MOL GENET METAB, V80, P1, DOI 10.1016/S1096-7192(03)00107-0; Palmert MR, 2001, J CLIN ENDOCR METAB, V86, P2364, DOI 10.1210/jc.86.6.2364; Parent AS, 2008, HORM RES, V69, P114, DOI 10.1159/000111815; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Plant TM, 2004, HUM REPROD UPDATE, V10, P67, DOI 10.1093/humupd/dmh001; San Lucas FA, 2012, BIOINFORMATICS, V28, P421, DOI 10.1093/bioinformatics/btr667; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Semple RK, 2010, CLIN ENDOCRINOL, V72, P427, DOI 10.1111/j.1365-2265.2009.03687.x; Silveira LG, 2010, J CLIN ENDOCR METAB, V95, P2276, DOI 10.1210/jc.2009-2421; SKLAD M, 1977, ACTA GENET MED GEMEL, V26, P221, DOI 10.1017/S0001566000009703; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Terasawa E, 2001, ENDOCR REV, V22, P111, DOI 10.1210/er.22.1.111; Zhao Y, 2010, NEUROSCI LETT, V486, P188, DOI 10.1016/j.neulet.2010.09.049; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	39	285	301	1	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					2467	2475		10.1056/NEJMoa1302160	http://dx.doi.org/10.1056/NEJMoa1302160			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KQ	23738509	Green Accepted			2022-12-01	WOS:000320926900007
J	Nesbit, MA; Hannan, FM; Howles, SA; Babinsky, VN; Head, RA; Cranston, T; Rust, N; Hobbs, MR; Heath, H; Thakker, RV				Nesbit, M. Andrew; Hannan, Fadil M.; Howles, Sarah A.; Babinsky, Valerie N.; Head, Rosie A.; Cranston, Treena; Rust, Nigel; Hobbs, Maurine R.; Heath, Hunter, III; Thakker, Rajesh V.			Mutations Affecting G-Protein Subunit alpha(11) in Hypercalcemia and Hypocalcemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CALCIUM-SENSING RECEPTOR; FAMILIAL BENIGN HYPERCALCEMIA; GENETIC-LINKAGE ANALYSIS; HYPOCALCIURIC HYPERCALCEMIA; CA2+-SENSING RECEPTOR; COUPLED RECEPTORS; UVEAL MELANOMA; HYPERPARATHYROIDISM; G(Q); ACTIVATION	BACKGROUND Familial hypocalciuric hypercalcemia is a genetically heterogeneous disorder with three variants: types 1, 2, and 3. Type 1 is due to loss-of-function mutations of the calcium-sensing receptor, a guanine nucleotide-binding protein (G-protein)-coupled receptor that signals through the G-protein subunit alpha(11) (G alpha(11)). Type 3 is associated with adaptor-related protein complex 2, sigma 1 subunit (AP2S1) mutations, which result in altered calcium-sensing receptor endocytosis. We hypothesized that type 2 is due to mutations effecting G alpha(11) loss of function, since G alpha(11) is involved in calcium-sensing receptor signaling, and its gene (GNA11) and the type 2 locus are colocalized on chromosome 19p13.3. We also postulated that mutations effecting G alpha(11) gain of function, like the mutations effecting calcium-sensing receptor gain of function that cause autosomal dominant hypocalcemia type 1, may lead to hypocalcemia. METHODS We performed GNA11 mutational analysis in a kindred with familial hypocalciuric hypercalcemia type 2 and in nine unrelated patients with familial hypocalciuric hypercalcemia who did not have mutations in the gene encoding the calcium-sensing receptor (CASR) or AP2S1. We also performed this analysis in eight unrelated patients with hypocalcemia who did not have CASR mutations. In addition, we studied the effects of GNA11 mutations on G alpha(11) protein structure and calcium-sensing receptor signaling in human embryonic kidney 293 (HEK293) cells. RESULTS The kindred with familial hypocalciuric hypercalcemia type 2 had an in-frame deletion of a conserved G alpha(11) isoleucine (Ile200del), and one of the nine unrelated patients with familial hypocalciuric hypercalcemia had a missense GNA11 mutation (Leu135Gln). Missense GNA11 mutations (Arg181Gln and Phe341Leu) were detected in two unrelated patients with hypocalcemia; they were therefore identified as having autosomal dominant hypocalcemia type 2. All four GNA11 mutations predicted disrupted protein structures, and assessment on the basis of in vitro expression showed that familial hypocalciuric hypercalcemia type 2-associated mutations decreased the sensitivity of cells expressing calcium-sensing receptors to changes in extracellular calcium concentrations, whereas autosomal dominant hypocalcemia type 2-associated mutations increased cell sensitivity. CONCLUSIONS G alpha(11) mutants with loss of function cause familial hypocalciuric hypercalcemia type 2, and G alpha(11) mutants with gain of function cause a clinical disorder designated as autosomal dominant hypocalcemia type 2.	[Nesbit, M. Andrew; Hannan, Fadil M.; Howles, Sarah A.; Babinsky, Valerie N.; Head, Rosie A.; Thakker, Rajesh V.] Univ Oxford, Nuffield Dept Clin Med, Acad Endocrine Unit, Oxford OX3 7LJ, England; [Rust, Nigel] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX3 7LJ, England; [Cranston, Treena] Churchill Hosp, Oxford Mol Genet Lab, Oxford OX3 7LJ, England; [Hobbs, Maurine R.] Univ Utah, Core Res Facil, Salt Lake City, UT USA; [Heath, Hunter, III] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	University of Oxford; University of Oxford; University of Oxford; Utah System of Higher Education; University of Utah; Indiana University System; Indiana University Bloomington	Thakker, RV (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Acad Endocrine Unit, S Parks Rd, Oxford OX3 7LJ, England.	rajesh.thakker@ndm.ox.ac.uk		Hannan, Fadil/0000-0002-2975-5170; Howles, Sarah/0000-0001-6342-0895; Thakker, Rajesh/0000-0002-1438-3220	United Kingdom Medical Research Council [G9825289, G1000467]; National Institute for Health Research Oxford Biomedical Research Centre Programme; European Commission Seventh Framework Programme [FP7-264663]; National Institutes of Health [DK-38855, DK-44292]; Medical Research Council [G9825289, G1000467] Funding Source: researchfish; MRC [G9825289, G1000467] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038855, R03DK044292] Funding Source: NIH RePORTER	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Oxford Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); European Commission Seventh Framework Programme(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the United Kingdom Medical Research Council and others.; Supported by grants from the United Kingdom Medical Research Council (G9825289 and G1000467, to Drs. Nesbit, Hannan, and Thakker), the National Institute for Health Research Oxford Biomedical Research Centre Programme (to Drs. Nesbit and Thakker), the European Commission Seventh Framework Programme (FP7-264663, to Ms. Babinsky), and the National Institutes of Health (DK-38855 and DK-44292, to Dr. Heath). Dr. Howles is a Wellcome Trust Clinical Research Training Fellow.	[Anonymous], 2007, MACPYMOL PYMOL BAS M; Bourne HR, 1997, NATURE, V389, P673, DOI 10.1038/39470; Bramucci E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S2; Christensen SE, 2008, EUR J ENDOCRINOL, V159, P719, DOI 10.1530/EJE-08-0440; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; Hannan FM, 2012, HUM MOL GENET, V21, P2768, DOI 10.1093/hmg/dds105; HEATH H, 1992, J CLIN ENDOCR METAB, V75, P846, DOI 10.1210/jc.75.3.846; HEATH H, 1993, AM J HUM GENET, V53, P193; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAW WM, 1985, ANN INTERN MED, V102, P511, DOI 10.7326/0003-4819-102-4-511; Marin EP, 2001, J BIOL CHEM, V276, P27400, DOI 10.1074/jbc.C100198200; Nesbit MA, 2013, NAT GENET, V45, P93, DOI 10.1038/ng.2492; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; Pearce SHS, 1995, J CLIN INVEST, V96, P2683, DOI 10.1172/JCI118335; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; Raue F, 2011, CLIN ENDOCRINOL, V75, P760, DOI 10.1111/j.1365-2265.2011.04142.x; Reed AAC, 2010, AM J PHYSIOL-RENAL, V298, pF365, DOI 10.1152/ajprenal.00038.2009; Schubbert S, 2007, MOL CELL BIOL, V27, P7765, DOI 10.1128/MCB.00965-07; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Thakker RV, 2004, CELL CALCIUM, V35, P275, DOI 10.1016/j.ceca.2003.10.010; Thomas Tarita O., 2001, Molecular Cell Biology Research Communications, V4, P282, DOI 10.1006/mcbr.2001.0293; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; VARRAULT A, 1995, ENDOCRINOLOGY, V136, P4390, DOI 10.1210/en.136.10.4390; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wettschureck N, 2007, MOL ENDOCRINOL, V21, P274, DOI 10.1210/me.2006-0110; Yamamoto M, 2000, J CLIN ENDOCR METAB, V85, P4583, DOI 10.1210/jc.85.12.4583	37	232	245	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					2476	2486		10.1056/NEJMoa1300253	http://dx.doi.org/10.1056/NEJMoa1300253			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KQ	23802516	Green Accepted			2022-12-01	WOS:000320926900008
J	Turner, L; Lavstsen, T; Berger, SS; Wang, CW; Petersen, JEV; Avril, M; Brazier, AJ; Freeth, J; Jespersen, JS; Nielsen, MA; Magistrado, P; Lusingu, J; Smith, JD; Higgins, MK; Theander, TG				Turner, Louise; Lavstsen, Thomas; Berger, Sanne S.; Wang, Christian W.; Petersen, Jens E. V.; Avril, Marion; Brazier, Andrew J.; Freeth, Jim; Jespersen, Jakob S.; Nielsen, Morten A.; Magistrado, Pamela; Lusingu, John; Smith, Joseph D.; Higgins, Matthew K.; Theander, Thor G.			Severe malaria is associated with parasite binding to endothelial protein C receptor	NATURE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; FALCIPARUM-INFECTED ERYTHROCYTES; VAR GENES; DROTRECOGIN-ALPHA; EXPRESSION; ACQUISITION; ANTIBODIES; ADHESION; SUBSET	Sequestration of Plasmodium falciparum-infected erythrocytes in host blood vessels is a key triggering event in the pathogenesis of severe childhood malaria, which is responsible for about one million deaths every year(1). Sequestration is mediated by specific interactions between members of the P. falciparum erythrocyte membrane protein 1 (PfEMP1) family and receptors on the endothelial lining(2). Severe childhood malaria is associated with expression of specific PfEMP1 subtypes containing domain cassettes (DCs) 8 and 13 (ref. 3), but the endothelial receptor for parasites expressing these proteins was unknown(4,5). Here we identify endothelial protein C receptor (EPCR), which mediates the cytoprotective effects of activated protein C-6, as the endothelial receptor for DC8 and DC13 PfEMP1. We show that EPCR binding is mediated through the amino-terminal cysteine-rich interdomain region (CIDRa1) of DC8 and group A PfEMP1 subfamilies, and that CIDRa1 interferes with protein C binding to EPCR. This PfEMP1 adhesive property links P. falciparum cytoadhesion to a host receptor involved in anticoagulation and endothelial cytoprotective pathways, and has implications for understanding malaria pathology and the development of new malaria interventions.	[Turner, Louise; Lavstsen, Thomas; Berger, Sanne S.; Wang, Christian W.; Petersen, Jens E. V.; Jespersen, Jakob S.; Nielsen, Morten A.; Theander, Thor G.] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Turner, Louise; Lavstsen, Thomas; Berger, Sanne S.; Wang, Christian W.; Petersen, Jens E. V.; Jespersen, Jakob S.; Nielsen, Morten A.; Theander, Thor G.] Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Avril, Marion; Brazier, Andrew J.; Smith, Joseph D.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Freeth, Jim] Retrogenix, Whaley Bridge SK23 7LY, High Peak, England; [Magistrado, Pamela; Lusingu, John] Natl Inst Med Res, Tanga Ctr, Tanga, Tanzania; [Smith, Joseph D.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Higgins, Matthew K.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Copenhagen; Rigshospitalet; University of Copenhagen; Center for Infectious Disease Research; National Institute of Medical Research; University of Washington; University of Washington Seattle; University of Oxford	Lavstsen, T (corresponding author), Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	lturner@sund.ku.dk; thomasl@sund.ku.dk	Lusingu, John P. A./GSJ-3228-2022; Theander, Thor/F-6714-2015	Theander, Thor/0000-0002-3509-7514; Nielsen, Morten Agertoug/0000-0003-2668-4992; Lavstsen, Thomas/0000-0002-3044-4249; Lusingu, John P. A./0000-0002-9407-0602; Schmidt Jespersen, Jakob/0000-0002-4930-5900; Berger, Sanne Schou/0000-0002-1440-4909; Wang, Christian/0000-0003-3140-6989; Turner, Louise/0000-0003-4494-2289; Higgins, Matthew/0000-0002-2870-1955; Petersen, Jens Emil Vang/0000-0001-5567-465X	University of Copenhagen Program of Excellence; Lundbeck Foundation; Danish International Development Agency; Augustinus Fonden; Malaria Capacity Development Consortium; Danish Medical Research Council; National Institutes of Health [R01 AI47953, U19 AI089688]; Medical Research Council; MRC [G0901062] Funding Source: UKRI; Lundbeck Foundation [R108-2012-10328] Funding Source: researchfish; Medical Research Council [G0901062] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089688, R01AI047953] Funding Source: NIH RePORTER	University of Copenhagen Program of Excellence; Lundbeck Foundation(Lundbeckfonden); Danish International Development Agency; Augustinus Fonden; Malaria Capacity Development Consortium; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Salanti for supplying the full-length VAR2CSA protein and S. Lucking Nielsen for technical assistance. The work was supported by the University of Copenhagen Program of Excellence, Lundbeck Foundation, Danish International Development Agency, Augustinus Fonden, Malaria Capacity Development Consortium and The Danish Medical Research Council, as well as the National Institutes of Health (R01 AI47953 and U19 AI089688 to J.D.S.). M. K. H. was funded by a research grant from the Medical Research Council.	Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Dennis J, 2012, BLOOD, V119, P2392, DOI 10.1182/blood-2011-10-383448; Fukudome K, 1996, J BIOL CHEM, V271, P17491, DOI 10.1074/jbc.271.29.17491; FUKUDOME K, 1994, J BIOL CHEM, V269, P26486; Ghumra A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002665; Gleeson EM, 2012, CELL MOL LIFE SCI, V69, P717, DOI 10.1007/s00018-011-0825-0; Kendrick BJL, 2006, ANAESTHESIA, V61, P899, DOI 10.1111/j.1365-2044.2006.04752.x; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; Pintao MC, 2011, J THROMB HAEMOST, V9, P969, DOI 10.1111/j.1538-7836.2011.04256.x; Rankin LG, 2007, ANAESTH INTENS CARE, V35, P428, DOI 10.1177/0310057X0703500320; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Robak O, 2010, ANAESTH INTENS CARE, V38, P751, DOI 10.1177/0310057X1003800421; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Schuepbach RA, 2009, THROMB HAEMOSTASIS, V101, P724, DOI 10.1160/TH08-10-0632; Simmonds RE, 1999, BLOOD, V94, P632, DOI 10.1182/blood.V94.2.632.414k24_632_641; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Stins MF, 1997, J NEUROIMMUNOL, V76, P81, DOI 10.1016/S0165-5728(97)00036-2; Sturn DH, 2003, BLOOD, V102, P1499, DOI 10.1182/blood-2002-12-3880; Turner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029025; Wang CW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-129; Xu J, 2000, J BIOL CHEM, V275, P6038, DOI 10.1074/jbc.275.8.6038	30	359	363	3	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					502	+		10.1038/nature12216	http://dx.doi.org/10.1038/nature12216			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23739325	Green Accepted			2022-12-01	WOS:000320929400056
J	Macilwain, C				Macilwain, Colin			Sharing information is preferable to patenting	NATURE			English	Editorial Material												cfmworldview@gmail.com						2004, NATURE, V431, P494	1	3	3	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					273	273		10.1038/498273a	http://dx.doi.org/10.1038/498273a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166XI	23783592	Bronze			2022-12-01	WOS:000320592900004
J	Tharakaraman, K; Raman, R; Viswanathan, K; Stebbins, NW; Jayaraman, A; Krishnan, A; Sasisekharan, V; Sasisekharan, R				Tharakaraman, Kannan; Raman, Rahul; Viswanathan, Karthik; Stebbins, Nathan W.; Jayaraman, Akila; Krishnan, Arvind; Sasisekharan, V.; Sasisekharan, Ram			Structural Determinants for Naturally Evolving H5N1 Hemagglutinin to Switch Its Receptor Specificity	CELL			English	Article							INFLUENZA-A VIRUSES; AVIAN INFLUENZA; BINDING PROPERTIES; MAMMALIAN HOST; HUMAN AIRWAY; TRANSMISSION; FERRETS; PATHOGENESIS; ADAPTATION; MUTATIONS	Of the factors governing human-to-human transmission of t he highly pathogenic avian-adapted H5N1 virus, the most critical is the acquisition of mutations on the viral hemagglutinin (HA) to "quantitatively switch" its binding from avian to human glycan receptors. Here, we describe a structural framework that outlines a necessary set of H5 HA receptor-binding site (RBS) features required for the H5 HA to quantitatively switch its preference to human receptors. We show here that the same RBS HA mutations that lead to aerosol transmission of A/Vietnam/1203/04 and A/Indonesia/5/05 viruses, when introduced in currently circulating H5N1, do not lead to a quantitative switch in receptor preference. We demonstrate that HAs from circulating clades require as few as a single base pair mutation to quantitatively switch their binding to human receptors. The mutations identified by this study can be used to monitor the emergence of strains having human-to-human transmission potential.	[Tharakaraman, Kannan; Raman, Rahul; Viswanathan, Karthik; Stebbins, Nathan W.; Jayaraman, Akila; Krishnan, Arvind; Sasisekharan, V.; Sasisekharan, Ram] MIT, Singapore MIT Alliance Res & Technol, Dept Biol Engn,Koch Inst Integrat Canc Res, Infect Dis Interdisciplinary Res Grp, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART)	Sasisekharan, R (corresponding author), MIT, Singapore MIT Alliance Res & Technol, Dept Biol Engn,Koch Inst Integrat Canc Res, Infect Dis Interdisciplinary Res Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@mit.edu		Krishnan, Arvind/0000-0002-7489-9229	National Institutes of Health [R37 GM057073-13]; National-Research-Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073, R01GM057073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National-Research-Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by the National Institutes of Health (R37 GM057073-13) and the National-Research-Foundation-supported Interdisciplinary Research group in Infectious Diseases of SMART (Singapore-MIT Alliance for Research and Technology).	Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Ge SQ, 2011, CRIT REV MICROBIOL, V37, P157, DOI 10.3109/1040841X.2010.536523; Guan Y, 2009, REV SCI TECH OIE, V28, P39, DOI 10.20506/rst.28.1.1868; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mansfield KG, 2007, AM J PATHOL, V171, P1089, DOI 10.2353/ajpath.2007.070695; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Neumann G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002932; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Pearce MB, 2012, P NATL ACAD SCI USA, V109, P3944, DOI 10.1073/pnas.1119945109; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Soundararajan V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00200; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Viswanathan K., 2010, PLOS ONE, V5; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Watanabe Y, 2012, TRENDS MICROBIOL, V20, P11, DOI 10.1016/j.tim.2011.10.003; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	32	68	71	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 20	2013	153	7					1475	1485		10.1016/j.cell.2013.05.035	http://dx.doi.org/10.1016/j.cell.2013.05.035			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23746829	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000320722000016
J	Malani, AN; Vandenberg, DM; Singal, B; Kasotakis, M; Koch, S; Moudgal, V; Jagarlamudi, R; Neelakanta, A; Otto, MH; Halasyamani, L; Kaakaji, R; Kauffman, CA				Malani, Anurag N.; Vandenberg, David M.; Singal, Bonita; Kasotakis, Michael; Koch, Spencer; Moudgal, Varsha; Jagarlamudi, Rajasekhar; Neelakanta, Anupama; Otto, Michael H.; Halasyamani, Lakshmi; Kaakaji, Rami; Kauffman, Carol A.			Magnetic Resonance Imaging Screening to Identify Spinal and Paraspinal Infections Associated With Injections of Contaminated Methylprednisolone Acetate	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; FUNGAL; OUTBREAK	Importance Injection of contaminated methylprednisolone has resulted in an unprecedented nationwide outbreak of Exserohilum rostratum fungal infections, manifested initially as meningitis and/or basilar stroke. Insidious onset of spinal or paraspinal infection at the injection site has been increasingly reported and is occurring months after receipt of injection with the contaminated drug. The clinical findings are often subtle and similar to those that led the patient to undergo the methylprednisolone injection. Objective To determine if patients who had not presented for medical care but who had received contaminated methylprednisolone developed spinal or paraspinal infection at the injection site using contrast-enhanced magnetic resonance imaging (MRI) screening. Design, Setting, and Participants There were 172 patients who had received an injection of contaminated methylprednisolone from a highly contaminated lot (No. 06292012@26) at a pain facility but had not presented for medical care related to adverse effects after the injection. Screening MRI was performed between November 9, 2012, and April 30, 2013. Main Outcomes and Measures Number of persons identified with previously undiagnosed spinal or paraspinal infection. Results Of the 172 patients screened, MRI was abnormal in 36 (21%), showing epidural or paraspinal abscess or phlegmon, arachnoiditis, spinal osteomyelitis or diskitis, or moderate to severe epidural, paraspinal, or intradural enhancement. Of the 115 patients asked about new or worsening back or neck pain, lower extremity weakness, or radiculopathy symptoms, 35 (30%) had at least 1 symptom. Thirty-five of the 36 patients with abnormal MRIs met the Centers for Disease Control and Prevention (CDC) case definition for probable (17 patients) or confirmed (18 patients) fungal spinal or paraspinal infection. All 35 patients were treated with antifungal agents (voriconazole, with or without liposomal amphotericin B), and 24 required surgical debridement. At the time of surgery, 17 of 24 patients (71%), including 5 patients who denied having symptoms, had laboratory evidence of fungal infection. Conclusions and Relevance Among patients who underwent screening MRI to look for infection at the site of injection of contaminated methylprednisolone, 21% had an abnormal MRI, and all but one met CDC criteria for probable or confirmed fungal spinal or paraspinal infection. Screening MRI led to identification of patients who had minimal or no symptoms of spinal or paraspinal infection and allowed early initiation of medical and surgical treatment.	[Malani, Anurag N.; Moudgal, Varsha; Jagarlamudi, Rajasekhar; Neelakanta, Anupama; Otto, Michael H.] St Joseph Mercy Hosp, Infect Dis Sect, Ann Arbor, MI 48104 USA; [Malani, Anurag N.; Vandenberg, David M.; Moudgal, Varsha; Jagarlamudi, Rajasekhar; Neelakanta, Anupama; Otto, Michael H.; Halasyamani, Lakshmi] St Joseph Mercy Hosp, Dept Internal Med, Ann Arbor, MI 48104 USA; [Singal, Bonita] St Joseph Mercy Hosp, Dept Clin Res, Ann Arbor, MI 48104 USA; [Kasotakis, Michael; Koch, Spencer; Kaakaji, Rami] St Joseph Mercy Hosp, Dept Radiol, Ann Arbor, MI 48104 USA; [Kauffman, Carol A.] Univ Michigan, Sch Med, Div Infect Dis, Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA	Saint Joseph Mercy Health System (SJMHS); Saint Joseph Mercy Health System (SJMHS); Saint Joseph Mercy Health System (SJMHS); Saint Joseph Mercy Health System (SJMHS); University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Malani, AN (corresponding author), St Joseph Mercy Hosp, 5333 McAuley Dr,Ste 3106, Ypsilanti, MI 48197 USA.	malania@trinity-health.org						Centers for Disease Control and Prevention, EM PREP RESP; Centers for Disease Control and Prevention, MULT FUNG MEN OUTBR; Kainer Marion, 2012, Morbidity and Mortality Weekly Report, V61, P839; Kainer MA, 2012, NEW ENGL J MED, V367, P2194, DOI 10.1056/NEJMoa1212972; Kerkering TM, 2013, ANN INTERN MED, V158, P154, DOI 10.7326/0003-4819-158-3-201302050-00568; Pettit AC, 2012, NEW ENGL J MED, V367, P2119, DOI 10.1056/NEJMoa1212292; Smith RM, NEW ENGL J MED, DOI [10.1056/NEJMoa1213978, DOI 10.1056/NEJMOA1213978]	7	23	24	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2465	2472		10.1001/jama.2013.6293	http://dx.doi.org/10.1001/jama.2013.6293			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23780459	Bronze			2022-12-01	WOS:000320505100027
J	Bagcchi, S				Bagcchi, Sanjeet			Improving cancer care in rural India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												drsanjitbagchi@gmail.com						[Anonymous], 2010, NATIONAL CANCER GRID; Bhaumik S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2858; Indian Space Research Organisation, TELEMEDICINE; Kambli R., 2013, EXPRESS HEALTHCARE; Marpakwar P., 2013, TIMES OF INDIA	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2013	346								f3826	10.1136/bmj.f3826	http://dx.doi.org/10.1136/bmj.f3826			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166XQ	23771224				2022-12-01	WOS:000320593900012
J	Britton, J; McNeill, A				Britton, John; McNeill, Ann			Nicotine regulation and tobacco harm reduction in the UK	LANCET			English	Editorial Material							CIGARETTES; SMOKING		[Britton, John] Univ Nottingham, UK Ctr Tobacco Control Studies, Nottingham NG5 1PB, England; [McNeill, Ann] Kings Coll London, Inst Psychiat, UK Ctr Tobacco Control Studies, London WC2R 2LS, England	University of Nottingham; University of London; King's College London	Britton, J (corresponding author), Univ Nottingham, UK Ctr Tobacco Control Studies, Nottingham NG5 1PB, England.	j.britton@virgin.net		McNeill, Ann/0000-0002-6223-4000				Department of Health, 2011, HLTH LIV HLTH PEOPL; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Gartner CE, 2007, LANCET, V369, P2010, DOI 10.1016/S0140-6736(07)60677-1; Medicines and Healthcare Products Regulatory Agency (MHRA), 2005, REP COMM SAF MED WOR; Moore D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1024; *ROYAL COLL PHYS T, 2007, HARM RED NIC ADD; RUSSELL MAH, 1976, BRIT MED J, V1, P1430, DOI 10.1136/bmj.1.6023.1430; Scientific Committee on Emerging and Newly Identified Health Risks, 2008, HLTH EFF SMOK TOB PR; Vansickel AR, 2013, NICOTINE TOB RES, V15, P267, DOI 10.1093/ntr/ntr316; West R, 2013, MONTHL TRACK KEY PER	10	5	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					1879	1880		10.1016/S0140-6736(13)61122-8	http://dx.doi.org/10.1016/S0140-6736(13)61122-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	163EV	23725716				2022-12-01	WOS:000320319500005
J	Bar-Peled, L; Chantranupong, L; Cherniack, AD; Chen, WW; Ottina, KA; Grabiner, BC; Spear, ED; Carter, SL; Meyerson, M; Sabatini, DM				Bar-Peled, Liron; Chantranupong, Lynne; Cherniack, Andrew D.; Chen, Walter W.; Ottina, Kathleen A.; Grabiner, Brian C.; Spear, Eric D.; Carter, Scott L.; Meyerson, Matthew; Sabatini, David M.			A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1	SCIENCE			English	Article							HOMOZYGOUS DELETION REGION; HUMAN-CHROMOSOME 3P21.3; PTEN-DEFICIENT; SENSITIVITY; INHIBITION; ACTIVATION; RAGULATOR; AUTOPHAGY; TARGET; CANCER	The mTOR complex 1 (mTORC1) pathway promotes cell growth in response to many cues, including amino acids, which act through the Rag guanosine triphosphatases (GTPases) to promote mTORC1 translocation to the lysosomal surface, its site of activation. Although progress has been made in identifying positive regulators of the Rags, it is unknown if negative factors also exist. Here, we identify GATOR as a complex that interacts with the Rags and is composed of two subcomplexes we call GATOR1 and -2. Inhibition of GATOR1 subunits (DEPDC5, Nprl2, and Nprl3) makes mTORC1 signaling resistant to amino acid deprivation. In contrast, inhibition of GATOR2 subunits (Mios, WDR24, WDR59, Seh1L, and Sec13) suppresses mTORC1 signaling, and epistasis analysis shows that GATOR2 negatively regulates DEPDC5. GATOR1 has GTPase-activating protein (GAP) activity for RagA and RagB, and its components are mutated in human cancer. In cancer cells with inactivating mutations in GATOR1, mTORC1 is hyperactive and insensitive to amino acid starvation, and such cells are hypersensitive to rapamycin, an mTORC1 inhibitor. Thus, we identify a key negative regulator of the Rag GTPases and reveal that, like other mTORC1 regulators, Rag function can be deregulated in cancer.	[Bar-Peled, Liron; Chantranupong, Lynne; Chen, Walter W.; Ottina, Kathleen A.; Grabiner, Brian C.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Bar-Peled, Liron; Chantranupong, Lynne; Chen, Walter W.; Ottina, Kathleen A.; Grabiner, Brian C.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Bar-Peled, Liron; Chantranupong, Lynne; Chen, Walter W.; Ottina, Kathleen A.; Grabiner, Brian C.; Sabatini, David M.] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Cherniack, Andrew D.; Carter, Scott L.; Meyerson, Matthew; Sabatini, David M.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Spear, Eric D.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Johns Hopkins University	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Cherniack, Andrew D./AAY-8132-2020	Cherniack, Andrew D./0000-0003-0470-0111; /0000-0002-1446-7256; Chen, Walter/0000-0002-7752-9581; Meyerson, Matthew/0000-0002-9133-8108	NIH [CA103866, AI47389]; Department of Defense [W81XWH-07-0448]; National Cancer Institute (NIH) [U24CA143867]; David H. Koch Graduate Fellowship Fund; NSF; Harvard-MIT Health, Sciences, and Technology IDEA2 program; American Cancer Society; NATIONAL CANCER INSTITUTE [F31CA180271, R01CA129105, R01CA103866, P30CA014051, U24CA143867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Cancer Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); David H. Koch Graduate Fellowship Fund; NSF(National Science Foundation (NSF)); Harvard-MIT Health, Sciences, and Technology IDEA2 program; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all members of the Sabatini lab fur helpful suggestions, E. Spooner fur the mass spectrometric analysis of samples, and N. Kory for technical assistance. This work was supported by grants from the NIH (CA103866 and AI47389) and Department of Defense (W81XWH-07-0448) to D.M.S. and the National Cancer Institute (NIH) (U24CA143867) to M.M. and awards from the David H. Koch Graduate Fellowship Fund to L.B.-P.; the NSF Graduate Research Fellowship Program to L.C.; the Harvard-MIT Health, Sciences, and Technology IDEA<SUP>2</SUP> program to W.W.C.; and the American Cancer Society to B.C.G. D.M.S. is an investigator of the Howard Hughes Medical Institute.	Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Dokudovskaya S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006478; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Iida T, 2004, DEVELOPMENT, V131, P1029, DOI 10.1242/dev.01001; Ji L, 2002, CANCER RES, V62, P2715; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leksa NC, 2010, NUCLEUS-PHILA, V1, P314, DOI 10.4161/nucl.1.4.11798; Lerman MI, 2000, CANCER RES, V60, P6116; Li F, 2004, CANCER RES, V64, P6438, DOI 10.1158/0008-5472.CAN-03-3869; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MATTSON G, 1993, MOL BIOL REP, V17, P167, DOI 10.1007/BF00986726; Meric-Bernstam F, 2012, CLIN CANCER RES, V18, P1777, DOI 10.1158/1078-0432.CCR-11-2123; Neklesa TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000515; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Seng TJ, 2005, GENE CHROMOSOME CANC, V43, P181, DOI 10.1002/gcc.20181; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Wu X, 2011, MOL BIOL CELL, V22, P4124, DOI 10.1091/mbc.E11-06-0525; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	26	653	706	3	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1100	1106		10.1126/science.1232044	http://dx.doi.org/10.1126/science.1232044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723238	Green Submitted, Green Accepted			2022-12-01	WOS:000319664500046
J	Galetti, M; Guevara, R; Cortes, MC; Fadini, R; Von Matter, S; Leite, AB; Labecca, F; Ribeiro, T; Carvalho, CS; Collevatti, RG; Pires, MM; Guimaraes, PR; Brancalion, PH; Ribeiro, MC; Jordano, P				Galetti, Mauro; Guevara, Roger; Cortes, Marina C.; Fadini, Rodrigo; Von Matter, Sandro; Leite, Abraao B.; Labecca, Fabio; Ribeiro, Thiago; Carvalho, Carolina S.; Collevatti, Rosane G.; Pires, Mathias M.; Guimaraes, Paulo R., Jr.; Brancalion, Pedro H.; Ribeiro, Milton C.; Jordano, Pedro			Functional Extinction of Birds Drives Rapid Evolutionary Changes in Seed Size	SCIENCE			English	Article							PALM EUTERPE-EDULIS; AVIAN FRUGIVORES; GERMINATION; PREDATORS; DISPERSAL; SURVIVAL; DENSITY; TREE	Local extinctions have cascading effects on ecosystem functions, yet little is known about the potential for the rapid evolutionary change of species in human-modified scenarios. We show that the functional extinction of large-gape seed dispersers in the Brazilian Atlantic forest is associated with the consistent reduction of the seed size of a keystone palm species. Among 22 palm populations, areas deprived of large avian frugivores for several decades present smaller seeds than nondefaunated forests, with negative consequences for palm regeneration. Coalescence and phenotypic selection models indicate that seed size reduction most Likely occurred within the past 100 years, associated with human-driven fragmentation. The fast-paced defaunation of large vertebrates is most Likely causing unprecedented changes in the evolutionary trajectories and community composition of tropical forests.	[Galetti, Mauro; Cortes, Marina C.; Leite, Abraao B.; Labecca, Fabio; Ribeiro, Thiago; Ribeiro, Milton C.] Univ Estadual Paulista, Dept Ecol, BR-13506900 Sao Paulo, Brazil; [Guevara, Roger] AC Red Biol Evolut, Inst Ecol, Xalapa 91070, Veracruz, Mexico; [Fadini, Rodrigo] Univ Fed Oeste Para, Inst Biodiversidade & Florestas, BR-68035110 Santarem, Para, Brazil; [Von Matter, Sandro] Univ Fed Rural Estado Rio de Janeiro, Dept Biol Anim, BR-23897000 Rio De Janeiro, Brazil; [Carvalho, Carolina S.; Collevatti, Rosane G.] Univ Fed Goias, Lab Genet & Biodiversidade, BR-74001970 Goiania, Go, Brazil; [Pires, Mathias M.; Guimaraes, Paulo R., Jr.] Univ Sao Paulo, Dept Ecol, BR-0550890 Sao Paulo, Brazil; [Brancalion, Pedro H.] Univ Sao Paulo, Esco Super Agr Luiz de Queiroz, Dept Ciencias Florestais, BR-13418900 Sao Paulo, Brazil; [Jordano, Pedro] CSIC, EBD, Integrat Ecol Grp, E-41092 Seville, Spain	Universidade Estadual Paulista; Instituto de Ecologia - Mexico; Universidade Federal do Oeste do Para; Universidade Federal de Goias; Universidade de Sao Paulo; Universidade de Sao Paulo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Galetti, M (corresponding author), Univ Estadual Paulista, Dept Ecol, BR-13506900 Sao Paulo, Brazil.	mgaletti@rc.unesp.br	Galetti, Mauro/M-8751-2013; Pires, Mathias/I-4489-2012; Guimaraes, Paulo R./E-1915-2016; Guimarães-Junior, Paulo R/M-1298-2016; Carvalho, Carolina/E-9746-2013; Brancalion, Pedro/D-6995-2012; Von Matter, Sandro/M-7151-2013; Fadini, Rodrigo/C-7574-2013; Collevatti, Rosane/D-8673-2013; Galetti, Mauro/C-5275-2008; Jordano, Pedro/A-5162-2008; Côrtes, Marina Corrêa/I-2155-2012; Guevara, Roger/F-3287-2010; Leite, Abraão/AAE-2362-2020	Galetti, Mauro/0000-0002-8187-8696; Pires, Mathias/0000-0003-2500-4748; Guimaraes, Paulo R./0000-0001-9161-8305; Carvalho, Carolina/0000-0002-0063-2185; Brancalion, Pedro/0000-0001-8245-4062; Von Matter, Sandro/0000-0002-0412-3820; Fadini, Rodrigo/0000-0002-6873-1438; Collevatti, Rosane/0000-0002-3733-7059; Galetti, Mauro/0000-0002-8187-8696; Jordano, Pedro/0000-0003-2142-9116; Côrtes, Marina Corrêa/0000-0003-3389-5050; Guevara, Roger/0000-0003-0768-3580; 	Fundacao de Amparo do Estado de Sao Paulo (BIOTA - FAPESP); Conselho Nacional de Desenvolvimento Cientifico (CNPq), (Excellence Grant-Junta Andalucia); Programa Iberoamericano de Ciencia y Tecnologia para el Desarollo (CYTED)	Fundacao de Amparo do Estado de Sao Paulo (BIOTA - FAPESP); Conselho Nacional de Desenvolvimento Cientifico (CNPq), (Excellence Grant-Junta Andalucia); Programa Iberoamericano de Ciencia y Tecnologia para el Desarollo (CYTED)	We thank the Fundacao de Amparo do Estado de Sao Paulo (BIOTA - FAPESP); Conselho Nacional de Desenvolvimento Cientifico (CNPq), (Excellence Grant-Junta Andalucia (to P.J.); and Programa lberoamericano de Ciencia y Tecnologia para el Desarollo (CYTED) for funding support. We thank J. Bascompte, R. Dirzo, D. Hansen, D. Levey, E. Bruna, D. Lapola, D. McCauley, M. A. Pizo, and three reviewers for useful comments and suggestions; T. A. Ferreira, E. Cazetta,	Anderson SH, 2011, SCIENCE, V331, P1068, DOI 10.1126/science.1199092; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Dean W., 1976, RIO CLARO BRAZILIAN; Falconer DS, 1996, INTRO QUANTITATIVE G; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Holbrook KM, 2009, ECOLOGY, V90, P1449, DOI 10.1890/08-1332.1; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Leishman M. R., 2000, Seeds: the ecology of regeneration in plant communities, P31, DOI 10.1079/9780851994321.0031; Leite AD, 2012, J TROP ECOL, V28, P615, DOI 10.1017/S0266467412000594; LEVEY DJ, 1987, AM NAT, V129, P471, DOI 10.1086/284652; Marengo JA, 2010, CLIMATIC CHANGE, V98, P509, DOI 10.1007/s10584-009-9743-7; Markl JS, 2012, CONSERV BIOL, V26, P1072, DOI 10.1111/j.1523-1739.2012.01927.x; Matos DMS, 1999, ECOLOGY, V80, P2635, DOI 10.2307/177246; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Pizo MA, 2001, ACTA OECOL, V22, P229, DOI 10.1016/S1146-609X(01)01108-0; Pizo MA, 2006, ACTA OECOL, V29, P311, DOI 10.1016/j.actao.2005.11.011; Roels SAB, 2011, EVOLUTION, V65, P2541, DOI 10.1111/j.1558-5646.2011.01326.x; Sodhi NS, 2004, ANNU REV ECOL EVOL S, V35, P323, DOI 10.1146/annurev.ecolsys.35.112202.130209	22	447	468	8	410	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1086	1090		10.1126/science.1233774	http://dx.doi.org/10.1126/science.1233774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723235				2022-12-01	WOS:000319664500042
J	Freynhagen, R; Geisslinger, G; Schug, SA				Freynhagen, Rainer; Geisslinger, Gerd; Schug, Stephan A.			Opioids for chronic non-cancer pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICIANS ASIPP GUIDELINES; NEUROPATHIC PAIN; CONTROLLED-RELEASE; CONTROLLED-TRIALS; AMERICAN SOCIETY; ACTING OPIOIDS; UNITED-STATES; MANAGEMENT; RISK; DEPENDENCE		[Freynhagen, Rainer] Benedictus Hosp Tutzing, Dept Anaesthesiol Crit Care Med Pain Therapy & Pa, D-82327 Tutzing, Germany; [Freynhagen, Rainer] Tech Univ Munich, Dept Anaesthesiol, D-80290 Munich, Germany; [Geisslinger, Gerd] Goethe Univ Frankfurt, Univ Hosp, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, D-60590 Frankfurt, Germany; [Schug, Stephan A.] Univ Western Australia, Royal Perth Hosp, Sch Med & Pharmacol, Pharmacol Pharm & Anaesthesiol Unit, Perth, WA 6847, Australia	Technical University of Munich; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Royal Perth Hospital; University of Western Australia	Freynhagen, R (corresponding author), Benedictus Hosp Tutzing, Dept Anaesthesiol Crit Care Med Pain Therapy & Pa, Bahnhofstr 5, D-82327 Tutzing, Germany.	r.freynhagen@krankenhaus-tutzing.de	Schug, Stephan/G-1432-2010	Schug, Stephan/0000-0002-0302-2315; Freynhagen, Rainer/0000-0002-3759-1508				Anastassopoulos KP, 2012, J MANAGE CARE PHARM, V18, P615, DOI 10.18553/jmcp.2012.18.8.615; Annemans L, 2011, CLIN DRUG INVEST, V31, P73, DOI 10.2165/11536290-000000000-00000; Avouac J, 2007, OSTEOARTHR CARTILAGE, V15, P957, DOI 10.1016/j.joca.2007.02.006; Beaulieu AD, 2008, PAIN RES MANAG, V13, P103, DOI 10.1155/2008/903784; Birnbaum HG, 2011, PAIN MED, V12, P657, DOI 10.1111/j.1526-4637.2011.01075.x; Bjordal JM, 2004, BMJ-BRIT MED J, V329, P1317, DOI 10.1136/bmj.38273.626655.63; Boscarino JA, 2011, J ADDICT DIS, V30, P185, DOI 10.1080/10550887.2011.581961; Brennan F, 2007, ANESTH ANALG, V105, P205, DOI 10.1213/01.ane.0000268145.52345.55; British Pain Society, 2010, OPIOIDS FOR PERSISTE; Camilleri M, 2011, AM J GASTROENTEROL, V106, P835, DOI 10.1038/ajg.2011.30; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Dhalla IA, 2009, CAN MED ASSOC J, V181, P891, DOI 10.1503/cmaj.090784; Edlund MJ, 2007, PAIN, V129, P355, DOI 10.1016/j.pain.2007.02.014; Eisenberg E, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006146; Elliott Jennifer A, 2011, J Opioid Manag, V7, P145; Eriksen J, 2006, PAIN, V125, P172, DOI 10.1016/j.pain.2006.06.009; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Fishbain DA, 2008, PAIN MED, V9, P444, DOI 10.1111/j.1526-4637.2007.00370.x; Freynhagen R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3002; Hollingshead J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651828.CD003726.pub3; Katz Nathaniel P, 2010, J Pain Palliat Care Pharmacother, V24, P141, DOI 10.3109/15360281003799098; Leider HL, 2011, AM J MANAG CARE, V17, P32; Li L, 2013, PAIN PHYSICIAN, V16, P77; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pS1; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pS67; Manchikanti L, 2011, PAIN PHYSICIAN, V14, P91; Mercadante S, 2013, EXPERT OPIN INV DRUG, V22, P161, DOI 10.1517/13543784.2013.752460; Mercadante S, 2012, DRUGS, V72, P2327, DOI 10.2165/11642230-000000000-00000; Modesto-Lowe V, 2010, J GEN INTERN MED, V25, P305, DOI 10.1007/s11606-009-1225-0; National Institute for Health and Clinical Excellence, 2010, NEUROPATHIC PAIN THE, V96; National Opioid Use Guideline Group Canadian guideline for safe and effective use of opioids for chronic non cancer pain National Opioid Use Guideline Group (NOUGG), 2010, CANADIAN GUIDELINE F; Noble M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006605.pub2; Nuesch E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003115.pub3; O'Donnell JB, 2009, J INT MED RES, V37, P1789, DOI 10.1177/147323000903700615; Obradovic M, 2012, CLIN THER, V34, P926, DOI 10.1016/j.clinthera.2012.02.011; Office of National Drug Control Policy, PRESCRIPTION DRUG AB; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Scharnagel R, 2013, SCHMERZ, V27, P7, DOI 10.1007/s00482-012-1278-6; Skurtveit S, 2011, PAIN, V152, P1555, DOI 10.1016/j.pain.2011.02.045; Soyka M, 2011, WORLD J BIOL PSYCHIA, V12, P160, DOI 10.3109/15622975.2011.561872; Tompkins DA, 2011, CURR PAIN HEADACHE R, V15, P129, DOI 10.1007/s11916-010-0171-1; Vestergaard P, 2006, J INTERN MED, V260, P76, DOI 10.1111/j.1365-2796.2006.01667.x; Webster LR, 2005, PAIN MED, V6, P432, DOI 10.1111/j.1526-4637.2005.00072.x; Webster Lynn, 2011, J Opioid Manag, V7, P235; Webster LR, 2008, PAIN MED, V9, P425, DOI 10.1111/j.1526-4637.2007.00343.x	45	21	21	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2013	346								f2937	10.1136/bmj.f2937	http://dx.doi.org/10.1136/bmj.f2937			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DG	23719636				2022-12-01	WOS:000319948200005
J	Haimovich, G; Medina, DA; Causse, SZ; Garber, M; Millan-Zambrano, G; Barkai, O; Chavez, S; Perez-Ortin, JE; Darzacq, X; Choder, M				Haimovich, Gal; Medina, Daniel A.; Causse, Sebastien Z.; Garber, Manuel; Millan-Zambrano, Gonzalo; Barkai, Oren; Chavez, Sebastian; Perez-Ortin, Jose E.; Darzacq, Xavier; Choder, Mordechai			Gene Expression Is Circular: Factors for mRNA Degradation Also Foster mRNA Synthesis	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; POLYMERASE-II; GENOME-WIDE; IN-VIVO; TRANSCRIPTION ELONGATION; YEAST; DECAY; COMPLEX; TRANSLATION; CYTOPLASM	Maintaining proper mRNA levels is a key aspect in the regulation of gene expression. The balance between mRNA synthesis and decay determines these levels. We demonstrate that most yeast mRNAs are degraded by the cytoplasmic 50-to-30 pathway (the "decaysome''), as proposed previously. Unexpectedly, the level of these mRNAs is highly robust to perturbations in this major pathway because defects in various decaysome components lead to transcription downregulation. Moreover, these components shuttle between the cytoplasm and the nucleus, in a manner dependent on proper mRNA degradation. In the nucleus, they associate with chromatin-preferentially similar to 30 bp upstream of transcription start-sites-and directly stimulate transcription initiation and elongation. The nuclear role of the decaysome in transcription is linked to its cytoplasmic role in mRNA decay; linkage, in turn, seems to depend on proper shuttling of its components. The gene expression process is therefore circular, whereby the hitherto first and last stages are interconnected.	[Haimovich, Gal; Barkai, Oren; Choder, Mordechai] Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Microbiol, IL-31096 Haifa, Israel; [Medina, Daniel A.; Perez-Ortin, Jose E.] Univ Valencia, Dept Bioquim & Biol Mol, Fac Biol, E-46100 Valencia, Spain; [Medina, Daniel A.; Perez-Ortin, Jose E.] Univ Valencia, ERI Biotecmed, E-46100 Valencia, Spain; [Causse, Sebastien Z.; Darzacq, Xavier] Ecole Normale Super, CNRS, UMR 8197, IBENS,Inst Biol, F-75005 Paris, France; [Garber, Manuel] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Millan-Zambrano, Gonzalo; Chavez, Sebastian] Univ Seville, Fac Biol, Dept Genet, E-41012 Seville, Spain	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Valencia; University of Valencia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; University of Massachusetts System; University of Massachusetts Worcester; University of Sevilla	Choder, M (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Microbiol, IL-31096 Haifa, Israel.	choder@technion.ac.il	Millan-Zambrano, Gonzalo/AAA-5562-2020; Chavez, Sebastian S/F-7574-2011; IBIS, GENICA/O-1906-2015; Medina, Daniel A./AAC-8572-2019; Haimovich, Gal/H-3316-2019; Causse, Sebastien Zwe/AAZ-7365-2021; Pérez-Ortín, José E./K-8582-2014; Chávez, Sebastián/GXF-7069-2022	Millan-Zambrano, Gonzalo/0000-0002-4530-6359; Chavez, Sebastian S/0000-0002-8064-4839; Haimovich, Gal/0000-0002-3360-5108; Pérez-Ortín, José E./0000-0002-1992-513X; Causse, Sebastien/0000-0003-3246-3491; Medina, Daniel/0000-0002-8183-0043; Darzacq, Xavier/0000-0003-2537-8395	Israel Science Foundation [1283/07]; Ministry of Health, and Rappaport Foundation [ANR JC 0118-01]; la Ligue; Spanish MCINN; European Union ERDF [BFU2010-21975-C03-01, BFU2010-21975-C03-02]; Regional Valencian Government [GV PROMETEO/2011/088]; Junta de Andalucia [P07-CVI02623, P08-CVI-03508]; MICINN GV; EU; DARPA [D12AP00004]; Center for Excellence in Genome Science from the NHGRI [1P50HG006193]; Gruss-Lipper family postdoctoral fellowship; GV; FPU MICINN; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Ministry of Health, and Rappaport Foundation; la Ligue; Spanish MCINN(Spanish Government); European Union ERDF(European Commission); Regional Valencian Government; Junta de Andalucia(Junta de Andalucia); MICINN GV; EU(European Commission); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Center for Excellence in Genome Science from the NHGRI; Gruss-Lipper family postdoctoral fellowship; GV; FPU MICINN(Spanish Government); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Roy Parker, Tatjana Trcek-Pulisic, Daniel Larson, and Robert Singer for critically reading the manuscript. Roy Parker, Wolf Heyer, Karsten Weis, Tien-Hsien Chang, Arlen Johnson, Shay Ben-Aroya, and Daniel Kornitzer generously shared strains and plasmids. We thank Laboratorio de Chips de DNA (S.C.S.I.E., Universitat de Valencia) for the GRO and the 3'/5' macroarrays and Daniel Larson for sharing algorithms. This work was supported by Israel Science Foundation (1283/07), Ministry of Health, and Rappaport Foundation (to M.C.), ANR JC 0118-01 and la Ligue (to X.D.), the Spanish MCINN and European Union ERDF (BFU2010-21975-C03-01 and BFU2010-21975-C03-02) to J.E.P.-O. and S.C., respectively, and the Regional Valencian Government (GV PROMETEO/2011/088) (to J.E.P.-O.) and from Junta de Andalucia (JA grants P07-CVI02623 and P08-CVI-03508) to S.C., MICINN GV and JA grants involve EDRF resources from the EU. DARPA D12AP00004 and Center for Excellence in Genome Science from the NHGRI 1P50HG006193 to M.G. G.H. is currently a recipient of the Gruss-Lipper family postdoctoral fellowship. D.A.M. is a recipient of a Santiago Grisolia fellowship from GV. G.M.-Z. is a recipient of a FPU MICINN fellowship. G.H. and M.C. conceived the main hypothesis. G.H. constructed strains and plasmids and performed and analyzed the transcription, decay and tethering experiments, shuttling assays, proliferation assays, and PBs analysis. S.Z.C. and X.D. designed, performed and analyzed the FISH experiments. D.A.M. and J.E.P.-O. designed, performed, and analyzed the GRO, RPCC and thiolutin shut-off experiments. G.H. and O.B. designed, performed, and analyzed the ChIP-TAP. G.Z.M and S.C. contributed to design 5'/3' GRO and RPCC experiments. G.Z.M. and S.C. designed, performed, and analyzed the Pol II and phosphoser-2 ChIP of GAL1 in glucose and galactose. M.G. and M.C. analyzed the ChIP-exo data. G.H. and M.C. wrote the manuscript. J.E.P.-O. and S.C. critically read and edited the manuscript. M.C. coordinated the project.	Alberola TM, 2004, INT MICROBIOL, V7, P199; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Badis G, 2004, MOL CELL, V15, P5, DOI 10.1016/j.molcel.2004.06.028; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; Brune C, 2005, RNA, V11, P517, DOI 10.1261/rna.7291205; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Dahan N, 2013, BBA-GENE REGUL MECH, V1829, P169, DOI 10.1016/j.bbagrm.2012.08.004; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Esberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020829; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Garcia-Martinez J, 2011, METHODS MOL BIOL, V734, P25, DOI 10.1007/978-1-61779-086-7_2; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Geisler S, 2012, MOL CELL, V45, P279, DOI 10.1016/j.molcel.2011.11.025; Goler-Baron V, 2008, GENE DEV, V22, P2022, DOI 10.1101/gad.473608; Gomez-Herreros F, 2012, NUCLEIC ACIDS RES, V40, P6508, DOI 10.1093/nar/gks340; Haimovich G, 2013, BBA-GENE REGUL MECH, V1829, P643, DOI 10.1016/j.bbagrm.2013.01.004; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Jinek M, 2011, MOL CELL, V41, P600, DOI 10.1016/j.molcel.2011.02.004; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Kruk JA, 2011, GENE DEV, V25, P581, DOI 10.1101/gad.2020911; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Malagon F, 2006, GENETICS, V172, P2201, DOI 10.1534/genetics.105.052415; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Morillo-Huesca M, 2006, FEBS J, V273, P756, DOI 10.1111/j.1742-4658.2005.05108.x; Muhlrad D, 2005, EMBO J, V24, P1033, DOI 10.1038/sj.emboj.7600560; Muhlrad D, 1999, MOL BIOL CELL, V10, P3971, DOI 10.1091/mbc.10.11.3971; Page AM, 1998, NUCLEIC ACIDS RES, V26, P3707, DOI 10.1093/nar/26.16.3707; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Pelechano V, 2008, YEAST, V25, P85, DOI 10.1002/yea.1548; Pelechano V, 2010, YEAST, V27, P413, DOI 10.1002/yea.1768; Pelechano V, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000614; Perez-Ortin JE, 2013, J MOL BIOL, V425, P3750, DOI 10.1016/j.jmb.2013.02.029; Perez-Ortin JE, 2012, BBA-GENE REGUL MECH, V1819, P604, DOI 10.1016/j.bbagrm.2011.12.002; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rodriguez-Gil A, 2010, NUCLEIC ACIDS RES, V38, P4651, DOI 10.1093/nar/gkq215; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Shalem O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002273; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Solinger JA, 1999, MOL CELL BIOL, V19, P5930; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Thompson NL, 2002, CURR OPIN STRUC BIOL, V12, P634, DOI 10.1016/S0959-440X(02)00368-8; Titz B, 2006, NUCLEIC ACIDS RES, V34, P955, DOI 10.1093/nar/gkj493; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	57	223	224	7	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1000	1011		10.1016/j.cell.2013.05.012	http://dx.doi.org/10.1016/j.cell.2013.05.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706738	Bronze, Green Submitted			2022-12-01	WOS:000319456800009
J	Belser, JA; Gustin, KM; Pearce, MB; Maines, TR; Zeng, H; Pappas, C; Sun, XJ; Carney, PJ; Villanueva, JM; Stevens, J; Katz, JM; Tumpey, TM				Belser, Jessica A.; Gustin, Kortney M.; Pearce, Melissa B.; Maines, Taronna R.; Zeng, Hui; Pappas, Claudia; Sun, Xiangjie; Carney, Paul J.; Villanueva, Julie M.; Stevens, James; Katz, Jacqueline M.; Tumpey, Terrence M.			Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice	NATURE			English	Article							H5N1 VIRUSES; INCREASED VIRULENCE; RECEPTOR-BINDING; HUMAN INFECTION; INTERFERON; TROPISM	On 29 March 2013, the Chinese Center for Disease Control and Prevention confirmed the first reported case of human infection with an avian influenza A (H7N9) virus(1). The recent human infections with H7N9 virus, totalling over 130 cases with 39 fatalities to date, have been characterized by severe pulmonary disease and acute respiratory distress syndrome (ARDS)(2). This is concerning because H7 viruses have typically been associated with ocular disease in humans, rather than severe respiratory disease(3). This recent outbreak underscores the need to better understand the pathogenesis and transmission of these viruses in mammals. Here we assess the ability of A/Anhui/1/2013 and A/Shanghai/1/2013 (H7N9) viruses, isolated from fatal human cases, to cause disease in mice and ferrets and to transmit to naive animals. Both H7N9 viruses replicated to higher titre in human airway epithelial cells and in the respiratory tract of ferrets compared to a seasonal H3N2 virus. Moreover, the H7N9 viruses showed greater infectivity and lethality in mice compared to genetically related H7N9 and H9N2 viruses. The H7N9 viruses were readily transmitted to naive ferrets through direct contact but, unlike the seasonal H3N2 virus, did not transmit readily by respiratory droplets. The lack of efficient respiratory droplet transmission was corroborated by low receptor-binding specificity for human-like alpha 2,6-linked sialosides. Our results indicate that H7N9 viruses have the capacity for efficient replication in mammals and human airway cells and highlight the need for continued public health surveillance of this emerging virus.	[Belser, Jessica A.; Gustin, Kortney M.; Pearce, Melissa B.; Maines, Taronna R.; Zeng, Hui; Pappas, Claudia; Sun, Xiangjie; Carney, Paul J.; Villanueva, Julie M.; Stevens, James; Katz, Jacqueline M.; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Tumpey, TM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	tft9@cdc.gov	Stevens, James/GQH-1081-2022; Sun, Xiangjie/AAP-5409-2020		National Institute of General Medical Sciences [GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the China CDC as part of the WHO Global Influenza Surveillance and Response System (GISRS) for facilitating access to viruses and A. Balish for preparation of viruses. The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agency. Glycan microarray slides were produced under contract for the CDC using a glycan library generously provided by the Consortium for Functional Glycomics, funded by National Institute of General Medical Sciences Grant GM62116.	Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belser JA, 2013, J VIROL, V87, P5746, DOI 10.1128/JVI.00154-13; Belser JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002569; Belser JA, 2009, J VIROL, V83, P7075, DOI 10.1128/JVI.00535-09; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Centers for Disease Control and Prevention, 2013, MMWR RECOMM REP, V62, P1; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; de Wit E, 2005, J VIROL, V79, P12401, DOI 10.1128/JVI.79.19.12401-12407.2005; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gerloff N. A, PLOS ONE IN PRESS; Hartley CA, 1997, ARCH VIROL, V142, P75, DOI 10.1007/s007050050060; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Van Hoeven N, 2009, J VIROL, V83, P2851, DOI 10.1128/JVI.02174-08; WHO, 2013, AV INFL A H7N9 VIR; WHO, 2013, REC COMP INFL VIR VA; Wu H, 2013, N ENGL J MED; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zeng H, 2013, J VIROL, V87, P2597, DOI 10.1128/JVI.02885-12; ZHU H, 2013, SCIENCE; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	28	248	266	4	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					556	+		10.1038/nature12391	http://dx.doi.org/10.1038/nature12391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	23842497	Green Published, Bronze			2022-12-01	WOS:000324826300060
J	Kesselheim, AS; Cook-Deegan, RM; Winickoff, DE; Mello, MM				Kesselheim, Aaron S.; Cook-Deegan, Robert M.; Winickoff, David E.; Mello, Michelle M.			Gene Patenting The Supreme Court Finally Speaks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BREAST-CANCER; OVARIAN-CANCER; BRCA2		[Kesselheim, Aaron S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02114 USA; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Cook-Deegan, Robert M.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Cook-Deegan, Robert M.] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Winickoff, David E.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Duke University; Duke University; University of California System; University of California Berkeley	Kesselheim, AS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02114 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Cook-Deegan, Robert/0000-0002-8251-4237	NHGRI NIH HHS [P50 HG003391] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], 2012, HUMAN GENE PATENT RE; [Anonymous], 1995, U. S. Patent, Patent No. [6,124,104, 6124104]; [Anonymous], 1995, U.S. Patent, Patent No. [6,033,857, 6033857]; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; Cook-Deegan R, 2013, ANN INTERN MED, V159, P298, DOI 10.7326/0003-4819-159-4-201308200-00668; Cook-Deegan R, 2012, SCIENCE, V338, P745, DOI 10.1126/science.1229854; Couch F, 1995, US Patent, Patent No. 5837492; Davies Kevin, 1996, BREAKTHROUGH RACE FI; Decker S., 2013, MYRIAD GENETICS SUES; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; GOLDGAR DE, 1994, J NATL CANCER I, V86, P200, DOI 10.1093/jnci/86.3.200; Graff GD, 2013, NAT BIOTECHNOL, V31, P404, DOI 10.1038/nbt.2568; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Kesselheim AS, 2012, NEW ENGL J MED, V366, P2338, DOI 10.1056/NEJMp1204164; Kesselheim AS, 2010, NEW ENGL J MED, V362, P1855, DOI 10.1056/NEJMp1004026; Kling J, 2005, EMBO REP, V6, P1012, DOI 10.1038/sj.embor.7400553; Kolata G., 2013, NEW YORK TIMES  0412, pA14; Langreth R, 2013, BLOOMBERG LAW   0614; Maxmen A, 2013, PERSONALIZED MED ENT; Merz JF, 2002, NATURE, V415, P577, DOI 10.1038/415577a; Park SS, 2013, BLOG RIGHTS     0613; Perkel JM, 2013, SCIENTIST; Rai AK, SCIENCE IN PRESS; United Nations Educational Scientific and Cultural Organization, 1997, UN DECL HUM GEN HUM; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Williams HL, 2013, J POLIT ECON, V121, P1, DOI 10.1086/669706; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Wooster R, 1996, NATURE, V379, P749, DOI 10.1038/379749a0	28	34	35	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2013	369	9					869	875		10.1056/NEJMhle1308199	http://dx.doi.org/10.1056/NEJMhle1308199			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	208KB	23841703	Green Accepted			2022-12-01	WOS:000323676100016
J	Esserman, LJ; Thompson, IM; Reid, B				Esserman, Laura J.; Thompson, Ian M., Jr.; Reid, Brian			Overdiagnosis and Overtreatment in Cancer An Opportunity for Improvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BREAST-CANCER; MORTALITY		[Esserman, Laura J.] Univ Calif San Francisco, San Francisco, CA 94115 USA; [Thompson, Ian M., Jr.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Reid, Brian] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Health San Antonio; Fred Hutchinson Cancer Center	Esserman, LJ (corresponding author), Univ Calif San Francisco, Mt Zion Carol Franc Buck Breast Care Ctr, 1600 Divisadero St,POB 1710, San Francisco, CA 94115 USA.	laura.esserman@ucsfmedctr.org						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Committee on a Framework for Development of a New Taxonomy of Disease; National Research Council, 2011, TOWARD PRECISION MED; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Howlader N., 2013, SEER CANCER STATISTI; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099	8	352	361	1	46	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					797	798		10.1001/jama.2013.108415	http://dx.doi.org/10.1001/jama.2013.108415			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23896967				2022-12-01	WOS:000323561400016
J	Ruel, MT; Alderman, H				Ruel, Marie T.; Alderman, Harold		Maternal Child Nutr Study Grp	Nutrition-sensitive interventions and programmes: how can they help to accelerate progress in improving maternal and child nutrition?	LANCET			English	Article							SEVERELY MALNOURISHED CHILDREN; CONDITIONAL CASH TRANSFERS; IN-KIND TRANSFERS; PSYCHOSOCIAL STIMULATION; DEVELOPING-COUNTRIES; YOUNG-CHILDREN; AGRICULTURAL-DEVELOPMENT; INCOME COUNTRIES; FOOD; GROWTH	Acceleration of progress in nutrition will require effective, large-scale nutrition-sensitive programmes that address key underlying determinants of nutrition and enhance the coverage and effectiveness of nutrition-specific interventions. We reviewed evidence of nutritional effects of programmes in four sectors-agriculture, social safety nets, early child development, and schooling. The need for investments to boost agricultural production, keep prices low, and increase incomes is undisputable; targeted agricultural programmes can complement these investments by supporting livelihoods, enhancing access to diverse diets in poor populations, and fostering women's empowerment. However, evidence of the nutritional effect of agricultural programmes is inconclusive-except for vitamin A from biofortification of orange sweet potatoes-largely because of poor quality evaluations. Social safety nets currently provide cash or food transfers to a billion poor people and victims of shocks (eg, natural disasters). Individual studies show some effects on younger children exposed for longer durations, but weaknesses in nutrition goals and actions, and poor service quality probably explain the scarcity of overall nutritional benefits. Combined early child development and nutrition interventions show promising additive or synergistic effects on child development-and in some cases nutrition-and could lead to substantial gains in cost, efficiency, and effectiveness, but these programmes have yet to be tested at scale. Parental schooling is strongly associated with child nutrition, and the effectiveness of emerging school nutrition education programmes needs to be tested. Many of the programmes reviewed were not originally designed to improve nutrition yet have great potential to do so. Ways to enhance programme nutrition-sensitivity include: improve targeting; use conditions to stimulate participation; strengthen nutrition goals and actions; and optimise women's nutrition, time, physical and mental health, and empowerment. Nutrition-sensitive programmes can help scale up nutrition-specific interventions and create a stimulating environment in which young children can grow and develop to their full potential.	[Ruel, Marie T.; Alderman, Harold] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20006 USA	CGIAR; International Food Policy Research Institute (IFPRI)	Ruel, MT (corresponding author), Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20006 USA.	m.ruel@cgiar.org		Ruel, Marie/0000-0002-9506-348X	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	Funding for the preparation of the Series was provided to the Johns Hopkins Bloomberg School of Public Health through a grant from the Bill & Melinda Gates Foundation. The sponsor has no role in the analysis and interpretation of the evidence or in writing the paper and the decision to submit for publication. We thank John Hoddinott, senior research fellow at IFPRI, who reviewed an early version of the paper, and to four anonymous reviewers for their insightful comments.	Aboud FE, 2011, PEDIATRICS, V127, pE1191, DOI 10.1542/peds.2010-2160; Adato M, 2000, FINAL REPORT; Adato M., 2010, CONDITIONAL CASH TRA; Adelman S, 2008, IFPRI FOOD POLICY RE; Afridi F, 2010, J DEV ECON, V92, P152, DOI 10.1016/j.jdeveco.2009.02.002; Akresh R, 2012, WORLD BANK POLICY RE; Alderman H, 2010, J DEV ORIG HLTH DIS, V1, P19, DOI 10.1017/S2040174409990158; Alderman H, 2012, WORLD BANK RES OBSER, V27, P204, DOI 10.1093/wbro/lkr005; Alderman H, 2010, J NUTR, V140, p148S, DOI 10.3945/jn.109.110825; Alderman H, 2009, FOOD NUTR BULL, V30, P265, DOI 10.1177/156482650903000308; Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; Arimond M, 2011, COMBATING MICRONUTRIENT DEFICIENCIES: FOOD-BASED APPROACHES, P41, DOI 10.1079/9781845937140.0041; Attanasio O, 2012, ECON J, V122, P92, DOI 10.1111/j.1468-0297.2011.02473.x; Barber SL, 2010, J DEV EFFECT, V2, P51, DOI 10.1080/19439341003592630; Barro R, 2010, NBER WORKING PAPER 1; Begum J M, 1994, Indian J Med Sci, V48, P61; Behrman JR, 2005, OXFORD B ECON STAT, V67, P547, DOI 10.1111/j.1468-0084.2005.00131.x; Bentley ME, 2011, J NUTR, V141, P502, DOI 10.3945/jn.110.130005; Berti PR, 2004, PUBLIC HEALTH NUTR, V7, P599, DOI 10.1079/PHN2003595; Bhutta ZA, 2013, LANCET; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black MM, 2009, AM J CLIN NUTR, V89, p951S, DOI 10.3945/ajcn.2008.26692E; Black R., 2013, LANCET; Block SA, 2007, OXFORD ECON PAP, V59, P330, DOI 10.1093/oep/gpm001; Bouis HE, 2011, FOOD NUTR BULL, V32, pS31, DOI 10.1079/9781780642994.0202; Bundy D, 2012, PUBLIC HEALTH NUTR; Bushamuka V, FOOD NUTR BULL, V26, P17; Carvalho LMJ, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.15618; Chaparro CM, 2010, MATERN CHILD NUTR, V6, P1, DOI 10.1111/j.1740-8709.2009.00224.x; Chou SY, 2010, AM ECON J-APPL ECON, V2, P33, DOI 10.1257/app.2.1.33; Connolly MA, 2004, LANCET, V364, P1974, DOI 10.1016/S0140-6736(04)17481-3; Coote C, 2011, 2020 CONFERENCE NOTE; Davis B, 2012, J DEV EFFECT, V4, P1, DOI 10.1080/19439342.2012.659024; De Brauw A, 2013, WORLD DEV; Demographic Health Surveys, MEASURE DHS STAT COM; DFID, 2011, CASH TRANSFER EVIDEN; Doak C, 2002, PUBLIC HEALTH NUTR, V5, P275, DOI 10.1079/PHN2001304; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; FAO, 2005, NUTRITION EDUCATION; FAO, 2010, THE STATE OF FOOD AN; FAO WFP & IFAD, 2012, THE STATE OF FOOD IN; Fernald LCH, 2012, THE OXFORD HANDBOOK; Gaarder MM, 2010, J DEV EFFECT, V2, P6, DOI 10.1080/19439341003646188; Gardner JMM, 2005, AM J CLIN NUTR, V82, P399, DOI 10.1093/ajcn/82.2.399; Garrett J, WORKING MULTISECTORA; Gelli A, 2010, PCD WORKING PAPER 21; Gereffi G, 2009, J HUNGER ENVIRON NUT, V4, P357, DOI 10.1080/19320240903321276; Giles J, 2010, POLICY RESEARCH WORK; Gillespie S, 2013, LANCET; Girard AW, 2012, PAEDIATR PERINAT EP, V26, P205, DOI 10.1111/j.1365-3016.2012.01282.x; Glewwe P, 1999, J HUM RESOUR, V34, P124, DOI 10.2307/146305; Grant MJ, 2010, POPUL DEV REV, V36, P71, DOI 10.1111/j.1728-4457.2010.00318.x; GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6; Grellety E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044549; Grosh M, 2008, FOR PROTECTION AND P; Haas JD, 2005, J NUTR, V135, P2823, DOI 10.1093/jn/135.12.2823; Haddad L, 2003, WORLD BANK ECON REV, V17, P107, DOI 10.1093/wber/lhg012; Hawkes C, 2011, VALUE CHAINS FOR NUT; Hawkes C, 2012, CURRENT AND PLANNED; Hawkes C, 2009, J HUNGER ENVIRON NUT, V4, P336, DOI 10.1080/19320240903321243; Helen Keller International, 2004, HOMESTEAD FOOD PRODU, V2, P1; Helen Keller International, 2004, NEP NUTR B, V2, P1; Helen Keller International Asian Vegetable and Research Development Centre, 1993, HOM GARD BANGL EV RE; Herforth A, 2012, PRIORITIZING NUTRITI; Hoddinott J, 2012, AGRICULTURE HEALTH A; Hoddinott J, 2011, IFPRI DISCUSSION PAP; Hoddinott J. F., 2013, COPENHAGEN CONSENSUS; Hoorweg J, 2000, ECOL FOOD NUTR, V39, P395, DOI 10.1080/03670244.2000.9991627; Hotz C, 2012, J NUTR, V142, P1871, DOI 10.3945/jn.111.151829; Hotz C, 2012, BRIT J NUTR, V108, P163, DOI 10.1017/S0007114511005174; Huybregts L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001313; IFPRI, 2012, 2011 GLOBAL FOOD POL; Kadiyala, 2012, IFPRI DISCUSSION PAP; Kagenimana V, 1999, RESEARCH REPORT 3; Kassa H, 2003, LIVEST RES RURAL DEV, V15, P6; Kazianga H, 2009, WORLD BANK POLICY RE; Kristjansson EA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004676.pub2; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Leroy JL, 2013, J NUTR, V143, P378, DOI 10.3945/jn.112.167627; Leroy JL, 2009, J DEV EFFECT, V1, P103, DOI 10.1080/19439340902924043; Leroy JL, 2010, J NUTR, V140, P612, DOI 10.3945/jn.109.116285; Leroy JL, 2013, THE MICRONUTRIENT IM; Low JW, 2007, J NUTR, V137, P1320; Manley J, 2012, HOW EFFECTIVE ARE CA; Masset E, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8222; Maxwell D, 2010, FOOD POLICY, V35, P91, DOI 10.1016/j.foodpol.2009.10.002; Mazur R, 2011, 2020 CONFERENCE NOTE; Menon P, 2007, J NUTR, V137, P1023, DOI 10.1093/jn/137.4.1023; Mullins G, 1996, HUM ECOL, V24, P231, DOI 10.1007/BF02169128; Nahar B, 2012, EUR J CLIN NUTR, V66, P701, DOI 10.1038/ejcn.2012.13; Nahar B, 2009, EUR J CLIN NUTR, V63, P725, DOI 10.1038/ejcn.2008.44; Nederveen L, GLOBAL MAPPING OF IN; Nelson J, 2009, CLIMATE CHANGE AND GLOBAL POVERTY: A BILLION LIVES IN THE BALANCE, P223; Neufed LM, 2011, J NUTR, V141, P2076, DOI 10.3945/jn.110.134957; Nielsen H, 1997, INTEGRATED FARMING I; OECD/FAO, 2012, OECD FAO AGRICULTURA, DOI 10.1787/agr_outlook-2012-en; Olney DK, 2009, FOOD NUTR BULL, V30, P355, DOI 10.1177/156482650903000407; Osei AK, 2010, J NUTR, V140, P1146, DOI 10.3945/jn.109.114751; Petry N, 2012, J NUTR, V142, P492, DOI 10.3945/jn.111.149286; Pettifor A, 2012, AIDS BEHAV, V16, P1729, DOI 10.1007/s10461-012-0240-z; Pinstrup A., 2011, ROLE GOVT GLOBAL NAT; Pinstrup-Andersen P, 2011, THE FOOD SYSTEM AND; Pinstrup-Andersen P, 2010, THE AFRICAN FOOD SYS; Pinstrup-Andersen P, 2013, GUIDING FOOD SYSTEM; Pinstrup-Andersen P, 2013, EUR J DEV RES, V25, P5, DOI 10.1057/ejdr.2012.44; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; Ruel MT, 2008, LANCET, V371, P588, DOI 10.1016/S0140-6736(08)60271-8; Ruel MT, 2001, FOOD POLICY REVIEW 5; Saltzman A, 2013, GLOB FOOD SECUR-AGR, V2, P9, DOI 10.1016/j.gfs.2012.12.003; Scaling Up Nutrition, 2011, SCALING UP NUTRITION; Schady N.R., 2009, WORLD BANK POLICY RE; Schady N, 2008, ECON LETT, V101, P246, DOI 10.1016/j.econlet.2008.08.015; Semba RD, 2008, LANCET, V371, P322, DOI 10.1016/S0140-6736(08)60169-5; Shekar M, 2013, MODULE A INTRODUCTIO; Skoufias E, 2001, FOOD CONSUMPTION AND; SOLON F, 1979, AM J CLIN NUTR, V32, P1445, DOI 10.1093/ajcn/32.7.1445; Sumberg J, 2011, FOOD POLICY, V36, P341, DOI 10.1016/j.foodpol.2011.03.001; Surkan PJ, 2011, B WORLD HEALTH ORGAN, V89, P607, DOI 10.2471/BLT.11.088187; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; Vazir S, 2013, MATERN CHILD NUTR, V9, P99, DOI 10.1111/j.1740-8709.2012.00413.x; Verstraeten R, 2012, AM J CLIN NUTR, V96, P415, DOI 10.3945/ajcn.112.035378; Walker SP, 2005, LANCET, V366, P1804, DOI 10.1016/S0140-6736(05)67574-5; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; Walker SP, 2011, PEDIATRICS, V127, P849, DOI 10.1542/peds.2010-2231; Webb P, 2010, J NUTR, V140, p143S, DOI 10.3945/jn.109.110536; WHO, 2012, GLOBAL DATABASE ON C; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Bank, 2009, GLOBAL ECONOMIC PROSPECTS: COMMODITIES AT THE CROSSROADS, P1, DOI 10.1596/978-0-8213-7799-4; World Bank, 2012, MANAGING RISK PROMOT; World Bank, EDUCATION STATISTICS; World Bank, WORLD DEVELOPMENT RE; World Bank, 2007, FROM AGRICULTURE TO; World Bank, 2013, IMPROVING NUTRITION; World Food Programme, 2012, GLOBAL FOOD AID FLOW; Yamano T, 2005, AM J AGR ECON, V87, P273, DOI 10.1111/j.1467-8276.2005.00721.x; Yousafzai AK, 2012, PAKISTAN EARLY CHILD	138	873	880	9	229	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 10	2013	382	9891					536	551		10.1016/S0140-6736(13)60843-0	http://dx.doi.org/10.1016/S0140-6736(13)60843-0			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201SD	23746780				2022-12-01	WOS:000323162400033
J	Morain, S; Greene, MF; Mello, MM				Morain, Stephanie; Greene, Michael F.; Mello, Michelle M.			A New Era in Noninvasive Prenatal Testing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Morain, Stephanie] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA; [Greene, Michael F.] Massachusetts Gen Hosp, Vincent Dept Obstet & Gynecol, Boston, MA 02114 USA; [Greene, Michael F.] Harvard Univ, Sch Med, Boston, MA USA; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Morain, S (corresponding author), Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA.			Morain, Stephanie/0000-0001-7278-7517				Lindsay R, 2013, BARCL CAP 2013 GLOB; Nicolaides KH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.033; Norton ME, 2013, OBSTET GYNECOL, V121, P847, DOI 10.1097/AOG.0b013e31828642c6; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Weiss RL, 2012, AM J CLIN PATHOL, V138, P20, DOI 10.1309/AJCP6OAULC3CMFEJ	5	68	74	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					499	501		10.1056/NEJMp1304843	http://dx.doi.org/10.1056/NEJMp1304843			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	197HX	23862975				2022-12-01	WOS:000322842000003
J	Poznik, GD; Henn, BM; Yee, MC; Sliwerska, E; Euskirchen, GM; Lin, AA; Snyder, M; Quintana-Murci, L; Kidd, JM; Underhill, PA; Bustamante, CD				Poznik, G. David; Henn, Brenna M.; Yee, Muh-Ching; Sliwerska, Elzbieta; Euskirchen, Ghia M.; Lin, Alice A.; Snyder, Michael; Quintana-Murci, Lluis; Kidd, Jeffrey M.; Underhill, Peter A.; Bustamante, Carlos D.			Sequencing Y Chromosomes Resolves Discrepancy in Time to Common Ancestor of Males Versus Females	SCIENCE			English	Article							MITOCHONDRIAL-DNA; MODERN HUMANS; TREE; DEPENDENCY; AMERICANS; EVOLUTION; ORIGINS; AFRICA	The Y chromosome and the mitochondrial genome have been used to estimate when the common patrilineal and matrilineal ancestors of humans lived. We sequenced the genomes of 69 males from nine populations, including two in which we find basal branches of the Y-chromosome tree. We identify ancient phylogenetic structure within African haplogroups and resolve a long-standing ambiguity deep within the tree. Applying equivalent methodologies to the Y chromosome and the mitochondrial genome, we estimate the time to the most recent common ancestor (T-MRCA) of the Y chromosome to be 120 to 156 thousand years and the mitochondrial genome T-MRCA to be 99 to 148 thousand years. Our findings suggest that, contrary to previous claims, male lineages do not coalesce significantly more recently than female lineages.	[Poznik, G. David] Stanford Univ, Sch Med, Program Biomed Informat, Stanford, CA 94305 USA; [Poznik, G. David] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Henn, Brenna M.; Yee, Muh-Ching; Euskirchen, Ghia M.; Snyder, Michael; Kidd, Jeffrey M.; Underhill, Peter A.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Henn, Brenna M.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Sliwerska, Elzbieta; Kidd, Jeffrey M.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Sliwerska, Elzbieta; Kidd, Jeffrey M.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Lin, Alice A.] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA; [Quintana-Murci, Lluis] Inst Pasteur, Unit Human Evolutionary Genet, F-75015 Paris, France; [Quintana-Murci, Lluis] CNRS, URA3012, F-75015 Paris, France	Stanford University; Stanford University; Stanford University; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Bustamante, CD (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	cdbustam@stanford.edu	Quintana-Murci, Lluis/AAB-7468-2022	Bustamante, Carlos D./0000-0002-4187-7920; Snyder, Michael/0000-0003-0784-7987; Kidd, Jeffrey/0000-0002-9631-1465; Quintana-Murci, Lluis/0000-0003-2429-6320	National Library of Medicine training grant [LM-07033]; NSF [DGE-1147470]; NIH [3R01HG003229, DP5OD009154]; Institut Pasteur; CNRS; Foundation Simone et Cino del Duca Research Grant; Ancestry.com; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009154] Funding Source: NIH RePORTER	National Library of Medicine training grant; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Foundation Simone et Cino del Duca Research Grant; Ancestry.com; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank O. Cornejo, S. Gravel, D. Siegmund, and E. Tsang for helpful discussions; M. Sikora and H. Costa for mapping reads from Gabonese samples; and H. Cann for assistance with HGDP samples. This work was supported by National Library of Medicine training grant LM-07033 and NSF graduate research fellowship DGE-1147470 (G. D. P.); NIH grant 3R01HG003229 (B. M. H. and C. D. B.); NIH grant DP5OD009154 (J.M.K. and E. S.); and Institut Pasteur, a CNRS Maladies Infectieuses Emergentes Grant, and a Foundation Simone et Cino del Duca Research Grant (L. Q. M.). P. A. U. consulted for, P. A. U. and B. M. H. have stock in, and C. D. B. is on the advisory board of a project at 23andMe. C. D. B. is on the scientific advisory boards of Personalis, Inc.; InVitae (formerly Locus Development, Inc.); and Ancestry.com. M. S. is a scientific advisory member and founder of Personalis, a scientific advisory member for Genapsys Former, and a consultant for Illumina and Beckman Coulter Society for American Medical Pathology. B. M. H. formerly had a paid consulting relationship with Ancestry.com. Variants have been deposited to dbSNP (ss825679106-825690384). Individual level genetic data are available, through a data access agreement to respect the privacy of the participants for transfer of genetic data, by contacting C.D.B.	CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; Dulik MC, 2012, AM J HUM GENET, V90, P229, DOI 10.1016/j.ajhg.2011.12.014; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Klein RG, 2008, EVOL ANTHROPOL, V17, P267, DOI 10.1002/evan.20181; Kumar S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-293; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Tang H, 2002, GENETICS, V161, P447; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032	23	142	146	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					562	565		10.1126/science.1237619	http://dx.doi.org/10.1126/science.1237619			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908239	Green Submitted, Green Accepted			2022-12-01	WOS:000322586700057
J	Basch, E				Basch, Ethan			Toward Patient-Centered Drug Development in Oncology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Basch, Ethan] Univ N Carolina, Sch Med, Canc Outcomes Res Program, Chapel Hill, NC 27599 USA; [Basch, Ethan] Univ N Carolina, Sch Publ Hlth, Canc Outcomes Res Program, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Basch, E (corresponding author), Univ N Carolina, Sch Med, Canc Outcomes Res Program, Chapel Hill, NC 27599 USA.							Basch E, 2012, JAMA-J AM MED ASSOC, V307, P1636, DOI 10.1001/jama.2012.466; Brundage M, 2011, QUAL LIFE RES, V20, P653, DOI 10.1007/s11136-010-9793-3; Food & Drug Administration, 2009, GUID IND PAT REP OUT; Gnanasakthy A, 2012, VALUE HEALTH, V15, P437, DOI 10.1016/j.jval.2011.11.032; Harrison PL, 2012, POPUL HEALTH MANAG, V15, P325, DOI 10.1089/pop.2011.0089	5	89	89	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					397	400		10.1056/NEJMp1114649	http://dx.doi.org/10.1056/NEJMp1114649			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193GQ	23822654	Green Published			2022-12-01	WOS:000322547400002
J	Talpalar, AE; Bouvier, J; Borgius, L; Fortin, G; Pierani, A; Kiehn, O				Talpalar, Adolfo E.; Bouvier, Julien; Borgius, Lotta; Fortin, Gilles; Pierani, Alessandra; Kiehn, Ole			Dual-mode operation of neuronal networks involved in left-right alternation	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; SPINAL-CORD; COMMISSURAL INTERNEURONS; LOCOMOTOR-ACTIVITY; MICE; IDENTIFICATION; COORDINATION; EXPRESSION; ZEBRAFISH; CIRCUITS	All forms of locomotion are repetitive motor activities that require coordinated bilateral activation of muscles. The executive elements of locomotor control are networks of spinal neurons that determine gait pattern through the sequential activation of motor-neuron pools on either side of the body axis(1-4). However, little is known about the constraints that link left-right coordination to locomotor speed. Recent advances have indicated that both excitatory and inhibitory commissural neurons may be involved in left-right coordination(5-7). But the neural underpinnings of this, and a possible causal link between these different groups of commissural neurons and left-right alternation, are lacking. Here we show, using intersectional mouse genetics, that ablation of a group of transcriptionally defined commissural neurons-the V0 population-leads to a quadrupedal hopping at all frequencies of locomotion. The selective ablation of inhibitory V0 neurons leads to a lack of left-right pattern at low frequencies, mixed coordination at medium frequencies, and alternation at high locomotor frequencies. When ablation is targeted to excitatory V0 neurons, left-right alternation is present at low frequencies, and hopping is restricted to medium and high locomotor frequencies. Therefore, the intrinsic logic of the central control of locomotion incorporates a modular organization, with two subgroups of V0 neurons required for the existence of left-right alternating modes at different speeds of locomotion. The two molecularly distinct sets of commissural neurons may constrain species-related naturally occurring frequency-dependent coordination and be involved in the evolution of different gaits.	[Talpalar, Adolfo E.; Bouvier, Julien; Borgius, Lotta; Kiehn, Ole] Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, S-17177 Stockholm, Sweden; [Fortin, Gilles] CNRS, F-91198 Gif Sur Yvette, France; [Pierani, Alessandra] Univ Paris Diderot, Sorbonne Paris Cite, Inst Jacques Monod, CNRS,UMR 7592, F-75205 Paris, France	Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Kiehn, O (corresponding author), Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, S-17177 Stockholm, Sweden.	ole.kiehn@ki.se	Pierani, Alessandra/O-6136-2017; Talpalar, Adolfo/H-3996-2019; kiehn, ole/AAT-7881-2021; Bouvier, Julien/C-1018-2017; kiehn, ole/AAB-1262-2019	Pierani, Alessandra/0000-0002-4872-4791; Talpalar, Adolfo/0000-0001-9056-6021; Bouvier, Julien/0000-0002-1307-4426; Kiehn, Ole/0000-0002-5954-469X; Fortin, Gilles/0000-0002-2123-8603	Soderberg Foundation; Swedish Research Council; European Research Council	Soderberg Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Soderberg Foundation, Swedish Research Council and European Research Council. J.B. is an EMBO fellow. We thank H. U. Zeilhofer for donating the Hoxb8::Cre mouse strain, S. Karaz, A. C. Westerdahl and P. Low for extensive genotyping, L. Lundfald for participating in early experiments, N. Sleiers for participating in the in vivo experiments, and P. L. Ruffault for providing mouse tissue. We thank colleagues for discussing different aspects of our study.	Andersson LS, 2012, NATURE, V488, P642, DOI 10.1038/nature11399; Ausborn J, 2012, P NATL ACAD SCI USA, V109, pE3631, DOI 10.1073/pnas.1216256110; Berger J, 2004, GENESIS, V40, P195, DOI 10.1002/gene.20081; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Borgius L, 2010, MOL CELL NEUROSCI, V45, P245, DOI 10.1016/j.mcn.2010.06.016; Bouvier J, 2010, NAT NEUROSCI, V13, P1066, DOI 10.1038/nn.2622; Butt SJB, 2003, NEURON, V38, P953, DOI 10.1016/S0896-6273(03)00353-2; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; Crone SA, 2009, J NEUROSCI, V29, P7098, DOI 10.1523/JNEUROSCI.1206-09.2009; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Jankowska E, 2008, BRAIN RES REV, V57, P46, DOI 10.1016/j.brainresrev.2007.06.022; Jordan L. M., 1991, NEUROBIOLOGICAL BASI, P3; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Liu B, 2007, DEV DYNAM, V236, P829, DOI 10.1002/dvdy.21061; Mahan R.P., 1991, 16 US ARM RES I BEH; McLean DL, 2009, J NEUROSCI, V29, P13566, DOI 10.1523/JNEUROSCI.3277-09.2009; Mor Y, 2007, J NEUROPHYSIOL, V98, P2807, DOI 10.1152/jn.00740.2007; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Quinlan KA, 2007, J NEUROSCI, V27, P6521, DOI 10.1523/JNEUROSCI.1618-07.2007; Restrepo CE, 2009, J COMP NEUROL, V517, P177, DOI 10.1002/cne.22144; Roberts A, 2008, BRAIN RES REV, V57, P22, DOI 10.1016/j.brainresrev.2007.06.015; Serradj N, 2009, BEHAV BRAIN RES, V201, P59, DOI 10.1016/j.bbr.2009.01.030; Skaggs K, 2011, DEVELOPMENT, V138, P3199, DOI 10.1242/dev.057281; Suster ML, 2009, DEV BIOL, V325, P422, DOI 10.1016/j.ydbio.2008.10.004; Talpalar AE, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00019; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Teissier A, 2010, J NEUROSCI, V30, P10563, DOI 10.1523/JNEUROSCI.0776-10.2010; Witschi R, 2010, GENESIS, V48, P596, DOI 10.1002/dvg.20656; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017; ZAR JH, 1974, BIOSTATISTICAL ANAL; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027	39	194	195	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2013	500	7460					85	U108		10.1038/nature12286	http://dx.doi.org/10.1038/nature12286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23812590				2022-12-01	WOS:000322514800033
J	Smith, C				Smith, Caitlin			CANCER SHOWS STRENGTH THROUGH DIVERSITY	NATURE			English	Editorial Material																		Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; Bendall SC, 2012, NAT BIOTECHNOL, V30, P639, DOI 10.1038/nbt.2283; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Yin Z, 2013, NAT CELL BIOL, V15, P860, DOI 10.1038/ncb2764	4	13	15	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2013	499	7459					505	508		10.1038/499505a	http://dx.doi.org/10.1038/499505a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23887432	Bronze			2022-12-01	WOS:000322157900048
J	Gray, JAM				Gray, J. A. Muir			The Art of Medicine The shift to personalised and population medicine	LANCET			English	Editorial Material									Oxford Univ Hosp NHS Trust, Oxford OX3 9DU, England	Oxford University Hospitals NHS Foundation Trust	Gray, JAM (corresponding author), Oxford Univ Hosp NHS Trust, Oxford OX3 9DU, England.	muir.gray@medknox.net						[Anonymous], 1995, LANCET, V346, P785; British Thoracic Society and the Primary Care Respiratory Society UK, 2012, BRITISH THORACIC SOC, V4; Christensen CM, 2009, THE INNOVATORS PRESC; Goldberg D, 1980, MENTAL ILLNESS COMMU; Gray JAM, 2007, HOW GET BETTER VALUE; Gray M, 2009, J HEALTH SERV RES PO, V14, P129, DOI 10.1258/jhsrp.2008.008105; Mulley AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6572; NHS, 2010, THE NHS ATLAS OF VAR; Ohno T., 1988, THE TOYOTA PRODUCTIO; Porter ME, 2008, WHAT IS VALUE IN HEA; Rothwell Peter M., 2007, TREATING INDIVIDUALS; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71	12	39	40	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 20	2013	382	9888					200	201		10.1016/S0140-6736(13)61590-1	http://dx.doi.org/10.1016/S0140-6736(13)61590-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193FL	23878859				2022-12-01	WOS:000322543700016
J	Barreto, L; Khan, AR; Khanbhai, M; Brain, JL				Barreto, L.; Khan, A. R.; Khanbhai, M.; Brain, J. L.			Umbilical hernia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Barreto, L.; Khan, A. R.; Brain, J. L.] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge CB2 2QQ, England; [Khanbhai, M.] NHS GP Surg, Watling Med Ctr, Burnt Oak HA8 0NR, Middx, England	Addenbrooke's Hospital; University of Cambridge	Khan, AR (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge CB2 2QQ, England.	arkhan@doctors.org.uk							0	4	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2013	347								f4252	10.1136/bmj.f4252	http://dx.doi.org/10.1136/bmj.f4252			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	189DN	23873946				2022-12-01	WOS:000322247400001
J	Santagata, S; Mendillo, ML; Tang, YC; Subramanian, A; Perley, CC; Roche, SP; Wong, B; Narayan, R; Kwon, H; Koeva, M; Amon, A; Golub, TR; Porco, JA; Whitesell, L; Lindquist, S				Santagata, Sandro; Mendillo, Marc L.; Tang, Yun-chi; Subramanian, Aravind; Perley, Casey C.; Roche, Stephane P.; Wong, Bang; Narayan, Rajiv; Kwon, Hyoungtae; Koeva, Martina; Amon, Angelika; Golub, Todd R.; Porco, John A., Jr.; Whitesell, Luke; Lindquist, Susan			Tight Coordination of Protein Translation and HSF1 Activation Supports the Anabolic Malignant State	SCIENCE			English	Article							HEAT-SHOCK FACTOR-1; TRANSCRIPTION FACTOR HSF1; EUKARYOTIC TRANSLATION; AMINO-ACID; IN-VITRO; CANCER; EXPRESSION; STRESS; SILVESTROL; INHIBITORS	The ribosome is centrally situated to sense metabolic states, but whether its activity, in turn, coherently rewires transcriptional responses is unknown. Here, through integrated chemical-genetic analyses, we found that a dominant transcriptional effect of blocking protein translation in cancer cells was inactivation of heat shock factor 1 (HSF1), a multifaceted transcriptional regulator of the heat-shock response and many other cellular processes essential for anabolic metabolism, cellular proliferation, and tumorigenesis. These analyses linked translational flux to the regulation of HSF1 transcriptional activity and to the modulation of energy metabolism. Targeting this link with translation initiation inhibitors such as rocaglates deprived cancer cells of their energy and chaperone armamentarium and selectively impaired the proliferation of both malignant and premalignant cells with early-stage oncogenic lesions.	[Santagata, Sandro] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA; [Santagata, Sandro] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Santagata, Sandro] Dana Farber Canc Inst, Boston, MA 02215 USA; [Santagata, Sandro; Mendillo, Marc L.; Perley, Casey C.; Kwon, Hyoungtae; Koeva, Martina; Whitesell, Luke; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Mendillo, Marc L.; Tang, Yun-chi; Perley, Casey C.; Kwon, Hyoungtae; Koeva, Martina; Amon, Angelika; Lindquist, Susan] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Tang, Yun-chi; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Tang, Yun-chi; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Subramanian, Aravind; Wong, Bang; Narayan, Rajiv; Golub, Todd R.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Roche, Stephane P.; Porco, John A., Jr.] Boston Univ, Dept Chem, Ctr Chem Methodol & Lib Dev CMLD BU, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University	Whitesell, L (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	whitesell@wi.mit.edu; lindquist_admin@wi.mit.edu	Tang, Yun-Chi/GRE-8205-2022	Mendillo, Marc/0000-0001-8128-0128; Santagata, Sandro/0000-0002-7528-9668; tang, yun qi/0000-0001-9385-2787; Amon, Angelika/0000-0001-9837-0314	Johnson & Johnson's Corporate Office of Science and Technology; Marble Fund; NIH [R01 CA175744-01, K08NS064168]; NIH Common Fund's LINCS program [5U54HG006093]; American Cancer Society New England Division-SpinOdyssey [PF-09-253-01-DMC]; Brain Science Foundation; American Brain Tumor Association; Beez Foundation; V Foundation; Jared Branfman Sunflowers for Life Fund;  [R03 MH086465-01];  [R03 DA027713-01];  [R01 GM073855]; NATIONAL CANCER INSTITUTE [R01CA175744] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS064168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027713] Funding Source: NIH RePORTER	Johnson & Johnson's Corporate Office of Science and Technology; Marble Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Common Fund's LINCS program; American Cancer Society New England Division-SpinOdyssey; Brain Science Foundation; American Brain Tumor Association; Beez Foundation; V Foundation; Jared Branfman Sunflowers for Life Fund; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank T. Volkert, J. Love, S. Gupta, and the WIBR-Genome Technology Core for sequencing support; S. Malstrom (Koch Institute for Integrative Cancer Research) for assistance with in vivo imaging; G. Bell, P. Thiru, and A. Lancaster for assistance with informatics analysis; the Connectivity Map team at the Broad Institute for generation of the LINCS data set and query tools; Joe Negri and the MLPCN team at the Broad Institute for chemical screening; and M. Duquette for assistance with animal experiments. We also thank C. Rodrigo (Boston University) for compound synthesis. We thank the Lindquist laboratory for helpful discussions and suggestions. The work was supported by the Johnson & Johnson's Corporate Office of Science and Technology focused funding program (L. W.), the Marble Fund (S. L.), and NIH R01 CA175744-01 (L. W.). The MLPCN screen was supported by R03 MH086465-01 and R03 DA027713-01 to L. W. This work was supported by the NIH Common Fund's LINCS program (5U54HG006093, "Large scale gene expression analysis of cellular states") to T. R. G. J. A. P. Jr. is supported by R01 GM073855. S. L. is an Investigator of the Howard Hughes Medical Institute. M. L. M. was supported by American Cancer Society New England Division-SpinOdyssey (PF-09-253-01-DMC). S. S. is supported by NIH (K08NS064168), the Brain Science Foundation, the American Brain Tumor Association, the Beez Foundation, the V Foundation, and the Jared Branfman Sunflowers for Life Fund. The expression profiling and ChIP-Seq data are deposited in GEO (GSE45853). The MLPCN chemical screening data are deposited in Pubchem (AID: 2118).	Alinari L, 2012, CLIN CANCER RES, V18, P4600, DOI 10.1158/1078-0432.CCR-12-0839; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; Chambers JM, 2013, ORG LETT, V15, P1406, DOI 10.1021/ol400401d; Chan JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001754; Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Fang F, 2012, CANCER-AM CANCER SOC, V118, P1782, DOI 10.1002/cncr.26482; Gabai VL, 2012, MOL CELL BIOL, V32, P929, DOI 10.1128/MCB.05921-11; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hensen SMM, 2012, CELL STRESS CHAPERON, V17, P743, DOI 10.1007/s12192-012-0347-1; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jin XJ, 2011, CELL METAB, V14, P91, DOI 10.1016/j.cmet.2011.03.025; Kim SY, 2007, CELL MOL IMMUNOL, V4, P345; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lucas DM, 2009, BLOOD, V113, P4656, DOI 10.1182/blood-2008-09-175430; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Okabe M, 1995, LEUKEMIA RES, V19, P933, DOI 10.1016/0145-2126(95)00039-9; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Roche SP, 2010, ANGEW CHEM INT EDIT, V49, P6533, DOI 10.1002/anie.201003212; Rodrigo CM, 2012, J MED CHEM, V55, P558, DOI 10.1021/jm201263k; Roux PP, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012252; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Santagata S, 2012, ACS CHEM BIOL, V7, P339, DOI 10.1021/cb200353m; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Scott KL, 2011, CANCER CELL, V20, P92, DOI 10.1016/j.ccr.2011.05.025; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Turbyville TJ, 2006, J NAT PROD, V69, P178, DOI 10.1021/np058095b; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Whitesell L, 2012, CURR MOL MED, V12, P1108, DOI 10.2174/156652412803306657; Whitesell L, 2009, EXPERT OPIN THER TAR, V13, P469, DOI [10.1517/14728220902832697, 10.1517/14728220902832697 ]; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058	44	187	194	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2013	341	6143					250	+	1238303	10.1126/science.1238303	http://dx.doi.org/10.1126/science.1238303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869022	Green Accepted, Green Submitted			2022-12-01	WOS:000321959300034
J	Han, H; Irimia, M; Ross, PJ; Sung, HK; Alipanahi, B; David, L; Golipour, A; Gabut, M; Michael, IP; Nachman, EN; Wang, E; Trcka, D; Thompson, T; O'Hanlon, D; Slobodeniuc, V; Barbosa-Morais, NL; Burge, CB; Moffat, J; Frey, BJ; Nagy, A; Ellis, J; Wrana, JL; Blencowe, BJ				Han, Hong; Irimia, Manuel; Ross, P. Joel; Sung, Hoon-Ki; Alipanahi, Babak; David, Laurent; Golipour, Azadeh; Gabut, Mathieu; Michael, Iacovos P.; Nachman, Emil N.; Wang, Eric; Trcka, Dan; Thompson, Tadeo; O'Hanlon, Dave; Slobodeniuc, Valentina; Barbosa-Morais, Nuno L.; Burge, Christopher B.; Moffat, Jason; Frey, Brendan J.; Nagy, Andras; Ellis, James; Wrana, Jeffrey L.; Blencowe, Benjamin J.			MBNL proteins repress ES-cell-specific alternative splicing and reprogramming	NATURE			English	Article							PLURIPOTENT STEM-CELLS; LARGE GENE LISTS; TRANSCRIPTIONAL NETWORK; MUSCLEBLIND PROTEINS; SELF-RENEWAL; DIFFERENTIATION; FIBROBLASTS; INTEGRATION; REGULATORS; PATHWAYS	Previous investigations of the core gene regulatory circuitry that controls the pluripotency of embryonic stem (ES) cells have largely focused on the roles of transcription, chromatin and non-coding RNA regulators(1-3). Alternative splicing represents a widely acting mode of gene regulation(4-8), yet its role in regulating ES-cell pluripotency and differentiation is poorly understood. Here we identify the muscleblind-like RNA binding proteins, MBNL1 and MBNL2, as conserved and direct negative regulators of a large program of cassette exon alternative splicing events that are differentially regulated between ES cells and other cell types. Knockdown of MBNL proteins in differentiated cells causes switching to an ES-cell-like alternative splicing pattern for approximately half of these events, whereas overexpression of MBNL proteins in ES cells promotes differentiated-cell-like alternative splicing patterns. Among the MBNL-regulated events is an ES-cell-specific alternative splicing switch in the forkhead family transcription factor FOXP1 that controls pluripotency(9). Consistent with a central and negative regulatory role for MBNL proteins in pluripotency, their knockdown significantly enhances the expression of key pluripotency genes and the formation of induced pluripotent stem cells during somatic cell reprogramming.	[Han, Hong; Irimia, Manuel; Gabut, Mathieu; Nachman, Emil N.; O'Hanlon, Dave; Slobodeniuc, Valentina; Barbosa-Morais, Nuno L.; Moffat, Jason; Frey, Brendan J.; Blencowe, Benjamin J.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Han, Hong; Irimia, Manuel; Gabut, Mathieu; Nachman, Emil N.; O'Hanlon, Dave; Slobodeniuc, Valentina; Barbosa-Morais, Nuno L.; Moffat, Jason; Frey, Brendan J.; Blencowe, Benjamin J.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Han, Hong; Golipour, Azadeh; Nachman, Emil N.; Moffat, Jason; Ellis, James; Wrana, Jeffrey L.; Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Ross, P. Joel; Thompson, Tadeo; Ellis, James] Hosp Sick Children, Toronto, ON M5G 1L7, Canada; [Sung, Hoon-Ki; Michael, Iacovos P.; Nagy, Andras] Mt Sinai Hosp, Ctr Stem Cells & Tissue Engn, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Alipanahi, Babak; Frey, Brendan J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; [David, Laurent; Golipour, Azadeh; Trcka, Dan; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Wang, Eric; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Barbosa-Morais, Nuno L.] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Nagy, Andras] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Massachusetts Institute of Technology (MIT); Universidade de Lisboa; University of Toronto	Blencowe, BJ (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada.	b.blencowe@utoronto.ca	Ross, Joel/K-3361-2019; Wrana, Jeffrey/F-8857-2013; Sung, Hoon-Ki/A-1922-2016; Irimia, Manuel/E-3040-2010; Burge, Christopher B./AAH-2177-2020; Michael, Iacovos P/C-8695-2016; GABUT, Mathieu/M-7624-2017; Moffat, Jason/AAC-1110-2020; Barbosa-Morais, Nuno L/I-2743-2013; Hoon, Dave SB/C-7146-2018; Nagy, Andras/G-6465-2013; Ellis, James/F-4789-2011	Ross, Joel/0000-0001-7105-7117; Sung, Hoon-Ki/0000-0001-6677-9385; Irimia, Manuel/0000-0002-2179-2567; Michael, Iacovos P/0000-0001-7674-1233; GABUT, Mathieu/0000-0001-7343-5361; Moffat, Jason/0000-0002-5663-8586; Barbosa-Morais, Nuno L/0000-0002-1215-0538; Hoon, Dave SB/0000-0003-1915-3683; Nagy, Andras/0000-0003-4311-0413; Ellis, James/0000-0002-4400-0091; Alipanahi, Babak/0000-0001-8216-7178; David, Laurent/0000-0003-3594-0353; Han, Hong/0000-0001-8977-9679	Canadian Institutes of Health Research (CIHR); Ontario Research Fund; Canadian Stem Cell Network; National Institutes of Health [R33MH087908]; University of Toronto; Ontario Stem Cell Initiative; Human Frontiers Science Program Organization; Marie Curie Actions; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087908] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Canadian Stem Cell Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Toronto(University of Toronto); Ontario Stem Cell Initiative; Human Frontiers Science Program Organization(Human Frontier Science Program); Marie Curie Actions(European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank U. Braunschweig, J. Ellis, S. Gueroussov and B. Raj for comments on the manuscript. We acknowledge D. Torti in the Donnelly Sequencing Centre for sequencing samples; L. Lee for assisting with the splicing code analysis; J. Garner (Hospital for Sick Children Embryonic Stem Cell Facility) for preparing feeder cells; A. Piekna for morphological examination of human iPSC colonies; M. Narimatsu for assisting with chimaerism analysis; and P. Mero for assisting with cell imaging. This work was supported by grants from the Canadian Institutes of Health Research (CIHR) (to B. J. B., J. L. W., A.N., J. E. and B. J. F.), the Ontario Research Fund (to J. L. W., B. J. B., A.N. and others), the Canadian Stem Cell Network (to A.N. and B. J. B.), and by a grant from the National Institutes of Health (R33MH087908) to J. E. H. H. was supported by a University of Toronto Open Fellowship. P. J. R., M. I. and N.L.B.-M. were supported by postdoctoral fellowships from the Ontario Stem Cell Initiative, Human Frontiers Science Program Organization, and the Marie Curie Actions, respectively.	Bao XC, 2013, CURR OPIN CELL BIOL, V25, P208, DOI 10.1016/j.ceb.2012.12.004; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Charizanis K, 2012, NEURON, V75, P437, DOI 10.1016/j.neuron.2012.05.029; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Fernandez-Costa JM, 2011, BIOL REV, V86, P947, DOI 10.1111/j.1469-185X.2011.00180.x; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Hotta A, 2009, NAT PROTOC, V4, P1828, DOI 10.1038/nprot.2009.201; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irimia M, 2012, CURR OPIN CELL BIOL, V24, P323, DOI 10.1016/j.ceb.2012.03.005; Irimia M, 2009, BIOESSAYS, V31, P40, DOI 10.1002/bies.080092; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Labbe RM, 2012, STEM CELLS, V30, P1734, DOI 10.1002/stem.1144; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Mayshar Y, 2008, STEM CELLS, V26, P767, DOI 10.1634/stemcells.2007-1037; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Polo JM, 2010, CELL STEM CELL, V7, P5, DOI 10.1016/j.stem.2010.05.018; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xiong HY, 2011, BIOINFORMATICS, V27, P2554, DOI 10.1093/bioinformatics/btr444; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	38	204	209	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					241	+		10.1038/nature12270	http://dx.doi.org/10.1038/nature12270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23739326	Green Submitted, Green Accepted			2022-12-01	WOS:000320283400051
J	Kato, H; Jiang, JS; Zhou, BR; Rozendaal, M; Feng, HQ; Ghirlando, R; Xiao, TS; Straight, AF; Bai, YW				Kato, Hidenori; Jiang, Jiansheng; Zhou, Bing-Rui; Rozendaal, Marieke; Feng, Hanqiao; Ghirlando, Rodolfo; Xiao, T. Sam; Straight, Aaron F.; Bai, Yawen			A Conserved Mechanism for Centromeric Nucleosome Recognition by Centromere Protein CENP-C	SCIENCE			English	Article							A NUCLEOSOMES; FUNCTIONAL DISSECTION; KINETOCHORE PROTEIN; CHROMATIN; COMPLEX; DNA; DOMAIN; NMR	Chromosome segregation during mitosis requires assembly of the kinetochore complex at the centromere. Kinetochore assembly depends on specific recognition of the histone variant CENP-A in the centromeric nucteosome by centromere protein C (CENP-C). We have defined the determinants of this recognition mechanism and discovered that CENP-C binds a hydrophobic region in the CENP-A tail and docks onto the acidic patch of histone H2A and H2B. We further found that the more broadly conserved CENP-C motif uses the same mechanism for CENP-A nucteosome recognition. Our findings reveal a conserved mechanism for protein recruitment to centromeres and a histone recognition mode whereby a disordered peptide binds the histone tail through hydrophobic interactions facilitated by nucleosome docking.	[Kato, Hidenori; Zhou, Bing-Rui; Feng, Hanqiao; Bai, Yawen] NCI, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA; [Jiang, Jiansheng; Xiao, T. Sam] NIAID, Immunol Lab, Bethesda, MD 20892 USA; [Rozendaal, Marieke; Straight, Aaron F.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Ghirlando, Rodolfo] NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bai, YW (corresponding author), NCI, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA.	yawen@helix.nih.gov	Xiao, Tsan/I-7616-2013; Xiao, Tsan Sam/A-8590-2010	Xiao, Tsan/0000-0001-9688-475X; Xiao, Tsan Sam/0000-0001-9688-475X; Zhou, Bing-Rui/0000-0002-5375-7977; Straight, Aaron/0000-0001-5885-7881; Jiang, Jiansheng/0000-0003-0964-5481	National Cancer Institute; National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; NIH [R01 GM074728]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; U.S. Department of Energy [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [ZIABC010808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074728] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advanced Photon Source (APS) (23-ID beamline) for technical support; C. Carroll for initial participation of the project; J. Barrowman for manuscript editing; A. Kelly, C. Wu, and C. Klee for comments; H. Kurumizaka and K. Morikawa for human histone plasmids and advice for CENP-A nucleosome reconstitution; and S. Tan for the 601 DNA prasmid. Supported by the intramural programs of the National Cancer Institute (H.K., H.F., B.-R.Z, and Y.B.); the National Institute of Allergy and Infectious Diseases (J.J. and T.S.X.); the National Institute of Diabetes and Digestive and Kidney Diseases (R.G.); NIH grant R01 GM074728 (M.R. and A.F.S.); and National Cancer Institute grant Y1-CO-1020, National Institute of General Medical Sciences grant Y1-GM-1104, and U.S. Department of Energy grant DE-AC02-06CH11357 (APS). The structure PDB ID is 4INM.	Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Black B, 2011, CELL, V144, P471, DOI 10.1016/j.cell.2011.02.002; Bock LJ, 2012, NAT CELL BIOL, V14, P614, DOI 10.1038/ncb2495; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cohen RL, 2008, MOL BIOL CELL, V19, P4480, DOI 10.1091/mbc.E08-03-0297; Guse A, 2011, NATURE, V477, P354, DOI 10.1038/nature10379; Heeger S, 2005, GENE DEV, V19, P2041, DOI 10.1101/gad.347805; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Kato H, 2011, P NATL ACAD SCI USA, V108, P12283, DOI 10.1073/pnas.1105848108; Khorasanizadeh S, 2011, CURR OPIN STRUC BIOL, V21, P744, DOI 10.1016/j.sbi.2011.10.001; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Milks KJ, 2009, MOL BIOL CELL, V20, P4246, DOI 10.1091/mbc.E09-05-0378; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Schleiffer A, 2012, NAT CELL BIOL, V14, P604, DOI 10.1038/ncb2493; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Song K, 2002, EXP CELL RES, V275, P81, DOI 10.1006/excr.2002.5495; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Tanaka K, 2009, DEV CELL, V17, P334, DOI 10.1016/j.devcel.2009.08.004; Trazzi S, 2002, J STRUCT BIOL, V140, P39, DOI 10.1016/S1047-8477(02)00506-3; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004	28	220	221	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1110	1113		10.1126/science.1235532	http://dx.doi.org/10.1126/science.1235532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723239	Green Accepted			2022-12-01	WOS:000319664500048
J	Mulcahy, A; Harris, K; Finegold, K; Kellermann, A; Edelman, L; Sommers, BD				Mulcahy, Andrew; Harris, Katherine; Finegold, Kenneth; Kellermann, Arthur; Edelman, Laurel; Sommers, Benjamin D.			Insurance Coverage of Emergency Care for Young Adults under Health Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; ACT; ECONOMICS; POLICIES; ACCESS	BACKGROUND The Affordable Care Act (ACA) established nationwide eligibility for young adults 19 to 25 years of age to retain coverage under their parents' private health plans. We conducted a study to determine how the implementation of this provision changed rates of insurance coverage for young adults seeking medical care for major emergencies. METHODS We evaluated more than 480,000 nondiscretionary visits made to emergency departments from 2009 through 2011, as recorded in a large, geographically diverse data set of hospital claims, to estimate how the ACA provision affected private insurance coverage of such visits by young adults (19 to 25 years of age). To adjust for underlying trends in insurance coverage, we compared changes in the target age group with changes among adults 26 to 31 years of age, who were unaffected by the provision (control group). RESULTS After the ACA provision took effect, private coverage of nondiscretionary visits to emergency departments by young adults increased by 3.1 percentage points (95% confidence interval [CI], 2.3 to 3.9; relative increase, 5.2%; P<0.001), as compared with similar visits in the control group. The percentage of visits by uninsured young adults also fell significantly (-1.7 percentage points; 95% CI, -2.8 to -0.7; relative decrease, 9.1%; P<0.001). The rates of nondiscretionary visits that were covered by Medicaid or other nonprivate insurers remained relatively steady throughout the study period. The coverage expansion led to an estimated 22,072 visits to emergency departments by newly insured young adults and $147 million in associated costs that were covered by private insurance plans during a 1-year period. CONCLUSIONS Enactment of the dependent-coverage provision was associated with a significant increase in the proportion of young adults who were protected from the financial consequences of a serious medical emergency.	[Mulcahy, Andrew; Harris, Katherine; Kellermann, Arthur] RAND, Arlington, VA USA; [Finegold, Kenneth; Sommers, Benjamin D.] Off Assistant Secretary Planning & Evaluat, Dept Hlth & Human Serv, Washington, DC USA; [Edelman, Laurel] IMS Hlth, Plymouth Meeting, PA USA; [Sommers, Benjamin D.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	RAND Corporation; Harvard University; Harvard T.H. Chan School of Public Health	Mulcahy, A (corresponding author), 1200 S Hayes St, Arlington, VA 22202 USA.	amulcahy@rand.org			Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services [HHSP23320095649WC]	Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services	Funded by the Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services.; Supported by a contract with the Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services (HHSP23320095649WC).	[Anonymous], 2009, NAT EM DEP SAMPL; [Anonymous], 2009, ANN SURV DAT FISC YE; [Anonymous], 2012, NUMBER YOUNG ADULTS; [Anonymous], 2010, INCOME POVERTY HLTH; Antwi YA, 2012, EFFECTS FEDERAL POLI; Bureau of Labor Statistics, LAB FORC STAT CURR P; Callahan ST, 2005, PEDIATRICS, V116, P88, DOI 10.1542/peds.2004-1449; Cantor JC, 2012, HEALTH SERV RES, V47, P1773, DOI 10.1111/j.1475-6773.2012.01458.x; DeNavas-Walt C., 2012, INCOME POVERTY HLTH; Hadley J, 2008, HEALTH AFFAIR, V27, pW399, DOI 10.1377/hlthaff.27.5.w399; Hsia RY, 2011, JAMA-J AM MED ASSOC, V305, P1978, DOI 10.1001/jama.2011.620; Institute of Medicine Committee on the Consequences of Uninsurance, 2002, HLTH INS IS FAM MATT; Institute of Medicine (US) Committee on the Consequences of Uninsurance, 2001, COV MATT INS HLTH CA; Levine PB, 2011, AM ECON J-ECON POLIC, V3, P129, DOI 10.1257/pol.3.1.129; MANNING WG, 1987, AM ECON REV, V77, P251; MEYER BD, 1995, J BUS ECON STAT, V13, P151, DOI 10.2307/1392369; Monheit AC, 2011, HEALTH SERV RES, V46, P251, DOI 10.1111/j.1475-6773.2010.01200.x; National Conference of State Legislatures, COV YOUNG AD THEIR P; Nicholson JL, 2009, RITE PASSAGE WHY YOU; PAULY MV, 1968, AM ECON REV, V58, P531; Sommers BD, 2011, 2 5 MILLION YOUNG AD; Sommers BD, 2013, HEALTH AFFAIR, V32, P165, DOI 10.1377/hlthaff.2012.0552; Sommers BD, 2012, JAMA-J AM MED ASSOC, V307, P913, DOI 10.1001/jama.307.9.913; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112	24	67	67	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					2105	2112		10.1056/NEJMsa1212779	http://dx.doi.org/10.1056/NEJMsa1212779			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AT	23718165	Green Published			2022-12-01	WOS:000319574200008
J	Sonati, T; Reimann, RR; Falsig, J; Baral, PK; O'Connor, T; Hornemann, S; Yaganoglu, S; Li, B; Herrmann, US; Wieland, B; Swayampakula, M; Rahman, MH; Das, D; Kav, N; Riek, R; Liberski, PP; James, MNG; Aguzzi, A				Sonati, Tiziana; Reimann, Regina R.; Falsig, Jeppe; Baral, Pravas Kumar; O'Connor, Tracy; Hornemann, Simone; Yaganoglu, Sine; Li, Bei; Herrmann, Uli S.; Wieland, Barbara; Swayampakula, Mridula; Rahman, Muhammad Hafizur; Das, Dipankar; Kav, Nat; Riek, Roland; Liberski, Pawel P.; James, Michael N. G.; Aguzzi, Adriano			The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein	NATURE			English	Article							PRP KNOCKOUT MICE; MACROMOLECULAR CRYSTALLOGRAPHY; MOUSE MODEL; NMR; DISEASE; SCRAPIE; DOMAIN; NEURODEGENERATION; SUSCEPTIBILITY; INFECTION	Prion infections cause lethal neurodegeneration. This process requires the cellular prion protein (PrPC; ref. 1), which contains a globular domain hinged to a long amino-proximal flexible tail(2). Here we describe rapid neurotoxicity in mice and cerebellar organotypic cultured slices exposed to ligands targeting the alpha 1 and alpha 3 helices of the PrPC globular domain. Ligands included seven distinct monoclonal antibodies(3), monovalent Fab(1) fragments and recombinant single-chain variable fragment miniantibodies. Similar to prion infections(4-6), the toxicity of globular domain ligands required neuronal PrPC, was exacerbated by PrPC overexpression, was associated with calpain activation and was antagonized by calpain inhibitors. Neurodegeneration was accompanied by a burst of reactive oxygen species, and was suppressed by antioxidants. Furthermore, genetic ablation of the superoxide-producing enzyme NOX2 (also known as CYBB) protected mice from globular domain ligand toxicity. We also found that neurotoxicity was prevented by deletions of the octapeptide repeats within the flexible tail. These deletions did not appreciably compromise globular domain antibody binding, suggesting that the flexible tail is required to transmit toxic signals that originate from the globular domain and trigger oxidative stress and calpain activation. Supporting this view, various octapeptide ligands were not only innocuous to both cerebellar organotypic cultured slices and mice, but also prevented the toxicity of globular domain ligands while not interfering with their binding. We conclude that PrPC consists of two functionally distinct modules, with the globular domain and the flexible tail exerting regulatory and executive functions, respectively. Octapeptide ligands also prolonged the life of mice expressing the toxic PrPC mutant(7), PrP(Lambda 94-134), indicating that the flexible tail mediates toxicity in two distinct PrPC-related conditions. Flexible tail-mediated toxicity may conceivably play a role in further prion pathologies, such as familial Creutzfeldt-Jakob disease in humans bearing supernumerary octapeptides.	[Sonati, Tiziana; Reimann, Regina R.; Falsig, Jeppe; O'Connor, Tracy; Hornemann, Simone; Yaganoglu, Sine; Li, Bei; Herrmann, Uli S.; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Baral, Pravas Kumar; Wieland, Barbara; Swayampakula, Mridula; James, Michael N. G.] Univ Alberta, Fac Med & Dent, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Rahman, Muhammad Hafizur; Das, Dipankar; Kav, Nat] Univ Alberta, Dept Agr Food & Nutr Sci, Agr Forestry Ctr 410, Edmonton, AB T6G 2P5, Canada; [Riek, Roland] ETH Honggerberg, ETH Zurich, CH-8093 Zurich, Switzerland; [Liberski, Pawel P.] Med Univ Lodz, Dept Mol Pathol & Neuropathol, Lab Electron Microscopy & Neuropathol, PL-92216 Lodz, Poland	University of Zurich; University Zurich Hospital; University of Alberta; University of Alberta; Swiss Federal Institutes of Technology Domain; ETH Zurich; Medical University Lodz	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	Adriano.Aguzzi@usz.ch	Reimann, Regina R./A-1195-2016	Reimann, Regina R./0000-0002-6396-4195; Riek, Roland/0000-0002-6333-066X; Herrmann, Uli Simon/0000-0002-1327-5199; James, Michael/0000-0002-5978-4562; Aguzzi, Adriano/0000-0002-0344-6708	European Research Council; European Union; Swiss National Foundation; Foundation Alliance BioSecure; Clinical Research Priority Program (KFSP) of the University of Zurich; Novartis Research Foundation; PrioNet Canada; Alberta Prion Research Institute (APRI); Polish Swiss Research [PSPB-062/2010]	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Foundation Alliance BioSecure; Clinical Research Priority Program (KFSP) of the University of Zurich; Novartis Research Foundation; PrioNet Canada; Alberta Prion Research Institute (APRI); Polish Swiss Research	We thank S. Izui, H. Monyer, D. Burton and G. Mallucci for reagents and mice, S. Schauer and the Functional Genomics Center Zurich for advice and help with affinity determinations, A. Steingotter, U. Ungethum, M. Polymenidou, A. Lau and A. Keller for input, R. Moos, B. Sikorska, C. Tiberi, P. Schwarz, A. Varol, K. Arroyo and M. Delic for technical help. A. A. is the recipient of an Advanced Grant of the European Research Council and is supported by grants from the European Union (PRIORITY, LUPAS and NEURINOX), the Swiss National Foundation, the Foundation Alliance BioSecure, the Clinical Research Priority Program (KFSP) of the University of Zurich, and the Novartis Research Foundation. J. F. is supported by a career development award of the University of Zurich. Research support from PrioNet Canada and Alberta Prion Research Institute (APRI) for the work conducted in the Canadian laboratories is gratefully acknowledged. P. P. L. and A. A. are supported by Polish Swiss Research grant nr PSPB-062/2010. This paper is dedicated to the memory of Dr Marek Fischer, who created the tga20 mouse line.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Aller MI, 2003, GENESIS, V36, P97, DOI 10.1002/gene.10204; Baral PK, 2011, ACTA CRYSTALLOGR F, V67, P1211, DOI 10.1107/S1744309111026273; Baudino L, 2007, BLOOD, V109, P5355, DOI 10.1182/blood-2006-11-059899; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Das D, 2005, PROTEIN EXPRES PURIF, V39, P199, DOI 10.1016/j.pep.2004.10.007; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faas H, 2010, NEUROIMAGE, V49, P2607, DOI 10.1016/j.neuroimage.2009.10.009; Falsig J, 2008, NAT PROTOC, V3, P555, DOI 10.1038/nprot.2008.13; Falsig J, 2008, NAT NEUROSCI, V11, P109, DOI 10.1038/nn2028; Falsig J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002985; Fatokun AA, 2008, FRONT BIOSCI-LANDMRK, V13, P3288, DOI 10.2741/2926; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Gonzalez A, 2008, J APPL CRYSTALLOGR, V41, P176, DOI 10.1107/S0021889807057822; Granados-Principal S, 2010, NUTR REV, V68, P191, DOI 10.1111/j.1753-4887.2010.00278.x; Grunecker B, 2010, NMR BIOMED, V23, P913, DOI 10.1002/nbm.1508; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hornemann S, 2009, FEBS J, V276, P2359, DOI 10.1111/j.1742-4658.2009.06968.x; Keller R., 2004, COMPUTER AIDED RESON; Krasemann S, 1995, Brain Res Mol Brain Res, V34, P173; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; Lysek DA, 2004, BIOCHEMISTRY-US, V43, P10393, DOI 10.1021/bi0494828; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mead S, 2006, BRAIN, V129, P2297, DOI 10.1093/brain/awl226; Meier P, 2003, CELL, V113, P49, DOI 10.1016/S0092-8674(03)00201-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Prinz M, 2004, J NEUROSCI, V24, P5974, DOI 10.1523/JNEUROSCI.0122-04.2004; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Riek R., 1998, THESIS ETH ZURICH; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vital C., 1999, Clinical and Experimental Pathology, V47, P153; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Yamaguchi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043540; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	55	150	151	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2013	501	7465					102	+		10.1038/nature12402	http://dx.doi.org/10.1038/nature12402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	23903654	Green Accepted			2022-12-01	WOS:000323888300040
J	Mashaghi, A; Kramer, G; Bechtluft, P; Zachmann-Brand, B; Driessen, AJM; Bukau, B; Tans, SJ				Mashaghi, Alireza; Kramer, Guenter; Bechtluft, Philipp; Zachmann-Brand, Beate; Driessen, Arnold J. M.; Bukau, Bernd; Tans, Sander J.			Reshaping of the conformational search of a protein by the chaperone trigger factor	NATURE			English	Article							SINGLE-MOLECULE; RIBOSOME; SPECTROSCOPY; DOMAIN	Protein folding is often described as a search process, in which polypeptides explore different conformations to find their native structure. Molecular chaperones are known to improve folding yields by suppressing aggregation between polypeptides before this conformational search starts(1,2), as well as by rescuing misfolds after it ends(1,3). Although chaperones have long been speculated to also affect the conformational search itself-by reshaping the underlying folding landscape along the folding trajectory(4,5)-direct experimental evidence has been scarce so far. In Escherichia coli, the general chaperone trigger factor(6-8) (TF) could play such a role. TF has been shown to interact with nascent chains at the ribosome(9,10), with polypeptides released from the ribosome into the cytosol(11), and with fully folded proteins before their assembly into larger complexes(12). To investigate the effect of TF from E. coli on the conformational search of polypeptides to their native state, we investigated individual maltose binding protein (MBP) molecules using optical tweezers. Here we show that TF binds folded structures smaller than one domain, which are then stable for seconds and ultimately convert to the native state. Moreover, TF stimulates native folding in constructs of repeated MBP domains. The results indicate that TF promotes correct folding by protecting partially folded states from distant interactions that produce stable misfolded states. As TF interacts with most newly synthesized proteins in E. coli, we expect these findings to be of general importance in understanding protein folding pathways.	[Mashaghi, Alireza; Bechtluft, Philipp; Tans, Sander J.] FOM Inst AMOLF, NL-1098 XG Amsterdam, Netherlands; [Kramer, Guenter; Zachmann-Brand, Beate; Bukau, Bernd] Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Allianz, D-69120 Heidelberg, Germany; [Driessen, Arnold J. M.] Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, NL-9749 AG Groningen, Netherlands; [Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, NL-9749 AG Groningen, Netherlands	AMOLF; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Groningen; University of Groningen	Tans, SJ (corresponding author), FOM Inst AMOLF, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands.	tans@amolf.nl	Tans, Sander/AAS-2901-2020; Mashaghi, Alireza/Q-8218-2017; Institute, Zernike/W-7033-2019; Driessen, Arnold J.M./D-1876-2012	Mashaghi, Alireza/0000-0002-2157-1211; Kramer, Gunter/0000-0001-7552-8393; Bukau, Bernd/0000-0003-0521-7199; Driessen, Arnold J.M./0000-0001-9258-9104	Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO); Deutsche Forschungsgemeinschaft [SFB 638, FOR967]	Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Work in the laboratory of S.J.T. is part of the research programme of the Stichting voor Fundamenteel Onderzoek der Materie (FOM), which is financially supported by the Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO). Work in the laboratory of B.B. and G.K. is supported by grants from the Deutsche Forschungsgemeinschaft (SFB 638, FOR967). We are grateful to M. Meyer for his support in performing and analysing FTIR experiments. We thank T. Shimizu, L. Guilbride, M. Dogterom and members of the Tans group for critical reading of the manuscript.	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592; Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972; Bertz M, 2008, J MOL BIOL, V378, P447, DOI 10.1016/j.jmb.2008.02.025; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; Cao Y, 2007, P NATL ACAD SCI USA, V104, P15677, DOI 10.1073/pnas.0705367104; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Fisher TE, 2000, NAT STRUCT BIOL, V7, P719; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hoffmann A, 2012, MOL CELL, V48, P63, DOI 10.1016/j.molcel.2012.07.018; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Jaenicke R, 1999, PROG BIOPHYS MOL BIO, V71, P155, DOI 10.1016/S0079-6107(98)00032-7; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Lakshmipathy SK, 2010, J BIOL CHEM, V285, P27911, DOI 10.1074/jbc.M110.134163; Maier R, 2001, J MOL BIOL, V314, P1181, DOI 10.1006/jmbi.2000.5192; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Martinez-Hackert E, 2009, CELL, V138, P923, DOI 10.1016/j.cell.2009.07.044; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Park S, 2007, BIOPHYS J, V93, P4108, DOI 10.1529/biophysj.107.108100; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; Thomas PD, 1996, P NATL ACAD SCI USA, V93, P11628, DOI 10.1073/pnas.93.21.11628; Wegrzyn RD, 2005, CELL MOL LIFE SCI, V62, P2727, DOI 10.1007/s00018-005-5292-z	30	90	92	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2013	500	7460					98	U125		10.1038/nature12293	http://dx.doi.org/10.1038/nature12293			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23831649				2022-12-01	WOS:000322514800036
J	Zhang, QY; Shi, JZ; Deng, GH; Guo, J; Zeng, XY; He, XJ; Kong, HH; Gu, CY; Li, XY; Liu, JX; Wang, GJ; Chen, Y; Liu, LL; Liang, LB; Li, YY; Fan, J; Wang, JL; Li, WH; Guan, LZ; Li, QM; Yang, HL; Chen, PC; Jiang, L; Guan, YT; Xin, XG; Jiang, YP; Tian, GB; Wang, XR; Qiao, CL; Li, CJ; Bu, ZG; Chen, HL				Zhang, Qianyi; Shi, Jianzhong; Deng, Guohua; Guo, Jing; Zeng, Xianying; He, Xijun; Kong, Huihui; Gu, Chunyang; Li, Xuyong; Liu, Jinxiong; Wang, Guojun; Chen, Yan; Liu, Liling; Liang, Libin; Li, Yuanyuan; Fan, Jun; Wang, Jinliang; Li, Wenhui; Guan, Lizheng; Li, Qimeng; Yang, Huanliang; Chen, Pucheng; Jiang, Li; Guan, Yuntao; Xin, Xiaoguang; Jiang, Yongping; Tian, Guobin; Wang, Xiurong; Qiao, Chuanling; Li, Chengjun; Bu, Zhigao; Chen, Hualan			H7N9 Influenza Viruses Are Transmissible in Ferrets by Respiratory Droplet	SCIENCE			English	Article							SINGLE AMINO-ACID; A VIRUS; RECEPTOR SPECIFICITY; MOLECULAR-BASIS; MOUSE MODEL; GUINEA-PIG; HOST-RANGE; HEMAGGLUTININ; POULTRY; HUMANS	A newly emerged H7N9 virus has caused 132 human infections with 37 deaths in China since 18 February 2013. Control measures in H7N9 virus-positive live poultry markets have reduced the number of infections; however, the character of the virus, including its pandemic potential, remains largely unknown. We systematically analyzed H7N9 viruses isolated from birds and humans. The viruses were genetically closely related and bound to human airway receptors; some also maintained the ability to bind to avian airway receptors. The viruses isolated from birds were nonpathogenic in chickens, ducks, and mice; however, the viruses isolated from humans caused up to 30% body weight loss in mice. Most importantly, one virus isolated from humans was highly transmissible in ferrets by respiratory droplet. Our findings indicate nothing to reduce the concern that these viruses can transmit between humans.	[Zhang, Qianyi; Shi, Jianzhong; Deng, Guohua; Guo, Jing; Zeng, Xianying; He, Xijun; Kong, Huihui; Gu, Chunyang; Li, Xuyong; Liu, Jinxiong; Wang, Guojun; Chen, Yan; Liu, Liling; Liang, Libin; Li, Yuanyuan; Fan, Jun; Wang, Jinliang; Li, Wenhui; Guan, Lizheng; Li, Qimeng; Yang, Huanliang; Chen, Pucheng; Jiang, Li; Guan, Yuntao; Xin, Xiaoguang; Jiang, Yongping; Tian, Guobin; Wang, Xiurong; Qiao, Chuanling; Li, Chengjun; Bu, Zhigao; Chen, Hualan] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China; [Zhang, Qianyi; Gu, Chunyang; Wang, Guojun; Li, Qimeng; Chen, Hualan] Gansu Agr Univ, Coll Vet Med, Lanzhou 730030, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Gansu Agricultural University	Chen, HL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China.	chenhualan@caas.cn	xuyong, li/CAG-6328-2022; He, Xijun/GQO-9594-2022; li, Yuanyuan/AAX-3953-2020; Li, Chengjun/GWM-7661-2022; Yang, Huanliang/GRX-5540-2022	li, Yuanyuan/0000-0001-8467-9759; 	Ministry of Agriculture [CARS-42-G08]; Ministry of Science and Technology [KJYJ-2013-01-01, 2012ZX10004214]	Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	We thank S. Watson for editing the manuscript, Y. Shu from the China Centers for Disease Control and Prevention for providing the H7N9 viruses isolated from humans, and the Consortium for Functional Glycomics (Scripps Research Institute, Department of Molecular Biology, La Jolla, CA) for providing the glycans. This work was supported by the Ministry of Agriculture (CARS-42-G08) and by the Ministry of Science and Technology (KJYJ-2013-01-01 and 2012ZX10004214). Virus sequence data from this study were deposited in GenBank with the accession numbers CY146905 to CY147200 and in Global Initiative on Sharing Avian Influenza Data with the accession numbers EPI440678 to 440701 and EIP457614 to 457885.	[Anonymous], 2011, MANUAL DIAGNOSTIC TE; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Li Q., 2013, NEW ENGL J MED, DOI [DOI 10.1056/NEJMOA1304617, 23614499]; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Seibert CW, 2010, J VIROL, V84, P11219, DOI 10.1128/JVI.01424-10; Shi JZ, 2013, CHINESE SCI BULL, V58, P1857, DOI 10.1007/s11434-013-5873-4; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; World Health Organization, 2013, NUMB CONF HUM CAS AV; Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455; Zhang Y, 2012, J VIROL, V86, P9666, DOI 10.1128/JVI.00958-12	25	315	369	4	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2013	341	6144					410	414		10.1126/science.1240532	http://dx.doi.org/10.1126/science.1240532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23868922				2022-12-01	WOS:000322259200053
J	Haiser, HJ; Gootenberg, DB; Chatman, K; Sirasani, G; Balskus, EP; Turnbaugh, PJ				Haiser, Henry J.; Gootenberg, David B.; Chatman, Kelly; Sirasani, Gopal; Balskus, Emily P.; Turnbaugh, Peter J.			Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta	SCIENCE			English	Article							DIGOXIN; FLORA	Despite numerous examples of the effects of the human gastrointestinal microbiome on drug efficacy and toxicity, there is often an incomplete understanding of the underlying mechanisms. Here, we dissect the inactivation of the cardiac drug digoxin by the gut Actinobacterium Eggerthella lenta. Transcriptional profiling, comparative genomics, and culture-based assays revealed a cytochrome-encoding operon up-regulated by digoxin, inhibited by arginine, absent in nonmetabolizing E. lenta strains, and predictive of digoxin inactivation by the human gut microbiome. Pharmacokinetic studies using gnotobiotic mice revealed that dietary protein reduces the in vivo microbial metabolism of digoxin, with significant changes to drug concentration in the serum and urine. These results emphasize the importance of viewing pharmacology from the perspective of both our human and microbial genomes.	[Haiser, Henry J.; Gootenberg, David B.; Chatman, Kelly; Turnbaugh, Peter J.] Harvard Univ, Ctr Syst Biol, FAS, Cambridge, MA 02138 USA; [Sirasani, Gopal; Balskus, Emily P.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Turnbaugh, PJ (corresponding author), Harvard Univ, Ctr Syst Biol, FAS, Cambridge, MA 02138 USA.	pturnbaugh@fas.harvard.edu	Haiser, Henry/AAN-5187-2020	Turnbaugh, Peter/0000-0002-0888-2875; Gootenberg, David/0000-0001-5416-106X	NIH [P50 GM068763]; Harvard Digestive Diseases Center [2P30DK034854-26]; Canadian Institutes of Health Research [MFE-112991]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	B. Budnik and S. Trauger for liquid chromatography-mass spectrometry (LC-MS) analyses; V. Yeliseyev, A. Liou, and R. Carmody for mouse studies; C. Reardon and C. Daly for sequencing support; C. Maurice, L. David, R. Dutton, B. Wolfe, J. Button, M. Elliot, Y. Falanga, R. Losick, A. Murray, and B. Stern for helpful discussions. Mouse experiments were done with the generous support of the Harvard Digestive Diseases Center and the University of North Carolina gnotobiotic cores. This work was supported by grants from the NIH (P50 GM068763) and the Harvard Digestive Diseases Center (2P30DK034854-26). H. J. H. is supported by the Canadian Institutes of Health Research (MFE-112991). RNA-Seq data are deposited in the Gene Expression Omnibus (GEO) database (accession GSE43919).	Brunton LL, 2011, GOODMAN GILMANS PHAR; DOBKIN JF, 1983, SCIENCE, V220, P325; Farr CD, 2002, BIOCHEMISTRY-US, V41, P1137, DOI 10.1021/bi011511g; Haiser HJ, 2012, SCIENCE, V336, P1253, DOI 10.1126/science.1224396; LINDENBAUM J, 1981, NEW ENGL J MED, V305, P789, DOI 10.1056/NEJM198110013051403; MATHAN VI, 1989, GUT, V30, P971, DOI 10.1136/gut.30.7.971; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Saunders E, 2009, STAND GENOMIC SCI, V1, P174, DOI 10.4056/sigs.33592; SPERRY JF, 1976, J BACTERIOL, V127, P780, DOI 10.1128/JB.127.2.780-784.1976; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175	11	366	387	2	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 19	2013	341	6143					295	298		10.1126/science.1235872	http://dx.doi.org/10.1126/science.1235872			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869020	Green Accepted, Green Submitted			2022-12-01	WOS:000321959300049
J	Darnovsky, M				Darnovsky, Marcy			A slippery slope to human germline modification	NATURE			English	Editorial Material									Ctr Genet & Soc, Berkeley, CA USA		Darnovsky, M (corresponding author), Ctr Genet & Soc, Berkeley, CA USA.	darnovsky@geneticsandsociety.org						Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391	1	23	23	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2013	499	7457					127	127		10.1038/499127a	http://dx.doi.org/10.1038/499127a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	179YA	23846625	Bronze			2022-12-01	WOS:000321557600006
J	Lawrence, MS; Stojanov, P; Polak, P; Kryukov, GV; Cibulskis, K; Sivachenko, A; Carter, SL; Stewart, C; Mermel, CH; Roberts, SA; Kiezun, A; Hammerman, PS; McKenna, A; Drier, Y; Zou, LH; Ramos, AH; Pugh, TJ; Stransky, N; Helman, E; Kim, J; Sougnez, C; Ambrogio, L; Nickerson, E; Shefler, E; Cortes, ML; Auclair, D; Saksena, G; Voet, D; Noble, M; DiCara, D; Lin, P; Lichtenstein, L; Heiman, DI; Fennell, T; Imielinski, M; Hernandez, B; Hodis, E; Baca, S; Dulak, AM; Lohr, J; Landau, DA; Wu, CJ; Melendez-Zajgla, J; Hidalgo-Miranda, A; Koren, A; McCarroll, SA; Mora, J; Lee, RS; Crompton, B; Onofrio, R; Parkin, M; Winckler, W; Ardlie, K; Gabriel, SB; Roberts, CWM; Biegel, JA; Stegmaier, K; Bass, AJ; Garraway, LA; Meyerson, M; Golub, TR; Gordenin, DA; Sunyaev, S; Lander, ES; Getz, G				Lawrence, Michael S.; Stojanov, Petar; Polak, Paz; Kryukov, Gregory V.; Cibulskis, Kristian; Sivachenko, Andrey; Carter, Scott L.; Stewart, Chip; Mermel, Craig H.; Roberts, Steven A.; Kiezun, Adam; Hammerman, Peter S.; McKenna, Aaron; Drier, Yotam; Zou, Lihua; Ramos, Alex H.; Pugh, Trevor J.; Stransky, Nicolas; Helman, Elena; Kim, Jaegil; Sougnez, Carrie; Ambrogio, Lauren; Nickerson, Elizabeth; Shefler, Erica; Cortes, Maria L.; Auclair, Daniel; Saksena, Gordon; Voet, Douglas; Noble, Michael; DiCara, Daniel; Lin, Pei; Lichtenstein, Lee; Heiman, David I.; Fennell, Timothy; Imielinski, Marcin; Hernandez, Bryan; Hodis, Eran; Baca, Sylvan; Dulak, Austin M.; Lohr, Jens; Landau, Dan-Avi; Wu, Catherine J.; Melendez-Zajgla, Jorge; Hidalgo-Miranda, Alfredo; Koren, Amnon; McCarroll, Steven A.; Mora, Jaume; Lee, Ryan S.; Crompton, Brian; Onofrio, Robert; Parkin, Melissa; Winckler, Wendy; Ardlie, Kristin; Gabriel, Stacey B.; Roberts, Charles W. M.; Biegel, Jaclyn A.; Stegmaier, Kimberly; Bass, Adam J.; Garraway, Levi A.; Meyerson, Matthew; Golub, Todd R.; Gordenin, Dmitry A.; Sunyaev, Shamil; Lander, Eric S.; Getz, Gad			Mutational heterogeneity in cancer and the search for new cancer-associated genes	NATURE			English	Article							SOMATIC MUTATIONS; HUMAN-PAPILLOMAVIRUS; DNA; GENOME; LANDSCAPE; PATTERNS; IMPACT	Major international projects are underway that are aimed at creating a comprehensive catalogue of all the genes responsible for the initiation and progression of cancer(1-9). These studies involve the sequencing of matched tumour-normal samples followed by mathematical analysis to identify those genes in which mutations occur more frequently than expected by random chance. Here we describe a fundamental problem with cancer genome studies: as the sample size increases, the list of putatively significant genes produced by current analytical methods burgeons into the hundreds. The list includes many implausible genes (such as those encoding olfactory receptors and the muscle protein titin), suggesting extensive false-positive findings that overshadow true driver events. We show that this problem stems largely from mutational heterogeneity and provide a novel analytical methodology, MutSigCV, for resolving the problem. We apply MutSigCV to exome sequences from 3,083 tumour-normal pairs and discover extraordinary variation in mutation frequency and spectrum within cancer types, which sheds light on mutational processes and disease aetiology, and in mutation frequency across the genome, which is strongly correlated with DNA replication timing and also with transcriptional activity. By incorporating mutational heterogeneity into the analyses, MutSigCV is able to eliminate most of the apparent artefactual findings and enable the identification of genes truly associated with cancer.	[Lawrence, Michael S.; Stojanov, Petar; Polak, Paz; Kryukov, Gregory V.; Cibulskis, Kristian; Sivachenko, Andrey; Carter, Scott L.; Stewart, Chip; Mermel, Craig H.; Kiezun, Adam; Hammerman, Peter S.; McKenna, Aaron; Drier, Yotam; Zou, Lihua; Ramos, Alex H.; Pugh, Trevor J.; Stransky, Nicolas; Helman, Elena; Kim, Jaegil; Sougnez, Carrie; Ambrogio, Lauren; Nickerson, Elizabeth; Shefler, Erica; Cortes, Maria L.; Auclair, Daniel; Saksena, Gordon; Voet, Douglas; Noble, Michael; DiCara, Daniel; Lin, Pei; Lichtenstein, Lee; Heiman, David I.; Fennell, Timothy; Imielinski, Marcin; Hernandez, Bryan; Hodis, Eran; Baca, Sylvan; Dulak, Austin M.; Lohr, Jens; Landau, Dan-Avi; Koren, Amnon; McCarroll, Steven A.; Onofrio, Robert; Parkin, Melissa; Winckler, Wendy; Ardlie, Kristin; Gabriel, Stacey B.; Stegmaier, Kimberly; Bass, Adam J.; Garraway, Levi A.; Meyerson, Matthew; Golub, Todd R.; Sunyaev, Shamil; Lander, Eric S.; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA 02141 USA; [Stojanov, Petar; Hammerman, Peter S.; Pugh, Trevor J.; Hodis, Eran; Baca, Sylvan; Dulak, Austin M.; Lohr, Jens; Landau, Dan-Avi; Wu, Catherine J.; Lee, Ryan S.; Crompton, Brian; Roberts, Charles W. M.; Stegmaier, Kimberly; Bass, Adam J.; Garraway, Levi A.; Meyerson, Matthew; Golub, Todd R.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Polak, Paz; Kryukov, Gregory V.; Drier, Yotam; Pugh, Trevor J.; Wu, Catherine J.; Koren, Amnon; McCarroll, Steven A.; Lee, Ryan S.; Roberts, Charles W. M.; Bass, Adam J.; Garraway, Levi A.; Meyerson, Matthew; Golub, Todd R.; Sunyaev, Shamil; Lander, Eric S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Polak, Paz; Kryukov, Gregory V.; Sunyaev, Shamil] Brigham & Womens Hosp, Boston, MA 02115 USA; [Mermel, Craig H.; Drier, Yotam; Imielinski, Marcin; Getz, Gad] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Roberts, Steven A.; Gordenin, Dmitry A.] NIEHS, Lab Mol Genet, NIH, DHHS, Res Triangle Pk, NC 27709 USA; [McKenna, Aaron] Univ Washington, Seattle, WA 98195 USA; [Drier, Yotam; Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Stransky, Nicolas] Blueprint Med, Cambridge, MA 02142 USA; [Helman, Elena; Lander, Eric S.] MIT, Cambridge, MA 02139 USA; [Landau, Dan-Avi] Yale Canc Ctr, Dept Hematol, New Haven, CT 06510 USA; [Melendez-Zajgla, Jorge; Hidalgo-Miranda, Alfredo] Inst Nacl Med Genom, Mexico City 14610, DF, Mexico; [Mora, Jaume] Hosp St Joan de Deu, Dept Pediat Oncol, Barcelona 08950, Spain; [Lee, Ryan S.; Crompton, Brian; Roberts, Charles W. M.; Stegmaier, Kimberly] Boston Childrens Hosp, Boston, MA 02115 USA; [Biegel, Jaclyn A.] Childrens Hosp, Philadelphia, PA 19104 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Yale University; Instituto Nacional de Medicina Genomica; University of Barcelona; Harvard University; Boston Children's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Lander, ES (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02141 USA.	lander@broadinstitute.org; gadgetz@broadinstitute.org	Mermel, Craig/AAZ-7322-2020; Roberts, Charles/N-2541-2018; Watanabe, Naoki/L-6185-2014; Melendez-Zajgla, Jorge/A-5708-2008; Lee, Ryan/AAE-4319-2019; Cibulskis, Kristian/AAC-7380-2019; Stojanov, Petar/GQI-4462-2022; Pugh, Trevor/Y-2535-2019; Drier, Yotam/K-5208-2012; Kryukov, Gregory V/A-9592-2008; Hidalgo-Miranda, Alfredo/B-2123-2010; Dmitry, Gordenin/C-3907-2018; Polak, Paz/AAH-9380-2020; Lawrence, Michael/AAC-8202-2020	Mermel, Craig/0000-0002-0816-3395; Roberts, Charles/0000-0003-1135-1896; Watanabe, Naoki/0000-0002-5849-6112; Stojanov, Petar/0000-0001-7815-776X; Pugh, Trevor/0000-0002-8073-5888; Drier, Yotam/0000-0003-1725-2995; Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Dmitry, Gordenin/0000-0002-8399-1836; Kryukov, Gregory/0000-0002-6131-9483; Meyerson, Matthew/0000-0002-9133-8108; Mora, Jaume/0000-0002-9386-5980; Cibulskis, Kristian/0000-0003-1343-1582; Heiman, David/0000-0001-7895-4259	Intramural Research Program of the National Institute of Environmental Health Sciences (National Institutes of Health, United States Department of Health and Human Services) [ES065073]; NATIONAL CANCER INSTITUTE [T32CA009216, U24CA143845, T32CA009172] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065073, ZIAES065073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Environmental Health Sciences (National Institutes of Health, United States Department of Health and Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was conducted as part of TCGA, a project of the National Cancer Institute and National Human Genome Research Institute. This work was conducted as part of the Slim Initiative for Genomic Medicine, a joint US-Mexico project founded by the Carlos Slim Health Institute. Support to D. A. G. and S. A. R. was through the Intramural Research Program of the National Institute of Environmental Health Sciences (National Institutes of Health, United States Department of Health and Human Services) project ES065073 (principal investigator M. Resnick).	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen CL, 2010, GENOME RES, V20, P447, DOI 10.1101/gr.098947.109; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Jimenez-Pacheco A, 2012, KOREAN J UROL, V53, P240, DOI 10.4111/kju.2012.53.4.240; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016	30	3520	3590	17	431	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					214	218		10.1038/nature12213	http://dx.doi.org/10.1038/nature12213			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23770567	Green Accepted, Green Submitted			2022-12-01	WOS:000321557600063
J	Leitner, A; Aebersold, R				Leitner, Alexander; Aebersold, Ruedi			SnapShot: Mass Spectrometry for Protein and Proteome Analyses	CELL			English	Editorial Material							BIOLOGY		[Leitner, Alexander; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8006 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Leitner, A (corresponding author), ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland.		Leitner, Alexander/U-1601-2019	Leitner, Alexander/0000-0003-4126-0725				Altelaar AFM, 2013, NAT REV GENET, V14, P35, DOI 10.1038/nrg3356; Bensimon A, 2012, ANNU REV BIOCHEM, V81, P379, DOI 10.1146/annurev-biochem-072909-100424; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Dunham WH, 2012, PROTEOMICS, V12, P1576, DOI 10.1002/pmic.201100523; Elschenbroich S, 2010, EXPERT REV PROTEOMIC, V7, P141, DOI [10.1586/epr.09.97, 10.1586/EPR.09.97]; Franck J, 2009, MOL CELL PROTEOMICS, V8, P2023, DOI 10.1074/mcp.R800016-MCP200; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Ornatsky O, 2010, J IMMUNOL METHODS, V361, P1, DOI 10.1016/j.jim.2010.07.002; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Walzthoeni T, 2013, CURR OPIN STRUC BIOL, V23, P252, DOI 10.1016/j.sbi.2013.02.008; Zhang YY, 2013, CHEM REV, V113, P2343, DOI 10.1021/cr3003533	11	14	14	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					252	253	252.e1	10.1016/j.cell.2013.06.025	http://dx.doi.org/10.1016/j.cell.2013.06.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827686	Bronze			2022-12-01	WOS:000321327900024
J	Ludwig, DS				Ludwig, David S.			Examining the Health Effects of Fructose	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLYCEMIC INDEX; DISEASE; METAANALYSIS; CONSUMPTION; RISK		[Ludwig, David S.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA 02115 USA; [Ludwig, David S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Ludwig, DS (corresponding author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NIDDK NIH HHS [K24 DK082730, K24DK082730] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; DUNNIGAN MG, 1970, CLIN SCI, V38, P1; He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212; HILL JO, 1995, AM J CLIN NUTR, V62, p264S, DOI 10.1093/ajcn/62.1.264S; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Lustig RH, 2013, ADV NUTR, V4, P226, DOI 10.3945/an.112.002998; MEYER B J, 1971, South African Medical Journal, V45, P253; Sievenpiper JL, 2012, J AM COLL NUTR, V31, P149, DOI 10.1080/07315724.2012.10720021; White JS, 2013, ADV NUTR, V4, P246, DOI 10.3945/an.112.003137	10	33	34	0	47	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					33	34		10.1001/jama.2013.6562	http://dx.doi.org/10.1001/jama.2013.6562			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175SK	23732692				2022-12-01	WOS:000321253000015
J	Housden, NG; Hopper, JTS; Lukoyanova, N; Rodriguez-Larrea, D; Wojdyla, JA; Klein, A; Kaminska, R; Bayley, H; Saibil, HR; Robinson, CV; Kleanthous, C				Housden, Nicholas G.; Hopper, Jonathan T. S.; Lukoyanova, Natalya; Rodriguez-Larrea, David; Wojdyla, Justyna A.; Klein, Alexander; Kaminska, Renata; Bayley, Hagan; Saibil, Helen R.; Robinson, Carol V.; Kleanthous, Colin			Intrinsically Disordered Protein Threads Through the Bacterial Outer-Membrane Porin OmpF	SCIENCE			English	Article							COMPETITIVE RECRUITMENT; COLICIN TRANSLOCATION; DOMAIN; TOLB; COMPLEXES; IMMUNITY; E9	Porins are beta-barrel outer-membrane proteins through which small solutes and metabolites diffuse that are also exploited during cell death. We have studied how the bacteriocin colicin E9 (ColE9) assembles a cytotoxic translocon at the surface of Escherichia coli that incorporates the trimeric porin OmpF. Formation of the translocon involved ColE9's unstructured N-terminal domain threading in opposite directions through two OmpF subunits, capturing its target TolB on the other side of the membrane in a fixed orientation that triggers colicin import. Thus, an intrinsically disordered protein can tunnel through the narrow pores of an oligomeric porin to deliver an epitope signal to the cell to initiate cell death.	[Housden, Nicholas G.; Wojdyla, Justyna A.; Klein, Alexander; Kaminska, Renata; Kleanthous, Colin] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Hopper, Jonathan T. S.; Rodriguez-Larrea, David; Bayley, Hagan; Robinson, Carol V.] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England; [Lukoyanova, Natalya; Saibil, Helen R.] Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England; [Lukoyanova, Natalya; Saibil, Helen R.] Univ London Birkbeck Coll, Inst Struct Mol Biol, London WC1E 7HX, England	University of Oxford; University of Oxford; University of London; Birkbeck University London; University of London; Birkbeck University London	Kleanthous, C (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	colin.kleanthous@bioch.ox.ac.uk	Rodriguez-Larrea, David/ABH-3171-2020	Rodriguez-Larrea, David/0000-0002-5580-7413; Lukoyanova, Natalya/0000-0002-2051-0812; Housden, Nicholas/0000-0002-4706-8278; Bayley, Hagan/0000-0003-2499-6116; robinson, carol/0000-0001-7829-5505; Kaminska, Renata/0000-0001-7252-379X	Department of Biochemistry (University of Oxford); National Institutes of Health [ROI HG003709]; Medical Research Council; European Research Council (ERC) Impress; Royal Society; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D00873/1]; ERC [294408]; Wellcome Trust [079605/2/06/2, WT082045]; BBSRC [BB/G020671/1]; Biotechnology and Biological Sciences Research Council [BB/G020671/1, BB/D008573/1, BB/G020671/2] Funding Source: researchfish; Medical Research Council [G1000819] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003709] Funding Source: NIH RePORTER; BBSRC [BB/D008573/1, BB/G020671/2] Funding Source: UKRI; MRC [G1000819] Funding Source: UKRI	Department of Biochemistry (University of Oxford); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council (ERC) Impress(European Research Council (ERC)); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Johnson (Department of Pathology, University of Oxford) for help with SEC-MALS experiments and D. Ashford (Department of Biology, York University) for LC-MS data. N.G.H. acknowledges the Department of Biochemistry (University of Oxford) for financial support. D. R.-L. was supported by the National Institutes of Health (grant ROI HG003709). C. V. R. acknowledges the Medical Research Council, European Research Council (ERC) Impress, and the Royal Society for financial support. H. R. S. acknowledges support from the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/D00873/1), ERC (294408), and The Wellcome Trust (079605/2/06/2). This work was supported by grants to C. K. from The Wellcome Trust (WT082045) and the BBSRC (BB/G020671/1). Atomic coordinates and structural amplitudes have been deposited in the Protein Data Bank (PDB) under accession number 4JML. The EM map has been deposited in the EM databank under accession number EMD-2372.	Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Bonsor DA, 2007, J AM CHEM SOC, V129, P4800, DOI 10.1021/ja070153n; Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Cornforth DM, 2013, NAT REV MICROBIOL, V11, P285, DOI 10.1038/nrmicro2977; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Farrance OE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001489; Housden NG, 2005, P NATL ACAD SCI USA, V102, P13849, DOI 10.1073/pnas.0503567102; Housden NG, 2010, P NATL ACAD SCI USA, V107, P21412, DOI 10.1073/pnas.1010780107; Jakes KS, 2012, ANNU REV GENET, V46, P209, DOI 10.1146/annurev-genet-110711-155427; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; Kleanthous C, 1999, NAT STRUCT BIOL, V6, P243, DOI 10.1038/6683; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Kurisu G, 2003, NAT STRUCT BIOL, V10, P948, DOI 10.1038/nsb997; Laganowsky A, 2013, NAT PROTOC, V8, P639, DOI 10.1038/nprot.2013.024; Loftus SR, 2006, P NATL ACAD SCI USA, V103, P12353, DOI 10.1073/pnas.0603433103; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Papadakos G, 2012, J MOL BIOL, V418, P269, DOI 10.1016/j.jmb.2012.01.039; SCHABERT FA, 1995, SCIENCE, V268, P92, DOI 10.1126/science.7701347; Schulz GE, 1993, CURR OPIN CELL BIOL, V5, P701, DOI 10.1016/0955-0674(93)90143-E; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Vankemmelbeke M, 2009, J BIOL CHEM, V284, P18932, DOI 10.1074/jbc.M806149200; Yamashita E, 2008, EMBO J, V27, P2171, DOI 10.1038/emboj.2008.137; Zakharov SD, 2004, BIOPHYS J, V87, P3901, DOI 10.1529/biophysj.104.046151; Zeth K, 2010, BIOCHEM J, V431, P13, DOI 10.1042/BJ20100371	25	92	94	2	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1570	1574		10.1126/science.1237864	http://dx.doi.org/10.1126/science.1237864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812713	Green Accepted			2022-12-01	WOS:000321007000041
J	Li, WB; Notani, D; Ma, Q; Tanasa, B; Nunez, E; Chen, AY; Merkurjev, D; Zhang, J; Ohgi, K; Song, XY; Oh, S; Kim, HS; Glass, CK; Rosenfeld, MG				Li, Wenbo; Notani, Dimple; Ma, Qi; Tanasa, Bogdan; Nunez, Esperanza; Chen, Aaron Yun; Merkurjev, Daria; Zhang, Jie; Ohgi, Kenneth; Song, Xiaoyuan; Oh, Soohwan; Kim, Hong-Sook; Glass, Christopher K.; Rosenfeld, Michael G.			Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation	NATURE			English	Article							LONG NONCODING RNA; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; CHROMATIN; PRINCIPLES; ALPHA; INSIGHTS; MEDIATOR	The functional importance of gene enhancers in regulated gene expression is well established(1-3). In addition to widespread transcription of long non-coding RNAs (lncRNAs) in mammalian cells(4-6), bidirectional ncRNAs are transcribed on enhancers, and are thus referred to as enhancer RNAs (eRNAs)(7-9). However, it has remained unclear whether these eRNAs are functional or merely a reflection of enhancer activation. Here we report that in human breast cancer cells 17 beta-oestradiol (E2)-bound oestrogen receptor alpha (ER-alpha) causes a global increase in eRNA transcription on enhancers adjacent to E2-upregulated coding genes. These induced eRNAs, as functional transcripts, seem to exert important roles for the observed ligand-dependent induction of target coding genes, increasing the strength of specific enhancer-promoter looping initiated by ER-alpha binding. Cohesin, present on many ER-alpha-regulated enhancers even before ligand treatment, apparently contributes to E2-dependent gene activation, at least in part by stabilizing E2/ER-alpha/eRNA-induced enhancer-promoter looping. Our data indicate that eRNAs are likely to have important functions in many regulated programs of gene transcription.	[Li, Wenbo; Notani, Dimple; Ma, Qi; Tanasa, Bogdan; Nunez, Esperanza; Chen, Aaron Yun; Merkurjev, Daria; Zhang, Jie; Ohgi, Kenneth; Song, Xiaoyuan; Oh, Soohwan; Kim, Hong-Sook; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Ma, Qi; Merkurjev, Daria] Univ Calif San Diego, Grad Program Bioinformat, La Jolla, CA 92093 USA; [Tanasa, Bogdan] Scripps Res Inst, Kellogg Sch Sci & Technol, Grad Program, La Jolla, CA 92037 USA; [Oh, Soohwan] Univ Calif San Diego, Grad Program Biol Sci, La Jolla, CA 92093 USA; [Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Glass, Christopher/AAI-3933-2021; , songxy/P-1094-2014; Ma, Qi/C-9716-2015; li, wenbo/GZM-8930-2022	Glass, Christopher/0000-0003-4344-3592; , songxy/0000-0002-9011-5033; Notani, Dimple/0000-0002-9460-8070; Ma, Qi/0000-0002-8705-4460	UCSD Cancer Center [P30 CA23100]; Department of Defense (DoD) [BC110381, BC103858]; DoD;  [DK 039949];  [DK018477];  [NS034934];  [HL065445];  [CA173903]; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA173903, T32CA009523, R01CA097134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949, R01DK018477, R37DK039949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	UCSD Cancer Center; Department of Defense (DoD)(United States Department of Defense); DoD(United States Department of Defense); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Hutt for help with statistical analyses; M. Ghassemian from the University of California, San Diego (UCSD) Biomolecular/Proteomics Mass Spectrometry Facility for assistance with mass spectrometry; C. Nelson for cell culture assistance; J. Hightower for assistance with figure and manuscript preparation. We thank H. Chang for providing the BoxB, lambda N-GAL4 constructs. We acknowledge the UCSD Cancer Center Specialized Support Grant P30 CA23100 for confocal microscopy. W. L. and D.N. are supported by Department of Defense (DoD) postdoctoral fellowships, BC110381 and BC103858, respectively. M. G. R. is an investigator with the Howard Hughes Medical Institute. This work was supported by grants DK 039949, DK018477, NS034934, HL065445, CA173903 to C. K. G., and from the DoD.	Abukhdeir AM, 2006, BREAST CANCER RES TR, V99, P23, DOI 10.1007/s10549-006-9177-0; Ahlenstiel CL, 2012, NUCLEIC ACIDS RES, V40, P1579, DOI 10.1093/nar/gkr891; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Cai ST, 1999, METHODS, V19, P394, DOI 10.1006/meth.1999.0875; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lajoie BR, 2009, NAT METHODS, V6, P690, DOI 10.1038/nmeth1009-690; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Newman JJ, 2010, COLD SH Q B, V75, P227, DOI 10.1101/sqb.2010.75.016; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Rueden CT, 2007, BIOTECHNIQUES, V43, P31, DOI 10.2144/000112511; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Servant N, 2012, BIOINFORMATICS, V28, P2843, DOI 10.1093/bioinformatics/bts521; Stadhouders R, 2012, EMBO J, V31, P986, DOI 10.1038/emboj.2011.450; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; White AK, 2011, P NATL ACAD SCI USA, V108, P13999, DOI 10.1073/pnas.1019446108; Zhong JF, 2008, LAB CHIP, V8, P68, DOI 10.1039/b712116d	40	649	667	4	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					516	+		10.1038/nature12210	http://dx.doi.org/10.1038/nature12210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23728302	Green Accepted			2022-12-01	WOS:000320929400059
J	Evans, DG; Graham, J; O'Connell, S; Arnold, S; Fitzsimmons, D				Evans, D. Gareth; Graham, John; O'Connell, Susan; Arnold, Stephanie; Fitzsimmons, Deborah			GUIDELINES Familial breast cancer: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Evans, D. Gareth] St Marys Hosp, Dept Med Genet, Manchester M13 9WL, Lancs, England; [Graham, John; O'Connell, Susan; Arnold, Stephanie] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales; [Fitzsimmons, Deborah] Swansea Univ, Swansea Ctr Hlth Econ, Swansea SA2 8PP, W Glam, Wales	University of Manchester; Swansea University	Graham, J (corresponding author), Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales.	john.graham@nhs.net	Evans, D Gareth/AAB-4308-2022; O'Connell, Susan/V-8945-2019	Evans, D Gareth/0000-0002-8482-5784; Graham, John/0000-0003-3381-9787				Evans DGR, 2009, J MED GENET, V46, P811, DOI 10.1136/jmg.2009.067850; National Institute for Health and Care Excellence, 2004, FAM BREAST CANC CLAS; National Institute for Health and Care Excellence, 2006, FAM BREAST CANC CLAS; National Institute for Health and Care Excellence, 2009, EARL LOC ADV BREAT C; NHS Breast Screening Programme, 2013, NHSBSP PUBL, V74; NICE, 2013, FAM BREAST CANC CLAS; Public Health and Primary Care University of Cambridge, BOADICEA BOADICEA IS; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668	8	47	49	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2013	346								f3829	10.1136/bmj.f3829	http://dx.doi.org/10.1136/bmj.f3829			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QI	23801680				2022-12-01	WOS:000321245900002
J	Hildner, R; Brinks, D; Nieder, JB; Cogdell, RJ; van Hulst, NF				Hildner, Richard; Brinks, Daan; Nieder, Jana B.; Cogdell, Richard J.; van Hulst, Niek F.			Quantum Coherent Energy Transfer over Varying Pathways in Single Light-Harvesting Complexes	SCIENCE			English	Article							PIGMENT-PROTEIN COMPLEXES; MATTHEWS-OLSON COMPLEX; DYNAMICS; PHOTOSYNTHESIS; SPECTROSCOPY; LH2; TEMPERATURE; MOLECULES; SYSTEMS	The initial steps of photosynthesis comprise the absorption of sunlight by pigment-protein antenna complexes followed by rapid and highly efficient funneling of excitation energy to a reaction center. In these transport processes, signatures of unexpectedly long-lived coherences have emerged in two-dimensional ensemble spectra of various light-harvesting complexes. Here, we demonstrate ultrafast quantum coherent energy transfer within individual antenna complexes of a purple bacterium under physiological conditions. We find that quantum coherences between electronically coupled energy eigenstates persist at least 400 femtoseconds and that distinct energy-transfer pathways that change with time can be identified in each complex. Our data suggest that long-lived quantum coherence renders energy transfer in photosynthetic systems robust in the presence of disorder, which is a prerequisite for efficient light harvesting.	[Hildner, Richard; Brinks, Daan; Nieder, Jana B.; van Hulst, Niek F.] ICFO Inst Ciencies Foton, Castelldefels 08860, Barcelona, Spain; [Cogdell, Richard J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8TA, Lanark, Scotland; [van Hulst, Niek F.] ICREA Inst Catalana Recerca & Estudis Avancats, Barcelona 08015, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); University of Glasgow; ICREA	van Hulst, NF (corresponding author), ICFO Inst Ciencies Foton, Mediterranean Technol Pk, Castelldefels 08860, Barcelona, Spain.	niek.vanhulst@icfo.eu	Nieder, Jana/N-1652-2013; van Hulst, Niek/J-2121-2012; Nieder, Jana B./N-3464-2019; Hildner, Richard/O-6386-2014	Nieder, Jana/0000-0002-4973-1889; van Hulst, Niek/0000-0003-4630-1776; Nieder, Jana B./0000-0002-4973-1889; Hildner, Richard/0000-0002-7282-3730; Brinks, Daan/0000-0002-5550-5140	Ministerio de Ciencia e Innovacion [CSD2007-046-NanoLight.es, MAT2006-08184, FIS2009-08203]; European Union (European Research Council) [247330]; Fundacio CELLEX (Barcelona); Biotechnology and Biological Sciences Research Council (Glasgow); Netherlands Organization for Scientific Research (NWO); German Research Foundation (DFG) [GRK 1640]; ICREA Funding Source: Custom	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Union (European Research Council)(European Research Council (ERC)European Commission); Fundacio CELLEX (Barcelona)(Foundation CELLEXEuropean Commission); Biotechnology and Biological Sciences Research Council (Glasgow)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); German Research Foundation (DFG)(German Research Foundation (DFG)); ICREA(ICREA)	We thank F. D. Stefani, F. Kulzer, and T. H. Taminiau for discussions and assistance with the experimental setup. Funding by Ministerio de Ciencia e Innovacion (CSD2007-046-NanoLight.es, MAT2006-08184, and FIS2009-08203), the European Union (European Research Council advanced grant no. 247330, FP6 Bio-Light-Touch), Fundacio CELLEX (Barcelona) and the Biotechnology and Biological Sciences Research Council (Glasgow) is gratefully acknowledged. D.B. acknowledges support by a Rubicon grant of the Netherlands Organization for Scientific Research (NWO), and R.H. by the German Research Foundation (DFG, GRK 1640).	Beljonne D, 2009, J PHYS CHEM B, V113, P6583, DOI 10.1021/jp900708f; Bopp MA, 1999, P NATL ACAD SCI USA, V96, P11271, DOI 10.1073/pnas.96.20.11271; Brinks D, 2010, NATURE, V465, P905, DOI 10.1038/nature09110; Brixner T, 2005, NATURE, V434, P625, DOI 10.1038/nature03429; Chin AW, 2013, NAT PHYS, V9, P113, DOI 10.1038/nphys2515; Cogdell RJ, 2006, Q REV BIOPHYS, V39, P227, DOI 10.1017/S0033583506004434; Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811; Curutchet C, 2011, J AM CHEM SOC, V133, P3078, DOI 10.1021/ja110053y; Fransted KA, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4752107; Harel E, 2012, P NATL ACAD SCI USA, V109, P706, DOI 10.1073/pnas.1110312109; Herek JL, 2000, BIOPHYS J, V78, P2590, DOI 10.1016/S0006-3495(00)76803-2; Herek JL, 2002, NATURE, V417, P533, DOI 10.1038/417533a; Hildner R, 2011, NAT PHYS, V7, P172, DOI [10.1038/nphys1858, 10.1038/NPHYS1858]; Hoyer S, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041911; Katz G, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/1/015003; Kim HW, 2012, J AM CHEM SOC, V134, P11640, DOI 10.1021/ja303025q; Kosumi D, 2011, ANGEW CHEM INT EDIT, V50, P1097, DOI 10.1002/anie.201003771; Lee H, 2007, SCIENCE, V316, P1462, DOI 10.1126/science.1142188; Mohseni M, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3002335; Panitchayangkoon G, 2010, P NATL ACAD SCI USA, V107, P12766, DOI 10.1073/pnas.1005484107; Plenio MB, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/11/113019; Prokhorenko VI, 2006, SCIENCE, V313, P1257, DOI 10.1126/science.1130747; Rebentrost P, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033003; Rutkauskas D, 2006, BIOPHYS J, V90, P2475, DOI 10.1529/biophysj.105.075903; Scholes GD, 2003, ANNU REV PHYS CHEM, V54, P57, DOI 10.1146/annurev.physchem.54.011002.103746; Scholes GD, 2010, J PHYS CHEM LETT, V1, P2, DOI 10.1021/jz900062f; Shim S, 2012, BIOPHYS J, V102, P649, DOI 10.1016/j.bpj.2011.12.021; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c; van Oijen AM, 1999, SCIENCE, V285, P400, DOI 10.1126/science.285.5426.400; Wu HM, 1996, J PHYS CHEM-US, V100, P12022, DOI 10.1021/jp9608178; Zigmantas D, 2006, P NATL ACAD SCI USA, V103, P12672, DOI 10.1073/pnas.0602961103	31	239	244	3	319	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1448	1451		10.1126/science.1235820	http://dx.doi.org/10.1126/science.1235820			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23788794				2022-12-01	WOS:000320647000041
J	Rivkin, E; Almeida, SM; Ceccarelli, DF; Juang, YC; MacLean, TA; Srikumar, T; Huang, H; Dunham, WH; Fukumura, R; Xie, G; Gondo, Y; Raught, B; Gingras, AC; Sicheri, F; Cordes, SP				Rivkin, Elena; Almeida, Stephanie M.; Ceccarelli, Derek F.; Juang, Yu-Chi; MacLean, Teresa A.; Srikumar, Tharan; Huang, Hao; Dunham, Wade H.; Fukumura, Ryutaro; Xie, Gang; Gondo, Yoichi; Raught, Brian; Gingras, Anne-Claude; Sicheri, Frank; Cordes, Sabine P.			The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis	NATURE			English	Article							KAPPA-B ACTIVATION; DU-CHAT-SYNDROME; POLYUBIQUITIN CHAINS; SIGNALING PATHWAY; MOUSE; INFLAMMATION; DERMATITIS; MUTATIONS; SHARPIN; COMPLEX	A complex interaction of signalling events, including the Wnt pathway, regulates sprouting of blood vessels from pre-existing vasculature during angiogenesis. Here we show that two distinct mutations in the (uro) chordate-specific gumby (also called Fam105b) gene cause an embryonic angiogenic phenotype in gumby mice. Gumby interacts with disheveled 2 (DVL2), is expressed in canonical Wnt-responsive endothelial cells and encodes an ovarian tumour domain class of deubiquitinase that specifically cleaves linear ubiquitin linkages. A crystal structure of gumby in complex with linear diubiquitin reveals how the identified mutations adversely affect substrate binding and catalytic function in line with the severity of their angiogenic phenotypes. Gumby interacts with HOIP (also called RNF31), a key component of the linear ubiquitin assemblycomplex, and decreases linear ubiquitination and activation of NF-kappa B-dependent transcription. This work provides support for the biological importance of linear (de) ubiquitination in angiogenesis, craniofacial and neural development and in modulating Wnt signalling.	[Rivkin, Elena; Almeida, Stephanie M.; Ceccarelli, Derek F.; Juang, Yu-Chi; MacLean, Teresa A.; Huang, Hao; Dunham, Wade H.; Xie, Gang; Gingras, Anne-Claude; Sicheri, Frank; Cordes, Sabine P.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Rivkin, Elena; Almeida, Stephanie M.; MacLean, Teresa A.; Dunham, Wade H.; Gingras, Anne-Claude; Sicheri, Frank; Cordes, Sabine P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Srikumar, Tharan; Raught, Brian] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Srikumar, Tharan; Raught, Brian] Princess Margaret Canc Ctr, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Fukumura, Ryutaro; Gondo, Yoichi] RIKEN BioResource Ctr, Mutagenesis & Genom Team, Tsukuba, Ibaraki 3050074, Japan	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; RIKEN	Sicheri, F (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	sicheri@lunenfeld.ca; cordes@lunenfeld.ca	Gondo, Yoichi/A-5375-2016; Sicheri, Frank/F-8856-2013; Gingras, Anne-Claude/E-9982-2010; Gingras, Anne-Claude/ABA-8341-2020; Srikumar, Tharan/Q-5642-2016; Cordes, Sabine P/A-5423-2012	Gondo, Yoichi/0000-0003-2184-6489; Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Ceccarelli, Derek/0000-0002-2674-9234	JSPS KAKENHI [15200032, 21240043]; Canadian Institutes for Health Research [MOP119289, MOP123433, MOP57795, MOP 97966, IHO 94384, MOP 111199]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	We thank T. Saunders and the Michigan University Transgenic Core facility for generating gumby BAC transgenic mice; K. Iwai for HOIL and HOIP constructs; K. Nakajima for NF-kappa B and AP2 reporter constructs; B. Alman and C. C. Hui for TOPGAL reporter mice; J. Woodgett for TOPFLASH, FOPFLASH and PRL vectors; T. Pawson for WNT3A expressing L-cells; M. Barrios-Ramos for help with fluorometry; J. Culotti and C. C. Hui for critical feedback; and I. Kourinov and staff at NE-CAT for collecting diffraction data set. B. R. holds the Canada research chair in proteomics and molecular medicine. A.-C. G. holds the Canada research chair in Functional Proteomics. F. S. holds the Canada research chair in Structural Principles of Signal Transduction. S. M. A. and T. S. were supported by CIHR predoctoral student fellowships. This work was supported by operating funds from the JSPS KAKENHI (grant numbers 15200032 to Y.G. and 21240043 to Y.G. and R. F.), and Canadian Institutes for Health Research to B. R. (MOP119289), A.-C. G. (MOP123433), F. S. (MOP57795) and S. P. C. (MOP 97966, IHO 94384 and MOP 111199).	Abr?moff MD., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; AMBULOS NP, 1987, GENE, V51, P281, DOI 10.1016/0378-1119(87)90317-9; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Choi Hyungwon, 2012, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0815s39; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Cirone P, 2008, ANGIOGENESIS, V11, P347, DOI 10.1007/s10456-008-9116-2; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dunham WH, 2011, PROTEOMICS, V11, P2603, DOI 10.1002/pmic.201000571; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gondo Y, 2008, NAT REV GENET, V9, P803, DOI 10.1038/nrg2431; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; HOGENESCH H, 1993, AM J PATHOL, V143, P972; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Iwai K, 2011, CELL CYCLE, V10, P3095, DOI 10.4161/cc.10.18.17437; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kean MJ, 2012, METHODS, V57, P400, DOI 10.1016/j.ymeth.2012.06.002; Kim FA, 2005, MECH DEVELOP, V122, P1300, DOI 10.1016/j.mod.2005.08.001; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Liebner S, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-1; Liu GM, 2010, NAT BIOTECHNOL, V28, P1015, DOI 10.1038/nbt1010-1015; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mainardi PC, 2006, EUR J MED GENET, V49, P363, DOI 10.1016/j.ejmg.2005.12.004; Mainardi PC, 2001, J MED GENET, V38, P151, DOI 10.1136/jmg.38.3.151; Mar L, 2005, J NEUROSCI, V25, P11787, DOI 10.1523/JNEUROSCI.3813-05.2005; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Matsumoto ML, 2012, J MOL BIOL, V418, P134, DOI 10.1016/j.jmb.2011.12.053; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Niu JX, 2011, EMBO J, V30, P3741, DOI 10.1038/emboj.2011.264; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; VECCHI A, 1994, EUR J CELL BIOL, V63, P247; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Walczak H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-23; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3; Zhang XX, 2005, AM J HUM GENET, V76, P312, DOI 10.1086/427762	49	188	201	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					318	+		10.1038/nature12296	http://dx.doi.org/10.1038/nature12296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23708998	Green Accepted			2022-12-01	WOS:000320592900031
J	Gale, EAM				Gale, Edwin A. M.			Is type 2 diabetes a category error?	LANCET			English	Editorial Material									[Gale, Edwin A. M.] Univ Bristol, Bristol, Avon, England	University of Bristol	Gale, EAM (corresponding author), Southmead Hosp, Bristol BS10 5NB, Avon, England.	edwin.gale@bristol.ac.uk						Faber K, 1923, NOSOGRAPHY MODERN IN; Gale EAM, 2006, DIABETOLOGIA, V49, P1989, DOI 10.1007/s00125-006-0348-7; Gale EAM, 2001, DIABETES, V50, P217, DOI 10.2337/diabetes.50.2.217; Ryle G, CONCEPT MIND; Von Noorden C., 1907, METABOLISM PRACTICAL, P527	5	31	31	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					1956	1957		10.1016/S0140-6736(12)62207-7	http://dx.doi.org/10.1016/S0140-6736(12)62207-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23725732				2022-12-01	WOS:000320319500036
J	Bergonzi, S; Albani, MC; van Themaat, EVL; Nordstrom, KJV; Wang, RH; Schneeberger, K; Moerland, PD; Coupland, G				Bergonzi, Sara; Albani, Maria C.; van Themaat, Emiel Ver Loren; Nordstroem, Karl J. V.; Wang, Renhou; Schneeberger, Korbinian; Moerland, Perry D.; Coupland, George			Mechanisms of Age-Dependent Response to Winter Temperature in Perennial Flowering of Arabis alpina	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; TARGET GENES; MICRORNA; APETALA2; INDUCTION; PATHWAYS; MUTANT; MIR172; SPL3	Perennial plants live for more than 1 year and flower only after an extended vegetative phase. We used Arabis alpina, a perennial relative of annual Arabidopsis thaliana, to study how increasing age and exposure to winter cold (vernalization) coordinate to establish competence to flower. We show that the APETALA2 transcription factor, a target of microRNA miR172, prevents flowering before vernalization. Additionally, miR156 levels decline as A. alpina ages, causing increased production of SPL (SQUAMOSA PROMOTER BINDING PROTEIN LIKE) transcription factors and ensuring that flowering occurs in response to cold. The age at which plants respond to vernalization can be altered by manipulating miR156 levels. Although miR156 and miR172 levels are uncoupled in A. alpina, miR156 abundance represents the timer controlling age-dependent flowering responses to cold.	[Bergonzi, Sara; Albani, Maria C.; van Themaat, Emiel Ver Loren; Nordstroem, Karl J. V.; Wang, Renhou; Schneeberger, Korbinian; Coupland, George] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [van Themaat, Emiel Ver Loren; Moerland, Perry D.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, NL-1100 DE Amsterdam, Netherlands	Max Planck Society; University of Amsterdam; Academic Medical Center Amsterdam	Coupland, G (corresponding author), Max Planck Inst Plant Breeding Res, Carl von Linne Weg 10, D-50829 Cologne, Germany.	coupland@mpipz.mpg.de	Coupland, George/AAP-8609-2020; Schneeberger, Korbinian/U-6329-2019; Moerland, Perry/AAG-1425-2020	Coupland, George/0000-0001-6988-4172; Schneeberger, Korbinian/0000-0002-5512-0443; Moerland, Perry/0000-0002-2357-3659; Albani, Maria/0000-0002-8215-020X; Nordstrom, Karl/0000-0001-6231-4417	Deutsche Forschungsgemeinschaft [SPP1530]; Max Planck Genome Centre; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Genome Centre; Max Planck Society(Max Planck Society)	We thank E. Willing, G. Velikkakam, and the "A. alpina genome consortium" for access to genomic information and Y. Zeng for technical support. We thank members of CC's laboratory and P. Huijser for critical reading of the manuscript and D. Weigel for MIR156 constructs and comments on the manuscript. We acknowledge funding from Deutsche Forschungsgemeinschaft SPP1530 grants to G.C. and M.C.A., the Max Planck Genome Centre, and a core grant from the Max Planck Society. GenBank accession numbers are GSE40455 (microarray data), KC815948 to KC815963 (AaSPLs), KC831439 (PEP2), and KC848668 (Aapre-miR156a). Materials described here are available from G.C. subject to a Material Transfer Agreement with the Max Planck Institute for Plant Breeding Research.	Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bergonzi S, 2011, J EXP BOT, V62, P4415, DOI 10.1093/jxb/err192; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; MOZLEY D, 1995, J EXP BOT, V46, P173, DOI 10.1093/jxb/46.2.173; Nordstrom KJV, 2013, NAT BIOTECHNOL, V31, P325, DOI 10.1038/nbt.2515; Poethig RS, 2010, PLANT PHYSIOL, V154, P541, DOI 10.1104/pp.110.161620; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Tanaka N, 2011, PLANT CELL, V23, P2143, DOI 10.1105/tpc.111.083436; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang RH, 2011, PLANT CELL, V23, P1307, DOI 10.1105/tpc.111.083451; Wang RH, 2009, NATURE, V459, P423, DOI 10.1038/nature07988; Wollmann H, 2010, DEVELOPMENT, V137, P3633, DOI 10.1242/dev.036673; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Yant L, 2010, PLANT CELL, V22, P2156, DOI 10.1105/tpc.110.075606	26	140	155	1	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1094	1097		10.1126/science.1234116	http://dx.doi.org/10.1126/science.1234116			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723236				2022-12-01	WOS:000319664500044
J	Lieberman, J; Slack, F; Pandolfi, PP; Chinnaiyan, A; Agami, R; Mendell, JT				Lieberman, Judy; Slack, Frank; Pandolfi, Pier Paolo; Chinnaiyan, Arul; Agami, Reuven; Mendell, Joshua T.			Noncoding RNAs and Cancer	CELL			English	News Item									[Lieberman, Judy] Boston Childrens Hosp, Beth Israel Deaconess Med Ctr, Boston, MA 06520 USA; [Slack, Frank] Yale Univ, New Haven, CT 02138 USA; [Pandolfi, Pier Paolo] Harvard Univ, Cambridge, MA 48109 USA; [Chinnaiyan, Arul] Univ Michigan, SW Med Ctr, Ann Arbor, MI USA; [Agami, Reuven] Netherlands Canc Inst, Amsterdam, Netherlands; [Mendell, Joshua T.] Univ Texas Dallas, Dallas, TX USA	Harvard University; Beth Israel Deaconess Medical Center; Boston Children's Hospital; Yale University; Harvard University; University of Michigan System; University of Michigan; University of Texas System; University of Texas Southwestern Medical Center Dallas; Netherlands Cancer Institute; University of Texas System; University of Texas Dallas			agami, reuven/GOG-8289-2022; Lieberman, Judy/A-2717-2015	Pandolfi, Pier Paolo/0000-0002-5352-5295; Agami, Reuven/0000-0002-2848-2473; Slack, Frank/0000-0001-8263-0409					0	35	36	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 28	2013	153	1					9	10		10.1016/j.cell.2013.03.019	http://dx.doi.org/10.1016/j.cell.2013.03.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	116AI	23781554	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000316853700024
J	Fullgrabe, J; Lynch-Day, MA; Heldring, N; Li, WB; Struijk, RB; Ma, Q; Hermanson, O; Rosenfeld, MG; Klionsky, DJ; Joseph, B				Fullgrabe, Jens; Lynch-Day, Melinda A.; Heldring, Nina; Li, Wenbo; Struijk, Robert B.; Ma, Qi; Hermanson, Ola; Rosenfeld, Michael G.; Klionsky, Daniel J.; Joseph, Bertrand			The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy	NATURE			English	Article							H4K16 ACETYLATION; IN-VIVO; GENOME; PROTEIN; ACTIVATION; DROSOPHILA; PATHWAY; DISEASE; GENES; DEATH	Autophagy is an evolutionarily conserved catabolic process involved in several physiological and pathological processes(1,2). Although primarily cytoprotective, autophagy can also contribute to cell death; it is thus important to understand what distinguishes the life or death decision in autophagic cells(3). Here we report that induction of autophagy is coupled to reduction of histone H4 lysine 16 acetylation (H4K16ac) through downregulation of the histone acetyltransferase hMOF (also called KAT8 or MYST1), and demonstrate that this histone modification regulates the outcome of autophagy. At a genome-wide level, we find that H4K16 deacetylation is associated predominantly with the downregulation of autophagy-related genes. Antagonizing H4K16ac downregulation upon autophagy induction results in the promotion of cell death. Our findings establish that alteration in a specific histone post-translational modification during autophagy affects the transcriptional regulation of autophagy-related genes and initiates a regulatory feedback loop, which serves as a key determinant of survival versus death responses upon autophagy induction.	[Fullgrabe, Jens; Struijk, Robert B.; Joseph, Bertrand] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, S-17176 Stockholm, Sweden; [Lynch-Day, Melinda A.; Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Lynch-Day, Melinda A.; Klionsky, Daniel J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Lynch-Day, Melinda A.; Klionsky, Daniel J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Heldring, Nina; Hermanson, Ola] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Li, Wenbo; Ma, Qi; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; [Ma, Qi] Univ Calif San Diego, Grad Program Bioinformat & Syst Biol, La Jolla, CA 92093 USA	Karolinska Institutet; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Karolinska Institutet; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Joseph, B (corresponding author), Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, S-17176 Stockholm, Sweden.	bertrand.joseph@ki.se	Ma, Qi/C-9716-2015; li, wenbo/GZM-8930-2022; , Ola/AAF-5126-2021	Joseph, Bertrand/0000-0001-5655-9979; Struijk, Robin/0000-0002-8581-864X; Hermanson, Ola/0000-0001-9320-7921; Fullgrabe, Jens/0000-0003-0047-4719; Ma, Qi/0000-0002-8705-4460	Karolinska Institutet Foundations; Rackham Predoctoral Fellowship; US Department of Defense [BC110381]; National Institutes of Health [GM53396]; National Institutes of Health/National Cancer Institute; Department of Defense; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Swedish Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	Karolinska Institutet Foundations(Karolinska Institutet); Rackham Predoctoral Fellowship; US Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Mc Inerney, M. Malewicz, S. Orrenius and T. Panaretakis for discussion, and L. Guarente, V. Kaminskyy, M. Komatsu, G. Mc Inerney, M. Panas, R. G. Roeder and L. Xiaoling for reagents and cell lines. J.F. is supported by a fellowship from the Karolinska Institutet Foundations, M.A.L.-D. is partly supported by a Rackham Predoctoral Fellowship and W.L. is supported by breast cancer research Postdoctoral Fellowship Award (BC110381) from the US Department of Defense. This work was supported by a National Institutes of Health grant GM53396 (to D.J.K.) and National Institutes of Health/National Cancer Institute and Department of Defense grants (to M.G.R.), the Swedish Cancer Society, the Swedish Childhood Cancer Foundation (to B.J. and O.H.) and the Swedish Research Council (to B.J.). M.G.R. is an investigator of the Howard Hughes Medical Institute.	Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Cao Y, 2008, J CELL BIOL, V182, P703, DOI 10.1083/jcb.200801035; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Fullgrabe J, 2010, CELL DEATH DIFFER, V17, P1238, DOI 10.1038/cdd.2010.58; Hajji N, 2010, ONCOGENE, V29, P2192, DOI 10.1038/onc.2009.505; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Katoh H, 2011, MOL CELL, V44, P770, DOI 10.1016/j.molcel.2011.10.012; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin SY, 2012, SCIENCE, V336, P477, DOI 10.1126/science.1217032; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morselli E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.8; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yi C, 2012, SCIENCE, V336, P474, DOI 10.1126/science.1216990; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057	36	205	211	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 22	2013	500	7463					468	+		10.1038/nature12313	http://dx.doi.org/10.1038/nature12313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203TJ	23863932	Green Accepted			2022-12-01	WOS:000323316100037
J	Kapczynski, A				Kapczynski, Amy			Engineered in India Patent Law 2.0	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Law, New Haven, CT 06520 USA	Yale University	Kapczynski, A (corresponding author), Yale Univ, Sch Law, New Haven, CT 06520 USA.							Hemphill CS, 2012, J HEALTH ECON, V31, P327, DOI 10.1016/j.jhealeco.2012.01.004; Hemphill CS, 2011, J EMPIR LEGAL STUD, V8, P613, DOI 10.1111/j.1740-1461.2011.01235.x; Kapczynski A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049470	3	22	22	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 8	2013	369	6					497	499		10.1056/NEJMp1304400	http://dx.doi.org/10.1056/NEJMp1304400			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	197HX	23862973				2022-12-01	WOS:000322842000002
J	Horton, R; Lo, S				Horton, Richard; Lo, Selina			Nutrition: a quintessential sustainable development goal	LANCET			English	Editorial Material									[Horton, Richard; Lo, Selina] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Bhutta ZA, 2013, LANCET; Black R., 2013, LANCET; Gillespie S, 2013, LANCET; Katz J, 2013, LANCET; Maternal and Child Nutrition Study Group, 2013, LANCET; Morris SS, 2008, LANCET, V371, P608, DOI 10.1016/S0140-6736(07)61695-X; Ruel M, 2013, LANCET	7	43	46	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 3	2013	382	9890					371	372		10.1016/S0140-6736(13)61100-9	http://dx.doi.org/10.1016/S0140-6736(13)61100-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194MX	23746782				2022-12-01	WOS:000322638500006
J	Salathe, M; Freifeld, CC; Mekaru, SR; Tomasulo, AF; Brownstein, JS				Salathe, Marcel; Freifeld, Clark C.; Mekaru, Sumiko R.; Tomasulo, Anna F.; Brownstein, John S.			Influenza A (H7N9) and the Importance of Digital Epidemiology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE DETECTION		[Salathe, Marcel] Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Freifeld, Clark C.; Mekaru, Sumiko R.; Tomasulo, Anna F.; Brownstein, John S.] Boston Childrens Hosp, Informat Program, Boston, MA USA; [Freifeld, Clark C.] Boston Univ, Coll Engn, Dept Biomed Engn, Boston, MA 02215 USA; [Mekaru, Sumiko R.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Brownstein, John S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Boston Children's Hospital; Boston University; Boston University; Harvard University; Harvard Medical School	Salathe, M (corresponding author), Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.			Salathe, Marcel/0000-0002-5079-7797; Mekaru, Sumiko/0000-0002-9782-3833	NLM NIH HHS [R01 LM010812] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [R01LM010812] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Chan EH, 2010, P NATL ACAD SCI USA, V107, P21701, DOI 10.1073/pnas.1006219107; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Xu C, MONITORING AVIAN INF	5	102	105	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					401	404		10.1056/NEJMp1307752	http://dx.doi.org/10.1056/NEJMp1307752			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193GQ	23822655	Green Accepted			2022-12-01	WOS:000322547400004
J	Alvarado, JC; Dewan, Y; Elsayed, HF; Gogichaishvili, T; Gupta, S; Hunt, BJ; Iribhogbe, P; Izurieta, M; Khamis, H; Komolafe, EO; Mantilla, JHM; Miranda, J; Uribe, CHM; Olaomi, O; Olldashi, F; Perel, P; Ramana, PV; Ravi, RR; Roberts, I; Shakur, H				Caballero Alvarado, Jose; Dewan, Yashbir; Elsayed, Hesham Fathy; Gogichaishvili, Tamar; Gupta, Sanjay; Hunt, B. J.; Iribhogbe, Pius; Izurieta, Mario; Khamis, Hussein; Komolafe, Edward O.; Mejia Mantilla, Jorge H.; Miranda, Jaime; Morales Uribe, Carlos H.; Olaomi, Oluwole; Olldashi, Fatos; Perel, Pablo; Ramana, P. V.; Ravi, R. R.; Roberts, Ian; Shakur, Haleema			IMPROVING TRAUMA CARE WORLDWIDE Tranexamic acid in trauma: we need stronger global health policy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY		[Caballero Alvarado, Jose] Hosp Reg Docente Trujillo, Trujillo, Peru; [Dewan, Yashbir] MIND Max Inst Neurosci Dehradun, Dehra Dun, India; [Elsayed, Hesham Fathy] Suez Canal Univ Hosp, Ismailia, Egypt; [Gupta, Sanjay] Fortis Hosp Delhi, Delhi, India; [Hunt, B. J.] Guys & St Thomas NHS Fdn Trust, London, England; [Iribhogbe, Pius] Univ Benin, Teaching Hosp, Benin, Nigeria; [Izurieta, Mario] Hosp Alcivar, Alcivar, Ecuador; [Komolafe, Edward O.] Obafemi Awolowo Univ, Teaching Hosp, Ife, Nigeria; [Mejia Mantilla, Jorge H.] Fdn Valle del Lili, Cali, Colombia; [Miranda, Jaime] Univ Peruana Cayetano Heredia, Lima, Peru; [Olaomi, Oluwole] Natl Hosp Abuja, Abuja, Nigeria; [Perel, Pablo; Roberts, Ian; Shakur, Haleema] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Ravi, R. R.] Med Trust Hosp Kochi, Kochi, Kerala, India	Egyptian Knowledge Bank (EKB); Suez Canal University; Guy's & St Thomas' NHS Foundation Trust; University of Benin; Obafemi Awolowo University; Universidad Peruana Cayetano Heredia; University of London; London School of Hygiene & Tropical Medicine	Roberts, I (corresponding author), Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.	ian.roberts@lshtm.ac.uk	Dewan, Yashbir/C-6503-2013	Dewan, Yashbir/0000-0002-7154-1301; Shakur-Still, Haleema/0000-0002-6511-109X; Miranda, J. Jaime/0000-0002-4738-5468; komolafe, edward/0000-0003-1261-3501; RAMANA, P V/0000-0003-4654-0590; Caballero-Alvarado, Jose/0000-0001-8297-6901; /0000-0002-2342-301X				[Anonymous], 2011, INJURED SOLDIERS AFG; Guerriero C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018987; Guerriero Carla, 2010, Cost Eff Resour Alloc, V8, P1, DOI 10.1186/1478-7547-8-1; Jayaraman S, 2010, TRANSFUSION, V50, P433, DOI 10.1111/j.1537-2995.2009.002402.x; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Road Safety Fund, UN DEC ACT ROAD SAF; Roberts I, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5839; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Sefeane TI, 2011, SA orthop. j., V10, P30; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sidibe M, 2012, LANCET, V380, P2058, DOI 10.1016/S0140-6736(12)62088-1	13	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2013	347								f4593	10.1136/bmj.f4593	http://dx.doi.org/10.1136/bmj.f4593			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192YR	23881931	Green Accepted			2022-12-01	WOS:000322524400006
J	Philippe, N; Legendre, M; Doutre, G; Coute, Y; Poirot, O; Lescot, M; Arslan, D; Seltzer, V; Bertaux, L; Bruley, C; Garin, J; Claverie, JM; Abergel, C				Philippe, Nadege; Legendre, Matthieu; Doutre, Gabriel; Coute, Yohann; Poirot, Olivier; Lescot, Magali; Arslan, Defne; Seltzer, Virginie; Bertaux, Lionel; Bruley, Christophe; Garin, Jerome; Claverie, Jean-Michel; Abergel, Chantal			Pandoraviruses: Amoeba Viruses with Genomes Up to 2.5 Mb Reaching That of Parasitic Eukaryotes	SCIENCE			English	Article							GIANT VIRUS; MIMIVIRUS; ACANTHAMOEBA; SEQUENCE; HIGHLIGHTS; REASONS; GENES	Ten years ago, the discovery of Mimivirus, a virus infecting Acanthamoeba, initiated a reappraisal of the upper limits of the viral world, both in terms of particle size (>0.7 micrometers) and genome complexity (>1000 genes), dimensions typical of parasitic bacteria. The diversity of these giant viruses (the Megaviridae) was assessed by sampling a variety of aquatic environments and their associated sediments worldwide. We report the isolation of two giant viruses, one off the coast of central Chile, the other from a freshwater pond near Melbourne (Australia), without morphological or genomic resemblance to any previously defined virus families. Their micrometer-sized ovoid particles contain DNA genomes of at least 2.5 and 1.9 megabases, respectively. These viruses are the first members of the proposed "Pandoravirus" genus, a term reflecting their lack of similarity with previously described microorganisms and the surprises expected from their future study.	[Philippe, Nadege; Legendre, Matthieu; Doutre, Gabriel; Poirot, Olivier; Lescot, Magali; Arslan, Defne; Seltzer, Virginie; Bertaux, Lionel; Claverie, Jean-Michel; Abergel, Chantal] Aix Marseille Univ, Struct & Genom Informat Lab, CNRS, UMR 7256, F-13288 Marseille 9, France; [Philippe, Nadege] Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, SE-75124 Uppsala, Sweden; [Coute, Yohann; Bruley, Christophe; Garin, Jerome] Univ Grenoble 1, CEA, IRTSV, INSERM,U1038, F-38054 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Uppsala University; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Claverie, JM (corresponding author), Aix Marseille Univ, Struct & Genom Informat Lab, CNRS, UMR 7256, 163 Ave Luminy,Case 934, F-13288 Marseille 9, France.	jean-michel.claverie@univ-amu.fr; chantal.abergel@igs.cnrs-mrs.fr	Couté, Yohann/G-2695-2015; Claverie, Jean Michel/Z-2183-2019; Claverie, Jean-Michel/AAG-4889-2019	Couté, Yohann/0000-0003-3896-6196; Claverie, Jean-Michel/0000-0003-1424-0315; Philippe, Nadege/0000-0001-9154-0341; Bertaux, Lionel/0000-0002-2343-0252; Legendre, Matthieu/0000-0002-8413-2910; Abergel, Chantal/0000-0003-1875-4049; Bruley, Christophe/0000-0003-2155-1234; Lescot, Magali/0000-0001-8189-0823; Olivier, Poirot/0000-0003-3570-7893	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Centre de l'Energie Atomique; Agence National pour la Recherche [ANR-BLAN08-0089, ANR-09-GENM-032-001, ANR-10-INBS-08-01]; ASSEMBLE grant [227799]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre de l'Energie Atomique; Agence National pour la Recherche(French National Research Agency (ANR)); ASSEMBLE grant	We thank S. Faugeron and R. Finke from the Estacion de Investigaciones Marinas in Chile for help during the sampling expedition. We also thank J. Hajdu for invaluable support and J.-P. Chauvin and A. Aouane for expert assistance on the Institut de Biologie du Developpement de Marseille Luminy imagery facility, as well as A. Bernadac and A. Kosta from the Institut de Microbiologie de la Mediterranee. We thank E. Fabre and V. Schmidt for technical assistance, and P. Bonin and R. Claverie for helpful discussions. This work was supported by Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Centre de l'Energie Atomique, and Agence National pour la Recherche (ANR-BLAN08-0089, ANR-09-GENM-032-001, and ANR-10-INBS-08-01). The sampling expedition was sponsored by the ASSEMBLE grant 227799. The genome sequences of P. salinus and P. dulcis have been deposited in GenBank (accession numbers KC977471 and KC977470, respectively). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the data set identifier PXD000213 and DOI 10.6019/PXD000213.	Abergel C, 2007, J VIROL, V81, P12406, DOI 10.1128/JVI.01107-07; Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108; Byrne D, 2009, GENOME RES, V19, P1233, DOI 10.1101/gr.091561.109; Cabeen MT, 2010, ANNU REV GENET, V44, P365, DOI 10.1146/annurev-genet-102108-134845; Clarke M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r11; Claverie JM, 2009, CURR TOP MICROBIOL, V328, P89; Claverie JM, 2013, ADV VIRUS RES, V85, P25, DOI 10.1016/B978-0-12-408116-1.00002-1; Claverie JM, 2010, TRENDS GENET, V26, P431, DOI 10.1016/j.tig.2010.07.003; Claverie JM, 2009, ANNU REV GENET, V43, P49, DOI 10.1146/annurev-genet-102108-134255; Claverie JM, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2108-c3; Colson Philippe, 2011, Genome Biol Evol, V3, P737, DOI 10.1093/gbe/evr048; Corradi N, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1082; Desnues C, 2012, P NATL ACAD SCI USA, V109, P18078, DOI 10.1073/pnas.1208835109; Dolan A, 1998, J VIROL, V72, P2010, DOI 10.1128/JVI.72.3.2010-2021.1998; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107; Hoffmann R, 1998, ENDOCYTOBIOSIS CELL, V12, P185; Hyun JK, 2007, J VIROL, V81, P11075, DOI 10.1128/JVI.00594-07; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Jeudy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003122; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; La Scola B, 2003, SCIENCE, V299, P2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Legendre M, 2010, GENOME RES, V20, P664, DOI 10.1101/gr.102582.109; Liu Hua, 2006, Korean Journal of Parasitology, V44, P117, DOI 10.3347/kjp.2006.44.2.117; LWOFF A, 1957, J GEN MICROBIOL, V17, P239, DOI 10.1099/00221287-17-2-239; Moreira D, 2009, NAT REV MICROBIOL, V7, P306, DOI 10.1038/nrmicro2108; Munson DA, 2006, J EUKARYOT MICROBIOL, V53, pS12, DOI 10.1111/j.1550-7408.2006.00157.x; Ogata H, 2011, ISME J, V5, P1143, DOI 10.1038/ismej.2010.210; Piacente F, 2012, J BIOL CHEM, V287, P3009, DOI 10.1074/jbc.M111.314559; Pombert JF, 2012, P NATL ACAD SCI USA, V109, P12638, DOI 10.1073/pnas.1205020109; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Samson RY, 2009, TRENDS MICROBIOL, V17, P507, DOI 10.1016/j.tim.2009.08.003; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gks1189, 10.1093/nar/gkr1184, 10.1093/nar/gky1069]; Scheid P, 2010, PARASITOL RES, V106, P1371, DOI 10.1007/s00436-010-1811-4; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Suhre K, 2005, P NATL ACAD SCI USA, V102, P14689, DOI 10.1073/pnas.0506465102; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092; Yoosuf N, 2012, GENOME BIOL EVOL, V4, P1324, DOI 10.1093/gbe/evs109; Zauberman N, 2008, PLOS BIOL, V6, P1104, DOI 10.1371/journal.pbio.0060114	45	359	369	5	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2013	341	6143					281	286		10.1126/science.1239181	http://dx.doi.org/10.1126/science.1239181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869018	Green Published			2022-12-01	WOS:000321959300045
J	Jiang, LB; Mu, JB; Zhang, QF; Ni, T; Srinivasan, P; Rayavara, K; Yang, WJ; Turner, L; Lavstsen, T; Theander, TG; Peng, WQ; Wei, GY; Jing, QQ; Wakabayashi, Y; Bansal, A; Luo, Y; Ribeiro, JMC; Scherf, A; Aravind, L; Zhu, J; Zhao, KJ; Miller, LH				Jiang, Lubin; Mu, Jianbing; Zhang, Qingfeng; Ni, Ting; Srinivasan, Prakash; Rayavara, Kempaiah; Yang, Wenjing; Turner, Louise; Lavstsen, Thomas; Theander, Thor G.; Peng, Weiqun; Wei, Guiying; Jing, Qingqing; Wakabayashi, Yoshiyuki; Bansal, Abhisheka; Luo, Yan; Ribeiro, Jose M. C.; Scherf, Artur; Aravind, L.; Zhu, Jun; Zhao, Keji; Miller, Louis H.			PfSETvs methylation of histone H3K36 represses virulence genes in Plasmodium falciparum	NATURE			English	Article							ANTIGENIC VARIATION; LYSINE 36; TRANSCRIPTION; ERYTHROCYTES; PARASITES; TARGETS; PROTEIN	The variant antigen Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), which is expressed on the surface of P. falciparum-infected red blood cells, is a critical virulence factor for malaria(1). Each parasite has 60 antigenically distinct var genes that each code for a different PfEMP1 protein. During infection the clonal parasite population expresses only one gene at a time before switching to the expression of a new variant antigen as an immune-evasion mechanism to avoid the host antibody response(2,3). The mechanism by which 59 of the 60 var genes are silenced remains largely unknown(4-7). Here we show that knocking out the P. falciparum variant-silencing SET gene (here termed PfSETvs), which encodes an orthologue of Drosophila melanogaster ASH1 and controls histone H3 lysine 36 trimethylation (H3K36me3) on var genes, results in the transcription of virtually all var genes in the single parasite nuclei and their expression as proteins on the surface of individual infected red blood cells. PfSETvs-dependent H3K36me3 is present along the entire gene body, including the transcription start site, to silence var genes. With low occupancy of PfSETvs at both the transcription start site of var genes and the intronic promoter, expression of var genes coincides with transcription of their corresponding antisense long noncoding RNA. These results uncover a previously unknown role of PfSETvs-dependent H3K36me3 in silencing var genes in P. falciparum that might provide a general mechanism by which orthologues of PfSETvs repress gene expression in other eukaryotes. PfSETvs knockout parasites expressing all PfEMP1 proteins may also be applied to the development of a malaria vaccine.	[Jiang, Lubin; Jing, Qingqing] Chinese Acad Sci, Inst Pasteur Shanghai, Unit Human Parasite Mol & Cell Biol, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China; [Jiang, Lubin; Jing, Qingqing] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Mu, Jianbing; Srinivasan, Prakash; Rayavara, Kempaiah; Bansal, Abhisheka; Ribeiro, Jose M. C.; Miller, Louis H.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Zhang, Qingfeng; Wei, Guiying] Tongji Univ, Sch Med, Inst Infect Dis & Vaccine Dev, Shanghai 200092, Peoples R China; [Zhang, Qingfeng; Scherf, Artur] Inst Pasteur, Dept Parasitol & Mycol, Unite Biol Interact Hote Parasite, F-75015 Paris, France; [Zhang, Qingfeng; Scherf, Artur] CNRS, URA 2581, F-75015 Paris, France; [Ni, Ting] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Ni, Ting] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Yang, Wenjing; Wakabayashi, Yoshiyuki; Luo, Yan; Zhu, Jun] NHLBI, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA; [Turner, Louise; Lavstsen, Thomas; Theander, Thor G.] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Ctr Med Parasitol, DK-1014 Copenhagen, Denmark; [Turner, Louise; Lavstsen, Thomas; Theander, Thor G.] Rigshosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-1014 Copenhagen, Denmark; [Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tongji University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Fudan University; Fudan University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Copenhagen; Rigshospitalet; University of Copenhagen; George Washington University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Jiang, LB (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Unit Human Parasite Mol & Cell Biol, Key Lab Mol Virol & Immunol, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	lbjiang@ips.ac.cn; lmiller@niaid.nih.gov	/AAI-2516-2019; Bansal, Abhisheka/ABC-7871-2020; Ribeiro, Jose/J-7011-2015; Theander, Thor/F-6714-2015; Scherf, Artur/A-9674-2014	Bansal, Abhisheka/0000-0002-2959-8494; Theander, Thor/0000-0002-3509-7514; Turner, Louise/0000-0003-4494-2289; Ribeiro, Jose/0000-0002-9107-0818; Lavstsen, Thomas/0000-0002-3044-4249; Scherf, Artur/0000-0003-2411-3328; Aravind, L/0000-0003-0771-253X; Peng, Weiqun/0000-0001-5521-9091; ZHANG, Qingfeng/0000-0002-8759-9102	Intramural Research Program of the National Institute of Allergy and Infectious Disease; National Heart, Lung, and Blood Institute, National Institutes of Health; National Natural Science Foundation of China [81271863]; Key Research Program of the Chinese Academy of Sciences [KSZD-EW-Z-003-1-2]; ERC [250320]; Lundbeck Foundation [R108-2012-10328, R140-2013-13448] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058, ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810, ZIAAI000241] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); ERC(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. K. Pierce at the National Institute of Allergy and Infectious Diseases, National Institutes of Health, for critical suggestions on the manuscript and A. F. Cowman for providing the pHTK transfection plasmid. We also thank V. Nair and E. Fisher at the NIH Research Technology Branch for assistance with electron microscopy. This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Disease and the National Heart, Lung, and Blood Institute, National Institutes of Health, and also by the National Natural Science Foundation of China (81271863) and the Key Research Program of the Chinese Academy of Sciences (KSZD-EW-Z-003-1-2). A. S. was supported by an ERC grant PlasmoEscape (250320). All authors have reviewed and agreed with the content of the manuscript.	Aravind L, 2011, PROG MOL BIOL TRANSL, V101, P105, DOI 10.1016/B978-0-12-387685-0.00004-4; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; Chantalat S, 2011, GENOME RES, V21, P1426, DOI 10.1101/gr.118091.110; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; Cui LW, 2008, INT J PARASITOL, V38, P1083, DOI 10.1016/j.ijpara.2008.01.002; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Epp C, 2009, RNA, V15, P116, DOI 10.1261/rna.1080109; Jiang HY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r33; Jiang LB, 2010, P NATL ACAD SCI USA, V107, P2224, DOI 10.1073/pnas.0913396107; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Kim T, 2012, CELL, V150, P1158, DOI 10.1016/j.cell.2012.08.016; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; NEWBOLD CI, 1992, EXP PARASITOL, V75, P281, DOI 10.1016/0014-4894(92)90213-T; Rechtsteiner A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001091; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Soubes SC, 1997, EXP PARASITOL, V86, P79, DOI 10.1006/expr.1997.4153; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Tanaka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028171; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Werven FJ, 2012, CELL, V150, P1170, DOI 10.1016/j.cell.2012.06.049; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Volz JC, 2012, CELL HOST MICROBE, V11, P7, DOI 10.1016/j.chom.2011.11.011; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; WELLEMS TE, 1988, REV BRAS GENET, V11, P813; Wu SF, 2011, GENOME RES, V21, P578, DOI 10.1101/gr.113167.110	36	161	174	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					223	+		10.1038/nature12361	http://dx.doi.org/10.1038/nature12361			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23823717	Bronze, Green Accepted			2022-12-01	WOS:000321557600065
J	Doll, J; Zeitler, E; Becker, R				Doll, Jacob; Zeitler, Emily; Becker, Richard			Generic Clopidogrel - Time to Substitute?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Doll, Jacob; Zeitler, Emily; Becker, Richard] Duke Univ, Med Ctr, Durham, NC USA	Duke University	Doll, J (corresponding author), Duke Univ, Med Ctr, Durham, NC USA.								0	8	8	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					145	146		10.1001/jama.2013.7155	http://dx.doi.org/10.1001/jama.2013.7155			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23839745				2022-12-01	WOS:000321511500034
J	Yoshimoto, S; Loo, TM; Atarashi, K; Kanda, H; Sato, S; Oyadomari, S; Iwakura, Y; Oshima, K; Morita, H; Hattori, M; Honda, K; Ishikawa, Y; Hara, E; Ohtani, N				Yoshimoto, Shin; Loo, Tze Mun; Atarashi, Koji; Kanda, Hiroaki; Sato, Seidai; Oyadomari, Seiichi; Iwakura, Yoichiro; Oshima, Kenshiro; Morita, Hidetoshi; Hattori, Masahisa; Honda, Kenya; Ishikawa, Yuichi; Hara, Eiji; Ohtani, Naoko			Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome	NATURE			English	Article							HEPATIC STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; MECHANISMS; CLOSTRIDIUM; EXPRESSION; ACID; INFLAMMATION; PHENOTYPE; BACTERIUM; STRESS	Obesity has become more prevalent in most developed countries over the past few decades, and is increasingly recognized as a major risk factor for several common types of cancer(1). As the worldwide obesity epidemic has shown no signs of abating(2), better understanding of the mechanisms underlying obesity-associated cancer is urgently needed. Although several events were proposed to be involved in obesity-associated cancer1,3, the exact molecular mechanisms that integrate these events have remained largely unclear. Here we show that senescence-associated secretory phenotype (SASP)(4,5) has crucial roles in promoting obesity-associated hepatocellular carcinoma (HCC) development in mice. Dietary or genetic obesity induces alterations of gut microbiota, thereby increasing the levels of deoxycholic acid (DCA), a gut bacterial metabolite known to cause DNA damage(6). The enterohepatic circulation of DCA provokes SASP phenotype in hepatic stellate cells (HSCs)(7), which in turn secretes various inflammatory and tumour-promoting factors in the liver, thus facilitating HCC development in mice after exposure to chemical carcinogen. Notably, blocking DCA production or reducing gut bacteria efficiently prevents HCC development in obese mice. Similar results were also observed in mice lacking an SASP inducer(8) or depleted of senescent HSCs, indicating that the DCA-SASP axis in HSCs has key roles in obesity-associated HCC development. Moreover, signs of SASP were also observed in the HSCs in the area of HCC arising in patients with non-alcoholic steatohepatitis(3), indicating that a similar pathway may contribute to at least certain aspects of obesity-associated HCC development in humans as well. These findings provide valuable new insights into the development of obesity-associated cancer and open up new possibilities for its control.	[Yoshimoto, Shin; Loo, Tze Mun; Sato, Seidai; Hara, Eiji; Ohtani, Naoko] Japanese Fdn Canc Res, Inst Canc, Div Canc Biol, Koto Ku, Tokyo 1358550, Japan; [Yoshimoto, Shin; Loo, Tze Mun; Sato, Seidai; Honda, Kenya; Hara, Eiji] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Loo, Tze Mun] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan; [Atarashi, Koji; Honda, Kenya] RIKEN, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan; [Atarashi, Koji; Ohtani, Naoko] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kanda, Hiroaki; Ishikawa, Yuichi] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Koto Ku, Tokyo 1358550, Japan; [Oyadomari, Seiichi] Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biol Sci, Noda, Chiba 2788510, Japan; [Oshima, Kenshiro; Hattori, Masahisa] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Morita, Hidetoshi] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa 2298501, Japan	Japanese Foundation for Cancer Research; Japan Science & Technology Agency (JST); Tokyo University of Science; RIKEN; Japan Science & Technology Agency (JST); Japanese Foundation for Cancer Research; Tokushima University; Tokyo University of Science; University of Tokyo; Azabu University	Hara, E (corresponding author), Japanese Fdn Canc Res, Inst Canc, Div Canc Biol, Koto Ku, Tokyo 1358550, Japan.	eiji.hara@jfcr.or.jp	Honda, Kenya/N-5297-2015; Oyadomari, Seiichi/GZA-7157-2022; Oyadomari, Seiichi/GZA-7072-2022; Ohtani, Naoko/AAB-1891-2021; Iwakura, Yoichiro/E-5457-2011; Atarashi, Koji/I-5363-2014	Ohtani, Naoko/0000-0001-8934-0797; Iwakura, Yoichiro/0000-0002-9934-5775; Atarashi, Koji/0000-0001-5422-0736; YOSHIMOTO, Shin/0000-0001-8405-0301; Loo, Tze Mun/0000-0001-5725-1423	Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Ministry of Health, Labour and Welfare of Japan (MHLW); Uehara Memorial Foundation; Takeda Science Foundation; Japan Society for Promotion of Science (JSPS); Ajinomoto Scholarship Foundation; Grants-in-Aid for Scientific Research [24650625, 221S0001] Funding Source: KAKEN	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan (MHLW)(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ajinomoto Scholarship Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank M. Oshima for suggestions in antibiotics treatment and members of the Hara laboratory for discussion during the preparation of this manuscript. This work was supported by grants from Japan Science and Technology Agency (JST), Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Ministry of Health, Labour and Welfare of Japan (MHLW), Uehara Memorial Foundation and Takeda Science Foundation. S.Y. was partly supported by a postdoctoral fellowship from the Japan Society for Promotion of Science (JSPS). T. M. L. was partly supported by an international scholarship from the Ajinomoto Scholarship Foundation.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Beuers U, 2006, NAT CLIN PRACT GASTR, V3, P318, DOI 10.1038/ncpgasthep0521; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Coppe JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; KITAZAWA S, 1990, CARCINOGENESIS, V11, P1323, DOI 10.1093/carcin/11.8.1323; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; Minamida K, 2006, BIOSCI BIOTECH BIOCH, V70, P332, DOI 10.1271/bbb.70.332; Muto A, 2012, J CHROMATOGR B, V900, P24, DOI 10.1016/j.jchromb.2012.05.023; Newell P, 2009, J HEPATOL, V51, P725, DOI 10.1016/j.jhep.2009.03.028; Ohtani N, 2007, P NATL ACAD SCI USA, V104, P15034, DOI 10.1073/pnas.0706949104; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Payne CM, 2007, CARCINOGENESIS, V28, P215, DOI 10.1093/carcin/bgl139; RAFTER JJ, 1987, AM J CLIN NUTR, V45, P559, DOI 10.1093/ajcn/45.3.559; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ridlon JM, 2012, J LIPID RES, V53, P66, DOI 10.1194/jlr.M020313; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097; Sekiya Y, 2011, J CELL PHYSIOL, V226, P2535, DOI 10.1002/jcp.22598; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018; Takuma Y, 2010, WORLD J GASTROENTERO, V16, P1436, DOI 10.3748/wjg.v16.i12.1436; Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105	39	1249	1338	10	424	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2013	499	7456					97	+		10.1038/nature12347	http://dx.doi.org/10.1038/nature12347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23803760				2022-12-01	WOS:000321285600041
J	Mehrotra, A				Mehrotra, Ateev			The Convenience Revolution for Treatment of Low-Acuity Conditions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RETAIL CLINICS; VISITS; CARE; OFFICE		Univ Pittsburgh, Sch Med, RAND Hlth, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; RAND Corporation	Mehrotra, A (corresponding author), Univ Pittsburgh, Sch Med, RAND Hlth, 4570 5th Ave,Ste 600, Pittsburgh, PA 15213 USA.	mehrotra@rand.org	Mehrotra, Ateev/AAO-8454-2021	Mehrotra, Ateev/0000-0003-2223-1582	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097759] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI097759, R21 AI097759-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Christensen C.M., 2000, HARVARD BUSINESS REV; Courneya PT, 2013, HEALTH AFFAIR, V32, P385, DOI 10.1377/hlthaff.2012.1157; Mehrotra A, 2008, HEALTH AFFAIR, V27, P1272, DOI 10.1377/hlthaff.27.5.1272; Mehrotra A, 2013, JAMA INTERN MED, V173, P72, DOI 10.1001/2013.jamainternmed.305; Mehrotra A, 2012, HEALTH AFFAIR, V31, P2123, DOI 10.1377/hlthaff.2011.1128; Mehrotra A, 2009, ANN INTERN MED, V151, P321, DOI 10.7326/0003-4819-151-5-200909010-00006; Pitts SR, 2010, HEALTH AFFAIR, V29, P1620, DOI 10.1377/hlthaff.2009.1026; Rohrer James E, 2012, Qual Manag Health Care, V21, P44, DOI 10.1097/QMH.0b013e3182418157	8	46	46	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					35	36		10.1001/jama.2013.6825	http://dx.doi.org/10.1001/jama.2013.6825			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175SK	23821082	Green Accepted			2022-12-01	WOS:000321253000016
J	Nedergaard, M				Nedergaard, Maiken			Garbage Truck of the Brain	SCIENCE			English	Editorial Material							MECHANISMS; PATHWAY; SYSTEM		Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester	Nedergaard, M (corresponding author), Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA.	nedergaard@urmc.rochester.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075177, R01NS078304, R01NS078167] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH099578] Funding Source: Medline; NINDS NIH HHS [R01 NS078167, R01 NS078304, R01 NS075177] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CSERR HF, 1971, PHYSIOL REV, V51, P273, DOI 10.1152/physrev.1971.51.2.273; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Goldstein L. E., 2012, SCI TRANSL MED, V4; Iliff JJ, 2013, STROKE, V44, pS93, DOI 10.1161/STROKEAHA.112.678698; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Loukas M, 2011, CLIN ANAT, V24, P807, DOI 10.1002/ca.21194; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Walker LC, 2013, JAMA NEUROL, V70, P304, DOI 10.1001/jamaneurol.2013.1453; Weller RO, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt6; Yang LJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-107; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7	15	344	354	7	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1529	1530		10.1126/science.1240514	http://dx.doi.org/10.1126/science.1240514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812703	Green Accepted			2022-12-01	WOS:000321007000023
J	Day, RO; Graham, GG				Day, Richard O.; Graham, Garry G.			Non-steroidal anti-inflammatory drugs (NSAIDs)	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SELECTIVE INHIBITORS; BREAST-MILK; OSTEOARTHRITIS; RECOMMENDATIONS; MANAGEMENT; CELECOXIB; SYSTEM; SAFETY; ADULTS; RISK		[Day, Richard O.; Graham, Garry G.] Univ New S Wales, Dept Pharmacol, Sydney, NSW, Australia; [Day, Richard O.; Graham, Garry G.] St Vincents Hosp, Dept Clin Pharmacol & Toxicol, Sydney, NSW 2010, Australia	University of New South Wales Sydney; St Vincents Hospital Sydney	Day, RO (corresponding author), Univ New S Wales, Dept Pharmacol, Sydney, NSW, Australia.	r.day@unsw.edu.au	Nassar, Mamdouh Ibrahim/H-9864-2019; Day, Richard/D-8699-2011	Nassar, Mamdouh Ibrahim/0000-0002-4624-740X; Day, Richard/0000-0002-6045-6937				Adebajo A, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-23; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; BROOKS PM, 1991, NEW ENGL J MED, V324, P1716; ClinRisk, WELC QRISK2 2013 RIS; Derry S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007400.pub2; Fortun PJ, 2005, CURR OPIN GASTROEN, V21, P169, DOI 10.1097/01.mog.0000153314.51198.58; Gardiner SJ, 2006, BRIT J CLIN PHARMACO, V61, P101, DOI 10.1111/j.1365-2125.2005.02520.x; Graham GG, 2013, INFLAMMOPHARMACOLOGY, DOI 10.1007; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; HOPPMANN RA, 1991, ARCH INTERN MED, V151, P1309, DOI 10.1001/archinte.151.7.1309; Hunt RH, 2009, ANN MED, V41, P423, DOI 10.1080/07853890902887295; Laine L, 2008, SEMIN ARTHRITIS RHEU, V38, P165, DOI 10.1016/j.semarthrit.2007.10.004; Latimer N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2538; Marjoribanks J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001751.pub2; Massey T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007402.pub2; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; Moore RA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008659.pub2; Nakhai-Pour HR, 2011, CAN MED ASSOC J, V183, P1713, DOI 10.1503/cmaj.110454; National Institute for Health and Clinical Excellence, 2008, OST CAR MAN OST AD C, V59; Risser A, 2009, AM FAM PHYSICIAN, V80, P1371; Roddy E, 2005, ANN RHEUM DIS, V64, P544, DOI 10.1136/ard.2004.028746; Roelofs PD, 2008, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000396.PUB3; Rostom A, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002296, DOI 10.1002/14651858.CD002296]; Solomon DH, 2010, ARCH INTERN MED, V170, P1979, DOI 10.1001/archinternmed.2010.450; Solomon DH, 2005, J RHEUMATOL, V32, P1415; Stevenson DD, 2004, IMMUNOL ALLERGY CLIN, V24, P491, DOI 10.1016/j.iac.2004.03.001; Strand V, 2007, LANCET, V370, P2138, DOI 10.1016/S0140-6736(07)61909-6; Strand V, 2011, J RHEUMATOL, V38, P2625, DOI 10.3899/jrheum.110636; Terkeltaub RA, 2010, ARTHRITIS RHEUM-US, V62, P1060, DOI 10.1002/art.27327; TOWNSEND RJ, 1984, AM J OBSTET GYNECOL, V149, P184, DOI 10.1016/0002-9378(84)90195-9; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Wilson SL, 2006, J HYPERTENS, V24, P1457, DOI 10.1097/01.hjh.0000239278.82196.a5; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	34	89	92	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2013	346								f3195	10.1136/bmj.f3195	http://dx.doi.org/10.1136/bmj.f3195			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179AA	23757736	Bronze, Green Submitted			2022-12-01	WOS:000321487300001
J	Roenneberg, T				Roenneberg, Till			The human sleep project	NATURE			English	Editorial Material							SOCIAL JETLAG		Univ Munich, Munich, Germany	University of Munich	Roenneberg, T (corresponding author), Univ Munich, Munich, Germany.	till.roenneberg@med.uni-muenchen.de		Roenneberg, Till/0000-0003-2939-0332				Hillman DR, 2006, SLEEP, V29, P299, DOI 10.1093/sleep/29.3.299; Levandovski R, 2011, CHRONOBIOL INT, V28, P771, DOI 10.3109/07420528.2011.602445; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152	6	66	69	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					427	428		10.1038/498427a	http://dx.doi.org/10.1038/498427a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171LH	23803826				2022-12-01	WOS:000320929400025
J	Husnik, F; Nikoh, N; Koga, R; Ross, L; Duncan, RP; Fujie, M; Tanaka, M; Satoh, N; Bachtrog, D; Wilson, ACC; von Dohlen, CD; Fukatsu, T; McCutcheon, JP				Husnik, Filip; Nikoh, Naruo; Koga, Ryuichi; Ross, Laura; Duncan, Rebecca P.; Fujie, Manabu; Tanaka, Makiko; Satoh, Nori; Bachtrog, Doris; Wilson, Alex C. C.; von Dohlen, Carol D.; Fukatsu, Takema; McCutcheon, John P.			Horizontal Gene Transfer from Diverse Bacteria to an Insect Genome Enables a Tripartite Nested Mealybug Symbiosis	CELL			English	Article							INTRACELLULAR BACTERIA; BETA-PROTEOBACTERIA; HOST-CELL; WOLBACHIA; ENDOSYMBIONTS; EVOLUTION; SEQUENCE; CHROMOSOME; REDUCTION; HEMIPTERA	The smallest reported bacterial genome belongs to Tremblaya princeps, a symbiont of Planococcus citri mealybugs (PCIT). Tremblaya PCIT not only has a 139 kb genome, but possesses its own bacterial endosymbiont, Moranella endobia. Genome and transcriptome sequencing, including genome sequencing from a Tremblaya lineage lacking intracellular bacteria, reveals that the extreme genomic degeneracy of Tremblaya PCIT likely resulted from acquiring Moranella as an endosymbiont. In addition, at least 22 expressed horizontally transferred genes from multiple diverse bacteria to the mealybug genome likely complement missing symbiont genes. However, none of these horizontally transferred genes are from Tremblaya, showing that genome reduction in this symbiont has not been enabled by gene transfer to the host nucleus. Our results thus indicate that the functioning of this three-way symbiosis is dependent on genes from at least six lineages of organisms and reveal a path to intimate endosym-biosis distinct from that followed by organelles.	[Husnik, Filip] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Husnik, Filip] Biol Ctr ASCR, Inst Parasitol, Ceske Budejovice 37005, Czech Republic; [Nikoh, Naruo] Open Univ Japan, Dept Liberal Arts, Chiba 2618586, Japan; [Koga, Ryuichi; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan; [Ross, Laura] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Duncan, Rebecca P.; Wilson, Alex C. C.] Univ Miami, Dept Biol, Coral Gables, FL 33146 USA; [Fujie, Manabu] Grad Univ, Okinawa Inst Sci & Technol, DNA Sequencing Sect, Onna, Okinawa 9040495, Japan; [Tanaka, Makiko; Satoh, Nori] Grad Univ, Okinawa Inst Sci & Technol, Marine Genom Unit, Onna, Okinawa 9040495, Japan; [Bachtrog, Doris] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [von Dohlen, Carol D.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [McCutcheon, John P.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; National Institute of Advanced Industrial Science & Technology (AIST); University of Oxford; University of Miami; Okinawa Institute of Science & Technology Graduate University; Okinawa Institute of Science & Technology Graduate University; University of California System; University of California Berkeley; Utah System of Higher Education; Utah State University; University of Montana System; University of Montana	McCutcheon, JP (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	john.mccutcheon@umontana.edu	Satoh, Nori/C-4123-2009; Husnik, Filip/U-2851-2017	Satoh, Nori/0000-0002-4480-3572; Husnik, Filip/0000-0002-5381-0125; von Dohlen, Carol/0000-0002-3961-251X; Ross, Laura/0000-0003-3184-4161; McCutcheon, John/0000-0002-5489-6039; Duncan, Rebecca/0000-0002-7236-7368	Grant Agency of the Czech Republic [P505/10/1401, 13-01878S]; Program for Promotion of Basic; Applied Researches for Innovations in Bio-oriented Industry (BRAIN); KAKENHI [22128001, 22128007]; Royal Society and Somerville College; University of Oxford; NSF Graduate Research Fellowship; Utah Agricultural Experiment Station; NIH [R01GM076007, R01GM093182]; Packard Fellowship; University of Miami; NSF [IOS-1121847, IOS-1256680]; Montana NSF-EPSCoR [EPS0701906]; Grants-in-Aid for Scientific Research [22128007] Funding Source: KAKEN; NERC [NE/K009516/1] Funding Source: UKRI; Natural Environment Research Council [NE/K009516/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076007, R01GM093182, R01GM101255] Funding Source: NIH RePORTER; Direct For Biological Sciences [1256680] Funding Source: National Science Foundation	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Program for Promotion of Basic; Applied Researches for Innovations in Bio-oriented Industry (BRAIN); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Royal Society and Somerville College; University of Oxford; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Utah Agricultural Experiment Station; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship(The David & Lucile Packard Foundation); University of Miami; NSF(National Science Foundation (NSF)); Montana NSF-EPSCoR; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Dan Vanderpool, Yu Matsuura, Kaoru Nikoh, and Dionna Norris for technical and experimental assistance, Minyong Chung for facilitating genome sequencing, Jesse Johnson for access to computing resources, and Nobuo Sawamura and Junko Makino for insect samples. The authors declare no conflicts of interest in this work. F.H. was supported by the Grant Agency of the Czech Republic (P505/10/1401 and 13-01878S). T.F. and N.N. were supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) and by KAKENHI (22128001 and 22128007). L.R. was supported by the Royal Society and Somerville College, University of Oxford. R.P.D. was supported by an NSF Graduate Research Fellowship. C.D.v.D. was supported by the Utah Agricultural Experiment Station. D.B. was supported by NIH grants (R01GM076007 and R01GM093182) and a Packard Fellowship. A.C.C. W. was supported by University of Miami start-up funds and NSF award IOS-1121847. J.P.M. was supported by NSF award IOS-1256680, the Montana NSF-EPSCoR award EPS0701906, and is an Associate in the Integrated Microbial Biodiversity Program of the Canadian Institute for Advanced Research.	Acuna R, 2012, P NATL ACAD SCI USA, V109, P4197, DOI 10.1073/pnas.1121190109; Aikawa T, 2009, P ROY SOC B-BIOL SCI, V276, P3791, DOI 10.1098/rspb.2009.1022; Altincicek B, 2012, BIOL LETTERS, V8, P253, DOI 10.1098/rsbl.2011.0704; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Carbonell P, 2011, J BIOL CHEM, V286, P43994, DOI 10.1074/jbc.M111.274050; Chang YJ, 2011, STAND GENOMIC SCI, V5, P97, DOI 10.4056/sigs.2114901; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Doudoumis V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S3; DOUGLAS AE, 1989, BIOL REV, V64, P409, DOI 10.1111/j.1469-185X.1989.tb00682.x; Gil R, 2003, P NATL ACAD SCI USA, V100, P9388, DOI 10.1073/pnas.1533499100; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Gruwell ME, 2010, APPL ENVIRON MICROB, V76, P7521, DOI 10.1128/AEM.01354-10; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Hardy NB, 2008, SYST ENTOMOL, V33, P51, DOI 10.1111/j.1365-3113.2007.00408.x; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hotopp JCD, 2011, TRENDS GENET, V27, P157, DOI 10.1016/j.tig.2011.01.005; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2008, CURR BIOL, V18, pR345, DOI 10.1016/j.cub.2008.02.065; Keeling PJ, 2011, CURR BIOL, V21, pR623, DOI 10.1016/j.cub.2011.06.061; Klasson L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-33; Koga R, 2013, FEMS MICROBIOL ECOL, V83, P93, DOI 10.1111/j.1574-6941.2012.01450.x; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Kono M, 2008, APPL ENVIRON MICROB, V74, P4175, DOI 10.1128/AEM.00250-08; Lopez-Madrigal S, 2011, J BACTERIOL, V193, P5587, DOI 10.1128/JB.05749-11; Lopez-Sanchez MJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000721; Macdonald SJ, 2012, P ROY SOC B-BIOL SCI, V279, P2965, DOI 10.1098/rspb.2012.0414; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; McCutcheon JP, 2011, CURR BIOL, V21, P1366, DOI 10.1016/j.cub.2011.06.051; McCutcheon JP, 2010, GENOME BIOL EVOL, V2, P708, DOI 10.1093/gbe/evq055; McCutcheon JP, 2010, CURR OPIN MICROBIOL, V13, P73, DOI 10.1016/j.mib.2009.12.002; McCutcheon JP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000565; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Moran NA, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-12-research0054; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Nakabachi A, 2005, P NATL ACAD SCI USA, V102, P5477, DOI 10.1073/pnas.0409034102; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nikoh N, 2008, GENOME RES, V18, P272, DOI 10.1101/gr.7144908; Nikoh N, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-12; Nikoh N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000827; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; Ochman H, 2006, SCIENCE, V311, P1730, DOI 10.1126/science.1119966; Penz T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003012; Poliakov A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007039; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Rose AB, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00098; Rothman SC, 2003, J MOL BIOL, V327, P593, DOI 10.1016/S0022-2836(03)00095-0; Sabree ZL, 2009, P NATL ACAD SCI USA, V106, P19521, DOI 10.1073/pnas.0907504106; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Sloan DB, 2012, MOL BIOL EVOL, V29, P3781, DOI 10.1093/molbev/mss180; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Thao ML, 2002, APPL ENVIRON MICROB, V68, P3190, DOI 10.1128/AEM.68.7.3190-3197.2002; Theissen U, 2006, CURR BIOL, V16, pR1016, DOI 10.1016/j.cub.2006.11.020; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; von Dohlen CD, 2001, NATURE, V412, P433, DOI 10.1038/35086563; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Woolfit M, 2009, MOL BIOL EVOL, V26, P367, DOI 10.1093/molbev/msn253; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	64	271	281	2	185	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1567	1578		10.1016/j.cell.2013.05.040	http://dx.doi.org/10.1016/j.cell.2013.05.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791183	Bronze			2022-12-01	WOS:000320722000023
J	Patel, AM; Shariff, S; Bailey, DG; Juurlink, DN; Gandhi, S; Mamdani, M; Gomes, T; Fleet, J; Hwang, J; Garg, AX				Patel, Amit M.; Shariff, Salimah; Bailey, David G.; Juurlink, David N.; Gandhi, Sonja; Mamdani, Muhammad; Gomes, Tara; Fleet, Jamie; Hwang, Joseph; Garg, Amit X.			Statin Toxicity From Macrolide Antibiotic Coprescription A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							DRUG-DRUG INTERACTIONS; RHABDOMYOLYSIS; ATORVASTATIN; SIMVASTATIN; CLARITHROMYCIN; ERYTHROMYCIN; PREVALENCE; LOVASTATIN; OUTCOMES; RISK	Background: Clarithromycin and erythromycin, but not azithromycin, inhibit cytochrome P450 isoenzyme 3A4 ( CYP3A4), and inhibition increases blood concentrations of statins that are metabolized by CYP3A4. Objective: To measure the frequency of statin toxicity after coprescription of a statin with clarithromycin or erythromycin. Design: Population-based cohort study. Setting: Ontario, Canada, from 2003 to 2010. Patients: Continuous statin users older than 65 years who were prescribed clarithromycin (n = 72 591) or erythromycin (n = 3267) compared with those prescribed azithromycin (n = 68 478). Measurements: The primary outcome was hospitalization with rhabdomyolysis within 30 days of the antibiotic prescription. Results: Atorvastatin was the most commonly prescribed statin (73%) followed by simvastatin and lovastatin. Compared with azithromycin, coprescription of a statin with clarithromycin or erythromycin was associated with a higher risk for hospitalization with rhabdomyolysis (absolute risk increase, 0.02% [95% CI, 0.01% to 0.03%]; relative risk [RR], 2.17 [CI, 1.04 to 4.53]) or with acute kidney injury (absolute risk increase, 1.26% [CI, 0.58% to 1.95%]; RR, 1.78 [CI, 1.49 to 2.14]) and for all-cause mortality (absolute risk increase, 0.25% [CI, 0.17% to 0.33%]; RR, 1.56 [CI, 1.36 to 1.80]). Limitations: Only older adults were included in the study. The absolute risk increase for rhabdomyolysis may be underestimated because the codes used to identify it were insensitive. Conclusion: In older adults, coprescription of clarithromycin or erythromycin with a statin that is metabolized by CYP3A4 increases the risk for statin toxicity.	Univ Western Ontario, London, ON, Canada; London Hlth Sci Ctr, Lawson Hlth Res Inst, London, ON N6A 4G5, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada; Univ Toronto, Toronto, ON, Canada	Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario); University of Toronto; University of Toronto	Garg, AX (corresponding author), London Hlth Sci Ctr, London Kidney Clin Res Unit, Room ELL 101,800 Commissioners Rd East, London, ON N6A 4G5, Canada.	amit.garg@lhsc.on.ca	Fleet, Jamie L/GYJ-7373-2022; Garg, Amit X/G-3295-2011	Gomes, Tara/0000-0002-1468-1965; Shariff, Salimah/0000-0002-1219-6763; Fleet, Jamie/0000-0002-9468-0697	Academic Medical Organization of Southwestern Ontario; Ontario Ministry of Health and Long-term Care; Canadian Institutes of Health Research Clinician Scientist Award	Academic Medical Organization of Southwestern Ontario; Ontario Ministry of Health and Long-term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research Clinician Scientist Award(Canadian Institutes of Health Research (CIHR))	Academic Medical Organization of Southwestern Ontario.; The investigators received grant support from the Academic Medical Organization of Southwestern Ontario to conduct this research. This project was conducted at the Institute for Clinical Evaluative Sciences site at Western University. The Institute for Clinical Evaluative Sciences is funded by an annual grant from the Ontario Ministry of Health and Long-term Care. The Institute for Clinical Evaluative Sciences site at Western University is funded by an operating grant from the Academic Medical Organization of Southwestern Ontario. Dr. Garg was supported by a Canadian Institutes of Health Research Clinician Scientist Award.	Amsden GW, 2002, J CLIN PHARMACOL, V42, P444, DOI 10.1177/0091270002424011; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bravo AER, 2005, DRUG SAFETY, V28, P263; Campbell G, 2007, AGE AGEING, V36, P597, DOI 10.1093/ageing/afm110; Drugs. com, DRUG INT CHECK; Egger SS, 2007, DRUG AGING, V24, P429, DOI 10.2165/00002512-200724050-00006; Fleet JL, 2012, BMJ OPEN, V2; Floyd JS, 2012, JAMA-J AM MED ASSOC, V307, P1580, DOI 10.1001/jama.2012.489; GABOW PA, 1982, MEDICINE, V61, P141, DOI 10.1097/00005792-198205000-00002; Gandhi S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001921; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Hwang YJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001821; Jacobson TA, 2004, AM J CARDIOL, V94, P1140, DOI 10.1016/j.amjcard.2004.07.080; Jain AK, 2012, KIDNEY INT, V81, P1248, DOI 10.1038/ki.2012.18; Kantola T, 1998, CLIN PHARMACOL THER, V64, P177, DOI 10.1016/S0009-9236(98)90151-5; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Merck & Co, 2012, FDA DRUG SAF COMM IN; Ming JBM, 2003, AIDS PATIENT CARE ST, V17, P207, DOI 10.1089/108729103321655854; Molden E, 2008, DRUG SAFETY, V31, P587, DOI 10.2165/00002018-200831070-00004; Neuvonen PJ, 2008, CLIN PHARMACOKINET, V47, P463, DOI 10.2165/00003088-200847070-00003; Neuvonen PJ, 2006, CLIN PHARMACOL THER, V80, P565, DOI 10.1016/j.clpt.2006.09.003; Paquette A, 2012, PHARM PRACTICE, V28, P45; Pfizer, 2012, FDA DRUG SAF COMM IN; Pfizer, 2013, ZITHR PACK INS; Piacentini N, 2005, EUR J CLIN PHARMACOL, V61, P615, DOI 10.1007/s00228-005-0972-z; Samineni D, 2012, J CLIN PHARMACOL, V52, P922, DOI 10.1177/0091270011407494; Seithel A, 2007, DRUG METAB DISPOS, V35, P779, DOI 10.1124/dmd.106.014407; Shih AWY, 2012, KIDNEY INT, V82, P903, DOI 10.1038/ki.2012.227; Siedlik PH, 1999, J CLIN PHARMACOL, V39, P501; SPACH DH, 1991, WESTERN J MED, V154, P213; Statistics Canada, 2012, POP SEX AG GROUP PRO; Tawadrous D, 2011, AM J KIDNEY DIS, V58, P903, DOI 10.1053/j.ajkd.2011.07.022; Trieu J, 2004, CLIN NUCL MED, V29, P803, DOI 10.1097/00003072-200412000-00008; U.S. Food and Drug Administration, 2012, FDA DRUG SAF COMM IN; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Zhao YY, 2012, ANN INTERN MED, V156, P560, DOI [10.7326/0003-4819-156-8-201204170-00401, 10.7326/0003-4819-156-8-201204170-00003]	40	106	112	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12					869	+		10.7326/0003-4819-158-12-201306180-00004	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778904				2022-12-01	WOS:000320645000015
J	Lazarus, JA				Lazarus, Jeremy A.			Physicians' ethical obligations to hunger strikers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICAL-ETHICS; GUANTANAMO		[Lazarus, Jeremy A.] Amer Med Assoc, Chicago, IL 60610 USA	American Medical Association								American Medical Association, COD MED ETH OP E 10; American Medical Association, PRINC MED ETH; American Medical Association, CODE MED ETH OP E 2; American Medical Association, CODE MED ETH OP E 8; American Medical Association, COD MED ETH OP E 8 0; Annas GJ, 2006, NEW ENGL J MED, V355, P1377, DOI 10.1056/NEJMhle062316; Center for Constitutional Rights, 2005, GUANT PRIS HUNG STRI; Golden Tim, 2006, NY TIMES; Okie S, 2005, NEW ENGL J MED, V353, P2529, DOI 10.1056/NEJMp058296; Reyes Hernan, 1998, MED ETHICAL ASPECTS, P291; World Medical Association, GUID PHYS TORT CRUEL	11	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2013	346								f3705	10.1136/bmj.f3705	http://dx.doi.org/10.1136/bmj.f3705			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166WQ	23766492				2022-12-01	WOS:000320590800001
J	Keusekotten, K; Elliott, PR; Glockner, L; Fiil, BK; Damgaard, RB; Kulathu, Y; Wauer, T; Hospenthal, MK; Gyrd-Hansen, M; Krappmann, D; Hofmann, K; Komander, D				Keusekotten, Kirstin; Elliott, Paul Ronald; Glockner, Laura; Fiil, Berthe Katrine; Damgaard, Rune Busk; Kulathu, Yogesh; Wauer, Tobias; Hospenthal, Manuela Kathrin; Gyrd-Hansen, Mads; Krappmann, Daniel; Hofmann, Kay; Komander, David			OTULIN Antagonizes LUBAC Signaling by Specifically Hydrolyzing Met1-Linked Polyubiquitin	CELL			English	Article							LINEAR UBIQUITIN CHAINS; LIGASE; INFLAMMATION; REVEALS; COMPLEX; DOMAIN; DEUBIQUITINASE; RECOGNITION; INHIBITION; MECHANISM	The linear ubiquitin (Ub) chain assembly complex (LUBAC) is an E3 ligase that specifically assembles Met1-linked (also known as linear) Ub chains that regulate nuclear factor kappa B (NF-kappa B) signaling. Deubiquitinases (DUBs) are key regulators of Ub signaling, but a dedicated DUB for Met1 linkages has not been identified. Here, we reveal a previously unannotated human DUB, OTULIN (also known as FAM105B), which is exquisitely specific for Met1 linkages. Crystal structures of the OTULIN catalytic domain in complex with diubiquitin reveal Met1-specific Ub-binding sites and a mechanism of substrate-assisted catalysis in which the proximal Ub activates the catalytic triad of the protease. Mutation of Ub Glu16 inhibits OTULIN activity by reducing k(cat) 240-fold. OTULIN overexpression or knockdown affects NF-kappa B responses to LUBAC, TNF alpha, and poly(I:C) and sensitizes cells to TNF alpha-induced cell death. We show that OTULIN binds LUBAC and that overexpression of OTULIN prevents TNF alpha-induced NEMO association with ubiquitinated RIPK1. Our data suggest that OTULIN regulates Met1-polyUb signaling.	[Keusekotten, Kirstin; Elliott, Paul Ronald; Kulathu, Yogesh; Wauer, Tobias; Hospenthal, Manuela Kathrin; Komander, David] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Glockner, Laura; Krappmann, Daniel] Inst Mol Toxicol & Pharmacol, Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Cellular Signal Integrat, D-85764 Neuherberg, Germany; [Fiil, Berthe Katrine; Damgaard, Rune Busk; Gyrd-Hansen, Mads] Univ Copenhagen, Dept Dis Biol, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Hofmann, Kay] Univ Cologne, Inst Genet, D-50674 Cologne, Germany	MRC Laboratory Molecular Biology; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Copenhagen; University of Cologne	Komander, D (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	dk@mrc-lmb.cam.ac.uk	Damgaard, Rune/AAX-4661-2021; Krappmann, Daniel/ABF-4038-2021; Hospenthal, Manuela/AAU-3210-2020; Krappmann, Daniel/AAT-4354-2021	Krappmann, Daniel/0000-0001-7640-3234; Hospenthal, Manuela/0000-0003-1175-6826; Krappmann, Daniel/0000-0001-7640-3234; Fiil, Berthe Katrine/0000-0002-9499-4848; Elliott, Paul/0000-0002-7641-2103; Kulathu, Yogesh/0000-0002-3274-1642; Damgaard, Rune Busk/0000-0002-1709-6534; Gyrd-Hansen, Mads/0000-0001-5641-5019	MRC [U105192732]; European Research Council [309756]; European Molecular Biology Organization Young Investigator program; Lister Institute for Preventive Medicine; German Research Foundation (DFG) [SPP1365]; Novo Nordisk Foundation; Steno Fellowship from the Danish Council for Independent Research; MRC [MC_U105192732] Funding Source: UKRI; Medical Research Council [MC_U105192732] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization Young Investigator program(European Molecular Biology Organization (EMBO)); Lister Institute for Preventive Medicine; German Research Foundation (DFG)(German Research Foundation (DFG)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Steno Fellowship from the Danish Council for Independent Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank S. McLaughlin, R. Williams, A. Finch, F. Randow, G. Murshudov (Medical Research Council [MRC] Laboratory of Molecular Biology), G. Praefcke (University of Cologne), and members of the D. Komander lab for advice, reagents, and critical comments on the manuscript. Liposome reagent for Jurkat T cell transfection was a kind gift of Silence Therapeutics, Berlin. This work was supported by the MRC (U105192732 to D. Komander), the European Research Council (309756 to D. Komander), the European Molecular Biology Organization Young Investigator program (D.K.), the Lister Institute for Preventive Medicine (D. Komander), the German Research Foundation (DFG Priority Programme SPP1365 to K.H. and D. Krappmann), the Novo Nordisk Foundation (M.G.H.), and a Steno Fellowship from the Danish Council for Independent Research (M.G.H.). Crystallographic data were collected at the European Synchrotron Radiation Facility at beam lines ID14-4 and ID23-1 and at Diamond Light Source beam line I04-1.	Amerik AY, 1997, EMBO J, V16, P4826; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Licchesi JDF, 2012, NAT STRUCT MOL BIOL, V19, P62, DOI 10.1038/nsmb.2169; Matsumoto ML, 2012, J MOL BIOL, V418, P134, DOI 10.1016/j.jmb.2011.12.053; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; OZKAYNAK E, 1984, NATURE, V312, P663, DOI 10.1038/312663a0; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Tokunaga F, 2012, MICROBES INFECT, V14, P563, DOI 10.1016/j.micinf.2012.01.011; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; van Wijk SJL, 2012, MOL CELL, V47, P797, DOI 10.1016/j.molcel.2012.06.017; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/NCHEMBIO.426, 10.1038/nchembio.426]; Walczak H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-23; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17	42	311	319	2	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1312	1326		10.1016/j.cell.2013.05.014	http://dx.doi.org/10.1016/j.cell.2013.05.014			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746843	hybrid, Green Published			2022-12-01	WOS:000319979200015
J	Akyuz, N; Altman, RB; Blanchard, SC; Boudker, O				Akyuz, Nurunisa; Altman, Roger B.; Blanchard, Scott C.; Boudker, Olga			Transport dynamics in a glutamate transporter homologue	NATURE			English	Article							TRANSLOCATION; SUBSTRATE; RIBOSOME; KINETICS; BINDING	Glutamate transporters are integral membrane proteins that catalyse neurotransmitter uptake from the synaptic cleft into the cytoplasm of glial cells and neurons(1). Their mechanism of action involves transitions between extracellular (outward)-facing and intracellular (inward)-facing conformations, whereby substrate binding sites become accessible to either side of the membrane(2). This process has been proposed to entail transmembrane movements of three discrete transport domains within a trimeric scaffold(3). Using single-molecule fluorescence resonance energy transfer (smFRET) imaging(4), we have directly observed large-scale transport domain movements in a bacterial homologue of glutamate transporters. We find that individual transport domains alternate between periods of quiescence and periods of rapid transitions, reminiscent of bursting patterns first recorded in single ion channels using patch-clamp methods(5,6). We propose that the switch to the dynamic mode in glutamate transporters is due to separation of the transport domain from the trimeric scaffold, which precedes domain movements across the bilayer. This spontaneous dislodging of the substrate-loaded transport domain is approximately 100-fold slower than subsequent transmembrane movements and may be rate determining in the transport cycle.	[Akyuz, Nurunisa; Altman, Roger B.; Blanchard, Scott C.; Boudker, Olga] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10064 USA	Cornell University	Blanchard, SC (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, 1300 York Ave, New York, NY 10064 USA.	scb2005@med.cornell.edu; olb2003@med.cornell.edu	Blanchard, Scott C./A-5804-2009	Blanchard, Scott C./0000-0003-2717-9365; Akyuz, Nurunisa/0000-0002-6340-1915	National Institute of Health [5U54GM087519, R01NS064357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064357] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank D. S. Terry for his help with the design of smFRET experiments and discussions; Z. Zhou for the synthesis of cyanine fluorophores; E. Georgieva for initial biochemical characterization of the single-cysteine mutants; G. Verdon, A. Accardi and N. Reyes for helpful discussions and comments on the manuscript. The work was supported in part by the National Institute of Health grants 5U54GM087519 and R01NS064357.	Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Blanchard SC, 2009, CURR OPIN STRUC BIOL, V19, P103, DOI 10.1016/j.sbi.2009.01.002; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; CULLCANDY SG, 1982, NATURE, V295, P410, DOI 10.1038/295410a0; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dave R, 2009, BIOPHYS J, V96, P2371, DOI 10.1016/j.bpj.2008.11.061; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Liu SX, 2007, P NATL ACAD SCI USA, V104, P12634, DOI 10.1073/pnas.0610597104; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Motulsky H, 2004, FITTING MODELS BIOL, P256; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Otis TS, 2000, J NEUROSCI, V20, P2749; Qin F, 2000, BIOPHYS J, V79, P1915, DOI 10.1016/S0006-3495(00)76441-1; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Reyes N, 2013, NAT STRUCT MOL BIOL, V20, P634, DOI 10.1038/nsmb.2548; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Stolzenberg S, 2012, J PHYS CHEM B, V116, P5372, DOI 10.1021/jp301726s; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057	35	123	123	2	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					114	+		10.1038/nature12265	http://dx.doi.org/10.1038/nature12265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	23792560	Green Accepted			2022-12-01	WOS:000325106000042
J	Atarashi, K; Tanoue, T; Oshima, K; Suda, W; Nagano, Y; Nishikawa, H; Fukuda, S; Saito, T; Narushima, S; Hase, K; Kim, S; Fritz, JV; Wilmes, P; Ueha, S; Matsushima, K; Ohno, H; Olle, B; Sakaguchi, S; Taniguchi, T; Morita, H; Hattori, M; Honda, K				Atarashi, Koji; Tanoue, Takeshi; Oshima, Kenshiro; Suda, Wataru; Nagano, Yuji; Nishikawa, Hiroyoshi; Fukuda, Shinji; Saito, Takuro; Narushima, Seiko; Hase, Koji; Kim, Sangwan; Fritz, Joelle V.; Wilmes, Paul; Ueha, Satoshi; Matsushima, Kouji; Ohno, Hiroshi; Olle, Bernat; Sakaguchi, Shimon; Taniguchi, Tadatsugu; Morita, Hidetoshi; Hattori, Masahira; Honda, Kenya			T-reg induction by a rationally selected mixture of Clostridia strains from the human microbiota	NATURE			English	Article							GUT MICROBIOTA; CELLS; COLONIZATION; DISEASE	Manipulation of the gut microbiota holds great promise for the treatment of inflammatory and allergic diseases(1,2). Although numerous probiotic microorganisms have been identified(3), there remains a compelling need to discover organisms that elicit more robust therapeutic responses, are compatible with the host, and can affect a specific arm of the host immune system in a well-controlled, physiological manner. Here we use a rational approach to isolate CD4(+)FOXP3(+) regulatory T (T-reg)-cell-inducing bacterial strains from the human indigenous microbiota. Starting with a healthy human faecal sample, a sequence of selection steps was applied to obtain mice colonized with human microbiota enriched in T-reg-cell-inducing species. From these mice, we isolated and selected 17 strains of bacteria on the basis of their high potency in enhancing T-reg cell abundance and inducing important anti-inflammatory molecules-including interleukin-10 (IL-10) and inducible T-cell co-stimulator (ICOS)-in T-reg cells upon inoculation into germ-free mice. Genome sequencing revealed that the 17 strains fall within clusters IV, XIVa and XVIII of Clostridia, which lack prominent toxins and virulence factors. The 17 strains act as a community to provide bacterial antigens and a TGF-beta-rich environment to help expansion and differentiation of T-reg cells. Oral administration of the combination of 17 strains to adult mice attenuated disease in models of colitis and allergic diarrhoea. Use of the isolated strains may allow for tailored therapeutic manipulation of human immune disorders.	[Atarashi, Koji; Tanoue, Takeshi; Nagano, Yuji; Fukuda, Shinji; Narushima, Seiko; Hase, Koji; Ohno, Hiroshi; Honda, Kenya] RIKEN Ctr Integrat Med Sci IMS RCAI, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Atarashi, Koji; Tanoue, Takeshi; Nagano, Yuji; Taniguchi, Tadatsugu; Honda, Kenya] Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; [Atarashi, Koji; Hase, Koji] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Oshima, Kenshiro; Morita, Hidetoshi; Honda, Kenya] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Oshima, Kenshiro; Suda, Wataru; Kim, Sangwan; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Nishikawa, Hiroyoshi; Saito, Takuro; Sakaguchi, Shimon] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Fukuda, Shinji] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan; [Fritz, Joelle V.; Wilmes, Paul] Univ Luxembourg, Luxembourg Ctr Syst Biomed, L-4362 Esch Sur Alzette, Luxembourg; [Ueha, Satoshi; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 1130033, Japan; [Olle, Bernat] PureTech Ventures, Boston, MA 02116 USA; [Morita, Hidetoshi] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa 2525201, Japan	RIKEN; University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); University of Tokyo; Osaka University; Keio University; University of Luxembourg; University of Tokyo; Azabu University	Hattori, M (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan.	hattori@k.u-tokyo.ac.jp; kenya@rcai.riken.jp	Suda, Wataru/AAF-4469-2019; Hattori, Masahira/C-6958-2016; Wilmes, Paul/B-1707-2017; Hattori, Masahira/AAD-3785-2019; Honda, Kenya/N-5297-2015; Atarashi, Koji/I-5363-2014; Saito, Takuro/AAN-9682-2021; Sakaguchi, Shimon/C-9535-2009; Nishikawa, Hiroyoshi/AAI-7044-2020; Ohno, Hiroshi/L-7899-2014	Hattori, Masahira/0000-0001-9467-0344; Wilmes, Paul/0000-0002-6478-2924; Atarashi, Koji/0000-0001-5422-0736; Ohno, Hiroshi/0000-0001-8776-9661; Fritz, Joelle/0000-0002-4694-3923; Hase, Koji/0000-0001-9550-2334; Fukuda, Shinji/0000-0001-5161-9880; Ueha, Satoshi/0000-0002-3871-9921	JSPS NEXT program; Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002]; global COE project of 'Genome Information Big Bang'; Waksman Foundation of Japan Inc.; Grants-in-Aid for Scientific Research [24117723, 23300354] Funding Source: KAKEN	JSPS NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); global COE project of 'Genome Information Big Bang'; Waksman Foundation of Japan Inc.(Waksman Foundation of Japan Inc.); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS NEXT program, Grant in Aid for Scientific Research on Innovative Areas 'Genome Science' from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No.221S0002), the global COE project of 'Genome Information Big Bang' and the Waksman Foundation of Japan Inc. We thank M. Suyama, K. Furuya, C. Yoshino, H. Inaba, E. Iioka, Y. Takayama, M. Kiuchi, Y. Hattori, N. Fukuda and A. Nakano for technical assistance, and P. D. Burrows for review of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Candela M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-95; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Jolley KA, 2012, MICROBIOL-SGM, V158, P1005, DOI 10.1099/mic.0.055459-0; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Kweon MN, 2000, J CLIN INVEST, V106, P199, DOI 10.1172/JCI8490; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Morita H, 2007, MICROBES ENVIRON, V22, P214, DOI 10.1264/jsme2.22.214; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; O'Toole Paul W, 2008, Interdiscip Perspect Infect Dis, V2008, P175285, DOI 10.1155/2008/175285; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	28	1722	1864	15	357	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					232	+		10.1038/nature12331	http://dx.doi.org/10.1038/nature12331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23842501				2022-12-01	WOS:000322825500040
J	Francalacci, P; Morelli, L; Angius, A; Berutti, R; Reinier, F; Atzeni, R; Pilu, R; Busonero, F; Maschio, A; Zara, I; Sanna, D; Useli, A; Urru, MF; Marcelli, M; Cusano, R; Oppo, M; Zoledziewska, M; Pitzalis, M; Deidda, F; Porcu, E; Poddie, F; Kang, HM; Lyons, R; Tarrier, B; Gresham, JB; Li, BS; Tofanelli, S; Alonso, S; Dei, M; Lai, S; Mulas, A; Whalen, MB; Uzzau, S; Jones, C; Schlessinger, D; Abecasis, GR; Sanna, S; Sidore, C; Cucca, F				Francalacci, Paolo; Morelli, Laura; Angius, Andrea; Berutti, Riccardo; Reinier, Frederic; Atzeni, Rossano; Pilu, Rosella; Busonero, Fabio; Maschio, Andrea; Zara, Ilenia; Sanna, Daria; Useli, Antonella; Urru, Maria Francesca; Marcelli, Marco; Cusano, Roberto; Oppo, Manuela; Zoledziewska, Magdalena; Pitzalis, Maristella; Deidda, Francesca; Porcu, Eleonora; Poddie, Fausto; Kang, Hyun Min; Lyons, Robert; Tarrier, Brendan; Gresham, Jennifer Bragg; Li, Bingshan; Tofanelli, Sergio; Alonso, Santos; Dei, Mariano; Lai, Sandra; Mulas, Antonella; Whalen, Michael B.; Uzzau, Sergio; Jones, Chris; Schlessinger, David; Abecasis, Gonalo R.; Sanna, Serena; Sidore, Carlo; Cucca, Francesco			Low-Pass DNA Sequencing of 1200 Sardinians Reconstructs European Y-Chromosome Phylogeny	SCIENCE			English	Article							HUMAN-EVOLUTION; MODERN HUMANS; AFRICA; ORIGIN; LEGACY; TREE; ROOT	Genetic variation within the male-specific portion of the Y chromosome (MSY) can clarify the origins of contemporary populations, but previous studies were hampered by partial genetic information. Population sequencing of 1204 Sardinian males identified 11,763 MSY single-nucleotide polymorphisms, 6751 of which have not previously been observed. We constructed a MSY phylogenetic tree containing all main haplogroups found in Europe, along with many Sardinian-specific lineage clusters within each haplogroup. The tree was calibrated with archaeological data from the initial expansion of the Sardinian population similar to 7700 years ago. The ages of nodes highlight different genetic strata in Sardinia and reveal the presumptive timing of coalescence with other human populations. We calculate a putative age for coalescence of similar to 180,000 to 200,000 years ago, which is consistent with previous mitochondrial DNA-based estimates.	[Francalacci, Paolo; Morelli, Laura; Sanna, Daria; Useli, Antonella] Univ Sassari, Dipartimento Sci Nat & Terr, I-07100 Sassari, Italy; [Angius, Andrea; Pilu, Rosella; Busonero, Fabio; Maschio, Andrea; Zoledziewska, Magdalena; Pitzalis, Maristella; Deidda, Francesca; Porcu, Eleonora; Dei, Mariano; Lai, Sandra; Mulas, Antonella; Whalen, Michael B.; Sanna, Serena; Sidore, Carlo; Cucca, Francesco] CNR, IRGB, Monserrato, Italy; [Angius, Andrea; Berutti, Riccardo; Reinier, Frederic; Atzeni, Rossano; Zara, Ilenia; Urru, Maria Francesca; Marcelli, Marco; Cusano, Roberto; Oppo, Manuela; Jones, Chris] Ctr Adv Studies Res & Dev Sardinia CRS4, Pula, Italy; [Berutti, Riccardo; Zoledziewska, Magdalena; Pitzalis, Maristella; Deidda, Francesca; Porcu, Eleonora; Poddie, Fausto; Uzzau, Sergio; Sidore, Carlo; Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Busonero, Fabio; Maschio, Andrea; Porcu, Eleonora; Kang, Hyun Min; Abecasis, Gonalo R.; Sidore, Carlo] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Lyons, Robert; Tarrier, Brendan; Gresham, Jennifer Bragg] Univ Michigan, DNA Sequencing Core, Ann Arbor, MI 48109 USA; [Li, Bingshan] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37235 USA; [Tofanelli, Sergio] Univ Pisa, Dipartimento Biol, I-56126 Pisa, Italy; [Alonso, Santos] Univ Pais Vasco Euskal Herriko Unibertsitatea, Dept Genet Antropol Fis & Fisiol Anim, Bilbao 48080, Spain; [Uzzau, Sergio] Porto Conte Ric, I-07041 Sassari, Italy; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA	University of Sassari; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Sassari; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University; University of Pisa; University of Basque Country; Porto Conte Ricerche; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Francalacci, P (corresponding author), Univ Sassari, Dipartimento Sci Nat & Terr, I-07100 Sassari, Italy.	pfrancalacci@uniss.it; fcucca@uniss.it	Mulas, Antonella/B-4231-2015; marcelli, marco/AGR-6853-2022; Sidore, Carlo/AAV-7967-2020; Alonso, Santos/L-8316-2014; Lai, Sandra/AAY-4176-2020; Uzzau, Sergio/F-3233-2015; sanna, serena/H-3009-2019; Deidda, Francesca/P-1541-2018; Dei, Mariano/AAY-3870-2020; Maschio, Andrea/AAX-8185-2020; Angius, Andrea/P-9549-2015	Sidore, Carlo/0000-0001-7504-7477; Alonso, Santos/0000-0003-0221-4048; Uzzau, Sergio/0000-0001-6246-2794; sanna, serena/0000-0002-3768-1749; Deidda, Francesca/0000-0003-3447-7440; Angius, Andrea/0000-0003-2596-6461; maschio, andrea/0000-0002-4238-9144; Atzeni, Rossano/0000-0003-0020-0013; LAI, SANDRA/0000-0003-4198-9989; TOFANELLI, Sergio/0000-0002-7399-9308; Angius, Andrea/0000-0001-9372-1162; CUCCA, Francesco/0000-0002-7414-1995; Mulas, Antonella/0000-0002-6856-1483; Dei, Mariano/0000-0002-7404-508X; WHALEN, MICHAELBERNARD/0000-0001-7300-8511; Pitzalis, Maristella/0000-0003-4975-6987; Poddie, Fausto PierAngelo/0000-0003-2893-9549; Cusano, Roberto/0000-0001-5543-7881; FRANCALACCI, Paolo/0000-0001-7912-162X; Zoledziewska, Magdalena/0000-0002-3033-6133	NIH from the National Institute of Aging [NO1-AG-1-2109]; Sardinian Autonomous Region [7/2009, cRP3-154, cRP2-597]; Fondazione Banco di Sardegna; Basque Government [G. I. C. IT-542-10]; National Human Genome Research Institute [HG005581, HG005552, HG006513, HG007022]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005581, U01HG006513, R01HG007022, RC2HG005552] Funding Source: NIH RePORTER	NIH from the National Institute of Aging; Sardinian Autonomous Region(Regione Sardegna); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna); Basque Government(Basque Government); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported in part by NIH contract NO1-AG-1-2109 from the National Institute of Aging to the IRGB institute; by Sardinian Autonomous Region (L. R. no. 7/2009) grants cRP3-154 to F. C. and cRP2-597 to P. F.; by Fondazione Banco di Sardegna grants to P. F. and L. M.; by Basque Government grant G. I. C. IT-542-10 to S. A.; and by National Human Genome Research Institute grants HG005581, HG005552, HG006513, and HG007022 to G. R. A. We are grateful to all the Sardinian donors for providing blood samples. We also thank the 1000 Genomes Project consortium for making available their sequencing data, in compliance with the Fort Lauderdale principles. We thank H. Skaletsky for detailed information about sequence blocks on the Y chromosome; M. Uda and R. Nagaraja for useful comments; C. Calo, D. Luiselli, and C. de la Rua for providing some non-Sardinian samples; E. Garau, M. Rendeli, A. Moravetti, and B. Wilkens for the archaeological background; and the CRS4 HPC group for their IT support, in particular L. Leoni and C. Podda. Genotype data have been deposited at the European Genome-phenome Archive (EGA, www.ebi.ac.uk/ega/), which is hosted by the European Bioinformatics Institute, under accession number EGAS00001000532.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; Francalacci P, 2003, AM J PHYS ANTHROPOL, V121, P270, DOI 10.1002/ajpa.10265; Gibbons A, 2012, SCIENCE, V338, P189, DOI 10.1126/science.338.6104.189; Hobolth A, 2011, GENOME RES, V21, P349, DOI 10.1101/gr.114751.110; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Lilliu G., 1982, LA CIVILTA NURAGICA; Mendez FL, 2013, AM J HUM GENET, V92, P454, DOI 10.1016/j.ajhg.2013.02.002; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Tykot RH., 1994, RADIOCARBON DATING I, P115; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112	18	98	101	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 2	2013	341	6145					565	569		10.1126/science.1237947	http://dx.doi.org/10.1126/science.1237947			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908240	Green Accepted			2022-12-01	WOS:000322586700058
J	Varghese, RT				Varghese, Ron Thomas			NON-COMMUNICABLE DISEASE The advent of bariatric surgery for diabetes in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICAL THERAPY; OBESITY; BMI		Christian Med Coll & Hosp, Dept Endocrinol Diabet & Metab, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore	Varghese, RT (corresponding author), Christian Med Coll & Hosp, Dept Endocrinol Diabet & Metab, Vellore, Tamil Nadu, India.	ronthomasv@gmail.com		VARGHESE, RON/0000-0002-6198-4352				Batsis JA, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.05.024; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Centre for Obesity and Digestive Surgery, AS CONS M MET SURG; Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; Dixon JB, 2011, DIABETIC MED, V28, P628, DOI 10.1111/j.1464-5491.2011.03306.x; Ikramuddin S, 2011, BRIT J SURG, V98, P1339, DOI 10.1002/bjs.7652; Klein S, 2011, OBESITY, V19, P581, DOI 10.1038/oby.2010.199; Lee W-J., CONSENSUS ASIAN DIAB; Leff DR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3402; Livingston EH, 2012, JAMA-J AM MED ASSOC, V307, P88, DOI 10.1001/jama.2011.1950; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Misra A, 2001, INT J OBESITY, V25, P1722, DOI 10.1038/sj.ijo.0801748; NHLBI Obesity Education Initiative, 2000, PRACT GUID ID EV TRE; Pandya H., 2011, INT J BIOL MED RES, V2, P556; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Shelar J., 2012, TIMES INDIA; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Varghese RT, 2008, CALICUT MED J, V6, pe3; Vijayakumar K, 2010, HDB DIS BURDENS QU 3, P2071; Wallace AE, 2010, OBES SURG, V20, P1354, DOI 10.1007/s11695-009-0054-x	20	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2013	347								f3391	10.1136/bmj.f3391	http://dx.doi.org/10.1136/bmj.f3391			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193BS	23894187				2022-12-01	WOS:000322532500001
J	Yuan, CX; Liang, Y; Hernandez, T; Berriochoa, A; Houk, KN; Siegel, D				Yuan, Changxia; Liang, Yong; Hernandez, Taylor; Berriochoa, Adrian; Houk, Kendall N.; Siegel, Dionicio			Metal-free oxidation of aromatic carbon-hydrogen bonds through a reverse-rebound mechanism	NATURE			English	Article							CYCLIC DIACYL PEROXIDES; C-H OXYGENATION; PHTHALOYL PEROXIDE; ATOM TRANSFER; SELECTIVITY; PHOTODECOMPOSITION; DECOMPOSITION; REACTIVITY; PRODUCTS; RADICALS	Methods for carbon-hydrogen (C-H) bond oxidation have a fundamental role in synthetic organic chemistry, providing functionality that is required in the final target molecule or facilitating subsequent chemical transformations. Several approaches to oxidizing aliphatic C-H bonds have been described, drastically simplifying the synthesis of complex molecules(1-6). However, the selective oxidation of aromatic C-H bonds under mild conditions, especially in the context of substituted arenes with diverse functional groups, remains a challenge. The direct hydroxylation of arenes was initially achieved through the use of strong Bronsted or Lewis acids to mediate electrophilic aromatic substitution reactions with super-stoichiometric equivalents of oxidants, significantly limiting the scope of the reaction(7). Because the products of these reactions are more reactive than the starting materials, over-oxidation is frequently a competitive process. Transition-metal-catalysed C-H oxidation of arenes with or without directing groups has been developed, improving on the acid-mediated process; however, precious metals are required(8-13). Here we demonstrate that phthaloyl peroxide functions as a selective oxidant for the transformation of arenes to phenols under mild conditions. Although the reaction proceeds through a radical mechanism, aromatic C-H bonds are selectively oxidized in preference to activated Csp3-H bonds. Notably, a wide array of functional groups are compatible with this reaction, and this method is therefore well suited for late-stage transformations of advanced synthetic intermediates. Quantum mechanical calculations indicate that this transformation proceeds through a novel addition-abstraction mechanism, a kind of 'reverse-rebound' mechanism as distinct from the common oxygen-rebound mechanism observed for metal-oxo oxidants. These calculations also identify the origins of the experimentally observed aryl selectivity.	[Yuan, Changxia; Hernandez, Taylor; Berriochoa, Adrian; Siegel, Dionicio] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Liang, Yong; Houk, Kendall N.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of Texas System; University of Texas Austin; University of California System; University of California Los Angeles	Siegel, D (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	dsiegel@cm.utexas.edu	Yuan, Changxia/K-9293-2013; Liang, Yong/J-4541-2017	Liang, Yong/0000-0001-5026-6710	University of Texas at Austin; Welch Foundation [F-1694]; US National Science Foundation [CHE-1059084, OCI-1053575]; Direct For Mathematical & Physical Scien [1361104] Funding Source: National Science Foundation	University of Texas at Austin; Welch Foundation(The Welch Foundation); US National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Financial support from the University of Texas at Austin, the Welch Foundation (F-1694 to D. S.), and the US National Science Foundation (CHE-1059084 to K.N.H.) are gratefully acknowledged. Calculations were performed on the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by the US National Science Foundation (OCI-1053575).	Chen K, 2009, NATURE, V459, P824, DOI 10.1038/nature08043; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Chen MS, 2010, SCIENCE, V327, P566, DOI 10.1126/science.1183602; Cheng X, 2010, ORG LETT, V12, P1304, DOI 10.1021/ol100214x; Curci R, 2006, ACCOUNTS CHEM RES, V39, P1, DOI 10.1021/ar050163y; Emmert MH, 2011, ANGEW CHEM INT EDIT, V50, P9409, DOI 10.1002/anie.201103327; Ensing B, 2004, J AM CHEM SOC, V126, P4355, DOI 10.1021/ja038865a; Frisch M.J., 2009, GUASSIAN 09 REVISION; Fujimori K, 1996, J CHEM SOC PERK T 2, P413, DOI 10.1039/p29960000413; GREENE FD, 1958, J AM CHEM SOC, V80, P3432, DOI 10.1021/ja01546a058; GREENE FD, 1956, J AM CHEM SOC, V78, P2250, DOI 10.1021/ja01591a061; Gulevich AV, 2012, J AM CHEM SOC, V134, P5528, DOI 10.1021/ja3010545; Gutekunst WR, 2011, CHEM SOC REV, V40, P1976, DOI 10.1039/c0cs00182a; Huang CH, 2011, J AM CHEM SOC, V133, P17630, DOI 10.1021/ja208572v; Jursic BS, 1996, INT J QUANTUM CHEM, V59, P495, DOI 10.1002/(SICI)1097-461X(1996)59:6<495::AID-QUA7>3.0.CO;2-T; Malkowsky IM, 2007, SYNTHESIS-STUTTGART, P773, DOI 10.1055/s-2007-965895; Neufeldt SR, 2012, ACCOUNTS CHEM RES, V45, P936, DOI 10.1021/ar300014f; Powers DC, 2010, J AM CHEM SOC, V132, P14530, DOI 10.1021/ja1054274; Rappoport Z., 2003, CHEM PHENOLS, V1, P395; Rappoport Z., 2003, CHEM PHENOLS, V2, P395; Roizen JL, 2012, ACCOUNTS CHEM RES, V45, P911, DOI 10.1021/ar200318q; RUSSELL KE, 1955, J AM CHEM SOC, V77, P4814, DOI 10.1021/ja01623a037; Shuklov IA, 2007, SYNTHESIS-STUTTGART, P2925, DOI 10.1055/s-2007-983902; Simmons EM, 2012, NATURE, V483, P70, DOI 10.1038/nature10785; TAKAHARA S, 1985, B CHEM SOC JPN, V58, P688, DOI 10.1246/bcsj.58.688; Virtamo J., 2011, JAMA-J AM MED ASSOC, V3, P962; WANG J, 1995, B CHEM SOC JPN, V68, P1213, DOI 10.1246/bcsj.68.1213; Wender PA, 2008, ACCOUNTS CHEM RES, V41, P40, DOI 10.1021/ar700155p; WILKERSON WW, 1993, BIOORG MED CHEM LETT, V3, P2087, DOI 10.1016/S0960-894X(01)81022-2; Yuan CX, 2011, TETRAHEDRON LETT, V52, P2540, DOI 10.1016/j.tetlet.2011.03.005; Zhang YH, 2009, J AM CHEM SOC, V131, P14654, DOI 10.1021/ja907198n	31	127	130	11	281	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					192	196		10.1038/nature12284	http://dx.doi.org/10.1038/nature12284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23846658				2022-12-01	WOS:000321557600058
J	Fradet-Turcotte, A; Canny, MD; Escribano-Diaz, C; Orthwein, A; Leung, CCY; Huang, H; Landry, MC; Kitevski-LeBlanc, J; Noordermeer, SM; Sicheri, F; Durocher, D				Fradet-Turcotte, Amelie; Canny, Marella D.; Escribano-Diaz, Cristina; Orthwein, Alexandre; Leung, Charles C. Y.; Huang, Hao; Landry, Marie-Claude; Kitevski-LeBlanc, Julianne; Noordermeer, Sylvie M.; Sicheri, Frank; Durocher, Daniel			53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark	NATURE			English	Article							DOUBLE-STRAND BREAKS; CLASS-SWITCH RECOMBINATION; DEPENDENT RESPONSE; FISSION YEAST; SITES; RECRUITMENT; METHYLATION; CHROMATIN; RESECTION; CRB2	53BP1 (also called TP53BP1) is a chromatin-associated factor that promotes immunoglobulin class switching and DNA double-strand-break (DSB) repair by non-homologous end joining. To accomplish its function in DNA repair, 53BP1 accumulates at DSB sites downstream of the RNF168 ubiquitin ligase. How ubiquitin recruits 53BP1 to break sites remains unknown as its relocalization involves recognition of histone H4 Lys 20 (H4K20) methylation by its Tudor domain. Here we elucidate how vertebrate 53BP1 is recruited to the chromatin that flanks DSB sites. We show that 53BP1 recognizes mononucleosomes containing dimethylated H4K20 (H4K20me2) and H2A ubiquitinated on Lys 15 (H2AK15ub), the latter being a product of RNF168 action on chromatin. 53BP1 binds to nucleosomes minimally as a dimer using its previously characterized methyl-lysine-binding Tudor domain and a carboxy-terminal extension, termed the ubiquitination-dependent recruitment (UDR) motif, which interacts with the epitope formed by H2AK15ub and its surrounding residues on the H2A tail. 53BP1 is therefore a bivalent histone modification reader that recognizes a histone 'code' produced by DSB signalling.	[Fradet-Turcotte, Amelie; Canny, Marella D.; Escribano-Diaz, Cristina; Orthwein, Alexandre; Leung, Charles C. Y.; Huang, Hao; Landry, Marie-Claude; Noordermeer, Sylvie M.; Sicheri, Frank; Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Kitevski-LeBlanc, Julianne; Sicheri, Frank; Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Kitevski-LeBlanc, Julianne; Sicheri, Frank] Univ Toronto, Dept Biochem, Toronto, ON M5S 3E1, Canada; [Kitevski-LeBlanc, Julianne] Univ Toronto, Dept Chem, Toronto, ON M5S 3E1, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto	Durocher, D (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	durocher@lunenfeld.ca	Durocher, Daniel/A-7733-2010; Noordermeer, Sylvie M/F-3517-2012; Sicheri, Frank/F-8856-2013; Noordermeer, Sylvie M/T-8095-2017; Fradet-Turcotte, Amelie/G-5790-2017	Durocher, Daniel/0000-0003-3863-8635; Noordermeer, Sylvie M/0000-0003-2737-9690; Noordermeer, Sylvie M/0000-0003-2737-9690; Fradet-Turcotte, Amelie/0000-0002-5431-8650; Orthwein, Alexandre/0000-0002-7350-3413	CIHR; Leukemia and Lymphoma Society; CIHR [MOP84297]; Ontario Research Fund [GL2-01-010]	CIHR(Canadian Institutes of Health Research (CIHR)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund	We are grateful to R. Szilard, J. Cote and S. Panier for critically reading the manuscript; to L.-L. Du, A. Nussenzweig, Y. Tong and C. Arrowsmith for plasmids; to M. Cook and A. Rosebrock for centrifugal elutriation; and to B. Sauriol for help with FRAP data analysis. A.F.-T. and A.O. both receive post-doctoral fellowships from the CIHR; C.E.-D. is an Ontario Post-doctoral Fellow; J. K.-L. receives a post-doctoral fellowship from the Leukemia and Lymphoma Society; and C. C. Y. L. and M.-C. L. are post-doctoral fellows of the Canadian Breast Cancer Foundation(Ontario Division). D. D. is the Thomas Kierans Chair in Mechanisms of Cancer Development and a Canada Research Chair (Tier 1) in the Molecular Mechanisms of Genome Integrity. Work in the D. D. laboratory was supported by CIHR grant MOP84297 and grant GL2-01-010 from the Ontario Research Fund.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chen JJ, 2010, NAT CHEM BIOL, V6, P270, DOI [10.1038/NCHEMBIO.316, 10.1038/nchembio.316]; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Gatti M, 2012, CELL CYCLE, V11, P2538, DOI 10.4161/cc.20919; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakamura K, 2006, DNA REPAIR, V5, P741, DOI 10.1016/j.dnarep.2006.03.008; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Nakamura TM, 2005, MOL CELL BIOL, V25, P10721, DOI 10.1128/MCB.25.24.10721-10730.2005; Panier S, 2012, MOL CELL, V47, P383, DOI 10.1016/j.molcel.2012.05.045; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Pryde F, 2005, J CELL SCI, V118, P2043, DOI 10.1242/jcs.02336; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; WANG AC, 1995, J BIOMOL NMR, V5, P376; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Wu LP, 2013, MOL CELL, V49, P1108, DOI 10.1016/j.molcel.2013.01.033; Zgheib O, 2009, MOL CELL BIOL, V29, P1050, DOI 10.1128/MCB.01011-08; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	40	458	476	3	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2013	499	7456					50	+		10.1038/nature12318	http://dx.doi.org/10.1038/nature12318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23760478	Green Accepted			2022-12-01	WOS:000321285600030
J	Nielsen, S; Yuzenkova, Y; Zenkin, N				Nielsen, Soren; Yuzenkova, Yulia; Zenkin, Nikolay			Mechanism of Eukaryotic RNA Polymerase III Transcription Termination	SCIENCE			English	Article							STRUCTURAL BASIS; ACTIVE-CENTER; DNA HYBRID; ELONGATION	Gene expression in organisms involves many factors and is tightly controlled. Although much is known about the initial phase of transcription by RNA polymerase III (Pol III), the enzyme that synthesizes the majority of RNA molecules in eukaryotic cells, termination is poorly understood. Here, we show that the extensive structure of Pol III-synthesized transcripts dictates the release of elongation complexes at the end of genes. The poly-T termination signal, which does not cause termination in itself, causes catalytic inactivation and backtracking of Pol III, thus committing the enzyme to termination and transporting it to the nearest RNA secondary structure, which facilitates Pol III release. Similarity between termination mechanisms of Pol III and bacterial RNA polymerase suggests that hairpin-dependent termination may date back to the common ancestor of multisubunit RNA polymerases.	[Nielsen, Soren; Yuzenkova, Yulia; Zenkin, Nikolay] Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England	Newcastle University - UK	Zenkin, N (corresponding author), Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Baddiley Clark Bldg,Richardson Rd, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	n.zenkin@ncl.ac.uk		Zenkin, Nikolay/0000-0003-2212-9545; yuzenkova, yulia/0000-0003-4036-9235	UK Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council under the SysMO initiative; European Research Council [ERC-2007-StG 202994-MTP]; Biotechnology and Biological Sciences Research Council [BB/J006378/1, BB/F013558/1] Funding Source: researchfish; BBSRC [BB/F013558/1, BB/J006378/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council under the SysMO initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is dedicated to the memory of Denis Izyumov. We thank J. Roberts, E. Nudler, P. E. Geiduschek, and J. Brown for critical reading of the paper; G. Kassavetis, R. van Nues, H. Murray, N. Proudfoot, and P. Braglia for experimental advice; and J. Chong for help with Archaea. This work was supported by the UK Biotechnology and Biological Sciences Research Council, the Biotechnology and Biological Sciences Research Council under the SysMO initiative, and the European Research Council [grant ERC-2007-StG 202994-MTP]. Data are available in the supplementary materials.	BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; Braglia P, 2005, J BIOL CHEM, V280, P19551, DOI 10.1074/jbc.M412238200; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; MATSUZAKI H, 1994, J MOL BIOL, V235, P1173, DOI 10.1006/jmbi.1994.1072; Orioli A, 2012, GENE, V493, P185, DOI 10.1016/j.gene.2011.06.015; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Santangelo TJ, 2009, J BACTERIOL, V191, P7102, DOI 10.1128/JB.00982-09; Santangelo TJ, 2004, MOL CELL, V14, P117, DOI 10.1016/S1097-2765(04)00154-6; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; WHITEHALL SK, 1994, J BIOL CHEM, V269, P2299; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zenkin N, 2006, NATURE, V439, P617, DOI 10.1038/nature04337; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422	21	88	92	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1577	1580		10.1126/science.1237934	http://dx.doi.org/10.1126/science.1237934			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812715	Green Accepted, Green Submitted			2022-12-01	WOS:000321007000043
J	Carmichael, M				Carmichael, Mary			DRUG SAFETY Double jeopardy	NATURE			English	Editorial Material							CHILDHOOD											Blanco JG, 2012, J CLIN ONCOL, V30, P1415, DOI 10.1200/JCO.2011.34.8987; Diller L, 2011, NEW ENGL J MED, V365, P1417, DOI 10.1056/NEJMcp1103645; Mulrooney DA, 2008, CANCER-AM CANCER SOC, V112, P2071, DOI 10.1002/cncr.23405; Sacco G, 2009, VASC PHARMACOL, V50, P166, DOI 10.1016/j.vph.2009.01.001; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	5	6	6	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					S14	S15		10.1038/498S14a	http://dx.doi.org/10.1038/498S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803944	Bronze			2022-12-01	WOS:000320929400008
J	Lam, MTY; Cho, H; Lesch, HP; Gosselin, D; Heinz, S; Tanaka-Oishi, Y; Benner, C; Kaikkonen, MU; Kim, AS; Kosaka, M; Lee, CY; Watt, A; Grossman, TR; Rosenfeld, MG; Evans, RM; Glass, CK				Lam, Michael T. Y.; Cho, Han; Lesch, Hanna P.; Gosselin, David; Heinz, Sven; Tanaka-Oishi, Yumiko; Benner, Christopher; Kaikkonen, Minna U.; Kim, Aneeza S.; Kosaka, Mika; Lee, Cindy Y.; Watt, Andy; Grossman, Tamar R.; Rosenfeld, Michael G.; Evans, Ronald M.; Glass, Christopher K.			Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription	NATURE			English	Article							ALPHA; OLIGONUCLEOTIDES; COREPRESSOR; METABOLISM; INITIATION; RECEPTORS; DOMAINS; CELLS	Rev-Erb-alpha and Rev-Erb-beta are nuclear receptors that regulate the expression of genes involved in the control of circadian rhythm(1,2), metabolism(3,4) and inflammatory responses(5). Rev-Erbs function as transcriptional repressors by recruiting nuclear receptor co-repressor (NCoR)-HDAC3 complexes to Rev-Erb response elements in enhancers and promoters of target genes(6-8), but the molecular basis for cell-specific programs of repressionis not known. Here we present evidence that in mouse macrophages Rev-Erbs regulate target gene expression by inhibiting the functions of distal enhancers that are selected by macrophage-lineage-determining factors, thereby establishing a macrophage-specific program of repression. Remarkably, the repressive functions of Rev-Erbs are associated with their ability to inhibit the transcription of enhancer-derived RNAs (eRNAs). Furthermore, targeted degradation of eRNAs at two enhancers subject to negative regulation by Rev-Erbs resulted in reduced expression of nearby messenger RNAs, suggesting a direct role of these eRNAs in enhancer function. By precisely defining eRNA start sites using a modified form of global run-on sequencing that quantifies nascent 5' ends, we show that transfer of full enhancer activity to a target promoter requires both the sequences mediating transcription-factor binding and the specific sequences encoding the eRNA transcript. These studies provide evidence for a direct role of eRNAs in contributing to enhancer functions and suggest that Rev-Erbs act to suppress gene expression at a distance by repressing eRNA transcription.	[Lam, Michael T. Y.; Lesch, Hanna P.; Gosselin, David; Heinz, Sven; Tanaka-Oishi, Yumiko; Benner, Christopher; Kaikkonen, Minna U.; Kosaka, Mika; Lee, Cindy Y.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Cho, Han; Evans, Ronald M.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Kim, Aneeza S.; Watt, Andy; Grossman, Tamar R.] Isis Pharmaceut Inc, Carlsbad, CA 92010 USA; [Rosenfeld, Michael G.; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Rosenfeld, Michael G.; Evans, Ronald M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of California System; University of California San Diego; Salk Institute; Isis Pharmaceuticals Inc; University of California System; University of California San Diego; Howard Hughes Medical Institute	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Glass, Christopher/AAI-3933-2021; Kaikkonen, Minna U/AAK-3612-2020; Evans, Ronald/AAF-4001-2019	Glass, Christopher/0000-0003-4344-3592; Kaikkonen, Minna U/0000-0001-6294-0979; Evans, Ronald/0000-0002-9986-5965; Benner, Christopher/0000-0002-4618-0719; Heinz, Sven/0000-0002-4665-1007; Lesch, Hanna P./0000-0002-2463-5567	National Institutes of Health [CA17390, U19DK62434, DK091183, DK063491, CA014195, DK057978, HL088093, HL105278, CA52599]; University of California, San Diego Medical Scientist Training Program [T32 GM007198-37]; University of California, San Diego Genetics Training Program [T32 GM008666]; National Institute of General Medical Sciences; LeDucq Foundation Fellowship; Finnish Cultural Foundation; Instumentarium Foundation; Paulo Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Maud Kuistila Memorial Foundation; Fulbright Center; Leona M. and Harry B. Helmsley Charitable Trust; Samuel Waxman Cancer Research Foundation; Glenn Foundation for Medical Research; Ellison Medical Foundation; Ipsen/Biomeasure; NATIONAL CANCER INSTITUTE [R01CA052599, P30CA014195, R01CA173903] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434, R37DK057978, P30DK063491, P01DK074868, R01DK018477, R01DK091183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198, T32GM008666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego Medical Scientist Training Program; University of California, San Diego Genetics Training Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); LeDucq Foundation Fellowship(Leducq Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Instumentarium Foundation; Paulo Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Maud Kuistila Memorial Foundation; Fulbright Center; Leona M. and Harry B. Helmsley Charitable Trust; Samuel Waxman Cancer Research Foundation; Glenn Foundation for Medical Research; Ellison Medical Foundation(Lawrence Ellison Foundation); Ipsen/Biomeasure(Ipsen); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Bautista for assistance with figure preparation. These studies were supported by National Institutes of Health grants CA17390, U19DK62434, DK091183, DK063491, CA014195, DK057978, HL088093, HL105278 and CA52599. M. G. R. and R. M. E. are Investigators of the Howard Hughes Medical Institute. M.T.Y.L. is supported by the University of California, San Diego Medical Scientist Training Program T32 GM007198-37, and Genetics Training Program T32 GM008666, National Institute of General Medical Sciences. M. U. K. was supported by a LeDucq Foundation Fellowship. H. P. L. was supported by the Finnish Cultural Foundation, Instumentarium Foundation, The Paulo Foundation, Paavo Nurmi Foundation, Finnish Foundation for Cardiovascular Research, The Maud Kuistila Memorial Foundation and The Fulbright Center. These studies were also supported by grants from the Leona M. and Harry B. Helmsley Charitable Trust, Samuel Waxman Cancer Research Foundation, the Glenn Foundation for Medical Research, the Ellison Medical Foundation and Ipsen/Biomeasure.	Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang WD, 2011, NATURE, V470, P414, DOI 10.1038/nature09703; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schanke J T, 1997, Methods Mol Biol, V67, P203; Schlaeger TM, 2005, BLOOD, V105, P3871, DOI 10.1182/blood-2004-11-4467; Seth Punit P, 2008, Nucleic Acids Symp Ser (Oxf), P553, DOI 10.1093/nass/nrn280; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Zamir I, 1996, MOL CELL BIOL, V16, P5458	30	397	407	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					511	+		10.1038/nature12209	http://dx.doi.org/10.1038/nature12209			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23728303	Green Accepted			2022-12-01	WOS:000320929400058
J	Civril, F; Deimling, T; Mann, CCD; Ablasser, A; Moldt, M; Witte, G; Hornung, V; Hopfner, KP				Civril, Filiz; Deimling, Tobias; Mann, Carina C. de Oliveira; Ablasser, Andrea; Moldt, Manuela; Witte, Gregor; Hornung, Veit; Hopfner, Karl-Peter			Structural mechanism of cytosolic DNA sensing by cGAS	NATURE			English	Article							CYCLIC GMP-AMP; INNATE IMMUNE SENSOR; I INTERFERON; RECOGNITION RECEPTORS; 2ND-MESSENGER; INFLAMMASOME; SURVEILLANCE; HELICASE; ADAPTER	Cytosolic DNA arising from intracellular bacterial or viral infections is a powerful pathogen-associated molecular pattern (PAMP) that leads to innate immune host defence by the production of type I interferon and inflammatory cytokines. Recognition of cytosolic DNA by the recently discovered cyclic-GMP-AMP (cGAMP) synthase (cGAS) induces the production of cGAMP to activate the stimulator of interferon genes (STING). Here we report the crystal structure of cGAS alone and in complex with DNA, ATP and GTP along with functional studies. Our results explain the broad DNA sensing specificity of cGAS, show how cGAS catalyses dinucleotide formation and indicate activation by a DNA-induced structural switch. cGAS possesses a remarkable structural similarity to the antiviral cytosolic double-stranded RNA sensor 2'-5'oligoadenylate synthase (OAS1), but contains a unique zinc thumb that recognizes B-form double-stranded DNA. Our results mechanistically unify dsRNA and dsDNA innate immune sensing by OAS1 and cGAS nucleotidyl transferases.	[Civril, Filiz; Deimling, Tobias; Mann, Carina C. de Oliveira; Moldt, Manuela; Witte, Gregor; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Civril, Filiz; Deimling, Tobias; Mann, Carina C. de Oliveira; Moldt, Manuela; Witte, Gregor; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Ablasser, Andrea; Hornung, Veit] Univ Bonn, Univ Hosp, Unit Clin Biochem, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Hopfner, Karl-Peter] Ctr Integrated Prot Sci, D-81377 Munich, Germany	University of Munich; University of Munich; University of Bonn; University of Munich	Hopfner, KP (corresponding author), Univ Munich, Dept Biochem, Marchioninistr 15, D-81377 Munich, Germany.	hopfner@genzentrum.lmu.de	Hopfner, Karl-Peter/B-6864-2014; Hornung, Veit/C-3565-2012; Witte, Gregor/B-4635-2011	Hopfner, Karl-Peter/0000-0002-4528-8357; Hornung, Veit/0000-0002-4150-194X; Witte, Gregor/0000-0003-0313-0962; de Oliveira Mann, Carina/0000-0002-1852-9880	National Institutes of Health [U19AI083025]; European Research Council [322869]; Center for Integrated Protein Science Munich (CIPSM); DFG [3717/2-1, SFB670]; ERC [243046];  [GRK1721]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Center for Integrated Protein Science Munich (CIPSM); DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Butryn for comments on the manuscript. We thank the Max-Planck-Crystallization facility for initial crystal screening and the Swiss Light Source, European Synchrotron Radiation Facility and the German electron synchrotron Petra III for beam time and on-site assistance. This work was funded by the National Institutes of Health (U19AI083025), the European Research Council Advanced Grant 322869, and the Center for Integrated Protein Science Munich (CIPSM) to K.-P. H., by DFG grant 3717/2-1 to G. W., by GRK1721 to K.-P. H. and G. W., by DFG grant SFB670 and ERC grant 243046 to V. H.; C.C.O.M. is supported by GRK1721.	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Ablasser A., 2013, NATURE, DOI 10.1038/nature12640.; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Krug Anne, 2008, V183, P129; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Rao F, 2009, ANAL BIOCHEM, V389, P138, DOI 10.1016/j.ab.2009.03.031; Rathinam VAK, 2011, CURR OPIN VIROL, V1, P455, DOI 10.1016/j.coviro.2011.11.004; Rathinam VAK, 2011, VIROLOGY, V411, P153, DOI 10.1016/j.virol.2011.02.003; Stagno J, 2007, J MOL BIOL, V366, P882, DOI 10.1016/j.jmb.2006.11.065; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	42	426	459	6	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					332	+		10.1038/nature12305	http://dx.doi.org/10.1038/nature12305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23722159	Green Published, Green Accepted, Green Submitted			2022-12-01	WOS:000320592900033
J	Tripathi, S; Li, HY; Poulos, TL				Tripathi, Sarvind; Li, Huiying; Poulos, Thomas L.			Structural Basis for Effector Control and Redox Partner Recognition in Cytochrome P450	SCIENCE			English	Article							ELECTRON-TRANSFER COMPLEX; CRYSTAL-STRUCTURE; PSEUDOMONAS-PUTIDA; PUTIDAREDOXIN REDUCTASE; METHYLENE HYDROXYLATION; MONOOXYGENASE SYSTEM; P450CAM; P-450CAM; ACTIVATION; RESOLUTION	Cytochromes P450 catalyze a variety of monooxygenase reactions that require electron transfer from redox partners. Although the structure of many P450s and a small handful of redox partners are known, there is very little structural information available on redox complexes, thus leaving a gap in our understanding on the control of P450-redox partner interactions. We have solved the crystal structure of oxidized and reduced P450cam complexed with its redox partner, putidaredoxin (Pdx), to 2.2 and 2.09 angstroms, respectively. It was anticipated that Pdx would favor closed substrate-bound P450cam, which differs substantially from the open conformer, but instead we found that Pdx favors the open state. These new structures indicate that the effector role of Pdx is to shift P450cam toward the open conformation, which enables the establishment of a water-mediated H-bonded network, which is required for proton-coupled electron transfer.	[Poulos, Thomas L.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Poulos, TL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	poulos@uci.edu	Tripathi, sarvind/F-6959-2015; Tripathi, Sarvind/Y-5229-2019	Tripathi, sarvind/0000-0002-6959-0577; Tripathi, Sarvind/0000-0002-6959-0577	NIH [GM33688]; DOE Office of Biological and Environmental Research; National Institute of General Medical Sciences (NIGMS) [P41GM103393]; National Center for Research Resources (NCRR) [P41RR001209]; Office of Science, Office of Basic Energy Sciences, of the DOE [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM033688] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Science, Office of Basic Energy Sciences, of the DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM33688. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U. S. Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by NIH, the National Institute of General Medical Sciences (NIGMS) (including P41GM103393), and the National Center for Research Resources (NCRR) (P41RR001209). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS, NCRR, or NIH. We also acknowledge the Advanced Light Source supported by the Director, Office of Science, Office of Basic Energy Sciences, of the DOE under contract DE-AC02-05CH11231. We thank C. Goulding and A. Borovik for invaluable discussions and advice, D. Goodin for the low Cys P450cam expression plasmid, and Y. Meharenna for assistance in developing cross-linking protocols.	GERBER NC, 1994, J BIOL CHEM, V269, P4260; GUNSALUS IC, 1973, ANN NY ACAD SCI, V212, P107, DOI 10.1111/j.1749-6632.1973.tb47590.x; Guo ML, 2004, P NATL ACAD SCI USA, V101, P5940, DOI 10.1073/pnas.0306708101; KATAGIRI M, 1968, J BIOL CHEM, V243, P3543; KOGA H, 1993, FEBS LETT, V331, P109, DOI 10.1016/0014-5793(93)80307-G; Kuznetsov VY, 2005, J BIOL CHEM, V280, P16135, DOI 10.1074/jbc.M500771200; Lee YT, 2010, BIOCHEMISTRY-US, V49, P3412, DOI 10.1021/bi100183g; LIPSCOMB JD, 1976, J BIOL CHEM, V251, P1116; Nagano S, 2003, BIOCHEMISTRY-US, V42, P14507, DOI 10.1021/bi035410p; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; NAKAMURA K, 1994, BBA-PROTEIN STRUCT M, V1207, P40, DOI 10.1016/0167-4838(94)90049-3; Pochapsky SS, 2003, BIOCHEMISTRY-US, V42, P5649, DOI 10.1021/bi034263s; Pochapsky TC, 1996, BIOCHIMIE, V78, P723, DOI 10.1016/S0300-9084(97)82530-8; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Sevrioukova IF, 2004, J MOL BIOL, V336, P889, DOI 10.1016/j.jmb.2003.12.067; Sevrioukova IF, 2003, J MOL BIOL, V333, P377, DOI 10.1016/j.jmb.2003.08.028; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Sevrioukova IF, 2010, J BIOL CHEM, V285, P13616, DOI 10.1074/jbc.M110.104968; Shimada H, 2001, J INORG BIOCHEM, V83, P255, DOI 10.1016/S0162-0134(00)00173-2; SHIRO Y, 1989, J AM CHEM SOC, V111, P7707, DOI 10.1021/ja00202a007; SLIGAR SG, 1974, P NATL ACAD SCI USA, V71, P3906, DOI 10.1073/pnas.71.10.3906; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Tosha T, 2003, J BIOL CHEM, V278, P39809, DOI 10.1074/jbc.M304265200; TYSON CA, 1972, J BIOL CHEM, V247, P5777; Unno M, 1997, J AM CHEM SOC, V119, P6614, DOI 10.1021/ja963785a; Unno M, 2002, J BIOL CHEM, V277, P2547, DOI 10.1074/jbc.M108917200; Zhang W, 2008, J MOL BIOL, V384, P349, DOI 10.1016/j.jmb.2008.09.037	28	128	128	5	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2013	340	6137					1227	1230		10.1126/science.1235797	http://dx.doi.org/10.1126/science.1235797			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744947				2022-12-01	WOS:000319972800049
J	Ni, XJ; Gebo, DL; Dagosto, M; Meng, J; Tafforeau, P; Flynn, JJ; Beard, KC				Ni, Xijun; Gebo, Daniel L.; Dagosto, Marian; Meng, Jin; Tafforeau, Paul; Flynn, John J.; Beard, K. Christopher			The oldest known primate skeleton and early haplorhine evolution	NATURE			English	Article							EARLY EOCENE; MIDDLE EOCENE; LOCOMOTOR ADAPTATIONS; OMOMYIDAE; REMAINS; MORPHOLOGY; DIVERSITY; DENTITION; REVISION; ELEMENTS	Reconstructing the earliest phases of primate evolution has been impeded by gaps in the fossil record, so that disagreements persist regarding the palaeobiology and phylogenetic relationships of the earliest primates. Here we report the discovery of a nearly complete and partly articulated skeleton of a primitive haplorhine primate from the early Eocene of China, about 55 million years ago, the oldest fossil primate of this quality ever recovered. Coupled with detailed morphological examination using propagation phase contrast X-ray synchrotron microtomography, our phylogenetic analysis based on total available evidence indicates that this fossil is the most basal known member of the tarsiiform clade. In addition to providing further support for an early dichotomy between the strepsirrhine and haplorhine clades, this new primate further constrains the age of divergence between tarsiiforms and anthropoids. It also strengthens the hypothesis that the earliest primates were probably diurnal, arboreal and primarily insectivorous mammals the size of modern pygmy mouse lemurs.	[Ni, Xijun] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing 100044, Peoples R China; [Ni, Xijun; Meng, Jin; Flynn, John J.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Ni, Xijun; Meng, Jin; Flynn, John J.] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA; [Gebo, Daniel L.] No Illinois Univ, Dept Anthropol, De Kalb, IL 60115 USA; [Dagosto, Marian] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Beard, K. Christopher] Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); Northern Illinois University; Northwestern University; Feinberg School of Medicine; European Synchrotron Radiation Facility (ESRF)	Ni, XJ (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, 142 Xi Zhi Men Wai St, Beijing 100044, Peoples R China.	nixijun@ivpp.ac.cn	Beard, K. Christopher/AAQ-4438-2021	Beard, K. Christopher/0000-0002-6279-9837; Tafforeau, Paul/0000-0002-5962-1683	Strategic Priority Research Program of Chinese Academy of Sciences (CAS) [XDB03020501]; National Basic Research Program of China [2012CB821904]; CAS 100-talent Program; National Natural Science Foundation of China [40672009, 40872032]; US National Science Foundation [BCS 0820602]; ESRF [ec347]; Postdoctoral Research Fellowship Program of the American Museum of Natural History (AMNH); Division Of Behavioral and Cognitive Sci [1157142] Funding Source: National Science Foundation	Strategic Priority Research Program of Chinese Academy of Sciences (CAS); National Basic Research Program of China(National Basic Research Program of China); CAS 100-talent Program(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Science Foundation(National Science Foundation (NSF)); ESRF; Postdoctoral Research Fellowship Program of the American Museum of Natural History (AMNH); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This project has been supported by the Strategic Priority Research Program of Chinese Academy of Sciences (CAS, XDB03020501), the National Basic Research Program of China (2012CB821904), the CAS 100-talent Program, the National Natural Science Foundation of China (40672009, 40872032), the US National Science Foundation (BCS 0820602), the ESRF (proposal ec347), and the Postdoctoral Research Fellowship Program of the American Museum of Natural History (AMNH). We are grateful to C. Li, Y. Wang, E. Delson, A. L. Rosenberger, E. Seiffert, M. T. Silcox and J. I. Bloch for helpful discussions. We thank C. Li and Q. Li for their assistance in the field, and C. Nemoz, T. Brochard and all the ID17 beamline team for their help during the synchrotron experiment. We thank the staff of the following museums for access to specimens: AMNH, Field Museum of Natural History, Chicago; Smithsonian Institution, Washington, D. C.; Carnegie Museum of Natural History, Pittsburgh; Royal Belgium Institute of Natural Sciences, Brussels.	Anemone RL, 2000, J HUM EVOL, V38, P607, DOI 10.1006/jhev.1999.0371; Beard KC, 2008, P NATL ACAD SCI USA, V105, P3815, DOI 10.1073/pnas.0710180105; BEARD KC, 1993, MAMMAL PHYLOGENY : PLACENTALS, P129; Beard KC, 2004, J HUM EVOL, V46, P401, DOI 10.1016/j.jhevol.2004.01.002; Beard KC, 1996, SCIENCE, V272, P82, DOI 10.1126/science.272.5258.82; COVERT HH, 1993, J HUM EVOL, V25, P351, DOI 10.1006/jhev.1993.1054; Covert HH, 2002, CAM S BIO EVOL ANTHR, V33, P13; Dagosto M, 1999, ANN CARNEGIE MUS, V68, P175; DAGOSTO M, 1988, J HUM EVOL, V17, P35, DOI 10.1016/0047-2484(88)90048-6; Dagosto M, 1993, POSTCRANIAL ADAPTATI, P150; Dagosto Marian, 1994, P567; Dagosto Marian, 2008, P315, DOI 10.1007/978-1-4020-6997-0_13; FLEAGLE JG, 1982, AM J PHYS ANTHROPOL, V59, P175, DOI 10.1002/ajpa.1330590207; FLEAGLE JG, 1995, AM J PHYS ANTHROPOL, V97, P235, DOI 10.1002/ajpa.1330970303; Fleagle JG, 2013, PRIMATE ADAPTATION AND EVOLUTION, 3RD EDITION, P1, DOI 10.1016/B978-0-12-378632-6.00001-X; Gebo DL, 2008, DEV PRIMATOL-PROG PR, P229, DOI 10.1007/978-0-387-73896-3_16; Gebo DL, 2012, EVOL ANTHROPOL, V21, P224, DOI 10.1002/evan.21336; Gebo DL, 2012, J HUM EVOL, V63, P205, DOI 10.1016/j.jhevol.2012.03.010; Gebo Daniel L., 1994, P203; Gebo DL, 2008, J HUM EVOL, V55, P999, DOI 10.1016/j.jhevol.2008.03.002; GEBO DL, 1987, AM J PRIMATOL, V13, P271, DOI 10.1002/ajp.1350130305; Gebo DL, 2000, NATURE, V404, P276, DOI 10.1038/35005066; Gebo DL, 2001, AM J PHYS ANTHROPOL, V116, P83, DOI 10.1002/ajpa.1105; GINGERICH PD, 1977, FOLIA PRIMATOL, V28, P144, DOI 10.1159/000155804; Godinot M, 1998, FOLIA PRIMATOL, V69, P218, DOI 10.1159/000052715; Gregory W. K., 1920, Memoirs from the American Museum of Natural History New York NS, V3, P49; Jouffroy F.K., 1979, P143; Kay RF, 2000, AM J PHYS ANTHROPOL, V113, P235, DOI 10.1002/1096-8644(200010)113:2<235::AID-AJPA7>3.0.CO;2-9; Kay RF, 1997, SCIENCE, V275, P797, DOI 10.1126/science.275.5301.797; Ni XJ, 2010, P ROY SOC B-BIOL SCI, V277, P247, DOI 10.1098/rspb.2009.0173; Ni XJ, 2004, NATURE, V427, P65, DOI 10.1038/nature02126; Rasoloarison RM, 2000, INT J PRIMATOL, V21, P963, DOI 10.1023/A:1005511129475; ROSE KD, 1985, AM J PHYS ANTHROPOL, V66, P73, DOI 10.1002/ajpa.1330660107; Rose KD, 2011, AM J PHYS ANTHROPOL, V146, P281, DOI 10.1002/ajpa.21579; Rose KD, 2009, J HUM EVOL, V56, P366, DOI 10.1016/j.jhevol.2009.01.008; Rose Kenneth D., 1994, Evolutionary Anthropology, V3, P159, DOI 10.1002/evan.1360030505; Rossie JB, 2006, P NATL ACAD SCI USA, V103, P4381, DOI 10.1073/pnas.0509424103; Seiffert ER, 2009, NATURE, V461, P1118, DOI 10.1038/nature08429; Simons EL, 1972, PRIMATE EVOLUTION IN; Szalay F.S., 1979, EVOLUTIONARY HIST PR; SZALAY FS, 1980, FOLIA PRIMATOL, V34, P1, DOI 10.1159/000155946; Wang YQ, 2010, SCI CHINA EARTH SCI, V53, P1918, DOI 10.1007/s11430-010-4095-8; White JL, 2004, AM J PRIMATOL, V64, P293, DOI 10.1002/ajp.20079	43	114	120	4	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					60	64		10.1038/nature12200	http://dx.doi.org/10.1038/nature12200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23739424				2022-12-01	WOS:000319947800032
J	Sen, P; Biswas, T				Sen, Parijat; Biswas, Tamoghna			Arsenic: the largest mass poisoning of a population in history	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DRINKING-WATER; CANCER; INDIA; CONTAMINATION; MORTALITY; EXPOSURE; BLADDER; HEALTH; BENGAL; STATE		[Sen, Parijat] DNGM Res Fdn, Kolkata, India		Sen, P (corresponding author), DNGM Res Fdn, Kolkata, India.	parijatsenstation@gmail.com		Sen, Parijat/0000-0002-5764-358X				Ahamed S, 2006, SCI TOTAL ENVIRON, V370, P310, DOI 10.1016/j.scitotenv.2006.06.015; Chakraborti D, 2002, TALANTA, V58, P3, DOI 10.1016/S0039-9140(02)00270-9; Chakraborti D, 2009, MOL NUTR FOOD RES, V53, P542, DOI 10.1002/mnfr.200700517; CHEN CJ, 1992, BRIT J CANCER, V66, P888, DOI 10.1038/bjc.1992.380; DATTA DV, 1979, GUT, V20, P378, DOI 10.1136/gut.20.5.378; Garai R, 1984, J Indian Med Assoc, V82, P34; Government of India, 2013, HIGHLIGHTS OF THE BU; Halder D, 2012, ENVIRON SCI TECHNOL, V46, P4142, DOI 10.1021/es204298a; Mazumder D. G., 2013, GLOB ADV RES J MED M, V2, P47; Mazumder D N, 1998, J Indian Med Assoc, V96, P4; Mazumder DNG, 2008, INDIAN J MED RES, V128, P436; Ministry of Drinking Water and Sanitation, 2013, SHRI BHARATSINH SOLA; Ministry of Water Resources, 2009, ARSENIC CONTAMINATED; Ministry of Water Resources, 2009, CONTAMINATION OF WAT; Nutt WH, 1913, LANCET, V2, P282; Rahman A, 2010, EPIDEMIOLOGY, V21, P797, DOI 10.1097/EDE.0b013e3181f56a0d; Sarkar A, 2006, EPIDEMIOLOGY, V17, pS210, DOI 10.1097/00001648-200611001-00537; Sengupta AK, ARSENIC CRISIS IN IN; Smith AH, 1998, AM J EPIDEMIOL, V147, P660, DOI 10.1093/oxfordjournals.aje.a009507; TSENG WP, 1968, J NATL CANCER I, V40, P453; World Health Organization, 2000, PR 2000 55 RESEARCHE; World Health Organization, 2012, MILLENNIUM DEVELOPME	22	11	11	2	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ BRIT MED J	BMJ-British Medical Journal	JUN 5	2013	346								f3625	10.1136/bmj.f3625	http://dx.doi.org/10.1136/bmj.f3625			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YF	23741031				2022-12-01	WOS:000320229500004
J	Messier, V; Zenklusen, D; Michnick, SW				Messier, Vincent; Zenklusen, Daniel; Michnick, Stephen W.			A Nutrient-Responsive Pathway that Determines M Phase Timing through Control of B-Cyclin mRNA Stability	CELL			English	Article							CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; COTRANSCRIPTIONAL RECRUITMENT; ARGININE METHYLTRANSFERASE; POSITIVE FEEDBACK; PROTEIN-KINASES; NUCLEAR EXPORT; MITOTIC EXIT; POLO-KINASE; S-PHASE	The rate of cell-cycle progression must be tuned in response to nutrient levels to ensure that sufficient materials are synthesized to generate viable daughters. We report that accumulation of the yeast M phase B-cyclin CLB2 mRNA depends on assembly and activation of the heterogeneous nuclear RNA-binding protein (hnRNP) arginine methyltransferase Hmt1, which is promoted by the kinase Dbf2 and countered by the PP2A phosphatase Pph22. Activated Hmt1 methylates hnRNPs, which in turn stabilize CLB2 transcripts. Dbf2 activation of Hmt1 is highly cooperative, producing a sharp increase in CLB2, whereas Pph22 dephosphorylation is graded such that small changes in PP2A activity can cause large shifts in Dbf2-mediated Hmt1 activity. Starvation and rapamycin inhibition of TOR activate Pph22, causing a depletion of CLB2 and delay of M phase. We propose a general model wherein changes to Pph22 activity modulate cyclin mRNA stability to tune cell-cycle progression to environmental conditions.	[Messier, Vincent; Zenklusen, Daniel; Michnick, Stephen W.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Michnick, SW (corresponding author), Univ Montreal, Dept Biochim, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	stephen.michnick@umontreal.ca	Zenklusen, Daniel/C-4503-2008	Zenklusen, Daniel/0000-0002-0067-0093	CIHR [MOP-GMX-152556, MOP-GMX- 231013, MOP-BMB-232642]; NSERC of Canada [194582]; Canadian Foundation for Innovation	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	We thank Anne McBride for strains; Tatjana Trcek and Robert H. Singer (Albert Einstein College of Medicine) for CBL2 and ACT1 FISH probes, strains, and sharing data prior to publication; Raymond J. Deshaies and Tiffany K. J. Chang for providing us with Dbf2-expressing insect cell lines; Damien D'Amours for the gift of D754 strain and Tub1 immunostaining reagents; and Tatjana Trcek, Robert H. Singer, and Damien D'Amours for valuable discussions and comments. The authors acknowledge support from CIHR grants MOP-GMX-152556 and MOP-GMX-231013 and NSERC of Canada grant 194582 (to S.W.M.) and CIHR grant MOP-BMB-232642 and the Canadian Foundation for Innovation (to D.Z.). D.Z. holds a FRSQ Chercheur Boursier Junior I.	Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Chen YC, 2010, MOL CELL BIOL, V30, P5245, DOI 10.1128/MCB.00359-10; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Enyenihi AH, 2003, GENETICS, V163, P47; Gandhi SJ, 2011, NAT STRUCT MOL BIOL, V18, P27, DOI 10.1038/nsmb.1934; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Hotz M, 2012, CELL, V148, P958, DOI 10.1016/j.cell.2012.01.041; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Kerr SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018302; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Lord PW, 2002, BIOINFORMATICS, V18, P1402, DOI 10.1093/bioinformatics/18.10.1402; Luo GZ, 2011, J BIOL CHEM, V286, P8759, DOI 10.1074/jbc.M110.196030; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; McBride AE, 2005, J BIOL CHEM, V280, P30888, DOI 10.1074/jbc.M505831200; Nakashima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002223; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Pestov DG, 2012, MOL CELL BIOL, V32, P2135, DOI 10.1128/MCB.06763-11; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shen ZF, 2010, GENE DEV, V24, P1914, DOI 10.1101/gad.1937510; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; St-Pierre J, 2009, MOL CELL, V34, P416, DOI 10.1016/j.molcel.2009.04.013; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; TOYN JH, 1994, EMBO J, V13, P1103, DOI 10.1002/j.1460-2075.1994.tb06359.x; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Wang YC, 2006, MOL BIOL CELL, V17, P80, DOI 10.1091/mbc.E04-12-1109; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	38	29	29	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1080	1093		10.1016/j.cell.2013.04.035	http://dx.doi.org/10.1016/j.cell.2013.04.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706744	Bronze			2022-12-01	WOS:000319456800015
J	Dorner, M; Horwitz, JA; Donovan, BM; Labitt, RN; Budell, WC; Friling, T; Vogt, A; Catanese, MT; Satoh, T; Kawai, T; Akira, S; Law, M; Rice, CM; Ploss, A				Dorner, Marcus; Horwitz, Joshua A.; Donovan, Bridget M.; Labitt, Rachael N.; Budell, William C.; Friling, Tamar; Vogt, Alexander; Catanese, Maria Teresa; Satoh, Takashi; Kawai, Taro; Akira, Shizuo; Law, Mansun; Rice, Charles M.; Ploss, Alexander			Completion of the entire hepatitis C virus life cycle in genetically humanized mice	NATURE			English	Article							B TYPE-I; TARGETED DISRUPTION; CYCLOPHILIN-A; RNA; INFECTION; CELLS; REPLICATION; EXPRESSION; RECEPTOR; ENTRY	More than 130 million people worldwide chronically infected with hepatitis C virus (HCV) are at risk of developing severe liver disease. Antiviral treatments are only partially effective against HCV infection, and a vaccine is not available. Development of more efficient therapies has been hampered by the lack of a small animal model. Building on the observation that CD81 and occludin (OCLN) comprise the minimal set of human factors required to render mouse cells permissive to HCV entry(1), we previously showed that transient expression of these two human genes is sufficient to allow viral uptake into fully immunocompetent inbred mice(2). Here we demonstrate that transgenic mice stably expressing human CD81 and OCLN also support HCV entry, but innate and adaptive immune responses restrict HCV infection in vivo. Blunting antiviral immunity in genetically humanized mice infected with HCV results in measurable viraemia over several weeks. In mice lacking the essential cellular cofactor cyclophilin A (CypA), HCV RNA replication is markedly diminished, providing genetic evidence that this process is faithfully recapitulated. Using a cell-based fluorescent reporter activated by the NS3-4A protease we visualize HCV infection in single hepatocytes in vivo. Persistently infected mice produce de novo infectious particles, which can be inhibited with directly acting antiviral drug treatment, thereby providing evidence for the completion of the entire HCV life cycle in inbred mice. This genetically humanized mouse model opens new opportunities to dissect genetically HCV infection in vivo and provides an important preclinical platform for testing and prioritizing drug candidates and may also have utility for evaluating vaccine efficacy.	[Dorner, Marcus; Horwitz, Joshua A.; Donovan, Bridget M.; Labitt, Rachael N.; Budell, William C.; Friling, Tamar; Vogt, Alexander; Catanese, Maria Teresa; Rice, Charles M.; Ploss, Alexander] Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10065 USA; [Satoh, Takashi; Kawai, Taro; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Host Def, Suita, Osaka 5650871, Japan; [Law, Mansun] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Rockefeller University; Osaka University; Scripps Research Institute	Ploss, A (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ricec@rockefeller.edu; aploss@princeton.edu	Ploss, Alexander/ABG-2330-2020; Akira, Shizuo/C-3134-2009	Ploss, Alexander/0000-0001-9322-7252; Law, Mansun/0000-0002-8934-9756; Kawai, Taro/0000-0001-7510-4662; Vogt, Alexander/0000-0002-9917-112X; Dorner, Marcus/0000-0003-0321-4226	National Institute of Diabetes and Digestive and Kidney Diseases [RC1DK087193]; National Institute for Allergy and Infectious Disease [R01AI072613, R01AI099284]; National Cancer Institute [R01CA057973]; The Starr Foundation; Greenberg Medical Research Institute; Richard Salomon Family Foundation; Ronald A. Shellow, M. D. Memorial Fund; MGM Mirage Voice Foundation; German Research Foundation (Deutsche Forschungsgesellschaft); The Rockefeller University Women & Science Fellowship; Infectious Disease Society of America; American Liver Foundation; NATIONAL CANCER INSTITUTE [R01CA057973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099284, R01AI107301, R01AI072613, R01AI079031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK087193] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23689030] Funding Source: KAKEN	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Starr Foundation; Greenberg Medical Research Institute; Richard Salomon Family Foundation; Ronald A. Shellow, M. D. Memorial Fund; MGM Mirage Voice Foundation; German Research Foundation (Deutsche Forschungsgesellschaft)(German Research Foundation (DFG)); The Rockefeller University Women & Science Fellowship; Infectious Disease Society of America; American Liver Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Sable, E. Castillo, B. Flatley, S. Shirley, A. Webson and E. Giang for laboratory support. A. North and the Rockefeller University Bioimaging Core Facility, S. Mazel and the Rockefeller University Flowcytometry Core Facility, C. Yang and the Gene Targeting Center and R. Tolwani and the staff of the Comparative Bioscience Center provided technical support. This study was supported in part by award number RC1DK087193 (to C. M. R. and A. P.) from the National Institute of Diabetes and Digestive and Kidney Diseases, R01AI072613, R01AI099284 (to C. M. R.), R01AI079031 (to M. L.) from the National Institute for Allergy and Infectious Disease, R01CA057973(to C. M. R.) from the National Cancer Institute, The Starr Foundation, the Greenberg Medical Research Institute, the Richard Salomon Family Foundation, the Ronald A. Shellow, M. D. Memorial Fund, the MGM Mirage Voice Foundation, Gregory F. Lloyd Memorial contributions, and anonymous donors. M. D. was supported by a postdoctoral fellowship from the German Research Foundation (Deutsche Forschungsgesellschaft). M. T. C. is a recipient of The Rockefeller University Women & Science Fellowship. A. P. is a recipient of the Astella Young Investigator Award from the Infectious Disease Society of America and a Liver Scholar Award from the American Liver Foundation. The funding sources were not involved in the study design, collection, analysis and interpretation of data or in the writing of the report.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Awatramani R, 2001, NAT GENET, V29, P257, DOI 10.1038/ng1101-257; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chang KS, 2006, J VIROL, V80, P7364, DOI 10.1128/JVI.00586-06; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Horwitz JA, 2013, VIROLOGY, V439, P23, DOI [10.1016/j.virol.2013.01.019, 10.1016/j.virol.201]; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lin LT, 2010, J VIROL, V84, P9170, DOI 10.1128/JVI.00559-10; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Long G, 2011, GASTROENTEROLOGY, V141, P1057, DOI 10.1053/j.gastro.2011.06.010; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Safran Michal, 2003, Mol Imaging, V2, P297, DOI 10.1162/153535003322750637; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Stoller JZ, 2008, GENESIS, V46, P200, DOI 10.1002/dvg.20384; Suemizu H, 2008, BIOCHEM BIOPH RES CO, V377, P248, DOI 10.1016/j.bbrc.2008.09.124; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	41	171	179	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					237	+		10.1038/nature12427	http://dx.doi.org/10.1038/nature12427			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23903655	Green Accepted, Green Submitted			2022-12-01	WOS:000324244900044
J	Sanna-Cherchi, S; Sampogna, RV; Papeta, N; Burgess, KE; Nees, SN; Perry, BJ; Choi, M; Bodria, M; Liu, Y; Weng, PL; Lozanovski, VJ; Verbitsky, M; Lugani, F; Sterken, R; Paragas, N; Caridi, G; Carrea, A; Dagnino, M; Materna-Kiryluk, A; Santamaria, G; Murtas, C; Ristoska-Bojkovska, N; Izzi, C; Kacak, N; Bianco, B; Giberti, S; Gigante, M; Piaggio, G; Gesualdo, L; Vukic, DK; Vukojevic, K; Saraga-Babic, M; Saraga, M; Gucev, Z; Allegri, L; Latos-Bielenska, A; Casu, D; State, M; Scolari, F; Ravazzolo, R; Kiryluk, K; Al-Awqati, Q; D'Agati, VD; Drummond, IA; Tasic, V; Lifton, RP; Ghiggeri, GM; Gharavi, AG				Sanna-Cherchi, S.; Sampogna, R. V.; Papeta, N.; Burgess, K. E.; Nees, S. N.; Perry, B. J.; Choi, M.; Bodria, M.; Liu, Y.; Weng, P. L.; Lozanovski, V. J.; Verbitsky, M.; Lugani, F.; Sterken, R.; Paragas, N.; Caridi, G.; Carrea, A.; Dagnino, M.; Materna-Kiryluk, A.; Santamaria, G.; Murtas, C.; Ristoska-Bojkovska, N.; Izzi, C.; Kacak, N.; Bianco, B.; Giberti, S.; Gigante, M.; Piaggio, G.; Gesualdo, L.; Vukic, D. Kosuljandic; Vukojevic, K.; Saraga-Babic, M.; Saraga, M.; Gucev, Z.; Allegri, L.; Latos-Bielenska, A.; Casu, D.; State, M.; Scolari, F.; Ravazzolo, R.; Kiryluk, K.; Al-Awqati, Q.; D'Agati, V. D.; Drummond, I. A.; Tasic, V.; Lifton, R. P.; Ghiggeri, G. M.; Gharavi, A. G.			Mutations in DSTYK and Dominant Urinary Tract Malformations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGENITAL-ANOMALIES; RENAL HYPODYSPLASIA; KIDNEY; FGF; CHILDREN; GENES	BackgroundCongenital abnormalities of the kidney and the urinary tract are the most common cause of pediatric kidney failure. These disorders are highly heterogeneous, and the etiologic factors are poorly understood. MethodsWe performed genomewide linkage analysis and whole-exome sequencing in a family with an autosomal dominant form of congenital abnormalities of the kidney or urinary tract (seven affected family members). We also performed a sequence analysis in 311 unrelated patients, as well as histologic and functional studies. ResultsLinkage analysis identified five regions of the genome that were shared among all affected family members. Exome sequencing identified a single, rare, deleterious variant within these linkage intervals, a heterozygous splice-site mutation in the dual serine-threonine and tyrosine protein kinase gene (DSTYK). This variant, which resulted in aberrant splicing of messenger RNA, was present in all affected family members. Additional, independent DSTYK mutations, including nonsense and splice-site mutations, were detected in 7 of 311 unrelated patients. DSTYK is highly expressed in the maturing epithelia of all major organs, localizing to cell membranes. Knockdown in zebrafish resulted in developmental defects in multiple organs, which suggested loss of fibroblast growth factor (FGF) signaling. Consistent with this finding is the observation that DSTYK colocalizes with FGF receptors in the ureteric bud and metanephric mesenchyme. DSTYK knockdown in human embryonic kidney cells inhibited FGF-stimulated phosphorylation of extracellular-signal-regulated kinase (ERK), the principal signal downstream of receptor tyrosine kinases. ConclusionsWe detected independent DSTYK mutations in 2.3% of patients with congenital abnormalities of the kidney or urinary tract, a finding that suggests that DSTYK is a major determinant of human urinary tract development, downstream of FGF signaling. (Funded by the National Institutes of Health and others.) Exome sequencing in a family with autosomal dominant congenital urinary tract malformations showed a mutation in dual serine-threonine and tyrosine protein kinase (DSTYK), confirmed in other, unrelated patients, identifying a major determinant of human urinary tract development. Congenital malformations of the kidney and urinary tract contribute to 23% of birth defects(1),(2) and account for 40 to 50% of pediatric cases and 7% of adult cases of end-stage renal disease (ESRD) worldwide.(3),(4) These disorders are genetically heterogeneous and encompass a wide range of anatomical defects, such as renal agenesis, renal hypodysplasia, ureteropelvic junction obstruction, or vesicoureteral reflux.(5) Mutations in genes that cause syndromic disorders, such as HNF1B and PAX2 mutations, are detected in only 5 to 10% of cases.(6),(7) Familial forms of nonsyndromic disease have been reported, further supporting genetic determination(8),(9); however, owing ...	[Sanna-Cherchi, S.; Sampogna, R. V.; Papeta, N.; Burgess, K. E.; Nees, S. N.; Perry, B. J.; Weng, P. L.; Verbitsky, M.; Lugani, F.; Sterken, R.; Paragas, N.; Kacak, N.; Kiryluk, K.; Al-Awqati, Q.; Gharavi, A. G.] Columbia Univ, Div Nephrol, New York, NY USA; [Weng, P. L.] Columbia Univ, Div Pediat Nephrol, New York, NY USA; [D'Agati, V. D.] Columbia Univ, Dept Pathol, New York, NY USA; [Sanna-Cherchi, S.] St Lukes Roosevelt Hosp, Dept Med, New York, NY USA; [Choi, M.; Saraga, M.; Lifton, R. P.] Yale Univ, Dept Genet, Howard & Hughes Med Inst, New Haven, CT USA; [Choi, M.; Saraga, M.; Lifton, R. P.] Yale Univ, Yale Ctr Mendelian Genom, New Haven, CT USA; [Choi, M.] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Bodria, M.; Lugani, F.; Caridi, G.; Carrea, A.; Dagnino, M.; Murtas, C.; Piaggio, G.; Ghiggeri, G. M.] Univ Genoa, Div Nephrol Dialysis & Transplantat, Ist Giannina Gaslini, I-16126 Genoa, Italy; [Santamaria, G.; Ravazzolo, R.] Univ Genoa, Mol Genet Lab, Ist Giannina Gaslini, I-16126 Genoa, Italy; [Bodria, M.] Univ Genoa, Div Nephrol, Dept Internal Med, I-16126 Genoa, Italy; [Ravazzolo, R.] Univ Genoa, Dipartimento Neurosci Riabilitaz Oftalmol Genet &, I-16126 Genoa, Italy; [Bodria, M.] IRCCS San Martino IST, Genoa, Italy; [Izzi, C.; Scolari, F.] Univ Brescia, Cattedra Nefrol, Div Nefrol 2, Azienda Osped Spedali Civili Brescia Presidio Mon, Brescia, Italy; [Bianco, B.; Giberti, S.; Allegri, L.] Univ Parma, Dept Clin Med Nephrol & Hlth Sci, Nephrol Unit, I-43100 Parma, Italy; [Gigante, M.] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy; [Gesualdo, L.] Univ Bari, Dept Emergency & Organ Transplantat, Bari, Italy; [Casu, D.] Hosp Alghero, Div Nephrol & Dialysis, Alghero, Italy; [Liu, Y.; Drummond, I. A.] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA USA; [Drummond, I. A.] Harvard Univ, Sch Med, Dept Genet, Charlestown, MA USA; [Lozanovski, V. J.; Ristoska-Bojkovska, N.; Gucev, Z.; Tasic, V.] Univ Childrens Hosp, Med Sch Skopje, Skopje, Macedonia; [Materna-Kiryluk, A.; Latos-Bielenska, A.] Poznan Univ Med Sci, Dept Med Genet, Poznan, Poland; [Vukic, D. Kosuljandic; Saraga, M.] Univ Split, Univ Hosp Split, Dept Pediat, Split, Croatia; [Vukojevic, K.; Saraga-Babic, M.] Univ Split, Dept Anat Histol & Embryol, Split, Croatia; [State, M.] Univ Split, Sch Med, Split, Croatia	Columbia University; Columbia University; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Howard Hughes Medical Institute; Yale University; Yale University; Seoul National University (SNU); University of Genoa; IRCCS Istituto Giannina Gaslini; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Brescia; University of Parma; University of Foggia; Universita degli Studi di Bari Aldo Moro; Harvard University; Massachusetts General Hospital; Harvard University; Poznan University of Medical Sciences; University of Split; University of Split; University of Split	Gharavi, AG (corresponding author), Columbia Univ Coll Phys & Surg, Div Nephrol, 1150 St Nicholas Ave,Russ Berrie Pavil 413, New York, NY 10032 USA.	ag2239@columbia.edu	Choi, Murim/AAP-9120-2021; Wang, Guilin/G-8794-2018; Caridi, Gianluca/F-7052-2010; State, Matthew/W-2256-2019; Lozanovski, Vladimir J/AAP-9781-2020; Saraga-Babic, Mirna/D-6362-2017; bodria, monica/K-2115-2016; scolari, francesco/AAC-5957-2022; Murtas, Corrado/N-4981-2019; Vukojevic, Katarina/D-5246-2017; Tasic, Velibor/H-8714-2019; Gesualdo, Loreto/K-7751-2016; Gigante, Maddalena/R-4369-2016; Izzi, Claudia/AAB-7004-2022; Santamaria, Giuseppe/AAB-4185-2021; Ghiggeri, Gian Marco/N-4712-2015; Piaggio, Giorgio/AAA-7344-2020; Izzi, Claudia/GZG-8769-2022; Saraga, Marijan/E-7647-2017; Vukojevic, Katarina/AAU-1906-2020; Lugani, Francesca/J-7183-2016	Caridi, Gianluca/0000-0001-6700-3001; Lozanovski, Vladimir J/0000-0002-7332-3973; Saraga-Babic, Mirna/0000-0002-9776-2532; bodria, monica/0000-0001-9690-9945; Murtas, Corrado/0000-0001-7801-6596; Vukojevic, Katarina/0000-0003-2182-2890; Tasic, Velibor/0000-0002-3377-1245; Gesualdo, Loreto/0000-0002-4861-0911; Gigante, Maddalena/0000-0001-8228-7639; Santamaria, Giuseppe/0000-0002-7686-6703; Ghiggeri, Gian Marco/0000-0003-3659-9062; Piaggio, Giorgio/0000-0003-3814-9997; Vukojevic, Katarina/0000-0003-2182-2890; Lugani, Francesca/0000-0002-4189-8561; Paragas, Neal/0000-0001-6084-8220; Nees, Shannon/0000-0003-4046-3942; State, Matthew/0000-0003-1624-8302; Scolari, Francesco/0000-0003-0233-9705; Al-Awqati, Qais/0000-0001-7141-1040; Izzi, Claudia/0000-0001-6253-3185	National Institutes of Health [1R01DK080099, DK071041]; Italian Telethon Foundation [GGP08050]; National Human Genome Research Institute Centers for Mendelian Genomics [HG006504]; National Institute of Diabetes and Digestive and Kidney Diseases [K23-DK090207]; American Heart Association Scientist Development Grant [0930151N]; American Heart Association Grant-in-Aid [13GRNT14680075]; American Society of Nephrology Carl W. Gottschalk Research Scholar Grant; Fondazione Malattie Renali nel Bambino; American Society of Nephrology; Doris Duke Charitable Foundation; Polish Ministry of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504, UM1HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071041, R01DK053093, P30DK079310, R01DK080099, K23DK090207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Telethon Foundation(Fondazione Telethon); National Human Genome Research Institute Centers for Mendelian Genomics; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association Scientist Development Grant(American Heart Association); American Heart Association Grant-in-Aid(American Heart Association); American Society of Nephrology Carl W. Gottschalk Research Scholar Grant; Fondazione Malattie Renali nel Bambino; American Society of Nephrology; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Polish Ministry of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institutes of Health (1R01DK080099, to Dr. Gharavi; DK071041, to Dr. Drummond), the Italian Telethon Foundation (GGP08050, to Dr. Ghiggeri), the National Human Genome Research Institute Centers for Mendelian Genomics (HG006504, to Dr. Lifton), and the National Institute of Diabetes and Digestive and Kidney Diseases (K23-DK090207, to Dr. Kiryluk); an American Heart Association Scientist Development Grant (0930151N), an American Heart Association Grant-in-Aid (13GRNT14680075), and an American Society of Nephrology Carl W. Gottschalk Research Scholar Grant (all to Dr. Sanna-Cherchi); and funding from the Fondazione Malattie Renali nel Bambino (to Dr. Ghiggeri), the American Society of Nephrology and the Doris Duke Charitable Foundation (to Dr. Nees), and the Polish Ministry of Health (to Drs. Materna-Kiryluk and Latos-Bielenska).	Abe G, 2007, DEV BIOL, V304, P355, DOI 10.1016/j.ydbio.2006.12.040; [Anonymous], 1993, TERATOLOGY, V48, P658; Ardissino G, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e382; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Bates CM, 2011, AM J PHYSIOL-RENAL, V301, pF245, DOI 10.1152/ajprenal.00186.2011; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Griffin KJP, 2003, DEV BIOL, V264, P456, DOI 10.1016/j.ydbio.2003.09.008; Guillemot F, 2011, NEURON, V71, P574, DOI 10.1016/j.neuron.2011.08.002; Langenau DM, 2005, P NATL ACAD SCI USA, V102, P6068, DOI 10.1073/pnas.0408708102; Loane M, 2011, BIRTH DEFECTS RES A, V91, pS31, DOI 10.1002/bdra.20778; Nissen RM, 2003, DEVELOPMENT, V130, P2543, DOI 10.1242/dev.00455; Poladia DP, 2006, DEV BIOL, V291, P325, DOI 10.1016/j.ydbio.2005.12.034; Sanna-Cherchi S, 2007, PEDIATR NEPHROL, V22, P1675, DOI 10.1007/s00467-007-0479-1; Sanna-Cherchi S, 2007, AM J HUM GENET, V80, P539, DOI 10.1086/512248; Sanna-Cherchi S, 2012, AM J HUM GENET, V91, P987, DOI 10.1016/j.ajhg.2012.10.007; Sanna-Cherchi S, 2011, KIDNEY INT, V80, P389, DOI 10.1038/ki.2011.148; Sanna-Cherchi S, 2009, KIDNEY INT, V76, P528, DOI 10.1038/ki.2009.220; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Thomas R, 2011, PEDIATR NEPHROL, V26, P897, DOI 10.1007/s00467-011-1826-9; Weber S, 2006, J AM SOC NEPHROL, V17, P2864, DOI 10.1681/ASN.2006030277; Weng PL, 2009, J AM SOC NEPHROL, V20, P1633, DOI 10.1681/ASN.2008111199; Woolf AS, 2002, PEDIATR DEVEL PATHOL, V5, P108, DOI 10.1007/s10024-001-0141-z; Zha J, 2004, BIOCHEM BIOPH RES CO, V319, P98; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	25	77	83	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 15	2013	369	7					621	629		10.1056/NEJMoa1214479	http://dx.doi.org/10.1056/NEJMoa1214479			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YO	23862974	Green Accepted, Green Published			2022-12-01	WOS:000326354500008
J	Claveria, C; Giovinazzo, G; Sierra, R; Torres, M				Claveria, Cristina; Giovinazzo, Giovanna; Sierra, Rocio; Torres, Miguel			Myc-driven endogenous cell competition in the early mammalian embryo	NATURE			English	Article							COMPARTMENTS; GROWTH; STEM; APOPTOSIS; PATTERNS; DEATH; LEADS; SIZE	The epiblast is the mammalian embryonic tissue that contains the pluripotent stem cells that generate the whole embryo. We have established a method for inducing functional genetic mosaics in the mouse. Using this system, here we show that induction of a mosaic imbalance of Myc expression in the epiblast provokes the expansion of cells with higher Myc levels through the apoptotic elimination of cells with lower levels, without disrupting development. In contrast, homogeneous shifts in Myc levels did not affect epiblast cell viability, indicating that the observed competition results from comparison of relative Myc levels between epiblast cells. During normal development we found that Myc levels are intrinsically heterogeneous among epiblast cells, and that endogenous cell competition refines the epiblast cell population through the elimination of cells with low relative Myc levels. These results show that natural cell competition in the early mammalian embryo contributes to the selection of the epiblast cell pool.	[Claveria, Cristina; Giovinazzo, Giovanna; Sierra, Rocio; Torres, Miguel] CNIC, Dept Desarrollo & Reparac Cardiovasc, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Torres, M (corresponding author), CNIC, Dept Desarrollo & Reparac Cardiovasc, E-28029 Madrid, Spain.	mtorres@cnic.es	Torres, Miguel/CAG-0003-2022; Torres, Miguel/A-7388-2013; Giovinazzo, Giovanna/I-1283-2015	Torres, Miguel/0000-0003-0906-4767; Torres, Miguel/0000-0003-0906-4767; Giovinazzo, Giovanna/0000-0002-5391-0441	Ministerio de Economia y Competitividad (MINECO); Pro-CNIC Foundation; MINECO/ISCIII TerCel [RD06/0010/0008]; Human Frontiers Science Program [RGP0008/2004]; Madrid Regional Government [S-SAL-0190-2006, P2010/BMD-2315]	Ministerio de Economia y Competitividad (MINECO); Pro-CNIC Foundation; MINECO/ISCIII TerCel; Human Frontiers Science Program(Human Frontier Science Program); Madrid Regional Government	We thank S. Srinivas for pBigT and pROSA26PA vectors; I. Moreno de Alboran for Myc<SUP>flox/flox</SUP> mice; C. G. Arques for suggestions and patience; M. Manzanares for comments on the manuscript; L. M. Criado and S. Ortega for mouse generation; T. Cordoba, V. Garcia, E. Escudero and S. Vela for mouse work; J. L. Ligos, M. Viton and R. Nieto for help with flow cytometry; E. Arza and A. M. Santos for help with microscopy and three-dimensional reconstruction; F. Sanchez-Cabo and P. Lopez-Romero for statistics; and S. Bartlett for text editing. The CNIC is supported by the Ministerio de Economia y Competitividad (MINECO) and the Pro-CNIC Foundation. This work was supported by a MINECO/ISCIII TerCel grant (RD06/0010/0008) and the Human Frontiers Science Program(RGP0008/2004). C. C. is supported by grants from the Madrid Regional Government (S-SAL-0190-2006 and P2010/BMD-2315).	Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Deming W. E., 1943, STAT ADJUSTMENT DATA; Diaz B, 2005, EXP CELL RES, V306, P317, DOI 10.1016/j.yexcr.2005.03.017; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Heyer BS, 2000, GENE DEV, V14, P2072; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Luscher B, 1986, Princess Takamatsu Symp, V17, P291; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; Marusyk A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000324; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049; Pinheiro J, 2020, NLME LINEAR NONLINEA; Pinheiro JC., 2000, MIXED EFFECTS MODELS, V43, P111; POELMANN RE, 1980, J EMBRYOL EXP MORPH, V55, P33; SIMPSON P, 1979, DEV BIOL, V69, P182, DOI 10.1016/0012-1606(79)90284-7; SIMPSON P, 1976, DEV BIOL, V54, P100, DOI 10.1016/0012-1606(76)90289-X; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tamori Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000422; Torres M, 1998, CURR TOP DEV BIOL, V36, P99; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147	31	229	232	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2013	500	7460					39	U53		10.1038/nature12389	http://dx.doi.org/10.1038/nature12389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23842495				2022-12-01	WOS:000322514800023
J	Hopkins, BD; Fine, B; Steinbach, N; Dendy, M; Rapp, Z; Shaw, J; Pappas, K; Yu, JS; Hodakoski, C; Mense, S; Klein, J; Pegno, S; Sulis, ML; Goldsteini, H; Amendolara, B; Lei, L; Maurer, M; Bruce, J; Canoll, P; Hibshoosh, H; Parsons, R				Hopkins, Benjamin D.; Fine, Barry; Steinbach, Nicole; Dendy, Meaghan; Rapp, Zachary; Shaw, Jacquelyn; Pappas, Kyrie; Yu, Jennifer S.; Hodakoski, Cindy; Mense, Sarah; Klein, Joshua; Pegno, Sarah; Sulis, Maria-Luisa; Goldsteini, Hannah; Amendolara, Benjamin; Lei, Liang; Maurer, Matthew; Bruce, Jeffrey; Canoll, Peter; Hibshoosh, Hanina; Parsons, Ramon			A Secreted PTEN Phosphatase That Enters Cells to Alter Signaling and Survival	SCIENCE			English	Article							TUMOR-SUPPRESSOR; PI3K PATHWAY; PROTEIN; PTEN/MMAC1; ACTIVATION; SYSTEMS; CANCER; DOMAIN; GENE	Phosphatase and tensin homolog on chromosome ten (PTEN) is a tumor suppressor and an antagonist of the phosphoinositide-3 kinase (PI3K) pathway. We identified a 576-amino acid translational variant of PTEN, termed PTEN-Long, that arises from an alternative translation start site 519 base pairs upstream of the ATG initiation sequence, adding 173 N-terminal amino acids to the normal PTEN open reading frame. PTEN-Long is a membrane-permeable lipid phosphatase that is secreted from cells and can enter other cells. As an exogenous agent, PTEN-Long antagonized PI3K signaling and induced tumor cell death in vitro and in vivo. By providing a means to restore a functional tumor-suppressor protein to tumor cells, PTEN-Long may have therapeutic uses.	[Hopkins, Benjamin D.; Steinbach, Nicole; Dendy, Meaghan; Pappas, Kyrie; Hodakoski, Cindy; Mense, Sarah; Parsons, Ramon] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Hopkins, Benjamin D.; Fine, Barry; Steinbach, Nicole; Shaw, Jacquelyn; Pappas, Kyrie; Yu, Jennifer S.; Klein, Joshua; Pegno, Sarah; Sulis, Maria-Luisa; Maurer, Matthew] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Hopkins, Benjamin D.; Fine, Barry; Steinbach, Nicole; Rapp, Zachary; Shaw, Jacquelyn; Pappas, Kyrie; Yu, Jennifer S.; Klein, Joshua; Pegno, Sarah; Sulis, Maria-Luisa; Goldsteini, Hannah; Amendolara, Benjamin; Lei, Liang; Maurer, Matthew; Canoll, Peter; Hibshoosh, Hanina] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Shaw, Jacquelyn; Klein, Joshua; Maurer, Matthew] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Sulis, Maria-Luisa] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Goldsteini, Hannah; Amendolara, Benjamin; Bruce, Jeffrey] Columbia Univ, New York Presbyterian Hosp, Neurol Inst, Dept Neurol Surg, New York, NY 10032 USA; [Lei, Liang; Canoll, Peter; Hibshoosh, Hanina] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA	Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University	Parsons, R (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, 1470 Madison Ave, New York, NY 10029 USA.	ramon.parsons@mssm.edu	Bruce, Jeffrey N/AAC-5307-2022	Parsons, Ramon/0000-0002-6656-3514	NIH [CA082783, R01NS066955, 2T32 CA09503]; NCI [CA097403]; Avon Foundation; OctoberWoman Foundation; NATIONAL CANCER INSTITUTE [P01CA097403, T32CA009503, R01CA155117, R01CA082783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066955, R01NS073610] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Avon Foundation; OctoberWoman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Greene, T. Ludwig, D. Yamashiro, K. Olive, and members of the Parsons laboratory for their assistance. This work was supported by NIH grant CA082783, NCI grant CA097403, NIH grant R01NS066955, the Avon Foundation, and the OctoberWoman Foundation. B. D. H. is supported by NIH grant 2T32 CA09503. Columbia University has applied for patents on PTEN-Long. NM_000314.4 is curated by GenBank. Additional data are present in the supplementary materials.	Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Lei L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020041; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li J, 1998, CANCER RES, V58, P5667; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; SUBRAMANIAN T, 1991, EMBO J, V10, P2311, DOI 10.1002/j.1460-2075.1991.tb07768.x; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486	23	220	254	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					399	402		10.1126/science.1234907	http://dx.doi.org/10.1126/science.1234907			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23744781	Green Accepted			2022-12-01	WOS:000322259200050
J	Kang, SA; Pacold, ME; Cervantes, CL; Lim, D; Lou, HJ; Ottina, K; Gray, NS; Turk, BE; Yaffe, MB; Sabatini, DM				Kang, Seong A.; Pacold, Michael E.; Cervantes, Christopher L.; Lim, Daniel; Lou, Hua Jane; Ottina, Kathleen; Gray, Nathanael S.; Turk, Benjamin E.; Yaffe, Michael B.; Sabatini, David M.			mTORC1 Phosphorylation Sites Encode Their Sensitivity to Starvation and Rapamycin	SCIENCE			English	Article							EXTENDS LIFE-SPAN; MAMMALIAN TARGET; S6 KINASE; FKBP12-RAPAMYCIN COMPLEX; PROTEIN; AUTOPHAGY; INHIBITION; RAPTOR; TOR; GENERATION	The mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) protein kinase promotes growth and is the target of rapamycin, a clinically useful drug that also prolongs life span in model organisms. A persistent mystery is why the phosphorylation of many bona fide mTORC1 substrates is resistant to rapamycin. We find that the in vitro kinase activity of mTORC1 toward peptides encompassing established phosphorylation sites varies widely and correlates strongly with the resistance of the sites to rapamycin, as well as to nutrient and growth factor starvation within cells. Slight modifications of the sites were sufficient to alter mTORC1 activity toward them in vitro and to cause concomitant changes within cells in their sensitivity to rapamycin and starvation. Thus, the intrinsic capacity of a phosphorylation site to serve as an mTORC1 substrate, a property we call substrate quality, is a major determinant of its sensitivity to modulators of the pathway. Our results reveal a mechanism through which mTORC1 effectors can respond differentially to the same signals.	[Kang, Seong A.; Pacold, Michael E.; Cervantes, Christopher L.; Ottina, Kathleen; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kang, Seong A.; Pacold, Michael E.; Cervantes, Christopher L.; Ottina, Kathleen; Yaffe, Michael B.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Pacold, Michael E.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Pacold, Michael E.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Lim, Daniel; Yaffe, Michael B.; Sabatini, David M.] MIT, David H Koch Ctr Integrat Canc Res, Cambridge, MA 02139 USA; [Lou, Hua Jane; Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Yaffe, Michael B.] Harvard Univ, Sch Med, Beth Israel Deaconess Hosp, Dept Surg, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Yale University; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256; Cervantes, Christopher/0000-0001-7351-6954	NIH [CA103866, AI047389, ES015339, GM59281, CA112967]; Department of Defense [W81XWH-07-0448]; W.M. Keck Foundation; LAM (lymphangioleiomyomatosis) Foundation; American Cancer Society; LAM Foundation; Damon Runyon Cancer Research Foundation; Department of Defense Breast Cancer Research Program; NATIONAL CANCER INSTITUTE [P30CA014051, U54CA112967, R01CA103866, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059281] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); W.M. Keck Foundation(W.M. Keck Foundation); LAM (lymphangioleiomyomatosis) Foundation; American Cancer Society(American Cancer Society); LAM Foundation; Damon Runyon Cancer Research Foundation; Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Sabatini laboratory for helpful discussions, especially S. Wang, D. Kim, C. Thoreen, T. Wang, and J. Cantor and E. Spooner for the mass spectrometric analysis of samples. We also thank M. Pende for the S6K1/2 null cells and R. Shaw and C. Thompson for the ULK1/2 null cells. This work was supported by grants from the NIH (CA103866 and AI047389 to D. M. S.; ES015339, GM59281, and CA112967 to M.B.Y.) and Department of Defense (W81XWH-07-0448 to D. M. S.); awards from the W.M. Keck Foundation and the LAM (lymphangioleiomyomatosis) Foundation to D. M. S.; fellowships from the American Cancer Society and the LAM Foundation to S. A. K. and the Damon Runyon Cancer Research Foundation and the Department of Defense Breast Cancer Research Program to M. E. P. D. M. S. is an investigator of the Howard Hughes Medical Institute. Torin1, the inhibitor used here, is part of a Whitehead-Dana-Farber Cancer Institute patent application on which S. A. K., N.S.G., and D. M. S. are inventors. Shared reagents are subject to a materials transfer agreement.	Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Boulbes D, 2010, MOL CANCER RES, V8, P896, DOI 10.1158/1541-7786.MCR-09-0409; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BROWN EJ, 1995, NATURE, V378, P644, DOI 10.1038/378644c0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; PRICE DJ, 1989, J BIOL CHEM, V264, P13825; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Tao ZH, 2010, BIOCHEMISTRY-US, V49, P8488, DOI 10.1021/bi100673c; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wander SA, 2011, J CLIN INVEST, V121, P1231, DOI 10.1172/JCI44145; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	49	316	327	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2013	341	6144					364	+	1236566	10.1126/science.1236566	http://dx.doi.org/10.1126/science.1236566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888043	Green Accepted, Green Submitted			2022-12-01	WOS:000322259200040
J	Rinke, C; Schwientek, P; Sczyrba, A; Ivanova, NN; Anderson, IJ; Cheng, JF; Darling, A; Malfatti, S; Swan, BK; Gies, EA; Dodsworth, JA; Hedlund, BP; Tsiamis, G; Sievert, SM; Liu, WT; Eisen, JA; Hallam, SJ; Kyrpides, NC; Stepanauskas, R; Rubin, EM; Hugenholtz, P; Woyke, T				Rinke, Christian; Schwientek, Patrick; Sczyrba, Alexander; Ivanova, Natalia N.; Anderson, Iain J.; Cheng, Jan-Fang; Darling, Aaron; Malfatti, Stephanie; Swan, Brandon K.; Gies, Esther A.; Dodsworth, Jeremy A.; Hedlund, Brian P.; Tsiamis, George; Sievert, Stefan M.; Liu, Wen-Tso; Eisen, Jonathan A.; Hallam, Steven J.; Kyrpides, Nikos C.; Stepanauskas, Ramunas; Rubin, Edward M.; Hugenholtz, Philip; Woyke, Tanja			Insights into the phylogeny and coding potential of microbial dark matter	NATURE			English	Article							LATERAL GENE-TRANSFER; HYDROTHERMAL VENT; SP-NOV.; DIVERSITY; BACTERIA; DIVISION; VERRUCOMICROBIA; METAGENOMICS; SUPERPHYLUM; CHLAMYDIAE	Genome sequencing enhances our understanding of the biological world by providing blueprints for the evolutionary and functional diversity that shapes the biosphere. However, microbial genomes that are currently available are of limited phylogenetic breadth, owing to our historical inability to cultivate most microorganisms in the laboratory. We apply single-cell genomics to target and sequence 201 uncultivated archaeal and bacterial cells from nine diverse habitats belonging to 29 major mostly uncharted branches of the tree of life, so-called 'microbial dark matter'. With this additional genomic information, we are able to resolve many intra-and inter-phylum-level relationships and to propose two new superphyla. We uncover unexpected metabolic features that extend our understanding of biology and challenge established boundaries between the three domains of life. These include a novel amino acid use for the opal stop codon, an archaeal-type purine synthesis in Bacteria and complete sigma factors in Archaea similar to those in Bacteria. The single-cell genomes also served to phylogenetically anchor up to 20% of metagenomic reads in some habitats, facilitating organism-level interpretation of ecosystem function. This study greatly expands the genomic representation of the tree of life and provides a systematic step towards a better understanding of biological evolution on our planet.	[Rinke, Christian; Schwientek, Patrick; Sczyrba, Alexander; Ivanova, Natalia N.; Anderson, Iain J.; Cheng, Jan-Fang; Malfatti, Stephanie; Kyrpides, Nikos C.; Rubin, Edward M.; Woyke, Tanja] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Sczyrba, Alexander] Univ Bielefeld, Ctr Biotechnol, D-33602 Bielefeld, Germany; [Darling, Aaron; Eisen, Jonathan A.] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; [Darling, Aaron] Univ Technol Sydney, Inst I3, Ultimo, NSW 2007, Australia; [Swan, Brandon K.; Stepanauskas, Ramunas] Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA; [Gies, Esther A.; Hallam, Steven J.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Gies, Esther A.; Hallam, Steven J.] Univ British Columbia, Grad Program Bioinformat, Vancouver, BC V6T 1Z3, Canada; [Dodsworth, Jeremy A.; Hedlund, Brian P.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Tsiamis, George] Univ Patras, Dept Environm & Nat Resources Management, Agrinion 30100, TK, Greece; [Sievert, Stefan M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Liu, Wen-Tso] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61802 USA; [Hugenholtz, Philip] Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogenom, St Lucia, Qld 4072, Australia; [Hugenholtz, Philip] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	United States Department of Energy (DOE); University of Bielefeld; University of California System; University of California Davis; University of Technology Sydney; Bigelow Laboratory for Ocean Sciences; University of British Columbia; University of British Columbia; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Patras; Woods Hole Oceanographic Institution; University of Illinois System; University of Illinois Urbana-Champaign; University of Queensland; University of Queensland	Hugenholtz, P (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogenom, St Lucia, Qld 4072, Australia.	p.hugenholtz@uq.edu.au; twoyke@lbl.gov	Rinke, Christian/AAE-8100-2019; Liu, Wen-Tso/C-8788-2011; Kyrpides, Nikos C./A-6305-2014; Rinke, Christian/ABA-3139-2021; Darling, Aaron/G-8119-2017; Hugenholtz, Philip/G-9608-2011; Eisen, Jonathan A./H-2706-2019; Swan, Brandon K/O-9824-2018; Hugenholtz, Philip/AAD-9138-2019	Rinke, Christian/0000-0003-4632-1187; Liu, Wen-Tso/0000-0002-8700-9803; Kyrpides, Nikos C./0000-0002-6131-0462; Hugenholtz, Philip/0000-0001-5386-7925; Eisen, Jonathan A./0000-0002-0159-2197; Swan, Brandon K/0000-0003-0465-1444; Hugenholtz, Philip/0000-0001-5386-7925; Darling, Aaron/0000-0003-2397-7925; Hedlund, Brian/0000-0001-8530-0448; Ivanova, Natalia/0000-0002-5802-9485; Sievert, Stefan/0000-0002-9541-2707; Sczyrba, Alexander/0000-0002-4405-3847; Malfatti, Stephanie/0000-0003-4225-9857; Cheng, Jan-Fang/0000-0001-7315-7613; Stepanauskas, Ramunas/0000-0003-4458-3108; Dodsworth, Jeremy/0000-0003-2014-5488	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; BMBF [031A190]; NASA [EXO-NNX11AR78G]; NSF [OISE 096842, OCE-0452333, OCE-1136727, DEB-841933, EF-826924, OCE-1232982, OCE-821374, OCE-1136488]; WHOI's Andrew W. Mellon Fund for Innovative Research; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund; National Sciences and Engineering Research Council (NSERC) of Canada; TULA foundation; Alfred P. Sloan Foundation; Australian Research Council [DP120103498]; Directorate For Geosciences [1232982, 1136727] Funding Source: National Science Foundation; Division Of Ocean Sciences [1136488] Funding Source: National Science Foundation	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); BMBF(Federal Ministry of Education & Research (BMBF)); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); WHOI's Andrew W. Mellon Fund for Innovative Research; Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); TULA foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Australian Research Council(Australian Research Council); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the DOE JGI production sequencing, IMG and GOLD teams for their support; J. Lee and E. Ng for experimental assistance; H.-P. Klenk and D. Gleim for providing a DSMZ inventory database dump and I. Letunic ' for his knowledge and support to make iTOL work for this project. We are very grateful to B. Schink for invaluable etymological advice. The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. We also thank the CeBiTec Bioinformatics Resource Facility, which is supported by BMBF grant 031A190. B. P. H. and J. A. D. were supported by the NASA Exobiology grant EXO-NNX11AR78G and NSF OISE 096842 and B. P. H. by a generous contribution from G. Fullmer through the UNLV Foundation. S. M. S was supported by NSF grants OCE-0452333 and OCE-1136727, and the WHOI's Andrew W. Mellon Fund for Innovative Research; and S. J. H. by the Canadian Foundation for Innovation, the British Columbia Knowledge Development Fund, the National Sciences and Engineering Research Council (NSERC) of Canada and the TULA foundation funded Centre for Microbial Diversity and Evolution (CMDE), and the Canadian Institute for Advanced Research (CIFAR). R. S. was supported by NSF grants DEB-841933, EF-826924, OCE-1232982, OCE-821374 and OCE-1136488, and the Deep Life I grant by the Alfred P. Sloan Foundation. P. H. was supported by a Discovery Outstanding Researcher Award (DORA) from the Australian Research Council, grant DP120103498.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Atkinson GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023479; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; Battistuzzi FU, 2009, MOL BIOL EVOL, V26, P335, DOI 10.1093/molbev/msn247; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Campbell JH, 2013, P NATL ACAD SCI USA, V110, P5540, DOI 10.1073/pnas.1303090110; Chouari R, 2005, APPL ENVIRON MICROB, V71, P2145, DOI 10.1128/AEM.71.4.2145-2153.2005; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dalevi D, 2001, INT J SYST EVOL MICR, V51, P385, DOI 10.1099/00207713-51-2-385; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; Droge J, 2012, BRIEF BIOINFORM, V13, P646, DOI 10.1093/bib/bbs031; Gilbert JA, 2011, ANNU REV MAR SCI, V3, P347, DOI 10.1146/annurev-marine-120709-142811; Gordon DA, 1996, APPL ENVIRON MICROB, V62, P1171, DOI 10.1128/AEM.62.4.1171-1177.1996; Gupta RS, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00327; Gupta RS, 2004, CRIT REV MICROBIOL, V30, P123, DOI 10.1080/10408410490435133; Guy L, 2011, TRENDS MICROBIOL, V19, P580, DOI 10.1016/j.tim.2011.09.002; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Harris JK, 2004, APPL ENVIRON MICROB, V70, P845, DOI 10.1128/AEM.70.2.845-849.2004; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Hugenholtz P, 2009, ENVIRON MICROBIOL, V11, P551, DOI 10.1111/j.1462-2920.2009.01888.x; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Kyrpides NC, 1997, J MOL EVOL, V45, P706; LAKE JA, 1984, P NATL ACAD SCI-BIOL, V81, P3786, DOI 10.1073/pnas.81.12.3786; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; McCutcheon JP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000565; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Miroshnichenko ML, 2003, INT J SYST EVOL MICR, V53, P323, DOI 10.1099/ijs.0.02390-0; Narasingarao P, 2012, ISME J, V6, P81, DOI 10.1038/ismej.2011.78; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Rajendhran J, 2011, MICROBIOL RES, V166, P99, DOI 10.1016/j.micres.2010.02.003; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Stepanauskas R, 2012, CURR OPIN MICROBIOL, V15, P613, DOI 10.1016/j.mib.2012.09.001; Sutcliffe IC, 2011, ENVIRON MICROBIOL, V13, P279, DOI 10.1111/j.1462-2920.2010.02339.x; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Szollosi GJ, 2012, P NATL ACAD SCI USA, V109, P17513, DOI 10.1073/pnas.1202997109; Takai K, 1999, GENETICS, V152, P1285; Takai K, 2001, APPL ENVIRON MICROB, V67, P5750, DOI 10.1128/AEM.67.21.5750-5760.2001; Tamaki H, 2011, INT J SYST EVOL MICR, V61, P1442, DOI 10.1099/ijs.0.025643-0; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005; Williams TA, 2012, P ROY SOC B-BIOL SCI, V279, P4870, DOI 10.1098/rspb.2012.1795; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; YAMAO F, 1985, P NATL ACAD SCI USA, V82, P2306, DOI 10.1073/pnas.82.8.2306; Zaneveld JR, 2010, NUCLEIC ACIDS RES, V38, P3869, DOI 10.1093/nar/gkq066; Zhang H, 2003, INT J SYST EVOL MICR, V53, P1155, DOI 10.1099/ijs.0.02520-0; Zhang Y, 2008, CELL MOL LIFE SCI, V65, P3699, DOI 10.1007/s00018-008-8295-8	50	1330	1408	23	670	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					431	437		10.1038/nature12352	http://dx.doi.org/10.1038/nature12352			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23851394	Green Published, hybrid, Green Submitted			2022-12-01	WOS:000322157900031
J	Takebe, T; Sekine, K; Enomura, M; Koike, H; Kimura, M; Ogaeri, T; Zhang, RR; Ueno, Y; Zheng, YW; Koike, N; Aoyama, S; Adachi, Y; Taniguchi, H				Takebe, Takanori; Sekine, Keisuke; Enomura, Masahiro; Koike, Hiroyuki; Kimura, Masaki; Ogaeri, Takunori; Zhang, Ran-Ran; Ueno, Yasuharu; Zheng, Yun-Wen; Koike, Naoto; Aoyama, Shinsuke; Adachi, Yasuhisa; Taniguchi, Hideki			Vascularized and functional human liver from an iPSC-derived organ bud transplant	NATURE			English	Article							CHIMERIC MICE; STEM-CELL; ORGANOGENESIS; GENERATION; ENDODERM; GROWTH; MOUSE; MODEL	A critical shortage of donor organs for treating end-stage organ failure highlights the urgent need for generating organs from human induced pluripotent stem cells (iPSCs)(1). Despite many reports describing functional cell differentiation(2-4), no studies have succeeded in generating a three-dimensional vascularized organ such as liver. Here we show the generation of vascularized and functional human liver from human iPSCs by transplantation of liver buds created in vitro (iPSC-LBs). Specified hepatic cells (immature endodermal cells destined to track the hepatic cell fate) self-organized into three-dimensional iPSC-LBs by recapitulating organogenetic interactions between endothelial and mesenchymal cells(5). Immunostaining and gene-expression analyses revealed a resemblance between in vitro grown iPSC-LBs and in vivo liver buds. Human vasculatures in iPSC-LB transplants became functional by connecting to the host vessels within 48 hours. The formation of functional vasculatures stimulated the maturation of iPSC-LBs into tissue resembling the adult liver. Highly metabolic iPSC-derived tissue performed liver-specific functions such as protein production and human-specific drug metabolism without recipient liver replacement(6). Furthermore, mesenteric transplantation of iPSC-LBs rescued the drug-induced lethal liver failure model. To our knowledge, this is the first report demonstrating the generation of a functional human organ from pluripotent stem cells. Although efforts must ensue to translate these techniques to treatments for patients, this proof-of-concept demonstration of organ-bud transplantation provides a promising new approach to study regenerative medicine.	[Takebe, Takanori; Sekine, Keisuke; Enomura, Masahiro; Koike, Hiroyuki; Kimura, Masaki; Ogaeri, Takunori; Zhang, Ran-Ran; Ueno, Yasuharu; Zheng, Yun-Wen; Koike, Naoto; Taniguchi, Hideki] Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Takebe, Takanori; Taniguchi, Hideki] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa 2360004, Japan; [Koike, Naoto] Seirei Sakura Citizen Hosp, Dept Surg, Sakura, Chiba 2858765, Japan; [Aoyama, Shinsuke; Adachi, Yasuhisa] Sekisui Med Co Ltd, ADME & Tox Res Inst, Tokai, Ibaraki 3191182, Japan	Yokohama City University; Yokohama City University; Sekisui Chemical Co Ltd	Takebe, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	ttakebe@yokohama-cu.ac.jp; rtanigu@yokohama-cu.ac.jp	Koike, Hiroyuki/AAT-6065-2020; Zheng, Yun-Wen/R-2874-2019; Koike, Hiroyuki/R-5103-2018; ZHANG, RANRAN/W-1020-2018; Koike, Hiroyuki/AAZ-9941-2020	Koike, Hiroyuki/0000-0001-9934-6930; Zheng, Yun-Wen/0000-0001-9002-3190; Koike, Hiroyuki/0000-0001-9934-6930; ZHANG, RANRAN/0000-0001-5698-1950; Koike, Hiroyuki/0000-0001-9934-6930; Adachi, Yasuhisa/0000-0003-4197-092X; Takebe, Takanori/0000-0002-6989-3041; Sekine, Keisuke/0000-0001-5133-0876	Strategic Promotion of Innovative Research and Development (S-innovation) of the Japan Science and Technology Agency (JST) [62890004]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24106510, 24689052, 22390260, 21249071, 25253079]; Takeda Science Foundation; Japan IDDM network; Yokohama Foundation for Advanced Medical Science; Grants-in-Aid for Scientific Research [25253079, 24659785] Funding Source: KAKEN	Strategic Promotion of Innovative Research and Development (S-innovation) of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan IDDM network; Yokohama Foundation for Advanced Medical Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank F. Kawamata, E. Yoshizawa, Y. Suzuki, S. Nakai, Y. Takahashi, N. Tsuchida and N. Sasaki for kindly providing technical support; J. Nakabayashi, K. Yasumura, R. Fujiwara, T. Amiya, A. Nakano, Y. Mitsuhashi and all of the members of our laboratory for help with several experiments and comments. We are also grateful to D. Fukumura, Y. Goshima, T. Hirose, M. Ichino, U. Yokoyama, T. Ogawa and R. K. Jain for critical evaluation of the manuscript. This work was supported by grants to H. Taniguchi from the Strategic Promotion of Innovative Research and Development (S-innovation, 62890004) of the Japan Science and Technology Agency (JST). This work was also supported by the Grants-in-Aid of the Ministry of Education, Culture, Sports, Science, and Technology of Japan to T. Takebe (no. 24106510, 24689052), N. Koike (no. 22390260) and H. Taniguchi (no. 21249071, 25253079); by the Specified Research Grant of the Takeda Science Foundation and a grant from the Japan IDDM network to H. Taniguchi; and by a grant of the Yokohama Foundation for Advanced Medical Science to T. Takebe.	Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Dudley SC, 2005, CIRC RES, V97, P99, DOI 10.1161/01.RES.00000175827.99824.7f; Espejel S, 2010, J CLIN INVEST, V120, P3120, DOI 10.1172/JCI43267; Gouysse G, 2002, J HEPATOL, V37, P730, DOI 10.1016/S0168-8278(02)00282-9; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; ISHIZAKI T, 1980, EUR J CLIN PHARMACOL, V18, P407, DOI 10.1007/BF00636794; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kamimura H, 2010, DRUG METAB PHARMACOK, V25, P223, DOI 10.2133/dmpk.25.223; Katoh M, 2007, J PHARM SCI-US, V96, P428, DOI 10.1002/jps.20783; Klein AS, 2010, AM J TRANSPLANT, V10, P973, DOI 10.1111/j.1600-6143.2009.03008.x; Kobayashi S, 2011, P NATL ACAD SCI USA, V108, P14479, DOI 10.1073/pnas.1109767108; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; MARTINEZHERNANDEZ A, 1984, LAB INVEST, V51, P57; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Takebe T, 2012, TRANSPL P, V44, P1130, DOI 10.1016/j.transproceed.2012.03.039; Yu AM, 2004, DRUG METAB REV, V36, P243, DOI 10.1081/DMR-120034000; Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691	23	1212	1293	34	529	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					481	+		10.1038/nature12271	http://dx.doi.org/10.1038/nature12271			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23823721				2022-12-01	WOS:000322157900041
J	Asai, M; Ramachandrappa, S; Joachim, M; Shen, Y; Zhang, R; Nuthalapati, N; Ramanathan, V; Strochlic, DE; Ferket, P; Linhart, K; Ho, C; Novoselova, TV; Garg, S; Ridderstrale, M; Marcus, C; Hirschhorn, JN; Keogh, JM; O'Rahilly, S; Chan, LF; Clark, AJ; Farooqi, IS; Majzoub, JA				Asai, Masato; Ramachandrappa, Shwetha; Joachim, Maria; Shen, Yuan; Zhang, Rong; Nuthalapati, Nikhil; Ramanathan, Visali; Strochlic, David E.; Ferket, Peter; Linhart, Kirsten; Ho, Caroline; Novoselova, Tatiana V.; Garg, Sumedha; Ridderstrale, Martin; Marcus, Claude; Hirschhorn, Joel N.; Keogh, Julia M.; O'Rahilly, Stephen; Chan, Li F.; Clark, Adrian J.; Farooqi, I. Sadaf; Majzoub, Joseph A.			Loss of Function of the Melanocortin 2 Receptor Accessory Protein 2 Is Associated with Mammalian Obesity	SCIENCE			English	Article							MRAP2	Melanocortin receptor accessory proteins (MRAPs) modulate signaling of melanocortin receptors in vitro. To investigate the physiological role of brain-expressed melanocortin 2 receptor accessory protein 2 (MRAP2), we characterized mice with whole-body and brain-specific targeted deletion of Mrap2, both of which develop severe obesity at a young age. Mrap2 interacts directly with melanocortin 4 receptor (Mc4r), a protein previously implicated in mammalian obesity, and it enhances Mc4r-mediated generation of the second messenger cyclic adenosine monophosphate, suggesting that alterations in Mc4r signaling may be one mechanism underlying the association between Mrap2 disruption and obesity. In a study of humans with severe, early-onset obesity, we found four rare, potentially pathogenic genetic variants in MRAP2, suggesting that the gene may also contribute to body weight regulation in humans.	[Asai, Masato; Joachim, Maria; Shen, Yuan; Zhang, Rong; Nuthalapati, Nikhil; Ramanathan, Visali; Strochlic, David E.; Linhart, Kirsten; Ho, Caroline; Hirschhorn, Joel N.; Majzoub, Joseph A.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Endocrinol,Dept Med, Boston, MA 02115 USA; [Asai, Masato] Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Asai, Masato] Nagoya Univ, Grad Sch Med, Dept Endocrinol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Asai, Masato] Nagoya Univ, Grad Sch Med, Dept Diabet, Showa Ku, Nagoya, Aichi 4668550, Japan; [Ramachandrappa, Shwetha; Garg, Sumedha; Keogh, Julia M.; O'Rahilly, Stephen; Farooqi, I. Sadaf] Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England; [Ramachandrappa, Shwetha; Garg, Sumedha; Keogh, Julia M.; O'Rahilly, Stephen; Farooqi, I. Sadaf] Addenbrookes Hosp, Inst Metab Sci, Natl Inst Hlth Res, Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England; [Ferket, Peter] N Carolina State Univ, Prestage Dept Poultry Sci, Raleigh, NC 27695 USA; [Novoselova, Tatiana V.; Chan, Li F.; Clark, Adrian J.] Univ London, Barts & London Sch Med & Dent, Ctr Endocrinol, William Harvey Res Inst, London EC1M 6BQ, England; [Ridderstrale, Martin] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Ridderstrale, Martin] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Marcus, Claude] Karolinska Inst, Natl Childhood Obes Ctr, Dept Clin Sci Intervent & Technol, Div Pediat, S-14186 Huddinge, Sweden; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Cambridge, MA 02142 USA; [Hirschhorn, Joel N.] Broad Inst, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Nagoya University; Nagoya University; Nagoya University; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of North Carolina; North Carolina State University; University of London; Queen Mary University London; Lund University; Steno Diabetes Center; Karolinska Institutet; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Farooqi, IS (corresponding author), Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England.	isf20@cam.ac.uk; joseph.majzoub@childrens.harvard.edu	Marcus, Claude/ABE-1177-2020; Farooqi, Ismaa Sadaf/AAZ-3046-2020; O'Rahilly, Stephen/ABF-6509-2020; asai, masato/I-7294-2014	Marcus, Claude/0000-0003-0890-2650; O'Rahilly, Stephen/0000-0003-2199-4449; Ferket, Peter/0000-0002-2897-4312; Chan, Li/0000-0001-5146-8242; Farooqi, Sadaf/0000-0001-7609-3504	National Institutes of Health [NIHP30-HD18655]; Timothy Murphy Fund; National Alliance for Research on Schizophrenia and Depression; Wellcome Trust; Medical Research Council [G0802796]; NIHR Cambridge Biomedical Research Centre; Pfizer; Correlagen Diagnostics;  [R01DK075787]; Medical Research Council [G0600717, MC_UU_12012/5/B, G0600717B, G0900554, MC_UU_12012/1, G9824984] Funding Source: researchfish; Novo Nordisk Fonden [NNF11OC1014660] Funding Source: researchfish; MRC [MC_UU_12012/1, G0802796, G0900554, G0600408, G9824984, G0600717] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007699, R01DK075787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Timothy Murphy Fund; National Alliance for Research on Schizophrenia and Depression(NARSAD); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Pfizer(Pfizer); Correlagen Diagnostics; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Nguyen for DNA analysis; H. Feldman and A. Fleisch for statistical advice; M. Mulcahey for thyroid assays; H. Turkova for catecholamine assays; S. Cabi for creating the software program used to analyze calorimetry data; M. Geibel for bioinformatics analyses; and D. Margulies, B. Lowell, J. Flier, and Boston Children's Hospital Endocrinology Division scientists for helpful discussions. We are indebted to the patients and their families for their participation and to the physicians involved in GOOS and the Swedish obese children's cohort study. This work was supported by grants from the National Institutes of Health, including NIHP30-HD18655 (J. A. M.), the Timothy Murphy Fund (J. A. M.), the National Alliance for Research on Schizophrenia and Depression (M. A.), the Wellcome Trust (I. S. F. and S.O'R.), the Medical Research Council [I. S. F. and L. F. C. (grant no. G0802796)], the NIHR Cambridge Biomedical Research Centre (I. S. F. and S.O'R.), and R01DK075787 (J.N.H.). S.O'R. is a paid Scientific Adviser for Pfizer in the area of cardiometabolic disease. Until 2010, J. A. M. was on the Board of, and was a paid Scientific Advisor for, Correlagen Diagnostics, a company whose projects included molecular diagnostic tests related to obesity. The authors (M. A., J. A. M., Boston Children's Hospital) have filed a patent application related to modulating Mrap2 to alter growth.	Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Chan LF, 2011, EUR J PHARMACOL, V660, P171, DOI 10.1016/j.ejphar.2010.11.041; Chan LF, 2009, P NATL ACAD SCI USA, V106, P6146, DOI 10.1073/pnas.0809918106; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Cooray SN, 2011, MOL CELL ENDOCRINOL, V331, P215, DOI 10.1016/j.mce.2010.07.015; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Hay DL, 2006, PHARMACOL THERAPEUT, V109, P173, DOI 10.1016/j.pharmthera.2005.06.015; Hinkle PM, 2009, MOL CELL ENDOCRINOL, V300, P25, DOI 10.1016/j.mce.2008.10.041; Johansson LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005327; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Sebag JA, 2013, SCIENCE, V341, P278, DOI 10.1126/science.1232995; Sebag JA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000593; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/nmeth.1806, 10.1038/NMETH.1806]	13	169	175	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 19	2013	341	6143					275	278		10.1126/science.1233000	http://dx.doi.org/10.1126/science.1233000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185HV	23869016	Green Accepted			2022-12-01	WOS:000321959300043
J	Tang, ZY; Chen, WY; Shimada, M; Nguyen, UTT; Kim, J; Sun, XJ; Sengoku, T; McGinty, RK; Fernandez, JP; Muir, TW; Roeder, RG				Tang, Zhanyun; Chen, Wei-Yi; Shimada, Miho; Nguyen, Uyen T. T.; Kim, Jaehoon; Sun, Xiao-Jian; Sengoku, Toru; McGinty, Robert K.; Fernandez, Joseph P.; Muir, Tom W.; Roeder, Robert G.			SET1 and p300 Act Synergistically, through Coupled Histone Modifications, in Transcriptional Activation by p53	CELL			English	Article							TRITHORAX GROUP PROTEINS; H3K4 METHYLATION; H2B UBIQUITYLATION; METHYLTRANSFERASE ACTIVITY; CHROMATIN TRANSCRIPTION; LYSINE 4; COMPLEX; CELLS; DIFFERENTIATION; TRIMETHYLATION	The H3K4me3 mark in chromatin is closely correlated with actively transcribed genes, although the mechanisms involved in its generation and function are not fully understood. In vitro studies with recombinant chromatin and purified human factors demonstrate a robust SET1 complex (SET1C)-mediated H3K4 trimethylation that is dependent upon p53- and p300-mediated H3 acetylation, a corresponding SET1C-mediated enhancement of p53- and p300-dependent transcription that reflects a primary effect of SET1C through H3K4 trimethylation, and direct SET1C-p53 and SET1C-p300 interactions indicative of a targeted recruitment mechanism. Complementary cell-based assays demonstrate a DNA-damage-induced p53- SET1C interaction, a corresponding enrichment of SET1C and H3K4me3 on a p53 target gene (p21/WAF1), and a corresponding codependency of H3K4 trimethylation and transcription upon p300 and SET1C. These results establish a mechanism in which SET1C and p300 act cooperatively, through direct interactions and coupled histone modifications, to facilitate the function of p53.	[Tang, Zhanyun; Chen, Wei-Yi; Shimada, Miho; Kim, Jaehoon; Sun, Xiao-Jian; Sengoku, Toru; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA; [McGinty, Robert K.; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10065 USA; [Fernandez, Joseph P.] Rockefeller Univ, Prote Resource Ctr, New York, NY 10065 USA; [Nguyen, Uyen T. T.; Muir, Tom W.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Rockefeller University; Rockefeller University; Rockefeller University; Princeton University	Roeder, RG (corresponding author), Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA.	roeder@rockefeller.edu	Sengoku, Toru/E-4304-2013; Sun, Xiao-Jian/D-1560-2011; Muir, Tom/AHD-0860-2022; Kim, Jaehoon/G-2711-2011	Sengoku, Toru/0000-0001-9461-8714; Sun, Xiao-Jian/0000-0001-8826-4614; Muir, Tom/0000-0001-9635-0344; Kim, Jaehoon/0000-0003-4035-0438; Chen, Wei-Yi/0000-0002-0661-6899	NIH [CA129325]; Leukemia and Lymphoma Society; Ellison Medical Foundation; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [R01CA129325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107047, T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Ellison Medical Foundation(Lawrence Ellison Foundation); Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ming Yu for advice on ChIP assays; laboratory members for discussions; Sohail Malik for critical reading of the manuscript; Wei Gu (Columbia University) for p53 7KR/8KR mutant plasmids; W. Lee Kraus (UT Southwestern) and James T. Kadonaga (UCSD) for the mutant p300 plasmids; Peter B. Becker (Adolf-Butenandt-Institute, Germany) for the ACF1 Delta bromodomain plasmid; Christina Hughes (The Rockefeller University), Winship Herr (University of Lausanne), and David G. Skalnik (Indiana University) for antibodies; and Carlos Caldas (University of Cambridge) for p300 WT and null HCT116 cell lines. This work was supported by grants from the NIH (CA129325), the Leukemia and Lymphoma Society, the Ellison Medical Foundation, and the Starr Cancer Consortium to R.G.R.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; An WJ, 2004, METHOD ENZYMOL, V377, P460; Clouaire T, 2012, GENE DEV, V26, P1714, DOI 10.1101/gad.194209.112; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Filippakopoulos P, 2012, FEBS LETT, V586, P2692, DOI 10.1016/j.febslet.2012.04.045; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Guo CC, 2012, P NATL ACAD SCI USA, V109, P17603, DOI 10.1073/pnas.1208807109; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kim J, 2013, MOL CELL, V49, P1121, DOI 10.1016/j.molcel.2013.01.034; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraus WL, 1999, MOL CELL BIOL, V19, P8123; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lee JS, 2012, GENE DEV, V26, P914, DOI 10.1101/gad.186841.112; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lin JJ, 2011, GENE DEV, V25, P2198, DOI 10.1101/gad.17554711; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Santoso BY, 2006, NAT STRUCT MOL BIOL, V13, P131, DOI 10.1038/nsmb1048; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Vermeulen M, 2010, EPIGENOMICS-UK, V2, P395, DOI [10.2217/epi.10.11, 10.2217/EPI.10.11]; Vethantham V, 2012, MOL CELL BIOL, V32, P1044, DOI 10.1128/MCB.06026-11; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang Z, 2009, J BIOL CHEM, V284, P34870, DOI 10.1074/jbc.M109.046250; Wu LP, 2013, MOL CELL, V49, P1108, DOI 10.1016/j.molcel.2013.01.033; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	44	122	124	0	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					297	310		10.1016/j.cell.2013.06.027	http://dx.doi.org/10.1016/j.cell.2013.06.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870121	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000321950700008
J	Bell, CH; Healey, E; van Erp, S; Bishop, B; Tang, CX; Gilbert, RJC; Aricescu, AR; Pasterkamp, RJ; Siebold, C				Bell, Christian H.; Healey, Eleanor; van Erp, Susan; Bishop, Benjamin; Tang, Chenxiang; Gilbert, Robert J. C.; Aricescu, A. Radu; Pasterkamp, R. Jeroen; Siebold, Christian			Structure of the Repulsive Guidance Molecule (RGM)-Neogenin Signaling Hub	SCIENCE			English	Article							NEOGENIN; HEMOJUVELIN; RGMA; IRON; MUTATIONS; GROWTH; INHIBITION; RECEPTOR; MEDIATE; DCC	Repulsive guidance molecule family members (RGMs) control fundamental and diverse cellular processes, including motility and adhesion, immune cell regulation, and systemic iron metabolism. However, it is not known how RGMs initiate signaling through their common cell-surface receptor, neogenin (NEO1). Here, we present crystal structures of the NEO1 RGM-binding region and its complex with human RGMB (also called dragon). The RGMB structure reveals a previously unknown protein fold and a functionally important autocatalytic cleavage mechanism and provides a framework to explain numerous disease-linked mutations in RGMs. In the complex, two RGMB ectodomains conformationally stabilize the juxtamembrane regions of two NEO1 receptors in a pH-dependent manner. We demonstrate that all RGM-NEO1 complexes share this architecture, which therefore represents the core of multiple signaling pathways.	[Bell, Christian H.; Healey, Eleanor; Bishop, Benjamin; Tang, Chenxiang; Gilbert, Robert J. C.; Aricescu, A. Radu; Siebold, Christian] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; [van Erp, Susan; Pasterkamp, R. Jeroen] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, NL-3584 CG Utrecht, Netherlands	University of Oxford; Wellcome Centre for Human Genetics; Utrecht University; Utrecht University Medical Center	Siebold, C (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England.	christian@strubi.ox.ac.uk	Aricescu, Alexandru/L-3891-2013	Aricescu, Alexandru ARadu/0000-0003-3783-1388; Siebold, Christian/0000-0002-6635-3621; Pasterkamp, Jeroen/0000-0003-1631-6440; Gilbert, Robert/0000-0001-9336-5604; van Erp, Susan/0000-0003-0883-2795; Healey, Eleanor/0000-0002-3036-8637	Wellcome Trust; Human Frontier Science Program; Netherlands Organization for Health Research and Development; Medical Research Council; MRC [G0700232] Funding Source: UKRI; Cancer Research UK [14414] Funding Source: researchfish; Medical Research Council [G0700232] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Human Frontier Science Program(Human Frontier Science Program); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Diamond and European Synchrotron Radiation Facility beamline staff for assistance; T. Walter, K. Harlos, and G. Sutton for technical support; and M. Zebisch, E. Y. Jones, and D. I. Stuart for discussions. Work was funded by the Wellcome Trust (C. S.) and Human Frontier Science Program and the Netherlands Organization for Health Research and Development (R.J.P.). The Division of Structural Biology is supported by a Wellcome Trust Core Grant. R.J.C.G. was a Royal Society University Research Fellow. A. R. A. was a Medical Research Council Career Development Award Fellow. C. S. is a Cancer Research UK Senior Research Fellow. Structure coordinates of eRGMB-NEO1<INF>FN56</INF>-Form 1, eRGMB-NEO1<INF>FN56</INF>-Form 2, eRGMB-NEO1<INF>FN56</INF>-Form 3, NEO1<INF>FN56</INF>-Form 1, NEO1<INF>FN56</INF>-Form 2, and NEO1<INF>FN56</INF>-SOS are deposited in the Protein Data Bank (identification codes 4BQ6, 4BQ7, 4BQ8, 4BQ9, 4BQB, and 4BQC, respectively).	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Conrad S, 2007, J BIOL CHEM, V282, P16423, DOI 10.1074/jbc.M610901200; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Hata K, 2009, J CELL BIOL, V184, P737, DOI 10.1083/jcb.200807029; Landon X., 1977, METHOD ENZYMOL, V47, P145; Lanzara C, 2004, BLOOD, V103, P4317, DOI 10.1182/blood-2004-01-0192; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Lee PL, 2004, BLOOD, V103, P4669, DOI 10.1182/blood-2004-01-0072; Li VSW, 2009, GASTROENTEROLOGY, V137, P176, DOI 10.1053/j.gastro.2009.03.005; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; Liu XX, 2009, BIOCHEM BIOPH RES CO, V382, P795, DOI 10.1016/j.bbrc.2009.03.115; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Muramatsu R, 2011, NAT MED, V17, P488, DOI 10.1038/nm.2321; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Wilson NH, 2007, INT J BIOCHEM CELL B, V39, P874, DOI 10.1016/j.biocel.2006.10.023; Xia Y, 2011, J IMMUNOL, V186, P1369, DOI 10.4049/jimmunol.1002047; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang F, 2008, BIOCHEMISTRY-US, V47, P4237, DOI 10.1021/bi800036h; Yang F, 2011, J STRUCT BIOL, V174, P239, DOI 10.1016/j.jsb.2010.10.005; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016	28	43	49	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2013	341	6141					77	80		10.1126/science.1232322	http://dx.doi.org/10.1126/science.1232322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23744777	Green Accepted			2022-12-01	WOS:000321291700052
J	Flood, TF; Iguchi, S; Gorczyca, M; White, B; Ito, K; Yoshihara, M				Flood, Thomas F.; Iguchi, Shinya; Gorczyca, Michael; White, Benjamin; Ito, Kei; Yoshihara, Motojiro			A single pair of interneurons commands the Drosophila feeding motor program	NATURE			English	Article							NEURONAL-SYNAPTOBREVIN; EXPRESSION; BEHAVIOR; REVEALS; RELEASE; PROTEIN; BRAIN; CELLS; GAL4	Many feeding behaviours are the result of stereotyped, organized sequences of motor patterns. These patterns have been the subject of neuroethological studies(1,2), such as electrophysiological characterization of neurons governing prey capture in toads(1,3). However, technical limitations have prevented detailed study of the functional role of these neurons, a common problem for vertebrate organisms. Complexities involved in studies of whole-animal behaviour can be resolved in Drosophila, in which remote activation of brain cells by genetic means(4) enables us to examine the nervous system in freely moving animals to identify neurons that govern a specific behaviour, and then to repeatedly target and manipulate these neurons to characterize their function. Here we show neurons that generate the feeding motor program in Drosophila. We carried out an unbiased screen using remote neuronal activation and identified a critical pair of brain cells that induces the entire feeding sequence when activated. These 'feeding neurons' (here abbreviated to Fdg neurons for brevity) are also essential for normal feeding as their suppression or ablation eliminates sugar-induced feeding behaviour. Activation of a single Fdg neuron induces asymmetric feeding behaviour and ablation of a single Fdg neuron distorts the sugar-induced feeding behaviour to become asymmetric, indicating the direct role of these neurons in shaping motor-program execution. Furthermore, recording neuronal activity and calcium imaging simultaneously during feeding behaviour(5) reveals that the Fdg neurons respond to food presentation, but only in starved flies. Our results demonstrate that Fdg neurons operate firmly within the sensorimotor watershed, downstream of sensory and metabolic cues and at the top of the feeding motor hierarchy, to execute the decision to feed.	[Flood, Thomas F.; Iguchi, Shinya; Gorczyca, Michael; Yoshihara, Motojiro] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [White, Benjamin] NIMH, Mol Biol Lab, Bethesda, MD 20892 USA; [Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Tokyo	Yoshihara, M (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	Motojiro.Yoshihara@umassmed.edu			National Institute of Mental Health [MH85958]; Worcester Foundation; National Institute of Mental Health Intramural Research Program; Japan Society for the Promotion of Science/National Science Foundation; Japan Science and Technology Agency CREST grant; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002800, R01MH085958] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Worcester Foundation; National Institute of Mental Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Japan Society for the Promotion of Science/National Science Foundation(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency CREST grant(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Waddell for discussions, fly stocks and reading of the manuscript; T. Lee for discussions and fly stocks; A. Sakurai for reading of the manuscript; S. Reppert for support; M. Alkema and T. Ip for discussions; members of the NP consortium for NP lines; T. Awasaki., C. Kao, V. Budnik, P. Garrity, M. Freeman, M. Rosbash, Y.-N. Jan, L. Luo, S. Sigrist, K. Scott, T. Tanimura, L. Looger, M. Ramaswami and K. Gajewski for fly stocks; K. Ikeda, T. Tanimura and H. Ishimoto for technical advices; A. Taylor and R. Seeham for technical help; and N. Yoshihara for material information. This work was supported by National Institute of Mental Health Grant MH85958, and the Worcester Foundation (to M.Y.), the National Institute of Mental Health Intramural Research Program(B. W.), the summer program of the Japan Society for the Promotion of Science/National Science Foundation (to T. F. F.), and a Japan Science and Technology Agency CREST grant (to K.I.).	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Dethier VG, 1976, HUNGRY FLY; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Ewert JP, 1997, TRENDS NEUROSCI, V20, P332; Ferris GF., 1950, BIOL DROSOPHILA, P368; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Gajewski KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010713; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; HAGIWARA S, 1978, J PHYSIOL-LONDON, V279, P167, DOI 10.1113/jphysiol.1978.sp012338; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leiss F, 2009, DEV NEUROBIOL, V69, P221, DOI 10.1002/dneu.20699; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Manzo A, 2012, P NATL ACAD SCI USA, V109, P6307, DOI 10.1073/pnas.1120305109; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; MATSUSHIMA T, 1989, J COMP PHYSIOL A, V166, P7; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miller A., 1950, BIOL DROSOPHILA, P420; Miyazaki T, 2010, J COMP NEUROL, V518, P4147, DOI 10.1002/cne.22433; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Peabody NC, 2009, J NEUROSCI, V29, P3343, DOI 10.1523/JNEUROSCI.4241-08.2009; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shiraiwa Takashi, 2007, J Vis Exp, P193, DOI 10.3791/193; Singh RN, 1997, MICROSC RES TECHNIQ, V39, P547, DOI 10.1002/(SICI)1097-0029(19971215)39:6<547::AID-JEMT7>3.0.CO;2-A; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tinbergen N, 1989, STUDY INSTINCT; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; WIERSMA CAG, 1964, COMP BIOCHEM PHYSIOL, V12, P509, DOI 10.1016/0010-406X(64)90153-7; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yoshihara M, 1997, J NEUROSCI, V17, P8408; Yoshihara M, 1999, J NEUROSCI, V19, P2432; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541; Yoshihara M., 2000, DROS INFORM SERV, V83, P199; Yoshihara M, 2012, JOVE-J VIS EXP, DOI 10.3791/3625; Zar JH., 1999, BIOSTAT ANAL	46	83	83	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					83	+		10.1038/nature12208	http://dx.doi.org/10.1038/nature12208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23748445	Green Accepted			2022-12-01	WOS:000321285600038
J	Park, SH; Kukushkin, Y; Gupta, R; Chen, T; Konagai, A; Hipp, MS; Hayer-Hartl, M; Hartl, FU				Park, Sae-Hun; Kukushkin, Yury; Gupta, Rajat; Chen, Taotao; Konagai, Ayano; Hipp, Mark S.; Hayer-Hartl, Manajit; Hartl, F. Ulrich			PolyQ Proteins Interfere with Nuclear Degradation of Cytosolic Proteins by Sequestering the Sis1p Chaperone	CELL			English	Article							UBIQUITIN-PROTEASOME SYSTEM; SPINOCEREBELLAR ATAXIA TYPE-3; QUALITY-CONTROL; MOLECULAR CHAPERONES; POLYGLUTAMINE EXPANSION; AGGREGATION; YEAST; TOXICITY; DISEASE; STRESS	Dysfunction of protein quality control contributes to the cellular pathology of polyglutamine (polyQ) expansion diseases and other neurodegenerative disorders associated with aggregate deposition. Here we analyzed how polyQ aggregation interferes with the clearance of misfolded proteins by the ubiquitin-proteasome system (UPS). We show in a yeast model that polyQ-expanded proteins inhibit the UPS-mediated degradation of misfolded cytosolic carboxypeptidase Y* fused to green fluorescent protein (GFP) (CG*) without blocking ubiquitylation or proteasome function. Quantitative proteomic analysis reveals that the polyQ aggregates sequester the low-abundant and essential Hsp40 chaperone Sis1p. Overexpression of Sis1p restores CG* degradation. Surprisingly, we find that Sis1p, and its homolog DnaJB1 in mammalian cells, mediates the delivery of misfolded proteins into the nucleus for proteasomal degradation. Sis1p shuttles between cytosol and nucleus, and its cellular level limits the capacity of this quality control pathway. Upon depletion of Sis1p by polyQ aggregation, misfolded proteins are barred from entering the nucleus and form cytoplasmic inclusions.	[Park, Sae-Hun; Kukushkin, Yury; Gupta, Rajat; Chen, Taotao; Konagai, Ayano; Hipp, Mark S.; Hayer-Hartl, Manajit; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82159 Martinsried, Germany	Max Planck Society	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82159 Martinsried, Germany.	uhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Hipp, Mark/AAA-4238-2022; Hayer-Hartl, Manajit/V-8078-2017	Hayer-Hartl, Manajit/0000-0001-8213-6742; gupta, rajat/0000-0002-9743-1995; Hipp, Mark/0000-0002-0497-3016; Park, Sae-Hun/0000-0002-8277-0732	Deutsche Forschungsgemeinschaft [SFB 596]; Human Frontier Science Program [HFSP RGP0048/2011]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program)	We thank J. Buchner, E.A. Craig, D. Cyr, C. Enenkel, S. Jentsch, W.K. Huh, R.R. Kopito, A. Varshavsky, and D. Wolf for reagents. R.M. Vabulas, A. Woerner, and S.A. Broadley constructed the plasmids pUb-GFP, pNES-LG*, pNLS-LG*, and p20Q and p96Q, respectively. Support by the Deutsche Forschungsgemeinschaft (SFB 596) and the Human Frontier Science Program (HFSP RGP0048/2011) is acknowledged.	Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Chai YH, 1999, J NEUROSCI, V19, P10338; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gidalevitz T, 2010, CURR OPIN STRUC BIOL, V20, P23, DOI 10.1016/j.sbi.2009.11.001; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Haacke A, 2006, HUM MOL GENET, V15, P555, DOI 10.1093/hmg/ddi472; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hines JK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001309; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Juretschke J, 2010, BIOCHEM BIOPH RES CO, V397, P447, DOI 10.1016/j.bbrc.2010.05.123; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Malinovska L, 2012, MOL BIOL CELL, V23, P3041, DOI 10.1091/mbc.E12-03-0194; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Rousseau E, 2009, J BIOL CHEM, V284, P1917, DOI 10.1074/jbc.M806256200; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Seidel K, 2012, NEUROPATH APPL NEURO, V38, P548, DOI 10.1111/j.1365-2990.2011.01220.x; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; Summers DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052099; Summers DW, 2009, PRION, V3, P59, DOI 10.4161/pri.3.2.9062; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Yan W, 1999, MOL CELL BIOL, V19, P7751; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zijlstra MP, 2010, EUR J NEUROSCI, V32, P760, DOI 10.1111/j.1460-9568.2010.07352.x	45	246	248	2	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					134	145		10.1016/j.cell.2013.06.003	http://dx.doi.org/10.1016/j.cell.2013.06.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23791384	Bronze			2022-12-01	WOS:000321327900015
J	Pedaste, M; de Jong, T; Sarapuu, T; Piksoot, J; van Joolingen, WR; Giemza, A				Pedaste, Margus; de Jong, Ton; Sarapuu, Tago; Piksoeoet, Jaanika; van Joolingen, Wouter R.; Giemza, Adam			Investigating Ecosystems as a Blended Learning Experience	SCIENCE			English	Editorial Material									[Pedaste, Margus; Sarapuu, Tago; Piksoeoet, Jaanika] Univ Tartu, EE-50103 Tartu, Estonia; [de Jong, Ton; van Joolingen, Wouter R.] Univ Twente, NL-7500 AE Enschede, Netherlands; [Giemza, Adam] Univ Duisburg Essen, D-47048 Duisburg, Germany	University of Tartu; University of Twente; University of Duisburg Essen	Pedaste, M (corresponding author), Univ Tartu, EE-50103 Tartu, Estonia.	margus.pedaste@ut.ee	van Joolingen, Wouter/AAD-8970-2019; Pedaste, Margus/H-3139-2012	van Joolingen, Wouter/0000-0002-4271-2861; Pedaste, Margus/0000-0002-5087-9637; Piksoot, Jaanika/0000-0002-0420-5850				de Jong T, 2012, ETR&D-EDUC TECH RES, V60, P883, DOI 10.1007/s11423-012-9258-1; de Jong T, 2010, BRIT J EDUC TECHNOL, V41, P909, DOI 10.1111/j.1467-8535.2010.01121.x	2	8	8	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1537	1538		10.1126/science.1229908	http://dx.doi.org/10.1126/science.1229908			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172ME	23812708				2022-12-01	WOS:000321007000029
J	van der Meer, JWM; Netea, MG				van der Meer, Jos W. M.; Netea, Mihai G.			A Salty Taste to Autoimmunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[van der Meer, Jos W. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6525 ED Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	van der Meer, JWM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6525 ED Nijmegen, Netherlands.		Netea, Mihai/N-5155-2014; van der Meer, Jos W.M./C-8521-2013	van der Meer, Jos W.M./0000-0001-5120-3690				Charalambous MP, 2008, SURG INFECT, V9, P67, DOI 10.1089/sur.2005.069; delaSierra A, 1996, CLIN SCI, V91, P155, DOI 10.1042/cs0910155; Kleinewietfeld M, 2013, NATURE; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Wu C, 2013, NATURE	5	39	39	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					2520	2521		10.1056/NEJMcibr1303292	http://dx.doi.org/10.1056/NEJMcibr1303292			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KQ	23802520				2022-12-01	WOS:000320926900017
J	Kachalia, A; Mello, MM				Kachalia, Allen; Mello, Michelle M.			Breast Cancer Screening Conflicting Guidelines and Medicolegal Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kachalia, Allen] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	mmello@hsph.harvard.edu						American College of Radiology, 2008, ACR PRACT GUID PERF; American College olf Obstetriciansbulletin, 2011, OBSTET GYNECOL, V118, P372, DOI DOI 10.1097/AOG.0B013E31822C98E5; [Anonymous], 2009, ANN INTERN MED, V151, P716; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Bovbjerg R. R., 2012, VALUE CLIN PRACTICE; Gandhi TK, 2006, ANN INTERN MED, V145, P488, DOI 10.7326/0003-4819-145-7-200610030-00006; Mello MM, 2001, U PENN LAW REV, V149, P645, DOI 10.2307/3312867; Smith RA, 2003, CA-CANCER J CLIN, V53, P141, DOI 10.3322/canjclin.53.3.141	8	14	14	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2555	2556		10.1001/jama.2013.7100	http://dx.doi.org/10.1001/jama.2013.7100			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23722969				2022-12-01	WOS:000320848100022
J	McMurdo, M				McMurdo, Marion			Clinical research must include more older people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEART-FAILURE; TRIALS; GUIDELINES; EXCLUSION; DISEASES		Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland	University of Dundee	McMurdo, M (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland.	m.e.t.mcmurdo@dundee.ac.uk						Age UK, 2013, IMPR LAT LIF UND OLD; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Cherubini A, 2011, ARCH INTERN MED, V171, P550, DOI 10.1001/archinternmed.2011.31; Fitzsimmons PR, 2012, PARKINSONISM RELAT D, V18, P585, DOI 10.1016/j.parkreldis.2012.03.003; Hughes LD, 2013, AGE AGEING, V42, P62, DOI 10.1093/ageing/afs100; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; McMurdo MET, 2011, AGE AGEING, V40, P659, DOI 10.1093/ageing/afr115; National Institute for Health Research Clinical Research Coordinating Centre, 2010, EQ CLIN RES INCL OLD; Taylor JS, 2012, J AM GERIATR SOC, V60, P413, DOI 10.1111/j.1532-5415.2011.03847.x; Wang OJ, 2009, EUR J HEART FAIL, V11, P1021, DOI 10.1093/eurjhf/hfp137; WENGER NK, 1993, INCLUSION ELDERLY IN	12	7	7	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2013	346								f3899	10.1136/bmj.f3899	http://dx.doi.org/10.1136/bmj.f3899			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171RC	23794156				2022-12-01	WOS:000320945700002
J	Drake, T; Rustom, J; Davies, M				Drake, Tamsin; Rustom, Jane; Davies, Melissa			Phimosis in childhood	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Drake, Tamsin; Davies, Melissa] Salisbury Dist Hosp, Salisbury, Wilts, England; [Rustom, Jane; Davies, Melissa] New St Surg, Salisbury, England	Salisbury District Hospital	Drake, T (corresponding author), Salisbury Dist Hosp, Salisbury, Wilts, England.	tamsindrake@hotmail.com							0	3	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 20	2013	346								f3678	10.1136/bmj.f3678	http://dx.doi.org/10.1136/bmj.f3678			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171QP	23788454				2022-12-01	WOS:000320944400004
J	O'Neill, D				O'Neill, Desmond			Should patients with dementia who wander be electronically tagged? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ETHICS; PEOPLE; CARE		Trinity Coll Dublin, Ctr Ageing Neurosci & Humanities, Dublin, Ireland	Trinity College Dublin	O'Neill, D (corresponding author), Trinity Coll Dublin, Ctr Ageing Neurosci & Humanities, Dublin, Ireland.	doneill@tcd.ie	O'Neill, Desmond/D-1486-2013	O'Neill, Desmond/0000-0002-5542-9897				Algase DL, 2007, AGING MENT HEALTH, V11, P686, DOI 10.1080/13607860701366434; Cahill S., 2007, T D, V19, P55, DOI [10.3233/TAD-2007-192-302, DOI 10.3233/TAD-2007-192-302]; Chodosh J, 2007, J AM GERIATR SOC, V55, P1260, DOI 10.1111/j.1532-5415.2007.01249.x; Hughes JC, 2002, J ROY SOC MED, V95, P242, DOI 10.1258/jrsm.95.5.242; Kitwood T., 1997, DEMENTIA RECONSIDERE; Landau R, 2010, INT PSYCHOGERIATR, V22, P1301, DOI 10.1017/S1041610210001316; Niemeijer AR, 2010, INT PSYCHOGERIATR, V22, P1129, DOI 10.1017/S1041610210000037; O'Neill D, 1997, IRISH J PSYCHOL MED, V14, P121, DOI 10.1017/S079096670000330X; O'Neill DJ, 2003, BRIT MED J, V326, P281; ONeil M.E., 2011, SYSTEMATIC EVIDENCE; Petonito G, 2013, GERONTOLOGIST, V53, P17, DOI 10.1093/geront/gns060; Robinson L, 2007, HEALTH RISK SOC, V9, P389, DOI 10.1080/13698570701612774; Silverstein N. M, 2002, DEMENTIA WANDERING B; Padilla DV, 2013, INT PSYCHOGERIATR, V25, P500, DOI 10.1017/S1041610212001810	14	10	10	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 20	2013	346								f3606	10.1136/bmj.f3606	http://dx.doi.org/10.1136/bmj.f3606			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171QP	23794097				2022-12-01	WOS:000320944400003
J	Wilson, AM; Lowe, JC; Roskilly, K; Hudson, PE; Golabek, KA; McNutt, JW				Wilson, A. M.; Lowe, J. C.; Roskilly, K.; Hudson, P. E.; Golabek, K. A.; McNutt, J. W.			Locomotion dynamics of hunting in wild cheetahs	NATURE			English	Article							ACINONYX-JUBATUS; FUNCTIONAL-ANATOMY; RUNNING SPEED; LIMITATIONS; ECOLOGY; GPS	Although the cheetah is recognised as the fastest land animal, little is known about other aspects of its notable athleticism, particularly when hunting in the wild. Here we describe and use a new tracking collar of our own design, containing a combination of Global Positioning System (GPS) and inertial measurement units, to capture the locomotor dynamics and outcome of 367 predominantly hunting runs of five wild cheetahs in Botswana. A remarkable top speed of 25.9 ms(-1) (58 m.p.h. or 93 km h(-1)) was recorded, but most cheetah hunts involved only moderate speeds. We recorded some of the highest measured values for lateral and forward acceleration, deceleration and body-mass-specific power for any terrestrial mammal. To our knowledge, this is the first detailed locomotor information on the hunting dynamics of a large cursorial predator in its natural habitat.	[Wilson, A. M.; Lowe, J. C.; Roskilly, K.; Hudson, P. E.] Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England; [Golabek, K. A.; McNutt, J. W.] Botswana Predator Conservat Trust, Maun, Botswana	University of London; University of London Royal Veterinary College	Wilson, AM (corresponding author), Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England.	awilson@rvc.ac.uk		Wilson, Alan/0000-0001-9914-3455	EPSRC [EP/H013016/1]; BBSRC [BB/J018007/1]; DARPA M3 Program [W91CRB-11-C-0048]; Boston Dynamics; Biotechnology and Biological Sciences Research Council [BB/J018007/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H013016/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DARPA M3 Program; Boston Dynamics; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank S. Amos and M. Dickson for fabricating collars, and F. Broekhuis, R. Furrer and N. Jordan for working with us in the study area; P. Apps for many discussions; T. Hubel and A. Wills for helping to collect and analyse validation data; P. Apps, J. Usherwood and A. Wilson for comments on the manuscript; and the EPSRC (EP/H013016/1), BBSRC (BB/J018007/1) and DARPA M3 Program (W91CRB-11-C-0048, with Boston Dynamics) for funding. This work was approved by RVC Ethics & Welfare Committee and was carried out under a Botswana Government Research Permit held by J. W. M. and Botswana Veterinary Registration held by A.M.W.	Bissett C, 2007, J ZOOL, V271, P310, DOI 10.1111/j.1469-7998.2006.00217.x; Broekhuis F., 2013, J ANIM ECOL; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Caro, 1994, CHEETAHS SERENGETI G; CAVAGNA GA, 1971, J PHYSIOL-LONDON, V217, P709, DOI 10.1113/jphysiol.1971.sp009595; Chang YH, 2007, J EXP BIOL, V210, P971, DOI 10.1242/jeb.02728; Curtin NA, 2005, P ROY SOC B-BIOL SCI, V272, P581, DOI 10.1098/rspb.2004.2982; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Eaton R. L., 1973, CHEETAH BIOL ECOLOGY; GREENE PR, 1985, J BIOMECH ENG-T ASME, V107, P96, DOI 10.1115/1.3138542; Grunewalder S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049120; HOtleferaaei M., 1961, Journal of Mammalogy, V42, P84; HOWLAND HC, 1974, J THEOR BIOL, V47, P333, DOI 10.1016/0022-5193(74)90202-1; Hudson PE, 2012, J EXP BIOL, V215, P2425, DOI 10.1242/jeb.066720; Hudson PE, 2011, J ANAT, V218, P375, DOI 10.1111/j.1469-7580.2011.01344.x; Hudson PE, 2011, J ANAT, V218, P363, DOI 10.1111/j.1469-7580.2010.01310.x; Ka1man R., 1960, J BASIC ENG-T ASME, V82, P34, DOI DOI 10.1115/1.3662552; Mills MGL, 2004, WILDLIFE BIOL, V10, P177, DOI 10.2981/wlb.2004.024; RAUCH HE, 1965, AIAA J, V3, P1445, DOI 10.2514/3.3166; Russell AP, 2001, J ZOOL, V254, P67, DOI 10.1017/S0952836901000565; SCHALLER G B, 1968, East African Wildlife Journal, V6, P95; Self ZT, 2012, J APPL PHYSIOL, V113, P602, DOI 10.1152/japplphysiol.00560.2011; Sharp NCC, 1997, J ZOOL, V241, P493, DOI 10.1111/j.1469-7998.1997.tb04840.x; Spence AJ, 2012, BIOL LETTERS, V8, P678, DOI 10.1098/rsbl.2011.1120; Tan HL, 2008, J BIOMECH, V41, P1398, DOI 10.1016/j.jbiomech.2008.02.021; Tan HL, 2011, P ROY SOC B-BIOL SCI, V278, P2105, DOI 10.1098/rspb.2010.2395; Titterton D. H., 2004, STRAPDOWN INERTIAL N, V207; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090; Usherwood JR, 2006, BIOL LETTERS, V2, P47, DOI 10.1098/rsbl.2005.0399; Usherwood JR, 2005, NATURE, V438, P753, DOI 10.1038/438753a; West T. G., 2013, J EXP BIOL; Williams SB, 2009, BIOL LETTERS, V5, P610, DOI 10.1098/rsbl.2009.0360	32	213	215	11	334	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					185	+		10.1038/nature12295	http://dx.doi.org/10.1038/nature12295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23765495				2022-12-01	WOS:000320283400038
J	Genther, DJ; Frick, KD; Chen, D; Betz, J; Lin, FR				Genther, Dane J.; Frick, Kevin D.; Chen, David; Betz, Joshua; Lin, Frank R.			Association of Hearing Loss With Hospitalization and Burden of Disease in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Genther, Dane J.; Chen, David; Lin, Frank R.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Frick, Kevin D.] Johns Hopkins Univ, Dept Hlth Policy & Management, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Betz, Joshua] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Genther, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	flin1@jhmi.edu		Genther, Dane/0000-0002-7925-012X; Betz, Joshua/0000-0003-4488-9799; Frick, Kevin/0000-0002-0178-5319	NIDCD NIH HHS [1K23DC011279, T32DC000027-24, K23 DC011279, T32 DC000027] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000027, K23DC011279] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Centers for Disease Control and Prevention National Center for Health Statistics, NAT HLTH NUTR EX SUR; Lin FR, 2011, J GERONTOL A-BIOL, V66, P582, DOI 10.1093/gerona/glr002; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Viljanen A, 2009, J AM GERIATR SOC, V57, P2282, DOI 10.1111/j.1532-5415.2009.02553.x; World Health Organization, PREV DEAFN HEAR IMP	6	105	114	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 12	2013	309	22					2322	2324		10.1001/jama.2013.5912	http://dx.doi.org/10.1001/jama.2013.5912			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161EV	23757078	Green Accepted, Bronze			2022-12-01	WOS:000320176000017
J	Sheridan, E; Wright, J; Small, N; Corry, PC; Oddie, S; Whibley, C; Petherick, ES; Malik, T; Pawson, N; McKinney, PA; Parslow, RC				Sheridan, Eamonn; Wright, John; Small, Neil; Corry, Peter C.; Oddie, Sam; Whibley, Catherine; Petherick, Emily S.; Malik, Teena; Pawson, Nicole; McKinney, Patricia A.; Parslow, Roger C.			Risk factors for congenital anomaly in a multiethnic birth cohort: an analysis of the Born in Bradford study	LANCET			English	Article							PARENTAL CONSANGUINITY; RECESSIVE DISEASE; PREGNANCY; DEFECTS; MALFORMATIONS; CONSEQUENCES; POPULATION; JERUSALEM; MORTALITY; CHILDREN	Background Congenital anomalies are a leading cause of infant death and disability and their incidence varies between ethnic groups in the UK. Rates of infant death are highest in children of Pakistani origin, and congenital anomalies are the most common cause of death in children younger than 12 in this ethnic group. We investigated the incidence of congenital anomalies in a large multiethnic birth cohort to identify the causes of the excess of congenital anomalies in this community. Methods We obtained questionnaire data from the mothers of children with one or more anomalies from the Born in Bradford study, a prospective birth cohort study of 13 776 babies and their families in which recruitment was undertaken between 2007 and 2011. Details of anomalies were prospectively reported to the study and we cross checked these details against medical records. We linked data for anomalies to maternal questionnaire and clinical data gathered as part of the Born in Bradford study. We calculated univariate and multivariate risk ratios (RRs) with 95% CIs for various maternal risk factors. Findings Of 11 396 babies for whom questionnaire data were available, 386 (3%) had a congenital anomaly. Rates for congenital anomaly were 305.74 per 10 000 livebirths, compared with a national rate of 165.90 per 10 000. The risk was greater for mothers of Pakistani origin than for those of white British origin (univariate RR 1.96, 95% CI 1.56-2.46). Overall, 2013 (18%) babies were the off spring of first-cousin unions. These babies were mainly of Pakistani origin-1922 (37%) of 5127 babies of Pakistani origin had parents in fi rst-cousin unions. Consanguinity was associated with a doubling of risk for congenital anomaly (multivariate RR 2.19, 95% CI 1.67-2.85); we noted no association with increasing deprivation. 31% of all anomalies in children of Pakistani origin could be attributed to consanguinity. We noted a similar increase in risk for mothers of white British origin older than 34 years (multivariate RR 1.83, 95% CI 1.14-3.00). Maternal education to degree level was protective (0.53, 95% CI 0.38-0.75), irrespective of ethnic origin. Interpretation Consanguinity is a major risk factor for congenital anomaly. The risk remains even after adjustment for deprivation, and accounts for almost a third of anomalies in babies of Pakistani origin. High levels of educational attainment are associated with reduced risk in all ethnic groups. Our findings will be valuable in health promotion and public health, and to those commissioning antenatal, paediatric, and clinical genetic services. Sensitive advice about the risks should be provided to communities at increased risk, and to couples in consanguineous unions, to assist in reproductive decision making.	[Sheridan, Eamonn; Wright, John; Corry, Peter C.; Oddie, Sam; Petherick, Emily S.; Pawson, Nicole] Bradford Royal Infirm, Bradford Inst Hlth Res, Bradford BD9 6RJ, W Yorkshire, England; [Sheridan, Eamonn] St James Univ Hosp, Dept Genet, Leeds LS9 7TF, W Yorkshire, England; [Small, Neil] Univ Bradford, Sch Hlth Studies, Bradford BD7 1DP, W Yorkshire, England; [Whibley, Catherine; McKinney, Patricia A.; Parslow, Roger C.] Univ Leeds, Leeds Inst Genet Therapeut & Hlth, Paediat Epidemiol Grp, Div Epidemiol & Biostat, Leeds, W Yorkshire, England; [Malik, Teena] Chapel Allerton Hosp, Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England	Bradford Royal Infirmary; Saint James's University Hospital; University of Bradford; University of Leeds; Chapel Allerton Hospital	Sheridan, E (corresponding author), St James Univ Hosp, Leeds Inst Biomed & Clin Sci, Genet Sect, Wellcome Trust Brenner Bldg,Beckett St, Leeds LS9 7TF, W Yorkshire, England.	medesh@leeds.ac.uk	Wright, John/H-1624-2012; Parslow, Roger/AAV-1477-2020; Petherick, Emily s/J-9755-2012	Wright, John/0000-0001-9572-7293; Petherick, Emily s/0000-0001-6778-8128; Parslow, Roger/0000-0002-3945-5294	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care programme	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care programme	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care programme.	AHMAD WIU, 1994, J PUBLIC HEALTH MED, V16, P423, DOI 10.1093/oxfordjournals.pubmed.a043023; Bennett Robin L, 2002, J Genet Couns, V11, P97, DOI 10.1023/A:1014593404915; Bittles A. H., 2008, PEDIAT CHILD HLTH, V18, P244, DOI [10.1016/j.paed.2008.02.008, DOI 10.1016/j.paed.2008.02.008]; British Isles Network of Congenital Anomaly Registers, CONG AN STAT 2009 EN; Bromiker R, 2004, CLIN GENET, V66, P63, DOI 10.1111/j.0009-9163.2004.00264.x; Bundey Sarah, 1993, European Journal of Human Genetics, V1, P206; Corrigan N, 2009, BIRTH DEFECTS RES A, V85, P523, DOI 10.1002/bdra.20567; Corry P C, 2002, Community Genet, V5, P201, DOI 10.1159/000066337; Department for Communities and Local Government, 2011, ENGL IND DEPR 2010; Department of Health, 2007, STAT PUBL HLTH ANN R; Devereux G, 2004, ARCH DIS CHILD, V89, P8; EUROCAT, 2005, EUROCAT GUID 1 3 REF; Evans J., 2010, GESTATION SPECIFIC I; Garner S., 2011, POVERTY ETHNICITY PL; Gibb F, RISE MARRIAGES COUSI; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; Hamamy H, 2011, GENET MED, V13, P841, DOI 10.1097/GIM.0b013e318217477f; Harlap S, 2008, HUM HERED, V66, P180, DOI 10.1159/000133837; Hollowell J, 2011, SEMIN PERINATOL, V35, P240, DOI 10.1053/j.semperi.2011.02.021; Kelly T, 2011, BRADFORD IS VERY INB; Kurinczuk JJ, 2010, 4 NAT PER EP UN; Macintosh MCM, 2006, BRIT MED J, V333, P177, DOI 10.1136/bmj.38856.692986.AE; Martinez-Frias ML, 2004, BIRTH DEFECTS RES A, V70, P194, DOI 10.1002/bdra.20017; NHS Bradford, 2006, BRADF DISTR INF MORT; Overall ADJ, 2009, HUM HERED, V67, P140, DOI 10.1159/000179561; Qureshi N, 2011, J ROY COLL PHYS EDIN, V41, P194, DOI 10.4997/JRCPE.2011.301; Schwarz K, 2002, EYE, V16, P530, DOI 10.1038/sj.eye.6700059; Stoltenberg C, 1997, AM J EPIDEMIOL, V145, P439; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875; World Health Organization, 2006, GLOB DAT BOD MASS IN; World Health Organization, 2006, DEFINITION DIAGNOSIS; Wright J, 2013, INT J EPIDEMIOL, V42, P978, DOI 10.1093/ije/dys112; Zlotogora J, 2010, AM J MED GENET A, V152A, P2023, DOI 10.1002/ajmg.a.33537; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	35	136	139	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2013	382	9901					1350	1359		10.1016/S0140-6736(13)61132-0	http://dx.doi.org/10.1016/S0140-6736(13)61132-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238UG	23830354				2022-12-01	WOS:000325975700025
J	Pollitzer, E				Pollitzer, Elizabeth			Cell sex matters	NATURE			English	Editorial Material							FEMALE CELLS		Portia, London, England		Pollitzer, E (corresponding author), Portia, London, England.	elizabeth@portiaweb.org.uk						Deasy BM, 2007, J CELL BIOL, V177, P73, DOI 10.1083/jcb.200612094; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; Jagsi R, 2009, CANCER-AM CANCER SOC, V115, P3293, DOI 10.1002/cncr.24366; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388; Wizemann TM, 2001, EXPLORING BIOL CONTR	7	39	40	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2013	500	7460					23	24		10.1038/500023a	http://dx.doi.org/10.1038/500023a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23903733	Bronze			2022-12-01	WOS:000322514800009
J	Shah, ASV; Newby, DE; Mills, NL				Shah, Anoop S. V.; Newby, David E.; Mills, Nicholas L.			RATIONAL TESTING High sensitivity cardiac troponin in patients with chest pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MYOCARDIAL-INFARCTION; EARLY-DIAGNOSIS; I ASSAY; T ASSAY		[Shah, Anoop S. V.; Newby, David E.; Mills, Nicholas L.] Univ Edinburgh, British Heart Fdn, Univ Ctr Cardiovasc Sci, Edinburgh EH16 4SU, Midlothian, Scotland	University of Edinburgh	Mills, NL (corresponding author), Univ Edinburgh, British Heart Fdn, Univ Ctr Cardiovasc Sci, Edinburgh EH16 4SU, Midlothian, Scotland.	nick.mills@ed.ac.uk	Newby, David Ernest/AAB-1364-2019	Shah, Anoop/0000-0002-2825-3419; Mills, Nicholas/0000-0003-0533-7991	British Heart Foundation [FS/10/024/28266, SP/12/10/29922] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Apple FS, 2012, CLIN CHEM, V58, P1574, DOI 10.1373/clinchem.2012.192716; Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; Cooper A, 2010, BRIT MED J, V340, pc1118; Fesmire FM, 1998, ANN EMERG MED, V31, P3, DOI 10.1016/S0196-0644(98)70274-4; Keller T, 2011, JAMA-J AM MED ASSOC, V306, P2684, DOI 10.1001/jama.2011.1896; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Mills NL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1533; Mills NL, 2011, JAMA-J AM MED ASSOC, V305, P1210, DOI 10.1001/jama.2011.338; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Thygesen K, 2012, EUR HEART J, V33, P2252, DOI 10.1093/eurheartj/ehs154; Twerenbold R, 2012, EUR HEART J, V33, P579, DOI 10.1093/eurheartj/ehr492	14	23	23	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2013	347								f4222	10.1136/bmj.f4222	http://dx.doi.org/10.1136/bmj.f4222			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192XV	23878152				2022-12-01	WOS:000322522200002
J	Song, SJ; Poliseno, L; Song, MS; Ala, U; Webster, K; Ng, C; Beringer, G; Brikbak, NJ; Yuan, X; Cantley, LC; Richardson, AL; Pandolfi, PP				Song, Su Jung; Poliseno, Laura; Song, Min Sup; Ala, Ugo; Webster, Kaitlyn; Ng, Christopher; Beringer, Gary; Brikbak, Nicolai J.; Yuan, Xin; Cantley, Lewis C.; Richardson, Andrea L.; Pandolfi, Pier Paolo			MicroRNA-Antagonism Regulates Breast Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling	CELL			English	Article							ESTROGEN-RECEPTOR-ALPHA; MESENCHYMAL TRANSITION; 5-HYDROXYMETHYLCYTOSINE CONTENT; EPITHELIAL PHENOTYPE; DOWN-REGULATION; MIR-200 FAMILY; MESSENGER-RNA; HUMAN GENES; TGF-BETA; CELLS	Tumor cells metastasize to distant organs through genetic and epigenetic alterations, including changes in microRNA (miR) expression. Here we find miR-22 triggers epithelial-mesenchymal transition (EMT), enhances invasiveness and promotes metastasis in mouse xenografts. In a conditional mammary gland-specific transgenic (TG) mouse model, we show that miR-22 enhances mammary gland side-branching, expands the stem cell compartment, and promotes tumor development. Critically, miR-22 promotes aggressive metastatic disease in MMTV-miR-22 TG mice, as well as compound MMTV-neu or -PyVT-miR-22 TG mice. We demonstrate that miR-22 exerts its metastatic potential by silencing antimetastatic miR-200 through direct targeting of the TET (Ten eleven translocation) family of methylcytosine dioxygenases, thereby inhibiting demethylation of the mir-200 promoter. Finally, we show that miR-22 overexpression correlates with poor clinical outcomes and silencing of the TET-miR-200 axis in patients. Taken together, our findings implicate miR-22 as a crucial epigenetic modifier and promoter of EMT and breast cancer stemness toward metastasis.	[Song, Su Jung; Poliseno, Laura; Song, Min Sup; Ala, Ugo; Webster, Kaitlyn; Ng, Christopher; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Genet Program,Div Genet,Dept Med & Pathol, Boston, MA 02115 USA; [Ng, Christopher; Cantley, Lewis C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct,Dept Med, Boston, MA 02115 USA; [Yuan, Xin] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Hematol Oncol Div,Dept Med, Boston, MA 02115 USA; [Beringer, Gary; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Brikbak, Nicolai J.; Richardson, Andrea L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Genet Program,Div Genet,Dept Med & Pathol, Boston, MA 02115 USA.	ppandolf@bidmc.harvard.edu	Ala, Ugo/K-2029-2016; Cantley, Lewis C/D-1800-2014; Poliseno, Laura/B-5711-2012	Ala, Ugo/0000-0001-5408-6397; Cantley, Lewis C/0000-0002-1298-7653; Poliseno, Laura/0000-0001-6557-955X; Ng, Christopher/0000-0001-8815-7958; Birkbak, Nicolai/0000-0003-1613-9587; Webster, Kaitlyn/0000-0001-9902-0500; Pandolfi, Pier Paolo/0000-0002-5352-5295	NIH [CA 082328-14]; NATIONAL CANCER INSTITUTE [R01CA082328] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to all members of the Pandolfi lab and in particular to Keisuke Ito and Leonardo Salmena for advice and discussion. We thank Thomas Garvey for critical editing of the manuscript as well as Yvonne Tay, Luo Man-Lee, April Greene-Colozzi, and Soon Jung Kim for experimental and technical support. This work was supported by NIH grant CA 082328-14 awarded to P.P.P.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Haffner MC, 2011, ONCOTARGET, V2, P627; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Ito K, 2009, CURR OPIN GENET DEV, V19, P51, DOI 10.1016/j.gde.2009.01.004; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jackson-Fisher AJ, 2004, P NATL ACAD SCI USA, V101, P17138, DOI 10.1073/pnas.0407057101; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li A, 2010, CANCER RES, V70, P5226, DOI 10.1158/0008-5472.CAN-09-4227; Ling B, 2012, J CANCER RES CLIN, V138, P1355, DOI 10.1007/s00432-012-1194-2; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MCCARTHY JB, 1985, CANCER METAST REV, V4, P125, DOI 10.1007/BF00050692; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Neves Rui, 2010, BMC Res Notes, V3, P219, DOI 10.1186/1756-0500-3-219; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Pandey DP, 2009, MOL CELL BIOL, V29, P3783, DOI 10.1128/MCB.01875-08; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shorning BY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016209; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Song SJ, 2013, CELL STEM CELL, V13, P87, DOI 10.1016/j.stem.2013.06.003; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Vuoristo M, 2007, MELANOMA RES, V17, P215, DOI 10.1097/CMR.0b013e328270b935; Wang T, 2012, INT J BIOCHEM CELL B, V44, P366, DOI 10.1016/j.biocel.2011.11.012; Withana NP, 2012, CANCER RES, V72, P1199, DOI 10.1158/0008-5472.CAN-11-2759; Xiong JH, 2010, FEBS J, V277, P1684, DOI 10.1111/j.1742-4658.2010.07594.x; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Yoshimoto N, 2011, BREAST CANCER RES TR, V130, P331, DOI 10.1007/s10549-011-1672-2	60	344	357	1	92	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					311	324		10.1016/j.cell.2013.06.026	http://dx.doi.org/10.1016/j.cell.2013.06.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23830207	Bronze, Green Accepted			2022-12-01	WOS:000321950700009
J	Lapi, F; Azoulay, L; Niazi, T; Yin, H; Benayoun, S; Suissa, S				Lapi, Francesco; Azoulay, Laurent; Niazi, Tamim; Yin, Hui; Benayoun, Serge; Suissa, Samy			Androgen Deprivation Therapy and Risk of Acute Kidney Injury in Patients With Prostate Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRACTICE RESEARCH DATABASE; ACUTE-RENAL-FAILURE; SERUM TESTOSTERONE; HORMONE AGONIST; MORTALITY; VALIDITY; TIME; CESSATION; DISEASE; OBESITY	IMPORTANCE The use of androgen deprivation therapy (ADT) in the treatment of advanced prostate cancer has been shown to delay the clinical progression of the disease. However, the testosterone suppression associated with this therapy may lead to a hypogonadal condition that can have detrimental effects on renal function, thus raising the hypothesis that ADT-induced hypogonadism could potentially lead to acute kidney injury (AKI). OBJECTIVE To determine whether the use of ADT is associated with an increased risk of AKI in patients newly diagnosed with prostate cancer. DESIGN AND SETTING A nested case-control analysis using medical information extracted from the UK Clinical Practice Research Datalink linked to the Hospital Episodes Statistics database. PARTICIPANTS Men newly diagnosed with nonmetastatic prostate cancer between January 1, 1997, and December 31, 2008, were selected and followed up until December 31, 2009. Cases were patients with incident AKI during follow-up who were randomly matched with up to 20 controls on age, calendar year of prostate cancer diagnosis, and duration of follow-up. MAIN OUTCOMES AND MEASURES Conditional logistic regression was used to estimate odds ratios (ORs) with 95% CIs of AKI associated with the use of ADT. ADT was categorized into 1 of 6 mutually exclusive groups: gonadotropin-releasing hormone agonists, oral antiandrogens, combined androgen blockade, bilateral orchiectomy, estrogens, and combination of the above. RESULTS A total of 10 250 patients met the study inclusion criteria. During a mean follow-up of 4.1 (SD, 2.9) years, 232 incident cases of AKI were identified (rate, 5.5/1000 person-years). Overall, current use of any ADT was associated with an increased risk of AKI when compared with never use (OR, 2.48 [95% CI, 1.61-3.82]), generating a rate difference of 4.43/1000 persons per year (95% CI, 1.54-7.33). This association was mainly driven by a combined androgen blockade consisting of gonadotropin-releasing hormone agonists with oral antiandrogens (OR, 4.50 [95% CI, 2.61-7.78]), estrogens (OR, 4.00 [95% CI, 1.06-15.03]), other combination therapies (OR, 4.04 [95% CI, 1.88-8.69]), and gonadotropin-releasing hormone agonists (OR, 1.93 [95% CI, 1.20-3.10]). CONCLUSIONS AND RELEVANCE In a cohort of patients with newly diagnosed nonmetastatic prostate cancer, the use of ADT was significantly associated with an increased risk of AKI. These findings require replication in other well-designed studies as well as further investigation of their clinical importance.	[Lapi, Francesco; Azoulay, Laurent; Yin, Hui; Suissa, Samy] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Lapi, Francesco; Suissa, Samy] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Lapi, Francesco] Univ Florence, Dept Preclin & Clin Pharmacol, Florence, Italy; [Azoulay, Laurent] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Niazi, Tamim] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Dept Oncol,Div Radiat Oncol, Montreal, PQ H3T 1E2, Canada; [Benayoun, Serge] Hop Maison Neuve Rosemont, Dept Surg, Serv Urol, Montreal, PQ H1T 2M4, Canada	Lady Davis Institute; McGill University; McGill University; University of Florence; McGill University; McGill University; Universite de Montreal	Suissa, S (corresponding author), McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst, 3755 Cote St Catherine, Montreal, PQ H3T 1E2, Canada.	samy.suissa@mcgill.ca	Azoulay, Laurent/Z-4421-2019	Azoulay, Laurent/0000-0001-5162-3556	Canadian Institutes of Health Research; Fonds de recherche en sante du Quebec; Prostate Cancer Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Prostate Cancer Canada	Dr Lapi was the recipient of a Canadian Institutes of Health Research Postdoctoral Research Award. Dr Azoulay is the recipient of a Chercheur-Boursier Award from the Fonds de recherche en sante du Quebec. Dr Suissa is the recipient of the James McGill Chair. The data in this study were acquired with a grant from Prostate Cancer Canada.	Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Altiparmak MR, 2002, MED ONCOL, V19, P117, DOI 10.1385/MO:19:2:117; Azoulay L, 2011, EUR UROL, V60, P1244, DOI 10.1016/j.eururo.2011.08.041; Basaria S, 2008, J ANDROL, V29, P534, DOI 10.2164/jandrol.108.005454; Billings FT, 2012, J AM SOC NEPHROL, V23, P1221, DOI 10.1681/ASN.2011090940; Billings FT, 2011, FREE RADICAL BIO MED, V50, P1480, DOI 10.1016/j.freeradbiomed.2011.02.011; Bong GW, 2008, UROLOGY, V71, P1177, DOI 10.1016/j.urology.2007.09.066; Braga-Basaria M, 2006, INT J IMPOT RES, V18, P494, DOI 10.1038/sj.ijir.3901471; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; Cooperberg MR, 2009, JNCI-J NATL CANCER I, V101, P878, DOI 10.1093/jnci/djp122; Cooperberg MR, 2003, J NATL CANCER I, V95, P981, DOI 10.1093/jnci/95.13.981; Essebag V, 2003, AM HEART J, V146, P581, DOI 10.1016/S0002-8703(03)00512-X; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hsiao PG, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.05.003; Hutchens MP, 2012, AM J PHYSIOL-RENAL, V303, pF377, DOI 10.1152/ajprenal.00354.2011; Kaku H, 2006, PROSTATE, V66, P439, DOI 10.1002/pros.20341; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Khatri M, J STROKE CEREBROVASC; Loboz KK, 2005, BRIT J CLIN PHARMACO, V59, P239, DOI 10.1111/j.0306-5251.2004.2188.x; Manabe Y, 2009, NEUROL INT, V1, P1, DOI 10.4081/ni.2009.e1; Molinari C, 2002, J PHYSIOL-LONDON, V543, P365, DOI 10.1113/jphysiol.2002.022756; PAUL AB, 1994, BRIT J UROL, V74, P642, DOI 10.1111/j.1464-410X.1994.tb09198.x; Perlmutter Mark A, 2007, Rev Urol, V9 Suppl 1, pS3; Quality and Outcomes Framework, 2009, QUAL OUTC FRAM; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Shahinian VB, 2005, CANCER-AM CANCER SOC, V103, P1615, DOI 10.1002/cncr.20955; Suissa S, 2007, NAT CLIN PRACT RHEUM, V3, P725, DOI 10.1038/ncprheum0652; Suissa S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P811; Vlasschaert MEO, 2011, AM J KIDNEY DIS, V57, P29, DOI 10.1053/j.ajkd.2010.08.031; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; Ympa YP, 2005, AM J MED, V118, P827, DOI 10.1016/j.amjmed.2005.01.069	35	74	75	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	2013	310	3					289	296		10.1001/jama.2013.8638	http://dx.doi.org/10.1001/jama.2013.8638			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183RU	23860987	Bronze			2022-12-01	WOS:000321835700016
J	Gross, ML				Gross, Michael L.			Force-Feeding, Autonomy, and the Public Interest	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Haifa, Sch Polit Sci, IL-31999 Haifa, Israel	University of Haifa	Gross, ML (corresponding author), Univ Haifa, Sch Polit Sci, IL-31999 Haifa, Israel.							[Anonymous], 2005, FORC FEED HUNG STRIK; Glick SM, 1997, NEW ENGL J MED, V336, P954; Howe EG, 2009, INTERROGATIONS FORCE, P75; Visser SL., 2003, TXB MILITARY MED MIL, P251; World Medical Association, 2006, WMA DECL MALT HUNG S	5	14	14	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					103	105		10.1056/NEJMp1306325	http://dx.doi.org/10.1056/NEJMp1306325			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180BH	23758204				2022-12-01	WOS:000321567300004
J	Zhang, LB; Prak, L; Rayon-Estrada, V; Thiru, P; Flygare, J; Lim, B; Lodish, HF				Zhang, Lingbo; Prak, Lina; Rayon-Estrada, Violeta; Thiru, Prathapan; Flygare, Johan; Lim, Bing; Lodish, Harvey F.			ZFP36L2 is required for self-renewal of early burst-forming unit erythroid progenitors	NATURE			English	Article							GLUCOCORTICOID-RECEPTOR; TRANSCRIPTION FACTOR; DIFFERENTIATION; ERYTHROPOIETIN; PROTEINS; CELLS; GENE; RED	Stem cells and progenitors in many lineages undergo self-renewing divisions, but the extracellular and intracellular proteins that regulate this process are largely unknown. Glucocorticoids stimulate red blood cell formation by promoting self-renewal of early burst-forming unit-erythroid (BFU-E) progenitors(1-4). Here we show that the RNA-binding protein ZFP36L2 is a transcriptional target of the glucocorticoid receptor (GR) in BFU-Es and is required for BFU-E self-renewal. ZFP36L2 is normally downregulated during erythroid differentiation from the BFU-E stage, but its expression is maintained by all tested GR agonists that stimulate BFU-E self-renewal, and the GR binds to several potential enhancer regions of ZFP36L2. Knockdown of ZFP36L2 in cultured BFU-E cells did not affect the rate of cell division but disrupted glucocorticoid-induced BFU-E self-renewal, and knockdown of ZFP36L2 in transplanted erythroid progenitors prevented expansion of erythroid lineage progenitors normally seen following induction of anaemia by phenylhydrazine treatment. ZFP36L2 preferentially binds to messenger RNAs that are induced or maintained at high expression levels during terminal erythroid differentiation and negatively regulates their expression levels. ZFP36L2 therefore functions as part of a molecular switch promoting BFU-E self-renewal and a subsequent increase in the total numbers of colony-forming unit-erythroid (CFU-E) progenitors and erythroid cells that are generated.	[Zhang, Lingbo; Prak, Lina; Rayon-Estrada, Violeta; Thiru, Prathapan; Flygare, Johan; Lodish, Harvey F.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Zhang, Lingbo; Prak, Lina; Rayon-Estrada, Violeta; Thiru, Prathapan; Flygare, Johan; Lodish, Harvey F.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Zhang, Lingbo; Lim, Bing; Lodish, Harvey F.] Singapore Massachusetts Inst Technol Alliance, Singapore 117576, Singapore; [Zhang, Lingbo; Lim, Bing] ASTAR, Genome Inst Singapore, Singapore 138627, Singapore; [Lim, Bing] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lodish, HF (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	lodish@wi.mit.edu	Flygare, Johan/C-6584-2014	Flygare, Johan/0000-0002-1962-5276	NIH [P01 HL 32262]; Singapore-Massachusetts Institute of Technology Alliance; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore-Massachusetts Institute of Technology Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by NIH grant P01 HL 32262 to H. F. L.; L.Z. is supported by a graduate fellowship from Singapore-Massachusetts Institute of Technology Alliance. We thank C. Sieff, J. Zhang, and P. Ji for providing reagents, T. Chavarria and F. Reinhardt for assisting with mouse transplantation experiments, J. Shih for helping with the making of constructs, M. Bousquet and C. Patterson for discussion and assistance with mouse transplantation experiment and antibody testing, S. Gupta, J. Kwon and I. Barrasa for processing raw RNA-seq data, processing microarray and discussion of bioinformatics analyses, and Sanofi Aventis for providing many GR agonists.	Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; Flygare J, 2011, BLOOD, V117, P3435, DOI 10.1182/blood-2010-07-295550; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Kumkhaek C, 2013, BLOOD, V121, P3216, DOI 10.1182/blood-2011-10-385252; Narla A, 2011, BLOOD, V118, P2296, DOI 10.1182/blood-2010-11-318543; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Shi ZT, 1999, J CLIN INVEST, V103, P331, DOI 10.1172/JCI3858; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Teittinen KJ, 2012, J CELL BIOCHEM, V113, P3843, DOI 10.1002/jcb.24298; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wessely O, 1997, EMBO J, V16, P267, DOI 10.1093/emboj/16.2.267; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Zhang LB, 2011, GENE DEV, V25, P119, DOI 10.1101/gad.1998711; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	22	75	76	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					92	+		10.1038/nature12215	http://dx.doi.org/10.1038/nature12215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23748442	Green Accepted, Green Submitted			2022-12-01	WOS:000321285600040
J	Elert, E				Elert, Emily			LIVING WITH LEUKAEMIA	NATURE			English	Editorial Material																			0	13	15	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					S2	S3		10.1038/498S2a	http://dx.doi.org/10.1038/498S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171LH	23803947	Bronze			2022-12-01	WOS:000320929400002
J	Roychoudhuri, R; Hirahara, K; Mousavi, K; Clever, D; Klebanoff, CA; Bonelli, M; Sciume, G; Zare, H; Vahedi, G; Dema, B; Yu, ZY; Liu, H; Takahashi, H; Rao, M; Muranski, P; Crompton, JG; Punkosdy, G; Bedognetti, D; Wang, E; Hoffmann, V; Rivera, J; Marincola, FM; Nakamura, A; Sartorelli, V; Kanno, Y; Gattinoni, L; Muto, A; Igarashi, K; O'Shea, JJ; Restifo, NP				Roychoudhuri, Rahul; Hirahara, Kiyoshi; Mousavi, Kambiz; Clever, David; Klebanoff, Christopher A.; Bonelli, Michael; Sciume, Giuseppe; Zare, Hossein; Vahedi, Golnaz; Dema, Barbara; Yu, Zhiya; Liu, Hui; Takahashi, Hayato; Rao, Mahadev; Muranski, Pawel; Crompton, Joseph G.; Punkosdy, George; Bedognetti, Davide; Wang, Ena; Hoffmann, Victoria; Rivera, Juan; Marincola, Francesco M.; Nakamura, Atsushi; Sartorelli, Vittorio; Kanno, Yuka; Gattinoni, Luca; Muto, Akihiko; Igarashi, Kazuhiko; O'Shea, John J.; Restifo, Nicholas P.			BACH2 represses effector programs to stabilize T-reg-mediated immune homeostasis	NATURE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; CELL-DIFFERENTIATION; SUSCEPTIBILITY LOCI; RISK LOCI; B-CELLS; TRANSCRIPTION; DISEASE; INTERLEUKIN-4; METAANALYSIS	Through their functional diversification, distinct lineages of CD4(+) T cells can act to either drive or constrain immune-mediated pathology. Transcription factors are critical in the generation of cellular diversity, and negative regulators antagonistic to alternate fates often act in conjunction with positive regulators to stabilize lineage commitment(1). Genetic polymorphisms within a single locus encoding the transcription factor BACH2 are associated with numerous autoimmune and allergic diseases including asthma(2), Crohn's disease(3,4), coeliac disease(5), vitiligo(6), multiple sclerosis(7) and type 1 diabetes(8). Although these associations point to a shared mechanism underlying susceptibility to diverse immune-mediated diseases, a function for BACH2 in the maintenance of immune homeostasis has not been established. Here, by studying mice in which the Bach2 gene is disrupted, we define BACH2 as a broad regulator of immune activation that stabilizes immunoregulatory capacity while repressing the differentiation programs of multiple effector lineages in CD4(+) T cells. BACH2 was required for efficient formation of regulatory (T-reg) cells and consequently for suppression of lethal inflammation in a manner that was T-reg-cell-dependent. Assessment of the genome-wide function of BACH2, however, revealed that it represses genes associated with effector cell differentiation. Consequently, its absence during T-reg polarization resulted in inappropriate diversion to effector lineages. In addition, BACH2 constrained full effector differentiation within T(H)1, T(H)2 and T(H)17 cell lineages. These findings identify BACH2 as a key regulator of CD4(+) T-cell differentiation that prevents inflammatory disease by controlling the balance between tolerance and immunity.	[Roychoudhuri, Rahul; Clever, David; Klebanoff, Christopher A.; Yu, Zhiya; Rao, Mahadev; Muranski, Pawel; Crompton, Joseph G.; Gattinoni, Luca; Restifo, Nicholas P.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hirahara, Kiyoshi; Bonelli, Michael; Sciume, Giuseppe; Vahedi, Golnaz; Takahashi, Hayato; Kanno, Yuka; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA; [Mousavi, Kambiz; Zare, Hossein; Sartorelli, Vittorio] NIAMS, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA; [Dema, Barbara; Rivera, Juan] NIAMS, Lab Mol Immunogenet, NIH, Bethesda, MD 20892 USA; [Liu, Hui; Bedognetti, Davide; Wang, Ena; Marincola, Francesco M.] NIH, Dept Transfus Med, Bethesda, MD 20892 USA; [Punkosdy, George] NIAID, NIH, Bethesda, MD 20892 USA; [Hoffmann, Victoria] NIH, Div Vet Resources, Bethesda, MD 20892 USA; [Marincola, Francesco M.] Sidra Med & Res Ctr, Doha, Qatar; [Nakamura, Atsushi; Muto, Akihiko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; [Muto, Akihiko; Igarashi, Kazuhiko] Japan Sci & Technol Agcy, CREST, Sendai, Miyagi 9808575, Japan; [Restifo, Nicholas P.] NIH, Ctr Regenerat Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; Sidra Medical & Research Center; Tohoku University; Japan Science & Technology Agency (JST); National Institutes of Health (NIH) - USA	Roychoudhuri, R (corresponding author), NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	roychoudhuri@mail.nih.gov; osheajo@mail.nih.gov; restifo@nih.gov	zare, hossein/ABB-5871-2021; Kanno, Yuka/B-5802-2013; Restifo, Nicholas Phillip/Z-1614-2019; Takahashi, Hayato/AAV-7707-2021; Hirahara, Kiyoshi/E-2460-2017; Restifo, Nicholas Phillip/M-6549-2019; Roychoudhuri, Rahul/A-7442-2010; Sciume, Giuseppe/K-8985-2016; Dema, Barbara/AAM-2354-2020; Bedognetti, Davide/GLQ-9410-2022; Gattinoni, Luca/A-2281-2008; Bedognetti, Davide/ADI-1011-2022	Kanno, Yuka/0000-0001-5668-9319; Takahashi, Hayato/0000-0001-6768-8821; Hirahara, Kiyoshi/0000-0002-9128-9449; Roychoudhuri, Rahul/0000-0002-5392-1853; Sciume, Giuseppe/0000-0003-0131-512X; Gattinoni, Luca/0000-0003-2239-3282; Crompton, Joseph/0000-0001-9325-2909; Restifo, Nicholas P./0000-0003-4229-4580; Igarashi, Kazuhiko/0000-0002-2470-2475; Bonelli, Michael/0000-0002-6122-7482; Bedognetti, Davide/0000-0002-5857-773X; Klebanoff, Christopher/0000-0001-9645-3896; Sartorelli, Vittorio/0000-0002-9284-3675; Clever, David/0000-0002-9137-8177	Intramural Research Programs of the National Cancer Institute (NIH); National Institute of Arthritis and Musculoskeletal and Skin Diseases; NIH Center for Regenerative Medicine; JSPS Research Fellowship for Japanese Biomedical and Behavioural Researchers at NIH; NATIONAL CANCER INSTITUTE [Z01BC011037] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041165, ZIAAR041164, ZIAAR041159] Funding Source: NIH RePORTER	Intramural Research Programs of the National Cancer Institute (NIH); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH Center for Regenerative Medicine; JSPS Research Fellowship for Japanese Biomedical and Behavioural Researchers at NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the Intramural Research Programs of the National Cancer Institute (NIH) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the NIH Center for Regenerative Medicine and the JSPS Research Fellowship for Japanese Biomedical and Behavioural Researchers at NIH. We thank D. N. Roychoudhuri, D. C. Macallan, G. E. Griffin, S. A. Rosenberg, M. S. Rao, Y. Ji, D. Palmer, M. Sukumar, G. Fabozzi, K. Hanada, E. Lugli, J. H. Pan and N. Van Panhuys for discussions, A. Mixon and S. Farid for cell sorting, G. McMullen for mouse handling and Y. Luo, Y. Wakabayashi, J. Zhu, G. Gutierrez-Cruz and H. W. Sun for help with sequencing and analysis.	Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cheng GY, 2012, J IMMUNOL, V189, P1780, DOI 10.4049/jimmunol.1103768; Christodoulou K., 2012, GUT; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Kashiwada M, 2011, EMBO J, V30, P2071, DOI 10.1038/emboj.2011.111; Lloyd CM, 2000, J EXP MED, V191, P265, DOI 10.1084/jem.191.2.265; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rothenberg EV, 2008, SEMIN IMMUNOL, V20, P236, DOI 10.1016/j.smim.2008.07.006; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Watford WT, 2008, J EXP MED, V205, P2803, DOI 10.1084/jem.20081461; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	35	264	275	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					506	+		10.1038/nature12199	http://dx.doi.org/10.1038/nature12199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23728300	Green Accepted			2022-12-01	WOS:000320929400057
J	Halfdanarson, TR; Pannala, R				Halfdanarson, Thorvardur R.; Pannala, Rahul			Incretins and risk of neoplasia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PANCREATITIS; CANCER; THERAPIES; TUMORS		[Halfdanarson, Thorvardur R.] Mayo Clin, Div Hematol & Oncol, Scottsdale, AZ 85259 USA; [Pannala, Rahul] Mayo Clin, Div Gastroenterol, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix	Halfdanarson, TR (corresponding author), Mayo Clin, Div Hematol & Oncol, Scottsdale, AZ 85259 USA.	thorvardur.halfdanarson@mayo.edu	Halfdanarson, Thorvardur/AAO-8706-2020	Halfdanarson, Thorvardur/0000-0001-8460-1257				[Anonymous], 2013, QUARTER WATCH; Busch SJ, 2013, DIABETES OBES METAB, V15, P72, DOI 10.1111/j.1463-1326.2012.01678.x; Butler AE, 2013, DIABETES IN PRESS; Cohen D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3680; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Engel SS, 2013, DIABETES THER; Gier B, 2012, DIABETES, V61, P1250, DOI 10.2337/db11-1109; Halfdanarson TR, 2008, ANN ONCOL, V19, P1727, DOI 10.1093/annonc/mdn351; Halfdanarson TR, 2012, J CLIN ONCOL, V30; KIMURA W, 1991, DIGEST DIS SCI, V36, P933, DOI 10.1007/BF01297144; Lando HM, 2012, ENDOCR PRACT, V18, P472, DOI 10.4158/EP11290.OR; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Spranger J, 2011, GASTROENTEROLOGY, V141, P20, DOI 10.1053/j.gastro.2011.05.019; Yu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021255	14	7	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2013	346								f3750	10.1136/bmj.f3750	http://dx.doi.org/10.1136/bmj.f3750			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166VK	23751908				2022-12-01	WOS:000320586700012
J	Callen, E; Di Virgilio, M; Kruhlak, MJ; Nieto-Soler, M; Wong, N; Chen, HT; Faryabi, RB; Polato, F; Santos, M; Starnes, LM; Wesemann, DR; Lee, JE; Tubbs, A; Sleckman, BP; Daniel, JA; Ge, K; Alt, FW; Fernandez-Capetillo, O; Nussenzweig, MC; Nussenzweig, A				Callen, Elsa; Di Virgilio, Michela; Kruhlak, Michael J.; Nieto-Soler, Maria; Wong, Nancy; Chen, Hua-Tang; Faryabi, Robert B.; Polato, Federica; Santos, Margarida; Starnes, Linda M.; Wesemann, Duane R.; Lee, Ji-Eun; Tubbs, Anthony; Sleckman, Barry P.; Daniel, Jeremy A.; Ge, Kai; Alt, Frederick W.; Fernandez-Capetillo, Oscar; Nussenzweig, Michel C.; Nussenzweig, Andre			53BP1 Mediates Productive and Mutagenic DNA Repair through Distinct Phosphoprotein Interactions	CELL			English	Article							CLASS SWITCH RECOMBINATION; LYSINE-4 METHYLTRANSFERASE COMPLEX; STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION; END RESECTION; BRCT-DOMAIN; DYSFUNCTIONAL TELOMERES; B-CELLS; PTIP; RIF1	The DNA damage response (DDR) protein 53BP1 protects DNA ends from excessive resection in G1, and thereby favors repair by nonhomologous end-joining (NHEJ) as opposed to homologous recombination (HR). During S phase, BRCA1 antagonizes 53BP1 to promote HR. The pro-NHEJ and antirecombinase functions of 53BP1 are mediated in part by RIF1, the only known factor that requires 53BP1 phosphorylation for its recruitment to double-strand breaks (DSBs). Here, we show that a 53BP1 phosphomutant, 53BP1(8A), comprising alanine substitutions of the eight most N-terminal S/TQ phosphorylation sites, mimics 53BP1 deficiency by restoring genome stability in BRCA1-deficient cells yet behaves like wild-type 53BP1 with respect to immunoglobulin class switch recombination (CSR). 53BP1(8A) recruits RIF1 but fails to recruit the DDR protein PTIP to DSBs, and disruption of PTIP phenocopies 53BP1(8A). We conclude that 53BP1 promotes productive CSR and suppresses mutagenic DNA repair through distinct phosphodependent interactions with RIF1 and PTIP.	[Callen, Elsa; Wong, Nancy; Chen, Hua-Tang; Faryabi, Robert B.; Polato, Federica; Santos, Margarida; Nussenzweig, Andre] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Kruhlak, Michael J.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Di Virgilio, Michela; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Di Virgilio, Michela; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Nieto-Soler, Maria; Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr CNIO, Gen Instabil Grp, Madrid 28029, Spain; [Santos, Margarida; Daniel, Jeremy A.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth & Med Sci, Copenhagen, Denmark; [Wesemann, Duane R.; Alt, Frederick W.] Childrens Hosp, Program Cellular & Mol Med, Immune Dis Inst, Boston, MA 02115 USA; [Wesemann, Duane R.; Alt, Frederick W.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Lee, Ji-Eun; Ge, Kai] NIDDKD, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Tubbs, Anthony; Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Copenhagen; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Washington University (WUSTL)	Nussenzweig, A (corresponding author), NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Daniel, Jeremy/S-4729-2016; Nussenzweig, Michel/AAE-7292-2019; Faryabi, Robert B/H-3544-2015; Santos, Margarida/GWR-2285-2022; Lee, Ji-Eun/F-7891-2011; Ge, Kai/H-2810-2019; Polato, Federica/Q-1803-2018; Faryabi, Robert/AAN-5512-2020; Fernandez-Capetillo, Oscar/H-3508-2015; Di Virgilio, Michela/AAE-9298-2022	Daniel, Jeremy/0000-0002-1981-5571; Faryabi, Robert B/0000-0002-7931-2175; Lee, Ji-Eun/0000-0002-3768-7016; Ge, Kai/0000-0002-7442-5138; Faryabi, Robert/0000-0002-7931-2175; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Nieto-Soler, Maria/0000-0002-4334-6533; Tubbs, Anthony/0000-0002-5605-8231; Di Virgilio, Michela/0000-0001-5189-0793; Starnes, Linda/0000-0002-7322-9928; Wesemann, Duane/0000-0002-6690-944X	NIH [AI89972]; American Association of Allergy Asthma and Immunology and CSL Behring; Career Award for Medical Scientists (Burroughs Wellcome Fund); Intramural Research Program of the NIH; National Cancer Institute; Center for Cancer Research; Department of Defense grant [BC102335]; NATIONAL CANCER INSTITUTE [ZIABC010959, Z01BC010959, ZICBC009255, ZIABC010283, ZICBC010915, Z01BC010283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074953, K08AI089972, R01AI047829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075003, ZIADK075017, ZIADK047055] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association of Allergy Asthma and Immunology and CSL Behring; Career Award for Medical Scientists (Burroughs Wellcome Fund); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all members of the A. Nussenzweig lab and Davide Robbiani for discussions; Titia de Lange for RIF1f/f mice; Susan Sharrow for flow cytometry; and Sandy Chang for the TRF2 shRNA construct. M.C.N., F.W.A and O.F.-C. are HHMI investigators. D.R.W. was supported by NIH grants AI89972, the American Association of Allergy Asthma and Immunology and CSL Behring, and a Career Award for Medical Scientists (Burroughs Wellcome Fund). This work was supported by the Intramural Research Program of the NIH, the National Cancer Institute, and the Center for Cancer Research, and by a Department of Defense grant to A.N. (BC102335).	Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Boboila C, 2010, P NATL ACAD SCI USA, V107, P3034, DOI 10.1073/pnas.0915067107; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bowman-Colin C, 2013, P NATL ACAD SCI USA, V110, P8632, DOI 10.1073/pnas.1305362110; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Buonomo SBC, 2009, J CELL BIOL, V187, P385, DOI 10.1083/jcb.200902039; Callen E, 2007, ONCOGENE, V26, P7759, DOI 10.1038/sj.onc.1210873; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Callen E, 2012, IMMUNITY, V37, P971, DOI 10.1016/j.immuni.2012.10.007; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Jaspers JE, 2013, CANCER DISCOV, V3, P68, DOI 10.1158/2159-8290.CD-12-0049; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Lopez-Contreras AJ, 2012, J EXP MED, V209, P455, DOI 10.1084/jem.20112147; Lottersberger F, 2013, P NATL ACAD SCI US; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Rai R, 2010, EMBO J, V29, P2598, DOI 10.1038/emboj.2010.142; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Schwab KR, 2011, MOL CELL BIOL, V31, P1503, DOI 10.1128/MCB.00990-10; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Wang X, 2010, GENES CELLS, V15, P243, DOI 10.1111/j.1365-2443.2009.01379.x; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Wesemann DR, 2011, J EXP MED, V208, P2733, DOI 10.1084/jem.20111155; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	53	246	249	2	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1266	1280		10.1016/j.cell.2013.05.023	http://dx.doi.org/10.1016/j.cell.2013.05.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23727112	Green Accepted, Bronze			2022-12-01	WOS:000319979200012
J	Sarkar, SK; Bumb, A; Mill, M; Neuman, KC				Sarkar, Susanta K.; Bumb, Ambika; Mills, Maria; Neuman, Keir C.			SnapShot: Single-Molecule Fluorescence	CELL			English	Editorial Material									NHLBI, NIH, Lab Mol Biophys, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sarkar, SK (corresponding author), NHLBI, NIH, Lab Mol Biophys, Bethesda, MD USA.		Neuman, Keir C./F-7400-2011	Neuman, Keir C./0000-0002-0863-5671; Mills, Kathleen/0000-0003-3840-0248	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006087] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Axelrod D, 2013, BIOPHYS J, V104, P1401, DOI 10.1016/j.bpj.2013.02.044; Benitez JJ, 2010, METHOD ENZYMOL, V472, P41, DOI 10.1016/S0076-6879(10)72016-4; Chao J, 2013, NAT METHODS, V10, P335, DOI [10.1038/NMETH.2396, 10.1038/nmeth.2396]; FORLEY JN, 2001, BIOL SINGLE MOL LEVE, V1; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Kim H, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/1/016601; MORANMIRABAL JM, 2008, BIOCHENISTREY, V46, P11; Sarkar SK, 2012, CURR BIOL, V22, P1047, DOI 10.1016/j.cub.2012.04.012; Walter NG, 2008, NAT METHODS, V5, P475, DOI 10.1038/nmeth.1215; Xia T, 2013, ANNU REV PHYS CHEM, V64, P459, DOI 10.1146/annurev-physchem-040412-110127	10	5	5	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1408	+		10.1016/j.cell.2013.05.024	http://dx.doi.org/10.1016/j.cell.2013.05.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746850	Bronze			2022-12-01	WOS:000319979200024
J	Kay, M				Kay, Meera			Unsafe abortion: why restricting abortive drugs only makes a bad situation worse	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INDIA					meerakay@ymail.com						Banerjee S, 2009, EXPLORING PATHWAYS U; Duggal R, 2004, REPROD HEALTH MATTER, V12, P122, DOI 10.1016/S0968-8080(04)24009-5; Ganatra B, 2005, REPROD HEALTH MATTER, V13, P65, DOI 10.1016/S0968-8080(05)26215-8; Indian Council of Medical Research, 1989, ILL AB RUR AR TASK F; International Consortium for Medical Abortion, COUNTR AB PROF IND; International Pregnancy Advisory Services (Ipas) India, DIS MED AB DRUGS FAC; Jain A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1957; Ministry of Health and Family Welfare, 2011, FAM WELF STAT IND; World Health Organization, 2011, UNS AB GLOB REG EST	9	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2013	346								f3159	10.1136/bmj.f3159	http://dx.doi.org/10.1136/bmj.f3159			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DQ	23729428				2022-12-01	WOS:000319949200002
J	Kouzine, F; Wojtowicz, D; Yamane, A; Resch, W; Kieffer-Kwon, KR; Bandle, R; Nelson, S; Nakahashi, H; Awasthi, P; Feigenbaum, L; Menoni, H; Hoeijmakers, J; Vermeulen, W; Ge, H; Przytycka, TM; Levens, D; Casellas, R				Kouzine, Fedor; Wojtowicz, Damian; Yamane, Arito; Resch, Wolfgang; Kieffer-Kwon, Kyong-Rim; Bandle, Russell; Nelson, Steevenson; Nakahashi, Hirotaka; Awasthi, Parirokh; Feigenbaum, Lionel; Menoni, Herve; Hoeijmakers, Jan; Vermeulen, Wim; Ge, Hui; Przytycka, Teresa M.; Levens, David; Casellas, Rafael			Global Regulation of Promoter Melting in Naive Lymphocytes	CELL			English	Article							RNA-POLYMERASE-II; EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTORS IIE; IN-VIVO; C-MYC; BASAL TRANSCRIPTION; HUMAN GENOME; QUADRUPLEX STRUCTURES; HISTONE ACETYLATION; ACTIVE PROMOTERS	Lymphocyte activation is initiated by a global increase in messenger RNA synthesis. However, the mechanisms driving transcriptome amplification during the immune response are unknown. By monitoring single-stranded DNA genome wide, we show that the genome of naive cells is poised for rapid activation. In G(0), similar to 90% of promoters from genes to be expressed in cycling lymphocytes are polymerase loaded but unmelted and support only basal transcription. Furthermore, the transition from abortive to productive elongation is kinetically limiting, causing polymerases to accumulate nearer to transcription start sites. Resting lymphocytes also limit the expression of the transcription factor IIH complex, including XPB and XPD helicases involved in promoter melting and open complex extension. To date, two rate-limiting steps have been shown to control global gene expression in eukaryotes: preinitiation complex assembly and polymerase pausing. Our studies identify promoter melting as a third key regulatory step and propose that this mechanism ensures a prompt lymphocyte response to invading pathogens.	[Kouzine, Fedor; Bandle, Russell; Levens, David] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wojtowicz, Damian; Przytycka, Teresa M.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Yamane, Arito; Resch, Wolfgang; Kieffer-Kwon, Kyong-Rim; Nelson, Steevenson; Nakahashi, Hirotaka; Casellas, Rafael] NIAMS, NIH, Bethesda, MD 20892 USA; [Casellas, Rafael] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Awasthi, Parirokh; Feigenbaum, Lionel] NCI, Sci Applicat Int Corp, NIH, Bethesda, MD 20892 USA; [Wojtowicz, Damian] Univ Warsaw, Inst Informat, PL-02098 Warsaw, Poland; [Menoni, Herve; Hoeijmakers, Jan; Vermeulen, Wim] Erasmus MC, Dept Genet, NL-3015 GE Rotterdam, Netherlands; [Ge, Hui] Ascentgene Inc, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); University of Warsaw; Erasmus University Rotterdam; Erasmus MC	Levens, D (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	levens@helix.nih.gov; casellar@mail.nih.gov	Vermeulen, Wim/W-8708-2019; Wojtowicz, Damian/AFG-8518-2022; Hoeijmakers, Jan/AAX-6972-2021; Wojtowicz, Damian/AAF-2007-2022; Yamane, Arito/A-2959-2013; Levens, David/C-9216-2009	Vermeulen, Wim/0000-0003-3616-734X; Wojtowicz, Damian/0000-0002-4274-6383; Wojtowicz, Damian/0000-0002-4274-6383; Levens, David/0000-0002-7616-922X; Menoni, Herve/0000-0002-5302-4933; Resch, Wolfgang/0000-0001-7594-5963; Przytycka, Teresa/0000-0002-6261-277X	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NAIMS); National Cancer Institute (Center for Cancer Research); National Library of Medicine of the NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041186, ZIAAR041148] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200887] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NAIMS); National Cancer Institute (Center for Cancer Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Library of Medicine of the NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank G. Gutierrez for technical assistance with the genome analyzer; J. Simone and J. Lay for bone marrow sorts; J. Qian and K. Zaal for the B cell confocal micrographs; and C. Benham for SIDD mapping. We thank the Casellas and Levens lab members for critically reading the manuscript. We also thank A. Hoofring from the National Institutes of Health (NIH) Medical Arts for designing the pictures shown in Figure 6D. This work was supported in part by the Intramural Research Program of National Institute of Arthritis and Musculoskeletal and Skin Diseases (NAIMS), the National Cancer Institute (Center for Cancer Research), and the National Library of Medicine of the NIH. This study utilized the high-performance computational capabilities of the Helix Systems at the NIH (http://helix.nih.gov). All animal experiments were performed according to the NIH guidelines for laboratory animals and were approved by the Scientific Committee of the NIAMS Animal Facilities. For questions regarding computational analysis, please contact T.M.P. (przytyck@ncbi.nlm.nih.gov).	Assfalg R, 2012, NUCLEIC ACIDS RES, V40, P650, DOI 10.1093/nar/gkr746; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Benham CJ, 2004, J COMPUT BIOL, V11, P519, DOI 10.1089/cmb.2004.11.519; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Calvo KR, 2008, BLOOD, V112, P3818, DOI 10.1182/blood-2008-02-138933; Cer RZ, 2011, NUCLEIC ACIDS RES, V39, pD383, DOI 10.1093/nar/gkq1170; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; Di Virgilio M., 2013, SCIENCE; Du Z, 2008, GENOME RES, V18, P233, DOI 10.1101/gr.6905408; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Giglia-Mari G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000220; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guzman E, 1999, MOL CELL BIOL, V19, P5652; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; JAEHNING JA, 1975, CELL, V4, P51, DOI 10.1016/0092-8674(75)90133-6; Jenne A, 1999, BIOTECHNIQUES, V26, P249, DOI 10.2144/99262bm15; KELLER W, 1975, P NATL ACAD SCI USA, V72, P4876, DOI 10.1073/pnas.72.12.4876; Khil PP, 2012, GENOME RES, V22, P957, DOI 10.1101/gr.130583.111; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; KLEMSZ MJ, 1989, J IMMUNOL, V143, P1032; Kouzine F, 2004, NAT STRUCT MOL BIOL, V11, P1092, DOI 10.1038/nsmb848; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Kouzine F, 2007, FRONT BIOSCI-LANDMRK, V12, P4409, DOI 10.2741/2398; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu MF, 2004, P NATL ACAD SCI USA, V101, P6911, DOI 10.1073/pnas.0401929101; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Lutz R, 2001, NUCLEIC ACIDS RES, V29, P3873, DOI 10.1093/nar/29.18.3873; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; MELCHERS F, 1984, CELL, V37, P715, DOI 10.1016/0092-8674(84)90407-0; MIRKOVITCH J, 1992, MOL BIOL CELL, V3, P1085, DOI 10.1091/mbc.3.10.1085; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; OHKUMA Y, 1995, MOL CELL BIOL, V15, P4856; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; POGO BGT, 1966, P NATL ACAD SCI USA, V55, P805, DOI 10.1073/pnas.55.4.805; POGO BGT, 1967, J CELL BIOL, V35, P477, DOI 10.1083/jcb.35.2.477; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Raghavan SC, 2006, BIOESSAYS, V28, P480, DOI 10.1002/bies.20353; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rawlings JS, 2011, EMBO J, V30, P263, DOI 10.1038/emboj.2010.314; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; SAWAI M, 1990, EXP CELL RES, V187, P4, DOI 10.1016/0014-4827(90)90108-M; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shklover J, 2010, NUCLEIC ACIDS RES, V38, P2369, DOI 10.1093/nar/gkp1208; SPRENT J, 1993, CURR OPIN IMMUNOL, V5, P433, DOI 10.1016/0952-7915(93)90065-Z; STERNER DE, 1995, MOL CELL BIOL, V15, P5716; TU CPD, 1980, GENE, V10, P177, DOI 10.1016/0378-1119(80)90135-3; Vermeulen W, 2001, NAT GENET, V27, P299, DOI 10.1038/85864; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yafe A, 2008, NUCLEIC ACIDS RES, V36, P3916, DOI 10.1093/nar/gkn340; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhou ZX, 2013, GENOME RES, V23, P705, DOI 10.1101/gr.146357.112	75	110	110	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					988	999		10.1016/j.cell.2013.04.033	http://dx.doi.org/10.1016/j.cell.2013.04.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706737	Bronze, Green Accepted			2022-12-01	WOS:000319456800008
J	Ostmeyer, J; Chakrapani, S; Pan, AC; Perozo, E; Roux, B				Ostmeyer, Jared; Chakrapani, Sudha; Pan, Albert C.; Perozo, Eduardo; Roux, Benoit			Recovery from slow inactivation in K+ channels is controlled by water molecules	NATURE			English	Article							C-TYPE INACTIVATION; STRUCTURAL BASIS; QUANTITATIVE DESCRIPTION; DYNAMICS; KCSA; ACTIVATION	Application of a specific stimulus opens the intracellular gate of a K+ channel (activation), yielding a transient period of ion conduction until the selectivity filter spontaneously undergoes a conformational change towards a non-conductive state (inactivation). Removal of the stimulus closes the gate and allows the selectivity filter to interconvert back to its conductive conformation (recovery). Given that the structural differences between the conductive and inactivated filter are very small, it is unclear why the recovery process can take up to several seconds. The bacterial K+ channel KcsA from Streptomyces lividans can be used to help elucidate questions about channel inactivation and recovery at the atomic level. Although KcsA contains only a pore domain, without voltage-sensing machinery, it has the structural elements necessary for ion conduction, activation and inactivation(1-7). Here we reveal, by means of a series of long molecular dynamics simulations, how the selectivity filter is sterically locked in the inactive conformation by buried water molecules bound behind the selectivity filter. Potential of mean force calculations show how the recovery process is affected by the buried water molecules and the rebinding of an external K+ ion. A kinetic model deduced from the simulations shows how releasing the buried water molecules can stretch the timescale of recovery to seconds. This leads to the prediction that reducing the occupancy of the buried water molecules by imposing a high osmotic stress should accelerate the rate of recovery, which was verified experimentally by measuring the recovery rate in the presence of a 2-molar sucrose concentration.	[Ostmeyer, Jared; Pan, Albert C.; Perozo, Eduardo; Roux, Benoit] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Chakrapani, Sudha] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	University of Chicago; Case Western Reserve University	Roux, B (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E57th St, Chicago, IL 60637 USA.	roux@uchicago.edu		chakrapani, sudha/0000-0003-0722-2338; Pan, Albert/0000-0001-5050-5603	National Institute of Health [R01-GM062342, R01-GM57846]; Office of Science of the Department of Energy [DE-AC05-00OR22725]; Pittsburgh Supercomputing Center (PSC) through National Institutes of Health [RC2GM093307]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093307, R01GM062342, R01GM057846] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science of the Department of Energy(United States Department of Energy (DOE)); Pittsburgh Supercomputing Center (PSC) through National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health through grant R01-GM062342 (J.O. and B. R) and R01-GM57846 (S. C. and E. P.). R. Hulse and C. Palka provided purified KcsA. J.O. is a student in the Graduate Program in Computational Neuroscience at the University of Chicago. This research used resources of the Oak Ridge Leadership Computing Facility located in the Oak Ridge National Laboratory, which is supported by the Office of Science of the Department of Energy under Contract DE-AC05-00OR22725. Anton computer time was provided by the National Resource for Biomedical Supercomputing and the Pittsburgh Supercomputing Center (PSC) through Grant RC2GM093307 from the National Institutes of Health and from a generous loan from D. E. Shaw. We are most grateful for the opportunity to use Anton<SUP>20</SUP> and for the support from R. Roskies and M. Dittrich at the PSC.	Bhate MP, 2010, J MOL BIOL, V401, P155, DOI 10.1016/j.jmb.2010.06.031; Chakrapani S, 2007, J GEN PHYSIOL, V130, P479, DOI 10.1085/jgp.200709844; Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843; Chakrapani S, 2011, NAT STRUCT MOL BIOL, V18, P67, DOI 10.1038/nsmb.1968; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cordero-Morales JF, 2011, BIOPHYS J, V100, P2387, DOI 10.1016/j.bpj.2011.01.073; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; DELCOUR AH, 1989, BIOPHYS J, V56, P631, DOI 10.1016/S0006-3495(89)82710-9; Dror RO, 2010, J GEN PHYSIOL, V135, P555, DOI 10.1085/jgp.200910373; Imai S, 2010, P NATL ACAD SCI USA, V107, P6216, DOI 10.1073/pnas.0911270107; Jiang W, 2012, J CHEM THEORY COMPUT, V8, P4672, DOI 10.1021/ct300468g; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Levy DI, 1996, BIOPHYS J, V70, P798, DOI 10.1016/S0006-3495(96)79619-4; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Meyer R, 1997, EUR BIOPHYS J BIOPHY, V26, P433, DOI 10.1007/s002490050098; Pan AC, 2011, J GEN PHYSIOL, V138, P571, DOI 10.1085/jgp.201110670; PARSEGIAN VA, 1986, METHOD ENZYMOL, V127, P400; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rector KD, 2001, J PHYS CHEM B, V105, P1081, DOI 10.1021/jp0023563; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; ROUX B, 1991, J PHYS CHEM-US, V95, P4856, DOI 10.1021/j100165a049; Shaw D. E., 2009, MILLISECOND SCALE SC, VSC09; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	26	133	135	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465								10.1038/nature12395	http://dx.doi.org/10.1038/nature12395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8YC	23892782	Green Accepted			2022-12-01	WOS:000339424700003
J	Engreitz, JM; Pandya-Jones, A; McDonel, P; Shishkin, A; Sirokman, K; Surka, C; Kadri, S; Xing, J; Goren, A; Lander, ES; Plath, K; Guttman, M				Engreitz, Jesse M.; Pandya-Jones, Amy; McDonel, Patrick; Shishkin, Alexander; Sirokman, Klara; Surka, Christine; Kadri, Sabah; Xing, Jeffrey; Goren, Alon; Lander, Eric S.; Plath, Kathrin; Guttman, Mitchell			The Xist lncRNA Exploits Three-Dimensional Genome Architecture to Spread Across the X Chromosome	SCIENCE			English	Article							LONG NONCODING RNAS; HISTONE H3; CHROMATIN INTERACTIONS; INACTIVATION; REVEALS; DOMAINS; METHYLATION; LOCALIZATION; ORGANIZATION; EXPRESSION	Many large noncoding RNAs (lncRNAs) regulate chromatin, but the mechanisms by which they localize to genomic targets remain unexplored. We investigated the localization mechanisms of the Xist lncRNA during X-chromosome inactivation (XCI), a paradigm of lncRNA-mediated chromatin regulation. During the maintenance of XCI, Xist binds broadly across the X chromosome. During initiation of XCI, Xist initially transfers to distal regions across the X chromosome that are not defined by specific sequences. Instead, Xist identifies these regions by exploiting the three-dimensional conformation of the X chromosome. Xist requires its silencing domain to spread across actively transcribed regions and thereby access the entire chromosome. These findings suggest a model in which Xist coats the X chromosome by searching in three dimensions, modifying chromosome structure, and spreading to newly accessible locations.	[Engreitz, Jesse M.; McDonel, Patrick; Shishkin, Alexander; Sirokman, Klara; Surka, Christine; Kadri, Sabah; Xing, Jeffrey; Goren, Alon; Lander, Eric S.; Guttman, Mitchell] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Engreitz, Jesse M.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Pandya-Jones, Amy; Plath, Kathrin] Univ Calif Los Angeles, Dept Biol Chem, Jonsson Comprehens Canc Ctr, Inst Mol Biol, Los Angeles, CA 90095 USA; [Pandya-Jones, Amy; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Lander, ES (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	lander@broadinstitute.org; kplath@mednet.ucla.edu; mguttman@caltech.edu		Goren, Alon/0000-0001-5669-9357; Pandya-Jones, Amy/0000-0001-5519-4613; Plath, Kathrin/0000-0001-7796-3372; Xing, Jeffrey/0000-0003-0696-1390; Kadri, Sabah/0000-0003-0365-6550	Fannie and John Hertz Foundation; National Defense Science and Engineering Graduate Fellowship; NIH [1F32GM103139-01, DP5OD012190]; National Human Genome Research Institute Center for Excellence for Genomic Sciences [P50HG006193]; National Institute of General Medical Sciences [P01GM099134]; California Institute for Regenerative Medicine [RN1-00564, RB3-05080, RB4-06133]; Broad Institute of MIT and Harvard; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM103139, P01GM099134] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012190] Funding Source: NIH RePORTER	Fannie and John Hertz Foundation; National Defense Science and Engineering Graduate Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute Center for Excellence for Genomic Sciences; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Broad Institute of MIT and Harvard; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Gnirke for initial discussions about the RAP method; T. Mikkelsen for assistance with oligonucleotide synthesis; M. Garber and J. Rinn for helpful discussions and ideas; A. Wutz for generously providing Xist transgenic cell lines; S. Rao, N. Cherniavsky, and E. Lieberman-Aiden for analytical help and discussions; P. Russell, M. Cabili, E. Hacisuleyman, and L. Goff for critical reading of the manuscript; L. Gaffney for assistance with figures; and S. Knemeyer for illustrations. Supported by the Fannie and John Hertz Foundation and National Defense Science and Engineering Graduate Fellowship (J.M.E.); an NIH postdoctoral fellowship (1F32GM103139-01) (A.P.-J.); NIH Director's Early Independence Award DP5OD012190 (M. G.), National Human Genome Research Institute Center for Excellence for Genomic Sciences grant P50HG006193 (M. G.); National Institute of General Medical Sciences grant P01GM099134 (K. P.); California Institute for Regenerative Medicine grants RN1-00564, RB3-05080, and RB4-06133 (K. P.); the Broad Institute of MIT and Harvard (M. G. and E. S. L.); and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA (K. P.). Sequencing data are available online from the NCBI Gene Expression Omnibus (accession no. GSE46918, www.ncbi.nlm.nih.gov/geo/) and additional data and information is available at www.lncRNA.caltech.edu/RAP/. J.M.E., E. S. L., and M. G. are inventors on a patent application from the Broad Institute that covers the selective purification of RNA-bound molecular complexes in cells.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Arthold S, 2011, HUM GENET, V130, P295, DOI 10.1007/s00439-011-1002-0; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Beletskii A, 2001, P NATL ACAD SCI USA, V98, P9215, DOI 10.1073/pnas.161173098; Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Chureau C, 2011, HUM MOL GENET, V20, P705, DOI 10.1093/hmg/ddq516; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dietzel S, 1999, EXP CELL RES, V252, P363, DOI 10.1006/excr.1999.4635; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Gontan C, 2011, PROG MOL SUBCELL BIO, V51, P43, DOI 10.1007/978-3-642-16502-3_3; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kanhere Aditi, 2012, Silence, V3, P2, DOI 10.1186/1758-907X-3-2; Kim DH, 2011, SEMIN CELL DEV BIOL, V22, P336, DOI 10.1016/j.semcdb.2011.02.025; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Maass PG, 2012, J CLIN INVEST, V122, P3990, DOI 10.1172/JCI65508; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Naughton C, 2010, MOL CELL, V40, P397, DOI 10.1016/j.molcel.2010.10.013; Nozawa RS, 2013, NAT STRUCT MOL BIOL, V20, P566, DOI 10.1038/nsmb.2532; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pinter SF, 2012, GENOME RES, V22, P1864, DOI 10.1101/gr.133751.111; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Pullirsch D, 2010, DEVELOPMENT, V137, P935, DOI 10.1242/dev.035956; Rego A, 2008, J CELL SCI, V121, P1119, DOI 10.1242/jcs.026104; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Senner CE, 2011, DEVELOPMENT, V138, P1541, DOI 10.1242/dev.056812; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Tattermusch A, 2011, HUM GENET, V130, P247, DOI 10.1007/s00439-011-1027-4; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Umlauf D, 2008, BIOL CHEM, V389, P323, DOI 10.1515/BC.2008.047; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	62	649	684	4	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					767	+	1237973	10.1126/science.1237973	http://dx.doi.org/10.1126/science.1237973			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23828888	Green Accepted, Green Submitted			2022-12-01	WOS:000323122200041
J	Assiri, A; McGeer, A; Perl, TM; Price, CS; Al Rabeeah, AA; Cummings, DAT; Alabdullatif, ZN; Assad, M; Almulhim, A; Makhdoom, H; Madani, H; Alhakeem, R; Al-Tawfiq, JA; Cotten, M; Watson, SJ; Kellam, P; Zumla, AI; Memish, ZA				Assiri, Abdullah; McGeer, Allison; Perl, Trish M.; Price, Connie S.; Al Rabeeah, Abdullah A.; Cummings, Derek A. T.; Alabdullatif, Zaki N.; Assad, Maher; Almulhim, Abdulmohsen; Makhdoom, Hatem; Madani, Hossam; Alhakeem, Rafat; Al-Tawfiq, Jaffar A.; Cotten, Matthew; Watson, Simon J.; Kellam, Paul; Zumla, Alimuddin I.; Memish, Ziad A.		KSA MERS-CoV Invest Team	Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFECTIONS; SARS	Background In September 2012, the World Health Organization reported the first cases of pneumonia caused by the novel Middle East respiratory syndrome coronavirus (MERS-CoV). We describe a cluster of health care-acquired MERS-CoV infections. Methods Medical records were reviewed for clinical and demographic information and determination of potential contacts and exposures. Case patients and contacts were interviewed. The incubation period and serial interval (the time between the successive onset of symptoms in a chain of transmission) were estimated. Viral RNA was sequenced. Results Between April 1 and May 23, 2013, a total of 23 cases of MERS-CoV infection were reported in the eastern province of Saudi Arabia. Symptoms included fever in 20 patients (87%), cough in 20 (87%), shortness of breath in 11 (48%), and gastrointestinal symptoms in 8 (35%); 20 patients (87%) presented with abnormal chest radiographs. As of June 12, a total of 15 patients (65%) had died, 6 (26%) had recovered, and 2 (9%) remained hospitalized. The median incubation period was 5.2 days (95% confidence interval [CI], 1.9 to 14.7), and the serial interval was 7.6 days (95% CI, 2.5 to 23.1). A total of 21 of the 23 cases were acquired by person-to-person transmission in hemodialysis units, intensive care units, or in-patient units in three different health care facilities. Sequencing data from four isolates revealed a single monophyletic clade. Among 217 household contacts and more than 200 health care worker contacts whom we identified, MERS-CoV infection developed in 5 family members (3 with laboratory-confirmed cases) and in 2 health care workers (both with laboratory-confirmed cases). Conclusions Person-to-person transmission of MERS-CoV can occur in health care settings and may be associated with considerable morbidity. Surveillance and infection-control measures are critical to a global public health response.	[Assiri, Abdullah; Al Rabeeah, Abdullah A.; Alabdullatif, Zaki N.; Assad, Maher; Almulhim, Abdulmohsen; Makhdoom, Hatem; Madani, Hossam; Alhakeem, Rafat; Zumla, Alimuddin I.; Memish, Ziad A.] Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh 11176, Saudi Arabia; [Memish, Ziad A.] Al Faisal Univ, Riyadh, Saudi Arabia; [Al-Tawfiq, Jaffar A.] Saudi Aramco Med Serv Org, Dhahran, Saudi Arabia; [McGeer, Allison] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [McGeer, Allison] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Perl, Trish M.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Perl, Trish M.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Perl, Trish M.; Cummings, Derek A. T.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Price, Connie S.] Univ Colorado Denver, Denver, CO USA; [Cotten, Matthew; Watson, Simon J.; Kellam, Paul] Wellcome Trust Sanger Inst, Hinxton, England; [Kellam, Paul; Zumla, Alimuddin I.] UCL, London WC1E 6BT, England; [Zumla, Alimuddin I.] Univ Coll London Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England	Alfaisal University; Saudi Aramco; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Wellcome Trust Sanger Institute; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Memish, ZA (corresponding author), Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh 11176, Saudi Arabia.	zmemish@yahoo.com	McGeer, Allison/AAB-6885-2020; Memish, Ziad Ahmed/AEJ-9424-2022; assiri, abdullah/AAF-5665-2021; ZUMLA, Alimuddin/ABA-8208-2020; mcgeer, allison/H-7747-2014; Assiri, Abdullah M./GQP-2239-2022	McGeer, Allison/0000-0001-5647-6137; Memish, Ziad Ahmed/0000-0002-5099-0714; assiri, abdullah/0000-0002-5605-2876; ZUMLA, Alimuddin/0000-0002-5111-5735; mcgeer, allison/0000-0001-5647-6137; Kellam, Paul/0000-0003-3166-4734; Cotten, Matthew/0000-0002-3361-3351	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070708, U54GM088491] Funding Source: NIH RePORTER; NIGMS NIH HHS [U01 GM070708, U54 GM088491] Funding Source: Medline; Wellcome Trust [093724] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; [Anonymous], 2013, SEVERE RESP DIS UNKN; [Anonymous], NOV COR INF UPD 12 M; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Buchholz U, 2013, EUROSURVEILLANCE, V18, P6; Centers for Disease Control and Prevention, 2013, COR MIDDL E RESP SYN; Corman VM, 2012, EUROSURVEILLANCE, V17, P3; Cotten M, 2013, EMERG INFECT DIS, V19, P736, DOI 10.3201/eid1905.130057; Drosten C, PRELIMINARY SEQUENCE; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P6212, DOI 10.1073/pnas.0400762101; Hijawi B, 2013, E MEDITERR HEALTH J, V19, pS12; Kwok KO, 2007, P R SOC B, V274, P611, DOI 10.1098/rspb.2006.0026; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Leung WK, 2003, GASTROENTEROLOGY, V125, P1011, DOI [10.1053/S0016-5085(03)01215-0, 10.1016/j.gastro.2003.08.001]; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; McDonald LC, 2004, EMERG INFECT DIS, V10, P777, DOI 10.3201/eid1005.030791; Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Rambaut A., NOVEL HUMAN BETACORO; Reich NG, 2009, STAT MED, V28, P2769, DOI 10.1002/sim.3659; Rha B, 2013, MMWR-MORBID MORTAL W, V62, P194; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Tahir M, 2013, EUROSURVEILLANCE, V18, P4; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Wang SX, 2006, EPIDEMIOL INFECT, V134, P786, DOI 10.1017/S095026880500556X; Wong SSY, 2008, J ANTIMICROB CHEMOTH, V62, P437, DOI 10.1093/jac/dkn243; World Health Organization, INT SURV REC HUM INF; World Health Organization Regional Office for the Eastern Mediterranean, 2012, WEEKLY EPIDEMIOLOGIC, V5; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	32	836	881	0	198	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	2013	369	5					407	416		10.1056/NEJMoa1306742	http://dx.doi.org/10.1056/NEJMoa1306742			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193GQ	23782161	Green Accepted, Bronze			2022-12-01	WOS:000322547400007
J	Fernandez, IS; Ng, CL; Kelley, AC; Wu, GW; Yu, YT; Ramakrishnan, V				Fernandez, Israel S.; Chyan Leong Ng; Kelley, Ann C.; Wu, Guowei; Yu, Yi-Tao; Ramakrishnan, V.			Unusual base pairing during the decoding of a stop codon by the ribosome	NATURE			English	Article							TRANSFER-RNA; MECHANISM; PSEUDOURIDINE; REFINEMENT; TU	During normal translation, the binding of a release factor to one of the three stop codons (UGA, UAA or UAG) results in the termination of protein synthesis. However, modification of the initial uridine to a pseudouridine (Psi) allows efficient recognition and readthrough of these stop codons by a transfer RNA(tRNA), although it requires the formation of two normally forbidden purine-purine base pairs(1). Here we determined the crystal structure at 3.1 angstrom resolution of the 30S ribosomal subunit in complex with the anticodon stem loop of tRNA(Ser) bound to the Psi AG stop codon in the A site. The Psi A base pair at the first position is accompanied by the formation of purine-purine base pairs at the second and third positions of the codon, which show an unusual Watson-Crick/Hoogsteen geometry. The structure shows a previously unsuspected ability of the ribosomal decoding centre to accommodate non-canonical base pairs.	[Fernandez, Israel S.; Chyan Leong Ng; Kelley, Ann C.; Ramakrishnan, V.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Wu, Guowei; Yu, Yi-Tao] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	MRC Laboratory Molecular Biology; University of Rochester	Ramakrishnan, V (corresponding author), MRC Lab Mol Biol, Cambridge CB2 0QH, England.	YiTao_Yu@URMC.Rochester.edu; ramak@mrc-lmb.cam.ac.uk	Ng, Chyan Leong/ABB-1385-2021; Ng, Chyan Leong/E-9689-2014	Ng, Chyan Leong/0000-0001-8590-7418; Fernandez, Israel/0000-0001-7218-1603; Ramakrishnan, V/0000-0002-4699-2194	UK Medical Research Council [U105184332]; Wellcome Trust; Agouron Institute; Louis-Jeantet Foundation; National Institutes of Health [GM104077]; University of Rochester CTSA from the National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000042]; Fundacion Ramon Areces; Medical Research Council [MC_U105184332] Funding Source: researchfish; MRC [MC_U105184332] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG039559] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester CTSA from the National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Fundacion Ramon Areces; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. Hall and G. Winter for help and advice with data collection at beamline I04, Diamond Light Source; T. Tomizaki at beamline X06SA for help with data collection at the Swiss Light Source; and A. McCarthy at beamline ID14-4, ESRF, where screening and initial data collection were done. We thank M. Hartlein for the gift of an overproducing tRNA<SUP>Ser</SUP> clone, M. Torrent for advice on yeast tRNA abundance, and G. Murshudov for advice and help with data analysis and refinement. V.R. was supported by the UK Medical Research Council (grant U105184332), a Programme Grant and Senior Investigator Award from the Wellcome Trust, the Agouron Institute and the Louis-Jeantet Foundation. Y.-T.Y. was supported by a grant from the National Institutes of Health (GM104077), and by the University of Rochester CTSA award (UL1TR000042) from the National Center for Advancing Translational Sciences of the National Institutes of Health. I.S.F. was supported by a postdoctoral fellowship from the Fundacion Ramon Areces.	BOREL F, 1993, FEBS LETT, V324, P162, DOI 10.1016/0014-5793(93)81385-D; Davis DR, 1998, J BIOMOL STRUCT DYN, V15, P1121, DOI 10.1080/07391102.1998.10509006; DeLano W. L., 2006, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Huang C, 2012, NAT PROTOC, V7, P789, DOI 10.1038/nprot.2012.029; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karijolich J, 2011, NATURE, V474, P395, DOI 10.1038/nature10165; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nikolova EN, 2011, NATURE, V470, P498, DOI 10.1038/nature09775; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Tomita K, 1999, NUCLEIC ACIDS RES, V27, P1683, DOI 10.1093/nar/27.7.1683; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yarian CS, 1999, NUCLEIC ACIDS RES, V27, P3543, DOI 10.1093/nar/27.17.3543	20	111	118	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 1	2013	500	7460					107	U136		10.1038/nature12302	http://dx.doi.org/10.1038/nature12302			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23812587	Green Accepted			2022-12-01	WOS:000322514800038
J	Mayer, K; Beyrer, C				Mayer, Kenneth; Beyrer, Chris			WHO's new HIV guidelines: opportunities and challenges	LANCET			English	Editorial Material							AFRICA; ART		[Mayer, Kenneth] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Fenway Hlth, Boston, MA 02215 USA; [Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Dept Epidemiol, Baltimore, MD USA	Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mayer, K (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Fenway Hlth, Boston, MA 02215 USA.	khmayer@gmail.com						[Anonymous], 2013, HUMAN RIGHTS WATCH; Audelin AM, 2013, JAIDS-J ACQ IMM DEF, V62, P102, DOI 10.1097/QAI.0b013e318276becc; Birrell PJ, 2013, LANCET INFECT DIS, V13, P313, DOI 10.1016/S1473-3099(12)70341-9; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; De Cock KM, 2013, NEW ENGL J MED, V368, P886, DOI 10.1056/NEJMp1300458; Deeks S, 2013, 7 IAS C PATH TREATM; International Diabetes Federation, 2019, IDF DIAB ATL; Lundgren JD, 2013, CLIN INFECT DIS, V57, P888, DOI 10.1093/cid/cit381; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; UNAIDS, 2012, GLOB REP UNAIDS REP; WHO, 2010, ANT THER HIV INF AD	11	8	8	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 27	2013	382	9889					287	288		10.1016/S0140-6736(13)61578-0	http://dx.doi.org/10.1016/S0140-6736(13)61578-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193FT	23890033				2022-12-01	WOS:000322544900004
J	Whiteman, G; Hope, C; Wadhams, P				Whiteman, Gail; Hope, Chris; Wadhams, Peter			Vast costs of Arctic change	NATURE			English	Editorial Material							ICE		[Whiteman, Gail] Erasmus Univ, NL-3000 DR Rotterdam, Netherlands; [Hope, Chris] Univ Cambridge, Judge Business Sch, Cambridge CB2 1TN, England; [Wadhams, Peter] Univ Cambridge, Cambridge CB2 1TN, England	Erasmus University Rotterdam; University of Cambridge; University of Cambridge	Whiteman, G (corresponding author), Erasmus Univ, NL-3000 DR Rotterdam, Netherlands.	gwhiteman@rsm.nl		Whiteman, Gail/0000-0002-4152-5538				Emmerson C., 2012, ARCTIC OPENING OPPOR; Francis JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051000; Gautier DL, 2009, SCIENCE, V324, P1175, DOI 10.1126/science.1169467; Hope C, 2013, CLIMATIC CHANGE, V117, P531, DOI 10.1007/s10584-012-0633-z; IMF, 2013, DOG DIDNT BARK HAS I; Maslowski W, 2012, ANNU REV EARTH PL SC, V40, P625, DOI 10.1146/annurev-earth-042711-105345; Shakhova NE, 2010, DOKL EARTH SCI, V430, P190, DOI 10.1134/S1028334X10020091; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Smith LC, 2013, P NATL ACAD SCI USA, V110, pE1191, DOI 10.1073/pnas.1214212110; Wadhams P, 2012, AMBIO, V41, P23, DOI 10.1007/s13280-011-0222-9	10	95	99	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2013	499	7459					401	403		10.1038/499401a	http://dx.doi.org/10.1038/499401a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23887416	Bronze			2022-12-01	WOS:000322157900015
J	Fan, P; Manoli, DS; Ahmed, OM; Chen, Y; Agarwal, N; Kwong, S; Cai, AG; Neitz, J; Renslo, A; Baker, BS; Shah, NM				Fan, Pu; Manoli, Devanand S.; Ahmed, Osama M.; Chen, Yi; Agarwal, Neha; Kwong, Sara; Cai, Allen G.; Neitz, Jeffrey; Renslo, Adam; Baker, Bruce S.; Shah, Nirao M.			Genetic and Neural Mechanisms that Inhibit Drosophila from Mating with Other Species	CELL			English	Article							MALE COURTSHIP BEHAVIOR; CANDIDATE TASTE RECEPTORS; MALE SEXUAL-BEHAVIOR; CUTICULAR HYDROCARBONS; REPRODUCTIVE ISOLATION; PHEROMONE RECEPTOR; INCIPIENT SPECIATION; CHEMOSENSORY SYSTEM; MOLECULAR-BASIS; MELANOGASTER	Genetically hard-wired neural mechanisms must enforce behavioral reproductive isolation because interspecies courtship is rare even in sexually naive animals of most species. We find that the chemoreceptor Gr32a inhibits male D. melanogaster from courting diverse fruit fly species. Gr32a recognizes nonvolatile aversive cues present on these reproductively dead-end targets, and activity of Gr32a neurons is necessary and sufficient to inhibit interspecies courtship. Male-specific Fruitless (Fru(M)), a master regulator of courtship, also inhibits interspecies courtship. Gr32a and Fru(M) are not coexpressed, but Fru(M) neurons contact Gr32a neurons, suggesting that these genes influence a shared neural circuit that inhibits interspecies courtship. Gr32a and Fru(M) also suppress within-species intermale courtship, but we show that distinct mechanisms preclude sexual displays toward conspecific males and other species. Although this chemosensory pathway does not inhibit interspecies mating in D. melanogaster females, similar mechanisms appear to inhibit this behavior in many other male drosophilids.	[Fan, Pu] Peking Univ, Peking Tsinghua Ctr Life Sci, Sch Life Sci, State Key Lab Biomembrane & Membrane Biol, Beijing 100871, Peoples R China; [Fan, Pu; Manoli, Devanand S.; Agarwal, Neha; Kwong, Sara; Cai, Allen G.; Shah, Nirao M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Manoli, Devanand S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Shah, Nirao M.] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94158 USA; [Ahmed, Osama M.; Shah, Nirao M.] Univ Calif San Francisco, Neurosci Program, San Francisco, CA 94158 USA; [Neitz, Jeffrey; Renslo, Adam] Univ Calif San Francisco, Dept Pharmaceut Chem, Small Mol Discovery Ctr, San Francisco, CA 94158 USA; [Chen, Yi] Univ Calif Los Angeles, Dept Biol Chem, HHMI, Los Angeles, CA 90095 USA; [Baker, Bruce S.] HHMI, Ashbum, VA 20147 USA	Peking University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute	Shah, NM (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA.	nms@ucsf.edu		Manoli, Devanand/0000-0002-7238-2330; Renslo, Adam/0000-0002-1240-2846; Ahmed, Osama/0000-0003-3539-3150	China Scholarship Council; NARSAD; Program for Breakthrough Biomedical Research; NSF graduate fellowship; Burroughs Wellcome Fund; Ellison Medical Foundation; McKnight Foundation for Neuroscience; Sloan Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060482] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); NARSAD(NARSAD); Program for Breakthrough Biomedical Research; NSF graduate fellowship(National Science Foundation (NSF)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Ellison Medical Foundation(Lawrence Ellison Foundation); McKnight Foundation for Neuroscience; Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to S.L. Zipursky for discussions and sharing GRASP reagents and data and to G. Meissner, A. Nern, B. Pfeiffer, and G. Rubin from JFRC for reagents and advice on GRASP studies. We thank S. Barondes, Y. Rao, and K. Yamamoto for support; C. Bargmann, E. Kandel, and Z. Knight for discussions; R. Axel, T. Clandinin, Y. Jan, D. Julius, S. Lomvardas, K. Scott, and Shah lab members for comments on the manuscript; the laboratories of J. Carlson, T. Clandinin, A. Dahanukar, G. Davis, U. Heberlein, L. Jan, and Y. Jan for sharing fly reagents or equipment; and the UCSF Nikon Imaging Center for providing critical imaging resources. This work was supported by China Scholarship Council (P.F.), NARSAD and Program for Breakthrough Biomedical Research (D.S.M. and N.M.S.), NSF graduate fellowship (O.M.A.), Career Awards in Biomedical Sciences from the Burroughs Wellcome Fund, Ellison Medical Foundation, McKnight Foundation for Neuroscience, and Sloan Foundation (N.M.S.).	Acebes A, 2003, J EXP BIOL, V206, P3095, DOI 10.1242/jeb.00522; Barbash DA, 2010, GENETICS, V186, P1, DOI 10.1534/genetics.110.121459; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; BLAIR WF, 1964, Q REV BIOL, V39, P333, DOI 10.1086/404323; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Dahanukar A, 2011, FLY, V5, P58, DOI 10.4161/fly.5.1.13794; Darwin C, 1860, ORIGIN SPECIES MEANS, DOI 10.1037/14088-000; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; DETHIER VG, 1948, PHYSIOL REV, V28, P220, DOI 10.1152/physrev.1948.28.2.220; Dewan A, 2013, NATURE, V497, P486, DOI 10.1038/nature12114; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dobzhansky T, 1937, AM NAT, V71, P404, DOI 10.1086/280726; Dobzhansky T, 1944, P NATL ACAD SCI USA, V30, P238, DOI 10.1073/pnas.30.9.238; Dukas R, 2004, BEHAV ECOL, V15, P695, DOI 10.1093/beheco/arh068; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Ejima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003246; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Ferrero DM, 2011, P NATL ACAD SCI USA, V108, P11235, DOI 10.1073/pnas.1103317108; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; FRINGS H, 1949, AM MIDL NAT, V41, P602, DOI 10.2307/2421776; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; GILL KULBIR S., 1963, AMER ZOOL, V3, P507; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Grillet M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00224; Grosjean Y, 2008, NAT NEUROSCI, V11, P54, DOI 10.1038/nn2019; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; HALL JC, 1978, BEHAV GENET, V8, P125, DOI 10.1007/BF01066870; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hampel S, 2011, NAT METHODS, V8, P253, DOI 10.1038/NMETH.1566; Higgie M, 2000, SCIENCE, V290, P519, DOI 10.1126/science.290.5491.519; Hollocher H, 1997, GENETICS, V147, P1191; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; JALLON JM, 1987, EVOLUTION, V41, P294, DOI 10.1111/j.1558-5646.1987.tb05798.x; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jiang PH, 2012, P NATL ACAD SCI USA, V109, P4956, DOI 10.1073/pnas.1118360109; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; JULIUS D, 1983, CELL, V32, P839, DOI 10.1016/0092-8674(83)90070-3; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Knight D, 2011, MOL NEUROBIOL, V44, P426, DOI 10.1007/s12035-011-8213-1; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Kowalski S, 2004, CAN J ZOOL, V82, P1258, DOI 10.1139/Z04-102; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Laturney Meghan, 2012, Int J Evol Biol, V2012, P328392, DOI 10.1155/2012/328392; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Lin HP, 2005, P NATL ACAD SCI USA, V102, P12831, DOI 10.1073/pnas.0506420102; Lu BK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002587; MANNING A., 1959, ANIMAL BEHAVIOR, V7, P60, DOI 10.1016/0003-3472(59)90031-4; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; MAYR E, 1988, BIOL PHILOS, V3, P431, DOI 10.1007/BF00647963; MAYR E, 1945, P NATL ACAD SCI USA, V31, P75, DOI 10.1073/pnas.31.2.75; MCCULLOUGH J, 1979, J BACTERIOL, V138, P146, DOI 10.1128/JB.138.1.146-154.1979; McGrath PT, 2011, NATURE, V477, P321, DOI 10.1038/nature10378; Meissner GW, 2011, GENETICS, V189, P195, DOI 10.1534/genetics.111.129940; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Moehring AJ, 2006, GENETICS, V173, P215, DOI 10.1534/genetics.105.052993; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Nanda P, 2012, J BIOSCIENCES, V37, P359, DOI 10.1007/s12038-012-9193-7; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Orr HA, 2004, CURR OPIN GENET DEV, V14, P675, DOI 10.1016/j.gde.2004.08.009; Ovid, 2009, METAMORPHOSES; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Park JH, 2011, MOL CELLS, V32, P375, DOI 10.1007/s10059-011-0128-1; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Ritchie MG, 1999, ANIM BEHAV, V58, P649, DOI 10.1006/anbe.1999.1167; ROBERTSON HM, 1983, EXPERIENTIA, V39, P333, DOI 10.1007/BF01955335; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Seehausen O, 1998, BEHAV ECOL SOCIOBIOL, V42, P1, DOI 10.1007/s002650050405; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Siwicki KK, 2009, CURR OPIN NEUROBIOL, V19, P200, DOI 10.1016/j.conb.2009.04.001; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Spieth H.T., 1952, B AMNH, V99; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; SPIETH HT, 1949, EVOLUTION, V3, P67, DOI 10.2307/2405453; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Sturtevant AH, 1920, GENETICS, V5, P488; Tauber E, 2003, CURR BIOL, V13, P140, DOI 10.1016/S0960-9822(03)00004-6; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Toda H, 2012, CELL REP, V1, P599, DOI 10.1016/j.celrep.2012.05.007; TOMPKINS L, 1982, BEHAV GENET, V12, P295, DOI 10.1007/BF01067849; TOMPKINS L, 1980, J INSECT PHYSIOL, V26, P689, DOI 10.1016/0022-1910(80)90042-6; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Watanabe K, 2011, BEHAV GENET, V41, P746, DOI 10.1007/s10519-011-9461-6; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; WHEELER DA, 1991, SCIENCE, V251, P1082, DOI 10.1126/science.1900131; Wisotsky Z, 2011, NAT NEUROSCI, V14, P1534, DOI 10.1038/nn.2944; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269; Yamaguchi S, 2011, FLY, V5, P333, DOI 10.4161/fly.5.4.16419; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	115	97	98	1	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					89	102		10.1016/j.cell.2013.06.008	http://dx.doi.org/10.1016/j.cell.2013.06.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23810192	Green Accepted, Bronze			2022-12-01	WOS:000321327900012
J	Turner, M				Turner, Marian			ANIMAL BEHAVIOUR Brain food	NATURE			English	Editorial Material																			0	0	0	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					446	446		10.1038/498446a	http://dx.doi.org/10.1038/498446a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803842	Bronze			2022-12-01	WOS:000320929400042
J	Noble, B				Noble, Bill			PERSONAL VIEW Legalising assisted dying puts vulnerable patients at risk and doctors must speak up	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIE		Univ Sheffield, Acad Unit Support Care, Sheffield S11 9NE, S Yorkshire, England	University of Sheffield	Noble, B (corresponding author), Univ Sheffield, Acad Unit Support Care, Sheffield S11 9NE, S Yorkshire, England.	bill.noble@sheffield.ac.uk						Godlee F, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4075; Heath I, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3755; McPherson A, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2827; McPherson T, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4007; Tallis R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4115	5	7	7	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2013	346								f4062	10.1136/bmj.f4062	http://dx.doi.org/10.1136/bmj.f4062			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QL	23804182				2022-12-01	WOS:000321246200011
J	Sidibe, M; Buse, K				Sidibe, Michel; Buse, Kent			AIDS governance: best practices for a post-2015 world	LANCET			English	Editorial Material							HEALTH		[Sidibe, Michel; Buse, Kent] Joint United Nations Programme HIV AIDS UNAIDS, CH-1211 Geneva 27, Switzerland	UNAIDS	Buse, K (corresponding author), Joint United Nations Programme HIV AIDS UNAIDS, CH-1211 Geneva 27, Switzerland.	busek@unaids.org	Buse, Kent/AAK-6688-2020	Buse, Kent/0000-0002-5485-0110				[Anonymous], 2012, LANCET, V380, P1881; [Anonymous], 2013, LANCET; Canfin P, 2013, LANCET, V381, P1885, DOI 10.1016/S0140-6736(13)60952-6; Carlsson G, 2012, LANCET, V380, P1533, DOI 10.1016/S0140-6736(12)61809-1; High-Level Panel of Eminent Persons on the Post-2015 Development Agenda, 2013, NEW GLOB PARTN ER PO; Horton R., 2012, AIDS MOVEMENT CREATE; Peersman G, 2009, JAIDS-J ACQ IMM DEF, V52, pS97, DOI 10.1097/QAI.0b013e3181baee06; Sidibe M., 2010, GLOBAL HLTH GOVERNAN, V4, P1; Task Team for the Global Thematic Consultation on Health, 2013, HLTH POST2015 AG REP; Tyler TomR., 2003, TRUST GOVERNANCE, P269; UNAIDS, 2012, UNAIDS GLOB REP GLOB	11	12	12	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 22	2013	381	9884					2147	2149		10.1016/S0140-6736(13)61413-0	http://dx.doi.org/10.1016/S0140-6736(13)61413-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KH	23791333				2022-12-01	WOS:000320925600011
J	Hudson, KL; Guttmacher, AE; Collins, FS				Hudson, Kathy L.; Guttmacher, Alan E.; Collins, Francis S.			In Support of SUPPORT - A View from the NIH	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SEVERE RETINOPATHY; INFANTS		[Hudson, Kathy L.; Guttmacher, Alan E.; Collins, Francis S.] Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA	Hudson, KL (corresponding author), Natl Inst Hlth, Bethesda, MD USA.							Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Chow LC, 2003, PEDIATRICS, V111, P339, DOI 10.1542/peds.111.2.339; Martin Joyce A, 2012, Natl Vital Stat Rep, V61, P1; Tin W, 2001, ARCH DIS CHILD-FETAL, V84, pF106, DOI 10.1136/fn.84.2.F106	4	38	38	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2349	2351		10.1056/NEJMp1306986	http://dx.doi.org/10.1056/NEJMp1306986			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	167AE	23738511	Bronze, Green Published			2022-12-01	WOS:000320601700003
J	Saver, JL; Fonarow, GC; Smith, EE; Reeves, MJ; Grau-Sepulveda, MV; Pan, WQ; Olson, DM; Hernandez, AF; Peterson, ED; Schwamm, LH				Saver, Jeffrey L.; Fonarow, Gregg C.; Smith, Eric E.; Reeves, Mathew J.; Grau-Sepulveda, Maria V.; Pan, Wenqin; Olson, DaiWai M.; Hernandez, Adrian F.; Peterson, Eric D.; Schwamm, Lee H.			Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUIDELINES-STROKE; MEDICARE BENEFICIARIES; CARE; THROMBOLYSIS; ASSOCIATION; IMPROVEMENT; ALTEPLASE; QUALITY; SYSTEMS; DELAYS	Importance Randomized clinical trials suggest the benefit of intravenous tissue-type plasminogen activator (tPA) in acute ischemic stroke is time dependent. However, modest sample sizes have limited characterization of the extent to which onset to treatment (OTT) time influences outcome; and the generalizability of findings to clinical practice is uncertain. Objective To evaluate the degree to which OTT time is associated with outcome among patients with acute ischemic stroke treated with intraveneous tPA. Design, Setting, and Patients Data were analyzed from 58 353 patients with acute ischemic stroke treated with tPA within 4.5 hours of symptom onset in 1395 hospitals participating in the Get With The Guidelines-Stroke Program, April 2003 to March 2012. Main Outcomes and Measures Relationship between OTT time and in-hospital mortality, symptomatic intracranial hemorrhage, ambulatory status at discharge, and discharge destination. Results Among the 58 353 tPA-treated patients, median age was 72 years, 50.3% were women, median OTT time was 144 minutes (interquartile range, 115-170), 9.3% (5404) had OTT time of 0 to 90 minutes, 77.2% (45 029) had OTT time of 91 to 180 minutes, and 13.6% (7920) had OTT time of 181 to 270 minutes. Median pretreatment National Institutes of Health Stroke Scale documented in 87.7% of patients was 11 (interquartile range, 6-17). Patient factors most strongly associated with shorter OTT included greater stroke severity (odds ratio [ OR], 2.8; 95% CI, 2.5-3.1 per 5-point increase), arrival by ambulance (OR, 5.9; 95% CI, 4.5-7.3), and arrival during regular hours (OR, 4.6; 95% CI, 3.8-5.4). Overall, there were 5142 (8.8%) in-hospital deaths, 2873 (4.9%) patients had intracranial hemorrhage, 19 491 (33.4%) patients achieved independent ambulation at hospital discharge, and 22 541 (38.6%) patients were discharged to home. Faster OTT, in 15-minute increments, was associated with reduced in-hospital mortality (OR, 0.96; 95% CI, 0.95-0.98; P < .001), reduced symptomatic intracranial hemorrhage (OR, 0.96; 95% CI, 0.95-0.98; P < .001), increased achievement of independent ambulation at discharge (OR, 1.04; 95% CI, 1.03-1.05; P < .001), and increased discharge to home (OR, 1.03; 95% CI, 1.02-1.04; P < .001). Conclusions and Relevance In a registry representing US clinical practice, earlier thrombolytic treatment was associated with reduced mortality and symptomatic intracranial hemorrhage, and higher rates of independent ambulation at discharge and discharge to home following acute ischemic stroke. These findings support intensive efforts to accelerate hospital presentation and thrombolytic treatment in patients with stroke.	[Saver, Jeffrey L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Los Angeles, CA 90095 USA; [Smith, Eric E.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Smith, Eric E.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Reeves, Mathew J.] Michigan State Univ, Dept Epidemiol, E Lansing, MI 48824 USA; [Grau-Sepulveda, Maria V.; Pan, Wenqin; Olson, DaiWai M.; Hernandez, Adrian F.; Peterson, Eric D.] Duke Clin Res Ctr, Durham, NC USA; [Schwamm, Lee H.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Calgary; University of Calgary; Michigan State University; Duke University; Harvard University; Massachusetts General Hospital	Saver, JL (corresponding author), Univ Calif Los Angeles, Comprehens Stroke Ctr, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	jsaver@mednet.ucla.edu	Peterson, Eric David/ABF-5033-2021; Smith, Eric E/C-5443-2012; Fonarow, Gregg C/D-5988-2014; Olson, DaiWai/I-5932-2019; Hernandez, Adrian F/A-7818-2016	Smith, Eric E/0000-0003-3956-1668; Fonarow, Gregg C/0000-0002-3192-8093; Olson, DaiWai/0000-0002-9280-078X; Hernandez, Adrian F/0000-0003-3387-9616; Schwamm, Lee/0000-0003-0592-9145; Saver, Jeffrey/0000-0001-9141-2251	Boehringer-Ingelheim; Merck; Bristol-Myers Squib/Sanofi Pharmaceutical Partnership; AHA Pharmaceutical Roundtable	Boehringer-Ingelheim(Boehringer Ingelheim); Merck(Merck & Company); Bristol-Myers Squib/Sanofi Pharmaceutical Partnership; AHA Pharmaceutical Roundtable(American Heart Association)	The GWTG-Stroke Program is provided by the AHA/American Stroke Association. The GWTG-Stroke Program is currently supported in part by a charitable contribution from Janssen Pharmaceutical Companies of Johnson & Johnson. The GWTG-Stroke Program has been funded in the past through support from Boehringer-Ingelheim, Merck, Bristol-Myers Squib/Sanofi Pharmaceutical Partnership, and the AHA Pharmaceutical Roundtable.	Acker JE, 2007, STROKE, V38, P3097, DOI 10.1161/STROKEAHA.107.186094; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Boden-Albala B, 2010, CONTEMP CLIN TRIALS, V31, P235, DOI 10.1016/j.cct.2010.02.003; Brott T, 1997, STROKE, V28, P1530, DOI 10.1161/01.STR.28.8.1530; Fonarow GC, 2012, J AM HEART ASSOC, V1, P42, DOI 10.1161/JAHA.111.000034; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; Hodgson C, 2007, STROKE, V38, P2115, DOI 10.1161/STROKEAHA.107.484071; Kohrmann M, 2011, INT J STROKE, V6, P493, DOI 10.1111/j.1747-4949.2011.00585.x; LaBresh KA, 2008, ARCH INTERN MED, V168, P411, DOI 10.1001/archinternmed.2007.101; Lansberg MG, 2009, STROKE, V40, P2079, DOI 10.1161/STROKEAHA.108.540708; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lin CB, 2012, CIRC-CARDIOVASC QUAL, V5, P514, DOI 10.1161/CIRCOUTCOMES.112.965210; Mazya M, 2012, STROKE, V43, P1524, DOI 10.1161/STROKEAHA.111.644815; Meng XJ, 2004, ANN NEUROL, V55, P207, DOI 10.1002/ana.10803; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Morgenstern LB, 2007, STROKE, V38, P2972, DOI 10.1161/STROKEAHA.107.490078; Ovbiagele B, 2010, CEREBROVASC DIS, V29, P50, DOI 10.1159/000255974; Reeves MJ, 2012, STROKE, V43, P44, DOI 10.1161/STROKEAHA.111.626978; Robinson TG, 2013, EMERG MED J, V30, P467, DOI 10.1136/emermed-2012-201471; Saposnik G, 2005, NEUROLOGY, V65, P1169, DOI 10.1212/01.wnl.0000180687.75907.4b; Saver JL, 2009, STROKE, V40, P2433, DOI 10.1161/STROKEAHA.108.543561; Saver JL, 2010, LANCET, V375, P1667, DOI 10.1016/S0140-6736(10)60634-4; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Schwamm LH, 2009, CIRCULATION, V119, P107, DOI 10.1161/CIRCULATIONAHA.108.783688; Schwamm LH, 2005, STROKE, V36, P690, DOI 10.1161/01.STR.0000158165.42884.4F; Sobesky J, 2007, CEREBROVASC DIS, V24, P56, DOI 10.1159/000103117; Strbian D, 2010, STROKE, V41, P712, DOI 10.1161/STROKEAHA.109.571976; Tveiten A, 2009, EMERG MED J, V26, P324, DOI 10.1136/emj.2008.063610; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Xian Y, 2012, AM HEART J, V163, P392, DOI 10.1016/j.ahj.2011.12.012; Zhang QH, 2013, STROKE, V44	31	529	548	4	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2480	2488		10.1001/jama.2013.6959	http://dx.doi.org/10.1001/jama.2013.6959			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23780461	Bronze			2022-12-01	WOS:000320505100029
J	Natarajan, C; Inoguchi, N; Weber, RE; Fago, A; Moriyama, H; Storz, JF				Natarajan, Chandrasekhar; Inoguchi, Noriko; Weber, Roy E.; Fago, Angela; Moriyama, Hideaki; Storz, Jay F.			Epistasis Among Adaptive Mutations in Deer Mouse Hemoglobin	SCIENCE			English	Article							GLOBIN GENES; EVOLUTION; ADAPTATION; PROTEIN; MICE; POLYMORPHISMS; SELECTION; INSIGHTS; PATHS	Epistatic interactions between mutant sites in the same protein can exert a strong influence on pathways of molecular evolution. We performed protein engineering experiments that revealed pervasive epistasis among segregating amino acid variants that contribute to adaptive functional variation in deer mouse hemoglobin (Hb). Amino acid mutations increased or decreased Hb-O-2 affinity depending on the allelic state of other sites. Structural analysis revealed that epistasis for Hb-O-2 affinity and allosteric regulatory control is attributable to indirect interactions between structurally remote sites. The prevalence of sign epistasis for fitness-related biochemical phenotypes has important implications for the evolutionary dynamics of protein polymorphism in natural populations.	[Natarajan, Chandrasekhar; Inoguchi, Noriko; Moriyama, Hideaki; Storz, Jay F.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Weber, Roy E.; Fago, Angela] Aarhus Univ, Dept Biosci, DK-8000 Aarhus, Denmark	University of Nebraska System; University of Nebraska Lincoln; Aarhus University	Storz, JF (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	jstorz2@unl.edu	Natarajan, Chandrasekhar/D-3144-2012; Natarajan, Chandrasekar/ABG-5195-2020; Fago, Angela/J-5946-2013	Natarajan, Chandrasekhar/0000-0002-4841-0426; Fago, Angela/0000-0001-7315-2628	NIH-National Heart, Lung, and Blood Institute [R01 HL087216, HL087216-S1]; NSF [DEB-0614342, IOS-0949931]; Faculty of Science and Technology, Aarhus University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087216] Funding Source: NIH RePORTER	NIH-National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NSF(National Science Foundation (NSF)); Faculty of Science and Technology, Aarhus University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by grants from the NIH-National Heart, Lung, and Blood Institute (R01 HL087216 and HL087216-S1), the NSF (DEB-0614342 and IOS-0949931), and the Faculty of Science and Technology, Aarhus University. We thank S. Kachman for statistical advice, A. Bang for assistance in the lab, and M. Harms, S. Smith, and two reviewers for helpful comments. All experimental data are tabulated in the main text and in the supplementary materials.	Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; CHAPPELL MA, 1988, EVOLUTION, V42, P681, DOI 10.1111/j.1558-5646.1988.tb02486.x; CHAPPELL MA, 1984, P NATL ACAD SCI-BIOL, V81, P5484, DOI 10.1073/pnas.81.17.5484; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Inoguchi N, 2013, ACTA CRYSTALLOGR F, V69, P393, DOI 10.1107/S1744309113005708; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Lozovsky ER, 2009, P NATL ACAD SCI USA, V106, P12025, DOI 10.1073/pnas.0905922106; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Lunzer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001162; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Rokyta DR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002075; Salverda MLM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001321; Storz JF, 2008, GENETICS, V180, P367, DOI 10.1534/genetics.108.088732; Storz JF, 2007, PLOS GENET, V3, P448, DOI 10.1371/journal.pgen.0030045; Storz JF, 2007, J MAMMAL, V88, P24, DOI 10.1644/06-MAMM-S-199R1.1; Storz JF, 2012, GENETICS, V190, P203, DOI 10.1534/genetics.111.134494; Storz JF, 2010, J EXP BIOL, V213, P2565, DOI 10.1242/jeb.042598; Storz JF, 2009, P NATL ACAD SCI USA, V106, P14450, DOI 10.1073/pnas.0905224106; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165	24	137	140	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1324	1327		10.1126/science.1236862	http://dx.doi.org/10.1126/science.1236862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766324	Green Published, Green Accepted			2022-12-01	WOS:000320320200043
J	Camaschella, C				Camaschella, Clara			Treating Iron Overload	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BETA-THALASSEMIA; MOUSE MODEL; HEMOCHROMATOSIS; MICE		[Camaschella, Clara] Univ Vita Salute San Raffaele, Milan, Italy; [Camaschella, Clara] Ist Sci San Raffaele, I-20132 Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Camaschella, C (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.		Camaschella, Clara/A-3289-2015; Girelli, Domenico/B-1183-2008	Girelli, Domenico/0000-0001-9684-1899				Finberg KE, 2011, BLOOD, V117, P4590, DOI 10.1182/blood-2010-10-315507; Guo SL, 2013, J CLIN INVEST, V123, P1531, DOI 10.1172/JCI66969; Nai A, 2012, BLOOD, V119, P5021, DOI 10.1182/blood-2012-01-401885; Ramos E, 2012, BLOOD, V120, P3829, DOI 10.1182/blood-2012-07-440743; Schmidt PJ, 2013, BLOOD, V121, P1200, DOI 10.1182/blood-2012-09-453977	5	27	29	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					2325	2327		10.1056/NEJMcibr1304338	http://dx.doi.org/10.1056/NEJMcibr1304338			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YN	23758239				2022-12-01	WOS:000320230500012
J	Whorton, MR; MacKinnon, R				Whorton, Matthew R.; MacKinnon, Roderick			X-ray structure of the mammalian GIRK2-beta gamma G-protein complex	NATURE			English	Article							BETA-GAMMA-SUBUNITS; SODIUM-DEPENDENT ACTIVATION; RECTIFYING K+ CHANNELS; CRYSTAL-STRUCTURE; POTASSIUM CHANNELS; RECEPTORS; BINDING; SYSTEM; PIP2; RGS9	G-protein-gated inward rectifier K+ (GIRK) channels allow neurotransmitters, through G-protein-coupled receptor stimulation, to control cellular electrical excitability. In cardiac and neuronal cells this control regulates heart rate and neural circuit activity, respectively. Here we present the 3.5 angstrom resolution crystal structure of the mammalian GIRK2 channel in complex with beta gamma G-protein subunits, the central signalling complex that links G-protein-coupled receptor stimulation to K+ channel activity. Short-range atomic and long-range electrostatic interactions stabilize four beta gamma G-protein subunits at the interfaces between four K+ channel subunits, inducing a pre-open state of the channel. The pre-open state exhibits a conformation that is intermediate between the closed conformation and the open conformation of the constitutively active mutant. The resultant structural picture is compatible with 'membrane delimited' activation of GIRK channels by G proteins and the characteristic burst kinetics of channel gating. The structures also permit a conceptual understanding of how the signalling lipid phosphatidylinositol-4,5-bisphosphate (PIP2) and intracellular Na+ ions participate in multi-ligand regulation of GIRK channels.	[Whorton, Matthew R.; MacKinnon, Roderick] Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA; [Whorton, Matthew R.; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu			National Center for Research Resources of the National Institutes of Health (NIH) [1S10RR022321-01, 1S10RR027037-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022321, S10RR027037] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank P. Hoff and members of D. Gadsby's laboratory (Rockefeller University) for assistance with oocyte preparation; Y. Hsiung for assistance with insect cell culture; R. Sanishvili, N. Venugopalan, and S. Corcoran (GM/CA, Advanced Photon Source, Argonne National laboratory) for assistance at the synchrotron; and members of the MacKinnon laboratory. The use of the Rigaku/MSC microMax007HF and Formulator robot in the Rockefeller University Structural Biology Resource Center was made possible by Grant Numbers 1S10RR022321-01 and 1S10RR027037-01, respectively, from the National Center for Research Resources of the National Institutes of Health (NIH). R. M. is an investigator in the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albsoul-Younes AM, 2001, J BIOL CHEM, V276, P12712, DOI 10.1074/jbc.M011231200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Echols N, 2003, NUCLEIC ACIDS RES, V31, P478, DOI 10.1093/nar/gkg104; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.biochem.56.1.615; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Ho IHM, 1999, J PHYSIOL-LONDON, V520, P645, DOI 10.1111/j.1469-7793.1999.00645.x; Ho IHM, 1999, J BIOL CHEM, V274, P8639, DOI 10.1074/jbc.274.13.8639; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14286, DOI 10.1021/bi991205r; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LOEWI O., 1926, PFLUGER S ARCH GES PHYSIOL, V214, P678, DOI 10.1007/BF01741946; Loewi O, 1921, PFLUG ARCH GES PHYS, V189, P239, DOI 10.1007/BF01738910; Loewi O., 1999, NOBLE LECT PHYSL MED; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.bb.18.060189.000553; Mirshahi T, 2002, J BIOL CHEM, V277, P7348, DOI 10.1074/jbc.M109999200; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P5873, DOI 10.1073/pnas.87.15.5873; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Qi Z, 2006, FEBS LETT, V580, P3879, DOI 10.1016/j.febslet.2006.06.016; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; SLESINGER PA, 1995, NEURON, V15, P1145, DOI 10.1016/0896-6273(95)90102-7; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sui JL, 1996, J GEN PHYSIOL, V108, P381, DOI 10.1085/jgp.108.5.381; TRAUTWEIN W, 1958, PFLUG ARCH GES PHYS, V266, P324, DOI 10.1007/BF00416781; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; YAMANE HK, 1990, P NATL ACAD SCI USA, V87, P5868, DOI 10.1073/pnas.87.15.5868; Yokogawa M, 2011, J BIOL CHEM, V286, P2215, DOI 10.1074/jbc.M110.160754; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhao Q, 2003, MOL PHARMACOL, V64, P1085, DOI 10.1124/mol.64.5.1085	61	214	217	3	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					190	+		10.1038/nature12241	http://dx.doi.org/10.1038/nature12241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23739333	Green Accepted			2022-12-01	WOS:000320283400039
J	Appleby, J				Appleby, John			Are accident and emergency attendances increasing?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Appleby J., 2013, SLIDESHOW PRESSURES; Department of Health, TOTAL TIME SPENT IN; NHS England, 2013, A E WAITING TIMES AN; NHS England, WEEKLY TIME SERIES A; NHS England, 2013, NHS SUPPORT PLAN LAU; Skidmore C., 2013, DAILY MAIL; Steventon A, 2011, J HEALTH SERV RES PO, V16, P90, DOI 10.1258/jhsrp.2010.010097	7	4	4	2	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ BRIT MED J	BMJ-British Medical Journal	JUN 7	2013	346								f3677	10.1136/bmj.f3677	http://dx.doi.org/10.1136/bmj.f3677			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YM	23747970				2022-12-01	WOS:000320230400007
J	Tosh, W				Tosh, William			It can be tough for families when patients choose to die at home	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Russells Hall Hosp, Dept Anaesthesia, Dudley DY1 2HQ, W Midlands, England	Russells Hall Hospital	Tosh, W (corresponding author), Russells Hall Hosp, Dept Anaesthesia, Dudley DY1 2HQ, W Midlands, England.	w.tosh@doctors.org.uk							0	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2013	346								f3397	10.1136/bmj.f3397	http://dx.doi.org/10.1136/bmj.f3397			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DG	23719642				2022-12-01	WOS:000319948200010
J	Uehata, T; Iwasaki, H; Vandenbon, A; Matsushita, K; Hernandez-Cuellar, E; Kuniyoshi, K; Satoh, T; Mino, T; Suzuki, Y; Standley, DM; Tsujimura, T; Rakugi, H; Isaka, Y; Takeuchi, O; Akira, S				Uehata, Takuya; Iwasaki, Hidenori; Vandenbon, Alexis; Matsushita, Kazufumi; Hernandez-Cuellar, Eduardo; Kuniyoshi, Kanako; Satoh, Takashi; Mino, Takashi; Suzuki, Yutaka; Standley, Daron M.; Tsujimura, Tohru; Rakugi, Hiromi; Isaka, Yoshitaka; Takeuchi, Osamu; Akira, Shizuo			Malt1-Induced Cleavage of Regnase-1 in CD4(+) Helper T Cells Regulates Immune Activation	CELL			English	Article							MESSENGER-RNA; TRANSCRIPTION FACTORS; C-REL; ROLES; GENES; MALT1; MICRORNAS; STABILITY; ALPHA	Regnase-1 (also known as Zc3h12a and MCPIP1) is an RNase that destabilizes a set of mRNAs, including Il6 and Il12b, through cleavage of their 3' UTRs. Although Regnase-1 inactivation leads to development of an autoimmune disease characterized by T cell activation and hyperimmunoglobulinemia in mice, the mechanism of Regnase-1-mediated immune regulation has remained unclear. We show that Regnase-1 is essential for preventing aberrant effector CD4(+) T cell generation cell autonomously. Moreover, in T cells, Regnase-1 regulates the mRNAs of a set of genes, including c-Rel, Ox40, and Il2, through cleavage of their 30 UTRs. Interestingly, T cell receptor (TCR) stimulation leads to cleavage of Regnase-1 at R111 by Malt1/paracaspase, freeing T cells from Regnase-1-mediated suppression. Furthermore, Malt1 protease activity is critical for controlling the mRNA stability of T cell effector genes. Collectively, these results indicate that dynamic control of Regnase-1 expression in T cells is critical for controlling T cell activation.	[Uehata, Takuya; Iwasaki, Hidenori; Matsushita, Kazufumi; Hernandez-Cuellar, Eduardo; Kuniyoshi, Kanako; Satoh, Takashi; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Lab Host Def, Suita, Osaka 5650871, Japan; [Vandenbon, Alexis; Standley, Daron M.] Osaka Univ, WPI Immunol Frontier Res Ctr IFReC, Lab Syst Immunol, Suita, Osaka 5650871, Japan; [Kuniyoshi, Kanako; Satoh, Takashi; Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Uehata, Takuya; Rakugi, Hiromi; Isaka, Yoshitaka] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan; [Iwasaki, Hidenori] Japan Tobacco, Cent Pharmaceut Res Inst, Takatsuki, Osaka 5691125, Japan; [Mino, Takashi; Takeuchi, Osamu] Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Sakyo Ku, Kyoto 6068507, Japan; [Takeuchi, Osamu] JST, CREST, Sakyo Ku, Kyoto 6068507, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Lab Funct Genom, Kashiwa, Chiba 2778562, Japan; [Tsujimura, Tohru] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Japan Tobacco Inc.; Kyoto University; Japan Science & Technology Agency (JST); University of Tokyo; Hyogo College of Medicine	Akira, S (corresponding author), Osaka Univ, Lab Host Def, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Standley, Daron/D-2343-2009; Mino, Takashi/GRO-0332-2022; Vandenbon, Alexis/N-4428-2019; Vandenbon, Alexis/A-8430-2017; Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/AAG-9359-2019	Mino, Takashi/0000-0002-9562-008X; Takeuchi, Osamu/0000-0002-1260-6232; Rakugi, Hiromi/0000-0001-6508-4338	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS); JSPS; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [25860355, 22689016] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all members of our laboratory, E. Kamada and M. Kageyama for secretarial assistance, and Y. Fujiwara, M. Kumagai, K. Nojima, and N. Umano for technical assistance. We also thank I. Taniuchi for CD4-Cre mice, S.W. Morris and S. Yamasaki for Bcl10<SUP>-</SUP>/-mice, V.M. Dixit and N. Kayagaki for Malt1<SUP>-</SUP>/-mice, S. Gerondakis and T. Kurosaki for c-Rel<SUP>-</SUP>/-mice, and L.M. McAllister-Lucas for the Flag-API2-Malt1 plasmids. This work was supported by the Cabinet Office, Government of Japan and the Japan Society for the Promotion of Science (JSPS) through the funding program for World-Leading Innovative R&D on Science and Technology (FIRST Program) and the Grant-in- Aid for Specially Promoted Research. This work was also supported by the JSPS Grant-in-Aid for Young Scientists (A) (OT) and a grant-in-aid for Scientific Research on Innovative Areas "Genome Science'' from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Campbell IK, 2000, J CLIN INVEST, V105, P1799, DOI 10.1172/JCI8298; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Linterman MA, 2009, IMMUNITY, V30, P228, DOI 10.1016/j.immuni.2008.12.015; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Rosebeck S, 2011, SCIENCE, V331, P468, DOI 10.1126/science.1198946; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thome M, 2008, NAT REV IMMUNOL, V8, P495, DOI 10.1038/nri2338; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253	35	230	240	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					1036	1049		10.1016/j.cell.2013.04.034	http://dx.doi.org/10.1016/j.cell.2013.04.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706741	Bronze			2022-12-01	WOS:000319456800012
J	Chang, JB; Ferrell, JE				Chang, Jeremy B.; Ferrell, James E., Jr.			Mitotic trigger waves and the spatial coordination of the Xenopus cell cycle	NATURE			English	Article							SURFACE CONTRACTION WAVES; NUCLEAR DIVISION; LOCALIZATION; ACTIVATION; EGGS; PROPAGATION; BISTABILITY; HYSTERESIS; OSCILLATOR; EXTRACTS	Despite the large size of the Xenopus laevis egg (approximately 1.2 mm diameter), a fertilized egg rapidly proceeds through mitosis in a spatially coordinated fashion. Mitosis is initiated by a bistable system of regulatory proteins centred on Cdk1 (refs 1, 2), raising the possibility that this spatial coordination could be achieved through trigger waves of Cdk1 activity(3). Using an extract system that performs cell cycles in vitro, here we show that mitosis does spread through Xenopus cytoplasm via trigger waves, propagating at a linear speed of approximately 60 mu m min(-1). Perturbing the feedback loops that give rise to the bistability of Cdk1 changes the speed and dynamics of the waves. Time-lapse imaging of intact eggs argues that trigger waves of Cdk1 activation are responsible for surface contraction waves, ripples in the cell cortex that precede cytokinesis(4,5). These findings indicate that Cdk1 trigger waves help ensure the spatiotemporal coordination of mitosis in large eggs. Trigger waves may be an important general mechanism for coordinating biochemical events over large distances.	[Chang, Jeremy B.; Ferrell, James E., Jr.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Ferrell, James E., Jr.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University	Chang, JB (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	jbchang@stanford.edu; james.ferrell@stanford.edu			National Institutes of Health [GM046383, GM077544]; National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046383, R01GM077544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Funabiki and M. Dasso for providing GFP-NLS protein and constructs, E. Sontag and L. Wang for discussions and calculations, T. Tsai for sharing his unpublished data on the effects of PD0166285 on Xenopus embryos, Q. Yang for helping to build the ordinary differential equation model upon which our partial differential equation model is based, G. Dey, H. Stone and B. Sullivan for discussions, S. Quake and the Quake laboratory for advice, J. Chen and the Chen laboratory for the use of their microscope and discussions, J. Pomerening for discussions and technical advice, the Stanford Cell Sciences Imaging Facility for technical assistance, and members of the Ferrell laboratory for discussions. This work was supported by grants from the National Institutes of Health (GM046383 and GM077544) and by a National Science Foundation Graduate Research Fellowship and a Lieberman Fellowship (to J.B.C.).	Bonnet J, 2008, CELL CYCLE, V7, P1991, DOI 10.4161/cc.7.13.6095; CLUTTERBUCK AJ, 1970, J GEN MICROBIOL, V60, P133, DOI 10.1099/00221287-60-1-133; FOE VE, 1983, J CELL SCI, V61, P31; Gerhart J.C., 1980, Biological Regulation and Development, V2, P133; Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003; HARA K, 1971, ROUX ARCH DEV BIOL, V167, P183, DOI 10.1007/BF00577039; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; Haskins EF, 1974, PUB WISS FILM SEKT B, V8, P1; Hausen P., 1991, EARLY DEV XENOPUS LA; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Luther R, 1906, Z ELKTROCHEM ANGEW P, V12, P596, DOI 10.1002/bbpc.19060123208; Markevich NI, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100108; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nakamura N, 2005, MOL REPROD DEV, V72, P336, DOI 10.1002/mrd.20348; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NOVAK B, 1993, J THEOR BIOL, V165, P101, DOI 10.1006/jtbi.1993.1179; Perez-Mongiovi D, 1998, J CELL SCI, V111, P385; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Rankin S, 1997, CURR BIOL, V7, P451, DOI 10.1016/S0960-9822(06)00192-8; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; SHINAGAWA A, 1989, DEV GROWTH DIFFER, V31, P249; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; TYSON JJ, 1988, PHYSICA D, V32, P327, DOI 10.1016/0167-2789(88)90062-0; Wang YL, 2001, CANCER RES, V61, P8211; Winfree, 1974, FARADAY S CHEM SOC, V9, P38; Yang Q, 2013, NAT CELL BIOL, V15, P519, DOI 10.1038/ncb2737	27	112	112	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					603	607		10.1038/nature12321	http://dx.doi.org/10.1038/nature12321			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23863935	Green Accepted			2022-12-01	WOS:000323625900040
J	Lomakin, IB; Steitz, TA				Lomakin, Ivan B.; Steitz, Thomas A.			The initiation of mammalian protein synthesis and mRNA scanning mechanism	NATURE			English	Article							EUKARYOTIC TRANSLATION INITIATION; 40S RIBOSOMAL-SUBUNIT; START CODON SELECTION; CRYSTAL-STRUCTURE; SITE SELECTION; 70S RIBOSOME; EIF1A; POSITION; COMPLEX; FIDELITY	During translation initiation in eukaryotes, the small ribosomal subunit binds messenger RNA at the 5' end and scans in the 5' to 3' direction to locate the initiation codon, form the 80S initiation complex and start protein synthesis. This simple, yet intricate, process is guided by multiple initiation factors. Here we determine the structures of three complexes of the small ribosomal subunit that represent distinct steps in mammalian translation initiation. These structures reveal the locations of eIF1, eIF1A, mRNA and initiator transfer RNA bound to the small ribosomal subunit and provide insights into the details of translation initiation specific to eukaryotes. Conformational changes associated with the captured functional states reveal the dynamics of the interactions in the P site of the ribosome. These results have functional implications for the mechanism of mRNA scanning.	[Lomakin, Ivan B.; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	ivan.lomakin@yale.edu; thomas.steitz@yale.edu		Lomakin, Ivan/0000-0001-6528-5068	National Institutes of Health (NIH) [GM022778]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Steitz laboratory for useful suggestions and discussions, the staff of the Advanced Photon Source beamline 24-ID, the National Synchrotron Light Source beamlines X25 and X29, and the Richards Center facility at Yale University for support. We also thank Y. Polikanov, J. Wang and Y. Xiong for advice with crystallographic software. This work was supported by the National Institutes of Health (NIH) grant GM022778 (to T.A.S.).	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; Dong J, 2008, GENE DEV, V22, P2242, DOI 10.1101/gad.1696608; Fekete CA, 2005, EMBO J, V24, P3588, DOI 10.1038/sj.emboj.7600821; Fekete CA, 2007, EMBO J, V26, P1602, DOI 10.1038/sj.emboj.7601613; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Julian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001095; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kolitz SE, 2009, RNA, V15, P138, DOI 10.1261/rna.1318509; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lancaster L, 2000, RNA, V6, P717, DOI 10.1017/S1355838200000303; Lomakin IB, 2006, EMBO J, V25, P196, DOI 10.1038/sj.emboj.7600904; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Myasnikov AG, 2009, CURR OPIN STRUC BIOL, V19, P300, DOI 10.1016/j.sbi.2009.04.010; Noller HF, 2005, FEBS LETT, V579, P855, DOI 10.1016/j.febslet.2004.11.026; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2004, EMBO REP, V5, P906, DOI 10.1038/sj.embor.7400240; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 2001, RNA, V7, P1496, DOI 10.1017/S135583820101038X; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Rees B, 2005, ACTA CRYSTALLOGR D, V61, P1299, DOI [10.1107/S0907444905019591, 10.1107/S0904777905019591]; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; Vila-Sanjurjo A, 2003, P NATL ACAD SCI USA, V100, P8682, DOI 10.1073/pnas.1133380100; Voigts-Hoffmann F, 2012, CURR OPIN STRUC BIOL, V22, P768, DOI 10.1016/j.sbi.2012.07.010; Wegrzyn JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-232; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	50	124	128	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					307	+		10.1038/nature12355	http://dx.doi.org/10.1038/nature12355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23873042	Green Accepted			2022-12-01	WOS:000323112400026
J	Blaschke, K; Ebata, KT; Karimi, MM; Zepeda-Martinez, JA; Goyal, P; Mahapatra, S; Tam, A; Laird, DJ; Hirst, M; Rao, A; Lorincz, MC; Ramalho-Santos, M				Blaschke, Kathryn; Ebata, Kevin T.; Karimi, Mohammad M.; Zepeda-Martinez, Jorge A.; Goyal, Preeti; Mahapatra, Sahasransu; Tam, Angela; Laird, Diana J.; Hirst, Martin; Rao, Anjana; Lorincz, Matthew C.; Ramalho-Santos, Miguel			Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells	NATURE			English	Article							GROUND-STATE; METHYLATION; 5-HYDROXYMETHYLCYTOSINE; DYNAMICS; GENES; PLURIPOTENCY; DIOXYGENASE; GENERATION; PARALLEL; TOOL	DNA methylation is a heritable epigenetic modification involved in gene silencing, imprinting, and the suppression of retrotransposons(1). Global DNA demethylation occurs in the early embryo and the germ line(2,3), and may be mediated by Tet (ten eleven translocation) enzymes(4-6), which convert 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC)(7). Tet enzymes have been studied extensively in mouse embryonic stem (ES) cells(8-12), which are generally cultured in the absence of vitamin C, a potential cofactor for Fe(II) 2-oxoglutarate dioxygenase enzymes such as Tet enzymes. Here we report that addition of vitamin C to mouse ES cells promotes Tet activity, leading to a rapid and global increase in 5hmC. This is followed by DNA demethylation of many gene promoters and upregulation of demethylated germline genes. Tet1 binding is enriched near the transcription start site of genes affected by vitamin C treatment. Importantly, vitamin C, but not other antioxidants, enhances the activity of recombinant Tet1 in a biochemical assay, and the vitamin-C-induced changes in 5hmC and 5mC are entirely suppressed in Tet1 and Tet2 double knockout ES cells. Vitamin C has a stronger effect on regions that gain methylation in cultured ES cells compared to blastocysts, and in vivo are methylated only after implantation. In contrast, imprinted regions and intracisternal A particle retroelements, which are resistant to demethylation in the early embryo(2,13), are resistant to vitamin-C-induced DNA demethylation. Collectively, the results of this study establish vitamin C as a direct regulator of Tet activity and DNA methylation fidelity in ES cells.	[Blaschke, Kathryn; Ebata, Kevin T.; Laird, Diana J.; Ramalho-Santos, Miguel] Univ Calif San Francisco, Dept Obstet & Gynecol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Blaschke, Kathryn; Ebata, Kevin T.; Laird, Diana J.; Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Karimi, Mohammad M.; Goyal, Preeti; Lorincz, Matthew C.] Univ British Columbia, Dept Med Genet, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Karimi, Mohammad M.; Tam, Angela; Hirst, Martin] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Zepeda-Martinez, Jorge A.; Mahapatra, Sahasransu; Rao, Anjana] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Zepeda-Martinez, Jorge A.; Mahapatra, Sahasransu; Rao, Anjana] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [Hirst, Martin] Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of British Columbia; British Columbia Cancer Agency; La Jolla Institute for Immunology; University of British Columbia	Lorincz, MC (corresponding author), Univ British Columbia, Dept Med Genet, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada.	mlorincz@mail.ubc.ca; mrsantos@diabetes.ucsf.edu	Laird, Diana/Y-4387-2019; Ramalho-Santos, Miguel/L-9092-2018; Hirst, Martin/B-7684-2016	Ramalho-Santos, Miguel/0000-0003-0177-5556; Ebata, Kevin/0000-0001-7166-7513; Karimi, Mohammad Mahdi/0000-0001-5017-1252; Lorincz, Matthew/0000-0003-0885-0467	NSF; California Institute of Regenerative Medicine postdoctoral training grant [TG2-01153]; Michael Smith Foundation for Health Research; CIHR [92093]; NIH [HD065812, CA151535, DP2OD004698, OD012204]; California Institute of Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065812] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA151535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD012204, DP2OD004698, DP2OD007420] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); California Institute of Regenerative Medicine postdoctoral training grant; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors wish to acknowledge the epigenomics and sequencing groups at the Michael Smith Genome Sciences Centre, Canada, for performing 5mC DIP and 5hmC DIP Illumina sequencing, as well as for technical support. We thank C. -J. Lin for technical advice on isolation of blastocysts. We particularly thank M. M. Dawlaty and R. Jaenisch for the Tet1<SUP>-/-</SUP> and Tet1<SUP>-/-</SUP> Tet2<SUP>-/-</SUP> ES cells. We also wish to thank M. Okano for the Dnmt1<SUP>-/-</SUP> Dnmt3a<SUP>-/-</SUP> Dnmt3b<SUP>-/-</SUP> ES cells. We thank J. S. Song for statistical advice, as well as M. Conti, S. Lomvardas, J. Costello and members of the Ramalho-Santos laboratory for critical reading of the manuscript. K. B. is a recipient of an NSF pre-doctoral fellowship and K. T. E. is supported by a California Institute of Regenerative Medicine postdoctoral training grant (TG2-01153). M. M. K. is supported by a postdoctoral fellowship from the Michael Smith Foundation for Health Research. M. C. L. is supported by a CIHR New Investigator Award. This work was funded by a CIHR grant (92093) to M. C. L. and M. H., NIH grants HD065812 and CA151535, a grant from the California Institute of Regenerative Medicine to A. R., and an NIH New Innovator Award (DP2OD004698) and R01 (OD012204) to M.R.-S.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Chung TL, 2010, STEM CELLS, V28, P1848, DOI 10.1002/stem.493; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Minor EA, 2013, J BIOL CHEM, V288, P13669, DOI 10.1074/jbc.C113.464800; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Younesy H, 2013, COMPUT GRAPH FORUM, V32, P91, DOI 10.1111/cgf.12096	42	560	580	5	222	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					222	+		10.1038/nature12362	http://dx.doi.org/10.1038/nature12362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23812591	Green Accepted, Green Submitted			2022-12-01	WOS:000322825500038
J	Lukas, D; Clutton-Brock, TH				Lukas, D.; Clutton-Brock, T. H.			The Evolution of Social Monogamy in Mammals	SCIENCE			English	Article							PATTERNS; ORGANIZATION; REPRODUCTION; PHYLOGENIES; PRIMATES; CARE	The evolution of social monogamy has intrigued biologists for over a century. Here, we show that the ancestral condition for all mammalian groups is of solitary individuals and that social monogamy is derived almost exclusively from this social system. The evolution of social monogamy does not appear to have been associated with a high risk of male infanticide, and paternal care is a consequence rather than a cause of social monogamy. Social monogamy has evolved in nonhuman mammals where breeding females are intolerant of each other and female density is low, suggesting that it represents a mating strategy that has developed where males are unable to defend access to multiple females.	[Lukas, D.; Clutton-Brock, T. H.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Lukas, D (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	dl384@cam.ac.uk		Lukas, Dieter/0000-0002-7141-3545	Leverhulme Trust; Isaac Newton Trust; European Research Council	Leverhulme Trust(Leverhulme Trust); Isaac Newton Trust; European Research Council(European Research Council (ERC)European Commission)	We thank D. Blumstein, S. Dobson, P. Kappeler, and N. Solomon for detailed comments and critical feedback on the classification of species and B. Dantzer, E. Huchard, C. Logan, and everyone in the Large Animal Research Group in Cambridge for helpful discussions. Data are available as supplementary materials. The Leverhulme Trust, the Isaac Newton Trust, and the European Research Council provided the funding for this study.	Brotherton Peter N. M., 2003, P42; Brotherton PNM, 1997, ANIM BEHAV, V54, P1413, DOI 10.1006/anbe.1997.0551; Cant MA, 2003, J ZOOL, V259, P115, DOI 10.1017/S0952836902003011; Clutton-Brock TH, 2006, BIOL LETTERS, V2, P513, DOI 10.1098/rsbl.2006.0531; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Dobson FS, 2010, BEHAV ECOL, V21, P747, DOI 10.1093/beheco/arq048; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Gavrilets S, 2012, P NATL ACAD SCI USA, V109, P9923, DOI 10.1073/pnas.1200717109; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; Langergraber KE, 2013, BEHAV ECOL SOCIOBIOL, V67, P861, DOI 10.1007/s00265-013-1509-6; Lukas D, 2012, P ROY SOC B-BIOL SCI, V279, P2151, DOI 10.1098/rspb.2011.2468; Mealy Linda, 2000, SEX DIFFERENCES DEV; ORIANS GH, 1969, AM NAT, V103, P589, DOI 10.1086/282628; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Plavcan JM, 2012, HUM NATURE-INT BIOS, V23, P45, DOI 10.1007/s12110-012-9130-3; Porter LM, 2001, FOLIA PRIMATOL, V72, P69, DOI 10.1159/000049925; Reichard Ulrich H., 2003, P190; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Shuster S. M., 2003, MATING SYSTEMS STRAT; TABER AB, 1992, J ZOOL, V227, P417, DOI 10.1111/j.1469-7998.1992.tb04404.x; van Schaik Carel P., 2003, P59; van Schaik Carel P., 2000, P61, DOI 10.1017/CBO9780511542312.005; VANSCHAIK CP, 1990, BEHAVIOUR, V115, P30, DOI 10.1163/156853990X00284; WITTENBERGER JF, 1980, ANNU REV ECOL SYST, V11, P197, DOI 10.1146/annurev.es.11.110180.001213; WRIGHT PC, 1990, INT J PRIMATOL, V11, P89, DOI 10.1007/BF02192783	31	309	312	9	556	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					526	530		10.1126/science.1238677	http://dx.doi.org/10.1126/science.1238677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23896459	Green Accepted			2022-12-01	WOS:000322586700047
J	Li, Y; Hsin, J; Zhao, LY; Cheng, YW; Shang, WN; Huang, KC; Wang, HW; Ye, S				Li, Ying; Hsin, Jen; Zhao, Lingyun; Cheng, Yiwen; Shang, Weina; Huang, Kerwyn Casey; Wang, Hong-Wei; Ye, Sheng			FtsZ Protofilaments Use a Hinge-Opening Mechanism for Constrictive Force Generation	SCIENCE			English	Article							DIVISION PROTEIN FTSZ; CELL-DIVISION; STRUCTURAL INSIGHTS; Z-RING; TUBULIN; POLYMERIZATION; CONFORMATIONS; ACTIVATION; MUTANTS	The essential bacterial protein FtsZ is a guanosine triphosphatase that self-assembles into a structure at the division site termed the "Z ring". During cytokinesis, the Z ring exerts a constrictive force on the membrane by using the chemical energy of guanosine triphosphate hydrolysis. However, the structural basis of this constriction remains unresolved. Here, we present the crystal structure of a guanosine diphosphate-bound Mycobacterium tuberculosis FtsZ protofilament, which exhibits a curved conformational state. The structure reveals a longitudinal interface that is important for function. The protofilament curvature highlights a hydrolysis-dependent conformational switch at the T3 loop that leads to longitudinal bending between subunits, which could generate sufficient force to drive cytokinesis.	[Li, Ying; Cheng, Yiwen; Shang, Weina; Ye, Sheng] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Hsin, Jen; Huang, Kerwyn Casey] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Zhao, Lingyun; Wang, Hong-Wei] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Minist Educ,Key Lab Prot Sci,Ctr Struct Biol, Beijing 100084, Peoples R China; [Ye, Sheng] Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Stanford University; Tsinghua University; Zhejiang University	Ye, S (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	sye@zju.edu.cn			National Natural Science Foundation of China [31070661]; Ministry of Science and Technology [2011CB910500, 2010CB912401, 2012CB966600]; Natural Science Foundation of Zhejiang Province [R2100439]; Specialized Research Fund for the Doctoral Program of Higher Education [20110101110122]; Fundamental Research Funds for the Central Universities; Research Funds of the Tsinghua-Peking Center for Life Sciences; NIH [DP2OD006466]; Stanford University School of Medicine; NIH Ruth L. Kirschstein National Research Service Award [1F32GM100677-01A1]; National Science Foundation of China [31090360]; NSF [OCI-1053575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100677] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006466] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Funds of the Tsinghua-Peking Center for Life Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University School of Medicine; NIH Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Erickson for insightful suggestions and the pJSB100 vector; J. Lutkenhaus for the JKD7-1/pKD3 strain; M. Rajagopalan for M. tuberculosis genomic DNA; Y. Huang, Y. Jiang, H. Song, X. Feng, and J. T. Shaw for discussions and critical reviews of the manuscript; S. Huang and J. He at the Shanghai Synchrotron Radiation Facility for on-site assistance; and Y. Xu at the National Center for Protein Sciences Beijing for EM facility assistance. This work was supported in part by funds from the National Natural Science Foundation of China (grant 31070661), the Ministry of Science and Technology (grants 2011CB910500 and 2010CB912401), the Natural Science Foundation of Zhejiang Province (grant R2100439), and the Specialized Research Fund for the Doctoral Program of Higher Education (grant 20110101110122), as well as the Fundamental Research Funds for the Central Universities (to S.Y.); Research Funds of the Tsinghua-Peking Center for Life Sciences (to H.-W.W.); a NIH Director's New Innovator Award DP2OD006466 (to K. C. H.); and a Stanford University School of Medicine Dean's Postdoctoral Fellowship and an NIH Ruth L. Kirschstein National Research Service Award 1F32GM100677-01A1 (to J.H.). Y.C. is supported by the National Science Foundation of China (grant 31090360) and the Ministry of Science and Technology (grant 2012CB966600). All simulations were performed with computer time provided by the Extreme Science and Engineering Discovery Environment, which is supported by NSF grant OCI-1053575, with allocation number TG-MCB110056 (to J.H. and K. C. H.). The structure coordinates and reflection files are deposited in the Protein Data Bank (PDB) under identification (ID) number 4KWE. We declare no competing financial interests.	Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; Diaz JF, 2001, J BIOL CHEM, V276, P17307, DOI 10.1074/jbc.M010920200; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Hsin J, 2012, P NATL ACAD SCI USA, V109, P9432, DOI 10.1073/pnas.1120761109; Huecas S, 2004, FEBS LETT, V569, P43, DOI 10.1016/j.febslet.2004.05.048; Huecas S, 2007, J BIOL CHEM, V282, P37515, DOI 10.1074/jbc.M706399200; Lappchen T, 2008, CHEM BIOL, V15, P189, DOI 10.1016/j.chembiol.2007.12.013; Leung AKW, 2004, J MOL BIOL, V342, P953, DOI 10.1016/j.jmb.2004.07.061; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Matsui T, 2012, ACTA CRYSTALLOGR D, V68, P1175, DOI 10.1107/S0907444912022640; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Raymond A, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-37; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Scheffers DJ, 2001, FEBS LETT, V506, P6, DOI 10.1016/S0014-5793(01)02855-1; Sossong TM, 1999, BIOCHEMISTRY-US, V38, P14843, DOI 10.1021/bi990917e; Stricker J, 2003, J BACTERIOL, V185, P4796, DOI 10.1128/JB.185.16.4796-4805.2003; Tan CM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003592	23	104	108	6	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					392	395		10.1126/science.1239248	http://dx.doi.org/10.1126/science.1239248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888039	Green Accepted			2022-12-01	WOS:000322259200048
J	Kagan, JC				Kagan, Jonathan C.			Recognition for an Innate Explorer	CELL			English	Editorial Material									[Kagan, Jonathan C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kagan, Jonathan C.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Kagan, JC (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu			NIAID NIH HHS [AI103082, R01 AI093589, AI093589, R56 AI103082] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093589, R56AI103082] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))			0	0	0	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					261	264		10.1016/j.cell.2013.06.047	http://dx.doi.org/10.1016/j.cell.2013.06.047			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870114	Bronze			2022-12-01	WOS:000321950700001
J	Kim, JY; Zhao, H; Martinez, J; Doggett, TA; Kolesnikov, AV; Tang, PH; Ablonczy, Z; Chan, CC; Zhou, ZQ; Green, DR; Ferguson, TA				Kim, Ji-Young; Zhao, Hui; Martinez, Jennifer; Doggett, Teresa Ann; Kolesnikov, Alexander V.; Tang, Peter H.; Ablonczy, Zsolt; Chan, Chi-Chao; Zhou, Zhenqing; Green, Douglas R.; Ferguson, Thomas A.			Noncanonical Autophagy Promotes the Visual Cycle	CELL			English	Article							RETINAL-PIGMENT EPITHELIUM; LIPID-PEROXIDATION PRODUCTS; LEBER CONGENITAL AMAUROSIS; AGE-RELATED MACULOPATHY; PHOTORECEPTOR DEGENERATION; ALPHA-V-BETA-5 INTEGRIN; MACULAR DEGENERATION; TARGETED DISRUPTION; BINDING PROTEIN; OUTER SEGMENTS	Phagocytosis and degradation of photoreceptor outer segments (POS) by retinal pigment epithelium (RPE) is fundamental to vision. Autophagy is also responsible for bulk degradation of cellular components, but its role in POS degradation is not well understood. We report that the morning burst of RPE phagocytosis coincided with the enzymatic conversion of autophagy protein LC3 to its lipidated form. LC3 associated with single-membrane phagosomes containing engulfed POS in an Atg5-dependent manner that required Beclin1, but not the autophagy preinitiation complex. The importance of this process was verified in mice with Atg5-deficient RPE cells that showed evidence of disrupted lysosomal processing. These mice also exhibited decreased photoreceptor responses to light stimuli and decreased chromophore levels that were restored with exogenous retinoid supplementation. These results establish that the interplay of phagocytosis and autophagy within the RPE is required for both POS degradation and the maintenance of retinoid levels to support vision.	[Kim, Ji-Young; Zhao, Hui; Doggett, Teresa Ann; Kolesnikov, Alexander V.; Zhou, Zhenqing; Ferguson, Thomas A.] Washington Univ, St Louis Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Martinez, Jennifer; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Tang, Peter H.; Ablonczy, Zsolt] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Chan, Chi-Chao] NEI, Immunopathol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	Saint Louis University; Washington University (WUSTL); St Jude Children's Research Hospital; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org; ferguson@vision.wustl.edu	Green, Douglas R/N-8083-2018; Kolesnikov, Alexander V/O-1840-2016; Martinez, Jennifer/C-3740-2019; Zhou, Zhenqing/I-7260-2016	Green, Douglas R/0000-0002-7332-1417; Martinez, Jennifer/0000-0002-3060-2518; 	National Institutes of Health [EY015570, AI40646]; Department of Ophthalmology and Visual Sciences [EY02687]; Research to Prevent Blindness (New York); BrightFocus Foundation (Clarksburg); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZICEY000461, ZIAEY000222, P30EY002687, R01EY019065, R01EY015570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Ophthalmology and Visual Sciences; Research to Prevent Blindness (New York)(Research to Prevent Blindness (RPB)); BrightFocus Foundation (Clarksburg)(BrightFocus Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants EY015570 (to T.A.F.) and AI40646 (to D.R.G.) and the Department of Ophthalmology and Visual Sciences core grant (EY02687). Support was also received from Research to Prevent Blindness (New York) and the BrightFocus Foundation (Clarksburg). The authors would like to thank Wandy Beatty for performing the TEM and Jayoung Choi for assistance with the figure layouts.	BOK D, 1993, J CELL SCI, P189; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; BOSCH E, 1993, J HISTOCHEM CYTOCHEM, V41, P253, DOI 10.1177/41.2.8419462; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Davidson AE, 2011, INVEST OPHTH VIS SCI, V52, P3730, DOI 10.1167/iovs.10-6707; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Edwards RB, 2000, EXP EYE RES, V70, P235, DOI 10.1006/exer.1999.0781; EDWARDS RB, 1977, SCIENCE, V197, P1001, DOI 10.1126/science.560718; Esumi N, 2004, J BIOL CHEM, V279, P19064, DOI 10.1074/jbc.M309881200; Fan J, 2008, INVEST OPHTH VIS SCI, V49, P2384, DOI 10.1167/iovs.08-1727; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gordiyenko NV, 2010, INVEST OPHTH VIS SCI, V51, P1143, DOI 10.1167/iovs.09-4117; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Jackson GR, 2002, AGEING RES REV, V1, P381, DOI 10.1016/S1568-1637(02)00007-7; KATZ ML, 1987, MECH AGEING DEV, V39, P81, DOI 10.1016/0047-6374(87)90088-1; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kopitz J, 2004, BIOCHIMIE, V86, P825, DOI 10.1016/j.biochi.2004.09.029; Krohne TU, 2010, EXP EYE RES, V90, P465, DOI 10.1016/j.exer.2009.12.011; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; Kunchithapautham K, 2007, AUTOPHAGY, V3, P65, DOI 10.4161/auto.3431; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Liou GI, 1998, J NEUROSCI, V18, P4511; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nandrot EF, 2006, AM J PHYSIOL-CELL PH, V290, pC1256, DOI 10.1152/ajpcell.00480.2005; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Nishiyama J, 2007, AUTOPHAGY, V3, P591, DOI 10.4161/auto.4964; Owsley C, 2006, INVEST OPHTH VIS SCI, V47, P1310, DOI 10.1167/iovs.05-1292; Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d; Rakoczy PE, 1997, BIOCHEM J, V324, P935, DOI 10.1042/bj3240935; Ramkumar HL, 2010, PROG RETIN EYE RES, V29, P169, DOI 10.1016/j.preteyeres.2010.02.002; Reme CE, 1999, INVEST OPHTH VIS SCI, V40, P2398; Ripps H, 2000, VISUAL NEUROSCI, V17, P97, DOI 10.1017/S095252380017110X; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Ruiz A, 2007, INVEST OPHTH VIS SCI, V48, P5377, DOI 10.1167/iovs.07-0673; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sanjuan MA, 2009, IMMUNOL REV, V227, P203, DOI 10.1111/j.1600-065X.2008.00732.x; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Tang PH, 2011, J NEUROSCI, V31, P18618, DOI 10.1523/JNEUROSCI.4265-11.2011; Tang PH, 2010, INVEST OPHTH VIS SCI, V51, P5958, DOI 10.1167/iovs.10-5766; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Vives-Bauza C, 2008, J BIOL CHEM, V283, P24770, DOI 10.1074/jbc.M800706200; WAHL HW, 1994, Z GERONTOL, V27, P399; Wang AL, 2009, AUTOPHAGY, V5, P1190, DOI 10.4161/auto.5.8.10087; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Zhang T, 2011, P NATL ACAD SCI USA, V108, P8879, DOI 10.1073/pnas.1017127108; Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653	63	233	237	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 18	2013	154	2					365	376		10.1016/j.cell.2013.06.012	http://dx.doi.org/10.1016/j.cell.2013.06.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870125	Green Accepted, Bronze			2022-12-01	WOS:000321950700013
J	Griffin, MR; Zhu, YW; Moore, MR; Whitney, CG; Grijalva, CG				Griffin, Marie R.; Zhu, Yuwei; Moore, Matthew R.; Whitney, Cynthia G.; Grijalva, Carlos G.			US Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; CHILDHOOD IMMUNIZATION; YOUNG-CHILDREN; DISEASE; IMPACT; PREVENTION; SEROTYPES; CARRIAGE; TRENDS	BACKGROUND The introduction of 7-valent pneumococcal conjugate vaccine (PCV7) into the U. S. childhood immunization schedule in 2000 has substantially reduced the incidence of vaccine-serotype invasive pneumococcal disease in young children and in unvaccinated older children and adults. By 2004, hospitalizations associated with pneumonia from any cause had also declined markedly among young children. Because of concerns about increases in disease caused by nonvaccine serotypes, we wanted to determine whether the reduction in pneumonia-related hospitalizations among young children had been sustained through 2009 and whether such hospitalizations in older age groups had also declined. METHODS We estimated annual rates of hospitalization for pneumonia from any cause using the Nationwide Inpatient Sample database. The reason for hospitalization was classified as pneumonia if pneumonia was the first listed diagnosis or if it was listed after a first diagnosis of sepsis, meningitis, or empyema. Average annual rates of pneumonia-related hospitalizations from 1997 through 1999 (before the introduction of PCV7) and from 2007 through 2009 (well after its introduction) were used to estimate annual declines in hospitalizations due to pneumonia. RESULTS The annual rate of hospitalization for pneumonia among children younger than 2 years of age declined by 551.1 per 100,000 children (95% confidence interval [CI], 445.1 to 657.1), which translates to 47,000 fewer hospitalizations annually than expected on the basis of the rates before PCV7 was introduced. The rate for adults 85 years of age or older declined by 1300.8 per 100,000 (95% CI, 984.0 to 1617.6), which translates to 73,000 fewer hospitalizations annually. For the three age groups of 18 to 39 years, 65 to 74 years, and 75 to 84 years, the annual rate of hospitalization for pneumonia declined by 8.4 per 100,000 (95% CI, 0.6 to 16.2), 85.3 per 100,000 (95% CI, 7.0 to 163.6), and 359.8 per 100,000 (95% CI, 199.6 to 520.0), respectively. Overall, we estimated an age-adjusted annual reduction of 54.8 per 100,000 (95% CI, 41.0 to 68.5), or 168,000 fewer hospitalizations for pneumonia annually. CONCLUSIONS Declines in hospitalizations for childhood pneumonia were sustained during the decade after the introduction of PCV7. Substantial reductions in hospitalizations for pneumonia among adults were also observed. (Funded by the Centers for Disease Control and Prevention.)	[Griffin, Marie R.; Grijalva, Carlos G.] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA; [Griffin, Marie R.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Zhu, Yuwei] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Griffin, Marie R.; Grijalva, Carlos G.] Vet Affairs Tennessee Valley Hlth Care Syst, Midsouth Geriatr Res Educ & Clin Ctr, Nashville, TN USA; [Moore, Matthew R.; Whitney, Cynthia G.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Centers for Disease Control & Prevention - USA	Griffin, MR (corresponding author), Village Vanderbilt, Dept Prevent Med, Suite 2600,1500 21st Ave S, Nashville, TN 37212 USA.	marie.griffin@vanderbilt.edu		Grijalva, Carlos/0000-0002-2329-7797	Centers for Disease Control and Prevention [11-IPA1110211, 12-IPA1210402]; Thrasher Research Fund [02832-9]; Glaxo-SmithKline; Pfizer	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Thrasher Research Fund; Glaxo-SmithKline(GlaxoSmithKline); Pfizer(Pfizer)	Supported in part by grants from the Centers for Disease Control and Prevention (11-IPA1110211, to Dr. Griffin, and 12-IPA1210402, to Dr. Grijalva) and the Thrasher Research Fund (02832-9, to Dr. Grijalva).; Dr. Grijalva reports receiving consulting fees from Glaxo-SmithKline and grant support through his institution from Pfizer; and Dr. Griffin, grant support through her institution from Pfizer. No other potential conflict of interest relevant to this article was reported.	Agency for Healthcare Research and Quality (US), 2009, FACTS FIG STAT HOSP; Bartlett JG, 2011, CLIN INFECT DIS, V52, pS296, DOI 10.1093/cid/cir045; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Bewick T, 2012, THORAX, V67, P540, DOI 10.1136/thoraxjnl-2011-201092; Centers for Disease Control and Prevention, SEAS INFL FLU VACC T; Cohen AL, 2010, AIDS, V24, P2253, DOI 10.1097/QAD.0b013e32833d46fd; Feikin DR, 2005, CLIN INFECT DIS, V41, P481, DOI 10.1086/432015; French N, 2010, NEW ENGL J MED, V362, P812, DOI 10.1056/NEJMoa0903029; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Grijalva CG, 2006, PEDIATRICS, V118, P865, DOI 10.1542/peds.2006-0492; Grijalva CG, 2010, CLIN INFECT DIS, V50, P805, DOI 10.1086/650573; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Jardine A, 2010, PEDIATR INFECT DIS J, V29, P607, DOI 10.1097/INF.0b013e3181d7d09c; Kayhty H, 2006, EXPERT REV VACCINES, V5, P651, DOI 10.1586/14760584.5.5.651; Klugman K P, 2001, Lancet Infect Dis, V1, P85, DOI 10.1016/S1473-3099(01)00063-9; Koshy E, 2010, THORAX, V65, P770, DOI 10.1136/thx.2010.137802; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; Muhammad Riyadh D, 2013, Clin Infect Dis, V56, pe59, DOI 10.1093/cid/cis971; Musher DM, 2012, CLIN INFECT DIS, V55, P265, DOI 10.1093/cid/cis364; O'Brien KL, 2009, PEDIATR INFECT DIS J, V28, P463, DOI 10.1097/INF.0b013e31819b9085; Pelton SI, 2004, PEDIATR INFECT DIS J, V23, P1015, DOI 10.1097/01.inf.0000143645.58215.f0; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Poehling KA, 2004, PEDIATRICS, V114, P755, DOI 10.1542/peds.2003-0592-F; Potter R., 2009, Morbidity and Mortality Weekly Report, V58, P1059; Rosen JB, 2011, CLIN INFECT DIS, V53, P137, DOI 10.1093/cid/cir326; Shapiro ED, 2012, JAMA-J AM MED ASSOC, V307, P847, DOI 10.1001/jama.2012.194; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Wroe PC, 2012, PEDIATR INFECT DIS J, V31, P249, DOI 10.1097/INF.0b013e31824214ac; Zhou FJ, 2007, ARCH PEDIAT ADOL MED, V161, P1162, DOI 10.1001/archpedi.161.12.1162	37	371	385	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					155	163		10.1056/NEJMoa1209165	http://dx.doi.org/10.1056/NEJMoa1209165			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180BH	23841730	Green Accepted			2022-12-01	WOS:000321567300011
J	Hasuwa, H; Ueda, J; Ikawa, M; Okabe, M				Hasuwa, Hidetoshi; Ueda, Jun; Ikawa, Masahito; Okabe, Masaru			MiR-200b and miR-429 Function in Mouse Ovulation and Are Essential for Female Fertility	SCIENCE			English	Article							MICRORNAS; MICE; INFERTILITY; FAMILY; CELLS; ZEB1	Ovulation in the mouse and other mammals is controlled by hormones secreted by the hypothalamo-pituitary-ovarian axis. We describe anovulation and infertility in female mice lacking the microRNAs miR-200b and miR-429. Both miRNAs are strongly expressed in the pituitary gland, where they suppress expression of the transcriptional repressor ZEB1. Eliminating these miRNAs, in turn, inhibits luteinizing hormone (LH) synthesis by repressing transcription of its beta-subunit gene, which leads to lowered serum LH concentration, an impaired LH surge, and failure to ovulate. Our results reveal roles for miR-200b and miR-429, and their target the Zeb1 gene, in the regulation of mammalian reproduction. Thus, the hypothalamo-pituitary-ovarian axis was shown to require miR-200b and miR-429 to support ovulation.	[Hasuwa, Hidetoshi; Ueda, Jun; Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Osaka University	Okabe, M (corresponding author), Osaka Univ, Microbial Dis Res Inst, Yamadaoka 3-1, Suita, Osaka 5650871, Japan.	okabe@biken.osaka-u.ac.jp	Hasuwa, Hidetoshi/B-1083-2009; ikawa, masahito/A-5315-2009; Ueda, Jun/AAX-9704-2020; Ueda, Jun/G-1670-2010; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Ueda, Jun/0000-0002-9766-203X; Ueda, Jun/0000-0002-9766-203X; Okabe, Masaru/0000-0002-0803-9044	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science KAKENHI [20062008, 20700364, 18700397, 24115710]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the late N. B. Hecht for critical reading of the manuscript and Y. Esaki and Y. Maruyama for preparing the KO and TG mice. We also thank T. Miyazawa and T. Yoshida of Kyowa Hakko Kirin Co., Ltd. for analyzing the miRNA target predictions. This work was supported by Ministry of Education, Culture, Sports, Science and Technology of Japan and the Japan Society for the Promotion of Science KAKENHI; grant numbers 20062008, 20700364, 18700397, and 24115710. The miR-DKO mice (RBRC05917) are available from RIKEN BioResource Center with a materials transfer agreement.	Alarid ET, 1996, DEVELOPMENT, V122, P3319; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Christian CA, 2005, P NATL ACAD SCI USA, V102, P15682, DOI 10.1073/pnas.0504270102; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kubosaki A, 2006, ENDOCRINOLOGY, V147, P811, DOI 10.1210/en.2005-0638; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Park CY, 2010, HUM MOL GENET, V19, pR169, DOI 10.1093/hmg/ddq367; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; SEKIDO R, 1994, MOL CELL BIOL, V14, P5692, DOI 10.1128/MCB.14.9.5692; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	16	122	132	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					71	73		10.1126/science.1237999	http://dx.doi.org/10.1126/science.1237999			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23765281				2022-12-01	WOS:000321291700050
J	James, MT; Tonelli, M; Ghali, WA; Knudtson, ML; Faris, P; Manns, BJ; Pannu, N; Galbraith, PD; Hemmelgarn, BR				James, Matthew T.; Tonelli, Marcello; Ghali, William A.; Knudtson, Merril L.; Faris, Peter; Manns, Braden J.; Pannu, Neesh; Galbraith, P. Diane; Hemmelgarn, Brenda R.		Alberta Prov Project Outcome Asses; Alberta Kidney Dis Network Investi	Renal outcomes associated with invasive versus conservative management of acute coronary syndrome: propensity matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE KIDNEY INJURY; CONTRAST-INDUCED NEPHROPATHY; ACUTE MYOCARDIAL-INFARCTION; ARTERY-DISEASE; SERUM CREATININE; RISK SCORE; INTERVENTION; STRATEGY; INSUFFICIENCY; ANGIOGRAPHY	Objectives To examine the association of early invasive management of acute coronary syndrome with adverse renal outcomes and survival, and to determine whether the risks or benefits of early invasive management differ in people with pre-existing chronic kidney disease. Design Propensity score matched cohort study. Setting Acute care hospitals in Alberta, Canada, 2004-09. Participants 10 516 adults with non-ST elevation acute coronary syndrome. Interventions Participants were stratified by baseline estimated glomerular filtration rate and matched 1:1 on their propensity score for early invasive management (coronary catheterisation within two days of hospital admission). Main outcome measures Risks of acute kidney injury, kidney injury requiring dialysis, progression to end stage renal disease, and all cause mortality were compared between those who received early invasive treatment versus conservative treatment. Results Of 10 516 included participants, 4276 (40.7%) received early invasive management. After using propensity score methods to assemble a matched cohort of conservative management participants with characteristics similar to those who received early invasive management (n=6768), early invasive management was associated with an increased risk of acute kidney injury (10.3% v 8.7%, risk ratio 1.18, 95% confidence interval 1.03 to 1.36; P=0.019), but no difference in the risk of acute kidney injury requiring dialysis (0.4% v 0.3%, 1.20, 0.52 to 2.78; P=0.670). Over a median follow-up of 2.5 years, the risk of progression to end stage renal disease did not differ between the groups (0.3 v 0.4 events per 100 person years, hazard ratio 0.91, 95% confidence interval 0.55 to 1.49; P=0.712); however, early invasive management was associated with reduced long term mortality (2.4 v 3.4 events per 100 person years, 0.69, 0.58 to 0.82; P<0.001). These associations were consistent among people with pre-existing reduced estimated glomerular filtration rate and with alternate definitions for early invasive management. Conclusions Compared with conservative management, early invasive management of acute coronary syndrome is associated with a small increase in risk of acute kidney injury but not dialysis or long term progression to end stage renal disease.	[James, Matthew T.; Ghali, William A.; Knudtson, Merril L.; Manns, Braden J.; Hemmelgarn, Brenda R.] Univ Calgary, Foothills Med Ctr, Dept Med, Calgary, AB T2N 2T9, Canada; [James, Matthew T.; Ghali, William A.; Faris, Peter; Manns, Braden J.; Galbraith, P. Diane; Hemmelgarn, Brenda R.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 2T9, Canada; [Tonelli, Marcello; Pannu, Neesh] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Calgary; University of Calgary; University of Alberta	James, MT (corresponding author), Univ Calgary, Foothills Med Ctr, Dept Med, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.	mjames@ucalgary.ca	Tonelli, Marcello/B-3028-2009; Faris, Peter/AAJ-3436-2020	Tonelli, Marcello/0000-0002-0846-3187; Faris, Peter/0000-0001-5208-817X	Kidney Foundation of Canada	Kidney Foundation of Canada	This study was funded by the Kidney Foundation of Canada. The study funder had no role in the study design; the collection, analysis, and interpretation of data; the writing of the report; and the decision to submit the article for publication. All authors, external and internal, had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis. All researchers acted independently of funders.	Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Austin PC, 2008, CIRC-CARDIOVASC QUAL, V1, P62, DOI 10.1161/CIRCOUTCOMES.108.790634; Bartholomew BA, 2004, AM J CARDIOL, V93, P1515, DOI 10.1016/j.amjcard.2004.03.008; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Chertow GM, 2004, J AM SOC NEPHROL, V15, P2462, DOI 10.1097/01.ASN.0000135969.33773.0B; Dangas G, 2005, AM J CARDIOL, V95, P13, DOI 10.1016/j.amjcard.2004.08.056; Finn William F, 2006, Nephrol Dial Transplant, V21, pi2, DOI 10.1093/ndt/gfl213; Fox CS, 2010, CIRCULATION, V121, P357, DOI 10.1161/CIRCULATIONAHA.109.865352; Fox KAA, 2007, HEART, V93, P177, DOI 10.1136/hrt.2005.084830; Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4; Ghali WA, 2000, CAN J CARDIOL, V16, P1225; Gruberg L, 2000, J AM COLL CARDIOL, V36, P1542, DOI 10.1016/S0735-1097(00)00917-7; Hemmelgarn BR, 2004, CIRCULATION, V110, P1890, DOI 10.1161/01.CIR.0000143629.55725.D9; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hoenig MR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004815.pub3; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Izaks GJ, 1999, JAMA-J AM MED ASSOC, V281, P1714, DOI 10.1001/jama.281.18.1714; Johnston N, 2006, AM HEART J, V152, P1052, DOI 10.1016/j.ahj.2006.07.014; Lagerqvist B, 2005, HEART, V91, P1047, DOI 10.1136/hrt.2003.031369; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2007, AM J KIDNEY DIS, V50, P1, DOI 10.1053/j.ajkd.2007.05.008; Liistro F, 2005, HEART, V91, P1284, DOI 10.1136/hrt.2004.051607; Manns BJ, 2001, CLIN INVEST MED, V24, P164; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Norris CM, 2000, J CLIN EPIDEMIOL, V53, P377, DOI 10.1016/S0895-4356(99)00181-X; Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Southern DA, 2006, J CLIN EPIDEMIOL, V59, P1110, DOI 10.1016/j.jclinepi.2006.07.002; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wallentin L, 1999, LANCET, V354, P708; Weisbord SD, 2006, J AM SOC NEPHROL, V17, P2871, DOI 10.1681/ASN.2006030301; Wong JA, 2009, EUR HEART J, V30, P549, DOI 10.1093/eurheartj/ehp014	37	21	21	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2013	347								f4151	10.1136/bmj.f4151	http://dx.doi.org/10.1136/bmj.f4151			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180DN	23833076	hybrid, Green Published			2022-12-01	WOS:000321573400002
J	Lee, EJ; Pontes, MH; Groisman, EA				Lee, Eun-Jin; Pontes, Mauricio H.; Groisman, Eduardo A.			A Bacterial Virulence Protein Promotes Pathogenicity by Inhibiting the Bacterium's Own F1Fo ATP Synthase	CELL			English	Article							SALMONELLA-TYPHIMURIUM; MYCOBACTERIUM-TUBERCULOSIS; F1F0-ATP SYNTHASE; MGTC; MAGNESIUM; ENTERICA; EXPRESSION; SURVIVAL; GROWTH; LOCUS	Several intracellular pathogens, including Salmonella enterica and Mycobacterium tuberculosis, require the virulence protein MgtC to survive within macrophages and to cause a lethal infection in mice. We now report that, unlike secreted virulence factors that target the host vacuolar ATPase to withstand phagosomal acidity, the MgtC protein acts on Salmonella's own F1Fo ATP synthase. This complex couples proton translocation to ATP synthesis/hydrolysis and is required for virulence. We establish that MgtC interacts with the a subunit of the F1Fo ATP synthase, hindering ATP-driven proton translocation and NADH-driven ATP synthesis in inverted vesicles. An mgtC null mutant displays heightened ATP levels and an acidic cytoplasm, whereas mgtC overexpression decreases ATP levels. A single amino acid substitution in MgtC that prevents binding to the F1Fo ATP synthase abolishes control of ATP levels and attenuates pathogenicity. MgtC provides a singular example of a virulence protein that promotes pathogenicity by interfering with another virulence protein.	[Lee, Eun-Jin; Groisman, Eduardo A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06536 USA; [Lee, Eun-Jin; Pontes, Mauricio H.; Groisman, Eduardo A.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA; [Lee, Eun-Jin; Pontes, Mauricio H.; Groisman, Eduardo A.] Yale Microbial Divers Inst, West Haven, CT 06516 USA; [Lee, Eun-Jin] Kyung Hee Univ, Coll Life Sci, Dept Genet Engn, Yongin 446701, South Korea	Howard Hughes Medical Institute; Yale University; Yale University; Kyung Hee University	Groisman, EA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06536 USA.	eduardo.groisman@yale.edu	Pontes, Mauricio H./AAV-1024-2020	Pontes, Mauricio H./0000-0002-2618-2039	National Institutes of Health [AI49561]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Xuanlin Tu for the crosslinking experiments, Dr. John Walker and Dr. Gregory Cook for comments on the manuscript, and anonymous reviewers for valuable suggestions. This work was supported, in part, by grant AI49561 from the National Institutes of Health to E.A.G., who is an investigator of the Howard Hughes Medical Institute.	Alix E, 2008, EMBO J, V27, P546, DOI 10.1038/sj.emboj.7601983; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Alteri CJ, 2011, MOL MICROBIOL, V82, P145, DOI 10.1111/j.1365-2958.2011.07804.x; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Blanc-Potard AB, 2003, J MOL EVOL, V57, P479, DOI 10.1007/s00239-003-2496-4; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Davis R., 1980, ADV BACTERIAL GENETI; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; FOSTER JW, 1991, J BACTERIOL, V173, P5129, DOI 10.1128/jb.173.16.5129-5135.1991; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gunzel D, 2006, J BACTERIOL, V188, P5586, DOI 10.1128/JB.00296-06; Harold F. M., 1996, ESCHERICHIA COLI SAL, P283; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Kumar Y, 2009, CELL HOST MICROBE, V5, P593, DOI 10.1016/j.chom.2009.05.014; Kuruma Y, 2012, BIOCHEM J, V442, P631, DOI 10.1042/BJ20111284; Lavigne JP, 2005, INFECT IMMUN, V73, P3160, DOI 10.1128/IAI.73.5.3160-3163.2005; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Lee EJ, 2012, MOL MICROBIOL, V86, P212, DOI 10.1111/j.1365-2958.2012.08188.x; Lee EJ, 2012, NATURE, V486, P271, DOI 10.1038/nature11090; Lee EJ, 2010, MOL MICROBIOL, V76, P1020, DOI 10.1111/j.1365-2958.2010.07161.x; Maloney KE, 2006, INFECT IMMUN, V74, P5477, DOI 10.1128/IAI.00798-06; Moncrief MBC, 1998, INFECT IMMUN, V66, P3802, DOI 10.1128/IAI.66.8.3802-3809.1998; Northen H, 2010, VACCINE, V28, P940, DOI 10.1016/j.vaccine.2009.10.146; Rang C, 2007, MOL MICROBIOL, V63, P605, DOI 10.1111/j.1365-2958.2006.05542.x; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Rathman M, 1996, INFECT IMMUN, V64, P2765, DOI 10.1128/IAI.64.7.2765-2773.1996; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; SNAVELY MD, 1991, J BIOL CHEM, V266, P815; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105; TAO T, 1995, J BACTERIOL, V177, P2654, DOI 10.1128/jb.177.10.2654-2662.1995; Turner AK, 2003, INFECT IMMUN, V71, P3392, DOI 10.1128/IAI.71.6.3392-3401.2003; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h	40	104	106	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					146	156		10.1016/j.cell.2013.06.004	http://dx.doi.org/10.1016/j.cell.2013.06.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827679	Green Accepted, Bronze			2022-12-01	WOS:000321327900016
J	Wiener, RS; Schwartz, LM; Woloshin, S				Wiener, Renda Soylemez; Schwartz, Lisa M.; Woloshin, Steven			When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEEP-VEIN THROMBOSIS; COMPUTED-TOMOGRAPHY; EMERGENCY-DEPARTMENT; CLINICAL-OUTCOMES; MANAGEMENT; DIAGNOSIS; PREVALENCE; MORTALITY; TRENDS; OVERDIAGNOSIS		[Wiener, Renda Soylemez] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Wiener, Renda Soylemez] ENRM VA Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA USA; [Schwartz, Lisa M.; Woloshin, Steven] Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Schwartz, Lisa M.; Woloshin, Steven] VA Med Ctr, VA Outcomes Grp, White River Jct, VT USA	Boston University; Dartmouth College; VA Outcomes Group	Wiener, RS (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.	rwiener@bu.edu	Wiener, Renda/AAO-1557-2020	Wiener, Renda/0000-0001-7712-2135	NCI NIH HHS [K07 CA138772, U19CA79689] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA138772, U19CA079689] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams DM, 2013, AM J MED, V126, P36, DOI 10.1016/j.amjmed.2012.05.028; Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743; Auer RC, 2009, J AM COLL SURGEONS, V208, P871, DOI 10.1016/j.jamcollsurg.2008.12.030; Bullano Michael F, 2005, J Manag Care Pharm, V11, P663; Burge AJ, 2008, CLIN RADIOL, V63, P381, DOI 10.1016/j.crad.2007.10.004; Calder KK, 2005, ANN EMERG MED, V45, P302, DOI 10.1016/j.annemergmed.2004.10.001; Campbell IA, 2003, THORAX, V58, P470; Carrier M, 2010, J THROMB HAEMOST, V8, P1716, DOI 10.1111/j.1538-7836.2010.03938.x; DeMonaco NA, 2008, AM J MED, V121, P611, DOI 10.1016/j.amjmed.2008.02.035; Donato AA, 2010, THROMB RES, V126, pE266, DOI 10.1016/j.thromres.2010.07.001; Duff Wilson A., 2010, SEATTLE TIMES; Gage BF, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6980; Ghaye B, 2007, JBR-BTR, V90, P100; Goodman LR, 2005, RADIOLOGY, V234, P654, DOI 10.1148/radiol.2343041326; Gottlieb RH, 2005, AM J ROENTGENOL, V185, P1399, DOI 10.2214/AJR.05.0482; Hall WB, 2009, ARCH INTERN MED, V169, P1961, DOI 10.1001/archinternmed.2009.360; HANDLER JA, 1995, POSTGRAD MED, V97, P61, DOI 10.1080/00325481.1995.11945946; Heit JA, 2011, BLOOD, V118, P4992, DOI 10.1182/blood-2011-05-357343; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Lapner ST, 2013, BMJ-BRIT MED J, V346, pf757; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Minet C, 2012, CRIT CARE MED, V40, P3202, DOI 10.1097/CCM.0b013e318265e461; National Heart Lung and Blood Institute, WHAT IS PULM EMB; Park B, 2009, CHEST, V136, P983, DOI 10.1378/chest.08-2258; Parvizi J, 2007, CLIN ORTHOP RELAT R, P107, DOI 10.1097/BLO.0b013e318145af41; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; PreventDVT.org, COAL PREV DEEP VEIN; Prologo JD, 2004, AM J ROENTGENOL, V183, P1093, DOI 10.2214/ajr.183.4.1831093; Raja AS, 2012, RADIOLOGY, V262, P468, DOI 10.1148/radiol.11110951; Remy-Jardin M, 2007, RADIOLOGY, V245, P315, DOI 10.1148/radiol.2452070397; Ritchie G, 2007, THORAX, V62, P536, DOI 10.1136/thx.2006.062299; ROBIN ED, 1977, ANN INTERN MED, V87, P775, DOI 10.7326/0003-4819-87-6-775; Rohacek M, 2012, INTENS CARE MED, V38, P1345, DOI 10.1007/s00134-012-2595-z; Schultz DJ, 2004, J TRAUMA, V56, P727, DOI 10.1097/01.TA.0000119687.23542.EC; Sheh SH, 2012, AM J ROENTGENOL, V198, P1340, DOI 10.2214/AJR.11.6426; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Stein EG, 2010, AM J ROENTGENOL, V194, P392, DOI 10.2214/AJR.09.2499; Stein PD, 2012, CLIN APPL THROMB-HEM, V18, P20, DOI 10.1177/1076029611422363; Stein PD, 2003, ARCH INTERN MED, V163, P1213, DOI 10.1001/archinte.163.10.1213; Stein PD, 1997, CHEST, V111, P1246, DOI 10.1378/chest.111.5.1246; Tapson VF, 2011, ARCH INTERN MED, V171, P837, DOI 10.1001/archinternmed.2011.174; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Weiss CR, 2006, ACAD RADIOL, V13, P434, DOI 10.1016/j.acra.2006.01.002; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wiener RS, 2011, ARCH INTERN MED, V171, P831, DOI 10.1001/archinternmed.2011.178; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414	49	131	133	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2013	347								f3368	10.1136/bmj.f3368	http://dx.doi.org/10.1136/bmj.f3368			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180CL	23820021	Green Published, Bronze			2022-12-01	WOS:000321570400001
J	Maddaluno, L; Rudini, N; Cuttano, R; Bravi, L; Giampietro, C; Corada, M; Ferrarini, L; Orsenigo, F; Papa, E; Boulday, G; Tournier-Lasserve, E; Chapon, F; Richichi, C; Retta, SF; Lampugnani, MG; Dejana, E				Maddaluno, Luigi; Rudini, Noemi; Cuttano, Roberto; Bravi, Luca; Giampietro, Costanza; Corada, Monica; Ferrarini, Luca; Orsenigo, Fabrizio; Papa, Eleanna; Boulday, Gwenola; Tournier-Lasserve, Elisabeth; Chapon, Francoise; Richichi, Cristina; Retta, Saverio Francesco; Lampugnani, Maria Grazia; Dejana, Elisabetta			EndMT contributes to the onset and progression of cerebral cavernous malformations	NATURE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BLOOD-BRAIN-BARRIER; GROWTH-FACTOR; VASCULAR INTEGRITY; SIGNALING PATHWAY; BETA-CATENIN; VE-CADHERIN; CANCER; CELLS; EXPRESSION	Cerebral cavernous malformation (CCM) is a vascular dysplasia, mainly localized within the brain and affecting up to 0.5% of the human population. CCM lesions are formed by enlarged and irregular blood vessels that often result in cerebral haemorrhages. CCM is caused by loss-of-function mutations in one of three genes, namely CCM1 (also known as KRIT1), CCM2 (OSM) and CCM3 (PDCD10), and occurs in both sporadic and familial forms(1). Recent studies(2-7) have investigated the cause of vascular dysplasia and fragility in CCM, but the in vivo functions of this ternary complex remain unclear(8). Postnatal deletion of any of the three Ccm genes in mouse endothelium results in a severe phenotype, characterized by multiple brain vascular malformations that are markedly similar to human CCM lesions(9). Endothelial-to-mesenchymal transition (EndMT) has been described in different pathologies, and it is defined as the acquisition of mesenchymal- and stem-cell-like characteristics by the endothelium(10-12). Here we show that endothelial-specific disruption of the Ccm1 gene in mice induces EndMT, which contributes to the development of vascular malformations. EndMT in CCM1-ablated endothelial cells is mediated by the upregulation of endogenous BMP6 that, in turn, activates the transforming growth factor-beta (TGF-beta) and bone morphogenetic protein (BMP) signalling pathway. Inhibitors of the TGF-beta and BMP pathway prevent EndMT both in vitro and in vivo and reduce the number and size of vascular lesions in CCM1-deficient mice. Thus, increased TGF-beta and BMP signalling, and the consequent EndMT of CCM1-null endothelial cells, are crucial events in the onset and progression of CCM disease. These studies offer novel therapeutic opportunities for this severe, and so far incurable, pathology.	[Maddaluno, Luigi; Rudini, Noemi; Cuttano, Roberto; Bravi, Luca; Giampietro, Costanza; Corada, Monica; Ferrarini, Luca; Orsenigo, Fabrizio; Papa, Eleanna; Lampugnani, Maria Grazia; Dejana, Elisabetta] IFOM Fdn, FIRC Inst Mol Oncol, I-20139 Milan, Italy; [Boulday, Gwenola; Tournier-Lasserve, Elisabeth] INSERM, UMR S740, F-75010 Paris, France; [Boulday, Gwenola; Tournier-Lasserve, Elisabeth] Univ Paris Diderot, Sorbonne Paris Cite, Genet Malad Vasc UMR S740, F-75010 Paris, France; [Tournier-Lasserve, Elisabeth] Grp Hosp St Louis Lariboisiere Fernand Widal, AP HP, F-75010 Paris, France; [Chapon, Francoise] CHU Caen, Dept Pathol, F-14032 Caen, France; [Richichi, Cristina] IEO European Inst Oncol, I-20139 Milan, Italy; [Retta, Saverio Francesco] Univ Turin, CCM Italia Dept Clin & Biol Sci, I-10043 Turin, Italy; [Lampugnani, Maria Grazia] Mario Negri Inst Pharmacol Res, I-20156 Milan, Italy; [Dejana, Elisabetta] Univ Milan, Dept Biosci, I-20133 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; Universite de Caen Normandie; IRCCS European Institute of Oncology (IEO); University of Turin; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan	Dejana, E (corresponding author), IFOM Fdn, FIRC Inst Mol Oncol, I-20139 Milan, Italy.	luigi.maddaluno@ifom.eu; elisabetta.dejana@ifom.eu	Retta, Saverio Francesco/Q-4770-2019; Giampietro, Costanza/D-4643-2016; Dejana, Elisabetta/A-6274-2016; Cuttano, Roberto/B-5884-2017; Cuttano, Roberto/AAT-4778-2021; Boulday, Gwenola/AAV-3768-2020; Tournier-Lasserve, Elisabeth/N-7134-2017	Retta, Saverio Francesco/0000-0001-9761-2959; Giampietro, Costanza/0000-0001-5229-3835; Cuttano, Roberto/0000-0003-4150-2114; Boulday, Gwenola/0000-0002-5591-1659; Tournier-Lasserve, Elisabeth/0000-0002-3039-1677; Orsenigo, Fabrizio/0000-0001-9135-8478; DEJANA, ELISABETTA/0000-0002-0007-0426; Lampugnani, Maria Grazia/0000-0002-4802-7064; Corada, Monica/0000-0001-8220-0871	Fondation Leducq Transatlantic Network of Excellence; Associazione Italiana per la Ricerca sul Cancro (AIRC); 'Special Program Molecular Clinical Oncology 5x1000' to AIRC-Gruppo Italiano Malattie Mieloproliferative (AGIMM); European Community: European Research Council (ERC) [268870, ERC-2010-SdG]; EU [202213, 223098, ENDOSTEM-HEALTH-2009-241440, JUSTBRAIN-HEALTH-2009-241861]; CARIPLO Foundation	Fondation Leducq Transatlantic Network of Excellence(Leducq Foundation); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); 'Special Program Molecular Clinical Oncology 5x1000' to AIRC-Gruppo Italiano Malattie Mieloproliferative (AGIMM)(Fondazione AIRC per la ricerca sul cancro); European Community: European Research Council (ERC); EU(European Commission); CARIPLO Foundation(Fondazione Cariplo)	This work was supported by grants from: Fondation Leducq Transatlantic Network of Excellence, Associazione Italiana per la Ricerca sul Cancro (AIRC) and a 'Special Program Molecular Clinical Oncology 5x1000' to AIRC-Gruppo Italiano Malattie Mieloproliferative (AGIMM); the European Community: European Research Council (ERC grant 268870 call identifier ERC-2010-SdG) (EU Networks: EUSTROKE-contract-202213, OPTISTEM-contract-223098, ENDOSTEM-HEALTH-2009-241440, ENDOSTEM-HEALTH-2009-241440, JUSTBRAIN-HEALTH-2009-241861, ITN-VESSEL), and the CARIPLO Foundation. We are strongly indebted to R. Adams and D. A. Melton for sharing Cdh5(PAC)-CreERT2 and NotchIC mice, respectively. We are grateful to M. Forni and the Italian research network for Cerebral Cavernous Malformation (CCM Italia; http://www.ccmitalia.unito.it) for contributing to the study with important biological materials.	Ao A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041627; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Boulday G, 2011, J EXP MED, V208, P1835, DOI 10.1084/jem.20110571; BUSSOLINO F, 1991, J IMMUNOL, V147, P2122; Chan AC, 2011, J CLIN INVEST, V121, P1871, DOI 10.1172/JCI44393; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Faurobert E, 2010, FEBS J, V277, P1084, DOI 10.1111/j.1742-4658.2009.07537.x; Felici A, 2003, EMBO J, V22, P4465, DOI 10.1093/emboj/cdg428; Gauger KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-59; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Korff T, 1999, J CELL SCI, V112, P3249; Korpal M, 2010, EUR J CANCER, V46, P1232, DOI 10.1016/j.ejca.2010.02.040; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329; Li YJ, 2007, J AM SOC NEPHROL, V18, P449, DOI 10.1681/ASN.2006030236; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liebner S, 2011, INT J DEV BIOL, V55, P467, DOI 10.1387/ijdb.103224sl; Lopez D, 2009, ARCH BIOCHEM BIOPHYS, V482, P77, DOI 10.1016/j.abb.2008.11.016; Louvi A, 2011, P NATL ACAD SCI USA, V108, P3737, DOI 10.1073/pnas.1012617108; Mariotti A, 2007, EXPERT OPIN INV DRUG, V16, P451, DOI 10.1517/13543784.16.4.451; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spagnuolo R, 2004, BLOOD, V103, P3005, DOI 10.1182/blood-2003-07-2459; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Tanaka H, 2010, ONCOL REP, V24, P1637, DOI 10.3892/or_00001028; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vivien C, 2012, J BIOL CHEM, V287, P7427, DOI 10.1074/jbc.M111.324368; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107; Yuan QJ, 2011, PHARMAZIE, V66, P961, DOI 10.1691/ph.2011.1535; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	37	323	335	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					492	+		10.1038/nature12207	http://dx.doi.org/10.1038/nature12207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23748444				2022-12-01	WOS:000320929400054
J	Nishihara, R; Lochhead, P; Kuchiba, A; Jung, S; Yamauchi, M; Liao, XY; Imamura, Y; Qian, ZR; Morikawa, T; Wang, ML; Spiegelman, D; Cho, E; Giovannucci, E; Fuchs, CS; Chan, AT; Ogino, S				Nishihara, Reiko; Lochhead, Paul; Kuchiba, Aya; Jung, Seungyoun; Yamauchi, Mai; Liao, Xiaoyun; Imamura, Yu; Qian, Zhi Rong; Morikawa, Teppei; Wang, Molin; Spiegelman, Donna; Cho, Eunyoung; Giovannucci, Edward; Fuchs, Charles S.; Chan, Andrew T.; Ogino, Shuji			Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISLAND METHYLATOR PHENOTYPE; MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; COLON-CANCER; MICROSATELLITE INSTABILITY; LINE-1 HYPOMETHYLATION; PIK3CA MUTATION; FAMILY-HISTORY; KRAS MUTATION; LIFE-STYLE; SURVIVAL	Importance Aspirin use reduces the risk of colorectal carcinoma. Experimental evidence implicates a role of RAF kinases in up-regulation of prostaglandin-endoperoxide synthase 2 (PTGS2, cyclooxygenase 2), suggesting that BRAF-mutant colonic cells might be less sensitive to the antitumor effects of aspirin than BRAF-wild-type neoplastic cells. Objective To examine whether the association of aspirin intake with colorectal cancer risk differs according to status of tumor BRAF oncogene mutation. Design and Setting We collected biennial questionnaire data on aspirin use and followed up participants in the Nurses' Health Study (from 1980) and the Health Professionals Follow-up Study (from 1986) until July 1, 2006, for cancer incidence and until January 1, 2012, for cancer mortality. Duplication-method Cox proportional cause-specific hazards regression for competing risks data was used to compute hazard ratios (HRs) for colorectal carcinoma incidence according to BRAF mutation status. Main Outcomes and Measures Incidence of colorectal cancer cases according to tumor BRAF mutation status. Results Among 127 865 individuals, with 3 165 985 person-years of follow-up, we identified 1226 incident rectal and colon cancers with available molecular data. Compared with nonuse, regular aspirin use was associated with lower BRAF-wild-type cancer risk (multivariable HR, 0.73; 95% CI, 0.64 to 0.83; age-adjusted incidence rate difference [RD], -9.7; 95% CI, -12.6 to -6.7 per 100 000 person-years). This association was observed irrespective of status of tumor PTGS2 expression or PIK3CA or KRAS mutation. In contrast, regular aspirin use was not associated with a lower risk of BRAF-mutated cancer (multivariable HR, 1.03; 95% CI, 0.76 to 1.38; age-adjusted, incidence RD, 0.7; 95% CI, -0.3 to 1.7 per 100 000 person-years: P for heterogeneity = .037, between BRAF-wild-type vs BRAF-mutated cancer risks). Compared with no aspirin use, aspirin use of more than 14 tablets per week was associated with a lower risk of BRAF-wild-type cancer (multivariable HR, 0.43; 95% CI, 0.25 to 0.75; age-adjusted incidence RD, -19.8; 95% CI, -26.3 to -13.3 per 100 000 person-years). The relationship between the number of aspirin tablets per week and colorectal cancer risk differed significantly by BRAF mutation status (P for heterogeneity = .005). Conclusions and Relevance Regular aspirin use was associated with lower risk of BRAF-wild-type colorectal cancer but not with BRAF-mutated cancer risk. These findings suggest that BRAF-mutant colon tumor cells may be less sensitive to the effect of aspirin. Given the modest absolute risk difference, further investigations are necessary to determine clinical implications of our findings.	[Nishihara, Reiko; Lochhead, Paul; Kuchiba, Aya; Yamauchi, Mai; Liao, Xiaoyun; Imamura, Yu; Qian, Zhi Rong; Morikawa, Teppei; Fuchs, Charles S.; Ogino, Shuji] Brigham & Womens Hosp, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Jung, Seungyoun; Wang, Molin; Spiegelman, Donna; Cho, Eunyoung; Giovannucci, Edward; Fuchs, Charles S.; Chan, Andrew T.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Nishihara, Reiko; Kuchiba, Aya; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Wang, Molin; Spiegelman, Donna; Giovannucci, Edward; Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wang, Molin; Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lochhead, Paul] Univ Aberdeen, Gastrointestinal Res Grp, Inst Med Sci, Aberdeen, Scotland; [Morikawa, Teppei] Tokyo Univ Hosp, Dept Pathol, Tokyo 113, Japan; [Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Aberdeen; University of Tokyo; Harvard University; Massachusetts General Hospital	Chan, AT (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, 55 Fruit St, Boston, MA 02114 USA.	achan@partners.org; shuji_ogino@dfci.harvard.edu	Chan, Andrew T/P-8293-2014; Cho, Eunyoung/AAV-4469-2020	Chan, Andrew T/0000-0001-7284-6767; Cho, Eunyoung/0000-0001-6594-2582; Qian, Zhi rong/0000-0003-1633-4120; Ogino, Shuji/0000-0002-3909-2323	National Institutes of Health (NIH) [P01 CA87969, P01 CA55075, UM1 CA167552, P50 CA127003, R01 CA137178, K24 DK098311, R01 CA151993]; Bennett Family Fund for Targeted Therapies Research; National Colorectal Cancer Research Alliance; Harvard University; Chief Scientist Office [CAF/10/15] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA169141, P01CA087969, P01CA055075, UM1CA167552, P50CA127003, R01CA137178, R01CA151993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, K24DK098311] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bennett Family Fund for Targeted Therapies Research; National Colorectal Cancer Research Alliance; Harvard University; Chief Scientist Office; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants P01 CA87969 to Dr Hankinson; P01 CA55075 and UM1 CA167552 to Dr Willett; P50 CA127003 to Dr Fuchs.; R01 CA137178 and K24 DK098311 to Dr Chan; and R01 CA151993 to Dr Ogino from the National Institutes of Health (NIH); the Bennett Family Fund for Targeted Therapies Research; and the National Colorectal Cancer Research Alliance. Dr Lochhead is a Scottish Government Clinical Academic Fellow and was supported by a Harvard University Frank Knox Memorial Fellowship. Dr Chan is a Damon Runyon Clinical Investigator.	Bosetti C, 2012, ANN ONCOL, V23, P1403, DOI 10.1093/annonc/mds113; Buchanan DD, 2013, CANCER EPIDEM BIOMAR, V22, P917, DOI 10.1158/1055-9965.EPI-12-1211; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Burnett-Hartman AN, 2013, CANCER RES, V73, P2863, DOI 10.1158/0008-5472.CAN-12-3462; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; Chang MS, 2009, PHARMACOL RES, V60, P247, DOI 10.1016/j.phrs.2009.03.015; Chia WK, 2012, NAT REV CLIN ONCOL, V9, P561, DOI 10.1038/nrclinonc.2012.137; Curtin K, 2011, NUTR CANCER, V63, P357, DOI 10.1080/01635581.2011.535965; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Funkhouser WK, 2012, J MOL DIAGN, V14, P91, DOI 10.1016/j.jmoldx.2011.11.001; Gavin PG, 2012, CLIN CANCER RES, V18, P6531, DOI 10.1158/1078-0432.CCR-12-0605; Gay LJ, 2012, J PATHOL, V228, P405, DOI 10.1002/path.4085; Hughes LAE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018571; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Liao XY, 2012, CLIN CANCER RES, V18, P2257, DOI 10.1158/1078-0432.CCR-11-2410; Morikawa T, 2011, JAMA-J AM MED ASSOC, V305, P1685, DOI 10.1001/jama.2011.513; Nosho K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003698; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2013, JNCI-J NATL CANCER I, V105, P130, DOI 10.1093/jnci/djs482; Ogino S, 2012, EXPERT REV MOL DIAGN, V12, P621, DOI [10.1586/erm.12.46, 10.1586/ERM.12.46]; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Phipps AI, 2012, CANCER EPIDEM BIOMAR, V21, P1792, DOI 10.1158/1055-9965.EPI-12-0674; Popovici V, 2012, J CLIN ONCOL, V30, P1288, DOI 10.1200/JCO.2011.39.5814; Razzak AA, 2012, NUTR CANCER, V64, P899, DOI 10.1080/01635581.2012.714833; Rosty C, 2013, MODERN PATHOL, V26, P825, DOI 10.1038/modpathol.2012.240; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Shigaki H, 2012, ANN SURG ONCOL, V19, P4238, DOI 10.1245/s10434-012-2488-y; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang Dingzhi, 2011, Cancers (Basel), V3, P3894, DOI 10.3390/cancers3043894; Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Zlobec I, 2011, J PATHOL, V225, P336, DOI 10.1002/path.2879	43	131	133	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2563	2571		10.1001/jama.2013.6599	http://dx.doi.org/10.1001/jama.2013.6599			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23800934	Green Accepted, Bronze			2022-12-01	WOS:000320848100026
J	Kvitsiani, D; Ranade, S; Hangya, B; Taniguchi, H; Huang, JZ; Kepecs, A				Kvitsiani, D.; Ranade, S.; Hangya, B.; Taniguchi, H.; Huang, J. Z.; Kepecs, A.			Distinct behavioural and network correlates of two interneuron types in prefrontal cortex	NATURE			English	Article							GABAERGIC NEURONS; PYRAMIDAL CELLS; CEREBRAL-CORTEX; IN-VIVO; INHIBITION; INFORMATION; COMPUTATION; RESPONSES; FEATURES; SUBTYPES	Neurons in the prefrontal cortex exhibit diverse behavioural correlates(1-4), an observation that has been attributed to cell-type diversity. To link identified neuron types with network and behavioural functions, we recorded from the two largest genetically defined inhibitory interneuron classes, the perisomatically targeting parvalbumin (PV) and the dendritically targeting somatostatin (SOM) neurons(5-8) in anterior cingulate cortex of mice performing a reward foraging task. Here we show that PV and a subtype of SOM neurons form functionally homogeneous populations showing a double dissociation between both their inhibitory effects and behavioural correlates. Out of several events pertaining to behaviour, a subtype of SOM neurons selectively responded at reward approach, whereas PV neurons responded at reward leaving and encoded preceding stay duration. These behavioural correlates of PV and SOM neurons defined a behavioural epoch and a decision variable important for foraging (whether to stay or to leave), a crucial function attributed to the anterior cingulate cortex(9-11). Furthermore, PV neurons could fire in millisecond synchrony, exerting fast and powerful inhibition on principal cell firing, whereas the inhibitory effect of SOM neurons on firing output was weak and more variable, consistent with the idea that they respectively control the outputs of, and inputs to, principal neurons(12-16). These results suggest a connection between the circuit-level function of different interneuron types in regulating the flow of information and the behavioural functions served by the cortical circuits. Moreover, these observations bolster the hope that functional response diversity during behaviour can in part be explained by cell-type diversity.	[Kvitsiani, D.; Ranade, S.; Hangya, B.; Taniguchi, H.; Huang, J. Z.; Kepecs, A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Kepecs, A (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	kepecs@cshl.edu	Core, Vector/CAF-4832-2022; Hangya, Balazs/H-5964-2019	Hangya, Balazs/0000-0003-2709-7407; Kvitsiani, Duda/0000-0003-3175-1774; Ranade, Sachin/0000-0002-5150-5776; Kepecs, Adam/0000-0003-0049-8120; Huang, Z. Josh/0000-0003-0592-028X	Klingenstein Foundation; John Merck Foundation; Sloan Foundation; Whitehall Foundation; National Institute of Neurological Disorders and Stroke (National Institutes of Health) [R01NS075531]; Swartz Foundation; The Robert Lee and Clara Guthrie Patterson Trust Postdoctoral Fellowship; Human Frontier Science Program; Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075531] Funding Source: NIH RePORTER	Klingenstein Foundation(Klingenstein Philanthropies); John Merck Foundation; Sloan Foundation(Alfred P. Sloan Foundation); Whitehall Foundation; National Institute of Neurological Disorders and Stroke (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swartz Foundation; The Robert Lee and Clara Guthrie Patterson Trust Postdoctoral Fellowship; Human Frontier Science Program(Human Frontier Science Program); Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Klingenstein, John Merck, Sloan and Whitehall Foundations to A. K. and the National Institute of Neurological Disorders and Stroke (National Institutes of Health) grant R01NS075531. B. H. received support from the Swartz Foundation and Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development (2007-2013). D. K. received support from The Robert Lee and Clara Guthrie Patterson Trust Postdoctoral Fellowship and Human Frontier Science Program(2008-2011). We are grateful to K. Deisseroth, E. Boyden, A. Reid and A. Zador for constructs, B. Burbach and R. Eifert for technical assistance, and to J. Lisman, B. Mensh, S. Shea and A. Zador for comments and discussions.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Endres DM, 2003, IEEE T INFORM THEORY, V49, P1858, DOI 10.1109/TIT.2003.813506; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Hangya B, 2010, J PHYSIOL-LONDON, V588, P4165, DOI 10.1113/jphysiol.2010.194274; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hartwich K, 2009, J NEUROSCI, V29, P9563, DOI 10.1523/JNEUROSCI.1397-09.2009; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Machens CK, 2010, J NEUROSCI, V30, P350, DOI 10.1523/JNEUROSCI.3276-09.2010; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; McGarry LM, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00012; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; Nikolic D, 2012, EUR J NEUROSCI, V35, P742, DOI 10.1111/j.1460-9568.2011.07987.x; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Van De Werd HJJM, 2010, BRAIN STRUCT FUNCT, V214, P339, DOI 10.1007/s00429-010-0247-z; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	44	278	278	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					363	+		10.1038/nature12176	http://dx.doi.org/10.1038/nature12176			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23708967	Green Accepted			2022-12-01	WOS:000320592900040
J	Parker, MJ				Parker, Martyn J.			PERSONAL VIEW We need an alternative to the Liverpool care pathway for patients who might recover	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Peterborough & Stamford Hosp NHS Fdn Trust, Peterborough City Hosp, Dept Orthopaed, Peterborough PE3 9GZ, Cambs, England		Parker, MJ (corresponding author), Peterborough & Stamford Hosp NHS Fdn Trust, Peterborough City Hosp, Dept Orthopaed, Peterborough PE3 9GZ, Cambs, England.	Martyn.Parker@pbh-tr.nhs.uk						Chinthapalli K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1184; National Institute for Health and Care Excellence, 2011, GUID COMM END LIF CA; Royal Brompton and Harefield NHS Foundation Trust, QUAL ACC 2010 11	3	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2013	346								f3702	10.1136/bmj.f3702	http://dx.doi.org/10.1136/bmj.f3702			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166VQ	23757741				2022-12-01	WOS:000320587600003
J	Galbraith, MD; Allen, MA; Bensard, CL; Wang, XX; Schwinn, MK; Qin, B; Long, HW; Daniels, DL; Hahn, WC; Dowell, RD; Espinosa, JM				Galbraith, Matthew D.; Allen, Mary A.; Bensard, Claire L.; Wang, Xiaoxing; Schwinn, Marie K.; Qin, Bo; Long, Henry W.; Daniels, Danette L.; Hahn, William C.; Dowell, Robin D.; Espinosa, Joaquin M.			HIF1A Employs CDK8-Mediator to Stimulate RNAPII Elongation in Response to Hypoxia	CELL			English	Article							BROMODOMAIN PROTEIN BRD4; POLYMERASE-II CTD; TRANSCRIPTION ELONGATION; P-TEFB; COMPLEX; CDK8; RECRUITMENT; COACTIVATOR; INITIATION; BINDING	The transcription factor HIF1A is a key mediator of the cellular response to hypoxia. Despite the importance of HIF1A in homeostasis and various pathologies, little is known about how it regulates RNA polymerase II (RNAPII). We report here that HIF1A employs a specific variant of the Mediator complex to stimulate RNAPII elongation. The Mediator-associated kinase CDK8, but not the paralog CDK19, is required for induction of many HIF1A target genes. HIF1A induces binding of CDK8-Mediator and the super elongation complex (SEC), containing AFF4 and CDK9, to alleviate RNAPII pausing. CDK8 is dispensable for HIF1A chromatin binding and histone acetylation, but it is essential for binding of SEC and RNAPII elongation. Global analysis of active RNAPII reveals that hypoxia-inducible genes are paused and active prior to their induction. Our results provide a mechanistic link between HIF1A and CDK8, two potent oncogenes, in the cellular response to hypoxia.	[Galbraith, Matthew D.; Allen, Mary A.; Bensard, Claire L.; Espinosa, Joaquin M.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Galbraith, Matthew D.; Allen, Mary A.; Bensard, Claire L.; Dowell, Robin D.; Espinosa, Joaquin M.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Allen, Mary A.; Dowell, Robin D.] Univ Colorado, Biofrontiers Inst, Boulder, CO 80309 USA; [Wang, Xiaoxing; Qin, Bo; Long, Henry W.; Hahn, William C.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Wang, Xiaoxing; Hahn, William C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Schwinn, Marie K.; Daniels, Danette L.] Promega Corp, Madison, WI 53711 USA; [Qin, Bo] Tongji Univ, Dept Bioinformat, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Promega Corporation; Tongji University	Espinosa, JM (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.	joaquin.espinosa@colorado.edu	Galbraith, Matthew D/I-3306-2019; Allen, Mary/AAQ-2364-2021	Galbraith, Matthew D/0000-0003-0485-3927; Allen, Mary/0000-0001-7490-0165; DOWELL, ROBIN/0000-0001-7665-9985	NSF [MCB-0842974, MCB-1243522]; NIH [RO1CA117907, RO1CA140545]; Butcher Seed Grant; Boettcher Foundation's Webb-Waring Biomedical Research program; DoD Breast Cancer Postdoctoral Fellowship [W81XWH-10-1-0062, 2T15LM009451]; Direct For Biological Sciences [1627615] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA140545, R01CA117907, P30CA046934] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Butcher Seed Grant; Boettcher Foundation's Webb-Waring Biomedical Research program; DoD Breast Cancer Postdoctoral Fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Shilatifard for AFF4 antibody, Dr. Taatjes and Dr. Lin for HeLa nuclear extracts and MED15 antibody, and Edward Head for helpful discussions. This work was supported primarily by NSF grants MCB-0842974 and MCB-1243522, and also by NIH RO1CA117907 grant (J.M.E.), a Butcher Seed Grant (J.M.E, R.D.D.), the Boettcher Foundation's Webb-Waring Biomedical Research program (R.D.D.), DoD Breast Cancer Postdoctoral Fellowship W81XWH-10-1-0062 (X.W.), 2T15LM009451 (M.A.A.), and NIH RO1CA140545 (W.C.H.). J.M.E. is an HHMI Early Career Scientist. W.C.H. is a consultant for Novartis. Promega Corporation is the commercial owner by assignment of patents of the HaloTag technology and its applications.	Adler AS, 2012, CANCER RES, V72, P2129, DOI 10.1158/0008-5472.CAN-11-3886; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Galbraith MD, 2010, TRANSCR-AUSTIN, V1, P4, DOI 10.4161/trns.1.1.12373; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Mukhopadhyay A, 2010, HUM GENET, V128, P281, DOI 10.1007/s00439-010-0848-x; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Westerling T, 2007, MOL CELL BIOL, V27, P6177, DOI 10.1128/MCB.01302-06; Xia XB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r113; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	40	218	222	0	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1327	1339		10.1016/j.cell.2013.04.048	http://dx.doi.org/10.1016/j.cell.2013.04.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746844	Bronze, Green Accepted			2022-12-01	WOS:000319979200016
J	Zhao, GP; Perilla, JR; Yufenyuy, EL; Meng, X; Chen, B; Ning, JY; Ahn, J; Gronenborn, AM; Schulten, K; Aiken, C; Zhang, PJ				Zhao, Gongpu; Perilla, Juan R.; Yufenyuy, Ernest L.; Meng, Xin; Chen, Bo; Ning, Jiying; Ahn, Jinwoo; Gronenborn, Angela M.; Schulten, Klaus; Aiken, Christopher; Zhang, Peijun			Mature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics	NATURE			English	Article							PROTEIN; CORE; RECONSTRUCTIONS; DOMAIN	Retroviral capsid proteins are conserved structurally but assemble into different morphologies(1). The mature human immunodeficiency virus-1 (HIV-1) capsid is best described by a 'fullerene cone' model(2,3), in which hexamers of the capsid protein are linked to form a hexagonal surface lattice that is closed by incorporating 12 capsid-protein pentamers. HIV-1 capsid protein contains an amino-terminal domain (NTD) comprising seven alpha-helices and a beta-hairpin(4,5), a carboxy-terminal domain (CTD) comprising four alpha-helices(6,7), and a flexible linker with a 3(10)-helix connecting the two structural domains(8). Structures of the capsid-protein assembly units have been determined by X-ray crystallography(9,10); however, structural information regarding the assembled capsid and the contacts between the assembly units is incomplete. Here we report the cryo-electron microscopy structure of a tubular HIV-1 capsid-protein assembly at 8 angstrom resolution and the three-dimensional structure of a native HIV-1 core by cryo-electron tomography. The structure of the tubular assembly shows, at the three-fold interface(11), a three-helix bundle with critical hydrophobic interactions. Mutagenesis studies confirm that hydrophobic residues in the centre of the three-helix bundle are crucial for capsid assembly and stability, and for viral infectivity. The cryo-electron-microscopy structures enable modelling by large-scale molecular dynamics simulation, resulting in all-atom models for the hexamer-of-hexamer and pentamer-of-hexamer elements as well as for the entire capsid. Incorporation of pentamers results in closer trimer contacts and induces acute surface curvature. The complete atomic HIV-1 capsid model provides a platform for further studies of capsid function and for targeted pharmacological intervention.	[Zhao, Gongpu; Meng, Xin; Ning, Jiying; Ahn, Jinwoo; Gronenborn, Angela M.; Zhang, Peijun] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Zhao, Gongpu; Yufenyuy, Ernest L.; Meng, Xin; Ning, Jiying; Ahn, Jinwoo; Gronenborn, Angela M.; Aiken, Christopher; Zhang, Peijun] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA; [Perilla, Juan R.; Schulten, Klaus] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Perilla, Juan R.; Schulten, Klaus] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Yufenyuy, Ernest L.; Aiken, Christopher] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Chen, Bo] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; [Zhang, Peijun] Univ Pittsburgh, Swanson Sch Engn, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Vanderbilt University; State University System of Florida; University of Central Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, PJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA.	kschulte@ks.uiuc.edu; chris.aiken@vanderbilt.edu; pez7@pitt.edu	Chen, Bo/AID-6923-2022; Chen, Bo/F-3573-2015; zhao, gongpu/B-8151-2012; NING, JIYING/L-3899-2016; Aiken, Christopher/Y-9252-2019	Chen, Bo/0000-0001-5589-2075; Perilla, Juan/0000-0003-1171-6816; Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [GM082251, GM085043, GM104601]; National Science Foundation [PHY0822613, MCB0744057, OCI 07-25070]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104601, R01GM085043, P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Schwerdtfeger for access to his software for creating fullerene models, T. Brosenitsch for reading the manuscript, and M. DeLucia and J. Mehrens for technical assistance. This work was supported by the National Institutes of Health (GM082251, GM085043 and GM104601) and the National Science Foundation (PHY0822613, MCB0744057). Large-scale molecular dynamics simulations were performed on the Blue Waters Computer, financed by the National Science Foundation (OCI 07-25070).	Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692; Bharat TAM, 2012, NATURE, V487, P385, DOI 10.1038/nature11169; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Byeon IJL, 2012, J AM CHEM SOC, V134, P6455, DOI 10.1021/ja300937v; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chen B, 2011, BIOPHYS J, V100, P3035, DOI 10.1016/j.bpj.2011.05.025; Du SC, 2011, J MOL BIOL, V406, P371, DOI 10.1016/j.jmb.2010.11.027; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Jiang JY, 2011, VIROLOGY, V421, P253, DOI 10.1016/j.virol.2011.09.012; Joshi A, 2006, J VIROL, V80, P7939, DOI 10.1128/JVI.00355-06; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Mastronarde DN, 2008, J MICROSC-OXFORD, V230, P212, DOI 10.1111/j.1365-2818.2008.01977.x; Meng X, 2011, JOVE-J VIS EXP, V54, pe3041, DOI 3010.3791/3041; Meng X, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002886; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Yeager M, 2011, J MOL BIOL, V410, P534, DOI 10.1016/j.jmb.2011.04.073	28	553	564	4	312	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2013	497	7451					643	646		10.1038/nature12162	http://dx.doi.org/10.1038/nature12162			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23719463	Green Accepted			2022-12-01	WOS:000319556100049
J	Haroon, MF; Hu, SH; Shi, Y; Imelfort, M; Keller, J; Hugenholtz, P; Yuan, ZG; Tyson, GW				Haroon, Mohamed F.; Hu, Shihu; Shi, Ying; Imelfort, Michael; Keller, Jurg; Hugenholtz, Philip; Yuan, Zhiguo; Tyson, Gene W.			Anaerobic oxidation of methane coupled to nitrate reduction in a novel archaeal lineage	NATURE			English	Article							IN-SITU HYBRIDIZATION; COENZYME-M REDUCTASE; OXIDIZING ARCHAEA; BACTERIA; COMMUNITY; MICROORGANISMS; NITRITE; GENOME; METATRANSCRIPTOMICS; METHANOGENESIS	Anaerobic oxidation of methane (AOM) is critical for controlling the flux of methane from anoxic environments. AOM coupled to iron(1), manganese(1) and sulphate(2) reduction have been demonstrated in consortia containing anaerobic methanotrophic (ANME) archaea. More recently it has been shown that the bacterium Candidatus 'Methylomirabilis oxyfera' can couple AOM to nitrite reduction through an intra-aerobic methane oxidation pathway(3). Bioreactors capable of AOM coupled to denitrification have resulted in the enrichment of 'M. oxyfera' and a novel ANME lineage, ANME-2d(4,5). However, as 'M. oxyfera' can independently couple AOM to denitrification, the role of ANME-2d in the process is unresolved. Here, a bioreactor fed with nitrate, ammonium and methane was dominated by a single ANME-2d population performing nitrate-driven AOM. Metagenomic, single-cell genomic and metatranscriptomic analyses combined with bioreactor performance and C-13- and N-15-labelling experiments show that ANME-2d is capable of independent AOM through reverse methanogenesis using nitrate as the terminal electron acceptor. Comparative analyses reveal that the genes for nitrate reduction were transferred laterally from a bacterial donor, suggesting selection for this novel process within ANME-2d. Nitrite produced by ANME-2d is reduced to dinitrogen gas through a syntrophic relationship with an anaerobic ammonium-oxidizing bacterium, effectively outcompeting 'M. oxyfera' in the system. We propose the name Candidatus 'Methanoperedens nitror-educens' for the ANME-2d population and the family Candidatus 'Methanoperedenaceae' for the ANME-2d lineage. We predict that 'M. nitroreducens' and other members of the 'Methanoperedenaceae' have an important role in linking the global carbon and nitrogen cycles in anoxic environments.	[Haroon, Mohamed F.; Imelfort, Michael; Hugenholtz, Philip; Tyson, Gene W.] Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogen, Brisbane, Qld 4072, Australia; [Hu, Shihu; Shi, Ying; Imelfort, Michael; Keller, Jurg; Yuan, Zhiguo; Tyson, Gene W.] Univ Queensland, Adv Water Management Ctr, Fac Engn Architecture & Informat Technol, Brisbane, Qld 4072, Australia; [Hugenholtz, Philip] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland; University of Queensland	Tyson, GW (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogen, Brisbane, Qld 4072, Australia.	z.yuan@awmc.uq.edu.au; g.tyson@uq.edu.au	Yuan, Zhiguo/AAO-1328-2021; Tyson, Gene W/C-6558-2013; Yuan, Zhiguo/C-4980-2013; Hugenholtz, Philip/AAD-9138-2019; Hugenholtz, Philip/G-9608-2011; Hu, Shihu/L-6085-2019	Tyson, Gene W/0000-0001-8559-9427; Yuan, Zhiguo/0000-0002-7566-1482; Hugenholtz, Philip/0000-0001-5386-7925; Hugenholtz, Philip/0000-0001-5386-7925; Hu, Shihu/0000-0002-1858-8872; Keller, Jurg/0000-0001-6796-0936	Australian Research Council (ARC) [DP0666762, DP0987204]; Australian Centre for Ecogenomics; ARC Queen Elizabeth II Fellowship [DP1093175]; ARC Discovery Outstanding Researcher Award [DP120103498]; China Scholarship Council	Australian Research Council (ARC)(Australian Research Council); Australian Centre for Ecogenomics; ARC Queen Elizabeth II Fellowship(Australian Research Council); ARC Discovery Outstanding Researcher Award(Australian Research Council); China Scholarship Council(China Scholarship Council)	We thank the ACE sequencing team; M. Butler, F. May and S. Low for their help with the 454 pyrosequencing, Illumina and Ion Torrent sequencing and the DOE Joint Genome Institute for single-cell sequencing. We also thank P. Lu for assistance with bioreactor operation, R. Zeng and P. Lant for their contribution to the development of initial bioreactors, B. Keller, J. Li, Y. Rui and Y. Wang for chemical and isotopic analyses, and D. Willner for assistance with genomic analysis. We are grateful to J. Euzeby for etymological advice. This work is supported by the Australian Research Council (ARC) through projects DP0666762 and DP0987204 and strategic funds from the Australian Centre for Ecogenomics. G. W. T. is supported by an ARC Queen Elizabeth II Fellowship (DP1093175). P. H. is supported by an ARC Discovery Outstanding Researcher Award (DP120103498). Y. S. is supported by the China Scholarship Council.	Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; BROOKS PD, 1989, SOIL SCI SOC AM J, V53, P1707, DOI 10.2136/sssaj1989.03615995005300060016x; Cabello P, 2004, MICROBIOL-SGM, V150, P3527, DOI 10.1099/mic.0.27303-0; Caldwell SL, 2008, ENVIRON SCI TECHNOL, V42, P6791, DOI 10.1021/es800120b; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Dekas AE, 2009, SCIENCE, V326, P422, DOI 10.1126/science.1178223; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; Hallam SJ, 2003, APPL ENVIRON MICROB, V69, P5483, DOI 10.1128/AEM.69.9.5483-5491.2003; Heller C, 2008, GEOMICROBIOL J, V25, P149, DOI 10.1080/01490450802006884; Hu SH, 2011, ENV MICROBIOL REP, V3, P315, DOI 10.1111/j.1758-2229.2010.00227.x; Hu SH, 2009, ENV MICROBIOL REP, V1, P377, DOI 10.1111/j.1758-2229.2009.00083.x; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kuenen JG, 2008, NAT REV MICROBIOL, V6, P320, DOI 10.1038/nrmicro1857; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luesken FA, 2011, APPL ENVIRON MICROB, V77, P6802, DOI 10.1128/AEM.05539-11; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Nauhaus K, 2005, ENVIRON MICROBIOL, V7, P98, DOI 10.1111/j.1462-2920.2004.00669.x; Orcutt B, 2008, ENVIRON MICROBIOL, V10, P1108, DOI 10.1111/j.1462-2920.2007.01526.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Scheller S, 2010, NATURE, V465, P606, DOI 10.1038/nature09015; Schmid M, 2001, ENVIRON MICROBIOL, V3, P450, DOI 10.1046/j.1462-2920.2001.00211.x; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; SMITH MR, 1983, J BACTERIOL, V156, P516, DOI 10.1128/JB.156.2.516-523.1983; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Stokke R, 2012, ENVIRON MICROBIOL, V14, P1333, DOI 10.1111/j.1462-2920.2012.02716.x; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Trotsenko YA, 2008, ADV APPL MICROBIOL, V63, P183, DOI 10.1016/S0065-2164(07)00005-6; Wu M, 2012, BIOINFORMATICS, V28, P1033, DOI 10.1093/bioinformatics/bts079; Yilmaz S, 2010, ISME J, V4, P1352, DOI 10.1038/ismej.2010.73	47	728	788	72	1216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					567	+		10.1038/nature12375	http://dx.doi.org/10.1038/nature12375			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23892779				2022-12-01	WOS:000323625900032
J	Yang, WT; Wang, JG; Moore, DC; Liang, HP; Dooner, M; Wu, Q; Terek, R; Chen, Q; Ehrlich, MG; Quesenberry, PJ; Neel, BG				Yang, Wentian; Wang, Jianguo; Moore, Douglas C.; Liang, Haipei; Dooner, Mark; Wu, Qian; Terek, Richard; Chen, Qian; Ehrlich, Michael G.; Quesenberry, Peter J.; Neel, Benjamin G.			Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling	NATURE			English	Article							OSSIFICATION GROOVE; RANVIER; CHONDROGENESIS; OSTEOGENESIS; RECEPTOR; PATHWAY; GROWTH; MUTANT; CELLS; MODEL	The tyrosine phosphatase SHP2, encoded by PTPN11, is required for the survival, proliferation and differentiation of various cell types(1,2). Germline activating mutations in PTPN11 cause Noonan syndrome, whereas somatic PTPN11 mutations cause childhood myeloproliferative disease and contribute to some solid tumours. Recently, heterozygous inactivating mutations in PTPN11 were found in metachondromatosis, a rare inherited disorder featuring multiple exostoses, enchondromas, joint destruction and bony deformities(3,4). The detailed pathogenesis of this disorder has remained unclear. Here we use a conditional knockout (floxed) Ptpn11 allele (Ptpn11(fl)) and Cre recombinase transgenic mice to delete Ptpn11 specifically in monocytes, macrophages and osteoclasts (lysozyme M-Cre; LysMCre) or in cathepsin K (Ctsk)-expressing cells, previously thought to be osteoclasts. LysMCre; Ptpn11(fl/fl) mice had mild osteopetrosis. Notably, however, CtskCre; Ptpn11(fl/fl) mice developed features very similar to metachondromatosis. Lineage tracing revealed a novel population of CtskCre-expressing cells in the perichondrial groove of Ranvier that display markers and functional properties consistent with mesenchymal progenitors. Chondroid neoplasms arise from these cells and show decreased extracellular signal-regulated kinase (ERK) pathway activation, increased Indian hedgehog (Ihh) and parathyroid hormone-related protein (Pthrp, also known as Pthlh) expression and excessive proliferation. Shp2-deficient chondroprogenitors had decreased fibroblast growth factor-evoked ERK activation and enhanced Ihh and Pthrp expression, whereas fibroblast growth factor receptor (FGFR) or mitogen-activated protein kinase kinase (MEK) inhibitor treatment of chondroid cells increased Ihh and Pthrp expression. Importantly, smoothened inhibitor treatment ameliorated metachondromatosis features in CtskCre; Ptpn11(fl/fl) mice. Thus, in contrast to its pro-oncogenic role in haematopoietic and epithelial cells, Ptpn11 is a tumour suppressor in cartilage, acting through a FGFR/MEK/ERK-dependent pathway in a novel progenitor cell population to prevent excessive Ihh production.	[Yang, Wentian; Wang, Jianguo; Moore, Douglas C.; Liang, Haipei; Terek, Richard; Chen, Qian; Ehrlich, Michael G.] Brown Univ, Alpert Med Sch, Dept Orthopaed, Providence, RI 02903 USA; [Yang, Wentian; Wang, Jianguo; Moore, Douglas C.; Liang, Haipei; Terek, Richard; Chen, Qian; Ehrlich, Michael G.] Rhode Isl Hosp, Providence, RI 02903 USA; [Dooner, Mark; Quesenberry, Peter J.] Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Dooner, Mark; Quesenberry, Peter J.] Rhode Isl Hosp, COBRE Ctr Stem Cell Biol, Providence, RI 02903 USA; [Dooner, Mark; Quesenberry, Peter J.] Brown Univ, Alpert Med Sch, Providence, RI 02903 USA; [Wu, Qian] Univ Connecticut, Ctr Hlth, Dept Pathol & Lab Med, Farmington, CT 06030 USA; [Neel, Benjamin G.] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Neel, Benjamin G.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; University of Connecticut; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Yang, WT (corresponding author), Brown Univ, Alpert Med Sch, Dept Orthopaed, Providence, RI 02903 USA.	wyang@lifespan.org	Chen, Qian/C-4354-2011	Chen, Qian/0000-0003-4406-5618; terek, richard/0000-0002-6322-6790; Dooner, Mark/0000-0003-0653-6562	National Institute for General Medicine Sciences (NIGMS) [8P20GM103468]; NIH [R21AR57156, R37CA49152]; Rhode Island Hospital Orthopaedic Foundation; Pediatric Orthopaedic Society of North America; Orthopaedic Research and Education Foundation; Ontario Ministry of Health and Long Term Care; Princess Margaret Cancer Foundation; NATIONAL CANCER INSTITUTE [R37CA049152] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR025179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR057156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937, P20GM103468] Funding Source: NIH RePORTER	National Institute for General Medicine Sciences (NIGMS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhode Island Hospital Orthopaedic Foundation; Pediatric Orthopaedic Society of North America; Orthopaedic Research and Education Foundation; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Princess Margaret Cancer Foundation(University of Toronto); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Kato for Ctsk-Cre mice, A. Craft for review of the manuscript, X. Wang and P. Monfils for help with histology and J. Cao for helping with mu-CT analysis. This publication was made possible by the National Institutes of Health (NIH) and the National Institute for General Medicine Sciences (NIGMS) grant no. 8P20GM103468. This work was also funded by NIH R21AR57156 (to W.Y.) and R37CA49152 (to B.G.N.), the Rhode Island Hospital Orthopaedic Foundation and a grant from the Pediatric Orthopaedic Society of North America and the Orthopaedic Research and Education Foundation (to W.Y.). B.G.N. is a Canada Research Chair, Tier 1, and is also supported in part by the Ontario Ministry of Health and Long Term Care and the Princess Margaret Cancer Foundation.	Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Bovee JVMG, 2010, NAT REV CANCER, V10, P481, DOI 10.1038/nrc2869; Bowen ME, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002050; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dodds RA, 1998, J BONE MINER RES, V13, P673, DOI 10.1359/jbmr.1998.13.4.673; Fenichel I, 2006, INT ORTHOP, V30, P353, DOI 10.1007/s00264-006-0082-2; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hidaka K, 2001, INT J BIOCHEM CELL B, V33, P1094, DOI 10.1016/S1357-2725(01)00067-X; Hopyan S, 2002, NAT GENET, V30, P306, DOI 10.1038/ng844; Karlsson C, 2009, J ANAT, V215, P355, DOI 10.1111/j.1469-7580.2009.01115.x; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Langenskiold A, 1998, J PEDIATR ORTHOPED, V18, P173, DOI 10.1097/00004694-199803000-00008; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Neel B. G., 2009, HDB CELL SIGNALING, P771; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Pannier S, 2008, BEST PRACT RES CL RH, V22, P45, DOI 10.1016/j.berh.2007.12.004; Pansuriya TC, 2010, INT J CLIN EXP PATHO, V3, P557; Pretzel D, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3320; Robinson D, 1999, CLIN ORTHOP RELAT R, pS163; RODRIGUEZ JI, 1985, CALCIFIED TISSUE INT, V37, P677, DOI 10.1007/BF02554930; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; SHAPIRO F, 1977, J BONE JOINT SURG AM, V59, P703, DOI 10.2106/00004623-197759060-00001; Sobreira NLM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000991; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tartaglia M, 2011, BEST PRACT RES CL EN, V25, P161, DOI 10.1016/j.beem.2010.09.002; Tiet TD, 2006, AM J PATHOL, V168, P321, DOI 10.2353/ajpath.2006.050001; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002	33	148	159	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					491	+		10.1038/nature12396	http://dx.doi.org/10.1038/nature12396			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23863940	Green Accepted			2022-12-01	WOS:000322157900043
J	Ebert, DH; Gabel, HW; Robinson, ND; Kastan, NR; Hu, LS; Cohen, S; Navarro, AJ; Lyst, MJ; Ekiert, R; Bird, AP; Greenberg, ME				Ebert, Daniel H.; Gabel, Harrison W.; Robinson, Nathaniel D.; Kastan, Nathaniel R.; Hu, Linda S.; Cohen, Sonia; Navarro, Adrija J.; Lyst, Matthew J.; Ekiert, Robert; Bird, Adrian P.; Greenberg, Michael E.			Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR	NATURE			English	Article							METHYL-CPG; BDNF TRANSCRIPTION; RETT-SYNDROME; BINDING; REPRESSION; CHROMATIN; ASSOCIATION; INHIBITION; MUTATIONS; DISORDER	Rett syndrome (RTT) is an X-linked human neurodevelopmental disorder with features of autism and severe neurological dysfunction in females. RTT is caused by mutations in methyl-CpG-binding protein 2 (MeCP2), a nuclear protein that, in neurons, regulates transcription, is expressed at high levels similar to that of histones, and binds to methylated cytosines broadly across the genome(1-5). By phosphotryptic mapping, we identify three sites (S86, S274 and T308) of activity-dependent MeCP2 phosphorylation. Phosphorylation of these sites is differentially induced by neuronal activity, brain-derived neurotrophic factor, or agents that elevate the intracellular level of 3',5'-cyclic AMP (cAMP), indicating that MeCP2 may function as an epigenetic regulator of gene expression that integrates diverse signals from the environment. Here we show that the phosphorylation of T308 blocks the interaction of the repressor domain of MeCP2 with the nuclear receptor co-repressor (NCoR) complex and suppresses the ability of MeCP2 to repress transcription. In knock-in mice bearing the common human RTT missense mutation R306C, neuronal activity fails to induce MeCP2 T308 phosphorylation, suggesting that the loss of T308 phosphorylation might contribute to RTT. Consistent with this possibility, the mutation of MeCP2 T308A in mice leads to a decrease in the induction of a subset of activity-regulated genes and to RTT-like symptoms. These findings indicate that the activity-dependent phosphorylation of MeCP2 at T308 regulates the interaction of MeCP2 with the NCoR complex, and that RTT in humans may be due, in part, to the loss of activity-dependent MeCP2 T308 phosphorylation and a disruption of the phosphorylation-regulated interaction of MeCP2 with the NCoR complex.	[Ebert, Daniel H.; Gabel, Harrison W.; Robinson, Nathaniel D.; Kastan, Nathaniel R.; Hu, Linda S.; Cohen, Sonia; Navarro, Adrija J.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Ebert, Daniel H.] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Lyst, Matthew J.; Ekiert, Robert; Bird, Adrian P.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Edinburgh	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	michael_greenberg@hms.harvard.edu		Ekiert, Robert/0000-0002-8879-0646; Bird, Adrian/0000-0002-8600-0372; Lyst, Matthew/0000-0001-9018-4138	NIH [RO1NS048276, K08MH90306, P30-HD 18655]; Rett Syndrome Research Trust; Dupont-Warren Fellowship in the Department of Psychiatry at Harvard Medical School; Nancy Lurie Marks Fellowship in Autism at Harvard Medical School; Damon Runyon Cancer Research Foundation [DRG-2048-10]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH090306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048276] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rett Syndrome Research Trust; Dupont-Warren Fellowship in the Department of Psychiatry at Harvard Medical School; Nancy Lurie Marks Fellowship in Autism at Harvard Medical School; Damon Runyon Cancer Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant RO1NS048276 and the Rett Syndrome Research Trust to M. E. G. D. H. E was supported by NIH grant K08MH90306, the Dupont-Warren Fellowship in the Department of Psychiatry at Harvard Medical School, and the Nancy Lurie Marks Fellowship in Autism at Harvard Medical School. H. W. G. was supported by Damon Runyon Cancer Research Foundation Grant DRG-2048-10. The Mouse Gene Manipulation Facility of the Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (IDDRC), funded by NIH grant P30-HD 18655, assisted in generation of the knock-in mice. We thank members of the Greenberg laboratory, particularly C. Mandel-Brehm and E. Griffith, and also G. Mandel and R. S. Greenberg for helpful discussions.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballestar E, 2000, BIOCHEMISTRY-US, V39, P7100, DOI 10.1021/bi0001271; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Dudek H, 2001, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0311s03; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Li HD, 2011, NAT NEUROSCI, V14, P1001, DOI 10.1038/nn.2866; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Lyst M. J., 2013, NATURE NEUROSCI; Meisenhelder J, 2001, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1809s48; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Ramocki MB, 2010, AM J MED GENET A, V152A, P1079, DOI 10.1002/ajmg.a.33184; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	26	152	157	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 18	2013	499	7458					341	U116		10.1038/nature12348	http://dx.doi.org/10.1038/nature12348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23770587	Green Accepted			2022-12-01	WOS:000321910700037
J	Kiyomitsu, T; Cheeseman, IM				Kiyomitsu, Tomomi; Cheeseman, Iain M.			Cortical Dynein and Asymmetric Membrane Elongation Coordinately Position the Spindle in Anaphase	CELL			English	Article							CELL-DIVISION; MITOTIC SPINDLE; CYTOPLASMIC DYNEIN; CONTRACTILE RING; CLEAVAGE FURROW; ACTIN CORTEX; AURORA-B; CYTOKINESIS; PROTEIN; ANILLIN	Mitotic spindle position defines the cell-cleavage site during cytokinesis. However, the mechanisms that control spindle positioning to generate equal-sized daughter cells remain poorly understood. Here, we demonstrate that two mechanisms act coordinately to center the spindle during anaphase in symmetrically dividing human cells. First, the spindle is positioned directly by the microtubule-based motor dynein, which we demonstrate is targeted to the cell cortex by two distinct pathways: a G alpha i/LGN/NuMA-dependent pathway and a 4.1G/R and NuMA-dependent, anaphase-specific pathway. Second, we find that asymmetric plasma membrane elongation occurs in response to spindle mispositioning to alter the cellular boundaries relative to the spindle. Asymmetric membrane elongation is promoted by chromosome-derived Ran-GTP signals that locally reduce Anillin at the growing cell cortex. In asymmetrically elongating cells, dynein-dependent spindle anchoring at the stationary cell cortex ensures proper spindle positioning. Our results reveal the anaphase-specific spindle centering systems that achieve equal-sized cell division.	[Kiyomitsu, Tomomi; Cheeseman, Iain M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kiyomitsu, Tomomi; Cheeseman, Iain M.] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Kiyomitsu, T (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	tomomi.kiyomitsu@gmail.com; icheese@wi.mit.edu		Cheeseman, Iain/0000-0002-3829-5612	Leukemia & Lymphoma Society; Human Frontiers Science Foundation; NIH/National Institute of General Medical Sciences [GM088313]; American Cancer Society [121776]; Human Frontiers Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088313] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Human Frontiers Science Foundation; NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Defne Yarar, Adam Martin, Jonathan Coravos, and members of the Cheeseman laboratory for discussions and critical readings of the manuscript. We also thank Duane Compton for providing reagents. This work was supported by a Scholar award to I.M.C. from the Leukemia & Lymphoma Society, an award from the Human Frontiers Science Foundation, a grant from the NIH/National Institute of General Medical Sciences (GM088313), and a Research Scholar Grant (121776) from the American Cancer Society. I.M.C. is a Thomas D. and Virginia W. Cabot Career Development Professor of Biology. T.K. is supported by a long-term fellowship from the Human Frontiers Science Program.	Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Burgess DR, 2005, TRENDS CELL BIOL, V15, P156, DOI 10.1016/j.tcb.2005.01.006; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Collins ES, 2012, MOL BIOL CELL, V23, P3380, DOI 10.1091/mbc.E12-02-0109; COMPTON DA, 1995, J CELL SCI, V108, P621; Connell M, 2011, MOL BIOL CELL, V22, P4220, DOI 10.1091/mbc.E11-02-0173; D'Avino PP, 2009, J CELL SCI, V122, P1071, DOI 10.1242/jcs.034785; Diakowski W, 2006, FOLIA HISTOCHEM CYTO, V44, P231; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kotadia S, 2012, J CELL BIOL, V199, P745, DOI 10.1083/jcb.201208041; Kotak S, 2012, J CELL BIOL, V199, P97, DOI 10.1083/jcb.201203166; Mattagajasingh SN, 1999, J CELL BIOL, V145, P29, DOI 10.1083/jcb.145.1.29; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Niiya F, 2005, J BIOL CHEM, V280, P36502, DOI 10.1074/jbc.M508007200; NISHITANI H, 1991, EMBO J, V10, P1555, DOI 10.1002/j.1460-2075.1991.tb07675.x; Ou GS, 2010, SCIENCE, V330, P677, DOI 10.1126/science.1196112; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Salbreux G, 2012, TRENDS CELL BIOL, V22, P536, DOI 10.1016/j.tcb.2012.07.001; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Sedzinski J, 2011, NATURE, V476, P462, DOI 10.1038/nature10286; Shi ZT, 1999, J CLIN INVEST, V103, P331, DOI 10.1172/JCI3858; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Silverman-Gavrila RV, 2008, MOL BIOL CELL, V19, P3735, DOI 10.1091/mbc.E08-01-0049; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Xiao ZN, 2012, BIOCHEM BIOPH RES CO, V420, P888, DOI 10.1016/j.bbrc.2012.03.095; Ye KQ, 1999, J NEUROSCI, V19, P10747, DOI 10.1523/JNEUROSCI.19-24-10747.1999	38	169	176	0	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					391	402		10.1016/j.cell.2013.06.010	http://dx.doi.org/10.1016/j.cell.2013.06.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870127	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000321950700015
J	Mouchiroud, L; Houtkooper, RH; Moullan, N; Katsyuba, E; Ryu, D; Canto, C; Mottis, A; Jo, YS; Viswanathan, M; Schoonjans, K; Guarente, L; Auwerx, J				Mouchiroud, Laurent; Houtkooper, Riekelt H.; Moullan, Norman; Katsyuba, Elena; Ryu, Dongryeol; Canto, Carles; Mottis, Adrienne; Jo, Young-Suk; Viswanathan, Mohan; Schoonjans, Kristina; Guarente, Leonard; Auwerx, Johan			The NAD(+)/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling	CELL			English	Article							DIET-INDUCED OBESITY; EXTENDS LIFE-SPAN; HIGH-FAT DIET; CAENORHABDITIS-ELEGANS; POLY(ADP-RIBOSE) POLYMERASE-1; TRANSCRIPTION FACTORS; CALORIE RESTRICTION; ENERGY-EXPENDITURE; OXIDATIVE STRESS; C. ELEGANS	NAD(+) is an important cofactor regulating metabolic homeostasis and a rate-limiting substrate for sirtuin deacylases. We show that NAD(+) levels are reduced in aged mice and Caenorhabditis elegans and that decreasing NAD(+) levels results in a further reduction in worm lifespan. Conversely, genetic or pharmacological restoration of NAD(+) prevents age-associated metabolic decline and promotes longevity in worms. These effects are dependent upon the protein deacetylase sir-2.1 and involve the induction of mitonuclear protein imbalance as well as activation of stress signaling via the mitochondrial unfolded protein response (UPRmt) and the nuclear translocation and activation of FOXO transcription factor DAF-16. Our data suggest that augmenting mitochondrial stress signaling through the modulation of NAD(+) levels may be a target to improve mitochondrial function and prevent or treat age-associated decline.	[Mouchiroud, Laurent; Houtkooper, Riekelt H.; Moullan, Norman; Katsyuba, Elena; Ryu, Dongryeol; Canto, Carles; Mottis, Adrienne; Jo, Young-Suk; Schoonjans, Kristina; Auwerx, Johan] Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Houtkooper, Riekelt H.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Viswanathan, Mohan; Guarente, Leonard] MIT, Dept Biol, Paul F Glenn Lab, Cambridge, MA 02139 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Amsterdam; Academic Medical Center Amsterdam; Massachusetts Institute of Technology (MIT)	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland.	admin.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021; Houtkooper, Riekelt H/E-1602-2011; Ryu, Dongryeol/AAQ-3642-2020; Houtkooper, Riekelt/P-5001-2019	Houtkooper, Riekelt H/0000-0001-9961-0842; Ryu, Dongryeol/0000-0001-5905-6760; Schoonjans, Kristina/0000-0003-1247-4265; Auwerx, Johan/0000-0002-5065-5393; Canto, Carles/0000-0002-5167-7922	Fondation pour la Recherche Medicale; ZonMw [91613050]; AMC; Ecole Polytechnique Federale de Lausanne; EU [ERC-2008-AdG-23138]; NIH [R01HL106511-01A, R01AG043930]; Velux Stiftung; Swiss National Science Foundation [31003A-124713, 31003A-125487, CSRII3-136201]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015339, R01AG043930] Funding Source: NIH RePORTER	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ZonMw(Netherlands Organization for Health Research and Development); AMC; Ecole Polytechnique Federale de Lausanne; EU(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Velux Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Pierre Gonczy for sharing reagents and equipment, the Caenorhabditis Genetics Center for providing worm strains, and the Auwerx team for discussions. L.M. is supported by the "Fondation pour la Recherche Medicale" and R.H.H. by a VENI grant from ZonMw (number 91613050) and an AMC postdoctoral fellowship. J.A. is the Nestle Chair in Energy Metabolism. This work is supported by grants from the Ecole Polytechnique Federale de Lausanne, EU Ideas program (ERC-2008-AdG-23138), NIH (R01HL106511-01A and R01AG043930), Velux Stiftung, and Swiss National Science Foundation (31003A-124713, 31003A-125487, and CSRII3-136201).	Alam H, 2010, CELL METAB, V12, P30, DOI 10.1016/j.cmet.2010.05.004; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Erener S, 2012, FASEB J, V26, P2631, DOI 10.1096/fj.11-200212; Ferraris DV, 2010, J MED CHEM, V53, P4561, DOI 10.1021/jm100012m; Gagnon SN, 2002, BIOCHEM J, V368, P263, DOI 10.1042/BJ20020669; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hashimoto T, 2010, BIOGERONTOLOGY, V11, P31, DOI 10.1007/s10522-009-9225-3; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Houtkooper RH, 2012, J CELL BIOL, V199, P205, DOI 10.1083/jcb.201207019; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Houtkooper RH, 2010, CELL, V142, P9, DOI 10.1016/j.cell.2010.06.029; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Mangerich A, 2010, MECH AGEING DEV, V131, P389, DOI 10.1016/j.mad.2010.05.005; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Mouchiroud L, 2011, AGING CELL, V10, P39, DOI 10.1111/j.1474-9726.2010.00640.x; Penning TD, 2009, J MED CHEM, V52, P514, DOI 10.1021/jm801171j; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Viswanathan M, 2011, NATURE, V477, pE1, DOI 10.1038/nature10440; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	49	731	759	11	194	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					430	441		10.1016/j.cell.2013.06.016	http://dx.doi.org/10.1016/j.cell.2013.06.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870130	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000321950700018
J	Vicoso, B; Bachtrog, D				Vicoso, Beatriz; Bachtrog, Doris			Reversal of an ancient sex chromosome to an autosome in Drosophila	NATURE			English	Article							DETERMINING MECHANISMS; X-CHROMOSOME; Y-CHROMOSOMES; GENES; MELANOGASTER; EVOLUTION; ALIGNMENT; DIPTERA; REPTILES; INSECTS	Although transitions of sex-determination mechanisms are frequent in species with homomorphic sex chromosomes(1-3), heteromorphic sex chromosomes are thought to represent a terminal evolutionary stage owing to chromosome-specific adaptations such as dosage compensation or an accumulation of sex-specific mutations(1,4). Here we show that an autosome of Drosophila, the dot chromosome, was ancestrally a differentiated X chromosome. We analyse the whole genome of true fruitflies (Tephritidae), flesh flies (Sarcophagidae) and soldier flies (Stratiomyidae) to show that genes located on the dot chromosome of Drosophila are X-linked in outgroup species, whereas Drosophila X-linked genes are autosomal. We date this chromosomal transition to early drosophilid evolution by sequencing the genome of other Drosophilidae. Our results reveal several puzzling aspects of Drosophila dot chromosome biology to be possible remnants of its former life as a sex chromosome, such as its minor feminizing role in sex determination(5) or its targeting by a chromosome-specific regulatory mechanism(6). We also show that patterns of biased gene expression of the dot chromosome during early embryogenesis, oogenesis and spermatogenesis resemble that of the current X chromosome. Thus, although sex chromosomes are not necessarily evolutionary end points and can revert back to an autosomal inheritance, the highly specialized genome architecture of this former X chromosome suggests that severe fitness costs must be overcome for such a turnover to occur.	[Vicoso, Beatriz; Bachtrog, Doris] Univ Calif Berkeley, Dept Integrat Biol, Ctr Theoret Evolutionary Genom, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bachtrog, D (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Ctr Theoret Evolutionary Genom, Berkeley, CA 94720 USA.	dbachtrog@berkeley.edu		Vicoso, Beatriz/0000-0002-4579-8306	National Institutes of Health [R01GM076007, R01GM093182]; Packard Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076007, R01GM093182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Kunhi Purayil, I. Kadow, P. Mavragani, J. Larsson and U. Schmidt-Ott for samples, C. Zonneveld, L. Mazzon, D. Obbard, V. Aguiar, N. Gompel and J. Larsson for images, and Q. Zhou and Z. Walton for technical assistance. Funded by National Institutes of Health grants (R01GM076007 and R01GM093182) and a Packard Fellowship to D.B.	Assis R, 2012, GENOME BIOL EVOL, V4, P1189, DOI 10.1093/gbe/evs093; Bellott DW, 2009, COLD SH Q B, V74, P345, DOI 10.1101/sqb.2009.74.048; Bridges CB, 1925, AM NAT, V59, P127, DOI 10.1086/280023; Bull J.J., 1983, EVOLUTION SEX DETERM; CLINE TW, 1993, TRENDS GENET, V9, P385, DOI 10.1016/0168-9525(93)90138-8; Deng XX, 2009, GENETICS, V182, P481, DOI 10.1534/genetics.109.102087; Drosopoulou E, 2012, GENETICA, V140, P169, DOI 10.1007/s10709-012-9668-3; Dubendorfer A, 2002, INT J DEV BIOL, V46, P75; Gabrieli P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017747; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; GETHMANN RC, 1988, J HERED, V79, P344, DOI 10.1093/oxfordjournals.jhered.a110526; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Koerich LB, 2008, NATURE, V456, P949, DOI 10.1038/nature07463; KRIVSHENKO J, 1959, GENETICS, V44, P1027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larracuente AM, 2010, MOL BIOL EVOL, V27, P1612, DOI 10.1093/molbev/msq045; Larsson J, 2004, P NATL ACAD SCI USA, V101, P9728, DOI 10.1073/pnas.0400978101; Larsson J, 2001, P NATL ACAD SCI USA, V98, P6273, DOI 10.1073/pnas.111581298; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; Lott SE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000590; Muller HJ., 1940, NEW SYSTEMATICS, P185; Ohno S., 1967, SEX CHROMOSOMES SEX; Parise-Maltempi PP., 2007, Braz. J. Biol., V67, P945, DOI 10.1590/S1519-69842007000500020; Parise-Maltempi PP, 2000, GENET MOL BIOL, V23, P563, DOI 10.1590/S1415-47572000000300011; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Pokorna M, 2009, ZOOL J LINN SOC-LOND, V156, P168, DOI 10.1111/j.1096-3642.2008.00481.x; Riddle NC, 2009, BIOCHEM CELL BIOL, V87, P229, DOI 10.1139/O08-119; Roy V, 2005, HEREDITY, V94, P388, DOI 10.1038/sj.hdy.6800612; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Sarre SD, 2011, ANNU REV GENOM HUM G, V12, P391, DOI 10.1146/annurev-genom-082410-101518; Traut W, 2010, J GENET, V89, P307, DOI 10.1007/s12041-010-0042-x; Vibranovski MD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000731; Vicoso B, 2011, GENOME BIOL EVOL, V3, P230, DOI 10.1093/gbe/evr010; WHITE MJD, 1949, EVOLUTION, V3, P252, DOI 10.2307/2405562; ZACHAROPOULOU A, 1987, GENOME, V29, P67, DOI 10.1139/g87-011; Zhou Q, 2012, SCIENCE, V337, P341, DOI 10.1126/science.1225385	38	128	130	3	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2013	499	7458					332	+		10.1038/nature12235	http://dx.doi.org/10.1038/nature12235			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23792562	Green Accepted			2022-12-01	WOS:000321910700035
J	Yu, HJ; Cowling, BJ; Feng, LZ; Lau, EHY; Liao, QH; Tsang, TK; Peng, ZB; Wu, P; Liu, FF; Fang, VJ; Zhang, HL; Li, M; Zeng, LJ; Xu, Z; Li, ZJ; Luo, HM; Li, Q; Feng, ZJ; Cao, B; Yang, WZ; Wu, JT; Wang, Y; Leung, GM				Yu, Hongjie; Cowling, Benjamin J.; Feng, Luzhao; Lau, Eric H. Y.; Liao, Qiaohong; Tsang, Tim K.; Peng, Zhibin; Wu, Peng; Liu, Fengfeng; Fang, Vicky J.; Zhang, Honglong; Li, Ming; Zeng, Lingjia; Xu, Zhen; Li, Zhongjie; Luo, Huiming; Li, Qun; Feng, Zijian; Cao, Bin; Yang, Weizhong; Wu, Joseph T.; Wang, Yu; Leung, Gabriel M.			Human infection with avian influenza A H7N9 virus: an assessment of clinical severity	LANCET			English	Article							CASE-FATALITY RATIO; RISK; CHINA	Background Characterisation of the severity profile of human infections with influenza viruses of animal origin is a part of pandemic risk assessment, and an important part of the assessment of disease epidemiology. Our objective was to assess the clinical severity of human infections with avian influenza A H7N9 virus, which emerged in China in early 2013. Methods We obtained information about laboratory-confirmed cases of avian influenza A H7N9 virus infection reported as of May 28, 2013, from an integrated database built by the Chinese Center for Disease Control and Prevention. We estimated the risk of fatality, mechanical ventilation, and admission to the intensive care unit for patients who required hospital admission for medical reasons. We also used information about laboratory-confirmed cases detected through sentinel influenza-like illness surveillance to estimate the symptomatic case fatality risk. Findings Of 123 patients with laboratory-confirmed avian influenza A H7N9 virus infection who were admitted to hospital, 37 (30%) had died and 69 (56%) had recovered by May 28, 2013. After we accounted for incomplete data for 17 patients who were still in hospital, we estimated the fatality risk for all ages to be 36% (95% CI 26-45) on admission to hospital. Risks of mechanical ventilation or fatality (69%, 95% CI 60-77) and of admission to an intensive care unit, mechanical ventilation, or fatality (83%, 76-90) were high. With assumptions about coverage of the sentinel surveillance network and health-care-seeking behaviour for patients with influenza-like illness associated with influenza A H7N9 virus infection, and pro-rata extrapolation, we estimated that the symptomatic case fatality risk could be between 160 (63-460) and 2800 (1000-9400) per 100 000 symptomatic cases. Interpretation Human infections with avian influenza A H7N9 virus seem to be less serious than has been previously reported. Many mild cases might already have occurred. Continued vigilance and sustained intensive control efforts are needed to minimise the risk of human infection.	[Yu, Hongjie; Feng, Luzhao; Liao, Qiaohong; Peng, Zhibin; Liu, Fengfeng; Zhang, Honglong; Li, Ming; Zeng, Lingjia; Xu, Zhen; Li, Zhongjie] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing 102206, Peoples R China; [Luo, Huiming] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing 102206, Peoples R China; [Li, Qun; Feng, Zijian] Chinese Ctr Dis Control & Prevent, Publ Hlth Emergency Ctr, Beijing 102206, Peoples R China; [Yang, Weizhong; Wang, Yu] Chinese Ctr Dis Control & Prevent, Off Director, Beijing 102206, Peoples R China; [Cowling, Benjamin J.; Lau, Eric H. Y.; Tsang, Tim K.; Wu, Peng; Fang, Vicky J.; Wu, Joseph T.; Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China; [Cao, Bin] Capital Med Univ, Beijing Inst Resp Med, Beijing Chao Yang Hosp, Dept Infect Dis & Clin Microbiol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; University of Hong Kong; Capital Medical University	Wu, JT (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China.	joewu@hku.hk; wangyu@chinacdc.cn	Wu, Joseph/ABD-5880-2021; Lau, Eric/AAJ-6588-2021; Cowling, Benjamin John/C-4263-2009; Yu, Hongjie/GZK-5351-2022	Lau, Eric/0000-0002-6688-9637; Cowling, Benjamin John/0000-0002-6297-7154; Leung, Gabriel/0000-0002-2503-6283; Wu, Peng/0000-0003-1157-9401; Tsang, Tim Kam Lun/0000-0001-5037-6776	Chinese Ministry of Science and Technology; Research Fund for the Control of Infectious Disease; Hong Kong University Grants Committee; China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; Harvard Center for Communicable Disease Dynamics; US National Institute of Allergy and Infectious Disease; US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Research Fund for the Control of Infectious Disease; Hong Kong University Grants Committee; China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; Harvard Center for Communicable Disease Dynamics; US National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Chinese Ministry of Science and Technology; Research Fund for the Control of Infectious Disease; Hong Kong University Grants Committee; China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; Harvard Center for Communicable Disease Dynamics; US National Institute of Allergy and Infectious Disease; and the US National Institutes of Health.	Alcorn T, 2013, LANCET, V381, P1347, DOI 10.1016/S0140-6736(13)60868-5; [Anonymous], 2013, LANCET INFECT DIS, V13, P465, DOI [10.1016/S1473-3099(13)70134-8, 10.1016/1473-3099(13)70134-8]; [Anonymous], 2013, LANCET; Wiwanitkit V, 2013, WEST PAC SURVEILL RE, V4, P24, DOI 10.5365/wpsar.2013.4.4.003; Arima Y, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/WPSAR.2013.4.2.005, 10.5365/wpsar.2013.4.2.005]; Baguelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017074; Boni MF, 2013, J INFECT DIS, V208, P554, DOI 10.1093/infdis/jit224; Centers for Disease Control and Prevention, INFL RISK ASS TOOL I; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, EUROSURVEILLANCE, V18, P2; Eurosurveillance editorial team, 2013, EUROSURVEILLANCE, V18, P5; Fleming DM, 2008, EPIDEMIOL INFECT, V136, P866, DOI 10.1017/S0950268807009910; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; Guan Y, 2013, J INFECT DEV COUNTR, V7, P302, DOI 10.3855/jidc.3675; Han J, 2013, EUROSURVEILLANCE, V18, P6; Horby P, 2013, NATURE, V496, P399, DOI 10.1038/496399a; Hvistendahl M, 2013, SCIENCE, V340, P414, DOI 10.1126/science.340.6131.414; Jewell NP, 2007, STAT MED, V26, P1982, DOI 10.1002/sim.2691; Kahn RE, 2013, VECTOR-BORNE ZOONOT, V13, P347, DOI 10.1089/vbz.2013.999.ceezad; Kelly H, 2013, EPIDEMIOLOGY, V24, P622, DOI 10.1097/EDE.0b013e318296c2b6; Koopmans M, 2013, LANCET, V381, P1882, DOI 10.1016/S0140-6736(13)60936-8; Lee N, 2011, J INFECT DIS, V203, P1739, DOI 10.1093/infdis/jir187; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Lipsitch M, 2011, BIOSECUR BIOTERROR, V9, P89, DOI 10.1089/bsp.2011.0007; Nicoll A, 2013, EUROSURVEILLANCE, V18, P15; Osterholm MT, 2013, JAMA-J AM MED ASSOC, V309, P2557, DOI 10.1001/jama.2013.6589; Parry J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2222; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Rubin D.B., 1987, MULTIPLE IMPUTATION, P1; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Shu YL, 2010, EMERG INFECT DIS, V16, P725, DOI 10.3201/eid1604.091578; Skowronski D, 2013, EUROSURVEILLANCE, V18, P4; Trock SC, 2012, AVIAN DIS, V56, P1058, DOI 10.1637/10204-041412-ResNote.1; Van Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P231, DOI 10.1111/irv.12068; Van Kerkhove MD, 2012, SCIENCE, V336, DOI 10.1126/science.1221434; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; WHO, 2013, CUM NUMB CONF HUM CA; WHO Implementation of the International Health Regulations, 2011, IMPL INT HLTH REG 20; Wong JY, 2013, AM J EPIDEMIOL, V177, P834, DOI 10.1093/aje/kws314; Wong JY, EPIDEMIOLOG IN PRESS; Wu SQ, 2013, LANCET, V381, P1539, DOI 10.1016/S0140-6736(13)60767-9; Xu C, 2013, MONITORING AVIAN INF; Xu CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017919; Xu JG, 2013, LANCET, V381, P1815, DOI 10.1016/S0140-6736(13)60950-2; Yip PSF, 2005, AM J EPIDEMIOL, V161, P700, DOI 10.1093/aje/kwi088; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; Zhang Wenyi, 2013, Clin Infect Dis, V57, P619, DOI 10.1093/cid/cit277	51	202	216	1	91	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 13	2013	382	9887					138	145		10.1016/S0140-6736(13)61207-6	http://dx.doi.org/10.1016/S0140-6736(13)61207-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187JY	23803487	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000322115300029
J	He, GZ; Zhang, L; Mol, APJ; Lu, YL; Liu, JG				He, Guizhen; Zhang, Lei; Mol, Arthur P. J.; Lu, Yonglong; Liu, Jianguo			Revising China's Environmental Law	SCIENCE			English	Editorial Material									[He, Guizhen; Lu, Yonglong] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing 100085, Peoples R China; [Zhang, Lei; Mol, Arthur P. J.] Wageningen Univ, NL-6706 KN Wageningen, Netherlands; [Zhang, Lei; Mol, Arthur P. J.] Renmin Univ China, Beijing 100086, Peoples R China; [Liu, Jianguo] Michigan State Univ, E Lansing, MI 48823 USA	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Wageningen University & Research; Renmin University of China; Michigan State University	Lu, YL (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing 100085, Peoples R China.	yllu@rcees.ac.cn	Liu, Jianguo/G-5211-2015; jingjing, yuan/N-1658-2013; mol, arthur PJ/H-2093-2012	Liu, Jianguo/0000-0001-6344-0087; mol, arthur/0000-0002-4446-2595				[Anonymous], 2012, 18 CPC NAT C 14 NOV; Chang J. W., 2008, US CHINA LAW REV, V5, P1; He GZ, 2012, ENVIRON DEV, V3, P25, DOI 10.1016/j.envdev.2012.05.005; He GZ, 2012, ENVIRON SCI TECHNOL, V46, P7442, DOI 10.1021/es302429e; He GZ, 2009, ENVIRON MANAGE, V44, P579, DOI 10.1007/s00267-009-9341-5; Liu JG, 2010, SCIENCE, V328, P50, DOI 10.1126/science.1186234; Ma X., 2000, ENV REGULATION CHINA; McElwee Charles R., 2011, ENV LAW CHINA MITIGA; Mol APJ, 2006, ENVIRON POLIT, V15, P149, DOI 10.1080/09644010600562765; Organisation for Economic Cooperation and Development, 2006, ENV COMPL ENF CHIN A; Wang C. F., 2006, J ENVIRON LAW, V8, P159; Wang J., 2011, ENV PROTECT, V11, P34; Wang T., 2012, SO WEEKLY GUANG 0914; World Bank, 2009, STRENGTH CHIN ENV PR; Wu J, 2011, ENVIRON IMPACT ASSES, V31, P77, DOI 10.1016/j.eiar.2010.04.010	15	45	48	9	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					133	133		10.1126/science.1235000	http://dx.doi.org/10.1126/science.1235000			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	185KA	23846893	Green Submitted			2022-12-01	WOS:000321965300025
J	Rai, AK; Cook-Deegan, R				Rai, Arti K.; Cook-Deegan, Robert			Moving Beyond "Isolated" Gene Patents	SCIENCE			English	Editorial Material									[Rai, Arti K.] Duke Univ, Sch Law, Durham, NC 27708 USA; [Cook-Deegan, Robert] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Cook-Deegan, Robert] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Rai, AK (corresponding author), Duke Univ, Sch Law, Durham, NC 27708 USA.	rai@law.duke.edu; bob.cd@duke.edu		Cook-Deegan, Robert/0000-0002-8251-4237	NHGRI NIH HHS [P50 HG003391] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Gold ER, 2010, GENET MED, V12, pS39, DOI 10.1097/GIM.0b013e3181d72661; Langreth R., 2013, BLOOMBERG NEWS; Pollack A., 2013, NEW YORK TIMES 0618	3	8	8	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					137	138		10.1126/science.1242217	http://dx.doi.org/10.1126/science.1242217			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	185KA	23811224	Green Accepted			2022-12-01	WOS:000321965300029
J	Aoto, J; Martinelli, DC; Malenka, RC; Tabuchi, K; Sudhof, TC				Aoto, Jason; Martinelli, David C.; Malenka, Robert C.; Tabuchi, Katsuhiko; Suedhof, Thomas C.			Presynaptic Neurexin-3 Alternative Splicing trans-Synaptically Controls Postsynaptic AMPA Receptor Trafficking	CELL			English	Article							SYNAPSE FORMATION; CA2+ CHANNELS; NEUROLIGINS; ALPHA; PROTEINS; SUBICULUM; NEURONS; DEPENDENCE; DIVERSITY; MECHANISM	Neurexins are essential presynaptic cell adhesion molecules that are linked to schizophrenia and autism and are subject to extensive alternative splicing. Here, we used a genetic approach to test the physiological significance of neurexin alternative splicing. We generated knockin mice in which alternatively spliced sequence #4 (SS4) of neuexin-3 is constitutively included but can be selectively excised by cre-recombination. SS4 of neurexin-3 was chosen because it is highly regulated and controls neurexin binding to neuroligins, LRRTMs, and other ligands. Unexpectedly, constitutive inclusion of SS4 in presynaptic neurexin-3 decreased postsynaptic AMPA, but not NMDA receptor levels, and enhanced postsynaptic AMPA receptor endocytosis. Moreover, constitutive inclusion of SS4 in presynaptic neurexin-3 abrogated postsynaptic AMPA receptor recruitment during NMDA receptor-dependent LTP. These phenotypes were fully rescued by constitutive excision of SS4 in neurexin-3. Thus, alternative splicing of presynaptic neurexin-3 controls postsynaptic AMPA receptor trafficking, revealing an unanticipated alternative splicing mechanism for trans-synaptic regulation of synaptic strength and long-term plasticity.	[Aoto, Jason; Martinelli, David C.; Tabuchi, Katsuhiko; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Aoto, Jason; Martinelli, David C.; Tabuchi, Katsuhiko; Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Malenka, Robert C.] Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat, Stanford, CA 94305 USA; [Tabuchi, Katsuhiko] Shinshu Univ, Sch Med, Dept Neurophysiol, Matsumoto, Nagano 3908621, Japan	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Shinshu University	Sudhof, TC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 265 Campus Dr, Stanford, CA 94305 USA.	tcs1@stanford.edu	Aoto, Jason/AAR-3604-2021	Martinelli, David/0000-0002-8318-3986; Aoto, Jason/0000-0003-0568-634X	NIMH [R37 MH052804]; NINDS [NS077906]; Simons Foundation [177850]; American Heart Association [11POST7360078]; NIDA [F32 DA031654]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH052804, P50MH086403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030379, F32DA031654] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Simons Foundation; American Heart Association(American Heart Association); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank Wei Xu, Wade Morishita, Lu Chen, and Csaba Foldy for advice. This paper was supported by grants from the NIMH (R37 MH052804), the NINDS (NS077906), and the Simons Foundation (177850) to T.C.S. and by fellowship awards from the American Heart Association (11POST7360078 to J.A.) and NIDA (F32 DA031654 to D.C.M.).	Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Chen YC, 2012, J NEUROSCI, V32, P16018, DOI 10.1523/JNEUROSCI.1685-12.2012; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; de la Prida LM, 2003, HIPPOCAMPUS, V13, P728, DOI 10.1002/hipo.10123; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Etherton MR, 2011, EMBO J, V30, P2908, DOI 10.1038/emboj.2011.182; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Hishimoto A, 2007, HUM MOL GENET, V16, P2880, DOI 10.1093/hmg/ddm247; Hu ZT, 2012, SCIENCE, V337, P980, DOI 10.1126/science.1224896; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Lachman HM, 2007, HUM MOL GENET, V16, P1327, DOI 10.1093/hmg/ddm081; Lee K, 2013, P NATL ACAD SCI USA, V110, P336, DOI 10.1073/pnas.1219987110; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; O'Mara S, 2005, J ANAT, V207, P271, DOI 10.1111/j.1469-7580.2005.00446.x; Reichelt AC, 2012, NEUROPHARMACOLOGY, V62, P1519, DOI 10.1016/j.neuropharm.2011.01.024; Resnick M, 2008, NEUROSCI LETT, V439, P235, DOI 10.1016/j.neulet.2008.05.034; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Rozic G, 2013, J MOL NEUROSCI, V50, P221, DOI 10.1007/s12031-012-9919-x; Schnell E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048045; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Shapiro-Reznik M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037894; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Soler-Llavina GJ, 2013, NEURON, V79, P439, DOI 10.1016/j.neuron.2013.06.007; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Sugita S, 1999, NEURON, V22, P489, DOI 10.1016/S0896-6273(00)80704-7; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; TAUBE JS, 1993, EXP BRAIN RES, V96, P304; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Vaags AK, 2012, AM J HUM GENET, V90, P133, DOI 10.1016/j.ajhg.2011.11.025; Wozny C, 2008, J PHYSIOL-LONDON, V586, P2725, DOI 10.1113/jphysiol.2007.149203; Xu W, 2012, NEURON, V73, P990, DOI 10.1016/j.neuron.2011.12.036	52	183	187	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					75	88		10.1016/j.cell.2013.05.060	http://dx.doi.org/10.1016/j.cell.2013.05.060			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827676	Green Accepted, Bronze			2022-12-01	WOS:000321327900011
J	Guo, JL; Covell, DJ; Daniels, JP; Iba, M; Stieber, A; Zhang, B; Riddle, DM; Kwong, LK; Xu, Y; Trojanowski, JQ; Lee, VMY				Guo, Jing L.; Covell, Dustin J.; Daniels, Joshua P.; Iba, Michiyo; Stieber, Anna; Zhang, Bin; Riddle, Dawn M.; Kwong, Linda K.; Xu, Yan; Trojanowski, John Q.; Lee, Virginia M. Y.			Distinct alpha-Synuclein Strains Differentially Promote Tau Inclusions in Neurons	CELL			English	Article							SPORADIC PARKINSONS-DISEASE; LEWY BODIES; IN-VITRO; ALZHEIMERS-DISEASE; FIBRIL FORMATION; BRAIN PATHOLOGY; AMYLOID FIBRILS; SYNTHETIC TAU; MOUSE MODEL; DEMENTIA	Many neurodegenerative diseases are characterized by the accumulation of insoluble protein aggregates, including neurofibrillary tangles comprised of tau in Alzheimer's disease and Lewy bodies composed of alpha-synuclein in Parkinson's disease. Moreover, different pathological proteins frequently codeposit in disease brains. To test whether aggregated alpha-synuclein can directly cross-seed tau fibrillization, we administered preformed alpha-synuclein fibrils assembled from recombinant protein to primary neurons and transgenic mice. Remarkably, we discovered two distinct strains of synthetic alpha-synuclein fibrils that demonstrated striking differences in the efficiency of cross-seeding tau aggregation, both in neuron cultures and in vivo. Proteinase K digestion revealed conformational differences between the two synthetic alpha-synuclein strains and also between sarkosyl-insoluble alpha-synuclein extracted from two subgroups of Parkinson's disease brains. We speculate that distinct strains of pathological alpha-synuclein likely exist in neurodegenerative disease brains and may underlie the tremendous heterogeneity of synucleinopathies.	[Lee, Virginia M. Y.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Inst Aging, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Inst Aging, Philadelphia, PA 19104 USA.	vmylee@upenn.edu			NIH/NIA [AG17586, NS53488]; Marian S. Ware Alzheimer Program; Dr. Arthur Peck Fund; Jeff and Anne Keefer Fund; Parkinson Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017586] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Marian S. Ware Alzheimer Program; Dr. Arthur Peck Fund; Jeff and Anne Keefer Fund; Parkinson Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank Patrick O'Brien and Insung Song for recombinant protein purification, Ashley Chen for mouse husbandry and technical assistance, Drs. Charlotte Chung and Hien Tran for providing extra neurons whenever needed, John Robinson for providing frozen brain tissues, Dr. David J. Irwin for helpful discussion, Drs. Kurt Brunden and Kelvin C. Luk for critical reading of the manuscript, and all the other members of the Center for Neurodegenerative Disease Research for their help and support. Patrick O'Brien is also thanked for providing the first preparation of strain B 1-120-Myc fibrils to make this study possible. The N-terminal sequencing analysis was provided by Nancy A. Williams from the Keck Biotechnology Resource Laboratory (Yale University). mAbs MC1 and TG3 are generous gifts from Dr. Peter Davies (Albert Einstein College of Medicine). The authors are also grateful to Drs. Zhong-yuan Kan and Walter Englander for training and use of the Aviv model 202 spectrophotometer and Robert Culik and Dr. Feng Gai for their assistance in acquiring FTIR spectra. This study was supported by NIH/NIA grant AG17586, NS53488, the Marian S. Ware Alzheimer Program, the Dr. Arthur Peck Fund, The Jeff and Anne Keefer Fund, and the Parkinson Council.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Baba M, 1998, AM J PATHOL, V152, P879; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Furukawa Y, 2011, J BIOL CHEM, V286, P27236, DOI 10.1074/jbc.M111.248963; Galpern WR, 2006, ANN NEUROL, V59, P449, DOI 10.1002/ana.20819; Gearing M, 1999, ARCH NEUROL-CHICAGO, V56, P203, DOI 10.1001/archneur.56.2.203; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Gomez-Tortosa E, 2000, ANN NY ACAD SCI, V920, P9; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Guo JL, 2013, FEBS LETT, V587, P717, DOI 10.1016/j.febslet.2013.01.051; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Halliday G, 2008, ACTA NEUROPATHOL, V115, P409, DOI 10.1007/s00401-008-0344-8; Halliday GM, 2011, ACTA NEUROPATHOL, V122, P187, DOI 10.1007/s00401-011-0852-9; Huang CY, 2002, P NATL ACAD SCI USA, V99, P2788, DOI 10.1073/pnas.052700099; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kikis EA, 2010, ADV EXP MED BIOL, V694, P138; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; KOSAKA K, 1988, CLIN NEUROPATHOL, V7, P299; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tsuboi Y, 2005, PARKINSONISM RELAT D, V11, pS47, DOI 10.1016/j.parkreldis.2004.10.014; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WITMAN GB, 1976, P NATL ACAD SCI USA, V73, P4070, DOI 10.1073/pnas.73.11.4070; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	54	462	470	4	100	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					103	117		10.1016/j.cell.2013.05.057	http://dx.doi.org/10.1016/j.cell.2013.05.057			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827677	Green Accepted, Bronze			2022-12-01	WOS:000321327900013
J	Constantinople, CM; Bruno, RM				Constantinople, Christine M.; Bruno, Randy M.			Deep Cortical Layers Are Activated Directly by Thalamus	SCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; PRIMARY VISUAL-CORTEX; BARREL CORTEX; STRIATE CORTEX; PYRAMIDAL NEURONS; RAT NEOCORTEX; MOUSE; CAT; PROJECTIONS; MACAQUE	The thalamocortical (TC) projection to layer 4 (L4) is thought to be the main route by which sensory organs communicate with cortex. Sensory information is believed to then propagate through the cortical column along the L4 -> L2/3 -> L5/6 pathway. Here, we show that sensory-evoked responses of L5/6 neurons in rats derive instead from direct TC synapses. Many L5/6 neurons exhibited sensory-evoked postsynaptic potentials with the same latencies as L4. Paired in vivo recordings from L5/6 neurons and thalamic neurons revealed substantial convergence of direct TC synapses onto diverse types of infragranular neurons, particularly in L5B. Pharmacological inactivation of L4 had no effect on sensory-evoked synaptic input to L5/6 neurons. L4 is thus not an obligatory distribution hub for cortical activity, and thalamus activates two separate, independent "strata" of cortex in parallel.	[Bruno, Randy M.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA	Columbia University; Columbia University	Bruno, RM (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	randybruno@columbia.edu	Bruno, Randy M./ABC-2117-2021	Bruno, Randy M./0000-0002-5122-4632	National Institute of Neurological Disorders and Stroke, NIH [NS069679]; Rita Allen Foundation; Klingenstein Fund; NSF Student Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069679] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Rita Allen Foundation; Klingenstein Fund(Klingenstein Philanthropies); NSF Student Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Abbott, R. Axel, A. Losonczy, and K. Miller for manuscript comments; D. Baughman for technical support; and M. Ilardi for morphological reconstruction. Supported by National Institute of Neurological Disorders and Stroke, NIH, NS069679; Rita Allen Foundation; Klingenstein Fund; and an NSF Student Fellowship.	AGMON A, 1992, J NEUROSCI, V12, P319; Beierlein M, 2002, J NEUROPHYSIOL, V88, P1924, DOI 10.1152/jn.2002.88.4.1924; BLASDEL GG, 1983, J NEUROSCI, V3, P1389; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Callaway EM, 2004, NEURAL NETWORKS, V17, P625, DOI 10.1016/j.neunet.2004.04.004; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; FERSTER D, 1978, J COMP NEUROL, V182, P923, DOI 10.1002/cne.901820510; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; Garcia-Marin V, 2013, J COMP NEUROL, V521, P130, DOI 10.1002/cne.23165; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; HERKENHAM M, 1980, SCIENCE, V207, P532, DOI 10.1126/science.7352263; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; Huang W, 1998, J NEUROPHYSIOL, V80, P3261, DOI 10.1152/jn.1998.80.6.3261; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Lee S, 2008, NAT NEUROSCI, V11, P1430, DOI 10.1038/nn.2227; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Oberlaender M, 2012, NEURON, V74, P648, DOI 10.1016/j.neuron.2012.03.022; Oberlaender M, 2011, P NATL ACAD SCI USA, V108, P4188, DOI 10.1073/pnas.1100647108; SCHWARK HD, 1986, J NEUROPHYSIOL, V56, P1074, DOI 10.1152/jn.1986.56.4.1074; Viaene AN, 2011, J NEUROSCI, V31, P12738, DOI 10.1523/JNEUROSCI.1565-11.2011; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068	33	263	266	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1591	1594		10.1126/science.1236425	http://dx.doi.org/10.1126/science.1236425			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812718	Green Accepted			2022-12-01	WOS:000321007000047
J	Buchan, JR; Kolaitis, RM; Taylor, JP; Parker, R				Buchan, J. Ross; Kolaitis, Regina-Maria; Taylor, J. Paul; Parker, Roy			Eukaryotic Stress Granules Are Cleared by Autophagy and Cdc48/VCP Function	CELL			English	Article							P-BODIES; MESSENGER-RNAS; TDP-43; DEGRADATION; REVEALS; LOCALIZATION; AGGREGATION; INHIBITION; ATPASE; FUSION	Stress granules and P bodies are conserved cytoplasmic aggregates of nontranslating messenger ribonucleoprotein complexes (mRNPs) implicated in the regulation of mRNA translation and decay and are related to RNP granules in embryos, neurons, and pathological inclusions in some degenerative diseases. Using baker's yeast, 125 genes were identified in a genetic screen that affected the dynamics of P bodies and/or stress granules. Analyses of such mutants, including CDC48 alleles, provide evidence that stress granules can be targeted to the vacuole by autophagy, in a process termed granulophagy. Moreover, stress granule clearance in mammalian cells is reduced by inhibition of autophagy or by depletion or pathogenic mutations in valosin-containing protein (VCP), the human ortholog of CDC48. Because mutations in VCP predispose humans to amyotrophic lateral sclerosis, frontotemporal lobar degeneration, inclusion body myopathy, and multisystem proteinopathy, this work suggests that autophagic clearance of stress granule related and pathogenic RNP granules that arise in degenerative diseases may be important in reducing their pathology.	[Buchan, J. Ross; Parker, Roy] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA; [Buchan, J. Ross; Parker, Roy] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80303 USA; [Kolaitis, Regina-Maria; Taylor, J. Paul] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; St Jude Children's Research Hospital	Taylor, JP (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jpaul.taylor@stjude.org; roy.parker@colorado.edu	Taylor, J. Paul/N-2482-2018	Taylor, J. Paul/0000-0002-5794-0349	ALS Association; Packard Center for ALS Research; Howard Hughes Medical Institute	ALS Association; Packard Center for ALS Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank the Chen lab (Institute of Molecular Biology, Taiwan) for Cdc48, Ufd1, and Npl4 conditional allele strains, the Klionsky lab (University of Michigan) for a GFP-Atg19 expressing plasmid, the Komatsu lab (Tokyo Metropolitan Institute of Medical Sciences) for Atg 3<SUP>-/-</SUP> MEF cell lines, and the Green lab (St. Jude Children's Research Hospital) for Atg<SUP>7-/-</SUP> MEF cell lines. We also thank the Cell and Tissue Imaging Core Facility at St. Jude Children's Research Hospital and all Parker lab members for feedback, particularly Saumya Jain for bioinformatics assistance. This work was supported by funds from the ALS Association to R.-M. K., the Packard Center for ALS Research to J.P.T., and the Howard Hughes Medical Institute to J.R.B. and R.P.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Armakola M, 2012, NAT GENET, V44, P1302, DOI 10.1038/ng.2434; Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004; Bhattacharyya SN, 2006, COLD SPRING HARB SYM, V71, P513, DOI 10.1101/sqb.2006.71.038; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chou TF, 2013, CHEMMEDCHEM, V8, P297, DOI 10.1002/cmdc.201200520; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Dewey CM, 2012, BRAIN RES, V1462, P16, DOI 10.1016/j.brainres.2012.02.032; Didiot MC, 2009, MOL BIOL CELL, V20, P428, DOI 10.1091/mbc.E08-07-0737; Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278; Erickson SL, 2011, J CELL SCI, V124, P293, DOI 10.1242/jcs.072140; Franks TM, 2010, CELL, V143, P938, DOI 10.1016/j.cell.2010.11.043; Gibbings D, 2012, NAT CELL BIOL, V14, P1314, DOI 10.1038/ncb2611; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Ginsberg SD, 1998, ACTA NEUROPATHOL, V96, P487, DOI 10.1007/s004010050923; Gkogkas C, 2010, J BIOL CHEM, V285, P31913, DOI 10.1074/jbc.R110.154476; Ito D, 2011, NEUROLOGY, V77, P1636, DOI 10.1212/WNL.0b013e3182343365; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Krick R, 2010, J CELL BIOL, V190, P965, DOI 10.1083/jcb.201002075; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Loschi M, 2009, J CELL SCI, V122, P3973, DOI 10.1242/jcs.051383; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.e06-12-1079; Medioni C, 2012, DEVELOPMENT, V139, P3263, DOI 10.1242/dev.078626; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Mijaljica D, 2011, AUTOPHAGY, V7, P666, DOI 10.4161/auto.7.6.15812; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Ossareh-Nazari B, 2010, EMBO REP, V11, P548, DOI 10.1038/embor.2010.74; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Salajegheh M, 2009, MUSCLE NERVE, V40, P19, DOI 10.1002/mus.21386; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; Wang CW, 2002, J BIOL CHEM, V277, P47917, DOI 10.1074/jbc.M208191200; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	61	450	458	2	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1461	1474		10.1016/j.cell.2013.05.037	http://dx.doi.org/10.1016/j.cell.2013.05.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791177	Bronze, Green Accepted			2022-12-01	WOS:000320722000015
J	Godefroit, P; Cau, A; Hu, DY; Escuillie, F; Wu, WH; Dyke, G				Godefroit, Pascal; Cau, Andrea; Hu Dong-Yu; Escuillie, Franois; Wu Wenhao; Dyke, Gareth			A Jurassic avialan dinosaur from China resolves the early phylogenetic history of birds	NATURE			English	Article							LONG FEATHERS; THEROPOD; ARCHAEOPTERYX; MANIRAPTORAN; EVOLUTION	The recent discovery of small paravian theropod dinosaurs with well-preserved feathers in the Middle-Late Jurassic Tiaojishan Formation of Liaoning Province (northeastern China)(1-4) has challenged the pivotal position of Archaeopteryx(3,4), regarded from its discovery to be the most basal bird. Removing Archaeopteryx from the base of Avialae to nest within Deinonychosauria implies that typical bird flight, powered by the forelimbs only, either evolved at least twice, or was subsequently lost or modified in some deinonychosaurians(3,5). Here we describe the complete skeleton of a new paravian from the Tiaojishan Formation of Liaoning Province, China. Including this new taxon in a comprehensive phylogenetic analysis for basal Paraves does the following: (1) it recovers it as the basal-most avialan; (2) it confirms the avialan status of Archaeopteryx; (3) it places Troodontidae as the sister-group to Avialae; (4) it supports a single origin of powered flight within Paraves; and (5) it implies that the early diversification of Paraves and Avialae took place in the Middle-Late Jurassic period.	[Godefroit, Pascal] Royal Belgian Inst Nat Sci, Operat Direct Earth & Hist Life, B-1000 Brussels, Belgium; [Cau, Andrea] Museo Geol Giovanni Capellini, I-40127 Bologna, Italy; [Hu Dong-Yu] Shenyang Normal Univ, Inst Paleontol, Shenyang 110034, Peoples R China; [Hu Dong-Yu] NE Normal Univ, Minist Educ, Key Lab Vegetat Ecol, Changchun 130024, Peoples R China; [Escuillie, Franois] Eldonia, F-3800 Gannat, France; [Wu Wenhao] Jilin Univ, Res Ctr Paleontol & Stratig, Changchun 130021, Peoples R China; [Dyke, Gareth] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England	Royal Belgian Institute of Natural Sciences; Shenyang Normal University; Northeast Normal University - China; Jilin University; NERC National Oceanography Centre; University of Southampton	Godefroit, P (corresponding author), Royal Belgian Inst Nat Sci, Operat Direct Earth & Hist Life, Rue Vautier 29, B-1000 Brussels, Belgium.	Pascal.Godefroit@naturalsciences.be	Dyke, Gareth/AAJ-9320-2020; Cau, Andrea/S-8546-2016; Wu, Wenhao/AAU-4325-2020; Cau, Andrea/ABB-7972-2021	Dyke, Gareth/0000-0002-8390-7817; Cau, Andrea/0000-0001-8761-3720	SPP Politique scientifique (Belgium) [BL/36/62]; Key Laboratory of Evolutionary Systematics of Vertebrates [CAS2011LESV011]; National Natural Science Foundation of China [41172026]	SPP Politique scientifique (Belgium); Key Laboratory of Evolutionary Systematics of Vertebrates; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank B. Pohl for making fossils available for study, S. Ge for help and comments on the manuscript and T. Hubin for photographs. This study was supported by a grant (BL/36/62) to P. G. from the SPP Politique scientifique (Belgium). D. H. was supported by the Key Laboratory of Evolutionary Systematics of Vertebrates (CAS2011LESV011) and by the National Natural Science Foundation of China (41172026).	Chiappe LM, 1999, B AM MUS NAT HIST, P3; Currie PJ, 2001, CAN J EARTH SCI, V38, P1753, DOI 10.1139/e01-065; Elzanowski A, 1996, J VERTEBR PALEONTOL, V16, P81, DOI 10.1080/02724634.1996.10011286; EVANS SE, 1994, IN THE SHADOW OF THE DINOSAURS, P303; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Gauthier J, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P7; Godefroit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2389; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Lee MSY, 2012, BIOL LETTERS, V8, P299, DOI 10.1098/rsbl.2011.0884; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P184; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Makovicky PJ, 2003, AM MUS NOVIT, P1; Mayr G, 2007, ZOOL J LINN SOC-LOND, V149, P97, DOI 10.1111/j.1096-3642.2006.00245.x; Norell MA, 2004, DINOSAURIA, 2ND EDITION, P196; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; van der Lubbe T, 2009, ACTA PALAEONTOL POL, V54, P401, DOI 10.4202/app.2008.0007; Wellnhofer P., 2008, ARCHAEOPTERYX URVOGE; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753; Zheng XT, 2010, P ROY SOC B-BIOL SCI, V277, P211, DOI 10.1098/rspb.2009.1178; Zinke Jens, 1998, Palaeontologische Zeitschrift, V72, P179	28	120	127	1	241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					359	362		10.1038/nature12168	http://dx.doi.org/10.1038/nature12168			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23719374				2022-12-01	WOS:000320592900039
J	Taylor, RC; Dillin, A				Taylor, Rebecca C.; Dillin, Andrew			XBP-1 Is a Cell-Nonautonomous Regulator of Stress Resistance and Longevity	CELL			English	Article							UNFOLDED PROTEIN RESPONSE; RESTRICTION-INDUCED LONGEVITY; ELEGANS LIFE-SPAN; CAENORHABDITIS-ELEGANS; DAF-16; THAPSIGARGIN; PROTEOSTASIS; SEROTONIN; DISEASE; GENE	The ability to ensure proteostasis is critical for maintaining proper cell function and organismal viability but is mitigated by aging. We analyzed the role of the endoplasmic reticulum unfolded protein response (UPRER) in aging of C. elegans and found that age-onset loss of ER proteostasis could be reversed by expression of a constitutively active form of XBP-1, XBP-1s. Neuronally derived XBP-1s was sufficient to rescue stress resistance, increase longevity, and activate the UPRER in distal, non-neuronal cell types through a cell-nonautonomous mechanism. Loss of UPR ER signaling components in distal cells blocked cell-nonautonomous signaling from the nervous system, thereby blocking increased longevity of the entire animal. Reduction of small clear vesicle (SCV) release blocked nonautonomous signaling downstream of xbp-1s, suggesting that the release of neurotransmitters is required for this intertissue signaling event. Our findings point toward a secreted ER stress signal (SERSS) that promotes ER stress resistance and longevity.	[Taylor, Rebecca C.; Dillin, Andrew] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Dillin, A (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	dillin@berkeley.edu		Taylor, Rebecca/0000-0003-3429-3123	NIH [R01 AG042679]; NATIONAL INSTITUTE ON AGING [R01AG042679] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Kapernick, Z. Liu, K. Berendzen, and Drs. S. Panowski, C. Riera, and V. Ramachandran for technical assistance. We also thank Dr. T. Lamitina, E. Morton, and R. S. Taylor for help with MATLAB analysis. We are grateful to Drs. S. Wolff and V. Ramachandran for insightful comments on the manuscript, to Dr. J. Durieux for help with the graphical abstract, and to Drs. Y. Jin and S. Chalasani and the Caenorhabditis Genetics Center for strains. R.C.T. is an Ellison Medical Foundation/AFAR Postdoctoral Fellow. A.D. is cofounder of Proteostasis Therapeutics, Inc. and declares no financial interest related to this work. This work was supported by NIH R01 AG042679.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carrano AC, 2009, NATURE, V460, P396, DOI 10.1038/nature08130; Caruso ME, 2008, MOL CELL BIOL, V28, P4261, DOI 10.1128/MCB.02252-07; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Galbadage T, 2008, MECH AGEING DEV, V129, P507, DOI 10.1016/j.mad.2008.04.012; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Hansen M, 2007, WESTERN HUM REV, V61, P6; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Henis-Korenblit S, 2010, P NATL ACAD SCI USA, V107, P9730, DOI 10.1073/pnas.1002575107; HONDA S, 1990, P NATL ACAD SCI USA, V87, P876, DOI 10.1073/pnas.87.3.876; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; KIJIMA Y, 1991, J BIOL CHEM, V266, P22912; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; LEWIS JA, 1980, GENETICS, V95, P905; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; Nonet ML, 1997, J NEUROSCI, V17, P8061; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Richardson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002391; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Shim J, 2004, MOL BIOL CELL, V15, P4818, DOI 10.1091/mbc.E04-02-0108; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Viswanathan M, 2011, NATURE, V477, pE1, DOI 10.1038/nature10440; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007	46	337	341	3	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 20	2013	153	7					1435	1447		10.1016/j.cell.2013.05.042	http://dx.doi.org/10.1016/j.cell.2013.05.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791175	Green Accepted, Bronze			2022-12-01	WOS:000320722000013
J	Jones, BRT; Renowden, SA; Lowis, SP; Kurian, KM				Jones, Benjamin R. T.; Renowden, Shelley A.; Lowis, Stephen P.; Kurian, Kathreena M.			Early morning headache with vomiting in a 5 year old boy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TUMORS		[Jones, Benjamin R. T.] Univ Bristol, Sch Med, Bristol BS8 1TH, Avon, England; [Renowden, Shelley A.] Frenchay Hosp, Dept Neuroradiol, Bristol BS16 1LE, Avon, England; [Lowis, Stephen P.] Bristol Royal Hosp Children, Dept Paediat Haematol, Bristol, Avon, England; [Lowis, Stephen P.] Bristol Royal Hosp Children, BMT, Bristol, Avon, England; [Kurian, Kathreena M.] Frenchay Hosp, Dept Neuropathol, Brain Tumour Res Grp, Bristol BS16 1LE, Avon, England	University of Bristol; Bristol Royal Hospital For Children; Bristol Royal Hospital For Children	Jones, BRT (corresponding author), Univ Bristol, Sch Med, Bristol BS8 1TH, Avon, England.	bjones7392@gmail.com		Kurian, Kathreena/0000-0003-0303-3716				Catsman-Berrevoets CE, 2010, CORTEX, V46, P933, DOI 10.1016/j.cortex.2009.10.007; Gandola L, 2009, J CLIN ONCOL, V27, P566, DOI 10.1200/JCO.2008.18.4176; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Lannering B, 2012, J CLIN ONCOL, V30, P3187, DOI 10.1200/JCO.2011.39.8719; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mulhern RK, 2005, J CLIN ONCOL, V23, P5511, DOI 10.1200/JCO.2005.00.703; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Souweidane MM, 2010, J NEUROSURG-PEDIATR, V5, P325, DOI 10.3171/2009.11.PEDS09369; Wilne S, 2007, LANCET ONCOL, V8, P685, DOI 10.1016/S1470-2045(07)70207-3	9	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2013	346								f3315	10.1136/bmj.f3315	http://dx.doi.org/10.1136/bmj.f3315			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158DG	23719641				2022-12-01	WOS:000319948200009
J	Singh, R; Ong-Abdullah, M; Low, ETL; Manaf, MAA; Rosli, R; Nookiah, R; Ooi, LCL; Ooi, SE; Chan, KL; Halim, MA; Azizi, N; Nagappan, J; Bacher, B; Lakey, N; Smith, SW; He, D; Hogan, M; Budiman, MA; Lee, EK; DeSalle, R; Kudrna, D; Goicoechea, JL; Wing, RA; Wilson, RK; Fulton, RS; Ordway, JM; Martienssen, RA; Sambanthamurthi, R				Singh, Rajinder; Ong-Abdullah, Meilina; Low, Eng-Ti Leslie; Manaf, Mohamad Arif Abdul; Rosli, Rozana; Nookiah, Rajanaidu; Ooi, Leslie Cheng-Li; Ooi, Siew-Eng; Chan, Kuang-Lim; Halim, Mohd Amin; Azizi, Norazah; Nagappan, Jayanthi; Bacher, Blaire; Lakey, Nathan; Smith, Steven W.; He, Dong; Hogan, Michael; Budiman, Muhammad A.; Lee, Ernest K.; DeSalle, Rob; Kudrna, David; Goicoechea, Jose Luis; Wing, Rod A.; Wilson, Richard K.; Fulton, Robert S.; Ordway, Jared M.; Martienssen, Robert A.; Sambanthamurthi, Ravigadevi			Oil palm genome sequence reveals divergence of interfertile species in Old and New Worlds	NATURE			English	Article							LINKAGE MAPS; MESOCARP; IDENTIFICATION; CONSTRUCTION; ANNOTATION; MATURATION; GENERATION; SOFTWARE; INSIGHTS; PROTEIN	Oil palm is the most productive oil-bearing crop. Although it is planted on only 5% of the total world vegetable oil acreage, palm oil accounts for 33% of vegetable oil and 45% of edible oil worldwide, but increased cultivation competes with dwindling rainforest reserves. We report the 1.8-gigabase (Gb) genome sequence of the African oil palm Elaeis guineensis, the predominant source of worldwide oil production. A total of 1.535 Gb of assembled sequence and transcriptome data from 30 tissue types were used to predict at least 34,802 genes, including oil biosynthesis genes and homologues of WRINKLED1 (WRI1), and other transcriptional regulators(1), which are highly expressed in the kernel. We also report the draft sequence of the South American oil palm Elaeis oleifera, which has the same number of chromosomes (2n=32) and produces fertile interspecific hybrids with E. guineensis(2) but seems to have diverged in the New World. Segmental duplications of chromosome arms define the palaeotetraploid origin of palm trees. The oil palm sequence enables the discovery of genes for important traits as well as somaclonal epigenetic alterations that restrict the use of clones in commercial plantings(3), and should therefore help to achieve sustainability for biofuels and edible oils, reducing the rainforest footprint of this tropical plantation crop.	[Singh, Rajinder; Ong-Abdullah, Meilina; Low, Eng-Ti Leslie; Manaf, Mohamad Arif Abdul; Rosli, Rozana; Nookiah, Rajanaidu; Ooi, Leslie Cheng-Li; Ooi, Siew-Eng; Chan, Kuang-Lim; Halim, Mohd Amin; Azizi, Norazah; Nagappan, Jayanthi; Sambanthamurthi, Ravigadevi] Persiaran Inst, Malaysian Palm Oil Board, Kajang 43000, Selangor, Malaysia; [Bacher, Blaire; Lakey, Nathan; Smith, Steven W.; He, Dong; Hogan, Michael; Budiman, Muhammad A.; Ordway, Jared M.] Orion Genom, St Louis, MO 63108 USA; [Lee, Ernest K.; DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Kudrna, David; Goicoechea, Jose Luis; Wing, Rod A.] Univ Arizona, Arizona Genom Inst, Tucson, AZ 85705 USA; [Wilson, Richard K.; Fulton, Robert S.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Cold Spring Harbor, NY 11724 USA	Malaysian Palm Oil Board; American Museum of Natural History (AMNH); University of Arizona; Washington University (WUSTL); Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu; raviga@mpob.gov.my	Wilson, Richard K./AAF-4139-2019; Low, Eng Ti Leslie/AHD-7011-2022; Wing, Rod A/Z-2885-2019; Singh, Rajinder/P-9179-2015	Wilson, Richard K./0000-0002-1992-1358; Low, Eng Ti Leslie/0000-0003-3414-8401; Wing, Rod A/0000-0001-6633-6226; Singh, Rajinder/0000-0001-9933-4884; Ong-Abdullah, Meilina/0000-0003-4825-5021; Lee, Ernest/0000-0002-0974-7763; Sambanthamurthi, Ravi/0000-0003-3023-9306; Ooi, Leslie/0000-0002-6996-2801; Chan, Kuang-Lim/0000-0002-8419-0432; Azizi, Norazah/0000-0001-5023-9763; Ooi, Siew-Eng/0000-0002-6621-5456	Malaysian Palm Oil Board; NSF [0421604]; Division Of Integrative Organismal Systems [0922738] Funding Source: National Science Foundation	Malaysian Palm Oil Board; NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We acknowledge the contributions of N. Ahmad, M. Marjuni and N. Abdullah for sampling of oil palm materials. We thank MoGene, GeneWorks, Beijing Genome Institute, Tufts University Core Facility and Macrogen for sequencing services. We thank D. Stevenson for discussions. We appreciate the constant support of Y. M. Choo, and the Ministry of Plantation Industries and Commodities, Malaysia. The project was endorsed by the Cabinet Committee on the Competitiveness of the Palm Oil Industry (CCPO) and funded by the Malaysian Palm Oil Board. E. K. L., R. D. and R. A. M. are supported by a grant from NSF 0421604 (Genomics of Comparative Seed Plant Evolution).	Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAFOR ME, 1986, J SCI FOOD AGR, V37, P825, DOI 10.1002/jsfa.2740370902; Bedell JA, 2005, PLOS BIOL, V3, P103, DOI 10.1371/journal.pbio.0030013; Bourgis F, 2011, P NATL ACAD SCI USA, V108, P12527, DOI 10.1073/pnas.1106502108; Castilho A, 2000, ANN BOT-LONDON, V85, P837, DOI 10.1006/anbo.2000.1145; Chiu JC, 2006, BIOINFORMATICS, V22, P699, DOI 10.1093/bioinformatics/btk040; Cochard B, 2005, OCL OILS FAT CROP LI, V12, P141, DOI 10.1051/ocl.2005.0141; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corley R. H. V., 2003, OIL PALM, V4th, P1; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dransfield J., 2008, GENERA PALMARUM EVOL; Du JC, 2010, PLANT J, V63, P584, DOI 10.1111/j.1365-313X.2010.04263.x; HARDON J J, 1969, Euphytica, V18, P372, DOI 10.1007/BF00397784; HARTLEY C, 1988, OIL PALM, P47; Ho CL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-381; Jaligot E, 2011, ANN BOT-LONDON, V108, P1453, DOI 10.1093/aob/mcq266; Jansen J, 2005, GENETICS, V170, P2013, DOI 10.1534/genetics.105.041822; Jouannic S, 2005, FEBS LETT, V579, P2709, DOI 10.1016/j.febslet.2005.03.093; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lee EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002411; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Low ETL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-62; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mayes S, 1997, GENOME, V40, P116, DOI 10.1139/g97-016; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Purseglove J. W, 1972, TROPICAL CROPS MONOC, P416; RICHARDS EJ, 1992, NUCLEIC ACIDS RES, V20, P4039, DOI 10.1093/nar/20.15.4039; Riggins CW, 2012, MOL PHYLOGENET EVOL, V64, P471, DOI 10.1016/j.ympev.2012.05.003; Sambanthamurthi R, 2000, PROG LIPID RES, V39, P507, DOI 10.1016/S0163-7827(00)00015-1; Shaarani SM, 2010, INT J AGRIC BIOL, V12, P101; Singh R, 2008, ASIA PAC J MOL BIOL, V16, P53; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tranbarger TJ, 2011, PLANT PHYSIOL, V156, P564, DOI 10.1104/pp.111.175141; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; ZEVEN A C, 1965, Journal of the Nigerian Institute for Oil Palm Research, V4, P218	42	333	356	5	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					335	+		10.1038/nature12309	http://dx.doi.org/10.1038/nature12309			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23883927	Green Accepted, hybrid			2022-12-01	WOS:000323112400033
J	Barve, A; Wagner, A				Barve, Aditya; Wagner, Andreas			A latent capacity for evolutionary innovation through exaptation in metabolic systems	NATURE			English	Article							ESCHERICHIA-COLI; GENOTYPE NETWORKS; EVOLVABILITY; RECRUITMENT; ROBUSTNESS; DATABASE; LIGAND; GENES; KEGG; RNA	Some evolutionary innovations may originate non-adaptively as exaptations, or pre-adaptations, which are by-products of other adaptive traits(1-5). Examples include feathers, which originated before they were used in flight(2), and lens crystallins, which are light-refracting proteins that originated as enzymes(6). The question of how often adaptive traits have non-adaptive origins has profound implications for evolutionary biology, but is difficult to address systematically. Here we consider this issue in metabolism, one of the most ancient biological systems that is central to all life. We analyse a metabolic trait of great adaptive importance: the ability of a metabolic reaction network to synthesize all biomass from a single source of carbon and energy. We use novel computational methods to sample randomly many metabolic networks that can sustain life on any given carbon source but contain an otherwise random set of known biochemical reactions. We show that when we require such networks to be viable on one particular carbon source, they are typically also viable on multiple other carbon sources that were not targets of selection. For example, viability on glucose may entail viability on up to 44 other sole carbon sources. Any one adaptation in these metabolic systems typically entails multiple potential exaptations. Metabolic systems thus contain a latent potential for evolutionary innovations with non-adaptive origins. Our observations suggest that many more metabolic traits may have non-adaptive origins than is appreciated at present. They also challenge our ability to distinguish adaptive from non-adaptive traits.	[Barve, Aditya; Wagner, Andreas] Univ Zurich, Inst Evolutionary Biol & Environm Sci, CH-8057 Zurich, Switzerland; [Barve, Aditya; Wagner, Andreas] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Wagner, Andreas] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Zurich; Swiss Institute of Bioinformatics; The Santa Fe Institute	Wagner, A (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Sci, Bldg Y27,Winterthurerstr 190, CH-8057 Zurich, Switzerland.	andreas.wagner@ieu.uzh.ch			Swiss National Science Foundation [315230-129708]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank K. Raman, N. Sabath, J. L. Payne and J. Rodrigues for discussions. A.W. acknowledges financial support through Swiss National Science Foundation grant 315230-129708.	Aguilar C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-385; Amitai G, 2007, HFSP J, V1, P67, DOI [10.2976/1.2739115, 10.2976/1.2739115/10.2976/1]; Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Barve A, 2012, P NATL ACAD SCI USA, V109, pE1121, DOI 10.1073/pnas.1113065109; Binder K, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-642-03163-2; Cowperthwaite MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000110; Darwin C., 1872, ORIGIN SPECIES MEANS, V144, P971; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Ferrada E, 2012, BIOPHYS J, V102, P1916, DOI 10.1016/j.bpj.2012.01.047; Goto S, 2002, NUCLEIC ACIDS RES, V30, P402, DOI 10.1093/nar/30.1.402; Goto S, 2000, NUCLEIC ACIDS RES, V28, P380, DOI 10.1093/nar/28.1.380; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; Kim JH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.88; Koskiniemi S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002787; LIPMAN DJ, 1991, P ROY SOC B-BIOL SCI, V245, P7, DOI 10.1098/rspb.1991.0081; Ma HW, 2003, BIOINFORMATICS, V19, P1423, DOI 10.1093/bioinformatics/btg177; Martin OC, 2008, BIOPHYS J, V94, P2927, DOI 10.1529/biophysj.107.114348; Meijnen JP, 2008, APPL ENVIRON MICROB, V74, P5031, DOI 10.1128/AEM.00924-08; Moore E., 1959, P INT S THEOR SWITCH, P285; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; Neidhardt F., 1987, ESCHERICHIA COLI SAL, V1, P13; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Pievani T, 2011, J ANTHROPOL SCI, V89, P9, DOI 10.4436/jass.89015; Poulsen TS, 1999, J BACTERIOL, V181, P7126, DOI 10.1128/JB.181.22.7126-7130.1999; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Rodrigues JFM, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-39; Rodrigues JFM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000613; Samal A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-30; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Tomarev SI, 1996, EUR J BIOCHEM, V235, P449, DOI 10.1111/j.1432-1033.1996.00449.x; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262	40	96	96	1	67	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 8	2013	500	7461					203	+		10.1038/nature12301	http://dx.doi.org/10.1038/nature12301			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197CH	23851393	Green Accepted			2022-12-01	WOS:000322825500034
J	Eskandarian, HA; Impens, F; Nahori, MA; Soubigou, G; Coppee, JY; Cossart, P; Hamon, MA				Eskandarian, Haig A.; Impens, Francis; Nahori, Marie-Anne; Soubigou, Guillaume; Coppee, Jean-Yves; Cossart, Pascale; Hamon, Melanie A.			A Role for SIRT2-Dependent Histone H3K18 Deacetylation in Bacterial Infection	SCIENCE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; IFN-GAMMA; SIRT2; CHROMATIN; ACETYLATION; SIRTUINS; PATTERNS; TARGETS; IDENTIFICATION	Pathogens dramatically affect host cell transcription programs for their own profit during infection, but in most cases, the underlying mechanisms remain elusive. We found that during infection with the bacterium Listeria monocytogenes, the host deacetylase sirtuin 2 (SIRT2) translocates to the nucleus, in a manner dependent on the bacterial factor InlB. SIRT2 associates with the transcription start site of a subset of genes repressed during infection and deacetylates histone H3 on lysine 18 (H3K18). Infecting cells in which SIRT2 activity was blocked or using SIRT2(-/-) mice resulted in a significant impairment of bacterial infection. Thus, SIRT2-mediated H3K18 deacetylation plays a critical role during infection, which reveals an epigenetic mechanism imposed by a pathogenic bacterium to reprogram its host.	[Eskandarian, Haig A.; Impens, Francis; Nahori, Marie-Anne; Cossart, Pascale; Hamon, Melanie A.] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Eskandarian, Haig A.; Impens, Francis; Nahori, Marie-Anne; Cossart, Pascale; Hamon, Melanie A.] INSERM, U604, F-75015 Paris, France; [Eskandarian, Haig A.; Impens, Francis; Nahori, Marie-Anne; Cossart, Pascale; Hamon, Melanie A.] INRA, Unite Contrat 2020, F-75015 Paris, France; [Impens, Francis] Univ Ghent VIB, Dept Med Prot Res, Ghent, Belgium; [Impens, Francis] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Soubigou, Guillaume; Coppee, Jean-Yves] Inst Pasteur, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pcossart@pasteur.fr; hamon@pasteur.fr		Eskandarian, Haig Alexander/0000-0002-0610-0550; Hamon, Melanie/0000-0001-5078-4083; Marie-Anne, Nahori/0000-0002-4066-4528; Impens, Francis/0000-0003-2886-9616	Pasteur Institute; Inserm [U604]; Institut National de la Recherche Agronomique [USC2020]; Fondation Louis Jeantet; European Research Council [233348 MODELIST]; Fondation Le Roch Les Mousquetaires; Agence Nationale pour la Recherche; French government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]	Pasteur Institute; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut National de la Recherche Agronomique; Fondation Louis Jeantet; European Research Council(European Research Council (ERC)European Commission); Fondation Le Roch Les Mousquetaires; Agence Nationale pour la Recherche(French National Research Agency (ANR)); French government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR))	We thank G. Dougan and S. Clare for their help with the Sirt2<SUP>tm1a(EUCOMM)</SUP> Wtsi mice, E. Verdin for providing the SIRT2N168 mutant, C. Becavin for his assistance with the heatmap, J. Chamot-Rooke and M. Duchateau for the use of the mass spectrometers, and K. Gevaert and B. Ruttens (VIB, Ghent University, Belgium) for providing N-hydroxysuccinimide propionate reagents. We extend a special thanks to A. Le for his time and effort during the summer of 2009. Work in the Cossart laboratory is funded by the Pasteur Institute, Inserm (U604), Institut National de la Recherche Agronomique (USC2020), the Fondation Louis Jeantet, the European Research Council (advanced grant 233348 MODELIST), the Fondation Le Roch Les Mousquetaires, and the Agence Nationale pour la Recherche grants (ERANET "LISTRESS" and EPILIS). We have received funding for this study from the French government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant ANR-10-LABX-62-IBEID). H. A. E. is a doctoral student supported by the Fondation pour la Recherche Medicale, F. I. is a Postdoctoral Fellow of the Research Foundation Flanders (FWO-Vlaanderen), and P. C. is an international senior research scholar of the Howard Hughes Medical Institute. The transcriptome analysis data for this publication can be found in ArrayExpress with the accession number E-MEXP-3912.	Arbibe L, 2008, CELL MICROBIOL, V10, P1582, DOI 10.1111/j.1462-5822.2008.01170.x; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bierne H, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010272; Black JC, 2008, MOL CELL, V32, P449, DOI 10.1016/j.molcel.2008.09.018; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boukarabila H, 2009, GENE DEV, V23, P1195, DOI 10.1101/gad.512009; Chico-Calero I, 2002, P NATL ACAD SCI USA, V99, P431, DOI 10.1073/pnas.012363899; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Dortet L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002168; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Garcia-Garcia JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000488; Gouin E, 2010, P NATL ACAD SCI USA, V107, P17333, DOI 10.1073/pnas.1007765107; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Hamon MA, 2007, P NATL ACAD SCI USA, V104, P13467, DOI 10.1073/pnas.0702729104; Hamon MA, 2012, TRENDS MICROBIOL, V20, P360, DOI 10.1016/j.tim.2012.04.006; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Hirschey MD, 2011, COLD SH Q B, V76, P267, DOI 10.1101/sqb.2011.76.010850; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kincaid EZ, 2003, J IMMUNOL, V171, P2042, DOI 10.4049/jimmunol.171.4.2042; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Li YZ, 2011, GENES CELLS, V16, P34, DOI 10.1111/j.1365-2443.2010.01460.x; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Pathak SK, 2006, J IMMUNOL, V177, P7950, DOI 10.4049/jimmunol.177.11.7950; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Ribet D, 2010, NATURE, V464, P1192, DOI 10.1038/nature08963; Rolando M, 2013, CELL HOST MICROBE, V13, P395, DOI 10.1016/j.chom.2013.03.004; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Smyth G.K., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Staes A, 2011, NAT PROTOC, V6, P1130, DOI 10.1038/nprot.2011.355; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Van Damme Petra, 2013, Methods Mol Biol, V981, P115, DOI 10.1007/978-1-62703-305-3_9; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang Y, 2005, J IMMUNOL, V174, P5687, DOI 10.4049/jimmunol.174.9.5687; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zuo T, 2011, CANCER RES, V71, P1752, DOI 10.1158/0008-5472.CAN-10-3573	62	175	184	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					525	+	1238858	10.1126/science.1238858	http://dx.doi.org/10.1126/science.1238858			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23908241				2022-12-01	WOS:000322586700046
J	Sun, XJ; Wang, ZX; Wang, L; Jiang, YW; Kost, N; Soong, TD; Chen, WY; Tang, ZY; Nakadai, T; Elemento, O; Fischle, W; Melnick, A; Patel, DJ; Nimer, SD; Roeder, RG				Sun, Xiao-Jian; Wang, Zhanxin; Wang, Lan; Jiang, Yanwen; Kost, Nils; Soong, T. David; Chen, Wei-Yi; Tang, Zhanyun; Nakadai, Tomoyoshi; Elemento, Olivier; Fischle, Wolfgang; Melnick, Ari; Patel, Dinshaw J.; Nimer, Stephen D.; Roeder, Robert G.			A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; FUSION PARTNER; ETO; PROTEINS; T(8/21); BINDING; DIFFERENTIATION; DOMAIN; SEQ; TRANSLOCATION	Transcription factors are frequently altered in leukaemia through chromosomal translocation, mutation or aberrant expression(1). AML1-ETO, a fusion protein generated by the t(8;21) translocation in acute myeloid leukaemia, is a transcription factor implicated in both gene repression and activation(2). AML1-ETO oligomerization, mediated by the NHR2 domain, is critical for leukaemogenesis(3-6), making it important to identify co-regulatory factors that 'read' the NHR2 oligomerization and contribute to leukaemogenesis(4). Here we show that, in human leukaemic cells, AML1-ETO resides in and functions through a stable AML1-ETO-containing transcription factor complex (AETFC) that contains several haematopoietic transcription (co)factors. These AETFC components stabilize the complex through multivalent interactions, provide multiple DNA-binding domains for diverse target genes, co-localize genome wide, cooperatively regulate gene expression, and contribute to leukaemogenesis. Within the AETFC complex, AML1-ETO oligomerization is required for a specific interaction between the oligomerized NHR2 domain and a novel NHR2-binding (N2B) motif in E proteins. Crystallographic analysis of the NHR2-N2B complex reveals a unique interaction pattern in which an N2B peptide makes direct contact with side chains of two NHR2 domains as a dimer, providing a novel model of how dimeric/oligomeric transcription factors create a new protein-binding interface through dimerization/oligomerization. Intriguingly, disruption of this interaction by point mutations abrogates AML1-ETO-induced haematopoietic stem/progenitor cell self-renewal and leukaemogenesis. These results reveal new mechanisms of action of AML1-ETO, and provide a potential therapeutic target in t(8;21)-positive acute myeloid leukaemia.	[Sun, Xiao-Jian; Chen, Wei-Yi; Tang, Zhanyun; Nakadai, Tomoyoshi; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA; [Wang, Zhanxin; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA; [Wang, Lan; Nimer, Stephen D.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Wang, Lan; Nimer, Stephen D.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Jiang, Yanwen; Melnick, Ari] Weill Cornell Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY 10065 USA; [Kost, Nils; Fischle, Wolfgang] Max Planck Inst Biophys Chem, Lab Chromatin Biochem, D-37077 Gottingen, Germany; [Soong, T. David; Elemento, Olivier] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10065 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Miami; Cornell University; Max Planck Society; Cornell University	Roeder, RG (corresponding author), Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA.	roeder@rockefeller.edu	Melnick, Ari/AAA-5763-2020; Sun, Xiao-Jian/D-1560-2011	Sun, Xiao-Jian/0000-0001-8826-4614; Chen, Wei-Yi/0000-0002-0661-6899	National Institutes of Health (NIH) [CA163086, CA129325, CA113872, CA166835]; Starr Cancer Consortium [I5-A554]; Leukemia and Lymphoma Society (LLS) SCOR [7013-02, 7132-08]; Rockefeller University Center for Clinical and Translational Science from NIH [UL1RR024143]; Abby Rockefeller Mauze Trust; Maloris Foundation; NATIONAL CANCER INSTITUTE [R01CA129325, R01CA163086, P30CA008748, R01CA166835, R01CA113872] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Leukemia and Lymphoma Society (LLS) SCOR; Rockefeller University Center for Clinical and Translational Science from NIH; Abby Rockefeller Mauze Trust; Maloris Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank N. A. Speck and J. H. Bushweller for providing the AML1-ETO m7 plasmid, and R. Baer for providing anti-SCL antibodies. This work was supported by National Institutes of Health (NIH) grants CA163086 (R.G.R.), CA129325 (R.G.R.), CA113872 (R.G.R.) and CA166835 (S.D.N.), Starr Cancer Consortium grant I5-A554 (R.G.R., D.J.P. and S.D.N.), Leukemia and Lymphoma Society (LLS) SCOR grants 7013-02 (R.G.R. and S.D.N.) and 7132-08 (R.G.R., A.M. and D.J.P.), and Rockefeller University Center for Clinical and Translational Science Pilot Project grant UL1RR024143 from NIH (X.-J.S.). X.-J.S. was a Starr Cancer Consortium Visiting Fellow. L.W. was an Empire State Stem Cell Scholar and an LLS Fellow. Y.J. was an American Society of Haematology Scholar. W.-Y.C. was an LLS Fellow. D.J.P. was supported by funds from the Abby Rockefeller Mauze Trust and the Maloris Foundation.	Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Follows GA, 2003, EMBO J, V22, P2798, DOI 10.1093/emboj/cdg250; Funnell APW, 2012, ADV EXP MED BIOL, V747, P105, DOI 10.1007/978-1-4614-3229-6_7; Gardini A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000275; Gelmetti V, 1998, MOL CELL BIOL, V18, P7185, DOI 10.1128/MCB.18.12.7185; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Guo C, 2009, MOL CELL BIOL, V29, P2644, DOI 10.1128/MCB.00073-09; Heidenreich O, 2003, BLOOD, V101, P3157, DOI 10.1182/blood-2002-05-1589; Huang G, 2008, NAT GENET, V40, P51, DOI 10.1038/ng.2007.7; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kwok C, 2009, P NATL ACAD SCI USA, V106, P2853, DOI 10.1073/pnas.0810558106; Liu YZ, 2006, CANCER CELL, V9, P249, DOI 10.1016/j.ccr.2006.03.012; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Mao SF, 1999, MOL CELL BIOL, V19, P3635; Martens JHA, 2012, BLOOD, V120, P4038, DOI 10.1182/blood-2012-05-429050; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; MIYOSHI H, 1993, EMBO J, V12, P2715, DOI 10.1002/j.1460-2075.1993.tb05933.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Okumura AJ, 2008, BLOOD, V112, P1392, DOI 10.1182/blood-2007-11-124735; Park S, 2009, BLOOD, V113, P3558, DOI 10.1182/blood-2008-06-161307; Peterson LF, 2004, ONCOGENE, V23, P4255, DOI 10.1038/sj.onc.1207727; Sanchez MJ, 1999, DEVELOPMENT, V126, P3891; Sharov AA, 2009, DNA RES, V16, P261, DOI 10.1093/dnares/dsp014; Shia WJ, 2012, BLOOD, V119, P4953, DOI 10.1182/blood-2011-04-347476; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Wang L, 2011, SCIENCE, V333, P765, DOI 10.1126/science.1201662; Westendorf JJ, 1998, MOL CELL BIOL, V18, P322, DOI 10.1128/MCB.18.1.322; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Yan M, 2009, BLOOD, V113, P883, DOI 10.1182/blood-2008-04-153742; Zhang JS, 2004, SCIENCE, V305, P1286, DOI 10.1126/science.1097937; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	37	100	108	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2013	500	7460					93	U120		10.1038/nature12287	http://dx.doi.org/10.1038/nature12287			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23812588	Green Accepted, Green Published			2022-12-01	WOS:000322514800035
J	Hollenstein, K; Kean, J; Bortolato, A; Cheng, RKY; Dore, AS; Jazayeri, A; Cooke, RM; Weir, M; Marshall, FH				Hollenstein, Kaspar; Kean, James; Bortolato, Andrea; Cheng, Robert K. Y.; Dore, Andrew S.; Jazayeri, Ali; Cooke, Robert M.; Weir, Malcolm; Marshall, Fiona H.			Structure of class B GPCR corticotropin-releasing factor receptor 1	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; MOLECULAR RECOGNITION; PARATHYROID-HORMONE; PEPTIDE RECEPTOR; AGONIST; BINDING; THERMOSTABILIZATION; REFINEMENT; ACTIVATION	Structural analysis of class B G-protein-coupled receptors (GPCRs), cell-surface proteins that respond to peptide hormones, has been restricted to the amino-terminal extracellular domain, thus providing little understanding of the membrane-spanning signal transduction domain. The corticotropin-releasing factor receptor type 1 is a class B receptor which mediates the response to stress and has been considered a drug target for depression and anxiety. Here we report the crystal structure of the transmembrane domain of the human corticotropin-releasing factor receptor type 1 incomplex with the small-molecule antagonist CP-376395. The structure provides detailed insight into the architecture of class B receptors. Atomic details of the interactions of the receptor with the non-peptide ligand that binds deep within the receptor are described. This structure provides a model for all class B GPCRs and may aid in the design of new small-molecule drugs for diseases of brain and metabolism.	[Hollenstein, Kaspar; Kean, James; Bortolato, Andrea; Cheng, Robert K. Y.; Dore, Andrew S.; Jazayeri, Ali; Cooke, Robert M.; Weir, Malcolm; Marshall, Fiona H.] Heptares Therapeut Ltd, Welwyn Garden City AL7 3AX, Herts, England	Heptares Therapeutics Ltd.	Marshall, FH (corresponding author), Heptares Therapeut Ltd, BioPk,Broadwater Rd, Welwyn Garden City AL7 3AX, Herts, England.	fiona.marshall@heptares.com	Marshall, Fiona/AAZ-9626-2020	Marshall, Fiona/0000-0002-8681-005X; Hollenstein, Kaspar/0000-0001-7606-4105				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Berg C, 2003, NAT REV DRUG DISCOV, V2, P257, DOI 10.1038/nrd1068; Bhavsar S, 2013, CURR DIABETES REV, V9, P161; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YL, 2008, J MED CHEM, V51, P1385, DOI 10.1021/jm070579c; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chugunov AO, 2010, MOL PHARMACOL, V78, P394, DOI 10.1124/mol.110.063578; Congreve M, 2011, ADV PHARMACOL, V62, P1, DOI 10.1016/B978-0-12-385952-5.00011-7; Conner AC, 2005, MOL PHARMACOL, V67, P20, DOI 10.1124/mol.67.1.20; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ganguli SC, 1998, J PHARMACOL EXP THER, V286, P593; Gardella TJ, 1996, J BIOL CHEM, V271, P12820, DOI 10.1074/jbc.271.22.12820; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Haddadian EJ, 2011, BIOPHYS J, V101, P899, DOI 10.1016/j.bpj.2011.06.063; Hansen MC, 2013, SCIENCE, V342, P850, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Heller RS, 1996, BIOCHEM BIOPH RES CO, V223, P624, DOI 10.1006/bbrc.1996.0945; Hemley CF, 2007, CURR DRUG TARGETS, V8, P105, DOI 10.2174/138945007779315542; Hjorth SA, 1998, MOL ENDOCRINOL, V12, P78, DOI 10.1210/mend.12.1.0045; Hoare SRJ, 2008, MOL PHARMACOL, V73, P1371, DOI 10.1124/mol.107.042978; Hoare SRJ, 2006, BIOCHEM PHARMACOL, V72, P244, DOI 10.1016/j.bcp.2006.04.007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019682; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lebon G, 2011, J MOL BIOL, V409, P298, DOI 10.1016/j.jmb.2011.03.075; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Mann RJ, 2010, PEPTIDES, V31, P2289, DOI 10.1016/j.peptides.2010.09.015; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Piserchio A, 2000, BIOCHEMISTRY-US, V39, P8153, DOI 10.1021/bi000196f; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Robertson N, 2011, NEUROPHARMACOLOGY, V60, P36, DOI 10.1016/j.neuropharm.2010.07.001; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vohra S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0846; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Zorrilla EP, 2010, DRUG DISCOV TODAY, V15, P371, DOI 10.1016/j.drudis.2010.02.011	55	336	346	1	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					438	+		10.1038/nature12357	http://dx.doi.org/10.1038/nature12357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23863939				2022-12-01	WOS:000322157900032
J	Morden, NE; Schwartz, LM; Fisher, ES; Woloshin, S				Morden, Nancy E.; Schwartz, Lisa M.; Fisher, Elliott S.; Woloshin, Steven			Accountable Prescribing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								<p id="p002">To avoid rewarding poor prescribing, we should move beyond numerically driven quality measures to measures that match treatment goals to the best evidence and encourage use of the safest, most effective, and lowest-cost drugs or nondrug treatments. <p id="p003">Physicians spend a lot of time treating numbers blood pressure, cholesterol levels, glycated hemoglobin levels. Professional guidelines, pharmaceutical marketing, and public health campaigns teach physicians and patients that better numbers mean success. Unfortunately, better numbers don't reliably translate into what really matters: patients who feel better and live longer. Often the health benefit gained by reaching a goal depends on how it is reached. When physicians strive for numerical goals without prioritizing the possible treatment strategies, patients may get less effective, less safe, or even unnecessary medications. <p id="p004">Many quality measures reinforce a focus on numerical goals. For example, performance-measure ...	[Morden, Nancy E.; Schwartz, Lisa M.; Fisher, Elliott S.; Woloshin, Steven] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Morden, Nancy E.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Morden, Nancy E.; Schwartz, Lisa M.; Fisher, Elliott S.; Woloshin, Steven] Geisel Sch Med, Dept Community & Family Med, Hanover, NH USA; [Schwartz, Lisa M.; Woloshin, Steven] Affairs Outcomes Grp, White River Jct, VT USA	Dartmouth College; Dartmouth College; Dartmouth College	Morden, NE (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA.				NIA NIH HHS [K23 AG035030, P01 AG019783] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K23AG035030, P01AG019783] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2007, ACT PIOGL HYDR TABL; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Fisher ES, 2011, NEW ENGL J MED, V365, P2445, DOI 10.1056/NEJMp1112442	3	4	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					299	302		10.1056/NEJMp1301805	http://dx.doi.org/10.1056/NEJMp1301805			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	188VJ	23883375	Green Accepted, Bronze			2022-12-01	WOS:000322223900003
J	Galagan, JE; Minch, K; Peterson, M; Lyubetskaya, A; Azizi, E; Sweet, L; Gomes, A; Rustad, T; Dolganov, G; Glotova, I; Abeel, T; Mahwinney, C; Kennedy, AD; Allard, R; Brabant, W; Krueger, A; Jaini, S; Honda, B; Yu, WH; Hickey, MJ; Zucker, J; Garay, C; Weiner, B; Sisk, P; Stolte, C; Winkler, JK; Van de Peer, Y; Iazzetti, P; Camacho, D; Dreyfuss, J; Liu, Y; Dorhoi, A; Mollenkopf, HJ; Drogaris, P; Lamontagne, J; Zhou, YY; Piquenot, J; Park, ST; Raman, S; Kaufmann, SHE; Mohney, RP; Chelsky, D; Moody, DB; Sherman, DR; Schoolnik, GK				Galagan, James E.; Minch, Kyle; Peterson, Matthew; Lyubetskaya, Anna; Azizi, Elham; Sweet, Linsday; Gomes, Antonio; Rustad, Tige; Dolganov, Gregory; Glotova, Irina; Abeel, Thomas; Mahwinney, Chris; Kennedy, Adam D.; Allard, Rene; Brabant, William; Krueger, Andrew; Jaini, Suma; Honda, Brent; Yu, Wen-Han; Hickey, Mark J.; Zucker, Jeremy; Garay, Christopher; Weiner, Brian; Sisk, Peter; Stolte, Christian; Winkler, Jessica K.; Van de Peer, Yves; Iazzetti, Paul; Camacho, Diogo; Dreyfuss, Jonathan; Liu, Yang; Dorhoi, Anca; Mollenkopf, Hans-Joachim; Drogaris, Paul; Lamontagne, Julie; Zhou, Yiyong; Piquenot, Julie; Park, Sang Tae; Raman, Sahadevan; Kaufmann, Stefan H. E.; Mohney, Robert P.; Chelsky, Daniel; Moody, D. Branch; Sherman, David R.; Schoolnik, Gary K.			The Mycobacterium tuberculosis regulatory network and hypoxia	NATURE			English	Article							CONTROLLING GENE-EXPRESSION; FREE MYCOLIC ACIDS; DEVR DOSR REGULON; VIRULENCE; CHOLESTEROL; INSIGHTS; PROTEIN; PHOP; BIOSYNTHESIS; MACROPHAGES	We have taken the first steps towards a complete reconstruction of the Mycobacterium tuberculosis regulatory network based on ChIP-Seq and combined this reconstruction with system-wide profiling of messenger RNAs, proteins, metabolites and lipids during hypoxia and re-aeration. Adaptations to hypoxia are thought to have a prominent role in M. tuberculosis pathogenesis. Using ChIP-Seq combined with expression data from the induction of the same factors, we have reconstructed a draft regulatory network based on 50 transcription factors. This network model revealed a direct interconnection between the hypoxic response, lipid catabolism, lipid anabolism and the production of cell wall lipids. As a validation of this model, in response to oxygen availability we observe substantial alterations in lipid content and changes in gene expression and metabolites in corresponding metabolic pathways. The regulatory network reveals transcription factors underlying these changes, allows us to computationally predict expression changes, and indicates that Rv0081 is a regulatory hub.	[Galagan, James E.; Peterson, Matthew; Mahwinney, Chris; Krueger, Andrew; Jaini, Suma; Honda, Brent; Yu, Wen-Han; Garay, Christopher; Iazzetti, Paul; Camacho, Diogo; Dreyfuss, Jonathan] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Galagan, James E.; Park, Sang Tae; Raman, Sahadevan] Boston Univ, Dept Microbiol, Boston, MA 02215 USA; [Galagan, James E.; Lyubetskaya, Anna; Azizi, Elham; Gomes, Antonio; Glotova, Irina] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Galagan, James E.; Abeel, Thomas; Zucker, Jeremy; Weiner, Brian; Sisk, Peter; Stolte, Christian] Eli & Edythe L Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Minch, Kyle; Rustad, Tige; Brabant, William; Hickey, Mark J.; Winkler, Jessica K.; Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Sweet, Linsday; Moody, D. Branch] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Sweet, Linsday; Moody, D. Branch] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Dolganov, Gregory; Liu, Yang; Schoolnik, Gary K.] Stanford Med Sch, Dept Med, Stanford, CA 94305 USA; [Dolganov, Gregory; Liu, Yang; Schoolnik, Gary K.] Stanford Med Sch, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Abeel, Thomas; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Kennedy, Adam D.; Mohney, Robert P.] Metabolon Inc, Durham, NC 27713 USA; [Allard, Rene; Drogaris, Paul; Lamontagne, Julie; Zhou, Yiyong; Piquenot, Julie; Chelsky, Daniel] Capr Prote Inc, Montreal, PQ H4S 2C8, Canada; [Dorhoi, Anca; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany; [Mollenkopf, Hans-Joachim] Max Planck Inst Infect Biol, Microarray Core Facil, D-10117 Berlin, Germany; [Sherman, David R.] Univ Washington, Dept Global Hlth, Interdisciplinary Program Pathobiol, Seattle, WA 98195 USA; [Schoolnik, Gary K.] Stanford Med Sch, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA	Boston University; Boston University; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Center for Infectious Disease Research; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Stanford University; Stanford University; Ghent University; Metabolon; Max Planck Society; Max Planck Society; University of Washington; University of Washington Seattle; Stanford University	Galagan, JE (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	jgalag@bu.edu	Lyubetskaya, Anna/A-6290-2017; Van de Peer, Yves/D-4388-2009; Van de Peer, Yves/AAE-7666-2019; Zucker, Jeremy/M-3643-2016; Mollenkopf, Hans-Joachim/AAH-2500-2019; Kaufmann, Stefan HE/I-5454-2014	Van de Peer, Yves/0000-0003-4327-3730; Van de Peer, Yves/0000-0003-4327-3730; Zucker, Jeremy/0000-0002-7276-9009; Stolte, Christian/0000-0002-8228-4195; Camacho, Diogo/0000-0002-1971-3524; Abeel, Thomas/0000-0002-7205-7431; Gomes, Antonio LC/0000-0003-3790-3724; Dreyfuss, Jonathan/0000-0001-7242-3991; Lyubetskaya, Anna/0000-0003-2485-3924; Azizi, Elham/0000-0001-5059-6971; Galagan, James/0000-0003-0542-3291; Mollenkopf, Hans-Joachim/0000-0003-1167-4783; Kaufmann, Stefan HE/0000-0001-9866-8268; Garay, Christopher/0000-0002-2682-5508; Raman, Sahadevan/0000-0001-5309-8169	National Institute of Allergy and Infectious Diseases National Institute of Health, Department of Health and Human Services [HHSN272200800059C, U19 AI 076217, R01 AI 071155]; Paul G. Allen Family Foundation; National Science Foundation Pre-doctoral Fellowship Program; Burroughs Wellcome Fund Award for Translational Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071155, T32AI007509, U19AI076217] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases National Institute of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Paul G. Allen Family Foundation; National Science Foundation Pre-doctoral Fellowship Program(National Science Foundation (NSF)); Burroughs Wellcome Fund Award for Translational Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases National Institute of Health, Department of Health and Human Services, under contract no. HHSN272200800059C and U19 AI 076217, R01 AI 071155, the Paul G. Allen Family Foundation (to DRS), the National Science Foundation Pre-doctoral Fellowship Program (to K. M.), and the Burroughs Wellcome Fund Award for Translational Research. We acknowledge D. C. Young for lipidomics mass spectrometry services and advice. We would also like to thank L. Carvalho for his advice on the statistical analysis of the gene expression modelling. We are grateful for the administrative assistance of S. Shiviah and S. Tucker and for the support and advice of V. Di Francesco, K. Lacourciere, P. Dudley and M. Polanski.	Abramovitch RB, 2011, MOL MICROBIOL, V80, P678, DOI 10.1111/j.1365-2958.2011.07601.x; Arnvig KB, 2012, RNA BIOL, V9, P427, DOI 10.4161/rna.20105; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Cho BK, 2012, NAT CHEM BIOL, V8, P65, DOI 10.1038/nchembio.710; Colangeli R, 2009, P NATL ACAD SCI USA, V106, P4414, DOI 10.1073/pnas.0810126106; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Ehrt S, 2006, FUTURE MICROBIOL, V1, P177, DOI 10.2217/17460913.1.2.177; Ernst J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100115; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Galagan J, 2013, CURR TOP MICROBIOL, V363, P43, DOI 10.1007/82_2012_257; Gao CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036255; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Gautam US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016500; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Gordon BRG, 2010, P NATL ACAD SCI USA, V107, P5154, DOI 10.1073/pnas.0913551107; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Klotzsche M, 2009, NUCLEIC ACIDS RES, V37, P1778, DOI 10.1093/nar/gkp015; Low KL, 2009, J BACTERIOL, V191, P5037, DOI 10.1128/JB.00530-09; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miner MD, 2009, INDIAN J EXP BIOL, V47, P407; Nazarova EV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P636, DOI 10.1134/S0006297911060034; Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Ojha AK, 2010, J BIOL CHEM, V285, P17380, DOI 10.1074/jbc.M110.112813; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rousseau C, 2004, CELL MICROBIOL, V6, P277, DOI 10.1046/j.1462-5822.2004.00368.x; Russell DG, 2002, J CELL BIOL, V158, P421, DOI 10.1083/jcb.200205034; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Ryndak M, 2008, TRENDS MICROBIOL, V16, P528, DOI 10.1016/j.tim.2008.08.006; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Vasudeva-Rao HM, 2008, INFECT IMMUN, V76, P2478, DOI 10.1128/IAI.01443-07; Yang XX, 2009, BIOCHEMISTRY-US, V48, P3819, DOI 10.1021/bi9005418	46	295	297	3	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					178	183		10.1038/nature12337	http://dx.doi.org/10.1038/nature12337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23823726	Green Accepted			2022-12-01	WOS:000321557600055
J	Modi, SR; Lee, HH; Spina, CS; Collins, JJ				Modi, Sheetal R.; Lee, Henry H.; Spina, Catherine S.; Collins, James J.			Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome	NATURE			English	Article							HUMAN GUT MICROBIOTA; GENES; DIVERSITY; VIRUSES	The mammalian gut ecosystem has considerable influence on host physiology(1-4), but the mechanisms that sustain this complex environment in the face of different stresses remain obscure. Perturbations to the gut ecosystem, such as through antibiotic treatment or diet, are at present interpreted at the level of bacterial phylogeny(5-7). Less is known about the contributions of the abundant population of phages to this ecological network. Here we explore the phageome as a potential genetic reservoir for bacterial adaptation by sequencing murine faecal phage populations following antibiotic perturbation. We show that antibiotic treatment leads to the enrichment of phage-encoded genes that confer resistance via disparate mechanisms to the administered drug, as well as genes that confer resistance to antibiotics unrelated to the administered drug, and we demonstrate experimentally that phages from treated mice provide aerobically cultured naive microbiota with increased resistance. Systems-wide analyses uncovered post-treatment phage-encoded processes related to host colonization and growth adaptation, indicating that the phageome becomes broadly enriched for functionally beneficial genes under stress-related conditions. We also show that antibiotic treatment expands the interactions between phage and bacterial species, leading to a more highly connected phage-bacterial network for gene exchange. Our work implicates the phageome in the emergence of multidrug resistance, and indicates that the adaptive capacity of the phageome may represent a community-based mechanism for protecting the gut microflora, preserving its functional robustness during antibiotic stress.	[Modi, Sheetal R.; Lee, Henry H.; Spina, Catherine S.; Collins, James J.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA; [Modi, Sheetal R.; Lee, Henry H.; Spina, Catherine S.; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Spina, Catherine S.; Collins, James J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Spina, Catherine S.; Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02118 USA	Boston University; Howard Hughes Medical Institute; Boston University; Boston University; Harvard University	Collins, JJ (corresponding author), Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA.	jcollins@bu.edu	Lee, Henry/GVS-2114-2022	Lee, Henry/0000-0002-0577-2275; Spina, Catherine/0000-0001-6067-5024	Howard Hughes Medical Institute; National Institutes of Health Director's Pioneer Award Program; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health Director's Pioneer Award Program; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Bodi and J. Schiemer at the Tufts Genomic Core for their sequencing assistance and A. Green and K. Pardee for ultracentrifugation help. This work was supported by the Howard Hughes Medical Institute and the National Institutes of Health Director's Pioneer Award Program.	Antunes LCM, 2011, ANTIMICROB AGENTS CH, V55, P1494, DOI 10.1128/AAC.01664-10; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chen J, 2009, SCIENCE, V323, P139, DOI 10.1126/science.1164783; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dorscht J, 2009, J BACTERIOL, V191, P7206, DOI 10.1128/JB.01041-09; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908; Hanaki H, 1998, J ANTIMICROB CHEMOTH, V42, P199, DOI 10.1093/jac/42.2.199; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Stern A, 2012, GENOME RES, V22, P1985, DOI 10.1101/gr.138297.112; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Zimmer M, 2002, J BACTERIOL, V184, P4359, DOI 10.1128/JB.184.16.4359-4368.2002	31	327	348	25	320	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					219	+		10.1038/nature12212	http://dx.doi.org/10.1038/nature12212			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23748443	Green Accepted, Green Submitted			2022-12-01	WOS:000321557600064
J	Orsi, WD; Edgcomb, VP; Christman, GD; Biddle, JF				Orsi, William D.; Edgcomb, Virginia P.; Christman, Glenn D.; Biddle, Jennifer F.			Gene expression in the deep biosphere	NATURE			English	Article							ARCHAEA; LIFE; ABUNDANCE; SEDIMENTS; BIOMASS	Scientific ocean drilling has revealed a deep biosphere of widespread microbial life in sub-seafloor sediment. Microbial metabolism in the marine subsurface probably has an important role in global biogeochemical cycles(1-3), but deep biosphere activities are not well understood(1). Here we describe and analyse the first sub-seafloor metatranscriptomes from anaerobic Peru Margin sediment up to 159 metres below the sea floor, represented by over 1 billion complementary DNA (cDNA) sequence reads. Anaerobic metabolismof amino acids, carbohydrates and lipids seem to be the dominant metabolic processes, and profiles of dissimilatory sulfite reductase (dsr) transcripts are consistent with pore-water sulphate concentration profiles(1). Moreover, transcripts involved in cell division increase as a function of microbial cell concentration, indicating that increases in sub-seafloor microbial abundance are a function of cell division across all three domains of life. These data support calculations(1) and models(4) of sub-seafloor microbial metabolism and represent the first holistic picture of deep biosphere activities.	[Orsi, William D.; Edgcomb, Virginia P.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Christman, Glenn D.; Biddle, Jennifer F.] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA	Woods Hole Oceanographic Institution; University of Delaware	Orsi, WD (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	william.orsi@gmail.com	Biddle, Jennifer F/F-8323-2010; Edgcomb, Virginia/Q-2434-2019	Biddle, Jennifer F/0000-0002-4344-8724; Edgcomb, Virginia/0000-0001-6805-381X	Center for Dark Energy Biosphere Investigations (CDEBI) [OCE-0939564]; National Science Foundation IOS [1238801]	Center for Dark Energy Biosphere Investigations (CDEBI); National Science Foundation IOS(National Science Foundation (NSF))	This work was fostered by a Center for Dark Energy Biosphere Investigations (CDEBI) grant OCE-0939564 to W.D.O. and a National Science Foundation IOS grant 1238801 to J.F.B. We thank C. House and A. Teske for providing samples. We also thank M. Sogin and R. Fox at the Josephine Bay Paul Center for providing access to computing resources. E. Leadbetter and S. Hallam provided comments on the manuscript, and we also thank S. D'Hondt for discussions on the deep biosphere. This is CDEBI contribution 137.	Biddle JF, 2005, GEOBIOLOGY, V3, P287, DOI 10.1111/j.1472-4669.2006.00062.x; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; D'Hondt S, 2009, P NATL ACAD SCI USA, V106, P11651, DOI 10.1073/pnas.0811793106; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Hinrichs KU, 2012, SCIENCE, V338, P204, DOI 10.1126/science.1229296; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; Jorgensen B. B., 2006, P OCEAN DRILLING PRO, V201, P1; Jorgensen BB, 2006, SCIENCE, V314, P932, DOI 10.1126/science.1133796; Jorgensen BB, 2011, P NATL ACAD SCI USA, V108, P18193, DOI 10.1073/pnas.1115421108; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Lever MA, 2013, FEMS MICROBIOL ECOL, V84, P1, DOI 10.1111/1574-6941.12051; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033; Lomstein BA, 2012, NATURE, V484, P101, DOI 10.1038/nature10905; Martino AJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00017; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Moran MA, 2013, ISME J, V7, P237, DOI 10.1038/ismej.2012.94; OREMLAND RS, 1982, APPL ENVIRON MICROB, V44, P1270, DOI 10.1128/AEM.44.6.1270-1276.1982; Orsi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056335; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; PARKES RJ, 2004, MICROBIAL DIVERSITY, P120; Schrenk MO, 2010, ANNU REV MAR SCI, V2, P279, DOI 10.1146/annurev-marine-120308-081000; Teske A., 2006, P OCEAN DRILLING PRO, V201, P1; Valentine DL, 2011, ANNU REV MAR SCI, V3, P147, DOI 10.1146/annurev-marine-120709-142734; Webster G, 2006, FEMS MICROBIOL ECOL, V58, P65, DOI 10.1111/j.1574-6941.2006.00147.x; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	30	188	190	6	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					205	+		10.1038/nature12230	http://dx.doi.org/10.1038/nature12230			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23760485				2022-12-01	WOS:000321557600061
J	Sharma, S; Quintana, A; Findlay, GM; Mettlen, M; Baust, B; Jain, M; Nilsson, R; Rao, A; Hogan, PG				Sharma, Sonia; Quintana, Ariel; Findlay, Gregory M.; Mettlen, Marcel; Baust, Beate; Jain, Mohit; Nilsson, Roland; Rao, Anjana; Hogan, Patrick G.			An siRNA screen for NFAT activation identifies septins as coordinators of store-operated Ca2+ entry	NATURE			English	Article							CHANNEL ACTIVATION; ORAI1; STIM1; CALCIUM; CYTOSKELETON; RELEASE; CRAC; FORCHLORFENURON; ORGANIZATION; DOMAINS	The STIM1-ORAI1 pathway of store-operated Ca2+ entry is an essential component of cellular Ca2+ signalling(1). STIM1 senses depletion of intracellular Ca2+ stores in response to physiological stimuli, and relocalizes within the endoplasmic reticulum to plasma-membrane-apposed junctions, where it recruits and gates open plasma membrane ORAI1 Ca2+ channels. Here we use a genome-wide RNA interference screen in HeLa cells to identify filamentous septin proteins as crucial regulators of store-operated Ca2+ entry. Septin filaments and phosphatidylinositol-4,5-bisphosphate (also known as PtdIns(4,5)P-2) rearrange locally at endoplasmic reticulum-plasma membrane junctions before and during formation of STIM1-ORAI1 clusters, facilitating STIM1 targeting to these junctions and promoting the stable recruitment of ORAI1. Septin rearrangement at junctions is required for PtdIns(4,5) P2 reorganization and efficient STIM1-ORAI1 communication. Septins are known to demarcate specialized membrane regions such as dendritic spines, the yeast bud and the primary cilium, and to serve as membrane diffusion barriers and/or signalling hubs in cellular processes such as vesicle trafficking, cell polarity and cytokinesis2-4. Our data show that septins also organize the highly localized plasma membrane domains that are important in STIM1-ORAI1 signalling, and indicate that septins may organize membrane microdomains relevant to other signalling processes.	[Sharma, Sonia; Quintana, Ariel; Rao, Anjana; Hogan, Patrick G.] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Sharma, Sonia; Quintana, Ariel; Findlay, Gregory M.; Baust, Beate; Rao, Anjana; Hogan, Patrick G.] Harvard Univ, Sch Med, Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA; [Mettlen, Marcel] Scripps Res Inst, La Jolla, CA 92037 USA; [Jain, Mohit] Broad Inst, Cambridge, MA 02142 USA; [Jain, Mohit] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Nilsson, Roland] Karolinska Inst, S-17176 Stockholm, Sweden	La Jolla Institute for Immunology; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Scripps Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Karolinska Institutet	Rao, A (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	arao@liai.org; phogan@liai.org	Mettlen, Marcel B/A-2357-2011; Nilsson, Roland/AAJ-3519-2021; Findlay, Gregory/AAX-9029-2020	Mettlen, Marcel B/0000-0001-7047-2749; Findlay, Gregory/0000-0002-7767-8608; Nilsson, Roland/0000-0002-6020-7498	National Institutes of Health (NIH) [AI040127, AI084167]; NIH [AI092763, K08 HL107451, R01GM73165]; Canadian Institutes for Health Research; Leukemia & Lymphoma Society; Deutsche Forschungsgemeinschaft [QU298/1-1]; Knut & Alice Wallenberg Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL107451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040127, RC4AI092763, R01AI084167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073165] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Shamu, S. Rudnicki, S. Johnston and D. Wrobel for screening support; A. Carpenter and M. Bray for CellProfiler optimization; P. Meraner and Y. Zhou for cell lines and constructs; S. Schmid, J. Fitzpatrick and the Waitt Advanced Biophotonics Center at the Salk Institute for access to TIRF microscopes; C. Junker for the RFP-ER construct; S. Field for the PLC delta-PH-eGFP plasmid; and S. Schmid for manuscript review. The work was supported by National Institutes of Health (NIH) R01 grants AI040127 and AI084167(to A. R. and P. G. H.), NIH RC4 grant AI092763 (to A. R. and S. S.); a Fellowship from the Canadian Institutes for Health Research and a Special Fellowship from The Leukemia & Lymphoma Society (to S. S.); postdoctoral fellowship QU298/1-1 from the Deutsche Forschungsgemeinschaft (to A. Q.); NIH grant K08 HL107451 (to M. J.); a postdoctoral scholarship from the Knut & Alice Wallenberg Foundation (to R. N.); NIH R01 grant R01GM73165 (to S. Schmid, which supports M.M.).	Bertin A, 2010, J MOL BIOL, V404, P711, DOI 10.1016/j.jmb.2010.10.002; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Demay BS, 2010, CYTOSKELETON, V67, P383, DOI 10.1002/cm.20452; Ercan E, 2009, TRAFFIC, V10, P1802, DOI 10.1111/j.1600-0854.2009.00995.x; Estey MP, 2011, CURR BIOL, V21, pR384, DOI 10.1016/j.cub.2011.03.067; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Walsh CM, 2010, BIOCHEM J, V425, P159, DOI 10.1042/BJ20090884; Yang YM, 2010, NEURON, V67, P100, DOI 10.1016/j.neuron.2010.06.003; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724	30	169	169	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2013	499	7457					238	+		10.1038/nature12229	http://dx.doi.org/10.1038/nature12229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23792561	Green Accepted			2022-12-01	WOS:000321557600068
J	Du, XF; Wang, J; Zhu, HP; Rinaldo, L; Lamar, KM; Palmenberg, AC; Hansel, C; Gomez, CM				Du, Xiaofei; Wang, Jun; Zhu, Haipeng; Rinaldo, Lorenzo; Lamar, Kay-Marie; Palmenberg, Ann C.; Hansel, Christian; Gomez, Christopher M.			Second Cistron in CACNA1A Gene Encodes a Transcription Factor Mediating Cerebellar Development and SCA6	CELL			English	Article							ALTERED SYNAPTIC-TRANSMISSION; CA2+ CHANNEL; CALCIUM-CHANNEL; CLIMBING FIBER; MICE LACKING; ATAXIA; RECEPTOR; DYSFUNCTION; ELIMINATION; MUTATION	The CACNA1A gene, encoding the voltage-gated calcium channel subunit alpha 1A, is involved in pre- and postsynaptic Ca2+ signaling, gene expression, and several genetic neurological disorders. We found that CACNA1A coordinates gene expression using a bicistronic mRNA bearing a cryptic internal ribosomal entry site (IRES). The first cistron encodes the well-characterized alpha 1A subunit. The second expresses a transcription factor, alpha 1ACT, which coordinates expression of a program of genes involved in neural and Purkinje cell development. alpha 1ACT also contains the polyglutamine (polyQ) tract that, when expanded, causes spinocerebellar ataxia type 6 (SCA6). When expressed as an independent polypeptide, alpha 1ACT-bearing an expanded polyQ tract-lacks transcription factor function and neurite outgrowth properties, causes cell death in culture, and leads to ataxia and cerebellar atrophy in transgenic mice. Suppression of CACNA1A IRES function in SCA6 may be a potential therapeutic strategy.	[Du, Xiaofei; Wang, Jun; Zhu, Haipeng; Lamar, Kay-Marie; Gomez, Christopher M.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Rinaldo, Lorenzo; Hansel, Christian] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Palmenberg, Ann C.] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA	University of Chicago; University of Chicago; University of Wisconsin System; University of Wisconsin Madison	Gomez, CM (corresponding author), Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	cgomez@neurology.bsd.uchicago.edu		Lamar, Kay-Marie/0000-0001-9572-8384	National Ataxia Foundation (NAF); National Organization of Rare Diseases (NORD); National Institute of Neurological Disorders and Stroke [NS-062771]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033202, R01NS062771] Funding Source: NIH RePORTER	National Ataxia Foundation (NAF); National Organization of Rare Diseases (NORD); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Professors Sangram S. Sisodia, Brian Popko, and Bert L. Semler for helpful comments on the manuscript, Dr. Raymond Roos for helpful discussions, Dr. Xiaorong Zhu for protein purification technical assistance, Dr. Jeremy Marks and Dr. Janice Wang for rat granule cell cultures and transfection, Dr. Yuanxin Hu for assembling the vectors for PC-alpha 1ACT<INF>WT</INF> and PC-alpha 1ACT<INF>SCA6</INF> mice and performing pilot immunoblot and immunohistochemical studies, Devon Collins and Kareisha Robinson for technical support in mouse breeding, genotyping, and DigiGait testing, and Tom Hampton for DigiGait assistance on data analysis. We also thank Professor Anne Willis for providing pRF vector, Dr. Suneil Malik for providing pGL3GRN vector, and Dr. Haiteng Deng for performing LC-MS/MS. We thank the Floyd family for supporting SCA6 research. This work was also supported by funding from the National Ataxia Foundation (NAF), the National Organization of Rare Diseases (NORD), and the National Institute of Neurological Disorders and Stroke (NS-062771) (to C.H.).	[Anonymous], NEURON, V41, P687; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Berthet C, 2002, GENES CELLS, V7, P29, DOI 10.1046/j.1356-9597.2001.00497.x; Cain SM, 2011, BIOFACTORS, V37, P197, DOI 10.1002/biof.158; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Cimato TR, 1997, J CELL BIOL, V138, P1089, DOI 10.1083/jcb.138.5.1089; Coldwell MJ, 2001, ONCOGENE, V20, P4095, DOI 10.1038/sj.onc.1204547; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Du XF, 2009, J CLIN ENDOCR METAB, V94, P2594, DOI 10.1210/jc.2009-0139; Fitzgerald KD, 2009, BBA-GENE REGUL MECH, V1789, P518, DOI 10.1016/j.bbagrm.2009.07.004; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Hashimoto K, 2005, NEUROSCI RES, V53, P221, DOI 10.1016/j.neures.2005.07.007; Hashimoto K, 2011, P NATL ACAD SCI USA, V108, P9987, DOI 10.1073/pnas.1101488108; Ishiguro T, 2010, ACTA NEUROPATHOL, V119, P447, DOI 10.1007/s00401-009-0630-0; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kordasiewicz HB, 2006, HUM MOL GENET, V15, P1587, DOI 10.1093/hmg/ddl080; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Kubodera T, 2003, NEUROSCI LETT, V341, P74, DOI 10.1016/S0304-3940(03)00156-3; Kurnellas MP, 2007, ANN NY ACAD SCI, V1099, P287, DOI 10.1196/annals.1387.025; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Liu SL, 2008, J PHYSIOL-LONDON, V586, P4501, DOI 10.1113/jphysiol.2008.156232; Marqueze-Pouey B, 2008, TRAFFIC, V9, P1088, DOI 10.1111/j.1600-0854.2008.00743.x; Matsukawa H, 2003, J NEUROSCI, V23, P7677; Matsushita K, 2002, J NEUROSCI, V22, P4388, DOI 10.1523/JNEUROSCI.22-11-04388.2002; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Palmenberg AC, 1997, SEMIN VIROL, V8, P231, DOI 10.1006/smvy.1997.0126; Rajakulendran S, 2012, NAT REV NEUROL, V8, P86, DOI 10.1038/nrneurol.2011.228; ROUAULT JP, 1993, GENE, V129, P303, DOI 10.1016/0378-1119(93)90284-A; Saegusa H, 2007, MOL CELL NEUROSCI, V34, P261, DOI 10.1016/j.mcn.2006.11.006; Scott VES, 1998, J NEUROSCI, V18, P641; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Spriggs KA, 2009, NUCLEIC ACIDS RES, V37, P5881, DOI 10.1093/nar/gkp623; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; Ul-Hussain M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-52; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Watanabe M, 2011, EUR J NEUROSCI, V34, P1697, DOI 10.1111/j.1460-9568.2011.07894.x; Watase K, 2008, P NATL ACAD SCI USA, V105, P11987, DOI 10.1073/pnas.0804350105; Wilkins MR, 1999, METH MOL B, V112, P531; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Zacharias DA, 1999, BBA-GEN SUBJECTS, V1428, P397, DOI 10.1016/S0304-4165(99)00058-6; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	107	110	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					118	133		10.1016/j.cell.2013.05.059	http://dx.doi.org/10.1016/j.cell.2013.05.059			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827678	Green Accepted, Bronze			2022-12-01	WOS:000321327900014
J	Schroy, PC; Coe, A; Chen, CA; O'Brien, MJ; Heeren, TC				Schroy, Paul C., III; Coe, Alison; Chen, Clara A.; O'Brien, Michael J.; Heeren, Timothy C.			Prevalence of Advanced Colorectal Neoplasia in White and Black Patients Undergoing Screening Colonoscopy in a Safety-Net Hospital	ANNALS OF INTERNAL MEDICINE			English	Article							HARVARD CANCER-RISK; PRIMARY PREVENTION; AFRICAN-AMERICANS; ADENOMAS; DISPARITIES; SURVEILLANCE; COLLEGE; POLYPS; INDEX	Background: Black persons are more likely than white persons to be diagnosed with colorectal cancer and to die from it. The extent to which genetic or biological factors versus disparities in screening rates explain this variance remains controversial. Objective: To define the prevalence and location of presymptomatic advanced colorectal neoplasia (ACN) among white and black persons undergoing screening colonoscopy, controlling for other epidemiologic risk factors. Design: Cross-sectional survey between 22 March 2005 and 31 January 2012. Setting: Urban, open-access, academic, safety-net hospital in Massachusetts. Participants: Asymptomatic, average-risk white (n = 1172) and black (n = 1681) persons aged 50 to 79 years undergoing screening colonoscopy. Measurements: Adjusted prevalence and location of ACN, defined as a tubular adenoma 10 mm or more in size, any adenoma with villous features or high-grade dysplasia, any dysplastic serrated lesion, or invasive cancer. Results: The prevalence of ACN was higher among white patients than black patients (6.8% vs. 5.0%; P = 0.039) but varied by sex (white vs. black men, 9.3% vs. 5.7%; white vs. black women, 3.5% vs. 4.3%; interaction P = 0.034). After controlling for many risk factors, black men were 41% less likely than white men (adjusted odds ratio [AOR], 0.59 [95% CI, 0.39 to 0.89]) to have ACN. No statistically significant difference was seen for women (AOR, 1.32 [CI, 0.73 to 2.40]). Black patients with ACN had a higher percentage of proximal disease (52% vs. 39%) after adjustment for age and sex (P = 0.055). Limitation: Single-institution study with inadequate statistical power for subgroup analyses and recall bias. Conclusion: Black men are less likely than white men to have ACN at screening colonoscopy in a safety-net health care setting. Disparities in access to screening and differential exposure to modifiable risk factors rather than genetic or biological factors may be largely responsible for the higher incidence of CRC among black men. Genetic or biological factors may explain the predilection for proximal disease.	Boston Univ, Sch Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA	Boston University; Boston University	Schroy, PC (corresponding author), Boston Univ, Sch Med, Dept Med, Gastroenterol Sect, 85 East Concord St, Boston, MA 02118 USA.	paul.schroy@bmc.org		Schroy, Paul/0000-0001-9273-7832; O'Brien, Michael J/0000-0003-1124-3537; Heeren, Timothy/0000-0001-5643-3559	National Cancer Institute [R01 CA13119]; NATIONAL CANCER INSTITUTE [R01CA131197] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: By the National Cancer Institute (grant R01 CA13119; Dr. Schroy).	Agrawal S, 2005, AM J GASTROENTEROL, V100, P515, DOI 10.1111/j.1572-0241.2005.41829.x; American Cancer Society, 2011, COL CANC FACTS FIG 2; [Anonymous], 2010, WHO CLASSIFICATION T; Ashktorab H, 2003, CLIN CANCER RES, V9, P1112; Botteri E, 2008, GASTROENTEROLOGY, V134, P388, DOI 10.1053/j.gastro.2007.11.007; Butterly LF, 2006, CLIN GASTROENTEROL H, V4, P343, DOI 10.1016/j.cgh.2005.12.021; Colditz GA, 2000, CANCER CAUSE CONTROL, V11, P477, DOI 10.1023/A:1008984432272; Cottet V, 2007, GASTROENTEROLOGY, V133, P1086, DOI 10.1053/j.gastro.2007.07.023; Dimou A, 2009, WORLD J GASTROENTERO, V15, P3734, DOI 10.3748/wjg.15.3734; Doubeni CA, 2010, AM J PREV MED, V38, P184, DOI 10.1016/j.amepre.2009.10.037; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; Elwing JE, 2006, AM J GASTROENTEROL, V101, P1866, DOI 10.1111/j.1572-0241.2006.00651.x; Friedenberg FK, 2012, DIGEST DIS SCI, V57, P489, DOI 10.1007/s10620-011-1952-z; Greenland S, 1996, INT J EPIDEMIOL, V25, P1107, DOI 10.1093/ije/25.6.1107-a; Howlader N, 2012, SEER CANC STAT REV C; Joseph D. A., 2008, Morbidity and Mortality Weekly Report, V57, P253; Kim DH, 2007, AM J ROENTGENOL, V188, P940, DOI 10.2214/AJR.06.0764; Kim DJ, 2004, J CLIN EPIDEMIOL, V57, P332, DOI 10.1016/j.jclinepi.2003.08.013; Laiyemo AO, 2010, JNCI-J NATL CANCER I, V102, P538, DOI 10.1093/jnci/djq068; Lansdorp-Vogelaar I, 2012, CANCER EPIDEM BIOMAR, V21, P728, DOI 10.1158/1055-9965.EPI-12-0023; Lebwohl B, 2012, ALIMENT PHARM THER, V35, P1467, DOI 10.1111/j.1365-2036.2012.05119.x; Levitzky BE, 2011, AM J GASTROENTEROL, V106, P1099, DOI 10.1038/ajg.2011.20; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2008, JAMA-J AM MED ASSOC, V300, P1417, DOI 10.1001/jama.300.12.1417; Massachusetts Cancer Registry, 2012, CANC INC MORT MASS 2; Massachusetts Cancer Registry, 2007, CANC INC MORT MASS 2; OBRIEN MJ, 1990, GASTROENTEROLOGY, V98, P371, DOI 10.1016/0016-5085(90)90827-N; Qaseem A, 2012, ANN INTERN MED, V156, P378, DOI 10.7326/0003-4819-156-5-201203060-00010; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Rim SH, 2009, CANCER-AM CANCER SOC, V115, P1967, DOI 10.1002/cncr.24216; Rostom A, 2007, ANN INTERN MED, V146, P376, DOI 10.7326/0003-4819-146-5-200703060-00010; Shapiro JA, 2008, CANCER EPIDEM BIOMAR, V17, P1623, DOI 10.1158/1055-9965.EPI-07-2838; Shavers VL, 2007, J NATL MED ASSOC, V99, P733; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siteman Cancer Center, 2013, YOUR DIS RISK; Weber TK, 1999, JAMA-J AM MED ASSOC, V281, P2316, DOI 10.1001/jama.281.24.2316; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301	39	51	52	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 2	2013	159	1					13	+		10.7326/0003-4819-159-1-201307020-00004	http://dx.doi.org/10.7326/0003-4819-159-1-201307020-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179JJ	23817700	Green Accepted			2022-12-01	WOS:000321516200002
J	Bayraktar, OA; Doe, CQ				Bayraktar, Omer Ali; Doe, Chris Q.			Combinatorial temporal patterning in progenitors expands neural diversity	NATURE			English	Article							AMPLIFYING NEUROBLAST LINEAGES; DROSOPHILA BRAIN-DEVELOPMENT; TWIN-OF-EYELESS; CENTRAL COMPLEX; STEM-CELLS; TRANSCRIPTION FACTORS; FACTOR GRAINYHEAD; GENE-EXPRESSION; MUSHROOM BODIES; NERVOUS-SYSTEM	Human outer subventricular zone (OSVZ) neural progenitors and Drosophila type II neuroblasts both generate intermediate neural progenitors (INPs) that populate the adult cerebral cortex or central complex, respectively. It is unknown whether INPs simply expand or also diversify neural cell types. Here we show that Drosophila INPs sequentially generate distinct neural subtypes, that INPs sequentially express Dichaete, Grainy head and Eyeless transcription factors, and that these transcription factors are required for the production of distinct neural subtypes. Moreover, parental type II neuroblasts also sequentially express transcription factors and generate different neuronal/glial progeny over time, providing a second temporal identity axis. We conclude that neuroblast and INP temporal patterning axes act together to generate increased neural diversity within the adult central complex; OSVZ progenitors may use similar mechanisms to increase neural diversity in the human brain.	[Bayraktar, Omer Ali; Doe, Chris Q.] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA; [Bayraktar, Omer Ali; Doe, Chris Q.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Doe, Chris Q.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon; University of Oregon; University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA.	cdoe@uoregon.edu		Bayraktar, Omer/0000-0001-6055-277X	National Institutes of Health (NIH) [T32HD216345, T32GM007413]; NIH [R01HD27056]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD027056] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759, T32GM007413] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Manning and K. Hirono for larval brain stains and imaging; S.-L. Lai, J. Eisen, T. Herman and B. Bowerman for comments on the manuscript; T. Carney and M. Miller for discussions; and the fly community for reagents. This work was supported by National Institutes of Health (NIH) grants T32HD216345 and T32GM007413 (to O.A.B.), NIH R01HD27056 (to C. Q. D.) and the Howard Hughes Medical Institute (to C.Q.D.).	Ali YO, 2011, JOVE-J VIS EXP, DOI 10.3791/2504; Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; Bayraktar OA, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-26; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829; Callaerts P, 2001, J NEUROBIOL, V46, P73, DOI 10.1002/1097-4695(20010205)46:2<73::AID-NEU10>3.0.CO;2-N; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; Chai PC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001494; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Furukubo-Tokunaga K, 2009, FLY, V3, P263, DOI 10.4161/fly.10385; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Grosskortenhaus R, 2006, GENE DEV, V20, P2618, DOI 10.1101/gad.1445306; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Han C, 2011, P NATL ACAD SCI USA, V108, P9673, DOI 10.1073/pnas.1106386108; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Izergina N, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-44; JONES B, 1993, DEVELOPMENT, V117, P793; Kao CF, 2012, NEURON, V73, P677, DOI 10.1016/j.neuron.2011.12.018; KRUMLAUF R, 1993, J NEUROBIOL, V24, P1328, DOI 10.1002/neu.480241006; Kurusu M, 2000, P NATL ACAD SCI USA, V97, P2140, DOI 10.1073/pnas.040564497; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Nambu PA, 1996, DEVELOPMENT, V122, P3467; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Noveen A, 2000, DEVELOPMENT, V127, P3475; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Russell SRH, 1996, DEVELOPMENT, V122, P3669; Spindler SR, 2009, DEV BIOL, V334, P355, DOI 10.1016/j.ydbio.2009.07.035; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Tran KD, 2008, DEVELOPMENT, V135, P3491, DOI 10.1242/dev.024349; Uv AE, 1997, MOL CELL BIOL, V17, P6727, DOI 10.1128/MCB.17.11.6727; UV AE, 1994, MOL CELL BIOL, V14, P4020, DOI 10.1128/MCB.14.6.4020; Viktorin G, 2011, DEV BIOL, V356, P553, DOI 10.1016/j.ydbio.2011.06.013; Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045; Zhu SJ, 2011, P NATL ACAD SCI USA, V108, P20615, DOI 10.1073/pnas.1118595109	47	107	108	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					449	+		10.1038/nature12266	http://dx.doi.org/10.1038/nature12266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23783519	Green Accepted			2022-12-01	WOS:000320929400045
J	Spence, D				Spence, Des			Reefer madness: doctors need more drugs training	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Frank, DRUGS A Z; Home Office, 2012, TABL DRUG MIS DECL F	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2013	346								f4105	10.1136/bmj.f4105	http://dx.doi.org/10.1136/bmj.f4105			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179AA	23814068				2022-12-01	WOS:000321487300005
J	Ilie, G; Boak, A; Adlaf, EM; Asbridge, M; Cusimano, MD				Ilie, Gabriela; Boak, Angela; Adlaf, Edward M.; Asbridge, Mark; Cusimano, Michael D.			Prevalence and Correlates of Traumatic Brain Injuries Among Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ilie, Gabriela] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Boak, Angela; Adlaf, Edward M.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Dalhousie University	Ilie, G (corresponding author), St Michaels Hosp, Injury Prevent Res Off, 30 Bond St, Toronto, ON M5B 1W8, Canada.	gilie@utsc.utoronto.ca	Cusimano, Michael/GWR-1025-2022; Ilie, Gabriela/AAM-9122-2021; Cusimano, Michael/X-4059-2019	Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Faul M., TRAUMATIC BRAIN INJU; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Institute of Medicine of the National Academies, COMM SPORTS REL CONC; Levy DT, 2004, MED SCI MONITOR, V10, pCR17; Paglia-Boak A, CAMH RES DOCUMENT SE, V32; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171	6	65	66	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2550	2552		10.1001/jama.2013.6750	http://dx.doi.org/10.1001/jama.2013.6750			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23800930	Bronze			2022-12-01	WOS:000320848100018
J	Winkler, JT				Winkler, J. T.			FOOD AND NUTRITION Brutal pragmatism on food	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH; TAXES		[Winkler, J. T.] London Metropolitan Univ, London, England	London Metropolitan University		jtw@blueyonder.co.uk						Brinsden HC, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002936; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; Sadler K, 2012, NATIONAL DIET AND NU; Smed S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6885; Stafford N, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7889; Winkler J, 1997, SUGAR CLAIMS STRAIGH; Winkler JT, 2012, BRIT J NUTR, V108, P395, DOI 10.1017/S0007114511006477	7	8	9	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2013	346								f3728	10.1136/bmj.f3728	http://dx.doi.org/10.1136/bmj.f3728			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QI	23801679				2022-12-01	WOS:000321245900001
J	Burguiere, E; Monteiro, P; Feng, GP; Graybiel, AM				Burguiere, Eric; Monteiro, Patricia; Feng, Guoping; Graybiel, Ann M.			Optogenetic Stimulation of Lateral Orbitofronto-Striatal Pathway Suppresses Compulsive Behaviors	SCIENCE			English	Article							DISORDER; INTERNEURONS; INHIBITION; ACTIVATION; CHOICE; OCD; RAT	Dysfunctions in frontostriatal brain circuits have been implicated in neuropsychiatric disorders, including those characterized by the presence of repetitive behaviors. We developed an optogenetic approach to block repetitive, compulsive behavior in a mouse model in which deletion of the synaptic scaffolding gene, Sapap3, results in excessive grooming. With a delay-conditioning task, we identified in the mutants a selective deficit in behavioral response inhibition and found this to be associated with defective down-regulation of striatal projection neuron activity. Focused optogenetic stimulation of the lateral orbitofrontal cortex and its terminals in the striatum restored the behavioral response inhibition, restored the defective down-regulation, and compensated for impaired fast-spiking neuron striatal microcircuits. These findings raise promising potential for the design of targeted therapy for disorders involving excessive repetitive behavior.	[Burguiere, Eric; Monteiro, Patricia; Feng, Guoping; Graybiel, Ann M.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Burguiere, Eric; Monteiro, Patricia; Feng, Guoping; Graybiel, Ann M.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Graybiel, AM (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	graybiel@mit.edu	Feng, Guoping/Y-2827-2019; Monteiro, Patricia/Q-7646-2017; Burguière, Eric/K-9925-2019; Burguière, Eric/G-1114-2015	Monteiro, Patricia/0000-0003-3288-4560; Burguière, Eric/0000-0002-9690-5909; Graybiel, Ann/0000-0002-4326-7720	Simons Initiative on Autism; Brain at MIT; National Institute of Child Health and Development, NIH [R37 HD028341]; Defense Advanced Research Projects Agency [W911NF1010059]; National Institute on Mental Health, NIH [R01 MH081201]; Simons Foundation Autism Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028341] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081201, R01MH097104] Funding Source: NIH RePORTER	Simons Initiative on Autism; Brain at MIT; National Institute of Child Health and Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institute on Mental Health, NIH; Simons Foundation Autism Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank D. Hu, H. F. Hall, C. Keller-McGandy, J. Lee, Y. Kubota, R. MacRae, and D. J. Gibson for their generous help. Funded by the Simons Initiative on Autism and the Brain at MIT (A. M. G. and E. B.); National Institute of Child Health and Development, NIH, R37 HD028341 and Defense Advanced Research Projects Agency, W911NF1010059 (A. M. G.); and National Institute on Mental Health, NIH, R01 MH081201 and Simons Foundation Autism Research Initiative (G. F.). E. B. and A. M. G. designed the experiments, performed data analysis, and wrote the manuscript; E. B. conducted the experiments; P. M. conducted the cell counts; G. F. provided the Sapap3 mutant mouse model and read the manuscript. The authors declare no competing financial interest. Correspondence and requests for materials should be addressed to A. M. G. (graybiel@mit.edu).	Canales JJ, 2000, NAT NEUROSCI, V3, P377, DOI 10.1038/73949; Chamberlain SR, 2008, SCIENCE, V321, P421, DOI 10.1126/science.1154433; Chen M, 2011, J NEUROSCI, V31, P9563, DOI 10.1523/JNEUROSCI.1701-11.2011; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; Eagle DM, 2011, J NEUROSCI, V31, P7349, DOI 10.1523/JNEUROSCI.6182-10.2011; Eagle DM, 2010, NEUROSCI BIOBEHAV R, V34, P50, DOI 10.1016/j.neubiorev.2009.07.003; Franklin ME, 2011, ANNU REV CLIN PSYCHO, V7, P229, DOI 10.1146/annurev-clinpsy-032210-104533; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Gittis AH, 2012, TRENDS NEUROSCI, V35, P557, DOI 10.1016/j.tins.2012.06.008; Goodman Wayne K, 2007, J Clin Psychiatry, V68, pe30; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Kalanithi PSA, 2005, P NATL ACAD SCI USA, V102, P13307, DOI 10.1073/pnas.0502624102; Leckman JF, 2002, LANCET, V360, P1577, DOI 10.1016/S0140-6736(02)11526-1; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; Mar AC, 2011, J NEUROSCI, V31, P6398, DOI 10.1523/JNEUROSCI.6620-10.2011; Milad MR, 2012, TRENDS COGN SCI, V16, P43, DOI 10.1016/j.tics.2011.11.003; Morein-Zamir S, 2010, PSYCHOL MED, V40, P263, DOI 10.1017/S003329170999033X; Otte Christian, 2011, Dialogues Clin Neurosci, V13, P413; RIDLEY RM, 1994, PROG NEUROBIOL, V44, P221, DOI 10.1016/0301-0082(94)90039-6; Saka E, 2004, J NEUROSCI, V24, P7557, DOI 10.1523/JNEUROSCI.1072-04.2004; Steinmetz JE, 2001, INTEGR PHYS BEH SCI, V36, P220, DOI 10.1007/BF02734095; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zuchner S, 2009, MOL PSYCHIATR, V14, P6, DOI 10.1038/mp.2008.83	24	266	272	0	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1243	1246		10.1126/science.1232380	http://dx.doi.org/10.1126/science.1232380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744950	Green Accepted, Green Submitted			2022-12-01	WOS:000319972800053
J	Czarna, A; Berndt, A; Singh, HR; Grudziecki, A; Ladurner, AG; Timinszky, G; Kramer, A; Wolf, E				Czarna, Anna; Berndt, Alex; Singh, Hari Raj; Grudziecki, Astrid; Ladurner, Andreas G.; Timinszky, Gyula; Kramer, Achim; Wolf, Eva			Structures of Drosophila Cryptochrome and Mouse Cryptochrome1 Provide Insight into Circadian Function	CELL			English	Article							LIGHT-DEPENDENT MAGNETOSENSITIVITY; CIRCULAR-DICHROISM SPECTRA; CRYSTAL-STRUCTURE; C-TERMINUS; MAMMALIAN CRY1; 6-4 PHOTOLYASE; FEEDBACK LOOP; CLOCK; PROTEIN; MECHANISM	Drosophila cryptochrome (dCRY) is a FAD-dependent circadian photoreceptor, whereas mammalian cryptochromes (CRY1/2) are integral clock components that repress mCLOCK/mBMAL1-dependent transcription. We report crystal structures of full-length dCRY, a dCRY loop deletion construct, and the photolyase homology region of mouse CRY1 (mCRY1). Our dCRY structures depict Phe534 of the regulatory tail in the same location as the photolesion in DNA-repairing photolyases and reveal that the sulfur loop and tail residue Cys523 plays key roles in the dCRYphotoreaction. OurmCRY1structure visualizes previously characterized mutations, an NLS, and MAPK and AMPK phosphorylation sites. We show that the FAD and antenna chromophore-binding regions, a predicted coiled-coil helix, the C-terminal lid, and charged surfaces are involved in FAD-independent mPER2 and FBXL3 binding and mCLOCK/mBMAL1 transcriptional repression. The structure of a mammalian cryptochrome1 protein may catalyze the development of CRY chemical probes and the design of therapeutic metabolic modulators.	[Czarna, Anna; Singh, Hari Raj; Ladurner, Andreas G.; Timinszky, Gyula; Wolf, Eva] Univ Munich, Dept Physiol Chem, D-81377 Munich, Germany; [Czarna, Anna; Singh, Hari Raj; Ladurner, Andreas G.; Timinszky, Gyula; Wolf, Eva] Univ Munich, CIPSM, Butenandt Inst, D-81377 Munich, Germany; [Czarna, Anna] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany; [Berndt, Alex] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Grudziecki, Astrid; Kramer, Achim] Charite Univ Med Berlin, Lab Chronobiol, D-10115 Berlin, Germany	University of Munich; University of Munich; Max Planck Society; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wolf, E (corresponding author), Univ Munich, Dept Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.	eva.wolf@med.uni-muenchen.de		Kramer, Achim/0000-0001-9671-6078; Ladurner, Andreas/0000-0003-3835-232X; Czarna, Anna/0000-0003-1068-0671; Timinszky, Gyula/0000-0001-6342-8985	Deutsche Forschungsgemeinschaft [WO695-3/4/5/6]; DFG-funded CIPSM [SFB740/D2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG-funded CIPSM	We thank the beamline staff at the Swiss Light Source (SLS, Villingen, CH) and the European Synchrotron Radiation Facility (ESRF, Grenoble) for excellent assistance and our colleagues at the Max Planck Institute of Biochemistry and the Max Planck Institute of Molecular Physiology for help with data collection. We also thank the staff of the Crystallization Facility and the Microchemistry Core Facility of the Max-Planck-Institute of Biochemistry for technical assistance. We are indebted to Michaela Rode for assistance with insect cell culture, Walter Erhardt for the construction of illumination devices, and Jo rg Tittor for introduction to the UV/VIS spectrophotometer. We also thank Katja Schellenberg for the G336D mutant, Helena Breitkreuz for the mCRY1 expression plasmid, Simone Grau for technical assistance, and Ira Schmalen, Torsten Merbitz-Zahradnik, and Justine Witosch for discussions. This work was supported by grants from the Deutsche Forschungsgemeinschaft (WO695-3/4/5/6 to E.W., DFG-funded CIPSM to A.G.L., and SFB740/D2 to A.K.).	Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Czarna A, 2011, J BIOL CHEM, V286, P22414, DOI 10.1074/jbc.M111.244749; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Foley LE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1364; Froy O, 2002, CURR BIOL, V12, P147, DOI 10.1016/S0960-9822(01)00656-X; Gatfield D, 2007, SCIENCE, V316, P1135, DOI 10.1126/science.1144165; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Glas AF, 2009, CHEM-EUR J, V15, P10387, DOI 10.1002/chem.200901004; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hemsley MJ, 2007, BIOCHEM BIOPH RES CO, V355, P531, DOI 10.1016/j.bbrc.2007.01.189; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kucera N, 2012, P NATL ACAD SCI USA, V109, P3311, DOI 10.1073/pnas.1113280109; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; McCarthy EV, 2009, MOL CELL BIOL, V29, P5465, DOI 10.1128/MCB.00641-09; Miyazaki K, 2001, MOL CELL BIOL, V21, P6651, DOI 10.1128/MCB.21.19.6651-6659.2001; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; Ozber N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-69; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Peschel N, 2009, CURR BIOL, V19, P241, DOI 10.1016/j.cub.2008.12.042; Sanada K, 2004, GENES CELLS, V9, P697, DOI 10.1111/j.1356-9597.2004.00758.x; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	44	127	134	1	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1394	1405		10.1016/j.cell.2013.05.011	http://dx.doi.org/10.1016/j.cell.2013.05.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746849	Green Published, Bronze			2022-12-01	WOS:000319979200021
J	Fang, LH; Choi, SH; Baek, JS; Liu, C; Almazan, F; Ulrich, F; Wiesner, P; Taleb, A; Deer, E; Pattison, J; Torres-Vazquez, J; Li, AC; Miller, YI				Fang, Longhou; Choi, Soo-Ho; Baek, Ji Sun; Liu, Chao; Almazan, Felicidad; Ulrich, Florian; Wiesner, Philipp; Taleb, Adam; Deer, Elena; Pattison, Jennifer; Torres-Vazquez, Jesus; Li, Andrew C.; Miller, Yury I.			Control of angiogenesis by AIBP-mediated cholesterol efflux	NATURE			English	Article							EMBRYONIC VASCULAR DEVELOPMENT; CASSETTE TRANSPORTER 1; I BINDING-PROTEIN; ENDOTHELIAL-CELLS; TANGIER-DISEASE; ZEBRAFISH; EXPRESSION; ABCG1; GENE; ACTIVATION	Cholesterol is a structural component of the cell and is indispensable for normal cellular function, although its excess often leads to abnormal proliferation, migration, inflammatory responses and/or cell death. To prevent cholesterol overload, ATP-binding cassette (ABC) transporters mediate cholesterol efflux from the cells to apolipoprotein A-I (apoA-I) and the apoA-I-containing high-density lipoprotein (HDL)(1-3). Maintaining efficient cholesterol efflux is essential for normal cellular function(4-6). However, the role of cholesterol efflux in angiogenesis and the identity of its local regulators are poorly understood. Here we show that apoA-I binding protein (AIBP) accelerates cholesterol efflux from endothelial cells to HDL and thereby regulates angiogenesis. AIBP- and HDL-mediated cholesterol depletion reduces lipid rafts, interferes with VEGFR2 (also known as KDR) dimerization and signalling and inhibits vascular endothelial growth factor-induced angiogenesis in vitro and mouse aortic neovascularization ex vivo. Notably, Aibp, a zebrafish homologue of human AIBP, regulates the membrane lipid order in embryonic zebrafish vasculature and functions as a non-cell-autonomous regulator of angiogenesis. aibp knockdown results in dysregulated sprouting/branching angiogenesis, whereas forced Aibp expression inhibits angiogenesis. Dysregulated angiogenesis is phenocopied in Abca1 (also known as Abca1a) Abcg1-deficient embryos, and cholesterol levels are increased in Aibp-deficient and Abca1Abcg1-deficient embryos. Our findings demonstrate that secreted AIBP positively regulates cholesterol efflux from endothelial cells and that effective cholesterol efflux is critical for proper angiogenesis.	[Fang, Longhou; Choi, Soo-Ho; Baek, Ji Sun; Liu, Chao; Almazan, Felicidad; Wiesner, Philipp; Taleb, Adam; Deer, Elena; Pattison, Jennifer; Li, Andrew C.; Miller, Yury I.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ulrich, Florian; Torres-Vazquez, Jesus] NYU, Langone Med Ctr, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA	University of California System; University of California San Diego; New York University; NYU Langone Medical Center	Miller, YI (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yumiller@ucsd.edu	Fang, Longhou/G-6582-2013	Fang, Longhou/0000-0003-1653-5221; Torres-Vazquez, Jesus/0000-0002-3808-3978	NIH [HL093767, HL055798, HL114734]; UC Tobacco-Related Disease Program [18FT-0137]; UCSD [P30NS047101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093767, P01HL055798, P01HL088093, R00HL114734, K99HL114734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Tobacco-Related Disease Program; UCSD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Traver, N. Chi, J. Witztum, R. Klemke, D. Yelon, T. Handel, K. Stoletov, W. Clements, C. Pouget, Z. Garavito-Aguilar, A. Ablooglu, R. Zhang, X. Yang, M. Angert, K. Pestonjamasp and J. Santini (University of California, San Diego), C. Hedrick, K. Ley, D. Sag, P. Sundd and A. Wu (La Jolla Institute for Allergy and Immunology), S. Trzaska (New York University), S. J. Du (University of Maryland), B. Schmid and C. Haass (Ludwig-Maximilians-University Munchen), D. Owen and A. Magenau (University of New South Wales), A. Siekmann (Max Planck Institute for Molecular Biomedicine) and C. Binder (Medical University of Vienna) for discussions, technical assistance and/or for providing reagents and access to equipment for this study. The project was supported by the NIH grants HL093767 (Y.I.M.), HL055798 (Y.I.M.) and HL114734 (L. F.), and the fellowship 18FT-0137 from the UC Tobacco-Related Disease Program (L. F.), as well as the UCSD Neuroscience Microscopy Facility Grant P30NS047101. The authors declare no conflicts of interests.	Archer A, 2008, DEV DYNAM, V237, P1090, DOI 10.1002/dvdy.21476; Armstrong AJ, 2010, J IMMUNOL, V184, P173, DOI 10.4049/jimmunol.0902372; Avraham-Davidi I, 2012, NAT MED, V18, P967, DOI 10.1038/nm.2759; Bellacen Keren, 2009, J Vis Exp, DOI 10.3791/1564; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Chung TW, 2009, GLYCOBIOLOGY, V19, P229, DOI 10.1093/glycob/cwn114; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002; Fang LH, 2010, J BIOL CHEM, V285, P32343, DOI 10.1074/jbc.M110.137257; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Gao F, 2011, INTEGR BIOL-UK, V3, P479, DOI 10.1039/c0ib00147c; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Jha KN, 2008, ENDOCRINOLOGY, V149, P2108, DOI 10.1210/en.2007-0582; Jowett T, 1999, METHOD CELL BIOL, V59, P63; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liao WX, 2009, MOL ENDOCRINOL, V23, P1428, DOI 10.1210/me.2008-0475; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Noghero A, 2012, ARTERIOSCL THROM VAS, V32, P2280, DOI 10.1161/ATVBAHA.112.250621; O'Connell BJ, 2004, CIRCULATION, V110, P2881, DOI 10.1161/01.CIR.0000146333.20727.2B; Oshikawa J, 2012, AM J PHYSIOL-HEART C, V302, pH724, DOI 10.1152/ajpheart.00739.2011; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Ritter M, 2002, GENOMICS, V79, P693, DOI 10.1006/geno.2002.6761; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schwend T, 2011, J LIPID RES, V52, P1328, DOI 10.1194/jlr.M012377; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Stefulj J, 2009, CIRC RES, V104, P600, DOI 10.1161/CIRCRESAHA.108.185066; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Westerfield M, 2007, ZEBRAFISH BOOK GUIDE, V5th ed.; Whetzel AM, 2010, ARTERIOSCL THROM VAS, V30, P809, DOI 10.1161/ATVBAHA.109.199166; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	42	128	134	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2013	498	7452					118	+		10.1038/nature12166	http://dx.doi.org/10.1038/nature12166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23719382	Green Accepted			2022-12-01	WOS:000319947800045
J	Sharon, M				Sharon, Michal			Structural MS Pulls Its Weight	SCIENCE			English	Editorial Material							IONIZATION-MASS-SPECTROMETRY; PROTEIN COMPLEXES; ARCHITECTURE		Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Sharon, M (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	michal.sharon@weizmann.ac.il		Sharon, Michal/0000-0003-3933-0595				Baldwin AJ, 2011, STRUCTURE, V19, P1855, DOI 10.1016/j.str.2011.09.015; Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Ben-Nissan G, 2011, CHEM SOC REV, V40, P3627, DOI 10.1039/c1cs15052a; Dyachenko A, 2013, P NATL ACAD SCI USA, V110, P7235, DOI 10.1073/pnas.1302395110; Ferguson CN, 2011, ANAL CHEM, V83, P6468, DOI 10.1021/ac201390w; Heck AJR, 2008, NAT METHODS, V5, P927, DOI 10.1038/nmeth.1265; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Mellors JS, 2010, ANAL CHEM, V82, P967, DOI 10.1021/ac902218y; Rosati S, 2012, ANGEW CHEM INT EDIT, V51, P12992, DOI 10.1002/anie.201206745; Rose RJ, 2012, NAT METHODS, V9, P1084, DOI [10.1038/NMETH.2208, 10.1038/nmeth.2208]; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Taverner T, 2008, ACCOUNTS CHEM RES, V41, P617, DOI 10.1021/ar700218q; Urban PL, 2011, ANAL CHEM, V83, P1843, DOI 10.1021/ac102702m; Zhou M, 2011, SCIENCE, V334, P380, DOI 10.1126/science.1210148	15	50	50	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1059	1060		10.1126/science.1236303	http://dx.doi.org/10.1126/science.1236303			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723227				2022-12-01	WOS:000319664500032
J	Goodnough, LT				Goodnough, Lawrence T.			Blood management: transfusion medicine comes of age	LANCET			English	Editorial Material							ANEMIA		[Goodnough, Lawrence T.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Goodnough, Lawrence T.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Goodnough, LT (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	ltgoodno@stanford.edu						[Anonymous], 2012, NY TIMES; Despotis GJ, 1997, CLIN CHEM, V43, P1684; Goodnough LT, 2011, BRIT J ANAESTH, V106, P13, DOI 10.1093/bja/aeq361; Goodnough LT, 2013, ANESTH ANALG, V116, P15, DOI 10.1213/ANE.0b013e318273f4ae; Goodnough LT, 2012, ANESTHESIOLOGY, V116, P1367, DOI 10.1097/ALN.0b013e318254d1a3; Goodnough LT, 2011, BLOOD, V117, P6091, DOI 10.1182/blood-2010-11-316075; Goodnough LT, 2010, BLOOD, V116, P4754, DOI 10.1182/blood-2010-05-286260; McCullough J, 2010, TRANSFUSION, V50, P2542, DOI 10.1111/j.1537-2995.2010.02787.x; Murphy WG, 2012, TRANSFUSION, V52, P2278, DOI 10.1111/j.1537-2995.2012.03931.x; Pattakos G, 2012, ARCH INTERN MED, V172, P1154, DOI 10.1001/archinternmed.2012.2449; Perkins HA, 2010, TRANSFUSION, V50, P2080, DOI 10.1111/j.1537-2995.2010.02851.x; Salisbury AC, 2011, ARCH INTERN MED, V171, P1646, DOI 10.1001/archinternmed.2011.361; Simmons G, 2011, SCIENCE, V334, P814, DOI 10.1126/science.1213841; The Joplin Globe, DECL NEED BLOOD LEAD; US Food and Drug Administration, FAT REP FDA FOLL BLO; Wang D, 2012, TRANSFUSION, V52, P1184, DOI 10.1111/j.1537-2995.2011.03466.x; World Health Organization (WHO), 63 WORLD HLTH ASS AV; ZUCK TF, 1990, ARCH PATHOL LAB MED, V114, P309	18	53	55	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 25	2013	381	9880					1791	1792		10.1016/S0140-6736(13)60673-X	http://dx.doi.org/10.1016/S0140-6736(13)60673-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151EO	23706789	Green Published, Bronze			2022-12-01	WOS:000319443700004
J	Benowitz, NL; Goniewicz, ML				Benowitz, Neal L.; Goniewicz, Maciej L.			The Regulatory Challenge of Electronic Cigarettes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NICOTINE		[Benowitz, Neal L.] Univ Calif San Francisco, Div Clin Pharmacol & Expt Therapeut, Dept Med, San Francisco, CA 94143 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Therapeut Sci, San Francisco Gen Hosp, Med Serv,Med Ctr, San Francisco, CA 94143 USA; [Goniewicz, Maciej L.] Roswell Pk Canc Inst, Dept Hlth Behav, Div Canc Prevent & Populat Sci, Buffalo, NY 14263 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Roswell Park Cancer Institute	Benowitz, NL (corresponding author), Univ Calif San Francisco, Div Clin Pharmacol & Expt Therapeut, POB 1220, San Francisco, CA 94143 USA.	nbenowitz@medsfgh.ucsf.edu	Goniewicz, Maciej Lukasz/Z-1604-2019; Goniewicz, Maciej L/D-8986-2012	Goniewicz, Maciej Lukasz/0000-0001-6748-3068; 				Adkison SE, 2013, AM J PREV MED, V44, P207, DOI 10.1016/j.amepre.2012.10.018; Benowitz NL, 2008, CLIN PHARMACOL THER, V83, P531, DOI 10.1038/clpt.2008.3; Caponnetto P, 2013, Monaldi Arch Chest Dis, V79, P12; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Goniewicz M. L., 2013, TOB CONTROL, DOI [10.1136/tobaccocontrol-2012-050859, DOI 10.1136/TOBACCOCONTR0L-2012-050859]; Noel JK, 2011, TOB CONTROL, V20, P81, DOI 10.1136/tc.2010.038562; Pearson JL, 2012, AM J PUBLIC HEALTH, V102, P1758, DOI 10.2105/AJPH.2011.300526; Polosa R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-786; US Food and Drug Aaministration, REG E CIG OTH TOB PR	9	135	136	0	106	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					685	686		10.1001/jama.2013.109501	http://dx.doi.org/10.1001/jama.2013.109501			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	202XP	23856948	Green Submitted			2022-12-01	WOS:000323254500012
J	Malhotra, A; Rakhit, R				Malhotra, Aseem; Rakhit, Roby			Improving the UK's performance on survival after cardiac arrest	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							REGION		[Malhotra, Aseem; Rakhit, Roby] Royal Free Hosp, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Malhotra, A (corresponding author), Royal Free Hosp, London, England.	aseem_malhotra@hotmail.com; roby.rakhit@nhs.net						[Anonymous], 2013, HUFFINGTON POST; [Anonymous], 2009, BBC NEWS; [Anonymous], 2013, BBC NEWS; Apps A, 2013, POSTGRAD MED J, V89, P376, DOI 10.1136/postgradmedj-2012-130818; ARRICH J, 2009, COCHRANE DB SYST REV, V7; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; British Heart Foundation, POL STAT EM LIF SUPP; Cave DM, 2011, CIRCULATION, V123, P691, DOI 10.1161/CIR.0b013e31820b5328; Dumas F, 2010, CIRC-CARDIOVASC INTE, V3, P200, DOI 10.1161/CIRCINTERVENTIONS.109.913665; Figueras J, 2009, AM HEART J, V158, P1011, DOI 10.1016/j.ahj.2009.10.007; Laerdal, SURV RAT AN 7 STAV R; Lindner TW, 2011, RESUSCITATION, V82, P1508, DOI 10.1016/j.resuscitation.2011.06.016; London Ambulance Service NHS Trust, 2010, CAP CARD ARR SURV RA; London Ambulance Service NHS Trust, 2012, CARD ARR ANN REP 201; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Oliver King Foundation, US; Payne P., 2013, PUGET SOUND BUS 0108; Pell JP, 2003, HEART, V89, P839, DOI 10.1136/heart.89.8.839; Perkins GD, 2012, EMERG MED J, V29, P3, DOI 10.1136/emermed-2011-200758; Resuscitation Council (UK), 2010, US AUT EXT DEF; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Stub D, 2011, HEART, V97, P1489, DOI 10.1136/hrt.2011.226431; Stub D, 2011, CIRCULATION, V123, P1428, DOI 10.1161/CIRCULATIONAHA.110.988725	23	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 1	2013	347								f4800	10.1136/bmj.f4800	http://dx.doi.org/10.1136/bmj.f4800			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BK	23902857				2022-12-01	WOS:000322822500004
J	Sabayan, B; Wijsman, LW; Foster-Dingley, JC; Stott, DJ; Ford, I; Buckley, BM; Sattar, N; Jukema, JW; van Osch, MJP; van der Grond, J; van Buchem, MA; Westendorp, RGJ; de Craen, AJM; Mooijaart, SP				Sabayan, Behnam; Wijsman, Liselotte W.; Foster-Dingley, Jessica C.; Stott, David J.; Ford, Ian; Buckley, Brendan M.; Sattar, Naveed; Jukema, J. Wouter; van Osch, Matthias J. P.; van der Grond, Jeroen; van Buchem, Mark A.; Westendorp, Rudi G. J.; de Craen, Anton J. M.; Mooijaart, Simon P.			Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WHITE-MATTER HYPERINTENSITIES; CEREBRAL MICROBLEEDS; BRAIN; RISK; DISEASE; STROKE; PRAVASTATIN; ADULTS; DAMAGE	Objective To investigate the association between visit-to-visit variability in blood pressure and cognitive function in old age (>70 years). Design Prospective cohort study. Setting PROSPER (PROspective Study of Pravastatin in the Elderly at Risk) study, a collaboration between centres in Ireland, Scotland, and the Netherlands. Participants 5461 participants, mean age 75.3 years, who were at risk of cardiovascular disease. Blood pressure was measured every three months during an average of 3.2 years. Visit-to-visit variability in blood pressure was defined as the standard deviation of blood pressure measurements between visits. Main outcome measures Four domains of cognitive function, testing selective attention, processing speed, and immediate and delayed memory. In a magnetic resonance imaging substudy of 553 participants, structural brain volumes, cerebral microbleeds, infarcts, and white matter hyperintensities were measured. Results Participants with higher visit-to-visit variability in systolic blood pressure had worse performance on all cognitive tests: attention (mean difference high versus low thirds) 3.08 seconds (95% confidence interval 0.85 to 5.31), processing speed -1.16 digits coded (95% confidence interval -1.69 to -0.63), immediate memory -0.27 pictures remembered (95% confidence interval -0.41 to -0.13), and delayed memory -0.30 pictures remembered (95% confidence interval -0.49 to -0.11). Furthermore, higher variability in both systolic and diastolic blood pressure was associated with lower hippocampal volume and cortical infarcts, and higher variability in diastolic blood pressure was associated with cerebral microbleeds (all P<0.05). All associations were adjusted for average blood pressure and cardiovascular risk factors. Conclusion Higher visit-to-visit variability in blood pressure independent of average blood pressure was associated with impaired cognitive function in old age.	[Sabayan, Behnam; Wijsman, Liselotte W.; Westendorp, Rudi G. J.; de Craen, Anton J. M.; Mooijaart, Simon P.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, NL-2300 RC Leiden, Netherlands; [Sabayan, Behnam; van Osch, Matthias J. P.; van der Grond, Jeroen; van Buchem, Mark A.] Leiden Univ, Med Ctr, Dept Radiol, NL-2300 RC Leiden, Netherlands; [Wijsman, Liselotte W.; Westendorp, Rudi G. J.; de Craen, Anton J. M.; Mooijaart, Simon P.] Netherlands Consortium Hlth Ageing, Leiden, Netherlands; [Foster-Dingley, Jessica C.] Leiden Univ, Med Ctr, Dept Psychiat, NL-2300 RC Leiden, Netherlands; [Stott, David J.] Univ Glasgow, Fac Med, Acad Sect Geriatr, Glasgow G12 8QQ, Lanark, Scotland; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland; [Buckley, Brendan M.] Natl Univ Ireland Univ Coll Cork, Dept Pharmacol & Therapeut, Cork, Ireland; [Sattar, Naveed] Univ Glasgow, Glasgow Cardiovasc Res Ctr, British Heart Fdn, Glasgow G12 8QQ, Lanark, Scotland; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands; [Mooijaart, Simon P.] Inst Evidence Based Med Old Age, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Glasgow; University of Glasgow; University College Cork; University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mooijaart, SP (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, POB 9600, NL-2300 RC Leiden, Netherlands.	s.p.mooijaart@lumc.nl	Mooijaart, Simon P./A-5306-2008; van Buchem, Mark/AAC-9843-2022; Van Osch, Matthias/AAV-3876-2021; Jukema, J. Wouter/ABD-6503-2021; Ford, Ian/ABE-6145-2020	Mooijaart, Simon P./0000-0003-3106-3568; van Buchem, Mark/0000-0003-1881-1998; Van Osch, Matthias/0000-0001-7034-8959; Jukema, J. Wouter/0000-0002-3246-8359; 	Bristol-Myers Squibb, USA	Bristol-Myers Squibb, USA(Bristol-Myers Squibb)	The original PROSPER clinical trial was funded by an investigator initiated grant from Bristol-Myers Squibb, USA. However, the company had no involvement in the formulation of hypotheses, analysis of the data, or in any aspect of the preparation of this manuscript.	Admiraal-Behloul F, 2005, NEUROIMAGE, V28, P607, DOI 10.1016/j.neuroimage.2005.06.061; Alagiakrishnan K, 2006, POSTGRAD MED J, V82, P101, DOI 10.1136/pgmj.2005.035030; Altmann-Schneider I, 2011, STROKE, V42, P638, DOI 10.1161/STROKEAHA.110.595611; Barnes J, 2009, NEUROBIOL AGING, V30, P1711, DOI 10.1016/j.neurobiolaging.2008.01.010; Brickman AM, 2010, ARCH NEUROL-CHICAGO, V67, P564, DOI 10.1001/archneurol.2010.70; Cecchi E, 2011, ATHEROSCLEROSIS, V214, P249, DOI 10.1016/j.atherosclerosis.2010.09.008; Dellasega C, 1993, J Neurosci Nurs, V25, P147; Diaz KM, 2012, HYPERTENS RES, V35, P55, DOI 10.1038/hr.2011.135; Diaz KM, 2013, J HUM HYPERTENS; Eguchi K, 2012, AM J HYPERTENS, V25, P962, DOI 10.1038/ajh.2012.75; Goldstein IB, 2005, NEUROLOGY, V64, P1846, DOI 10.1212/01.WNL.0000164712.24389.BB; Goldstein IB, 2002, NEUROLOGY, V59, P713, DOI 10.1212/WNL.59.5.713; Gomez-Angelats E, 2004, AM J HYPERTENS, V17, P696, DOI 10.1016/j.amjhyper.2004.05.002; Gunstad J, 2005, BLOOD PRESSURE, V14, P353, DOI 10.1080/08037050500364117; HAVEKES LM, 1987, J LIPID RES, V28, P455; Havlik RJ, 2002, STROKE, V33, P26, DOI 10.1161/hs0102.101890; Houx PJ, 2002, J NEUROL NEUROSUR PS, V73, P385, DOI 10.1136/jnnp.73.4.385; Kario K, 1997, HYPERTENSION, V30, P1504, DOI 10.1161/01.HYP.30.6.1504; Kim KI, 2008, CIRC J, V72, P293, DOI 10.1253/circj.72.293; Kim YS, 2008, CLIN SCI, V115, P255, DOI 10.1042/CS20070458; Kovari E, 2004, STROKE, V35, P410, DOI 10.1161/01.STR.0000110791.51378.4E; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liu WH, 2012, STROKE, V43, P2916, DOI 10.1161/STROKEAHA.112.658369; Lopez-Arrieta J M, 2002, Cochrane Database Syst Rev, pCD000147; Mancia G, 2003, J HYPERTENS, V21, pS17, DOI 10.1097/00004872-200307006-00004; Nagai M, 2012, J HYPERTENS, V30, P1556, DOI 10.1097/HJH.0b013e3283552735; Olindo S, 2003, STROKE, V34, P1593, DOI 10.1161/01.STR.0000077924.71088.02; Packard CJ, 2007, J AM GERIATR SOC, V55, P1777, DOI 10.1111/j.1532-5415.2007.01415.x; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Parati G, 2002, J HYPERTENS, V20, P1725, DOI 10.1097/00004872-200209000-00014; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Sadigh-Eteghad S, 2012, NEUROSCIENCES, V17, P321; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; ten Dam VH, 2005, STROKE, V36, P1633, DOI 10.1161/01.STR.0000173162.88600.29; ten Dam VH, 2005, NEUROLOGY, V64, P1807, DOI 10.1212/01.WNL.0000161844.00797.73; Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7; van Es ACGM, 2011, NEUROLOGY, V77, P1446, DOI 10.1212/WNL.0b013e318232ab1d; Wardlaw JM, 2003, STROKE, V34, P806, DOI 10.1161/01.STR.0000058480.77236.B3; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Widya RL, 2011, AM J CLIN NUTR, V93, P1190, DOI 10.3945/ajcn.110.006304	42	99	107	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2013	347								f4600	10.1136/bmj.f4600	http://dx.doi.org/10.1136/bmj.f4600			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BE	23900315	hybrid, Green Accepted			2022-12-01	WOS:000322821500004
J	Briggs, F; Mangun, GR; Usrey, WM				Briggs, Farran; Mangun, George R.; Usrey, W. Martin			Attention enhances synaptic efficacy and the signal-to-noise ratio in neural circuits	NATURE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; MACAQUE AREA V4; SELECTIVE ATTENTION; SPATIAL ATTENTION; NEURONAL RESPONSES; SIMPLE CELLS; MONKEY; V1; PERFORMANCE	Attention is a critical component of perception(1). However, the mechanisms by which attention modulates neuronal communication to guide behaviour are poorly understood. To elucidate the synaptic mechanisms of attention, we developed a sensitive assay of attentional modulation of neuronal communication. In alert monkeys performing a visual spatial attention task, we probed thalamocortical communication by electrically stimulating neurons in the lateral geniculate nucleus of the thalamus while simultaneously recording shock-evoked responses from monosynaptically connected neurons in primary visual cortex. We found that attention enhances neuronal communication by increasing the efficacy of presynaptic input in driving postsynaptic responses, by increasing synchronous responses among ensembles of postsynaptic neurons receiving independent input, and by decreasing redundant signals between postsynaptic neurons receiving common input. The results demonstrate that attention finely tunes neuronal communication at the synaptic level by selectively altering synaptic weights, enabling enhanced detection of salient events in the noisy sensory environment.	[Briggs, Farran; Usrey, W. Martin] Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA; [Briggs, Farran] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH 03756 USA; [Mangun, George R.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95618 USA; [Mangun, George R.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Mangun, George R.; Usrey, W. Martin] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Usrey, W. Martin] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; Dartmouth College; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Usrey, WM (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Court, Davis, CA 95618 USA.	wmusrey@ucdavis.edu		Briggs, Farran/0000-0002-4037-4731	National Institutes of Health [EY18683, EY013588, MH055714]; NSF [BCS-0727115, 1228535]; Division Of Behavioral and Cognitive Sci [1228535] Funding Source: National Science Foundation; NATIONAL EYE INSTITUTE [R00EY018683, K99EY018683, R01EY013588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH055714, R01MH055714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank K. E. Neverkovec, D. J. Sperka and R. Oates-O'Brien for technical and veterinary assistance. This work was supported by National Institutes of Health grants EY18683 (F. B.), EY013588 (W. M. U.), MH055714 (G. R. M.) and NSF grants BCS-0727115 and 1228535 (G. R. M. and W.M.U.).	Briggs F, 2007, J NEUROSCI, V27, P5431, DOI 10.1523/JNEUROSCI.1035-07.2007; Briggs F, 2009, NEURON, V62, P135, DOI 10.1016/j.neuron.2009.02.024; Brody CD, 1998, J NEUROPHYSIOL, V80, P3345, DOI 10.1152/jn.1998.80.6.3345; BULLIER J, 1980, J COMP NEUROL, V193, P913, DOI 10.1002/cne.901930407; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Kelly SP, 2008, CEREB CORTEX, V18, P2629, DOI 10.1093/cercor/bhn022; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Pestilli F, 2011, NEURON, V72, P832, DOI 10.1016/j.neuron.2011.09.025; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Skottun BC, 1991, VISION RES, V31, P1078; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Thiele A, 2009, CEREB CORTEX, V19, P2970, DOI 10.1093/cercor/bhp070; Usrey WM, 2002, CURR OPIN NEUROBIOL, V12, P411, DOI 10.1016/S0959-4388(02)00339-2; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Vanduffel W, 2000, CEREB CORTEX, V10, P109, DOI 10.1093/cercor/10.2.109; VANVOORHIS S, 1977, PERCEPT PSYCHOPHYS, V22, P54, DOI 10.3758/BF03206080; Yoshor D, 2007, J NEUROSCI, V27, P13205, DOI 10.1523/JNEUROSCI.2944-07.2007; Zenon A, 2012, NATURE, V489, P434, DOI 10.1038/nature11497; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	34	115	118	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 25	2013	499	7459					476	+		10.1038/nature12276	http://dx.doi.org/10.1038/nature12276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23803766	Green Accepted			2022-12-01	WOS:000322157900040
J	Saterberg, T; Sellman, S; Ebenman, B				Saterberg, Torbjorn; Sellman, Stefan; Ebenman, Bo			High frequency of functional extinctions in ecological networks	NATURE			English	Article							TROPHIC CASCADES; FOOD; INCREASES; VIABILITY; SHIFTS	Intensified exploitation of natural populations and habitats has led to increased mortality rates and decreased abundances of many species(1,2). There is a growing concern that this might cause critical abundance thresholds of species to be crossed(1,3-5), with extinction cascades and state shifts in ecosystems as a consequence(4,6,7). When increased mortality rate and decreased abundance of a given species lead to extinction of other species, this species can be characterized as functionally extinct even though it still exists. Although such functional extinctions have been observed in some ecosystems(3,4,8), their frequency is largely unknown. Here we use a new modelling approach to explore the frequency and pattern of functional extinctions in ecological networks. Specifically, we analytically derive critical abundance thresholds of species by increasing their mortality rates until an extinction occurs in the network. Applying this approach on natural and theoretical food webs, we show that the species most likely to go extinct first is not the one whose mortality rate is increased but instead another species. Indeed, up to 80% of all first extinctions are of another species, suggesting that a species' ecological functionality is often lost before its own existence is threatened. Furthermore, we find that large-bodied species at the top of the food chains can only be exposed to small increases in mortality rate and small decreases in abundance before going functionally extinct compared to small-bodied species lower in the food chains. These results illustrate the potential importance of functional extinctions in ecological networks and lend strong support to arguments advocating a more community-oriented approach in conservation biology, with target levels for populations based on ecological functionality rather than on mere persistence(8-11).	[Saterberg, Torbjorn; Sellman, Stefan; Ebenman, Bo] Linkoping Univ, Dept Phys Chem & Biol, Div Theoret Biol, SE-58183 Linkoping, Sweden	Linkoping University	Ebenman, B (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Div Theoret Biol, SE-58183 Linkoping, Sweden.	boebe@ifm.liu.se		Saterberg, Torbjorn/0000-0002-5881-7983; Sellman, Stefan/0000-0002-5595-8780	Linkoping University	Linkoping University	We thank N. Virgo, A. Clark, R. Law, O. Petchey, P. Munger, D. Gilljam, A. Curtsdotter and U. Wennergren for comments and discussion. D. Gilljam and A. Curtsdotter also provided computer code for part of the analysis. This project was supported by a Faculty grant from Linkoping University to B.E.	Anderson SH, 2011, SCIENCE, V331, P1068, DOI 10.1126/science.1199092; [Anonymous], 2001, IUCN RED LIST CAT CR; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; BENDER EA, 1984, ECOLOGY, V65, P1, DOI 10.2307/1939452; Berg S, 2011, OIKOS, V120, P510, DOI 10.1111/j.1600-0706.2010.18864.x; Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borrvall C, 2000, ECOL LETT, V3, P131, DOI 10.1046/j.1461-0248.2000.00130.x; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Chesson P, 2008, NATURE, V456, P235, DOI 10.1038/nature07248; Colwell RK, 2012, ANNU REV ECOL EVOL S, V43, P183, DOI 10.1146/annurev-ecolsys-110411-160304; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Ebenman B, 2005, TRENDS ECOL EVOL, V20, P568, DOI 10.1016/j.tree.2005.06.011; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Estes JA, 2010, CONSERV BIOL, V24, P852, DOI 10.1111/j.1523-1739.2009.01428.x; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Ives AR, 2004, NATURE, V429, P174, DOI 10.1038/nature02515; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Lewis HM, 2007, J THEOR BIOL, V247, P64, DOI 10.1016/j.jtbi.2007.02.006; McConkey KR, 2006, ECOLOGY, V87, P271, DOI 10.1890/05-0386; Montoya JM, 2009, ECOLOGY, V90, P2426, DOI 10.1890/08-0657.1; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Sabo JL, 2008, BIOL CONSERV, V141, P276, DOI 10.1016/j.biocon.2007.10.002; Sahasrabudhe S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1163; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Soule ME, 2005, BIOSCIENCE, V55, P168, DOI 10.1641/0006-3568(2005)055[0168:SISCPM]2.0.CO;2; Soule ME, 2003, CONSERV BIOL, V17, P1238, DOI 10.1046/j.1523-1739.2003.01599.x; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Terborgh J., 2010, TROPHIC CASCADES PRE	32	130	138	3	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					468	+		10.1038/nature12277	http://dx.doi.org/10.1038/nature12277			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23831648				2022-12-01	WOS:000322157900038
J	Siu, FY; He, M; de Graaf, C; Han, GW; Yang, DH; Zhang, ZY; Zhou, CH; Xu, QP; Wacker, D; Joseph, JS; Liu, W; Lau, J; Cherezov, V; Katritch, V; Wang, MW; Stevens, RC				Siu, Fai Yiu; He, Min; de Graaf, Chris; Han, Gye Won; Yang, Dehua; Zhang, Zhiyun; Zhou, Caihong; Xu, Qingping; Wacker, Daniel; Joseph, Jeremiah S.; Liu, Wei; Lau, Jesper; Cherezov, Vadim; Katritch, Vsevolod; Wang, Ming-Wei; Stevens, Raymond C.			Structure of the human glucagon class B G-protein-coupled receptor	NATURE			English	Article							2ND TRANSMEMBRANE HELIX; LIGAND-BINDING; PEPTIDE-1 RECEPTOR; CRYSTALLIZING MEMBRANE; EXTRACELLULAR LOOP; PHOTOLABILE PROBES; OPIOID RECEPTOR; MOLECULAR-BASIS; VPAC1 RECEPTOR; AMINO-TERMINUS	Binding of the glucagon peptide to the glucagon receptor (GCGR) triggers the release of glucose from the liver during fasting; thus GCGR plays an important role in glucose homeostasis. Here we report the crystal structure of the seven transmembrane helical domain of human GCGR at 3.4 angstrom resolution, complemented by extensive site-specific mutagenesis, and a hybrid model of glucagon bound to GCGR to understand the molecular recognition of the receptor for its native ligand. Beyond the shared seven transmembrane fold, the GCGR transmembrane domain deviates from class A G-protein-coupled receptors witha large ligand-binding pocket and the first transmembrane helix having a 'stalk' region that extends three alpha-helical turns above the plane of the membrane. The stalk positions the extracellular domain (similar to 12 kilodaltons) relative to the membrane to form the glucagon-binding site that captures the peptide and facilitates the insertion of glucagon's amino terminus into the seven transmembrane domain.	[Siu, Fai Yiu; Han, Gye Won; Wacker, Daniel; Joseph, Jeremiah S.; Liu, Wei; Cherezov, Vadim; Katritch, Vsevolod; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [He, Min; Yang, Dehua; Zhang, Zhiyun; Zhou, Caihong; Wang, Ming-Wei] Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; [He, Min; Yang, Dehua; Zhang, Zhiyun; Zhou, Caihong; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [de Graaf, Chris] Vrije Univ Amsterdam, Amsterdam Inst Mol Med & Syst AIMMS, Fac Sci, Div Med Chem, NL-1081 HV Amsterdam, Netherlands; [Xu, Qingping] SLAC Natl Accelerator Lab, Joint Ctr Struct Genom, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Lau, Jesper] Novo Nordisk, Prot & Peptide Chem, DK-2760 Malov, Denmark	Scripps Research Institute; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Vrije Universiteit Amsterdam; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Novo Nordisk	Wang, MW (corresponding author), Natl Ctr Drug Screening, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.	wangmw@mail.shcnc.ac.cn; stevens@scripps.edu	Katritch, Vsevolod/Y-2721-2019; Han, Gye Won/GLQ-8673-2022; Han, Gye Won/GLQ-8724-2022; Stevens, Raymond/K-7272-2015; Yang, Dehua/M-5789-2019; Lau, Jesper/G-3834-2011; Han, Gye Won/GLT-1531-2022; Katritch, Vsevolod/Q-8357-2016; Cherezov, Vadim/L-9812-2013; Yang, Dehua/S-6156-2017; de Graaf, Chris/J-8549-2017	Han, Gye Won/0000-0003-4107-835X; Stevens, Raymond/0000-0002-4522-8725; Katritch, Vsevolod/0000-0003-3883-4505; Cherezov, Vadim/0000-0002-5265-3914; de Graaf, Chris/0000-0002-1226-2150	NIH Road map [P50GM073197, U54 GM094618, U54 GM094586]; Ministry of Health [2012ZX09304-011, 2013ZX09507002]; Shanghai Science and Technology Development Fund [11DZ2292200]; Novo Nordisk-Chinese Academy of Sciences Research Fund [NNCAS-2011-7]; Thousand Talents Program in China; NIH [F32 DK088392]; Netherlands Organization for Scientific Research (NWO) through a VENI [700.59.408]; COST Action [CM1207]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK088392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586, P50GM073197, U54GM094618] Funding Source: NIH RePORTER	NIH Road map(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health; Shanghai Science and Technology Development Fund; Novo Nordisk-Chinese Academy of Sciences Research Fund; Thousand Talents Program in China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research (NWO) through a VENI(Netherlands Organization for Scientific Research (NWO)); COST Action(European Cooperation in Science and Technology (COST)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Road map grant P50GM073197 for technology development (V. C. and R. C. S.), and PSI: Biology grant U54 GM094618 for biological studies and structure production (target GPCR-49) (V. K., V. C. and R. C. S.); PSI: Biology grant U54 GM094586 for structure QC; The Ministry of Health grants 2012ZX09304-011 and 2013ZX09507002 (M.-W.W.), Shanghai Science and Technology Development Fund 11DZ2292200 (M.-W.W.); Novo Nordisk-Chinese Academy of Sciences Research Fund NNCAS-2011-7 (M.-W.W.); Thousand Talents Program in China (R. C. S. and M.-W. W.); NIH Postdoctoral Training Grant (NRSA) F32 DK088392 (F.Y.S.); The Netherlands Organization for Scientific Research (NWO) through a VENI grant (Grant 700.59.408 to C.d.G.); COST Action CM1207, GLISTEN (C.d.G). We also thank V. Hruby and M. Cai for advice with the glucagon binding assay and general discussions; J. Velasquez for help with molecular biology; T. Trinh and M. Chu for help with baculovirus expression; K. Kadyshevskaya for assistance with figure preparation; X. Q. Cai, J. Wang, Y. Feng, A. T. Dai, Y. Zhou, J. J. Deng, Y. B. Dai and J. W. Zhao for technical assistance in mutation studies; A. Walker for assistance with manuscript preparation; and J. Smith and R. Fischetti for assistance in development and use of the minibeam and beamtime at GM/CA-CAT beamline 23-ID at the Advanced Photon Source, which is supported by National Cancer Institute grant Y1-CO-1020 and National Institute of General Medical Sciences grant Y1-GM-1104.	Ahn JM, 2001, J MED CHEM, V44, P1372, DOI 10.1021/jm000453e; [Anonymous], 2009, BUSTER V 2 8 0; [Anonymous], 2012, ICM MAN V 3 0; Arnautova YA, 2011, PROTEINS, V79, P477, DOI 10.1002/prot.22896; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; BHAT TN, 1988, J APPL CRYSTALLOGR, V21, P279, DOI 10.1107/S0021889887012755; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cascieri MA, 1999, J BIOL CHEM, V274, P8694, DOI 10.1074/jbc.274.13.8694; Ceraudo E, 2012, FASEB J, V26, P2060, DOI 10.1096/fj.11-196444; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Cho YM, 2012, PHARMACOL THERAPEUT, V135, P247, DOI 10.1016/j.pharmthera.2012.05.009; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; de Graaf C, 2011, CHEMMEDCHEM, V6, P2159, DOI 10.1002/cmdc.201100317; Di Paolo E, 1999, RECEPTOR CHANNEL, V6, P309; Di Paolo E, 1999, PEPTIDES, V20, P1187, DOI 10.1016/S0196-9781(99)00122-9; Di Paolo E, 1998, FEBS LETT, V424, P207, DOI 10.1016/S0014-5793(98)00175-6; Dong MQ, 2012, FASEB J, V26, P5092, DOI 10.1096/fj.12-212399; Dong M, 2011, J BIOL CHEM, V286, P23888, DOI 10.1074/jbc.M111.245969; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Ganguli SC, 1998, J PHARMACOL EXP THER, V286, P593; Gensure RC, 2003, MOL ENDOCRINOL, V17, P2647, DOI 10.1210/me.2003-0275; Hanson MA, 2007, PROTEIN EXPRES PURIF, V56, P85, DOI 10.1016/j.pep.2007.06.003; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Inooka H, 2001, NAT STRUCT BIOL, V8, P161, DOI 10.1038/84159; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; Miller LA, 2007, ART AM, V95, P35; Misquitta Y, 2003, BIOPHYS J, V85, P3084, DOI 10.1016/S0006-3495(03)74727-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neumann JM, 2008, TRENDS BIOCHEM SCI, V33, P314, DOI 10.1016/j.tibs.2008.05.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Perret J, 2002, BIOCHEM J, V362, P389, DOI 10.1042/0264-6021:3620389; Prevost M, 2010, J BIOL CHEM, V285, P30951, DOI 10.1074/jbc.M110.102814; Roberts DJ, 2011, PEPTIDES, V32, P1593, DOI 10.1016/j.peptides.2011.06.009; Runge S, 2003, J BIOL CHEM, V278, P28005, DOI 10.1074/jbc.M301085200; Schwarzenbacher R, 2008, ACTA CRYSTALLOGR D, V64, P133, DOI 10.1107/S0907444907050111; Solano RM, 2001, J BIOL CHEM, V276, P1084, DOI 10.1074/jbc.M007696200; Tan YV, 2004, J BIOL CHEM, V279, P38889, DOI 10.1074/jbc.M404460200; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger Thomas C., 2012, Journal of Structural and Functional Genomics, V13, P81, DOI 10.1007/s10969-012-9129-3; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tseng CC, 1997, BIOCHEM BIOPH RES CO, V232, P96, DOI 10.1006/bbrc.1997.6231; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Unson CG, 2002, BIOCHEMISTRY-US, V41, P11795, DOI 10.1021/bi025711j; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Xu F, 2011, CRYST GROWTH DES, V11, P1193, DOI 10.1021/cg101385e; Yaqub T, 2010, MOL PHARMACOL, V77, P547, DOI 10.1124/mol.109.060111	61	299	309	7	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					444	+		10.1038/nature12393	http://dx.doi.org/10.1038/nature12393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23863937	Green Accepted			2022-12-01	WOS:000322157900033
J	Shao, ZY; Watanabe, S; Christensen, R; Jorgensen, EM; Colon-Ramos, DA				Shao, Zhiyong; Watanabe, Shigeki; Christensen, Ryan; Jorgensen, Erik M.; Colon-Ramos, Daniel A.			Synapse Location during Growth Depends on Glia Location	CELL			English	Article							CELL-ADHESION MOLECULE; CAENORHABDITIS-ELEGANS EPIDERMIS; NERVOUS-SYSTEM; FUNCTIONAL-CHARACTERIZATION; FGF RECEPTOR; MAINTENANCE; TRANSPORTER; MECHANISMS; PROTEIN; FAMILY	Synaptic contacts are largely established during embryogenesis and are then maintained during growth. To identify molecules involved in this process, we conducted a forward genetic screen in C. elegans and identified cima-1. In cima-1 mutants, synaptic contacts are correctly established during embryogenesis, but ectopic synapses emerge during postdevelopmental growth. cima-1 encodes a solute carrier in the SLC17 family of transporters that includes sialin, a protein that when mutated in humans results in neurological disorders. cima-1 does not function in neurons but rather functions in the nearby epidermal cells to correctly position glia during postlarval growth. Our findings indicate that CIMA-1 antagonizes the FGF receptor (FGFR), and does so most likely by inhibiting FGFR's role in epidermal-glia adhesion rather than signaling. Our data suggest that epidermal-glia crosstalk, in this case mediated by a transporter and the FGF receptor, is vital to preserve embryonically derived circuit architecture during postdevelopmental growth.	[Shao, Zhiyong; Christensen, Ryan; Colon-Ramos, Daniel A.] Yale Univ, Sch Med, Dept Cell Biol, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06536 USA; [Watanabe, Shigeki; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Dept Biol, Salt Lake City, UT 84112 USA	Yale University; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Colon-Ramos, DA (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, Program Cellular Neurosci Neurodegenerat & Repair, POB 9812, New Haven, CT 06536 USA.			Watanabe, Shigeki/0000-0001-7580-8141	Klingenstein Foundation; Alfred P. Sloan Foundation; March of Dimes Research Grant;  [R00 NS057931];  [R01 NS076558];  [NIH R01 NS034307];  [NSF 0920069]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076558, R01NS034307, R00NS057931] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Klingenstein Foundation(Klingenstein Philanthropies); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); March of Dimes Research Grant(March of Dimes); ; ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some illustrations were created by Z.F. Altun and D.H. Hall from WormAtlas. The EM in Fig 5A, Fig S1C and S1D were prepared by J. White, E. Southgate, N. Thomson and S. Brenner at the LMB/MRC labs in Cambridge, England (White et al., 1986). The adult image in the graphical abstract was created by Dr. Maria Gallegos of Cal State University. We thank Dr. H. Bulow, Dr. M. Stern, Dr. S. Shaham, Dr. T. Kinnunen, Dr. J. Fares, Dr. K. Shen, and CGC for strains and reagents. We also thank A. Perez and A. Roque for technical assistance, Dr. X. Song for helping with the protein blots, and D. Hall, S. Margolis, P. De Camilli, S. Strittmatter, M. Hammarlund, and members of the Colon-Ramos lab for helpful discussions and sharing of advice. This work was funded by the following grants to D.C.-R. (R00 NS057931, R01 NS076558, a fellowship from the Klingenstein Foundation and the Alfred P. Sloan Foundation and a March of Dimes Research Grant) and to E.M.J (NIH R01 NS034307, NSF 0920069). E.M.J. is an Investigator of the Howard Hughes Medical Institute. Z.S. and D.A.C-R. designed experiments. S.W. and E.M.J. performed the fEM experiments. R.C. performed wild type EM reconstruction and AIY Zone 1 length quantification. Z.S. performed all other experiments. Z.S. and D.A.C-R. analyzed and interpreted the data. Z.S., S.W., E.M.J., and D.A.C.-R. wrote the paper.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Allan S, 2006, CEREBROVASC DIS, V21, P137, DOI 10.1159/000090447; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Aurelio O, 2002, SCIENCE, V295, P686, DOI 10.1126/science.1066642; Banerjee S, 2007, ANNU REV NEUROSCI, V30, P235, DOI 10.1146/annurev.neuro.30.051606.094345; Benard C, 2009, CURR TOP DEV BIOL, V87, P175, DOI 10.1016/S0070-2153(09)01206-X; Benard CY, 2006, DEVELOPMENT, V133, P3329, DOI 10.1242/dev.02507; Benard CY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002819; Borland CZ, 2001, BIOESSAYS, V23, P1120, DOI 10.1002/bies.10007; BRENNER S, 1974, GENETICS, V77, P71; Brink DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037876; Bulow HE, 2004, NEURON, V42, P367, DOI 10.1016/S0896-6273(04)00246-6; Chelur DS, 2007, P NATL ACAD SCI USA, V104, P2283, DOI 10.1073/pnas.0610877104; Chisholm Andrew D, 2005, WormBook, P1; Chisholm AD, 2012, WIRES DEV BIOL, V1, P861, DOI 10.1002/wdev.79; Chisholm AD, 2012, WIRES DEV BIOL, V1, P879, DOI 10.1002/wdev.77; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; COX GN, 1985, MOL CELL BIOL, V5, P363, DOI 10.1128/MCB.5.2.363; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fuentes-Medel Y, 2012, CURR BIOL, V22, P1831, DOI 10.1016/j.cub.2012.07.063; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Goodman SJ, 2003, DEVELOPMENT, V130, P3757, DOI 10.1242/dev.00604; Hildebrandt H, 2009, BRAIN, V132, P2831, DOI 10.1093/brain/awp117; Huang P, 2004, DEVELOPMENT, V131, P2595, DOI 10.1242/dev.01135; Johnson RP, 2012, GENETICS, V190, P1365, DOI 10.1534/genetics.111.136184; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kim JH, 2006, J BIOCHEM MOL BIOL, V39, P339; Knight CG, 2002, EVOL DEV, V4, P16, DOI 10.1046/j.1525-142x.2002.01058.x; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; LIU ZC, 1991, NATURE, V350, P162, DOI 10.1038/350162a0; McMiller TL, 2005, GENE, V356, P1, DOI 10.1016/j.gene.2005.05.003; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miyaji T, 2011, J NEUROCHEM, V119, P1, DOI 10.1111/j.1471-4159.2011.07388.x; Miyaji T, 2010, BIOL PHARM BULL, V33, P1783, DOI 10.1248/bpb.33.1783; Morin P, 2004, EMBO J, V23, P4560, DOI 10.1038/sj.emboj.7600464; Myall NJ, 2007, MOL GENET METAB, V92, P371, DOI 10.1016/j.ymgme.2007.08.121; Nonet ML, 1997, J NEUROSCI, V17, P8061; Page AP, 2007, WORMBOOK, DOI [10.1895/wormbook.1.138.1, DOI 10.1895/W0RMB00K.1.138.1]; Pfrieger FW, 2010, BRAIN RES REV, V63, P39, DOI 10.1016/j.brainresrev.2009.11.002; Pocock R, 2008, MOL CELL NEUROSCI, V37, P56, DOI 10.1016/j.mcn.2007.08.014; Polanska UM, 2009, J BIOL CHEM, V284, P33030, DOI 10.1074/jbc.M109.058925; Qin LZ, 2012, P NATL ACAD SCI USA, V109, P13434, DOI 10.1073/pnas.1116633109; Reimer RJ, 2013, MOL ASPECTS MED, V34, P350, DOI 10.1016/j.mam.2012.05.004; Sasakura H, 2005, EMBO J, V24, P1477, DOI 10.1038/sj.emboj.7600621; Shaham S, 2006, CURR OPIN NEUROBIOL, V16, P522, DOI 10.1016/j.conb.2006.08.001; Shi L, 2012, TRENDS NEUROSCI, V35, P441, DOI 10.1016/j.tins.2012.04.005; Sreedharan S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-17; Stavoe AKH, 2012, J CELL BIOL, V197, P75, DOI 10.1083/jcb.201110127; Stevens B, 2008, NEUROSIGNALS, V16, P278, DOI 10.1159/000123038; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sundaram Meera V, 2006, WormBook, P1; Tam SJ, 2010, ANNU REV NEUROSCI, V33, P379, DOI 10.1146/annurev-neuro-060909-152829; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Watanabe S, 2012, METHOD CELL BIOL, V111, P283, DOI 10.1016/B978-0-12-416026-2.00015-7; Watanabe S, 2011, NAT METHODS, V8, P80, DOI 10.1038/NMETH.1537; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Woo WM, 2008, DEVELOPMENT, V135, P2747, DOI 10.1242/dev.015289; Wreden CC, 2005, J BIOL CHEM, V280, P1408, DOI 10.1074/jbc.M411295200; Yoshimura S, 2008, DEVELOPMENT, V135, P2263, DOI 10.1242/dev.019547	63	47	55	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 18	2013	154	2					337	350		10.1016/j.cell.2013.06.028	http://dx.doi.org/10.1016/j.cell.2013.06.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870123	Green Accepted, Bronze			2022-12-01	WOS:000321950700011
J	Baillie, JK; Digard, P				Baillie, J. Kenneth; Digard, Paul			Influenza - Time to Target the Host?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Baillie, J. Kenneth; Digard, Paul] Univ Edinburgh, Roslin Inst, Easter Bush, England; [Baillie, J. Kenneth] Royal Infirm, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Royal Infirmary of Edinburgh	Baillie, JK (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush, England.		Digard, Paul/B-7717-2008; Baillie, John Kenneth/F-3124-2011; Baillie, Kenneth/AEK-6650-2022	Digard, Paul/0000-0002-0872-9440; Baillie, John Kenneth/0000-0001-5258-793X; Baillie, Kenneth/0000-0001-5258-793X	BBSRC [BBS/E/D/20241864] Funding Source: UKRI; MRC [G0700815] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864] Funding Source: researchfish; Medical Research Council [G0700815] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Horby P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033180; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Porter CJH, 2007, NAT REV DRUG DISCOV, V6, P231, DOI 10.1038/nrd2197; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294	5	39	44	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					191	193		10.1056/NEJMcibr1304414	http://dx.doi.org/10.1056/NEJMcibr1304414			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180BH	23841736	Green Published			2022-12-01	WOS:000321567300019
J	Steinacher, M; Joos, F; Stocker, TF				Steinacher, Marco; Joos, Fortunat; Stocker, Thomas F.			Allowable carbon emissions lowered by multiple climate targets	NATURE			English	Article							OCEAN ACIDIFICATION; MITIGATION; CALCIFICATION; 21ST-CENTURY; SENSITIVITY; RISK	Climate targets are designed to inform policies that would limit the magnitude and impacts of climate change caused by anthropogenic emissions of greenhouse gases and other substances. The target that is currently recognized by most world governments(1) places a limit of two degrees Celsius on the global mean warming since preindustrial times. This would require large sustained reductions in carbon dioxide emissions during the twenty-first century and beyond(2-4). Such a global temperature target, however, is not sufficient to control many other quantities, such as transient sea level rise(5), ocean acidification(6,7) and net primary production on land(8,9). Here, using an Earth system model of intermediate complexity (EMIC) in an observation-informed Bayesian approach, we show that allowable carbon emissions are substantially reduced when multiple climate targets are set. We take into account uncertainties in physical and carbon cycle model parameters, radiative efficiencies(10), climate sensitivity(11) and carbon cycle feedbacks(12,13) along with a large set of observational constraints. Within this framework, we explore a broad range of economically feasible greenhouse gas scenarios from the integrated assessment community(14-17) to determine the likelihood of meeting a combination of specific global and regional targets under various assumptions. For any given likelihood of meeting a set of such targets, the allowable cumulative emissions are greatly reduced from those inferred from the temperature target alone. Therefore, temperature targets alone are unable to comprehensively limit the risks from anthropogenic emissions.	[Steinacher, Marco; Joos, Fortunat; Stocker, Thomas F.] Univ Bern, CH-3012 Bern, Switzerland; [Steinacher, Marco; Joos, Fortunat; Stocker, Thomas F.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland	University of Bern; University of Bern	Steinacher, M (corresponding author), Univ Bern, CH-3012 Bern, Switzerland.	steinacher@climate.unibe.ch	Steinacher, Marco/J-1527-2012; Joos, Fortunat/B-4118-2018; Stocker, Thomas/B-1273-2013	Steinacher, Marco/0000-0002-4795-1749; Joos, Fortunat/0000-0002-9483-6030; 	Swiss National Science Foundation; European Commission [EPOCA 211384, 264879]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank T. Kaminski for providing the Global Atmospheric Tracer Model (TM2) transport matrices, J. M. Lyman, H. Keith, and S. Gerber for providing observational data sets, R. Spahni, R. Roth, S. Ritz, B. Stocker and K. Strassmann for discussions and help with the model code, and K. Bieri for the IT support. We are grateful to the modelling teams participating in the EMF-21, International Institute for Applied Systems Analysis (IIASA) GGI, and AME projects for providing scenario data, and to the EMIC AR5 and coupled model intercomparison (CMIP5) projects for providing model forcing data sets. This project was funded by the Swiss National Science Foundation and the European Project on Ocean Acidification (EPOCA 211384) and the European Project CARBOCHANGE (264879) which both received funding from the European Commission's Seventh Framework Programme (FP7/20072013).	Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; Boden T., 2012, GLOBAL CO2 EMISSIONS; Calvin K, 2012, ENERG ECON, V34, pS251, DOI 10.1016/j.eneco.2012.09.003; Chan NCS, 2013, GLOBAL CHANGE BIOL, V19, P282, DOI 10.1111/gcb.12011; Church JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048794; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; FORSTER P, 2007, PHYS SCI BASIS, P129; Frieler K, 2013, NAT CLIM CHANGE, V3, P165, DOI 10.1038/NCLIMATE1674; Fung IY, 2005, P NATL ACAD SCI USA, V102, P11201, DOI 10.1073/pnas.0504949102; Grubler A, 2007, TECHNOL FORECAST SOC, V74, P873, DOI 10.1016/j.techfore.2006.07.009; Harrould-Kolieb ER, 2012, CLIM POLICY, V12, P378, DOI 10.1080/14693062.2012.620788; Hickler T, 2008, GLOBAL CHANGE BIOL, V14, P1531, DOI 10.1111/j.1365-2486.2008.01598.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; IPCC, 2022, CLIMATE CHANGE 2022; Isaaks E. H., 1989, APPL GEOSTATISTICS, P278; Johnson MD, 2012, J EXP MAR BIOL ECOL, V434, P94, DOI 10.1016/j.jembe.2012.08.005; Joos F, 2001, GLOBAL BIOGEOCHEM CY, V15, P891, DOI 10.1029/2000GB001375; Joos F., 2011, OCEAN ACIDIFICATION, P319; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Knox J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034032; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Meehl GA, 2012, NAT CLIM CHANGE, V2, P576, DOI 10.1038/NCLIMATE1529; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Muller SA, 2006, J CLIMATE, V19, P5479, DOI 10.1175/JCLI3911.1; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parekh P, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001531; Powlson DS, 2011, FOOD POLICY, V36, pS72, DOI 10.1016/j.foodpol.2010.11.025; Ritz SP, 2011, QUATERNARY SCI REV, V30, P3728, DOI 10.1016/j.quascirev.2011.09.021; Ritz SP, 2011, J CLIMATE, V24, P349, DOI 10.1175/2010JCLI3351.1; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Rougier J, 2007, CLIMATIC CHANGE, V81, P247, DOI 10.1007/s10584-006-9156-9; Running SW, 2012, SCIENCE, V337, P1458, DOI 10.1126/science.1227620; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284, DOI 10.4319/lo.2006.51.3.1284; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Spahni R., 2012, CLIM PAST DISCUSS, V8, P5633, DOI [10.5194/cpd-8-5633-2012, DOI 10.5194/CPD-8-5633-2012]; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Strassmann KM, 2008, TELLUS B, V60, P583, DOI 10.1111/j.1600-0889.2008.00340.x; Tomassini L, 2010, CLIMATIC CHANGE, V103, P399, DOI 10.1007/s10584-009-9763-3; United Nations, 2011, C PART 16 SESS CANC; Weyant JR, 2006, ENERG J, P1; Yamamoto-Kawai M, 2009, SCIENCE, V326, P1098, DOI 10.1126/science.1174190; Yara Y, 2012, BIOGEOSCIENCES, V9, P4955, DOI 10.5194/bg-9-4955-2012; Zickfeld K, 2009, P NATL ACAD SCI USA, V106, P16129, DOI 10.1073/pnas.0805800106	49	69	69	6	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	2013	499	7457					197	+		10.1038/nature12269	http://dx.doi.org/10.1038/nature12269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23823728				2022-12-01	WOS:000321557600059
J	Van Damme, P; Leuridan, E; Hendrickx, G; Vorsters, A; Theeten, H; Leino, T; Salminen, M; Kuusi, M				Van Damme, Pierre; Leuridan, Elke; Hendrickx, Greet; Vorsters, Alex; Theeten, Heidi; Leino, Tuija; Salminen, Mika; Kuusi, Markku			Should Europe have a universal hepatitis B vaccination programme?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VIRUS INFECTION; SEX WORKERS; TRANSMISSION; NETHERLANDS; RISK; IMMUNIZATION; EPIDEMIOLOGY; PREVALENCE; STRATEGIES; MIGRATION		[Van Damme, Pierre; Leuridan, Elke; Hendrickx, Greet; Vorsters, Alex; Theeten, Heidi] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, B-2020 Antwerp, Belgium; [Leino, Tuija] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Salminen, Mika; Kuusi, Markku] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland	University of Antwerp; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Van Damme, P (corresponding author), Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, B-2020 Antwerp, Belgium.	pierre.vandamme@ua.ac.be; markku.kuusi@thl.fi	van damme, pierre/I-4846-2013; Salminen, Mika/D-8784-2013; vorsters, alex/A-9605-2012	Salminen, Mika/0000-0003-3020-0866; vorsters, alex/0000-0002-0265-058X; Leuridan, Elke/0000-0001-7482-799X; van damme, pierre/0000-0002-8642-1249	GlaxoSmithKline Biologicals; Sanofi Pasteur; Merck	GlaxoSmithKline Biologicals(GlaxoSmithKline); Sanofi Pasteur; Merck(Merck & Company)	The authors have read and understood the BMJ Group policy on declaration of interests and declare the following interests: PvD is head of the Vaccine and Infectious Disease Institute at the University of Antwerp, which is a WHO collaborating centre for the prevention and control of infectious diseases; chair of the European Technical Advisory Group of Experts on immunisation at WHO EURO; and executive secretary of the Viral Hepatitis Prevention Board, which is supported by unrestricted grants from the vaccine industry (GlaxoSmithKline Biologicals, Sanofi Pasteur, and Merck). PvD acts as chief and principal investigator for vaccine trials, for which the university obtains research grants from vaccine manufacturers.	Aweis D, 2001, Commun Dis Public Health, V4, P247; Baars JE, 2011, EUR J PUBLIC HEALTH, V21, P333, DOI 10.1093/eurpub/ckq117; Baars JE, 2009, WOMEN HEALTH ISS, V19, P61, DOI 10.1016/j.whi.2008.09.002; Beeching NJ, 2004, BRIT MED J, V329, P1059, DOI 10.1136/bmj.329.7474.1059; Beutels P, 2001, HEALTH ECON, V10, P751, DOI 10.1002/hec.625; Boccalini S, 2013, HUM VACC IMMUNOTHER, V9, P1; Cai W, 2011, PEDIATR INFECT DIS J, V30, P19, DOI 10.1097/INF.0b013e3181ef22d5; Chu JJ, 2012, EUR J PUBLIC HLTH; Day CA, 2010, DRUG ALCOHOL DEPEN, V108, P134, DOI 10.1016/j.drugalcdep.2009.11.013; Edmunds W J, 1998, Commun Dis Public Health, V1, P221; Fisker N, 2004, J CLIN VIROL, V31, P46, DOI 10.1016/j.jcv.2004.05.004; Gjorup IE, 2003, J INFECTION, V47, P231, DOI 10.1016/S0163-4453(03)00070-7; Hahne S, 2004, J CLIN VIROL, V29, P211, DOI 10.1016/j.jcv.2003.09.016; Heininger U, 2010, PEDIATR INFECT DIS J, V29, P248, DOI 10.1097/INF.0b013e3181bd7f89; Kretzschmar M, 2002, EPIDEMIOL INFECT, V128, P229, DOI 10.1017/S0950268801006562; Kretzschmar M, 2009, VACCINE, V27, P1254, DOI 10.1016/j.vaccine.2008.12.009; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lindh M, 2000, INFECTION, V28, P161, DOI 10.1007/s150100050071; MAHONEY FJ, 1995, PEDIATRICS, V96, P1113; Marschall T, 2008, EUR J GASTROEN HEPAT, V20, P1214, DOI 10.1097/MEG.0b013e32830e289e; Nardone A, 2009, EPIDEMIOL INFECT, V137, P961, DOI 10.1017/S0950268808001672; Organization WH, 2009, WEEKLY EPIDEMIOLOGIC, V84, P405; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Rantala M, 2008, EUROSURVEILLANCE, V13, P1; Rimseliene G, 2009, EUR SCI C APPL INF D; Romano L, 2011, DIGEST LIVER DIS, V43, pS2, DOI 10.1016/S1590-8658(10)60685-8; Salleras L, 2007, VACCINE, V25, P8726, DOI 10.1016/j.vaccine.2007.10.027; Tilson L, 2008, EUR J PUBLIC HEALTH, V18, P275, DOI 10.1093/eurpub/ckm123; Van Damme P., 2013, VACCINES-BASEL, P205; van Houdt R, 2009, VACCINE, V27, P3530, DOI 10.1016/j.vaccine.2009.03.072; WHO, 2012, PREV CONTR VIR HEP I; World Health Organization, 2010, 63 WORLD HLTH ASS VI; Wouters K, 2007, VACCINE, V25, P1893, DOI 10.1016/j.vaccine.2006.09.073	33	13	13	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2013	347								f4057	10.1136/bmj.f4057	http://dx.doi.org/10.1136/bmj.f4057			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	184MC	23843546	Green Submitted			2022-12-01	WOS:000321893000004
J	Weiskopf, K; Ring, AM; Ho, CCM; Volkmer, JP; Levin, AM; Volkmer, AK; Ozkan, E; Fernhoff, NB; van de Rijn, M; Weissman, IL; Garcia, KC				Weiskopf, Kipp; Ring, Aaron M.; Ho, Chia Chi M.; Volkmer, Jens-Peter; Levin, Aron M.; Volkmer, Anne Kathrin; Oezkan, Engin; Fernhoff, Nathaniel B.; van de Rijn, Matt; Weissman, Irving L.; Garcia, K. Christopher			Engineered SIRP alpha Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies	SCIENCE			English	Article							SIGNAL-REGULATORY-PROTEIN; STEM-CELLS; CD47; RECEPTOR; THERAPY; CLEARANCE; RITUXIMAB; EFFICACY; TARGET; SAFETY	CD47 is an antiphagocytic signal that cancer cells employ to inhibit macrophage-mediated destruction. Here, we modified the binding domain of human SIRP alpha, the receptor for CD47, for use as a CD47 antagonist. We engineered high-affinity SIRP alpha variants with about a 50,000-fold increased affinity for human CD47 relative to wild-type SIRP alpha. As high-affinity SIRP alpha monomers, they potently antagonized CD47 on cancer cells but did not induce macrophage phagocytosis on their own. Instead, they exhibited remarkable synergy with all tumor-specific monoclonal antibodies tested by increasing phagocytosis in vitro and enhancing antitumor responses in vivo. This "one-two punch" directs immune responses against tumor cells while lowering the threshold for macrophage activation, thereby providing a universal method for augmenting the efficacy of therapeutic anticancer antibodies.	[Weiskopf, Kipp; Ring, Aaron M.; Ho, Chia Chi M.; Volkmer, Jens-Peter; Volkmer, Anne Kathrin; Fernhoff, Nathaniel B.; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Weiskopf, Kipp; Ring, Aaron M.; Ho, Chia Chi M.; Volkmer, Jens-Peter; Volkmer, Anne Kathrin; Fernhoff, Nathaniel B.; Weissman, Irving L.; Garcia, K. Christopher] Stanford Univ, Sch Med, Ludwig Ctr Canc Stem Cell Res & Med, Stanford, CA 94305 USA; [Weiskopf, Kipp; Ring, Aaron M.; Ho, Chia Chi M.; Volkmer, Jens-Peter; Volkmer, Anne Kathrin; Fernhoff, Nathaniel B.; Weissman, Irving L.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Ring, Aaron M.; Ho, Chia Chi M.; Levin, Aron M.; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ring, Aaron M.; Ho, Chia Chi M.; Levin, Aron M.; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Ring, Aaron M.; Ho, Chia Chi M.; Levin, Aron M.; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Volkmer, Anne Kathrin] Univ Dusseldorf, Dept Obstet & Gynaecol, Dusseldorf, Germany; [van de Rijn, Matt; Weissman, Irving L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Heinrich Heine University Dusseldorf; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Ludwig Ctr Canc Stem Cell Res & Med, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		van de Rijn, Matt/0000-0002-1909-9739; Ozkan, Engin/0000-0002-0263-6729; Ring, Aaron/0000-0003-3699-2446	National Cancer Institute [F30CA168059, CA139490]; National Institute of Diabetes and Digestive and Kidney Diseases [F30DK094541]; Stanford Medical Scientist Training Program [NIH-GM07365]; Stanford University SPARK Program; Deutsche Forschungsgemeinschaft [VO 1976/1]; Joseph and Laurie Lacob Gynecologic/Ovarian Cancer Fund; Virginia and D. K. Ludwig Fund for Cancer Research; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA112270, P01CA139490, R01CA086017, R01CA177684, F30CA168059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK094541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Stanford Medical Scientist Training Program; Stanford University SPARK Program(Stanford University); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Joseph and Laurie Lacob Gynecologic/Ovarian Cancer Fund; Virginia and D. K. Ludwig Fund for Cancer Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank members of the Weissman and Garcia laboratories for helpful advice and discussions. The authors thank R. Majeti, J. Liu, and the CD47 Disease Team for discussions and for providing antibodies to CD47. The authors thank T. Storm, L. Jerabek, H. Contreras-Trujillo, A. McCarty, S. Jaiswal, B. di Robilant, S. Varma, T. Naik, S. Willingham, H. Kohrt, N. Goriatcheva, D. Waghray, and S. Fischer for technical assistance, discussions, and reagents. The data presented in this paper are tabulated in the main paper and the supplementary materials. Atomic coordinates and structure factors of the FD6:CD47 complex (PDB code 4KJY) have been deposited in the Protein Data Bank. Research reported in this publication was supported by the National Cancer Institute (F30CA168059 to K. W. and CA139490 to I. L. W.), the National Institute of Diabetes and Digestive and Kidney Diseases (F30DK094541 to A. M. R.), the Stanford Medical Scientist Training Program (NIH-GM07365 to K. W. and A. M. R.), the Stanford University SPARK Program (to K. W. and A. M. R.), the Deutsche Forschungsgemeinschaft (VO 1976/1 to A. K. V.), the Joseph and Laurie Lacob Gynecologic/Ovarian Cancer Fund (to I. L. W), the Virginia and D. K. Ludwig Fund for Cancer Research (to I. L. W.), and the Howard Hughes Medical Institute (to K. C. G.). The content of this manuscript is solely the responsibility of the authors. K. W., A. M. R., A. M. L., I. L. W., and K. C. G. have filed a patent describing the high-affinity SIRP alpha reagents.	Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Beckman RA, 2007, CANCER-AM CANCER SOC, V109, P170, DOI 10.1002/cncr.22402; Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Edris B, 2012, P NATL ACAD SCI USA, V109, P6656, DOI 10.1073/pnas.1121629109; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Korman AJ, 2006, ADV IMMUNOL, V90, P297, DOI 10.1016/S0065-2776(06)90008-X; Lapalombella R, 2008, CLIN CANCER RES, V14, P569, DOI 10.1158/1078-0432.CCR-07-1006; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Maloney DG, 1997, BLOOD, V90, P2188; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Reichert JM, 2012, DRUG DISCOV TODAY, V17, P954, DOI 10.1016/j.drudis.2012.04.006; Rodriguez PL, 2013, SCIENCE, V339, P971, DOI 10.1126/science.1229568; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; STANCOVSKI I, 1991, P NATL ACAD SCI USA, V88, P8691, DOI 10.1073/pnas.88.19.8691; Tabrizi MA, 2007, DRUG DISCOV TODAY, V12, P540, DOI 10.1016/j.drudis.2007.05.010; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Theocharides APA, 2012, J EXP MED, V209, P1883, DOI 10.1084/jem.20120502; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Yamauchi T, 2013, BLOOD, V121, P1316, DOI 10.1182/blood-2012-06-440354; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108	30	288	347	4	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2013	341	6141					88	91		10.1126/science.1238856	http://dx.doi.org/10.1126/science.1238856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23722425	Green Accepted			2022-12-01	WOS:000321291700055
J	Tam, VC; Quehenberger, O; Oshansky, CM; Suen, R; Armando, AM; Treuting, PM; Thomas, PG; Dennis, EA; Aderem, A				Tam, Vincent C.; Quehenberger, Oswald; Oshansky, Christine M.; Suen, Rosa; Armando, Aaron M.; Treuting, Piper M.; Thomas, Paul G.; Dennis, Edward A.; Aderem, Alan			Lipidomic Profiling of Influenza Infection Identifies Mediators that Induce and Resolve Inflammation	CELL			English	Article							HUMAN PLASMA; VIRUS; ACID; LUNG; RECEPTOR; LEUKOTOXIN; RESOLUTION; ROLES; NEUTROPHILS; ACTIVATION	Bioactive lipid mediators play a crucial role in the induction and resolution of inflammation. To elucidate their involvement during influenza infection, liquid chromatography/mass spectrometry lipidomic profiling of 141 lipid species was performed on a mouse influenza model using two viruses of significantly different pathogenicity. Infection by the low-pathogenicity strain X31/H3N2 induced a proinflammatory response followed by a distinct antiinflammatory response; infection by the high-pathogenicity strain PR8/H1N1 resulted in overlapping pro-and anti-inflammatory states. Integration of the large-scale lipid measurements with targeted gene expression data demonstrated that 5-lipoxygenase metabolites correlated with the pathogenic phase of the infection, whereas 12/15-lipoxygenase metabolites were associated with the resolution phase. Hydroxylated linoleic acid, specifically the ratio of 13- to 9-hydroxyoctadecadienoic acid, was identified as a potential biomarker for immune status during an active infection. Importantly, some of the findings from the animal model were recapitulated in studies of human nasopharyngeal lavages obtained during the 2009-2011 influenza seasons.	[Tam, Vincent C.; Suen, Rosa; Aderem, Alan] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Quehenberger, Oswald] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Armando, Aaron M.; Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Quehenberger, Oswald; Armando, Aaron M.; Dennis, Edward A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Oshansky, Christine M.; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Treuting, Piper M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; St Jude Children's Research Hospital; University of Washington; University of Washington Seattle	Aderem, A (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	alan.aderem@seattlebiomed.org	Thomas, Paul G./H-1063-2018; Dennis, Edward A./M-5554-2019; Treuting, Piper M./AAB-2721-2019	Thomas, Paul G./0000-0001-7955-0256; Dennis, Edward A./0000-0003-3738-3140; Treuting, Piper M./0000-0002-1812-1519; Tam, Vincent/0000-0003-0898-2531	National Institute of Allergy and Infectious Diseases [HHSN272200800058C]; American Lebanese Syrian Associated Charities (ALSAC); NIH/NIAID Center of Excellence for Influenza Research and Surveillance [HHSN266200700005C]; NIGMS [U54 GM069338]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NIH/NIAID Center of Excellence for Influenza Research and Surveillance(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Alan Diercks and Peter Askovich for helpful advice and critical reading of the manuscript. This work was supported by National Institute of Allergy and Infectious Diseases Contract no. HHSN272200800058C, "A Systems Biology Approach to Infectious Disease Research'', the American Lebanese Syrian Associated Charities (ALSAC), the NIH/NIAID Center of Excellence for Influenza Research and Surveillance (HHSN266200700005C), and NIGMS U54 GM069338 (to E.A.D.).	ALLAN W, 1990, J IMMUNOL, V144, P3980; Altmann R, 2007, BIOCHEM PHARMACOL, V74, P612, DOI 10.1016/j.bcp.2007.05.027; Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Belvisi MG, 2009, BRIT J PHARMACOL, V158, P994, DOI 10.1111/j.1476-5381.2009.00373.x; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Drake DR, 2008, J LIPID RES, V49, P4, DOI 10.1194/jlr.R700016-JLR200; Dumlao DS, 2011, BBA-MOL CELL BIOL L, V1811, P724, DOI 10.1016/j.bbalip.2011.06.005; FRANCIS T, 1945, J INFECT DIS, V76, P70, DOI 10.1093/infdis/76.1.70; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Hattori T, 2008, J INVEST DERMATOL, V128, P1123, DOI 10.1038/sj.jid.5701172; ISHIZAKI T, 1995, AM J PHYSIOL-LUNG C, V269, pL65, DOI 10.1152/ajplung.1995.269.1.L65; Ishizaki T, 1999, PULM PHARMACOL THER, V12, P145, DOI 10.1006/pupt.1999.0179; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jankov RP, 2002, J PHARMACOL EXP THER, V301, P435, DOI 10.1124/jpet.301.2.435; Ji RR, 2011, TRENDS NEUROSCI, V34, P599, DOI 10.1016/j.tins.2011.08.005; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kiss L, 2000, AM J RESP CRIT CARE, V161, P1917, DOI 10.1164/ajrccm.161.6.9906058; Kronke G, 2009, J IMMUNOL, V183, P3383, DOI 10.4049/jimmunol.0900327; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Levy BD, 2007, J IMMUNOL, V178, P496, DOI 10.4049/jimmunol.178.1.496; Morgan LT, 2010, BIOCHEM J, V431, P141, DOI 10.1042/BJ20100415; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; O'Flaherty JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045480; Obinata H, 2009, PROSTAG OTH LIPID M, V89, P66, DOI 10.1016/j.prostaglandins.2008.11.002; Quehenberger O, 2011, NEW ENGL J MED, V365, P1812, DOI 10.1056/NEJMra1104901; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; SERHAN CN, 1995, BIOCHEMISTRY-US, V34, P14609, DOI 10.1021/bi00044a041; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Sisemore MF, 2001, ARCH BIOCHEM BIOPHYS, V392, P32, DOI 10.1006/abbi.2001.2434; Spiteller P, 1997, CHEM PHYS LIPIDS, V89, P131, DOI 10.1016/S0009-3084(97)00070-4; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Thomson SJ, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/605101; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Totani Y, 2000, EUR RESPIR J, V15, P75, DOI 10.1183/09031936.00.15107500; Wray JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007421	43	164	172	1	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					213	227		10.1016/j.cell.2013.05.052	http://dx.doi.org/10.1016/j.cell.2013.05.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827684	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000321327900021
J	Wright, J				Wright, Jessica			EPIGENETICS Reversible tags	NATURE			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; MUTATIONS; METHYLATION											Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020	7	19	19	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					S10	S11		10.1038/498S10a	http://dx.doi.org/10.1038/498S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803942	Bronze			2022-12-01	WOS:000320929400006
J	Rummer, JL; McKenzie, DJ; Innocenti, A; Supuran, CT; Brauner, CJ				Rummer, Jodie L.; McKenzie, David J.; Innocenti, Alessio; Supuran, Claudiu T.; Brauner, Colin J.			Root Effect Hemoglobin May Have Evolved to Enhance General Tissue Oxygen Delivery	SCIENCE			English	Article							TROUT SALMO-GAIRDNERI; RAINBOW-TROUT; CARBONIC-ANHYDRASE; ONCORHYNCHUS-MYKISS; SKELETAL-MUSCLE; CATECHOLAMINES; ERYTHROCYTES; SECRETION; EXERCISE; FISHES	The Root effect is a pH-dependent reduction in hemoglobin-O-2 carrying capacity. Specific to ray-finned fishes, the Root effect has been ascribed specialized roles in retinal oxygenation and swimbladder inflation. We report that when rainbow trout are exposed to elevated water carbon dioxide (CO2), red muscle partial pressure of oxygen (PO2) increases by 65%-evidence that Root hemoglobins enhance general tissue O-2 delivery during acidotic stress. Inhibiting carbonic anhydrase (CA) in the plasma abolished this effect. We argue that CA activity in muscle capillaries short-circuits red blood cell (RBC) pH regulation. This acidifies RBCs, unloads O-2 from hemoglobin, and elevates tissue PO2, which could double O-2 delivery with no change in perfusion. This previously undescribed mechanism to enhance O-2 delivery during stress may represent the incipient function of Root hemoglobins in fishes.	[Rummer, Jodie L.; Brauner, Colin J.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Rummer, Jodie L.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [McKenzie, David J.] Univ Montpellier 2, Equipe Diversite & Ecol Poissons, UMR Ecol Syst Marins Cotiers 5119, F-34095 Montpellier 5, France; [Innocenti, Alessio; Supuran, Claudiu T.] Univ Florence, Neurofarba Dept, Sez Sci Farmaceut, I-50019 Florence, Italy	University of British Columbia; James Cook University; Universite de Montpellier; University of Florence	Rummer, JL (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	jodie.rummer@jcu.edu.au	Rummer, Jodie L/A-6524-2015; McKenzie, David J./K-3090-2012; McKenzie, David/AAA-5179-2021	Rummer, Jodie L/0000-0001-6067-5892; McKenzie, David J./0000-0003-0961-9101; McKenzie, David/0000-0003-0961-9101; Supuran, Claudiu/0000-0003-4262-0323	Natural Sciences and Engineering Research Council of Canada; University of British Columbia; Australian Research Council	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of British Columbia; Australian Research Council(Australian Research Council)	This project was funded by a Natural Sciences and Engineering Research Council of Canada Discovery grant to C.J.B. and a University of British Columbia Graduate Fellowship and Australian Research Council grant to J.L.R. The authors wish to thank S. F. Perry for catecholamine analysis, W. K. Milsom for tubocurarine advice, and D. J. Randall, M. Regan, D. W. Baker, C. Ciuhandu, A. P. Farrell, K. Gilmour, A. Morash, P. Allen, N. Farrell, C. Fu, L. Hanson, K. Kamo, M. Roshan-Moniri, K. Suvadzjic, and the University of British Columbia Zoology workshop for interesting discussions and editorial and technical assistance. Additional information and all supporting data can be found in the supplementary materials.	BAROIN A, 1984, J PHYSIOL-LONDON, V356, P21, DOI 10.1113/jphysiol.1984.sp015450; Behnke BJ, 2001, RESP PHYSIOL, V126, P53, DOI 10.1016/S0034-5687(01)00195-5; Berenbrink M, 2005, SCIENCE, V307, P1752, DOI 10.1126/science.1107793; Berenbrink M, 2007, J EXP BIOL, V210, P1641, DOI 10.1242/jeb.003319; Bohr C, 1904, SKAND ARCH PHYSIOL, V16, P402, DOI 10.1111/j.1748-1716.1904.tb01382.x; Helfman GS, 2009, DIVERSITY FISHES BIO; Henry RP, 2000, RESP PHYSIOL, V121, P1, DOI 10.1016/S0034-5687(00)00110-9; Hutter J, 1999, J APPL PHYSIOL, V86, P860, DOI 10.1152/jappl.1999.86.3.860; LAPENNAS GN, 1983, RESP PHYSIOL, V54, P161, DOI 10.1016/0034-5687(83)90054-3; McKenzie DJ, 2004, J EXP BIOL, V207, P3629, DOI 10.1242/jeb.01199; NIKINMAA M, 1992, PHYSIOL REV, V72, P301, DOI 10.1152/physrev.1992.72.2.301; PERRY SF, 1989, RESP PHYSIOL, V77, P365, DOI 10.1016/0034-5687(89)90123-0; PRIMMETT DRN, 1986, J EXP BIOL, V122, P139; RAHIM SM, 1988, HISTOCHEMISTRY, V89, P451, DOI 10.1007/BF00492602; Romero MG, 1996, J EXP BIOL, V199, P415; Root RW, 1931, BIOL BULL-US, V61, P427, DOI 10.2307/1536959; Rummer J.L, 2010, THESIS U BRIT COLUMB; Rummer JL, 2011, J EXP BIOL, V214, P2319, DOI 10.1242/jeb.054049; SCHOLANDER PF, 1954, BIOL BULL, V107, P247, DOI 10.2307/1538611; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Wang YX, 1998, AM J PHYSIOL-REG I, V275, pR1766, DOI 10.1152/ajpregu.1998.275.6.R1766; Weaver YR, 1999, J EXP BIOL, V202, P21; WITTENBERG JB, 1974, BIOL BULL-US, V146, P116, DOI 10.2307/1540402	23	102	103	0	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1327	1329		10.1126/science.1233692	http://dx.doi.org/10.1126/science.1233692			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766325				2022-12-01	WOS:000320320200044
J	de Wit, E; Bouwman, BAM; Zhu, Y; Klous, P; Splinter, E; Verstegen, MJAM; Krijger, PHL; Festuccia, N; Nora, EP; Welling, M; Heard, E; Geijsen, N; Poot, RA; Chambers, I; de Laat, W				de Wit, Elzo; Bouwman, Britta A. M.; Zhu, Yun; Klous, Petra; Splinter, Erik; Verstegen, Marjon J. A. M.; Krijger, Peter H. L.; Festuccia, Nicola; Nora, Elphege P.; Welling, Maaike; Heard, Edith; Geijsen, Niels; Poot, Raymond A.; Chambers, Ian; de Laat, Wouter			The pluripotent genome in three dimensions is shaped around pluripotency factors	NATURE			English	Article							CHROMOSOME CONFORMATION CAPTURE; CHROMATIN INTERACTIONS; REGULATORY LANDSCAPE; GENE-EXPRESSION; SELF-RENEWAL; DOMAINS; MAPS; DIFFERENTIATION; PROTEINS; CELLS	It is becoming increasingly clear that the shape of the genome importantly influences transcription regulation. Pluripotent stem cells such as embryonic stem cells were recently shown to organize their chromosomes into topological domains that are largely invariant between cell types(1,2). Here we combine chromatin conformation capture technologies with chromatin factor binding data to demonstrate that inactive chromatin is unusually disorganized in pluripotent stem-cell nuclei. We show that gene promoters engage in contacts between topological domains in a largely tissue-independent manner, whereas enhancers have a more tissue-restricted interaction profile. Notably, genomic clusters of pluripotency factor binding sites find each other very efficiently, in a manner that is strictly pluripotent-stem-cell-specific, dependent on the presence of Oct4 and Nanog protein and inducible after artificial recruitment of Nanog to a selected chromosomal site. We conclude that pluripotent stem cells have a unique higher-order genome structure shaped by pluripotency factors. We speculate that this interactome enhances the robustness of the pluripotent state.	[de Wit, Elzo; Bouwman, Britta A. M.; Zhu, Yun; Klous, Petra; Splinter, Erik; Verstegen, Marjon J. A. M.; Krijger, Peter H. L.; Welling, Maaike; Geijsen, Niels; de Laat, Wouter] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [de Wit, Elzo; Bouwman, Britta A. M.; Zhu, Yun; Klous, Petra; Splinter, Erik; Verstegen, Marjon J. A. M.; Krijger, Peter H. L.; Welling, Maaike; Geijsen, Niels; de Laat, Wouter] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Festuccia, Nicola; Chambers, Ian] Univ Edinburgh, Inst Stem Cell Res, Sch Biol Sci, MRC Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland; [Nora, Elphege P.; Heard, Edith] Inst Curie, CNRS, Mammalian Dev Epigenet Grp, INSERM,UMR3215,U934, F-75231 Paris, France; [Geijsen, Niels] Univ Utrecht, Sch Vet Med, NL-3584 CL Utrecht, Netherlands; [Poot, Raymond A.] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Utrecht University; Erasmus University Rotterdam; Erasmus MC	de Laat, W (corresponding author), Hubrecht Inst KNAW, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	w.delaat@hubrecht.eu	Heard, Edith/D-7197-2017; Nora, Elphège/AAW-9646-2021	Heard, Edith/0000-0001-8052-7117; Nora, Elphège/0000-0002-8347-4396; Bouwman, Britta/0000-0002-9827-9497; de Wit, Elzo/0000-0003-2883-1415; de Laat, Wouter/0000-0002-6393-595X; Chambers, Ian/0000-0003-2605-1597; Welling, Maaike/0000-0003-3253-3410; Krijger, Peter/0000-0003-1702-348X	Netherlands Institute for Regenerative Medicine (NIRM) network; Medical Research Council UK; Dutch Scientific Organization (NWO) [700.10.402, 91204082, 935170621]; InteGeR FP7 Marie Curie ITN [PITN-GA-2007-214902]; European Research Council Starting Grant [209700]; MRC [G0901533] Funding Source: UKRI; Medical Research Council [G0901533] Funding Source: researchfish	Netherlands Institute for Regenerative Medicine (NIRM) network; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dutch Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); InteGeR FP7 Marie Curie ITN; European Research Council Starting Grant(European Research Council (ERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank C. Vermeulen and S. Holwerda for counting FISH slides; G. Geeven for the analysis of sequencing data; J. Brandsma for technical assistance; P. Verschure for the LacR-GFP backbone construct; and H. Niwa for providing ZHBTc4 ES cells. We also thank the Netherlands Institute for Regenerative Medicine (NIRM) network for supporting the R. A. P. laboratory and the Medical Research Council UK for supporting the I. C. laboratory. This work was financially supported by grants from the Dutch Scientific Organization (NWO) to E.d.W. (700.10.402, 'Veni') and W.d.L. (91204082 and 935170621), InteGeR FP7 Marie Curie ITN (PITN-GA-2007-214902) and a European Research Council Starting Grant (209700, '4C') to W.d.L.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Apostolou E, 2013, CELL STEM CELL, V12, P699, DOI 10.1016/j.stem.2013.04.013; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dhar SS, 2010, J NEUROCHEM, V115, P676, DOI 10.1111/j.1471-4159.2010.06956.x; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Holwerda S. J., 2013, NUCL ACIDS RES; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Karantzali E, 2011, J BIOL CHEM, V286, P1037, DOI 10.1074/jbc.M110.170050; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Krijger PHL, 2013, CURR OPIN GENET DEV, V23, P191, DOI 10.1016/j.gde.2012.12.010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Smith AG., 1991, J TISSUE CULTURE MET, V13, P89, DOI [DOI 10.1007/BF01666137, 10.1007/BF01666137, 10.1007/bf01666137]; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Splinter E, 2011, EMBO J, V30, P4345, DOI 10.1038/emboj.2011.344; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Wilson AA, 2008, AM J RESP CELL MOL, V39, P133, DOI 10.1165/rcmb.2007-0133OC; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Xu M, 2008, J CELL BIOL, V181, P615, DOI 10.1083/jcb.200710053	40	195	196	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					227	+		10.1038/nature12420	http://dx.doi.org/10.1038/nature12420			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	23883933				2022-12-01	WOS:000324244900042
J	Perera, MA; Cavallari, LH; Limdi, NA; Gamazon, ER; Konkashbaev, A; Daneshjou, R; Pluzhnikov, A; Crawford, DC; Wang, JL; Liu, NJ; Tatonetti, N; Bourgeois, S; Takahashi, H; Bradford, Y; Burkley, BM; Desnick, RJ; Halperin, JL; Khalifa, SI; Langaee, TY; Lubitz, SA; Nutescu, EA; Oetjens, M; Shahin, MH; Patel, SR; Sagreiya, H; Tector, M; Weck, KE; Rieder, MJ; Scott, SA; Wu, AHB; Burmester, JK; Wadelius, M; Deloukas, P; Wagner, MJ; Mushiroda, T; Kubo, M; Roden, DM; Cox, NJ; Altman, RB; Klein, TE; Nakamura, Y; Johnson, JA				Perera, Minoli A.; Cavallari, Larisa H.; Limdi, Nita A.; Gamazon, Eric R.; Konkashbaev, Anuar; Daneshjou, Roxana; Pluzhnikov, Anna; Crawford, Dana C.; Wang, Jelai; Liu, Nianjun; Tatonetti, Nicholas; Bourgeois, Stephane; Takahashi, Harumi; Bradford, Yukiko; Burkley, Benjamin M.; Desnick, Robert J.; Halperin, Jonathan L.; Khalifa, Sherief I.; Langaee, Taimour Y.; Lubitz, Steven A.; Nutescu, Edith A.; Oetjens, Matthew; Shahin, Mohamed H.; Patel, Shitalben R.; Sagreiya, Hersh; Tector, Matthew; Weck, Karen E.; Rieder, Mark J.; Scott, Stuart A.; Wu, Alan H. B.; Burmester, James K.; Wadelius, Mia; Deloukas, Panos; Wagner, Michael J.; Mushiroda, Taisei; Kubo, Michiaki; Roden, Dan M.; Cox, Nancy J.; Altman, Russ B.; Klein, Teri E.; Nakamura, Yusuke; Johnson, Julie A.			Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study	LANCET			English	Article							EUROPEAN-AMERICANS; VKORC1; CYP2C9; ANTICOAGULATION; REQUIREMENTS; POLYMORPHISM; MAINTENANCE; HAPLOTYPES; GENOTYPE; PHARMACOGENETICS	Background VKORC1 and CYP2C9 are important contributors to warfarin dose variability, but explain less variability for individuals of African descent than for those of European or Asian descent. We aimed to identify additional variants contributing to warfarin dose requirements in African Americans. Methods We did a genome-wide association study of discovery and replication cohorts. Samples from African-American adults (aged >= 18 years) who were taking a stable maintenance dose of warfarin were obtained at International Warfarin Pharmacogenetics Consortium (IWPC) sites and the University of Alabama at Birmingham (Birmingham, AL, USA). Patients enrolled at IWPC sites but who were not used for discovery made up the independent replication cohort. All participants were genotyped. We did a stepwise conditional analysis, conditioning first for VKORC1 -1639G -> A, followed by the composite genotype of CYP2C9*2 and CYP2C9*3. We prespecified a genome-wide significance threshold of p<5x10(-8) in the discovery cohort and p<0.0038 in the replication cohort. Findings The discovery cohort contained 533 participants and the replication cohort 432 participants. After the prespecified conditioning in the discovery cohort, we identified an association between a novel single nucleotide polymorphism in the CYP2C cluster on chromosome 10 (rs12777823) and warfarin dose requirement that reached genome-wide significance (p=1.51x10(-8)). This association was confirmed in the replication cohort (p=5.04x10(-5)); analysis of the two cohorts together produced a p value of 4.5x10(-12). Individuals heterozygous for the rs12777823 A allele need a dose reduction of 6.92 mg/week and those homozygous 9.34 mg/week. Regression analysis showed that the inclusion of rs12777823 significantly improves warfarin dose variability explained by the IWPC dosing algorithm (21% relative improvement). Interpretation A novel CYP2C single nucleotide polymorphism exerts a clinically relevant effect on warfarin dose in African Americans, independent of CYP2C9*2 and CYP2C9*3. Incorporation of this variant into pharmacogenetic dosing algorithms could improve warfarin dose prediction in this population.	[Perera, Minoli A.; Gamazon, Eric R.; Konkashbaev, Anuar; Pluzhnikov, Anna; Cox, Nancy J.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Cavallari, Larisa H.; Nutescu, Edith A.; Patel, Shitalben R.] Univ Illinois, Dept Pharm Practice, Chicago, IL USA; [Limdi, Nita A.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Limdi, Nita A.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Wang, Jelai; Liu, Nianjun] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Daneshjou, Roxana; Tatonetti, Nicholas; Sagreiya, Hersh; Altman, Russ B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Klein, Teri E.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Crawford, Dana C.; Bradford, Yukiko; Oetjens, Matthew] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Roden, Dan M.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Roden, Dan M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Bourgeois, Stephane; Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge, England; [Takahashi, Harumi] Meiji Pharmaceut Univ, Dept Biopharmaceut, Tokyo, Japan; [Burkley, Benjamin M.; Langaee, Taimour Y.; Shahin, Mohamed H.; Johnson, Julie A.] Univ Florida, Ctr Pharmacogen, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA; [Desnick, Robert J.; Scott, Stuart A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Halperin, Jonathan L.] Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY USA; [Khalifa, Sherief I.] Qatar Univ, Coll Pharm, Pharmaceut Sci Sect, Doha, Qatar; [Lubitz, Steven A.] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA; [Lubitz, Steven A.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Tector, Matthew] Aurora St Lukes Med Ctr, Milwaukee, WI USA; [Weck, Karen E.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Weck, Karen E.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Wagner, Michael J.] Univ N Carolina, Sch Pharm, Chapel Hill, NC USA; [Rieder, Mark J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Wu, Alan H. B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Burmester, James K.] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA; [Wadelius, Mia] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Mushiroda, Taisei; Kubo, Michiaki; Nakamura, Yusuke] RIKEN Ctr Genom Med, Yokohama, Kanagawa, Japan	University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Stanford University; Stanford University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Wellcome Trust Sanger Institute; Meiji Pharmaceutical University; State University System of Florida; University of Florida; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Qatar University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Marshfield Clinic; Uppsala University; RIKEN	Johnson, JA (corresponding author), Univ Florida, Ctr Pharmacogen, Dept Pharmacotherapy & Translat Res, Box 100486, Gainesville, FL 32610 USA.	johnson@cop.ufl.edu	Roden, Dan/ABD-5412-2021; Mushiroda, Taisei/E-3022-2010; Wadelius, Mia/C-7740-2016; Kubo, Michiaki/N-7947-2015; Deloukas, Panos/B-2922-2013; Sagreiya, Hersh/Z-1641-2019; Daneshjou, Roxana/ABE-7764-2021; Halperin, Jonathan/AAJ-4721-2020; Shahin, Mohamed/Q-2874-2019; Gamazon, Eric/I-6873-2018; Crawford, Dana/O-5578-2019; Perera, Minoli/AHD-3525-2022	Wadelius, Mia/0000-0002-6368-2622; Deloukas, Panos/0000-0001-9251-070X; Halperin, Jonathan/0000-0002-8318-5471; Gamazon, Eric/0000-0003-4204-8734; Crawford, Dana/0000-0002-6437-6248; Perera, Minoli/0000-0002-1146-2791; Scott, Stuart/0000-0001-5720-1864; Patel, Shitalben/0000-0003-3710-0497; Nutescu, Edith/0000-0002-2651-0020; Khalifa, Sherief/0000-0003-3590-1397; Tatonetti, Nicholas/0000-0002-2700-2597; Weck, Karen/0000-0002-8516-333X	National Institutes of Health; American Heart Association; Howard Hughes Medical Institute; Wisconsin Network for Health Research; Wellcome Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000069, UL1TR000427, UL1TR000165] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL112908, R01HL092173, R21HL106097, U19HL065962, K23HL089808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081488, R24GM061374, U01GM061393, U19GM061390, RC2GM092618, U01GM074492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS045598] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wisconsin Network for Health Research; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	National Institutes of Health, American Heart Association, Howard Hughes Medical Institute, Wisconsin Network for Health Research, and the Wellcome Trust.	Anderson JL, 2012, CIRCULATION, V125, P1997, DOI 10.1161/CIRCULATIONAHA.111.070920; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Cavallari LH, 2010, CLIN PHARMACOL THER, V87, P459, DOI 10.1038/clpt.2009.223; Cavallari LH, 2012, PHARMACOGENET GENOM, V22, P152, DOI 10.1097/FPC.0b013e32834f288f; Cha PC, 2010, HUM MOL GENET, V19, P4735, DOI 10.1093/hmg/ddq389; Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247; Ferder NS, 2010, J THROMB HAEMOST, V8, P95, DOI 10.1111/j.1538-7836.2009.03677.x; French B, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-108; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Gamazon ER, 2012, AM J HUM GENET, V90, P1046, DOI 10.1016/j.ajhg.2012.04.023; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Kirley K, 2012, CIRC-CARDIOVASC QUAL, V5, P615, DOI 10.1161/CIRCOUTCOMES.112.967299; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Limdi NA, 2008, PHARMACOGENOMICS, V9, P1445, DOI 10.2217/14622416.9.10.1445; Limdi NA, 2008, PHARMACOGENOMICS, V9, P511, DOI 10.2217/14622416.9.5.511; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Liu Y, 2012, CLIN PHARMACOL THER, V91, P660, DOI 10.1038/clpt.2011.269; Perera MA, 2011, CLIN PHARMACOL THER, V89, P408, DOI 10.1038/clpt.2010.322; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramirez AH, 2012, PHARMACOGENOMICS, V13, P407, DOI [10.2217/PGS.11.164, 10.2217/pgs.11.164]; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Schelleman H, 2010, BRIT J CLIN PHARMACO, V70, P393, DOI 10.1111/j.1365-2125.2010.03709.x; Shahin MHA, 2011, PHARMACOGENET GENOM, V21, P130, DOI 10.1097/FPC.0b013e3283436b86; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Takahashi H, 1998, CLIN PHARMACOL THER, V63, P519, DOI 10.1016/S0009-9236(98)90103-5; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Teichert M, 2009, HUM MOL GENET, V18, P3758, DOI 10.1093/hmg/ddp309; The National Board of Health and Welfare, LAKEMEDELSSTATISTIK; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; van Schie RMF, 2009, PHARMACOGENOMICS, V10, P1687, DOI [10.2217/pgs.09.125, 10.2217/PGS.09.125]; Voora D, 2010, CLIN PHARMACOL THER, V87, P445, DOI 10.1038/clpt.2009.291	33	175	189	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2013	382	9894					790	796		10.1016/S0140-6736(13)60681-9	http://dx.doi.org/10.1016/S0140-6736(13)60681-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VP	23755828	Green Published, Green Accepted			2022-12-01	WOS:000324239200029
J	Rudolph, CJ; Upton, AL; Stockum, A; Nieduszynski, CA; Lloyd, RG				Rudolph, Christian J.; Upton, Amy L.; Stockum, Anna; Nieduszynski, Conrad A.; Lloyd, Robert G.			Avoiding chromosome pathology when replication forks collide	NATURE			English	Article							ESCHERICHIA-COLI RECG; DNA-REPLICATION; RNA-POLYMERASE; GENOME INSTABILITY; TRANSCRIPTION; HELICASE; INITIATION; MUTATIONS; CONFLICTS; RECOMBINATION	Chromosome duplication normally initiates through the assembly of replication fork complexes at defined origins(1,2). DNA synthesis by any one fork is thought to cease when it meets another travelling in the opposite direction, at which stage the replication machinery may simply dissociate before the nascent strands are finally ligated. But what actually happens is not clear. Here we present evidence consistent with the idea that every fork collision has the potential to threaten genomic integrity. In Escherichia coli this threat is kept at bay by RecG DNA translocase(3) and by single-strand DNA exonucleases. Without RecG, replication initiates where forks meet through a replisome assembly mechanism normally associated with fork repair, replication restart and recombination(4,5), establishing new forks with the potential to sustain cell growth and division without an active origin. This potential is realized when roadblocks to fork progression are reduced or eliminated. It relies on the chromosome being circular, reinforcing the idea that replication initiation is triggered repeatedly by fork collision. The results reported raise the question of whether replication fork collisions have pathogenic potential for organisms that exploit several origins to replicate each chromosome.	[Rudolph, Christian J.; Upton, Amy L.; Stockum, Anna; Nieduszynski, Conrad A.; Lloyd, Robert G.] Univ Nottingham, Queens Med Ctr, Ctr Genet & Genom, Nottingham NG7 2UH, England; [Rudolph, Christian J.; Upton, Amy L.] Brunel Univ, Div Biosci, Sch Hlth Sci & Social Care, London UB8 3PH, England	University of Nottingham; Brunel University	Rudolph, CJ (corresponding author), Univ Nottingham, Queens Med Ctr, Ctr Genet & Genom, Nottingham NG7 2UH, England.	christian.rudolph@brunel.ac.uk	Nieduszynski, Conrad/B-2170-2010; Rudolph, Christian J./L-6525-2019	Nieduszynski, Conrad/0000-0003-2001-076X; Rudolph, Christian J./0000-0003-2493-3748	MRC [G0800970]; Leverhulme Trust; BBSRC [BB/E023754/1]; Biotechnology and Biological Sciences Research Council [BB/E023754/1] Funding Source: researchfish; Medical Research Council [G0800970] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Horiuchi and D. Sherratt for E. coli strains, A. Mahdi for help with DNA extractions, S. Malla and M. Blythe for deep sequencing, S. Demolli and D. Ivanova for control experiments, and C. Buckman and L. Harris for assistance. This work was supported by grants from the MRC (R. G. L., G0800970), the Leverhulme Trust (C.J.R.) and the BBSRC (C.A.N., BB/E023754/1).	Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Cui TL, 2007, EMBO REP, V8, P181, DOI 10.1038/sj.embor.7400880; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diffley JFX, 2011, PHILOS T R SOC B, V366, P3545, DOI 10.1098/rstb.2011.0073; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; Gregg AV, 2002, MOL CELL, V9, P241, DOI 10.1016/S1097-2765(02)00455-0; Killen MW, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-33; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Mahdi AA, 2012, MOL MICROBIOL, V86, P675, DOI 10.1111/mmi.12010; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; Miller JH., 1972, EXPT MOL GENETICS; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Muller CA, 2012, GENOME RES, V22, P1953, DOI 10.1101/gr.139477.112; Paul S, 2013, NATURE, V495, P512, DOI 10.1038/nature11989; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Reyes-Larnothe R, 2008, TRENDS MICROBIOL, V16, P238, DOI 10.1016/j.tim.2008.02.003; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; Rudolph CJ, 2010, GENETICS, V186, P473, DOI 10.1534/genetics.110.120691; Rudolph CJ, 2010, DNA REPAIR, V9, P210, DOI 10.1016/j.dnarep.2009.12.014; Rudolph CJ, 2009, MOL MICROBIOL, V74, P940, DOI 10.1111/j.1365-2958.2009.06909.x; Rybchin VN, 1999, MOL MICROBIOL, V33, P895, DOI 10.1046/j.1365-2958.1999.01533.x; Skovgaard O, 2011, GENOME RES, V21, P1388, DOI 10.1101/gr.117416.110; Steinacher R, 2012, GENE DEV, V26, P594, DOI 10.1101/gad.184663.111; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Wang XD, 2011, P NATL ACAD SCI USA, V108, pE243, DOI 10.1073/pnas.1100874108; Whitby MC, 2010, DNA REPAIR, V9, P224, DOI 10.1016/j.dnarep.2009.12.012	31	89	89	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					608	+		10.1038/nature12312	http://dx.doi.org/10.1038/nature12312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23892781	Green Accepted			2022-12-01	WOS:000323625900041
J	Katz, SJ; Morrow, M				Katz, Steven J.; Morrow, Monica			Contralateral Prophylactic Mastectomy for Breast Cancer Addressing Peace of Mind	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OUTCOMES		[Katz, Steven J.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Katz, Steven J.] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Morrow, Monica] Cornell Univ, Weill Med Coll, Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cornell University; Memorial Sloan Kettering Cancer Center	Katz, SJ (corresponding author), Univ Michigan, Dept Med, 2800 Plymouth Rd,North Campus Res Complex,Bldg 16, Ann Arbor, MI 48109 USA.	skatz@umich.edu	KATZ, STEVEN/ABH-8886-2020		NATIONAL CANCER INSTITUTE [P01CA163233] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA163233] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bedrosian I, 2010, JNCI-J NATL CANCER I, V102, P401, DOI 10.1093/jnci/djq018; Cemal Y, 2013, PLAST RECONSTR SURG, V131, p320E, DOI 10.1097/PRS.0b013e31827cf576; Houssami N, 2013, ANN SURG, V257, P249, DOI 10.1097/SLA.0b013e31827a8d17; Katz SJ, CANCER, DOI [10.1002/cncr.28260, DOI 10.1002/CNCR.28260]; Nichols HB, 2011, J CLIN ONCOL, V29, P1564, DOI 10.1200/JCO.2010.32.7395; Tuttle TM, 2009, J CLIN ONCOL, V27, P1362, DOI 10.1200/JCO.2008.20.1681	6	63	63	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					793	794		10.1001/jama.2013.101055	http://dx.doi.org/10.1001/jama.2013.101055			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23907558				2022-12-01	WOS:000323561400014
J	Nelson, WA; Bjornstad, ON; Yamanaka, T				Nelson, William A.; Bjornstad, Ottar N.; Yamanaka, Takehiko			Recurrent Insect Outbreaks Caused by Temperature-Driven Changes in System Stability	SCIENCE			English	Article							LIFE-CYCLES; FOOD-WEB; DYNAMICS; POPULATIONS; PREY; SIZE; TRANSITIONS; HERBIVORES; ENRICHMENT; MODELS	Insects often undergo regular outbreaks in population density but identifying the causal mechanism for such outbreaks in any particular species has proven difficult. Here, we show that outbreak cycles in the tea tortrix Adoxophyes honmai can be explained by temperature-driven changes in system stability. Wavelet analysis of a 51-year time series spanning more than 200 outbreaks reveals a threshold in outbreak amplitude each spring when temperature exceeds 15 degrees C and a secession of outbreaks each fall as temperature decreases. This is in close agreement with our independently parameterized mathematical model that predicts the system crosses a Hopf bifurcation from stability to sustained cycles as temperature increases. These results suggest that temperature can alter system stability and provide an explanation for generation cycles in multivoltine insects.	[Nelson, William A.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Bjornstad, Ottar N.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Bjornstad, Ottar N.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Yamanaka, Takehiko] Natl Inst Agroenvironm Sci, Nat Resources Inventory Ctr, Tsukuba, Ibaraki 3058604, Japan	Queens University - Canada; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institute for Agro-Environmental Sciences (NIAES) Japan	Nelson, WA (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	nelsonw@queensu.ca	Nelson, William A/D-1405-2013	Yamanaka, Takehiko/0000-0003-2888-1076	Natural Sciences and Engineering Research Council Discovery grants; U.S. Department of Agricultures National Research Initiative	Natural Sciences and Engineering Research Council Discovery grants; U.S. Department of Agricultures National Research Initiative(United States Department of Agriculture (USDA))	We thank K. Uchimura for access to up-to-date light-catch data. W.A.N. was supported by Natural Sciences and Engineering Research Council Discovery grants. O.N.B. received support from the U.S. Department of Agricultures National Research Initiative. Raw time-series data are provided in Dryad (doi:10.5061/dryad.n11d4).	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/S0065-2504(08)60212-3; Becks L, 2008, ECOLOGY, V89, P3222, DOI 10.1890/07-1988.1; Binzer A, 2012, PHILOS T R SOC B, V367, P2935, DOI 10.1098/rstb.2012.0230; Carmona R., 1998, PRACTICAL TIME FREQU, V9; Cornulier T, 2013, SCIENCE, V340, P63, DOI 10.1126/science.1228992; COSTANTINO RF, 1995, NATURE, V375, P227, DOI 10.1038/375227a0; Danks HV, 1987, INSECT DORMANCY ECOL; Forster J, 2011, AM NAT, V178, P668, DOI 10.1086/662174; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GURNEY WSC, 1994, THEOR POPUL BIOL, V46, P319, DOI 10.1006/tpbi.1994.1030; Johnson DM, 2010, P NATL ACAD SCI USA, V107, P20576, DOI 10.1073/pnas.1010270107; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; Massie TM, 2010, P NATL ACAD SCI USA, V107, P4236, DOI 10.1073/pnas.0908725107; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; Murdoch WW, 2002, NATURE, V417, P541, DOI 10.1038/417541a; O'Connor MI, 2011, AM NAT, V178, P626, DOI 10.1086/662171; Ohlberger J, 2011, AM NAT, V177, P211, DOI 10.1086/657925; Powell JA, 2000, B MATH BIOL, V62, P977, DOI 10.1006/bulm.2000.0192; RINALDI S, 1993, B MATH BIOL, V55, P15, DOI 10.1007/BF02460293; ROFF D, 1983, DIAPAUSE LIFE CYCLE, P253; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; Stenseth NC, 1997, P NATL ACAD SCI USA, V94, P5147, DOI 10.1073/pnas.94.10.5147; Tamaki Y., 1991, TORTRICID PESTS THEI, P541; Tauber M.J., 1986, SEASONAL ADAPTATIONS; TAYLOR F, 1981, AM NAT, V117, P1, DOI 10.1086/283683; Taylor RA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2714; Vasseur DA, 2005, AM NAT, V166, P184, DOI 10.1086/431285; Yamanaka T, 2012, AM NAT, V179, P95, DOI 10.1086/663201	30	72	74	3	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 16	2013	341	6147					796	799		10.1126/science.1238477	http://dx.doi.org/10.1126/science.1238477			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201DZ	23907532				2022-12-01	WOS:000323122200051
J	Shulman, Z; Gitlin, AD; Targ, S; Jankovic, M; Pasqual, G; Nussenzweig, MC; Victora, GD				Shulman, Ziv; Gitlin, Alexander D.; Targ, Sasha; Jankovic, Mila; Pasqual, Giulia; Nussenzweig, Michel C.; Victora, Gabriel D.			T Follicular Helper Cell Dynamics in Germinal Centers	SCIENCE			English	Article							LYMPH-NODE; RESPONSES; SELECTION; FH	T follicular helper (T-FH) cells are a specialized subset of effector T cells that provide help to and thereby select high-affinity B cells in germinal centers (GCs). To examine the dynamic behavior of T-FH cells in GCs in mice, we used two-photon microscopy in combination with a photoactivatable fluorescent reporter. Unlike GC B cells, which are clonally restricted, T-FH cells distributed among all GCs in lymph nodes and continually emigrated into the follicle and neighboring GCs. Moreover, newly activated T-FH cells invaded preexisting GCs, where they contributed to B cell selection and plasmablast differentiation. Our data suggest that the dynamic exchange of T-FH cells between GCs ensures maximal diversification of T cell help and that their ability to enter ongoing GCs accommodates antigenic variation during the immune response.	[Shulman, Ziv; Gitlin, Alexander D.; Jankovic, Mila; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Targ, Sasha; Pasqual, Giulia; Victora, Gabriel D.] Whitehead Inst Biomed Res, Cambridge, MA 02138 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	nussen@rockefeller.edu; victora@wi.mit.edu	Pasqual, Giulia/AAD-8378-2022; Nussenzweig, Michel/AAE-7292-2019	Pasqual, Giulia/0000-0002-1476-2669; Victora, Gabriel/0000-0001-8807-348X; Gitlin, Alexander/0000-0002-9229-0919	Empire State Stem Cell Fund through New York State Department of Health [C023046]; NIH Medical Scientist Training Program [T32GM07739]; NIH [5DP5OD012146-02, AI037526-19, AI072529-06, AI100663-01]; March of Dimes Foundation Basil O'Connor Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037526, UM1AI100663, R01AI072529, R37AI037526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012146] Funding Source: NIH RePORTER	Empire State Stem Cell Fund through New York State Department of Health; NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation Basil O'Connor Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Ploegh, K. Strijbis, and H. Sive for mice and equipment use and E. Browne for helpful discussion. The data presented are tabulated in the main paper and in the supplementary materials. Support for the Rockefeller University multiphoton microscope was granted by the Empire State Stem Cell Fund through New York State Department of Health contract C023046. Supported by NIH Medical Scientist Training Program grant T32GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program (A. D. G.), NIH grant 5DP5OD012146-02 and March of Dimes Foundation Basil O'Connor Award (G. D. V.), and NIH grants AI037526-19, AI072529-06, and AI100663-01 (M.C.N.). Z.S. is a Human Frontiers of Science fellow. G. P. is a Swiss National Science Foundation fellow. M.C.N. is an HHMI investigator.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Golby SJC, 1999, EUR J IMMUNOL, V29, P3729, DOI 10.1002/(SICI)1521-4141(199911)29:11<3729::AID-IMMU3729>3.0.CO;2-I; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; KROESE FGM, 1987, EUR J IMMUNOL, V17, P1069, DOI 10.1002/eji.1830170726; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Roers A, 2000, AM J PATHOL, V156, P1067, DOI 10.1016/S0002-9440(10)64974-7; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Zheng B, 1996, J EXP MED, V184, P1083, DOI 10.1084/jem.184.3.1083	23	225	234	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 9	2013	341	6146					673	677		10.1126/science.1241680	http://dx.doi.org/10.1126/science.1241680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23887872	Green Accepted, Green Submitted			2022-12-01	WOS:000322884800044
J	Bassi, C; Ho, J; Srikumar, T; Dowling, RJO; Gorrini, C; Miller, SJ; Mak, TW; Neel, BG; Raught, B; Stambolic, V				Bassi, C.; Ho, J.; Srikumar, T.; Dowling, R. J. O.; Gorrini, C.; Miller, S. J.; Mak, T. W.; Neel, B. G.; Raught, B.; Stambolic, V.			Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; TUMOR-SUPPRESSOR; PROSTATE-CANCER; MAMMALIAN-CELLS; GENE; IDENTIFICATION; RECOGNITION; PTEN/MMAC1; DELETION; DAMAGE	Loss of function of the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) tumor suppressor gene is associated with many human cancers. In the cytoplasm, PTEN antagonizes the phosphatidylinositol 3-kinase (PI3K) signaling pathway. PTEN also accumulates in the nucleus, where its function remains poorly understood. We demonstrate that SUMOylation (SUMO, small ubiquitin-like modifier) of PTEN controls its nuclear localization. In cells exposed to genotoxic stress, SUMO-PTEN was rapidly excluded from the nucleus dependent on the protein kinase ataxia telangiectasia mutated (ATM). Cells lacking nuclear PTEN were hypersensitive to DNA damage, whereas PTEN-deficient cells were susceptible to killing by a combination of genotoxic stress and a small-molecule PI3K inhibitor both in vitro and in vivo. Our findings may have implications for individualized therapy for patients with PTEN-deficient tumors.	[Bassi, C.; Srikumar, T.; Mak, T. W.; Neel, B. G.; Raught, B.; Stambolic, V.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Ho, J.; Dowling, R. J. O.; Gorrini, C.; Mak, T. W.; Neel, B. G.; Raught, B.; Stambolic, V.] Univ Hlth Network, Campbell Family Canc Res Inst, Ontario Canc Inst, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Gorrini, C.; Mak, T. W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Princess Margaret Canc Ctr, Toronto, ON M5G 2C1, Canada; [Miller, S. J.; Neel, B. G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol Oncol,Dept Med, Boston, MA 02115 USA; [Miller, S. J.; Neel, B. G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Biol Program,Dept Med, Boston, MA 02115 USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Stambolic, V (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada.	vuks@uhnres.utoronto.ca	Srikumar, Tharan/Q-5642-2016; Dowling, Ryan/Q-8912-2018	Gorrini, Chiara/0000-0002-5239-6671; Dowling, Ryan/0000-0002-5381-8805; Stambolic, Vuk/0000-0001-8853-3239	Canadian Cancer Society [2011-700891]; NIH [R37 CA49152]; Ontario Ministry of Health and Long Term Care; Princess Margaret Hospital Foundation; Excellence in Radiation Research for the 21st century (EIRR21st) fellowship; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [R01CA049152, R37CA049152] Funding Source: NIH RePORTER	Canadian Cancer Society(Canadian Cancer Society (CCS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Princess Margaret Hospital Foundation; Excellence in Radiation Research for the 21st century (EIRR21st) fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Fraser for reagents, D. Durocher for advice on DNA repair assays, R. Hakem for critical reading of the manuscript, A. Wakeham for advice on xenograft experiments, and Novartis for BKM120. Supported by grants from the Canadian Cancer Society to V. S. (2011-700891) and from NIH to B.G.N. (R37 CA49152) and partially supported by a grant from the Ontario Ministry of Health and Long Term Care and the Princess Margaret Hospital Foundation. B.G.N. and T. W. M. hold Canada Research Chairs (Tier I), and B. R. holds Canada Research Chair (Tier II). C. B. was supported by the Excellence in Radiation Research for the 21st century (EIRR21st) fellowship, and R.J.O.D. was supported by a Banting Postdoctoral Fellowship from the Canadian Institutes of Health Research. C. B. and V. S. designed research; C. B., J.H., T. S., R. D., C. G., and S.J.M. performed research; C. B., T. S., B.G.N., B. R., and V. S. analyzed data; T. M., B.G.N., B. R., and V. S. supervised research; and C. B., B.G.N., and V. S. wrote the paper.	Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Cairns P, 1997, CANCER RES, V57, P4997; Elliott B, 2001, MOL CELL BIOL, V21, P2671, DOI 10.1128/MCB.21.8.2671-2682.2001; Fraser M, 2012, CLIN CANCER RES, V18, P1015, DOI 10.1158/1078-0432.CCR-11-2189; Guldberg P, 1997, CANCER RES, V57, P3660; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Pedrioli PGA, 2006, NAT METHODS, V3, P533, DOI 10.1038/NMETH891; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Rasheed BKA, 1997, CANCER RES, V57, P4187; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002	21	296	308	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					395	399		10.1126/science.1236188	http://dx.doi.org/10.1126/science.1236188			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888040	Green Accepted, Green Submitted			2022-12-01	WOS:000322259200049
J	Annas, GJ; Crosby, SS; Glantz, LH				Annas, George J.; Crosby, Sondra S.; Glantz, Leonard H.			Guantanamo Bay: A Medical Ethics-free Zone?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HUNGER STRIKES		[Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University; Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831; Crosby, Sondra/0000-0002-1672-5407; Glantz, Leonard/0000-0003-4591-2305				Annas GJ, 2006, NEW ENGL J MED, V355, P1377, DOI 10.1056/NEJMhle062316; Annas GJ., 2010, WORST CASE BIOETHICS; [Anonymous], 2013, REP CONST PROJ TASK; BEAM T, 2003, MILITARY MED ETHICS, V2; Crosby SS, 2007, JAMA-J AM MED ASSOC, V298, P563, DOI 10.1001/jama.298.5.563	5	22	23	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	2013	369	2					101	103		10.1056/NEJMp1306065	http://dx.doi.org/10.1056/NEJMp1306065			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180BH	23758205				2022-12-01	WOS:000321567300003
J	Ananthanarayanan, V; Schattat, M; Vogel, SK; Krull, A; Pavin, N; Tolic-Norrelykke, IM				Ananthanarayanan, Vaishnavi; Schattat, Martin; Vogel, Sven K.; Krull, Alexander; Pavin, Nenad; Tolic-Norrelykke, Iva M.			Dynein Motion Switches from Diffusive to Directed upon Cortical Anchoring	CELL			English	Article							SINGLE-MOLECULE ANALYSIS; CYTOPLASMIC DYNEIN; FISSION YEAST; CAENORHABDITIS-ELEGANS; MEIOTIC PROPHASE; NUCLEAR-MOVEMENT; TAIL DOMAIN; SPINDLE ORIENTATION; MYOSIN VA; IN-VIVO	Cytoplasmic dynein is a motor protein that exerts force on microtubules. To generate force for the movement of large organelles, dynein needs to be anchored, with the anchoring sites being typically located at the cell cortex. However, the mechanism by which dyneins target sites where they can generate large collective forces is unknown. Here, we directly observe single dyneins during meiotic nuclear oscillations in fission yeast and identify the steps of the dynein binding process: from the cytoplasm to the microtubule and from the microtubule to cortical anchors. We observed that dyneins on the microtubule move either in a diffusive or directed manner, with the switch from diffusion to directed movement occurring upon binding of dynein to cortical anchors. This dual behavior of dynein on the microtubule, together with the two steps of binding, enables dyneins to self-organize into a spatial pattern needed for them to generate large collective forces.	[Ananthanarayanan, Vaishnavi; Schattat, Martin; Vogel, Sven K.; Krull, Alexander; Pavin, Nenad; Tolic-Norrelykke, Iva M.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Pavin, Nenad] Univ Zagreb, Fac Sci, Dept Phys, Zagreb 10002, Croatia	Max Planck Society; University of Zagreb; University of Zagreb, School of Dental Medicine	Pavin, N (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	npavin@phy.hr; tolic@mpi-cbg.de	Tolić, Iva/F-1704-2014; Schattat, Martin/AAT-8247-2020; Ananthanarayanan, Vaishnavi/AAJ-7170-2020; Pavin, Nenad/N-6376-2013	Tolić, Iva/0000-0003-1305-7922; Schattat, Martin/0000-0002-1995-1960; Ananthanarayanan, Vaishnavi/0000-0003-2936-7853; Pavin, Nenad/0000-0002-4313-1081; Vogel, Sven Kenjiro/0000-0003-2540-5947; Krull, Alexander/0000-0002-7778-7169	Max Planck Society; German Research Foundation (DFG)	Max Planck Society(Max Planck Society); German Research Foundation (DFG)(German Research Foundation (DFG))	V.A. carried out all experiments and data analysis. M.S. established a protocol for fast imaging and obtained initial data. S.K.V. performed pilot experiments. A.K. developed the tracking software. I.M.T-N. and N.P. designed the project and wrote the paper with input from V.A. We thank G. Rodel, K. Bloom, K. Sawin, A. Yamashita, and the Yeast Genetic Resource Center for strains and plasmids; Dr. Jacob Kerssemakers and Dr. Marileen Dogterom for the STEPFINDER software; B. Schroth-Diez and D.J. White from the Light Microscopy Facility of MPI-CBG; P. Delivani, D. Ramunno-Johnson, and H. Weisse for technical help; I. Saric for the drawings; J. Howard, S.W. Grill, N. Maghelli, M. Neetz, M. Chacon, A. Klemm, D. Accardi, and I. Kalinina for discussions and comments on the manuscript; and the Max Planck Society and the German Research Foundation (DFG) for funding.	Abraham AV, 2009, OPT EXPRESS, V17, P23352, DOI 10.1364/OE.17.023352; Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Coelho M, 2013, INTEGR BIOL-UK, V5, P748, DOI 10.1039/c3ib40018b; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; ESHEL D, 1993, P NATL ACAD SCI USA, V90, P11172, DOI 10.1073/pnas.90.23.11172; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Friedman DS, 1999, NAT CELL BIOL, V1, P293, DOI 10.1038/13008; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; HACKNEY DD, 1992, J BIOL CHEM, V267, P8696; Hammond JW, 2010, J CELL BIOL, V189, P1013, DOI 10.1083/jcb.201001057; Hammond JW, 2009, PLOS BIOL, V7, P650, DOI 10.1371/journal.pbio.1000072; Heil-Chapdelaine RA, 2000, J CELL BIOL, V151, P1337, DOI 10.1083/jcb.151.6.1337; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; JOHNSON KA, 1983, J CELL BIOL, V96, P669, DOI 10.1083/jcb.96.3.669; Kalinina I, 2013, NAT CELL BIOL, V15, P82, DOI 10.1038/ncb2640; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Kimura K, 2011, P NATL ACAD SCI USA, V108, P137, DOI 10.1073/pnas.1013275108; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; LI YY, 1993, P NATL ACAD SCI USA, V90, P10096, DOI 10.1073/pnas.90.21.10096; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Markus SM, 2009, CURR BIOL, V19, P196, DOI 10.1016/j.cub.2008.12.047; Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Saito TT, 2006, J CELL BIOL, V173, P27, DOI 10.1083/jcb.200512129; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Trokter M, 2012, P NATL ACAD SCI USA, V109, P20895, DOI 10.1073/pnas.1210573110; Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yamamoto A, 2001, MOL BIOL CELL, V12, P3933, DOI 10.1091/mbc.12.12.3933; Yamashita A, 2006, GENETICS, V173, P1187, DOI 10.1534/genetics.105.050062; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	50	56	57	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 20	2013	153	7					1526	1536		10.1016/j.cell.2013.05.020	http://dx.doi.org/10.1016/j.cell.2013.05.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	168RA	23791180	Bronze			2022-12-01	WOS:000320722000020
J	Eriksson, UK; Fischer, G; Friemann, R; Enkavi, G; Tajkhorshid, E; Neutze, R				Eriksson, Urszula Kosinska; Fischer, Gerhard; Friemann, Rosmarie; Enkavi, Giray; Tajkhorshid, Emad; Neutze, Richard			Subangstrom Resolution X-Ray Structure Details Aquaporin-Water Interactions	SCIENCE			English	Article							CRYSTAL-STRUCTURE; PROTON EXCLUSION; CHANNEL; PERMEATION; MECHANISM; SELECTIVITY; TRANSPORT; DYNAMICS	Aquaporins are membrane channels that facilitate the flow of water across biological membranes. Two conserved regions are central for selective function: the dual asparagine-proline-alanine (NPA) aquaporin signature motif and the aromatic and arginine selectivity filter (SF). Here, we present the crystal structure of a yeast aquaporin at 0.88 angstrom resolution. We visualize the H-bond donor interactions of the NPA motif's asparagine residues to passing water molecules; observe a polarized water-water H-bond configuration within the channel; assign the tautomeric states of the SF histidine and arginine residues; and observe four SF water positions too closely spaced to be simultaneously occupied. Strongly correlated movements break the connectivity of SF waters to other water molecules within the channel and prevent proton transport via a Grotthuss mechanism.	[Eriksson, Urszula Kosinska; Fischer, Gerhard; Friemann, Rosmarie; Neutze, Richard] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden; [Enkavi, Giray; Tajkhorshid, Emad] Univ Illinois, Ctr Biophys & Computat Biol, Coll Med, Dept Biochem, Urbana, IL 61802 USA; [Enkavi, Giray; Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61802 USA	University of Gothenburg; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Tajkhorshid, E (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Coll Med, Dept Biochem, Urbana, IL 61802 USA.	emad@life.illinois.edu; richard.neutze@chem.gu.se	Tajkhorshid, Emad/AAN-8323-2021; Neutze, Richard/A-7573-2010; Friemann, Rosmarie/C-1018-2008; Fischer, Gerhard/B-2900-2011	Neutze, Richard/0000-0003-0986-6153; Friemann, Rosmarie/0000-0002-5633-2894; Fischer, Gerhard/0000-0001-9861-1528; Tajkhorshid, Emad/0000-0001-8434-1010	European Union Integrated Project EDICT; Marie Curie Training Network Aqua(glycero)porins; Olle Engkvist Foundation; Swedish Research Council; NIH [R01-GM086749, U54-GM087519, P41-GM104601]; NSF supercomputing centers [MCA06N060]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519, R01GM086749, P41GM104601] Funding Source: NIH RePORTER	European Union Integrated Project EDICT; Marie Curie Training Network Aqua(glycero)porins; Olle Engkvist Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF supercomputing centers(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support is acknowledged from the European Union Integrated Project EDICT and the Marie Curie Training Network Aqua(glycero)porins, the Olle Engkvist Foundation, the Swedish Research Council, and NIH (grants R01-GM086749, U54-GM087519, and P41-GM104601). All simulations were performed using XSEDE resources at NSF supercomputing centers (grant MCA06N060). We thank staff of beamline ID29 of the ESRF for assistance during data collection and Karin Rodstrom for setting up crystallization plates at the ESRF in advance of data collection. The authors have made the following contributions: G. F., U. K. E., and R.N. conceived and designed the experiments; G. F. and U. K. E. performed the experiments; G. F., R. F., and U. K. E. analyzed the crystallographic data; G. E. and E. T. conceived and designed the MD simulations; and G. E. performed and analyzed the simulations. All authors contributed to writing the manuscript. Coordinates and structure factors have been deposited in the Protein Data Bank with accession number 3zoj.	Burykin A, 2003, BIOPHYS J, V85, P3696, DOI 10.1016/S0006-3495(03)74786-9; Chakrabarti N, 2004, STRUCTURE, V12, P65, DOI 10.1016/j.str.2003.11.017; de Groot BL, 2005, CURR OPIN STRUC BIOL, V15, P176, DOI 10.1016/j.sbi.2005.02.003; de Groot BL, 2003, J MOL BIOL, V333, P279, DOI 10.1016/j.jmb.2003.08.003; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; de Grotthuss CJT, 2006, BBA-BIOENERGETICS, V1757, P871, DOI 10.1016/j.bbabio.2006.07.004; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105; Jensen MO, 2003, BIOPHYS J, V85, P2884, DOI 10.1016/S0006-3495(03)74711-0; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Lee JK, 2005, P NATL ACAD SCI USA, V102, P18932, DOI 10.1073/pnas.0509469102; Li H, 2011, J MOL BIOL, V407, P607, DOI 10.1016/j.jmb.2011.01.036; Marx D, 2006, CHEMPHYSCHEM, V7, P1848, DOI 10.1002/cphc.200600128; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Newby ZER, 2008, NAT STRUCT MOL BIOL, V15, P619, DOI 10.1038/nsmb.1431; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Wang Y, 2005, STRUCTURE, V13, P1107, DOI 10.1016/j.str.2005.05.005; Wree D, 2011, FEBS J, V278, P740, DOI 10.1111/j.1742-4658.2010.07993.x; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	26	142	144	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1346	1349		10.1126/science.1234306	http://dx.doi.org/10.1126/science.1234306			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23766328	Green Accepted			2022-12-01	WOS:000320320200049
J	Spence, D				Spence, Des			Bad medicine: epilepsy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; SUDDEN UNEXPECTED DEATH; LAMOTRIGINE; TOPIRAMATE; SANAD					destwo@yahoo.co.uk						[Anonymous], 2012, TELEGRAPH; Beghi E, 2003, EPILEPSY RES, V57, P1, DOI 10.1016/j.eplepsyres.2003.09.007; Cohen SA, 2012, J PAEDIATR CHILD H, V48, P490, DOI 10.1111/j.1440-1754.2011.02223.x; Department of Justice, 2004, WARN LAMB PAY 430 MI; Health and Social Care Information Centre, 2013, PRESCR COST AN ENGL; Hixson JD, 2010, CURR TREAT OPTION NE, V12, P434, DOI 10.1007/s11940-010-0083-8; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; Meeraus WH, 2013, ARCH DIS CHILD, V98, P195, DOI 10.1136/archdischild-2012-302237; National Institute for Health and Care Excellence, 2012, NICE CLIN GUID; Ryvlin P, 2011, LANCET NEUROL, V10, P961, DOI 10.1016/S1474-4422(11)70193-4; Scottish Intercollegiate Guideline Network Guidelines, 2005, SCOTT INT GUID NETW; Tomson T, 2008, LANCET NEUROL, V7, P1021, DOI 10.1016/S1474-4422(08)70202-3; US Department of Justice Office of Public Affairs, 2011, US SUBS BELG PHARM M; US Department of Justice Office of Public Affairs, 2010, 2 JOHNS JOHNS SUBS P; Wilson D., 2010, NY TIMES	16	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2013	346								f3396	10.1136/bmj.f3396	http://dx.doi.org/10.1136/bmj.f3396			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158CZ	23714678				2022-12-01	WOS:000319947500015
J	Fritsch, R; de Krijger, I; Fritsch, K; George, R; Reason, B; Kumar, MS; Diefenbacher, M; Stamp, G; Downward, J				Fritsch, Ralph; de Krijger, Inge; Fritsch, Kornelia; George, Roger; Reason, Beth; Kumar, Madhu S.; Diefenbacher, Markus; Stamp, Gordon; Downward, Julian			RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms	CELL			English	Article							G-BETA-GAMMA; P110-BETA ISOFORM; BINDING DOMAIN; ACTIVATION; KINASE; ROLES; TRANSFORMATION; P110-GAMMA; P110-ALPHA; MUTATIONS	RAS proteins are important direct activators of p110 alpha, p110 gamma, and p110 delta type I phosphoinositide 3-kinases (PI3Ks), interacting via an amino-terminal RAS-binding domain (RBD). Here, we investigate the regulation of the ubiquitous p110 beta isoform of PI3K, implicated in G-protein-coupled receptor (GPCR) signaling, PTEN-loss-driven cancers, and thrombocyte function. Unexpectedly, RAS is unable to interact with p110 beta, but instead RAC1 and CDC42 from the RHO subfamily of small GTPases bind and activate p110 beta via its RBD. In fibroblasts, GPCRs couple to PI3K through Dock180/Elmo1-mediated RAC activation and subsequent interaction with p110 beta. Cells from mice carrying mutations in the p110b RBD show reduced PI3K activity and defective chemotaxis, and these mice are resistant to experimental lung fibrosis. These findings revise our understanding of the regulation of type I PI3K by showing that both RAS and RHO family GTPases directly regulate distinct ubiquitous PI3K isoforms and that RAC activates p110 beta downstream of GPCRs.	[Fritsch, Ralph; de Krijger, Inge; Reason, Beth; Kumar, Madhu S.; Downward, Julian] Canc Res UK London Res Inst, Signal Transduct Lab, London WC2A 3LY, England; [Fritsch, Kornelia; Stamp, Gordon] Canc Res UK London Res Inst, Expt Histopathol Lab, London WC2A 3LY, England; [George, Roger] Canc Res UK London Res Inst, Prot Purificat Facil, London WC2A 3LY, England; [Diefenbacher, Markus] Canc Res UK London Res Inst, Mammalian Genet Lab, London WC2A 3LY, England; [Downward, Julian] Inst Canc Res, Div Canc Biol, Lung Canc Grp, London SW3 6JB, England	Cancer Research UK; Cancer Research UK; Cancer Research UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University College London	Downward, J (corresponding author), Canc Res UK London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	julian.downward@cancer.org.uk	Fritsch, Ralph/Q-8836-2019; Diefenbacher, Markus Elmar/AAY-8650-2021	Diefenbacher, Markus Elmar/0000-0002-7402-7949; Downward, Julian/0000-0002-2331-4729; Fritsch, Ralph/0000-0001-9639-3213	Worldwide Cancer Research [13-0142] Funding Source: Medline; Cancer Research UK [15680] Funding Source: researchfish	Worldwide Cancer Research; Cancer Research UK(Cancer Research UK)		Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kulkarni S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001617; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Martin V, 2010, BLOOD, V115, P2008, DOI 10.1182/blood-2009-04-217224; Orme MH, 2006, NAT CELL BIOL, V8, P1298, DOI 10.1038/ncb1493; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Patel M, 2011, J BIOL CHEM, V286, P38969, DOI 10.1074/jbc.M111.274191; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Schulte A, 2008, STRUCTURE, V16, P1313, DOI 10.1016/j.str.2008.06.008; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Yan JS, 2012, DEV CELL, V22, P92, DOI 10.1016/j.devcel.2011.11.007; Yang HW, 2012, MOL CELL, V47, P281, DOI 10.1016/j.molcel.2012.05.007; Yart A, 2002, BBA-MOL CELL BIOL L, V1582, P107, DOI 10.1016/S1388-1981(02)00144-0; Zhang XX, 2011, MOL CELL, V41, P567, DOI 10.1016/j.molcel.2011.01.026; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	40	186	193	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					1050	1063		10.1016/j.cell.2013.04.031	http://dx.doi.org/10.1016/j.cell.2013.04.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706742	Green Published, hybrid			2022-12-01	WOS:000319456800013
J	Qian, MX; Pang, Y; Liu, CH; Haratake, K; Du, BY; Ji, DY; Wang, GF; Zhu, QQ; Song, W; Yu, YD; Zhang, XX; Huang, HT; Miao, SY; Chen, LB; Zhang, ZH; Liang, YN; Liu, S; Cha, HH; Yang, D; Zhai, YG; Komatsu, T; Tsuruta, F; Li, HT; Cao, C; Li, W; Li, GH; Cheng, YF; Chiba, T; Wang, LF; Goldberg, AL; Shen, Y; Qiu, XB				Qian, Min-Xian; Pang, Ye; Liu, Cui Hua; Haratake, Kousuke; Du, Bo-Yu; Ji, Dan-Yang; Wang, Guang-Fei; Zhu, Qian-Qian; Song, Wei; Yu, Yadong; Zhang, Xiao-Xu; Huang, Hai-Tao; Miao, Shiying; Chen, Lian-Bin; Zhang, Zi-Hui; Liang, Ya-Nan; Liu, Shan; Cha, Hwangho; Yang, Dong; Zhai, Yonggong; Komatsu, Takuo; Tsuruta, Fuminori; Li, Haitao; Cao, Cheng; Li, Wei; Li, Guo-Hong; Cheng, Yifan; Chiba, Tomoki; Wang, Linfang; Goldberg, Alfred L.; Shen, Yan; Qiu, Xiao-Bo			Acetylation-Mediated Proteasomal Degradation of Core Histones during DNA Repair and Spermatogenesis	CELL			English	Article							DOUBLE-STRAND BREAKS; ACTIVATOR PA200; SACCHAROMYCES-CEREVISIAE; CHROMATIN; PROTEINS; TURNOVER; BINDING; YEAST; UBIQUITYLATION; RECOGNITION	Histone acetylation plays critical roles in chromatin remodeling, DNA repair, and epigenetic regulation of gene expression, but the underlying mechanisms are unclear. Proteasomes usually catalyze ATP- and polyubiquitin-dependent proteolysis. Here, we show that the proteasomes containing the activator PA200 catalyze the polyubiquitin-independent degradation of histones. Most proteasomes in mammalian testes ("spermatoproteasomes'') contain a spermatid/sperm-specific alpha subunit alpha 4 s/PSMA8 and/or the catalytic beta subunits of immuno-proteasomes in addition to PA200. Deletion of PA200 in mice abolishes acetylation-dependent degradation of somatic core histones during DNA double-strand breaks and delays core histone disappearance in elongated spermatids. Purified PA200 greatly promotes ATP-independent proteasomal degradation of the acetylated core histones, but not polyubiquitinated proteins. Furthermore, acetylation on histones is required for their binding to the bromodomain-like regions in PA200 and its yeast ortholog, Blm10. Thus, PA200/Blm10 specifically targets the core histones for acetylation-mediated degradation by proteasomes, providing mechanisms by which acetylation regulates histone degradation, DNA repair, and spermatogenesis.	[Qian, Min-Xian; Pang, Ye; Liu, Cui Hua; Ji, Dan-Yang; Wang, Guang-Fei; Zhu, Qian-Qian; Zhang, Xiao-Xu; Chen, Lian-Bin; Zhang, Zi-Hui; Liang, Ya-Nan; Liu, Shan; Cha, Hwangho; Yang, Dong; Zhai, Yonggong; Qiu, Xiao-Bo] Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China; [Qian, Min-Xian; Pang, Ye; Liu, Cui Hua; Ji, Dan-Yang; Wang, Guang-Fei; Zhu, Qian-Qian; Zhang, Xiao-Xu; Chen, Lian-Bin; Zhang, Zi-Hui; Liang, Ya-Nan; Liu, Shan; Cha, Hwangho; Yang, Dong; Zhai, Yonggong; Qiu, Xiao-Bo] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Liu, Cui Hua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Li, Wei] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China; [Li, Guo-Hong] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Haratake, Kousuke; Komatsu, Takuo; Tsuruta, Fuminori; Chiba, Tomoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Du, Bo-Yu; Song, Wei; Huang, Hai-Tao; Miao, Shiying; Wang, Linfang; Shen, Yan; Qiu, Xiao-Bo] Peking Union Med Coll, Sch Basic Med, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Du, Bo-Yu; Song, Wei; Huang, Hai-Tao; Miao, Shiying; Wang, Linfang; Shen, Yan; Qiu, Xiao-Bo] Chinese Acad Med Sci, Beijing 100005, Peoples R China; [Yu, Yadong; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Li, Haitao] Tsinghua Univ, Sch Life Sci, Ctr Struct Biol, Beijing 100084, Peoples R China; [Li, Haitao] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Cao, Cheng] Beijing Inst Biotechnol, Beijing 100850, Peoples R China; [Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Beijing Normal University; Beijing Normal University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Tsukuba; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; University of California System; University of California San Francisco; Tsinghua University; Tsinghua University; Harvard University; Harvard Medical School	Qiu, XB (corresponding author), Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, 19 Xinjiekouwai Ave, Beijing 100875, Peoples R China.	xqiu@bnu.edu.cn	Li, Haitao/B-2668-2012; Cao, Cheng/GNP-6156-2022	Li, Haitao/0000-0001-6741-293X; Qiu, Xiao-Bo/0000-0003-2608-9376; Cheng, Yifan/0000-0001-9535-0369; Qian, Minxian/0000-0002-1763-2325	Ministry of Science and Technology of China [2012CB910300]; National Natural Science Foundation of China [30525033, 30730024]; Fundamental Research Funds for the Central Universities of China; National Basic Research Program of China [2012CB518700]; MEX, Japan; NIGMS [5R01 GM51923]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Basic Research Program of China(National Basic Research Program of China); MEX, Japan; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Finley for critical comments on the manuscript, Y. Cong, D. Finley, and O.J. Rando for reagents, T. Walz for providing the original EM images of Blm10 and PA28, H. Matsumoto and C. Xiong for technical assistance, as well as O. Gozani, D. Patel, H. Wang, and Z. Wang for assistance in the acetyl-peptide binding assay. T.C. thanks K. Tanaka for support and encouragement. This work was supported by grants from the Ministry of Science and Technology of China (2012CB910300); the National Natural Science Foundation of China (30525033 and 30730024); and the Fundamental Research Funds for the Central Universities of China to X.-B.Q.; a National Basic Research Program of China (2012CB518700) to C.H.L.; grants-in-aid for Scientific Research on Priority Areas, MEX, Japan to T.C.; and a grant from NIGMS (5R01 GM51923) to A.L. G.X.-B.Q. conceived the project. M.-X.Q., C.H.L., D.-Y.J., G.-F.W., and X.-B.Q. contributed to protein purification, characterization of proteasomal subunits and activities, and the studies on mutant mouse materials and yeast mutants. Y.P., M.-X.Q., X.-X.Z., H.C., D.Y., H.L., and X.-B.Q. performed acetylation-related studies. B.-Y.D., W.S., Z.-H.Z., H.-T.H., S.M., and L.W. contributed to purification and characterization of proteasomal subunits. K.H., T.K., F.T., and T.C. constructed PA200-deficient mice. Y.Y. and Y.C. conducted electron microscopic studies. Q.-Q.Z., L.-B.C., Y.-N.L., S.L., Y.Z., W.L., G.-H. L., and C.C. contributed to plasmid construction, antibody production, animal handling, or immunohistochemical studies. A.L.G., Y.S., and X.-B.Q. wrote the manuscript.	Blickwedehl J, 2008, P NATL ACAD SCI USA, V105, P16165, DOI 10.1073/pnas.0803145105; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Chen YS, 2012, J GENET GENOMICS, V39, P575, DOI 10.1016/j.jgg.2012.09.001; Dange T, 2011, J BIOL CHEM, V286, P42830, DOI 10.1074/jbc.M111.300178; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gaucher J, 2010, FEBS J, V277, P599, DOI 10.1111/j.1742-4658.2009.07504.x; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Liu ZQ, 2007, DEV DYNAM, V236, P2889, DOI 10.1002/dvdy.21302; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; Mateo F, 2009, ONCOGENE, V28, P2654, DOI 10.1038/onc.2009.127; MILLS NC, 1977, BIOL REPROD, V17, P760, DOI 10.1095/biolreprod17.5.760; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Ortega J, 2005, J MOL BIOL, V346, P1221, DOI 10.1016/j.jmb.2004.12.049; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Shabason JE, 2011, J CELL MOL MED, V15, P2735, DOI 10.1111/j.1582-4934.2011.01296.x; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Toulmay A, 2006, YEAST, V23, P825, DOI 10.1002/yea.1397; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Ustrell V, 2005, METHOD ENZYMOL, V398, P321, DOI 10.1016/S0076-6879(05)98026-9; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008; Zhu B, 2011, CELL RES, V21, P435, DOI 10.1038/cr.2011.26	46	197	223	5	116	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1012	1024		10.1016/j.cell.2013.04.032	http://dx.doi.org/10.1016/j.cell.2013.04.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706739	Bronze, Green Accepted			2022-12-01	WOS:000319456800010
J	Fazel, S; Wolf, A; Langstrom, N; Newton, CR; Lichtenstein, P				Fazel, Seena; Wolf, Achim; Langstrom, Niklas; Newton, Charles R.; Lichtenstein, Paul			Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study	LANCET			English	Article							SUDDEN UNEXPECTED DEATH; BIPOLAR DISORDER; SUICIDE; CLASSIFICATION; SCHIZOPHRENIA; TERMINOLOGY; DIAGNOSES; VALIDITY; ILLNESS; RISK	Background Epilepsy is associated with high rates of premature mortality, but the contribution of psychiatric comorbidity is uncertain. We assessed the prevalence and risks of premature mortality from external causes such as suicide, accidents, and assaults in people with epilepsy with and without psychiatric comorbidity. Methods We studied all individuals born in Sweden between 1954 and 2009 with inpatient and outpatient diagnoses of epilepsy (n=69 995) for risks and causes of premature mortality. Patients were compared with age-matched and sex-matched general population controls (n=660 869) and unaffected siblings (n=81 396). Sensitivity analyses were done to investigate whether these odds differed by sex, age, seizure types, comorbid psychiatric diagnosis, and different time periods after epilepsy diagnosis. Findings 6155 (8.8%) people with epilepsy died during follow-up, at a median age of 34.5 (IQR 21.0-44.0) years with substantially elevated odds of premature mortality (adjusted odds ratio [aOR] of 11.1 [95% CI 10.6-11.6] compared with general population controls, and 11.4 [10.4-12.5] compared with unaffected siblings). Of those deaths, 15.8% (n=972) were from external causes, with high odds for non-vehicle accidents (aOR 5.5, 95 % CI 4.7-6.5) and suicide (3.7, 3.3-4.2). Of those who died from external causes, 75.2% had comorbid psychiatric disorders, with strong associations in individuals with co-occurring depression (13.0, 10.3-16.6) and substance misuse (22.4, 18.3-27.3), compared with patients with no epilepsy and no psychiatric comorbidity. Interpretation Reducing premature mortality from external causes of death should be a priority in epilepsy management. Psychiatric comorbidity plays an important part in the premature mortality seen in epilepsy. The ability of health services and public health measures to prevent such deaths requires review.	[Fazel, Seena; Wolf, Achim; Newton, Charles R.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Langstrom, Niklas; Lichtenstein, Paul] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of Oxford; Karolinska Institutet	Fazel, S (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Warneford Lane, Oxford OX3 7JX, England.	seena.fazel@psych.ox.ac.uk	Newton, Charles RJC/B-7578-2014; Newton, Charles/V-7872-2019; Fazel, Seena/B-5307-2008; Langstrom, Niklas/C-5615-2009	Newton, Charles RJC/0000-0002-6999-5507; Newton, Charles/0000-0002-6999-5507; Fazel, Seena/0000-0002-5383-5365; Langstrom, Niklas/0000-0002-2686-6799; lichtenstein, paul/0000-0003-3037-5287	Wellcome Trust; Swedish Prison and Probation Service; Swedish Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Prison and Probation Service; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Wellcome Trust, the Swedish Prison and Probation Service, and the Swedish Research Council.	Bell GS, 2009, EPILEPSIA, V50, P1933, DOI 10.1111/j.1528-1167.2009.02106.x; Bell GS, 2009, CURR OPIN NEUROL, V22, P174, DOI 10.1097/WCO.0b013e328328f8c3; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Christensen J, 2007, LANCET NEUROL, V6, P693, DOI 10.1016/S1474-4422(07)70175-8; Christensen J, 2012, EPILEPSIA, V53, P14, DOI 10.1111/j.1528-1167.2012.03553.x; COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5; Department of Health, 2012, PREV SUIC ENGL CROSS; Ekholm B, 2005, NORD J PSYCHIAT, V59, P457, DOI 10.1080/08039480500360906; Eurostat, DEATH DUE SUIC SEX S; Faingold CL, 2011, EPILEPSY BEHAV, V22, P186, DOI 10.1016/j.yebeh.2011.06.015; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Fazel S, 2010, ARCH GEN PSYCHIAT, V67, P931, DOI 10.1001/archgenpsychiatry.2010.97; Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675; Gaitatzis A, 2004, ACTA NEUROL SCAND, V110, P207, DOI 10.1111/j.1600-0404.2004.00324.x; Hjern A, 2002, LANCET, V360, P443, DOI 10.1016/S0140-6736(02)09674-5; JIANG GX, 1995, ACTA NEUROL SCAND, V91, P109; Klein-Geltink JE, 2007, J CLIN EPIDEMIOL, V60, P766, DOI 10.1016/j.jclinepi.2006.11.008; Kondziella D, 2009, ACTA NEUROL SCAND, V119, P75, DOI 10.1111/j.1600-0404.2008.01088.x; Kwon C, 2011, NEUROLOGY, V76, P801, DOI 10.1212/WNL.0b013e31820e7b3b; Lhatoo SD, 2005, EPILEPSIA, V46, P36, DOI 10.1111/j.1528-1167.2005.00406.x; LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Board of Health and Welfare, 2009, CAUS DEATH REG; National Board of Health and Welfare, 1993, EXP REP EP PREV MAN; Neeleman J, 1997, PSYCHOL MED, V27, P467, DOI 10.1017/S0033291796004631; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Nilsson L, 1997, EPILEPSIA, V38, P1062, DOI 10.1111/j.1528-1157.1997.tb01194.x; Rai D, 2012, EPILEPSIA, V53, P1095, DOI 10.1111/j.1528-1167.2012.03500.x; Rockett IRH, 1999, SUICIDE LIFE-THREAT, V29, P141; Runeson B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3222; Sander JW, 2004, J NEUROL NEUROSUR PS, V75, P349, DOI 10.1136/jnnp.2003.029223; Sellgren C, 2011, ACTA PSYCHIAT SCAND, V124, P447, DOI 10.1111/j.1600-0447.2011.01747.x; Shorvon S, 2011, LANCET, V378, P2028, DOI 10.1016/S0140-6736(11)60176-1; Statistics Sweden, 2005, FLERG 2004 BESKR INN; Swedish National Board of Health and Welfare, PAT REG; Tellez-Zenteno JF, 2005, EPILEPSY RES, V65, P101, DOI 10.1016/j.eplepsyres.2005.05.004; Tellez-Zenteno JF, 2007, EPILEPSIA, V48, P2336; US Department of Health and Human Services (HHS) Office of the Surgeon General and National Action Alliance for Suicide Prevention, 2012, NAT STRAT SUIC PREV; van den Broek M, 2004, EPILEPSIA, V45, P667, DOI 10.1111/j.0013-9580.2004.33903.x; WHO, 2000, PREV SUIC RES PRIM H	42	211	215	0	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1646	1654		10.1016/S0140-6736(13)60899-5	http://dx.doi.org/10.1016/S0140-6736(13)60899-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254CN	23883699	Green Published			2022-12-01	WOS:000327140700023
J	Lister, R; Mukamel, EA; Nery, JR; Urich, M; Puddifoot, CA; Johnson, ND; Lucero, J; Huang, Y; Dwork, AJ; Schultz, MD; Yu, M; Tonti-Filippini, J; Heyn, H; Hu, SJ; Wu, JC; Rao, A; Esteller, M; He, C; Haghighi, FG; Sejnowski, TJ; Behrens, MM; Ecker, JR				Lister, Ryan; Mukamel, Eran A.; Nery, Joseph R.; Urich, Mark; Puddifoot, Clare A.; Johnson, Nicholas D.; Lucero, Jacinta; Huang, Yun; Dwork, Andrew J.; Schultz, Matthew D.; Yu, Miao; Tonti-Filippini, Julian; Heyn, Holger; Hu, Shijun; Wu, Joseph C.; Rao, Anjana; Esteller, Manel; He, Chuan; Haghighi, Fatemeh G.; Sejnowski, Terrence J.; Behrens, M. Margarita; Ecker, Joseph R.			Global Epigenomic Reconfiguration During Mammalian Brain Development	SCIENCE			English	Article							HUMAN PREFRONTAL CORTEX; HUMAN CEREBRAL-CORTEX; EMBRYONIC STEM-CELLS; DNA METHYLATION; ACCESSIBLE CHROMATIN; DEOXYRIBONUCLEIC-ACID; TRANSCRIPTION FACTOR; SYNAPTIC PLASTICITY; MEMORY FORMATION; NERVOUS-SYSTEM	DNA methylation is implicated in mammalian brain development and plasticity underlying learning and memory. We report the genome-wide composition, patterning, cell specificity, and dynamics of DNA methylation at single-base resolution in human and mouse frontal cortex throughout their lifespan. Widespread methylome reconfiguration occurs during fetal to young adult development, coincident with synaptogenesis. During this period, highly conserved non-CG methylation (mCH) accumulates in neurons, but not glia, to become the dominant form of methylation in the human neuronal genome. Moreover, we found an mCH signature that identifies genes escaping X-chromosome inactivation. Last, whole-genome single-base resolution 5-hydroxymethylcytosine (hmC) maps revealed that hmC marks fetal brain cell genomes at putative regulatory regions that are CG-demethylated and activated in the adult brain and that CG demethylation at these hmC-poised loci depends on Tet2 activity.	[Lister, Ryan; Nery, Joseph R.; Urich, Mark; Schultz, Matthew D.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Lister, Ryan; Tonti-Filippini, Julian] Univ Western Australia, Sch Chem & Biochem, Plant Energy Biol Australian Res Council Ctr Exce, Perth, WA 6009, Australia; [Lister, Ryan; Tonti-Filippini, Julian] Univ Western Australia, Sch Chem & Biochem, Computat Syst Biol Western Australia CoE, Perth, WA 6009, Australia; [Mukamel, Eran A.; Puddifoot, Clare A.; Johnson, Nicholas D.; Lucero, Jacinta; Sejnowski, Terrence J.; Behrens, M. Margarita] Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; [Huang, Yun; Rao, Anjana] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Huang, Yun; Rao, Anjana] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA; [Dwork, Andrew J.; Haghighi, Fatemeh G.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Dwork, Andrew J.; Haghighi, Fatemeh G.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Dwork, Andrew J.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Schultz, Matthew D.] Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; [Yu, Miao; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Yu, Miao; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Heyn, Holger; Esteller, Manel] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Canc Epigenet Grp, Barcelona 08907, Spain; [Hu, Shijun; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Div Cardiol, Stanford, CA 94305 USA; [Esteller, Manel] ICREA, Barcelona, Catalonia, Spain; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92037 USA; [Sejnowski, Terrence J.; Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; University of Western Australia; University of Western Australia; Salk Institute; La Jolla Institute for Immunology; Columbia University; New York State Psychiatry Institute; Columbia University; University of California System; University of California San Diego; University of Chicago; University of Chicago; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Stanford University; ICREA; University of California System; University of California San Diego; Howard Hughes Medical Institute; Salk Institute	Lister, R (corresponding author), Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ryan.lister@uwa.edu.au; mbehrens@salk.edu; ecker@salk.edu	Esteller, Manel/L-5956-2014; Behrens, M. Margarita/K-2576-2014; Sejnowski, Terrence/AAV-5558-2021; Nery, Joseph/AAE-8422-2019; Lister, Ryan/B-5168-2012; Ecker, Joseph R/B-9144-2008; Tonti-Filippini, Julian S/L-8020-2018; Hu, Shijun/I-5818-2012; Wu, Joseph/H-1067-2013	Esteller, Manel/0000-0003-4490-6093; Nery, Joseph/0000-0003-0153-5659; Lister, Ryan/0000-0001-6637-7239; Ecker, Joseph R/0000-0001-5799-5895; Tonti-Filippini, Julian S/0000-0003-3464-0770; Mukamel, Eran/0000-0003-3203-9535; Huang, Yun/0000-0001-5950-9168; Hu, Shijun/0000-0002-0068-8429; Johnson, Nicholas/0000-0003-3229-6849; Heyn, Holger/0000-0002-3276-1889; Wu, Joseph/0000-0002-6068-8041	European Commission [LSHM-CT-2004-503039]; National Institutes of Mental Health [MH094670]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GMBF3034]; NIH [HG006827, AI44432, HD065812, CA151535]; California Institute of Regenerative Medicine [RM-01729]; Leukemia and Lymphoma Society [TRP 6187-12]; Australian Research Council; Government of Western Australia; Center for Theoretical Biological Physics, University of California San Diego; NIH (National Institute of Neurological Diseases and Stroke) [K99NS080911]; NSF; ICREA Funding Source: Custom; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065812] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA151535] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094774, R01MH094670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS080911] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Australian Research Council(Australian Research Council); Government of Western Australia; Center for Theoretical Biological Physics, University of California San Diego; NIH (National Institute of Neurological Diseases and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NSF(National Science Foundation (NSF)); ICREA(ICREA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. F. Loomis for critical reading of this manuscript; J. Chambers for technical assistance with animal breeding; D. Chambers for technical assistance with cell sorting; M. Lutz and T. Berggren for provision of the HUES6 cells; F. Yue, G. Hon, and B. Ren for providing mapped mouse ChIP-Seq data and assistance with TAB-Seq; and A. Nimmerjahn for providing the S100b-eGFP mice. Human brain tissue was obtained from the National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, Maryland, the IDIBELL Biobank, which is part of the BrainNet Europe Bank funded by the European Commission (LSHM-CT-2004-503039). We thank the Stamatoyannopoulos laboratory (University of Washington) and the Mouse ENCODE Consortium for generating and providing access to the DNaseI hypersensitivity data sets (35). This work was supported by a National Institutes of Mental Health grant to M. M. B. and J. R. E. (MH094670); the Howard Hughes Medical Institute to T. J. S. and J. R. E.; the Gordon and Betty Moore Foundation (GMBF3034) to J. R. E.; NIH grant HG006827 to C. H.; NIH RO1 grants AI44432, HD065812, and CA151535; grant RM-01729 from the California Institute of Regenerative Medicine; and Translational Research grant TRP 6187-12 from the Leukemia and Lymphoma Society (to A. R.). R. L. was supported by an Australian Research Council Future Fellowship. Support was also provided by the Government of Western Australia through funding for the Western Australia CoE for Computational Systems Biology. E. A. M. was supported by the Center for Theoretical Biological Physics, University of California San Diego, and NIH (National Institute of Neurological Diseases and Stroke grant K99NS080911). W. A. P. was supported by a predoctoral graduate research fellowship from the NSF. Analyzed data sets can be accessed at http://neomorph.salk.edu/brain_methylomes. Sequence data can be downloaded from National Center for Biotechnology Information GEO (GSE47966). Tet2 mutant mice are available under a material transfer agreement from the La Jolla Institute for Allergy and Immunology. Correspondence and requests for materials should be addressed to R. L. (ryan.lister@uwa.edu.au), M. M. B. (mbehrens@salk.edu), and J.R.E. (ecker@salk.edu).	Akhtar MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034863; Auerbach RK, 2009, P NATL ACAD SCI USA, V106, P14926, DOI 10.1073/pnas.0905443106; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chugani HT, 1998, PREV MED, V27, P184, DOI 10.1006/pmed.1998.0274; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Huang Y, 2012, NAT PROTOC, V7, P1897, DOI 10.1038/nprot.2012.103; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Johnston CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040009; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Levitt P, 2003, J PEDIATR-US, V143, pS35, DOI 10.1067/S0022-3476(03)00400-1; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; PENN NW, 1972, BIOCHEM J, V126, P781, DOI 10.1042/bj1260781; PENN NW, 1976, BIOCHEM J, V155, P709, DOI 10.1042/bj1550709; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Sharp AJ, 2011, GENOME RES, V21, P1592, DOI 10.1101/gr.112680.110; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Suderman M, 2012, P NATL ACAD SCI USA, V109, P17266, DOI 10.1073/pnas.1121260109; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Uhlhaas PJ, 2011, SCHIZOPHRENIA BULL, V37, P514, DOI 10.1093/schbul/sbr034; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389; Zovkic IB, 2013, LEARN MEMORY, V20, P61, DOI 10.1101/lm.026575.112	61	1180	1200	3	237	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 9	2013	341	6146					629	+	1237905	10.1126/science.1237905	http://dx.doi.org/10.1126/science.1237905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197XC	23828890	Green Submitted, Green Accepted			2022-12-01	WOS:000322884800030
J	Sikes, JM; Newmark, PA				Sikes, James M.; Newmark, Phillip A.			Restoration of anterior regeneration in a planarian with limited regenerative ability	NATURE			English	Article							POLARITY; HEAD; SYSTEM; WOUNDS	Variability of regenerative potential among animals has long perplexed biologists(1). On the basis of their exceptional regenerative abilities, planarians have become important models for understanding the molecular basis of regeneration(2). However, planarian species with limited regenerative abilities are also found(3,4). Despite the importance of understanding the differences between closely related, regenerating and non-regenerating organisms, few studies have focused on the evolutionary loss of regeneration(5), and the molecular mechanisms leading to such regenerative loss remain obscure. Here we examine Procotyla fluviatilis, a planarian with restricted ability to replace missing tissues(6), using next-generation sequencing to define the gene expression programs active in regeneration-permissive and regeneration-deficient tissues. We found that Wnt signalling is aberrantly activated in regeneration-deficient tissues. Notably, downregulation of canonical Wnt signalling in regeneration-deficient regions restores regenerative abilities: blastemas form and new heads regenerate in tissues that normally never regenerate. This work reveals that manipulating a single signalling pathway can reverse the evolutionary loss of regenerative potential.	[Sikes, James M.; Newmark, Phillip A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA; [Sikes, James M.; Newmark, Phillip A.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Sikes, JM (corresponding author), Univ San Francisco, Dept Biol, San Francisco, CA 94117 USA.	jsikes@usfca.edu		Newmark, Phillip/0000-0003-0793-022X	National Institute of General Medicine Sciences [F32GM097921]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM097921] Funding Source: NIH RePORTER	National Institute of General Medicine Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Newmark laboratory members for comments, A. Vieira for technical assistance, A. Hernandez and the W.M. Keck Center for Comparative and Functional Genomics for sequencing assistance, and the National Forest Service, Illinois Department of Natural Resources, USA, and Montgomery County (Maryland) Department of Parks, USA, for field collection permits. We also thank A. Boney, J. Brubacher, T. Chong, M. Issigonis, H. Iyer and B. Lambrus for assistance in field collections. This work was supported by National Institute of General Medicine Sciences fellowship F32GM097921 (J.M.S.). P.A.N. is an investigator of the Howard Hughes Medical Institute.	Bely AE, 2010, INTEGR COMP BIOL, V50, P515, DOI 10.1093/icb/icq118; Bely AE, 2010, TRENDS ECOL EVOL, V25, P161, DOI 10.1016/j.tree.2009.08.005; Calow P., 1978, LIFE CYCLES EVOLUTIO; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Chong T, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-69; Collins JJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000509; Fedecka-Bruner B., 1967, Bull biol Fr Belg, V101, P255; Forsthoefel DJ, 2011, DEV BIOL, V356, P445, DOI 10.1016/j.ydbio.2011.05.669; GRASSO M, 1978, Bollettino di Zoologia, V45, P365; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Gurley KA, 2010, DEV BIOL, V347, P24, DOI 10.1016/j.ydbio.2010.08.007; Kenk R., 1972, BIOTA FRESHWATER ECO; Lillie FR, 1901, AM J PHYSIOL, V6, P129, DOI 10.1152/ajplegacy.1901.6.2.129; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; Morgan TH, 1904, BIOL BULL-US, V6, P159, DOI 10.2307/1535722; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Pellettieri J, 2010, DEV BIOL, V338, P76, DOI 10.1016/j.ydbio.2009.09.015; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2011, SCIENCE, V332, P852, DOI 10.1126/science.1202143; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; ROMERO R, 1988, FORTSCHR ZOOL, V36, P283; Rouhana L, 2012, DEVELOPMENT, V139, P1083, DOI 10.1242/dev.076182; STEPH.F, 1961, J EMBRYOL EXP MORPH, V9, P642; Tasaki J, 2011, DEVELOPMENT, V138, P2417, DOI 10.1242/dev.060764; Wenemoser D, 2012, GENE DEV, V26, P988, DOI 10.1101/gad.187377.112; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; Yazawa S, 2009, P NATL ACAD SCI USA, V106, P22329, DOI 10.1073/pnas.0907464106	31	86	90	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 1	2013	500	7460					77	U98		10.1038/nature12403	http://dx.doi.org/10.1038/nature12403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	192VK	23883929	Green Accepted			2022-12-01	WOS:000322514800031
J	Ma, L; Roman-Campos, D; Austin, ED; Eyries, M; Sampson, KS; Soubrier, F; Germain, M; Tregouet, DA; Borczuk, A; Rosenzweig, EB; Girerd, B; Montani, D; Humbert, M; Loyd, JE; Kass, RS; Chung, WK				Ma, Lijiang; Roman-Campos, Danilo; Austin, Eric D.; Eyries, Melanie; Sampson, Kevin S.; Soubrier, Florent; Germain, Marine; Tregouet, David-Alexandre; Borczuk, Alain; Rosenzweig, Erika Berman; Girerd, Barbara; Montani, David; Humbert, Marc; Loyd, James E.; Kass, Robert S.; Chung, Wendy K.			A Novel Channelopathy in Pulmonary Arterial Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; MORPHOGENETIC PROTEIN-RECEPTOR; DOMAIN POTASSIUM CHANNELS; SMOOTH-MUSCLE-CELLS; K+ CHANNEL; TASK-1; GENE; EXPRESSION; MUTATIONS; ENDOGLIN	BACKGROUND Pulmonary arterial hypertension is a devastating disease with high mortality. Familial cases of pulmonary arterial hypertension are usually characterized by autosomal dominant transmission with reduced penetrance, and some familial cases have unknown genetic causes. METHODS We studied a family in which multiple members had pulmonary arterial hypertension without identifiable mutations in any of the genes known to be associated with the disease, including BMPR2, ALK1, ENG, SMAD9, and CAV1. Three family members were studied with whole-exome sequencing. Additional patients with familial or idiopathic pulmonary arterial hypertension were screened for the mutations in the gene that was identified on whole-exome sequencing. All variants were expressed in COS-7 cells, and channel function was studied by means of patch-clamp analysis. RESULTS We identified a novel heterozygous missense variant c.608 GA (G203D) in KCNK3 (the gene encoding potassium channel subfamily K, member 3) as a disease-causing candidate gene in the family. Five additional heterozygous missense variants in KCNK3 were independently identified in 92 unrelated patients with familial pulmonary arterial hypertension and 230 patients with idiopathic pulmonary arterial hypertension. We used in silico bioinformatic tools to predict that all six novel variants would be damaging. Electrophysiological studies of the channel indicated that all these missense mutations resulted in loss of function, and the reduction in the potassium-channel current was remedied by the application of the phospholipase inhibitor ONO-RS-082. CONCLUSIONS Our study identified the association of a novel gene, KCNK3, with familial and idiopathic pulmonary arterial hypertension. Mutations in this gene produced reduced potassium-channel current, which was successfully remedied by pharmacologic manipulation. (Funded by the National Institutes of Health.)	[Ma, Lijiang; Eyries, Melanie; Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Sampson, Kevin S.; Rosenzweig, Erika Berman; Loyd, James E.] Columbia Univ, Med Ctr, Dept Pharmacol, Columbia, NY USA; [Soubrier, Florent] Columbia Univ, Med Ctr, Dept Pathol, Columbia, NY USA; [Austin, Eric D.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN USA; [Humbert, Marc] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Germain, Marine] ICAN, AP HP, Paris, France; [Tregouet, David-Alexandre] UPMC, INSERM, Paris, France; [Germain, Marine; Tregouet, David-Alexandre] UPMC UMRS 937, INSERM, ICAN, Paris, France; [Montani, David; Loyd, James E.] INSERM, APHP, Dept Hosp, DHU TORINO, Le Kremlin Bicetre, France; [Girerd, Barbara; Montani, David; Humbert, Marc] LERMIT, Le Kremlin Bicetre, France	Columbia University; Columbia University; Columbia University; Vanderbilt University; Vanderbilt University; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ma, L (corresponding author), Columbia Univ, Med Ctr, Dept Pediat, 1150 St Nicholas Ave, New York, NY 10032 USA.	wkc15@columbia.edu	BORCZUK, alain/AHA-5172-2022; Trégouët, David-Alexandre/P-9210-2019; Humbert, Marc/ABD-5112-2021; Borczuk, Alain/AFU-5278-2022; Tregouet, David-Alexandre/E-3961-2016; EYRIES, melanie/ABF-1034-2020; Campos, Danilo Roman/I-2655-2012; Humbert, Marc/AAC-8459-2019; Borczuk, Alain/AAI-8226-2021; David, Montani/I-6885-2019; Rosenzweig, Erika/AAC-3680-2019; Olschewski, Horst/L-3547-2019	Trégouët, David-Alexandre/0000-0001-9084-7800; Borczuk, Alain/0000-0001-6807-8064; Campos, Danilo Roman/0000-0002-2690-912X; Humbert, Marc/0000-0003-0703-2892; Borczuk, Alain/0000-0001-6807-8064; David, Montani/0000-0002-9358-6922; Olschewski, Horst/0000-0002-2834-7466; Rosenzweig, Erika B./0000-0003-4849-214X; Germain, Marine/0000-0002-8489-8916; Loyd, James/0000-0002-5042-7390	National Institutes of Health [R01 HL060056, P01 HL072058, K23 HL098743, R01 HL 56810]; Vanderbilt Clinical and Translational Science Awards grant from the National Center for Research Resources [UL1 RR024975]; National Heart, Lung, and Blood Institute (NHLBI) [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924]; NHLBI [RC2 HL-102925, RC2 HL-102926]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102923, P01HL072058, R01HL056810, R01HL111259, RC2HL102924, K23HL098743, R01HL060056, R01HL048164, P01HL108800, RC2HL102925, RC2HL103010, RC2HL102926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Clinical and Translational Science Awards grant from the National Center for Research Resources; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Institutes of Health.; Supported by grants (R01 HL060056, P01 HL072058, K23 HL098743, and R01 HL 56810) from the National Institutes of Health and a Vanderbilt Clinical and Translational Science Awards grant (UL1 RR024975) from the National Center for Research Resources. Funding for the Grand Opportunity Exome Sequencing Project (GO-ESP) was provided by grants (RC2 HL-103010, RC2 HL-102923, and RC2 HL-102924) from the National Heart, Lung, and Blood Institute (NHLBI). Exome sequencing was performed through grants (RC2 HL-102925 and RC2 HL-102926) from the NHLBI.	Abdalla SA, 2000, HUM MOL GENET, V9, P1227, DOI 10.1093/hmg/9.8.1227; [Anonymous], 2001, Method of treating a condition associated with phosphorylation of TASK-1: patent, Patent No. 8097650; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Gardener MJ, 2004, BRIT J PHARMACOL, V142, P192, DOI 10.1038/sj.bjp.0705691; Girerd B, 2010, AM J RESP CRIT CARE, V181, P851, DOI 10.1164/rccm.200908-1284OC; Gurney AM, 2003, CIRC RES, V93, P957, DOI 10.1161/01.RES.0000099883.68414.61; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Hartness ME, 2001, J BIOL CHEM, V276, P26499, DOI 10.1074/jbc.M010357200; HIGENBOTTAM T, 1984, LANCET, V1, P1046; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Machado RD, 2009, J AM COLL CARDIOL, V54, pS32, DOI 10.1016/j.jacc.2009.04.015; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Morecroft I, 2009, BRIT J PHARMACOL, V157, P1241, DOI 10.1111/j.1476-5381.2009.00283.x; Nasim MT, 2011, HUM MUTAT, V32, P1385, DOI 10.1002/humu.21605; Olschewski A, 2006, CIRC RES, V98, P1072, DOI 10.1161/01.RES.0000219677.12988.e9; Osipenko ON, 1997, BRIT J PHARMACOL, V120, P1461, DOI 10.1038/sj.bjp.0701075; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Remillard CV, 2007, AM J PHYSIOL-CELL PH, V292, pC1837, DOI 10.1152/ajpcell.00405.2006; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Seyler C, 2012, BRIT J PHARMACOL, V165, P1467, DOI 10.1111/j.1476-5381.2011.01626.x; Shintani M, 2009, J MED GENET, V46, P331, DOI 10.1136/jmg.2008.062703; Streit AK, 2011, J BIOL CHEM, V286, P13977, DOI 10.1074/jbc.M111.227884; Tang B, 2009, AM J RESP CELL MOL, V41, P476, DOI 10.1165/rcmb.2008-0412OC; Trapp S, 2008, J NEUROSCI, V28, P8844, DOI 10.1523/JNEUROSCI.1810-08.2008; Yu SP, 2000, P NATL ACAD SCI USA, V97, P9360, DOI 10.1073/pnas.97.17.9360; Yuan XJ, 1998, LANCET, V351, P726, DOI 10.1016/S0140-6736(05)78495-6; Yuill KH, 2007, PFLUG ARCH EUR J PHY, V455, P333, DOI 10.1007/s00424-007-0282-7; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	36	319	333	1	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 25	2013	369	4					351	361		10.1056/NEJMoa1211097	http://dx.doi.org/10.1056/NEJMoa1211097			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188VJ	23883380	Green Accepted			2022-12-01	WOS:000322223900010
J	Sandin, S; Nygren, KG; Iliadou, A; Hultman, CM; Reichenberg, A				Sandin, Sven; Nygren, Karl-Gosta; Iliadou, Anastasia; Hultman, Christina M.; Reichenberg, Abraham			Autism and Mental Retardation Among Offspring Born After In Vitro Fertilization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDREN BORN; ASSISTED CONCEPTION; SPECTRUM DISORDERS; NEUROLOGICAL SEQUELAE; COGNITIVE-DEVELOPMENT; SINGLETONS BORN; FOLLOW-UP; RISK; ICSI; INJECTION	IMPORTANCE Between 1978 and 2010, approximately 5 million infants were born after in vitro fertilization (IVF) treatments. Yet limited information on neurodevelopment after IVF exists, especially after the first year of life. OBJECTIVE To examine the association between use of any IVF and different IVF procedures and the risk of autistic disorder and mental retardation in the offspring. DESIGN, SETTING, AND PARTICIPANTS A population-based, prospective cohort study using Swedish national health registers. Offspring born between 1982 and 2007 were followed up for a clinical diagnosis of autistic disorder or mental retardation until December 31, 2009. The exposure of interest was IVF, categorized according to whether intracytoplasmic sperm injection (ICSI) for male infertility was used and whether embryos were fresh or frozen. For ICSI, whether sperm were ejaculated or surgically extracted was also considered. MAIN OUTCOMES AND MEASURES Relative risks (RRs) for autistic disorder and mental retardation and rates per 100 000 person-years, comparing spontaneously conceived offspring with those born after an IVF procedure and comparing 5 IVF procedures used in Sweden vs IVF without ICSI with fresh embryo transfer, the most common treatment. We also analyzed the subgroup restricted to singletons. RESULTS Of the more than 2.5 million infants born, 30 959 (1.2%) were conceived by IVF and were followed up for a mean 10 (SD, 6) years. Overall, 103 of 6959 children (1.5%) with autistic disorder and 180 of 15 830 (1.1%) with mental retardation were conceived by IVF. The RR for autistic disorder after any procedure compared with spontaneous conception was 1.14 (95% CI, 0.94-1.39; 19.0 vs 15.6 per 100 000 person-years). The RR for mental retardation was 1.18 (95% CI, 1.01-1.36; 46.3 vs 39.8 per 100 000 person-years). For both outcomes, there was no statistically significant association when restricting analysis to singletons. Compared with IVF without ICSI with fresh embryo transfer, there were statistically significantly increased risks of autistic disorder following ICSI using surgically extracted sperm and fresh embryos (RR, 4.60 [95% CI, 2.14-9.88]; 135.7 vs 29.3 per 100 000 person-years); for mental retardation following ICSI using surgically extracted sperm and fresh embryos (RR, 2.35 [95% CI, 1.01-5.45]; 144.1 vs 60.8 per 100 000 person-years); and following ICSI using ejaculated sperm and fresh embryos (RR, 1.47 [95% CI, 1.03-2.09]; 90.6 vs 60.8 per 100 000 person-years). When restricting the analysis to singletons, the risks of autistic disorder associated with ICSI using surgically extracted sperm were not statistically significant, but the risks associated with ICSI using frozen embryos were significant for mental retardation (with frozen embryos, RR, 2.36 [95% CI, 1.04-5.36], 118.4 vs 50.6 per 100 000 person-years]; with fresh embryos, RR, 1.60 [95% CI, 1.00-2.57], 80.0 vs 50.6 per 100 000 person-years). CONCLUSIONS AND RELEVANCE Compared with spontaneous conception, IVF treatment overall was not associated with autistic disorder but was associated with a small but statistically significantly increased risk of mental retardation. For specific procedures, IVF with ICSI for paternal infertility was associated with a small increase in the RR for autistic disorder and mental retardation compared with IVF without ICSI. The prevalence of these disorders was low, and the increase in absolute risk associated with IVF was small. JAMA. 2013;310(1):75-84.	[Sandin, Sven; Reichenberg, Abraham] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London SE5 8AF, England; [Sandin, Sven; Nygren, Karl-Gosta; Iliadou, Anastasia; Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Reichenberg, Abraham] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Reichenberg, Abraham] Mt Sinai Sch Med, Dept Prevent Med, New York, NY USA	University of London; King's College London; Karolinska Institutet; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Sandin, S (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychosis Studies, De Crespigny Pk, London SE5 8AF, England.	sven.sandin@kcl.ac.uk	Sandin, Sven/L-5357-2015; Sandin, Sven/ABE-2959-2021; Reichenberg, Abraham/GQB-1227-2022	Sandin, Sven/0000-0001-6994-4884; Sandin, Sven/0000-0001-6994-4884; 	Autism Speaks; Swedish Research Council; EU [259 679]	Autism Speaks; Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission)	This study was funded by Autism Speaks and the Swedish Research Council. Dr Iliadou was supported by grant 259 679 from the EU-FP7 HEALTH.	Allen C, 2005, BJOG-INT J OBSTET GY, V112, P1589, DOI 10.1111/j.1471-0528.2005.00784.x; [Anonymous], 2012, HUM FERTIL, V15, P62, DOI 10.3109/14647273.2012.663571; Axelsson O, 2003, ACTA OBSTET GYN SCAN, V82, P491, DOI 10.1034/j.1600-0412.2003.00172.x; Benedetti A, 2004, STAT MED, V23, P3781, DOI 10.1002/sim.2073; Bonduelle M, 1998, LANCET, V351, P1553, DOI 10.1016/S0140-6736(98)24021-9; Carson C, 2010, HUM REPROD, V25, P244, DOI 10.1093/humrep/dep344; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.1093/biomet/26.4.404; Dada R, 2012, J ASSIST REPROD GEN, V29, P213, DOI 10.1007/s10815-012-9715-0; De Rycke M, 2002, HUM REPROD, V17, P2487, DOI 10.1093/humrep/17.10.2487; Ekbom A, 2011, METHODS MOL BIOL, V675, P215, DOI 10.1007/978-1-59745-423-0_10; Ekholm B, 2005, NORD J PSYCHIAT, V59, P457, DOI 10.1080/08039480500360906; Eroglu A, 2012, SEMIN REPROD MED, V30, P92, DOI 10.1055/s-0032-1307417; FITZMAURICE GM, 2004, APPL LONGITUDINAL AN, P291; FUNDERBURK SJ, 1983, J AUTISM DEV DISORD, V13, P325, DOI 10.1007/BF01531570; Grether JK, 2009, AM J EPIDEMIOL, V170, P1118, DOI 10.1093/aje/kwp247; Hastie T., 2011, ELEMENTS STAT LEARNI, V2, DOI DOI 10.1007/978-0-387-84858-7; Hollander E, 2010, TXB AUTISM SPECTRUM; HOLM S, 1979, SCAND J STAT, V6, P65; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Hvidtjorn D, 2011, J EPIDEMIOL COMMUN H, V65, P497, DOI 10.1136/jech.2009.093823; Hvidtjorn D, 2009, ARCH PEDIAT ADOL MED, V163, P72, DOI 10.1001/archpediatrics.2008.507; Knoester M, 2008, FERTIL STERIL, V90, P289, DOI 10.1016/j.fertnstert.2007.06.090; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Leslie GI, 2003, HUM REPROD, V18, P2067, DOI 10.1093/humrep/deg408; Leunens L, 2008, HUM REPROD, V23, P105, DOI 10.1093/humrep/dem257; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lyall K, 2012, PAEDIATR PERINAT EP, V26, P361, DOI 10.1111/j.1365-3016.2012.01294.x; Maimburg RD, 2007, HUM REPROD, V22, P1841, DOI 10.1093/humrep/dem082; Mann MRW, 1999, HUM MOL GENET, V8, P1867, DOI 10.1093/hmg/8.10.1867; Mash EJ, 2002, CHILD PSYCHOPATHOLOG; Middelburg KJ, 2008, HUM REPROD UPDATE, V14, P219, DOI 10.1093/humupd/dmn005; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Paoloni-Giacobino Ariane, 2004, Reprod Health, V1, P6, DOI 10.1186/1742-4755-1-6; Pinborg A, 2004, BMJ-BRIT MED J, V329, P311, DOI 10.1136/bmj.38156.715694.3A; Ponjaert-Kristoffersen I, 2005, PEDIATRICS, V115, pE283, DOI 10.1542/peds.2004-1445; Practice Comm Amer Soc Reprod Med, 2004, FERTIL STERIL, V82, pS151, DOI 10.1016/j.fertnstert.2004.05.037; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Sandin S, 2012, J AM ACAD CHILD ADOL, V51, pe1; Sandin S, 2012, J AM ACAD CHILD PSY, V51, P477, DOI 10.1016/j.jaac.2012.02.018; Sazonova A, 2011, HUM REPROD, V26, P2878, DOI 10.1093/humrep/der241; Schanen NC, 2006, HUM MOL GENET, V15, pR138, DOI 10.1093/hmg/ddl213; Sellgren C, 2011, ACTA PSYCHIAT SCAND, V124, P447, DOI 10.1111/j.1600-0447.2011.01747.x; Stromberg B, 2002, LANCET, V359, P461, DOI 10.1016/S0140-6736(02)07674-2; Whitehead J., 1980, Applied Statistics, V29, P268, DOI 10.2307/2346901; Zachor DA, 2011, RES DEV DISABIL, V32, P2950, DOI 10.1016/j.ridd.2011.05.007	45	127	143	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					75	84		10.1001/jama.2013.7222	http://dx.doi.org/10.1001/jama.2013.7222			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175SK	23821091	Bronze			2022-12-01	WOS:000321253000025
J	Bright, AT; Winzeler, EA				Bright, A. Taylor; Winzeler, Elizabeth A.			EPIDEMIOLOGY Resistance mapping in malaria	NATURE			English	Editorial Material							ZINC-FINGER NUCLEASES; PLASMODIUM-FALCIPARUM; SPREAD; POPULATIONS; CAMBODIA		[Bright, A. Taylor; Winzeler, Elizabeth A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Bright, AT (corresponding author), Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.	ewinzeler@ucsd.edu	Winzeler, Elizabeth/AAP-6752-2020	Winzeler, Elizabeth/0000-0002-4049-2113				Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mita T, 2011, J INFECT DIS, V204, P1980, DOI 10.1093/infdis/jir664; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; WHO, 2012, WORLD MALARIA REPORT 2012, P1	12	10	10	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					446	447		10.1038/498446b	http://dx.doi.org/10.1038/498446b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171LH	23803843				2022-12-01	WOS:000320929400043
J	Katsnelson, A				Katsnelson, Alla			DRUG DEVELOPMENT Target practice	NATURE			English	Editorial Material																		Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Deshpande AJ, 2013, BLOOD, V121, P2533, DOI 10.1182/blood-2012-11-465120; Estey EH, 2003, BLOOD, V102, P442, DOI 10.1182/blood-2002-09-2937; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Tyner JW, 2013, CANCER RES, V73, P285, DOI 10.1158/0008-5472.CAN-12-1906	5	5	6	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					S8	S9		10.1038/498S8a	http://dx.doi.org/10.1038/498S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803950	Bronze			2022-12-01	WOS:000320929400005
J	Jacobs, BL; Zhang, Y; Schroeck, FR; Skolarus, TA; Wei, JT; Montie, JE; Gilbert, SM; Strope, SA; Dunn, RL; Miller, DC; Hollenbeck, BK				Jacobs, Bruce L.; Zhang, Yun; Schroeck, Florian R.; Skolarus, Ted A.; Wei, John T.; Montie, James E.; Gilbert, Scott M.; Strope, Seth A.; Dunn, Rodney L.; Miller, David C.; Hollenbeck, Brent K.			Use of Advanced Treatment Technologies Among Men at Low Risk of Dying From Prostate Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MODULATED RADIATION-THERAPY; RADICAL PROSTATECTOMY; LIFE EXPECTANCY; HEALTH; CLINICIAN; OUTCOMES; ILLNESS; INDEX	Importance The use of advanced treatment technologies (ie, intensity-modulated radiotherapy [IMRT] and robotic prostatectomy) for prostate cancer is increasing. The extent to which these advanced treatment technologies have disseminated among patients at low risk of dying from prostate cancer is uncertain. Objective To assess the use of advanced treatment technologies, compared with prior standards (ie, traditional external beam radiation treatment [EBRT] and open radical prostatectomy) and observation, among men with a low risk of dying from prostate cancer. Design, Setting, and Patients Using Surveillance, Epidemiology, and End Results (SEER)-Medicare data, we identified a retrospective cohort of men diagnosed with prostate cancer between 2004 and 2009 who underwent IMRT (n=23 633), EBRT (n=3926), robotic prostatectomy (n=5881), open radical prostatectomy (n=6123), or observation (n=16 384). Follow-up data were available through December 31, 2010. Main Outcomes and Measures The use of advanced treatment technologies among men unlikely to die from prostate cancer, as assessed by low-risk disease (clinical stage <= T2a, biopsy Gleason score <= 6, and prostate-specific antigen level <= 10 ng/mL), high risk of noncancer mortality (based on the predicted probability of death within 10 years in the absence of a cancer diagnosis), or both. Results In our cohort, the use of advanced treatment technologies increased from 32% (95% CI, 30%-33%) to 44% (95% CI, 43%-46%) among men with low-risk disease (P < .001) and from 36% (95% CI, 35%-38%) to 57% (95% CI, 55%-59%) among men with high risk of noncancer mortality (P < .001). The use of these advanced treatment technologies among men with both low-risk disease and high risk of noncancer mortality increased from 25% (95% CI, 23%-28%) to 34% (95% CI, 31%-37%) (P < .001). Among all patients diagnosed in SEER, the use of advanced treatment technologies for men unlikely to die from prostate cancer increased from 13% (95% CI, 12%-14%), or 129.2 per 1000 patients diagnosed with prostate cancer, to 24% (95% CI, 24%-25%), or 244.2 per 1000 patients diagnosed with prostate cancer (P < .001). Conclusion and Relevance Among men diagnosed with prostate cancer between 2004 and 2009 who had low-risk disease, high risk of noncancer mortality, or both, the use of advanced treatment technologies has increased.	[Jacobs, Bruce L.; Schroeck, Florian R.; Skolarus, Ted A.; Montie, James E.; Miller, David C.; Hollenbeck, Brent K.] Univ Michigan, Dept Urol, Div Oncol, Ann Arbor, MI 48109 USA; [Jacobs, Bruce L.; Zhang, Yun; Schroeck, Florian R.; Skolarus, Ted A.; Wei, John T.; Montie, James E.; Dunn, Rodney L.; Miller, David C.; Hollenbeck, Brent K.] Univ Michigan, Div Hlth Serv Res, Ann Arbor, MI 48109 USA; [Wei, John T.] Univ Michigan, Div Gen Urol, Ann Arbor, MI 48109 USA; [Skolarus, Ted A.] VA Ann Arbor Healthcare Syst, Ctr Clin Management Res, Ann Arbor, MI USA; [Gilbert, Scott M.] Univ Florida, Dept Urol, Gainesville, FL USA; [Strope, Seth A.] Washington Univ, Sch Med, Dept Surg, Div Urol Surg, St Louis, MO 63110 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; State University System of Florida; University of Florida; Washington University (WUSTL)	Hollenbeck, BK (corresponding author), Univ Michigan, Dept Urol, Bldg 16,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	bhollen@med.umich.edu	Wei, John T/E-8967-2012; Schroeck, Florian R./I-5342-2019; Björklund, Johan K/G-3097-2015	Schroeck, Florian R./0000-0002-1860-2611; Björklund, Johan K/0000-0003-3254-3993; Strope, Seth/0000-0002-5176-1550	American Cancer Society [121805-PF-12-008-01-CPHPS, PF-12-118-01-CPPB]; National Institutes of Health [NIH 5 T32 DK007782-12]; National Cancer Institute [R01-CA-168691-01]; NATIONAL CANCER INSTITUTE [R01CA168691] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, KL2TR000450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007782] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr Jacobs is supported in part by an American Cancer Society Postdoctoral Fellowship Grant (121805-PF-12-008-01-CPHPS). Dr Schroeck is supported in part by an American Cancer Society Postdoctoral Fellowship Grant (PF-12-118-01-CPPB) and by a National Institutes of Health Training Grant (NIH 5 T32 DK007782-12). Dr Miller is supported in part by Blue Cross Blue Shield of Michigan for efforts as director of the Michigan Urological Surgery Improvement Collaborative. Dr Hollenbeck is supported in part by the National Cancer Institute (R01-CA-168691-01).	Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Allison P.D., 1999, LOGISTIC REGRESSION; Altekruse S, 2010, SEER CANC STAT REV 1; [Anonymous], OBS RAD TREATM PAT P; Barbash GI, 2010, NEW ENGL J MED, V363, P701, DOI 10.1056/NEJMp1006602; Buhlmann P, 2002, ANN STAT, V30, P927; Carreyrou J, 2010, WALL STREET J; Carter HB, 2012, J CLIN ONCOL, V30, P4294, DOI 10.1200/JCO.2012.44.0586; Chamie K, 2012, J GEN INTERN MED, V27, P492, DOI 10.1007/s11606-011-1869-4; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Etzioni R, 2012, CLIN CANCER RES, V18, P6742, DOI 10.1158/1078-0432.CCR-12-1537; Fendrick AM, 2012, HEALTH SERV RES, V47, P404, DOI 10.1111/j.1475-6773.2011.01358.x; Gross CP, 2006, ANN INTERN MED, V145, P646, DOI 10.7326/0003-4819-145-9-200611070-00006; Grossfeld GD, 2001, J UROLOGY, V165, P851, DOI 10.1016/S0022-5347(05)66543-3; Heidenreich A, 2011, EUR UROL, V59, P61, DOI 10.1016/j.eururo.2010.10.039; Hu JC, 2009, JAMA-J AM MED ASSOC, V302, P1557, DOI 10.1001/jama.2009.1451; Jacobs BL, 2014, EUR UROL, V65, P162, DOI 10.1016/j.eururo.2012.06.055; Jacobs BL, 2012, HEALTH AFFAIR, V31, P750, DOI 10.1377/hlthaff.2011.1062; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.3322/caac.20105]; Kim SP, 2012, J CLIN ONCOL, V30; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Konski A, 2006, INT J RADIAT ONCOL, V66, P408, DOI 10.1016/j.ijrobp.2006.04.049; Krahn MD, 2002, UROLOGY, V60, P258, DOI 10.1016/S0090-4295(02)01712-0; Litwin MS, 2007, CANCER-AM CANCER SOC, V109, P1777, DOI 10.1002/cncr.22615; Lu-Yao GL, 2009, JAMA-J AM MED ASSOC, V302, P1202, DOI 10.1001/jama.2009.1348; Mell LK, 2005, CANCER-AM CANCER SOC, V104, P1296, DOI 10.1002/cncr.21284; Mohler JL, 2010, J NATL COMPR CANC NE, V8, P145, DOI 10.6004/jnccn.2010.0010; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; R Core Team,, 2021, R LANG ENV STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Ries L, 2008, SEER CANC STAT REV 1; Roehrig C, 2009, HEALTH AFFAIR, V28, pW358, DOI 10.1377/hlthaff.28.2.w358; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Smedley D.B, 2003, UNEQUAL TREATMENT CO, P1, DOI [10.17226/12875, DOI 10.17226/12875]	35	109	109	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2587	2595		10.1001/jama.2013.6882	http://dx.doi.org/10.1001/jama.2013.6882			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23800935	Green Accepted			2022-12-01	WOS:000320848100029
J	Marmot, MG				Marmot, Michael G.			Sorting Through the Arguments on Breast Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CANCER		UCL, Inst Hlth Equ, Dept Epidemiol & Publ Hlth, London WC1E 7HB, England	University of London; University College London	Marmot, MG (corresponding author), UCL, Inst Hlth Equ, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 7HB, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	Economic and Social Research Council [ES/F02679X/1] Funding Source: researchfish; ESRC [ES/F02679X/1] Funding Source: UKRI; MRC [G0701830, G1000616, G0902037, G0601647] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G0100222, G1000616, G0902037, G0601647, G19/35, G0701830, G8802774] Funding Source: Medline	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Independent UK Panel on Breast Cancer Screening, 2013, Lancet, V381, P803, DOI 10.1016/S0140-6736(13)60628-5; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Ransohoff DF, 2013, JAMA-J AM MED ASSOC, V309, P139, DOI 10.1001/jama.2012.156703	6	24	24	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2553	2554		10.1001/jama.2013.6822	http://dx.doi.org/10.1001/jama.2013.6822			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23722915				2022-12-01	WOS:000320848100021
J	Kanamori, T; Kanai, MI; Dairyo, Y; Yasunaga, K; Morikawa, RK; Emoto, K				Kanamori, Takahiro; Kanai, Makoto I.; Dairyo, Yusuke; Yasunaga, Kei-ichiro; Morikawa, Rei K.; Emoto, Kazuo			Compartmentalized Calcium Transients Trigger Dendrite Pruning in Drosophila Sensory Neurons	SCIENCE			English	Article							INDICATORS; MECHANISMS; CELLS	Dendrite pruning is critical for sculpting the final connectivity of neural circuits as it removes inappropriate projections, yet how neurons can selectively eliminate unnecessary dendritic branches remains elusive. Here, we show that calcium transients that are compartmentalized in specific dendritic branches act as temporal and spatial cues to trigger pruning in Drosophila sensory neurons. Calcium transients occurred in local dendrites at similar to 3 hours before branch elimination. In dendritic branches, intrinsic excitability increased locally to activate calcium influx via the voltage-gated calcium channels (VGCCs), and blockade of the VGCC activities impaired pruning. Further genetic analyses suggest that the calcium-activated protease calpain functions downstream of the calcium transients. Our findings reveal the importance of the compartmentalized subdendritic calcium signaling in spatiotemporally selective elimination of dendritic branches.	[Kanamori, Takahiro; Kanai, Makoto I.; Dairyo, Yusuke; Yasunaga, Kei-ichiro; Morikawa, Rei K.; Emoto, Kazuo] Osaka Biosci Inst, Dept Cell Biol, Suita, Osaka 5650872, Japan; [Emoto, Kazuo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Dairyo, Yusuke] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan	University of Tokyo; Nara Institute of Science & Technology	Emoto, K (corresponding author), Osaka Biosci Inst, Dept Cell Biol, 6-2-4 Furuedai, Suita, Osaka 5650872, Japan.	emoto@biol.s.u-tokyo.ac.jp	EMOTO, KAZUO/G-4992-2014		Japanese Government Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Strategic Research Program for Brain Science, CREST; Takeda Science Foundation	Japanese Government Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Program for Brain Science, CREST; Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank Y. N. Jan, C. Montel, M. Miura, L. L Looger, K. Deisseroth, Bloomington Stock Center, and Kyoto Stock Center for reagents; Riken BSI-Olympus collaboration center for measuring the blue-light intensity; W. Sugano and A. Kawasaki for technical assistance; S. Nakanishi and J. Z. Parrish for helpful comments on the manuscript. This work was supported by grants-in-aid for Science and Technology from the Japanese Government Ministry of Education, Culture, Sports, Science, and Technology (MEXT), the Strategic Research Program for Brain Science, CREST, and Takeda Science Foundation.	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Emoto K, 2012, CURR OPIN NEUROBIOL, V22, P805, DOI 10.1016/j.conb.2012.04.005; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	17	81	82	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1475	1478		10.1126/science.1234879	http://dx.doi.org/10.1126/science.1234879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23722427				2022-12-01	WOS:000320647000048
J	Hayes, JH; Ollendorf, DA; Pearson, SD; Barry, MJ; Kantoff, PW; Lee, PA; McMahon, PM				Hayes, Julia H.; Ollendorf, Daniel A.; Pearson, Steven D.; Barry, Michael J.; Kantoff, Philip W.; Lee, Pablo A.; McMahon, Pamela M.			Observation Versus Initial Treatment for Men With Localized, Low-Risk Prostate Cancer A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							ACTIVE SURVEILLANCE; RADICAL PROSTATECTOMY; CONTROLLED-TRIAL; MANAGEMENT; OUTCOMES; MORTALITY; THERAPY; RADIATION; BIOPSY; GRADE	Background: Observation is underutilized among men with localized, low-risk prostate cancer. Objective: To assess the costs and benefits of observation versus initial treatment. Design: Decision analysis simulating treatment or observation. Data Sources: Medicare schedules, published literature. Target Population: Men aged 65 and 75 years who had newly diagnosed low-risk prostate cancer (prostate-specific antigen level <10 mu g/L, stage <= T2a, Gleason score <= 3 + 3). Time Horizon: Lifetime. Perspective: Societal. Intervention: Treatment (brachytherapy, intensity-modulated radiation therapy, or radical prostatectomy) or observation (active surveillance [AS] or watchful waiting [WW]). Outcome Measures: Quality-adjusted life expectancy and costs. Results of Base-Case Analysis: Observation was more effective and less costly than initial treatment. Compared with AS, WW provided 2 additional months of quality-adjusted life expectancy (9.02 vs. 8.85 years) at a savings of $15 374 ($24 520 vs. $39 894) in men aged 65 years and 2 additional months (6.14 vs. 5.98 years) at a savings of $11 746 ($18 302 vs. $30 048) in men aged 75 years. Brachytherapy was the most effective and least expensive initial treatment. Results of Sensitivity Analysis: Treatment became more effective than observation when it led to more dramatic reductions in prostate cancer death (hazard ratio, 0.47 vs. WW and 0.64 vs. AS). Active surveillance became as effective as WW in men aged 65 years when the probability of progressing to treatment on AS decreased below 63% or when the quality of life with AS versus WW was 4% higher in men aged 65 years or 1% higher in men aged 75 years. Watchful waiting remained least expensive in all analyses. Limitation: Results depend on outcomes reported in the published literature, which is limited. Conclusion: Among these men, observation is more effective and costs less than initial treatment, and WW is most effective and least expensive under a wide range of clinical scenarios.	Harvard Univ, Sch Med, Dana Farber Canc Inst,Inst Technol Assessment, Lank Ctr Genitourinary Oncol,Inst Clin & Econ Rev, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts General Hospital	Hayes, JH (corresponding author), Dana Farber Canc Inst, Dana 1230,450 Brookline Ave, Boston, MA 02115 USA.	Julia_Hayes@dfci.harvard.edu		Kantoff, Philip/0000-0001-7275-0597	National Cancer Institute; U.S. Department of Defense [W81XWH-09-1-0512]; Prostate Cancer Foundation; Institute for Clinical and Economic Review; National Cancer Institute at the National Institutes of Health [R25 CA92203-08]; Blue Shield of California Foundation; Agency for Healthcare Research and Quality; Health Dialog; NATIONAL CANCER INSTITUTE [R25CA092203] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense(United States Department of Defense); Prostate Cancer Foundation; Institute for Clinical and Economic Review; National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Blue Shield of California Foundation; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Health Dialog; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute, U.S. Department of Defense, Prostate Cancer Foundation, and Institute for Clinical and Economic Review.; By grant R25 CA92203-08 (National Cancer Institute at the National Institutes of Health), grant W81XWH-09-1-0512 (U.S. Department of Defense), a Young Investigators Award to Dr. Hayes (Prostate Cancer Foundation), and funding to the Institute for Clinical and Economic Review from the Blue Shield of California Foundation.; Dr. Hayes: Grants (money to institution): U.S. Department of Defense, Prostate Cancer Foundation; Royalties: UpToDate. Dr. Ollendorf: Grants (money to institution): Blue Shield of California Foundation. Dr. Pearson: Consultancy: National Institutes of Health, Yale University; Employment: Massachusetts General Hospital; Grants/grants pending (money to institution): Agency for Healthcare Research and Quality. Dr. Barry: Board membership: Informed Medical Decisions Foundation; Employment: Informed Medical Decisions Foundation; Royalties (money to institution): Health Dialog. Dr. McMahon: Grants (money to institution): Blue Shield of California Foundation, Harvard Community Health Plan. All other authors have no disclosures. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M12-0857.	Alibhai SMH, 2003, J CLIN ONCOL, V21, P3318, DOI 10.1200/JCO.2003.09.034; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; [Anonymous], 2012, PROTECT TRIAL EVALUA; Berglund RK, 2008, J UROLOGY, V180, P1964, DOI 10.1016/j.juro.2008.07.051; Carter HB, 2007, J UROLOGY, V178, P2359, DOI 10.1016/j.juro.2007.08.039; Centers for Medicare & Medicaid Services, 2008, HOSP OUTP PROSP PAYM; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; Corcoran AT, 2010, UROLOGY, V76, P703, DOI 10.1016/j.urology.2009.12.071; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; Dahabreh IJ, 2012, ANN INTERN MED, V156, P582, DOI [10.7326/0003-4819-156-8-201204170-00009, 10.7326/0003-4819-156-8-201204170-00397]; Dale W, 2008, MED DECIS MAKING, V28, P102, DOI 10.1177/0272989X07309639; Dall'Era MA, 2008, CANCER-AM CANCER SOC, V112, P2664, DOI 10.1002/cncr.23502; Fleshner NE, 2012, LANCET, V379, P1103, DOI 10.1016/S0140-6736(11)61619-X; Gold MR, 1996, COST EFFECTIVENESS H, P425; Hardie C, 2005, BJU INT, V95, P956, DOI 10.1111/j.1464-410X.2005.05446.x; Hayes JH, 2010, JAMA-J AM MED ASSOC, V304, P2373, DOI 10.1001/jama.2010.1720; Horwitz EM, 2005, J UROLOGY, V173, P797, DOI 10.1097/01.ju.0000152556.53602.64; Institute for Clinical and Economic Review, 2009, ACT SURV RAD PROST F; Institute for Clinical and Economic Review, 2009, FIN APPR DOC BRACH P; Institute for Clinical and Economic Review, 2007, IMRT FIN APPR FULL R; Keegan KA, 2012, CANCER-AM CANCER SOC, V118, P3512, DOI 10.1002/cncr.26688; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Koerkamp BG, 2007, MED DECIS MAKING, V27, P101, DOI 10.1177/0272989X06297394; Lu-Yao GL, 2009, JAMA-J AM MED ASSOC, V302, P1202, DOI 10.1001/jama.2009.1348; Patel MI, 2004, J UROLOGY, V171, P1520, DOI 10.1097/01.ju.0000118224.54949.78; Penson DF, 2007, J UROLOGY, V177, P2020, DOI 10.1016/j.juro.2007.01.121; Porten SP, 2011, J CLIN ONCOL, V29, P2795, DOI 10.1200/JCO.2010.33.0134; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sheridan TB, 2008, J UROLOGY, V179, P901, DOI 10.1016/j.juro.2007.10.062; Shteynshlyuger A, 2011, J UROLOGY, V185, P828, DOI 10.1016/j.juro.2010.10.079; Stattin P, 2010, JNCI-J NATL CANCER I, V102, P950, DOI 10.1093/jnci/djq154; U.S. Bureau of Labor Statistics, 2013, CONS PRIC IND MED CA; U.S. Bureau of Labor Statistics, 2013, HOUS DAT TABLE 3 MED; van As NJ, 2008, EUR UROL, V54, P1297, DOI 10.1016/j.eururo.2008.02.039; van den Bergh RCN, 2010, BJU INT, V105, P956, DOI 10.1111/j.1464-410X.2009.08887.x; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Wilson LS, 2007, CANCER-AM CANCER SOC, V109, P518, DOI 10.1002/cncr.22433; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Xia J, 2012, CLIN CANCER RES, V18, P5471, DOI 10.1158/1078-0432.CCR-12-1502	39	96	97	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12					853	+		10.7326/0003-4819-158-12-201306180-00002	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-00002			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23778902	Green Accepted			2022-12-01	WOS:000320645000013
J	Brenner, SE				Brenner, Steven E.			Be prepared for the big genome leak	NATURE			English	Editorial Material									Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Brenner, SE (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	brenner@compbio.berkeley.edu	Brenner, Steven E/A-8729-2008	Brenner, Steven E/0000-0001-7559-6185					0	20	20	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					139	139		10.1038/498139a	http://dx.doi.org/10.1038/498139a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	162RR	23765454	Bronze			2022-12-01	WOS:000320283400007
J	Chang, CH; Curtis, JD; Maggi, LB; Faubert, B; Villarino, AV; O'Sullivan, D; Huang, SCC; van der Windt, GJW; Blagih, J; Qiu, J; Weber, JD; Pearce, EJ; Jones, RG; Pearce, EL				Chang, Chih-Hao; Curtis, Jonathan D.; Maggi, Leonard B., Jr.; Faubert, Brandon; Villarino, Alejandro V.; O'Sullivan, David; Huang, Stanley Ching-Cheng; van der Windt, Gerritje J. W.; Blagih, Julianna; Qiu, Jing; Weber, Jason D.; Pearce, Edward J.; Jones, Russell G.; Pearce, Erika L.			Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis	CELL			English	Article							MESSENGER-RNA STABILITY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ENERGY-METABOLISM; OVARIAN-CANCER; ACTIVATION; DIFFERENTIATION; EXPRESSION; GLUTAMINE; MECHANISM; BINDING	A "switch'' from oxidative phosphorylation (OXPHOS) to aerobic glycolysis is a hallmark of T cell activation and is thought to be required to meet the metabolic demands of proliferation. However, why proliferating cells adopt this less efficient metabolism, especially in an oxygen-replete environment, remains incompletely understood. We show here that aerobic glycolysis is specifically required for effector function in T cells but that this pathway is not necessary for proliferation or survival. When activated T cells are provided with costimulation and growth factors but are blocked from engaging glycolysis, their ability to produce IFN-gamma is markedly compromised. This defect is translational and is regulated by the binding of the glycolysis enzyme GAPDH to AU-rich elements within the 3' UTR of IFN-gamma mRNA. GAPDH, by engaging/disengaging glycolysis and through fluctuations in its expression, controls effector cytokine production. Thus, aerobic glycolysis is a metabolically regulated signaling mechanism needed to control cellular function.	[Chang, Chih-Hao; Curtis, Jonathan D.; O'Sullivan, David; Huang, Stanley Ching-Cheng; van der Windt, Gerritje J. W.; Qiu, Jing; Pearce, Edward J.; Pearce, Erika L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Maggi, Leonard B., Jr.; Weber, Jason D.] Washington Univ, Sch Med, Div Mol Oncol, BRIGHT Inst, St Louis, MO 63110 USA; [Faubert, Brandon; Blagih, Julianna; Jones, Russell G.] McGill Univ, Dept Physiol, Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Villarino, Alejandro V.] NIAMSD, NIH, Bethesda, MD 20892 USA	Washington University (WUSTL); Washington University (WUSTL); McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Pearce, EL (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	erikapearce@path.wustl.edu	Jones, Russell/AAC-2861-2022; Villarino, Alejandro/AAE-3517-2020; Maggi, Leonard/L-5217-2019; Huang, Stanley Ching-Cheng/AAE-7866-2019; Jones, Russell Graham/ABD-5261-2021	Villarino, Alejandro/0000-0001-8068-2176; Maggi, Leonard/0000-0003-0138-0984; Huang, Stanley Ching-Cheng/0000-0002-6557-3737; Jones, Russell Graham/0000-0003-2250-4675; Weber, Jason/0000-0002-1069-6983; Faubert, Brandon/0000-0002-2886-886X; CHANG, CHIH-HAO/0000-0002-0139-7439	NIH [AI091965, CA158823, CA164062]; CIHR [MOP-93799]; Emerald Foundation Young Investigator Award; NATIONAL CANCER INSTITUTE [R21CA158823, R01CA164062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091965] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Emerald Foundation Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Andrey Shaw, Ken Murphy, Skip Virgin, Abul Abbas, Eyal Amiel, Rong Zeng, Qiongyu Chen, Monika Vig, Georgia Perona-Wright, Bart Everts, and the Goodman Cancer Research Centre Metabolomics Core Facility at McGIll University. This work was supported in part by grants from the NIH (AI091965 and CA158823 to E.L.P. and CA164062 to E.J.P.), CIHR (MOP-93799 to R.G.J.), The Arthritis Society of Canada (R.G.J.), NWO (G.J.W.v.d.W.), and the Emerald Foundation Young Investigator Award ( E.L.P.). C.- H.C., L.B.M., J.D.W., A.V.V., E.J.P., R. G. J., and E. L. P. designed the research. C.C., J.D.C., S.C.- C.H., G. J.W.v.d., D.O., J.B., B.F., J.Q., and E.L.P. analyzed data. C. C., J. D. C., L.B.M., B.F., S.C.- C.H., D.O., G.J.W.v.d. W., J.Q., and E.L.P. performed experiments. C.C., E.J.P., and E.L.P. contributed to the preparation of the manuscript. C.C. and E.L.P. wrote the manuscript.	Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Arif A, 2012, MOL CELL BIOL, V32, P5046, DOI 10.1128/MCB.01168-12; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bonafe N, 2005, CANCER RES, V65, P3762, DOI 10.1158/0008-5472.CAN-04-3954; Bustamente E, 1977, Adv Exp Med Biol, V92, P363; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; GarciaSanz JA, 1996, J EXP MED, V184, P159, DOI 10.1084/jem.184.1.159; Gatza E, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001975; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kondo S, 2011, BIOCHEM BIOPH RES CO, V405, P382, DOI 10.1016/j.bbrc.2011.01.034; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Le Goffe C, 1999, BIOCHEM J, V344, P643, DOI 10.1042/0264-6021:3440643; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Miceli AP, 2012, MOL CELL BIOL, V32, P348, DOI 10.1128/MCB.06030-11; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nagy E, 2000, BIOCHEM BIOPH RES CO, V275, P253, DOI 10.1006/bbrc.2000.3246; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Rodriguez-Pascual F, 2008, MOL CELL BIOL, V28, P7139, DOI 10.1128/MCB.01145-08; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Tripmacher R, 2008, EUR J IMMUNOL, V38, P1631, DOI 10.1002/eji.200738047; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; Villarino AV, 2011, IMMUNITY, V34, P50, DOI 10.1016/j.immuni.2010.12.014; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Zhou Y, 2008, MOL CANCER RES, V6, P1375, DOI 10.1158/1541-7786.MCR-07-2170	42	1235	1287	19	163	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1239	1251		10.1016/j.cell.2013.05.016	http://dx.doi.org/10.1016/j.cell.2013.05.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746840	Bronze, Green Published, Green Accepted			2022-12-01	WOS:000319979200010
J	Spalding, KL; Bergmann, O; Alkass, K; Bernard, S; Salehpour, M; Huttner, HB; Bostrom, E; Westerlund, I; Vial, C; Buchholz, BA; Possnert, G; Mash, DC; Druid, H; Frisen, J				Spalding, Kirsty L.; Bergmann, Olaf; Alkass, Kanar; Bernard, Samuel; Salehpour, Mehran; Huttner, Hagen B.; Bostrom, Emil; Westerlund, Isabelle; Vial, Celine; Buchholz, Bruce A.; Possnert, Goran; Mash, Deborah C.; Druid, Henrik; Frisen, Jonas			Dynamics of Hippocampal Neurogenesis in Adult Humans	CELL			English	Article							ENHANCED SYNAPTIC PLASTICITY; GRANULE CELLS; OLFACTORY-BULB; DENTATE GYRUS; NEURONS; C-14; AGE; RADIOCARBON; BRAIN	Adult-born hippocampal neurons are important for cognitive plasticity in rodents. There is evidence for hippocampal neurogenesis in adult humans, although whether its extent is sufficient to have functional significance has been questioned. We have assessed the generation of hippocampal cells in humans by measuring the concentration of nuclearbomb-test-derived C-14 in genomic DNA, and we present an integrated model of the cell turnover dynamics. We found that a large subpopulation of hippocampal neurons constituting one-third of the neurons is subject to exchange. In adult humans, 700 new neurons are added in each hippocampus per day, corresponding to an annual turnover of 1.75% of the neurons within the renewing fraction, with a modest decline during aging. We conclude that neurons are generated throughout adulthood and that the rates are comparable in middle-aged humans and mice, suggesting that adult hippocampal neurogenesis may contribute to human brain function.	[Spalding, Kirsty L.; Bergmann, Olaf; Alkass, Kanar; Huttner, Hagen B.; Bostrom, Emil; Westerlund, Isabelle; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Alkass, Kanar; Druid, Henrik] Karolinska Inst, Dept Oncol Pathol, S-17177 Stockholm, Sweden; [Bernard, Samuel; Vial, Celine] Univ Lyon, CNRS UMR 5208, Inst Camille Jordan, F-69622 Villeurbanne, France; [Salehpour, Mehran; Possnert, Goran] Uppsala Univ, Dept Phys & Astron, S-75120 Uppsala, Sweden; [Huttner, Hagen B.] Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; [Buchholz, Bruce A.] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94550 USA; [Mash, Deborah C.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA	Karolinska Institutet; Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Uppsala University; University of Erlangen Nuremberg; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Miami	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Bernard, Samuel/A-5623-2009; Bergmann, Olaf/A-5706-2009; Buchholz, Bruce A/G-1356-2011; spalding, kirsty/I-6046-2017; Spalding, Kirsty/CAF-4248-2022	Bernard, Samuel/0000-0002-8442-9968; Bergmann, Olaf/0000-0003-1065-4107; Buchholz, Bruce A/0000-0002-9531-551X; Spalding, Kirsty/0000-0002-5189-7028; Druid, Henrik/0000-0002-9198-023X; alkass, kanar/0000-0002-9154-5393	Swedish Research Council; T. Stiftelsen, Hjarnfonden; Swedish Foundation for Strategic Research; National Alliance for Research on Schizophrenia and Depression; AFA Forsakringar; Knut and Alice Wallenberg Foundation; National Institute on Drug Abuse [DA031429]; European Research Council; National Institutes of Health (NIH); National Center for Research Resources [5P41RR013461]; National Institute of General Medical Sciences [8P41GM103483]; regional agreement on medical training and clinical research between Stockholm County Council and the Karolinska Institute [ALF 20080508]; Lawrence Livermore National Laboratory [AC5207NA27344]; German Research Foundation (DFG) [Hu 1961/1-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031429] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); T. Stiftelsen, Hjarnfonden; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); National Alliance for Research on Schizophrenia and Depression(NARSAD); AFA Forsakringar; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); European Research Council(European Research Council (ERC)European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); regional agreement on medical training and clinical research between Stockholm County Council and the Karolinska Institute; Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Toro, S. Giatrellis, A. Busch, E. Kiss, and H. Ismail for flow cytometry; K. Hakansson for AMS sample preparation; A. Racz for tissue procurement; and F. Gage, G. Kempermann, and L. Slomianka for valuable discussions. The staff at the Swedish National Board of Forensic Medicine is acknowledged for cooperation in tissue donation. This study was supported by the Swedish Research Council, T. Stiftelsen, Hjarnfonden, the Swedish Foundation for Strategic Research, the National Alliance for Research on Schizophrenia and Depression, AFA Forsakringar, the Knut and Alice Wallenberg Foundation, the National Institute on Drug Abuse (DA031429), the European Research Council, the National Institutes of Health (NIH) and the National Center for Research Resources (5P41RR013461), the NIH and the National Institute of General Medical Sciences (8P41GM103483), and the regional agreement on medical training and clinical research between Stockholm County Council and the Karolinska Institute (ALF 20080508). This work was performed, in part, with the support of the U.S.Department of Energy by the Lawrence Livermore National Laboratory (under contract DE-AC5207NA27344). H.B.H. was funded by a grant from the German Research Foundation (DFG: Hu 1961/1-1).	Amrein I, 2011, EUR J NEUROSCI, V34, P978, DOI 10.1111/j.1460-9568.2011.07804.x; Appleby PA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001063; Arellano JI, 2011, NATURE, V478, P333, DOI 10.1038/478333a; BAYER SA, 1985, ANN NY ACAD SCI, V457, P163, DOI 10.1111/j.1749-6632.1985.tb20804.x; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Brown TA, 1997, NUCL INSTRUM METH B, V123, P208, DOI 10.1016/S0168-583X(96)00676-3; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fallon SJ, 2007, NUCL INSTRUM METH B, V259, P106, DOI 10.1016/j.nimb.2007.01.149; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Goritz C, 2012, CELL STEM CELL, V10, P657, DOI 10.1016/j.stem.2012.04.005; HARKNESS DD, 1972, NATURE, V240, P302, DOI 10.1038/240302a0; Hua Q, 2004, NUCL INSTRUM METH B, V223, P284, DOI 10.1016/j.nimb.2004.04.057; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jabes A, 2010, EUR J NEUROSCI, V31, P273, DOI 10.1111/j.1460-9568.2009.07061.x; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Kheirbek MA, 2012, NAT NEUROSCI, V15, P1613, DOI 10.1038/nn.3262; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Kohler SJ, 2011, P NATL ACAD SCI USA, V108, P10326, DOI 10.1073/pnas.1017099108; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; Levin I, 2010, TELLUS B, V62, P26, DOI 10.1111/j.1600-0889.2009.00446.x; LIBBY WF, 1964, SCIENCE, V146, P1171; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; NYDAL R, 1965, NATURE, V206, P1029, DOI 10.1038/2061029a0; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; Salehpour M, 2013, NUCL INSTRUM METH B, V294, P97, DOI 10.1016/j.nimb.2012.08.054; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Santos GM, 2007, NUCL INSTRUM METH B, V259, P293, DOI 10.1016/j.nimb.2007.01.172; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spalding KL, 2005, NATURE, V437, P333, DOI 10.1038/437333a; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; VRIES HD, 1958, SCIENCE, V128, P250; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83	44	1138	1177	4	207	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1219	1227		10.1016/j.cell.2013.05.002	http://dx.doi.org/10.1016/j.cell.2013.05.002			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746839	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000319979200008
J	Stevens, B; Bony, S				Stevens, Bjorn; Bony, Sandrine			What Are Climate Models Missing?	SCIENCE			English	Editorial Material							EARTH SYSTEM MODELS; SENSITIVITY		[Stevens, Bjorn] Max Planck Inst Meteorol, D-20146 Hamburg, Germany; [Bony, Sandrine] Univ Paris 06, CNRS, Meteorol Dynam Lab, Inst Pierre Simon Laplace, Paris, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay	Stevens, B (corresponding author), Max Planck Inst Meteorol, Bundesstr 53, D-20146 Hamburg, Germany.	bjorn.stevens@mpimet.mpg.de	Bony, Sandrine/AAG-5804-2019; Stevens, Bjorn/A-1757-2013	Bony, Sandrine/0000-0002-4791-4438; Stevens, Bjorn/0000-0003-3795-0475				Bony S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023851; Bony S, 2013, CLIMATE SCI SERVING; Charney J. G., 1949, TELLUS, V1, P38, DOI DOI 10.3402/TELLUSA.V1I2.8500; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; Dufresne JL, 2008, J CLIMATE, V21, P5135, DOI 10.1175/2008JCLI2239.1; Flato GM, 2011, WIRES CLIM CHANGE, V2, P783, DOI 10.1002/wcc.148; Good P, 2013, J CLIMATE, V26, P495, DOI 10.1175/JCLI-D-11-00366.1; Medeiros B, 2008, J CLIMATE, V21, P4974, DOI 10.1175/2008JCLI1995.1; Min QL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032398; Ocko IB, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018019; Oueslati B, 2013, J CLIMATE, V26, P2931, DOI 10.1175/JCLI-D-12-00314.1; Popke D, 2013, J ADV MODEL EARTH SY, V5, P1, DOI 10.1029/2012MS000191; Simmons AJ, 2002, Q J ROY METEOR SOC, V128, P647, DOI 10.1256/003590002321042135; Smagorinsky J., 1963, MON WEA REV, V91, P99, DOI [10.1175/1520-0493(1963)0912.3.CO;2, DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2, DOI 10.1175/1520-0493(1963)0912.3.CO;2, 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2]	14	262	266	5	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1053	1054		10.1126/science.1237554	http://dx.doi.org/10.1126/science.1237554			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154HJ	23723223				2022-12-01	WOS:000319664500028
J	Shu, J; Wu, C; Wu, YT; Li, ZY; Shao, SD; Zhao, WH; Tang, X; Yang, H; Shen, LJ; Zuo, XH; Yang, WF; Shi, Y; Chi, XC; Zhang, HQ; Gao, G; Shu, YM; Yuan, KH; He, WW; Tang, C; Zhao, Y; Deng, HK				Shu, Jian; Wu, Chen; Wu, Yetao; Li, Zhiyuan; Shao, Sida; Zhao, Wenhui; Tang, Xing; Yang, Huan; Shen, Lijun; Zuo, Xiaohan; Yang, Weifeng; Shi, Yan; Chi, Xiaochun; Zhang, Hongquan; Gao, Ge; Shu, Youmin; Yuan, Kehu; He, Weiwu; Tang, Chao; Zhao, Yang; Deng, Hongkui			Induction of Pluripotency in Mouse Somatic Cells with Lineage Specifiers	CELL			English	Article							EMBRYONIC STEM-CELLS; PRIMITIVE ENDODERM; DIRECT CONVERSION; HUMAN FIBROBLASTS; DIFFERENTIATION; OCT4; EXPRESSION; GENERATION; GENE; DEDIFFERENTIATION	The reprogramming factors that induce pluripotency have been identified primarily from embryonic stem cell (ESC)-enriched, pluripotency-associated factors. Here, we report that, during mouse somatic cell reprogramming, pluripotency can be induced with lineage specifiers that are pluripotency rivals to suppress ESC identity, most of which are not enriched in ESCs. We found that OCT4 and SOX2, the core regulators of pluripotency, can be replaced by lineage specifiers that are involved in mesendo-dermal (ME) specification and in ectodermal (ECT) specification, respectively. OCT4 and its substitutes attenuated the elevated expression of a group of ECT genes, whereas SOX2 and its substitutes curtailed a group of ME genes during reprogramming. Surprisingly, the two counteracting lineage specifiers can synergistically induce pluripotency in the absence of both OCT4 and SOX2. Our study suggests a "seesaw model'' in which a balance that is established using pluripotency factors and/or counteracting lineage specifiers can facilitate reprogramming.	[Shu, Jian; Shao, Sida; Zhao, Wenhui; Shen, Lijun; Yang, Weifeng; Zhao, Yang; Deng, Hongkui] Peking Univ, Coll Life Sci, MOE Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Li, Zhiyuan; Tang, Chao] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Shu, Jian; Wu, Chen; Wu, Yetao; Zhao, Wenhui; Yang, Huan; Zuo, Xiaohan; Tang, Chao; Zhao, Yang; Deng, Hongkui] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Tang, Xing; Gao, Ge] Peking Univ, Ctr Bioinformat, State Key Lab Prot & Plant Gene Res, Coll Life Sci, Beijing 100871, Peoples R China; [Chi, Xiaochun; Zhang, Hongquan] Peking Univ, Sch Basic Med Sci, Lab Stem Cells Dev & Reprod Med, Beijing 100191, Peoples R China; [Wu, Chen; Wu, Yetao; Yang, Huan; Zuo, Xiaohan; Shi, Yan; Deng, Hongkui] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Lab Chem Genom, Shenzhen 518055, Peoples R China; [Li, Zhiyuan] Univ Calif San Francisco, Biophys Grad Program, San Francisco, CA 94158 USA; [Shu, Youmin; Yuan, Kehu; He, Weiwu] OriGene Technol, Rockville, MD 20850 USA	Peking University; Peking University; Peking University; Peking University; Peking University; Peking University; University Town of Shenzhen; University of California System; University of California San Francisco	Tang, C (corresponding author), Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China.	tangc@pku.edu.cn; hongkui_deng@pku.edu.cn	Gao, Ge/F-3615-2012; Zhang, Xiaoming/L-2904-2013; li, zhiyuan/M-8378-2013	li, zhiyuan/0000-0001-6662-2636; Tang, Chao/0000-0003-1474-3705; Yang, Huan/0000-0001-8345-9957	National Basic Research Program of China (973 program) [2012CB966401, 2009CB941101, 2010CB945204, 2009CB918500]; Key New Drug Creation and Manufacturing Program [2011ZX09102-010-03]; National Natural Science Foundation of China [90919031, 11021463]; 111 project; NSF [CMMI-0941355]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284] Funding Source: NIH RePORTER	National Basic Research Program of China (973 program)(National Basic Research Program of China); Key New Drug Creation and Manufacturing Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project(Ministry of Education, China - 111 Project); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Chengyan Wang and Xiaolei Yin for helpful discussions. We also thank Haisong Liu, Jiancheng Wang, Zhiyuan Hou, Ren Li, Fangfang Zhu, Dongyi Xu, and Xing Zhang for technical assistance. J.S., C.W., and Y.W. conducted most of the experiments in this study. Z.L. performed the computer analysis and mathematical model analysis. H.D., Y.Z., and C.T. conceived of and supervised the study. This work was supported by grants from the National Basic Research Program of China (973 program grant numbers 2012CB966401, 2009CB941101, 2010CB945204, and 2009CB918500), the Key New Drug Creation and Manufacturing Program (grant numbers 2011ZX09102-010-03), the National Natural Science Foundation of China (grant numbers 90919031 and 11021463), the 111 project, and NSF (CMMI-0941355).	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cao Q, 2012, DEVELOPMENT, V139, P3950, DOI 10.1242/dev.082024; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Guo G, 2010, DEVELOPMENT, V137, P3185, DOI 10.1242/dev.052753; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tontsch S, 2001, MECH DEVELOP, V108, P165, DOI 10.1016/S0925-4773(01)00477-4; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Yang P, 2011, STEM CELLS, V29, P791, DOI 10.1002/stem.634; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng WL, 2010, BIOCHEM BIOPH RES CO, V394, P1024, DOI 10.1016/j.bbrc.2010.03.115; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	52	206	225	10	215	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					963	975		10.1016/j.cell.2013.05.001	http://dx.doi.org/10.1016/j.cell.2013.05.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706735	Bronze, Green Accepted			2022-12-01	WOS:000319456800006
J	Huntingford, C; Jones, PD; Livina, VN; Lenton, TM; Cox, PM				Huntingford, Chris; Jones, Philip D.; Livina, Valerie N.; Lenton, Timothy M.; Cox, Peter M.			No increase in global temperature variability despite changing regional patterns	NATURE			English	Article							EXTREME EVENTS; CLIMATE; ERA-40; CMIP5; ICE	Evidence from Greenland ice cores shows that year-to-year temperature variability was probably higher in some past cold periods(1), but there is considerable interest in determining whether global warming is increasing climate variability at present(2-6). This interest is motivated by an understanding that increased variability and resulting extreme weather conditions may be more difficult for society to adapt to than altered mean conditions(3). So far, however, in spite of suggestions of increased variability(2), there is considerable uncertainty as to whether it is occurring(7). Here we show that although fluctuations in annual temperature have indeed shown substantial geographical variation over the past few decades(2), the time-evolving standard deviation of globally averaged temperature anomalies has been stable. A feature of the changes has been a tendency for many regions of low variability to experience increases, which might contribute to the perception of increased climate volatility. The normalization of temperature anomalies(2) creates the impression of larger relative overall increases, but our use of absolute values, which we argue is a more appropriate approach, reveals little change. Regionally, greater year-to-year changes recently occurred in much of North America and Europe. Many climate models predict that total variability will ultimately decrease under high greenhouse gas concentrations, possibly associated with reductions in sea-ice cover. Our findings contradict the view that a warming world will automatically be one of more overall climatic variation.	[Huntingford, Chris] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England; [Jones, Philip D.] Univ E Anglia, Fac Sci, Sch Environm Sci, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England; [Jones, Philip D.] King Abdulaziz Univ, Dept Meteorol, Ctr Excellence Climate Change Res, Jeddah 21589, Saudi Arabia; [Livina, Valerie N.] Univ E Anglia, Fac Sci, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Livina, Valerie N.] Natl Phys Lab, Teddington TW11 0LW, Middx, England; [Lenton, Timothy M.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4PS, Devon, England; [Cox, Peter M.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England	UK Centre for Ecology & Hydrology (UKCEH); University of East Anglia; King Abdulaziz University; University of East Anglia; National Physical Laboratory - UK; University of Exeter; University of Exeter	Huntingford, C (corresponding author), Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England.	chg@ceh.ac.uk	Livina, Valerie N/C-7636-2011; Lenton, Tim M/X-1893-2018; Cox, Peter Michae;/B-3299-2012; Jones, Philip Douglas/C-8718-2009; Huntingford, Christopher/A-4307-2008	Livina, Valerie N/0000-0003-3759-9013; Lenton, Tim M/0000-0002-6725-7498; Cox, Peter Michae;/0000-0002-0679-2219; Jones, Philip Douglas/0000-0001-5032-5493; Huntingford, Christopher/0000-0002-5941-7770	US DOE [DE-SC0005689]; NERC [NE/F005474/1]; Natural Environment Research Council [NE/F005474/1, ceh010023] Funding Source: researchfish	US DOE(United States Department of Energy (DOE)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We gratefully acknowledge the Newton Institute for Mathematical Sciences programme Mathematical and Statistical Approaches to Climate Modelling and Prediction. C. H. also acknowledges the CEH National Capability Budget. P.D.J. has been supported by the US DOE (grant DE-SC0005689). V.N.L. and T. M. L. were supported by NERC (grant NE/F005474/1).	Bender FAM, 2012, CLIM DYNAM, V38, P2037, DOI 10.1007/s00382-011-1065-6; Budikova D, 2009, GLOBAL PLANET CHANGE, V68, P149, DOI 10.1016/j.gloplacha.2009.04.001; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Dethloff K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025245; Field C.B., 2012, MANAGING RISKS EXTRE; Francis JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051000; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Hartmann B, 2005, J CLIMATE, V18, P4824, DOI 10.1175/JCLI3532.1; Johanson CM, 2009, J CLIMATE, V22, P2713, DOI 10.1175/2008JCLI2620.1; Jones CD, 2011, GEOSCI MODEL DEV, V4, P543, DOI 10.5194/gmd-4-543-2011; Jones PD, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017139; KATZ RW, 1992, CLIMATIC CHANGE, V21, P289, DOI 10.1007/BF00139728; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; Lu J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036076; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Rahmstorf S, 2011, P NATL ACAD SCI USA, V108, P17905, DOI 10.1073/pnas.1101766108; Raisanen J, 2002, J CLIMATE, V15, P2395, DOI 10.1175/1520-0442(2002)015<2395:CICIIT>2.0.CO;2; Rhines A, 2013, P NATL ACAD SCI USA, V110, pE546, DOI 10.1073/pnas.1218748110; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; Simmons AJ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012442; Simmons AJ, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD005306; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; TRENBERTH KE, 1990, B AM METEOROL SOC, V71, P988, DOI 10.1175/1520-0477(1990)071<0988:ROICCI>2.0.CO;2; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Zhou YP, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015197	31	162	163	5	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					327	+		10.1038/nature12310	http://dx.doi.org/10.1038/nature12310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23883935				2022-12-01	WOS:000323112400031
J	Zhang, JW; Ferre-D'Amare, AR				Zhang, Jinwei; Ferre-D'Amare, Adrian R.			Co-crystal structure of a T-box riboswitch stem I domain in complex with its cognate tRNA	NATURE			English	Article							AMINOACYL-TRANSFER-RNA; RIBOSOMAL-RNA; BACILLUS-SUBTILIS; RIBONUCLEASE-P; ANTITERMINATION; MOTIF; RECOGNITION; SYNTHETASE; TRNA(GLY); FEATURES	In Gram-positive bacteria, T-box riboswitches regulate the expression of aminoacyl-tRNA synthetases and other proteins in response to fluctuating transfer RNA aminoacylation levels under various nutritional states(1). T-boxes reside in the 5'-untranslated regions of the messenger RNAs they regulate, and consist of two conserved domains. Stem I contains the specifier trinucleotide that base pairs with the anticodon of cognate tRNA. 3' to stem I is the antiterminator domain, which base pairs with the tRNA acceptor end and evaluates its aminoacylation state(2). Despite high phylogenetic conservation and widespread occurrence in pathogens, the structural basis of tRNA recognition(3,4) by this riboswitch remains ill defined. Here we demonstrate that the similar to 100-nucleotide T-box stem I is necessary and sufficient for specific, high-affinity (dissociation constant (K-d) similar to 150 nM) tRNA binding, and report the structure of Oceanobacillus iheyensis glyQ stem I in complex with its cognate tRNA at 3.2 angstrom resolution. Stem I recognizes the overall architecture of tRNA in addition to its anticodon, something accomplished by large ribonucleoproteins such as the ribosome, or proteins such as aminoacyl-tRNA synthetases(5), but is unprecedented for a compact mRNA domain. The C-shaped stem I cradles the L-shaped tRNA, forming an extended (1,604 angstrom(2)) intermolecular interface. In addition to the specifier-anticodon interaction, two interdigitated T-loops near the apex of stem I stack on the tRNA elbow in a manner analogous to those of the J11/12-J12/11 motif(6) of RNase P and the L1 stalk(7) of the ribosomal E-site. Because these ribonucleoproteins and T-boxes are unrelated, this strategy to recognize a universal tRNA feature probably evolved convergently. Mutually induced fit of stem I and the tRNA exploiting the intrinsic flexibility of tRNA and its conserved post-transcriptional modifications results in high shape complementarity, which in addition to providing specificity and affinity, globally organizes the T-box to orchestrate tRNA-dependent transcription regulation.	[Zhang, Jinwei; Ferre-D'Amare, Adrian R.] NHLBI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Ferre-D'Amare, AR (corresponding author), NHLBI, 50 South Dr,MSC 8012, Bethesda, MD 20892 USA.	adrian.ferre@nih.gov	Zhang, Jinwei/AAU-9195-2020	Zhang, Jinwei/0000-0002-2114-173X	National Institute for General Medical Sciences, National Institutes of Health (NIH); US Department of Energy; intramural program of the National Heart, Lung, and Blood Institute, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006102] Funding Source: NIH RePORTER	National Institute for General Medical Sciences, National Institutes of Health (NIH); US Department of Energy(United States Department of Energy (DOE)); intramural program of the National Heart, Lung, and Blood Institute, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the staff at beamlines 24-ID-C and 24-ID-E of APS and 5.0.1 and 5.0.2 of the ALS for crystallographic data collection support, G. Piszczek for ITC support, R. Levine and D.-Y. Lee for help with mass spectrometry, K. Perry and K. R. Rajashankar for assistance with initial crystallographic phasing, and N. Baird, T. Hamma, C. Jones, M. Lau, J. Posakony, A. Roll-Mecak, O. Uhlenbeck and K. Warner for discussions. This work is partly based on research conducted at the APS on the Northeastern Collaborative Access Team (NE-CAT) beamlines, and at the ALS on the Berkeley Center for Structural Biology beamlines, which are both supported by the National Institute for General Medical Sciences, National Institutes of Health (NIH). Use of ALS and APS was supported by the US Department of Energy. This work was supported in part by the intramural program of the National Heart, Lung, and Blood Institute, NIH.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baird NJ, 2013, RNA, V19, P167, DOI 10.1261/rna.036269.112; Baird NJ, 2012, RNA, V18, P759, DOI 10.1261/rna.031518.111; Baird NJ, 2010, RNA, V16, P598, DOI 10.1261/rna.1852310; Byrne RT, 2010, NUCLEIC ACIDS RES, V38, P4154, DOI 10.1093/nar/gkq133; Chan C. W., 2013, WILEY INTERDISC 0623; Chang AT, 2012, BIOCHEMISTRY-US, V51, P3662, DOI 10.1021/bi201900j; Correll CC, 1997, CELL, V91, P705, DOI 10.1016/S0092-8674(00)80457-2; Dalluge JJ, 1996, NUCLEIC ACIDS RES, V24, P1073, DOI 10.1093/nar/24.6.1073; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Edwards TE, 2007, CURR OPIN STRUC BIOL, V17, P273, DOI 10.1016/j.sbi.2007.05.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Green NJ, 2010, FEBS LETT, V584, P318, DOI 10.1016/j.febslet.2009.11.056; Grigg JC, 2013, P NATL ACAD SCI USA, V110, P7240, DOI 10.1073/pnas.1222214110; GRUNDY FJ, 1993, CELL, V74, P475, DOI 10.1016/0092-8674(93)80049-K; Gutierrez-Preciado A, 2009, MICROBIOL MOL BIOL R, V73, P36, DOI 10.1128/MMBR.00026-08; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Krasilnikov AS, 2003, NATURE, V421, P760, DOI 10.1038/nature01386; Kulshina N, 2010, RNA, V16, P186, DOI 10.1261/rna.1847310; Lehmann J, 2013, NUCLEIC ACIDS RES, V41, P5494, DOI 10.1093/nar/gkt219; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Leontis NB, 1998, RNA, V4, P1134, DOI 10.1017/S1355838298980566; Lescoute A, 2005, NUCLEIC ACIDS RES, V33, P2395, DOI 10.1093/nar/gki535; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nikulin A, 2003, NAT STRUCT BIOL, V10, P104, DOI 10.1038/nsb886; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perona JJ, 2012, BIOCHEMISTRY-US, V51, P8705, DOI 10.1021/bi301180x; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Vitreschak AG, 2008, RNA, V14, P717, DOI 10.1261/rna.819308; Wang JC, 2011, J MOL BIOL, V408, P99, DOI 10.1016/j.jmb.2011.02.014; Winkler WC, 2001, RNA, V7, P1165, DOI 10.1017/S1355838201002370; Winkler WC, 2002, THESIS OHIO STATE U; Xiao H, 2008, CHEM BIOL, V15, P1125, DOI 10.1016/j.chembiol.2008.09.004; Xiao H, 2008, NATURE, V454, P358, DOI 10.1038/nature07033; Yousef MR, 2005, J MOL BIOL, V349, P273, DOI 10.1016/j.jmb.2005.03.061; Yousef MR, 2003, RNA, V9, P1148, DOI 10.1261/rna.5540203	52	101	104	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 15	2013	500	7462					363	+		10.1038/nature12440	http://dx.doi.org/10.1038/nature12440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23892783	Green Accepted			2022-12-01	WOS:000323112400039
J	Zhang, ZR; Bonifacino, JS; Hegde, RS				Zhang, Zai-Rong; Bonifacino, Juan S.; Hegde, Ramanujan S.			Deubiquitinases Sharpen Substrate Discrimination during Membrane Protein Degradation from the ER	CELL			English	Article							VPU PROTEIN; IN-VITRO; TRANSMEMBRANE DOMAIN; CYTOPLASMIC DOMAIN; QUALITY-CONTROL; CD4; MECHANISM; COMPLEX; UBIQUITINATION; TAIL	Newly synthesized membrane proteins are queried by ubiquitin ligase complexes and triaged between degradative and nondegradative fates. The mechanisms that convert modest differences in substrateligase interactions into decisive outcomes of ubiquitination are not well understood. Here, we reconstitute membrane protein recognition and ubiquitination in liposomes using purified components from a viral-mediated degradation pathway. We find that substrate-ligase interactions in the membrane directly influence processivity of ubiquitin attachment to modulate polyubiquitination. Unexpectedly, differential processivity alone could not explain the differential fates in cultured cells of degraded and nondegraded clients. Both computational and experimental analyses identified continuous deubiquitination as a prerequisite for maximal substrate discrimination. Deubiquitinases reduce polyubiquitin dwell times preferentially on clients that dissociate more rapidly from the ligase. This explains how small differences in substrate-ligase interaction can be amplified into larger differences in net degradation. These results provide a conceptual framework for substrate discrimination during membrane protein quality control.	[Zhang, Zai-Rong; Bonifacino, Juan S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Hegde, Ramanujan S.] MRC Lab Mol Biol, Cambridge CB2 0QH, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); MRC Laboratory Molecular Biology	Zhang, ZR (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, Nanobiol Inst, Orange, CT 06477 USA.	zairong.zhang@gmail.com; rhegde@mrc-lmb.cam.ac.uk	Zhang, Zairong/G-1030-2013	ZHANG, ZAIRONG/0000-0001-9768-0548; Hegde, Ramanujan/0000-0001-8338-852X; Bonifacino, Juan S./0000-0002-5673-6370	NIH; Medical Research Council of the UK; MRC [MC_UP_A022_1007] Funding Source: UKRI; Medical Research Council [MC_UP_A022_1007] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607, ZIAHD008909] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank R. Deshaies, B. Schulman, X. Yang, H. Ploegh, and V. Denic for reagents, M. Mariappan, J. Magada n, M.M. Babu, S. Shao, and M. RodrigoBrenni for discussions, and A. Sharma for technical support. This research was supported by the Intramural Research Program of the NIH, Intramural AIDS Targeted Antiviral Program of the NIH, and the Medical Research Council of the UK. Z.-R.Z. designed most of the experiments, performed all of the experiments, analyzed data, and helped draft the paper; R.S.H. conceived and guided the project, designed some of the experiments, analyzed data, and wrote the paper with input from Z.-R.Z.; J.S.B. provided advice, support, and comments on the paper.	Blount JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036542; BOUR S, 1995, J VIROL, V69, P1510, DOI 10.1128/JVI.69.3.1510-1520.1995; CHEN MY, 1993, J VIROL, V67, P3877, DOI 10.1128/JVI.67.7.3877-3884.1993; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Furman MH, 2002, J BIOL CHEM, V277, P3258, DOI 10.1074/jbc.M109765200; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; Grove DE, 2011, MOL BIOL CELL, V22, P301, DOI 10.1091/mbc.E10-09-0760; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hassiepen U, 2007, ANAL BIOCHEM, V371, P201, DOI 10.1016/j.ab.2007.07.034; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Ishikura S, 2010, J BIOL CHEM, V285, P23916, DOI 10.1074/jbc.M110.127936; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; Li T, 2005, METHOD ENZYMOL, V398, P125, DOI 10.1016/S0076-6879(05)98012-9; Magadan JG, 2012, J VIROL, V86, P757, DOI 10.1128/JVI.05933-11; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Melikova MS, 2006, CELL BIOL INT, V30, P31, DOI 10.1016/j.cellbi.2005.09.003; Meusser B, 2004, MOL CELL, V14, P247, DOI 10.1016/S1097-2765(04)00212-6; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nomaguchi M, 2008, MICROBES INFECT, V10, P960, DOI 10.1016/j.micinf.2008.07.006; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; SCHUBERT U, 1994, J VIROL, V68, P2260, DOI 10.1128/JVI.68.4.2260-2271.1994; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Sharma A, 2010, METHODS MOL BIOL, V619, P339, DOI 10.1007/978-1-60327-412-8_20; Singh SK, 2012, FEBS J, V279, P3705, DOI 10.1111/j.1742-4658.2012.08732.x; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tian XF, 2011, ASSAY DRUG DEV TECHN, V9, P165, DOI 10.1089/adt.2010.0317; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025	50	50	50	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 1	2013	154	3					609	622		10.1016/j.cell.2013.06.038	http://dx.doi.org/10.1016/j.cell.2013.06.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	194JY	23890821	hybrid, Green Published			2022-12-01	WOS:000322629900014
J	Dyer, O				Dyer, Owen			The growth of medical marijuana	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												owen_dyer@hotmail.com						Anderson D. M., 2011, MED MARIJUANA LAWS T; [Anonymous], CANN READ GLOB ISS L; [Anonymous], 2013, MAR ITS LEG NOW WHAT; [Anonymous], 2012 AR YOUTH SURV; Grinspoon L, 2005, HIST CANNABIS MED DR; Harper S, 2012, ANN EPIDEMIOL, V22, P207, DOI 10.1016/j.annepidem.2011.12.002; Joy JE, 1999, MARIJUANA MED ASSESS; Korn P, 2010, PORTLAND TRIBUN 0414; Lynne-Landsman SD, 2013, AM J PUBLIC HEALTH, V103, P1500, DOI 10.2105/AJPH.2012.301117	9	4	4	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2013	347								f4755	10.1136/bmj.f4755	http://dx.doi.org/10.1136/bmj.f4755			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BI	23903247				2022-12-01	WOS:000322822200008
J	Moynihan, R; Glassock, R; Doust, J				Moynihan, Ray; Glassock, Richard; Doust, Jenny			Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR-DISEASE; POPULATION; PREVALENCE; MORTALITY; ALBUMINURIA; ASSOCIATION; QUALITY; HEALTH; IMPACT		[Moynihan, Ray; Doust, Jenny] Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia; [Glassock, Richard] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Bond University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Moynihan, R (corresponding author), Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia.	raymoynihan@bond.edu.au	Doust, Jenny/AGI-8773-2022; Moynihan, Ray/ABC-3010-2020	Doust, Jenny/0000-0002-4024-9308; 				[Anonymous], 2002, KIDN DIS OUTC QUAL I; [Anonymous], 2012, BMJ; [Anonymous], 2013, KIDNEY INT S, V3; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Crinson I, 2010, BRIT J GEN PRACT, V60, P403, DOI 10.3399/bjgp10X502100; De Boer IH., 2012, JAMA-J AM MED ASSOC, V308, P1; den Hartog JR, 2009, CLIN J AM SOC NEPHRO, V4, P419, DOI 10.2215/CJN.04080808; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; Drawz PE, 2012, AM HEART J, V164, P925, DOI 10.1016/j.ahj.2012.09.003; Eriksen BO, 2007, KIDNEY INT, V72, P1242, DOI 10.1038/sj.ki.5002472; Fink HA, 2012, COMP EFFECTIVENESS R; Glassock RJ, 2008, NEPHROL DIAL TRANSPL, V23, P1117, DOI 10.1093/ndt/gfn086; Glassock RJ, 2010, CURR HYPERTENS REP, V12, P364, DOI 10.1007/s11906-010-0133-3; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Hoy WE, 1998, KIDNEY INT, V54, P1296, DOI 10.1046/j.1523-1755.1998.00099.x; Kidney Health Australia, 2012, CHRON KIDN DIS MAN G; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Moyer VA, 2012, ANN INTERN MED, V157, P567, DOI 10.7326/0003-4819-157-8-201210160-00533; National Institute for Health and Care Excellence, CHRON KIDN DIS EARL; National Institute for Health and Care Excellence, QUAL OUTC FRAM; National Kidney Foundation, CHRON KIDN DIS; National Kidney Foundation, 2012, CHRON KIDN DIS; National Kidney Foundation/, 2012, KDIGO GUID CKD CLASS; National Kidney Foundation, 2002, AM J KIDNEY DIS S, V39, pS17; Nissenson AR, 2001, AM J KIDNEY DIS, V37, P1177, DOI 10.1053/ajkd.2001.24520; Noble E, 2008, NEPHROL DIAL TRANSPL, V23, P3845, DOI 10.1093/ndt/gfn385; O'Hare AM, 2013, JAMA-J AM MED ASSOC, V309, P1343, DOI 10.1001/jama.2013.1328; Parikh NI, 2008, AM J CARDIOL, V102, P47, DOI 10.1016/j.amjcard.2008.02.095; Phillips LA, 2009, QJM-INT J MED, V102, P415, DOI 10.1093/qjmed/hcp030; Pickering Thomas G, 2006, J Clin Hypertens (Greenwich), V8, P57, DOI 10.1111/j.1524-6175.2005.05121.x; Rutkowski M, 2009, AM J KIDNEY DIS, V53, pS86, DOI 10.1053/j.ajkd.2008.07.052; Samal L, 2013, CLIN J AM SOC NEPHRO, V8, P131, DOI 10.2215/CJN.12681211; Schaeffner ES, 2012, ANN INTERN MED, V157, P471, DOI 10.7326/0003-4819-157-7-201210020-00003; Spence D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3188; Weiner DE, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.05.054; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Winearls CG, 2010, NEFROLOGIA, V30, P493, DOI 10.3265/Nefrologia.pre2010.Jul.10501; Winearls CG, 2011, NEPHRON CLIN PRACT, V119, pC2, DOI 10.1159/000328013	42	97	100	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2013	347								f4298	10.1136/bmj.f4298	http://dx.doi.org/10.1136/bmj.f4298			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197BE	23900313				2022-12-01	WOS:000322821500001
J	Wang, Z; Chinoy, ZS; Ambre, SG; Peng, WJ; McBride, R; de Vries, RP; Glushka, J; Paulson, JC; Boons, GJ				Wang, Zhen; Chinoy, Zoeisha S.; Ambre, Shailesh G.; Peng, Wenjie; McBride, Ryan; de Vries, Robert P.; Glushka, John; Paulson, James C.; Boons, Geert-Jan			A General Strategy for the Chemoenzymatic Synthesis of Asymmetrically Branched N-Glycans	SCIENCE			English	Article							RECEPTOR SPECIFICITY; INFLUENZA-VIRUSES; GLYCOSYLATION; OLIGOSACCHARIDE; GLYCOMICS; BINDING; HEMAGGLUTININ; TRANSMISSION; MICROARRAYS; ACTIVATION	A systematic, efficient means of producing diverse libraries of asymmetrically branched N-glycans is needed to investigate the specificities and biology of glycan-binding proteins. To that end, we describe a core pentasaccharide that at potential branching positions is modified by orthogonal protecting groups to allow selective attachment of specific saccharide moieties by chemical glycosylation. The appendages were selected so that the antenna of the resulting deprotected compounds could be selectively extended by glycosyltransferases to give libraries of asymmetrical multi-antennary glycans. The power of the methodology was demonstrated by the preparation of a series of complex oligosaccharides that were printed as microarrays and screened for binding to lectins and influenza-virus hemagglutinins, which showed that recognition is modulated by presentation of minimal epitopes in the context of complex N-glycans.	[Wang, Zhen; Chinoy, Zoeisha S.; Ambre, Shailesh G.; Glushka, John; Boons, Geert-Jan] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Chinoy, Zoeisha S.; Ambre, Shailesh G.; Boons, Geert-Jan] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Peng, Wenjie; McBride, Ryan; de Vries, Robert P.; Paulson, James C.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Peng, Wenjie; McBride, Ryan; de Vries, Robert P.; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Scripps Research Institute; Scripps Research Institute	Boons, GJ (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	gjboons@ccrc.uga.edu	Chinoy, Zoeisha S/K-3974-2015; Boons, Geert-Jan P H/J-3211-2016; de Vries, Robert/K-7212-2013; McBride, Ryan/E-6812-2011; Paulson, James/AAG-3565-2019	Boons, Geert-Jan P H/0000-0003-3111-5954; Chinoy, Zoeisha/0000-0003-4654-5711; de Vries, Robert/0000-0002-1586-4464; Peng, Wenjie/0000-0001-5093-7115	NIH from the National Center for Research Resources [P41RR005351]; National Institute of General Medical Sciences [P41GM103390, R01GM090269]; Institute of Allergy and Infectious Disease [AI058113]; Centers for Disease Control; Netherlands Organization for Scientific Research (NWO); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, R01GM090269] Funding Source: NIH RePORTER	NIH from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grant P41RR005351 from the National Center for Research Resources (G.J.-B. and J.G.), National Institute of General Medical Sciences grants P41GM103390 (G.J.B. and J.G.) and R01GM090269 (G.J.-B.), Institute of Allergy and Infectious Disease grant AI058113 (J.C.P.), and a contract from the Centers for Disease Control (J.C.P.). R.P.d.V. is a recipient of a Rubicon grant from the Netherlands Organization for Scientific Research (NWO). We thank A. Crie and M. Wolfert for assistance in preparation of the manuscript, K. Moremen (University of Georgia) for providing ST6Gal-1 and ST3Gal-IV, and P. Wu (Albert Einstein College of Medicine) and W. Wakarchuk (Ryerson University) for providing the plasmids for alpha 1,3FucT and beta 1,3GlcNAcT, respectively. G.J.-B. conceived the idea, Z.W. performed the chemical synthesis, S. G. A. assisted with chemical synthesis, Z.S.C. performed the enzymatic transformations, and W. P. and Z.W. assisted with the enzymatic transformation. Z.S.C. and J.G. performed the analysis of the complex glycans. W. P. performed the attachment of the reactive linker to the glycans, R. M. performed the microarray screening, R.P.d.V. prepared the influenza HA, and J.C.P. supervised and analyzed the microarray studies. G.J.-B. and J.C.P. wrote the paper. The data for this report are archived as supplementary materials on Science Online. A patent application related to the described chemoenzymatic approach has been filed by the University of Georgia Research Foundation and lists G.J.-B and Z.W. as inventors. The authors declare no competing financial interests.	Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Blixt O, 2006, METHOD ENZYMOL, V415, P137, DOI 10.1016/S0076-6879(06)15009-0; Bohorov O, 2006, GLYCOBIOLOGY, V16, p21C, DOI 10.1093/glycob/cwl044; Boltje TJ, 2009, NAT CHEM, V1, P611, DOI [10.1038/NCHEM.399, 10.1038/nchem.399]; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Gabius HJ, 2011, TRENDS BIOCHEM SCI, V36, P298, DOI 10.1016/j.tibs.2011.01.005; Hanashima S, 2005, ANGEW CHEM INT EDIT, V44, P4218, DOI 10.1002/anie.200500777; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Itakura Y, 2007, J BIOCHEM, V142, P459, DOI 10.1093/jb/mvm153; Jonke S, 2006, CHEM-EUR J, V12, P1274, DOI 10.1002/chem.200500707; Laurent N, 2008, CHEM COMMUN, P4400, DOI 10.1039/b806983m; Lepenies B, 2010, CURR OPIN CHEM BIOL, V14, P404, DOI 10.1016/j.cbpa.2010.02.016; Marino K, 2010, NAT CHEM BIOL, V6, P713, DOI [10.1038/nchembio.437, 10.1038/NCHEMBIO.437]; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; North SJ, 2009, CURR OPIN STRUC BIOL, V19, P498, DOI 10.1016/j.sbi.2009.05.005; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Palcic MM, 2011, CURR OPIN CHEM BIOL, V15, P226, DOI 10.1016/j.cbpa.2010.11.022; Pearce MB, 2012, P NATL ACAD SCI USA, V109, P3944, DOI 10.1073/pnas.1119945109; Ranzinger R, 2009, GLYCOBIOLOGY, V19, P1563, DOI 10.1093/glycob/cwp137; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Sauerzapfe B, 2009, GLYCOCONJUGATE J, V26, P141, DOI 10.1007/s10719-008-9172-2; Schmaltz RM, 2011, CHEM REV, V111, P4259, DOI 10.1021/cr200113w; SCHMIDT RR, 1994, ADV CARBOHYD CHEM BI, V50, P21, DOI 10.1016/S0065-2318(08)60150-X; Serna S, 2010, CHEM-EUR J, V16, P13163, DOI 10.1002/chem.201001295; SPIK G, 1985, FEBS LETT, V183, P65, DOI 10.1016/0014-5793(85)80955-8; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Sun B, 2008, CHEM-EUR J, V14, P7072, DOI 10.1002/chem.200800757; Unverzagt C, 1996, ANGEW CHEM INT EDIT, V35, P2350, DOI 10.1002/anie.199623501; Unverzagt C, 2009, CHEM-EUR J, V15, P12292, DOI 10.1002/chem.200901908; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Walczak MA, 2012, J AM CHEM SOC, V134, P16430, DOI 10.1021/ja307628w; Walther T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003223; Wang W, 2009, P NATL ACAD SCI USA, V106, P16096, DOI 10.1073/pnas.0908248106; Yu B, 2001, TETRAHEDRON LETT, V42, P2405, DOI 10.1016/S0040-4039(01)00157-5; Zhu XM, 2009, ANGEW CHEM INT EDIT, V48, P1900, DOI 10.1002/anie.200802036	38	242	266	1	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 26	2013	341	6144					379	383		10.1126/science.1236231	http://dx.doi.org/10.1126/science.1236231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888036	Green Accepted			2022-12-01	WOS:000322259200045
J	Kaltenbrunner, M; Sekitani, T; Reeder, J; Yokota, T; Kuribara, K; Tokuhara, T; Drack, M; Schwodiauer, R; Graz, I; Bauer-Gogonea, S; Bauer, S; Someya, T				Kaltenbrunner, Martin; Sekitani, Tsuyoshi; Reeder, Jonathan; Yokota, Tomoyuki; Kuribara, Kazunori; Tokuhara, Takeyoshi; Drack, Michael; Schwoediauer, Reinhard; Graz, Ingrid; Bauer-Gogonea, Simona; Bauer, Siegfried; Someya, Takao			An ultra-lightweight design for imperceptible plastic electronics	NATURE			English	Article							FIELD-EFFECT TRANSISTORS; ORGANIC TRANSISTORS; THIN-FILM; N-CHANNEL; SILICON; PERFORMANCE; CIRCUITS; SEMICONDUCTORS; MECHANICS; PRESSURE	Electronic devices have advanced from their heavy, bulky origins to become smart, mobile appliances. Nevertheless, they remain rigid, which precludes their intimate integration into everyday life. Flexible, textile and stretchable electronics are emerging research areas and may yield mainstream technologies(1-3). Rollable and unbreakable backplanes with amorphous silicon field-effect transistors on steel substrates only 3 mu m thick have been demonstrated(4). On polymer substrates, bending radii of 0.1 mm have been achieved inflexible electronic devices(5-7). Concurrently, the need for compliant electronics that can not only be flexed but also conform to three-dimensional shapes has emerged(3). Approaches include the transfer of ultrathin polyimide layers encapsulating silicon CMOS circuits onto pre-stretched elastomers(8), the use of conductive elastomers integrated with organic field-effect transistors (OFETs) on polyimide islands(9), and fabrication of OFETs and gold interconnects on elastic substrates(10) to realize pressure, temperature and optical sensors(11-14). Here we present a platform that makes electronics both virtually unbreakable(4) and imperceptible. Fabricated directly on ultrathin (1 mu m) polymer foils, our electronic circuits are light (3 g m(-2)) and ultraflexible and conform to their ambient, dynamic environment. Organic transistors with an ultra-dense oxide gate dielectric a few nanometres thick formed at room temperature enable sophisticated large-area electronic foils with unprecedented mechanical and environmental stability: they withstand repeated bending to radii of 5 mu m and less, can be crumpled like paper, accommodate stretching up to 230% on prestrained elastomers, and can be operated at high temperatures and in aqueous environments. Because manufacturing costs of organic electronics are potentially low, imperceptible electronic foils may be as common in the future as plastic wrap is today. Applications include matrix-addressed tactile sensor foils for health care and monitoring, thin-film heaters, temperature and infrared sensors, displays(15), and organic solar cells(16).	[Kaltenbrunner, Martin; Sekitani, Tsuyoshi; Reeder, Jonathan; Yokota, Tomoyuki; Kuribara, Kazunori; Tokuhara, Takeyoshi; Someya, Takao] Univ Tokyo, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan; [Kaltenbrunner, Martin; Sekitani, Tsuyoshi; Someya, Takao] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Bunkyo Ku, Tokyo 1130032, Japan; [Kaltenbrunner, Martin; Drack, Michael; Schwoediauer, Reinhard; Graz, Ingrid; Bauer-Gogonea, Simona; Bauer, Siegfried] Johannes Kepler Univ Linz, A-4040 Linz, Austria	University of Tokyo; Japan Science & Technology Agency (JST); Johannes Kepler University Linz	Someya, T (corresponding author), Univ Tokyo, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	martin@ntech.t.u-tokyo.ac.jp; someya@ee.t.u-tokyo.ac.jp	Sekitani, Tsuyoshi/G-4599-2018; Someya, Takao/H-3052-2015; Kaltenbrunner, Martin/G-8743-2012; Graz, Ingrid/AFP-2308-2022; Bauer, Siegfried/A-2354-2009; Kuribara, Kazunori/M-2674-2018; Reeder, Jonathan/T-5358-2018; Graz, Ingrid/A-7994-2011	Someya, Takao/0000-0003-3051-1138; Kaltenbrunner, Martin/0000-0002-7247-9183; Graz, Ingrid/0000-0001-7205-4161; Bauer, Siegfried/0000-0002-7770-9435; Kuribara, Kazunori/0000-0003-2746-1467; Reeder, Jonathan/0000-0002-7624-7355; Graz, Ingrid/0000-0001-7205-4161; Bauer-Gogonea, Simona/0000-0002-6538-3992	JST Someya Bio-Harmonized ERATO; ERC; Wilhelm Macke Foundation; mobility programme of the Johannes Kepler University Linz (KIP)	JST Someya Bio-Harmonized ERATO; ERC(European Research Council (ERC)European Commission); Wilhelm Macke Foundation; mobility programme of the Johannes Kepler University Linz (KIP)	We thank I. Abfalter for discussions. This work was supported by the JST Someya Bio-Harmonized ERATO grant and the ERC Advanced Investigators Grant 'Soft-Map' of S. Bauer. M. K. acknowledges financial support from the Wilhelm Macke Foundation and the mobility programme of the Johannes Kepler University Linz (KIP).	Baeg KJ, 2011, J POLYM SCI POL PHYS, V49, P62, DOI 10.1002/polb.22148; BAUER S, 1990, J APPL PHYS, V68, P6361, DOI 10.1063/1.346882; Cherenack K, 2012, J APPL PHYS, V112, DOI 10.1063/1.4742728; de Almeida LAL, 2004, APPL PHYS LETT, V85, P3605, DOI 10.1063/1.1808890; Facchetti A, 2005, ADV MATER, V17, P1705, DOI 10.1002/adma.200500517; Garditz C, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2711708; Geib S, 2013, ADV FUNCT MATER, V23, P3866, DOI 10.1002/adfm.201203600; Gonzalez M., 2010, 11 INT C THERM MECH, P1; Graz IM, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3570661; Jung BJ, 2010, ADV FUNCT MATER, V20, P2930, DOI 10.1002/adfm.201000655; Kaltenbrunner M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1772; Khang DY, 2006, SCIENCE, V311, P208, DOI 10.1126/science.1121401; Kim DH, 2008, SCIENCE, V320, P507, DOI 10.1126/science.1154367; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Klauk H, 2007, NATURE, V445, P745, DOI 10.1038/nature05533; Lipomi DJ, 2011, NAT NANOTECHNOL, V6, P788, DOI [10.1038/NNANO.2011.184, 10.1038/nnano.2011.184]; LOHRENGEL MM, 1993, MAT SCI ENG R, V11, P243, DOI 10.1016/0927-796X(93)90005-N; Ma EY, 1999, APPL PHYS LETT, V74, P2661, DOI 10.1063/1.123930; Mardare AI, 2012, PHYS STATUS SOLIDI A, V209, P813, DOI 10.1002/pssa.201100785; Oh DW, 2011, ADV MATER, V23, P5028, DOI 10.1002/adma.201102994; Oh JH, 2010, ADV FUNCT MATER, V20, P2148, DOI 10.1002/adfm.201000425; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Sekitani T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2115075; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Sekitani T, 2010, NAT MATER, V9, P1015, DOI 10.1038/NMAT2896; Shahrjerdi D, 2013, NANO LETT, V13, P315, DOI 10.1021/nl304310x; Sokolov AN, 2012, ACCOUNTS CHEM RES, V45, P361, DOI 10.1021/ar2001233; Someya T, 2005, P NATL ACAD SCI USA, V102, P12321, DOI 10.1073/pnas.0502392102; Suo Z, 1999, APPL PHYS LETT, V74, P1177, DOI 10.1063/1.123478; Tu KN, 2003, J APPL PHYS, V94, P5451, DOI 10.1063/1.1611263; Usta H, 2008, J AM CHEM SOC, V130, P8580, DOI 10.1021/ja802266u; Wagner S, 2012, MRS BULL, V37, P207, DOI 10.1557/mrs.2012.37; Wang B, 2013, INFRARED PHYS TECHN, V57, P8, DOI 10.1016/j.infrared.2012.10.006; White M. S., NATURE PHOT IN PRESS; Wong W. S., 2010, FLEXIBLE ELECT MAT A; Yamamoto T, 2007, J AM CHEM SOC, V129, P2224, DOI 10.1021/ja068429z; Yan H, 2009, NATURE, V457, P679, DOI 10.1038/nature07727; Zang J., 2013, NAT MATER, V12, P1; Zhang XH, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3077025; Zschieschang U, 2012, J MATER CHEM, V22, P4273, DOI 10.1039/c1jm14917b	40	1778	1821	114	2435	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 25	2013	499	7459					458	+		10.1038/nature12314	http://dx.doi.org/10.1038/nature12314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187YP	23887430				2022-12-01	WOS:000322157900036
J	Palmer, TM; Nordestgaard, BG; Benn, M; Tybjaerg-Hansen, A; Smith, GD; Lawlor, DA; Timpson, NJ				Palmer, Tom M.; Nordestgaard, Borge G.; Benn, Marianne; Tybjaerg-Hansen, Anne; Smith, George Davey; Lawlor, Debbie A.; Timpson, Nicholas J.			Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SERUM URATE; TRANSPORTER SLC2A9; GENERAL-POPULATION; ALL-CAUSE; RISK; MORTALITY	Objectives To assess the associations between both uric acid levels and hyperuricaemia, with ischaemic heart disease and blood pressure, and to explore the potentially confounding role of body mass index. Design Mendelian randomisation analysis, using variation at specific genes (SLC2A9 (rs7442295) as an instrument for uric acid; and FTO (rs9939609), MC4R (rs17782313), and TMEM18 (rs6548238) for body mass index). Setting Two large, prospective cohort studies in Denmark. Participants We measured levels of uric acid and related covariables in 58 072 participants from the Copenhagen General Population Study and 10 602 from the Copenhagen City Heart Study, comprising 4890 and 2282 cases of ischaemic heart disease, respectively. Main outcome Blood pressure and prospectively assessed ischaemic heart disease. Results Estimates confirmed known observational associations between plasma uric acid and hyperuricaemia with risk of ischaemic heart disease and diastolic and systolic blood pressure. However, when using genotypic instruments for uric acid and hyperuricaemia, we saw no evidence for causal associations between uric acid, ischaemic heart disease, and blood pressure. We used genetic instruments to investigate body mass index as a potentially confounding factor in observational associations, and saw a causal effect on uric acid levels. Every four unit increase of body mass index saw a rise in uric acid of 0.03 mmol/L (95% confidence interval 0.02 to 0.04), and an increase in risk of hyperuricaemia of 7.5% (3.9% to 11.1%). Conclusion By contrast with observational findings, there is no strong evidence for causal associations between uric acid and ischaemic heart disease or blood pressure. However, evidence supports a causal effect between body mass index and uric acid level and hyperuricaemia. This finding strongly suggests body mass index as a confounder in observational associations, and suggests a role for elevated body mass index or obesity in the development of uric acid related conditions.	[Palmer, Tom M.] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Warwick, England; [Smith, George Davey; Lawlor, Debbie A.; Timpson, Nicholas J.] Univ Bristol, Med Res Council Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Nordestgaard, Borge G.; Benn, Marianne; Tybjaerg-Hansen, Anne] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Nordestgaard, Borge G.; Benn, Marianne; Tybjaerg-Hansen, Anne] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Nordestgaard, Borge G.; Benn, Marianne; Tybjaerg-Hansen, Anne] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Tybjaerg-Hansen, Anne] Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark	University of Warwick; University of Bristol; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Timpson, NJ (corresponding author), Univ Bristol, Med Res Council Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England.	n.j.timpson@bristol.ac.uk	Nordestgaard, Borge Gronne/ABF-1310-2020; Fox, Laura J/C-6249-2016; Davey Smith, George/A-7407-2013; Benn, Marianne/O-4164-2019; Attrill, Lauren/V-1688-2018; Timpson, Nicholas John/O-7548-2015	Davey Smith, George/0000-0002-1407-8314; Benn, Marianne/0000-0002-1701-595X; Timpson, Nicholas John/0000-0002-7141-9189; Lawlor, Debbie A/0000-0002-6793-2262; Nordestgaard, Borge/0000-0002-1954-7220; Palmer, Tom/0000-0003-4655-4511; s, hema/0000-0002-3440-9475	UK Medical Research Council [G0601625]; Danish Heart Foundation; Danish Medical Research Council; Copenhagen County Foundation; Herlev Hospital, Copenhagen University Hospital; MRC [G0601625, MC_UU_12013/1, MC_UU_12013/5, MC_UU_12013/3] Funding Source: UKRI; Medical Research Council [MC_UU_12013/1, G0601625, MC_UU_12013/5, MC_UU_12013/3] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Heart Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Copenhagen County Foundation; Herlev Hospital, Copenhagen University Hospital; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	NJT, DAL, and GDS work in the UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol. TMP also received support from a UK Medical Research Council grant (G0601625). The Copenhagen General Population Study and Copenhagen City Heart Study are supported by the Danish Heart Foundation, Danish Medical Research Council, Copenhagen County Foundation, and Herlev Hospital, Copenhagen University Hospital. All researchers operate independently of the funding bodies noted in this disclosure.	Alderman M, 2004, CURR MED RES OPIN, V20, P369, DOI 10.1185/030079904125002982; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ANGRIST JD, 1995, J AM STAT ASSOC, V90, P431, DOI 10.2307/2291054; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Brandstatter A, 2008, DIABETES CARE, V31, P1662, DOI 10.2337/dc08-0349; Burgess S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7325; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Deveci OS, 2010, INT J CLIN PRACT, V64, P900, DOI 10.1111/j.1742-1241.2009.02263.x; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Ishizaka N, 2010, J RHEUMATOL, V37, P410, DOI 10.3899/jrheum.090736; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Liese AD, 1999, EPIDEMIOLOGY, V10, P391, DOI 10.1097/00001648-199907000-00009; Lyngdoh T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039321; McKeigue PM, 2010, INT J EPIDEMIOL, V39, P907, DOI 10.1093/ije/dyp397; Meisinger C, 2008, ARTERIOSCL THROM VAS, V28, P1186, DOI 10.1161/ATVBAHA.107.160184; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Nordestgaard BG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001212; Parsa A, 2012, KIDNEY INT, V81, P502, DOI 10.1038/ki.2011.414; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Sethi AA, 2001, HYPERTENSION, V37, P875, DOI 10.1161/01.HYP.37.3.875; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stark K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007729; Strasak A, 2008, CLIN CHEM, V54, P273, DOI 10.1373/clinchem.2007.094425; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Thomas DC, 2007, ANN EPIDEMIOL, V17, P511, DOI 10.1016/j.annepidem.2006.12.005; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; Timpson NJ, 2009, HYPERTENSION, V54, P84, DOI 10.1161/HYPERTENSIONAHA.109.130005; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Williams G. C, 1996, EVOLUTION HEALING NE; Wright AF, 2010, KIDNEY INT, V78, P446, DOI 10.1038/ki.2010.206; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI 10.1161/CIRCGENETICS.109.934455; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	45	177	178	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 18	2013	347								f4262	10.1136/bmj.f4262	http://dx.doi.org/10.1136/bmj.f4262			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	189DI	23869090	Green Published, hybrid			2022-12-01	WOS:000322246900010
J	Subramanian, R; Ti, SC; Tan, L; Darst, SA; Kapoor, TM				Subramanian, Radhika; Ti, Shih-Chieh; Tan, Lei; Darst, Seth A.; Kapoor, Tarun M.			Marking and Measuring Single Microtubules by PRC1 and Kinesin-4	CELL			English	Article							SPINDLE MIDZONE FORMATION; MONOPOLAR CYTOKINESIS; CROSS-LINKING; CELL-CYCLE; PROTEIN; BINDING; KIF4; LENGTH; POLARIZATION; INSIGHTS	Error-free cell division depends on the assembly of the spindle midzone, a specialized array of overlapping microtubules that emerges between segregating chromosomes during anaphase. The molecular mechanisms by which a subset of dynamic microtubules from the metaphase spindle are selected and organized into a stable midzone array are poorly understood. Here, we show using in vitro reconstitution assays that PRC1 and kinesin-4, two microtubule-associated proteins required for midzone assembly, can tag microtubule plus ends. Remarkably, the size of these tags is proportional to filament length. We determine the crystal structure of the PRC1 homodimer and map the protein-protein interactions needed for tagging microtubule ends. Importantly, length-dependent microtubule plus-end-tagging by PRC1 is also observed in dividing cells. Our findings suggest how biochemically similar microtubules can be differentially marked, based on length, for selective regulation during the formation of specialized arrays, such as those required for cytokinesis.	[Subramanian, Radhika; Ti, Shih-Chieh; Tan, Lei; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA; [Darst, Seth A.] Rockefeller Univ, Lab Mol Biophys, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Kapoor, TM (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, 1230 York Ave, New York, NY 10065 USA.	kapoor@rockefeller.edu		Ti, Shih-Chieh/0000-0002-0517-0899	NIH [GM065933]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022321, S10RR023748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065933] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Sarah Wacker (while at the Rockefeller University) for assistance with purification of full-length kinesin-4 and Deena Oren (Rockefeller University Structural Biology Resource Center [SBRC]) for technical support. T.M.K. is a Scholar of the Leukemia and Lymphoma Society and is grateful to the NIH (GM065933) for support. We also acknowledge the SBRC (NIH 1S10RR022321-01) and the Keck Facility (Yale University) (NIH 1S10RR023748-01) for instrument use.	Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Duellberg C, 2013, TRENDS CELL BIOL, V23, P54, DOI 10.1016/j.tcb.2012.10.003; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Golji J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000389; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Hill RB, 2000, ACCOUNTS CHEM RES, V33, P745, DOI 10.1021/ar970004h; Ho CMK, 2011, PLANT CELL, V23, P2909, DOI 10.1105/tpc.110.078204; Hu CK, 2008, J CELL BIOL, V181, P195, DOI 10.1083/jcb.200711105; Hu CK, 2011, CURR BIOL, V21, P815, DOI 10.1016/j.cub.2011.04.019; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; SEKINE Y, 1994, J CELL BIOL, V127, P187, DOI 10.1083/jcb.127.1.187; Shannon KB, 2005, MOL BIOL CELL, V16, P4423, DOI 10.1091/mbc.E04-11-0974; Shrestha S, 2012, MOL BIOL CELL, V23, P1196, DOI 10.1091/mbc.E11-12-1008; Subramanian R, 2012, DEV CELL, V23, P874, DOI 10.1016/j.devcel.2012.10.011; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103	23	98	99	1	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 18	2013	154	2					377	390		10.1016/j.cell.2013.06.021	http://dx.doi.org/10.1016/j.cell.2013.06.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870126	Green Accepted, Bronze			2022-12-01	WOS:000321950700014
J	Sutter, BM; Wu, X; Laxman, S; Tu, BP				Sutter, Benjamin M.; Wu, Xi; Laxman, Sunil; Tu, Benjamin P.			Methionine Inhibits Autophagy and Promotes Growth by Inducing the SAM-Responsive Methylation of PP2A	CELL			English	Article							PHOSPHOPROTEIN PHOSPHATASE 2A; TRANSFER-RNA SYNTHETASE; SULFUR AMINO-ACIDS; SACCHAROMYCES-CEREVISIAE; BOVINE BRAIN; CARBOXYL METHYLATION; CATALYTIC SUBUNIT; PROTEIN PHOSPHATASE-2A; REGULATE AUTOPHAGY; YEAST PROTEOME	Autophagy is a process of cellular self-digestion induced by various forms of starvation. Although nitrogen deficit is a common trigger, some yeast cells induce autophagy upon switch from a rich to minimal media without nitrogen starvation. We show that the amino acid methionine is sufficient to inhibit such non-nitrogen-starvation (NNS)-induced autophagy. Methionine boosts synthesis of the methyl donor, S-adenosylmethionine (SAM). SAM inhibits autophagy and promotes growth through the action of the methyltransferase Ppm1p, which modifies the catalytic subunit of PP2A in tune with SAM levels. Methylated PP2A promotes dephosphorylation of Npr2p, a component of a conserved complex that regulates NNS autophagy and other growth-related processes. Thus, methionine and SAM levels represent a critical gauge of amino acid availability that is sensed via the methylation of PP2A to reciprocally regulate cell growth and autophagy.	[Sutter, Benjamin M.; Wu, Xi; Laxman, Sunil; Tu, Benjamin P.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Tu, BP (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	benjamin.tu@utsouthwestern.edu	Laxman, Sunil/F-9886-2018	Laxman, Sunil/0000-0002-0861-5080	Chilton Foundation; Med into Grad Initiative; HHMI; NIGMS [R01GM094314]; UTSW Endowed Scholars Program; Welch Foundation [I-1797]; Burroughs Wellcome Fund; David and Lucile Packard Foundation; Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094314] Funding Source: NIH RePORTER	Chilton Foundation; Med into Grad Initiative; HHMI(Howard Hughes Medical Institute); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UTSW Endowed Scholars Program; Welch Foundation(The Welch Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Tu lab for helpful discussions. X.W. was supported by a fellowship from the Chilton Foundation and a Med into Grad Initiative sponsored by HHMI. This research was supported by award R01GM094314 from NIGMS, the UTSW Endowed Scholars Program, the Welch Foundation (I-1797), the Burroughs Wellcome Fund, the David and Lucile Packard Foundation, and the Damon Runyon Cancer Research Foundation. B.P.T. is a consultant and shareholder of Peloton Therapeutics.	Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Dokudovskaya S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006478; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Ganguli D, 2007, GENETICS, V175, P1137, DOI 10.1534/genetics.106.066944; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hickman MJ, 2011, MOL BIOL CELL, V22, P4192, DOI 10.1091/mbc.E11-05-0467; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Ji L, 2002, CANCER RES, V62, P2715; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kaiser P, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-16; Kalhor HR, 2001, ARCH BIOCHEM BIOPHYS, V395, P239, DOI 10.1006/abbi.2001.2558; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; KODAKI T, 1987, J BIOL CHEM, V262, P15428; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laxman S, 2013, CELL, V154, P416, DOI 10.1016/j.cell.2013.06.043; LEE J, 1993, J BIOL CHEM, V268, P19192; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Ma XQ, 2011, CHEM BIOL, V18, P1474, DOI 10.1016/j.chembiol.2011.08.009; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Neklesa TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000515; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; Patton EE, 2000, EMBO J, V19, P1613, DOI 10.1093/emboj/19.7.1613; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Singhal T, 2008, MOL IMAGING BIOL, V10, P1, DOI 10.1007/s11307-007-0115-2; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; UNGER MW, 1976, P NATL ACAD SCI USA, V73, P1664, DOI 10.1073/pnas.73.5.1664; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Wu X, 2011, MOL BIOL CELL, V22, P4124, DOI 10.1091/mbc.E11-06-0525; XIE HY, 1994, BIOCHEM BIOPH RES CO, V203, P1710, DOI 10.1006/bbrc.1994.2383; XIE HY, 1993, J BIOL CHEM, V268, P13364; XIE HY, 1994, J BIOL CHEM, V269, P1981	45	145	148	1	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 18	2013	154	2					403	415		10.1016/j.cell.2013.06.041	http://dx.doi.org/10.1016/j.cell.2013.06.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	185FF	23870128	Green Accepted, Bronze			2022-12-01	WOS:000321950700016
J	Ozkan, E; Carrillo, RA; Eastman, CL; Weiszmann, R; Waghray, D; Johnson, KG; Zinn, K; Celniker, SE; Garcia, KC				Oezkan, Engin; Carrillo, Robert A.; Eastman, Catharine L.; Weiszmann, Richard; Waghray, Deepa; Johnson, Karl G.; Zinn, Kai; Celniker, Susan E.; Garcia, K. Christopher			An Extracellular Interactome of Immunoglobulin and LRR Proteins Reveals Receptor-Ligand Networks	CELL			English	Article							RICH REPEAT PROTEINS; DROSOPHILA-MELANOGASTER; SECRETED PROTEIN; AXON GUIDANCE; GENE; SUPERFAMILY; IDENTIFICATION; RESOURCE; PATHWAY; SLIT	Extracellular domains of cell surface receptors and ligands mediate cell-cell communication, adhesion, and initiation of signaling events, but most existing protein-protein "interactome'' data sets lack information for extracellular interactions. We probed interactions between receptor extracellular domains, focusing on a set of 202 proteins composed of the Drosophila melanogaster immunoglobulin superfamily (IgSF), fibronectin type III (FnIII), and leucinerich repeat (LRR) families, which are known to be important in neuronal and developmental functions. Out of 20,503 candidate protein pairs tested, we observed 106 interactions, 83 of which were previously unknown. We "deorphanized'' the 20 member subfamily of defective-in-proboscis-response IgSF proteins, showing that they selectively interact with an 11 member subfamily of previously uncharacterized IgSF proteins. Both subfamilies interact with a single common "orphan'' LRR protein. We also observed interactions between Hedgehog and EGFR pathway components. Several of these interactions could be visualized in live-dissected embryos, demonstrating that this approach can identify physiologically relevant receptor-ligand pairs.	[Oezkan, Engin; Eastman, Catharine L.; Waghray, Deepa; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Oezkan, Engin; Eastman, Catharine L.; Waghray, Deepa; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Carrillo, Robert A.; Zinn, Kai] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Weiszmann, Richard; Celniker, Susan E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Dept Genome Dynam, Berkeley, CA 94720 USA; [Johnson, Karl G.] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Johnson, Karl G.] Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; California Institute of Technology; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Claremont Colleges; Pomona College; Claremont Colleges; Pomona College	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Johnson, Karl/0000-0003-3931-5985; Carrillo, Robert/0000-0002-2067-9861; Ozkan, Engin/0000-0002-0263-6729	NSF [0841551]; NIH RO1 [NS62821, NS28182]; NHGRI [P41HG3487]; Department of Energy [DE-AC02-05CH11231]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG003487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062821, R37NS028182, R01NS028182] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Natalia Goriatcheva for technical help; Kevin J. Mitchell and Karsten Hokamp for sharing their list of Drosophila melanogaster LRR proteins; Claudia Y. Janda for technical discussions on interaction assays; Stephen R. Quake, Liqun Luo, Xiaomeng M. Yu, Weizhe Hong, and Marena Tynan La Fontaine for discussions; Nick V. Grishin for discussions on bioinformatics; and Demet Arac, and Michael E. Birnbaum for critical reading of the manuscript. Work at Pomona, Caltech, and LBNL was supported by NSF grant 0841551 to K.G.J., by NIH RO1 grants NS62821 and NS28182 to K.Z., and by NHGRI grant P41HG3487 to S.E.C. through the Department of Energy under contract DE-AC02-05CH11231, respectively. K.C.G. is an Investigator of the Howard Hughes Medical Institute.	Aberle H, 2009, FLY, V3, P270, DOI 10.4161/fly.9790; Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Amin A, 1999, DEVELOPMENT, V126, P2623; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Ben-Shlomo Izhar, 2003, Sci STKE, V2003, pRE9, DOI 10.1126/stke.2003.187.re9; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Crozatier M, 2002, DEVELOPMENT, V129, P4261; da Cunha JPC, 2009, P NATL ACAD SCI USA, V106, P16752, DOI 10.1073/pnas.0907939106; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; Diehn M, 2006, PLOS GENET, V2, P39, DOI 10.1371/journal.pgen.0020011; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Donaldson T, 2004, GENETICS, V167, P687, DOI 10.1534/genetics.103.019588; Fambrough D, 1996, CELL, V87, P1049, DOI 10.1016/S0092-8674(00)81799-7; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Holler N, 2000, J IMMUNOL METHODS, V237, P159, DOI 10.1016/S0022-1759(99)00239-2; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee Hyung-Kook Peter, 2009, J Vis Exp, DOI 10.3791/1647; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Murali T, 2011, NUCLEIC ACIDS RES, V39, pD736, DOI 10.1093/nar/gkq1092; Nakamura M, 2002, J NEUROSCI, V22, P3463; Palsson-McDermott EM, 2007, BIOCHEM SOC T, V35, P1437, DOI 10.1042/BST0351437; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Pipes GCT, 2001, DEVELOPMENT, V128, P4545; Ramani SR, 2012, ANAL BIOCHEM, V420, P127, DOI 10.1016/j.ab.2011.09.017; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Siebert M, 2009, GENE DEV, V23, P1052, DOI 10.1101/gad.520509; Sink H, 2001, CELL, V105, P57, DOI 10.1016/S0092-8674(01)00296-3; Sollner C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r99; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Stapleton M, 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0080, DOI 10.1186/GB-2002-3-12-RESEARCH0080]; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Vogel C, 2003, DEVELOPMENT, V130, P6317, DOI 10.1242/dev.00848; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Voulgaraki D, 2005, IMMUNOLOGY, V115, P337, DOI 10.1111/j.1365-2567.2005.02161.x; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Wright GJ, 2010, BIOCHEM SOC T, V38, P919, DOI 10.1042/BST0380919; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461; Zinn K, 2009, GENE DEV, V23, P1042, DOI 10.1101/gad.1803009	54	134	135	2	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 3	2013	154	1					228	239		10.1016/j.cell.2013.06.006	http://dx.doi.org/10.1016/j.cell.2013.06.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176TM	23827685	Green Accepted, Bronze			2022-12-01	WOS:000321327900022
J	DeGennaro, M; McBride, CS; Seeholzer, L; Nakagawa, T; Dennis, EJ; Goldman, C; Jasinskiene, N; James, AA; Vosshall, LB				DeGennaro, Matthew; McBride, Carolyn S.; Seeholzer, Laura; Nakagawa, Takao; Dennis, Emily J.; Goldman, Chloe; Jasinskiene, Nijole; James, Anthony A.; Vosshall, Leslie B.			orco mutant mosquitoes lose strong preference for humans and are not repelled by volatile DEET	NATURE			English	Article							DROSOPHILA ODORANT RECEPTORS; AEDES-AEGYPTI; ANOPHELES-GAMBIAE; CHANNELS; FEMALE	Female mosquitoes of some species are generalists and will blood-feed on a variety of vertebrate hosts, whereas others display marked host preference. Anopheles gambiae and Aedes aegypti have evolved a strong preference for humans, making them dangerously efficient vectors of malaria and Dengue haemorrhagic fever(1). Specific host odours probably drive this strong preference because other attractive cues, including body heat and exhaled carbon dioxide (CO2), are common to all warm-blooded hosts(2,3). Insects sense odours via several chemosensory receptor families, including the odorant receptors (ORs), membrane proteins that form heteromeric odour-gated ion channels(4,5) comprising a variable ligand-selective subunit and an obligate co-receptor called Orco (ref. 6). Here we use zinc-finger nucleases to generate targeted mutations in the orco gene of A. aegypti to examine the contribution of Orco and the odorant receptor pathway to mosquito host selection and sensitivity to the insect repellent DEET (N,N-diethyl-meta-toluamide). orco mutant olfactory sensory neurons have greatly reduced spontaneous activity and lack odour-evoked responses. Behaviourally, orco mutant mosquitoes have severely reduced attraction to honey, an odour cue related to floral nectar, and do not respond to human scent in the absence of CO2. However, in the presence of CO2, female orco mutant mosquitoes retain strong attraction to both human and animal hosts, but no longer strongly prefer humans. orco mutant females are attracted to human hosts even in the presence of DEET, but are repelled upon contact, indicating that olfactory- and contact-mediated effects of DEET are mechanistically distinct. We conclude that the odorant receptor pathway is crucial for an anthropophilic vector mosquito to discriminate human from non-human hosts and to be effectively repelled by volatile DEET.	[DeGennaro, Matthew; McBride, Carolyn S.; Seeholzer, Laura; Nakagawa, Takao; Dennis, Emily J.; Goldman, Chloe; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [DeGennaro, Matthew; Vosshall, Leslie B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Jasinskiene, Nijole; James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet & Mol Biol & Biochem, Irvine, CA 92697 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of California System; University of California Irvine; University of California System; University of California Irvine	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA.	Leslie.Vosshall@rockefeller.edu	; DeGennaro, Matthew/H-4975-2015	Dennis, Emily/0000-0002-9858-7190; James, Anthony/0000-0001-5577-3308; DeGennaro, Matthew/0000-0003-3837-4430; Vosshall, Leslie/0000-0002-6060-8099	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; National Institutes of Health [DC012069, AI29746]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029746, R37AI029746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC012069, R00DC012069] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank K. J. Lee and members of the Vosshall lab for comments on the manuscript. F. Urnov of Sangamo BioSciences suggested the experiments in Supplementary Fig. 1. We thank C. McMeniman for initiating the A. aegypti GFP ZFN disruption project together with M. D. and for establishing mosquito microinjection at Genetic Services Inc. S. Dewell of the Rockefeller University Genomics Resource Center provided bioinformatic assistance. W. Takken and N. Verhulst suggested the use of nylon stockings in Figs 4 and 5. Roman Corfas provided advice on imaging in Fig. 5b. This work was funded in part by a grant to R. Axel and L. B. V. from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative. This work was supported in part by grants from the National Institutes of Health to C. S. M. (DC012069) and N. J. and A. A. J. (AI29746). L. B. V. is an investigator of the Howard Hughes Medical Institute.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Besansky NJ, 2004, TRENDS PARASITOL, V20, P249, DOI 10.1016/j.pt.2004.03.007; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Bohbot JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007032; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Dogan EB, 1999, MED VET ENTOMOL, V13, P97, DOI 10.1046/j.1365-2915.1999.00145.x; Foster WA, 2004, B ENTOMOL RES, V94, P145, DOI 10.1079/BER2003288; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Ghaninia M, 2007, EUR J NEUROSCI, V26, P1611, DOI 10.1111/j.1460-9568.2007.05786.x; GOUCK HK, 1972, B WORLD HEALTH ORGAN, V47, P680; Grant AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021785; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Remy S, 2010, TRANSGENIC RES, V19, P363, DOI 10.1007/s11248-009-9323-7; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; SKINNER WA, 1965, NATURE, V207, P661, DOI 10.1038/207661a0; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861	29	237	248	11	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					487	491		10.1038/nature12206	http://dx.doi.org/10.1038/nature12206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23719379	Green Accepted, Green Submitted			2022-12-01	WOS:000320929400053
J	Levine, BL; June, CH				Levine, Bruce L.; June, Carl H.			PERSPECTIVE Assembly line immunotherapy	NATURE			English	Editorial Material									[Levine, Bruce L.; June, Carl H.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Levine, BL (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.							Baker M, 2011, NAT MED, V17, P519, DOI 10.1038/nm0511-519; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Levine BL, 1996, SCIENCE, V272, P1939, DOI 10.1126/science.272.5270.1939; Michalos G, 2010, CIRP J MANUF SCI TEC, V2, P81, DOI 10.1016/j.cirpj.2009.12.001; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849	5	33	33	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					S17	S17		10.1038/498S17a	http://dx.doi.org/10.1038/498S17a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23803946	Bronze			2022-12-01	WOS:000320929400010
J	Cooper, A; Garcia, M; Petrovas, C; Yamamoto, T; Koup, RA; Nabel, GJ				Cooper, Arik; Garcia, Mayra; Petrovas, Constantinos; Yamamoto, Takuya; Koup, Richard A.; Nabel, Gary J.			HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTIOUS MOLECULAR CLONE; T-CELLS; IN-VIVO; RETROVIRAL INFECTION; QUANTITATIVE ASSAY; LYMPHOCYTES; INHIBITOR; DEPLETION; DYNAMICS	Human immunodeficiency virus-1 (HIV-1) has infected more than 60 million people and caused nearly 30 million deaths worldwide(1), ultimately the consequence of cytolytic infection of CD4(+) T cells. In humans and in macaque models, most of these cells contain viral DNA and are rapidly eliminated at the peak of viraemia(2-4), yet the mechanism by which HIV-1 induces helper T-cell death has not been defined. Here we show that virus-induced cell killing is triggered by viral integration. Infection by wild-type HIV-1, but not an integrase-deficient mutant, induced the death of activated primary CD4 lymphocytes. Similarly, raltegravir, a pharmacologic integrase inhibitor, abolished HIV-1-induced cell killing both in cell culture and in CD4(+) T cells from acutely infected subjects. The mechanism of killing during viral integration involved the activation of DNA-dependent protein kinase (DNA-PK), a central integrator of the DNA damage response, which caused phosphorylation of p53 and histone H2AX. Pharmacological inhibition of DNA-PK abolished cell death during HIV-1 infection in vitro, suggesting that processes which reduce DNA-PK activation in CD4 cells could facilitate the formation of latently infected cells that give rise to reservoirs in vivo. We propose that activation of DNA-PK during viral integration has a central role in CD4(+) T-cell depletion, raising the possibility that integrase inhibitors and interventions directed towards DNA-PK may improve T-cell survival and immune function in infected individuals.	[Cooper, Arik; Garcia, Mayra; Nabel, Gary J.] NIAID, Virol Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Petrovas, Constantinos; Yamamoto, Takuya; Koup, Richard A.] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), NIAID, Virol Lab, Vaccine Res Ctr, NIH, Bldg 40,Room 4502,MSC 3005,40 Convent Dr, Bethesda, MD 20892 USA.	Gary.Nabel@sanofi.com	Yamamoto, Takuya/L-2642-2013	Yamamoto, Takuya/0000-0003-3753-1211	Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005014, ZIAAI005058] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Ambrozak, R. Nguyen, and S. Perfetto for help with cell sorting, U. Olshevsky, J. Casazza, D. Bolton, A. Pegu and M. Louder for discussions and technical help, and A. Tislerics and B. Hartman for manuscript preparation. This research was supported by the Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health. The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agency.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; Ariumi Y, 2005, J VIROL, V79, P2973, DOI 10.1128/JVI.79.5.2973-2978.2005; Baekelandt V, 2000, J VIROL, V74, P11278, DOI 10.1128/JVI.74.23.11278-11285.2000; Bolton DL, 2007, J VIROL, V81, P8878, DOI 10.1128/JVI.00122-07; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Callen E, 2009, MOL CELL, V34, P285, DOI 10.1016/j.molcel.2009.04.025; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; CHEN H, 1992, P NATL ACAD SCI USA, V89, P7678, DOI 10.1073/pnas.89.16.7678; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; Daniel R, 2001, MOL CELL BIOL, V21, P1164, DOI 10.1128/MCB.21.4.1164-1172.2001; Daniel R, 1999, SCIENCE, V284, P644, DOI 10.1126/science.284.5414.644; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Hill R, 2010, CELL CYCLE, V9, P3460, DOI 10.4161/cc.9.17.13043; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP FACT SHEET; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lau A, 2004, EMBO J, V23, P3421, DOI 10.1038/sj.emboj.7600348; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Leavitt AD, 1996, J VIROL, V70, P721, DOI 10.1128/JVI.70.2.721-728.1996; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; LI YX, 1992, J VIROL, V66, P6587, DOI 10.1128/JVI.66.11.6587-6600.1992; Martinez E, 2012, AIDS, V26, P2315, DOI 10.1097/QAD.0b013e328359f29c; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; MOROZOV VE, 1994, J BIOL CHEM, V269, P16684; Nagasawa M, 1997, CELL STRUCT FUNCT, V22, P585, DOI 10.1247/csf.22.585; Nilsson A, 1999, CELL PROLIFERAT, V32, P239, DOI 10.1046/j.1365-2184.1999.3240239.x; Nishimura Y, 2005, P NATL ACAD SCI USA, V102, P8000, DOI 10.1073/pnas.0503233102; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Suzuki Y, 2003, VIRUS GENES, V27, P177, DOI 10.1023/A:1025732728195; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Yamamoto T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000279	39	158	162	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					376	+		10.1038/nature12274	http://dx.doi.org/10.1038/nature12274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23739328	Green Published			2022-12-01	WOS:000320592900043
J	Misra, S; Oliver, NS; Dornhorst, A				Misra, S.; Oliver, N. S.; Dornhorst, A.			PRACTICE POINTER Diabetic ketoacidosis: not always due to type 1 diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEAR-NORMOGLYCEMIC REMISSION; AFRICAN-AMERICANS; OBESE; PATHOPHYSIOLOGY; CLASSIFICATION; SUGGESTS; HISTORY		[Misra, S.] Imperial Healthcare NHS Trust, Charing Cross Hosp, Dept Metab Med & Clin Biochem, London W6 8RF, England; [Oliver, N. S.; Dornhorst, A.] Imperial Healthcare NHS Trust, Charing Cross Hosp, Dept Endocrinol & Diabet, London W6 8RF, England	Imperial College London; Imperial College London	Misra, S (corresponding author), Imperial Healthcare NHS Trust, Charing Cross Hosp, Dept Metab Med & Clin Biochem, London W6 8RF, England.	smisra@imperial.ac.uk	Oliver, Nick S/G-9109-2016	Oliver, Nick S/0000-0003-3525-3633				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc11-S011, 10.2337/dc12-S064, 10.2337/dc09-S062]; Balasubramanyam A, 1999, ARCH INTERN MED, V159, P2317, DOI 10.1001/archinte.159.19.2317; Balasubramanyam A, 2006, DIABETES CARE, V29, P2575, DOI 10.2337/dc06-0749; Banerji MA, 1996, DIABETES, V45, P337, DOI 10.2337/diabetes.45.3.337; Choukem SP, 2008, DIABETES CARE, V31, P2332, DOI 10.2337/dc08-0914; Joint British Diabetes Societies for Inpatient Care Group, 2012, MAN HYP HYP STAT HHS; Jones AG, 2013, DIABET MED; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Maldonado MR, 2004, ETHNIC DIS, V14, P243; Mauvais-Jarvis F, 2004, HUM MOL GENET, V13, P3151, DOI 10.1093/hmg/ddh341; Mauvais-Jarvis F, 2004, DIABETES, V53, P645, DOI 10.2337/diabetes.53.3.645; McFarlane SI, 2001, DIABETIC MED, V18, P10, DOI 10.1046/j.1464-5491.2001.00395.x; National Institute for Health and Care Excellence, 2008, TYP 1 DIAB AD FULL G; PinhasHamiel O, 1997, DIABETES CARE, V20, P484, DOI 10.2337/diacare.20.4.484; Savage MW, 2011, DIABETIC MED, V28, P508, DOI 10.1111/j.1464-5491.2011.03246.x; Smiley Dawn, 2011, Diabetes Manag (Lond), V1, P589; Sobngwi E, 2005, J CLIN ENDOCR METAB, V90, P4446, DOI 10.1210/jc.2004-2545; Umpierrez GE, 2006, ANN INTERN MED, V144, P350, DOI 10.7326/0003-4819-144-5-200603070-00011; UMPIERREZ GE, 1995, DIABETES, V44, P790, DOI 10.2337/diabetes.44.7.790; Umpierrez GE, 1999, DIABETES CARE, V22, P1517, DOI 10.2337/diacare.22.9.1517; Umpierrez GE, 1997, DIABETES CARE, V20, P479, DOI 10.2337/diacare.20.4.479; Umpierrez GE, 2006, DIABETES CARE, V29, P2755, DOI 10.2337/dc06-1870	22	26	26	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2013	346								f3501	10.1136/bmj.f3501	http://dx.doi.org/10.1136/bmj.f3501			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	166VK	23751904				2022-12-01	WOS:000320586700010
J	Chou, SJ; Babot, Z; Leingartner, A; Studer, M; Nakagawa, Y; O'Leary, DDM				Chou, Shen-Ju; Babot, Zoila; Leingaertner, Axel; Studer, Michele; Nakagawa, Yasushi; O'Leary, Dennis D. M.			Geniculocortical Input Drives Genetic Distinctions Between Primary and Higher-Order Visual Areas	SCIENCE			English	Article							COUP-TFI; THALAMOCORTICAL CONNECTIONS; CEREBRAL-CORTEX; ROR-BETA; EXPRESSION; NEOCORTEX; FOREBRAIN; EMX2; SPECIFICATION; AXONS	Studies of area patterning of the neocortex have focused on primary areas, concluding that the primary visual area, V1, is specified by transcription factors (TFs) expressed by progenitors. Mechanisms that determine higher-order visual areas (V-HO) and distinguish them from V1 are unknown. We demonstrated a requirement for thalamocortical axon (TCA) input by genetically deleting geniculocortical TCAs and showed that they drive differentiation of patterned gene expression that distinguishes V1 and V-HO. Our findings suggest a multistage process for area patterning: TFs expressed by progenitors specify an occipital visual cortical field that differentiates into V1 and V-HO; this latter phase requires geniculocortical TCA input to the nascent V1 that determines genetic distinctions between V1 and V-HO for all layers and ultimately determines their area-specific functional properties.	[Chou, Shen-Ju; Babot, Zoila; Leingaertner, Axel; Nakagawa, Yasushi; O'Leary, Dennis D. M.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Studer, Michele] Fac Med Nice, INSERM, Inst Biol Valrose, F-06034 Nice, France	Salk Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	doleary@salk.edu	Studer, Michele/P-4580-2016	Studer, Michele/0000-0001-7105-2957; Babot, Zoila/0000-0003-4551-0189	NIH [NS31558, MH086147]; Vincent J. Coates Chair of Molecular Neurobiology; ANR, France [R09125AA]; Spanish Ministry of Education and Science; Generalitat de Catalunya (Spain); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031558, R37NS031558] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vincent J. Coates Chair of Molecular Neurobiology; ANR, France(French National Research Agency (ANR)); Spanish Ministry of Education and Science(Spanish Government); Generalitat de Catalunya (Spain)(Generalitat de Catalunya); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the O'Leary lab for discussion, including S. May for developing Igfbp5 as a V1 marker using WMISH, and B. Higgins and H. Gutierrez for maintaining mice. We thank M. Goulding (Salk Institute) for the ROSA-GAP43-eGFP reporter line, K.-F. Lee (Salk Institute) for the IRES/Cre/FRT/neo/FRT construct, A. Nagy (Mount Sinai Hospital) for the R1 ES cells, J. Simon (Salk MultiMedia Relations) for help making Adobe Illustrator schematics, and C. Peto (Salk Institute Neuroscience Imaging Core) for help using ImageJ software. Support was provided by NIH R01 grants NS31558 and MH086147 and the Vincent J. Coates Chair of Molecular Neurobiology (D.D.M.O.). M. S. is supported by the ANR "2009 Chaires d'Excellence" Program, France, grant number R09125AA. Z.B. was a recipient of postdoctoral fellowships from the Spanish Ministry of Education and Science and from the Generalitat de Catalunya (Spain).	Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; Armentano M, 2006, DEVELOPMENT, V133, P4151, DOI 10.1242/dev.02600; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Bulchand S, 2003, DEV DYNAM, V226, P460, DOI 10.1002/dvdy.10235; Dehay C, 1996, J COMP NEUROL, V367, P70, DOI 10.1002/(SICI)1096-9861(19960325)367:1<70::AID-CNE6>3.0.CO;2-G; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Hamasaki T, 2004, NEURON, V43, P359, DOI 10.1016/j.neuron.2004.07.016; Jabaudon D, 2012, CEREB CORTEX, V22, P996, DOI 10.1093/cercor/bhr182; Karlen SJ, 2006, NEUROSCIENCE, V142, P843, DOI 10.1016/j.neuroscience.2006.06.055; Kashani AH, 2006, J NEUROSCI, V26, P8398, DOI 10.1523/JNEUROSCI.0618-06.2006; Leingartner A, 2003, CEREB CORTEX, V13, P648, DOI 10.1093/cercor/13.6.648; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; LUND RD, 1977, J COMP NEUROL, V173, P289, DOI 10.1002/cne.901730206; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Nakagawa Y, 2003, DEV NEUROSCI-BASEL, V25, P234, DOI 10.1159/000072271; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; RAKIC P, 1991, P NATL ACAD SCI USA, V88, P2083, DOI 10.1073/pnas.88.6.2083; Van der Gucht E, 2007, CEREB CORTEX, V17, P2805, DOI 10.1093/cercor/bhm012; VANDERZEE EA, 1989, HISTOCHEMISTRY, V92, P475, DOI 10.1007/BF00524759; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	25	96	96	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2013	340	6137					1239	1242		10.1126/science.1232806	http://dx.doi.org/10.1126/science.1232806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744949	Green Accepted			2022-12-01	WOS:000319972800052
J	Adler, JN; Colbert, JA				Adler, Jonathan N.; Colbert, James A.			Medicinal Use of Marijuana - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2013, N ENGL J MED, V368, P866	1	54	55	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					E30	E30		10.1056/NEJMclde1305159	http://dx.doi.org/10.1056/NEJMclde1305159			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AT	23718175				2022-12-01	WOS:000319574200015
J	Zhou, WJ; Geng, ZH; Spence, JR; Geng, JG				Zhou, Wei-Jie; Geng, Zhen H.; Spence, Jason R.; Geng, Jian-Guo			Induction of intestinal stem cells by R-spondin 1 and Slit2 augments chemoradioprotection	NATURE			English	Article							IN-VITRO; R-SPONDIN1; CANCER; GROWTH; COLON; MICE	Cancer research has been rightly and successfully focused on prevention, early detection, and identification of specific molecular targets that distinguish the malignant cells from the neighbouring benign cells(1). However, reducing lethal tissue injury caused by intensive chemoradiotherapy during treatment of late-stage metastatic cancers remains a key clinical challenge. Here we tested whether the induction of adult stem cells could repair chemoradiation-induced tissue injury and prolong overall survival in mice. We found that intestinal stem cells (ISCs)(2) expressed Slit2 and its single-span transmembrane cell-surface receptor roundabout 1 (Robo1)(3,4). Partial genetic deletion of Robo1 decreased ISC numbers and caused villus hypotrophy, whereas a Slit2 transgene increased ISC numbers and triggered villus hypertrophy. During lethal dosages of chemoradiation, administering a short pulse of R-spondin 1 (Rspo1; a Wnt agonist)(5-14) plus Slit2 reduced ISC loss, mitigated gut impairment and protected animals from death, without concomitantly decreasing tumour sensitivity to chemotherapy. Therefore Rspo1 and Slit2 may act as therapeutic adjuvants to enhance host tolerance to aggressive chemoradiotherapy for eradicating metastatic cancers.	[Zhou, Wei-Jie; Geng, Zhen H.; Geng, Jian-Guo] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Spence, Jason R.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Spence, Jason R.] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Geng, JG (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	jgeng@umich.edu		Zhou, Weijie/0000-0002-0021-9454	National Institutes of Health [CA126897]; NATIONAL CANCER INSTITUTE [R01CA126897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK091415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Ma for generating recombinant proteins, M. H. Geng for technical assistance, X. Yang for helping with the in situ hybridization and J. Connett for critical reading of the manuscript. This work was supported by a grant from the National Institutes of Health (CA126897 to J.-G.G.).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bhanja P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008014; Booth C, 1999, EXP CELL RES, V249, P359, DOI 10.1006/excr.1999.4483; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Duan LP, 2004, J LIPID RES, V45, P1312, DOI 10.1194/jlr.M400030-JLR200; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; MARTIN DS, 1982, CANCER RES, V42, P3964; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Phutthaphadoong S, 2010, ONCOL REP, V23, P53, DOI 10.3892/or_00000605; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Solanas G, 2011, EXP CELL RES, V317, P2695, DOI 10.1016/j.yexcr.2011.07.019; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Takashima S, 2011, J EXP MED, V208, P285, DOI 10.1084/jem.20101559; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wang HB, 2007, NAT IMMUNOL, V8, P882, DOI 10.1038/ni1491; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yang XS, 2008, DEVELOPMENT, V135, P3521, DOI 10.1242/dev.023416; Ye BQ, 2010, J IMMUNOL, V185, P6294, DOI 10.4049/jimmunol.1001648; Zhao JS, 2007, GASTROENTEROLOGY, V132, P1331, DOI 10.1053/j.gastro.2007.02.001; Zhao JS, 2009, P NATL ACAD SCI USA, V106, P2331, DOI 10.1073/pnas.0805159106; Zhou WJ, 2011, CELL RES, V21, P609, DOI 10.1038/cr.2011.17	30	99	107	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					107	+		10.1038/nature12416	http://dx.doi.org/10.1038/nature12416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	23903657	Green Accepted			2022-12-01	WOS:000323888300041
J	Jiang, J; Jing, YC; Cost, GJ; Chiang, JC; Kolpa, HJ; Cotton, AM; Carone, DM; Carone, BR; Shivak, DA; Guschin, DY; Pearl, JR; Rebar, EJ; Byron, M; Gregory, PD; Brown, CJ; Urnov, FD; Hall, LL; Lawrence, JB				Jiang, Jun; Jing, Yuanchun; Cost, Gregory J.; Chiang, Jen-Chieh; Kolpa, Heather J.; Cotton, Allison M.; Carone, Dawn M.; Carone, Benjamin R.; Shivak, David A.; Guschin, Dmitry Y.; Pearl, Jocelynn R.; Rebar, Edward J.; Byron, Meg; Gregory, Philip D.; Brown, Carolyn J.; Urnov, Fyodor D.; Hall, Lisa L.; Lawrence, Jeanne B.			Translating dosage compensation to trisomy 21	NATURE			English	Article							EMBRYONIC STEM-CELLS; HUMAN XIST GENE; DNA METHYLATION; X-CHROMOSOME; INACTIVATION; RNA; EXPRESSION	Down's syndrome is a common disorder with enormous medical and social costs, caused by trisomy for chromosome 21. We tested the concept that gene imbalance across an extra chromosome can be de facto corrected by manipulating a single gene, XIST (the X-inactivation gene). Using genome editing with zinc finger nucleases, we inserted a large, inducible XIST transgene into the DYRK1A locus on chromosome 21, in Down's syndrome pluripotent stem cells. The XIST non-coding RNA coats chromosome 21 and triggers stable heterochromatin modifications, chromosome-wide transcriptional silencing and DNA methylation to form a 'chromosome 21 Barr body'. This provides a model to study human chromosome inactivation and creates a system to investigate genomic expression changes and cellular pathologies of trisomy 21, free from genetic and epigenetic noise. Notably, deficits in proliferation and neural rosette formation are rapidly reversed upon silencing one chromosome 21. Successful trisomy silencing in vitro also surmounts the major first step towards potential development of 'chromosome therapy'.	[Jiang, Jun; Jing, Yuanchun; Chiang, Jen-Chieh; Kolpa, Heather J.; Carone, Dawn M.; Carone, Benjamin R.; Byron, Meg; Hall, Lisa L.; Lawrence, Jeanne B.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA; [Cost, Gregory J.; Shivak, David A.; Guschin, Dmitry Y.; Pearl, Jocelynn R.; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.] Sangamo BioSci, Richmond, CA 94804 USA; [Cotton, Allison M.; Brown, Carolyn J.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada	University of Massachusetts System; University of Massachusetts Worcester; Sangamo Therapeutics, Inc.; University of British Columbia	Lawrence, JB (corresponding author), Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, 55 Lake Ave North, Worcester, MA 01655 USA.	furnov@sangamo.com; Jeanne.Lawrence@umassmed.edu	Guschin, Dmitry/O-7594-2018; Guschin, Dmitry/U-3731-2019; Brown, Carolyn J/A-5159-2014	Guschin, Dmitry/0000-0002-4184-0001; Guschin, Dmitry/0000-0002-4184-0001; Brown, Carolyn J/0000-0002-8959-0101; Carone, Dawn/0000-0002-4362-6690; Matthews, Allison/0000-0001-8394-0337; Lawrence, Jeanne/0000-0001-6572-3128; Gregory, Philip/0000-0001-9249-2468; Cost, Gregory/0000-0002-8509-4653; Carone, Benjamin/0000-0002-9822-4218	CIHR [MOP-13680]; NIH [1F32CA154086, 2T32HD007439];  [GM053234];  [GM085548];  [GM096400 RC4]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007439] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [F32CA154086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC4GM096400, R01GM085548, R01GM053234] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We appreciate recent initiatives by administrators of NIGMS and NIH to support more high-risk, high-impact research. Research began with support from GM053234 to J.B.L. for basic X chromosome research, and was made fully possible by GM085548 and GM096400 RC4 to J.B.L. C.J.B. and A.M.C. were supported by CIHR (MOP-13680) to C.J.B. We thank T. Flotte for encouragement and advice regarding genome editing strategies, and similarly appreciate the support of S. Jones and P. Newburger. We thank T. Collingwood for initial discussions regarding this project, and the George Daley laboratory (Harvard) for the Down's syndrome iPS cell line. L. Lizotte, Z. Matijasevic, K. Smith and E. Swanson provided various assistance. M. S. Kobor and L. Lam (Kobor laboratory) assisted with methylation analysis. D.M.C. is supported by an NIH fellowship 1F32CA154086 and B.R.C. (O. Rando laboratory) is supported by NIH training grant 2T32HD007439 (G. Witman, PI).	Biancotti JC, 2010, STEM CELLS, V28, P1530, DOI 10.1002/stem.483; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Byron Meg, 2013, Curr Protoc Hum Genet, VChapter 4, DOI 10.1002/0471142905.hg0415s76; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Cotton AM, 2011, HUM GENET, V130, P187, DOI 10.1007/s00439-011-1007-8; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Gardiner KJ, 2010, TRENDS PHARMACOL SCI, V31, P66, DOI 10.1016/j.tips.2009.10.010; Guidi S, 2011, BRAIN PATHOL, V21, P361, DOI 10.1111/j.1750-3639.2010.00459.x; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hall LL, 2010, COLD SH Q B, V75, P345, DOI 10.1101/sqb.2010.75.030; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Hall LL, 2002, HUM MOL GENET, V11, P3157, DOI 10.1093/hmg/11.25.3157; Haydar TF, 2012, TRENDS NEUROSCI, V35, P81, DOI 10.1016/j.tins.2011.11.001; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Lavon N, 2008, STEM CELLS, V26, P1874, DOI 10.1634/stemcells.2008-0156; Lee B, 2011, HUM MOL GENET, V20, pR1, DOI 10.1093/hmg/ddr188; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Megarbane A, 2009, GENET MED, V11, P611, DOI 10.1097/GIM.0b013e3181b2e34c; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yahya-Graison EA, 2007, AM J HUM GENET, V81, P475, DOI 10.1086/520000	35	213	224	1	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 15	2013	500	7462					296	+		10.1038/nature12394	http://dx.doi.org/10.1038/nature12394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AF	23863942	Green Submitted, Green Accepted			2022-12-01	WOS:000323112400024
J	Pinstrup-Andersen, P				Pinstrup-Andersen, Per			Nutrition-sensitive food systems: from rhetoric to action	LANCET			English	Editorial Material									Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University	Pinstrup-Andersen, P (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	pp94@cornell.edu						Bhutta ZA, 2013, LANCET; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Gillespie S, 2013, LANCET; Herforth A., 2012, PRIORITIZING NUTR AG; Masset E., 2011, SYSTEMATIC REV AGR I; Monteiro CA, 2009, PUBLIC HEALTH NUTR, V12, P729, DOI 10.1017/S1368980009005291; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Pinstrup-Andersen P., 2012, CTR FOOD SECURITY EN, P51; Pinstrup-Anderson P., 2011, FOOD POLICY DEV COUN; Ruel M, 2013, LANCET	10	70	71	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 3	2013	382	9890					375	376		10.1016/S0140-6736(13)61053-3	http://dx.doi.org/10.1016/S0140-6736(13)61053-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194MX	23746779				2022-12-01	WOS:000322638500008
J	Ma, DKK; Rothe, M; Zheng, S; Bhatla, N; Pender, CL; Menzel, R; Horvitz, HR				Ma, Dengke K.; Rothe, Michael; Zheng, Shu; Bhatla, Nikhil; Pender, Corinne L.; Menzel, Ralph; Horvitz, H. Robert			Cytochrome P450 Drives a HIF-Regulated Behavioral Response to Reoxygenation by C. elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; DISEASE; UPDATE; OMEGA-3-FATTY-ACIDS; EGL-9; ACID	Oxygen deprivation followed by reoxygenation causes pathological responses in many disorders, including ischemic stroke, heart attacks, and reperfusion injury. Key aspects of ischemia-reperfusion can be modeled by a Caenorhabditis elegans behavior, the O2-ON response, which is suppressed by hypoxic preconditioning or inactivation of the O-2-sensing HIF (hypoxia-inducible factor) hydroxylase EGL-9. From a genetic screen, we found that the cytochrome P450 oxygenase CYP-13A12 acts in response to the EGL-9-HIF-1 pathway to facilitate the O2-ON response. CYP-13A12 promotes oxidation of polyunsaturated fatty acids into eicosanoids, signaling molecules that can strongly affect inflammatory pain and ischemia-reperfusion injury responses in mammals. We propose that roles of the EGL-9-HIF-1 pathway and cytochrome P450 in controlling responses to reoxygenation after anoxia are evolutionarily conserved.	[Ma, Dengke K.; Zheng, Shu; Bhatla, Nikhil; Pender, Corinne L.; Horvitz, H. Robert] MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, Dept Biol,McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Rothe, Michael] Lipidomix GmbH, D-13125 Berlin, Germany; [Menzel, Ralph] Humboldt Univ, Dept Biol, D-12437 Berlin, Germany	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Humboldt University of Berlin	Horvitz, HR (corresponding author), MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, Dept Biol,McGovern Inst Brain Res, Cambridge, MA 02139 USA.	horvitz@mit.edu		Pender, Corinne/0000-0001-7092-3079	NIH [GM24663]; German Research Foundation [ME2056/3-1]; NSF; MIT Undergraduate Research Opportunities Program; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007484, R37GM024663, R01GM024663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); MIT Undergraduate Research Opportunities Program; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Bargmann, A. Fire, A. Hart, Y. Iino, J. Powell-Coffman, and C. Rongo for reagents and the Caenorhabditis Genetics Center and the Million Mutation Project for strains. H. R. H. is an Investigator of the Howard Hughes Medical Institute. Supported by NIH grant GM24663 (H. R. H), German Research Foundation grant ME2056/3-1 (R. M.), a NSF Graduate Research Fellowship (N.B.), the MIT Undergraduate Research Opportunities Program (S.Z.), and a Helen Hay Whitney Foundation postdoctoral fellowship (D.K.M.).	Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chapkin R. S., 2009, PROSTAGLANDINS LEUKO, V81, P187; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gerber M, 2012, BRIT J NUTR, V107, pS228, DOI 10.1017/S0007114512001614; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gotoh O, 1998, MOL BIOL EVOL, V15, P1447, DOI 10.1093/oxfordjournals.molbev.a025872; Gottlieb RA, 2003, ARCH BIOCHEM BIOPHYS, V420, P262, DOI 10.1016/j.abb.2003.07.004; Harder DR, 1996, CIRC RES, V79, P54, DOI 10.1161/01.RES.79.1.54; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kosel M, 2011, BIOCHEM J, V435, P689, DOI 10.1042/BJ20101942; Kulas J, 2008, ARCH BIOCHEM BIOPHYS, V472, P65, DOI 10.1016/j.abb.2008.02.002; Ma Dengke K, 2012, Front Biol (Beijing), V7, P246; Ma DK, 2012, NEURON, V73, P925, DOI 10.1016/j.neuron.2011.12.037; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Panigrahy D, 2010, CANCER METAST REV, V29, P723, DOI 10.1007/s10555-010-9264-x; Powell-Coffman JA, 2010, TRENDS ENDOCRIN MET, V21, P435, DOI 10.1016/j.tem.2010.02.006; Rappleye Chad A, 2003, BMC Dev Biol, V3, P8, DOI 10.1186/1471-213X-3-8; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Semenza Gregg L, 2011, Biochim Biophys Acta, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Szefel J, 2011, Curr Mol Med, V11, P13, DOI 10.2174/156652411794474374; TRENT C, 1983, GENETICS, V104, P619; Ward JPT, 2008, BBA-BIOENERGETICS, V1777, P1, DOI 10.1016/j.bbabio.2007.10.010; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018	30	24	29	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 2	2013	341	6145					554	558		10.1126/science.1235753	http://dx.doi.org/10.1126/science.1235753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193UJ	23811225	Green Accepted, Green Submitted			2022-12-01	WOS:000322586700055
J	Saeidi, N; Meoli, L; Nestoridi, E; Gupta, NK; Kvas, S; Kucharczyk, J; Bonab, AA; Fischman, AJ; Yarmush, ML; Stylopoulos, N				Saeidi, Nima; Meoli, Luca; Nestoridi, Eirini; Gupta, Nitin K.; Kvas, Stephanie; Kucharczyk, John; Bonab, Ali A.; Fischman, Alan J.; Yarmush, Martin L.; Stylopoulos, Nicholas			Reprogramming of Intestinal Glucose Metabolism and Glycemic Control in Rats After Gastric Bypass	SCIENCE			English	Article							BARIATRIC SURGERY; INSULIN SENSITIVITY; MEDICAL THERAPY; TRANSPORT	The resolution of type 2 diabetes after Roux-en-Y gastric bypass (RYGB) attests to the important role of the gastrointestinal tract in glucose homeostasis. Previous studies in RYGB-treated rats have shown that the Roux limb displays hyperplasia and hypertrophy. Here, we report that the Roux limb of RYGB-treated rats exhibits reprogramming of intestinal glucose metabolism to meet its increased bioenergetic demands; glucose transporter-1 is up-regulated, basolateral glucose uptake is enhanced, aerobic glycolysis is augmented, and glucose is directed toward metabolic pathways that support tissue growth. We show that reprogramming of intestinal glucose metabolism is triggered by the exposure of the Roux limb to undigested nutrients. We demonstrate by positron emission tomography-computed tomography scanning and biodistribution analysis using 2-deoxy-2-[18F]fluoro-D-glucose that reprogramming of intestinal glucose metabolism renders the intestine a major tissue for glucose disposal, contributing to the improvement in glycemic control after RYGB.	[Saeidi, Nima; Meoli, Luca; Nestoridi, Eirini; Gupta, Nitin K.; Kvas, Stephanie; Kucharczyk, John; Stylopoulos, Nicholas] Harvard Univ, Sch Med, Ctr Basic & Translat Obes Res, Div Endocrinol,Boston Childrens Hosp, Boston, MA 02115 USA; [Saeidi, Nima; Bonab, Ali A.; Fischman, Alan J.; Yarmush, Martin L.] Shriners Hosp Children, Boston, MA 02114 USA; [Saeidi, Nima; Yarmush, Martin L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Stylopoulos, N (corresponding author), Harvard Univ, Sch Med, Ctr Basic & Translat Obes Res, Div Endocrinol,Boston Childrens Hosp, Boston, MA 02115 USA.	Nicholas.Stylopoulos@childrens.harvard.edu	Gupta, Nitin/A-1076-2016; Stylopoulos, Nicholas/V-1377-2019	Gupta, Nitin/0000-0002-4471-2363; Stylopoulos, Nicholas/0000-0002-5025-7854; Yarmush, Martin/0000-0003-4986-8444	Department of Medicine; Clinical and Translational Executive Committee at Boston Children's Hospital; National Institutes of Health (NIH) [T32DK007191, F32DK095558]; NIH [DK089503]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095558, T32DK007191, P30DK089503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM021700] Funding Source: NIH RePORTER	Department of Medicine; Clinical and Translational Executive Committee at Boston Children's Hospital; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Li for help with tissue sectioning, G. Gorski for help with electron microscopy, M. Markle and M. Luitje for help with biodistribution analysis, and A. Moses for help with lipid analysis. This research was supported by funds from the Department of Medicine and the Clinical and Translational Executive Committee at Boston Children's Hospital (N. Stylopoulos) and grants T32DK007191 (N. K. G.) and F32DK095558 (N. Saeidi) from the National Institutes of Health (NIH). We used the core services of the Lipidomics Lab at the Nutrition Obesity Research Center of the University of Michigan (Ann Arbor, MI), which is supported by grant DK089503 from NIH.	Bradley D, 2012, J CLIN INVEST, V122, P4667, DOI 10.1172/JCI64895; Buchwald H., 2004, JAMA (Journal of the American Medical Association), V292, P1724, DOI 10.1001/jama.292.14.1724; Bueter M, 2010, GASTROENTEROLOGY, V138, P1845, DOI 10.1053/j.gastro.2009.11.012; Carlsson LMS, 2012, NEW ENGL J MED, V367, P695, DOI 10.1056/NEJMoa1112082; Cummings DE, 2012, NAT MED, V18, P656, DOI 10.1038/nm.2773; Falken Y, 2011, J CLIN ENDOCR METAB, V96, P2227, DOI 10.1210/jc.2010-2876; Hayes MT, 2011, OBES SURG, V21, P759, DOI 10.1007/s11695-011-0380-7; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Isbell JM, 2010, DIABETES CARE, V33, P1438, DOI 10.2337/dc09-2107; Kucharczyk J, 2013, J SURG RES, V179, pE91, DOI 10.1016/j.jss.2012.02.036; Laferrere B, 2011, ENDOCRINE, V40, P162, DOI 10.1007/s12020-011-9514-x; le Roux CW, 2010, ANN SURG, V252, P50, DOI 10.1097/SLA.0b013e3181d3d21f; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Mumphrey MB, 2013, NEUROGASTROENT MOTIL, V25, pE70, DOI 10.1111/nmo.12034; Nestoridi E, 2012, ENDOCRINOLOGY, V153, P2234, DOI 10.1210/en.2011-2041; Pacha J, 2000, PHYSIOL REV, V80, P1633, DOI 10.1152/physrev.2000.80.4.1633; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Rodieux F, 2008, OBESITY, V16, P298, DOI 10.1038/oby.2007.83; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Spak E, 2010, HISTOPATHOLOGY, V57, P680, DOI 10.1111/j.1365-2559.2010.03677.x; Stearns AT, 2009, AM J PHYSIOL-GASTR L, V297, pG950, DOI 10.1152/ajpgi.00253.2009; Stefater MA, 2012, ENDOCR REV, V33, P595, DOI 10.1210/er.2011-1044; Taqia E, 2010, J PEDIATR SURG, V45, P987, DOI 10.1016/j.jpedsurg.2010.02.036; Thorens B, 1996, AM J PHYSIOL-GASTR L, V270, pG541, DOI 10.1152/ajpgi.1996.270.4.G541; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Wang G, 2012, OBES SURG, V22, P1263, DOI 10.1007/s11695-012-0656-6; Wilson-Perez HE, 2013, DIABETES, V62, P2380, DOI 10.2337/db12-1498; Wolff BS, 2009, AM J PHYSIOL-GASTR L, V297, pG594, DOI 10.1152/ajpgi.00104.2009	31	250	261	4	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 26	2013	341	6144					406	410		10.1126/science.1235103	http://dx.doi.org/10.1126/science.1235103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189HX	23888041	Green Accepted			2022-12-01	WOS:000322259200052
J	Chen, SS; Oldham, ML; Davidson, AL; Chen, J				Chen, Shanshuang; Oldham, Michael L.; Davidson, Amy L.; Chen, Jue			Carbon catabolite repression of the maltose transporter revealed by X-ray crystallography	NATURE			English	Article							GLUCOSE PHOSPHOTRANSFERASE SYSTEM; SIGNAL-TRANSDUCING PROTEIN; PHOSPHORYL TRANSFER COMPLEX; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; INDUCER EXCLUSION; ABC TRANSPORTER; REGULATORY PROTEIN; CRYSTAL-STRUCTURE; LACTOSE PERMEASE	Efficient carbon utilization is critical to the survival of microorganisms in competitive environments. To optimize energy usage, bacteria have developed an integrated control system to preferentially uptake carbohydrates that support rapid growth. The availability of a preferred carbon source, such as glucose, represses the synthesis and activities of proteins necessary for the transport and metabolism of secondary carbon sources. This regulatory phenomenon is defined as carbon catabolite repression(1). In enteric bacteria, the key player of carbon catabolite repression is a component of the glucose-specific phosphotransferase system, enzyme IIA (EIIA(Glc))(1,2). It is known that unphosphorylated EIIA(Glc) binds to and inhibits a variety of transporters when glucose is available(1,2). However, understanding the underlying molecular mechanism has been hindered by the complete absence of structures for any EIIA(Glc)-transporter complexes. Here we present the 3.9 angstrom crystal structure of Escherichia coli EIIA(Glc) in complex with the maltose transporter, an ATP-binding cassette (ABC) transporter. The structure shows that two EIIA(Glc) molecules bind to the cytoplasmic ATPase subunits, stabilizing the transporter in an inward-facing conformation and preventing the structural rearrangements necessary for ATP hydrolysis. We also show that the half-maximal inhibitory concentrations of the full-length EIIA(Glc) and an amino-terminal truncation mutant differ by 60-fold, consistent with the hypothesis that the amino-terminal region, disordered in the crystal structure, functions as a membrane anchor to increase the effective EIIA(Glc) concentration at the membrane(3,4). Together these data suggest a model of how the central regulatory protein EIIAGlc allosterically inhibits maltose uptake in E. coli.	[Chen, Shanshuang; Chen, Jue] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Oldham, Michael L.; Chen, Jue] Howard Hughes Med Inst, W Lafayette, IN 47907 USA; [Davidson, Amy L.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Howard Hughes Medical Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chen, J (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	chenjue@purdue.edu	Chen, Shanshuang/N-6665-2019	Chen, Shanshuang/0000-0003-2317-6589	National Institutes of Health [GM070515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM070515, R01GM070515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advance Photon Source GM/CA-CAT, NE-CAT and SBC for assistance with data collection. This work was supported by a National Institutes of Health grant (GM070515 to J.C. and A.L.D.).	Alvarez FJD, 2010, J AM CHEM SOC, V132, P9513, DOI 10.1021/ja104047c; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bluschke B, 2006, J BIOL CHEM, V281, P12833, DOI 10.1074/jbc.M512646200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; DEAN DA, 1990, J BIOL CHEM, V265, P21005; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; DORSCHUG M, 1984, EUR J BIOCHEM, V144, P113, DOI 10.1111/j.1432-1033.1984.tb08438.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; KUHNAU S, 1991, J BACTERIOL, V173, P2180; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEADOW ND, 1982, J BIOL CHEM, V257, P4526; Meadow ND, 2006, J BIOL CHEM, V281, P11450, DOI 10.1074/jbc.M507417200; MISKO TP, 1987, J BIOL CHEM, V262, P16261; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; OSUMI T, 1982, P NATL ACAD SCI-BIOL, V79, P1457, DOI 10.1073/pnas.79.5.1457; OSUMI T, 1982, ANN INST PASTEUR MIC, VA133, P269; PELTON JG, 1992, BIOCHEMISTRY-US, V31, P5215, DOI 10.1021/bi00137a017; ROSSMANN MG, 1990, ACTA CRYSTALLOGR A, V46, P73, DOI 10.1107/S0108767389009815; SAIER MH, 1983, J BACTERIOL, V155, P1351, DOI 10.1128/JB.155.3.1351-1357.1983; SCHARSCHMIDT BF, 1979, J LAB CLIN MED, V93, P790; SCHOLTE BJ, 1981, J BACTERIOL, V148, P257, DOI 10.1128/JB.148.1.257-264.1981; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Stein A, 2002, EUR J BIOCHEM, V269, P4074, DOI 10.1046/j.1432-1033.2002.03099.x; Ujwal R, 2012, JOVE-J VIS EXP, DOI 10.3791/3383; VANDERVLAG J, 1994, J BACTERIOL, V176, P3518, DOI 10.1128/JB.176.12.3518-3526.1994; Wang GS, 2000, EMBO J, V19, P5635, DOI 10.1093/emboj/19.21.5635; Wang GS, 2003, PROTEIN SCI, V12, P1087, DOI 10.1110/ps.0301503; Wang GS, 2000, J BIOL CHEM, V275, P39811, DOI 10.1074/jbc.C000709200; WORTHYLAKE D, 1991, P NATL ACAD SCI USA, V88, P10382, DOI 10.1073/pnas.88.23.10382	41	63	65	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 18	2013	499	7458					364	U147		10.1038/nature12232	http://dx.doi.org/10.1038/nature12232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	184RJ	23770568	Green Accepted			2022-12-01	WOS:000321910700042
J	Luyckx, VA; Naicker, S; McKee, M				Luyckx, Valerie A.; Naicker, Saraladevi; McKee, Martin			Equity and economics of kidney disease in sub-Saharan Africa	LANCET			English	Editorial Material							DIALYSIS; BURDEN		[Luyckx, Valerie A.; McKee, Martin] London Sch Hyg & Trop Med, London WC1, England; [Luyckx, Valerie A.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada; [Naicker, Saraladevi] Univ Witwatersrand, Dept Internal Med, Fac Hlth Sci, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Alberta; University of Witwatersrand	Luyckx, VA (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	vluyckx@ualberta.ca	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018; Luyckx, Valerie/J-9747-2019	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Luyckx, Valerie/0000-0001-7066-8135; Naicker, Saraladevi/0000-0002-7058-9725				Abu-Aisha H, 2010, PERITON DIALYSIS INT, V30, P23, DOI 10.3747/pdi.2008.00226; Arogundade FA, 2011, AFR HEALTH SCI, V11, P594; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Dreyer G., 2012, BR J RENAL MED, V17, P24; Fresenius Medical Care, 2012, ESRD PAT 2011 GLOB P; Garcia GG, 2012, SAUDI J KIDNEY DIS T, V23, P215; Moosa MR, 2006, KIDNEY INT, V70, P1107, DOI 10.1038/sj.ki.5001750; Naicker S, 2010, CLIN NEPHROL, V74, pS13; Pozo ME, 2012, TRANSPL INT, V25, P652, DOI 10.1111/j.1432-2277.2012.01468.x; Tantivess S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f462; The World Bank, GNI PER CAP ATL METH; WHO, 2011, WORLD GLOB EXP ATL	14	26	26	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 13	2013	382	9887					103	104		10.1016/S0140-6736(13)60817-X	http://dx.doi.org/10.1016/S0140-6736(13)60817-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	187JY	23727172				2022-12-01	WOS:000322115300004
J	Hu, ZH; Yan, CY; Liu, PY; Huang, ZW; Ma, R; Zhang, CL; Wang, RY; Zhang, YT; Martinon, F; Miao, D; Deng, HT; Wang, JW; Chang, JB; Chai, JJ				Hu, Zehan; Yan, Chuangye; Liu, Peiyuan; Huang, Zhiwei; Ma, Rui; Zhang, Chenlu; Wang, Ruiyong; Zhang, Yueteng; Martinon, Fabio; Miao, Di; Deng, Haiteng; Wang, Jiawei; Chang, Junbiao; Chai, Jijie			Crystal Structure of NLRC4 Reveals Its Autoinhibition Mechanism	SCIENCE			English	Article							III SECRETION APPARATUS; CAENORHABDITIS-ELEGANS; INFLAMMASOME RECEPTORS; FLAGELLIN; ACTIVATION; APOPTOSOME; CASPASE-1; APAF-1; DEATH; IPAF	Nucleotide-binding and oligomerization domain-like receptor (NLR) proteins oligomerize into multiprotein complexes termed inflammasomes when activated. Their autoinhibition mechanism remains poorly defined. Here, we report the crystal structure of mouse NLRC4 in a closed form. The adenosine diphosphate-mediated interaction between the central nucleotide-binding domain (NBD) and the winged-helix domain (WHD) was critical for stabilizing the closed conformation of NLRC4. The helical domain HD2 repressively contacted a conserved and functionally important alpha-helix of the NBD. The C-terminal leucine-rich repeat (LRR) domain is positioned to sterically occlude one side of the NBD domain and consequently sequester NLRC4 in a monomeric state. Disruption of ADP-mediated NBD-WHD or NBD-HD2/NBD-LRR interactions resulted in constitutive activation of NLRC4. Together, our data reveal the NBD-organized cooperative autoinhibition mechanism of NLRC4 and provide insight into its activation.	[Hu, Zehan; Yan, Chuangye; Liu, Peiyuan; Ma, Rui; Zhang, Chenlu; Miao, Di; Deng, Haiteng; Wang, Jiawei; Chai, Jijie] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Hu, Zehan; Yan, Chuangye; Liu, Peiyuan; Ma, Rui; Zhang, Chenlu; Miao, Di; Deng, Haiteng; Wang, Jiawei; Chai, Jijie] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Hu, Zehan] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Hu, Zehan] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Huang, Zhiwei] Harbin Inst Technol, Sch Life Sci & Biotechnol, Harbin 150080, Peoples R China; [Wang, Ruiyong; Zhang, Yueteng; Chang, Junbiao] Zhengzhou Univ, Coll Chem & Mol Engn, Zhengzhou 450001, Peoples R China; [Martinon, Fabio] Univ Lausanne, Dept Biochem, CH-1066 Lausanne, Switzerland	Tsinghua University; Tsinghua University; National Institute of Biological Sciences, Beijing; Beijing Normal University; Harbin Institute of Technology; Zhengzhou University; University of Lausanne	Chai, JJ (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	chaijj@mail.tsinghua.edu.cn	Ma, Rui/N-4436-2018; Hu, Zehan/AAU-4752-2021; Wang, Jiawei/D-1144-2010; chang, junbiao/P-1095-2014; Hu, Zehan/AAH-7139-2020; Liu, Peiyuan/B-2824-2016; Martinon, Fabio/A-5575-2009; Huang, Zhiwei/AAF-6846-2019; Yan, Chuangye/AAJ-5832-2021	Ma, Rui/0000-0003-0045-2157; Hu, Zehan/0000-0002-4648-5301; Wang, Jiawei/0000-0001-9893-8539; chang, junbiao/0000-0001-6236-1256; Martinon, Fabio/0000-0002-6969-822X; Deng, Haiteng/0000-0001-9496-1280; Yan, Chuangye/0000-0001-9338-8048; Zhang, Yueteng/0000-0002-6882-196X; Chai, Jijie/0000-0001-7591-3873	National Outstanding Young Scholar Science Foundation of China [20101331722]; State Key Program of National Natural Science of China [31130063]	National Outstanding Young Scholar Science Foundation of China; State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC))	We thank P. Schulze-Lefert for critically reading the manuscript, F. Yu and J. He at Shanghai Synchrotron Radiation Facility BL17U1 for data collection, L. Yu for helpful suggestions on culturing 293T cells, G. He from Y. Yan's laboratory assistance with CD, and J. Yang from F. Shao's laboratory for suggestions on cell-based assays. The coordinates and structural factors for mNLRC4 Delta CARD have been deposited in the Protein Data Bank (PDB) with the accession code 4KXF. This research was funded by the National Outstanding Young Scholar Science Foundation of China (20101331722) and State Key Program of National Natural Science of China (31130063) to J. Chai.	Danot O, 2009, STRUCTURE, V17, P172, DOI 10.1016/j.str.2009.01.001; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Halff EF, 2012, J BIOL CHEM, V287, P38460, DOI 10.1074/jbc.M112.393512; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Ng TM, 2013, CURR OPIN IMMUNOL, V25, P34, DOI 10.1016/j.coi.2012.11.009; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Reubold TF, 2011, STRUCTURE, V19, P1074, DOI 10.1016/j.str.2011.05.013; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; Yuan SJ, 2013, BIOCHEMISTRY-US, V52, P2319, DOI 10.1021/bi301721g; Yuan SJ, 2011, STRUCTURE, V19, P128, DOI 10.1016/j.str.2010.10.009; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	28	260	272	3	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					172	175		10.1126/science.1236381	http://dx.doi.org/10.1126/science.1236381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23765277				2022-12-01	WOS:000321965300042
J	Ray, D; Kazan, H; Cook, KB; Weirauch, MT; Najafabadi, HS; Li, X; Gueroussov, S; Albu, M; Zheng, H; Yang, A; Na, H; Irimia, M; Matzat, LH; Dale, RK; Smith, SA; Yarosh, CA; Kelly, SM; Nabet, B; Mecenas, D; Li, WM; Laishram, RS; Qiao, M; Lipshitz, HD; Piano, F; Corbett, AH; Carstens, RP; Frey, BJ; Anderson, RA; Lynch, KW; Penalva, LOF; Lei, EP; Fraser, AG; Blencowe, BJ; Morris, QD; Hughes, TR				Ray, Debashish; Kazan, Hilal; Cook, Kate B.; Weirauch, Matthew T.; Najafabadi, Hamed S.; Li, Xiao; Gueroussov, Serge; Albu, Mihai; Zheng, Hong; Yang, Ally; Na, Hong; Irimia, Manuel; Matzat, Leah H.; Dale, Ryan K.; Smith, Sarah A.; Yarosh, Christopher A.; Kelly, Seth M.; Nabet, Behnam; Mecenas, Desirea; Li, Weimin; Laishram, Rakesh S.; Qiao, Mei; Lipshitz, Howard D.; Piano, Fabio; Corbett, Anita H.; Carstens, Russ P.; Frey, Brendan J.; Anderson, Richard A.; Lynch, Kristen W.; Penalva, Luiz O. F.; Lei, Elissa P.; Fraser, Andrew G.; Blencowe, Benjamin J.; Morris, Quaid D.; Hughes, Timothy R.			A compendium of RNA-binding motifs for decoding gene regulation	NATURE			English	Article							PRE-MESSENGER-RNA; GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTORS; SPLICING REGULATOR; PROTEINS; SPECIFICITIES; RECOGNITION; REVEALS; FAMILY; CODE	RNA-binding proteins are key regulators of gene expression, yet only a small fraction have been functionally characterized. Here we report a systematic analysis of the RNA motifs recognized by RNA-binding proteins, encompassing 205 distinct genes from 24 diverse eukaryotes. The sequence specificities of RNA-binding proteins display deep evolutionary conservation, and the recognition preferences for a large fraction of metazoan RNA-binding proteins can thus be inferred from their RNA-binding domain sequence. The motifs that we identify in vitro correlate well with in vivo RNA-binding data. Moreover, we can associate them with distinct functional roles in diverse types of post-transcriptional regulation, enabling new insights into the functions of RNA-binding proteins both in normal physiology and in human disease. These data provide an unprecedented overview of RNA-binding proteins and their targets, and constitute an invaluable resource for determining post-transcriptional regulatory mechanisms in eukaryotes.	[Ray, Debashish; Weirauch, Matthew T.; Najafabadi, Hamed S.; Albu, Mihai; Zheng, Hong; Yang, Ally; Na, Hong; Irimia, Manuel; Fraser, Andrew G.; Blencowe, Benjamin J.; Morris, Quaid D.; Hughes, Timothy R.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Kazan, Hilal; Morris, Quaid D.] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 2E4, Canada; [Cook, Kate B.; Li, Xiao; Gueroussov, Serge; Lipshitz, Howard D.; Fraser, Andrew G.; Blencowe, Benjamin J.; Morris, Quaid D.; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Najafabadi, Hamed S.; Frey, Brendan J.; Morris, Quaid D.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; [Matzat, Leah H.; Dale, Ryan K.; Lei, Elissa P.] NIDDK, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA; [Smith, Sarah A.; Yarosh, Christopher A.; Nabet, Behnam; Carstens, Russ P.; Lynch, Kristen W.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Kelly, Seth M.; Corbett, Anita H.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Mecenas, Desirea; Piano, Fabio] NYU, Dept Biol, New York, NY 10003 USA; [Mecenas, Desirea; Piano, Fabio] NYU, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Li, Weimin; Laishram, Rakesh S.; Anderson, Richard A.] Univ Wisconsin, Sch Med & Publ Hlth, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA; [Qiao, Mei; Penalva, Luiz O. F.] UTHSCSA, Childrens Canc Res Inst, San Antonio, TX 78229 USA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Pennsylvania; Pennsylvania Medicine; Emory University; New York University; New York University; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Health San Antonio	Hughes, TR (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada.	quaid.morris@utoronto.ca; t.hughes@utoronto.ca	Nabet, Behnam/AAZ-4987-2020; Irimia, Manuel/E-3040-2010; Morris, Quaid/ABE-8343-2020; Weirauch, Matthew/M-5459-2019; Kazan, Hilal/B-2247-2014; Corbett, Anita/AAH-6106-2021	Nabet, Behnam/0000-0002-6738-4200; Irimia, Manuel/0000-0002-2179-2567; Corbett, Anita/0000-0002-0461-6895; Morris, Quaid/0000-0002-2760-6999; Najafabadi, Hamed/0000-0003-2735-4231; Laishram, Rakesh/0000-0003-4124-0468; Anderson, Richard/0000-0001-6265-8359; Lipshitz, Howard/0000-0002-7372-4419; Dale, Ryan/0000-0003-2664-3744; Cook, Kate/0000-0002-0174-1113; Fraser, Andrew/0000-0001-9939-6014; Li, Weimin/0000-0002-2170-7094; Penalva, Luiz/0000-0003-4491-6769	NIH [1R01HG00570, R01GM084034]; CIHR [MOP-49451, MOP-93671, MOP-125894, MOP-67011, MOP-14409]; Intramural Program of the NIDDK [DK015602-05]; NSERC Alexander Graham Bell Canada Graduate Scholarships; CIHR; CIFAR; Charles H. Best Fellowship; HFSP LT Fellowship; NATIONAL CANCER INSTITUTE [R01CA104708, P30CA014520] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058728, R01GM114386, R01GM084034, R01GM051968, T32GM008061] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Intramural Program of the NIDDK; NSERC Alexander Graham Bell Canada Graduate Scholarships; CIHR(Canadian Institutes of Health Research (CIHR)); CIFAR(Canadian Institute for Advanced Research (CIFAR)); Charles H. Best Fellowship; HFSP LT Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. van Bakel for computational support, A. Ramani and J. Calarco for discussions, Y. Wu, G. Rasanathan, M. Krishnamoorthy, O. Boright, A. Janska, J. Li, S. Talukder, A. Cote and S. Votruba for technical assistance, L. Sutherland for purchasing RBM5 protein and for feedback on the manuscript, S. Jain for software modified to create Fig. 2, and N. Barbosa-Morais for generating cRPKM values from autism RNA-seq data. We thank M. Kiledjian (PCBP1 and PCBP2), J. Stevenin (SRSF2 and SFRS7), S. Richard (QKI), M. Gorospe (TIA1), B. Chabot (SRSF9), A. Berglund (MBNL1), F. Pagani (DAZAP1), A. Bindereif (HNRNPL), M. Freeman (HNRNPK), E. Miska (LIN28A), K. Kohno (YBX1), M. Garcia-Blanco (PTBP1), R. Wharton (PUM-HD), C. Smibert (Vts1p) and M. Blanchette (Hrb27C, Hrb87F and Hrb98DE) for sending published constructs. This work was supported by funding from NIH (1R01HG00570 to T. R. H. and Q. D. M., R01GM084034 to K. W. L.), CIHR (MOP-49451 to T. R. H., MOP-93671 to Q. D. M., MOP-125894 to Q. D. M. and T. R. H., MOP-67011 to B. J. B., and MOP-14409 to H. D. L.), and the Intramural Program of the NIDDK (DK015602-05 to E. P. L.). K. B. C. and S. G. hold NSERC Alexander Graham Bell Canada Graduate Scholarships. M. T. W. was funded by fellowships from CIHR and CIFAR. H. S. N. holds a Charles H. Best Fellowship and was funded partially by awards from CIFAR to T. R. H. and B. J. F. M. I. is the recipient of an HFSP LT Fellowship.	Anyanful A, 2004, J CELL BIOL, V167, P639, DOI 10.1083/jcb.200407085; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Biedermann B, 2010, CELL CYCLE, V9, P1929, DOI 10.4161/cc.9.10.11533; Blanchette M, 2009, MOL CELL, V33, P438, DOI 10.1016/j.molcel.2009.01.022; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Christensen RG, 2012, BIOINFORMATICS, V28, pI84, DOI 10.1093/bioinformatics/bts202; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; De Gaudenzi JG, 2011, ESSAYS BIOCHEM, V51, P31, DOI [10.1042/BSE0510031, 10.1042/bse0510031]; Fogel BL, 2012, HUM MOL GENET, V21, P4171, DOI 10.1093/hmg/dds240; Gabut M, 2008, CELL, V133, P192, DOI 10.1016/j.cell.2008.03.010; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Izquierdo JM, 2008, J BIOL CHEM, V283, P19077, DOI 10.1074/jbc.M800017200; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Li X, 2010, RNA, V16, P1096, DOI 10.1261/rna.2017210; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Liu JJ, 2008, BIOINFORMATICS, V24, P1850, DOI 10.1093/bioinformatics/btn331; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Markus MA, 2009, INT J BIOCHEM CELL B, V41, P740, DOI 10.1016/j.biocel.2008.05.027; Miyamoto S, 2009, GENES CELLS, V14, P1241, DOI 10.1111/j.1365-2443.2009.01347.x; Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Qin XL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r63; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; Van Etten J, 2012, J BIOL CHEM, V287, P36370, DOI 10.1074/jbc.M112.373522; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	47	885	916	7	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 11	2013	499	7457					172	177		10.1038/nature12311	http://dx.doi.org/10.1038/nature12311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	179YA	23846655	Green Accepted			2022-12-01	WOS:000321557600054
J	Madison, K; Schmidt, H; Volpp, KG				Madison, Kristin; Schmidt, Harald; Volpp, Kevin G.			Smoking, Obesity, Health Insurance, and Health Incentives in the Affordable Care Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Madison, Kristin] Northeastern Univ, Sch Law, Boston, MA 02115 USA; [Madison, Kristin] Northeastern Univ, Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Schmidt, Harald] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA; [Volpp, Kevin G.] Philadelphia VA Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Volpp, Kevin G.] Univ Penn, Perelman Sch Med, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA	Northeastern University; Northeastern University; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania	Madison, K (corresponding author), Northeastern Univ, Sch Law, 400 Huntington Ave, Boston, MA 02115 USA.	k.madison@neu.edu		Volpp, Kevin/0000-0003-1423-4599				[Anonymous], 2011, FED REGISTER, V76, P67992; Blumenthal KJ, 2013, HEALTH AFFAIR, V32, P497, DOI 10.1377/hlthaff.2012.0431; Department of Health and Human Services, 2013, FED REG, V78, P13405; Department of the Treasury Department of Labor Department of Health and Human Services, 2013, FED REGISTER, V78, P33157; Internal Revenue Service Department of the Treasury; Employee Benefits Security Administration Department of Labor; Centers for Medicare & Medicaid Services Department of Health and Human Services, 2012, FED REG, V77, P70627; Volpp KG, 2011, NEW ENGL J MED, V365, P388, DOI 10.1056/NEJMp1105966	6	33	33	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	2013	310	2					143	144		10.1001/jama.2013.7617	http://dx.doi.org/10.1001/jama.2013.7617			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179HU	23765171				2022-12-01	WOS:000321511500009
J	Garcia-Pichel, F; Loza, V; Marusenko, Y; Mateo, P; Potrafka, RM				Garcia-Pichel, Ferran; Loza, Virginia; Marusenko, Yevgeniy; Mateo, Pilar; Potrafka, Ruth M.			Temperature Drives the Continental-Scale Distribution of Key Microbes in Topsoil Communities	SCIENCE			English	Article							BIOLOGICAL SOIL CRUSTS; COLORADO PLATEAU; CYANOBACTERIA; DIVERSITY; BIOGEOGRAPHY; WATER	Global warming will likely force terrestrial plant and animal species to migrate toward cooler areas or sustain range losses; whether this is also true for microorganisms remains unknown. Through continental-scale compositional surveys of soil crust microbial communities across arid North America, we observed a latitudinal replacement in dominance between two key topsoil cyanobacteria that was driven largely by temperature. The responses to temperature of enrichment cultures and cultivated strains support this contention, with one cyanobacterium (Microcoleus vaginatus) being more psychrotolerant and less thermotolerant than the other (M. steenstrupii). In view of our data and regional climate predictions, the latter cyanobacterium may replace the former in much of the studied area within the next few decades, with unknown ecological consequences for soil fertility and erodibility.	[Garcia-Pichel, Ferran; Loza, Virginia; Marusenko, Yevgeniy; Mateo, Pilar; Potrafka, Ruth M.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Loza, Virginia; Mateo, Pilar] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, E-28049 Madrid, Spain	Arizona State University; Arizona State University-Tempe; Autonomous University of Madrid	Garcia-Pichel, F (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	ferran@asu.edu	Marusenko, Yevgeniy/F-8304-2013	Marusenko, Yevgeniy/0000-0002-2399-7689	NSF; Division Of Environmental Biology [1235828] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant (NSF-Biodiversity Surveys and Inventories) to F. G.-P. P. M. acknowledges the support of Universidad Autonoma de Madrid for a sabbatical leave at Arizona State University. Data are available in the supplementary materials and at the Desert Soil Microbe Web page and database (http://garcia-pichel.lab.asu.edu/databases.html).	Bates ST, 2012, MYCOLOGIA, V104, P353, DOI 10.3852/11-232; BELNAP J, 1993, GREAT BASIN NAT, V53, P40; Belnap J, 1998, J ARID ENVIRON, V39, P133, DOI 10.1006/jare.1998.0388; Belnap J., 2001, BIOL SOIL CRUSTS STR, V150; Belnap J, 2006, HYDROL PROCESS, V20, P3159, DOI 10.1002/hyp.6325; BROCK TD, 1975, J PHYCOL, V11, P316; Budel B, 2001, ECOL STU AN, V150, P141; Chen LZ, 2003, J ARID ENVIRON, V55, P645, DOI 10.1016/S0140-1963(02)00292-6; Elbert W, 2012, NAT GEOSCI, V5, P459, DOI 10.1038/ngeo1486; Ellis AW, 2008, CLIM RES, V35, P227, DOI 10.3354/cr00727; Garcia-Pichel F, 2001, NATURE, V413, P380, DOI 10.1038/35096640; Garcia-Pichel F, 2001, APPL ENVIRON MICROB, V67, P1902, DOI 10.1128/AEM.67.4.1902-1910.2001; Garcia-Pichel F., 2002, ENCY ENV MICROBIOLOG, P1019; Garcia-Pichel F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007801; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Gundlapally SR, 2006, MICROB ECOL, V52, P345, DOI 10.1007/s00248-006-9011-6; Johnson SL, 2007, ENVIRON MICROBIOL, V9, P680, DOI 10.1111/j.1462-2920.2006.01187.x; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Nagy ML, 2005, FEMS MICROBIOL ECOL, V54, P233, DOI 10.1016/j.femsec.2005.03.011; Overpeck J, 2010, SCIENCE, V328, P1642, DOI 10.1126/science.1186591; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Philippot L, 2010, NAT REV MICROBIOL, V8, P523, DOI 10.1038/nrmicro2367; Reed SC, 2012, NAT CLIM CHANGE, V2, P752, DOI [10.1038/nclimate1596, 10.1038/NCLIMATE1596]; Seager R, 2010, P NATL ACAD SCI USA, V107, P21277, DOI 10.1073/pnas.0910856107; Smith SM, 2004, MICROB ECOL, V48, P200, DOI 10.1007/s00248-004-0254-9; Starkenburg SR, 2011, J BACTERIOL, V193, P4569, DOI 10.1128/JB.05138-11; Strauss SL, 2012, BIOGEOCHEMISTRY, V108, P171, DOI 10.1007/s10533-011-9587-x; Yeager CM, 2007, FEMS MICROBIOL ECOL, V60, P85, DOI 10.1111/j.1574-6941.2006.00265.x	28	185	194	10	275	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1574	1577		10.1126/science.1236404	http://dx.doi.org/10.1126/science.1236404			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812714				2022-12-01	WOS:000321007000042
J	Xue, L; Li, HB; Brodsky, EE; Xu, ZQ; Kano, Y; Wang, H; Mori, JJ; Si, JL; Pei, JL; Zhang, W; Yang, G; Sun, ZM; Huang, Y				Xue, Lian; Li, Hai-Bing; Brodsky, Emily E.; Xu, Zhi-Qing; Kano, Yasuyuki; Wang, Huan; Mori, James J.; Si, Jia-Liang; Pei, Jun-Ling; Zhang, Wei; Yang, Guang; Sun, Zhi-Ming; Huang, Yao			Continuous Permeability Measurements Record Healing Inside the Wenchuan Earthquake Fault Zone	SCIENCE			English	Article							PRESSURE SOLUTION; FLUID; COMPACTION; CALIFORNIA	Permeability controls fluid flow in fault zones and is a proxy for rock damage after an earthquake. We used the tidal response of water level in a deep borehole to track permeability for 18 months in the damage zone of the causative fault of the 2008 moment magnitude 7.9 Wenchuan earthquake. The unusually high measured hydraulic diffusivity of 2.4 x 10(-2) square meters per second implies a major role for water circulation in the fault zone. For most of the observation period, the permeability decreased rapidly as the fault healed. The trend was interrupted by abrupt permeability increases attributable to shaking from remote earthquakes. These direct measurements of the fault zone reveal a process of punctuated recovery as healing and damage interact in the aftermath of a major earthquake.	[Xue, Lian; Brodsky, Emily E.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Xue, Lian; Li, Hai-Bing; Xu, Zhi-Qing; Wang, Huan; Si, Jia-Liang; Zhang, Wei; Yang, Guang] Chinese Acad Geol Sci, Inst Geol, State Key Lab Continental Tecton & Dynam, Beijing 100037, Peoples R China; [Kano, Yasuyuki; Mori, James J.] Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan; [Pei, Jun-Ling; Sun, Zhi-Ming] Chinese Acad Geol Sci, Inst Geomech, Beijing 100081, Peoples R China; [Zhang, Wei] Shandong Prov Lunan Geoengn Explorat Inst, Yangzhou 272100, Shandong, Peoples R China; [Yang, Guang] Guangdong Zhuhai Engn Invest Inst, Zhuhai 519000, Peoples R China; [Huang, Yao] 6 Brigade Jiangsu Geol & Mineral Resources Bur, Lianyungang 222023, Jiangsu, Peoples R China	University of California System; University of California Santa Cruz; Chinese Academy of Geological Sciences; Kyoto University; Chinese Academy of Geological Sciences	Xue, L (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	lxue3@ucsc.edu	Brodsky, Emily/B-9139-2014	Brodsky, Emily/0000-0002-6855-6860; Kano, Yasuyuki/0000-0002-3809-698X	National Science and Technology Planning Project in China; NSF [EAR1220642]; Directorate For Geosciences [1220642] Funding Source: National Science Foundation	National Science and Technology Planning Project in China; NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Supported by the National Science and Technology Planning Project in China (H.-B.L.) and NSF grant EAR1220642 (E. E. B.). Seismic data from the Chinese national network are archived and distributed by Incorporated Research Institutions for Seismology (IRIS) Data Management System.	Andrews DJ, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2002JB001942; Brenguier F, 2008, SCIENCE, V321, P1478, DOI 10.1126/science.1160943; Brodsky E. E., 2010, EOS T AGU, V91, P237, DOI [DOI 10.1029/2010E0270001, DOI 10.1029/2010EO270001]; Brudy M, 1999, INT J ROCK MECH MIN, V36, P191, DOI 10.1016/S0148-9062(98)00182-X; Caine JS, 1996, GEOLOGY, V24, P1025, DOI 10.1130/0091-7613(1996)024<1025:FZAAPS>2.3.CO;2; Doan ML, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026889; Elkhoury JE, 2006, NATURE, V441, P1135, DOI 10.1038/nature04798; Elkhoury JE, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007759; Freeze R. A., 1977, GROUNDWATER; Fulton PM, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB007103; Gratier JP, 2011, OIL GAS SCI TECHNOL, V66, P491, DOI 10.2516/ogst/2010014; Gratier JP, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000380; HSIEH PA, 1987, WATER RESOUR RES, V23, P1824, DOI 10.1029/WR023i010p01824; HUBBERT MK, 1959, GEOL SOC AM BULL, V70, P115; Kitagawa Y, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014030; Li HB, 2013, TECTONOPHYSICS, V584, P23, DOI 10.1016/j.tecto.2012.08.021; Li Y., 2012, IMAGING MODELING ASS, V1, P151; Li YG, 1998, SCIENCE, V279, P217, DOI 10.1126/science.279.5348.217; Lockner D., 1999, P INT WORKSH NOJ FAU, P22; Manga M, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000382; Marone C., 2007, SEISMOGENIC ZONE SUB, P346; Rempel AW, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2006JB004314; Renard F, 2000, J STRUCT GEOL, V22, P1395, DOI 10.1016/S0191-8141(00)00064-X; Rice JR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004006; Rukai Z., 2009, PETROL EXPLOR DEV, V36, P46; Savage HM, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007665; SIBSON RH, 1992, TECTONOPHYSICS, V211, P283, DOI 10.1016/0040-1951(92)90065-E; Xu ZQ, 2008, EPISODES, V31, P291, DOI 10.18814/epiiugs/2008/v31i3/002	28	173	200	4	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2013	340	6140					1555	1559		10.1126/science.1237237	http://dx.doi.org/10.1126/science.1237237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23812711				2022-12-01	WOS:000321007000037
J	Ahmari, SE; Spellman, T; Douglass, NL; Kheirbek, MA; Simpson, HB; Deisseroth, K; Gordon, JA; Hen, R				Ahmari, Susanne E.; Spellman, Timothy; Douglass, Neria L.; Kheirbek, Mazen A.; Simpson, H. Blair; Deisseroth, Karl; Gordon, Joshua A.; Hen, Rene			Repeated Cortico-Striatal Stimulation Generates Persistent OCD-Like Behavior	SCIENCE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; DEEP BRAIN-STIMULATION; NEUROBIOLOGY; CIRCUITRY; NEURONS	Although cortico-striato-thalamo-cortical (CSTC) circuit dysregulation is correlated with obsessive compulsive disorder (OCD), causation cannot be tested in humans. We used optogenetics in mice to simulate CSTC hyperactivation observed in OCD patients. Whereas acute orbitofrontal cortex (OFC)-ventromedial striatum (VMS) stimulation did not produce repetitive behaviors, repeated hyperactivation over multiple days generated a progressive increase in grooming, a mouse behavior related to OCD. Increased grooming persisted for 2 weeks after stimulation cessation. The grooming increase was temporally coupled with a progressive increase in light-evoked firing of postsynaptic VMS cells. Both increased grooming and evoked firing were reversed by chronic fluoxetine, a first-line OCD treatment. Brief but repeated episodes of abnormal circuit activity may thus set the stage for the development of persistent psychopathology.	[Ahmari, Susanne E.; Douglass, Neria L.; Kheirbek, Mazen A.; Simpson, H. Blair; Gordon, Joshua A.; Hen, Rene] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Ahmari, Susanne E.; Douglass, Neria L.; Kheirbek, Mazen A.; Gordon, Joshua A.; Hen, Rene] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA; [Ahmari, Susanne E.; Simpson, H. Blair] New York State Psychiat Inst & Hosp, Div Clin Therapeut, New York, NY 10032 USA; [Ahmari, Susanne E.; Simpson, H. Blair] New York State Psychiat Inst & Hosp, Anxiety Disorders Clin, New York, NY 10032 USA; [Ahmari, Susanne E.; Simpson, H. Blair] New York State Psychiat Inst & Hosp, OCD Res Program, New York, NY 10032 USA; [Spellman, Timothy] Columbia Univ Coll Phys & Surg, Dept Physiol, New York, NY 10032 USA; [Deisseroth, Karl] Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA	Columbia University; New York State Psychiatry Institute; New York State Psychiatry Institute; New York State Psychiatry Institute; New York State Psychiatry Institute; Columbia University; Stanford University; Stanford University	Ahmari, SE (corresponding author), Columbia Univ Coll Phys & Surg, Dept Psychiat, 722 W 168th St, New York, NY 10032 USA.	sea2103@columbia.edu	Kheirbek, Mazen A/J-3656-2015; Ahmari, Susanne E./J-5812-2013	Kheirbek, Mazen A/0000-0001-9157-7363; Ahmari, Susanne E./0000-0003-4576-076X	National Institute of Mental Health (NIMH) [K08MH087718]; Louis V. Gerstner, Jr., Scholars Program; Irving Institute for Clinical and Translational Research; Gray Matters Foundation; Leon Levy Foundation; Brain and Behavior Research Foundation NARSAD Young Investigator Award; NIMH [K01MH099371]; Sackler Institute; NARSAD; Howard Hughes Medical Institute, NIH, California Institute for Regenerative Medicine; Defense Advance Research Projects Agency The Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) Program; NIH [R01 MH096274]; Hope for Depression Research Foundation; International Mental Health Research Organization; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099371, K08MH087718, R01MH096274, K24MH091555] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Louis V. Gerstner, Jr., Scholars Program; Irving Institute for Clinical and Translational Research; Gray Matters Foundation; Leon Levy Foundation; Brain and Behavior Research Foundation NARSAD Young Investigator Award; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sackler Institute; NARSAD(NARSAD); Howard Hughes Medical Institute, NIH, California Institute for Regenerative Medicine(Howard Hughes Medical Institute); Defense Advance Research Projects Agency The Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Depression Research Foundation; International Mental Health Research Organization; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank H. B. Simpson and C. Kellendonk for critical discussions and reading of the manuscript and D. Flicker and M. Cloidt for behavioral scoring assistance. S. E. A. is supported by National Institute of Mental Health (NIMH) K08MH087718; the Louis V. Gerstner, Jr., Scholars Program; the Irving Institute for Clinical and Translational Research; the Gray Matters Foundation; the Leon Levy Foundation; and a Brain and Behavior Research Foundation NARSAD Young Investigator Award. M. A. K. is supported by NIMH K01MH099371, the Sackler Institute, and a NARSAD Young Investigator Award. K. D. is supported by the Howard Hughes Medical Institute, NIH, California Institute for Regenerative Medicine, and the Defense Advance Research Projects Agency The Reorganization and Plasticity to Accelerate Injury Recovery (REPAIR) Program. J.G. is supported by NIH R01 MH096274, the Hope for Depression Research Foundation, and the International Mental Health Research Organization. R. H. is supported by the Hope for Depression Research Foundation.	Abelson JL, 2005, BIOL PSYCHIAT, V57, P510, DOI 10.1016/j.biopsych.2004.11.042; Abler B, 2012, J NEUROSCI, V32, P1329, DOI 10.1523/JNEUROSCI.5826-11.2012; Ahmari SE, 2012, NEUROPSYCHOPHARMACOL, V37, P1216, DOI 10.1038/npp.2011.308; Antzoulatos EG, 2011, NEURON, V71, P243, DOI 10.1016/j.neuron.2011.05.040; BAXTER LR, 1988, AM J PSYCHIAT, V145, P1560; Bourne SK, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00029; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; de Koning PP, 2011, CURR PSYCHIAT REP, V13, P274, DOI 10.1007/s11920-011-0200-8; Dzirasa K, 2010, J NEUROSCI, V30, P6387, DOI 10.1523/JNEUROSCI.0764-10.2010; Gorski JA, 2002, J NEUROSCI, V22, P6309; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Greenberg BD, 2010, MOL PSYCHIATR, V15, P64, DOI 10.1038/mp.2008.55; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P1, DOI 10.1038/npp.2009.146; INSEL TR, 1992, PSYCHIAT CLIN N AM, V15, P813; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koran LM, 2007, AM J PSYCHIAT, V164, P5; Leckman JE, 2010, DEPRESS ANXIETY, V27, P507, DOI 10.1002/da.20669; Marsh R, 2009, AM J PSYCHIAT, V166, P664, DOI 10.1176/appi.ajp.2009.08091354; Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/NMETH.1808, 10.1038/nmeth.1808]; McCabe C, 2010, BIOL PSYCHIAT, V67, P439, DOI 10.1016/j.biopsych.2009.11.001; Milad MR, 2012, TRENDS COGN SCI, V16, P43, DOI 10.1016/j.tics.2011.11.003; Murray CJL, 1996, GLOBAL BURDEN DIS, V1; Pittenger C, 2011, PHARMACOL THERAPEUT, V132, P314, DOI 10.1016/j.pharmthera.2011.09.006; Rauch SL, 1997, BIOL PSYCHIAT, V42, P446, DOI 10.1016/S0006-3223(97)00145-5; Rosenberg DR, 1998, BIOL PSYCHIAT, V43, P623, DOI 10.1016/S0006-3223(97)00443-5; Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019; Saxena S, 2001, Semin Clin Neuropsychiatry, V6, P82, DOI 10.1053/scnp.2001.21833; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Ting JT, 2011, CURR OPIN NEUROBIOL, V21, P842, DOI 10.1016/j.conb.2011.04.010; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104	32	286	291	4	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1234	1239		10.1126/science.1234733	http://dx.doi.org/10.1126/science.1234733			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23744948	Green Accepted			2022-12-01	WOS:000319972800051
J	van Oosten-Hawle, P; Porter, RS; Morimoto, RI				van Oosten-Hawle, Patricija; Porter, Robert S.; Morimoto, Richard I.			Regulation of Organismal Proteostasis by Transcellular Chaperone Signaling	CELL			English	Article							MYOSIN HEAVY-CHAIN; CAENORHABDITIS-ELEGANS; SHOCK FACTORS; HSP90; STRESS; EXPRESSION; LONGEVITY; IDENTIFICATION; ENDOCYTOSIS; EXOCYTOSIS	A major challenge for metazoans is to ensure that different tissues, each expressing distinctive proteomes, are nevertheless well protected at an organismal level from proteotoxic stress. We show that expression of endogenous metastable proteins in muscle cells, which rely on chaperones for proper folding, induces a systemic stress response throughout multiple tissues of C. elegans. Suppression of misfolding in muscle cells can be achieved not only by enhanced expression of HSP90 in muscle cells but as effectively by elevated expression of HSP90 in intestine or neuronal cells. This cell-nonautonomous control of HSP90 expression relies upon transcriptional feedback between somatic tissues that is regulated by the FoxA transcription factor PHA-4. This transcellular chaperone signaling response maintains organismal proteostasis when challenged by a local tissue imbalance in folding and provides the basis for organismal stress-sensing surveillance.	[van Oosten-Hawle, Patricija; Porter, Robert S.; Morimoto, Richard I.] Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Morimoto, RI (corresponding author), Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, Evanston, IL 60208 USA.	r-morimoto@northwestern.edu	van Oosten-Hawle, Patricija/GVS-1791-2022	van Oosten-Hawle, Patricija/0000-0002-5713-6457	Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; Erwin-Schroedinger postdoctoral fellowship by the Austrian Science Fund (FWF) [J2895]; NIGMS [P50-GM081192]; National Institutes of Health (NIGMS, NIA, and NINDS); Ellison Medical Foundation; Daniel F. and Ada L. Rice Foundation; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026647, R37AG026647] Funding Source: NIH RePORTER	Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; Erwin-Schroedinger postdoctoral fellowship by the Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIGMS, NIA, and NINDS); Ellison Medical Foundation(Lawrence Ellison Foundation); Daniel F. and Ada L. Rice Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Caenorhabditis Genetics Center (University of Minnesota) for strains used in this study, the BC C. elegans Gene Expression Consortium for strain BC10293, Dr. Daniel Czyz for the hsp70pr::mCherry reporter strain (AM722), Dr. P.W. Piper and Dr. S. Millson (University of Sheffield, UK) for providing yeast strains and plasmids, and Chris Low for advice on the graphical abstract. This work was funded by the Chicago Biomedical Consortium, with support from the Searle Funds at The Chicago Community Trust (a postdoctoral fellowship of the Institute for Genomics and Systems Biology), by an Erwin-Schroedinger postdoctoral fellowship by the Austrian Science Fund (FWF; J2895) to P.v.O.-H., by a NIGMS P50 grant (P50-GM081192), and by grants from the National Institutes of Health (NIGMS, NIA, and NINDS), the Ellison Medical Foundation, the Chicago Biomedical Consortium, and the Daniel F. and Ada L. Rice Foundation (to R.I.M.).	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Altun Z.F., 2009, WORMATLAS, DOI DOI 10.3908/W0RMATLAS.1.11; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; Birnby DA, 2000, GENETICS, V155, P85; Burga A, 2012, FEBS J, V279, P3765, DOI 10.1111/j.1742-4658.2012.08810.x; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; Fares H, 2001, GENETICS, V159, P133; Gaiser AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025485; Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; GENGYOANDO K, 1991, J MOL BIOL, V219, P429, DOI 10.1016/0022-2836(91)90184-8; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gidalevitz T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009704; Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423; Hammarlund M, 2008, J CELL BIOL, V180, P483, DOI 10.1083/jcb.200708018; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kohn RE, 2000, MOL BIOL CELL, V11, P3441, DOI 10.1091/mbc.11.10.3441; MACLEOD AR, 1977, J MOL BIOL, V114, P133, DOI 10.1016/0022-2836(77)90287-X; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Casanueva MO, 2012, SCIENCE, V335, P82, DOI 10.1126/science.1213491; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Richmond JE, 2002, CURR OPIN NEUROBIOL, V12, P499, DOI 10.1016/S0959-4388(02)00360-4; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Zhao C, 2002, EXP CELL RES, V275, P200, DOI 10.1006/excr.2002.5501; Zhong M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000848; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	46	128	129	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1366	1378		10.1016/j.cell.2013.05.015	http://dx.doi.org/10.1016/j.cell.2013.05.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23746847	Green Accepted, Bronze			2022-12-01	WOS:000319979200019
J	Zeitlin, C; Hassler, DM; Cucinotta, FA; Ehresmann, B; Wimmer-Schweingruber, RF; Brinza, DE; Kang, S; Weigle, G; Bottcher, S; Bohm, E; Burmeister, S; Guo, J; Kohler, J; Martin, C; Posner, A; Rafkin, S; Reitz, G				Zeitlin, C.; Hassler, D. M.; Cucinotta, F. A.; Ehresmann, B.; Wimmer-Schweingruber, R. F.; Brinza, D. E.; Kang, S.; Weigle, G.; Boettcher, S.; Boehm, E.; Burmeister, S.; Guo, J.; Koehler, J.; Martin, C.; Posner, A.; Rafkin, S.; Reitz, G.			Measurements of Energetic Particle Radiation in Transit to Mars on the Mars Science Laboratory	SCIENCE			English	Article							SPACE EXPLORATION; TRANSPORT	The Mars Science Laboratory spacecraft, containing the Curiosity rover, was launched to Mars on 26 November 2011, and for most of the 253-day, 560-minion-kilometer cruise to Mars, the Radiation Assessment Detector made detailed measurements of the energetic particle radiation environment inside the spacecraft. These data provide insights into the radiation hazards that would be associated with a human mission to Mars. We report measurements of the radiation dose, dose equivalent, and linear energy transfer spectra. The dose equivalent for even the shortest round-trip with current propulsion systems and comparable shielding is found to be 0.66 +/- 0.12 sievert.	[Zeitlin, C.; Hassler, D. M.; Ehresmann, B.; Rafkin, S.] SW Res Inst, Boulder, CO USA; [Cucinotta, F. A.; Guo, J.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Wimmer-Schweingruber, R. F.; Boettcher, S.; Boehm, E.; Burmeister, S.; Koehler, J.; Martin, C.] Univ Kiel, Kiel, Germany; [Brinza, D. E.; Kang, S.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Weigle, G.] SW Res Inst, San Antonio, TX USA; [Posner, A.] NASA Headquarters, Washington, DC USA; [Reitz, G.] German Aerosp Ctr DLR, Cologne, Germany	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Kiel; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Southwest Research Institute; National Aeronautics & Space Administration (NASA); Helmholtz Association; German Aerospace Centre (DLR)	Zeitlin, C (corresponding author), SW Res Inst, Boulder, CO USA.	zeitlin@boulder.swri.edu	Cucinotta, Francis/AAZ-5941-2020; Wimmer-Schweingruber, Robert/AAQ-5794-2021; Reitz, Guenther/ABC-8921-2021; Guo, Jingnan/ABB-3749-2021	Wimmer-Schweingruber, Robert/0000-0002-7388-173X; Guo, Jingnan/0000-0002-8707-076X; Posner, Arik/0000-0003-1572-8734	NASA (Human Exploration and Operations Mission Directorate) under Jet Propulsion Laboratory (JPL) [1273039]; German Aerospace Center (DLR); DLR's Space Administration [50QM0501, 50 QM1201]; NASA	NASA (Human Exploration and Operations Mission Directorate) under Jet Propulsion Laboratory (JPL); German Aerospace Center (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); DLR's Space Administration; NASA(National Aeronautics & Space Administration (NASA))	The RAD is supported by NASA (Human Exploration and Operations Mission Directorate) under Jet Propulsion Laboratory (JPL) subcontract 1273039 to the Southwest Research Institute and in Germany by the German Aerospace Center (DLR) and DLR's Space Administration, grant numbers 50QM0501 and 50 QM1201, to the Christian Albrechts University, Kid. Part of this research was carried out at JPL, California Institute of Technology, under a contact with NASA. We appreciate discussions with P. O'Neill and M. Kim at NASA's JSC and with S. Blattnig, F. Badavi, T. Slaba, and C. Mertens of NASA's Langley Research Center. We extend thanks to I. Simmonds, I. Grotzinger, I. Crisp, A. Vasvada, H. Mortensen, and the Operations Product Generation Subsystem team at NASA-JPL. We also thank M. Meyer, E. Stolper, G. Allen, C. Moore, and V. Friedensen at NASA headquarters and H. Witte at DLR in Germany for their support of the RAD over the years. The data used in this paper are archived in the NASA Planetary Data System's Planetary Plasma Interactions Node at the University of California, Los Angeles. The archival volume includes the full binary raw data files, detailed descriptions of the structures therein, and higher-level data products in human-readable form. The PPI node is hosted at http://ppi.pds.nasa.gov/.	Aghara SK, 2009, NUCL INSTRUM METH B, V267, P1115, DOI 10.1016/j.nimb.2009.01.136; [Anonymous], 1991, Ann ICRP, V21, P1; [Anonymous], 1996, RADIATION HAZARDS TO; [Anonymous], 2006, NCRP REPORT NO 153; [Anonymous], 1993, ICRU REPORT 51; [Anonymous], 2000, NCRP REPORT NO 132; [Anonymous], 2006, HEALTH RISKS FROM EX; BADHWAR GD, 1992, NUCL TRACKS RAD MEAS, V20, P403; Cucinotta F. A., 2011, NASA TECHNICAL PAPER; Cucinotta F. A., 2013, NASA TECHNICAL PAPER; Cucinotta FA, 2006, RADIAT MEAS, V41, P1235, DOI 10.1016/j.radmeas.2006.03.012; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Cucinotta FA, 2011, RADIAT RES, V176, P102, DOI 10.1667/RR2540.1; Drake B. G., 2010, AER C 2010 IEEE, P1, DOI [10.1109/AERO.2010.5446736, DOI 10.1109/AERO.2010.5446736]; Hassler DM, 2012, SPACE SCI REV, V170, P503, DOI 10.1007/s11214-012-9913-1; Kohler J, 2011, NUCL INSTRUM METH B, V269, P2641, DOI 10.1016/j.nimb.2011.07.021; Koontz SL, 2005, NSREC: 2005 IEEE Radiation Effects Data Workshop, Workshop Record, P110; McKenna-Lawlor S, 2012, PLANET SPACE SCI, V63-64, P123, DOI 10.1016/j.pss.2011.06.017; Mrigakshi AI, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017611; Norman RB, 2012, ADV SPACE RES, V50, P146, DOI 10.1016/j.asr.2012.03.023; O'Neill PM, 2010, IEEE T NUCL SCI, V57, P3148, DOI 10.1109/TNS.2010.2083688; Onsager TG, 1996, P SOC PHOTO-OPT INS, V2812, P281, DOI 10.1117/12.254075; PARKER EN, 1958, ASTROPHYS J, V128, P664, DOI 10.1086/146579; Posner A, 2005, ADV SPACE RES, V36, P1426, DOI 10.1016/j.asr.2004.11.040; Posner A, 2007, SPACE WEATHER, V5, DOI 10.1029/2006SW000268; Sato T, 2011, RADIAT ENVIRON BIOPH, V50, P115, DOI 10.1007/s00411-010-0330-0; Schwadron NA, 2010, SPACE WEATHER, V8, DOI 10.1029/2010SW000567; Slaba TC, 2010, J COMPUT PHYS, V229, P9397, DOI 10.1016/j.jcp.2010.09.010; Usoskin IG, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011250; Wilson J., 1995, NASA TECHNICAL PAPER; Wilson J. W., 1997, NASA TECHNICAL PAPER	31	367	381	7	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1080	1084		10.1126/science.1235989	http://dx.doi.org/10.1126/science.1235989			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723233				2022-12-01	WOS:000319664500040
